data_1zwm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1zwm _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.312 -1.515 . . . . 0.01 109.312 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -148.51 136.5 20.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.976 -1.308 . . . . 0.02 110.374 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.7 tt -130.62 140.68 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.724 -0.843 . . . . 0.02 108.724 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 t -120.83 130.42 53.95 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.573 -0.704 . . . . 0.39 109.952 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.6 m-85 -110.33 139.94 45.01 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 109.217 -0.66 . . . . 0.02 109.217 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.564 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.7 m-85 -121.41 137.87 54.52 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.232 -0.917 . . . . 0.02 109.572 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -69.72 -27.43 64.97 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.995 -1.066 . . . . 0.03 111.36 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 3.1 m-20 -114.23 169.68 8.85 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.927 -1.108 . . . . 0.03 110.203 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.462 ' CG ' HD21 ' A' ' 37' ' ' ASN . 71.2 mtm180 -75.5 157.79 33.48 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.707 0.765 . . . . 0.03 110.41 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 m120 66.16 33.84 7.13 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.884 0.85 . . . . 0.74 111.192 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 55.54 41.25 30.93 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.301 0.572 . . . . 0.02 111.241 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -113.11 165.51 12.31 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.273 -1.01 . . . . 0.02 108.273 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.3 -166.97 35.32 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.767 -1.206 . . . . 0.03 110.651 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.417 ' HG3' HH11 ' A' ' 18' ' ' ARG . 25.8 ttm-85 -68.77 141.68 55.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.494 -1.004 . . . . 2.76 109.247 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -122.66 150.13 43.1 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.547 -0.721 . . . . 1.89 109.88 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -138.11 134.02 34.14 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.706 -0.621 . . . . 0.02 109.659 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -109.08 136.17 49.03 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.393 -0.817 . . . . 1.12 108.83 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.6 t -127.17 138.15 53.08 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.575 -0.703 . . . . 0.02 109.406 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.501 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 2.0 m-20 -118.93 11.75 12.63 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.494 -0.754 . . . . 0.2 110.633 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 22.0 m -159.4 174.11 15.22 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.818 -1.176 . . . . 1.23 109.058 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -62.57 145.84 53.38 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.824 -1.173 . . . . 0.02 110.453 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 7.5 m -133.74 117.47 16.97 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 108.777 -0.823 . . . . 0.02 108.777 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.14 -21.92 49.59 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.167 -0.958 . . . . 0.24 111.731 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -150.22 105.68 3.38 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.799 -1.188 . . . . 1.14 109.526 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.8 5.32 45.54 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.54 0.686 . . . . 6.37 110.067 -178.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -61.53 -28.3 69.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.404 -0.81 . . . . 3.11 112.311 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.1 m -78.69 -18.85 53.72 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.248 -1.533 . . . . 0.88 111.741 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -105.74 -21.5 13.16 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.175 -0.953 . . . . 0.02 110.472 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 47.6 mt -148.55 127.81 12.96 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.098 -1.001 . . . . 3.32 109.125 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.5 p -86.18 -11.3 52.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.791 -0.568 . . . . 0.02 110.414 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -172.44 161.83 5.2 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.133 -1.062 . . . . 0.02 108.133 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 80.4 m -143.68 116.25 8.64 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.1 -1.0 . . . . 0.02 108.454 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.462 HD21 ' CG ' ' A' ' 13' ' ' ARG . 52.5 t30 -110.23 0.94 18.36 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 120.862 -1.149 . . . . 0.03 111.519 -177.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.6 t -155.71 152.8 29.01 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.647 -1.242 . . . . 0.02 107.647 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.7 mt -146.94 148.7 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.104 -0.998 . . . . 0.02 110.63 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -124.52 125.35 44.06 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.614 -1.254 . . . . 0.02 107.614 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.5 t -105.24 113.99 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 107.018 -1.475 . . . . 0.02 107.018 177.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -84.71 -34.67 22.88 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.411 -0.805 . . . . 3.81 110.135 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.83 150.02 18.52 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 118.519 -1.8 . . . . 0.02 110.802 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.15 172.13 48.84 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.269 -1.132 . . . . 0.01 110.269 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.4 m -119.62 135.17 54.92 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 107.934 -1.135 . . . . 1.48 107.934 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.436 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 35.6 m95 -127.94 155.55 44.05 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 122.625 1.202 . . . . 0.02 112.518 -176.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.65 134.26 51.63 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 105.283 -2.117 . . . . 0.24 105.283 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.8 m -118.36 143.82 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 109.172 -0.677 . . . . 0.65 109.172 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -120.93 145.19 47.96 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 122.172 0.987 . . . . 0.02 109.977 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -66.07 -33.52 75.99 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.917 -0.583 . . . . 0.02 111.385 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -124.97 158.15 64.09 Favored Pre-proline 0 N--CA 1.503 2.222 0 O-C-N 121.127 -0.983 . . . . 0.02 109.43 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.62 166.92 1.1 Allowed 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.753 1.635 . . . . 0.02 112.905 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' ' 53' ' ' ASN . 1.5 t30 63.38 36.31 11.61 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 115.279 -0.873 . . . . 0.02 111.048 178.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.438 ' H ' ' HG ' ' A' ' 81' ' ' SER . 7.2 m-85 45.47 51.49 9.7 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.611 0.72 . . . . 3.39 110.904 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 t -126.08 163.46 23.02 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.182 0.515 . . . . 2.33 109.88 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.61 -161.69 31.18 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.878 -1.289 . . . . 0.02 109.878 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 15.0 m80 -64.54 138.94 58.68 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.001 -1.293 . . . . 0.02 110.077 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.44 ' SD ' ' C ' ' A' ' 58' ' ' MET . 10.9 tmm? -119.09 137.16 53.76 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 121.301 0.572 . . . . 5.01 109.72 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.544 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 86.1 m-85 -135.33 138.96 43.92 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.477 -0.764 . . . . 0.02 109.854 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.5 mm -95.51 131.52 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 109.192 -0.67 . . . . 1.72 109.192 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.2 mt -121.04 111.98 33.65 Favored Pre-proline 0 N--CA 1.506 2.333 0 O-C-N 121.368 -0.832 . . . . 0.02 110.984 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -77.85 169.61 20.36 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 CA-C-N 119.886 0.995 . . . . 1.47 110.092 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -53.06 140.74 24.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.768 -1.207 . . . . 4.25 110.439 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.64 -177.48 32.75 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.548 -1.311 . . . . 0.02 110.533 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -119.3 130.6 55.48 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.267 -1.137 . . . . 0.96 109.759 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -120.97 94.59 48.99 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 108.113 -1.069 . . . . 0.02 108.113 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.404 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 2.5 Cg_endo -66.8 -3.49 9.5 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 120.874 1.049 . . . . 0.02 113.908 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 35.0 mt-10 -157.95 154.97 28.65 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.687 -1.258 . . . . 2.02 108.238 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.461 ' CD1' ' OD1' ' A' ' 37' ' ' ASN . 24.2 p90 -60.25 -39.17 85.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.57 -0.706 . . . . 0.02 112.019 -177.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -59.88 -23.83 63.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.946 -1.096 . . . . 0.02 110.189 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -69.99 -18.93 63.35 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.947 0.879 . . . . 3.42 108.895 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.544 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.5 t90 -107.7 9.85 29.07 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.402 -1.333 . . . . 0.02 107.402 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 33.2 mtm 60.46 23.03 12.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.589 -0.695 . . . . 0.02 110.266 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.46 144.11 45.91 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.598 -1.401 . . . . 0.02 109.598 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.0 tp -79.37 -31.17 42.84 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.5 -1.296 . . . . 0.98 107.5 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -157.16 -171.76 3.75 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.342 -1.725 . . . . 0.02 106.342 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -98.43 28.54 4.09 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.618 -1.302 . . . . 0.02 110.703 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -97.0 122.61 40.18 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.83 -1.169 . . . . 3.2 111.014 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 75.5 mt -141.92 119.21 11.48 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.541 -1.281 . . . . 2.61 107.541 178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.21 -18.33 9.91 Favored Glycine 0 N--CA 1.498 2.809 0 O-C-N 121.157 -0.964 . . . . 0.02 112.344 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.438 ' HG ' ' H ' ' A' ' 54' ' ' PHE . 91.3 p -156.38 155.86 32.88 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.256 -1.732 . . . . 0.02 110.491 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 49.1 t -145.35 148.23 33.15 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.493 -0.754 . . . . 0.02 109.912 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.43 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 41.8 mtm180 -138.3 142.98 39.78 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.253 -0.904 . . . . 0.01 109.429 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.21 132.04 36.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.23 -0.919 . . . . 0.43 109.691 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.9 t -91.14 125.21 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.796 -0.816 . . . . 1.25 108.796 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -93.31 131.97 37.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.762 -1.211 . . . . 1.77 108.995 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mt -97.01 139.3 33.22 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.249 -1.019 . . . . 1.63 108.249 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.6 m -111.49 127.39 55.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.291 -0.881 . . . . 1.08 109.192 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.9 m -103.88 -154.18 0.5 Allowed 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 106.387 -1.709 . . . . 1.26 106.387 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.46 -51.58 0.79 Allowed Glycine 0 N--CA 1.501 2.985 0 O-C-N 120.408 -1.433 . . . . 0.01 112.656 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.68 -100.86 0.15 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 118.493 -1.813 . . . . 0.01 111.977 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -121.43 118.7 30.05 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.085 -1.244 . . . . 4.43 110.668 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.99 130.06 36.05 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.881 -0.728 . . . . 2.99 109.374 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -130.2 140.48 50.73 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.459 -0.776 . . . . 6.36 109.139 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.5 tt -128.33 145.54 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 121.425 -0.797 . . . . 1.09 110.215 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -122.18 133.2 54.73 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 107.607 -1.257 . . . . 2.05 107.607 177.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.8 m -124.57 146.1 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 O-C-N 120.657 -1.277 . . . . 1.1 109.805 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.581 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 62.3 m-85 -119.49 141.47 49.15 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 122.036 0.922 . . . . 0.73 111.134 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -67.07 -30.31 70.33 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 115.963 -0.562 . . . . 0.02 111.511 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -116.05 169.28 9.38 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.13 -0.981 . . . . 3.18 110.264 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.46 165.12 52.25 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.982 -0.847 . . . . 0.01 110.982 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 57.07 38.34 29.12 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.785 -0.833 . . . . 0.01 111.418 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.584 ' H ' ' HG ' ' A' ' 128' ' ' SER . 21.1 m-85 52.16 54.46 10.74 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.459 -0.776 . . . . 0.01 111.271 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -129.48 165.87 20.77 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.994 -1.113 . . . . 3.15 107.994 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.08 -163.65 29.32 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.259 -1.537 . . . . 0.01 109.259 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -76.1 143.55 41.21 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.948 -1.325 . . . . 0.01 108.918 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.581 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 38.1 ttp -116.44 142.52 46.76 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.575 0.702 . . . . 0.01 109.803 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -131.64 136.55 47.82 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.234 -1.024 . . . . 2.48 108.234 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -118.45 134.1 55.34 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.541 -0.725 . . . . 0.01 110.193 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.9 t -148.4 150.04 32.81 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 122.191 0.996 . . . . 1.69 110.973 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.7 p -110.31 10.23 23.56 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 115.555 -0.748 . . . . 0.01 110.214 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -120.96 163.53 18.11 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.234 -0.916 . . . . 3.21 111.597 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -66.89 156.71 35.03 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.951 -1.129 . . . . 0.01 107.951 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.608 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 22.0 p -122.83 115.16 29.48 Favored Pre-proline 0 N--CA 1.5 2.069 0 O-C-N 121.459 -0.776 . . . . 0.01 109.153 178.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -78.15 -34.72 1.53 Allowed 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 119.993 1.033 . . . . 0.01 110.906 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.6 m -141.07 107.91 5.39 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.687 -0.856 . . . . 0.02 108.687 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.86 -38.93 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.988 -0.445 . . . . 1.83 110.897 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 19.6 ttt -67.59 -38.11 83.54 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.155 -1.018 . . . . 1.34 110.034 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -68.85 -38.09 79.54 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.407 -1.433 . . . . 2.11 109.599 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -79.72 -46.92 16.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.324 -0.86 . . . . 2.08 112.267 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -112.07 -0.51 15.63 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.398 -0.814 . . . . 0.02 112.841 -176.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.417 ' ND1' ' N ' ' A' ' 122' ' ' HIS . 2.2 m-70 61.61 34.66 17.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.852 -1.155 . . . . 0.02 109.811 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.1 mt -114.13 135.99 53.43 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.446 -0.784 . . . . 0.02 109.299 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -90.87 -22.09 21.1 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.239 -0.913 . . . . 5.32 110.868 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -147.59 163.71 35.75 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.992 -1.067 . . . . 0.02 109.863 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.1 mm -129.49 125.68 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 107.853 -1.166 . . . . 2.17 107.853 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -110.9 -13.4 14.13 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.204 -0.935 . . . . 0.02 112.821 -177.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.584 ' HG ' ' H ' ' A' ' 103' ' ' PHE . 2.2 t -159.45 150.96 20.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.673 -1.267 . . . . 0.01 109.312 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.511 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 7.9 p -166.29 148.5 6.86 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.092 -1.005 . . . . 1.22 108.992 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.03 109.26 15.72 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 122.395 1.093 . . . . 1.41 109.095 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.1 t -113.27 128.41 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 107.648 -1.241 . . . . 0.01 107.648 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.4 t -129.55 93.23 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 107.391 -1.336 . . . . 1.98 107.391 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.52 ' OE1' ' NE1' ' A' ' 136' ' ' TRP . 31.5 tt0 -147.08 -75.34 0.19 Allowed 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 105.882 -1.895 . . . . 0.01 105.882 177.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 177.26 -77.01 0.07 OUTLIER Glycine 0 N--CA 1.483 1.821 0 N-CA-C 108.403 -1.879 . . . . 0.01 108.403 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.7 t -120.23 125.5 48.29 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.541 -0.976 . . . . 2.3 110.226 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.52 ' NE1' ' OE1' ' A' ' 133' ' ' GLU . 8.2 m95 -128.97 151.57 49.54 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 107.066 -1.457 . . . . 0.01 107.066 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 41.0 mt -119.53 134.84 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 120.383 -1.448 . . . . 1.69 109.987 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -114.36 143.91 44.14 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.262 -1.384 . . . . 2.49 107.262 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.511 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 11.5 m-85 -123.02 144.67 49.12 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.244 -0.91 . . . . 0.02 109.346 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -76.3 -28.89 57.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.687 -0.633 . . . . 0.02 111.732 -176.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.1 mt -116.32 155.03 48.87 Favored Pre-proline 0 N--CA 1.504 2.248 0 O-C-N 120.698 -1.251 . . . . 1.48 108.896 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -56.17 167.2 2.65 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.186 1.257 . . . . 0.02 113.072 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 59.49 31.3 20.93 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 114.995 -1.002 . . . . 0.75 111.363 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 57.63 51.22 9.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.536 -0.727 . . . . 0.02 111.092 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -127.02 165.19 19.92 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.583 -0.698 . . . . 0.02 110.157 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.89 -166.03 33.66 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.395 -1.082 . . . . 0.02 110.395 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -69.38 142.54 53.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.551 -0.97 . . . . 0.02 109.162 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -115.13 149.76 37.08 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.729 -0.607 . . . . 0.02 110.028 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -123.68 134.27 53.76 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 109.004 -0.739 . . . . 0.01 109.004 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.6 tp -97.07 121.11 38.6 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.797 -1.189 . . . . 0.01 109.4 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.439 ' CD1' ' CD1' ' A' ' 162' ' ' TRP . 12.9 tp -98.5 146.52 25.69 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.234 -0.916 . . . . 0.01 108.787 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -104.68 -124.77 0.22 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.465 -0.772 . . . . 2.27 110.251 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -138.63 50.45 1.86 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.218 -0.926 . . . . 1.84 109.657 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.49 ' H ' ' HH ' ' A' ' 156' ' ' TYR . 59.6 mttm -115.37 -167.2 1.21 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.344 -0.848 . . . . 2.28 109.517 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -105.6 109.97 22.13 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.565 -0.902 . . . . 0.01 108.565 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.632 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 4.1 m-85 -99.97 111.53 23.83 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.382 -0.823 . . . . 0.01 110.301 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -96.14 -22.1 17.51 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.147 -0.97 . . . . 0.01 111.32 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -127.42 154.11 77.29 Favored Pre-proline 0 N--CA 1.505 2.275 0 O-C-N 121.04 -1.037 . . . . 2.54 108.957 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -59.62 -38.4 82.07 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 120.442 0.761 . . . . 0.7 110.533 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 65.5 t -61.07 -19.68 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.948 -1.095 . . . . 0.86 109.047 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -65.24 -15.18 62.2 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.973 -1.079 . . . . 0.02 109.856 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.632 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 9.8 m0 -97.65 11.04 38.39 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.173 -0.954 . . . . 0.02 108.985 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.31 11.13 84.61 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.899 -1.144 . . . . 0.02 110.988 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.71 140.88 33.27 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.042 -1.269 . . . . 0.02 110.155 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.39 -8.53 58.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.64 -0.662 . . . . 0.59 110.178 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.7 p -142.29 150.95 56.94 Favored Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 120.93 -1.106 . . . . 0.87 109.237 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -75.69 16.8 0.73 Allowed 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 120.81 1.007 . . . . 0.38 112.241 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.14 121.78 27.03 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.359 1.076 . . . . 0.18 111.27 -178.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.1 mt -149.33 124.21 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 106.096 -1.816 . . . . 3.99 106.096 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -112.32 -15.46 13.15 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.217 -0.927 . . . . 5.17 113.271 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 5.4 p -157.34 160.77 38.84 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 119.285 -2.135 . . . . 0.02 110.204 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.608 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 7.1 p90 -152.25 154.07 35.02 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.007 -1.058 . . . . 2.02 110.737 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.4 mtm180 -145.61 150.41 36.31 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.272 -0.892 . . . . 0.01 110.293 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -88.31 143.55 26.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.554 -0.716 . . . . 0.01 109.199 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.1 mt -94.58 129.77 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.242 -0.912 . . . . 3.04 109.034 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.47 146.84 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.203 -0.936 . . . . 1.89 109.639 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.365 -0.834 . . . . 4.89 109.462 -179.922 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 107.86 -2.096 . . . . 0.01 107.86 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -148.51 134.66 19.29 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.96 -1.318 . . . . 0.02 110.983 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.426 HG21 HD13 ' A' ' 7' ' ' ILE . 6.9 tt -128.56 138.95 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 107.703 -1.221 . . . . 0.02 107.703 178.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.4 t -122.33 130.21 52.91 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.225 -0.922 . . . . 0.39 110.339 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 5.2 m-85 -110.36 140.45 44.54 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.82 -0.807 . . . . 0.02 108.82 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.555 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.7 m-85 -122.39 138.69 54.45 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.219 -0.926 . . . . 0.02 109.512 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -68.62 -27.46 66.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.083 -1.011 . . . . 0.03 111.438 -178.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -114.77 170.17 8.53 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.822 -1.174 . . . . 0.03 110.161 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -75.4 161.68 29.03 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.932 0.872 . . . . 0.03 110.39 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.534 ' N ' ' ND2' ' A' ' 14' ' ' ASN . 0.9 OUTLIER 63.22 32.9 14.67 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.048 0.928 . . . . 0.74 110.853 179.196 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.4 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 1.3 m-85 55.03 40.02 31.83 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.94 -0.573 . . . . 0.02 110.874 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -110.08 166.07 11.24 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.134 -1.061 . . . . 0.02 108.134 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.14 -167.59 36.21 Favored Glycine 0 N--CA 1.496 2.638 0 C-N-CA 119.765 -1.207 . . . . 0.03 111.037 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -69.01 143.03 54.46 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.49 -1.006 . . . . 2.76 109.171 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -120.76 149.02 43.18 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.5 0.667 . . . . 1.89 110.197 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -132.7 127.56 35.04 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.323 -0.991 . . . . 0.02 108.323 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 7.8 p30 -112.6 136.76 51.77 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.429 -0.794 . . . . 1.12 109.934 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 10.9 t -131.5 138.79 49.11 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.631 -0.668 . . . . 0.02 109.547 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -116.63 11.07 14.59 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.671 -0.643 . . . . 0.2 109.912 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.405 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 9.8 p -158.63 174.86 14.42 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.408 -0.96 . . . . 1.23 108.408 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -60.75 143.66 53.96 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.669 -1.269 . . . . 0.02 109.912 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.3 t -131.51 117.44 18.79 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.487 -0.931 . . . . 0.02 108.487 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.81 -25.04 48.61 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.156 -0.965 . . . . 0.24 110.83 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -155.15 101.38 2.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.031 -1.043 . . . . 1.14 108.968 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.402 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 24.1 p90 -104.92 9.83 34.5 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 122.111 0.958 . . . . 6.37 109.622 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 45.4 mtp180 -58.65 -24.0 60.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.509 -0.744 . . . . 3.11 110.847 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.5 t -74.46 -16.49 60.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.796 -1.19 . . . . 0.88 110.071 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -104.53 -22.17 13.32 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.536 -0.728 . . . . 0.02 109.588 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.9 tp -150.38 128.89 12.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.194 -0.941 . . . . 3.32 109.085 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.2 t -85.44 -9.86 56.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.786 -0.571 . . . . 0.02 111.11 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -171.36 162.75 6.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.859 -1.15 . . . . 0.02 107.954 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.2 p -143.25 115.42 8.4 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.806 -1.184 . . . . 0.02 108.717 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -108.0 2.36 23.16 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 120.877 -1.14 . . . . 0.03 110.889 -178.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.0 p -156.94 154.63 30.01 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.553 -1.277 . . . . 0.02 107.553 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.3 mt -147.02 148.37 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.039 -1.038 . . . . 0.02 110.376 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.403 ' CB ' ' HH ' ' A' ' 10' ' ' TYR . 62.0 ttt180 -124.59 125.79 44.73 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.982 -1.118 . . . . 0.02 107.982 177.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.1 t -107.16 115.31 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 107.105 -1.443 . . . . 0.02 107.105 177.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -83.88 -34.14 24.64 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.585 -0.697 . . . . 3.81 110.824 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.95 152.3 22.1 Favored Glycine 0 N--CA 1.486 2.016 0 C-N-CA 118.935 -1.602 . . . . 0.02 110.816 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.31 172.78 49.12 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.517 -1.325 . . . . 0.01 110.398 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 47.1 m -119.82 134.89 55.08 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.053 -1.091 . . . . 1.48 108.053 178.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.598 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 3.3 m95 -125.99 154.53 42.77 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 122.522 1.153 . . . . 0.02 112.178 -176.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.98 133.56 52.81 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 105.369 -2.085 . . . . 0.24 105.369 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.0 m -118.46 143.17 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 109.005 -0.739 . . . . 0.65 109.005 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -121.03 146.76 46.37 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 122.192 0.996 . . . . 0.02 110.041 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.25 -34.6 78.74 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.831 -0.622 . . . . 0.02 111.517 -177.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.55 163.02 45.41 Favored Pre-proline 0 N--CA 1.509 2.489 0 O-C-N 120.92 -1.113 . . . . 0.02 109.135 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -55.94 168.07 2.01 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.294 1.33 . . . . 0.02 113.208 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 63.79 36.41 10.52 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.103 -0.953 . . . . 0.02 111.863 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 45.57 52.24 9.38 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.669 0.747 . . . . 3.39 111.188 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.1 m -127.2 164.22 22.15 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.261 0.553 . . . . 2.33 109.912 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.32 -161.58 32.79 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.918 -1.273 . . . . 0.02 109.918 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -65.85 137.94 57.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.101 -1.234 . . . . 0.02 109.99 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 14.8 ptm -118.66 136.68 53.78 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.82 -0.55 . . . . 5.01 109.556 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.425 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 96.5 m-85 -133.04 138.88 46.92 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-O 121.639 0.733 . . . . 0.02 109.756 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.9 mm -95.17 131.16 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.934 -0.765 . . . . 1.72 108.934 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.517 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 1.1 mt -120.02 110.73 36.16 Favored Pre-proline 0 N--CA 1.504 2.246 0 O-C-N 121.477 -0.764 . . . . 0.02 110.711 -178.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -77.65 168.59 22.28 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 CA-C-N 119.979 1.028 . . . . 1.47 110.139 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -54.18 141.15 30.19 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.836 -1.165 . . . . 4.25 110.395 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.43 -177.27 32.69 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 119.684 -1.246 . . . . 0.02 110.52 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -119.21 130.53 55.53 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.433 -1.039 . . . . 0.96 109.662 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.517 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 51.1 m-85 -120.87 97.97 47.97 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 107.762 -1.199 . . . . 0.02 107.762 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -70.23 -3.91 13.27 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 120.681 0.921 . . . . 0.02 113.674 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -157.33 154.79 29.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.651 -1.281 . . . . 2.02 108.048 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -60.14 -39.23 85.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.542 -0.724 . . . . 0.02 111.871 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -59.89 -23.99 63.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.003 -1.061 . . . . 0.02 110.329 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -70.19 -18.79 63.2 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.955 0.883 . . . . 3.42 108.898 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.544 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.4 t90 -108.27 10.39 27.75 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.396 -1.335 . . . . 0.02 107.396 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 7.5 mmt 60.6 22.52 12.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.533 -0.729 . . . . 0.02 110.51 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.66 145.17 47.72 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.535 -1.426 . . . . 0.02 109.535 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.8 mt -79.62 -30.85 41.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.062 -1.258 . . . . 0.98 108.09 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -157.67 -171.48 3.58 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.541 -1.652 . . . . 0.02 106.541 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -98.57 28.56 4.13 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.628 -1.295 . . . . 0.02 110.518 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.579 ' CG ' HH11 ' A' ' 78' ' ' ARG . 3.1 mtt-85 -97.87 122.74 41.34 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.163 -0.96 . . . . 3.2 111.361 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.402 ' O ' ' CZ ' ' A' ' 29' ' ' PHE . 34.7 mt -144.78 122.24 11.68 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 107.6 -1.259 . . . . 2.61 107.6 177.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.09 -16.06 11.88 Favored Glycine 0 N--CA 1.503 3.112 0 O-C-N 121.184 -0.948 . . . . 0.02 112.696 -177.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.8 t -156.55 155.91 32.73 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.171 -1.782 . . . . 0.02 110.363 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.1 p -145.39 148.03 32.91 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.532 -0.73 . . . . 0.02 110.303 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -138.44 143.61 39.75 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.311 -0.868 . . . . 0.01 109.386 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.95 133.13 36.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.43 109.813 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.5 t -92.23 125.58 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.968 -0.753 . . . . 1.25 108.968 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -93.31 132.63 37.34 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.833 -1.167 . . . . 1.77 109.173 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.5 mt -98.95 141.27 31.92 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.499 -0.75 . . . . 1.63 109.029 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.0 t -111.6 125.11 53.58 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.693 -0.855 . . . . 1.08 108.693 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 90.2 p -116.7 133.29 56.19 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.717 -1.239 . . . . 1.26 108.039 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.02 -48.99 0.01 OUTLIER Glycine 0 N--CA 1.505 3.284 0 C-N-CA 117.723 -2.179 . . . . 0.01 113.839 -177.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -167.26 -105.47 0.18 Allowed Glycine 0 N--CA 1.491 2.358 0 CA-C-N 120.045 1.923 . . . . 0.01 111.098 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -118.95 117.23 28.27 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.061 -1.258 . . . . 4.43 109.998 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.04 130.58 36.62 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.834 -0.747 . . . . 2.99 109.132 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.3 ttmm -130.16 139.95 50.82 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.51 -0.744 . . . . 6.36 109.258 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.5 tt -129.28 145.8 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 O-C-N 121.39 -0.819 . . . . 1.09 110.159 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.456 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 7.1 pt20 -122.52 134.03 54.56 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 107.761 -1.2 . . . . 2.05 107.761 177.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.6 m -123.18 146.06 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 120.868 -1.145 . . . . 1.1 109.612 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.584 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 67.2 m-85 -118.51 140.56 49.69 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 122.104 0.954 . . . . 0.73 110.845 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.43 ' OE2' ' O ' ' A' ' 99' ' ' GLU . 4.3 tm-20 -66.35 -30.18 70.53 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.957 -0.565 . . . . 0.02 111.357 -178.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.434 ' O ' ' OG ' ' A' ' 128' ' ' SER . 79.1 mttt -117.04 170.56 8.55 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.078 -1.014 . . . . 3.18 110.327 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.48 170.86 41.65 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 111.003 -0.839 . . . . 0.01 111.003 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 51.86 38.76 24.26 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.55 0.691 . . . . 0.01 111.629 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 51.94 48.24 23.16 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.569 -0.707 . . . . 0.01 111.174 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.508 ' OD1' ' N ' ' A' ' 105' ' ' GLY . 21.2 t-20 -122.52 166.26 15.08 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.331 -0.988 . . . . 3.15 108.331 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.508 ' N ' ' OD1' ' A' ' 104' ' ' ASN . . . 91.95 -164.45 28.72 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.507 -1.437 . . . . 0.01 109.507 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 64.0 tp60 -76.36 144.22 40.24 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.988 -1.301 . . . . 0.01 108.559 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.584 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 31.8 ttp -116.44 142.61 46.63 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.684 0.754 . . . . 0.01 109.907 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -131.15 137.4 49.0 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.225 -1.028 . . . . 2.48 108.225 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -118.16 133.82 55.56 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.549 -0.719 . . . . 0.01 110.044 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.473 ' HG1' ' N ' ' A' ' 111' ' ' THR . 4.3 t -148.67 149.45 31.5 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 122.287 1.041 . . . . 1.69 110.984 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.473 ' N ' ' HG1' ' A' ' 110' ' ' THR . 1.2 p -111.03 9.65 22.1 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 115.452 -0.794 . . . . 0.01 110.025 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -121.17 163.28 18.71 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.202 -0.936 . . . . 3.21 111.719 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -67.42 156.64 36.06 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.326 -0.99 . . . . 0.01 108.326 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.59 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 92.2 m -124.7 111.14 27.67 Favored Pre-proline 0 N--CA 1.502 2.165 0 O-C-N 121.43 -0.794 . . . . 0.01 109.098 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -76.53 -32.83 3.5 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 CA-C-N 120.099 1.071 . . . . 0.01 111.492 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.9 t -140.41 106.33 5.18 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.331 -0.989 . . . . 0.02 108.331 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 73.8 mt -65.2 -38.84 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.81 -0.556 . . . . 1.83 111.044 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.437 ' SD ' ' C ' ' A' ' 123' ' ' LEU . 8.9 tpt -66.52 -38.24 86.78 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.046 -1.062 . . . . 1.34 110.022 -178.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -69.6 -38.53 77.32 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.455 -1.403 . . . . 2.11 109.77 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -80.55 -47.12 14.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.34 -0.85 . . . . 2.08 112.453 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -111.7 -1.3 15.72 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.433 -0.792 . . . . 0.02 112.556 -176.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 61.42 34.08 18.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.837 -1.164 . . . . 0.02 109.655 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.437 ' C ' ' SD ' ' A' ' 118' ' ' MET . 38.7 mt -114.21 136.13 53.29 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.48 -0.763 . . . . 0.02 109.269 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -90.63 -21.9 21.46 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.212 -0.93 . . . . 5.32 110.918 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -148.18 164.02 35.21 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.853 -1.155 . . . . 0.02 110.009 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.4 mm -129.8 126.02 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 107.554 -1.276 . . . . 2.17 107.554 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -109.84 -13.4 14.46 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.156 -0.965 . . . . 0.02 112.966 -177.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 16.6 p -161.2 153.07 19.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.59 -1.319 . . . . 0.01 109.295 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 6.6 t -169.34 145.47 3.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.385 -0.822 . . . . 1.22 108.832 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -124.98 107.83 11.24 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 122.311 1.053 . . . . 1.41 109.685 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.431 ' CG2' ' NE1' ' A' ' 136' ' ' TRP . 11.9 p -110.91 138.26 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.46 -1.311 . . . . 0.01 107.46 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.5 t -127.78 94.46 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 107.186 -1.412 . . . . 1.98 107.186 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.518 ' OE1' ' NE1' ' A' ' 136' ' ' TRP . 52.2 tt0 -146.19 -75.31 0.21 Allowed 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 105.987 -1.857 . . . . 0.01 105.987 177.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 176.57 -77.39 0.07 OUTLIER Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.648 -1.781 . . . . 0.01 108.648 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.6 t -119.49 126.13 50.55 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.623 -0.928 . . . . 2.3 110.318 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.518 ' NE1' ' OE1' ' A' ' 133' ' ' GLU . 43.8 m95 -128.72 150.01 50.45 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 107.166 -1.42 . . . . 0.01 107.166 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.413 HG22 HD13 ' A' ' 137' ' ' ILE . 56.2 mt -120.87 136.5 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 120.441 -1.412 . . . . 1.69 109.973 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -114.75 144.38 43.57 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.604 -1.258 . . . . 2.49 107.604 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 24.0 m-85 -122.8 144.13 49.38 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.372 -0.83 . . . . 0.02 109.53 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -75.62 -29.18 59.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.448 -0.782 . . . . 0.02 111.671 -176.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.3 mt -116.39 154.78 48.97 Favored Pre-proline 0 N--CA 1.505 2.302 0 O-C-N 120.759 -1.213 . . . . 1.48 109.029 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -55.62 167.2 2.22 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.19 1.26 . . . . 0.02 113.022 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 11.3 m120 59.62 30.74 20.38 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.105 -0.952 . . . . 0.75 111.318 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 57.47 51.24 10.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.426 -0.796 . . . . 0.02 110.921 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -126.17 164.52 20.77 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.55 -0.719 . . . . 0.02 109.911 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.95 -165.61 33.26 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.17 -1.172 . . . . 0.02 110.17 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -69.42 142.07 53.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.551 -0.97 . . . . 0.02 109.142 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.47 ' N ' ' CD ' ' A' ' 148' ' ' GLN . 7.1 mp0 -114.79 149.39 37.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.831 -0.543 . . . . 0.02 110.047 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 149' ' ' TYR . 20.2 m-85 -124.51 134.4 53.02 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.18 -0.674 . . . . 0.01 109.18 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.6 tt -98.93 121.39 40.82 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.865 -1.147 . . . . 0.01 108.972 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.4 tp -100.2 151.12 21.81 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.253 -0.904 . . . . 0.01 108.89 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.452 ' CG ' ' H ' ' A' ' 153' ' ' LYS . 62.8 t0 -104.23 -124.4 0.21 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.369 -0.832 . . . . 2.27 109.883 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.452 ' H ' ' CG ' ' A' ' 152' ' ' ASP . 29.0 ttmt -136.46 49.55 2.08 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.352 -0.843 . . . . 1.84 109.586 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -113.55 -172.36 2.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.546 -0.721 . . . . 2.28 109.252 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -105.61 113.32 26.82 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.752 -0.833 . . . . 0.01 108.752 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -98.58 112.68 24.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.328 -0.857 . . . . 0.01 110.133 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -94.81 -24.5 17.03 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.195 -0.941 . . . . 0.01 110.91 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -125.43 154.99 72.44 Favored Pre-proline 0 N--CA 1.498 1.972 0 N-CA-C 108.383 -0.969 . . . . 2.54 108.383 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.553 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 8.4 Cg_endo -60.48 -39.19 67.92 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 CA-C-N 119.197 0.749 . . . . 0.7 110.844 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 68.0 t -61.45 -18.8 19.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 O-C-N 120.742 -1.224 . . . . 0.86 109.282 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -65.44 -17.84 64.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.915 -1.116 . . . . 0.02 111.852 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.553 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.6 OUTLIER -101.74 16.39 25.99 Favored 'General case' 0 N--CA 1.513 2.702 0 O-C-N 120.886 -1.134 . . . . 0.02 110.19 178.476 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.03 9.74 79.91 Favored Glycine 0 N--CA 1.499 2.844 0 O-C-N 121.136 -0.978 . . . . 0.02 113.091 176.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.43 ' HB2' ' HE1' ' A' ' 162' ' ' TRP . . . -100.02 141.6 32.62 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.799 -1.412 . . . . 0.02 110.193 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.78 -8.25 58.89 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.374 -0.602 . . . . 0.59 109.374 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.3 t -142.96 150.55 53.41 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.078 -1.014 . . . . 0.87 108.887 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -75.63 18.47 0.6 Allowed 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 120.746 0.964 . . . . 0.38 112.33 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.57 121.99 27.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.899 -1.126 . . . . 0.18 111.282 -178.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.8 mt -149.12 123.62 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 105.986 -1.857 . . . . 3.99 105.986 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -112.17 -15.92 13.12 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.103 -0.998 . . . . 5.17 113.301 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.502 ' HG ' ' N ' ' A' ' 172' ' ' PHE . 26.0 t -156.71 159.71 38.63 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 119.231 -2.168 . . . . 0.02 109.993 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.59 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 12.7 p90 -152.69 153.89 34.17 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.969 -1.082 . . . . 2.02 110.53 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 48.5 mtp180 -144.83 150.62 37.44 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.907 0.861 . . . . 0.01 110.439 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -88.5 143.77 26.76 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.424 -0.584 . . . . 0.01 109.424 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.2 mt -95.17 128.82 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.158 -0.964 . . . . 3.04 109.039 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 75.0 t -136.3 146.56 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.136 -0.977 . . . . 1.89 109.543 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.335 -0.853 . . . . 4.89 109.586 -179.928 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.349 -1.5 . . . . 0.01 109.349 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -147.12 136.13 22.35 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.098 -1.237 . . . . 0.02 110.77 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.4 HG21 HD11 ' A' ' 7' ' ' ILE . 8.0 tt -130.73 140.13 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 108.927 -0.768 . . . . 0.02 108.927 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.0 t -122.12 130.51 53.31 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.428 -0.795 . . . . 0.39 110.009 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 8.7 m-85 -110.93 140.96 44.99 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 109.092 -0.707 . . . . 0.02 109.092 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.526 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 7.5 m-85 -122.97 139.21 54.31 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.222 -0.924 . . . . 0.02 109.76 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -68.97 -27.75 66.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.033 -1.042 . . . . 0.03 111.599 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -114.54 169.56 8.96 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.876 -1.14 . . . . 0.03 110.306 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -75.21 158.24 33.27 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.651 0.739 . . . . 0.03 110.211 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 66.26 33.37 7.25 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.906 0.86 . . . . 0.74 111.131 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 55.26 41.82 30.98 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.185 0.517 . . . . 0.02 111.177 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -113.15 165.99 11.86 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.208 -1.034 . . . . 0.02 108.208 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.89 -167.26 36.31 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.834 -1.174 . . . . 0.03 110.683 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -69.44 142.05 53.92 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.44 -1.036 . . . . 2.76 109.135 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -120.89 149.41 42.65 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.586 0.708 . . . . 1.89 110.204 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -132.54 127.5 35.24 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.358 -0.978 . . . . 0.02 108.358 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -112.48 137.12 51.14 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.566 -0.709 . . . . 1.12 109.806 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.481 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 14.9 t -131.67 139.1 48.98 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.514 0.673 . . . . 0.02 109.761 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -116.91 11.22 14.33 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.578 -0.701 . . . . 0.2 109.674 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.638 ' HG ' ' H ' ' A' ' 25' ' ' ASP . 50.4 t -158.19 174.4 15.25 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.362 -0.977 . . . . 1.23 108.362 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.638 ' H ' ' HG ' ' A' ' 24' ' ' CYS . 3.2 p30 -60.97 144.08 53.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.646 -1.284 . . . . 0.02 109.867 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.1 p -131.76 117.42 18.57 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.494 -0.928 . . . . 0.02 108.494 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.16 -25.62 47.36 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.052 -1.03 . . . . 0.24 110.889 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 28' ' ' ASP . 8.4 p30 -154.14 101.31 2.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.966 -1.084 . . . . 1.14 109.022 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -104.71 9.46 35.06 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 122.219 1.009 . . . . 6.37 109.897 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -58.52 -24.13 59.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.411 -0.805 . . . . 3.11 111.012 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.7 p -74.47 -16.69 60.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.656 -1.278 . . . . 0.88 110.105 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -103.97 -22.1 13.52 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.458 -0.776 . . . . 0.02 109.628 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.8 tp -150.43 128.98 12.23 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.131 -0.981 . . . . 3.32 109.223 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.8 p -85.86 -10.19 55.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.791 -0.568 . . . . 0.02 111.124 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -171.23 162.68 6.98 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.908 -1.145 . . . . 0.02 107.908 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.1 p -144.11 116.36 8.47 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.826 -1.171 . . . . 0.02 109.056 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.0 OUTLIER -108.28 1.63 22.1 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.745 -1.222 . . . . 0.03 110.924 -178.601 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 56.1 m -155.86 154.24 30.98 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.786 -1.19 . . . . 0.02 107.786 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.8 mt -146.02 146.8 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.118 -0.989 . . . . 0.02 110.616 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -123.46 124.63 43.32 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.112 -1.07 . . . . 0.02 108.112 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.0 t -106.15 114.47 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 106.849 -1.537 . . . . 0.02 106.849 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -84.67 -34.32 23.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.476 -0.765 . . . . 3.81 110.452 -178.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.82 149.89 18.25 Favored Glycine 0 N--CA 1.486 1.991 0 C-N-CA 119.071 -1.538 . . . . 0.02 110.507 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.29 172.48 49.09 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.915 -1.136 . . . . 0.01 110.448 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.5 m -119.13 135.12 54.82 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.045 -1.094 . . . . 1.48 108.045 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 36.2 m95 -126.86 154.24 44.64 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 122.563 1.173 . . . . 0.02 112.316 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.75 134.41 51.51 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 105.448 -2.056 . . . . 0.24 105.448 176.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.4 m -118.44 143.31 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.622 -0.674 . . . . 0.65 109.257 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.538 ' CE2' ' SD ' ' A' ' 58' ' ' MET . 33.0 m-85 -120.95 145.53 47.62 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 122.256 1.027 . . . . 0.02 109.975 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -66.5 -34.18 77.35 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.798 -0.637 . . . . 0.02 111.42 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -125.61 157.92 66.68 Favored Pre-proline 0 N--CA 1.502 2.158 0 O-C-N 121.194 -0.941 . . . . 0.02 109.511 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -53.68 167.1 1.08 Allowed 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.707 1.604 . . . . 0.02 113.169 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.414 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.5 m-20 63.9 36.2 10.4 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.079 -0.964 . . . . 0.02 111.092 178.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 45.39 51.92 9.27 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.692 0.758 . . . . 3.39 110.673 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.8 m -126.52 163.89 22.39 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.235 0.54 . . . . 2.33 109.871 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.11 -161.8 31.92 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.958 -1.257 . . . . 0.02 109.958 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -65.22 138.88 58.52 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.093 -1.239 . . . . 0.02 110.176 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.538 ' SD ' ' CE2' ' A' ' 49' ' ' TYR . 48.6 ttp -118.52 136.97 53.53 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.798 -0.564 . . . . 5.01 109.507 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.455 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 90.1 m-85 -134.5 138.42 44.68 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 121.763 0.792 . . . . 0.02 109.807 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.8 mm -96.06 131.64 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.082 -0.711 . . . . 1.72 109.082 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.2 mt -121.5 112.18 32.8 Favored Pre-proline 0 N--CA 1.506 2.326 0 O-C-N 121.365 -0.835 . . . . 0.02 110.853 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -77.7 169.98 19.91 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 CA-C-N 119.822 0.972 . . . . 1.47 109.981 177.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -52.64 140.98 21.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.833 -1.167 . . . . 4.25 110.263 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.44 -178.25 32.17 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.507 -1.33 . . . . 0.02 110.845 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -120.37 131.85 55.01 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.492 -1.005 . . . . 0.96 109.804 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -121.91 96.1 47.15 Favored Pre-proline 0 N--CA 1.495 1.822 0 N-CA-C 107.958 -1.127 . . . . 0.02 107.958 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.4 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.3 Cg_endo -67.21 -3.84 10.59 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 120.712 0.941 . . . . 0.02 113.868 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 35.0 mt-10 -157.52 155.44 30.28 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.64 -1.288 . . . . 2.02 108.239 179.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -60.42 -39.22 86.64 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.6 -0.687 . . . . 0.02 112.048 -177.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -59.88 -23.77 63.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.091 -1.006 . . . . 0.02 110.202 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -70.36 -19.2 63.06 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.87 0.843 . . . . 3.42 108.948 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.544 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 1.6 t90 -107.68 9.9 29.1 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.483 -1.303 . . . . 0.02 107.483 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.7 mtt 60.52 22.5 12.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.605 -0.684 . . . . 0.02 110.335 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.35 144.6 47.3 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.435 -1.466 . . . . 0.02 109.435 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.0 mt -79.13 -30.42 43.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.101 -1.235 . . . . 0.98 107.779 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.413 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 64.7 t30 -157.68 -171.26 3.49 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 106.393 -1.706 . . . . 0.02 106.393 178.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.413 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 90.5 m-20 -98.61 29.04 3.87 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.7 -1.25 . . . . 0.02 110.484 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.568 ' CG ' HH11 ' A' ' 78' ' ' ARG . 0.4 OUTLIER -98.58 123.08 42.54 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.178 -0.951 . . . . 3.2 111.383 -178.771 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.4 mt -144.93 122.73 11.91 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 107.39 -1.337 . . . . 2.61 107.39 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.96 -16.57 11.27 Favored Glycine 0 N--CA 1.502 3.096 0 O-C-N 121.158 -0.964 . . . . 0.02 112.686 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 90.2 p -156.68 156.42 33.4 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.154 -1.792 . . . . 0.02 110.351 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 12.7 m -145.0 147.81 33.05 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.545 -0.722 . . . . 0.02 110.012 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -138.04 142.99 40.32 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.317 -0.864 . . . . 0.01 109.593 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.56 132.99 36.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.31 -0.869 . . . . 0.43 109.804 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.9 t -91.57 125.07 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.994 -0.743 . . . . 1.25 108.994 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -93.61 132.06 38.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.735 -1.228 . . . . 1.77 109.044 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -97.37 139.79 32.79 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.579 -0.897 . . . . 1.63 108.579 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.5 t -111.8 127.72 55.89 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.351 -0.843 . . . . 1.08 109.281 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.6 p -104.32 -154.33 0.5 Allowed 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 106.506 -1.664 . . . . 1.26 106.506 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.82 -51.37 0.78 Allowed Glycine 0 N--CA 1.5 2.95 0 O-C-N 120.39 -1.444 . . . . 0.01 112.771 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.43 -101.14 0.15 Allowed Glycine 0 N--CA 1.489 2.203 0 C-N-CA 118.515 -1.803 . . . . 0.01 111.877 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -121.4 119.1 31.13 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.194 -1.18 . . . . 4.43 110.556 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.62 128.8 33.99 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.66 -0.816 . . . . 2.99 109.359 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -130.62 141.75 50.44 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.458 -0.776 . . . . 6.36 109.064 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.6 tt -129.69 146.76 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 O-C-N 121.281 -0.887 . . . . 1.09 110.307 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -121.55 133.56 55.02 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 107.437 -1.319 . . . . 2.05 107.437 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.5 m -124.04 146.09 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 120.768 -1.207 . . . . 1.1 109.902 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.581 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 61.4 m-85 -118.74 141.27 48.77 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 122.007 0.908 . . . . 0.73 110.879 -178.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -66.58 -30.55 70.88 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 116.007 -0.542 . . . . 0.02 111.351 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -116.82 170.28 8.73 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.124 -0.985 . . . . 3.18 110.298 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.54 170.09 43.24 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.874 -0.89 . . . . 0.01 110.874 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 2.5 m-20 52.74 38.61 26.84 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.562 0.696 . . . . 0.01 111.704 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 52.42 48.71 22.02 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.65 -0.656 . . . . 0.01 110.944 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.516 ' ND2' ' H ' ' A' ' 105' ' ' GLY . 8.3 t-20 -123.08 165.36 16.95 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.252 -1.018 . . . . 3.15 108.252 178.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.516 ' H ' ' ND2' ' A' ' 104' ' ' ASN . . . 91.9 -163.93 28.48 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.476 -1.45 . . . . 0.01 109.476 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.2 tp60 -76.73 144.05 39.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.936 -1.332 . . . . 0.01 108.899 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.581 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 30.5 ttp -116.4 142.32 47.01 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.65 0.738 . . . . 0.01 109.93 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -131.66 137.16 48.22 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.51 -0.922 . . . . 2.48 108.51 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -117.9 133.9 55.47 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.425 -0.797 . . . . 0.01 110.141 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.1 t -148.18 148.49 30.61 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 122.262 1.029 . . . . 1.69 110.967 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 63.4 p -110.87 10.35 22.41 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 115.579 -0.737 . . . . 0.01 110.331 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -121.16 163.16 18.88 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.152 -0.967 . . . . 3.21 111.566 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -67.03 156.46 35.99 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.107 -1.072 . . . . 0.01 108.107 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.436 ' SG ' ' CZ ' ' A' ' 172' ' ' PHE . 19.9 m -125.37 113.75 25.7 Favored Pre-proline 0 N--CA 1.501 2.115 0 O-C-N 121.485 -0.759 . . . . 0.01 109.37 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.44 ' O ' ' OG ' ' A' ' 171' ' ' SER . 22.1 Cg_endo -76.91 -31.6 3.81 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 CA-C-N 119.916 1.006 . . . . 0.01 111.562 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.0 t -142.49 108.12 5.1 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.238 -0.913 . . . . 0.02 109.068 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.428 HD13 HG22 ' A' ' 117' ' ' ILE . 97.1 mt -63.67 -38.82 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.885 -0.509 . . . . 1.83 110.949 -178.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.8 ttt -68.33 -37.2 80.3 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.222 -0.991 . . . . 1.34 110.263 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -70.36 -38.95 74.88 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.532 -1.355 . . . . 2.11 110.302 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -79.01 -47.39 16.33 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.307 -0.871 . . . . 2.08 112.483 -176.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -110.64 1.18 17.84 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.348 -0.845 . . . . 0.02 112.53 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.2 m170 59.31 32.77 22.16 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.724 -1.235 . . . . 0.02 109.236 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.7 mt -112.29 135.69 52.66 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 108.631 -0.877 . . . . 0.02 108.631 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -90.69 -22.39 21.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.842 . . . . 5.32 110.109 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -150.47 164.47 35.85 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.24 -0.913 . . . . 0.02 110.16 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.9 mt -132.25 129.64 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 107.38 -1.341 . . . . 2.17 107.38 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -107.91 -11.64 15.31 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.321 -0.862 . . . . 0.02 112.571 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.0 t -159.21 152.26 22.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.816 -1.177 . . . . 0.01 109.101 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 6.5 p -169.44 144.71 3.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.187 -0.945 . . . . 1.22 109.168 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -126.18 111.75 14.99 Favored 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 122.445 1.117 . . . . 1.41 110.161 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.4 p -113.89 137.44 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 107.361 -1.348 . . . . 0.01 107.361 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 23.4 t -127.74 94.43 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 106.854 -1.536 . . . . 1.98 106.854 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.461 ' OE1' ' N ' ' A' ' 134' ' ' GLY . 10.4 tm-20 -145.07 -77.78 0.2 Allowed 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 105.929 -1.878 . . . . 0.01 105.929 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.461 ' N ' ' OE1' ' A' ' 133' ' ' GLU . . . 175.58 -73.76 0.08 OUTLIER Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.934 -1.666 . . . . 0.01 108.934 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 29.8 p -119.18 120.14 36.19 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.565 -0.962 . . . . 2.3 110.262 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.46 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 8.1 m95 -127.45 149.53 50.06 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 107.227 -1.398 . . . . 0.01 107.227 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 83.6 mt -123.31 138.88 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 120.504 -1.373 . . . . 1.69 110.491 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -115.29 144.73 43.3 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 107.158 -1.423 . . . . 2.49 107.158 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.496 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 14.0 m-85 -123.06 145.23 48.72 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.15 -0.969 . . . . 0.02 109.617 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -75.77 -30.21 59.05 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.5 -0.75 . . . . 0.02 112.237 -176.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.5 mt -115.07 155.07 47.09 Favored Pre-proline 0 N--CA 1.506 2.366 0 O-C-N 120.595 -1.316 . . . . 1.48 109.225 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.91 165.54 2.61 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.183 1.255 . . . . 0.02 112.547 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 60.08 31.38 20.57 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.131 -0.94 . . . . 0.75 111.484 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 57.55 51.77 9.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.367 -0.833 . . . . 0.02 111.183 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -126.15 164.52 20.75 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.547 -0.721 . . . . 0.02 109.859 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.27 -165.69 32.89 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.419 -1.073 . . . . 0.02 110.419 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -68.89 142.79 54.68 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.612 -0.934 . . . . 0.02 109.053 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -115.18 148.91 38.47 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.386 0.612 . . . . 0.02 109.869 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -124.38 134.4 53.14 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.532 -0.73 . . . . 0.01 109.069 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.8 tt -98.85 120.22 38.93 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.941 -1.099 . . . . 0.01 108.651 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.448 ' CD1' ' CD1' ' A' ' 162' ' ' TRP . 6.6 tp -103.07 150.89 23.15 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.27 -0.894 . . . . 0.01 109.12 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -104.56 -110.26 0.26 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.431 -0.793 . . . . 2.27 109.54 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -156.5 51.68 0.52 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.118 -0.989 . . . . 1.84 109.638 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -112.71 -163.08 0.83 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.584 -0.697 . . . . 2.28 109.264 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -106.39 104.41 14.1 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.452 -0.78 . . . . 0.01 109.073 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.625 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 6.5 m-85 -98.7 112.36 24.45 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.244 -0.91 . . . . 0.01 109.51 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -95.09 -22.15 18.08 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.188 -0.945 . . . . 0.01 111.775 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -127.73 154.24 77.9 Favored Pre-proline 0 N--CA 1.502 2.171 0 O-C-N 120.715 -1.241 . . . . 2.54 109.036 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -60.53 -38.68 71.36 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 120.483 0.789 . . . . 0.7 110.517 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.93 -20.08 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.819 -1.176 . . . . 0.86 108.93 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 161' ' ' ASP . 13.7 t0 -65.18 -15.4 62.4 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.955 -1.091 . . . . 0.02 109.925 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.625 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 9.9 m0 -97.89 11.34 37.69 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.111 -0.993 . . . . 0.02 109.099 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.83 10.21 85.93 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.789 -1.196 . . . . 0.02 110.968 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.49 141.47 32.23 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.313 -1.11 . . . . 0.02 110.061 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.57 -8.97 57.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.663 -0.648 . . . . 0.59 109.948 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.1 p -143.2 150.35 51.86 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 120.919 -1.113 . . . . 0.87 108.869 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -76.6 18.81 0.68 Allowed 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 120.825 1.016 . . . . 0.38 112.371 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.14 123.08 28.66 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.855 -1.153 . . . . 0.18 111.496 -177.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 16.1 mm -151.75 127.04 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 106.815 -1.55 . . . . 3.99 106.815 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -113.92 -12.91 12.6 Favored 'General case' 0 N--CA 1.508 2.429 0 O-C-N 121.065 -1.022 . . . . 5.17 113.725 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 115' ' ' PRO . 22.7 m -157.53 161.77 38.81 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 119.12 -2.237 . . . . 0.02 110.439 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.436 ' CZ ' ' SG ' ' A' ' 114' ' ' CYS . 21.3 p90 -152.74 153.77 33.87 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.044 -1.035 . . . . 2.02 110.662 178.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 48.8 mtp180 -145.44 150.38 36.4 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.775 0.798 . . . . 0.01 110.23 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -87.9 143.99 26.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.483 -0.761 . . . . 0.01 109.183 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.1 mt -94.38 129.26 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.184 -0.948 . . . . 3.04 109.045 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.4 t -136.17 146.6 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.174 -0.953 . . . . 1.89 109.675 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 4.89 109.51 179.962 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 107.85 -2.1 . . . . 0.01 107.85 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -149.67 136.11 19.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.916 -1.344 . . . . 0.02 110.755 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.418 HG22 HD13 ' A' ' 7' ' ' ILE . 5.7 tt -128.62 139.25 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 107.822 -1.177 . . . . 0.02 107.822 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 t -121.11 129.63 53.38 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.321 -0.862 . . . . 0.39 110.337 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 11.5 m-85 -109.67 139.69 44.41 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.803 -0.814 . . . . 0.02 108.803 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.528 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 6.3 m-85 -122.15 138.33 54.51 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.139 -0.975 . . . . 0.02 109.664 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.521 ' OE2' ' N ' ' A' ' 35' ' ' ARG . 6.1 mm-40 -67.83 -28.63 67.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.934 . . . . 0.03 111.093 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.5 m-20 -114.77 170.06 8.61 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.882 -1.136 . . . . 0.03 110.163 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -75.56 162.35 28.37 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.729 0.776 . . . . 0.03 110.295 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 3.0 t30 62.8 33.33 15.4 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.002 0.906 . . . . 0.74 110.806 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 55.0 40.36 32.0 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.975 -0.557 . . . . 0.02 110.843 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -110.67 165.96 11.4 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.14 -1.059 . . . . 0.02 108.14 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.02 -167.73 36.56 Favored Glycine 0 N--CA 1.495 2.62 0 C-N-CA 119.719 -1.229 . . . . 0.03 110.918 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -68.73 142.66 54.92 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.63 -0.923 . . . . 2.76 109.354 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 -120.6 148.83 43.37 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.658 0.742 . . . . 1.89 110.195 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -132.81 127.57 34.84 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.436 -0.95 . . . . 0.02 108.436 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 21.4 p-10 -112.79 137.28 51.35 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.499 -0.75 . . . . 1.12 109.857 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 15.3 t -131.48 139.08 49.25 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.742 -0.599 . . . . 0.02 109.515 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.0 p30 -117.04 11.4 14.25 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.528 -0.733 . . . . 0.2 109.939 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.513 ' HG ' ' H ' ' A' ' 25' ' ' ASP . 34.7 t -158.31 174.46 15.11 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.389 -0.967 . . . . 1.23 108.389 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.513 ' H ' ' HG ' ' A' ' 24' ' ' CYS . 2.3 p30 -61.17 144.25 54.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.597 -1.315 . . . . 0.02 109.869 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.5 t -131.75 117.32 18.44 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.54 -0.911 . . . . 0.02 108.54 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.66 -25.02 49.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.122 -0.986 . . . . 0.24 110.778 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.47 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 20.8 p-10 -154.8 101.26 2.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.09 -1.006 . . . . 1.14 108.882 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -105.85 9.58 32.79 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-O 122.004 0.907 . . . . 6.37 109.835 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -58.63 -24.24 60.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.674 -0.641 . . . . 3.11 110.861 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.5 m -74.05 -16.59 61.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.716 -1.24 . . . . 0.88 109.836 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -105.72 -21.99 13.06 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.616 -0.677 . . . . 0.02 109.561 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.453 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 3.0 tp -148.83 126.36 11.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.023 -1.048 . . . . 3.32 109.686 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.7 m -86.83 -11.0 52.16 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.488 -0.757 . . . . 0.02 111.446 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.521 ' N ' ' OE2' ' A' ' 11' ' ' GLU . 17.8 ttp180 -170.98 161.17 6.84 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.682 -1.229 . . . . 0.02 107.682 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.5 t -141.65 115.41 9.12 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.8 -1.187 . . . . 0.02 109.213 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.416 ' ND2' ' OD2' ' A' ' 77' ' ' ASP . 3.5 m120 -107.57 -0.19 22.2 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.914 -1.116 . . . . 0.03 110.858 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.467 ' HG ' ' N ' ' A' ' 39' ' ' ILE . 11.1 t -156.18 153.38 29.13 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.851 -1.166 . . . . 0.02 107.851 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.467 ' N ' ' HG ' ' A' ' 38' ' ' SER . 84.5 mt -145.43 147.57 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.11 -0.994 . . . . 0.02 110.313 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -123.22 124.13 42.32 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.753 -1.203 . . . . 0.02 107.753 176.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.3 t -106.56 114.88 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 107.058 -1.46 . . . . 0.02 107.058 177.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.434 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 30.3 tt0 -83.61 -34.07 25.19 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 120.099 -0.64 . . . . 3.81 110.912 -178.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.96 152.21 21.95 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 118.896 -1.621 . . . . 0.02 111.03 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.43 172.86 49.24 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.627 -1.273 . . . . 0.01 110.514 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.4 m -119.51 135.06 54.94 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.978 -1.119 . . . . 1.48 107.978 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.458 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 32.5 m95 -127.14 155.77 42.83 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 122.56 1.172 . . . . 0.02 112.151 -176.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.59 134.3 52.1 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 105.697 -1.964 . . . . 0.24 105.697 176.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.6 m -116.65 141.73 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.556 -0.715 . . . . 0.65 109.222 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -120.61 143.32 48.72 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 122.098 0.951 . . . . 0.02 109.793 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -65.69 -34.24 77.75 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.661 -0.7 . . . . 0.02 111.646 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -125.15 157.6 66.62 Favored Pre-proline 0 N--CA 1.502 2.173 0 O-C-N 121.033 -1.042 . . . . 0.02 109.359 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.56 167.2 1.0 Allowed 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.718 1.612 . . . . 0.02 113.015 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.3 m120 63.76 36.09 10.81 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.154 -0.93 . . . . 0.02 111.16 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.407 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 4.2 m-85 45.38 51.56 9.46 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.722 0.772 . . . . 3.39 110.503 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 90.3 p -126.13 163.83 22.26 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.318 0.58 . . . . 2.33 109.847 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.88 -161.76 32.19 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.816 -1.314 . . . . 0.02 109.816 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.717 ' HD1' ' H ' ' A' ' 57' ' ' HIS . 1.9 m80 -65.27 138.72 58.39 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.065 -1.256 . . . . 0.02 110.337 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.497 ' SD ' ' O ' ' A' ' 58' ' ' MET . 2.6 ppp? -119.11 137.13 53.79 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.492 0.663 . . . . 5.01 109.517 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -134.28 138.81 45.28 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.395 -0.816 . . . . 0.02 109.648 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.4 mm -95.32 131.09 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 109.057 -0.719 . . . . 1.72 109.057 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.561 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -119.6 110.83 36.73 Favored Pre-proline 0 N--CA 1.503 2.184 0 O-C-N 121.299 -0.876 . . . . 0.02 110.769 -178.266 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -77.54 168.49 22.59 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 CA-C-N 119.934 1.012 . . . . 1.47 110.221 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.434 ' NE2' ' O ' ' A' ' 42' ' ' GLU . 63.1 tt0 -53.58 141.19 26.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.824 -1.173 . . . . 4.25 110.43 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.79 -177.76 31.9 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.529 -1.32 . . . . 0.02 110.712 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -120.5 131.69 54.84 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.558 -0.966 . . . . 0.96 109.732 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.561 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 63.8 m-85 -122.3 94.19 48.04 Favored Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 108.023 -1.103 . . . . 0.02 108.023 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.402 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 5.3 Cg_exo -64.44 -4.24 7.8 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 120.928 1.085 . . . . 0.02 113.799 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 34.8 mt-10 -157.58 155.3 29.95 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.555 -1.34 . . . . 2.02 108.287 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -60.63 -39.0 86.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.481 -0.762 . . . . 0.02 112.199 -176.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -59.93 -23.72 63.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.093 -1.004 . . . . 0.02 110.329 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -70.62 -18.57 62.87 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.782 0.801 . . . . 3.42 109.021 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.547 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.6 t90 -107.98 10.14 28.42 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.415 -1.328 . . . . 0.02 107.415 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.4 mmt 60.77 22.49 12.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.66 -0.65 . . . . 0.02 110.545 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.78 144.33 46.35 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.401 -1.48 . . . . 0.02 109.401 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.8 tp -79.29 -31.03 43.23 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.617 -1.253 . . . . 0.98 107.617 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -157.02 -171.74 3.76 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 106.342 -1.725 . . . . 0.02 106.342 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.416 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 52.1 m-20 -98.71 27.54 4.82 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.616 -1.303 . . . . 0.02 110.708 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -95.97 122.56 38.92 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.939 -1.101 . . . . 3.2 110.865 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.2 mt -142.9 121.35 12.4 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.558 -1.275 . . . . 2.61 107.558 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.2 -17.85 9.15 Favored Glycine 0 N--CA 1.501 2.977 0 O-C-N 121.257 -0.902 . . . . 0.02 112.878 -177.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.407 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 11.1 t -156.03 155.78 33.28 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-N 120.004 1.902 . . . . 0.02 111.023 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 13.5 p -145.34 147.43 32.29 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.321 -0.862 . . . . 0.02 110.624 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -138.23 143.63 40.22 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.529 -0.732 . . . . 0.01 109.292 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.66 132.11 36.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -0.915 . . . . 0.43 109.759 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.8 t -91.28 125.2 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.961 -0.755 . . . . 1.25 108.961 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -94.36 131.13 40.33 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.884 -1.135 . . . . 1.77 109.029 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 mt -95.76 140.3 30.74 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.621 -0.881 . . . . 1.63 108.621 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t -111.64 127.87 55.89 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.37 -0.831 . . . . 1.08 109.33 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 71.5 p -104.41 -154.58 0.51 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 106.631 -1.618 . . . . 1.26 106.631 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.32 -52.65 0.73 Allowed Glycine 0 N--CA 1.5 2.956 0 O-C-N 120.498 -1.376 . . . . 0.01 112.895 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.18 -101.44 0.15 Allowed Glycine 0 N--CA 1.49 2.256 0 C-N-CA 118.456 -1.83 . . . . 0.01 112.022 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -121.88 119.53 31.84 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.056 -1.261 . . . . 4.43 110.695 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.42 129.22 34.26 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.682 -0.807 . . . . 2.99 109.303 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -130.54 142.1 50.47 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.866 -0.79 . . . . 6.36 108.866 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.7 tt -129.97 146.05 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 O-C-N 121.255 -0.903 . . . . 1.09 110.451 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -121.26 133.61 55.15 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.354 -1.35 . . . . 2.05 107.354 177.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.4 m -123.93 146.41 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 120.895 -1.128 . . . . 1.1 109.709 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.576 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 72.0 m-85 -119.32 141.61 48.86 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.978 0.894 . . . . 0.73 111.059 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -66.96 -30.28 70.36 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 116.066 -0.515 . . . . 0.02 111.734 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.414 ' O ' ' OG ' ' A' ' 128' ' ' SER . 43.8 mttp -116.37 167.22 11.22 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.965 -1.084 . . . . 3.18 110.425 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.05 164.05 44.24 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.958 -0.857 . . . . 0.01 110.958 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 57.23 38.87 28.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.932 -0.746 . . . . 0.01 110.913 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 52.29 55.72 8.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.723 -0.611 . . . . 0.01 111.079 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -128.97 165.66 20.68 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.29 -1.004 . . . . 3.15 108.29 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.66 -164.0 27.57 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.279 -1.528 . . . . 0.01 109.279 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -75.69 144.29 41.67 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.968 -1.313 . . . . 0.01 108.438 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.576 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 27.6 ttp -116.41 142.19 47.18 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.543 0.687 . . . . 0.01 109.889 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -131.58 136.54 47.88 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.176 -1.046 . . . . 2.48 108.176 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -119.19 134.48 55.18 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.57 -0.706 . . . . 0.01 109.923 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.477 ' HG1' ' N ' ' A' ' 111' ' ' THR . 2.9 t -148.67 150.52 33.35 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 122.278 1.037 . . . . 1.69 111.145 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.477 ' N ' ' HG1' ' A' ' 110' ' ' THR . 48.2 p -110.89 9.62 22.38 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 115.572 -0.74 . . . . 0.01 110.336 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -121.15 163.22 18.78 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.15 -0.969 . . . . 3.21 111.721 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -68.2 157.18 36.0 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.268 -1.012 . . . . 0.01 108.268 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 19.1 t -126.88 114.16 22.21 Favored Pre-proline 0 N--CA 1.501 2.075 0 O-C-N 121.457 -0.777 . . . . 0.01 109.101 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -75.05 -29.72 7.85 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 CA-C-N 120.247 1.124 . . . . 0.01 111.035 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.5 m -142.3 109.19 5.45 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.309 -0.869 . . . . 0.02 109.121 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.402 HG22 HD13 ' A' ' 117' ' ' ILE . 97.7 mt -63.58 -38.99 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.866 -0.521 . . . . 1.83 110.59 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 19.0 ttt -68.82 -37.74 79.4 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.349 -0.94 . . . . 1.34 110.399 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -69.46 -38.57 77.8 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.417 -1.427 . . . . 2.11 109.995 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -80.11 -47.14 15.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.331 -0.856 . . . . 2.08 112.339 -177.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -111.18 0.0 16.66 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.363 -0.836 . . . . 0.02 112.637 -176.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.7 m80 60.01 33.64 21.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.768 -1.208 . . . . 0.02 109.516 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.0 mt -112.65 135.51 53.29 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 108.83 -0.804 . . . . 0.02 108.83 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -91.69 -22.96 19.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.254 -0.904 . . . . 5.32 110.393 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -149.45 164.34 35.27 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.187 -0.945 . . . . 0.02 109.813 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.477 ' C ' ' HD1' ' A' ' 127' ' ' HIS . 38.5 mt -132.15 128.89 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 107.804 -1.184 . . . . 2.17 107.804 178.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.477 ' HD1' ' C ' ' A' ' 126' ' ' ILE . 0.3 OUTLIER -108.39 -11.98 15.1 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.365 -0.834 . . . . 0.02 112.25 -178.012 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 8.2 p -160.31 151.06 18.72 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.917 -1.114 . . . . 0.01 109.273 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 27.1 p -168.25 145.01 3.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.362 -0.836 . . . . 1.22 109.133 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 40.5 tttm -126.31 111.67 14.8 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 122.42 1.105 . . . . 1.41 110.417 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.2 p -114.38 138.44 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 107.408 -1.33 . . . . 0.01 107.408 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.5 t -126.8 94.03 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 106.732 -1.581 . . . . 1.98 106.732 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.422 ' CD ' ' N ' ' A' ' 134' ' ' GLY . 6.1 tm-20 -145.65 -80.65 0.16 Allowed 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 106.218 -1.771 . . . . 0.01 106.218 177.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.422 ' N ' ' CD ' ' A' ' 133' ' ' GLU . . . 176.45 -76.2 0.07 OUTLIER Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.987 -1.645 . . . . 0.01 108.987 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 30.9 p -118.0 118.14 31.13 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.593 -0.945 . . . . 2.3 110.192 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -124.88 150.4 46.52 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 107.244 -1.391 . . . . 0.01 107.244 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 12.4 mt -121.79 136.88 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 120.484 -1.385 . . . . 1.69 110.15 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -114.55 144.29 43.6 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.364 -1.347 . . . . 2.49 107.364 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 24.5 m-85 -123.29 143.56 49.99 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.271 -0.893 . . . . 0.02 109.575 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.461 ' O ' ' NE2' ' A' ' 170' ' ' GLN . 81.8 tt0 -73.96 -29.24 61.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.506 -0.746 . . . . 0.02 111.911 -176.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.1 mt -116.09 154.9 48.58 Favored Pre-proline 0 N--CA 1.505 2.291 0 O-C-N 120.725 -1.234 . . . . 1.48 108.964 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -55.66 167.36 2.17 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.151 1.234 . . . . 0.02 112.757 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.617 ' N ' HD21 ' A' ' 143' ' ' ASN . 0.8 OUTLIER 59.37 31.11 20.87 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.174 -0.921 . . . . 0.75 111.233 178.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 57.41 50.62 11.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.45 -0.781 . . . . 0.02 111.064 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -125.13 164.36 20.42 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.554 -0.716 . . . . 0.02 109.898 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.427 ' O ' ' OE1' ' A' ' 148' ' ' GLN . . . 89.16 -165.72 33.06 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.184 -1.167 . . . . 0.02 110.184 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -69.08 142.55 54.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.54 -0.977 . . . . 0.02 109.034 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.472 ' N ' ' CD ' ' A' ' 148' ' ' GLN . 0.1 OUTLIER -114.53 148.54 37.78 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.44 0.638 . . . . 0.02 110.011 -178.191 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -124.92 134.98 52.45 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 109.083 -0.71 . . . . 0.01 109.083 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.1 tt -100.09 121.25 41.11 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.872 -1.142 . . . . 0.01 108.92 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.9 tp -99.32 145.34 27.43 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.198 -0.939 . . . . 0.01 108.96 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.551 ' H ' ' HH ' ' A' ' 156' ' ' TYR . 3.9 m-20 -106.73 -166.41 1.17 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.647 -0.658 . . . . 2.27 109.882 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -90.68 52.85 2.28 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.405 -0.809 . . . . 1.84 109.833 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -115.35 -178.88 3.48 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.473 -0.767 . . . . 2.28 109.448 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -105.47 111.48 24.21 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.476 -0.935 . . . . 0.01 108.476 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.551 ' HH ' ' H ' ' A' ' 152' ' ' ASP . 54.0 m-85 -99.65 112.7 24.9 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.387 -0.82 . . . . 0.01 110.493 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -94.54 -24.06 17.41 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.165 -0.959 . . . . 0.01 110.855 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -126.04 153.59 73.96 Favored Pre-proline 0 N--CA 1.501 2.078 0 N-CA-C 108.451 -0.944 . . . . 2.54 108.451 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -59.85 -39.73 69.49 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 CA-C-N 119.285 0.78 . . . . 0.7 110.609 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 6.7 t -61.84 -19.57 21.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.755 -1.216 . . . . 0.86 108.863 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 161' ' ' ASP . 10.6 t0 -65.96 -18.06 65.09 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.954 -1.091 . . . . 0.02 111.059 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.58 ' HE1' ' CB ' ' A' ' 164' ' ' ALA . 1.8 p90 -103.0 14.16 32.6 Favored 'General case' 0 N--CA 1.508 2.467 0 O-C-N 121.077 -1.014 . . . . 0.02 109.811 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 87.42 10.37 70.89 Favored Glycine 0 N--CA 1.497 2.728 0 O-C-N 121.462 -0.774 . . . . 0.02 113.854 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.58 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . . . -100.93 141.32 33.98 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 120.472 -1.604 . . . . 0.02 110.757 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.61 -7.66 59.17 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.673 -0.642 . . . . 0.59 109.484 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 39.0 m -143.54 150.67 51.82 Favored Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 120.961 -1.087 . . . . 0.87 109.154 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -76.75 18.45 0.72 Allowed 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.0 1.134 . . . . 0.38 112.474 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.87 125.47 31.38 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 122.373 1.082 . . . . 0.18 111.698 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.419 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 1.6 mt -149.94 127.01 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.344 -1.354 . . . . 3.99 107.344 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.461 ' NE2' ' O ' ' A' ' 140' ' ' GLU . 2.9 mp0 -111.95 -18.06 12.74 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.075 -1.016 . . . . 5.17 112.816 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 20.5 t -157.06 159.93 38.42 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 119.141 -2.224 . . . . 0.02 110.315 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.431 ' CD1' ' C ' ' A' ' 172' ' ' PHE . 19.0 p90 -151.67 153.38 34.29 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.971 -1.081 . . . . 2.02 110.538 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 -144.97 149.98 36.14 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.882 0.849 . . . . 0.01 110.433 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -87.17 143.14 27.43 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.874 -0.788 . . . . 0.01 108.874 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.1 mt -94.76 129.13 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.28 -0.887 . . . . 3.04 109.108 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 11.7 p -136.38 146.99 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.194 -0.942 . . . . 1.89 109.686 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 4.89 109.411 -179.991 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 110.45 -1.06 . . . . 0.01 110.45 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -152.85 138.34 17.68 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.52 -0.988 . . . . 0.02 109.666 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.416 HD12 HG22 ' A' ' 7' ' ' ILE . 6.8 tt -130.85 140.87 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 109.222 -0.659 . . . . 0.02 109.222 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.8 m -121.95 130.89 53.7 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.444 -0.785 . . . . 0.39 109.996 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.487 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 5.4 m-85 -111.11 140.74 45.41 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.561 -0.712 . . . . 0.02 109.332 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.575 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.1 m-85 -122.68 138.6 54.56 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.266 -0.896 . . . . 0.02 109.756 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -69.29 -27.29 65.27 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.925 -1.11 . . . . 0.03 111.736 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 3.3 m-20 -113.87 169.4 9.03 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.804 -1.185 . . . . 0.03 110.172 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -75.33 158.31 32.99 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.662 0.744 . . . . 0.03 110.034 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.413 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 7.1 t-20 65.96 33.44 7.8 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.913 0.863 . . . . 0.74 111.173 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.413 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 0.8 OUTLIER 55.42 41.8 30.65 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.296 0.57 . . . . 0.02 111.214 177.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -112.8 165.6 12.15 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.236 -1.024 . . . . 0.02 108.236 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.17 -167.59 34.49 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.801 -1.19 . . . . 0.03 110.6 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -70.19 143.88 52.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.425 -1.044 . . . . 2.76 108.957 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -120.41 149.13 42.85 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.65 0.738 . . . . 1.89 110.296 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -132.76 127.7 35.23 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.399 -0.963 . . . . 0.02 108.399 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 18.9 p30 -112.22 136.85 51.13 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.441 -0.787 . . . . 1.12 109.709 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.424 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 12.0 t -130.65 138.6 50.15 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.515 0.674 . . . . 0.02 109.679 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.498 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 33.9 t70 -117.07 11.14 14.13 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.567 -0.708 . . . . 0.2 109.852 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 42.3 m -158.55 174.57 14.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.118 -0.988 . . . . 1.23 108.505 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -61.27 144.04 54.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.71 -1.244 . . . . 0.02 110.09 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.5 t -131.67 117.46 18.69 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.654 -0.869 . . . . 0.02 108.654 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.12 -25.77 47.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.974 -1.079 . . . . 0.24 110.988 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -153.4 101.6 2.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.979 -1.075 . . . . 1.14 108.977 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -104.0 9.28 36.62 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 122.109 0.956 . . . . 6.37 109.806 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.4 mtm180 -59.3 -24.69 63.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.525 -0.734 . . . . 3.11 111.221 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.3 t -75.39 -16.93 60.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.629 -1.295 . . . . 0.88 110.315 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -105.14 -21.69 13.22 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.366 -0.833 . . . . 0.02 109.503 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.4 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 4.5 tp -148.7 126.81 12.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.223 -0.923 . . . . 3.32 109.447 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.5 t -86.51 -11.88 50.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.634 -0.666 . . . . 0.02 111.206 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.4 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 24.4 ttp180 -171.47 161.58 6.36 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.84 -1.162 . . . . 0.02 108.154 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 p -142.55 114.98 8.46 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.881 -1.137 . . . . 0.02 108.761 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -106.63 1.15 24.95 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 120.777 -1.202 . . . . 0.03 110.379 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.8 t -155.94 154.51 31.28 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.5 -1.296 . . . . 0.02 107.5 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.8 mt -146.63 147.68 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.029 -1.045 . . . . 0.02 110.401 -178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.562 ' CG ' HH11 ' A' ' 40' ' ' ARG . 0.2 OUTLIER -124.39 125.02 43.61 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.997 -1.112 . . . . 0.02 107.997 177.651 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.1 t -105.1 113.65 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 106.644 -1.613 . . . . 0.02 106.644 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -84.18 -34.76 23.91 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.467 -0.77 . . . . 3.81 110.033 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.41 150.93 20.21 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 118.618 -1.753 . . . . 0.02 110.722 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.43 171.99 48.58 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.357 -1.097 . . . . 0.01 110.357 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.8 m -119.6 134.9 55.03 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 107.805 -1.183 . . . . 1.48 107.805 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.467 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 31.2 m95 -127.36 154.94 44.36 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 122.583 1.182 . . . . 0.02 112.329 -176.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.29 134.06 51.64 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 105.282 -2.118 . . . . 0.24 105.282 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.7 m -119.12 143.7 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 109.066 -0.716 . . . . 0.65 109.066 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -120.96 145.92 47.21 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 122.276 1.036 . . . . 0.02 110.041 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -66.09 -34.05 77.18 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 115.816 -0.629 . . . . 0.02 111.009 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -125.46 157.54 67.63 Favored Pre-proline 0 N--CA 1.502 2.162 0 O-C-N 121.051 -1.03 . . . . 0.02 109.487 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.45 167.26 0.93 Allowed 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.692 1.594 . . . . 0.02 113.074 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.8 m120 63.77 36.36 10.59 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.253 -0.885 . . . . 0.02 111.113 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 45.09 51.58 8.88 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.66 0.743 . . . . 3.39 110.67 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.7 m -126.36 163.82 22.43 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.168 0.509 . . . . 2.33 109.814 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.78 -161.65 32.24 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.815 -1.314 . . . . 0.02 109.815 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -65.3 139.15 58.57 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.124 -1.221 . . . . 0.02 110.146 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.497 ' SD ' ' O ' ' A' ' 58' ' ' MET . 2.8 ppp? -118.84 137.28 53.53 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.714 -0.616 . . . . 5.01 109.593 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.404 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 96.2 m-85 -134.85 138.63 44.36 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.494 -0.754 . . . . 0.02 109.78 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.4 mm -95.2 131.61 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.857 -0.794 . . . . 1.72 108.857 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.561 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -120.08 110.64 36.15 Favored Pre-proline 0 N--CA 1.505 2.278 0 O-C-N 121.289 -0.882 . . . . 0.02 110.858 -178.346 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -77.86 168.99 21.38 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 CA-C-N 119.916 1.006 . . . . 1.47 110.296 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -53.9 140.62 30.15 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.861 -1.15 . . . . 4.25 110.522 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.93 -177.79 32.82 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.451 -1.356 . . . . 0.02 110.618 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -119.93 131.16 55.12 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.362 -1.081 . . . . 0.96 109.646 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.561 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 75.9 m-85 -121.8 96.27 47.21 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 108.128 -1.064 . . . . 0.02 108.128 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.404 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.6 Cg_endo -67.07 -3.75 10.29 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 120.778 0.986 . . . . 0.02 113.756 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 35.1 mt-10 -157.81 155.21 29.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.685 -1.259 . . . . 2.02 108.288 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -60.56 -39.37 87.72 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.572 -0.705 . . . . 0.02 112.042 -177.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -59.96 -23.68 63.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.083 -1.011 . . . . 0.02 110.276 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -69.97 -18.92 63.37 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.778 0.799 . . . . 3.42 109.021 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.547 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.1 t90 -108.04 10.6 28.19 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.432 -1.321 . . . . 0.02 107.432 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.5 mtt 61.08 22.27 12.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.537 -0.727 . . . . 0.02 110.463 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.76 143.65 44.88 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.49 -1.444 . . . . 0.02 109.49 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.4 tp -79.57 -31.93 41.98 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.558 -1.275 . . . . 0.98 107.558 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -157.63 -172.65 4.04 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 106.312 -1.736 . . . . 0.02 106.312 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -98.49 28.06 4.4 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.821 -1.174 . . . . 0.02 110.823 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 -96.83 121.89 39.19 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.828 -1.17 . . . . 3.2 110.887 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.0 mt -144.0 121.39 11.65 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 107.574 -1.269 . . . . 2.61 107.574 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.34 -16.19 11.48 Favored Glycine 0 N--CA 1.505 3.243 0 O-C-N 121.192 -0.943 . . . . 0.02 112.804 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.6 p -157.09 156.37 32.66 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.107 -1.819 . . . . 0.02 110.344 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 23.4 m -144.89 147.93 33.33 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.584 -0.698 . . . . 0.02 110.047 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 39.1 mtp180 -137.84 143.19 40.84 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.368 -0.832 . . . . 0.01 109.585 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.57 132.21 36.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.201 -0.937 . . . . 0.43 109.669 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.3 t -91.0 125.03 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.873 -0.788 . . . . 1.25 108.873 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -92.56 132.53 36.77 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.877 -1.139 . . . . 1.77 108.865 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mt -98.42 140.57 32.48 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.865 -0.791 . . . . 1.63 108.865 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 52.9 p -112.08 124.68 52.95 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.474 -0.936 . . . . 1.08 108.474 178.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.4 m -115.76 132.81 56.53 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 107.754 -1.202 . . . . 1.26 107.754 177.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -156.78 -49.58 0.01 OUTLIER Glycine 0 N--CA 1.505 3.279 0 C-N-CA 117.709 -2.186 . . . . 0.01 113.636 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.71 -105.73 0.19 Allowed Glycine 0 N--CA 1.489 2.203 0 CA-C-N 120.192 1.996 . . . . 0.01 111.352 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -120.81 118.59 30.39 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.125 -1.221 . . . . 4.43 110.401 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.14 129.14 34.81 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.806 -0.758 . . . . 2.99 109.369 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -131.23 141.19 49.98 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.497 -0.752 . . . . 6.36 109.241 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.0 tt -129.8 146.91 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 O-C-N 121.247 -0.908 . . . . 1.09 110.344 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.523 ' NE2' ' O ' ' A' ' 130' ' ' LYS . 2.4 pm0 -122.1 134.31 54.76 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 107.561 -1.274 . . . . 2.05 107.561 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.8 m -124.37 146.25 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 O-C-N 120.721 -1.237 . . . . 1.1 110.158 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.584 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 79.5 m-85 -119.4 141.2 49.29 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.973 0.892 . . . . 0.73 111.081 -178.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -67.18 -30.22 70.12 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 115.921 -0.581 . . . . 0.02 111.819 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -116.18 168.99 9.62 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.028 -1.045 . . . . 3.18 110.441 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.27 164.94 50.0 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.796 -0.921 . . . . 0.01 110.796 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 56.46 38.45 29.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.719 -0.871 . . . . 0.01 111.432 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 51.94 55.08 9.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.559 -0.713 . . . . 0.01 111.256 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -129.06 165.01 22.02 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.018 -1.105 . . . . 3.15 108.018 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.18 -163.64 27.95 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.255 -1.538 . . . . 0.01 109.255 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.498 ' NE2' ' OH ' ' A' ' 108' ' ' TYR . 57.1 tt0 -76.19 144.19 40.64 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.005 -1.291 . . . . 0.01 108.834 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.584 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 32.7 ttp -116.66 142.55 46.75 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.524 0.678 . . . . 0.01 109.821 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.498 ' OH ' ' NE2' ' A' ' 106' ' ' GLN . 55.5 m-85 -131.48 136.86 48.26 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.265 -1.013 . . . . 2.48 108.265 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -118.15 134.16 55.25 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.551 -0.718 . . . . 0.01 110.248 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.9 t -149.01 148.33 29.61 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.276 1.036 . . . . 1.69 111.197 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 30.1 p -111.16 9.7 21.88 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 115.547 -0.751 . . . . 0.01 110.496 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -120.85 163.16 18.61 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.235 -0.916 . . . . 3.21 111.438 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -67.46 156.8 35.72 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.217 -1.031 . . . . 0.01 108.217 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.609 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 26.4 p -123.86 116.47 27.6 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.515 -0.741 . . . . 0.01 109.414 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -76.7 -31.93 3.86 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 CA-C-N 120.181 1.1 . . . . 0.01 110.445 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.4 p -143.84 108.91 4.98 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.733 0.778 . . . . 0.02 109.016 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.9 mt -64.16 -39.27 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.771 -0.581 . . . . 1.83 110.822 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 118' ' ' MET . 1.8 tmt? -67.95 -37.24 81.34 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.175 -1.01 . . . . 1.34 110.034 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -69.47 -38.02 77.55 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.543 -1.348 . . . . 2.11 109.87 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -80.25 -46.72 15.75 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.274 -0.891 . . . . 2.08 112.373 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -110.87 0.13 17.07 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.395 -0.815 . . . . 0.02 112.58 -176.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.519 ' O ' ' NH1' ' A' ' 124' ' ' ARG . 8.7 m80 60.01 33.47 21.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.768 -1.207 . . . . 0.02 109.639 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.6 mt -112.63 135.8 52.94 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 108.754 -0.832 . . . . 0.02 108.754 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 122' ' ' HIS . 0.1 OUTLIER -92.27 -22.79 19.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.242 -0.911 . . . . 5.32 110.208 -179.486 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -149.33 163.61 37.21 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.189 -0.945 . . . . 0.02 109.883 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.404 HD13 HG23 ' A' ' 126' ' ' ILE . 42.1 mt -131.91 128.81 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 107.899 -1.148 . . . . 2.17 107.899 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -107.61 -12.54 15.24 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.27 -0.893 . . . . 0.02 112.084 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.5 m -158.44 150.7 21.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.848 -1.158 . . . . 0.01 108.511 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.6 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 0.5 OUTLIER -169.62 144.67 2.97 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.425 -0.954 . . . . 1.22 108.425 -179.526 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.523 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 32.1 tttp -125.93 110.6 13.82 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 122.497 1.142 . . . . 1.41 110.61 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.1 p -109.09 134.5 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 106.948 -1.501 . . . . 0.01 106.948 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 50.7 t -128.58 94.77 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 N-CA-C 107.148 -1.427 . . . . 1.98 107.148 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -146.66 -76.58 0.19 Allowed 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 105.816 -1.92 . . . . 0.01 105.816 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 156.27 -54.14 0.41 Allowed Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.982 -1.647 . . . . 0.01 108.982 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 76.3 p -119.21 98.32 6.1 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.643 -0.916 . . . . 2.3 111.021 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -129.25 145.38 51.35 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 107.265 -1.383 . . . . 0.01 107.265 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.426 HG23 HD11 ' A' ' 137' ' ' ILE . 96.4 mt -123.74 139.47 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 120.957 -1.089 . . . . 1.69 110.071 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -114.26 144.06 43.84 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 106.99 -1.485 . . . . 2.49 106.99 177.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 14.3 m-85 -123.19 144.19 49.53 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.348 -0.845 . . . . 0.02 109.465 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -74.1 -29.45 61.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.595 -0.69 . . . . 0.02 111.838 -176.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.3 mt -115.94 154.76 48.36 Favored Pre-proline 0 N--CA 1.505 2.283 0 O-C-N 120.693 -1.254 . . . . 1.48 108.985 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -56.15 167.22 2.62 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.123 1.215 . . . . 0.02 112.889 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 143' ' ' ASN . 0.4 OUTLIER 59.58 31.15 20.76 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.149 -0.932 . . . . 0.75 111.487 178.588 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 144' ' ' TYR . 0.7 OUTLIER 58.05 50.98 9.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.447 -0.783 . . . . 0.02 111.152 177.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -125.99 164.57 20.54 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.494 -0.754 . . . . 0.02 109.973 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.06 -165.6 33.11 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.323 -1.111 . . . . 0.02 110.323 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -69.4 142.22 53.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.596 -0.943 . . . . 0.02 109.055 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.467 ' N ' ' CD ' ' A' ' 148' ' ' GLN . 5.3 mp0 -115.34 149.55 37.71 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.851 -0.531 . . . . 0.02 109.75 -178.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -124.72 134.61 52.78 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.618 -0.676 . . . . 0.01 109.189 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.8 tt -99.91 121.46 41.37 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.072 -1.017 . . . . 0.01 108.743 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -99.98 165.33 11.59 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.022 -1.049 . . . . 0.01 109.506 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -109.91 -96.96 0.4 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.59 -0.694 . . . . 2.27 109.215 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -176.37 51.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.198 -0.939 . . . . 1.84 109.626 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -113.82 -159.77 0.7 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.547 -0.721 . . . . 2.28 109.512 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.518 ' OE2' ' NZ ' ' A' ' 130' ' ' LYS . 66.3 mm-40 -106.37 107.05 17.87 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.494 -0.753 . . . . 0.01 109.064 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.656 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 29.7 m-85 -99.96 114.3 27.47 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.301 -0.874 . . . . 0.01 109.993 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -96.09 -22.34 17.39 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.227 -0.921 . . . . 0.01 111.928 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -127.84 155.34 77.61 Favored Pre-proline 0 N--CA 1.504 2.26 0 O-C-N 120.803 -1.185 . . . . 2.54 109.023 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -60.79 -39.64 60.94 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 120.497 0.798 . . . . 0.7 110.614 178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.0 t -60.72 -20.76 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.763 -1.211 . . . . 0.86 109.011 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -65.09 -14.93 61.72 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.815 -1.178 . . . . 0.02 109.732 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.656 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 21.8 m0 -96.2 10.71 36.91 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.329 -0.857 . . . . 0.02 108.712 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.03 9.47 87.07 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.727 -1.225 . . . . 0.02 110.716 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -98.63 141.86 30.93 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.296 -1.12 . . . . 0.02 110.065 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.19 -9.09 58.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.574 -0.703 . . . . 0.59 109.661 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.1 t -144.61 150.09 45.96 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.079 -1.013 . . . . 0.87 108.728 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -75.9 19.96 0.56 Allowed 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 120.663 0.908 . . . . 0.38 112.259 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.26 123.57 29.72 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.88 -1.138 . . . . 0.18 111.584 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.8 mt -149.49 128.15 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 107.041 -1.466 . . . . 3.99 107.041 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -112.15 -17.39 12.82 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.055 -1.028 . . . . 5.17 113.356 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.6 p -158.11 160.98 37.9 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 119.122 -2.236 . . . . 0.02 110.148 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.609 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 3.8 p90 -151.51 153.66 35.03 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.056 -1.028 . . . . 2.02 110.925 178.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -145.38 149.64 35.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.297 -0.877 . . . . 0.01 110.215 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -88.36 144.03 26.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.527 -0.733 . . . . 0.01 109.51 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.5 mt -93.59 129.59 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.155 -0.965 . . . . 3.04 109.159 178.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 10.2 p -136.09 146.56 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.254 -0.904 . . . . 1.89 109.473 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.291 -0.881 . . . . 4.89 109.404 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.194 -1.562 . . . . 0.01 109.194 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -147.87 136.89 22.09 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.059 -1.259 . . . . 0.02 110.641 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.8 tt -130.72 139.62 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.731 -0.841 . . . . 0.02 108.731 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 m -120.89 130.14 53.78 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.489 -0.757 . . . . 0.39 109.866 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -109.94 139.57 44.88 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.077 -0.712 . . . . 0.02 109.077 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.534 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 5.3 m-85 -122.14 138.41 54.47 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.146 -0.971 . . . . 0.02 109.531 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -69.39 -27.67 65.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.193 -0.942 . . . . 0.03 111.539 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -114.05 169.16 9.22 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.849 -1.157 . . . . 0.03 110.14 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -75.39 158.32 32.9 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.598 0.713 . . . . 0.03 110.218 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 66.42 33.3 6.98 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.948 0.88 . . . . 0.74 111.117 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 55.48 41.94 30.36 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 116.056 -0.52 . . . . 0.02 111.324 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -113.66 165.68 12.28 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.193 -1.04 . . . . 0.02 108.193 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.39 -167.46 35.66 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.826 -1.178 . . . . 0.03 110.793 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -69.22 142.27 54.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.398 -1.06 . . . . 2.76 109.315 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -120.76 149.09 43.08 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.618 0.723 . . . . 1.89 110.167 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -132.43 127.16 34.76 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.255 -1.017 . . . . 0.02 108.255 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -112.48 137.41 50.72 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.57 -0.706 . . . . 1.12 109.827 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.9 t -131.67 139.21 49.01 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 121.523 0.678 . . . . 0.02 109.777 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -116.98 11.26 14.26 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.583 -0.698 . . . . 0.2 109.671 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.455 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 29.5 p -158.29 174.3 15.37 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.275 -1.009 . . . . 1.23 108.275 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 2.3 p30 -60.93 143.84 54.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.647 -1.283 . . . . 0.02 109.855 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 26' ' ' CYS . 27.4 p -131.19 117.14 18.62 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.52 -0.918 . . . . 0.02 108.52 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.46 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -78.17 -24.83 47.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.143 -0.973 . . . . 0.24 110.965 -178.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -154.8 101.65 2.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.834 -1.166 . . . . 1.14 108.985 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -105.21 9.53 34.03 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 122.197 0.998 . . . . 6.37 109.903 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -58.86 -24.55 62.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.388 -0.82 . . . . 3.11 110.934 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.5 m -74.16 -16.55 60.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.755 -1.216 . . . . 0.88 110.124 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -103.97 -21.97 13.54 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.482 -0.761 . . . . 0.02 109.488 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.6 tp -150.04 128.86 12.48 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.196 -0.94 . . . . 3.32 109.207 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.7 t -85.54 -10.1 56.44 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.768 -0.583 . . . . 0.02 111.191 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -170.55 162.28 8.02 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.696 -1.224 . . . . 0.02 107.696 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.6 t -143.05 115.57 8.58 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.73 -1.231 . . . . 0.02 109.136 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.609 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.5 OUTLIER -109.8 1.95 19.66 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 120.839 -1.163 . . . . 0.03 111.532 -178.563 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.503 ' HG ' ' N ' ' A' ' 39' ' ' ILE . 22.2 t -156.67 154.47 30.14 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.098 -1.075 . . . . 0.02 108.098 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.503 ' N ' ' HG ' ' A' ' 38' ' ' SER . 11.1 mt -145.94 146.61 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-O 122.402 1.096 . . . . 0.02 111.209 -178.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -123.07 124.22 42.62 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.672 -1.233 . . . . 0.02 107.672 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.3 t -106.47 113.92 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 106.91 -1.515 . . . . 0.02 106.91 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -84.07 -34.42 24.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.746 -0.596 . . . . 3.81 110.5 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.84 149.93 18.32 Favored Glycine 0 N--CA 1.486 2.026 0 C-N-CA 119.064 -1.541 . . . . 0.02 110.589 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.96 172.08 48.84 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.845 -1.169 . . . . 0.01 110.432 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.7 m -119.99 135.69 54.82 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.171 -1.048 . . . . 1.48 108.171 178.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.421 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 35.8 m95 -127.41 155.48 43.58 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 122.62 1.2 . . . . 0.02 112.526 -176.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.41 134.69 51.53 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 105.586 -2.005 . . . . 0.24 105.586 176.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.5 m -120.12 144.51 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.629 -0.669 . . . . 0.65 109.408 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -121.15 146.04 47.18 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 122.291 1.043 . . . . 0.02 110.22 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.405 ' CD ' ' HD1' ' A' ' 57' ' ' HIS . 28.3 tt0 -67.5 -34.55 77.37 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.801 -0.636 . . . . 0.02 111.496 -177.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 24.4 mtm180 -124.72 158.22 63.11 Favored Pre-proline 0 N--CA 1.504 2.249 0 O-C-N 120.983 -1.073 . . . . 0.02 109.576 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -54.04 165.32 2.08 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.619 1.546 . . . . 0.02 113.253 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.474 ' N ' ' ND2' ' A' ' 53' ' ' ASN . 1.2 m120 64.37 37.02 8.65 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.111 -0.949 . . . . 0.02 111.268 178.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 45.22 51.68 9.06 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.662 0.744 . . . . 3.39 110.603 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.9 p -126.2 163.47 23.1 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.58 -0.526 . . . . 2.33 109.58 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.92 -161.76 32.14 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.811 -1.316 . . . . 0.02 109.811 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.405 ' HD1' ' CD ' ' A' ' 50' ' ' GLU . 16.5 m80 -65.27 138.91 58.51 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.085 -1.244 . . . . 0.02 110.388 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.446 ' SD ' ' C ' ' A' ' 58' ' ' MET . 11.6 tmm? -120.1 137.18 54.29 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 109.376 -0.601 . . . . 5.01 109.376 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.424 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 86.7 m-85 -134.67 139.68 45.44 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.799 0.809 . . . . 0.02 109.949 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.7 mm -94.77 131.26 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.762 -0.829 . . . . 1.72 108.762 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.556 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -120.45 111.95 34.58 Favored Pre-proline 0 N--CA 1.505 2.311 0 O-C-N 121.397 -0.814 . . . . 0.02 110.946 -178.165 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -78.31 169.16 20.55 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 CA-C-N 119.842 0.979 . . . . 1.47 110.338 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -53.72 141.52 26.22 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.88 -1.137 . . . . 4.25 110.514 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.85 -177.46 32.12 Favored Glycine 0 N--CA 1.496 2.636 0 C-N-CA 119.515 -1.326 . . . . 0.02 110.824 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -119.99 131.39 55.14 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.46 -1.023 . . . . 0.96 109.803 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.556 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 75.1 m-85 -121.73 97.83 46.12 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 107.795 -1.187 . . . . 0.02 107.795 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.402 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 5.8 Cg_endo -69.6 -3.34 11.71 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 120.704 0.936 . . . . 0.02 113.671 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 33.4 mt-10 -157.77 155.11 29.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.723 -1.235 . . . . 2.02 108.137 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -60.4 -39.5 87.59 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.666 -0.646 . . . . 0.02 112.018 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -60.06 -24.02 64.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.058 -1.026 . . . . 0.02 110.411 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -69.74 -18.5 63.52 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.903 0.859 . . . . 3.42 108.87 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.558 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.3 t90 -108.21 10.59 27.84 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.458 -1.312 . . . . 0.02 107.458 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.7 mtt 61.5 22.55 12.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.53 -0.731 . . . . 0.02 110.536 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.53 145.46 47.24 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.579 -1.409 . . . . 0.02 109.579 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.3 mt -80.48 -31.04 37.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -1.158 . . . . 0.98 108.039 177.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -157.02 -171.55 3.69 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 106.513 -1.662 . . . . 0.02 106.513 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.424 ' OD2' ' OD1' ' A' ' 37' ' ' ASN . 66.0 m-20 -98.63 28.31 4.31 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.595 -1.316 . . . . 0.02 110.774 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.4 mtp180 -97.19 122.89 40.71 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.059 -1.026 . . . . 3.2 110.99 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.8 mt -143.47 121.59 12.17 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 107.632 -1.247 . . . . 2.61 107.632 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.07 -17.27 9.67 Favored Glycine 0 N--CA 1.506 3.327 0 O-C-N 121.098 -1.001 . . . . 0.02 113.026 -177.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 22.9 m -156.74 156.86 34.05 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.085 -1.832 . . . . 0.02 110.483 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 44.9 t -144.79 147.26 32.69 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.529 -0.732 . . . . 0.02 110.242 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 38.1 mtm180 -138.52 143.17 39.4 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.33 -0.856 . . . . 0.01 109.392 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.81 132.46 36.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.251 -0.906 . . . . 0.43 109.816 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.6 t -91.25 125.44 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.851 -0.796 . . . . 1.25 108.851 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -94.1 131.34 39.73 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.773 -1.204 . . . . 1.77 109.085 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mt -96.37 140.18 31.41 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.439 -0.949 . . . . 1.63 108.439 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.2 t -111.89 127.86 55.97 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.285 -0.884 . . . . 1.08 109.406 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.6 p -104.34 -154.17 0.5 Allowed 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 106.573 -1.64 . . . . 1.26 106.573 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.93 -52.97 0.73 Allowed Glycine 0 N--CA 1.502 3.044 0 O-C-N 120.392 -1.443 . . . . 0.01 112.895 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.81 -101.42 0.15 Allowed Glycine 0 N--CA 1.491 2.312 0 C-N-CA 118.467 -1.825 . . . . 0.01 111.966 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -121.64 118.89 30.31 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.057 -1.261 . . . . 4.43 110.648 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.3 129.1 34.13 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.702 -0.799 . . . . 2.99 109.555 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -131.1 142.23 50.24 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 109.039 -0.726 . . . . 6.36 109.039 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.2 tt -129.68 147.36 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 O-C-N 121.24 -0.912 . . . . 1.09 110.362 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -121.64 134.13 54.98 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.615 -1.254 . . . . 2.05 107.615 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.7 m -124.36 145.88 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 120.69 -1.256 . . . . 1.1 110.002 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.592 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 96.4 m-85 -119.13 141.44 48.81 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.995 0.902 . . . . 0.73 110.935 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -67.02 -30.93 71.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.881 -0.512 . . . . 0.02 111.852 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -116.36 167.63 10.86 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.949 -1.094 . . . . 3.18 110.561 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.18 164.17 44.49 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 111.057 -0.817 . . . . 0.01 111.057 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 57.1 38.56 29.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.884 -0.774 . . . . 0.01 110.963 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 52.4 55.32 9.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.582 -0.699 . . . . 0.01 111.058 178.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -129.08 165.85 20.42 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.216 -1.031 . . . . 3.15 108.216 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.41 -163.8 27.76 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.231 -1.548 . . . . 0.01 109.231 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -76.0 144.24 41.02 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.025 -1.279 . . . . 0.01 108.711 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.592 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 52.2 ttp -116.29 141.84 47.63 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.608 0.718 . . . . 0.01 109.882 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -131.57 136.63 47.97 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.237 -1.023 . . . . 2.48 108.237 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -118.1 133.69 55.67 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.502 -0.749 . . . . 0.01 110.012 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.1 t -147.84 148.76 31.23 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 122.195 0.998 . . . . 1.69 110.941 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 60.3 p -111.17 10.06 21.87 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 115.619 -0.718 . . . . 0.01 110.293 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -121.67 163.09 19.58 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.257 -0.902 . . . . 3.21 111.677 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.17 157.48 36.82 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.278 -1.008 . . . . 0.01 108.278 178.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.621 ' SG ' ' CD2' ' A' ' 172' ' ' PHE . 0.8 OUTLIER -128.46 119.51 20.54 Favored Pre-proline 0 N--CA 1.504 2.26 0 O-C-N 121.476 -0.765 . . . . 0.01 108.989 177.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -76.47 -28.76 6.57 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 CA-C-N 120.24 1.121 . . . . 0.01 110.85 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 64.1 m -144.04 109.75 5.25 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.718 0.771 . . . . 0.02 109.25 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.72 -38.28 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.819 -0.551 . . . . 1.83 110.514 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 20.5 ttt -68.49 -36.39 78.87 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.399 -0.92 . . . . 1.34 110.359 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -70.91 -39.06 72.96 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.5 -1.375 . . . . 2.11 110.167 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -79.66 -47.54 15.22 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.307 -0.871 . . . . 2.08 112.535 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -110.27 0.51 18.12 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.358 -0.839 . . . . 0.02 112.476 -176.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.6 m80 59.49 32.64 21.84 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.757 -1.214 . . . . 0.02 109.32 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.1 mt -112.2 135.46 52.84 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 108.477 -0.934 . . . . 0.02 108.477 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -91.24 -22.66 20.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.289 -0.882 . . . . 5.32 110.158 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -149.84 164.04 36.42 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.296 -0.878 . . . . 0.02 110.024 -178.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 48.6 mt -131.42 128.49 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 107.558 -1.275 . . . . 2.17 107.558 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -107.81 -12.25 15.24 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.313 -0.867 . . . . 0.02 112.376 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.429 ' HG ' ' N ' ' A' ' 129' ' ' CYS . 3.4 t -158.74 151.39 21.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.837 -1.164 . . . . 0.01 108.911 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.504 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 2.8 p -170.41 145.25 2.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.092 -1.005 . . . . 1.22 109.178 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -124.67 110.18 14.07 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 122.361 1.077 . . . . 1.41 109.894 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.6 p -111.21 135.34 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.365 -1.346 . . . . 0.01 107.365 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.9 t -128.95 94.69 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 107.05 -1.463 . . . . 1.98 107.05 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -146.03 -74.73 0.22 Allowed 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 105.869 -1.9 . . . . 0.01 105.869 177.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 167.36 -69.74 0.18 Allowed Glycine 0 N--CA 1.485 1.902 0 N-CA-C 108.7 -1.76 . . . . 0.01 108.7 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.18 115.4 23.57 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.556 -0.967 . . . . 2.3 110.456 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -127.05 149.37 49.94 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 106.809 -1.552 . . . . 0.01 106.809 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 97.7 mt -122.98 138.37 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 120.42 -1.425 . . . . 1.69 110.647 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -113.72 143.64 44.28 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.265 -1.383 . . . . 2.49 107.265 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.501 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 10.5 m-85 -122.45 144.68 48.9 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.178 -0.951 . . . . 0.02 109.307 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -75.72 -29.34 58.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.608 -0.682 . . . . 0.02 111.566 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mt -116.41 154.21 48.91 Favored Pre-proline 0 N--CA 1.504 2.234 0 O-C-N 120.69 -1.256 . . . . 1.48 108.899 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -55.16 170.02 0.83 Allowed 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.225 1.283 . . . . 0.02 112.962 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 14.2 t30 58.25 31.62 21.04 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 114.937 -1.029 . . . . 0.75 111.274 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 56.21 48.01 18.21 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.532 -0.73 . . . . 0.02 110.424 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -123.03 164.4 18.65 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.585 -0.697 . . . . 0.02 109.97 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.86 -166.03 32.35 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.375 -1.09 . . . . 0.02 110.375 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -69.04 142.85 54.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.581 -0.952 . . . . 0.02 109.133 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -114.49 147.99 38.54 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.393 0.616 . . . . 0.02 110.242 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -125.22 135.71 52.84 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.919 -0.771 . . . . 0.01 108.919 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.7 tt -97.9 121.64 40.05 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.839 -1.163 . . . . 0.01 109.495 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.04 145.5 25.4 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.309 -0.869 . . . . 0.01 108.752 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -103.06 -116.15 0.21 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.339 -0.851 . . . . 2.27 109.412 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -157.78 49.69 0.42 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.053 -1.029 . . . . 1.84 109.712 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -113.64 -162.97 0.83 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.495 -0.753 . . . . 2.28 109.315 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -105.93 103.52 13.03 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.43 -0.794 . . . . 0.01 108.94 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.616 ' CG ' ' NE1' ' A' ' 162' ' ' TRP . 66.8 m-85 -98.7 113.24 25.24 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.365 -0.835 . . . . 0.01 109.722 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -95.11 -22.33 17.95 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.297 -0.877 . . . . 0.01 111.61 -177.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -127.39 154.52 77.24 Favored Pre-proline 0 N--CA 1.504 2.25 0 O-C-N 120.767 -1.208 . . . . 2.54 108.855 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -60.5 -38.97 69.58 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 120.58 0.854 . . . . 0.7 110.512 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 84.6 t -61.51 -20.02 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.958 -1.089 . . . . 0.86 108.931 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -65.41 -15.6 62.77 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.934 -1.104 . . . . 0.02 110.074 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.616 ' NE1' ' CG ' ' A' ' 156' ' ' TYR . 9.7 m0 -98.22 11.4 37.98 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.144 -0.973 . . . . 0.02 108.925 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.06 10.34 85.65 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.842 -1.171 . . . . 0.02 111.087 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.57 141.25 32.6 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.181 -1.188 . . . . 0.02 110.023 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.08 -9.46 57.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.671 -0.643 . . . . 0.59 110.217 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.0 m -143.49 149.78 48.75 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 120.891 -1.131 . . . . 0.87 109.057 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -76.64 19.1 0.66 Allowed 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 120.822 1.015 . . . . 0.38 112.294 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.7 124.7 29.82 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.812 -1.18 . . . . 0.18 111.493 -177.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -150.21 126.6 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 107.075 -1.454 . . . . 3.99 107.075 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -115.11 -15.07 11.74 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.051 -1.031 . . . . 5.17 113.582 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 6.2 t -156.77 160.16 38.99 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 119.189 -2.194 . . . . 0.02 110.294 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.621 ' CD2' ' SG ' ' A' ' 114' ' ' CYS . 13.9 p90 -151.84 153.29 33.93 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.919 -1.113 . . . . 2.02 110.718 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -144.78 149.42 35.46 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.364 -0.835 . . . . 0.01 110.293 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -89.26 145.46 25.37 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.27 -0.641 . . . . 0.01 109.27 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.7 mt -96.76 129.93 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.308 -0.87 . . . . 3.04 109.324 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.14 146.31 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.227 -0.92 . . . . 1.89 109.484 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 4.89 109.404 179.931 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.421 -1.471 . . . . 0.01 109.421 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.519 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 2.8 ttmp? -145.99 135.27 22.9 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.174 -1.192 . . . . 0.02 110.517 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.425 HG23 HD11 ' A' ' 7' ' ' ILE . 7.5 tt -129.54 139.15 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.062 -1.088 . . . . 0.02 108.062 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.49 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.4 t -122.41 130.86 53.53 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.348 -0.845 . . . . 0.39 110.119 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.0 m-85 -111.18 141.54 44.57 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 109.067 -0.716 . . . . 0.02 109.067 178.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.548 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.9 m-85 -122.08 138.58 54.39 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.181 -0.949 . . . . 0.02 109.61 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -68.33 -27.91 66.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.878 -1.139 . . . . 0.03 111.39 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.1 m-20 -114.65 169.88 8.73 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.873 -1.142 . . . . 0.03 110.163 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -75.5 161.91 28.78 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.793 0.806 . . . . 0.03 110.411 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.3 m120 63.12 33.13 14.75 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.054 0.931 . . . . 0.74 110.894 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 54.92 40.07 31.83 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.865 -0.607 . . . . 0.02 110.978 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -110.29 165.75 11.52 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.215 -1.031 . . . . 0.02 108.215 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.46 -167.57 35.63 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.889 -1.148 . . . . 0.03 110.889 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -69.65 143.28 53.26 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.477 -1.014 . . . . 2.76 109.261 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -120.47 149.23 42.72 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.505 0.669 . . . . 1.89 110.171 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -132.34 127.59 35.85 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.25 -1.018 . . . . 0.02 108.25 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -112.78 136.75 52.04 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.422 -0.799 . . . . 1.12 109.751 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 15.9 t -131.22 139.14 49.64 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.765 -0.585 . . . . 0.02 109.515 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -116.58 11.69 14.83 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.624 -0.672 . . . . 0.2 109.836 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.634 ' HG ' ' H ' ' A' ' 25' ' ' ASP . 52.9 t -158.37 174.69 14.75 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.248 -1.019 . . . . 1.23 108.248 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.634 ' H ' ' HG ' ' A' ' 24' ' ' CYS . 1.1 m-20 -60.53 144.19 52.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.756 -1.215 . . . . 0.02 109.721 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 22.2 t -131.75 117.41 18.56 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.654 -0.869 . . . . 0.02 108.654 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.89 -24.42 48.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.143 -0.973 . . . . 0.24 110.919 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -155.18 102.36 2.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.927 -1.108 . . . . 1.14 109.234 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -102.57 9.9 39.13 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 122.024 0.916 . . . . 6.37 109.734 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -59.45 -25.22 64.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.589 -0.694 . . . . 3.11 111.416 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.9 m -76.23 -17.3 59.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.508 -1.37 . . . . 0.88 110.687 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -103.88 -22.06 13.56 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.361 -0.837 . . . . 0.02 109.411 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.1 tp -150.25 129.1 12.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.317 -0.865 . . . . 3.32 109.0 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.5 m -85.03 -9.81 57.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.743 -0.598 . . . . 0.02 110.944 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -171.15 162.36 6.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.954 -1.091 . . . . 0.02 108.066 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.9 p -144.03 115.09 7.88 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.747 -1.221 . . . . 0.02 108.53 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -108.65 3.29 22.66 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.787 -1.195 . . . . 0.03 110.862 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.3 m -155.48 154.28 31.58 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.651 -1.241 . . . . 0.02 107.651 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.5 mt -146.36 147.1 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.977 -1.077 . . . . 0.02 110.574 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -124.6 125.07 43.55 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 107.814 -1.18 . . . . 0.02 107.814 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.7 t -106.38 115.21 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 106.972 -1.492 . . . . 0.02 106.972 177.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.519 ' OE1' ' NZ ' ' A' ' 6' ' ' LYS . 30.5 tt0 -83.38 -34.0 25.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.37 -0.831 . . . . 3.81 110.93 -178.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.04 152.58 22.5 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 118.893 -1.622 . . . . 0.02 110.799 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.53 172.97 49.39 Favored Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.698 -1.239 . . . . 0.01 110.423 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 86.6 m -119.81 135.16 54.97 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 107.982 -1.118 . . . . 1.48 107.982 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.442 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 32.0 m95 -126.53 154.99 43.07 Favored 'General case' 0 N--CA 1.502 2.173 0 CA-C-O 122.581 1.181 . . . . 0.02 112.301 -176.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.14 134.28 51.92 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 105.225 -2.139 . . . . 0.24 105.225 176.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.5 m -116.99 141.93 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.532 -0.73 . . . . 0.65 109.235 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -121.18 143.89 48.88 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 122.061 0.934 . . . . 0.02 109.753 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -65.01 -34.82 79.36 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.448 -0.796 . . . . 0.02 111.655 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.9 mtm180 -125.37 157.74 66.67 Favored Pre-proline 0 N--CA 1.503 2.2 0 O-C-N 121.004 -1.06 . . . . 0.02 109.332 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.48 167.73 0.84 Allowed 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.657 1.572 . . . . 0.02 113.022 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 63.13 36.39 12.19 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.212 -0.903 . . . . 0.02 111.207 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' A' ' 54' ' ' PHE . 0.6 OUTLIER 45.5 51.62 9.67 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.591 0.71 . . . . 3.39 110.717 178.472 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.8 m -126.02 163.85 22.13 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.187 0.517 . . . . 2.33 109.846 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.85 -161.54 32.06 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.869 -1.292 . . . . 0.02 109.869 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.407 ' CD2' ' N ' ' A' ' 57' ' ' HIS . 15.8 m170 -65.22 138.62 58.36 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.035 -1.274 . . . . 0.02 110.068 -178.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.447 ' SD ' ' C ' ' A' ' 58' ' ' MET . 11.2 tmm? -118.97 136.39 54.11 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.362 0.601 . . . . 5.01 109.693 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -134.31 138.76 45.2 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 121.714 0.768 . . . . 0.02 109.828 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.9 mm -95.38 131.11 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 109.031 -0.729 . . . . 1.72 109.031 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.565 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -119.66 110.62 36.85 Favored Pre-proline 0 N--CA 1.504 2.247 0 O-C-N 121.449 -0.782 . . . . 0.02 110.67 -178.3 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -77.26 167.86 24.01 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 CA-C-N 119.966 1.024 . . . . 1.47 110.167 177.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.538 ' CD ' ' H ' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -53.36 141.61 23.88 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.834 -1.166 . . . . 4.25 110.445 -179.621 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.13 -177.81 32.15 Favored Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.549 -1.31 . . . . 0.02 110.671 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -119.78 131.64 55.39 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.382 -1.07 . . . . 0.96 109.823 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.565 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 75.6 m-85 -121.46 97.81 46.78 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 108.047 -1.094 . . . . 0.02 108.047 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -69.42 -3.88 12.68 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 120.743 0.962 . . . . 0.02 113.48 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -157.65 154.76 28.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.781 -1.199 . . . . 2.02 108.041 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.596 ' HH ' HE21 ' A' ' 70' ' ' GLN . 28.4 p90 -60.36 -38.8 84.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.58 -0.7 . . . . 0.02 112.154 -177.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.596 HE21 ' HH ' ' A' ' 69' ' ' TYR . 73.6 mt-30 -60.52 -24.15 65.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.176 -0.953 . . . . 0.02 110.494 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -68.74 -18.03 64.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.327 -0.858 . . . . 3.42 109.076 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.562 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.3 t90 -108.09 11.74 27.39 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.673 -1.232 . . . . 0.02 107.673 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.3 mmt 60.48 22.3 11.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.556 -0.715 . . . . 0.02 110.295 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.89 143.33 45.48 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.429 -1.468 . . . . 0.02 109.429 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.0 tp -78.58 -31.26 47.15 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.293 -1.373 . . . . 0.98 107.293 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -157.75 -172.07 3.8 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 106.097 -1.816 . . . . 0.02 106.097 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -98.16 28.26 4.13 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.701 -1.249 . . . . 0.02 110.692 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -96.76 121.87 39.09 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.736 -1.227 . . . . 3.2 111.039 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.4 mt -142.96 122.02 12.87 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 107.422 -1.325 . . . . 2.61 107.422 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.84 -17.61 9.55 Favored Glycine 0 N--CA 1.504 3.222 0 O-C-N 121.231 -0.918 . . . . 0.02 112.859 -177.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 p -156.37 156.48 33.96 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.04 -1.859 . . . . 0.02 110.61 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 44.2 t -144.34 146.85 32.8 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.38 -0.825 . . . . 0.02 110.476 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 -138.33 143.48 39.93 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.408 -0.807 . . . . 0.01 109.486 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.42 132.25 36.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.946 . . . . 0.43 109.825 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.3 t -91.56 125.63 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.878 -0.786 . . . . 1.25 108.878 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -94.26 131.85 39.44 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.783 -1.198 . . . . 1.77 109.234 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.3 mt -96.79 140.34 31.5 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.307 -0.871 . . . . 1.63 108.681 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.5 p -111.93 127.63 55.91 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.411 -0.806 . . . . 1.08 109.339 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.7 t -103.94 -154.66 0.51 Allowed 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 106.551 -1.648 . . . . 1.26 106.551 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.01 -52.45 0.75 Allowed Glycine 0 N--CA 1.5 2.944 0 O-C-N 120.512 -1.368 . . . . 0.01 112.807 177.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.26 -101.19 0.15 Allowed Glycine 0 N--CA 1.491 2.306 0 C-N-CA 118.457 -1.83 . . . . 0.01 112.161 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -121.94 119.8 32.57 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.033 -1.275 . . . . 4.43 110.791 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.4 129.73 34.74 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.833 -0.747 . . . . 2.99 109.362 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -130.1 142.23 50.62 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.347 -0.846 . . . . 6.36 109.073 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.0 tt -129.19 146.13 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 121.302 -0.874 . . . . 1.09 110.373 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -121.54 133.25 55.02 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.432 -1.321 . . . . 2.05 107.432 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.8 m -123.58 145.35 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 120.693 -1.255 . . . . 1.1 109.772 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -119.75 141.46 49.42 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 122.064 0.935 . . . . 0.73 111.012 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -67.24 -30.5 70.43 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.922 -0.581 . . . . 0.02 112.126 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -116.27 167.33 11.11 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 120.998 -1.064 . . . . 3.18 110.413 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.64 163.85 43.02 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 111.039 -0.825 . . . . 0.01 111.039 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.2 t70 56.82 38.75 29.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.921 -0.753 . . . . 0.01 110.896 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.437 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 21.2 m-85 52.26 55.95 8.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.656 -0.652 . . . . 0.01 111.103 178.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -128.8 165.39 21.05 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.256 -1.016 . . . . 3.15 108.256 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.22 -163.79 27.99 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.324 -1.511 . . . . 0.01 109.324 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 48.3 tp60 -75.03 143.48 43.5 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.998 -1.295 . . . . 0.01 108.551 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.45 ' SD ' ' C ' ' A' ' 107' ' ' MET . 12.3 tmm? -115.99 142.45 46.77 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.52 0.676 . . . . 0.01 109.746 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -131.83 136.5 47.53 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.249 -1.019 . . . . 2.48 108.249 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -118.76 134.14 55.35 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.576 -0.703 . . . . 0.01 109.948 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.62 ' HG1' ' H ' ' A' ' 112' ' ' GLU . 4.0 t -148.86 149.99 32.23 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.24 1.019 . . . . 1.69 110.946 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 32.2 p -109.94 10.38 24.32 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 115.485 -0.78 . . . . 0.01 110.106 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.62 ' H ' ' HG1' ' A' ' 110' ' ' THR . 28.1 mm-40 -121.29 163.16 19.04 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.264 -0.898 . . . . 3.21 111.715 -178.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -67.48 156.61 36.22 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.253 -1.017 . . . . 0.01 108.253 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 37.5 t -125.4 111.95 25.9 Favored Pre-proline 0 N--CA 1.503 2.177 0 O-C-N 121.368 -0.832 . . . . 0.01 109.035 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.438 ' O ' ' OG ' ' A' ' 171' ' ' SER . 19.1 Cg_endo -76.37 -32.62 3.8 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 CA-C-N 119.997 1.034 . . . . 0.01 111.635 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.504 ' HG ' ' H ' ' A' ' 119' ' ' GLU . 7.8 t -140.6 106.54 5.17 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.223 -0.923 . . . . 0.02 108.592 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 68.0 mt -65.03 -38.82 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.717 -0.615 . . . . 1.83 111.183 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.2 ttt -66.92 -38.07 85.51 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 118.946 -1.102 . . . . 1.34 109.929 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.504 ' H ' ' HG ' ' A' ' 116' ' ' SER . 62.6 mt-10 -69.15 -38.28 78.7 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.489 -1.382 . . . . 2.11 109.546 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -79.77 -47.25 15.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.322 -0.861 . . . . 2.08 112.269 -177.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -111.77 -0.53 15.91 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.378 -0.826 . . . . 0.02 112.824 -176.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.8 m80 61.71 34.67 17.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.752 -1.218 . . . . 0.02 109.837 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 40.9 mt -114.47 136.12 53.36 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.454 -0.779 . . . . 0.02 109.426 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -90.62 -22.04 21.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.3 -0.875 . . . . 5.32 110.864 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -148.05 163.92 35.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.99 -1.069 . . . . 0.02 109.97 -178.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.9 mm -129.28 125.28 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 107.857 -1.164 . . . . 2.17 107.857 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -109.74 -13.61 14.46 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.233 -0.917 . . . . 0.02 112.833 -177.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.437 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 2.3 t -158.87 149.63 20.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.797 -1.189 . . . . 0.01 108.987 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.581 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 30.0 p -170.14 148.81 3.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 1.22 108.865 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -120.88 113.03 19.54 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 122.453 1.12 . . . . 1.41 110.062 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.0 t -112.19 128.72 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.561 -1.274 . . . . 0.01 107.561 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 47.5 t -128.73 93.11 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 107.071 -1.455 . . . . 1.98 107.071 177.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -147.71 -75.99 0.18 Allowed 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 105.831 -1.914 . . . . 0.01 105.831 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 156.55 -54.53 0.4 Allowed Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.184 -1.567 . . . . 0.01 109.184 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 54.7 p -119.77 97.8 5.8 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.551 -0.97 . . . . 2.3 111.012 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -128.16 145.53 50.99 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 107.108 -1.442 . . . . 0.01 107.108 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 61.4 mt -122.02 138.89 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 120.883 -1.136 . . . . 1.69 110.714 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -113.71 144.11 43.5 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 106.873 -1.529 . . . . 2.49 106.873 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.513 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 15.7 m-85 -123.17 144.36 49.4 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.311 -0.868 . . . . 0.02 109.658 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -76.54 -28.97 56.52 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.624 -0.673 . . . . 0.02 111.999 -176.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mt -116.04 154.93 48.52 Favored Pre-proline 0 N--CA 1.506 2.331 0 O-C-N 120.544 -1.348 . . . . 1.48 108.915 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.95 165.94 2.4 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.235 1.29 . . . . 0.02 113.071 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.559 ' N ' ' ND2' ' A' ' 143' ' ' ASN . 1.2 m120 59.68 31.48 20.9 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 115.071 -0.968 . . . . 0.75 111.471 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 57.39 51.09 10.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.45 -0.781 . . . . 0.02 111.186 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -126.26 164.91 19.96 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.426 -0.796 . . . . 0.02 109.944 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.463 ' O ' ' NE2' ' A' ' 148' ' ' GLN . . . 89.01 -165.98 33.42 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.255 -1.138 . . . . 0.02 110.255 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -69.39 142.66 53.88 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.724 -0.868 . . . . 0.02 109.061 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.47 ' N ' ' CD ' ' A' ' 148' ' ' GLN . 7.2 mp0 -115.63 149.54 38.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.803 -0.56 . . . . 0.02 109.728 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -123.53 134.76 53.82 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.616 -0.678 . . . . 0.01 109.219 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.3 tp -95.24 121.15 36.59 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.632 -1.292 . . . . 0.01 108.956 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.47 ' CD1' ' CZ ' ' A' ' 156' ' ' TYR . 0.2 OUTLIER -94.63 160.24 14.72 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.325 -0.859 . . . . 0.01 109.045 -179.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.413 ' OD2' ' OH ' ' A' ' 156' ' ' TYR . 1.4 p-10 -109.34 -111.65 0.32 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.445 -0.784 . . . . 2.27 109.335 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.525 ' N ' ' OH ' ' A' ' 156' ' ' TYR . 49.7 pttt -168.81 45.55 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.114 -0.991 . . . . 1.84 109.923 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -113.59 -153.77 0.53 Allowed 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.503 -0.748 . . . . 2.28 109.122 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -106.39 106.37 16.85 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.417 -0.802 . . . . 0.01 109.075 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.623 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 2.9 m-85 -99.34 112.4 24.58 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.267 -0.895 . . . . 0.01 109.667 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -94.56 -22.67 18.05 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.129 -0.982 . . . . 0.01 111.411 -178.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -128.19 154.44 78.79 Favored Pre-proline 0 N--CA 1.502 2.146 0 O-C-N 120.84 -1.163 . . . . 2.54 108.822 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -60.12 -37.21 85.46 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 CA-C-N 119.268 0.774 . . . . 0.7 110.631 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 6.0 t -61.11 -19.88 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.756 -1.215 . . . . 0.86 109.048 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -65.15 -15.28 62.25 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.94 -1.1 . . . . 0.02 109.921 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.623 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 12.9 m0 -97.93 11.29 37.94 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.14 -0.975 . . . . 0.02 109.025 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.4 11.0 84.7 Favored Glycine 0 N--CA 1.491 2.329 0 O-C-N 120.793 -1.192 . . . . 0.02 111.177 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.34 140.88 32.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.066 -1.255 . . . . 0.02 110.066 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.68 -8.76 58.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.598 -0.689 . . . . 0.59 110.045 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 8.1 p -142.47 151.31 57.39 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 120.981 -1.075 . . . . 0.87 109.318 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -76.21 16.67 0.82 Allowed 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 120.837 1.024 . . . . 0.38 112.263 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.41 122.17 27.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.872 -1.142 . . . . 0.18 111.366 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 3.1 mt -149.12 123.51 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 105.873 -1.899 . . . . 3.99 105.873 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -112.21 -15.9 13.11 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.227 -0.92 . . . . 5.17 113.286 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 115' ' ' PRO . 20.9 m -156.6 160.42 39.4 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 119.245 -2.159 . . . . 0.02 110.041 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.419 ' CD1' ' C ' ' A' ' 172' ' ' PHE . 21.4 p90 -152.67 153.0 32.41 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.147 -0.971 . . . . 2.02 110.633 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 29.6 mtp180 -145.58 149.65 34.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.36 -0.837 . . . . 0.01 109.679 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -88.4 142.44 27.72 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.507 -0.746 . . . . 0.01 109.455 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.7 mt -93.59 129.93 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.257 -0.902 . . . . 3.04 109.126 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.5 p -137.53 148.7 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.239 -0.913 . . . . 1.89 109.902 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 . . . . . 0 N--CA 1.494 1.764 0 O-C-N 121.514 -0.741 . . . . 4.89 109.656 179.827 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.768 -1.333 . . . . 0.01 109.768 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -149.92 136.45 19.12 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.481 -1.011 . . . . 0.02 109.882 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.418 HG22 HD12 ' A' ' 7' ' ' ILE . 6.3 tt -128.87 139.24 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.157 -1.053 . . . . 0.02 108.157 178.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.1 t -121.7 130.18 53.26 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.328 -0.858 . . . . 0.39 110.033 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.545 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.8 m-85 -110.25 140.65 44.18 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.871 -0.788 . . . . 0.02 108.871 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.528 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 6.0 m-85 -122.37 138.79 54.41 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.214 -0.929 . . . . 0.02 109.612 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.425 ' OE2' ' NH2' ' A' ' 18' ' ' ARG . 87.7 mt-10 -68.03 -27.74 66.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.025 -1.047 . . . . 0.03 111.663 -178.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -114.53 169.86 8.74 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.812 -1.18 . . . . 0.03 110.379 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -75.67 158.92 31.72 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.611 0.719 . . . . 0.03 109.974 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 66.09 32.99 7.86 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.949 0.88 . . . . 0.74 110.97 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 55.23 41.57 31.27 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.31 0.576 . . . . 0.02 111.392 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 -112.94 166.23 11.59 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.327 -0.99 . . . . 0.02 108.327 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.68 -168.06 35.73 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 119.857 -1.163 . . . . 0.03 110.75 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.425 ' NH2' ' OE2' ' A' ' 11' ' ' GLU . 23.4 ttp180 -68.83 143.37 54.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.476 -1.014 . . . . 2.76 109.135 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -120.87 148.98 43.3 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.506 -0.746 . . . . 1.89 110.189 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -132.79 127.76 35.3 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.327 -0.99 . . . . 0.02 108.327 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -112.2 136.67 51.33 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.403 -0.811 . . . . 1.12 109.789 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.4 t -131.17 139.06 49.69 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.663 -0.648 . . . . 0.02 109.602 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -116.46 11.85 15.01 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.677 -0.639 . . . . 0.2 109.655 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.435 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 7.0 p -158.63 174.6 14.81 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.358 -0.978 . . . . 1.23 108.358 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -60.45 144.66 50.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.642 -1.286 . . . . 0.02 109.858 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 44.2 t -131.97 117.76 18.86 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.691 -0.855 . . . . 0.02 108.691 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.49 -25.37 50.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.18 -0.95 . . . . 0.24 110.894 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -154.2 102.96 2.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.97 -1.082 . . . . 1.14 109.218 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -102.41 9.43 39.72 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 122.127 0.965 . . . . 6.37 109.673 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -59.55 -25.17 64.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.523 -0.736 . . . . 3.11 111.362 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.3 t -76.15 -17.55 59.51 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.505 -1.372 . . . . 0.88 110.596 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -104.08 -21.86 13.52 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.358 -0.839 . . . . 0.02 109.486 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.4 tp -150.43 129.25 12.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.194 -0.941 . . . . 3.32 109.005 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.0 p -85.26 -10.22 56.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.81 -0.556 . . . . 0.02 111.131 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -171.1 162.38 7.06 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.009 -1.108 . . . . 0.02 108.009 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.8 p -144.08 115.33 7.97 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.703 -1.248 . . . . 0.02 108.766 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -108.26 1.75 22.22 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 120.86 -1.15 . . . . 0.03 110.969 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.8 t -154.95 154.3 32.38 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.636 -1.246 . . . . 0.02 107.636 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 61.3 mt -145.14 146.84 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.038 -1.039 . . . . 0.02 110.044 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -123.33 124.0 41.97 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.86 -1.163 . . . . 0.02 107.86 177.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.0 t -106.64 115.09 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 106.867 -1.531 . . . . 0.02 106.867 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -83.69 -33.75 25.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.655 -0.653 . . . . 3.81 110.754 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.76 152.09 21.83 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 118.92 -1.609 . . . . 0.02 110.881 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.76 173.21 49.6 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.727 -1.225 . . . . 0.01 110.617 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.2 m -119.62 135.4 54.82 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 107.861 -1.163 . . . . 1.48 107.861 177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.449 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 33.7 m95 -126.6 155.57 42.29 Favored 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 122.576 1.179 . . . . 0.02 112.188 -176.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.68 134.16 52.29 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 105.666 -1.976 . . . . 0.24 105.666 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.3 m -119.4 143.72 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.542 -0.724 . . . . 0.65 109.054 178.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -120.9 146.28 46.78 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 122.226 1.012 . . . . 0.02 109.963 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -66.42 -34.59 78.29 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.756 -0.656 . . . . 0.02 111.183 -177.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -125.38 157.95 65.94 Favored Pre-proline 0 N--CA 1.502 2.139 0 O-C-N 121.162 -0.961 . . . . 0.02 109.465 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -53.89 167.17 1.17 Allowed 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 121.672 1.581 . . . . 0.02 113.082 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.2 t30 63.79 36.53 10.42 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.04 -0.982 . . . . 0.02 111.119 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 45.93 51.68 10.49 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.596 0.712 . . . . 3.39 110.663 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.4 m -126.63 164.03 22.14 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.121 0.486 . . . . 2.33 109.924 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.86 -161.74 32.2 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.881 -1.288 . . . . 0.02 109.881 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -65.66 139.51 58.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.109 -1.23 . . . . 0.02 110.017 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 17.2 ptm -117.94 137.07 53.08 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.761 -0.587 . . . . 5.01 109.53 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -133.75 136.31 44.5 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.487 -0.758 . . . . 0.02 109.847 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.449 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 1.8 mp -95.39 131.64 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.522 -0.918 . . . . 1.72 108.522 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.7 mt -120.05 111.06 35.79 Favored Pre-proline 0 N--CA 1.502 2.146 0 O-C-N 121.504 -0.748 . . . . 0.02 110.682 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -77.13 168.73 22.73 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 CA-C-N 119.846 0.981 . . . . 1.47 109.981 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -52.67 141.49 20.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.831 -1.168 . . . . 4.25 110.184 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.04 -176.68 31.84 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.579 -1.296 . . . . 0.02 110.666 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -119.65 130.98 55.34 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.467 -1.019 . . . . 0.96 109.58 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.41 ' CD1' ' N ' ' A' ' 66' ' ' TYR . 31.3 m-85 -120.41 96.53 49.05 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 107.889 -1.152 . . . . 0.02 107.889 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.4 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.8 Cg_endo -67.24 -5.03 12.82 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 120.746 0.964 . . . . 0.02 114.0 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 32.6 mt-10 -157.66 156.07 31.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.592 -1.317 . . . . 2.02 108.373 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -61.55 -38.17 86.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.408 -0.807 . . . . 0.02 112.324 -177.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -61.01 -22.08 64.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.023 -1.048 . . . . 0.02 109.961 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.9 tpm_? -67.0 -19.04 65.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.508 -0.745 . . . . 3.42 110.03 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.454 ' C ' ' SD ' ' A' ' 73' ' ' MET . 2.2 p90 -110.42 16.3 21.68 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.336 -0.852 . . . . 0.02 109.091 178.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.454 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 3.0 mpp? 63.34 25.03 14.48 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.482 0.658 . . . . 0.02 110.768 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.51 145.17 47.41 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.838 -1.305 . . . . 0.02 109.838 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.6 tp -80.77 -31.2 35.89 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.663 -1.236 . . . . 0.98 107.663 177.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -157.56 -171.84 3.73 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 106.482 -1.673 . . . . 0.02 106.482 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -98.99 28.27 4.49 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.707 -1.245 . . . . 0.02 110.835 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.582 ' CG ' HH11 ' A' ' 78' ' ' ARG . 3.3 mtt-85 -96.2 122.66 39.29 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.859 -1.151 . . . . 3.2 110.872 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.0 mt -144.13 122.49 12.34 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.73 -1.211 . . . . 2.61 107.73 178.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.44 -16.45 10.23 Favored Glycine 0 N--CA 1.504 3.216 0 O-C-N 121.102 -0.998 . . . . 0.02 112.94 -177.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 73.3 p -156.79 156.53 33.43 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.177 -1.778 . . . . 0.02 110.339 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 53.2 t -143.97 147.2 33.6 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.539 -0.725 . . . . 0.02 110.191 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.1 mtp180 -137.8 142.83 40.84 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.335 -0.853 . . . . 0.01 109.456 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.87 132.03 36.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.92 . . . . 0.43 109.7 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.9 t -90.67 124.7 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.618 -0.882 . . . . 1.25 108.618 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -93.14 132.32 37.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.847 -1.158 . . . . 1.77 108.928 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.2 mt -97.37 139.77 32.82 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.669 -0.863 . . . . 1.63 108.669 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.3 m -110.74 124.87 52.81 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.46 -0.941 . . . . 1.08 108.46 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.8 t -115.85 130.39 56.82 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.651 -1.281 . . . . 1.26 107.608 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -154.13 -51.93 0.01 OUTLIER Glycine 0 N--CA 1.505 3.295 0 C-N-CA 117.951 -2.071 . . . . 0.01 113.24 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.11 -106.17 0.19 Allowed Glycine 0 N--CA 1.489 2.176 0 O-C-N 120.162 -1.787 . . . . 0.01 111.198 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -119.8 117.55 28.49 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.0 -1.294 . . . . 4.43 110.212 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.77 130.28 36.53 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.066 -0.654 . . . . 2.99 109.395 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.415 ' NZ ' ' CB ' ' A' ' 94' ' ' LYS . 7.3 ttpm? -131.72 141.27 49.5 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.492 -0.755 . . . . 6.36 109.409 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.0 tt -127.65 146.99 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.418 0 CA-C-O 121.809 0.814 . . . . 1.09 110.292 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -122.79 131.63 53.86 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.904 -1.147 . . . . 2.05 107.904 177.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.7 m -125.35 147.65 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 O-C-N 120.95 -1.094 . . . . 1.1 109.947 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.563 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 80.5 m-85 -119.19 141.67 48.66 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-O 121.948 0.88 . . . . 0.73 111.139 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -67.74 -31.17 70.91 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 116.104 -0.498 . . . . 0.02 111.322 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.436 ' O ' ' OG ' ' A' ' 128' ' ' SER . 45.6 mttp -116.31 170.15 8.76 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.089 -1.007 . . . . 3.18 110.04 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.56 169.72 43.97 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 111.174 -0.77 . . . . 0.01 111.174 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.6 t70 52.68 39.32 28.22 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.654 0.74 . . . . 0.01 111.611 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 52.42 48.72 22.01 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.601 -0.687 . . . . 0.01 110.975 178.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -123.09 164.93 17.68 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.379 -0.971 . . . . 3.15 108.379 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.64 -163.54 28.56 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.427 -1.469 . . . . 0.01 109.427 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -76.93 144.05 39.11 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.049 -1.265 . . . . 0.01 109.121 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.563 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 28.1 ttp -116.19 142.32 46.97 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.487 0.66 . . . . 0.01 109.824 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -131.75 136.26 47.44 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.413 -0.958 . . . . 2.48 108.413 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -121.55 135.21 55.03 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.53 -0.731 . . . . 0.01 109.9 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.0 t -148.57 151.94 35.93 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.97 -1.081 . . . . 1.69 110.799 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.4 p -111.54 8.68 21.09 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 116.028 -0.533 . . . . 0.01 110.618 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -120.63 162.96 18.76 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.162 -0.961 . . . . 3.21 111.311 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -67.6 156.52 36.59 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.397 -0.964 . . . . 0.01 108.397 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.492 ' SG ' ' OE1' ' A' ' 120' ' ' GLN . 42.8 t -125.57 114.36 25.19 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 108.928 -0.767 . . . . 0.01 108.928 178.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.446 ' O ' ' OG ' ' A' ' 171' ' ' SER . 20.6 Cg_endo -77.05 -31.92 3.49 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 CA-C-N 120.156 1.091 . . . . 0.01 111.122 178.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 41.1 t -141.74 107.56 5.13 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.556 -0.905 . . . . 0.02 108.556 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.419 HG22 HD12 ' A' ' 117' ' ' ILE . 64.7 mt -65.3 -38.69 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.656 -0.653 . . . . 1.83 110.951 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 118' ' ' MET . 1.1 tmt? -66.69 -38.37 86.63 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.942 -1.103 . . . . 1.34 109.758 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -68.56 -38.27 80.62 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.463 -1.398 . . . . 2.11 109.63 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.492 ' OE1' ' SG ' ' A' ' 114' ' ' CYS . 54.5 tt0 -80.11 -46.73 15.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.245 -0.91 . . . . 2.08 112.314 -177.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -112.27 -0.86 15.33 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.28 -0.887 . . . . 0.02 112.852 -176.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.7 m80 61.61 34.91 17.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.666 -1.272 . . . . 0.02 109.871 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.0 mt -114.01 135.63 53.8 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.521 -0.737 . . . . 0.02 109.229 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -90.9 -22.1 21.07 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.277 -0.889 . . . . 5.32 110.965 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -148.03 164.0 35.15 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.993 -1.067 . . . . 0.02 110.022 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.0 mm -128.69 124.77 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 107.555 -1.276 . . . . 2.17 107.555 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -109.43 -14.69 14.38 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.165 -0.959 . . . . 0.02 112.982 -176.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 10.0 p -161.14 153.21 19.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.563 -1.336 . . . . 0.01 109.467 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.428 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 27.9 p -167.79 149.43 5.47 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.796 -1.187 . . . . 1.22 107.796 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -112.83 103.59 11.59 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.104 -0.997 . . . . 1.41 108.924 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.8 t -111.22 125.92 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 115.766 -0.652 . . . . 0.01 109.569 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.2 t -122.92 86.42 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.77 -1.937 . . . . 1.98 105.77 175.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.438 ' O ' ' O ' ' A' ' 152' ' ' ASP . 3.3 tp10 -161.36 -158.17 0.55 Allowed 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 106.786 -1.561 . . . . 0.01 106.786 178.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -157.65 -3.7 0.08 OUTLIER Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.113 -1.995 . . . . 0.01 108.113 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.6 p -115.06 45.04 1.69 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 122.0 -0.706 . . . . 2.3 109.66 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -125.97 136.17 52.68 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.293 -0.879 . . . . 0.01 108.927 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 12.4 mt -123.71 141.28 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.693 -0.63 . . . . 1.69 109.383 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -114.3 144.82 42.63 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.059 -1.46 . . . . 2.49 107.059 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 19.9 m-85 -123.23 144.44 49.38 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.493 -0.754 . . . . 0.02 109.674 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.44 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 78.1 tt0 -75.58 -29.31 59.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.634 -0.667 . . . . 0.02 111.781 -176.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mt -115.05 154.94 47.15 Favored Pre-proline 0 N--CA 1.505 2.309 0 O-C-N 120.654 -1.279 . . . . 1.48 109.128 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -55.91 165.55 3.7 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.159 1.239 . . . . 0.02 112.809 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.485 ' OD1' ' N ' ' A' ' 143' ' ' ASN . 1.0 OUTLIER 60.71 32.46 20.25 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.198 -0.91 . . . . 0.75 111.451 178.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.417 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.9 m-85 57.43 51.72 9.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.563 -0.711 . . . . 0.02 110.96 177.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -127.13 165.11 20.18 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.492 -0.755 . . . . 0.02 110.325 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.59 -166.29 32.88 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.553 -1.019 . . . . 0.02 110.553 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -70.31 144.44 51.71 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.672 -0.899 . . . . 0.02 109.116 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -113.51 148.96 35.05 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.808 -0.558 . . . . 0.02 110.218 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -125.91 134.0 51.7 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.629 -0.669 . . . . 0.01 109.584 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.6 tt -103.91 123.56 47.37 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.073 -1.017 . . . . 0.01 109.776 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 8.8 mp -96.6 152.3 18.78 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.971 -1.081 . . . . 0.01 108.374 178.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.438 ' O ' ' O ' ' A' ' 133' ' ' GLU . 74.9 m-20 -111.32 -126.18 0.28 Allowed 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.309 -0.869 . . . . 2.27 110.492 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -129.25 42.03 3.37 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.399 -0.813 . . . . 1.84 109.7 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.411 ' H ' ' HH ' ' A' ' 156' ' ' TYR . 63.0 mttm -113.01 -174.39 2.44 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.403 -0.81 . . . . 2.28 109.141 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -105.11 111.87 24.8 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.667 -0.864 . . . . 0.01 108.667 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.624 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 20.2 m-85 -97.94 110.53 23.09 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.289 -0.882 . . . . 0.01 109.859 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -95.1 -22.19 18.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.143 -0.973 . . . . 0.01 111.128 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -127.55 155.15 77.35 Favored Pre-proline 0 N--CA 1.501 2.122 0 O-C-N 121.034 -1.042 . . . . 2.54 108.521 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -60.19 -36.74 87.32 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 120.449 0.766 . . . . 0.7 110.264 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -61.26 -20.16 21.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.936 -1.102 . . . . 0.86 109.255 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -66.11 -16.04 63.61 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.92 -1.113 . . . . 0.02 110.188 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.624 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 10.4 m0 -97.42 11.16 37.67 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.086 -1.009 . . . . 0.02 108.712 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.65 11.04 85.16 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.805 -1.188 . . . . 0.02 110.774 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.36 141.29 33.41 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.176 -1.191 . . . . 0.02 110.1 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.16 -8.58 58.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.567 -0.708 . . . . 0.59 110.302 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 9.7 p -143.96 151.02 51.52 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 120.769 -1.207 . . . . 0.87 109.21 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.81 18.42 0.62 Allowed 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 120.931 1.087 . . . . 0.38 112.318 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.8 121.84 26.94 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 122.427 1.108 . . . . 0.18 111.346 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.415 HD12 HG23 ' A' ' 169' ' ' ILE . 3.1 mt -150.05 123.7 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 105.831 -1.915 . . . . 3.99 105.831 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.528 ' N ' ' OE1' ' A' ' 170' ' ' GLN . 9.7 mp0 -113.5 -13.26 12.82 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.108 -0.995 . . . . 5.17 113.109 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 115' ' ' PRO . 26.7 m -157.05 160.63 39.13 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 119.255 -2.153 . . . . 0.02 110.185 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -152.59 151.92 31.22 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.163 -0.96 . . . . 2.02 110.301 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.417 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 27.0 mtp180 -145.16 152.41 39.98 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.3 -0.875 . . . . 0.01 110.252 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -89.5 143.42 26.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.695 -0.628 . . . . 0.01 109.588 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 9.1 mt -95.64 130.32 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 108.482 -0.933 . . . . 3.04 108.482 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.22 147.12 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.121 -0.987 . . . . 1.89 109.825 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.365 -0.834 . . . . 4.89 109.525 -179.927 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 109.557 -1.417 . . . . 0.01 109.557 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -152.71 137.84 17.36 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.334 -1.098 . . . . 0.02 109.66 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.8 tt -129.69 141.02 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.96 -0.756 . . . . 0.02 108.96 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.528 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.3 t -121.47 130.26 53.46 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.577 -0.702 . . . . 0.39 109.699 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 8.4 m-85 -109.76 139.97 44.21 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 109.123 -0.695 . . . . 0.02 109.123 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.528 ' CZ ' ' OG ' ' A' ' 8' ' ' SER . 6.3 m-85 -122.4 138.35 54.56 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.152 -0.967 . . . . 0.02 109.487 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -68.69 -27.75 66.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.219 -0.926 . . . . 0.03 111.424 -178.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.1 m-20 -114.75 170.49 8.28 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.937 -1.102 . . . . 0.03 110.384 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.487 ' CZ ' ' OE2' ' A' ' 68' ' ' GLU . 7.6 mtp180 -75.18 160.84 29.94 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.59 0.709 . . . . 0.03 110.122 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.596 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 2.0 m-80 62.87 35.13 13.77 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.792 0.806 . . . . 0.74 110.661 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.596 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 21.0 p90 49.58 42.21 22.65 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.451 -0.795 . . . . 0.02 111.057 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -109.03 165.95 11.2 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.851 -1.166 . . . . 0.02 107.851 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.82 -167.64 35.08 Favored Glycine 0 N--CA 1.495 2.628 0 O-C-N 120.687 -1.258 . . . . 0.03 110.794 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -69.07 144.08 54.06 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.426 -1.044 . . . . 2.76 109.285 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.478 ' NE ' ' OG ' ' A' ' 8' ' ' SER . 56.0 ttt180 -120.29 148.28 43.91 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.577 0.703 . . . . 1.89 109.996 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -132.38 127.42 35.4 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.169 -1.049 . . . . 0.02 108.169 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -112.28 136.85 51.21 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.37 -0.831 . . . . 1.12 109.89 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.4 t -131.17 138.99 49.69 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.582 -0.698 . . . . 0.02 109.681 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.498 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 33.3 t70 -117.09 10.67 13.98 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.648 -0.658 . . . . 0.2 109.7 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 48.9 m -158.35 174.21 15.49 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.377 -0.972 . . . . 1.23 108.377 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -61.12 144.66 53.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.66 -1.275 . . . . 0.02 110.163 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.3 t -131.92 117.69 18.79 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.56 -0.904 . . . . 0.02 108.56 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.54 -26.09 45.65 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.091 -1.005 . . . . 0.24 110.996 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 28.3 p-10 -153.47 101.39 2.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.971 -1.08 . . . . 1.14 108.968 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -104.69 9.73 35.0 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 122.108 0.956 . . . . 6.37 109.96 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -58.75 -24.79 62.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.541 -0.724 . . . . 3.11 111.035 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.0 t -74.1 -16.78 61.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.806 -1.184 . . . . 0.88 110.192 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.51 ' CD1' ' N ' ' A' ' 32' ' ' TYR . 18.1 m-85 -103.88 -22.03 13.56 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.349 -0.844 . . . . 0.02 109.388 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.2 tp -149.8 128.11 12.13 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.247 -0.908 . . . . 3.32 108.98 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.5 m -85.2 -9.85 57.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.698 -0.626 . . . . 0.02 110.828 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -170.55 163.05 8.28 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.619 -1.252 . . . . 0.02 107.619 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 t -142.04 114.98 8.68 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.723 -1.236 . . . . 0.02 108.772 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.55 ' N ' HD21 ' A' ' 37' ' ' ASN . 1.1 m-80 -108.86 -1.82 18.89 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.807 -1.183 . . . . 0.03 111.422 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 t -153.42 154.04 33.68 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.188 -1.041 . . . . 0.02 108.188 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.3 mt -145.85 145.86 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 120.955 -1.091 . . . . 0.02 110.802 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -124.03 124.84 43.42 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.495 -1.298 . . . . 0.02 107.495 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.7 t -104.91 114.18 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 107.144 -1.428 . . . . 0.02 107.144 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -84.56 -34.49 23.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.471 -0.768 . . . . 3.81 110.098 -178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.45 150.26 18.73 Favored Glycine 0 N--CA 1.489 2.212 0 C-N-CA 118.552 -1.785 . . . . 0.02 110.845 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.69 171.99 48.67 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.168 -1.173 . . . . 0.01 110.168 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.9 m -119.5 134.9 55.01 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.763 -1.199 . . . . 1.48 107.763 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.455 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 33.6 m95 -126.69 155.81 42.07 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 122.655 1.217 . . . . 0.02 112.448 -176.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.21 134.0 52.31 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 105.571 -2.011 . . . . 0.24 105.571 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.3 m -118.6 143.21 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.624 -0.673 . . . . 0.65 109.387 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -120.89 145.61 47.47 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 122.318 1.056 . . . . 0.02 110.06 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -66.22 -34.5 78.17 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.607 -0.724 . . . . 0.02 111.125 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 40.5 mtm180 -124.95 157.78 65.38 Favored Pre-proline 0 N--CA 1.503 2.215 0 O-C-N 121.035 -1.041 . . . . 0.02 109.546 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.58 167.09 1.03 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.773 1.649 . . . . 0.02 112.99 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 63.53 36.74 10.93 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.126 -0.943 . . . . 0.02 111.156 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 45.05 51.7 8.73 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.678 0.751 . . . . 3.39 110.574 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 94.8 p -125.86 163.53 22.73 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.27 0.557 . . . . 2.33 109.779 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.94 -161.5 31.92 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.686 -1.366 . . . . 0.02 109.686 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -67.01 139.94 57.69 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.992 -1.299 . . . . 0.02 110.281 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 15.4 ptm -118.69 138.16 52.82 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.578 -0.701 . . . . 5.01 109.962 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.421 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 58.8 m-85 -134.01 137.41 44.73 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.48 -0.762 . . . . 0.02 109.938 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.461 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 1.8 mp -96.03 131.81 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.597 -0.89 . . . . 1.72 108.597 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.5 mt -120.86 112.32 33.71 Favored Pre-proline 0 N--CA 1.504 2.231 0 O-C-N 121.329 -0.857 . . . . 0.02 110.886 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -77.64 169.95 20.01 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 CA-C-N 119.901 1.0 . . . . 1.47 110.061 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -53.46 140.56 27.59 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.917 -1.115 . . . . 4.25 110.449 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.07 -177.92 32.04 Favored Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.463 -1.351 . . . . 0.02 110.709 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -118.98 130.65 55.8 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.586 -0.949 . . . . 0.96 109.528 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -119.87 96.26 49.42 Favored Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 107.912 -1.144 . . . . 0.02 107.912 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -71.83 -6.18 18.59 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 120.891 1.061 . . . . 0.02 113.909 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.527 ' OE1' ' CE1' ' A' ' 69' ' ' TYR . 1.0 OUTLIER -154.57 152.53 30.15 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.755 -1.202 . . . . 2.02 107.755 179.384 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.527 ' CE1' ' OE1' ' A' ' 68' ' ' GLU . 9.3 p90 -60.24 -37.6 80.88 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.52 -0.737 . . . . 0.02 111.522 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -59.64 -24.3 63.75 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.77 -1.206 . . . . 0.02 109.491 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -71.74 -21.43 61.75 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.699 0.762 . . . . 3.42 109.064 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.548 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 2.2 t90 -108.22 6.77 26.99 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.482 -1.303 . . . . 0.02 107.482 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 13.3 mmt 61.01 22.37 12.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.646 -0.659 . . . . 0.02 110.832 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.83 145.78 47.71 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.293 -1.523 . . . . 0.02 109.293 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.446 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 7.6 mp -80.29 -31.14 38.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.225 -1.162 . . . . 0.98 108.336 178.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.515 ' ND2' ' CZ ' ' A' ' 78' ' ' ARG . 66.8 t30 -157.6 -171.86 3.73 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.635 -1.617 . . . . 0.02 106.635 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -98.62 28.53 4.17 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.723 -1.235 . . . . 0.02 110.613 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.574 ' CG ' HH11 ' A' ' 78' ' ' ARG . 3.3 mtt-85 -97.47 122.51 40.61 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.082 -1.011 . . . . 3.2 110.849 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.9 mt -143.65 121.89 12.26 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.684 -1.228 . . . . 2.61 107.684 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.83 -17.53 9.62 Favored Glycine 0 N--CA 1.504 3.184 0 O-C-N 121.078 -1.014 . . . . 0.02 112.981 -177.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.1 p -156.82 156.12 32.68 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.082 -1.834 . . . . 0.02 110.365 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 33.7 m -144.68 147.9 33.58 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.522 -0.736 . . . . 0.02 110.221 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 24.6 mtm180 -138.24 142.95 39.92 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.255 -0.903 . . . . 0.01 109.42 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.95 131.55 36.39 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.107 -0.995 . . . . 0.43 109.85 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.5 t -90.8 124.9 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.809 -0.811 . . . . 1.25 108.809 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -93.79 131.77 38.84 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.81 -1.181 . . . . 1.77 109.339 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.5 mt -96.38 140.19 31.41 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.408 -0.96 . . . . 1.63 108.408 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.2 m -111.73 127.17 55.7 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.374 -0.829 . . . . 1.08 109.313 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.3 m -103.56 -154.89 0.51 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 106.425 -1.694 . . . . 1.26 106.425 176.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.53 -52.36 0.74 Allowed Glycine 0 N--CA 1.5 2.942 0 O-C-N 120.404 -1.435 . . . . 0.01 112.772 177.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.44 -101.52 0.15 Allowed Glycine 0 N--CA 1.489 2.193 0 C-N-CA 118.533 -1.794 . . . . 0.01 111.942 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -121.0 119.41 32.45 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.09 -1.241 . . . . 4.43 110.549 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.08 129.48 35.26 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.808 -0.757 . . . . 2.99 109.355 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -129.9 140.55 50.94 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.559 -0.713 . . . . 6.36 109.172 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.8 tt -129.6 146.42 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 O-C-N 121.36 -0.837 . . . . 1.09 110.157 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -122.2 133.86 54.72 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 107.558 -1.275 . . . . 2.05 107.558 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.4 m -123.73 145.73 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 120.729 -1.232 . . . . 1.1 109.829 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.587 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 39.6 m-85 -119.88 141.62 49.41 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-O 122.02 0.915 . . . . 0.73 111.158 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -67.37 -31.04 71.0 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 116.025 -0.534 . . . . 0.02 111.776 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -115.9 167.44 10.95 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.912 -1.118 . . . . 3.18 110.46 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.512 ' CA ' ' HD1' ' A' ' 127' ' ' HIS . . . -66.96 164.12 43.87 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 111.005 -0.838 . . . . 0.01 111.005 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.0 t70 56.75 39.11 29.83 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.656 0.741 . . . . 0.01 110.927 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 52.1 55.74 8.77 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.577 -0.702 . . . . 0.01 111.085 177.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -129.24 165.7 20.86 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 108.304 -0.999 . . . . 3.15 108.304 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.36 -163.42 27.59 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.31 -1.516 . . . . 0.01 109.31 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.523 ' OE1' ' CE2' ' A' ' 108' ' ' TYR . 10.4 tm0? -75.94 143.62 41.51 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.946 -1.326 . . . . 0.01 108.459 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.587 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 33.2 ttp -116.33 142.36 46.95 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.492 0.663 . . . . 0.01 109.774 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.523 ' CE2' ' OE1' ' A' ' 106' ' ' GLN . 49.3 m-85 -131.39 136.54 48.11 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.197 -1.038 . . . . 2.48 108.197 178.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -117.73 133.59 55.78 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.558 -0.714 . . . . 0.01 109.959 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.1 t -148.47 149.24 31.32 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.352 1.072 . . . . 1.69 111.223 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.42 ' OG1' ' OE2' ' A' ' 112' ' ' GLU . 1.1 p -110.05 10.17 24.12 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.38 -0.827 . . . . 0.01 110.122 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 42.0 mp0 -121.42 163.36 18.86 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.253 -0.904 . . . . 3.21 111.694 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.54 156.46 36.67 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.153 -1.054 . . . . 0.01 108.153 178.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.566 ' SG ' ' NE2' ' A' ' 120' ' ' GLN . 48.2 t -124.84 112.36 27.12 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 121.429 -0.795 . . . . 0.01 109.077 178.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -76.52 -33.17 3.32 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 CA-C-N 120.073 1.062 . . . . 0.01 111.515 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.7 m -140.73 107.12 5.27 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.22 -0.925 . . . . 0.02 108.585 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 76.0 mt -64.92 -38.82 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.854 -0.529 . . . . 1.83 111.037 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 34.2 ttp -66.95 -38.47 86.18 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 118.902 -1.119 . . . . 1.34 109.95 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.85 -38.16 79.59 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.381 -1.45 . . . . 2.11 109.723 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.566 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 7.7 tt0 -79.68 -47.35 15.5 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.358 -0.839 . . . . 2.08 112.322 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -112.37 -0.67 15.3 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.39 -0.819 . . . . 0.02 112.832 -176.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 61.71 34.74 17.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.743 -1.223 . . . . 0.02 109.846 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 43.6 mt -114.09 136.15 53.24 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.453 -0.78 . . . . 0.02 109.442 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -90.59 -22.12 21.4 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.142 -0.974 . . . . 5.32 110.768 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -147.99 164.26 34.34 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.015 -1.053 . . . . 0.02 109.948 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.1 mm -129.2 125.94 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 107.784 -1.191 . . . . 2.17 107.784 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.512 ' HD1' ' CA ' ' A' ' 101' ' ' GLY . 22.0 t-80 -108.74 -13.97 14.69 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.175 -0.953 . . . . 0.02 112.599 -177.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.6 m -160.07 151.35 19.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.754 -1.216 . . . . 0.01 109.072 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.564 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 19.6 p -167.5 146.11 4.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.316 -0.865 . . . . 1.22 109.057 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.3 111.02 14.05 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-O 122.151 0.977 . . . . 1.41 110.27 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.6 p -112.84 137.71 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.03 -1.1 . . . . 0.01 108.03 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.8 t -128.32 93.65 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 106.768 -1.567 . . . . 1.98 106.768 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 134' ' ' GLY . 10.4 tm-20 -146.55 -77.69 0.18 Allowed 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 105.827 -1.916 . . . . 0.01 105.827 177.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.512 ' N ' ' OE1' ' A' ' 133' ' ' GLU . . . -177.63 -80.39 0.06 OUTLIER Glycine 0 N--CA 1.485 1.916 0 N-CA-C 108.263 -1.935 . . . . 0.01 108.263 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.1 t -120.72 127.3 51.89 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.559 -0.965 . . . . 2.3 110.161 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -127.3 152.24 47.7 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 106.907 -1.516 . . . . 0.01 106.907 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.5 mt -121.0 136.99 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 120.427 -1.421 . . . . 1.69 110.088 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -113.62 143.95 43.72 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.34 -1.355 . . . . 2.49 107.34 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 26.3 m-85 -122.42 144.71 48.87 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.292 -0.88 . . . . 0.02 109.297 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.436 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 78.0 tt0 -76.46 -29.0 56.76 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.501 -0.749 . . . . 0.02 111.705 -176.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.0 mt -115.95 154.67 48.37 Favored Pre-proline 0 N--CA 1.505 2.282 0 O-C-N 120.751 -1.218 . . . . 1.48 108.806 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -55.69 167.37 2.19 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 121.213 1.275 . . . . 0.02 112.794 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 59.47 31.14 20.83 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.147 -0.933 . . . . 0.75 111.408 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 57.28 51.25 10.33 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.534 -0.729 . . . . 0.02 110.993 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -126.1 164.62 20.5 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.545 -0.722 . . . . 0.02 109.938 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.18 -165.84 33.12 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.283 -1.127 . . . . 0.02 110.283 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.413 ' HG3' HH11 ' A' ' 147' ' ' ARG . 23.5 ttm-85 -69.34 142.6 53.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.51 -0.994 . . . . 0.02 109.067 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.464 ' N ' ' CD ' ' A' ' 148' ' ' GLN . 7.9 mp0 -114.8 148.52 38.32 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.343 0.592 . . . . 0.02 110.184 -178.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -124.78 135.61 53.11 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 109.048 -0.723 . . . . 0.01 109.048 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.7 tt -99.45 120.28 39.35 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.889 -1.132 . . . . 0.01 108.846 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.0 tp -101.85 154.06 19.27 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.256 -0.903 . . . . 0.01 109.066 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -104.71 -121.18 0.21 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.233 -0.917 . . . . 2.27 109.432 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.7 pttm -155.56 51.6 0.57 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.043 -1.036 . . . . 1.84 109.608 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -112.48 -152.99 0.51 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.496 -0.753 . . . . 2.28 109.068 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -106.39 100.21 9.75 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.385 -0.822 . . . . 0.01 109.045 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.655 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 6.7 m-85 -98.33 112.03 24.17 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.269 -0.894 . . . . 0.01 109.464 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -94.45 -22.52 18.22 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.242 -0.911 . . . . 0.01 111.448 -178.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -129.14 154.1 80.45 Favored Pre-proline 0 N--CA 1.502 2.167 0 O-C-N 120.758 -1.214 . . . . 2.54 108.808 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -59.46 -36.19 94.17 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 120.507 0.805 . . . . 0.7 110.795 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 60.5 t -61.02 -20.2 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.758 -1.214 . . . . 0.86 108.909 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -65.21 -15.31 62.32 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.882 -1.136 . . . . 0.02 109.691 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.655 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 11.5 m0 -98.06 11.06 38.88 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.254 -0.904 . . . . 0.02 109.067 178.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.81 11.45 83.9 Favored Glycine 0 N--CA 1.491 2.336 0 O-C-N 120.829 -1.169 . . . . 0.02 111.213 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.03 140.6 34.03 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.056 -1.261 . . . . 0.02 110.076 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -86.02 -8.77 57.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.566 -0.709 . . . . 0.59 110.322 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 9.7 p -141.41 150.97 59.74 Favored Pre-proline 0 N--CA 1.5 2.051 0 O-C-N 121.019 -1.05 . . . . 0.87 109.712 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -75.88 14.62 1.02 Allowed 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 120.908 1.072 . . . . 0.38 112.142 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.72 122.07 27.19 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.361 1.077 . . . . 0.18 111.212 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 3.8 mt -148.97 122.98 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 105.89 -1.892 . . . . 3.99 105.89 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.53 ' N ' ' OE1' ' A' ' 170' ' ' GLN . 13.9 mp0 -112.95 -15.69 12.82 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.115 -0.99 . . . . 5.17 113.07 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 12.8 t -156.31 159.57 38.95 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 119.328 -2.107 . . . . 0.02 109.941 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -153.08 154.12 34.21 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.039 -1.038 . . . . 2.02 110.689 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -145.24 149.93 35.78 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.776 0.798 . . . . 0.01 110.12 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -88.11 143.29 27.15 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.132 -0.692 . . . . 0.01 109.132 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.7 mt -94.48 129.71 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.266 -0.896 . . . . 3.04 109.024 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.3 m -136.29 147.04 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.158 -0.964 . . . . 1.89 109.526 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.533 ' CD ' ' H ' ' A' ' 177' ' ' GLU . 1.4 pm0 . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.89 . . . . 4.89 109.725 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.402 0 N-CA-C 110.037 -1.225 . . . . 0.01 110.037 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.5 tttm -149.19 135.82 19.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.473 -1.016 . . . . 0.02 109.753 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.428 HG22 HD12 ' A' ' 7' ' ' ILE . 7.7 tt -128.24 138.34 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 108.054 -1.091 . . . . 0.02 108.054 178.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 m -121.5 129.99 53.28 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.325 -0.86 . . . . 0.39 110.169 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 4.4 m-85 -110.58 141.18 44.12 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.967 -0.753 . . . . 0.02 108.967 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.546 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.7 m-85 -122.35 138.43 54.52 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.223 -0.923 . . . . 0.02 109.53 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -67.91 -27.78 66.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.99 -1.069 . . . . 0.03 111.409 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 2.4 m-20 -114.62 170.24 8.47 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.844 -1.16 . . . . 0.03 110.22 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -75.85 162.1 28.43 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.794 0.807 . . . . 0.03 110.241 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.402 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 21.2 t-20 62.76 33.09 15.68 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.106 0.955 . . . . 0.74 110.836 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 55.22 39.81 31.48 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.841 -0.618 . . . . 0.02 110.973 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -110.11 165.65 11.57 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.18 -1.044 . . . . 0.02 108.18 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.82 -168.07 35.49 Favored Glycine 0 N--CA 1.497 2.708 0 C-N-CA 119.827 -1.178 . . . . 0.03 110.748 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -69.45 143.87 53.45 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.483 -1.01 . . . . 2.76 109.239 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -120.67 148.95 43.25 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.584 0.707 . . . . 1.89 110.214 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -132.09 127.56 36.31 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.189 -1.041 . . . . 0.02 108.189 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.52 136.71 51.72 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.434 -0.791 . . . . 1.12 109.888 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 13.3 t -131.26 139.22 49.6 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.665 -0.647 . . . . 0.02 109.557 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.497 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 2.5 m-20 -116.83 11.13 14.38 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.71 -0.619 . . . . 0.2 109.694 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 47.5 m -158.23 174.76 14.68 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.263 -1.014 . . . . 1.23 108.263 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 3.5 m-20 -60.57 144.32 51.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.644 -1.285 . . . . 0.02 109.899 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 41.9 t -132.01 117.82 18.9 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.577 -0.897 . . . . 0.02 108.577 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.87 -25.26 48.48 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.168 -0.958 . . . . 0.24 110.922 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -154.31 102.87 2.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.931 -1.106 . . . . 1.14 109.274 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.433 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 43.6 p90 -102.06 9.95 39.93 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 122.019 0.914 . . . . 6.37 109.788 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.3 mtm180 -59.43 -25.46 64.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.475 -0.765 . . . . 3.11 111.505 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.9 p -76.05 -17.68 59.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.58 -1.325 . . . . 0.88 110.769 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -104.07 -22.17 13.48 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.335 -0.853 . . . . 0.02 109.589 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.4 tp -150.4 129.44 12.63 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.278 -0.889 . . . . 3.32 108.967 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.7 p -85.24 -9.92 57.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.8 -0.563 . . . . 0.02 111.129 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -171.46 162.78 6.71 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.77 -1.206 . . . . 0.02 108.015 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.493 ' C ' HD21 ' A' ' 37' ' ' ASN . 5.1 p -143.55 115.23 8.16 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.827 -1.17 . . . . 0.02 108.66 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.493 HD21 ' C ' ' A' ' 36' ' ' CYS . 2.0 m120 -107.54 2.08 23.83 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 120.756 -1.215 . . . . 0.03 110.881 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.531 ' HG ' ' N ' ' A' ' 39' ' ' ILE . 4.1 t -155.54 154.84 32.37 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.821 -1.177 . . . . 0.02 107.821 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.531 ' N ' ' HG ' ' A' ' 38' ' ' SER . 10.4 mt -146.29 146.58 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.951 -1.093 . . . . 0.02 110.654 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -123.68 124.82 43.6 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.159 -1.052 . . . . 0.02 108.159 177.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.5 t -106.6 115.19 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 106.803 -1.554 . . . . 0.02 106.803 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -83.98 -33.85 24.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.636 -0.665 . . . . 3.81 110.759 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.79 152.38 22.26 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 118.821 -1.656 . . . . 0.02 110.807 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.26 173.21 49.53 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.62 -1.276 . . . . 0.01 110.474 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.2 m -119.68 135.4 54.84 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.983 -1.118 . . . . 1.48 107.983 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.458 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 32.9 m95 -126.35 155.26 42.33 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-O 122.573 1.178 . . . . 0.02 112.263 -176.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.5 134.16 52.22 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 105.509 -2.034 . . . . 0.24 105.509 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.2 m -118.96 143.3 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.154 -0.684 . . . . 0.65 109.154 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.565 ' CE2' ' SD ' ' A' ' 58' ' ' MET . 28.1 m-85 -121.41 146.32 47.01 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 122.386 1.089 . . . . 0.02 110.046 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -66.2 -35.1 79.57 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.509 -0.769 . . . . 0.02 111.228 -177.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -125.36 157.67 66.89 Favored Pre-proline 0 N--CA 1.503 2.182 0 O-C-N 121.051 -1.03 . . . . 0.02 109.498 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -53.63 167.3 1.0 Allowed 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.704 1.602 . . . . 0.02 112.958 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 63.68 36.53 10.72 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 114.999 -1.0 . . . . 0.02 111.182 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 45.15 51.54 9.01 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.631 0.729 . . . . 3.39 110.612 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.0 t -126.29 163.78 22.46 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 121.201 0.524 . . . . 2.33 109.804 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.61 -161.57 32.4 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.738 -1.345 . . . . 0.02 109.738 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.98 140.34 57.72 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.054 -1.263 . . . . 0.02 110.346 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.565 ' SD ' ' CE2' ' A' ' 49' ' ' TYR . 49.2 ttp -118.84 138.17 52.91 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.691 -0.631 . . . . 5.01 109.827 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.47 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 56.1 m-85 -133.66 137.06 45.15 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.492 -0.755 . . . . 0.02 109.695 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.8 mm -94.74 131.09 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.912 -0.773 . . . . 1.72 108.912 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.561 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -119.21 110.56 37.67 Favored Pre-proline 0 N--CA 1.505 2.277 0 O-C-N 121.461 -0.775 . . . . 0.02 110.73 -178.316 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -77.63 168.32 22.74 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 CA-C-N 119.791 0.961 . . . . 1.47 110.068 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -53.16 141.74 22.4 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.757 -1.214 . . . . 4.25 110.35 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.27 -177.96 31.37 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.584 -1.293 . . . . 0.02 110.844 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -119.65 131.8 55.54 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.393 -1.063 . . . . 0.96 109.692 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.561 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 69.9 m-85 -122.04 96.07 46.96 Favored Pre-proline 0 N--CA 1.494 1.755 0 N-CA-C 108.015 -1.105 . . . . 0.02 108.015 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.28 -4.38 10.43 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 120.811 1.007 . . . . 0.02 113.729 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -157.61 155.44 30.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.603 -1.311 . . . . 2.02 108.229 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -60.46 -39.17 86.59 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.535 -0.728 . . . . 0.02 112.17 -177.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -60.34 -23.82 64.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.132 -0.98 . . . . 0.02 110.373 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -69.37 -18.45 63.78 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.764 0.793 . . . . 3.42 108.982 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.553 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.4 t90 -108.38 11.06 27.35 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.584 -1.265 . . . . 0.02 107.584 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.6 mmt 60.74 22.09 12.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.585 -0.697 . . . . 0.02 110.553 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.68 143.7 44.6 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.319 -1.512 . . . . 0.02 109.319 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.3 tp -78.79 -31.51 46.04 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.452 -1.314 . . . . 0.98 107.452 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -157.87 -172.47 3.94 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 106.262 -1.755 . . . . 0.02 106.262 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -98.44 28.39 4.18 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.659 -1.276 . . . . 0.02 110.627 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.421 ' HG3' HH11 ' A' ' 78' ' ' ARG . 20.9 ttm-85 -97.23 122.05 39.81 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.725 -1.234 . . . . 3.2 110.905 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.433 ' O ' ' CZ ' ' A' ' 29' ' ' PHE . 35.1 mt -144.14 122.8 12.55 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.566 -1.272 . . . . 2.61 107.566 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.17 -16.9 10.62 Favored Glycine 0 N--CA 1.504 3.189 0 O-C-N 121.024 -1.048 . . . . 0.02 112.814 -177.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 73.3 p -156.8 156.34 33.08 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.22 -1.753 . . . . 0.02 110.299 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 28.4 p -143.84 147.29 33.87 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.481 -0.762 . . . . 0.02 110.038 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.5 mtm180 -138.25 143.15 39.96 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.469 -0.769 . . . . 0.01 109.644 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.26 132.54 36.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.43 109.829 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.6 t -91.29 125.16 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.863 -0.791 . . . . 1.25 108.863 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -94.1 131.79 39.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.831 -1.168 . . . . 1.77 109.298 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.9 mt -96.38 140.15 31.45 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.312 -0.867 . . . . 1.63 108.855 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.1 t -111.57 127.1 55.62 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.449 -0.782 . . . . 1.08 109.092 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.5 p -103.56 -154.94 0.51 Allowed 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 106.485 -1.672 . . . . 1.26 106.485 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.96 -53.14 0.73 Allowed Glycine 0 N--CA 1.5 2.9 0 O-C-N 120.366 -1.459 . . . . 0.01 112.684 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -179.53 -101.72 0.15 Allowed Glycine 0 N--CA 1.489 2.221 0 C-N-CA 118.605 -1.76 . . . . 0.01 112.029 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -121.19 119.45 32.37 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.098 -1.236 . . . . 4.43 110.72 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.87 130.59 35.82 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.822 -0.751 . . . . 2.99 109.294 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -131.03 141.81 50.25 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.483 -0.761 . . . . 6.36 108.964 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.8 tt -129.28 146.66 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.366 -0.834 . . . . 1.09 110.038 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -122.01 133.68 54.81 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.766 -1.198 . . . . 2.05 107.766 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.2 m -123.42 145.56 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 120.788 -1.195 . . . . 1.1 109.736 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.594 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 32.2 m-85 -118.7 141.19 48.84 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 122.016 0.913 . . . . 0.73 110.716 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -66.2 -30.21 70.63 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.995 -0.548 . . . . 0.02 111.295 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -116.54 170.16 8.78 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.099 -1.001 . . . . 3.18 110.412 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.02 170.37 44.26 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.742 -0.943 . . . . 0.01 110.742 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 52.91 38.94 28.25 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.527 0.68 . . . . 0.01 111.587 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.424 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 24.7 m-85 51.8 49.17 21.35 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.525 -0.734 . . . . 0.01 111.059 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -123.62 165.59 16.94 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.322 -0.992 . . . . 3.15 108.322 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.72 -163.79 27.36 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.519 -1.432 . . . . 0.01 109.519 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.4 tp60 -76.75 144.56 39.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.028 -1.277 . . . . 0.01 108.497 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.594 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 12.6 ttt -116.01 141.53 48.0 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.658 0.742 . . . . 0.01 109.801 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -131.0 136.42 48.5 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.069 -1.086 . . . . 2.48 108.069 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -118.89 133.7 55.66 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.52 -0.738 . . . . 0.01 110.117 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 t -148.17 149.41 31.92 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 122.318 1.056 . . . . 1.69 110.962 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.0 p -111.33 9.95 21.59 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 115.501 -0.772 . . . . 0.01 110.336 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.468 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 23.6 mp0 -121.11 163.12 18.89 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.214 -0.929 . . . . 3.21 111.491 -178.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.74 156.61 37.98 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.471 -0.937 . . . . 0.01 108.471 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 19.6 t -127.15 113.67 21.67 Favored Pre-proline 0 N--CA 1.501 2.088 0 N-CA-C 108.749 -0.834 . . . . 0.01 108.749 178.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -74.52 -29.17 9.41 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 CA-C-N 120.446 1.195 . . . . 0.01 111.034 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 7.8 p -142.34 109.12 5.41 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.444 -0.785 . . . . 0.02 109.074 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.411 HG21 HD11 ' A' ' 117' ' ' ILE . 97.6 mt -63.81 -38.74 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.884 -0.51 . . . . 1.83 110.653 -178.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 118' ' ' MET . 12.4 tmm? -68.52 -37.74 80.27 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.255 -0.978 . . . . 1.34 110.208 -178.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -69.53 -38.27 77.46 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.48 -1.388 . . . . 2.11 109.958 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -79.78 -47.21 15.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.238 -0.914 . . . . 2.08 112.381 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -111.39 0.41 16.59 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.299 -0.875 . . . . 0.02 112.647 -176.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 59.98 33.48 21.42 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.749 -1.219 . . . . 0.02 109.529 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.3 mt -112.09 135.54 52.62 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.718 -0.845 . . . . 0.02 108.718 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -91.61 -22.9 20.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.17 -0.956 . . . . 5.32 110.24 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -149.48 164.28 35.46 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.159 -0.963 . . . . 0.02 109.88 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 35.0 mt -131.89 129.0 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 107.654 -1.239 . . . . 2.17 107.654 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 61.2 m80 -108.09 -11.95 15.2 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.364 -0.835 . . . . 0.02 112.314 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.424 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 2.7 t -159.01 151.14 21.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.915 -1.115 . . . . 0.01 108.871 178.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 5.7 t -168.43 144.05 3.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 1.22 108.873 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.7 tttm -125.57 109.33 12.53 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 122.509 1.147 . . . . 1.41 109.963 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.5 p -111.32 135.86 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.184 -1.413 . . . . 0.01 107.184 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 72.1 t -126.68 93.31 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 106.788 -1.56 . . . . 1.98 106.788 177.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -147.13 -75.3 0.19 Allowed 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 105.781 -1.933 . . . . 0.01 105.781 177.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 152.82 -53.79 0.46 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.567 -1.413 . . . . 0.01 109.567 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.4 p -120.16 99.79 6.81 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.494 -1.004 . . . . 2.3 111.348 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -128.64 145.37 51.17 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 107.572 -1.27 . . . . 0.01 107.572 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.448 HG23 HD12 ' A' ' 137' ' ' ILE . 56.8 mt -121.01 137.93 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 120.662 -1.274 . . . . 1.69 110.37 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -114.92 144.72 43.11 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 106.935 -1.506 . . . . 2.49 106.935 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 10.3 m-85 -124.2 144.32 50.0 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.411 -0.806 . . . . 0.02 109.857 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.42 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 38.7 tt0 -74.13 -29.08 61.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.687 -0.633 . . . . 0.02 111.874 -176.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.5 mt -115.74 154.56 48.08 Favored Pre-proline 0 N--CA 1.504 2.241 0 O-C-N 120.735 -1.228 . . . . 1.48 108.997 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -55.81 167.38 2.28 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.113 1.209 . . . . 0.02 112.726 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.1 m120 59.64 31.15 20.73 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.215 -0.902 . . . . 0.75 111.391 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 57.91 51.51 8.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.46 -0.775 . . . . 0.02 111.171 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -126.92 164.86 20.52 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.454 -0.779 . . . . 0.02 110.1 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.46 -165.95 32.82 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 110.414 -1.074 . . . . 0.02 110.414 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -69.37 142.73 53.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.554 -0.968 . . . . 0.02 108.883 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -114.69 148.94 37.54 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.339 0.59 . . . . 0.02 110.123 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.437 ' CD1' ' N ' ' A' ' 149' ' ' TYR . 13.0 m-85 -124.84 135.03 52.55 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 109.169 -0.678 . . . . 0.01 109.169 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.1 tt -100.36 122.42 43.1 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.907 -1.121 . . . . 0.01 109.021 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.1 mp -97.19 164.25 12.57 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.072 -1.018 . . . . 0.01 108.656 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -108.2 -101.71 0.37 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.462 -0.773 . . . . 2.27 109.527 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -172.99 43.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 1.84 109.617 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -112.41 -156.55 0.59 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.524 -0.735 . . . . 2.28 109.343 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -106.86 108.23 19.64 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.445 -0.785 . . . . 0.01 109.196 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.612 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 37.1 m-85 -98.92 113.58 25.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.343 -0.848 . . . . 0.01 109.532 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -94.62 -22.72 17.99 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.149 -0.97 . . . . 0.01 111.596 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -127.49 154.94 77.45 Favored Pre-proline 0 N--CA 1.503 2.187 0 O-C-N 120.916 -1.115 . . . . 2.54 108.775 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -60.7 -37.97 75.0 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 CA-C-N 119.317 0.792 . . . . 0.7 110.543 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 95.7 t -61.04 -19.92 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.842 -1.161 . . . . 0.86 109.259 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -65.26 -15.34 62.39 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.901 -1.125 . . . . 0.02 110.023 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.612 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 8.8 m0 -97.65 11.68 36.22 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.096 -1.003 . . . . 0.02 109.152 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.52 10.72 84.94 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.827 -1.178 . . . . 0.02 111.127 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.39 140.61 33.32 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.081 -1.246 . . . . 0.02 110.008 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.18 -8.92 58.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.708 -0.62 . . . . 0.59 110.025 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 4.6 m -143.26 150.03 50.51 Favored Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.033 -1.042 . . . . 0.87 109.013 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.5 17.68 0.64 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 120.583 0.855 . . . . 0.38 112.102 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.31 123.25 28.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.851 -1.155 . . . . 0.18 111.524 -177.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.5 mt -150.04 126.32 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 106.714 -1.588 . . . . 3.99 106.714 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' A' ' 170' ' ' GLN . 10.8 mp0 -112.3 -16.83 12.88 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.082 -1.011 . . . . 5.17 113.059 -177.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.7 p -157.33 160.77 38.85 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 119.162 -2.211 . . . . 0.02 110.242 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.414 ' CD1' ' C ' ' A' ' 172' ' ' PHE . 21.1 p90 -152.4 152.65 32.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.074 -1.016 . . . . 2.02 110.521 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -144.85 149.84 36.08 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.467 -0.77 . . . . 0.01 109.698 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -87.17 140.87 29.11 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.246 -0.65 . . . . 0.01 109.246 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 31.4 mt -92.47 129.44 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.14 -0.975 . . . . 3.04 108.839 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.9 m -136.76 148.04 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.244 -0.91 . . . . 1.89 109.793 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 4.89 109.529 179.925 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.603 -1.399 . . . . 0.01 109.603 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.519 ' NZ ' ' CB ' ' A' ' 6' ' ' LYS . 5.5 ttpm? -146.41 135.68 22.79 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.263 -1.139 . . . . 0.02 110.43 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.402 HG21 HD11 ' A' ' 7' ' ' ILE . 6.7 tt -129.77 139.85 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.256 -1.016 . . . . 0.02 108.256 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 m -120.7 129.48 53.68 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.337 -0.852 . . . . 0.39 110.065 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -109.8 139.46 44.83 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.846 -0.798 . . . . 0.02 108.846 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.551 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.6 m-85 -122.07 138.44 54.44 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.258 -0.901 . . . . 0.02 109.731 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -69.29 -27.5 65.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.03 111.575 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -114.36 169.5 8.99 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.894 -1.129 . . . . 0.03 110.242 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -75.44 158.56 32.48 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.663 0.744 . . . . 0.03 110.105 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.417 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 4.5 t-20 66.13 33.48 7.43 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.954 0.883 . . . . 0.74 111.16 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.417 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 1.0 OUTLIER 55.42 41.63 30.82 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 116.053 -0.521 . . . . 0.02 111.161 177.901 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -113.46 166.15 11.78 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.374 -0.973 . . . . 0.02 108.374 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.9 -167.29 36.33 Favored Glycine 0 N--CA 1.494 2.539 0 C-N-CA 119.927 -1.13 . . . . 0.03 110.765 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -69.06 142.0 54.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.524 -0.986 . . . . 2.76 109.302 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -120.48 149.09 42.94 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.625 0.726 . . . . 1.89 110.144 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -132.73 127.55 34.96 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.325 -0.991 . . . . 0.02 108.325 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 23.0 p-10 -112.57 136.85 51.62 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.412 -0.805 . . . . 1.12 109.733 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 13.2 t -131.07 138.83 49.75 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.678 -0.639 . . . . 0.02 109.626 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.494 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 2.6 p30 -116.41 11.06 14.83 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.529 -0.732 . . . . 0.2 109.817 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 43.1 m -158.38 174.66 14.79 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.318 -0.993 . . . . 1.23 108.318 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -60.8 144.16 53.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.714 -1.242 . . . . 0.02 109.916 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.5 p -131.57 117.16 18.36 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.594 -0.891 . . . . 0.02 108.594 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.03 -25.43 47.86 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.107 -0.996 . . . . 0.24 110.799 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -154.33 101.17 2.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.977 -1.077 . . . . 1.14 108.948 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -105.33 9.42 33.85 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.103 0.954 . . . . 6.37 109.788 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -58.52 -23.93 59.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.492 -0.755 . . . . 3.11 110.865 -178.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 53.6 p -74.58 -16.28 60.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.739 -1.226 . . . . 0.88 110.328 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -104.63 -22.14 13.29 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.462 -0.774 . . . . 0.02 109.63 -179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.7 tp -150.56 129.22 12.31 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.15 -0.969 . . . . 3.32 109.287 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.0 p -86.83 -10.41 53.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.657 -0.652 . . . . 0.02 111.69 -178.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.51 HH21 ' ND2' ' A' ' 37' ' ' ASN . 42.7 ttt180 -170.36 161.34 8.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.811 -1.181 . . . . 0.02 107.963 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.1 m -141.96 115.27 8.9 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.702 -1.249 . . . . 0.02 109.642 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.523 ' ND2' ' OD2' ' A' ' 77' ' ' ASP . 0.8 OUTLIER -107.88 0.14 21.87 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.837 -1.165 . . . . 0.03 110.801 -178.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 66' ' ' TYR . 37.1 t -156.31 154.58 30.86 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.039 -1.097 . . . . 0.02 108.039 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.4 mt -146.42 147.31 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.132 -0.98 . . . . 0.02 110.477 -178.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.506 ' NE ' ' HH ' ' A' ' 10' ' ' TYR . 25.3 ttm180 -123.53 124.4 42.76 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.189 -1.041 . . . . 0.02 108.189 177.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.8 t -106.54 115.04 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 106.921 -1.511 . . . . 0.02 106.921 177.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -83.76 -33.64 24.98 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.939 -0.705 . . . . 3.81 110.643 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.7 152.11 21.89 Favored Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.009 -1.567 . . . . 0.02 110.831 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.57 172.98 49.4 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.517 -1.325 . . . . 0.01 110.522 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.5 m -119.7 135.28 54.89 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 108.019 -1.104 . . . . 1.48 108.019 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.42 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 36.1 m95 -126.94 155.58 42.86 Favored 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 122.486 1.136 . . . . 0.02 112.112 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.39 134.05 52.31 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 105.573 -2.01 . . . . 0.24 105.573 176.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.3 m -118.6 143.59 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.584 -0.697 . . . . 0.65 109.226 178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -121.46 145.93 47.42 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 122.427 1.108 . . . . 0.02 110.335 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -66.35 -33.93 76.82 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.678 -0.692 . . . . 0.02 111.198 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.8 mtp180 -125.41 157.85 66.4 Favored Pre-proline 0 N--CA 1.502 2.16 0 O-C-N 121.046 -1.034 . . . . 0.02 109.515 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -53.74 166.97 1.15 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.742 1.628 . . . . 0.02 113.0 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 64.03 36.53 9.84 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.214 -0.903 . . . . 0.02 111.175 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 45.31 51.88 9.13 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.638 0.732 . . . . 3.39 110.593 178.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.3 p -126.51 163.84 22.5 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.167 0.508 . . . . 2.33 109.87 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.37 -162.12 31.81 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.766 -1.334 . . . . 0.02 109.766 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.414 ' H ' ' CD2' ' A' ' 57' ' ' HIS . 20.9 m-70 -65.52 138.27 57.96 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.035 -1.274 . . . . 0.02 110.066 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 20.6 ptm -118.12 137.21 53.1 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.326 0.584 . . . . 5.01 109.583 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.531 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 86.9 m-85 -133.98 138.67 45.58 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.419 -0.801 . . . . 0.02 109.752 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.1 mm -95.54 131.37 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 109.089 -0.708 . . . . 1.72 109.089 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.4 mt -120.89 111.91 33.94 Favored Pre-proline 0 N--CA 1.506 2.328 0 O-C-N 121.361 -0.837 . . . . 0.02 110.962 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -77.52 169.77 20.45 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 CA-C-N 119.876 0.991 . . . . 1.47 109.871 177.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -52.9 141.19 22.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.794 -1.192 . . . . 4.25 110.211 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.42 -177.83 32.38 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.52 -1.324 . . . . 0.02 110.781 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -120.67 131.93 54.83 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.374 -1.074 . . . . 0.96 109.832 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.411 ' O ' ' OG ' ' A' ' 38' ' ' SER . 94.7 m-85 -121.68 96.41 47.35 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 108.068 -1.086 . . . . 0.02 108.068 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.37 -3.8 10.67 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 120.796 0.997 . . . . 0.02 113.702 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -157.58 155.69 30.6 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.621 -1.3 . . . . 2.02 108.36 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -60.43 -39.29 86.93 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.54 -0.725 . . . . 0.02 112.013 -177.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -60.17 -23.37 63.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.968 -1.083 . . . . 0.02 110.279 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -70.61 -18.72 62.88 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.897 0.856 . . . . 3.42 109.044 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.546 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 1.3 t90 -107.8 10.29 28.75 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.409 -1.33 . . . . 0.02 107.409 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 13.5 mmt 60.46 22.26 11.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.627 -0.671 . . . . 0.02 110.294 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.76 144.39 46.28 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.398 -1.481 . . . . 0.02 109.398 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.9 mt -78.86 -30.44 45.12 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.626 -1.25 . . . . 0.98 107.626 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -157.11 -171.61 3.7 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 106.427 -1.694 . . . . 0.02 106.427 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.523 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 92.4 m-20 -98.82 28.37 4.35 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.733 -1.229 . . . . 0.02 110.42 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -96.91 122.62 40.09 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.005 -1.059 . . . . 3.2 110.936 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.7 mt -143.56 120.96 11.65 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.585 -1.265 . . . . 2.61 107.585 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.35 -17.3 10.11 Favored Glycine 0 N--CA 1.506 3.302 0 O-C-N 121.065 -1.022 . . . . 0.02 112.928 -177.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.2 t -156.99 156.46 33.0 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.159 -1.789 . . . . 0.02 110.331 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 38.6 m -145.42 148.19 33.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.453 -0.779 . . . . 0.02 110.086 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -138.14 143.12 40.17 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.308 -0.87 . . . . 0.01 109.413 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.37 132.36 36.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -0.952 . . . . 0.43 109.68 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.4 t -91.59 125.28 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.938 -0.764 . . . . 1.25 108.938 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 26.3 m-70 -95.57 129.99 42.57 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.707 -1.246 . . . . 1.77 109.274 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.6 mt -94.47 141.27 28.79 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.159 -0.963 . . . . 1.63 108.688 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.5 m -111.21 128.14 55.82 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.386 -0.821 . . . . 1.08 109.237 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.0 p -104.54 -153.96 0.49 Allowed 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 106.63 -1.618 . . . . 1.26 106.63 177.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.64 -52.76 0.74 Allowed Glycine 0 N--CA 1.501 3.024 0 O-C-N 120.414 -1.428 . . . . 0.01 112.807 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.35 -101.95 0.16 Allowed Glycine 0 N--CA 1.49 2.237 0 C-N-CA 118.533 -1.794 . . . . 0.01 112.108 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -121.53 119.13 31.08 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.144 -1.209 . . . . 4.43 110.788 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.05 130.39 35.47 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.92 -0.712 . . . . 2.99 109.267 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.473 ' NZ ' ' CB ' ' A' ' 94' ' ' LYS . 2.8 ttmp? -129.79 141.57 50.83 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.423 -0.798 . . . . 6.36 109.149 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.8 tt -128.14 145.64 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 121.356 -0.84 . . . . 1.09 110.465 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.541 ' OE1' ' N ' ' A' ' 96' ' ' GLN . 0.5 OUTLIER -122.32 132.29 54.33 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.382 -1.34 . . . . 2.05 107.382 177.203 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.5 m -124.51 146.47 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 O-C-N 120.601 -1.312 . . . . 1.1 109.746 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.577 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 71.3 m-85 -119.58 141.01 49.65 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 122.045 0.926 . . . . 0.73 111.161 -178.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -66.12 -30.37 70.85 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 116.004 -0.544 . . . . 0.02 111.365 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -117.0 170.57 8.53 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.13 -0.981 . . . . 3.18 110.473 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.66 169.29 45.05 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.805 -0.918 . . . . 0.01 110.805 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 23.9 t70 53.23 38.83 28.6 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.576 0.703 . . . . 0.01 111.55 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.464 ' H ' ' HG ' ' A' ' 128' ' ' SER . 20.1 m-85 52.14 48.8 21.95 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.503 -0.748 . . . . 0.01 110.846 178.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -123.28 165.55 16.77 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.215 -1.032 . . . . 3.15 108.215 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.43 -164.29 28.03 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.302 -1.519 . . . . 0.01 109.302 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.459 ' NE2' ' HH ' ' A' ' 108' ' ' TYR . 55.1 tt0 -76.84 144.57 38.97 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.053 -1.263 . . . . 0.01 108.675 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.577 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 30.3 ttp -116.74 142.57 46.74 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.638 0.732 . . . . 0.01 109.984 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.459 ' HH ' ' NE2' ' A' ' 106' ' ' GLN . 68.0 m-85 -131.27 136.49 48.23 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.184 -1.043 . . . . 2.48 108.184 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -118.56 133.92 55.49 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.466 -0.771 . . . . 0.01 109.817 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.459 ' HG1' ' N ' ' A' ' 111' ' ' THR . 4.5 t -148.15 149.86 32.77 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.128 0.966 . . . . 1.69 110.965 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.459 ' N ' ' HG1' ' A' ' 110' ' ' THR . 1.2 p -110.44 9.97 23.31 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 115.614 -0.721 . . . . 0.01 110.168 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -121.53 163.1 19.4 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.214 -0.929 . . . . 3.21 111.901 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 9.8 p30 -68.15 157.28 35.69 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.233 -1.025 . . . . 0.01 108.233 178.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.574 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 86.2 m -125.77 112.8 24.87 Favored Pre-proline 0 N--CA 1.501 2.104 0 O-C-N 121.503 -0.748 . . . . 0.01 109.172 178.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.446 ' O ' ' OG ' ' A' ' 171' ' ' SER . 19.1 Cg_endo -75.62 -30.93 5.84 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 CA-C-N 120.095 1.07 . . . . 0.01 111.042 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.4 m -141.96 106.55 4.85 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.493 -0.928 . . . . 0.02 108.493 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 95.0 mt -65.12 -38.1 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.745 -0.597 . . . . 1.83 111.203 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.1 ttt -67.75 -37.16 81.76 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.013 -1.075 . . . . 1.34 109.815 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -69.75 -38.34 76.77 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.493 -1.379 . . . . 2.11 109.721 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.529 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 7.7 tt0 -80.19 -47.24 14.99 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.404 -0.81 . . . . 2.08 112.345 -177.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -110.95 -0.4 16.76 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.386 -0.821 . . . . 0.02 112.67 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.9 m170 59.86 33.44 21.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.818 -1.176 . . . . 0.02 109.58 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 11.7 mt -112.42 135.53 53.01 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 108.791 -0.818 . . . . 0.02 108.791 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -92.06 -23.09 19.6 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.256 -0.902 . . . . 5.32 110.565 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -149.14 163.81 36.52 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.142 -0.973 . . . . 0.02 109.911 -178.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.408 HD11 HG21 ' A' ' 126' ' ' ILE . 43.2 mt -132.57 129.39 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 107.811 -1.181 . . . . 2.17 107.811 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.5 m80 -108.96 -12.07 14.91 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.364 -0.835 . . . . 0.02 112.466 -177.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.464 ' HG ' ' H ' ' A' ' 103' ' ' PHE . 3.2 t -159.26 151.21 20.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.736 -1.228 . . . . 0.01 109.239 178.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 28.4 p -166.5 149.61 7.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.971 -1.08 . . . . 1.22 109.295 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.434 ' O ' ' OE1' ' A' ' 96' ' ' GLN . 3.7 tmtp? -119.69 108.99 15.12 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 122.298 1.047 . . . . 1.41 109.422 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.4 t -114.71 127.84 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 107.673 -1.232 . . . . 0.01 107.673 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.2 t -130.67 94.88 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 107.378 -1.341 . . . . 1.98 107.378 177.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.606 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 22.5 tt0 -146.39 -74.61 0.21 Allowed 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 106.128 -1.804 . . . . 0.01 106.128 177.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 167.91 -65.69 0.19 Allowed Glycine 0 N--CA 1.484 1.841 0 N-CA-C 108.697 -1.761 . . . . 0.01 108.697 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.7 p -122.87 115.15 21.48 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.52 -0.988 . . . . 2.3 110.508 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.606 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 8.3 m95 -126.57 148.18 49.78 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 107.338 -1.356 . . . . 0.01 107.338 178.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.2 mt -120.4 134.67 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 120.392 -1.443 . . . . 1.69 110.343 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -114.71 143.93 44.26 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.366 -1.346 . . . . 2.49 107.366 178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.541 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 8.4 m-85 -123.65 144.78 49.41 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.373 -0.829 . . . . 0.02 109.741 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -77.36 -28.17 52.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.569 -0.707 . . . . 0.02 112.046 -176.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 47.7 mt -114.86 151.92 45.93 Favored Pre-proline 0 N--CA 1.504 2.235 0 O-C-N 120.683 -1.26 . . . . 1.48 109.143 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -52.93 166.12 1.01 Allowed 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 120.737 0.958 . . . . 0.02 112.72 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 59.25 31.19 21.0 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.111 -0.949 . . . . 0.75 111.432 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 57.24 51.47 10.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.562 -0.711 . . . . 0.02 111.298 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 51.0 mtp180 -125.96 164.46 20.77 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.499 -0.751 . . . . 0.02 109.935 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.37 -165.31 32.5 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.312 -1.115 . . . . 0.02 110.312 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -69.48 142.99 53.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.617 -0.931 . . . . 0.02 109.109 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -115.11 149.01 38.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.801 -0.562 . . . . 0.02 109.77 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -124.97 135.68 53.03 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.653 -0.654 . . . . 0.01 109.284 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.9 tp -97.07 120.61 37.74 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.648 -1.282 . . . . 0.01 109.368 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.4 tp -100.38 150.18 22.88 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.291 -0.881 . . . . 0.01 109.013 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -104.17 -108.72 0.27 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.673 -0.642 . . . . 2.27 109.374 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -167.59 54.68 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.967 -1.083 . . . . 1.84 109.839 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -113.76 -167.51 1.22 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.523 -0.736 . . . . 2.28 109.268 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -106.14 105.45 15.49 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.879 -0.785 . . . . 0.01 108.879 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -99.41 115.83 30.17 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.354 -0.841 . . . . 0.01 110.018 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -92.33 -25.26 18.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.993 -1.067 . . . . 0.01 110.873 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -127.5 153.73 77.42 Favored Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 108.14 -1.059 . . . . 2.54 108.14 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -58.78 -40.47 72.29 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 CA-C-N 119.502 0.858 . . . . 0.7 110.462 178.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 5.6 t -63.09 -22.96 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.716 -1.24 . . . . 0.86 109.821 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -66.37 -16.35 64.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.556 -1.34 . . . . 0.02 110.076 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.539 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 18.9 t90 -100.31 10.68 40.87 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.424 -0.797 . . . . 0.02 109.03 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.42 8.52 87.49 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 120.208 -0.996 . . . . 0.02 111.902 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -98.51 141.3 31.54 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.056 -1.261 . . . . 0.02 110.154 -178.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -88.66 -13.08 40.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.63 -0.669 . . . . 0.59 110.701 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 60.6 p -147.31 150.23 37.12 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 120.717 -1.239 . . . . 0.87 108.988 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -78.6 20.25 0.79 Allowed 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 120.816 1.011 . . . . 0.38 113.085 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.17 123.86 29.95 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.446 -1.409 . . . . 0.18 111.78 -177.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 11.7 mm -151.5 127.63 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 107.03 -1.47 . . . . 3.99 107.03 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -112.07 -16.6 13.02 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 121.078 -1.014 . . . . 5.17 113.719 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 115' ' ' PRO . 67.2 m -156.92 160.44 39.1 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 119.124 -2.235 . . . . 0.02 110.288 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.574 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 9.8 p90 -152.74 153.28 32.9 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.131 -0.981 . . . . 2.02 111.004 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -145.12 149.57 35.26 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.469 -0.769 . . . . 0.01 110.112 -179.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -88.52 144.1 26.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.603 -0.685 . . . . 0.01 109.416 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 8.2 mt -95.74 129.44 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.212 -0.93 . . . . 3.04 109.218 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.8 m -136.37 146.97 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.189 -0.944 . . . . 1.89 109.589 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.337 -0.852 . . . . 4.89 109.485 -179.854 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.705 -1.358 . . . . 0.01 109.705 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -145.33 134.66 23.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.248 -1.148 . . . . 0.02 110.522 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.412 HG23 HD11 ' A' ' 7' ' ' ILE . 6.8 tt -129.55 139.71 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.097 -1.075 . . . . 0.02 108.097 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.529 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.7 t -121.99 130.19 53.1 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.336 -0.853 . . . . 0.39 110.174 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.9 m-85 -110.61 140.37 45.01 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.919 -0.771 . . . . 0.02 108.919 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.577 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 1.9 m-85 -122.2 138.99 54.28 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.28 -0.888 . . . . 0.02 109.758 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -69.34 -27.79 65.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.075 -1.016 . . . . 0.03 111.673 -178.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -114.0 169.16 9.21 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.956 -1.09 . . . . 0.03 110.117 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -75.5 158.28 32.8 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.731 0.777 . . . . 0.03 110.087 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.408 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 2.0 m-20 66.72 33.36 6.34 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.948 0.88 . . . . 0.74 111.225 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.408 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 1.3 m-85 55.64 42.23 29.69 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.28 0.562 . . . . 0.02 111.555 177.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -113.79 165.6 12.4 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.216 -1.031 . . . . 0.02 108.216 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.46 -167.38 35.44 Favored Glycine 0 N--CA 1.494 2.504 0 C-N-CA 119.769 -1.205 . . . . 0.03 111.023 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -68.62 141.75 55.32 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.473 -1.016 . . . . 2.76 109.468 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.524 ' NE ' ' OG ' ' A' ' 8' ' ' SER . 54.4 ttt180 -121.09 149.16 43.16 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.609 -0.682 . . . . 1.89 109.935 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -134.99 130.03 35.11 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 108.729 -0.841 . . . . 0.02 108.729 178.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 3.3 m-20 -110.64 136.08 50.28 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.471 -0.768 . . . . 1.12 109.105 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.6 t -129.08 138.17 51.69 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.714 -0.616 . . . . 0.02 109.491 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -117.76 12.31 13.87 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.626 -0.671 . . . . 0.2 110.282 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 44.4 t -159.45 174.29 14.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.949 -1.094 . . . . 1.23 108.777 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.466 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 3.3 p-10 -61.91 145.36 53.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.685 -1.26 . . . . 0.02 110.142 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.0 t -132.6 117.09 17.49 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.78 -0.822 . . . . 0.02 108.78 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.55 -23.31 50.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.308 -0.87 . . . . 0.24 111.173 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -155.3 101.41 2.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.197 -0.939 . . . . 1.14 108.779 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.489 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 21.2 p90 -108.02 9.65 28.44 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 122.059 0.933 . . . . 6.37 110.504 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -59.58 -22.77 62.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.359 -0.838 . . . . 3.11 110.663 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.0 m -74.71 -15.73 60.77 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.672 -1.267 . . . . 0.88 109.968 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -103.77 -21.32 13.7 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.587 -0.696 . . . . 0.02 109.396 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.1 mt -149.8 129.64 13.33 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.915 0.864 . . . . 3.32 109.519 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.4 p -85.86 -10.11 55.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.819 -0.551 . . . . 0.02 110.23 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -171.77 161.81 6.04 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.098 -1.075 . . . . 0.02 108.098 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 77.4 m -143.24 116.44 8.96 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.902 -1.124 . . . . 0.02 108.861 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.523 ' ND2' ' OD2' ' A' ' 77' ' ' ASP . 4.0 m120 -108.43 0.58 21.13 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 120.901 -1.125 . . . . 0.03 111.429 -178.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.9 p -156.41 154.43 30.47 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.964 -1.124 . . . . 0.02 107.964 178.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.2 mt -146.81 147.77 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.188 -0.945 . . . . 0.02 110.357 -178.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -124.65 125.77 44.65 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.987 -1.116 . . . . 0.02 107.987 177.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.3 t -106.75 115.46 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 107.0 -1.481 . . . . 0.02 107.0 177.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -83.46 -33.95 25.51 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.652 -0.655 . . . . 3.81 110.486 -178.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.94 152.21 21.97 Favored Glycine 0 N--CA 1.488 2.126 0 C-N-CA 118.917 -1.611 . . . . 0.02 110.834 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.67 173.08 49.5 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.505 -1.331 . . . . 0.01 110.374 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.5 m -119.22 134.9 54.95 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 107.844 -1.169 . . . . 1.48 107.844 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.407 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 38.1 m95 -127.54 155.52 43.65 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 122.499 1.142 . . . . 0.02 111.991 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.98 134.19 51.97 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 105.676 -1.972 . . . . 0.24 105.676 176.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.4 m -117.76 143.06 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.629 -0.67 . . . . 0.65 109.213 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -120.97 145.32 47.86 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 122.23 1.015 . . . . 0.02 110.064 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -66.32 -32.78 74.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.756 -0.59 . . . . 0.02 111.326 -177.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -125.12 157.61 66.51 Favored Pre-proline 0 N--CA 1.502 2.146 0 O-C-N 121.114 -0.991 . . . . 0.02 109.503 -178.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -53.12 167.1 0.79 Allowed 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 121.739 1.626 . . . . 0.02 112.915 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 63.34 36.57 11.53 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.407 -0.815 . . . . 0.02 110.99 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.476 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 2.3 m-85 44.92 51.6 8.55 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.535 0.683 . . . . 3.39 110.565 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.0 p -125.97 163.68 22.47 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.207 0.527 . . . . 2.33 110.016 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.56 -162.1 31.54 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.794 -1.323 . . . . 0.02 109.794 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.599 ' HD1' ' H ' ' A' ' 57' ' ' HIS . 4.1 m80 -64.15 138.04 58.25 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.957 -1.319 . . . . 0.02 109.938 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 17.2 ptm -118.59 136.9 53.61 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.317 0.58 . . . . 5.01 109.643 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.542 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 84.5 m-85 -134.3 139.39 45.66 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 121.62 0.724 . . . . 0.02 109.702 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.5 mm -94.94 131.32 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.768 -0.827 . . . . 1.72 108.768 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.526 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.17 110.51 36.12 Favored Pre-proline 0 N--CA 1.505 2.282 0 O-C-N 121.386 -0.821 . . . . 0.02 110.693 -178.29 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -77.24 168.86 22.37 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 CA-C-N 119.958 1.021 . . . . 1.47 109.997 177.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -53.33 141.16 24.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.626 -1.296 . . . . 4.25 110.415 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.57 -177.71 32.57 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.558 -1.306 . . . . 0.02 110.571 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -120.04 131.14 55.01 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.537 -0.978 . . . . 0.96 109.656 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.526 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 48.7 m-85 -123.11 94.37 47.18 Favored Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 108.371 -0.974 . . . . 0.02 108.371 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -65.95 -3.04 7.61 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.027 1.152 . . . . 0.02 114.11 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -157.53 155.83 30.95 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.55 -1.343 . . . . 2.02 108.589 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -60.78 -39.41 88.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.484 -0.76 . . . . 0.02 112.21 -177.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -59.86 -23.63 63.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.969 -1.082 . . . . 0.02 110.324 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -70.72 -18.36 62.8 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.833 0.825 . . . . 3.42 108.858 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.544 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.1 t90 -108.07 10.42 28.16 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.29 -1.374 . . . . 0.02 107.29 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.445 ' N ' ' SD ' ' A' ' 73' ' ' MET . 2.6 mpt? 59.82 23.63 12.6 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.495 0.664 . . . . 0.02 110.535 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.54 144.89 45.55 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.377 -1.489 . . . . 0.02 109.377 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.3 tp -79.92 -31.05 40.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.119 -1.224 . . . . 0.98 107.701 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -157.47 -172.06 3.83 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 106.312 -1.736 . . . . 0.02 106.312 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.523 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 54.0 m-20 -97.9 27.52 4.44 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.705 -1.247 . . . . 0.02 110.674 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -95.98 121.62 37.92 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.879 -1.138 . . . . 3.2 110.561 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.489 ' O ' ' CZ ' ' A' ' 29' ' ' PHE . 27.5 mt -144.47 121.17 11.18 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 107.735 -1.209 . . . . 2.61 107.735 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -111.99 -15.97 9.53 Favored Glycine 0 N--CA 1.507 3.402 0 O-C-N 121.152 -0.968 . . . . 0.02 113.087 -177.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.496 ' HG ' ' N ' ' A' ' 82' ' ' CYS . 37.3 t -156.42 156.68 34.24 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 119.862 1.831 . . . . 0.02 110.921 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.496 ' N ' ' HG ' ' A' ' 81' ' ' SER . 20.0 p -145.92 148.29 32.65 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.635 -0.666 . . . . 0.02 110.108 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -137.81 142.91 40.81 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.386 -0.821 . . . . 0.01 109.396 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.85 131.99 36.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.43 109.767 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 t -91.11 125.47 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.843 -0.799 . . . . 1.25 108.843 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -93.13 132.32 37.37 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.764 -1.21 . . . . 1.77 108.826 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mt -98.56 140.33 32.95 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.3 -0.875 . . . . 1.63 108.928 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 60.7 p -111.41 124.8 52.99 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.533 -0.914 . . . . 1.08 108.533 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.4 m -116.35 133.0 56.51 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.697 -1.252 . . . . 1.26 107.924 177.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.11 -49.26 0.01 OUTLIER Glycine 0 N--CA 1.505 3.277 0 C-N-CA 117.707 -2.187 . . . . 0.01 113.724 -177.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -167.57 -105.76 0.19 Allowed Glycine 0 N--CA 1.49 2.25 0 CA-C-N 119.962 1.881 . . . . 0.01 111.213 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -120.11 117.89 29.14 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.97 -1.312 . . . . 4.43 110.306 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.38 129.92 35.53 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.684 -0.806 . . . . 2.99 109.392 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -131.03 140.79 50.14 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.545 -0.722 . . . . 6.36 109.178 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.9 tt -129.31 146.07 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.322 -0.861 . . . . 1.09 110.211 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -121.24 133.7 55.16 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.559 -1.274 . . . . 2.05 107.559 177.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.2 m -124.34 145.98 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 120.965 -1.084 . . . . 1.1 109.783 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -119.13 141.61 48.65 Favored 'General case' 0 N--CA 1.503 2.205 0 CA-C-O 122.124 0.964 . . . . 0.73 111.092 -178.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -66.63 -30.31 70.55 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 115.87 -0.605 . . . . 0.02 111.908 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -116.53 167.65 10.87 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.004 -1.06 . . . . 3.18 110.494 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.71 163.9 43.21 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 111.01 -0.836 . . . . 0.01 111.01 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 102' ' ' ASP . 2.3 m-20 57.09 38.73 29.28 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.808 0.813 . . . . 0.01 110.823 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.407 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 15.2 m-85 52.3 55.75 8.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.571 -0.705 . . . . 0.01 111.045 178.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -128.06 165.81 19.62 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 108.425 -0.954 . . . . 3.15 108.425 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.4 -163.95 27.86 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.235 -1.546 . . . . 0.01 109.235 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -75.31 144.64 42.32 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.993 -1.298 . . . . 0.01 108.527 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.45 ' SD ' ' C ' ' A' ' 107' ' ' MET . 10.8 tmm? -116.59 142.33 47.03 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.569 0.7 . . . . 0.01 109.865 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -131.97 136.3 47.21 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.259 -1.015 . . . . 2.48 108.259 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.519 ' OE2' ' N ' ' A' ' 110' ' ' THR . 1.9 tm-20 -118.94 134.88 54.89 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.575 -0.703 . . . . 0.01 109.931 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.519 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 3.0 t -148.55 150.71 33.83 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 122.27 1.033 . . . . 1.69 111.166 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 65.8 p -112.0 9.3 20.42 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 115.581 -0.736 . . . . 0.01 110.41 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -121.06 162.93 19.16 Favored 'General case' 0 N--CA 1.508 2.452 0 O-C-N 121.201 -0.937 . . . . 3.21 111.762 -178.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -67.97 156.62 36.89 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.266 -1.013 . . . . 0.01 108.266 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 30.6 t -127.12 114.84 21.79 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.556 -0.715 . . . . 0.01 109.196 178.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -75.08 -28.9 8.65 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 CA-C-N 120.396 1.177 . . . . 0.01 111.0 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 56.0 m -142.88 109.07 5.25 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.389 -0.819 . . . . 0.02 109.224 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 117' ' ' ILE . 97.3 mt -63.17 -38.77 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.832 -0.542 . . . . 1.83 110.627 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.5 ttp -68.89 -37.23 78.88 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.164 -1.014 . . . . 1.34 110.259 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -69.53 -38.8 77.66 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 120.352 -1.468 . . . . 2.11 110.058 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -79.99 -46.47 16.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.392 -0.817 . . . . 2.08 112.227 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -110.62 0.14 17.44 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.364 -0.835 . . . . 0.02 112.573 -176.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 59.63 33.22 21.92 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.644 -1.285 . . . . 0.02 109.404 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.0 mt -112.52 135.57 53.08 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 108.716 -0.846 . . . . 0.02 108.716 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -91.39 -22.53 20.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.155 -0.966 . . . . 5.32 110.361 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -149.64 164.02 36.32 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.136 -0.978 . . . . 0.02 109.833 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.6 mt -131.83 128.61 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 107.557 -1.275 . . . . 2.17 107.557 178.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.513 ' ND1' ' N ' ' A' ' 127' ' ' HIS . 1.8 m80 -107.93 -12.44 15.17 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.496 -0.753 . . . . 0.02 112.293 -177.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.407 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 7.0 t -159.92 152.12 20.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.015 -1.053 . . . . 0.01 109.05 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 6.3 p -169.98 145.17 2.86 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.183 -0.948 . . . . 1.22 109.016 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.6 tttp -125.74 111.58 15.08 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 122.452 1.12 . . . . 1.41 110.172 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.2 p -111.86 136.5 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.282 -1.377 . . . . 0.01 107.282 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 44.5 t -128.32 93.53 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 N-CA-C 106.865 -1.532 . . . . 1.98 106.865 177.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -146.33 -81.26 0.15 Allowed 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 105.911 -1.885 . . . . 0.01 105.911 178.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -178.91 -79.13 0.06 OUTLIER Glycine 0 N--CA 1.486 1.985 0 N-CA-C 108.488 -1.845 . . . . 0.01 108.488 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.4 t -119.08 122.13 41.41 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.454 -1.027 . . . . 2.3 110.068 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -125.75 150.74 47.49 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 106.847 -1.538 . . . . 0.01 106.847 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 82.6 mt -121.17 136.78 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 120.467 -1.396 . . . . 1.69 110.166 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -115.59 144.88 43.25 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.625 -1.25 . . . . 2.49 107.625 178.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.517 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 12.1 m-85 -123.4 144.09 49.71 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.436 -0.79 . . . . 0.02 109.666 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -74.74 -29.4 61.14 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.478 -0.764 . . . . 0.02 111.771 -176.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.5 mt -115.64 154.65 47.94 Favored Pre-proline 0 N--CA 1.505 2.29 0 O-C-N 120.706 -1.246 . . . . 1.48 108.939 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -55.64 167.31 2.18 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.131 1.221 . . . . 0.02 112.609 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.404 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 14.4 t-20 59.7 30.94 20.54 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.009 -0.996 . . . . 0.75 111.284 178.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 58.02 51.64 8.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.425 -0.797 . . . . 0.02 111.208 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -127.04 164.89 20.54 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.541 -0.725 . . . . 0.02 110.187 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.98 -165.81 33.36 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.385 -1.086 . . . . 0.02 110.385 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -69.1 142.5 54.44 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.558 -0.966 . . . . 0.02 109.027 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -113.99 148.52 36.79 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.554 0.692 . . . . 0.02 110.257 -177.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -125.09 134.34 52.53 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.01 -0.737 . . . . 0.01 109.01 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.9 tt -99.25 121.9 41.69 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.92 -1.113 . . . . 0.01 109.221 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.6 tt -98.35 140.98 31.82 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.587 -0.894 . . . . 0.01 108.587 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -103.39 -108.32 0.26 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.313 -0.867 . . . . 2.27 109.967 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 14.2 ttpp -153.27 52.47 0.73 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.939 -1.1 . . . . 1.84 109.611 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.413 ' CG ' ' H ' ' A' ' 155' ' ' GLU . 71.0 tttt -115.25 175.58 5.45 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.374 -0.829 . . . . 2.28 109.087 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.413 ' H ' ' CG ' ' A' ' 154' ' ' LYS . 78.8 mt-10 -102.94 111.72 24.18 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.237 -0.914 . . . . 0.01 108.644 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.51 ' N ' ' CD1' ' A' ' 156' ' ' TYR . 16.1 m-85 -99.76 115.6 29.9 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.373 -0.829 . . . . 0.01 110.506 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -92.82 -24.91 18.35 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.927 -1.108 . . . . 0.01 110.633 -178.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -127.82 154.04 78.05 Favored Pre-proline 0 N--CA 1.499 2.018 0 N-CA-C 108.139 -1.06 . . . . 2.54 108.139 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -58.86 -40.31 73.28 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 CA-C-N 119.416 0.827 . . . . 0.7 110.518 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 51.1 t -62.14 -23.02 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.887 -1.133 . . . . 0.86 109.594 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -66.54 -16.22 63.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.588 -1.32 . . . . 0.02 109.824 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.572 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 12.5 t90 -99.66 9.53 42.96 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.648 -0.871 . . . . 0.02 108.648 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 78.57 8.4 87.66 Favored Glycine 0 N--CA 1.492 2.373 0 O-C-N 120.904 -1.122 . . . . 0.02 111.512 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -98.23 141.61 30.93 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.231 -1.158 . . . . 0.02 109.973 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -87.27 -12.35 46.9 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.796 -0.565 . . . . 0.59 110.439 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.9 m -147.22 149.99 36.66 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 120.713 -1.242 . . . . 0.87 108.758 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -78.17 22.46 0.62 Allowed 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 120.807 1.005 . . . . 0.38 112.98 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.433 ' O ' ' CD1' ' A' ' 169' ' ' ILE . . . -83.6 123.18 29.52 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.618 -1.301 . . . . 0.18 111.812 -177.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.433 ' CD1' ' O ' ' A' ' 168' ' ' ALA . 5.4 mm -147.75 128.9 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 106.975 -1.491 . . . . 3.99 106.975 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -112.64 -17.83 12.51 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 120.95 -1.094 . . . . 5.17 113.497 -177.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.406 ' HG ' ' N ' ' A' ' 172' ' ' PHE . 20.1 t -157.36 160.52 38.55 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 119.108 -2.245 . . . . 0.02 110.265 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.441 ' CD1' ' C ' ' A' ' 172' ' ' PHE . 16.0 p90 -151.8 152.83 33.17 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.075 -1.015 . . . . 2.02 110.937 179.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -145.31 149.78 35.45 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.832 0.825 . . . . 0.01 110.119 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -88.77 145.5 25.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.732 -0.605 . . . . 0.01 109.403 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.1 mt -95.29 128.79 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.316 -0.865 . . . . 3.04 109.169 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 20.1 t -136.09 145.84 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.114 -0.991 . . . . 1.89 109.47 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.273 -0.892 . . . . 4.89 109.376 -179.978 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.555 -1.418 . . . . 0.01 109.555 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -145.55 135.4 23.54 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.233 -1.157 . . . . 0.02 110.436 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.417 HG21 HD13 ' A' ' 7' ' ' ILE . 6.6 tt -129.67 139.04 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.204 -1.036 . . . . 0.02 108.204 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.9 m -121.28 129.81 53.33 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.348 -0.845 . . . . 0.39 110.141 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 8.0 m-85 -110.06 140.29 44.27 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.672 -0.862 . . . . 0.02 108.672 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.556 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.3 m-85 -122.04 138.6 54.38 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.202 -0.936 . . . . 0.02 109.538 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -69.02 -27.6 65.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.012 -1.055 . . . . 0.03 111.44 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -114.29 169.26 9.17 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.787 -1.196 . . . . 0.03 110.161 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -75.68 158.84 31.81 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.736 0.779 . . . . 0.03 110.207 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.7 t30 65.9 33.49 7.89 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.992 0.901 . . . . 0.74 111.21 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 55.33 41.87 30.78 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.195 0.522 . . . . 0.02 111.341 178.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -113.6 166.08 11.88 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.232 -1.025 . . . . 0.02 108.232 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.73 -167.34 36.67 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.773 -1.203 . . . . 0.03 110.783 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -69.06 141.6 54.74 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.613 -0.934 . . . . 2.76 109.407 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -120.57 149.28 42.7 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.575 -0.703 . . . . 1.89 110.165 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -132.69 127.67 35.3 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.271 -1.011 . . . . 0.02 108.271 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -112.85 137.3 51.4 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.479 -0.763 . . . . 1.12 109.765 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 10.6 t -131.29 139.04 49.52 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.628 -0.67 . . . . 0.02 109.642 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.489 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 19.0 t70 -116.61 10.92 14.56 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.593 -0.692 . . . . 0.2 109.925 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 40.4 m -158.24 174.34 15.31 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.245 -1.02 . . . . 1.23 108.245 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 11.9 p-10 -60.66 144.31 52.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.541 -1.349 . . . . 0.02 109.848 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.1 t -131.83 117.61 18.77 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.559 -0.904 . . . . 0.02 108.559 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.94 -25.06 48.05 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.239 -0.913 . . . . 0.24 110.841 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -155.08 101.72 2.27 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.061 -1.024 . . . . 1.14 109.021 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.401 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 24.0 p90 -105.25 9.56 33.96 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 122.157 0.98 . . . . 6.37 109.84 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -58.5 -23.75 58.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.448 -0.782 . . . . 3.11 110.873 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.8 m -74.55 -16.77 60.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.641 -1.287 . . . . 0.88 110.174 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -104.12 -21.98 13.49 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.499 -0.751 . . . . 0.02 109.6 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.8 tp -150.58 129.15 12.24 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.11 -0.994 . . . . 3.32 109.157 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.7 m -85.38 -9.94 56.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.831 -0.543 . . . . 0.02 111.06 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -171.45 162.9 6.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.847 -1.158 . . . . 0.02 107.931 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.4 p -143.21 115.16 8.28 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.789 -1.194 . . . . 0.02 108.905 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -107.21 1.94 24.37 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.759 -1.213 . . . . 0.03 110.875 -178.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.6 t -156.23 154.37 30.63 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.749 -1.204 . . . . 0.02 107.749 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.8 mt -146.66 147.61 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 120.959 -1.088 . . . . 0.02 110.362 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -124.58 125.06 43.55 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.083 -1.08 . . . . 0.02 108.083 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.8 t -106.87 115.12 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 107.147 -1.427 . . . . 0.02 107.147 177.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -83.52 -33.9 25.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.528 -0.732 . . . . 3.81 110.906 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.15 152.35 22.11 Favored Glycine 0 N--CA 1.487 2.037 0 C-N-CA 118.919 -1.61 . . . . 0.02 110.937 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.45 173.13 49.5 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.577 -1.297 . . . . 0.01 110.418 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.5 m -119.23 134.97 54.91 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.827 -1.175 . . . . 1.48 107.827 178.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.425 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 35.0 m95 -126.8 155.22 43.21 Favored 'General case' 0 N--CA 1.504 2.234 0 CA-C-O 122.506 1.146 . . . . 0.02 112.08 -176.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.52 133.89 52.56 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 105.724 -1.954 . . . . 0.24 105.724 176.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.8 m -118.09 142.92 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 109.009 -0.737 . . . . 0.65 109.009 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -121.39 146.28 47.04 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 122.325 1.06 . . . . 0.02 110.155 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.497 ' OE2' ' ND2' ' A' ' 76' ' ' ASN . 7.6 tp10 -66.31 -35.08 79.46 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.548 -0.751 . . . . 0.02 111.185 -177.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 -125.44 157.77 66.78 Favored Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 121.126 -0.983 . . . . 0.02 109.529 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -53.61 167.17 1.03 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.761 1.641 . . . . 0.02 112.992 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 53' ' ' ASN . 1.1 t30 63.57 36.52 10.99 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.027 -0.988 . . . . 0.02 111.191 178.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 45.28 51.82 9.12 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.621 0.724 . . . . 3.39 110.572 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 88.2 p -126.1 163.61 22.72 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 121.223 0.535 . . . . 2.33 109.755 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.88 -161.92 32.32 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.708 -1.357 . . . . 0.02 109.708 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -66.7 139.23 57.83 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.015 -1.285 . . . . 0.02 110.281 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 14.3 ptm -118.64 137.98 52.91 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.598 -0.689 . . . . 5.01 109.758 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.442 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 59.4 m-85 -133.25 137.84 46.23 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.506 -0.746 . . . . 0.02 109.836 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.7 mm -94.98 131.12 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.846 -0.798 . . . . 1.72 108.846 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.56 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.19 110.94 35.67 Favored Pre-proline 0 N--CA 1.505 2.297 0 O-C-N 121.452 -0.78 . . . . 0.02 110.748 -178.233 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -77.74 168.37 22.5 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 CA-C-N 119.958 1.021 . . . . 1.47 110.115 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.89 141.28 28.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.822 -1.174 . . . . 4.25 110.489 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.26 -177.81 32.26 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 119.535 -1.316 . . . . 0.02 110.567 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -119.41 131.13 55.6 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.527 -0.984 . . . . 0.96 109.766 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.56 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 70.6 m-85 -122.05 96.26 46.79 Favored Pre-proline 0 N--CA 1.494 1.737 0 N-CA-C 108.162 -1.051 . . . . 0.02 108.162 178.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.401 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.6 Cg_endo -67.41 -3.77 10.66 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 120.77 0.98 . . . . 0.02 113.734 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.401 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 34.2 mt-10 -157.55 155.19 29.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.592 -1.317 . . . . 2.02 108.132 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -60.48 -38.92 85.8 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.622 -0.674 . . . . 0.02 112.11 -177.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -60.49 -23.83 64.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.042 -1.036 . . . . 0.02 110.366 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -69.46 -18.95 63.76 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.427 -0.796 . . . . 3.42 108.992 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.553 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 1.1 t90 -108.3 11.09 27.49 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.403 -1.332 . . . . 0.02 107.403 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.5 mtt 60.88 22.21 12.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.47 -0.769 . . . . 0.02 110.215 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.11 145.11 46.6 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.169 -1.572 . . . . 0.02 109.169 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.62 -31.03 41.6 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.66 -1.237 . . . . 0.98 107.66 178.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.657 ' N ' HD21 ' A' ' 76' ' ' ASN . 0.0 OUTLIER -157.16 -171.45 3.63 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 106.525 -1.657 . . . . 0.02 106.525 178.453 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -98.86 28.6 4.23 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.85 -1.156 . . . . 0.02 110.425 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -98.47 123.37 42.57 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.152 -0.967 . . . . 3.2 111.183 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.401 ' O ' ' CZ ' ' A' ' 29' ' ' PHE . 36.1 mt -145.03 122.33 11.57 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.518 -1.29 . . . . 2.61 107.518 177.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.99 -16.44 11.43 Favored Glycine 0 N--CA 1.504 3.173 0 O-C-N 121.132 -0.98 . . . . 0.02 112.695 -177.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.6 t -156.96 155.97 32.22 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.242 -1.74 . . . . 0.02 110.304 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.5 p -145.28 147.85 32.81 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.503 -0.748 . . . . 0.02 110.332 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.0 mtm180 -137.7 143.0 41.05 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.278 -0.889 . . . . 0.01 109.36 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.52 132.16 36.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.127 -0.983 . . . . 0.43 109.76 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.4 t -91.06 125.03 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.782 -0.821 . . . . 1.25 108.782 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -94.6 131.18 40.63 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.82 -1.175 . . . . 1.77 109.16 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -94.87 139.62 31.06 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.196 -0.94 . . . . 1.63 108.508 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.7 t -110.66 127.87 55.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.388 -0.82 . . . . 1.08 109.108 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 95.5 p -104.52 -154.32 0.5 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 106.547 -1.649 . . . . 1.26 106.547 177.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.55 -53.1 0.74 Allowed Glycine 0 N--CA 1.5 2.9 0 O-C-N 120.553 -1.342 . . . . 0.01 112.762 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.46 -101.5 0.15 Allowed Glycine 0 N--CA 1.489 2.168 0 C-N-CA 118.603 -1.76 . . . . 0.01 111.978 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -122.39 119.56 31.4 Favored 'General case' 0 N--CA 1.506 2.343 0 CA-C-N 118.666 1.233 . . . . 4.43 110.757 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.36 130.82 35.8 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.762 -0.775 . . . . 2.99 109.483 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -129.62 141.85 50.86 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.377 -0.827 . . . . 6.36 109.229 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.9 tt -128.3 144.73 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 O-C-N 121.35 -0.844 . . . . 1.09 110.123 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -122.5 133.39 54.59 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.501 -1.296 . . . . 2.05 107.501 177.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.9 m -124.56 146.36 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 O-C-N 120.628 -1.295 . . . . 1.1 109.884 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -120.04 141.85 49.38 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 122.013 0.911 . . . . 0.73 111.129 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -67.28 -30.82 70.8 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 116.03 -0.532 . . . . 0.02 111.908 -178.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -115.98 167.47 10.93 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.938 -1.101 . . . . 3.18 110.384 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.15 164.26 44.28 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.974 -0.851 . . . . 0.01 110.974 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 57.08 38.77 29.33 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.701 0.762 . . . . 0.01 110.935 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 52.44 55.97 8.36 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.467 -0.77 . . . . 0.01 110.991 178.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -129.14 165.77 20.63 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.238 -1.023 . . . . 3.15 108.238 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.57 -163.73 27.52 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.244 -1.542 . . . . 0.01 109.244 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -75.7 144.41 41.57 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.05 -1.265 . . . . 0.01 108.543 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.452 ' SD ' ' C ' ' A' ' 107' ' ' MET . 12.8 tmm? -116.56 142.33 47.02 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.623 0.725 . . . . 0.01 109.831 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -131.88 135.7 46.86 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.255 -1.017 . . . . 2.48 108.255 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.519 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.1 tm-20 -118.55 134.11 55.34 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.584 -0.698 . . . . 0.01 110.033 -178.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.574 ' HG1' ' H ' ' A' ' 112' ' ' GLU . 6.0 t -148.17 150.74 34.34 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.278 1.037 . . . . 1.69 111.072 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 72.9 p -110.85 9.68 22.47 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 115.498 -0.774 . . . . 0.01 110.227 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.574 ' H ' ' HG1' ' A' ' 110' ' ' THR . 58.5 mt-10 -120.86 162.74 19.31 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.234 -0.916 . . . . 3.21 111.563 -178.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -68.59 157.54 35.87 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.392 -0.966 . . . . 0.01 108.392 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 19.2 t -127.36 113.43 21.32 Favored Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 121.491 -0.756 . . . . 0.01 109.072 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -75.25 -28.09 9.06 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 CA-C-N 120.315 1.148 . . . . 0.01 111.02 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.8 t -142.38 109.08 5.38 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.363 -0.836 . . . . 0.02 109.088 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.405 HG23 HD13 ' A' ' 117' ' ' ILE . 98.0 mt -63.63 -39.31 84.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.824 -0.547 . . . . 1.83 110.76 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 15.3 ttt -68.85 -38.16 79.6 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.246 -0.982 . . . . 1.34 110.372 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -69.26 -38.48 78.43 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.528 -1.358 . . . . 2.11 109.872 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -79.98 -47.02 15.62 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.219 -0.925 . . . . 2.08 112.331 -177.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.448 ' C ' ' HD1' ' A' ' 122' ' ' HIS . 54.3 m-85 -110.94 0.23 17.01 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.251 -0.905 . . . . 0.02 112.653 -176.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.448 ' HD1' ' C ' ' A' ' 121' ' ' PHE . 5.3 m80 60.14 33.34 21.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.753 -1.217 . . . . 0.02 109.407 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.9 mt -112.46 135.36 53.25 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 108.791 -0.818 . . . . 0.02 108.791 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -91.47 -22.82 20.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.233 -0.917 . . . . 5.32 110.174 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -149.29 164.1 35.8 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.216 -0.928 . . . . 0.02 109.899 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 31.9 mt -131.78 128.7 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 N-CA-C 107.854 -1.165 . . . . 2.17 107.854 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -108.5 -12.88 14.94 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.286 -0.884 . . . . 0.02 112.256 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.5 m -159.4 150.75 20.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.992 -1.067 . . . . 0.01 108.937 178.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.46 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 24.9 p -168.95 147.63 3.98 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.356 -0.84 . . . . 1.22 108.782 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -121.3 111.39 17.29 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 122.542 1.163 . . . . 1.41 109.845 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.47 129.78 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.472 -1.307 . . . . 0.01 107.472 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.7 t -129.52 93.57 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 107.328 -1.36 . . . . 1.98 107.328 177.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.451 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 11.0 tm-20 -147.41 -75.55 0.19 Allowed 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 105.914 -1.884 . . . . 0.01 105.914 177.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.438 ' N ' ' OE1' ' A' ' 133' ' ' GLU . . . 171.06 -71.81 0.11 Allowed Glycine 0 N--CA 1.483 1.813 0 N-CA-C 108.601 -1.8 . . . . 0.01 108.601 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 16.5 p -119.56 115.82 24.79 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.604 -0.939 . . . . 2.3 110.24 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.451 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 6.4 m95 -126.33 149.71 49.0 Favored 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 106.677 -1.601 . . . . 0.01 106.677 178.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 81.3 mt -122.51 137.72 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 120.377 -1.452 . . . . 1.69 110.586 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -114.48 143.95 44.12 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.221 -1.4 . . . . 2.49 107.221 178.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.516 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 10.6 m-85 -123.18 143.87 49.73 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.241 -0.912 . . . . 0.02 109.521 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -74.32 -29.99 61.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.715 -0.616 . . . . 0.02 111.754 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.5 mt -116.76 153.97 49.33 Favored Pre-proline 0 N--CA 1.504 2.261 0 O-C-N 120.877 -1.14 . . . . 1.48 108.856 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.46 169.49 0.74 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.281 1.32 . . . . 0.02 113.122 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.414 HD21 ' NH2' ' A' ' 145' ' ' ARG . 53.4 m-20 57.61 32.31 21.66 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.046 -0.979 . . . . 0.75 111.511 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 55.83 48.36 18.31 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.551 -0.718 . . . . 0.02 110.908 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.414 ' NH2' HD21 ' A' ' 143' ' ' ASN . 82.9 mtm180 -122.6 163.92 19.14 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.505 -0.747 . . . . 0.02 109.914 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.23 -165.85 33.06 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.361 -1.096 . . . . 0.02 110.361 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.477 ' CZ ' ' OH ' ' A' ' 149' ' ' TYR . 17.9 ttp180 -69.26 142.71 54.08 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.523 -0.987 . . . . 0.02 109.244 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -114.62 148.36 38.23 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.368 0.604 . . . . 0.02 110.261 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.477 ' OH ' ' CZ ' ' A' ' 147' ' ' ARG . 67.4 m-85 -125.07 135.19 52.48 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.871 -0.788 . . . . 0.01 108.871 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.4 tt -99.73 122.18 42.34 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.919 -1.113 . . . . 0.01 109.12 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.9 tp -96.75 146.45 24.87 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.101 -1.0 . . . . 0.01 108.736 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -104.31 -130.65 0.27 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.422 -0.799 . . . . 2.27 110.215 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -133.78 52.0 2.1 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.398 -0.814 . . . . 1.84 109.654 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -116.24 -169.52 1.63 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.463 -0.773 . . . . 2.28 109.473 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -105.49 108.39 19.88 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.335 -0.987 . . . . 0.01 108.335 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.605 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 6.0 m-85 -99.42 111.78 24.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.343 -0.848 . . . . 0.01 110.522 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -96.34 -22.03 17.44 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.294 -0.879 . . . . 0.01 111.412 -178.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -127.4 154.36 77.26 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 121.018 -1.051 . . . . 2.54 108.845 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -59.52 -38.76 80.92 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 CA-C-N 119.261 0.772 . . . . 0.7 110.538 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 41.0 t -60.71 -20.18 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.901 -1.124 . . . . 0.86 109.014 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -65.46 -15.67 62.87 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.91 -1.119 . . . . 0.02 110.022 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.605 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 10.0 m0 -98.11 10.96 39.22 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.148 -0.97 . . . . 0.02 108.842 178.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.42 11.39 84.24 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.839 -1.172 . . . . 0.02 111.079 178.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.23 140.63 34.19 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.137 -1.213 . . . . 0.02 110.191 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.18 -8.54 58.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.608 -0.682 . . . . 0.59 110.271 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.8 t -143.42 150.38 51.19 Favored Pre-proline 0 N--CA 1.5 2.048 0 O-C-N 120.905 -1.122 . . . . 0.87 109.345 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -75.79 17.72 0.67 Allowed 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 120.771 0.98 . . . . 0.38 112.122 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.431 ' O ' ' CD1' ' A' ' 169' ' ' ILE . . . -82.84 122.89 28.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.883 -1.136 . . . . 0.18 111.258 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.431 ' CD1' ' O ' ' A' ' 168' ' ' ALA . 4.6 mm -147.27 128.14 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 106.725 -1.583 . . . . 3.99 106.725 178.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -111.22 -18.37 12.98 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.111 -0.993 . . . . 5.17 113.115 -177.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 4.8 p -157.91 161.58 38.24 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 119.319 -2.113 . . . . 0.02 110.309 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' A' ' 172' ' ' PHE . 17.5 p90 -150.73 152.07 33.34 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.142 -0.974 . . . . 2.02 110.02 178.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -144.9 149.23 34.93 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.701 0.762 . . . . 0.01 109.758 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 18.4 ttm180 -87.9 144.06 26.78 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.67 -0.644 . . . . 0.01 109.503 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.0 mt -94.27 128.84 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.249 -0.907 . . . . 3.04 109.045 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 25.6 m -136.34 146.79 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.061 -1.024 . . . . 1.89 109.586 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.337 -0.852 . . . . 4.89 109.438 -179.94 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.444 -1.462 . . . . 0.01 109.444 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -148.17 136.63 21.46 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.004 -1.292 . . . . 0.02 110.344 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.6 tt -130.73 140.86 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.906 -0.775 . . . . 0.02 108.906 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 m -121.42 130.4 53.56 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.499 -0.75 . . . . 0.39 109.934 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.6 m-85 -109.92 138.88 45.67 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.496 -0.752 . . . . 0.02 109.224 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.534 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.5 m-85 -122.32 139.14 54.16 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.317 -0.865 . . . . 0.02 109.805 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -69.5 -28.3 65.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.139 -0.976 . . . . 0.03 111.868 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -114.17 168.87 9.45 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.85 -1.156 . . . . 0.03 110.18 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -74.94 158.52 33.17 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.683 0.754 . . . . 0.03 109.938 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 66.52 33.52 6.63 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.953 0.882 . . . . 0.74 111.217 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 55.56 42.51 29.58 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.241 0.543 . . . . 0.02 111.32 177.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -113.56 165.88 12.07 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.357 -0.979 . . . . 0.02 108.357 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.63 -167.5 35.26 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.825 -1.179 . . . . 0.03 110.974 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -68.74 142.1 55.07 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.506 -0.997 . . . . 2.76 109.314 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -121.59 149.9 42.47 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.551 -0.718 . . . . 1.89 110.302 -178.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -134.72 129.28 34.47 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.662 -0.866 . . . . 0.02 108.662 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 15.9 p-10 -110.59 136.49 49.63 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.525 -0.734 . . . . 1.12 109.156 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 14.2 t -129.33 137.88 51.25 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.483 0.659 . . . . 0.02 109.44 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -116.96 12.02 14.51 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.597 -0.689 . . . . 0.2 109.753 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.444 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 42.3 t -159.44 174.24 15.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.052 -1.03 . . . . 1.23 108.559 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.419 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.4 p30 -61.03 144.16 53.95 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.715 -1.241 . . . . 0.02 110.006 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.8 t -131.85 116.96 17.89 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.576 -0.898 . . . . 0.02 108.576 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.53 -24.76 45.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.181 -0.95 . . . . 0.24 111.31 -178.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -153.85 101.97 2.48 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.955 -1.09 . . . . 1.14 109.113 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -104.5 9.31 35.55 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 122.148 0.975 . . . . 6.37 109.839 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -58.99 -25.31 63.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.466 -0.771 . . . . 3.11 111.17 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.0 p -74.28 -15.98 60.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.74 -1.225 . . . . 0.88 110.139 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -103.59 -21.81 13.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.46 -0.775 . . . . 0.02 109.741 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.5 mt -149.01 128.7 13.24 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.817 0.818 . . . . 3.32 109.443 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 76.7 p -84.74 -9.71 57.94 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.322 0.582 . . . . 0.02 109.626 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -171.51 162.09 6.45 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.835 -1.172 . . . . 0.02 107.835 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.0 p -142.21 115.1 8.68 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.952 -1.093 . . . . 0.02 108.462 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.429 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 50.8 t-20 -106.92 -0.59 23.07 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 120.811 -1.181 . . . . 0.03 111.649 -177.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 t -153.48 154.37 34.23 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.884 -1.154 . . . . 0.02 107.884 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.5 mt -146.47 145.93 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.864 -1.147 . . . . 0.02 110.726 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -124.97 125.73 44.36 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.044 -1.095 . . . . 0.02 108.044 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.0 t -104.93 113.71 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 106.727 -1.583 . . . . 0.02 106.727 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -84.92 -34.51 22.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.414 -0.804 . . . . 3.81 110.266 -178.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.32 150.43 19.16 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 118.541 -1.79 . . . . 0.02 110.879 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.75 172.0 48.7 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.102 -1.199 . . . . 0.01 110.102 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.6 m -119.43 134.72 55.08 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.844 -1.169 . . . . 1.48 107.844 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.453 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 32.8 m95 -127.2 154.95 44.18 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 122.567 1.175 . . . . 0.02 112.339 -176.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.91 134.62 51.33 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 105.267 -2.123 . . . . 0.24 105.267 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.2 m -116.5 141.42 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.589 -0.695 . . . . 0.65 109.251 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -120.72 143.56 48.7 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 122.04 0.924 . . . . 0.02 109.655 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -65.51 -34.55 78.52 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.472 -0.786 . . . . 0.02 111.595 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -125.52 157.84 66.72 Favored Pre-proline 0 N--CA 1.504 2.229 0 O-C-N 120.985 -1.072 . . . . 0.02 109.45 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -53.71 167.54 0.98 Allowed 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.711 1.607 . . . . 0.02 112.992 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 63.22 36.59 11.82 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 115.191 -0.913 . . . . 0.02 111.136 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 45.03 51.92 8.58 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.671 0.748 . . . . 3.39 110.674 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.9 t -125.94 163.66 22.5 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.183 0.516 . . . . 2.33 109.811 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.99 -162.08 32.3 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.744 -1.342 . . . . 0.02 109.744 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -66.06 138.58 57.87 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.079 -1.248 . . . . 0.02 110.204 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 23.4 ptm -118.87 137.12 53.66 Favored 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.326 0.584 . . . . 5.01 109.666 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -134.04 139.33 45.93 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.484 -0.76 . . . . 0.02 109.735 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.3 mm -95.35 131.04 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 109.048 -0.723 . . . . 1.72 109.048 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.537 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -119.56 111.3 36.4 Favored Pre-proline 0 N--CA 1.506 2.329 0 O-C-N 121.417 -0.802 . . . . 0.02 110.732 -178.259 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -78.28 168.98 20.87 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 CA-C-N 119.859 0.985 . . . . 1.47 110.258 177.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -54.19 141.0 30.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.812 -1.18 . . . . 4.25 110.593 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.31 -177.67 32.38 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.548 -1.311 . . . . 0.02 110.604 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -119.95 131.67 55.27 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.534 -0.98 . . . . 0.96 109.618 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.537 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 67.9 m-85 -120.4 95.86 49.04 Favored Pre-proline 0 N--CA 1.493 1.715 0 N-CA-C 108.144 -1.058 . . . . 0.02 108.144 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -68.29 -5.75 15.73 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 120.77 0.98 . . . . 0.02 113.394 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -156.74 154.08 29.43 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.653 -1.279 . . . . 2.02 107.705 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -60.04 -37.92 81.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.627 -0.671 . . . . 0.02 112.157 -177.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -59.8 -23.35 63.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.066 -1.021 . . . . 0.02 110.442 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -70.54 -19.21 62.91 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.822 0.82 . . . . 3.42 109.053 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.543 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.8 t90 -108.01 9.84 28.41 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.672 -1.233 . . . . 0.02 107.672 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.2 mtt 61.14 22.57 12.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.588 -0.695 . . . . 0.02 110.622 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.67 143.89 46.4 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.526 -1.43 . . . . 0.02 109.526 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.2 mt -79.2 -30.86 43.55 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.525 -1.287 . . . . 0.98 107.525 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.612 ' ND2' ' H ' ' A' ' 77' ' ' ASP . 18.0 t30 -157.33 -171.71 3.71 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 106.206 -1.775 . . . . 0.02 106.206 178.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.612 ' H ' ' ND2' ' A' ' 76' ' ' ASN . 72.0 m-20 -98.71 28.62 4.15 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.65 -1.281 . . . . 0.02 110.633 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.4 ttp180 -96.66 122.08 39.2 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.827 -1.171 . . . . 3.2 111.107 -178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.2 mt -142.91 121.83 12.76 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.473 -1.306 . . . . 2.61 107.473 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.6 -17.21 9.37 Favored Glycine 0 N--CA 1.502 3.082 0 O-C-N 121.15 -0.969 . . . . 0.02 112.894 -177.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.0 t -156.36 156.13 33.37 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.019 -1.871 . . . . 0.02 110.761 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.2 p -145.24 147.33 32.28 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.395 -0.816 . . . . 0.02 110.609 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 33.9 mtp180 -137.74 143.19 41.06 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.568 -0.707 . . . . 0.01 109.208 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.36 132.48 36.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.43 109.724 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.2 t -91.64 125.35 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.056 -0.72 . . . . 1.25 109.056 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -93.51 131.78 38.42 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.752 -1.217 . . . . 1.77 108.835 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.4 mt -98.15 141.62 30.84 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.369 -0.832 . . . . 1.63 109.147 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.1 m -111.78 124.86 53.24 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.547 -0.909 . . . . 1.08 108.547 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.4 t -116.57 134.02 55.33 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.686 -1.259 . . . . 1.26 108.173 177.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.66 -48.13 0.01 OUTLIER Glycine 0 N--CA 1.505 3.245 0 C-N-CA 117.677 -2.201 . . . . 0.01 114.077 -177.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -168.0 -105.45 0.18 Allowed Glycine 0 N--CA 1.491 2.364 0 CA-C-N 120.336 2.068 . . . . 0.01 111.29 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -120.01 117.98 29.46 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.998 -1.295 . . . . 4.43 110.391 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.56 129.93 35.37 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.74 -0.784 . . . . 2.99 109.291 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -129.22 140.84 51.32 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.46 -0.775 . . . . 6.36 109.158 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.9 tt -128.49 144.55 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.35 0 O-C-N 121.306 -0.871 . . . . 1.09 110.215 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -122.81 133.59 54.44 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.562 -1.273 . . . . 2.05 107.562 177.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.0 m -124.53 146.15 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 120.679 -1.263 . . . . 1.1 109.788 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.581 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 77.5 m-85 -118.67 141.56 48.49 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-O 121.99 0.9 . . . . 0.73 111.11 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -67.73 -30.9 70.5 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 116.012 -0.54 . . . . 0.02 111.829 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -116.54 167.43 11.07 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.023 -1.048 . . . . 3.18 110.413 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.403 ' CA ' ' ND1' ' A' ' 127' ' ' HIS . . . -66.68 164.07 42.89 Favored Glycine 0 N--CA 1.493 2.447 0 CA-C-O 121.989 0.771 . . . . 0.01 111.309 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.0 t70 56.45 39.13 30.11 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.647 0.737 . . . . 0.01 110.965 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 52.24 55.14 9.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.69 -0.631 . . . . 0.01 110.985 177.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -129.09 165.19 21.72 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.047 -1.094 . . . . 3.15 108.047 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.53 -163.93 27.7 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.27 -1.532 . . . . 0.01 109.27 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.519 ' NE2' ' HH ' ' A' ' 108' ' ' TYR . 9.2 tt0 -75.96 144.11 41.17 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.928 -1.336 . . . . 0.01 108.782 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.581 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 25.3 ttp -116.52 142.36 46.98 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.473 0.654 . . . . 0.01 109.928 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.519 ' HH ' ' NE2' ' A' ' 106' ' ' GLN . 60.9 m-85 -131.12 136.34 48.28 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.231 -1.026 . . . . 2.48 108.231 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -117.74 134.15 55.2 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.666 -0.646 . . . . 0.01 110.127 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.5 t -148.98 149.11 30.62 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.025 -1.047 . . . . 1.69 111.087 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 37.4 p -111.04 9.64 22.09 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 115.505 -0.77 . . . . 0.01 110.349 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -120.82 163.12 18.65 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 121.234 -0.916 . . . . 3.21 111.56 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.69 156.92 35.78 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.318 -0.993 . . . . 0.01 108.318 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 20.6 t -127.55 113.8 21.03 Favored Pre-proline 0 N--CA 1.498 1.973 0 N-CA-C 108.846 -0.798 . . . . 0.01 108.846 178.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -75.01 -27.7 9.78 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 CA-C-N 120.389 1.175 . . . . 0.01 110.911 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.2 t -143.05 109.01 5.18 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.336 -0.853 . . . . 0.02 109.137 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.41 HG21 HD12 ' A' ' 117' ' ' ILE . 87.1 mt -63.45 -39.24 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.892 -0.505 . . . . 1.83 110.547 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 118' ' ' MET . 0.7 OUTLIER -68.73 -37.27 79.32 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.277 -0.969 . . . . 1.34 110.365 -178.308 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -69.8 -38.66 76.72 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.4 -1.437 . . . . 2.11 109.974 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -79.71 -46.54 16.89 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.291 -0.881 . . . . 2.08 112.264 -177.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -111.05 0.49 16.95 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.312 -0.867 . . . . 0.02 112.674 -176.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 59.95 33.53 21.48 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.737 -1.227 . . . . 0.02 109.442 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.2 mt -112.62 135.38 53.41 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 108.713 -0.847 . . . . 0.02 108.713 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -91.25 -22.86 20.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.144 -0.972 . . . . 5.32 110.246 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -149.62 164.33 35.46 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.241 -0.912 . . . . 0.02 109.791 -178.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.7 mt -131.74 128.64 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 107.65 -1.241 . . . . 2.17 107.65 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 127' ' ' HIS . 51.4 t-80 -107.97 -12.85 15.08 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.421 -0.799 . . . . 0.02 112.107 -177.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.4 m -159.15 150.62 20.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.004 -1.06 . . . . 0.01 109.018 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 6.0 p -169.39 148.45 3.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.39 -0.818 . . . . 1.22 109.045 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -122.96 113.4 19.03 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 122.396 1.093 . . . . 1.41 110.102 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 t -112.09 129.86 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 107.351 -1.352 . . . . 0.01 107.351 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 96.3 t -129.61 93.9 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 107.392 -1.336 . . . . 1.98 107.392 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.462 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 3.5 tm-20 -146.97 -78.48 0.17 Allowed 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 105.87 -1.9 . . . . 0.01 105.87 177.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 173.24 -69.49 0.1 Allowed Glycine 0 N--CA 1.484 1.882 0 N-CA-C 108.77 -1.732 . . . . 0.01 108.77 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.9 p -120.51 114.04 21.19 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.587 -0.949 . . . . 2.3 110.387 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.462 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 6.5 m95 -124.94 148.8 48.18 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 107.303 -1.369 . . . . 0.01 107.303 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.8 mt -121.58 136.46 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 120.452 -1.405 . . . . 1.69 110.184 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -115.32 144.35 43.89 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.69 -1.226 . . . . 2.49 107.69 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 8.9 m-85 -123.45 144.04 49.77 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.324 -0.86 . . . . 0.02 109.648 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -75.9 -28.95 58.28 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.698 -0.626 . . . . 0.02 111.881 -176.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 47.3 mt -114.64 151.37 45.25 Favored Pre-proline 0 N--CA 1.504 2.267 0 O-C-N 120.712 -1.242 . . . . 1.48 109.014 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -53.6 167.36 0.97 Allowed 'Trans proline' 0 N--CA 1.49 1.275 0 CA-C-O 122.555 0.981 . . . . 0.02 112.543 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.6 m120 59.51 30.45 20.11 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 115.023 -0.99 . . . . 0.75 111.268 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.428 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.7 m-85 57.8 51.3 9.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.429 -0.794 . . . . 0.02 111.236 177.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -126.24 164.25 21.39 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.498 -0.751 . . . . 0.02 109.993 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.23 -165.25 32.64 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.352 -1.099 . . . . 0.02 110.352 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.573 ' CZ ' ' HH ' ' A' ' 149' ' ' TYR . 16.6 ttp180 -69.19 142.29 54.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.685 -0.891 . . . . 0.02 109.122 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -114.58 148.42 38.06 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.343 0.592 . . . . 0.02 110.134 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.573 ' HH ' ' CZ ' ' A' ' 147' ' ' ARG . 80.9 m-85 -124.07 134.3 53.43 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 109.019 -0.734 . . . . 0.01 109.019 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.1 tt -98.51 121.55 40.59 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.852 -1.155 . . . . 0.01 108.86 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 42.5 tp -97.3 142.45 29.17 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.212 -0.93 . . . . 0.01 108.67 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -107.13 -113.3 0.28 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.612 -0.68 . . . . 2.27 109.662 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -149.04 57.28 1.02 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.129 -0.982 . . . . 1.84 109.212 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -118.11 -179.31 3.73 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.386 -0.821 . . . . 2.28 109.091 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -106.49 107.41 18.4 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.63 -0.878 . . . . 0.01 108.63 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 156' ' ' TYR . 30.9 m-85 -98.78 113.44 25.55 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.29 -0.881 . . . . 0.01 110.328 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -93.51 -24.66 17.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.0 -1.062 . . . . 0.01 110.445 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -129.08 154.51 80.45 Favored Pre-proline 0 N--CA 1.498 1.974 0 N-CA-C 107.969 -1.123 . . . . 2.54 107.969 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -58.09 -38.62 90.87 Favored 'Trans proline' 0 N--CA 1.489 1.214 0 CA-C-N 119.467 0.845 . . . . 0.7 110.245 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.2 t -63.77 -24.71 36.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.825 -1.172 . . . . 0.86 109.586 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.06 -18.14 65.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.592 -1.317 . . . . 0.02 109.938 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.569 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 12.4 t90 -100.18 9.03 43.4 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.789 -1.189 . . . . 0.02 107.789 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.09 10.12 86.43 Favored Glycine 0 N--CA 1.485 1.96 0 C-N-CA 120.229 -0.986 . . . . 0.02 111.244 178.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.63 140.98 33.03 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.073 -1.251 . . . . 0.02 110.207 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -87.23 -11.85 48.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.627 -0.671 . . . . 0.59 110.733 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 43.5 m -147.83 149.85 34.44 Favored Pre-proline 0 N--CA 1.499 1.994 0 O-C-N 120.547 -1.345 . . . . 0.87 108.895 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -78.1 22.86 0.6 Allowed 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 120.879 1.052 . . . . 0.38 112.872 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.43 ' O ' ' CD1' ' A' ' 169' ' ' ILE . . . -83.61 124.32 30.68 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.708 -1.245 . . . . 0.18 111.784 -177.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.43 ' CD1' ' O ' ' A' ' 168' ' ' ALA . 4.8 mm -147.83 129.52 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 106.908 -1.516 . . . . 3.99 106.908 178.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -112.58 -18.38 12.4 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 120.998 -1.064 . . . . 5.17 113.475 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.4 p -157.21 161.0 39.26 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 119.36 -2.088 . . . . 0.02 110.117 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.418 ' CD1' ' C ' ' A' ' 172' ' ' PHE . 19.8 p90 -152.27 152.4 32.12 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.051 -1.03 . . . . 2.02 110.809 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.428 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 26.0 mtp180 -144.49 149.92 36.75 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.38 -0.825 . . . . 0.01 110.155 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 60.4 mtm180 -87.76 144.1 26.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.535 -0.728 . . . . 0.01 109.363 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.2 mt -94.82 128.57 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.282 -0.886 . . . . 3.04 109.149 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.1 t -136.44 146.68 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.254 -0.903 . . . . 1.89 109.65 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 4.89 109.476 179.935 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.287 -1.525 . . . . 0.01 109.287 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -148.55 136.94 21.25 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.124 -1.221 . . . . 0.02 110.376 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.41 HD13 HG23 ' A' ' 7' ' ' ILE . 7.3 tt -130.66 140.55 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 109.073 -0.714 . . . . 0.02 109.073 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.1 m -121.78 130.82 53.69 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.4 -0.812 . . . . 0.39 109.979 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.4 m-85 -110.6 140.54 44.82 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.624 -0.673 . . . . 0.02 109.38 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.516 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 5.1 m-85 -122.8 139.17 54.29 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.223 -0.923 . . . . 0.02 109.646 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -69.75 -27.77 65.21 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.167 -0.958 . . . . 0.03 112.097 -178.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 2.9 m-20 -114.24 169.44 9.03 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.887 -1.133 . . . . 0.03 110.225 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -75.04 157.81 34.22 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.69 0.757 . . . . 0.03 109.982 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.2 t30 66.54 33.47 6.63 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.918 0.866 . . . . 0.74 111.158 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 55.58 41.91 30.15 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.249 0.547 . . . . 0.02 111.413 177.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -112.86 165.75 12.02 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.244 -1.021 . . . . 0.02 108.244 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.48 -167.84 34.29 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.85 -1.167 . . . . 0.03 110.677 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.564 HH11 ' CG ' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -70.11 144.02 52.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.419 -1.047 . . . . 2.76 108.999 179.453 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -120.2 148.63 43.43 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.559 -0.713 . . . . 1.89 110.219 -178.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -131.99 127.31 35.99 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.221 -1.029 . . . . 0.02 108.221 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.46 136.9 51.4 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.42 -0.8 . . . . 1.12 109.779 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 13.2 t -130.94 138.73 49.88 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.446 0.641 . . . . 0.02 109.654 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.3 p30 -116.77 11.23 14.48 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.631 -0.668 . . . . 0.2 109.77 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.458 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 28.2 p -158.74 174.91 14.3 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.348 -0.982 . . . . 1.23 108.348 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -60.94 143.88 54.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.665 -1.272 . . . . 0.02 109.832 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 43.5 t -131.28 117.48 19.02 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.51 -0.922 . . . . 0.02 108.51 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.437 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -78.07 -25.08 47.52 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.045 -1.035 . . . . 0.24 110.989 -178.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -155.1 102.38 2.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.025 -1.047 . . . . 1.14 109.256 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -102.65 10.08 38.89 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 122.017 0.913 . . . . 6.37 109.753 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -59.68 -25.41 64.73 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.532 -0.73 . . . . 3.11 111.582 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.2 m -76.24 -17.15 59.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.522 -1.361 . . . . 0.88 110.609 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -104.06 -21.91 13.52 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.387 -0.82 . . . . 0.02 109.457 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.5 tp -149.92 128.56 12.36 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.328 -0.858 . . . . 3.32 109.159 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.7 p -85.71 -10.96 54.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.642 -0.661 . . . . 0.02 111.069 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -171.72 162.3 6.23 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.927 -1.138 . . . . 0.02 107.927 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.2 p -141.48 113.95 8.24 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.987 -1.07 . . . . 0.02 108.452 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.17 0.17 27.1 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.767 -1.208 . . . . 0.03 110.964 -178.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 m -154.44 155.65 35.34 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.669 -1.234 . . . . 0.02 107.669 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.5 mt -146.24 145.51 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.795 -1.19 . . . . 0.02 110.928 -178.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -124.09 124.84 43.4 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.874 -1.158 . . . . 0.02 107.874 177.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.6 t -105.16 114.03 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 106.745 -1.576 . . . . 0.02 106.745 177.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -84.7 -34.74 22.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.559 -0.713 . . . . 3.81 110.101 -178.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.01 150.54 19.55 Favored Glycine 0 N--CA 1.488 2.128 0 C-N-CA 118.514 -1.803 . . . . 0.02 110.722 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.19 172.15 48.84 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 120.027 -1.082 . . . . 0.01 110.563 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.9 m -119.42 135.03 54.93 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 107.711 -1.218 . . . . 1.48 107.711 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.448 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 32.7 m95 -127.49 155.0 44.44 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 122.584 1.183 . . . . 0.02 112.462 -176.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.99 134.51 51.54 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 105.545 -2.02 . . . . 0.24 105.545 176.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.7 m -119.03 143.63 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.585 -0.697 . . . . 0.65 109.158 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -120.84 146.05 46.96 Favored 'General case' 0 N--CA 1.503 2.204 0 CA-C-O 122.143 0.973 . . . . 0.02 109.949 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -67.35 -34.59 77.62 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.839 -0.619 . . . . 0.02 111.392 -177.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -125.17 157.91 65.51 Favored Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 121.047 -1.033 . . . . 0.02 109.379 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -53.84 166.4 1.45 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 121.63 1.553 . . . . 0.02 113.242 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 63.9 36.66 10.05 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.218 -0.901 . . . . 0.02 111.116 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 45.36 51.68 9.35 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.667 0.746 . . . . 3.39 110.633 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.7 m -126.11 163.64 22.66 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.13 0.491 . . . . 2.33 109.714 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.8 -161.82 32.35 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.803 -1.319 . . . . 0.02 109.803 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -66.16 140.1 58.18 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.081 -1.247 . . . . 0.02 110.314 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.452 ' SD ' ' C ' ' A' ' 58' ' ' MET . 10.4 tmm? -119.37 136.81 54.1 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.76 -0.588 . . . . 5.01 109.639 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.418 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 97.9 m-85 -133.98 138.35 45.37 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.393 -0.817 . . . . 0.02 109.935 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.3 mm -96.23 132.17 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 109.205 -0.665 . . . . 1.72 109.205 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.1 mt -120.35 111.6 34.96 Favored Pre-proline 0 N--CA 1.505 2.288 0 O-C-N 121.413 -0.804 . . . . 0.02 110.897 -178.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -77.72 169.72 20.32 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 CA-C-N 119.79 0.961 . . . . 1.47 110.042 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -53.14 140.89 24.57 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.745 -1.222 . . . . 4.25 110.458 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.96 -178.05 31.88 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.505 -1.331 . . . . 0.02 110.746 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -120.47 131.76 54.9 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.454 -1.027 . . . . 0.96 109.822 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -121.11 94.98 48.91 Favored Pre-proline 0 N--CA 1.494 1.725 0 N-CA-C 108.094 -1.076 . . . . 0.02 108.094 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.402 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 3.4 Cg_exo -66.11 -4.65 10.71 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 120.829 1.019 . . . . 0.02 113.641 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 77.7 mt-10 -157.64 155.27 29.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.818 -1.176 . . . . 2.02 108.306 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -61.21 -38.53 86.92 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.371 -0.831 . . . . 0.02 112.08 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -59.95 -23.44 63.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.971 -1.081 . . . . 0.02 110.191 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -70.55 -19.38 62.89 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.706 0.765 . . . . 3.42 109.09 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.542 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 1.6 t90 -108.37 9.08 27.82 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.627 -1.249 . . . . 0.02 107.627 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 10.3 mtt 60.94 22.22 12.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.649 -0.657 . . . . 0.02 110.53 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.65 143.44 44.76 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.494 -1.443 . . . . 0.02 109.494 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 26.8 tp -78.96 -31.64 45.1 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.387 -1.338 . . . . 0.98 107.387 177.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -157.87 -172.31 3.88 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 106.191 -1.781 . . . . 0.02 106.191 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -98.67 28.46 4.24 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.591 -1.318 . . . . 0.02 110.805 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 -96.94 122.05 39.49 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.779 -1.201 . . . . 3.2 110.997 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.9 mt -144.03 122.19 12.2 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 107.627 -1.249 . . . . 2.61 107.627 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.55 -16.41 11.0 Favored Glycine 0 N--CA 1.504 3.211 0 O-C-N 121.279 -0.888 . . . . 0.02 112.741 -177.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 23.5 m -156.69 156.32 33.23 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.245 -1.738 . . . . 0.02 110.445 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 25.1 t -144.03 146.89 33.17 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.574 -0.704 . . . . 0.02 110.027 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -138.47 143.6 39.69 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.174 -0.954 . . . . 0.01 109.691 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.86 132.78 36.18 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.282 -0.886 . . . . 0.43 110.001 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.6 t -92.18 126.14 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 109.363 -0.606 . . . . 1.25 109.363 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -94.48 130.92 40.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.741 -1.224 . . . . 1.77 109.379 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.7 mt -97.7 142.69 29.18 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.384 -0.823 . . . . 1.63 109.07 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 51.7 p -113.33 126.41 55.35 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.331 -0.855 . . . . 1.08 109.422 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 90' ' ' GLY . 54.5 m -108.15 9.33 28.24 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 106.766 -1.568 . . . . 1.26 106.766 176.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 89' ' ' SER . . . -26.35 -49.83 0.05 OUTLIER Glycine 0 N--CA 1.495 2.583 0 CA-C-N 115.54 -0.755 . . . . 0.01 112.528 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.76 -105.89 0.19 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 118.724 -1.703 . . . . 0.01 111.737 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.428 ' NE2' ' C ' ' A' ' 92' ' ' GLN . 0.8 OUTLIER -122.07 120.47 34.4 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.125 -1.221 . . . . 4.43 110.434 -178.317 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.48 129.28 34.41 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.893 -0.723 . . . . 2.99 109.637 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -130.57 143.02 50.48 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 108.605 -0.887 . . . . 6.36 108.605 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.405 ' C ' ' NE2' ' A' ' 96' ' ' GLN . 4.7 tt -129.35 145.22 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 121.151 -0.968 . . . . 1.09 110.708 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.629 ' NE2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -122.93 133.26 54.4 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 107.599 -1.26 . . . . 2.05 107.599 177.296 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.5 m -124.26 146.2 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 O-C-N 120.658 -1.276 . . . . 1.1 109.826 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.584 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 71.7 m-85 -118.83 141.09 48.96 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.939 0.876 . . . . 0.73 110.862 -178.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -66.09 -30.13 70.59 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 116.09 -0.504 . . . . 0.02 111.572 -178.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -117.3 170.88 8.35 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.024 -1.047 . . . . 3.18 110.247 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.41 169.88 43.21 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.862 -0.895 . . . . 0.01 110.862 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 52.92 38.95 28.3 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.501 0.667 . . . . 0.01 111.663 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 52.25 48.93 21.64 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.495 -0.753 . . . . 0.01 111.022 178.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -123.42 165.95 16.19 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.311 -0.996 . . . . 3.15 108.311 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.02 -164.36 28.58 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.538 -1.425 . . . . 0.01 109.538 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -76.38 144.97 39.73 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.942 -1.328 . . . . 0.01 108.569 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.584 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 28.3 ttp -117.09 142.65 46.72 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.637 0.732 . . . . 0.01 110.028 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -131.15 137.07 48.85 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.067 -1.086 . . . . 2.48 108.067 178.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -118.3 133.76 55.61 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.611 -0.681 . . . . 0.01 110.153 -178.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.2 t -148.6 148.61 30.33 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.284 1.04 . . . . 1.69 111.061 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 31.2 p -111.38 9.7 21.51 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 115.435 -0.802 . . . . 0.01 110.26 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -121.2 163.01 19.17 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.204 -0.935 . . . . 3.21 111.479 -178.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.05 156.27 37.75 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.645 -0.872 . . . . 0.01 108.645 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.489 ' SG ' ' OE1' ' A' ' 120' ' ' GLN . 23.9 t -127.7 114.15 20.82 Favored Pre-proline 0 N--CA 1.5 2.032 0 N-CA-C 108.795 -0.817 . . . . 0.01 108.795 178.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -74.59 -29.0 9.45 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 CA-C-N 120.364 1.166 . . . . 0.01 111.07 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 65.3 m -142.58 108.94 5.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.41 -0.806 . . . . 0.02 108.954 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 92.1 mt -63.54 -38.64 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.936 -0.477 . . . . 1.83 110.674 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 118' ' ' MET . 12.2 tmm? -68.32 -37.23 80.35 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.31 -0.956 . . . . 1.34 110.048 -178.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -69.54 -38.54 77.52 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.578 -1.326 . . . . 2.11 110.074 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.489 ' OE1' ' SG ' ' A' ' 114' ' ' CYS . 50.5 tt0 -79.82 -46.84 16.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.279 -0.888 . . . . 2.08 112.333 -177.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.452 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 32.5 m-85 -111.0 0.01 16.83 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.379 -0.826 . . . . 0.02 112.712 -176.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 59.93 33.44 21.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.774 -1.204 . . . . 0.02 109.433 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 11.0 mt -112.52 135.81 52.78 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 108.77 -0.826 . . . . 0.02 108.77 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -91.8 -22.68 20.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.198 -0.939 . . . . 5.32 110.361 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -149.64 164.08 36.15 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.169 -0.957 . . . . 0.02 109.981 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.411 HD12 HG21 ' A' ' 126' ' ' ILE . 42.2 mt -132.1 128.92 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 107.751 -1.203 . . . . 2.17 107.751 178.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -108.54 -11.91 15.06 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.343 -0.848 . . . . 0.02 112.278 -177.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.4 m -159.1 151.73 21.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.948 -1.095 . . . . 0.01 108.765 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 8.2 t -165.38 149.01 8.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.107 -0.996 . . . . 1.22 109.157 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.415 ' O ' ' OE1' ' A' ' 96' ' ' GLN . 7.2 ttpt -119.49 108.24 14.28 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 122.339 1.066 . . . . 1.41 109.28 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.2 t -113.52 127.15 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.555 -1.276 . . . . 0.01 107.555 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.9 t -131.42 94.18 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 107.632 -1.247 . . . . 1.98 107.632 177.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.599 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 26.7 tt0 -147.46 -77.2 0.17 Allowed 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 105.772 -1.936 . . . . 0.01 105.772 177.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 170.64 -63.59 0.17 Allowed Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.737 -1.745 . . . . 0.01 108.737 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.8 p -123.33 113.2 18.54 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.497 -1.002 . . . . 2.3 110.846 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.599 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 9.8 m95 -126.07 147.15 49.65 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 107.335 -1.358 . . . . 0.01 107.335 178.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.5 mt -121.86 136.2 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 O-C-N 120.568 -1.332 . . . . 1.69 110.248 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -116.17 145.28 43.21 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.339 -1.356 . . . . 2.49 107.339 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.5 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 15.2 m-85 -123.21 143.75 49.83 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.311 -0.868 . . . . 0.02 109.722 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -74.59 -29.31 61.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.523 -0.735 . . . . 0.02 111.74 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.4 mt -115.78 154.9 48.16 Favored Pre-proline 0 N--CA 1.503 2.212 0 O-C-N 120.697 -1.252 . . . . 1.48 109.054 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -56.06 166.9 2.75 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 121.123 1.215 . . . . 0.02 112.802 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.2 m120 59.79 31.24 20.69 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.043 -0.98 . . . . 0.75 111.437 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 57.68 51.62 9.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.513 -0.742 . . . . 0.02 111.141 177.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 41.2 mtm180 -127.1 164.91 20.55 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.531 -0.73 . . . . 0.02 110.241 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.74 -165.67 33.64 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.538 -1.025 . . . . 0.02 110.538 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -69.25 142.33 54.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.539 -0.977 . . . . 0.02 108.98 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -113.64 148.33 36.47 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.834 -0.541 . . . . 0.02 110.344 -178.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -124.23 133.56 53.49 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 108.853 -0.795 . . . . 0.01 108.853 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.2 tt -100.22 122.47 43.08 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.06 -1.025 . . . . 0.01 109.231 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.6 mp -98.12 147.03 24.98 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.235 -1.024 . . . . 0.01 108.235 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -105.06 -121.08 0.22 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.627 -0.671 . . . . 2.27 110.009 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -139.28 53.32 1.73 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.229 -0.919 . . . . 1.84 109.401 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -116.38 -172.35 2.17 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.406 -0.809 . . . . 2.28 109.195 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -105.55 109.51 21.51 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.39 -0.967 . . . . 0.01 108.39 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.606 ' CG ' ' NE1' ' A' ' 162' ' ' TRP . 35.9 m-85 -98.58 111.36 23.75 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.239 -0.913 . . . . 0.01 110.575 -178.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -95.65 -22.22 17.71 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.21 -0.931 . . . . 0.01 111.298 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 39.6 mttp -127.51 154.59 77.49 Favored Pre-proline 0 N--CA 1.502 2.153 0 O-C-N 121.142 -0.974 . . . . 2.54 108.656 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -59.59 -39.05 78.27 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 120.423 0.748 . . . . 0.7 110.596 178.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.99 -20.08 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.895 -1.128 . . . . 0.86 109.079 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -65.33 -15.48 62.59 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.946 -1.096 . . . . 0.02 110.134 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.606 ' NE1' ' CG ' ' A' ' 156' ' ' TYR . 9.6 m0 -97.55 11.85 35.47 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.245 -0.909 . . . . 0.02 108.94 178.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.14 10.07 85.92 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.767 -1.206 . . . . 0.02 111.089 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.03 141.08 32.23 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.193 -1.181 . . . . 0.02 110.073 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.12 -8.95 58.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.654 -0.654 . . . . 0.59 109.797 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.3 p -143.59 150.74 51.88 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 121.044 -1.035 . . . . 0.87 108.924 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -76.04 18.74 0.63 Allowed 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 120.704 0.936 . . . . 0.38 112.3 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.43 ' O ' ' CD1' ' A' ' 169' ' ' ILE . . . -83.07 122.24 28.09 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.824 -1.173 . . . . 0.18 111.321 -178.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.43 ' CD1' ' O ' ' A' ' 168' ' ' ALA . 4.1 mm -146.54 126.82 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 106.521 -1.659 . . . . 3.99 106.521 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -112.16 -18.09 12.65 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.955 -1.091 . . . . 5.17 113.405 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.6 p -157.49 160.67 38.49 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 119.196 -2.19 . . . . 0.02 110.179 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 172' ' ' PHE . 21.0 p90 -151.45 152.26 32.78 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.069 -1.019 . . . . 2.02 110.481 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -145.26 150.67 37.09 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.857 0.837 . . . . 0.01 110.393 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -89.11 145.24 25.58 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.138 -0.69 . . . . 0.01 109.138 178.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.1 mt -95.85 129.81 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.399 -0.813 . . . . 3.04 108.89 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 25.4 m -137.76 147.63 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.088 -1.007 . . . . 1.89 109.912 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.371 -0.831 . . . . 4.89 109.366 179.479 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.706 -1.357 . . . . 0.01 109.706 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -144.13 133.57 23.32 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.226 -1.161 . . . . 0.02 110.538 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.418 HG23 HD11 ' A' ' 7' ' ' ILE . 7.4 tt -129.45 139.41 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.11 -1.07 . . . . 0.02 108.11 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.1 m -120.99 129.14 53.29 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.291 -0.88 . . . . 0.39 110.103 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 9.1 m-85 -109.8 140.19 44.01 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.641 -0.874 . . . . 0.02 108.641 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.554 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.8 m-85 -121.9 138.09 54.53 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.334 -0.854 . . . . 0.02 109.446 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -68.69 -27.14 65.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -0.943 . . . . 0.03 111.389 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.0 OUTLIER -114.56 170.12 8.55 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.992 -1.068 . . . . 0.03 109.958 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -75.98 161.87 28.56 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.633 0.73 . . . . 0.03 110.4 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 62.9 33.02 15.39 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.025 0.917 . . . . 0.74 110.916 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 55.46 40.32 31.25 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.858 -0.61 . . . . 0.02 111.05 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -110.62 165.22 11.99 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.188 -1.041 . . . . 0.02 108.188 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.25 -167.91 34.67 Favored Glycine 0 N--CA 1.497 2.708 0 O-C-N 120.907 -1.12 . . . . 0.03 110.911 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.42 ' HG3' HH11 ' A' ' 18' ' ' ARG . 13.4 ttm-85 -69.95 143.46 52.65 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.471 -1.017 . . . . 2.76 109.316 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.1 ttp180 -122.03 149.98 42.74 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.38 -0.825 . . . . 1.89 110.431 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.49 ' CZ ' ' CG ' ' A' ' 32' ' ' TYR . 9.4 t80 -135.14 131.35 36.73 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.811 -0.811 . . . . 0.02 108.811 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -111.7 137.08 50.08 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.458 -0.776 . . . . 1.12 109.463 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 40.2 t -129.35 138.75 51.73 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 121.41 0.624 . . . . 0.02 109.629 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -117.7 11.9 13.8 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.545 -0.722 . . . . 0.2 110.245 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.483 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 42.5 t -159.17 174.24 15.15 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.916 -1.115 . . . . 1.23 108.757 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.473 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 17.6 p30 -61.74 145.14 53.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.613 -1.304 . . . . 0.02 110.219 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.423 ' CB ' ' CZ ' ' A' ' 29' ' ' PHE . 0.6 OUTLIER -134.35 119.12 18.25 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.543 -0.91 . . . . 0.02 108.543 178.59 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.62 -19.73 57.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.557 -0.715 . . . . 0.24 111.672 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -154.28 108.72 3.03 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.923 -1.111 . . . . 1.14 111.005 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.423 ' CZ ' ' CB ' ' A' ' 26' ' ' CYS . 22.2 m-85 -96.01 5.88 50.16 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.283 -0.886 . . . . 6.37 109.283 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -60.63 -30.7 70.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.282 -0.886 . . . . 3.11 112.246 -176.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.5 m -78.72 -19.07 53.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.271 -1.518 . . . . 0.88 111.55 -178.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.49 ' CG ' ' CZ ' ' A' ' 20' ' ' TYR . 65.2 m-85 -107.06 -21.83 12.86 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.266 -0.896 . . . . 0.02 110.819 -178.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.415 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 6.1 tp -149.16 127.63 12.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.895 -1.128 . . . . 3.32 109.793 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.9 m -86.56 -11.77 50.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.53 -0.731 . . . . 0.02 111.127 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.415 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 4.8 ptp180 -171.68 161.95 6.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.933 -1.105 . . . . 0.02 108.24 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -142.65 115.75 8.87 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.909 -1.119 . . . . 0.02 108.887 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -109.49 0.32 19.2 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.85 -1.156 . . . . 0.03 111.458 -178.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.3 m -156.8 153.81 28.9 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.385 -0.969 . . . . 0.02 108.385 178.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.0 mt -146.2 147.16 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-O 122.325 1.06 . . . . 0.02 111.176 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -122.59 123.66 41.71 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.738 -1.208 . . . . 0.02 107.738 176.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.3 t -106.8 115.2 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 106.902 -1.518 . . . . 0.02 106.902 177.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -83.31 -33.85 25.85 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 120.068 -0.653 . . . . 3.81 111.024 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.97 152.36 22.19 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 118.878 -1.63 . . . . 0.02 110.854 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.602 ' H ' ' NE2' ' A' ' 63' ' ' GLN . . . 83.59 173.24 49.59 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.66 -1.257 . . . . 0.01 110.418 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 65.6 m -119.6 135.16 54.92 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.033 -1.099 . . . . 1.48 108.033 178.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -127.31 155.98 42.68 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 122.639 1.209 . . . . 0.02 112.172 -176.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.422 ' O ' ' SG ' ' A' ' 82' ' ' CYS . . . -109.51 134.57 51.73 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 105.527 -2.027 . . . . 0.24 105.527 176.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.6 m -116.31 142.01 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.549 -0.719 . . . . 0.65 109.306 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -120.53 143.32 48.64 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 122.056 0.931 . . . . 0.02 109.508 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.504 ' OE1' ' CE1' ' A' ' 57' ' ' HIS . 36.9 tt0 -65.67 -33.37 75.73 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.671 -0.695 . . . . 0.02 111.712 -177.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 35.8 mtm180 -124.85 157.8 65.0 Favored Pre-proline 0 N--CA 1.503 2.194 0 O-C-N 120.991 -1.068 . . . . 0.02 109.368 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -53.31 167.36 0.83 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.753 1.635 . . . . 0.02 112.634 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 63.02 36.2 12.58 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 115.254 -0.885 . . . . 0.02 111.273 178.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.509 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 5.5 m-85 45.28 51.11 9.53 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.707 0.765 . . . . 3.39 110.706 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.8 m -125.54 163.57 22.41 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 121.2 0.524 . . . . 2.33 109.802 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.44 -161.67 31.39 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.844 -1.302 . . . . 0.02 109.844 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.504 ' CE1' ' OE1' ' A' ' 50' ' ' GLU . 10.1 m80 -65.13 137.84 57.9 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.11 -1.229 . . . . 0.02 110.219 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.496 ' SD ' ' O ' ' A' ' 58' ' ' MET . 2.8 ppp? -118.68 137.49 53.28 Favored 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 121.357 0.599 . . . . 5.01 109.553 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.437 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 81.6 m-85 -135.44 140.48 44.92 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.503 -0.748 . . . . 0.02 109.61 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.9 mm -95.19 131.05 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.607 -0.683 . . . . 1.72 109.164 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.531 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 1.0 OUTLIER -121.09 111.39 33.95 Favored Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 121.284 -0.885 . . . . 0.02 110.743 -178.284 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -77.27 169.02 22.07 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 CA-C-N 119.898 0.999 . . . . 1.47 110.371 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.602 ' NE2' ' H ' ' A' ' 44' ' ' GLY . 71.0 mt-30 -53.39 141.73 23.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.96 -1.087 . . . . 4.25 110.369 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.81 -177.7 31.96 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.523 -1.322 . . . . 0.02 110.755 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -120.21 131.56 55.02 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.464 -1.021 . . . . 0.96 109.661 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.531 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 59.5 m-85 -122.41 97.62 44.75 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 108.022 -1.103 . . . . 0.02 108.022 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.404 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 3.4 Cg_endo -68.77 -3.26 10.94 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 120.745 0.963 . . . . 0.02 113.898 -178.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 79.2 mt-10 -157.64 155.2 29.65 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.433 -1.417 . . . . 2.02 108.281 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -60.69 -39.1 87.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.63 -0.669 . . . . 0.02 112.108 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -60.28 -23.47 64.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.058 -1.026 . . . . 0.02 110.32 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -69.82 -18.75 63.47 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.88 -0.785 . . . . 3.42 108.88 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.56 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.7 t90 -107.95 10.95 28.29 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.464 -1.31 . . . . 0.02 107.464 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.3 mtt 61.21 22.49 12.82 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.476 0.655 . . . . 0.02 110.409 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.72 144.29 48.07 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.574 -1.41 . . . . 0.02 109.574 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.3 mp -79.78 -29.95 40.52 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.708 -1.219 . . . . 0.98 107.708 177.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -156.83 -171.17 3.56 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 106.342 -1.725 . . . . 0.02 106.342 178.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 23.0 p-10 -98.91 28.72 4.18 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.697 -1.252 . . . . 0.02 110.526 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -96.49 122.33 39.27 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.796 -1.19 . . . . 3.2 111.057 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.1 mt -141.92 119.83 11.97 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.609 -1.256 . . . . 2.61 107.609 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.51 -18.54 8.47 Favored Glycine 0 N--CA 1.499 2.853 0 O-C-N 121.245 -0.909 . . . . 0.02 112.809 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.509 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 12.6 t -156.0 156.48 34.54 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-N 120.324 2.062 . . . . 0.02 111.13 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 47' ' ' ALA . 11.9 t -146.45 148.78 32.61 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.342 -0.849 . . . . 0.02 110.723 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.425 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 52.1 mtp180 -138.16 143.13 40.13 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.509 -0.745 . . . . 0.01 109.345 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.19 132.46 36.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.102 -0.998 . . . . 0.43 109.938 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.9 t -91.12 125.01 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.571 -0.706 . . . . 1.25 109.139 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -93.97 131.89 38.97 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.877 -1.139 . . . . 1.77 109.079 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 mt -96.66 139.45 32.71 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.54 -0.911 . . . . 1.63 108.54 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.1 p -111.8 127.88 55.94 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.362 -0.836 . . . . 1.08 109.312 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.7 m -104.39 -153.97 0.49 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 106.492 -1.669 . . . . 1.26 106.492 176.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.33 -53.15 0.72 Allowed Glycine 0 N--CA 1.5 2.928 0 O-C-N 120.386 -1.446 . . . . 0.01 112.818 177.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.16 -101.65 0.16 Allowed Glycine 0 N--CA 1.491 2.337 0 C-N-CA 118.476 -1.821 . . . . 0.01 111.844 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -121.25 118.91 30.77 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.043 -1.269 . . . . 4.43 110.569 -178.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.0 129.62 34.65 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.79 -0.764 . . . . 2.99 109.349 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.449 ' NZ ' ' CB ' ' A' ' 94' ' ' LYS . 6.8 ttpm? -129.15 141.95 51.02 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.334 -0.854 . . . . 6.36 109.09 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.3 tt -128.64 144.92 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 O-C-N 121.352 -0.842 . . . . 1.09 110.237 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -122.67 134.02 54.49 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.911 -1.144 . . . . 2.05 107.911 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.1 m -123.78 145.05 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 120.823 -1.173 . . . . 1.1 110.051 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.572 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 47.5 m-85 -119.92 142.16 48.97 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-O 121.996 0.903 . . . . 0.73 111.098 -178.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -67.53 -31.84 72.21 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 116.06 -0.518 . . . . 0.02 111.745 -178.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -115.62 167.44 10.9 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 120.811 -1.181 . . . . 3.18 110.593 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.15 163.69 45.01 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.833 -0.907 . . . . 0.01 110.833 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 57.6 38.93 27.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.913 -0.757 . . . . 0.01 110.99 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 52.57 55.92 8.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.696 -0.627 . . . . 0.01 111.184 178.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -128.45 165.87 19.84 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.266 -1.013 . . . . 3.15 108.266 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.17 -163.39 27.81 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.234 -1.547 . . . . 0.01 109.234 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 38.4 tp60 -76.29 144.5 40.23 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.965 -1.315 . . . . 0.01 108.656 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.572 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 29.5 ttp -116.68 141.8 47.73 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.638 0.733 . . . . 0.01 109.812 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -131.57 136.3 47.7 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.328 -0.99 . . . . 2.48 108.328 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.521 ' OE2' ' N ' ' A' ' 110' ' ' THR . 1.9 tm-20 -118.12 133.9 55.49 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.559 -0.713 . . . . 0.01 109.997 -178.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.521 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 6.2 t -148.09 148.89 31.14 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.106 -0.996 . . . . 1.69 110.969 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 33.3 p -110.78 10.17 22.61 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 115.551 -0.75 . . . . 0.01 110.365 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -120.92 163.16 18.65 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.28 -0.888 . . . . 3.21 111.571 -178.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.06 156.67 36.9 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.255 -1.017 . . . . 0.01 108.255 178.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 19.8 t -125.92 112.53 24.53 Favored Pre-proline 0 N--CA 1.502 2.138 0 O-C-N 121.456 -0.778 . . . . 0.01 108.944 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -75.41 -31.63 5.56 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 120.133 1.083 . . . . 0.01 111.102 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 16.5 m -141.05 107.95 5.41 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.287 -0.883 . . . . 0.02 108.798 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.9 mt -63.36 -39.19 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.949 -0.469 . . . . 1.83 110.74 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 118' ' ' MET . 1.7 tmt? -67.81 -37.18 81.64 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.416 -0.914 . . . . 1.34 110.46 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -71.09 -39.26 72.23 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 120.464 -1.397 . . . . 2.11 110.243 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -79.56 -46.7 16.83 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.239 -0.913 . . . . 2.08 112.358 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -109.67 -0.11 18.74 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.34 -0.85 . . . . 0.02 112.531 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 58.85 32.03 21.84 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.687 -1.258 . . . . 0.02 108.865 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.7 mt -111.47 135.3 52.22 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.656 -0.868 . . . . 0.02 108.656 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -92.09 -23.4 19.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.158 -0.964 . . . . 5.32 110.031 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -149.76 163.41 38.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.231 -0.918 . . . . 0.02 109.839 -178.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 45.6 mt -133.31 130.32 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 107.493 -1.299 . . . . 2.17 107.493 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -107.83 -11.76 15.32 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.301 -0.875 . . . . 0.02 112.787 -177.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.9 m -158.98 152.7 23.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.734 -1.229 . . . . 0.01 108.82 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 9.2 t -167.65 147.67 5.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.121 -0.987 . . . . 1.22 109.123 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.442 ' NZ ' ' OE2' ' A' ' 155' ' ' GLU . 4.8 tptm -121.0 111.09 17.04 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 122.346 1.069 . . . . 1.41 109.717 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.2 t -112.23 128.7 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.603 -1.258 . . . . 0.01 107.603 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.2 t -129.81 94.02 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 106.922 -1.51 . . . . 1.98 106.922 177.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -146.84 -78.57 0.17 Allowed 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 105.824 -1.917 . . . . 0.01 105.824 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 178.51 -75.14 0.07 OUTLIER Glycine 0 N--CA 1.485 1.951 0 N-CA-C 108.144 -1.982 . . . . 0.01 108.144 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.22 120.55 35.51 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.654 -0.909 . . . . 2.3 110.12 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -126.42 151.0 48.29 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 106.77 -1.567 . . . . 0.01 106.77 179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 59.1 mt -121.41 135.13 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 120.552 -1.343 . . . . 1.69 110.495 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -111.03 142.73 42.79 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 106.269 -1.752 . . . . 2.49 106.269 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -122.76 143.49 49.79 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.014 -1.054 . . . . 0.02 109.763 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -74.66 -29.66 61.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.409 -0.807 . . . . 0.02 111.869 -176.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.4 mt -116.1 155.04 48.55 Favored Pre-proline 0 N--CA 1.506 2.372 0 O-C-N 120.793 -1.192 . . . . 1.48 108.983 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -55.92 167.36 2.37 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.116 1.211 . . . . 0.02 112.843 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.448 ' N ' ' ND2' ' A' ' 143' ' ' ASN . 2.2 m120 59.31 30.44 20.16 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.035 -0.984 . . . . 0.75 111.211 178.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 58.06 51.43 8.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.484 -0.76 . . . . 0.02 111.055 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -125.97 164.88 19.84 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.546 -0.721 . . . . 0.02 109.863 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.432 ' O ' ' OE1' ' A' ' 148' ' ' GLN . . . 88.79 -166.06 33.84 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.093 -1.203 . . . . 0.02 110.093 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -69.25 142.62 54.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.55 -0.971 . . . . 0.02 108.97 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.474 ' N ' ' CD ' ' A' ' 148' ' ' GLN . 0.1 OUTLIER -114.58 148.38 38.12 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.315 0.579 . . . . 0.02 110.155 -178.155 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 149' ' ' TYR . 13.1 m-85 -124.48 135.32 53.12 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.66 -0.867 . . . . 0.01 108.66 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.5 tt -98.33 122.44 41.5 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.872 -1.143 . . . . 0.01 109.253 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.406 ' CD1' ' N ' ' A' ' 151' ' ' LEU . 10.3 mp -96.43 146.86 24.4 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.294 -0.879 . . . . 0.01 109.043 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -104.68 -124.71 0.22 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.348 -0.845 . . . . 2.27 109.418 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -146.49 47.7 1.19 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.177 -0.952 . . . . 1.84 109.514 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -112.73 -161.26 0.75 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.543 -0.723 . . . . 2.28 109.168 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.442 ' OE2' ' NZ ' ' A' ' 130' ' ' LYS . 4.1 mm-40 -107.02 104.72 14.45 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.579 -0.701 . . . . 0.01 109.154 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.609 ' CD2' ' CD1' ' A' ' 162' ' ' TRP . 55.3 m-85 -98.15 111.27 23.66 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.249 -0.907 . . . . 0.01 109.448 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -94.39 -22.51 18.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.042 -1.036 . . . . 0.01 111.268 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -127.59 154.42 77.62 Favored Pre-proline 0 N--CA 1.503 2.177 0 O-C-N 120.977 -1.077 . . . . 2.54 108.548 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -59.71 -36.83 90.67 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 CA-C-N 119.148 0.731 . . . . 0.7 110.265 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 92.0 t -61.68 -19.78 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.975 -1.078 . . . . 0.86 109.094 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -65.57 -15.78 63.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.963 -1.086 . . . . 0.02 110.267 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.609 ' CD1' ' CD2' ' A' ' 156' ' ' TYR . 6.1 m0 -98.6 11.75 37.44 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.175 -0.953 . . . . 0.02 108.986 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.67 10.37 85.27 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 119.861 -1.161 . . . . 0.02 111.207 178.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.63 141.09 32.88 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.179 -1.189 . . . . 0.02 110.072 -178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.27 -9.32 57.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.627 -0.671 . . . . 0.59 110.062 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 39.8 m -143.94 150.09 48.31 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 120.921 -1.112 . . . . 0.87 109.098 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -76.41 18.43 0.69 Allowed 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 120.876 1.05 . . . . 0.38 112.512 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.75 123.45 28.77 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.794 -1.192 . . . . 0.18 111.698 -177.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 29.2 mm -148.52 127.96 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 106.77 -1.567 . . . . 3.99 106.77 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -112.31 -15.93 13.06 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.137 -0.977 . . . . 5.17 112.525 -178.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.419 ' HG ' ' N ' ' A' ' 172' ' ' PHE . 22.9 t -157.89 160.67 37.9 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 119.459 -2.026 . . . . 0.02 109.858 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 172' ' ' PHE . 18.0 p90 -151.12 152.93 34.08 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.18 -0.95 . . . . 2.02 110.113 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -145.0 150.26 36.59 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.192 -0.942 . . . . 0.01 110.408 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -88.81 144.8 25.99 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.925 -0.768 . . . . 0.01 108.925 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.9 mt -96.22 130.13 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.354 -0.841 . . . . 3.04 109.398 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 24.7 t -136.13 146.77 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.315 -0.866 . . . . 1.89 109.671 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.181 -0.949 . . . . 4.89 109.454 179.953 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.521 -1.432 . . . . 0.01 109.521 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.53 ' HZ1' HH21 ' A' ' 40' ' ' ARG . 26.0 ttpp -145.95 135.55 23.22 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.296 -1.12 . . . . 0.02 110.373 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.4 tt -129.63 139.1 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.02 -1.104 . . . . 0.02 108.02 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 m -120.61 129.25 53.66 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.35 -0.844 . . . . 0.39 110.316 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.437 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.9 m-85 -110.76 140.78 44.86 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.852 -0.795 . . . . 0.02 108.852 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.557 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.9 m-85 -122.57 138.61 54.52 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.294 -0.879 . . . . 0.02 109.425 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -68.91 -27.21 65.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.121 -0.987 . . . . 0.03 111.597 -178.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.3 m-20 -114.43 169.85 8.74 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.944 -1.098 . . . . 0.03 109.995 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -75.02 161.91 29.04 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.617 0.722 . . . . 0.03 110.262 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.592 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 11.4 t-20 62.45 35.11 14.97 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.892 0.853 . . . . 0.74 110.634 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.592 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.7 p90 49.27 43.16 22.8 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.478 -0.783 . . . . 0.02 110.94 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -109.62 165.91 11.31 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.676 -1.231 . . . . 0.02 107.676 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.7 -167.71 35.35 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 119.707 -1.235 . . . . 0.03 110.752 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.567 HH11 ' CG ' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -69.62 143.28 53.3 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.408 -1.054 . . . . 2.76 109.059 179.368 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -122.59 150.7 42.27 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.499 -0.75 . . . . 1.89 110.244 -178.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.472 ' CE1' ' CE1' ' A' ' 29' ' ' PHE . 34.4 t80 -136.34 133.11 36.48 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.689 -0.632 . . . . 0.02 109.678 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 20.6 p-10 -110.74 136.63 49.52 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.389 -0.819 . . . . 1.12 109.309 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 42.2 t -128.73 138.65 52.24 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.631 -0.668 . . . . 0.02 109.422 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.434 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 0.9 OUTLIER -118.93 11.4 12.53 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.477 -0.765 . . . . 0.2 110.877 -179.406 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.491 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 8.0 p -159.31 173.84 15.68 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.644 -1.285 . . . . 1.23 109.305 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 22.8 p30 -62.13 145.22 53.97 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.684 -1.26 . . . . 0.02 110.361 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.553 ' CB ' ' CE2' ' A' ' 29' ' ' PHE . 51.2 t -134.49 118.44 17.34 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.529 -0.732 . . . . 0.02 109.046 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.81 -20.67 56.12 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.494 -0.754 . . . . 0.24 111.515 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -155.45 104.78 2.41 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.851 -1.155 . . . . 1.14 109.417 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.553 ' CE2' ' CB ' ' A' ' 26' ' ' CYS . 0.4 OUTLIER -101.82 9.03 41.11 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.321 -0.862 . . . . 6.37 109.934 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -60.32 -27.18 67.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.391 -0.818 . . . . 3.11 111.83 -177.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.3 t -77.89 -18.07 56.58 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.477 -1.389 . . . . 0.88 111.391 -178.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.551 ' CD1' ' N ' ' A' ' 32' ' ' TYR . 8.3 m-85 -106.64 -21.08 13.16 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.306 -0.871 . . . . 0.02 110.561 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.9 tp -148.66 127.16 12.35 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.95 -1.094 . . . . 3.32 109.472 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.3 t -87.53 -12.55 45.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.629 -0.669 . . . . 0.02 111.388 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -172.5 161.95 5.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.743 -1.223 . . . . 0.02 108.47 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.3 p -143.45 115.74 8.49 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.069 -1.02 . . . . 0.02 108.877 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.469 ' N ' HD21 ' A' ' 37' ' ' ASN . 1.5 m-80 -107.8 -0.41 21.65 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.812 -1.18 . . . . 0.03 111.007 -178.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.3 m -155.08 153.58 31.11 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.829 -1.175 . . . . 0.02 107.829 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.7 mt -146.83 147.14 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 122.205 1.002 . . . . 0.02 110.778 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.53 HH21 ' HZ1' ' A' ' 6' ' ' LYS . 35.3 ttp180 -124.03 124.73 43.19 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.181 -1.044 . . . . 0.02 108.181 177.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.8 t -106.68 115.27 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 106.876 -1.527 . . . . 0.02 106.876 177.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -83.88 -33.81 24.72 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.565 -0.709 . . . . 3.81 110.952 -177.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.13 152.64 22.57 Favored Glycine 0 N--CA 1.49 2.272 0 C-N-CA 118.811 -1.661 . . . . 0.02 110.877 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.45 172.98 49.39 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.688 -1.244 . . . . 0.01 110.468 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.1 m -119.85 134.94 55.07 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 107.97 -1.122 . . . . 1.48 107.97 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.42 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 35.3 m95 -127.46 156.11 42.63 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 122.595 1.188 . . . . 0.02 112.212 -176.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.83 134.39 52.1 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 105.613 -1.995 . . . . 0.24 105.613 176.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.7 m -117.09 142.6 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.53 -0.731 . . . . 0.65 109.14 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -120.68 143.57 48.65 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 122.093 0.949 . . . . 0.02 109.66 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -65.05 -33.7 76.67 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.584 -0.735 . . . . 0.02 111.534 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -125.3 157.95 65.73 Favored Pre-proline 0 N--CA 1.503 2.21 0 O-C-N 121.029 -1.044 . . . . 0.02 109.425 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -53.49 167.36 0.92 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.688 1.592 . . . . 0.02 112.916 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.532 ' N ' ' ND2' ' A' ' 53' ' ' ASN . 0.9 OUTLIER 63.36 36.31 11.66 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.232 -0.895 . . . . 0.02 111.134 178.19 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.414 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 4.9 m-85 44.92 51.65 8.51 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.614 0.721 . . . . 3.39 110.77 178.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.9 t -125.8 163.6 22.53 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.186 0.517 . . . . 2.33 109.846 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.33 -161.86 31.67 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.892 -1.283 . . . . 0.02 109.892 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 -65.54 139.03 58.43 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.038 -1.272 . . . . 0.02 110.245 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.495 ' SD ' ' O ' ' A' ' 58' ' ' MET . 2.6 ppp? -118.88 137.03 53.72 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.662 -0.649 . . . . 5.01 109.802 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.4 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 90.8 m-85 -134.06 138.86 45.59 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.497 -0.752 . . . . 0.02 109.693 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.7 mm -95.76 131.17 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.123 -0.695 . . . . 1.72 109.123 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.3 mt -120.77 111.78 34.2 Favored Pre-proline 0 N--CA 1.506 2.335 0 O-C-N 121.41 -0.806 . . . . 0.02 110.929 -178.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -77.53 169.25 21.33 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 CA-C-N 119.868 0.989 . . . . 1.47 110.126 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -53.29 141.26 24.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.878 -1.139 . . . . 4.25 110.368 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.23 -177.94 32.16 Favored Glycine 0 N--CA 1.496 2.667 0 C-N-CA 119.54 -1.314 . . . . 0.02 110.825 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -120.25 131.7 55.04 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.433 -1.039 . . . . 0.96 109.746 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -121.08 95.82 48.65 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 108.041 -1.096 . . . . 0.02 108.041 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -65.98 -4.7 10.62 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 120.761 0.974 . . . . 0.02 113.618 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -157.58 155.2 29.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.655 -1.278 . . . . 2.02 108.15 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -60.25 -38.6 83.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.576 -0.702 . . . . 0.02 112.029 -177.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -60.07 -23.42 63.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.142 -0.974 . . . . 0.02 110.293 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -70.79 -18.76 62.74 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.831 0.824 . . . . 3.42 109.063 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.54 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 1.6 t90 -107.9 9.8 28.65 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.424 -1.324 . . . . 0.02 107.424 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.8 mtt 60.83 22.08 12.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.601 -0.687 . . . . 0.02 110.419 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.89 143.83 46.8 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.336 -1.506 . . . . 0.02 109.336 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.427 HD11 ' H ' ' A' ' 76' ' ' ASN . 0.2 OUTLIER -78.71 -28.88 45.14 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.609 -1.256 . . . . 0.98 107.609 177.783 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.427 ' H ' HD11 ' A' ' 75' ' ' LEU . 65.6 m-80 -158.75 -171.69 3.52 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 106.286 -1.746 . . . . 0.02 106.286 178.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -98.53 29.01 3.85 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.642 -1.286 . . . . 0.02 110.472 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -97.86 122.77 41.37 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.974 -1.079 . . . . 3.2 111.43 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.3 mt -142.28 119.53 11.5 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 107.232 -1.396 . . . . 2.61 107.232 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.69 -18.6 9.94 Favored Glycine 0 N--CA 1.497 2.736 0 O-C-N 121.207 -0.933 . . . . 0.02 112.27 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.5 p -155.83 156.36 34.59 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 119.612 1.706 . . . . 0.02 110.839 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 20.5 p -146.14 148.47 32.62 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.453 -0.779 . . . . 0.02 110.529 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.414 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 50.5 mtp180 -138.55 143.12 39.3 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.473 -0.767 . . . . 0.01 109.327 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.28 132.16 36.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.128 -0.982 . . . . 0.43 109.829 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.4 t -90.76 125.23 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.529 -0.732 . . . . 1.25 109.117 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -93.87 132.18 38.54 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.701 -1.249 . . . . 1.77 109.26 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.1 mt -97.31 139.96 32.49 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.805 -0.813 . . . . 1.63 108.805 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.9 t -112.52 127.83 56.17 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.377 -0.827 . . . . 1.08 109.465 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 77.8 p -104.26 -154.43 0.5 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 106.602 -1.629 . . . . 1.26 106.602 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 139.25 -52.53 0.72 Allowed Glycine 0 N--CA 1.501 3.003 0 O-C-N 120.356 -1.465 . . . . 0.01 113.111 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.8 -101.66 0.16 Allowed Glycine 0 N--CA 1.49 2.281 0 C-N-CA 118.413 -1.851 . . . . 0.01 112.095 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -121.35 119.17 31.37 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.133 -1.216 . . . . 4.43 110.676 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.15 129.56 34.59 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.745 -0.782 . . . . 2.99 109.403 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -129.76 143.09 50.64 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.383 -0.823 . . . . 6.36 108.917 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.2 tt -128.84 145.0 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 O-C-N 121.292 -0.88 . . . . 1.09 110.437 -178.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -122.25 134.08 54.69 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.58 -1.266 . . . . 2.05 107.58 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.6 m -124.61 145.71 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 O-C-N 120.772 -1.205 . . . . 1.1 109.914 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.587 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 64.4 m-85 -119.35 141.62 48.87 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 121.971 0.891 . . . . 0.73 110.91 -178.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -67.23 -30.73 70.73 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 116.066 -0.515 . . . . 0.02 111.904 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.434 ' O ' ' OG ' ' A' ' 128' ' ' SER . 48.0 mttm -116.35 167.46 11.01 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.97 -1.082 . . . . 3.18 110.492 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.52 164.02 42.37 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.899 -0.88 . . . . 0.01 110.899 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 56.77 38.85 29.77 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.628 0.727 . . . . 0.01 110.932 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 52.29 55.91 8.47 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.58 -0.7 . . . . 0.01 111.11 178.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -129.18 165.68 20.84 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.319 -0.993 . . . . 3.15 108.319 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.23 -163.87 28.02 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.242 -1.543 . . . . 0.01 109.242 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -75.6 144.34 41.84 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.034 -1.274 . . . . 0.01 108.664 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.587 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 27.0 ttp -116.99 142.16 47.31 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.47 0.653 . . . . 0.01 109.859 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -131.72 136.61 47.76 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.127 -1.064 . . . . 2.48 108.127 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -117.96 134.3 55.09 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.495 -0.753 . . . . 0.01 110.08 -178.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.5 t -148.45 149.42 31.67 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 122.276 1.036 . . . . 1.69 111.119 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.5 p -110.51 10.25 23.16 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 115.45 -0.795 . . . . 0.01 110.304 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -121.36 163.45 18.65 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.155 -0.966 . . . . 3.21 111.826 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.5 156.64 36.17 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.142 -1.059 . . . . 0.01 108.142 178.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 21.9 t -126.51 113.17 23.04 Favored Pre-proline 0 N--CA 1.501 2.115 0 O-C-N 121.401 -0.812 . . . . 0.01 108.843 178.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -76.27 -31.21 4.82 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 CA-C-N 120.086 1.066 . . . . 0.01 111.516 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.6 m -141.42 108.05 5.35 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.264 -0.898 . . . . 0.02 109.006 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.88 -38.83 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.861 -0.524 . . . . 1.83 110.876 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.1 ttt -68.16 -36.76 80.15 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.234 -0.986 . . . . 1.34 110.384 -178.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -71.15 -39.08 72.14 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.421 -1.424 . . . . 2.11 110.18 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -79.48 -47.41 15.67 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.236 -0.915 . . . . 2.08 112.448 -176.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -110.25 0.85 18.28 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.405 -0.809 . . . . 0.02 112.517 -176.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.565 ' ND1' ' N ' ' A' ' 122' ' ' HIS . 1.2 m-70 59.11 32.36 22.07 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.815 -1.178 . . . . 0.02 109.269 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.3 mt -112.29 135.9 52.39 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 108.433 -0.951 . . . . 0.02 108.433 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -91.44 -22.73 20.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 5.32 110.108 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -149.82 163.95 36.65 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.222 -0.924 . . . . 0.02 110.204 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 44.8 mt -132.21 129.34 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 107.434 -1.321 . . . . 2.17 107.434 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -106.95 -12.08 15.54 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.318 -0.864 . . . . 0.02 112.457 -177.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 12.5 p -159.54 153.05 22.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.855 -1.153 . . . . 0.01 108.835 178.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 7.2 t -168.51 147.36 4.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.303 -0.873 . . . . 1.22 108.751 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.516 ' NZ ' ' OE1' ' A' ' 155' ' ' GLU . 26.1 tttp -121.1 111.64 17.7 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 122.422 1.106 . . . . 1.41 109.561 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.3 t -112.52 129.06 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 107.352 -1.351 . . . . 0.01 107.352 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.2 t -129.48 92.93 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 107.267 -1.383 . . . . 1.98 107.267 177.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.476 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 4.1 tm-20 -147.85 -74.58 0.19 Allowed 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 105.683 -1.969 . . . . 0.01 105.683 177.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 157.55 -55.03 0.38 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.45 -1.46 . . . . 0.01 109.45 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 41.8 p -119.75 101.52 7.95 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.542 -0.975 . . . . 2.3 111.446 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.476 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 11.4 m95 -129.51 144.54 51.3 Favored 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 107.516 -1.29 . . . . 0.01 107.516 178.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.426 HG22 HD11 ' A' ' 137' ' ' ILE . 97.6 mt -124.25 140.87 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 120.874 -1.141 . . . . 1.69 110.486 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -114.17 143.97 43.95 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.153 -1.425 . . . . 2.49 107.153 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 11.8 m-85 -122.93 144.88 48.94 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.146 -0.971 . . . . 0.02 109.531 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -74.64 -29.53 61.3 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.532 -0.73 . . . . 0.02 111.97 -176.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.4 mt -115.82 154.79 48.2 Favored Pre-proline 0 N--CA 1.505 2.299 0 O-C-N 120.783 -1.198 . . . . 1.48 109.166 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -55.37 167.38 1.94 Allowed 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.219 1.279 . . . . 0.02 112.674 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 59.6 31.23 20.81 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.193 -0.912 . . . . 0.75 111.283 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 57.55 51.08 10.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.451 -0.781 . . . . 0.02 111.136 177.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -126.54 165.07 19.82 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.52 -0.737 . . . . 0.02 110.153 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.41 -166.21 33.06 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.285 -1.126 . . . . 0.02 110.285 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -68.68 142.59 55.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.606 -0.937 . . . . 0.02 108.898 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -114.53 148.95 37.19 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.336 0.588 . . . . 0.02 109.932 -178.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -124.48 134.65 52.98 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.824 -0.806 . . . . 0.01 108.824 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.1 tt -98.23 121.32 40.02 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.737 -1.227 . . . . 0.01 108.728 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 59.6 tp -95.47 155.28 16.81 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.247 -0.908 . . . . 0.01 109.171 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -105.46 -117.88 0.23 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.295 -0.878 . . . . 2.27 109.374 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -156.97 44.6 0.38 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.049 -1.032 . . . . 1.84 109.671 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -112.35 -156.06 0.58 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.459 -0.776 . . . . 2.28 109.289 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.516 ' OE1' ' NZ ' ' A' ' 130' ' ' LYS . 77.9 mm-40 -106.94 106.24 16.67 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.442 -0.786 . . . . 0.01 109.141 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.612 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 5.2 m-85 -98.97 111.51 23.89 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.341 -0.849 . . . . 0.01 109.531 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -94.7 -22.29 18.22 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.184 -0.947 . . . . 0.01 111.566 -177.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -128.15 154.16 78.69 Favored Pre-proline 0 N--CA 1.503 2.176 0 O-C-N 120.875 -1.141 . . . . 2.54 108.708 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -59.4 -37.19 91.46 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 CA-C-N 119.286 0.781 . . . . 0.7 110.64 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 85.3 t -61.25 -19.76 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.795 -1.191 . . . . 0.86 109.146 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -65.32 -15.32 62.41 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.952 -1.093 . . . . 0.02 109.996 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.612 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 8.5 m0 -98.13 11.71 36.83 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.19 -0.944 . . . . 0.02 109.102 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 81.11 10.46 84.85 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.934 -1.127 . . . . 0.02 111.341 178.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.09 140.64 32.94 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.031 -1.276 . . . . 0.02 110.206 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.73 -9.54 56.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.608 -0.683 . . . . 0.59 109.978 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.1 m -142.02 150.49 56.2 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.181 -0.949 . . . . 0.87 109.134 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -76.61 16.53 0.9 Allowed 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 120.741 0.96 . . . . 0.38 112.47 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.65 122.72 27.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.649 -1.282 . . . . 0.18 111.198 -177.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 15.2 mm -151.81 126.39 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 106.595 -1.631 . . . . 3.99 106.595 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 64.1 mm-40 -113.57 -12.9 12.82 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.081 -1.012 . . . . 5.17 113.634 -177.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.0 p -157.6 162.05 38.71 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 119.083 -2.261 . . . . 0.02 110.235 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.426 ' CD1' ' C ' ' A' ' 172' ' ' PHE . 16.9 p90 -151.97 151.98 31.89 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.132 -0.98 . . . . 2.02 110.633 179.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -145.0 149.66 35.53 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.304 -0.872 . . . . 0.01 109.991 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -88.52 144.29 26.43 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.512 -0.742 . . . . 0.01 109.439 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.4 mt -93.67 129.55 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.233 -0.917 . . . . 3.04 109.092 178.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 14.5 t -137.1 147.4 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.248 -0.907 . . . . 1.89 109.676 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.35 -0.844 . . . . 4.89 109.39 179.815 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 109.416 -1.474 . . . . 0.01 109.416 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -146.18 135.18 22.58 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.363 -1.081 . . . . 0.02 110.603 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 7' ' ' ILE . 6.3 tt -129.44 139.6 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.108 -1.071 . . . . 0.02 108.108 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 m -120.45 129.55 53.93 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.326 -0.859 . . . . 0.39 110.208 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 6.2 m-85 -110.34 139.89 45.08 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 109.026 -0.731 . . . . 0.02 109.026 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.561 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.2 m-85 -121.28 137.99 54.44 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.135 -0.978 . . . . 0.02 109.299 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -69.71 -27.59 65.11 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.096 -1.003 . . . . 0.03 111.531 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -113.68 169.54 8.91 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.932 -1.105 . . . . 0.03 110.067 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -75.37 157.41 34.28 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.66 0.743 . . . . 0.03 110.401 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.546 ' N ' ' ND2' ' A' ' 14' ' ' ASN . 0.6 OUTLIER 66.31 33.95 6.77 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.768 0.794 . . . . 0.74 111.297 178.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 55.41 41.23 31.24 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.247 0.546 . . . . 0.02 111.335 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -113.13 165.61 12.22 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.152 -1.055 . . . . 0.02 108.152 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.09 -167.01 35.72 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.758 -1.211 . . . . 0.03 110.757 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.557 HH11 ' CG ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -68.59 141.57 55.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.502 -0.999 . . . . 2.76 109.275 179.553 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -121.96 150.1 42.52 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.629 -0.67 . . . . 1.89 109.842 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -137.96 133.95 34.33 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.559 -0.713 . . . . 0.02 109.677 178.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -109.26 135.77 49.8 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.327 -0.858 . . . . 1.12 108.886 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.536 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 5.6 t -127.16 137.98 53.06 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.55 -0.719 . . . . 0.02 109.125 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.5 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 4.1 p30 -118.62 11.72 12.91 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.644 -0.66 . . . . 0.2 110.611 -179.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 25.5 m -158.88 174.26 15.26 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.664 -1.272 . . . . 1.23 108.948 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 2.3 m-20 -62.2 145.98 52.04 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.756 -1.215 . . . . 0.02 110.418 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.536 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 18.0 m -134.04 117.05 16.22 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.779 -0.822 . . . . 0.02 108.779 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.12 -20.48 52.07 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.369 -0.832 . . . . 0.24 111.911 -177.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -151.16 106.14 3.3 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.57 -1.331 . . . . 1.14 109.547 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.61 5.04 43.8 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.436 -0.79 . . . . 6.37 110.276 -178.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -61.22 -28.36 69.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 3.11 112.204 -177.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.5 t -79.12 -18.7 52.74 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.262 -1.523 . . . . 0.88 111.779 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -105.75 -21.82 13.09 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.138 -0.976 . . . . 0.02 110.682 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 50.9 mt -148.88 128.31 13.05 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.032 -1.043 . . . . 3.32 109.109 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.2 t -86.1 -11.11 53.58 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.676 -0.64 . . . . 0.02 110.385 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -172.84 162.26 4.78 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.147 -1.056 . . . . 0.02 108.147 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 24.9 m -144.03 116.32 8.5 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.064 -1.022 . . . . 0.02 108.632 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.421 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 17.9 t-20 -108.84 0.46 20.32 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 120.822 -1.174 . . . . 0.03 111.673 -177.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.2 t -155.87 153.51 29.83 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.048 -1.093 . . . . 0.02 108.048 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.7 mt -146.9 147.37 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.069 -1.019 . . . . 0.02 110.871 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -123.65 124.56 43.03 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.154 -1.054 . . . . 0.02 108.154 177.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.7 t -106.32 115.0 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 106.917 -1.512 . . . . 0.02 106.917 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -83.32 -33.8 25.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.448 -0.782 . . . . 3.81 110.728 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.48 152.09 21.93 Favored Glycine 0 N--CA 1.488 2.11 0 C-N-CA 118.883 -1.627 . . . . 0.02 110.82 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.04 173.18 49.62 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.655 -1.259 . . . . 0.01 110.708 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.2 m -119.32 134.88 54.98 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.011 -1.107 . . . . 1.48 108.011 177.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -126.75 155.51 42.64 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 122.587 1.185 . . . . 0.02 112.214 -176.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.39 134.02 52.35 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 105.631 -1.989 . . . . 0.24 105.631 176.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.3 m -118.86 143.76 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.561 -0.712 . . . . 0.65 109.083 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -120.99 145.72 47.45 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 122.222 1.01 . . . . 0.02 110.079 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -65.92 -33.8 76.66 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.805 -0.634 . . . . 0.02 111.052 -177.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -125.17 157.7 66.3 Favored Pre-proline 0 N--CA 1.503 2.21 0 O-C-N 121.092 -1.005 . . . . 0.02 109.416 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.47 166.95 1.01 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.714 1.61 . . . . 0.02 113.119 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.519 ' N ' ' ND2' ' A' ' 53' ' ' ASN . 1.0 OUTLIER 63.73 36.4 10.66 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.198 -0.91 . . . . 0.02 111.123 178.219 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 45.19 51.71 9.01 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.576 0.703 . . . . 3.39 110.804 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.4 t -126.03 163.44 23.05 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.137 0.494 . . . . 2.33 109.857 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.18 -161.62 31.69 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.761 -1.335 . . . . 0.02 109.761 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -64.88 138.97 58.7 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.102 -1.234 . . . . 0.02 110.029 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 14.6 ptm -119.06 137.18 53.73 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.674 -0.641 . . . . 5.01 109.524 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.551 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 89.8 m-85 -134.03 138.46 45.38 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.422 -0.798 . . . . 0.02 109.836 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.1 mm -95.24 131.45 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.058 -0.719 . . . . 1.72 109.058 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.2 mt -121.0 111.45 34.06 Favored Pre-proline 0 N--CA 1.504 2.244 0 O-C-N 121.411 -0.806 . . . . 0.02 110.812 -178.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -77.11 169.55 21.3 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 CA-C-N 119.867 0.988 . . . . 1.47 109.853 177.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -52.6 141.31 20.91 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.766 -1.208 . . . . 4.25 110.338 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.38 -177.76 32.39 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.621 -1.276 . . . . 0.02 110.692 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -120.48 131.83 54.92 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.432 -1.04 . . . . 0.96 109.774 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -121.49 98.68 46.02 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 108.15 -1.056 . . . . 0.02 108.15 179.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -70.39 -3.66 12.88 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 120.861 1.041 . . . . 0.02 113.813 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -157.55 154.46 28.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.824 -1.172 . . . . 2.02 108.141 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -60.46 -38.85 85.5 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.557 -0.715 . . . . 0.02 111.929 -177.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -59.79 -23.71 63.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.916 -1.115 . . . . 0.02 110.272 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -70.68 -18.68 62.83 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.924 0.869 . . . . 3.42 108.763 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.551 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.2 t90 -107.96 9.93 28.5 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.496 -1.298 . . . . 0.02 107.496 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 8.5 mtt 61.29 22.63 12.97 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.494 0.664 . . . . 0.02 110.503 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.52 144.41 45.81 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.762 -1.335 . . . . 0.02 109.762 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.63 -31.54 41.61 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.34 -1.356 . . . . 0.98 107.34 177.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.581 ' ND2' ' H ' ' A' ' 77' ' ' ASP . 15.4 t30 -157.02 -171.43 3.64 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 106.317 -1.734 . . . . 0.02 106.317 178.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.581 ' H ' ' ND2' ' A' ' 76' ' ' ASN . 10.6 p30 -98.49 28.52 4.12 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.55 -1.344 . . . . 0.02 110.757 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -97.07 122.51 40.15 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.863 -1.148 . . . . 3.2 110.974 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 75.0 mt -141.92 119.13 11.41 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.611 -1.255 . . . . 2.61 107.611 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.73 -18.04 9.86 Favored Glycine 0 N--CA 1.499 2.875 0 O-C-N 121.211 -0.931 . . . . 0.02 112.524 -177.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.4 p -156.18 155.67 32.87 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 119.967 -1.902 . . . . 0.02 110.464 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 24.8 p -145.32 147.92 32.86 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.698 -0.626 . . . . 0.02 110.0 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 33.5 mtp180 -137.47 142.74 41.54 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.412 -0.805 . . . . 0.01 109.397 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.73 132.99 36.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 0.43 109.862 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.6 t -91.97 124.86 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 109.027 -0.731 . . . . 1.25 109.027 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -94.36 132.1 39.33 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.706 -1.246 . . . . 1.77 109.238 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -96.33 139.77 31.98 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.672 -0.862 . . . . 1.63 108.672 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.424 ' O ' ' OE2' ' A' ' 133' ' ' GLU . 87.8 p -111.47 128.02 55.87 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.345 -0.847 . . . . 1.08 109.26 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.8 m -104.47 -154.18 0.5 Allowed 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 106.63 -1.618 . . . . 1.26 106.63 177.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.75 -52.7 0.74 Allowed Glycine 0 N--CA 1.5 2.965 0 O-C-N 120.399 -1.438 . . . . 0.01 112.737 177.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.17 -101.65 0.16 Allowed Glycine 0 N--CA 1.491 2.335 0 C-N-CA 118.467 -1.825 . . . . 0.01 111.953 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -121.61 118.86 30.25 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.122 -1.222 . . . . 4.43 110.635 -178.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.5 129.85 34.85 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.836 -0.746 . . . . 2.99 109.488 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -129.82 142.41 50.68 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.436 -0.79 . . . . 6.36 109.058 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.435 ' O ' ' OE2' ' A' ' 109' ' ' GLU . 4.3 tt -128.81 144.56 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.344 -0.848 . . . . 1.09 110.181 -179.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -121.52 134.16 55.04 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.541 -1.281 . . . . 2.05 107.541 177.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.5 m -124.03 145.51 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 O-C-N 120.728 -1.232 . . . . 1.1 109.903 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -119.05 141.4 48.76 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.983 0.896 . . . . 0.73 110.851 -178.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -67.09 -30.64 70.73 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 116.065 -0.516 . . . . 0.02 111.812 -178.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -116.46 168.1 10.46 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.945 -1.097 . . . . 3.18 110.473 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.2 163.92 44.86 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 111.044 -0.822 . . . . 0.01 111.044 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.5 t0 56.91 39.33 29.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.878 -0.778 . . . . 0.01 111.059 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 51.71 56.47 7.81 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.617 -0.677 . . . . 0.01 111.007 178.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -129.7 165.98 20.75 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.023 -1.103 . . . . 3.15 108.023 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.24 -164.41 28.34 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.13 -1.588 . . . . 0.01 109.13 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -75.7 144.61 41.47 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.981 -1.305 . . . . 0.01 108.573 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.452 ' SD ' ' C ' ' A' ' 107' ' ' MET . 12.5 tmm? -116.25 142.21 47.14 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.634 0.73 . . . . 0.01 109.897 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.501 ' CD1' ' N ' ' A' ' 108' ' ' TYR . 8.0 m-85 -131.15 136.48 48.37 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.337 -0.986 . . . . 2.48 108.337 178.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.435 ' OE2' ' O ' ' A' ' 95' ' ' ILE . 5.2 tp10 -115.72 133.47 56.0 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.687 -0.633 . . . . 0.01 109.968 -178.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.9 t -148.47 147.95 29.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.021 -1.049 . . . . 1.69 111.183 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.421 ' OG1' ' OE2' ' A' ' 112' ' ' GLU . 21.1 p -111.67 9.72 21.0 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 115.451 -0.795 . . . . 0.01 110.24 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 26.5 mp0 -121.39 163.5 18.6 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 121.238 -0.914 . . . . 3.21 111.72 -178.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -68.1 156.81 36.65 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.323 -0.991 . . . . 0.01 108.323 178.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.483 ' SG ' ' OE1' ' A' ' 120' ' ' GLN . 33.7 t -125.57 113.98 25.23 Favored Pre-proline 0 N--CA 1.502 2.142 0 O-C-N 121.531 -0.731 . . . . 0.01 109.23 178.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -75.27 -30.89 6.34 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 CA-C-N 120.245 1.123 . . . . 0.01 111.035 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.4 p -142.45 108.44 5.19 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.804 0.811 . . . . 0.02 109.0 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 73.1 mt -63.21 -38.35 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.839 -0.538 . . . . 1.83 110.742 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 20.4 ttt -68.14 -36.53 79.83 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.121 -1.032 . . . . 1.34 110.227 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -70.53 -38.75 74.27 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.514 -1.367 . . . . 2.11 110.001 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.483 ' OE1' ' SG ' ' A' ' 114' ' ' CYS . 52.0 tt0 -79.61 -47.47 15.4 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.317 -0.865 . . . . 2.08 112.471 -177.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -110.42 0.46 17.87 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.362 -0.837 . . . . 0.02 112.698 -176.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 59.28 32.99 22.37 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.761 -1.212 . . . . 0.02 109.067 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 mt -112.09 135.26 52.98 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 108.487 -0.931 . . . . 0.02 108.487 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -91.23 -22.28 20.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 5.32 110.031 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -149.79 163.89 36.77 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.36 -0.838 . . . . 0.02 110.0 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.418 HG22 HD11 ' A' ' 126' ' ' ILE . 55.4 mt -131.33 128.47 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 107.474 -1.306 . . . . 2.17 107.474 178.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -107.85 -12.16 15.24 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.412 -0.805 . . . . 0.02 112.36 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.3 m -159.16 152.17 22.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.887 -1.133 . . . . 0.01 108.99 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 10.9 t -168.86 146.87 3.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 1.22 108.795 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.3 tttp -120.6 112.45 18.93 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 122.422 1.106 . . . . 1.41 109.515 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.3 t -113.46 129.52 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 107.821 -1.177 . . . . 0.01 107.821 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.9 t -129.72 92.97 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 106.936 -1.505 . . . . 1.98 106.936 177.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.541 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 9.4 tm-20 -147.16 -74.84 0.2 Allowed 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 105.829 -1.915 . . . . 0.01 105.829 177.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.422 ' N ' ' OE1' ' A' ' 133' ' ' GLU . . . 169.68 -69.64 0.15 Allowed Glycine 0 N--CA 1.482 1.723 0 N-CA-C 108.656 -1.777 . . . . 0.01 108.656 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.9 p -121.17 118.48 29.76 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.631 -0.923 . . . . 2.3 110.569 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.541 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 8.4 m95 -128.1 148.55 50.58 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 107.063 -1.458 . . . . 0.01 107.063 178.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 89.9 mt -123.27 138.07 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 120.373 -1.454 . . . . 1.69 110.491 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -114.96 144.11 44.09 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 107.553 -1.277 . . . . 2.49 107.553 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.507 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 12.1 m-85 -123.02 143.94 49.6 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.235 -0.916 . . . . 0.02 109.592 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -75.06 -28.79 60.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.389 -0.82 . . . . 0.02 112.028 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 55.0 mt -115.28 151.82 46.23 Favored Pre-proline 0 N--CA 1.504 2.264 0 O-C-N 120.563 -1.335 . . . . 1.48 109.027 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -54.06 167.66 1.11 Allowed 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 120.906 1.071 . . . . 0.02 112.54 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 4.5 m120 59.12 30.18 19.9 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 115.164 -0.925 . . . . 0.75 111.19 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 57.94 51.39 9.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.4 -0.813 . . . . 0.02 111.469 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -125.84 164.13 21.39 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.398 -0.814 . . . . 0.02 109.951 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.38 -165.18 32.41 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.31 -1.116 . . . . 0.02 110.31 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -69.06 142.09 54.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.604 -0.939 . . . . 0.02 109.126 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -115.24 149.07 38.34 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.832 -0.543 . . . . 0.02 109.918 -178.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.534 ' CE1' ' O ' ' A' ' 162' ' ' TRP . 42.6 t80 -124.94 135.82 53.18 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 109.15 -0.685 . . . . 0.01 109.15 179.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.5 tt -98.45 120.88 39.63 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.941 -1.1 . . . . 0.01 108.808 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.4 tt -98.51 149.74 22.41 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.139 -0.976 . . . . 0.01 108.857 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.462 ' CG ' ' H ' ' A' ' 153' ' ' LYS . 2.1 p-10 -104.93 -98.47 0.32 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.424 -0.798 . . . . 2.27 110.007 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.462 ' H ' ' CG ' ' A' ' 152' ' ' ASP . 47.1 pttt -167.36 49.09 0.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.077 -1.014 . . . . 1.84 109.515 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.607 ' CG ' ' H ' ' A' ' 155' ' ' GLU . 38.5 tttm -113.34 -175.58 2.7 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.984 -0.747 . . . . 2.28 108.984 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.607 ' H ' ' CG ' ' A' ' 154' ' ' LYS . 84.6 mt-10 -100.25 109.5 21.72 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.197 -0.939 . . . . 0.01 108.693 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.628 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 30.2 m-85 -98.33 113.87 25.99 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.427 -0.795 . . . . 0.01 110.079 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -94.8 -22.48 18.03 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.23 -0.919 . . . . 0.01 111.614 -178.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -127.7 154.79 77.87 Favored Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 120.771 -1.206 . . . . 2.54 109.148 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -60.78 -38.94 66.9 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 120.489 0.793 . . . . 0.7 110.443 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 96.8 t -60.94 -20.11 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.867 -1.146 . . . . 0.86 108.821 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 161' ' ' ASP . 43.2 t0 -65.68 -15.39 62.74 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.976 -1.078 . . . . 0.02 109.785 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.628 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 22.8 m0 -95.79 10.74 36.01 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.497 -0.927 . . . . 0.02 108.497 178.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 78.56 9.87 86.67 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.603 -1.284 . . . . 0.02 110.621 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.38 142.04 31.38 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.361 -1.082 . . . . 0.02 110.078 -178.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.59 -8.72 58.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.655 -0.653 . . . . 0.59 109.629 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 21.6 p -144.81 150.32 46.03 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 120.894 -1.129 . . . . 0.87 108.534 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -75.94 21.26 0.51 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 120.718 0.945 . . . . 0.38 112.518 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.38 123.05 28.75 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.786 -1.197 . . . . 0.18 111.566 -177.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 4.1 mt -149.78 127.6 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 107.041 -1.466 . . . . 3.99 107.041 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -113.67 -15.15 12.53 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 113.684 0.994 . . . . 5.17 113.684 -177.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 8.2 t -157.63 160.96 38.6 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 119.132 -2.23 . . . . 0.02 110.445 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 172' ' ' PHE . 16.4 p90 -151.66 152.73 33.21 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.085 -1.01 . . . . 2.02 110.499 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 43.4 mtp180 -144.76 149.93 36.36 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.882 0.849 . . . . 0.01 110.189 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -88.08 144.32 26.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.59 -0.694 . . . . 0.01 109.154 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.6 mt -94.32 128.86 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.274 -0.891 . . . . 3.04 109.128 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.8 p -136.2 146.24 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.124 -0.985 . . . . 1.89 109.499 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 N--CA 1.488 1.448 0 O-C-N 121.151 -0.968 . . . . 4.89 109.465 -179.978 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.412 -1.475 . . . . 0.01 109.412 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -145.9 134.74 22.44 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.312 -1.111 . . . . 0.02 110.531 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.404 HG22 HD11 ' A' ' 7' ' ' ILE . 7.1 tt -129.46 139.57 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.053 -1.092 . . . . 0.02 108.053 178.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.527 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.0 OUTLIER -121.89 130.54 53.44 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.437 -0.789 . . . . 0.39 110.119 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.1 m-85 -110.18 139.98 44.77 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 109.114 -0.699 . . . . 0.02 109.114 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.527 ' CZ ' ' OG ' ' A' ' 8' ' ' SER . 4.8 m-85 -121.9 138.47 54.39 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.302 -0.874 . . . . 0.02 109.325 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -69.32 -27.32 65.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.16 -0.962 . . . . 0.03 111.508 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 2.1 m-20 -114.11 169.4 9.04 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.921 -1.112 . . . . 0.03 110.217 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -75.96 158.71 31.66 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.612 0.72 . . . . 0.03 110.258 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.9 t30 66.06 33.25 7.72 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 122.018 0.913 . . . . 0.74 111.123 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 55.68 42.29 29.52 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 116.007 -0.542 . . . . 0.02 111.471 177.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -113.81 166.18 11.82 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.395 -0.965 . . . . 0.02 108.395 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.87 -167.61 34.97 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 119.923 -1.132 . . . . 0.03 110.75 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.573 HH11 ' CG ' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -69.42 143.0 53.74 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.48 -1.012 . . . . 2.76 109.091 179.445 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.466 ' HE ' ' CB ' ' A' ' 8' ' ' SER . 52.5 ttt180 -121.58 148.94 43.86 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.582 -0.699 . . . . 1.89 110.105 -178.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.603 ' CZ ' ' CG ' ' A' ' 32' ' ' TYR . 7.2 t80 -135.1 130.75 36.0 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.781 -0.822 . . . . 0.02 108.781 178.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 18.7 p-10 -111.94 137.78 49.46 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.468 -0.77 . . . . 1.12 109.411 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 45.9 t -130.38 139.81 50.62 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.596 -0.69 . . . . 0.02 109.6 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.5 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 10.8 p30 -117.78 11.93 13.73 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.723 -0.611 . . . . 0.2 110.225 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 34.6 m -158.63 174.77 14.54 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.887 -1.133 . . . . 1.23 108.644 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -61.96 145.17 53.76 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.694 -1.254 . . . . 0.02 110.033 -179.731 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.435 ' CB ' ' CZ ' ' A' ' 29' ' ' PHE . 0.8 OUTLIER -133.68 119.08 18.9 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 108.725 -0.842 . . . . 0.02 108.725 178.449 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.44 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -77.11 -19.39 57.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.24 111.745 -177.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -154.13 107.94 2.97 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.559 -1.338 . . . . 1.14 110.862 -178.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.435 ' CZ ' ' CB ' ' A' ' 26' ' ' CYS . 17.1 m-85 -96.53 5.72 50.2 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.206 -0.934 . . . . 6.37 109.303 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -60.25 -30.67 69.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.364 -0.835 . . . . 3.11 112.206 -176.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.6 m -78.82 -18.96 53.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.308 -1.495 . . . . 0.88 111.29 -178.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.603 ' CG ' ' CZ ' ' A' ' 20' ' ' TYR . 56.6 m-85 -106.68 -22.17 12.82 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.345 -0.847 . . . . 0.02 110.905 -178.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.442 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 5.1 tp -149.24 127.2 11.9 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.83 -1.169 . . . . 3.32 109.609 -178.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.0 t -86.21 -11.31 52.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.64 -0.662 . . . . 0.02 110.95 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.442 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 13.2 ptm180 -172.96 162.69 4.72 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.914 -1.117 . . . . 0.02 108.404 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.0 t -142.23 115.02 8.63 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.968 -1.083 . . . . 0.02 108.663 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 16.1 t-20 -107.5 -0.71 21.98 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.864 -1.147 . . . . 0.03 110.866 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.5 t -156.08 152.67 28.29 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.902 -1.147 . . . . 0.02 107.902 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 87.6 mt -145.67 148.12 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 CA-C-O 122.435 1.112 . . . . 0.02 110.313 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -123.86 124.08 41.86 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.82 -1.178 . . . . 0.02 107.82 176.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.7 t -106.47 115.25 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 106.859 -1.534 . . . . 0.02 106.859 177.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -83.49 -33.74 25.51 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.021 -0.672 . . . . 3.81 110.738 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.48 152.17 22.05 Favored Glycine 0 N--CA 1.489 2.175 0 C-N-CA 118.922 -1.608 . . . . 0.02 110.891 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.97 173.22 49.63 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.709 -1.234 . . . . 0.01 110.632 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.6 m -120.15 135.76 54.85 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.099 -1.075 . . . . 1.48 108.099 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.417 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 37.8 m95 -128.01 155.74 43.82 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 122.7 1.238 . . . . 0.02 112.17 -176.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.75 134.5 51.38 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 105.57 -2.011 . . . . 0.24 105.57 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.4 m -119.92 144.76 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.579 -0.701 . . . . 0.65 109.3 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -121.45 145.7 47.66 Favored 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 122.313 1.054 . . . . 0.02 110.263 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -66.87 -34.09 77.03 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.836 -0.62 . . . . 0.02 111.496 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -124.93 157.97 64.64 Favored Pre-proline 0 N--CA 1.503 2.185 0 O-C-N 121.028 -1.045 . . . . 0.02 109.36 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.35 165.31 1.55 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.716 1.611 . . . . 0.02 113.176 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 63.84 36.95 10.02 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.159 -0.928 . . . . 0.02 111.055 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 45.08 51.84 8.71 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.686 0.755 . . . . 3.39 110.78 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.5 t -125.92 163.61 22.59 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 121.145 0.498 . . . . 2.33 109.811 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.83 -161.46 32.04 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.797 -1.321 . . . . 0.02 109.797 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.564 ' HD1' ' H ' ' A' ' 57' ' ' HIS . 4.7 m80 -64.63 139.77 58.8 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.075 -1.25 . . . . 0.02 110.289 -179.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.497 ' SD ' ' O ' ' A' ' 58' ' ' MET . 2.9 ppp? -119.97 136.95 54.34 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.648 -0.657 . . . . 5.01 109.594 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.546 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 88.2 m-85 -134.81 138.85 44.62 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.353 -0.842 . . . . 0.02 109.948 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.417 HG21 HD11 ' A' ' 60' ' ' ILE . 20.5 mm -95.25 131.36 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.034 -0.728 . . . . 1.72 109.034 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.4 mt -120.26 111.06 35.47 Favored Pre-proline 0 N--CA 1.506 2.361 0 O-C-N 121.371 -0.831 . . . . 0.02 110.763 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -77.32 169.42 21.3 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 CA-C-N 119.836 0.977 . . . . 1.47 109.769 177.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -52.59 140.94 21.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.821 -1.174 . . . . 4.25 110.307 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.75 -177.52 32.82 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.454 -1.355 . . . . 0.02 110.597 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -120.48 131.75 54.88 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.535 -0.98 . . . . 0.96 109.692 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -121.54 99.13 45.51 Favored Pre-proline 0 N--CA 1.495 1.783 0 N-CA-C 107.882 -1.155 . . . . 0.02 107.882 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -70.86 -3.71 13.29 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 120.628 0.885 . . . . 0.02 113.642 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -157.6 154.9 29.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.71 -1.243 . . . . 2.02 108.029 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -60.2 -39.0 85.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.474 -0.767 . . . . 0.02 111.881 -177.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -59.79 -24.0 63.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.094 -1.004 . . . . 0.02 110.386 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -70.59 -18.83 62.89 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.901 0.858 . . . . 3.42 108.802 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.546 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.4 t90 -107.92 9.9 28.6 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.477 -1.305 . . . . 0.02 107.477 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.5 mtp 61.27 22.47 12.82 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.495 0.664 . . . . 0.02 110.536 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.53 144.08 46.06 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.492 -1.443 . . . . 0.02 109.492 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.7 tp -79.05 -30.92 44.33 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.552 -1.277 . . . . 0.98 107.552 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -157.05 -171.39 3.62 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 106.241 -1.763 . . . . 0.02 106.241 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -98.22 28.33 4.12 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.647 -1.283 . . . . 0.02 110.609 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.7 mtm180 -96.84 122.15 39.49 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.95 -1.094 . . . . 3.2 110.985 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.5 mt -142.82 120.5 11.84 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.672 -1.232 . . . . 2.61 107.672 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.68 -18.32 9.07 Favored Glycine 0 N--CA 1.502 3.05 0 O-C-N 121.215 -0.928 . . . . 0.02 112.871 -177.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 12.6 m -156.96 157.71 35.27 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 119.956 1.878 . . . . 0.02 110.864 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 27.0 m -146.49 149.84 34.42 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.627 -0.671 . . . . 0.02 109.943 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -138.51 143.17 39.42 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.395 -0.815 . . . . 0.01 109.183 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.3 132.18 36.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -0.94 . . . . 0.43 109.725 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.8 t -90.61 124.83 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.726 -0.842 . . . . 1.25 108.726 178.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -93.35 132.17 37.83 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.797 -1.189 . . . . 1.77 109.017 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mt -96.8 139.29 33.07 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.453 -0.943 . . . . 1.63 108.453 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.5 p -111.35 127.5 55.67 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.355 -0.84 . . . . 1.08 109.17 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 51.8 p -104.12 -154.53 0.51 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 106.448 -1.686 . . . . 1.26 106.448 177.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.39 -51.63 0.78 Allowed Glycine 0 N--CA 1.502 3.05 0 O-C-N 120.558 -1.339 . . . . 0.01 112.636 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.26 -100.92 0.15 Allowed Glycine 0 N--CA 1.489 2.193 0 C-N-CA 118.464 -1.827 . . . . 0.01 111.932 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -121.4 118.79 30.31 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.034 -1.274 . . . . 4.43 110.543 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.41 131.08 36.79 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.819 -0.753 . . . . 2.99 109.399 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -129.81 140.56 51.0 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.472 -0.767 . . . . 6.36 109.203 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 tt -127.4 144.12 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.407 -0.808 . . . . 1.09 109.864 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -122.29 133.05 54.69 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.692 -1.225 . . . . 2.05 107.692 176.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.8 m -123.67 145.86 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 O-C-N 120.662 -1.274 . . . . 1.1 109.682 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -119.13 141.31 48.92 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 121.97 0.891 . . . . 0.73 110.843 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -67.03 -30.41 70.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.888 -0.507 . . . . 0.02 111.775 -178.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.445 ' HZ2' ' CA ' ' A' ' 105' ' ' GLY . 42.5 mttp -116.12 167.39 11.03 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.046 -1.033 . . . . 3.18 110.533 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.06 164.43 43.79 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.981 -0.848 . . . . 0.01 110.981 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.423 ' O ' ' ND2' ' A' ' 104' ' ' ASN . 3.0 m-20 56.95 38.8 29.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.909 -0.759 . . . . 0.01 110.884 179.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 52.14 56.02 8.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.637 -0.665 . . . . 0.01 111.047 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.423 ' ND2' ' O ' ' A' ' 102' ' ' ASP . 24.5 m-80 -129.19 165.81 20.6 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 108.208 -1.034 . . . . 3.15 108.208 178.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.445 ' CA ' ' HZ2' ' A' ' 100' ' ' LYS . . . 92.99 -163.92 27.11 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.247 -1.541 . . . . 0.01 109.247 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.619 ' NE2' ' CE2' ' A' ' 108' ' ' TYR . 0.6 OUTLIER -76.0 144.39 40.94 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.043 -1.269 . . . . 0.01 108.348 179.116 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.526 ' N ' ' NE2' ' A' ' 106' ' ' GLN . 12.8 tmm? -116.57 141.81 47.7 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.635 0.731 . . . . 0.01 109.959 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.619 ' CE2' ' NE2' ' A' ' 106' ' ' GLN . 39.4 m-85 -131.2 136.45 48.27 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.176 -1.046 . . . . 2.48 108.176 178.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.522 ' OE2' ' N ' ' A' ' 110' ' ' THR . 1.9 tm-20 -119.47 134.73 55.08 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.544 -0.723 . . . . 0.01 109.961 -178.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.522 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 7.8 t -148.69 151.81 35.58 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 122.233 1.016 . . . . 1.69 111.065 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.483 ' N ' ' HG1' ' A' ' 110' ' ' THR . 21.7 p -111.83 9.49 20.72 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.645 -0.707 . . . . 0.01 110.377 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -121.43 163.27 19.02 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.122 -0.986 . . . . 3.21 111.719 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -68.12 157.09 36.08 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.344 -0.984 . . . . 0.01 108.344 178.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 20.7 t -126.59 114.15 22.87 Favored Pre-proline 0 N--CA 1.504 2.231 0 O-C-N 121.48 -0.763 . . . . 0.01 109.088 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.427 ' O ' ' OG ' ' A' ' 171' ' ' SER . 19.4 Cg_endo -75.12 -29.42 8.06 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 CA-C-N 120.319 1.15 . . . . 0.01 111.213 178.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 69.4 m -142.61 109.1 5.33 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.485 -0.759 . . . . 0.02 109.055 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.404 HG23 HD13 ' A' ' 117' ' ' ILE . 97.4 mt -63.9 -38.96 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.801 -0.562 . . . . 1.83 110.667 -178.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 41.9 ttp -68.58 -37.29 79.73 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.272 -0.971 . . . . 1.34 110.247 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -69.93 -38.64 76.26 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.502 -1.374 . . . . 2.11 110.026 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -79.93 -46.89 15.93 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.289 -0.882 . . . . 2.08 112.379 -176.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -110.67 -0.01 17.32 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.434 -0.792 . . . . 0.02 112.657 -176.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.1 m80 59.69 33.13 21.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.73 -1.231 . . . . 0.02 109.489 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.5 mt -112.78 135.94 52.95 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 108.728 -0.841 . . . . 0.02 108.728 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -91.6 -22.71 20.16 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.266 -0.896 . . . . 5.32 110.415 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -149.59 164.33 35.43 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.089 -1.007 . . . . 0.02 109.867 -178.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.428 ' C ' ' HD1' ' A' ' 127' ' ' HIS . 37.3 mt -131.92 128.86 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 107.642 -1.244 . . . . 2.17 107.642 178.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.431 ' N ' ' HD1' ' A' ' 127' ' ' HIS . 1.3 m80 -108.76 -12.3 14.94 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.342 -0.849 . . . . 0.02 112.462 -177.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.5 t -159.03 151.75 21.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.736 -1.228 . . . . 0.01 109.019 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 7.6 t -168.74 147.25 4.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 1.22 109.114 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -121.9 111.48 17.14 Favored 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 122.415 1.103 . . . . 1.41 109.711 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.1 t -113.33 130.7 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.678 -1.23 . . . . 0.01 107.678 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 44.1 t -129.89 93.37 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 107.176 -1.416 . . . . 1.98 107.176 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.465 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 26.0 tt0 -147.02 -75.21 0.2 Allowed 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 105.799 -1.926 . . . . 0.01 105.799 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 177.44 -78.19 0.07 OUTLIER Glycine 0 N--CA 1.483 1.791 0 N-CA-C 108.104 -1.998 . . . . 0.01 108.104 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.2 t -121.82 125.3 46.17 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.649 -0.912 . . . . 2.3 110.183 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.465 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 7.5 m95 -126.47 151.98 47.04 Favored 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 107.07 -1.456 . . . . 0.01 107.07 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 48.2 mt -120.61 135.37 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 120.329 -1.482 . . . . 1.69 110.297 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -114.73 144.56 43.27 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 107.465 -1.309 . . . . 2.49 107.465 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.503 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 15.2 m-85 -123.25 143.68 49.89 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.33 -0.856 . . . . 0.02 109.631 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -76.15 -29.23 57.7 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.54 -0.725 . . . . 0.02 112.389 -176.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.4 mt -115.43 154.78 47.67 Favored Pre-proline 0 N--CA 1.507 2.408 0 O-C-N 120.654 -1.279 . . . . 1.48 109.081 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.34 164.71 2.66 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 121.191 1.261 . . . . 0.02 112.79 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 51.9 t30 59.94 32.0 20.95 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.077 -0.965 . . . . 0.75 111.59 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 57.24 51.48 10.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.482 -0.762 . . . . 0.02 111.315 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -126.05 164.86 19.93 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.487 -0.758 . . . . 0.02 109.864 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.19 -165.92 33.15 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.346 -1.102 . . . . 0.02 110.346 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -69.57 143.31 53.38 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.563 -0.963 . . . . 0.02 109.207 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -115.16 149.67 37.28 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.206 0.526 . . . . 0.02 109.788 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -124.38 135.11 53.06 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 109.17 -0.678 . . . . 0.01 109.17 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.7 tp -96.7 119.93 36.09 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.608 -1.308 . . . . 0.01 109.264 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 59.1 tp -98.92 153.44 18.82 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.347 -0.846 . . . . 0.01 109.159 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.415 ' CG ' ' H ' ' A' ' 153' ' ' LYS . 21.2 t70 -104.41 -113.3 0.24 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.496 -0.752 . . . . 2.27 109.336 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.415 ' H ' ' CG ' ' A' ' 152' ' ' ASP . 17.6 pttm -163.04 50.59 0.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.081 -1.012 . . . . 1.84 109.855 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -113.01 -155.71 0.57 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.466 -0.771 . . . . 2.28 109.225 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -106.28 103.86 13.42 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.807 -0.812 . . . . 0.01 108.807 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.609 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 17.4 m-85 -98.36 112.31 24.36 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.263 -0.898 . . . . 0.01 109.739 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 22.5 mtm180 -95.27 -22.87 17.51 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.232 -0.918 . . . . 0.01 111.685 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -127.3 154.41 77.06 Favored Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 120.878 -1.139 . . . . 2.54 108.764 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -59.52 -37.92 86.03 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 CA-C-N 119.235 0.763 . . . . 0.7 110.637 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.9 t -60.99 -20.05 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.869 -1.145 . . . . 0.86 109.2 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -65.43 -15.59 62.77 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.983 -1.073 . . . . 0.02 109.98 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.609 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 9.5 m0 -97.8 11.43 37.27 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.124 -0.985 . . . . 0.02 108.997 178.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.59 10.6 85.04 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.89 -1.148 . . . . 0.02 111.04 178.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.38 140.84 32.97 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.111 -1.229 . . . . 0.02 110.126 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.32 -9.09 58.08 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.59 -0.694 . . . . 0.59 109.989 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.8 m -143.6 150.83 52.15 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.039 -1.038 . . . . 0.87 109.032 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -75.98 17.95 0.68 Allowed 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 120.721 0.947 . . . . 0.38 112.405 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.04 123.59 29.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.916 -1.115 . . . . 0.18 111.56 -177.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.0 mt -149.46 126.92 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.071 -1.455 . . . . 3.99 107.071 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 24.1 mm100 -111.38 -18.26 12.93 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.165 -0.959 . . . . 5.17 113.248 -177.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 115' ' ' PRO . 3.8 m -156.73 160.22 39.08 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 119.216 -2.177 . . . . 0.02 110.4 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.433 ' CD1' ' C ' ' A' ' 172' ' ' PHE . 18.3 p90 -151.72 153.05 33.59 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.101 -0.999 . . . . 2.02 110.321 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.3 mtm180 -145.79 150.53 36.37 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.358 -0.839 . . . . 0.01 110.145 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -87.83 144.04 26.81 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.233 -0.655 . . . . 0.01 109.233 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.4 mt -94.79 129.25 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.308 -0.87 . . . . 3.04 108.967 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.49 146.71 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.153 -0.967 . . . . 1.89 109.649 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.33 -0.856 . . . . 4.89 109.466 179.954 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.273 -1.531 . . . . 0.01 109.273 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -147.45 136.28 22.07 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.099 -1.236 . . . . 0.02 110.52 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.4 tt -130.12 138.91 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.698 -0.853 . . . . 0.02 108.698 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 m -120.91 130.24 53.81 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.559 -0.713 . . . . 0.39 110.014 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.9 m-85 -110.4 139.68 45.37 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.581 -0.699 . . . . 0.02 109.247 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.525 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 6.6 m-85 -121.31 138.32 54.3 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.427 -0.796 . . . . 0.02 109.32 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.523 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 83.3 mt-10 -69.38 -27.43 65.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.041 -1.037 . . . . 0.03 111.475 -178.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 2.3 m-20 -114.05 169.35 9.08 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.888 -1.133 . . . . 0.03 110.097 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -76.03 158.66 31.63 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.567 0.699 . . . . 0.03 110.229 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 66.53 33.17 6.82 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 122.012 0.911 . . . . 0.74 111.185 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 55.32 41.72 30.93 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.374 0.607 . . . . 0.02 111.373 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -113.64 165.81 12.15 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.25 -1.019 . . . . 0.02 108.25 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.44 -167.46 35.56 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.765 -1.207 . . . . 0.03 110.766 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.564 HH11 ' CG ' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -68.84 141.69 55.04 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.535 -0.979 . . . . 2.76 109.37 179.383 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -122.77 150.19 43.12 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.6 0.714 . . . . 1.89 110.124 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -135.87 131.74 35.68 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 109.113 -0.699 . . . . 0.02 109.113 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -109.53 136.47 48.87 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.83 -0.804 . . . . 1.12 108.83 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 49.6 t -128.63 138.15 52.04 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.617 -0.677 . . . . 0.02 109.619 -179.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -118.14 12.17 13.48 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.673 -0.642 . . . . 0.2 110.144 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.495 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 14.6 t -159.46 174.2 15.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.822 -1.174 . . . . 1.23 108.918 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -61.55 144.35 54.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.849 -1.157 . . . . 0.02 110.376 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.6 m -134.16 117.92 17.08 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.733 -0.839 . . . . 0.02 108.733 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.38 -19.81 52.57 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.524 -0.735 . . . . 0.24 112.55 -177.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 19.2 p30 -152.95 108.75 3.31 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.703 -1.248 . . . . 1.14 110.831 -178.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -97.68 5.29 49.52 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.428 -0.795 . . . . 6.37 109.771 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.2 mtm180 -60.33 -30.35 69.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.481 -0.762 . . . . 3.11 112.307 -176.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.435 ' OG ' ' CE2' ' A' ' 32' ' ' TYR . 30.3 p -79.35 -18.77 51.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.258 -1.526 . . . . 0.88 111.631 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.435 ' CE2' ' OG ' ' A' ' 31' ' ' SER . 51.1 m-85 -106.57 -22.04 12.88 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.291 -0.881 . . . . 0.02 110.98 -178.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.0 mt -148.89 128.15 12.92 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.948 -1.095 . . . . 3.32 109.216 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.9 t -86.76 -11.13 51.94 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.766 -0.584 . . . . 0.02 110.439 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.0 ttp180 -171.5 160.92 6.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.016 -1.053 . . . . 0.02 108.187 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 82.0 m -144.19 116.49 8.5 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.907 -1.121 . . . . 0.02 109.011 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 11' ' ' GLU . 1.3 m-80 -109.93 0.87 18.78 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 120.836 -1.165 . . . . 0.03 111.857 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.2 m -156.01 153.22 29.16 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.11 -1.07 . . . . 0.02 108.11 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.5 mt -146.9 148.04 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 CA-C-O 122.207 1.004 . . . . 0.02 110.753 -178.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -123.59 124.85 43.72 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.136 -1.061 . . . . 0.02 108.136 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.2 t -106.69 113.92 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 106.805 -1.554 . . . . 0.02 106.805 177.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -84.16 -34.07 24.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.691 -0.631 . . . . 3.81 110.475 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.82 150.25 19.0 Favored Glycine 0 N--CA 1.486 2.004 0 C-N-CA 118.885 -1.626 . . . . 0.02 110.601 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.0 172.44 49.19 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.758 -1.211 . . . . 0.01 110.235 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.9 m -120.04 135.75 54.82 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.098 -1.075 . . . . 1.48 108.098 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.422 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 36.9 m95 -128.35 156.2 43.48 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 122.698 1.237 . . . . 0.02 112.468 -176.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.96 135.02 50.83 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 105.412 -2.07 . . . . 0.24 105.412 176.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.6 m -116.21 141.81 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.597 -0.689 . . . . 0.65 109.286 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -120.72 143.01 48.99 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.987 0.899 . . . . 0.02 109.643 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.46 -33.69 76.52 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.627 -0.715 . . . . 0.02 111.832 -177.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -124.71 157.82 64.5 Favored Pre-proline 0 N--CA 1.504 2.227 0 O-C-N 120.991 -1.068 . . . . 0.02 109.357 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.21 166.7 0.96 Allowed 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 121.724 1.616 . . . . 0.02 112.827 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.5 m120 63.42 36.74 11.2 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.262 -0.881 . . . . 0.02 111.163 178.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.449 ' CD1' ' CD ' ' A' ' 83' ' ' ARG . 3.8 m-85 45.09 51.39 8.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.584 -0.698 . . . . 3.39 110.767 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.7 t -125.65 163.49 22.67 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.241 0.543 . . . . 2.33 109.883 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.53 -161.72 31.31 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.779 -1.328 . . . . 0.02 109.779 -179.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 12.4 m80 -64.61 138.13 58.22 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.983 -1.304 . . . . 0.02 110.209 -178.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 16.0 ptm -118.79 136.7 53.85 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.721 -0.612 . . . . 5.01 109.672 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.486 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 86.6 m-85 -134.33 139.59 45.77 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.483 -0.761 . . . . 0.02 109.647 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.9 mm -95.0 131.03 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.983 -0.747 . . . . 1.72 108.983 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.551 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -120.59 111.32 34.79 Favored Pre-proline 0 N--CA 1.505 2.28 0 O-C-N 121.319 -0.863 . . . . 0.02 110.767 -178.347 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -77.55 169.02 21.72 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 CA-C-N 119.958 1.021 . . . . 1.47 110.135 177.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -53.04 141.43 22.57 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.831 -1.168 . . . . 4.25 110.417 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.78 -177.2 32.2 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 119.403 -1.379 . . . . 0.02 110.743 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -120.72 131.79 54.72 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.334 -1.098 . . . . 0.96 109.8 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.551 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 63.2 m-85 -122.52 95.77 46.46 Favored Pre-proline 0 N--CA 1.496 1.846 0 N-CA-C 107.903 -1.147 . . . . 0.02 107.903 179.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.401 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.9 Cg_endo -66.91 -3.5 9.66 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 120.787 0.992 . . . . 0.02 113.865 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.401 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 79.1 mt-10 -157.47 155.17 29.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.617 -1.302 . . . . 2.02 108.142 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -60.47 -39.26 86.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.623 -0.673 . . . . 0.02 111.974 -177.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -60.02 -23.91 64.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.031 -1.043 . . . . 0.02 110.395 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -69.73 -18.67 63.54 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.809 0.814 . . . . 3.42 108.907 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.547 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.1 t90 -107.84 11.06 28.45 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.515 -1.291 . . . . 0.02 107.515 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 17.9 mtt 61.09 22.49 12.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.446 -0.784 . . . . 0.02 110.439 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.98 144.03 46.86 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.391 -1.484 . . . . 0.02 109.391 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.4 mt -78.87 -30.49 45.09 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.684 -1.228 . . . . 0.98 107.684 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.645 ' N ' HD21 ' A' ' 76' ' ' ASN . 0.0 OUTLIER -157.0 -171.31 3.6 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 106.386 -1.709 . . . . 0.02 106.386 178.299 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.409 ' OD2' ' OD1' ' A' ' 37' ' ' ASN . 63.6 m-20 -98.2 28.21 4.18 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.722 -1.236 . . . . 0.02 110.698 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -96.55 122.33 39.35 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.856 -1.153 . . . . 3.2 110.898 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 68.4 mt -142.17 119.56 11.59 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 107.636 -1.246 . . . . 2.61 107.636 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.86 -17.92 9.29 Favored Glycine 0 N--CA 1.5 2.907 0 O-C-N 121.293 -0.879 . . . . 0.02 112.738 -177.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.446 ' HG ' ' N ' ' A' ' 82' ' ' CYS . 26.4 t -156.16 156.59 34.48 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 120.239 2.02 . . . . 0.02 111.033 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.446 ' N ' ' HG ' ' A' ' 81' ' ' SER . 18.7 m -145.89 148.07 32.45 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.621 -0.674 . . . . 0.02 110.395 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.449 ' CD ' ' CD1' ' A' ' 54' ' ' PHE . 19.4 mtp180 -138.21 143.22 40.07 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.559 -0.713 . . . . 0.01 109.186 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.22 131.69 36.27 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.192 -0.942 . . . . 0.43 109.635 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.5 t -91.2 125.07 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.906 -0.775 . . . . 1.25 108.906 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -93.91 131.21 39.56 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.808 -1.182 . . . . 1.77 108.974 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 mt -96.05 140.01 31.4 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.389 -0.967 . . . . 1.63 108.389 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.2 m -111.83 127.52 55.84 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.347 -0.846 . . . . 1.08 109.318 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.3 m -104.09 -154.04 0.49 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 106.62 -1.622 . . . . 1.26 106.62 177.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.95 -52.6 0.74 Allowed Glycine 0 N--CA 1.501 2.981 0 O-C-N 120.396 -1.44 . . . . 0.01 112.82 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.92 -101.28 0.15 Allowed Glycine 0 N--CA 1.49 2.253 0 C-N-CA 118.491 -1.814 . . . . 0.01 112.042 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 38.8 tp60 -121.48 118.99 30.73 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.172 -1.193 . . . . 4.43 110.683 -178.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.59 130.54 35.47 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.769 -0.772 . . . . 2.99 109.424 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -129.53 142.01 50.86 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.353 -0.842 . . . . 6.36 109.062 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.0 tt -128.28 144.77 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 O-C-N 121.322 -0.862 . . . . 1.09 110.245 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -123.15 133.83 54.23 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.838 -1.171 . . . . 2.05 107.838 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.2 m -124.24 146.25 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 O-C-N 120.625 -1.297 . . . . 1.1 109.882 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -119.31 141.32 49.09 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.844 0.831 . . . . 0.73 110.848 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -66.99 -30.26 70.33 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 116.126 -0.488 . . . . 0.02 111.581 -178.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -116.31 169.69 9.11 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.138 -0.976 . . . . 3.18 110.44 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.4 165.25 52.01 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.827 -0.909 . . . . 0.01 110.827 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.435 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 0.9 OUTLIER 57.27 38.23 28.55 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.925 -0.75 . . . . 0.01 111.57 178.659 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 51.97 54.68 10.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.467 -0.771 . . . . 0.01 111.228 177.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' A' ' 105' ' ' GLY . 19.6 t-20 -129.71 166.01 20.69 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.92 -1.141 . . . . 3.15 107.92 178.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.512 ' N ' ' OD1' ' A' ' 104' ' ' ASN . . . 91.1 -163.37 29.14 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.19 -1.564 . . . . 0.01 109.19 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.7 tp60 -76.68 143.65 39.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.968 -1.313 . . . . 0.01 108.974 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.447 ' SD ' ' C ' ' A' ' 107' ' ' MET . 12.6 tmm? -116.47 142.23 47.13 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.553 0.692 . . . . 0.01 109.985 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -131.46 136.8 48.25 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.326 -0.99 . . . . 2.48 108.326 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -118.83 134.47 55.13 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.495 -0.753 . . . . 0.01 110.007 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.4 t -148.89 149.57 31.48 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.255 1.026 . . . . 1.69 110.951 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 20.2 p -110.97 9.76 22.21 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 115.53 -0.759 . . . . 0.01 110.314 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -120.9 163.24 18.52 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.203 -0.936 . . . . 3.21 111.514 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -68.08 156.57 37.15 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.212 -1.033 . . . . 0.01 108.212 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 19.8 t -126.72 114.04 22.58 Favored Pre-proline 0 N--CA 1.5 2.053 0 O-C-N 121.484 -0.76 . . . . 0.01 109.029 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -75.1 -29.43 8.07 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 CA-C-N 120.376 1.17 . . . . 0.01 111.116 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 69.6 m -142.12 109.37 5.57 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.383 -0.823 . . . . 0.02 109.324 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.58 -39.38 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.777 -0.577 . . . . 1.83 110.567 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 22.6 ttt -68.82 -37.57 79.29 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.398 -0.921 . . . . 1.34 110.358 -178.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -69.58 -38.67 77.47 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.434 -1.416 . . . . 2.11 109.986 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -79.94 -46.93 15.83 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.291 -0.881 . . . . 2.08 112.297 -177.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -111.34 0.06 16.53 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.391 -0.818 . . . . 0.02 112.663 -176.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.3 m80 60.27 33.48 20.92 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.789 -1.194 . . . . 0.02 109.618 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.1 mt -112.51 135.02 53.72 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 108.743 -0.836 . . . . 0.02 108.743 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -91.59 -22.79 20.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 5.32 110.27 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -149.05 163.79 36.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.198 -0.939 . . . . 0.02 109.702 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.0 mt -131.63 129.06 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 107.831 -1.174 . . . . 2.17 107.831 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -108.84 -12.54 14.89 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.368 -0.832 . . . . 0.02 112.231 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.0 t -158.86 150.56 20.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.851 -1.156 . . . . 0.01 109.196 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 6.2 t -167.75 147.04 4.88 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.696 -0.853 . . . . 1.22 108.696 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -122.06 111.64 17.27 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 122.348 1.071 . . . . 1.41 109.79 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 t -112.56 130.32 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 107.532 -1.284 . . . . 0.01 107.532 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 48.6 t -129.57 93.6 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 N-CA-C 107.204 -1.406 . . . . 1.98 107.204 177.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.485 ' OE1' ' N ' ' A' ' 134' ' ' GLY . 11.7 tm-20 -147.19 -76.54 0.18 Allowed 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 105.869 -1.9 . . . . 0.01 105.869 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.485 ' N ' ' OE1' ' A' ' 133' ' ' GLU . . . 176.31 -75.63 0.08 OUTLIER Glycine 0 N--CA 1.485 1.905 0 N-CA-C 108.308 -1.917 . . . . 0.01 108.308 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.29 121.04 37.78 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.686 -0.891 . . . . 2.3 110.235 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.451 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 6.8 m95 -126.99 151.17 48.92 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 106.87 -1.53 . . . . 0.01 106.87 179.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 81.1 mt -122.55 137.43 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 120.321 -1.487 . . . . 1.69 110.669 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -114.77 144.39 43.57 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 107.268 -1.382 . . . . 2.49 107.268 178.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.501 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 14.6 m-85 -122.75 143.76 49.61 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.217 -0.927 . . . . 0.02 109.559 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -74.66 -29.08 61.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.524 -0.735 . . . . 0.02 111.864 -176.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mt -116.18 154.89 48.69 Favored Pre-proline 0 N--CA 1.506 2.346 0 O-C-N 120.757 -1.215 . . . . 1.48 108.92 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -55.69 167.23 2.25 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.19 1.26 . . . . 0.02 112.817 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 59.67 30.67 20.29 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.125 -0.943 . . . . 0.75 111.286 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 57.82 51.44 9.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.59 -0.694 . . . . 0.02 111.152 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -126.21 164.89 19.98 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.457 -0.777 . . . . 0.02 110.106 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.07 -165.82 33.24 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.387 -1.085 . . . . 0.02 110.387 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -69.0 142.45 54.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.544 -0.974 . . . . 0.02 108.903 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -114.2 148.47 37.26 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.414 0.626 . . . . 0.02 110.129 -178.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -125.13 134.75 52.32 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.073 -0.714 . . . . 0.01 109.073 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.6 tt -99.27 121.67 41.39 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.907 -1.121 . . . . 0.01 109.004 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.484 ' CD1' ' CD1' ' A' ' 162' ' ' TRP . 21.3 tp -97.27 144.64 26.86 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.245 -0.909 . . . . 0.01 109.247 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -106.42 -162.07 0.83 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.494 -0.753 . . . . 2.27 109.852 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -99.78 51.31 0.92 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.337 -0.852 . . . . 1.84 109.867 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -115.06 -174.93 2.58 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.361 -0.837 . . . . 2.28 109.578 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -105.01 110.28 22.62 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.497 -0.927 . . . . 0.01 108.497 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.626 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 4.5 m-85 -100.72 113.46 26.36 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.385 -0.822 . . . . 0.01 110.523 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -96.48 -22.23 17.24 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.31 -0.869 . . . . 0.01 111.586 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -127.23 153.67 76.9 Favored Pre-proline 0 N--CA 1.505 2.294 0 O-C-N 120.892 -1.13 . . . . 2.54 109.173 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -59.76 -40.38 64.53 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 120.466 0.777 . . . . 0.7 110.574 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 41.7 t -61.03 -19.83 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.751 -1.218 . . . . 0.86 108.675 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 161' ' ' ASP . 41.4 t0 -65.54 -15.37 62.63 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.019 -1.05 . . . . 0.02 109.851 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.626 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 11.1 m0 -97.68 11.01 38.5 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.219 -0.926 . . . . 0.02 108.887 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.67 11.09 85.09 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.817 -1.182 . . . . 0.02 110.939 178.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.1 141.26 33.17 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.188 -1.184 . . . . 0.02 110.15 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.94 -8.64 58.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.592 -0.692 . . . . 0.59 110.219 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.1 t -143.62 150.32 50.26 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 120.931 -1.105 . . . . 0.87 109.195 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -75.91 18.52 0.63 Allowed 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 120.708 0.939 . . . . 0.38 112.161 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.62 124.19 29.94 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.952 -1.093 . . . . 0.18 111.42 -178.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.9 mt -149.48 126.88 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.052 -1.462 . . . . 3.99 107.052 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -112.11 -17.25 12.87 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.05 -1.031 . . . . 5.17 113.096 -177.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 17.0 t -157.04 160.13 38.65 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 119.14 -2.225 . . . . 0.02 110.374 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.428 ' CD1' ' C ' ' A' ' 172' ' ' PHE . 18.7 p90 -151.17 152.7 33.7 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.037 -1.039 . . . . 2.02 110.37 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -144.96 149.45 35.21 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.807 0.813 . . . . 0.01 110.225 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -88.62 145.15 25.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.613 -0.679 . . . . 0.01 109.293 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.2 mt -95.3 129.18 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.319 -0.863 . . . . 3.04 109.359 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.9 p -135.77 146.12 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.222 -0.924 . . . . 1.89 109.605 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.311 -0.868 . . . . 4.89 109.413 179.965 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 41.0 m . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.483 -0.562 . . . . 5.28 109.483 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -74.92 65.48 1.42 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.933 . . . . 5.96 109.385 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.1 m -81.0 142.93 32.92 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.411 -0.959 . . . . 2.22 108.411 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.98 -179.84 47.73 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 118.31 -1.9 . . . . 0.81 112.147 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.58 157.64 44.27 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.312 -1.515 . . . . 0.01 109.312 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -148.51 136.5 20.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.976 -1.308 . . . . 0.02 110.374 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.7 tt -130.62 140.68 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.724 -0.843 . . . . 0.02 108.724 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 t -120.83 130.42 53.95 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.573 -0.704 . . . . 0.39 109.952 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.6 m-85 -110.33 139.94 45.01 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 109.217 -0.66 . . . . 0.02 109.217 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.564 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.7 m-85 -121.41 137.87 54.52 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.232 -0.917 . . . . 0.02 109.572 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -69.72 -27.43 64.97 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.995 -1.066 . . . . 0.03 111.36 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 3.1 m-20 -114.23 169.68 8.85 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.927 -1.108 . . . . 0.03 110.203 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.462 ' CG ' HD21 ' A' ' 37' ' ' ASN . 71.2 mtm180 -75.5 157.79 33.48 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.707 0.765 . . . . 0.03 110.41 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 m120 66.16 33.84 7.13 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.884 0.85 . . . . 0.74 111.192 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 55.54 41.25 30.93 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.301 0.572 . . . . 0.02 111.241 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -113.11 165.51 12.31 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.273 -1.01 . . . . 0.02 108.273 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.3 -166.97 35.32 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.767 -1.206 . . . . 0.03 110.651 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.417 ' HG3' HH11 ' A' ' 18' ' ' ARG . 25.8 ttm-85 -68.77 141.68 55.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.494 -1.004 . . . . 2.76 109.247 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -122.66 150.13 43.1 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.547 -0.721 . . . . 1.89 109.88 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -138.11 134.02 34.14 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.706 -0.621 . . . . 0.02 109.659 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -109.08 136.17 49.03 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.393 -0.817 . . . . 1.12 108.83 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.6 t -127.17 138.15 53.08 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.575 -0.703 . . . . 0.02 109.406 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.501 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 2.0 m-20 -118.93 11.75 12.63 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.494 -0.754 . . . . 0.2 110.633 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 22.0 m -159.4 174.11 15.22 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.818 -1.176 . . . . 1.23 109.058 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -62.57 145.84 53.38 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.824 -1.173 . . . . 0.02 110.453 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 7.5 m -133.74 117.47 16.97 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 108.777 -0.823 . . . . 0.02 108.777 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.14 -21.92 49.59 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.167 -0.958 . . . . 0.24 111.731 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -150.22 105.68 3.38 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.799 -1.188 . . . . 1.14 109.526 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.8 5.32 45.54 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.54 0.686 . . . . 6.37 110.067 -178.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -61.53 -28.3 69.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.404 -0.81 . . . . 3.11 112.311 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.1 m -78.69 -18.85 53.72 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.248 -1.533 . . . . 0.88 111.741 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -105.74 -21.5 13.16 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.175 -0.953 . . . . 0.02 110.472 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 47.6 mt -148.55 127.81 12.96 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.098 -1.001 . . . . 3.32 109.125 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.5 p -86.18 -11.3 52.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.791 -0.568 . . . . 0.02 110.414 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -172.44 161.83 5.2 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.133 -1.062 . . . . 0.02 108.133 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 80.4 m -143.68 116.25 8.64 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.1 -1.0 . . . . 0.02 108.454 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.462 HD21 ' CG ' ' A' ' 13' ' ' ARG . 52.5 t30 -110.23 0.94 18.36 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 120.862 -1.149 . . . . 0.03 111.519 -177.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.6 t -155.71 152.8 29.01 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.647 -1.242 . . . . 0.02 107.647 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.7 mt -146.94 148.7 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.104 -0.998 . . . . 0.02 110.63 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -124.52 125.35 44.06 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.614 -1.254 . . . . 0.02 107.614 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.5 t -105.24 113.99 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 107.018 -1.475 . . . . 0.02 107.018 177.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -84.71 -34.67 22.88 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.411 -0.805 . . . . 3.81 110.135 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.83 150.02 18.52 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 118.519 -1.8 . . . . 0.02 110.802 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.15 172.13 48.84 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.269 -1.132 . . . . 0.01 110.269 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.4 m -119.62 135.17 54.92 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 107.934 -1.135 . . . . 1.48 107.934 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.436 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 35.6 m95 -127.94 155.55 44.05 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 122.625 1.202 . . . . 0.02 112.518 -176.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.65 134.26 51.63 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 105.283 -2.117 . . . . 0.24 105.283 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.8 m -118.36 143.82 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 109.172 -0.677 . . . . 0.65 109.172 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -120.93 145.19 47.96 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 122.172 0.987 . . . . 0.02 109.977 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -66.07 -33.52 75.99 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.917 -0.583 . . . . 0.02 111.385 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -124.97 158.15 64.09 Favored Pre-proline 0 N--CA 1.503 2.222 0 O-C-N 121.127 -0.983 . . . . 0.02 109.43 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.62 166.92 1.1 Allowed 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.753 1.635 . . . . 0.02 112.905 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' ' 53' ' ' ASN . 1.5 t30 63.38 36.31 11.61 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 115.279 -0.873 . . . . 0.02 111.048 178.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.438 ' H ' ' HG ' ' A' ' 81' ' ' SER . 7.2 m-85 45.47 51.49 9.7 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.611 0.72 . . . . 3.39 110.904 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 t -126.08 163.46 23.02 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.182 0.515 . . . . 2.33 109.88 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.61 -161.69 31.18 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.878 -1.289 . . . . 0.02 109.878 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 15.0 m80 -64.54 138.94 58.68 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.001 -1.293 . . . . 0.02 110.077 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.44 ' SD ' ' C ' ' A' ' 58' ' ' MET . 10.9 tmm? -119.09 137.16 53.76 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 121.301 0.572 . . . . 5.01 109.72 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.544 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 86.1 m-85 -135.33 138.96 43.92 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.477 -0.764 . . . . 0.02 109.854 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.5 mm -95.51 131.52 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 109.192 -0.67 . . . . 1.72 109.192 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.2 mt -121.04 111.98 33.65 Favored Pre-proline 0 N--CA 1.506 2.333 0 O-C-N 121.368 -0.832 . . . . 0.02 110.984 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -77.85 169.61 20.36 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 CA-C-N 119.886 0.995 . . . . 1.47 110.092 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -53.06 140.74 24.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.768 -1.207 . . . . 4.25 110.439 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.64 -177.48 32.75 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.548 -1.311 . . . . 0.02 110.533 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -119.3 130.6 55.48 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.267 -1.137 . . . . 0.96 109.759 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -120.97 94.59 48.99 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 108.113 -1.069 . . . . 0.02 108.113 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.404 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 2.5 Cg_endo -66.8 -3.49 9.5 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 120.874 1.049 . . . . 0.02 113.908 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 35.0 mt-10 -157.95 154.97 28.65 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.687 -1.258 . . . . 2.02 108.238 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.461 ' CD1' ' OD1' ' A' ' 37' ' ' ASN . 24.2 p90 -60.25 -39.17 85.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.57 -0.706 . . . . 0.02 112.019 -177.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -59.88 -23.83 63.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.946 -1.096 . . . . 0.02 110.189 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -69.99 -18.93 63.35 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.947 0.879 . . . . 3.42 108.895 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.544 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.5 t90 -107.7 9.85 29.07 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.402 -1.333 . . . . 0.02 107.402 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 33.2 mtm 60.46 23.03 12.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.589 -0.695 . . . . 0.02 110.266 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.46 144.11 45.91 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.598 -1.401 . . . . 0.02 109.598 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.0 tp -79.37 -31.17 42.84 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.5 -1.296 . . . . 0.98 107.5 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -157.16 -171.76 3.75 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.342 -1.725 . . . . 0.02 106.342 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -98.43 28.54 4.09 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.618 -1.302 . . . . 0.02 110.703 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -97.0 122.61 40.18 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.83 -1.169 . . . . 3.2 111.014 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 75.5 mt -141.92 119.21 11.48 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.541 -1.281 . . . . 2.61 107.541 178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.21 -18.33 9.91 Favored Glycine 0 N--CA 1.498 2.809 0 O-C-N 121.157 -0.964 . . . . 0.02 112.344 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.438 ' HG ' ' H ' ' A' ' 54' ' ' PHE . 91.3 p -156.38 155.86 32.88 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.256 -1.732 . . . . 0.02 110.491 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 49.1 t -145.35 148.23 33.15 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.493 -0.754 . . . . 0.02 109.912 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.43 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 41.8 mtm180 -138.3 142.98 39.78 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.253 -0.904 . . . . 0.01 109.429 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.21 132.04 36.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.23 -0.919 . . . . 0.43 109.691 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.9 t -91.14 125.21 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.796 -0.816 . . . . 1.25 108.796 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -93.31 131.97 37.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.762 -1.211 . . . . 1.77 108.995 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mt -97.01 139.3 33.22 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.249 -1.019 . . . . 1.63 108.249 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.6 m -111.49 127.39 55.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.291 -0.881 . . . . 1.08 109.192 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.9 m -103.88 -154.18 0.5 Allowed 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 106.387 -1.709 . . . . 1.26 106.387 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.46 -51.58 0.79 Allowed Glycine 0 N--CA 1.501 2.985 0 O-C-N 120.408 -1.433 . . . . 0.01 112.656 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.68 -100.86 0.15 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 118.493 -1.813 . . . . 0.01 111.977 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -121.43 118.7 30.05 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.085 -1.244 . . . . 4.43 110.668 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.99 130.06 36.05 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.881 -0.728 . . . . 2.99 109.374 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -130.2 140.48 50.73 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.459 -0.776 . . . . 6.36 109.139 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.5 tt -128.33 145.54 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 121.425 -0.797 . . . . 1.09 110.215 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -122.18 133.2 54.73 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 107.607 -1.257 . . . . 2.05 107.607 177.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.8 m -124.57 146.1 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 O-C-N 120.657 -1.277 . . . . 1.1 109.805 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.581 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 62.3 m-85 -119.49 141.47 49.15 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 122.036 0.922 . . . . 0.73 111.134 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -67.07 -30.31 70.33 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 115.963 -0.562 . . . . 0.02 111.511 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -116.05 169.28 9.38 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.13 -0.981 . . . . 3.18 110.264 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.46 165.12 52.25 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.982 -0.847 . . . . 0.01 110.982 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 57.07 38.34 29.12 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.785 -0.833 . . . . 0.01 111.418 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.584 ' H ' ' HG ' ' A' ' 128' ' ' SER . 21.1 m-85 52.16 54.46 10.74 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.459 -0.776 . . . . 0.01 111.271 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -129.48 165.87 20.77 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.994 -1.113 . . . . 3.15 107.994 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.08 -163.65 29.32 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.259 -1.537 . . . . 0.01 109.259 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -76.1 143.55 41.21 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.948 -1.325 . . . . 0.01 108.918 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.581 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 38.1 ttp -116.44 142.52 46.76 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.575 0.702 . . . . 0.01 109.803 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -131.64 136.55 47.82 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.234 -1.024 . . . . 2.48 108.234 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -118.45 134.1 55.34 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.541 -0.725 . . . . 0.01 110.193 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.9 t -148.4 150.04 32.81 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 122.191 0.996 . . . . 1.69 110.973 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.7 p -110.31 10.23 23.56 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 115.555 -0.748 . . . . 0.01 110.214 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -120.96 163.53 18.11 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.234 -0.916 . . . . 3.21 111.597 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -66.89 156.71 35.03 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.951 -1.129 . . . . 0.01 107.951 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.608 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 22.0 p -122.83 115.16 29.48 Favored Pre-proline 0 N--CA 1.5 2.069 0 O-C-N 121.459 -0.776 . . . . 0.01 109.153 178.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -78.15 -34.72 1.53 Allowed 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 119.993 1.033 . . . . 0.01 110.906 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.6 m -141.07 107.91 5.39 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.687 -0.856 . . . . 0.02 108.687 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.86 -38.93 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.988 -0.445 . . . . 1.83 110.897 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 19.6 ttt -67.59 -38.11 83.54 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.155 -1.018 . . . . 1.34 110.034 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -68.85 -38.09 79.54 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.407 -1.433 . . . . 2.11 109.599 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -79.72 -46.92 16.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.324 -0.86 . . . . 2.08 112.267 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -112.07 -0.51 15.63 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.398 -0.814 . . . . 0.02 112.841 -176.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.417 ' ND1' ' N ' ' A' ' 122' ' ' HIS . 2.2 m-70 61.61 34.66 17.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.852 -1.155 . . . . 0.02 109.811 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.1 mt -114.13 135.99 53.43 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.446 -0.784 . . . . 0.02 109.299 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -90.87 -22.09 21.1 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.239 -0.913 . . . . 5.32 110.868 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -147.59 163.71 35.75 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.992 -1.067 . . . . 0.02 109.863 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.1 mm -129.49 125.68 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 107.853 -1.166 . . . . 2.17 107.853 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -110.9 -13.4 14.13 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.204 -0.935 . . . . 0.02 112.821 -177.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.584 ' HG ' ' H ' ' A' ' 103' ' ' PHE . 2.2 t -159.45 150.96 20.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.673 -1.267 . . . . 0.01 109.312 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.511 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 7.9 p -166.29 148.5 6.86 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.092 -1.005 . . . . 1.22 108.992 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.03 109.26 15.72 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 122.395 1.093 . . . . 1.41 109.095 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.1 t -113.27 128.41 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 107.648 -1.241 . . . . 0.01 107.648 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.4 t -129.55 93.23 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 107.391 -1.336 . . . . 1.98 107.391 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.52 ' OE1' ' NE1' ' A' ' 136' ' ' TRP . 31.5 tt0 -147.08 -75.34 0.19 Allowed 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 105.882 -1.895 . . . . 0.01 105.882 177.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 177.26 -77.01 0.07 OUTLIER Glycine 0 N--CA 1.483 1.821 0 N-CA-C 108.403 -1.879 . . . . 0.01 108.403 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.7 t -120.23 125.5 48.29 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.541 -0.976 . . . . 2.3 110.226 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.52 ' NE1' ' OE1' ' A' ' 133' ' ' GLU . 8.2 m95 -128.97 151.57 49.54 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 107.066 -1.457 . . . . 0.01 107.066 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 41.0 mt -119.53 134.84 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 120.383 -1.448 . . . . 1.69 109.987 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -114.36 143.91 44.14 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.262 -1.384 . . . . 2.49 107.262 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.511 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 11.5 m-85 -123.02 144.67 49.12 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.244 -0.91 . . . . 0.02 109.346 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -76.3 -28.89 57.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.687 -0.633 . . . . 0.02 111.732 -176.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.1 mt -116.32 155.03 48.87 Favored Pre-proline 0 N--CA 1.504 2.248 0 O-C-N 120.698 -1.251 . . . . 1.48 108.896 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -56.17 167.2 2.65 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.186 1.257 . . . . 0.02 113.072 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 59.49 31.3 20.93 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 114.995 -1.002 . . . . 0.75 111.363 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 57.63 51.22 9.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.536 -0.727 . . . . 0.02 111.092 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -127.02 165.19 19.92 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.583 -0.698 . . . . 0.02 110.157 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.89 -166.03 33.66 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.395 -1.082 . . . . 0.02 110.395 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -69.38 142.54 53.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.551 -0.97 . . . . 0.02 109.162 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -115.13 149.76 37.08 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.729 -0.607 . . . . 0.02 110.028 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -123.68 134.27 53.76 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 109.004 -0.739 . . . . 0.01 109.004 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.6 tp -97.07 121.11 38.6 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.797 -1.189 . . . . 0.01 109.4 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.439 ' CD1' ' CD1' ' A' ' 162' ' ' TRP . 12.9 tp -98.5 146.52 25.69 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.234 -0.916 . . . . 0.01 108.787 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -104.68 -124.77 0.22 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.465 -0.772 . . . . 2.27 110.251 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -138.63 50.45 1.86 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.218 -0.926 . . . . 1.84 109.657 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.49 ' H ' ' HH ' ' A' ' 156' ' ' TYR . 59.6 mttm -115.37 -167.2 1.21 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.344 -0.848 . . . . 2.28 109.517 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -105.6 109.97 22.13 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.565 -0.902 . . . . 0.01 108.565 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.632 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 4.1 m-85 -99.97 111.53 23.83 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.382 -0.823 . . . . 0.01 110.301 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -96.14 -22.1 17.51 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.147 -0.97 . . . . 0.01 111.32 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -127.42 154.11 77.29 Favored Pre-proline 0 N--CA 1.505 2.275 0 O-C-N 121.04 -1.037 . . . . 2.54 108.957 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -59.62 -38.4 82.07 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 120.442 0.761 . . . . 0.7 110.533 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 65.5 t -61.07 -19.68 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.948 -1.095 . . . . 0.86 109.047 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -65.24 -15.18 62.2 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.973 -1.079 . . . . 0.02 109.856 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.632 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 9.8 m0 -97.65 11.04 38.39 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.173 -0.954 . . . . 0.02 108.985 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.31 11.13 84.61 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.899 -1.144 . . . . 0.02 110.988 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.71 140.88 33.27 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.042 -1.269 . . . . 0.02 110.155 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.39 -8.53 58.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.64 -0.662 . . . . 0.59 110.178 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.7 p -142.29 150.95 56.94 Favored Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 120.93 -1.106 . . . . 0.87 109.237 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -75.69 16.8 0.73 Allowed 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 120.81 1.007 . . . . 0.38 112.241 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.14 121.78 27.03 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.359 1.076 . . . . 0.18 111.27 -178.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.1 mt -149.33 124.21 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 106.096 -1.816 . . . . 3.99 106.096 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -112.32 -15.46 13.15 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.217 -0.927 . . . . 5.17 113.271 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 5.4 p -157.34 160.77 38.84 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 119.285 -2.135 . . . . 0.02 110.204 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.608 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 7.1 p90 -152.25 154.07 35.02 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.007 -1.058 . . . . 2.02 110.737 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.4 mtm180 -145.61 150.41 36.31 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.272 -0.892 . . . . 0.01 110.293 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -88.31 143.55 26.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.554 -0.716 . . . . 0.01 109.199 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.1 mt -94.58 129.77 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.242 -0.912 . . . . 3.04 109.034 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.47 146.84 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.203 -0.936 . . . . 1.89 109.639 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.365 -0.834 . . . . 4.89 109.462 -179.922 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.4 t . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.316 0.579 . . . . 5.28 109.495 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -61.55 156.56 19.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.955 . . . . 5.96 109.458 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 73.7 p -65.4 141.13 58.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.187 -1.57 . . . . 2.22 111.166 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.89 36.87 4.09 Favored Glycine 0 N--CA 1.502 3.071 0 O-C-N 120.997 -1.064 . . . . 0.81 113.444 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.81 143.25 34.77 Favored Glycine 0 N--CA 1.491 2.328 0 CA-C-N 120.927 2.364 . . . . 0.01 107.86 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -148.51 134.66 19.29 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.96 -1.318 . . . . 0.02 110.983 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.426 HG21 HD13 ' A' ' 7' ' ' ILE . 6.9 tt -128.56 138.95 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 107.703 -1.221 . . . . 0.02 107.703 178.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.4 t -122.33 130.21 52.91 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.225 -0.922 . . . . 0.39 110.339 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 5.2 m-85 -110.36 140.45 44.54 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.82 -0.807 . . . . 0.02 108.82 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.555 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.7 m-85 -122.39 138.69 54.45 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.219 -0.926 . . . . 0.02 109.512 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -68.62 -27.46 66.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.083 -1.011 . . . . 0.03 111.438 -178.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -114.77 170.17 8.53 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.822 -1.174 . . . . 0.03 110.161 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -75.4 161.68 29.03 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.932 0.872 . . . . 0.03 110.39 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.534 ' N ' ' ND2' ' A' ' 14' ' ' ASN . 0.9 OUTLIER 63.22 32.9 14.67 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.048 0.928 . . . . 0.74 110.853 179.196 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.4 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 1.3 m-85 55.03 40.02 31.83 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.94 -0.573 . . . . 0.02 110.874 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -110.08 166.07 11.24 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.134 -1.061 . . . . 0.02 108.134 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.14 -167.59 36.21 Favored Glycine 0 N--CA 1.496 2.638 0 C-N-CA 119.765 -1.207 . . . . 0.03 111.037 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -69.01 143.03 54.46 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.49 -1.006 . . . . 2.76 109.171 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -120.76 149.02 43.18 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.5 0.667 . . . . 1.89 110.197 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -132.7 127.56 35.04 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.323 -0.991 . . . . 0.02 108.323 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 7.8 p30 -112.6 136.76 51.77 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.429 -0.794 . . . . 1.12 109.934 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 10.9 t -131.5 138.79 49.11 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.631 -0.668 . . . . 0.02 109.547 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -116.63 11.07 14.59 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.671 -0.643 . . . . 0.2 109.912 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.405 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 9.8 p -158.63 174.86 14.42 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.408 -0.96 . . . . 1.23 108.408 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -60.75 143.66 53.96 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.669 -1.269 . . . . 0.02 109.912 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.3 t -131.51 117.44 18.79 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.487 -0.931 . . . . 0.02 108.487 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.81 -25.04 48.61 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.156 -0.965 . . . . 0.24 110.83 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -155.15 101.38 2.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.031 -1.043 . . . . 1.14 108.968 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.402 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 24.1 p90 -104.92 9.83 34.5 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 122.111 0.958 . . . . 6.37 109.622 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 45.4 mtp180 -58.65 -24.0 60.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.509 -0.744 . . . . 3.11 110.847 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.5 t -74.46 -16.49 60.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.796 -1.19 . . . . 0.88 110.071 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -104.53 -22.17 13.32 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.536 -0.728 . . . . 0.02 109.588 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.9 tp -150.38 128.89 12.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.194 -0.941 . . . . 3.32 109.085 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.2 t -85.44 -9.86 56.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.786 -0.571 . . . . 0.02 111.11 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -171.36 162.75 6.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.859 -1.15 . . . . 0.02 107.954 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.2 p -143.25 115.42 8.4 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.806 -1.184 . . . . 0.02 108.717 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -108.0 2.36 23.16 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 120.877 -1.14 . . . . 0.03 110.889 -178.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.0 p -156.94 154.63 30.01 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.553 -1.277 . . . . 0.02 107.553 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.3 mt -147.02 148.37 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.039 -1.038 . . . . 0.02 110.376 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.403 ' CB ' ' HH ' ' A' ' 10' ' ' TYR . 62.0 ttt180 -124.59 125.79 44.73 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.982 -1.118 . . . . 0.02 107.982 177.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.1 t -107.16 115.31 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 107.105 -1.443 . . . . 0.02 107.105 177.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -83.88 -34.14 24.64 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.585 -0.697 . . . . 3.81 110.824 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.95 152.3 22.1 Favored Glycine 0 N--CA 1.486 2.016 0 C-N-CA 118.935 -1.602 . . . . 0.02 110.816 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.31 172.78 49.12 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.517 -1.325 . . . . 0.01 110.398 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 47.1 m -119.82 134.89 55.08 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.053 -1.091 . . . . 1.48 108.053 178.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.598 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 3.3 m95 -125.99 154.53 42.77 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 122.522 1.153 . . . . 0.02 112.178 -176.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.98 133.56 52.81 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 105.369 -2.085 . . . . 0.24 105.369 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.0 m -118.46 143.17 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 109.005 -0.739 . . . . 0.65 109.005 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -121.03 146.76 46.37 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 122.192 0.996 . . . . 0.02 110.041 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.25 -34.6 78.74 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.831 -0.622 . . . . 0.02 111.517 -177.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.55 163.02 45.41 Favored Pre-proline 0 N--CA 1.509 2.489 0 O-C-N 120.92 -1.113 . . . . 0.02 109.135 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -55.94 168.07 2.01 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.294 1.33 . . . . 0.02 113.208 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 63.79 36.41 10.52 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.103 -0.953 . . . . 0.02 111.863 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 45.57 52.24 9.38 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.669 0.747 . . . . 3.39 111.188 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.1 m -127.2 164.22 22.15 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.261 0.553 . . . . 2.33 109.912 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.32 -161.58 32.79 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.918 -1.273 . . . . 0.02 109.918 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -65.85 137.94 57.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.101 -1.234 . . . . 0.02 109.99 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 14.8 ptm -118.66 136.68 53.78 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.82 -0.55 . . . . 5.01 109.556 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.425 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 96.5 m-85 -133.04 138.88 46.92 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-O 121.639 0.733 . . . . 0.02 109.756 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.9 mm -95.17 131.16 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.934 -0.765 . . . . 1.72 108.934 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.517 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 1.1 mt -120.02 110.73 36.16 Favored Pre-proline 0 N--CA 1.504 2.246 0 O-C-N 121.477 -0.764 . . . . 0.02 110.711 -178.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -77.65 168.59 22.28 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 CA-C-N 119.979 1.028 . . . . 1.47 110.139 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -54.18 141.15 30.19 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.836 -1.165 . . . . 4.25 110.395 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.43 -177.27 32.69 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 119.684 -1.246 . . . . 0.02 110.52 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -119.21 130.53 55.53 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.433 -1.039 . . . . 0.96 109.662 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.517 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 51.1 m-85 -120.87 97.97 47.97 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 107.762 -1.199 . . . . 0.02 107.762 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -70.23 -3.91 13.27 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 120.681 0.921 . . . . 0.02 113.674 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -157.33 154.79 29.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.651 -1.281 . . . . 2.02 108.048 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -60.14 -39.23 85.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.542 -0.724 . . . . 0.02 111.871 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -59.89 -23.99 63.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.003 -1.061 . . . . 0.02 110.329 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -70.19 -18.79 63.2 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.955 0.883 . . . . 3.42 108.898 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.544 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.4 t90 -108.27 10.39 27.75 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.396 -1.335 . . . . 0.02 107.396 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 7.5 mmt 60.6 22.52 12.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.533 -0.729 . . . . 0.02 110.51 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.66 145.17 47.72 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.535 -1.426 . . . . 0.02 109.535 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.8 mt -79.62 -30.85 41.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.062 -1.258 . . . . 0.98 108.09 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -157.67 -171.48 3.58 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.541 -1.652 . . . . 0.02 106.541 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -98.57 28.56 4.13 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.628 -1.295 . . . . 0.02 110.518 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.579 ' CG ' HH11 ' A' ' 78' ' ' ARG . 3.1 mtt-85 -97.87 122.74 41.34 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.163 -0.96 . . . . 3.2 111.361 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.402 ' O ' ' CZ ' ' A' ' 29' ' ' PHE . 34.7 mt -144.78 122.24 11.68 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 107.6 -1.259 . . . . 2.61 107.6 177.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.09 -16.06 11.88 Favored Glycine 0 N--CA 1.503 3.112 0 O-C-N 121.184 -0.948 . . . . 0.02 112.696 -177.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.8 t -156.55 155.91 32.73 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.171 -1.782 . . . . 0.02 110.363 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.1 p -145.39 148.03 32.91 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.532 -0.73 . . . . 0.02 110.303 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -138.44 143.61 39.75 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.311 -0.868 . . . . 0.01 109.386 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.95 133.13 36.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.43 109.813 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.5 t -92.23 125.58 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.968 -0.753 . . . . 1.25 108.968 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -93.31 132.63 37.34 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.833 -1.167 . . . . 1.77 109.173 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.5 mt -98.95 141.27 31.92 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.499 -0.75 . . . . 1.63 109.029 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.0 t -111.6 125.11 53.58 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.693 -0.855 . . . . 1.08 108.693 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 90.2 p -116.7 133.29 56.19 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.717 -1.239 . . . . 1.26 108.039 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.02 -48.99 0.01 OUTLIER Glycine 0 N--CA 1.505 3.284 0 C-N-CA 117.723 -2.179 . . . . 0.01 113.839 -177.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -167.26 -105.47 0.18 Allowed Glycine 0 N--CA 1.491 2.358 0 CA-C-N 120.045 1.923 . . . . 0.01 111.098 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -118.95 117.23 28.27 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.061 -1.258 . . . . 4.43 109.998 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.04 130.58 36.62 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.834 -0.747 . . . . 2.99 109.132 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.3 ttmm -130.16 139.95 50.82 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.51 -0.744 . . . . 6.36 109.258 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.5 tt -129.28 145.8 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 O-C-N 121.39 -0.819 . . . . 1.09 110.159 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.456 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 7.1 pt20 -122.52 134.03 54.56 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 107.761 -1.2 . . . . 2.05 107.761 177.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.6 m -123.18 146.06 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 120.868 -1.145 . . . . 1.1 109.612 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.584 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 67.2 m-85 -118.51 140.56 49.69 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 122.104 0.954 . . . . 0.73 110.845 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.43 ' OE2' ' O ' ' A' ' 99' ' ' GLU . 4.3 tm-20 -66.35 -30.18 70.53 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.957 -0.565 . . . . 0.02 111.357 -178.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.434 ' O ' ' OG ' ' A' ' 128' ' ' SER . 79.1 mttt -117.04 170.56 8.55 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.078 -1.014 . . . . 3.18 110.327 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.48 170.86 41.65 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 111.003 -0.839 . . . . 0.01 111.003 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 51.86 38.76 24.26 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.55 0.691 . . . . 0.01 111.629 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 51.94 48.24 23.16 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.569 -0.707 . . . . 0.01 111.174 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.508 ' OD1' ' N ' ' A' ' 105' ' ' GLY . 21.2 t-20 -122.52 166.26 15.08 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.331 -0.988 . . . . 3.15 108.331 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.508 ' N ' ' OD1' ' A' ' 104' ' ' ASN . . . 91.95 -164.45 28.72 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.507 -1.437 . . . . 0.01 109.507 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 64.0 tp60 -76.36 144.22 40.24 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.988 -1.301 . . . . 0.01 108.559 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.584 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 31.8 ttp -116.44 142.61 46.63 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.684 0.754 . . . . 0.01 109.907 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -131.15 137.4 49.0 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.225 -1.028 . . . . 2.48 108.225 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -118.16 133.82 55.56 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.549 -0.719 . . . . 0.01 110.044 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.473 ' HG1' ' N ' ' A' ' 111' ' ' THR . 4.3 t -148.67 149.45 31.5 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 122.287 1.041 . . . . 1.69 110.984 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.473 ' N ' ' HG1' ' A' ' 110' ' ' THR . 1.2 p -111.03 9.65 22.1 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 115.452 -0.794 . . . . 0.01 110.025 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -121.17 163.28 18.71 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.202 -0.936 . . . . 3.21 111.719 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -67.42 156.64 36.06 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.326 -0.99 . . . . 0.01 108.326 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.59 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 92.2 m -124.7 111.14 27.67 Favored Pre-proline 0 N--CA 1.502 2.165 0 O-C-N 121.43 -0.794 . . . . 0.01 109.098 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -76.53 -32.83 3.5 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 CA-C-N 120.099 1.071 . . . . 0.01 111.492 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.9 t -140.41 106.33 5.18 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.331 -0.989 . . . . 0.02 108.331 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 73.8 mt -65.2 -38.84 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.81 -0.556 . . . . 1.83 111.044 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.437 ' SD ' ' C ' ' A' ' 123' ' ' LEU . 8.9 tpt -66.52 -38.24 86.78 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.046 -1.062 . . . . 1.34 110.022 -178.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -69.6 -38.53 77.32 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.455 -1.403 . . . . 2.11 109.77 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -80.55 -47.12 14.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.34 -0.85 . . . . 2.08 112.453 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -111.7 -1.3 15.72 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.433 -0.792 . . . . 0.02 112.556 -176.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 61.42 34.08 18.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.837 -1.164 . . . . 0.02 109.655 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.437 ' C ' ' SD ' ' A' ' 118' ' ' MET . 38.7 mt -114.21 136.13 53.29 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.48 -0.763 . . . . 0.02 109.269 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -90.63 -21.9 21.46 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.212 -0.93 . . . . 5.32 110.918 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -148.18 164.02 35.21 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.853 -1.155 . . . . 0.02 110.009 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.4 mm -129.8 126.02 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 107.554 -1.276 . . . . 2.17 107.554 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -109.84 -13.4 14.46 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.156 -0.965 . . . . 0.02 112.966 -177.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 16.6 p -161.2 153.07 19.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.59 -1.319 . . . . 0.01 109.295 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 6.6 t -169.34 145.47 3.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.385 -0.822 . . . . 1.22 108.832 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -124.98 107.83 11.24 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 122.311 1.053 . . . . 1.41 109.685 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.431 ' CG2' ' NE1' ' A' ' 136' ' ' TRP . 11.9 p -110.91 138.26 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.46 -1.311 . . . . 0.01 107.46 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.5 t -127.78 94.46 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 107.186 -1.412 . . . . 1.98 107.186 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.518 ' OE1' ' NE1' ' A' ' 136' ' ' TRP . 52.2 tt0 -146.19 -75.31 0.21 Allowed 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 105.987 -1.857 . . . . 0.01 105.987 177.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 176.57 -77.39 0.07 OUTLIER Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.648 -1.781 . . . . 0.01 108.648 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.6 t -119.49 126.13 50.55 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.623 -0.928 . . . . 2.3 110.318 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.518 ' NE1' ' OE1' ' A' ' 133' ' ' GLU . 43.8 m95 -128.72 150.01 50.45 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 107.166 -1.42 . . . . 0.01 107.166 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.413 HG22 HD13 ' A' ' 137' ' ' ILE . 56.2 mt -120.87 136.5 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 120.441 -1.412 . . . . 1.69 109.973 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -114.75 144.38 43.57 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.604 -1.258 . . . . 2.49 107.604 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 24.0 m-85 -122.8 144.13 49.38 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.372 -0.83 . . . . 0.02 109.53 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -75.62 -29.18 59.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.448 -0.782 . . . . 0.02 111.671 -176.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.3 mt -116.39 154.78 48.97 Favored Pre-proline 0 N--CA 1.505 2.302 0 O-C-N 120.759 -1.213 . . . . 1.48 109.029 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -55.62 167.2 2.22 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.19 1.26 . . . . 0.02 113.022 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 11.3 m120 59.62 30.74 20.38 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.105 -0.952 . . . . 0.75 111.318 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 57.47 51.24 10.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.426 -0.796 . . . . 0.02 110.921 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -126.17 164.52 20.77 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.55 -0.719 . . . . 0.02 109.911 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.95 -165.61 33.26 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.17 -1.172 . . . . 0.02 110.17 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -69.42 142.07 53.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.551 -0.97 . . . . 0.02 109.142 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.47 ' N ' ' CD ' ' A' ' 148' ' ' GLN . 7.1 mp0 -114.79 149.39 37.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.831 -0.543 . . . . 0.02 110.047 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 149' ' ' TYR . 20.2 m-85 -124.51 134.4 53.02 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.18 -0.674 . . . . 0.01 109.18 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.6 tt -98.93 121.39 40.82 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.865 -1.147 . . . . 0.01 108.972 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.4 tp -100.2 151.12 21.81 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.253 -0.904 . . . . 0.01 108.89 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.452 ' CG ' ' H ' ' A' ' 153' ' ' LYS . 62.8 t0 -104.23 -124.4 0.21 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.369 -0.832 . . . . 2.27 109.883 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.452 ' H ' ' CG ' ' A' ' 152' ' ' ASP . 29.0 ttmt -136.46 49.55 2.08 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.352 -0.843 . . . . 1.84 109.586 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -113.55 -172.36 2.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.546 -0.721 . . . . 2.28 109.252 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -105.61 113.32 26.82 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.752 -0.833 . . . . 0.01 108.752 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -98.58 112.68 24.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.328 -0.857 . . . . 0.01 110.133 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -94.81 -24.5 17.03 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.195 -0.941 . . . . 0.01 110.91 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -125.43 154.99 72.44 Favored Pre-proline 0 N--CA 1.498 1.972 0 N-CA-C 108.383 -0.969 . . . . 2.54 108.383 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.553 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 8.4 Cg_endo -60.48 -39.19 67.92 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 CA-C-N 119.197 0.749 . . . . 0.7 110.844 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 68.0 t -61.45 -18.8 19.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 O-C-N 120.742 -1.224 . . . . 0.86 109.282 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -65.44 -17.84 64.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.915 -1.116 . . . . 0.02 111.852 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.553 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.6 OUTLIER -101.74 16.39 25.99 Favored 'General case' 0 N--CA 1.513 2.702 0 O-C-N 120.886 -1.134 . . . . 0.02 110.19 178.476 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.03 9.74 79.91 Favored Glycine 0 N--CA 1.499 2.844 0 O-C-N 121.136 -0.978 . . . . 0.02 113.091 176.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.43 ' HB2' ' HE1' ' A' ' 162' ' ' TRP . . . -100.02 141.6 32.62 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.799 -1.412 . . . . 0.02 110.193 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.78 -8.25 58.89 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.374 -0.602 . . . . 0.59 109.374 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.3 t -142.96 150.55 53.41 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.078 -1.014 . . . . 0.87 108.887 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -75.63 18.47 0.6 Allowed 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 120.746 0.964 . . . . 0.38 112.33 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.57 121.99 27.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.899 -1.126 . . . . 0.18 111.282 -178.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.8 mt -149.12 123.62 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 105.986 -1.857 . . . . 3.99 105.986 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -112.17 -15.92 13.12 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.103 -0.998 . . . . 5.17 113.301 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.502 ' HG ' ' N ' ' A' ' 172' ' ' PHE . 26.0 t -156.71 159.71 38.63 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 119.231 -2.168 . . . . 0.02 109.993 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.59 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 12.7 p90 -152.69 153.89 34.17 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.969 -1.082 . . . . 2.02 110.53 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 48.5 mtp180 -144.83 150.62 37.44 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.907 0.861 . . . . 0.01 110.439 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -88.5 143.77 26.76 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.424 -0.584 . . . . 0.01 109.424 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.2 mt -95.17 128.82 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.158 -0.964 . . . . 3.04 109.039 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 75.0 t -136.3 146.56 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.136 -0.977 . . . . 1.89 109.543 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.335 -0.853 . . . . 4.89 109.586 -179.928 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.446 -0.576 . . . . 5.28 109.446 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 50.8 mttp -79.26 166.87 21.69 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.171 -0.956 . . . . 5.96 109.457 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.77 141.7 34.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.135 -0.978 . . . . 2.22 108.413 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.26 -179.83 47.89 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 118.27 -1.919 . . . . 0.81 111.935 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.98 157.87 43.8 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.349 -1.5 . . . . 0.01 109.349 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -147.12 136.13 22.35 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.098 -1.237 . . . . 0.02 110.77 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.4 HG21 HD11 ' A' ' 7' ' ' ILE . 8.0 tt -130.73 140.13 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 108.927 -0.768 . . . . 0.02 108.927 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.0 t -122.12 130.51 53.31 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.428 -0.795 . . . . 0.39 110.009 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 8.7 m-85 -110.93 140.96 44.99 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 109.092 -0.707 . . . . 0.02 109.092 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.526 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 7.5 m-85 -122.97 139.21 54.31 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.222 -0.924 . . . . 0.02 109.76 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -68.97 -27.75 66.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.033 -1.042 . . . . 0.03 111.599 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -114.54 169.56 8.96 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.876 -1.14 . . . . 0.03 110.306 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -75.21 158.24 33.27 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.651 0.739 . . . . 0.03 110.211 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 66.26 33.37 7.25 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.906 0.86 . . . . 0.74 111.131 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 55.26 41.82 30.98 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.185 0.517 . . . . 0.02 111.177 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -113.15 165.99 11.86 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.208 -1.034 . . . . 0.02 108.208 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.89 -167.26 36.31 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.834 -1.174 . . . . 0.03 110.683 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -69.44 142.05 53.92 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.44 -1.036 . . . . 2.76 109.135 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -120.89 149.41 42.65 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.586 0.708 . . . . 1.89 110.204 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -132.54 127.5 35.24 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.358 -0.978 . . . . 0.02 108.358 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -112.48 137.12 51.14 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.566 -0.709 . . . . 1.12 109.806 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.481 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 14.9 t -131.67 139.1 48.98 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.514 0.673 . . . . 0.02 109.761 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -116.91 11.22 14.33 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.578 -0.701 . . . . 0.2 109.674 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.638 ' HG ' ' H ' ' A' ' 25' ' ' ASP . 50.4 t -158.19 174.4 15.25 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.362 -0.977 . . . . 1.23 108.362 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.638 ' H ' ' HG ' ' A' ' 24' ' ' CYS . 3.2 p30 -60.97 144.08 53.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.646 -1.284 . . . . 0.02 109.867 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.1 p -131.76 117.42 18.57 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.494 -0.928 . . . . 0.02 108.494 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.16 -25.62 47.36 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.052 -1.03 . . . . 0.24 110.889 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 28' ' ' ASP . 8.4 p30 -154.14 101.31 2.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.966 -1.084 . . . . 1.14 109.022 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -104.71 9.46 35.06 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 122.219 1.009 . . . . 6.37 109.897 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -58.52 -24.13 59.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.411 -0.805 . . . . 3.11 111.012 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.7 p -74.47 -16.69 60.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.656 -1.278 . . . . 0.88 110.105 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -103.97 -22.1 13.52 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.458 -0.776 . . . . 0.02 109.628 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.8 tp -150.43 128.98 12.23 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.131 -0.981 . . . . 3.32 109.223 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.8 p -85.86 -10.19 55.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.791 -0.568 . . . . 0.02 111.124 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -171.23 162.68 6.98 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.908 -1.145 . . . . 0.02 107.908 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.1 p -144.11 116.36 8.47 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.826 -1.171 . . . . 0.02 109.056 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.0 OUTLIER -108.28 1.63 22.1 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.745 -1.222 . . . . 0.03 110.924 -178.601 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 56.1 m -155.86 154.24 30.98 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.786 -1.19 . . . . 0.02 107.786 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.8 mt -146.02 146.8 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.118 -0.989 . . . . 0.02 110.616 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -123.46 124.63 43.32 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.112 -1.07 . . . . 0.02 108.112 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.0 t -106.15 114.47 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 106.849 -1.537 . . . . 0.02 106.849 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -84.67 -34.32 23.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.476 -0.765 . . . . 3.81 110.452 -178.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.82 149.89 18.25 Favored Glycine 0 N--CA 1.486 1.991 0 C-N-CA 119.071 -1.538 . . . . 0.02 110.507 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.29 172.48 49.09 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.915 -1.136 . . . . 0.01 110.448 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.5 m -119.13 135.12 54.82 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.045 -1.094 . . . . 1.48 108.045 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 36.2 m95 -126.86 154.24 44.64 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 122.563 1.173 . . . . 0.02 112.316 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.75 134.41 51.51 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 105.448 -2.056 . . . . 0.24 105.448 176.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.4 m -118.44 143.31 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.622 -0.674 . . . . 0.65 109.257 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.538 ' CE2' ' SD ' ' A' ' 58' ' ' MET . 33.0 m-85 -120.95 145.53 47.62 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 122.256 1.027 . . . . 0.02 109.975 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -66.5 -34.18 77.35 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.798 -0.637 . . . . 0.02 111.42 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -125.61 157.92 66.68 Favored Pre-proline 0 N--CA 1.502 2.158 0 O-C-N 121.194 -0.941 . . . . 0.02 109.511 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -53.68 167.1 1.08 Allowed 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.707 1.604 . . . . 0.02 113.169 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.414 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.5 m-20 63.9 36.2 10.4 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.079 -0.964 . . . . 0.02 111.092 178.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 45.39 51.92 9.27 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.692 0.758 . . . . 3.39 110.673 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.8 m -126.52 163.89 22.39 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.235 0.54 . . . . 2.33 109.871 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.11 -161.8 31.92 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.958 -1.257 . . . . 0.02 109.958 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -65.22 138.88 58.52 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.093 -1.239 . . . . 0.02 110.176 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.538 ' SD ' ' CE2' ' A' ' 49' ' ' TYR . 48.6 ttp -118.52 136.97 53.53 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.798 -0.564 . . . . 5.01 109.507 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.455 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 90.1 m-85 -134.5 138.42 44.68 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 121.763 0.792 . . . . 0.02 109.807 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.8 mm -96.06 131.64 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.082 -0.711 . . . . 1.72 109.082 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.2 mt -121.5 112.18 32.8 Favored Pre-proline 0 N--CA 1.506 2.326 0 O-C-N 121.365 -0.835 . . . . 0.02 110.853 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -77.7 169.98 19.91 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 CA-C-N 119.822 0.972 . . . . 1.47 109.981 177.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -52.64 140.98 21.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.833 -1.167 . . . . 4.25 110.263 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.44 -178.25 32.17 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.507 -1.33 . . . . 0.02 110.845 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -120.37 131.85 55.01 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.492 -1.005 . . . . 0.96 109.804 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -121.91 96.1 47.15 Favored Pre-proline 0 N--CA 1.495 1.822 0 N-CA-C 107.958 -1.127 . . . . 0.02 107.958 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.4 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.3 Cg_endo -67.21 -3.84 10.59 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 120.712 0.941 . . . . 0.02 113.868 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 35.0 mt-10 -157.52 155.44 30.28 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.64 -1.288 . . . . 2.02 108.239 179.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -60.42 -39.22 86.64 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.6 -0.687 . . . . 0.02 112.048 -177.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -59.88 -23.77 63.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.091 -1.006 . . . . 0.02 110.202 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -70.36 -19.2 63.06 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.87 0.843 . . . . 3.42 108.948 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.544 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 1.6 t90 -107.68 9.9 29.1 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.483 -1.303 . . . . 0.02 107.483 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.7 mtt 60.52 22.5 12.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.605 -0.684 . . . . 0.02 110.335 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.35 144.6 47.3 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.435 -1.466 . . . . 0.02 109.435 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.0 mt -79.13 -30.42 43.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.101 -1.235 . . . . 0.98 107.779 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.413 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 64.7 t30 -157.68 -171.26 3.49 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 106.393 -1.706 . . . . 0.02 106.393 178.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.413 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 90.5 m-20 -98.61 29.04 3.87 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.7 -1.25 . . . . 0.02 110.484 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.568 ' CG ' HH11 ' A' ' 78' ' ' ARG . 0.4 OUTLIER -98.58 123.08 42.54 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.178 -0.951 . . . . 3.2 111.383 -178.771 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.4 mt -144.93 122.73 11.91 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 107.39 -1.337 . . . . 2.61 107.39 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.96 -16.57 11.27 Favored Glycine 0 N--CA 1.502 3.096 0 O-C-N 121.158 -0.964 . . . . 0.02 112.686 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 90.2 p -156.68 156.42 33.4 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.154 -1.792 . . . . 0.02 110.351 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 12.7 m -145.0 147.81 33.05 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.545 -0.722 . . . . 0.02 110.012 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -138.04 142.99 40.32 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.317 -0.864 . . . . 0.01 109.593 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.56 132.99 36.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.31 -0.869 . . . . 0.43 109.804 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.9 t -91.57 125.07 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.994 -0.743 . . . . 1.25 108.994 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -93.61 132.06 38.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.735 -1.228 . . . . 1.77 109.044 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -97.37 139.79 32.79 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.579 -0.897 . . . . 1.63 108.579 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.5 t -111.8 127.72 55.89 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.351 -0.843 . . . . 1.08 109.281 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.6 p -104.32 -154.33 0.5 Allowed 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 106.506 -1.664 . . . . 1.26 106.506 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.82 -51.37 0.78 Allowed Glycine 0 N--CA 1.5 2.95 0 O-C-N 120.39 -1.444 . . . . 0.01 112.771 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.43 -101.14 0.15 Allowed Glycine 0 N--CA 1.489 2.203 0 C-N-CA 118.515 -1.803 . . . . 0.01 111.877 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -121.4 119.1 31.13 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.194 -1.18 . . . . 4.43 110.556 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.62 128.8 33.99 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.66 -0.816 . . . . 2.99 109.359 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -130.62 141.75 50.44 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.458 -0.776 . . . . 6.36 109.064 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.6 tt -129.69 146.76 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 O-C-N 121.281 -0.887 . . . . 1.09 110.307 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -121.55 133.56 55.02 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 107.437 -1.319 . . . . 2.05 107.437 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.5 m -124.04 146.09 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 120.768 -1.207 . . . . 1.1 109.902 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.581 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 61.4 m-85 -118.74 141.27 48.77 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 122.007 0.908 . . . . 0.73 110.879 -178.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -66.58 -30.55 70.88 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 116.007 -0.542 . . . . 0.02 111.351 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -116.82 170.28 8.73 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.124 -0.985 . . . . 3.18 110.298 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.54 170.09 43.24 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.874 -0.89 . . . . 0.01 110.874 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 2.5 m-20 52.74 38.61 26.84 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.562 0.696 . . . . 0.01 111.704 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 52.42 48.71 22.02 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.65 -0.656 . . . . 0.01 110.944 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.516 ' ND2' ' H ' ' A' ' 105' ' ' GLY . 8.3 t-20 -123.08 165.36 16.95 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.252 -1.018 . . . . 3.15 108.252 178.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.516 ' H ' ' ND2' ' A' ' 104' ' ' ASN . . . 91.9 -163.93 28.48 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.476 -1.45 . . . . 0.01 109.476 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.2 tp60 -76.73 144.05 39.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.936 -1.332 . . . . 0.01 108.899 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.581 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 30.5 ttp -116.4 142.32 47.01 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.65 0.738 . . . . 0.01 109.93 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -131.66 137.16 48.22 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.51 -0.922 . . . . 2.48 108.51 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -117.9 133.9 55.47 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.425 -0.797 . . . . 0.01 110.141 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.1 t -148.18 148.49 30.61 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 122.262 1.029 . . . . 1.69 110.967 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 63.4 p -110.87 10.35 22.41 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 115.579 -0.737 . . . . 0.01 110.331 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -121.16 163.16 18.88 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.152 -0.967 . . . . 3.21 111.566 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -67.03 156.46 35.99 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.107 -1.072 . . . . 0.01 108.107 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.436 ' SG ' ' CZ ' ' A' ' 172' ' ' PHE . 19.9 m -125.37 113.75 25.7 Favored Pre-proline 0 N--CA 1.501 2.115 0 O-C-N 121.485 -0.759 . . . . 0.01 109.37 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.44 ' O ' ' OG ' ' A' ' 171' ' ' SER . 22.1 Cg_endo -76.91 -31.6 3.81 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 CA-C-N 119.916 1.006 . . . . 0.01 111.562 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.0 t -142.49 108.12 5.1 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.238 -0.913 . . . . 0.02 109.068 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.428 HD13 HG22 ' A' ' 117' ' ' ILE . 97.1 mt -63.67 -38.82 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.885 -0.509 . . . . 1.83 110.949 -178.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.8 ttt -68.33 -37.2 80.3 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.222 -0.991 . . . . 1.34 110.263 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -70.36 -38.95 74.88 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.532 -1.355 . . . . 2.11 110.302 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -79.01 -47.39 16.33 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.307 -0.871 . . . . 2.08 112.483 -176.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -110.64 1.18 17.84 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.348 -0.845 . . . . 0.02 112.53 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.2 m170 59.31 32.77 22.16 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.724 -1.235 . . . . 0.02 109.236 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.7 mt -112.29 135.69 52.66 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 108.631 -0.877 . . . . 0.02 108.631 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -90.69 -22.39 21.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.842 . . . . 5.32 110.109 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -150.47 164.47 35.85 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.24 -0.913 . . . . 0.02 110.16 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.9 mt -132.25 129.64 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 107.38 -1.341 . . . . 2.17 107.38 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -107.91 -11.64 15.31 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.321 -0.862 . . . . 0.02 112.571 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.0 t -159.21 152.26 22.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.816 -1.177 . . . . 0.01 109.101 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 6.5 p -169.44 144.71 3.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.187 -0.945 . . . . 1.22 109.168 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -126.18 111.75 14.99 Favored 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 122.445 1.117 . . . . 1.41 110.161 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.4 p -113.89 137.44 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 107.361 -1.348 . . . . 0.01 107.361 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 23.4 t -127.74 94.43 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 106.854 -1.536 . . . . 1.98 106.854 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.461 ' OE1' ' N ' ' A' ' 134' ' ' GLY . 10.4 tm-20 -145.07 -77.78 0.2 Allowed 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 105.929 -1.878 . . . . 0.01 105.929 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.461 ' N ' ' OE1' ' A' ' 133' ' ' GLU . . . 175.58 -73.76 0.08 OUTLIER Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.934 -1.666 . . . . 0.01 108.934 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 29.8 p -119.18 120.14 36.19 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.565 -0.962 . . . . 2.3 110.262 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.46 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 8.1 m95 -127.45 149.53 50.06 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 107.227 -1.398 . . . . 0.01 107.227 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 83.6 mt -123.31 138.88 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 120.504 -1.373 . . . . 1.69 110.491 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -115.29 144.73 43.3 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 107.158 -1.423 . . . . 2.49 107.158 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.496 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 14.0 m-85 -123.06 145.23 48.72 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.15 -0.969 . . . . 0.02 109.617 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -75.77 -30.21 59.05 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.5 -0.75 . . . . 0.02 112.237 -176.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.5 mt -115.07 155.07 47.09 Favored Pre-proline 0 N--CA 1.506 2.366 0 O-C-N 120.595 -1.316 . . . . 1.48 109.225 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.91 165.54 2.61 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.183 1.255 . . . . 0.02 112.547 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 60.08 31.38 20.57 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.131 -0.94 . . . . 0.75 111.484 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 57.55 51.77 9.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.367 -0.833 . . . . 0.02 111.183 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -126.15 164.52 20.75 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.547 -0.721 . . . . 0.02 109.859 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.27 -165.69 32.89 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.419 -1.073 . . . . 0.02 110.419 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -68.89 142.79 54.68 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.612 -0.934 . . . . 0.02 109.053 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -115.18 148.91 38.47 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.386 0.612 . . . . 0.02 109.869 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -124.38 134.4 53.14 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.532 -0.73 . . . . 0.01 109.069 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.8 tt -98.85 120.22 38.93 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.941 -1.099 . . . . 0.01 108.651 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.448 ' CD1' ' CD1' ' A' ' 162' ' ' TRP . 6.6 tp -103.07 150.89 23.15 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.27 -0.894 . . . . 0.01 109.12 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -104.56 -110.26 0.26 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.431 -0.793 . . . . 2.27 109.54 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -156.5 51.68 0.52 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.118 -0.989 . . . . 1.84 109.638 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -112.71 -163.08 0.83 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.584 -0.697 . . . . 2.28 109.264 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -106.39 104.41 14.1 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.452 -0.78 . . . . 0.01 109.073 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.625 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 6.5 m-85 -98.7 112.36 24.45 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.244 -0.91 . . . . 0.01 109.51 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -95.09 -22.15 18.08 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.188 -0.945 . . . . 0.01 111.775 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -127.73 154.24 77.9 Favored Pre-proline 0 N--CA 1.502 2.171 0 O-C-N 120.715 -1.241 . . . . 2.54 109.036 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -60.53 -38.68 71.36 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 120.483 0.789 . . . . 0.7 110.517 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.93 -20.08 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.819 -1.176 . . . . 0.86 108.93 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 161' ' ' ASP . 13.7 t0 -65.18 -15.4 62.4 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.955 -1.091 . . . . 0.02 109.925 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.625 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 9.9 m0 -97.89 11.34 37.69 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.111 -0.993 . . . . 0.02 109.099 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.83 10.21 85.93 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.789 -1.196 . . . . 0.02 110.968 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.49 141.47 32.23 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.313 -1.11 . . . . 0.02 110.061 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.57 -8.97 57.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.663 -0.648 . . . . 0.59 109.948 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.1 p -143.2 150.35 51.86 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 120.919 -1.113 . . . . 0.87 108.869 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -76.6 18.81 0.68 Allowed 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 120.825 1.016 . . . . 0.38 112.371 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.14 123.08 28.66 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.855 -1.153 . . . . 0.18 111.496 -177.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 16.1 mm -151.75 127.04 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 106.815 -1.55 . . . . 3.99 106.815 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -113.92 -12.91 12.6 Favored 'General case' 0 N--CA 1.508 2.429 0 O-C-N 121.065 -1.022 . . . . 5.17 113.725 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 115' ' ' PRO . 22.7 m -157.53 161.77 38.81 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 119.12 -2.237 . . . . 0.02 110.439 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.436 ' CZ ' ' SG ' ' A' ' 114' ' ' CYS . 21.3 p90 -152.74 153.77 33.87 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.044 -1.035 . . . . 2.02 110.662 178.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 48.8 mtp180 -145.44 150.38 36.4 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.775 0.798 . . . . 0.01 110.23 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -87.9 143.99 26.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.483 -0.761 . . . . 0.01 109.183 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.1 mt -94.38 129.26 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.184 -0.948 . . . . 3.04 109.045 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.4 t -136.17 146.6 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.174 -0.953 . . . . 1.89 109.675 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 4.89 109.51 179.962 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 65.1 m . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.433 -0.58 . . . . 5.28 109.433 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -65.47 136.55 56.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 5.96 109.53 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 39.1 m -144.13 145.47 32.14 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.01 -1.056 . . . . 2.22 109.158 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.37 31.79 8.25 Favored Glycine 0 N--CA 1.504 3.194 0 O-C-N 120.493 -1.38 . . . . 0.81 113.798 -176.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.14 142.52 33.13 Favored Glycine 0 N--CA 1.491 2.307 0 CA-C-N 121.174 2.487 . . . . 0.01 107.85 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -149.67 136.11 19.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.916 -1.344 . . . . 0.02 110.755 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.418 HG22 HD13 ' A' ' 7' ' ' ILE . 5.7 tt -128.62 139.25 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 107.822 -1.177 . . . . 0.02 107.822 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 t -121.11 129.63 53.38 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.321 -0.862 . . . . 0.39 110.337 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 11.5 m-85 -109.67 139.69 44.41 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.803 -0.814 . . . . 0.02 108.803 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.528 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 6.3 m-85 -122.15 138.33 54.51 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.139 -0.975 . . . . 0.02 109.664 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.521 ' OE2' ' N ' ' A' ' 35' ' ' ARG . 6.1 mm-40 -67.83 -28.63 67.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.934 . . . . 0.03 111.093 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.5 m-20 -114.77 170.06 8.61 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.882 -1.136 . . . . 0.03 110.163 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -75.56 162.35 28.37 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.729 0.776 . . . . 0.03 110.295 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 3.0 t30 62.8 33.33 15.4 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.002 0.906 . . . . 0.74 110.806 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 55.0 40.36 32.0 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.975 -0.557 . . . . 0.02 110.843 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -110.67 165.96 11.4 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.14 -1.059 . . . . 0.02 108.14 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.02 -167.73 36.56 Favored Glycine 0 N--CA 1.495 2.62 0 C-N-CA 119.719 -1.229 . . . . 0.03 110.918 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -68.73 142.66 54.92 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.63 -0.923 . . . . 2.76 109.354 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 -120.6 148.83 43.37 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.658 0.742 . . . . 1.89 110.195 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -132.81 127.57 34.84 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.436 -0.95 . . . . 0.02 108.436 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 21.4 p-10 -112.79 137.28 51.35 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.499 -0.75 . . . . 1.12 109.857 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 15.3 t -131.48 139.08 49.25 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.742 -0.599 . . . . 0.02 109.515 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.0 p30 -117.04 11.4 14.25 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.528 -0.733 . . . . 0.2 109.939 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.513 ' HG ' ' H ' ' A' ' 25' ' ' ASP . 34.7 t -158.31 174.46 15.11 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.389 -0.967 . . . . 1.23 108.389 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.513 ' H ' ' HG ' ' A' ' 24' ' ' CYS . 2.3 p30 -61.17 144.25 54.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.597 -1.315 . . . . 0.02 109.869 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.5 t -131.75 117.32 18.44 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.54 -0.911 . . . . 0.02 108.54 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.66 -25.02 49.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.122 -0.986 . . . . 0.24 110.778 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.47 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 20.8 p-10 -154.8 101.26 2.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.09 -1.006 . . . . 1.14 108.882 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -105.85 9.58 32.79 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-O 122.004 0.907 . . . . 6.37 109.835 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -58.63 -24.24 60.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.674 -0.641 . . . . 3.11 110.861 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.5 m -74.05 -16.59 61.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.716 -1.24 . . . . 0.88 109.836 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -105.72 -21.99 13.06 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.616 -0.677 . . . . 0.02 109.561 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.453 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 3.0 tp -148.83 126.36 11.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.023 -1.048 . . . . 3.32 109.686 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.7 m -86.83 -11.0 52.16 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.488 -0.757 . . . . 0.02 111.446 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.521 ' N ' ' OE2' ' A' ' 11' ' ' GLU . 17.8 ttp180 -170.98 161.17 6.84 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.682 -1.229 . . . . 0.02 107.682 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.5 t -141.65 115.41 9.12 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.8 -1.187 . . . . 0.02 109.213 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.416 ' ND2' ' OD2' ' A' ' 77' ' ' ASP . 3.5 m120 -107.57 -0.19 22.2 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.914 -1.116 . . . . 0.03 110.858 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.467 ' HG ' ' N ' ' A' ' 39' ' ' ILE . 11.1 t -156.18 153.38 29.13 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.851 -1.166 . . . . 0.02 107.851 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.467 ' N ' ' HG ' ' A' ' 38' ' ' SER . 84.5 mt -145.43 147.57 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.11 -0.994 . . . . 0.02 110.313 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -123.22 124.13 42.32 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.753 -1.203 . . . . 0.02 107.753 176.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.3 t -106.56 114.88 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 107.058 -1.46 . . . . 0.02 107.058 177.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.434 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 30.3 tt0 -83.61 -34.07 25.19 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 120.099 -0.64 . . . . 3.81 110.912 -178.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.96 152.21 21.95 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 118.896 -1.621 . . . . 0.02 111.03 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.43 172.86 49.24 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.627 -1.273 . . . . 0.01 110.514 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.4 m -119.51 135.06 54.94 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.978 -1.119 . . . . 1.48 107.978 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.458 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 32.5 m95 -127.14 155.77 42.83 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 122.56 1.172 . . . . 0.02 112.151 -176.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.59 134.3 52.1 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 105.697 -1.964 . . . . 0.24 105.697 176.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.6 m -116.65 141.73 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.556 -0.715 . . . . 0.65 109.222 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -120.61 143.32 48.72 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 122.098 0.951 . . . . 0.02 109.793 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -65.69 -34.24 77.75 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.661 -0.7 . . . . 0.02 111.646 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -125.15 157.6 66.62 Favored Pre-proline 0 N--CA 1.502 2.173 0 O-C-N 121.033 -1.042 . . . . 0.02 109.359 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.56 167.2 1.0 Allowed 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.718 1.612 . . . . 0.02 113.015 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.3 m120 63.76 36.09 10.81 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.154 -0.93 . . . . 0.02 111.16 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.407 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 4.2 m-85 45.38 51.56 9.46 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.722 0.772 . . . . 3.39 110.503 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 90.3 p -126.13 163.83 22.26 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.318 0.58 . . . . 2.33 109.847 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.88 -161.76 32.19 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.816 -1.314 . . . . 0.02 109.816 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.717 ' HD1' ' H ' ' A' ' 57' ' ' HIS . 1.9 m80 -65.27 138.72 58.39 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.065 -1.256 . . . . 0.02 110.337 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.497 ' SD ' ' O ' ' A' ' 58' ' ' MET . 2.6 ppp? -119.11 137.13 53.79 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.492 0.663 . . . . 5.01 109.517 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -134.28 138.81 45.28 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.395 -0.816 . . . . 0.02 109.648 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.4 mm -95.32 131.09 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 109.057 -0.719 . . . . 1.72 109.057 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.561 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -119.6 110.83 36.73 Favored Pre-proline 0 N--CA 1.503 2.184 0 O-C-N 121.299 -0.876 . . . . 0.02 110.769 -178.266 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -77.54 168.49 22.59 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 CA-C-N 119.934 1.012 . . . . 1.47 110.221 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.434 ' NE2' ' O ' ' A' ' 42' ' ' GLU . 63.1 tt0 -53.58 141.19 26.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.824 -1.173 . . . . 4.25 110.43 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.79 -177.76 31.9 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.529 -1.32 . . . . 0.02 110.712 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -120.5 131.69 54.84 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.558 -0.966 . . . . 0.96 109.732 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.561 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 63.8 m-85 -122.3 94.19 48.04 Favored Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 108.023 -1.103 . . . . 0.02 108.023 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.402 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 5.3 Cg_exo -64.44 -4.24 7.8 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 120.928 1.085 . . . . 0.02 113.799 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 34.8 mt-10 -157.58 155.3 29.95 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.555 -1.34 . . . . 2.02 108.287 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -60.63 -39.0 86.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.481 -0.762 . . . . 0.02 112.199 -176.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -59.93 -23.72 63.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.093 -1.004 . . . . 0.02 110.329 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -70.62 -18.57 62.87 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.782 0.801 . . . . 3.42 109.021 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.547 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.6 t90 -107.98 10.14 28.42 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.415 -1.328 . . . . 0.02 107.415 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.4 mmt 60.77 22.49 12.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.66 -0.65 . . . . 0.02 110.545 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.78 144.33 46.35 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.401 -1.48 . . . . 0.02 109.401 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.8 tp -79.29 -31.03 43.23 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.617 -1.253 . . . . 0.98 107.617 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -157.02 -171.74 3.76 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 106.342 -1.725 . . . . 0.02 106.342 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.416 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 52.1 m-20 -98.71 27.54 4.82 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.616 -1.303 . . . . 0.02 110.708 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -95.97 122.56 38.92 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.939 -1.101 . . . . 3.2 110.865 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.2 mt -142.9 121.35 12.4 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.558 -1.275 . . . . 2.61 107.558 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.2 -17.85 9.15 Favored Glycine 0 N--CA 1.501 2.977 0 O-C-N 121.257 -0.902 . . . . 0.02 112.878 -177.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.407 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 11.1 t -156.03 155.78 33.28 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-N 120.004 1.902 . . . . 0.02 111.023 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 13.5 p -145.34 147.43 32.29 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.321 -0.862 . . . . 0.02 110.624 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -138.23 143.63 40.22 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.529 -0.732 . . . . 0.01 109.292 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.66 132.11 36.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -0.915 . . . . 0.43 109.759 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.8 t -91.28 125.2 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.961 -0.755 . . . . 1.25 108.961 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -94.36 131.13 40.33 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.884 -1.135 . . . . 1.77 109.029 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 mt -95.76 140.3 30.74 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.621 -0.881 . . . . 1.63 108.621 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t -111.64 127.87 55.89 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.37 -0.831 . . . . 1.08 109.33 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 71.5 p -104.41 -154.58 0.51 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 106.631 -1.618 . . . . 1.26 106.631 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.32 -52.65 0.73 Allowed Glycine 0 N--CA 1.5 2.956 0 O-C-N 120.498 -1.376 . . . . 0.01 112.895 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.18 -101.44 0.15 Allowed Glycine 0 N--CA 1.49 2.256 0 C-N-CA 118.456 -1.83 . . . . 0.01 112.022 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -121.88 119.53 31.84 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.056 -1.261 . . . . 4.43 110.695 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.42 129.22 34.26 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.682 -0.807 . . . . 2.99 109.303 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -130.54 142.1 50.47 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.866 -0.79 . . . . 6.36 108.866 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.7 tt -129.97 146.05 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 O-C-N 121.255 -0.903 . . . . 1.09 110.451 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -121.26 133.61 55.15 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.354 -1.35 . . . . 2.05 107.354 177.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.4 m -123.93 146.41 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 120.895 -1.128 . . . . 1.1 109.709 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.576 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 72.0 m-85 -119.32 141.61 48.86 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.978 0.894 . . . . 0.73 111.059 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -66.96 -30.28 70.36 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 116.066 -0.515 . . . . 0.02 111.734 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.414 ' O ' ' OG ' ' A' ' 128' ' ' SER . 43.8 mttp -116.37 167.22 11.22 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.965 -1.084 . . . . 3.18 110.425 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.05 164.05 44.24 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.958 -0.857 . . . . 0.01 110.958 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 57.23 38.87 28.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.932 -0.746 . . . . 0.01 110.913 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 52.29 55.72 8.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.723 -0.611 . . . . 0.01 111.079 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -128.97 165.66 20.68 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.29 -1.004 . . . . 3.15 108.29 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.66 -164.0 27.57 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.279 -1.528 . . . . 0.01 109.279 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -75.69 144.29 41.67 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.968 -1.313 . . . . 0.01 108.438 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.576 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 27.6 ttp -116.41 142.19 47.18 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.543 0.687 . . . . 0.01 109.889 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -131.58 136.54 47.88 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.176 -1.046 . . . . 2.48 108.176 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -119.19 134.48 55.18 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.57 -0.706 . . . . 0.01 109.923 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.477 ' HG1' ' N ' ' A' ' 111' ' ' THR . 2.9 t -148.67 150.52 33.35 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 122.278 1.037 . . . . 1.69 111.145 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.477 ' N ' ' HG1' ' A' ' 110' ' ' THR . 48.2 p -110.89 9.62 22.38 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 115.572 -0.74 . . . . 0.01 110.336 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -121.15 163.22 18.78 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.15 -0.969 . . . . 3.21 111.721 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -68.2 157.18 36.0 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.268 -1.012 . . . . 0.01 108.268 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 19.1 t -126.88 114.16 22.21 Favored Pre-proline 0 N--CA 1.501 2.075 0 O-C-N 121.457 -0.777 . . . . 0.01 109.101 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -75.05 -29.72 7.85 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 CA-C-N 120.247 1.124 . . . . 0.01 111.035 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.5 m -142.3 109.19 5.45 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.309 -0.869 . . . . 0.02 109.121 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.402 HG22 HD13 ' A' ' 117' ' ' ILE . 97.7 mt -63.58 -38.99 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.866 -0.521 . . . . 1.83 110.59 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 19.0 ttt -68.82 -37.74 79.4 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.349 -0.94 . . . . 1.34 110.399 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -69.46 -38.57 77.8 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.417 -1.427 . . . . 2.11 109.995 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -80.11 -47.14 15.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.331 -0.856 . . . . 2.08 112.339 -177.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -111.18 0.0 16.66 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.363 -0.836 . . . . 0.02 112.637 -176.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.7 m80 60.01 33.64 21.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.768 -1.208 . . . . 0.02 109.516 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.0 mt -112.65 135.51 53.29 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 108.83 -0.804 . . . . 0.02 108.83 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -91.69 -22.96 19.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.254 -0.904 . . . . 5.32 110.393 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -149.45 164.34 35.27 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.187 -0.945 . . . . 0.02 109.813 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.477 ' C ' ' HD1' ' A' ' 127' ' ' HIS . 38.5 mt -132.15 128.89 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 107.804 -1.184 . . . . 2.17 107.804 178.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.477 ' HD1' ' C ' ' A' ' 126' ' ' ILE . 0.3 OUTLIER -108.39 -11.98 15.1 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.365 -0.834 . . . . 0.02 112.25 -178.012 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 8.2 p -160.31 151.06 18.72 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.917 -1.114 . . . . 0.01 109.273 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 27.1 p -168.25 145.01 3.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.362 -0.836 . . . . 1.22 109.133 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 40.5 tttm -126.31 111.67 14.8 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 122.42 1.105 . . . . 1.41 110.417 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.2 p -114.38 138.44 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 107.408 -1.33 . . . . 0.01 107.408 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.5 t -126.8 94.03 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 106.732 -1.581 . . . . 1.98 106.732 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.422 ' CD ' ' N ' ' A' ' 134' ' ' GLY . 6.1 tm-20 -145.65 -80.65 0.16 Allowed 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 106.218 -1.771 . . . . 0.01 106.218 177.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.422 ' N ' ' CD ' ' A' ' 133' ' ' GLU . . . 176.45 -76.2 0.07 OUTLIER Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.987 -1.645 . . . . 0.01 108.987 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 30.9 p -118.0 118.14 31.13 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.593 -0.945 . . . . 2.3 110.192 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -124.88 150.4 46.52 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 107.244 -1.391 . . . . 0.01 107.244 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 12.4 mt -121.79 136.88 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 120.484 -1.385 . . . . 1.69 110.15 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -114.55 144.29 43.6 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.364 -1.347 . . . . 2.49 107.364 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 24.5 m-85 -123.29 143.56 49.99 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.271 -0.893 . . . . 0.02 109.575 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.461 ' O ' ' NE2' ' A' ' 170' ' ' GLN . 81.8 tt0 -73.96 -29.24 61.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.506 -0.746 . . . . 0.02 111.911 -176.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.1 mt -116.09 154.9 48.58 Favored Pre-proline 0 N--CA 1.505 2.291 0 O-C-N 120.725 -1.234 . . . . 1.48 108.964 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -55.66 167.36 2.17 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.151 1.234 . . . . 0.02 112.757 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.617 ' N ' HD21 ' A' ' 143' ' ' ASN . 0.8 OUTLIER 59.37 31.11 20.87 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.174 -0.921 . . . . 0.75 111.233 178.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 57.41 50.62 11.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.45 -0.781 . . . . 0.02 111.064 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -125.13 164.36 20.42 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.554 -0.716 . . . . 0.02 109.898 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.427 ' O ' ' OE1' ' A' ' 148' ' ' GLN . . . 89.16 -165.72 33.06 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.184 -1.167 . . . . 0.02 110.184 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -69.08 142.55 54.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.54 -0.977 . . . . 0.02 109.034 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.472 ' N ' ' CD ' ' A' ' 148' ' ' GLN . 0.1 OUTLIER -114.53 148.54 37.78 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.44 0.638 . . . . 0.02 110.011 -178.191 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -124.92 134.98 52.45 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 109.083 -0.71 . . . . 0.01 109.083 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.1 tt -100.09 121.25 41.11 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.872 -1.142 . . . . 0.01 108.92 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.9 tp -99.32 145.34 27.43 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.198 -0.939 . . . . 0.01 108.96 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.551 ' H ' ' HH ' ' A' ' 156' ' ' TYR . 3.9 m-20 -106.73 -166.41 1.17 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.647 -0.658 . . . . 2.27 109.882 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -90.68 52.85 2.28 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.405 -0.809 . . . . 1.84 109.833 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -115.35 -178.88 3.48 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.473 -0.767 . . . . 2.28 109.448 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -105.47 111.48 24.21 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.476 -0.935 . . . . 0.01 108.476 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.551 ' HH ' ' H ' ' A' ' 152' ' ' ASP . 54.0 m-85 -99.65 112.7 24.9 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.387 -0.82 . . . . 0.01 110.493 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -94.54 -24.06 17.41 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.165 -0.959 . . . . 0.01 110.855 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -126.04 153.59 73.96 Favored Pre-proline 0 N--CA 1.501 2.078 0 N-CA-C 108.451 -0.944 . . . . 2.54 108.451 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -59.85 -39.73 69.49 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 CA-C-N 119.285 0.78 . . . . 0.7 110.609 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 6.7 t -61.84 -19.57 21.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.755 -1.216 . . . . 0.86 108.863 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 161' ' ' ASP . 10.6 t0 -65.96 -18.06 65.09 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.954 -1.091 . . . . 0.02 111.059 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.58 ' HE1' ' CB ' ' A' ' 164' ' ' ALA . 1.8 p90 -103.0 14.16 32.6 Favored 'General case' 0 N--CA 1.508 2.467 0 O-C-N 121.077 -1.014 . . . . 0.02 109.811 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 87.42 10.37 70.89 Favored Glycine 0 N--CA 1.497 2.728 0 O-C-N 121.462 -0.774 . . . . 0.02 113.854 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.58 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . . . -100.93 141.32 33.98 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 120.472 -1.604 . . . . 0.02 110.757 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.61 -7.66 59.17 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.673 -0.642 . . . . 0.59 109.484 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 39.0 m -143.54 150.67 51.82 Favored Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 120.961 -1.087 . . . . 0.87 109.154 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -76.75 18.45 0.72 Allowed 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.0 1.134 . . . . 0.38 112.474 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.87 125.47 31.38 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 122.373 1.082 . . . . 0.18 111.698 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.419 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 1.6 mt -149.94 127.01 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.344 -1.354 . . . . 3.99 107.344 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.461 ' NE2' ' O ' ' A' ' 140' ' ' GLU . 2.9 mp0 -111.95 -18.06 12.74 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.075 -1.016 . . . . 5.17 112.816 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 20.5 t -157.06 159.93 38.42 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 119.141 -2.224 . . . . 0.02 110.315 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.431 ' CD1' ' C ' ' A' ' 172' ' ' PHE . 19.0 p90 -151.67 153.38 34.29 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.971 -1.081 . . . . 2.02 110.538 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 -144.97 149.98 36.14 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.882 0.849 . . . . 0.01 110.433 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -87.17 143.14 27.43 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.874 -0.788 . . . . 0.01 108.874 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.1 mt -94.76 129.13 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.28 -0.887 . . . . 3.04 109.108 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 11.7 p -136.38 146.99 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.194 -0.942 . . . . 1.89 109.686 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 4.89 109.411 -179.991 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.346 -0.613 . . . . 5.28 109.346 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -82.25 -12.79 57.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.907 . . . . 5.96 109.707 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 26.9 p -99.87 110.88 23.23 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 106.862 -1.533 . . . . 2.22 106.862 177.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.71 94.05 0.09 OUTLIER Glycine 0 N--CA 1.492 2.379 0 N-CA-C 106.619 -2.592 . . . . 0.81 106.619 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.69 146.94 33.21 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.45 -1.06 . . . . 0.01 110.45 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -152.85 138.34 17.68 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.52 -0.988 . . . . 0.02 109.666 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.416 HD12 HG22 ' A' ' 7' ' ' ILE . 6.8 tt -130.85 140.87 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 109.222 -0.659 . . . . 0.02 109.222 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.8 m -121.95 130.89 53.7 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.444 -0.785 . . . . 0.39 109.996 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.487 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 5.4 m-85 -111.11 140.74 45.41 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.561 -0.712 . . . . 0.02 109.332 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.575 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.1 m-85 -122.68 138.6 54.56 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.266 -0.896 . . . . 0.02 109.756 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -69.29 -27.29 65.27 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.925 -1.11 . . . . 0.03 111.736 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 3.3 m-20 -113.87 169.4 9.03 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.804 -1.185 . . . . 0.03 110.172 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -75.33 158.31 32.99 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.662 0.744 . . . . 0.03 110.034 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.413 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 7.1 t-20 65.96 33.44 7.8 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.913 0.863 . . . . 0.74 111.173 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.413 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 0.8 OUTLIER 55.42 41.8 30.65 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.296 0.57 . . . . 0.02 111.214 177.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -112.8 165.6 12.15 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.236 -1.024 . . . . 0.02 108.236 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.17 -167.59 34.49 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.801 -1.19 . . . . 0.03 110.6 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -70.19 143.88 52.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.425 -1.044 . . . . 2.76 108.957 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -120.41 149.13 42.85 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.65 0.738 . . . . 1.89 110.296 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -132.76 127.7 35.23 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.399 -0.963 . . . . 0.02 108.399 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 18.9 p30 -112.22 136.85 51.13 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.441 -0.787 . . . . 1.12 109.709 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.424 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 12.0 t -130.65 138.6 50.15 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.515 0.674 . . . . 0.02 109.679 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.498 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 33.9 t70 -117.07 11.14 14.13 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.567 -0.708 . . . . 0.2 109.852 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 42.3 m -158.55 174.57 14.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.118 -0.988 . . . . 1.23 108.505 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -61.27 144.04 54.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.71 -1.244 . . . . 0.02 110.09 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.5 t -131.67 117.46 18.69 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.654 -0.869 . . . . 0.02 108.654 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.12 -25.77 47.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.974 -1.079 . . . . 0.24 110.988 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -153.4 101.6 2.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.979 -1.075 . . . . 1.14 108.977 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -104.0 9.28 36.62 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 122.109 0.956 . . . . 6.37 109.806 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.4 mtm180 -59.3 -24.69 63.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.525 -0.734 . . . . 3.11 111.221 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.3 t -75.39 -16.93 60.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.629 -1.295 . . . . 0.88 110.315 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -105.14 -21.69 13.22 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.366 -0.833 . . . . 0.02 109.503 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.4 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 4.5 tp -148.7 126.81 12.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.223 -0.923 . . . . 3.32 109.447 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.5 t -86.51 -11.88 50.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.634 -0.666 . . . . 0.02 111.206 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.4 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 24.4 ttp180 -171.47 161.58 6.36 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.84 -1.162 . . . . 0.02 108.154 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 p -142.55 114.98 8.46 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.881 -1.137 . . . . 0.02 108.761 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -106.63 1.15 24.95 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 120.777 -1.202 . . . . 0.03 110.379 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.8 t -155.94 154.51 31.28 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.5 -1.296 . . . . 0.02 107.5 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.8 mt -146.63 147.68 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.029 -1.045 . . . . 0.02 110.401 -178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.562 ' CG ' HH11 ' A' ' 40' ' ' ARG . 0.2 OUTLIER -124.39 125.02 43.61 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.997 -1.112 . . . . 0.02 107.997 177.651 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.1 t -105.1 113.65 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 106.644 -1.613 . . . . 0.02 106.644 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -84.18 -34.76 23.91 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.467 -0.77 . . . . 3.81 110.033 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.41 150.93 20.21 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 118.618 -1.753 . . . . 0.02 110.722 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.43 171.99 48.58 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.357 -1.097 . . . . 0.01 110.357 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.8 m -119.6 134.9 55.03 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 107.805 -1.183 . . . . 1.48 107.805 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.467 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 31.2 m95 -127.36 154.94 44.36 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 122.583 1.182 . . . . 0.02 112.329 -176.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.29 134.06 51.64 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 105.282 -2.118 . . . . 0.24 105.282 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.7 m -119.12 143.7 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 109.066 -0.716 . . . . 0.65 109.066 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -120.96 145.92 47.21 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 122.276 1.036 . . . . 0.02 110.041 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -66.09 -34.05 77.18 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 115.816 -0.629 . . . . 0.02 111.009 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -125.46 157.54 67.63 Favored Pre-proline 0 N--CA 1.502 2.162 0 O-C-N 121.051 -1.03 . . . . 0.02 109.487 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.45 167.26 0.93 Allowed 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.692 1.594 . . . . 0.02 113.074 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.8 m120 63.77 36.36 10.59 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.253 -0.885 . . . . 0.02 111.113 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 45.09 51.58 8.88 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.66 0.743 . . . . 3.39 110.67 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.7 m -126.36 163.82 22.43 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.168 0.509 . . . . 2.33 109.814 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.78 -161.65 32.24 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.815 -1.314 . . . . 0.02 109.815 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -65.3 139.15 58.57 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.124 -1.221 . . . . 0.02 110.146 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.497 ' SD ' ' O ' ' A' ' 58' ' ' MET . 2.8 ppp? -118.84 137.28 53.53 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.714 -0.616 . . . . 5.01 109.593 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.404 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 96.2 m-85 -134.85 138.63 44.36 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.494 -0.754 . . . . 0.02 109.78 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.4 mm -95.2 131.61 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.857 -0.794 . . . . 1.72 108.857 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.561 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -120.08 110.64 36.15 Favored Pre-proline 0 N--CA 1.505 2.278 0 O-C-N 121.289 -0.882 . . . . 0.02 110.858 -178.346 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -77.86 168.99 21.38 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 CA-C-N 119.916 1.006 . . . . 1.47 110.296 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -53.9 140.62 30.15 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.861 -1.15 . . . . 4.25 110.522 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.93 -177.79 32.82 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.451 -1.356 . . . . 0.02 110.618 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -119.93 131.16 55.12 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.362 -1.081 . . . . 0.96 109.646 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.561 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 75.9 m-85 -121.8 96.27 47.21 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 108.128 -1.064 . . . . 0.02 108.128 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.404 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.6 Cg_endo -67.07 -3.75 10.29 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 120.778 0.986 . . . . 0.02 113.756 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 35.1 mt-10 -157.81 155.21 29.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.685 -1.259 . . . . 2.02 108.288 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -60.56 -39.37 87.72 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.572 -0.705 . . . . 0.02 112.042 -177.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -59.96 -23.68 63.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.083 -1.011 . . . . 0.02 110.276 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -69.97 -18.92 63.37 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.778 0.799 . . . . 3.42 109.021 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.547 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.1 t90 -108.04 10.6 28.19 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.432 -1.321 . . . . 0.02 107.432 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.5 mtt 61.08 22.27 12.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.537 -0.727 . . . . 0.02 110.463 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.76 143.65 44.88 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.49 -1.444 . . . . 0.02 109.49 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.4 tp -79.57 -31.93 41.98 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.558 -1.275 . . . . 0.98 107.558 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -157.63 -172.65 4.04 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 106.312 -1.736 . . . . 0.02 106.312 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -98.49 28.06 4.4 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.821 -1.174 . . . . 0.02 110.823 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 -96.83 121.89 39.19 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.828 -1.17 . . . . 3.2 110.887 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.0 mt -144.0 121.39 11.65 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 107.574 -1.269 . . . . 2.61 107.574 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.34 -16.19 11.48 Favored Glycine 0 N--CA 1.505 3.243 0 O-C-N 121.192 -0.943 . . . . 0.02 112.804 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.6 p -157.09 156.37 32.66 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.107 -1.819 . . . . 0.02 110.344 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 23.4 m -144.89 147.93 33.33 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.584 -0.698 . . . . 0.02 110.047 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 39.1 mtp180 -137.84 143.19 40.84 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.368 -0.832 . . . . 0.01 109.585 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.57 132.21 36.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.201 -0.937 . . . . 0.43 109.669 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.3 t -91.0 125.03 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.873 -0.788 . . . . 1.25 108.873 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -92.56 132.53 36.77 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.877 -1.139 . . . . 1.77 108.865 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mt -98.42 140.57 32.48 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.865 -0.791 . . . . 1.63 108.865 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 52.9 p -112.08 124.68 52.95 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.474 -0.936 . . . . 1.08 108.474 178.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.4 m -115.76 132.81 56.53 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 107.754 -1.202 . . . . 1.26 107.754 177.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -156.78 -49.58 0.01 OUTLIER Glycine 0 N--CA 1.505 3.279 0 C-N-CA 117.709 -2.186 . . . . 0.01 113.636 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.71 -105.73 0.19 Allowed Glycine 0 N--CA 1.489 2.203 0 CA-C-N 120.192 1.996 . . . . 0.01 111.352 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -120.81 118.59 30.39 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.125 -1.221 . . . . 4.43 110.401 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.14 129.14 34.81 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.806 -0.758 . . . . 2.99 109.369 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -131.23 141.19 49.98 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.497 -0.752 . . . . 6.36 109.241 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.0 tt -129.8 146.91 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 O-C-N 121.247 -0.908 . . . . 1.09 110.344 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.523 ' NE2' ' O ' ' A' ' 130' ' ' LYS . 2.4 pm0 -122.1 134.31 54.76 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 107.561 -1.274 . . . . 2.05 107.561 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.8 m -124.37 146.25 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 O-C-N 120.721 -1.237 . . . . 1.1 110.158 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.584 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 79.5 m-85 -119.4 141.2 49.29 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.973 0.892 . . . . 0.73 111.081 -178.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -67.18 -30.22 70.12 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 115.921 -0.581 . . . . 0.02 111.819 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -116.18 168.99 9.62 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.028 -1.045 . . . . 3.18 110.441 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.27 164.94 50.0 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.796 -0.921 . . . . 0.01 110.796 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 56.46 38.45 29.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.719 -0.871 . . . . 0.01 111.432 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 51.94 55.08 9.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.559 -0.713 . . . . 0.01 111.256 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -129.06 165.01 22.02 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.018 -1.105 . . . . 3.15 108.018 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.18 -163.64 27.95 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.255 -1.538 . . . . 0.01 109.255 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.498 ' NE2' ' OH ' ' A' ' 108' ' ' TYR . 57.1 tt0 -76.19 144.19 40.64 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.005 -1.291 . . . . 0.01 108.834 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.584 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 32.7 ttp -116.66 142.55 46.75 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.524 0.678 . . . . 0.01 109.821 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.498 ' OH ' ' NE2' ' A' ' 106' ' ' GLN . 55.5 m-85 -131.48 136.86 48.26 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.265 -1.013 . . . . 2.48 108.265 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -118.15 134.16 55.25 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.551 -0.718 . . . . 0.01 110.248 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.9 t -149.01 148.33 29.61 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.276 1.036 . . . . 1.69 111.197 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 30.1 p -111.16 9.7 21.88 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 115.547 -0.751 . . . . 0.01 110.496 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -120.85 163.16 18.61 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.235 -0.916 . . . . 3.21 111.438 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -67.46 156.8 35.72 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.217 -1.031 . . . . 0.01 108.217 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.609 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 26.4 p -123.86 116.47 27.6 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.515 -0.741 . . . . 0.01 109.414 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -76.7 -31.93 3.86 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 CA-C-N 120.181 1.1 . . . . 0.01 110.445 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.4 p -143.84 108.91 4.98 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.733 0.778 . . . . 0.02 109.016 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.9 mt -64.16 -39.27 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.771 -0.581 . . . . 1.83 110.822 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 118' ' ' MET . 1.8 tmt? -67.95 -37.24 81.34 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.175 -1.01 . . . . 1.34 110.034 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -69.47 -38.02 77.55 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.543 -1.348 . . . . 2.11 109.87 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -80.25 -46.72 15.75 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.274 -0.891 . . . . 2.08 112.373 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -110.87 0.13 17.07 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.395 -0.815 . . . . 0.02 112.58 -176.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.519 ' O ' ' NH1' ' A' ' 124' ' ' ARG . 8.7 m80 60.01 33.47 21.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.768 -1.207 . . . . 0.02 109.639 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.6 mt -112.63 135.8 52.94 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 108.754 -0.832 . . . . 0.02 108.754 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 122' ' ' HIS . 0.1 OUTLIER -92.27 -22.79 19.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.242 -0.911 . . . . 5.32 110.208 -179.486 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -149.33 163.61 37.21 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.189 -0.945 . . . . 0.02 109.883 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.404 HD13 HG23 ' A' ' 126' ' ' ILE . 42.1 mt -131.91 128.81 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 107.899 -1.148 . . . . 2.17 107.899 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -107.61 -12.54 15.24 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.27 -0.893 . . . . 0.02 112.084 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.5 m -158.44 150.7 21.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.848 -1.158 . . . . 0.01 108.511 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.6 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 0.5 OUTLIER -169.62 144.67 2.97 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.425 -0.954 . . . . 1.22 108.425 -179.526 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.523 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 32.1 tttp -125.93 110.6 13.82 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 122.497 1.142 . . . . 1.41 110.61 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.1 p -109.09 134.5 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 106.948 -1.501 . . . . 0.01 106.948 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 50.7 t -128.58 94.77 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 N-CA-C 107.148 -1.427 . . . . 1.98 107.148 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -146.66 -76.58 0.19 Allowed 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 105.816 -1.92 . . . . 0.01 105.816 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 156.27 -54.14 0.41 Allowed Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.982 -1.647 . . . . 0.01 108.982 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 76.3 p -119.21 98.32 6.1 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.643 -0.916 . . . . 2.3 111.021 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -129.25 145.38 51.35 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 107.265 -1.383 . . . . 0.01 107.265 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.426 HG23 HD11 ' A' ' 137' ' ' ILE . 96.4 mt -123.74 139.47 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 120.957 -1.089 . . . . 1.69 110.071 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -114.26 144.06 43.84 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 106.99 -1.485 . . . . 2.49 106.99 177.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 14.3 m-85 -123.19 144.19 49.53 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.348 -0.845 . . . . 0.02 109.465 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -74.1 -29.45 61.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.595 -0.69 . . . . 0.02 111.838 -176.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.3 mt -115.94 154.76 48.36 Favored Pre-proline 0 N--CA 1.505 2.283 0 O-C-N 120.693 -1.254 . . . . 1.48 108.985 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -56.15 167.22 2.62 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.123 1.215 . . . . 0.02 112.889 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 143' ' ' ASN . 0.4 OUTLIER 59.58 31.15 20.76 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.149 -0.932 . . . . 0.75 111.487 178.588 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 144' ' ' TYR . 0.7 OUTLIER 58.05 50.98 9.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.447 -0.783 . . . . 0.02 111.152 177.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -125.99 164.57 20.54 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.494 -0.754 . . . . 0.02 109.973 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.06 -165.6 33.11 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.323 -1.111 . . . . 0.02 110.323 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -69.4 142.22 53.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.596 -0.943 . . . . 0.02 109.055 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.467 ' N ' ' CD ' ' A' ' 148' ' ' GLN . 5.3 mp0 -115.34 149.55 37.71 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.851 -0.531 . . . . 0.02 109.75 -178.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -124.72 134.61 52.78 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.618 -0.676 . . . . 0.01 109.189 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.8 tt -99.91 121.46 41.37 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.072 -1.017 . . . . 0.01 108.743 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -99.98 165.33 11.59 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.022 -1.049 . . . . 0.01 109.506 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -109.91 -96.96 0.4 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.59 -0.694 . . . . 2.27 109.215 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -176.37 51.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.198 -0.939 . . . . 1.84 109.626 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -113.82 -159.77 0.7 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.547 -0.721 . . . . 2.28 109.512 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.518 ' OE2' ' NZ ' ' A' ' 130' ' ' LYS . 66.3 mm-40 -106.37 107.05 17.87 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.494 -0.753 . . . . 0.01 109.064 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.656 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 29.7 m-85 -99.96 114.3 27.47 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.301 -0.874 . . . . 0.01 109.993 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -96.09 -22.34 17.39 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.227 -0.921 . . . . 0.01 111.928 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -127.84 155.34 77.61 Favored Pre-proline 0 N--CA 1.504 2.26 0 O-C-N 120.803 -1.185 . . . . 2.54 109.023 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -60.79 -39.64 60.94 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 120.497 0.798 . . . . 0.7 110.614 178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.0 t -60.72 -20.76 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.763 -1.211 . . . . 0.86 109.011 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -65.09 -14.93 61.72 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.815 -1.178 . . . . 0.02 109.732 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.656 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 21.8 m0 -96.2 10.71 36.91 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.329 -0.857 . . . . 0.02 108.712 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.03 9.47 87.07 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.727 -1.225 . . . . 0.02 110.716 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -98.63 141.86 30.93 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.296 -1.12 . . . . 0.02 110.065 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.19 -9.09 58.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.574 -0.703 . . . . 0.59 109.661 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.1 t -144.61 150.09 45.96 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.079 -1.013 . . . . 0.87 108.728 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -75.9 19.96 0.56 Allowed 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 120.663 0.908 . . . . 0.38 112.259 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.26 123.57 29.72 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.88 -1.138 . . . . 0.18 111.584 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.8 mt -149.49 128.15 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 107.041 -1.466 . . . . 3.99 107.041 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -112.15 -17.39 12.82 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.055 -1.028 . . . . 5.17 113.356 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.6 p -158.11 160.98 37.9 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 119.122 -2.236 . . . . 0.02 110.148 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.609 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 3.8 p90 -151.51 153.66 35.03 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.056 -1.028 . . . . 2.02 110.925 178.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -145.38 149.64 35.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.297 -0.877 . . . . 0.01 110.215 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -88.36 144.03 26.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.527 -0.733 . . . . 0.01 109.51 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.5 mt -93.59 129.59 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.155 -0.965 . . . . 3.04 109.159 178.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 10.2 p -136.09 146.56 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.254 -0.904 . . . . 1.89 109.473 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.291 -0.881 . . . . 4.89 109.404 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 82.3 p . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.417 -0.586 . . . . 5.28 109.417 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -56.4 166.62 0.83 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 5.96 109.501 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 53.7 m -80.92 141.92 34.06 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.325 -0.991 . . . . 2.22 108.325 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.12 179.91 47.69 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 118.326 -1.892 . . . . 0.81 112.13 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.86 158.06 44.25 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.194 -1.562 . . . . 0.01 109.194 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -147.87 136.89 22.09 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.059 -1.259 . . . . 0.02 110.641 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.8 tt -130.72 139.62 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.731 -0.841 . . . . 0.02 108.731 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 m -120.89 130.14 53.78 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.489 -0.757 . . . . 0.39 109.866 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -109.94 139.57 44.88 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.077 -0.712 . . . . 0.02 109.077 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.534 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 5.3 m-85 -122.14 138.41 54.47 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.146 -0.971 . . . . 0.02 109.531 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -69.39 -27.67 65.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.193 -0.942 . . . . 0.03 111.539 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -114.05 169.16 9.22 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.849 -1.157 . . . . 0.03 110.14 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -75.39 158.32 32.9 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.598 0.713 . . . . 0.03 110.218 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 66.42 33.3 6.98 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.948 0.88 . . . . 0.74 111.117 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 55.48 41.94 30.36 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 116.056 -0.52 . . . . 0.02 111.324 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -113.66 165.68 12.28 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.193 -1.04 . . . . 0.02 108.193 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.39 -167.46 35.66 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.826 -1.178 . . . . 0.03 110.793 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -69.22 142.27 54.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.398 -1.06 . . . . 2.76 109.315 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -120.76 149.09 43.08 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.618 0.723 . . . . 1.89 110.167 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -132.43 127.16 34.76 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.255 -1.017 . . . . 0.02 108.255 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -112.48 137.41 50.72 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.57 -0.706 . . . . 1.12 109.827 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.9 t -131.67 139.21 49.01 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 121.523 0.678 . . . . 0.02 109.777 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -116.98 11.26 14.26 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.583 -0.698 . . . . 0.2 109.671 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.455 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 29.5 p -158.29 174.3 15.37 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.275 -1.009 . . . . 1.23 108.275 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 2.3 p30 -60.93 143.84 54.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.647 -1.283 . . . . 0.02 109.855 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 26' ' ' CYS . 27.4 p -131.19 117.14 18.62 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.52 -0.918 . . . . 0.02 108.52 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.46 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -78.17 -24.83 47.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.143 -0.973 . . . . 0.24 110.965 -178.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -154.8 101.65 2.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.834 -1.166 . . . . 1.14 108.985 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -105.21 9.53 34.03 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 122.197 0.998 . . . . 6.37 109.903 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -58.86 -24.55 62.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.388 -0.82 . . . . 3.11 110.934 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.5 m -74.16 -16.55 60.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.755 -1.216 . . . . 0.88 110.124 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -103.97 -21.97 13.54 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.482 -0.761 . . . . 0.02 109.488 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.6 tp -150.04 128.86 12.48 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.196 -0.94 . . . . 3.32 109.207 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.7 t -85.54 -10.1 56.44 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.768 -0.583 . . . . 0.02 111.191 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -170.55 162.28 8.02 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.696 -1.224 . . . . 0.02 107.696 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.6 t -143.05 115.57 8.58 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.73 -1.231 . . . . 0.02 109.136 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.609 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.5 OUTLIER -109.8 1.95 19.66 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 120.839 -1.163 . . . . 0.03 111.532 -178.563 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.503 ' HG ' ' N ' ' A' ' 39' ' ' ILE . 22.2 t -156.67 154.47 30.14 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.098 -1.075 . . . . 0.02 108.098 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.503 ' N ' ' HG ' ' A' ' 38' ' ' SER . 11.1 mt -145.94 146.61 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-O 122.402 1.096 . . . . 0.02 111.209 -178.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -123.07 124.22 42.62 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.672 -1.233 . . . . 0.02 107.672 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.3 t -106.47 113.92 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 106.91 -1.515 . . . . 0.02 106.91 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -84.07 -34.42 24.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.746 -0.596 . . . . 3.81 110.5 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.84 149.93 18.32 Favored Glycine 0 N--CA 1.486 2.026 0 C-N-CA 119.064 -1.541 . . . . 0.02 110.589 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.96 172.08 48.84 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.845 -1.169 . . . . 0.01 110.432 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.7 m -119.99 135.69 54.82 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.171 -1.048 . . . . 1.48 108.171 178.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.421 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 35.8 m95 -127.41 155.48 43.58 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 122.62 1.2 . . . . 0.02 112.526 -176.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.41 134.69 51.53 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 105.586 -2.005 . . . . 0.24 105.586 176.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.5 m -120.12 144.51 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.629 -0.669 . . . . 0.65 109.408 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -121.15 146.04 47.18 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 122.291 1.043 . . . . 0.02 110.22 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.405 ' CD ' ' HD1' ' A' ' 57' ' ' HIS . 28.3 tt0 -67.5 -34.55 77.37 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.801 -0.636 . . . . 0.02 111.496 -177.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 24.4 mtm180 -124.72 158.22 63.11 Favored Pre-proline 0 N--CA 1.504 2.249 0 O-C-N 120.983 -1.073 . . . . 0.02 109.576 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -54.04 165.32 2.08 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.619 1.546 . . . . 0.02 113.253 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.474 ' N ' ' ND2' ' A' ' 53' ' ' ASN . 1.2 m120 64.37 37.02 8.65 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.111 -0.949 . . . . 0.02 111.268 178.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 45.22 51.68 9.06 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.662 0.744 . . . . 3.39 110.603 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.9 p -126.2 163.47 23.1 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.58 -0.526 . . . . 2.33 109.58 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.92 -161.76 32.14 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.811 -1.316 . . . . 0.02 109.811 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.405 ' HD1' ' CD ' ' A' ' 50' ' ' GLU . 16.5 m80 -65.27 138.91 58.51 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.085 -1.244 . . . . 0.02 110.388 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.446 ' SD ' ' C ' ' A' ' 58' ' ' MET . 11.6 tmm? -120.1 137.18 54.29 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 109.376 -0.601 . . . . 5.01 109.376 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.424 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 86.7 m-85 -134.67 139.68 45.44 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.799 0.809 . . . . 0.02 109.949 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.7 mm -94.77 131.26 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.762 -0.829 . . . . 1.72 108.762 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.556 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -120.45 111.95 34.58 Favored Pre-proline 0 N--CA 1.505 2.311 0 O-C-N 121.397 -0.814 . . . . 0.02 110.946 -178.165 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -78.31 169.16 20.55 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 CA-C-N 119.842 0.979 . . . . 1.47 110.338 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -53.72 141.52 26.22 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.88 -1.137 . . . . 4.25 110.514 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.85 -177.46 32.12 Favored Glycine 0 N--CA 1.496 2.636 0 C-N-CA 119.515 -1.326 . . . . 0.02 110.824 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -119.99 131.39 55.14 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.46 -1.023 . . . . 0.96 109.803 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.556 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 75.1 m-85 -121.73 97.83 46.12 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 107.795 -1.187 . . . . 0.02 107.795 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.402 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 5.8 Cg_endo -69.6 -3.34 11.71 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 120.704 0.936 . . . . 0.02 113.671 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 33.4 mt-10 -157.77 155.11 29.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.723 -1.235 . . . . 2.02 108.137 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -60.4 -39.5 87.59 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.666 -0.646 . . . . 0.02 112.018 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -60.06 -24.02 64.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.058 -1.026 . . . . 0.02 110.411 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -69.74 -18.5 63.52 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.903 0.859 . . . . 3.42 108.87 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.558 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.3 t90 -108.21 10.59 27.84 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.458 -1.312 . . . . 0.02 107.458 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.7 mtt 61.5 22.55 12.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.53 -0.731 . . . . 0.02 110.536 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.53 145.46 47.24 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.579 -1.409 . . . . 0.02 109.579 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.3 mt -80.48 -31.04 37.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -1.158 . . . . 0.98 108.039 177.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -157.02 -171.55 3.69 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 106.513 -1.662 . . . . 0.02 106.513 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.424 ' OD2' ' OD1' ' A' ' 37' ' ' ASN . 66.0 m-20 -98.63 28.31 4.31 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.595 -1.316 . . . . 0.02 110.774 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.4 mtp180 -97.19 122.89 40.71 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.059 -1.026 . . . . 3.2 110.99 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.8 mt -143.47 121.59 12.17 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 107.632 -1.247 . . . . 2.61 107.632 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.07 -17.27 9.67 Favored Glycine 0 N--CA 1.506 3.327 0 O-C-N 121.098 -1.001 . . . . 0.02 113.026 -177.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 22.9 m -156.74 156.86 34.05 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.085 -1.832 . . . . 0.02 110.483 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 44.9 t -144.79 147.26 32.69 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.529 -0.732 . . . . 0.02 110.242 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 38.1 mtm180 -138.52 143.17 39.4 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.33 -0.856 . . . . 0.01 109.392 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.81 132.46 36.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.251 -0.906 . . . . 0.43 109.816 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.6 t -91.25 125.44 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.851 -0.796 . . . . 1.25 108.851 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -94.1 131.34 39.73 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.773 -1.204 . . . . 1.77 109.085 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mt -96.37 140.18 31.41 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.439 -0.949 . . . . 1.63 108.439 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.2 t -111.89 127.86 55.97 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.285 -0.884 . . . . 1.08 109.406 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.6 p -104.34 -154.17 0.5 Allowed 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 106.573 -1.64 . . . . 1.26 106.573 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.93 -52.97 0.73 Allowed Glycine 0 N--CA 1.502 3.044 0 O-C-N 120.392 -1.443 . . . . 0.01 112.895 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.81 -101.42 0.15 Allowed Glycine 0 N--CA 1.491 2.312 0 C-N-CA 118.467 -1.825 . . . . 0.01 111.966 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -121.64 118.89 30.31 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.057 -1.261 . . . . 4.43 110.648 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.3 129.1 34.13 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.702 -0.799 . . . . 2.99 109.555 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -131.1 142.23 50.24 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 109.039 -0.726 . . . . 6.36 109.039 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.2 tt -129.68 147.36 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 O-C-N 121.24 -0.912 . . . . 1.09 110.362 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -121.64 134.13 54.98 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.615 -1.254 . . . . 2.05 107.615 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.7 m -124.36 145.88 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 120.69 -1.256 . . . . 1.1 110.002 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.592 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 96.4 m-85 -119.13 141.44 48.81 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.995 0.902 . . . . 0.73 110.935 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -67.02 -30.93 71.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.881 -0.512 . . . . 0.02 111.852 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -116.36 167.63 10.86 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.949 -1.094 . . . . 3.18 110.561 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.18 164.17 44.49 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 111.057 -0.817 . . . . 0.01 111.057 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 57.1 38.56 29.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.884 -0.774 . . . . 0.01 110.963 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 52.4 55.32 9.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.582 -0.699 . . . . 0.01 111.058 178.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -129.08 165.85 20.42 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.216 -1.031 . . . . 3.15 108.216 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.41 -163.8 27.76 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.231 -1.548 . . . . 0.01 109.231 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -76.0 144.24 41.02 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.025 -1.279 . . . . 0.01 108.711 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.592 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 52.2 ttp -116.29 141.84 47.63 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.608 0.718 . . . . 0.01 109.882 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -131.57 136.63 47.97 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.237 -1.023 . . . . 2.48 108.237 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -118.1 133.69 55.67 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.502 -0.749 . . . . 0.01 110.012 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.1 t -147.84 148.76 31.23 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 122.195 0.998 . . . . 1.69 110.941 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 60.3 p -111.17 10.06 21.87 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 115.619 -0.718 . . . . 0.01 110.293 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -121.67 163.09 19.58 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.257 -0.902 . . . . 3.21 111.677 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.17 157.48 36.82 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.278 -1.008 . . . . 0.01 108.278 178.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.621 ' SG ' ' CD2' ' A' ' 172' ' ' PHE . 0.8 OUTLIER -128.46 119.51 20.54 Favored Pre-proline 0 N--CA 1.504 2.26 0 O-C-N 121.476 -0.765 . . . . 0.01 108.989 177.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -76.47 -28.76 6.57 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 CA-C-N 120.24 1.121 . . . . 0.01 110.85 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 64.1 m -144.04 109.75 5.25 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.718 0.771 . . . . 0.02 109.25 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.72 -38.28 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.819 -0.551 . . . . 1.83 110.514 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 20.5 ttt -68.49 -36.39 78.87 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.399 -0.92 . . . . 1.34 110.359 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -70.91 -39.06 72.96 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.5 -1.375 . . . . 2.11 110.167 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -79.66 -47.54 15.22 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.307 -0.871 . . . . 2.08 112.535 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -110.27 0.51 18.12 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.358 -0.839 . . . . 0.02 112.476 -176.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.6 m80 59.49 32.64 21.84 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.757 -1.214 . . . . 0.02 109.32 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.1 mt -112.2 135.46 52.84 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 108.477 -0.934 . . . . 0.02 108.477 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -91.24 -22.66 20.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.289 -0.882 . . . . 5.32 110.158 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -149.84 164.04 36.42 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.296 -0.878 . . . . 0.02 110.024 -178.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 48.6 mt -131.42 128.49 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 107.558 -1.275 . . . . 2.17 107.558 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -107.81 -12.25 15.24 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.313 -0.867 . . . . 0.02 112.376 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.429 ' HG ' ' N ' ' A' ' 129' ' ' CYS . 3.4 t -158.74 151.39 21.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.837 -1.164 . . . . 0.01 108.911 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.504 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 2.8 p -170.41 145.25 2.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.092 -1.005 . . . . 1.22 109.178 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -124.67 110.18 14.07 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 122.361 1.077 . . . . 1.41 109.894 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.6 p -111.21 135.34 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.365 -1.346 . . . . 0.01 107.365 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.9 t -128.95 94.69 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 107.05 -1.463 . . . . 1.98 107.05 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -146.03 -74.73 0.22 Allowed 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 105.869 -1.9 . . . . 0.01 105.869 177.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 167.36 -69.74 0.18 Allowed Glycine 0 N--CA 1.485 1.902 0 N-CA-C 108.7 -1.76 . . . . 0.01 108.7 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.18 115.4 23.57 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.556 -0.967 . . . . 2.3 110.456 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -127.05 149.37 49.94 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 106.809 -1.552 . . . . 0.01 106.809 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 97.7 mt -122.98 138.37 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 120.42 -1.425 . . . . 1.69 110.647 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -113.72 143.64 44.28 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.265 -1.383 . . . . 2.49 107.265 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.501 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 10.5 m-85 -122.45 144.68 48.9 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.178 -0.951 . . . . 0.02 109.307 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -75.72 -29.34 58.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.608 -0.682 . . . . 0.02 111.566 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mt -116.41 154.21 48.91 Favored Pre-proline 0 N--CA 1.504 2.234 0 O-C-N 120.69 -1.256 . . . . 1.48 108.899 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -55.16 170.02 0.83 Allowed 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.225 1.283 . . . . 0.02 112.962 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 14.2 t30 58.25 31.62 21.04 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 114.937 -1.029 . . . . 0.75 111.274 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 56.21 48.01 18.21 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.532 -0.73 . . . . 0.02 110.424 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -123.03 164.4 18.65 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.585 -0.697 . . . . 0.02 109.97 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.86 -166.03 32.35 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.375 -1.09 . . . . 0.02 110.375 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -69.04 142.85 54.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.581 -0.952 . . . . 0.02 109.133 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -114.49 147.99 38.54 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.393 0.616 . . . . 0.02 110.242 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -125.22 135.71 52.84 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.919 -0.771 . . . . 0.01 108.919 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.7 tt -97.9 121.64 40.05 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.839 -1.163 . . . . 0.01 109.495 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.04 145.5 25.4 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.309 -0.869 . . . . 0.01 108.752 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -103.06 -116.15 0.21 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.339 -0.851 . . . . 2.27 109.412 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -157.78 49.69 0.42 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.053 -1.029 . . . . 1.84 109.712 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -113.64 -162.97 0.83 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.495 -0.753 . . . . 2.28 109.315 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -105.93 103.52 13.03 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.43 -0.794 . . . . 0.01 108.94 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.616 ' CG ' ' NE1' ' A' ' 162' ' ' TRP . 66.8 m-85 -98.7 113.24 25.24 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.365 -0.835 . . . . 0.01 109.722 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -95.11 -22.33 17.95 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.297 -0.877 . . . . 0.01 111.61 -177.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -127.39 154.52 77.24 Favored Pre-proline 0 N--CA 1.504 2.25 0 O-C-N 120.767 -1.208 . . . . 2.54 108.855 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -60.5 -38.97 69.58 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 120.58 0.854 . . . . 0.7 110.512 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 84.6 t -61.51 -20.02 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.958 -1.089 . . . . 0.86 108.931 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -65.41 -15.6 62.77 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.934 -1.104 . . . . 0.02 110.074 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.616 ' NE1' ' CG ' ' A' ' 156' ' ' TYR . 9.7 m0 -98.22 11.4 37.98 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.144 -0.973 . . . . 0.02 108.925 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.06 10.34 85.65 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.842 -1.171 . . . . 0.02 111.087 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.57 141.25 32.6 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.181 -1.188 . . . . 0.02 110.023 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.08 -9.46 57.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.671 -0.643 . . . . 0.59 110.217 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.0 m -143.49 149.78 48.75 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 120.891 -1.131 . . . . 0.87 109.057 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -76.64 19.1 0.66 Allowed 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 120.822 1.015 . . . . 0.38 112.294 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.7 124.7 29.82 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.812 -1.18 . . . . 0.18 111.493 -177.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -150.21 126.6 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 107.075 -1.454 . . . . 3.99 107.075 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -115.11 -15.07 11.74 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.051 -1.031 . . . . 5.17 113.582 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 6.2 t -156.77 160.16 38.99 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 119.189 -2.194 . . . . 0.02 110.294 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.621 ' CD2' ' SG ' ' A' ' 114' ' ' CYS . 13.9 p90 -151.84 153.29 33.93 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.919 -1.113 . . . . 2.02 110.718 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -144.78 149.42 35.46 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.364 -0.835 . . . . 0.01 110.293 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -89.26 145.46 25.37 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.27 -0.641 . . . . 0.01 109.27 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.7 mt -96.76 129.93 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.308 -0.87 . . . . 3.04 109.324 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.14 146.31 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.227 -0.92 . . . . 1.89 109.484 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 4.89 109.404 179.931 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 89.5 p . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.223 0.535 . . . . 5.28 109.59 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -56.1 -31.21 63.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.309 -0.869 . . . . 5.96 109.503 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 55.8 p -80.48 141.82 34.84 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.194 -1.039 . . . . 2.22 108.194 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.92 179.57 48.04 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 118.223 -1.941 . . . . 0.81 112.117 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.12 157.76 43.4 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.421 -1.471 . . . . 0.01 109.421 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.519 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 2.8 ttmp? -145.99 135.27 22.9 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.174 -1.192 . . . . 0.02 110.517 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.425 HG23 HD11 ' A' ' 7' ' ' ILE . 7.5 tt -129.54 139.15 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.062 -1.088 . . . . 0.02 108.062 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.49 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.4 t -122.41 130.86 53.53 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.348 -0.845 . . . . 0.39 110.119 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.0 m-85 -111.18 141.54 44.57 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 109.067 -0.716 . . . . 0.02 109.067 178.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.548 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.9 m-85 -122.08 138.58 54.39 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.181 -0.949 . . . . 0.02 109.61 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -68.33 -27.91 66.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.878 -1.139 . . . . 0.03 111.39 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.1 m-20 -114.65 169.88 8.73 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.873 -1.142 . . . . 0.03 110.163 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -75.5 161.91 28.78 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.793 0.806 . . . . 0.03 110.411 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.3 m120 63.12 33.13 14.75 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.054 0.931 . . . . 0.74 110.894 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 54.92 40.07 31.83 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.865 -0.607 . . . . 0.02 110.978 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -110.29 165.75 11.52 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.215 -1.031 . . . . 0.02 108.215 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.46 -167.57 35.63 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.889 -1.148 . . . . 0.03 110.889 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -69.65 143.28 53.26 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.477 -1.014 . . . . 2.76 109.261 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -120.47 149.23 42.72 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.505 0.669 . . . . 1.89 110.171 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -132.34 127.59 35.85 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.25 -1.018 . . . . 0.02 108.25 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -112.78 136.75 52.04 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.422 -0.799 . . . . 1.12 109.751 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 15.9 t -131.22 139.14 49.64 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.765 -0.585 . . . . 0.02 109.515 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -116.58 11.69 14.83 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.624 -0.672 . . . . 0.2 109.836 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.634 ' HG ' ' H ' ' A' ' 25' ' ' ASP . 52.9 t -158.37 174.69 14.75 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.248 -1.019 . . . . 1.23 108.248 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.634 ' H ' ' HG ' ' A' ' 24' ' ' CYS . 1.1 m-20 -60.53 144.19 52.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.756 -1.215 . . . . 0.02 109.721 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 22.2 t -131.75 117.41 18.56 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.654 -0.869 . . . . 0.02 108.654 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.89 -24.42 48.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.143 -0.973 . . . . 0.24 110.919 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -155.18 102.36 2.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.927 -1.108 . . . . 1.14 109.234 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -102.57 9.9 39.13 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 122.024 0.916 . . . . 6.37 109.734 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -59.45 -25.22 64.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.589 -0.694 . . . . 3.11 111.416 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.9 m -76.23 -17.3 59.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.508 -1.37 . . . . 0.88 110.687 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -103.88 -22.06 13.56 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.361 -0.837 . . . . 0.02 109.411 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.1 tp -150.25 129.1 12.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.317 -0.865 . . . . 3.32 109.0 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.5 m -85.03 -9.81 57.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.743 -0.598 . . . . 0.02 110.944 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -171.15 162.36 6.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.954 -1.091 . . . . 0.02 108.066 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.9 p -144.03 115.09 7.88 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.747 -1.221 . . . . 0.02 108.53 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -108.65 3.29 22.66 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.787 -1.195 . . . . 0.03 110.862 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.3 m -155.48 154.28 31.58 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.651 -1.241 . . . . 0.02 107.651 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.5 mt -146.36 147.1 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.977 -1.077 . . . . 0.02 110.574 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -124.6 125.07 43.55 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 107.814 -1.18 . . . . 0.02 107.814 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.7 t -106.38 115.21 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 106.972 -1.492 . . . . 0.02 106.972 177.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.519 ' OE1' ' NZ ' ' A' ' 6' ' ' LYS . 30.5 tt0 -83.38 -34.0 25.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.37 -0.831 . . . . 3.81 110.93 -178.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.04 152.58 22.5 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 118.893 -1.622 . . . . 0.02 110.799 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.53 172.97 49.39 Favored Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.698 -1.239 . . . . 0.01 110.423 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 86.6 m -119.81 135.16 54.97 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 107.982 -1.118 . . . . 1.48 107.982 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.442 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 32.0 m95 -126.53 154.99 43.07 Favored 'General case' 0 N--CA 1.502 2.173 0 CA-C-O 122.581 1.181 . . . . 0.02 112.301 -176.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.14 134.28 51.92 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 105.225 -2.139 . . . . 0.24 105.225 176.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.5 m -116.99 141.93 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.532 -0.73 . . . . 0.65 109.235 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -121.18 143.89 48.88 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 122.061 0.934 . . . . 0.02 109.753 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -65.01 -34.82 79.36 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.448 -0.796 . . . . 0.02 111.655 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.9 mtm180 -125.37 157.74 66.67 Favored Pre-proline 0 N--CA 1.503 2.2 0 O-C-N 121.004 -1.06 . . . . 0.02 109.332 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.48 167.73 0.84 Allowed 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.657 1.572 . . . . 0.02 113.022 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 63.13 36.39 12.19 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.212 -0.903 . . . . 0.02 111.207 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' A' ' 54' ' ' PHE . 0.6 OUTLIER 45.5 51.62 9.67 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.591 0.71 . . . . 3.39 110.717 178.472 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.8 m -126.02 163.85 22.13 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.187 0.517 . . . . 2.33 109.846 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.85 -161.54 32.06 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.869 -1.292 . . . . 0.02 109.869 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.407 ' CD2' ' N ' ' A' ' 57' ' ' HIS . 15.8 m170 -65.22 138.62 58.36 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.035 -1.274 . . . . 0.02 110.068 -178.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.447 ' SD ' ' C ' ' A' ' 58' ' ' MET . 11.2 tmm? -118.97 136.39 54.11 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.362 0.601 . . . . 5.01 109.693 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -134.31 138.76 45.2 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 121.714 0.768 . . . . 0.02 109.828 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.9 mm -95.38 131.11 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 109.031 -0.729 . . . . 1.72 109.031 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.565 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -119.66 110.62 36.85 Favored Pre-proline 0 N--CA 1.504 2.247 0 O-C-N 121.449 -0.782 . . . . 0.02 110.67 -178.3 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -77.26 167.86 24.01 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 CA-C-N 119.966 1.024 . . . . 1.47 110.167 177.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.538 ' CD ' ' H ' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -53.36 141.61 23.88 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.834 -1.166 . . . . 4.25 110.445 -179.621 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.13 -177.81 32.15 Favored Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.549 -1.31 . . . . 0.02 110.671 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -119.78 131.64 55.39 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.382 -1.07 . . . . 0.96 109.823 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.565 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 75.6 m-85 -121.46 97.81 46.78 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 108.047 -1.094 . . . . 0.02 108.047 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -69.42 -3.88 12.68 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 120.743 0.962 . . . . 0.02 113.48 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -157.65 154.76 28.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.781 -1.199 . . . . 2.02 108.041 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.596 ' HH ' HE21 ' A' ' 70' ' ' GLN . 28.4 p90 -60.36 -38.8 84.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.58 -0.7 . . . . 0.02 112.154 -177.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.596 HE21 ' HH ' ' A' ' 69' ' ' TYR . 73.6 mt-30 -60.52 -24.15 65.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.176 -0.953 . . . . 0.02 110.494 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -68.74 -18.03 64.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.327 -0.858 . . . . 3.42 109.076 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.562 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.3 t90 -108.09 11.74 27.39 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.673 -1.232 . . . . 0.02 107.673 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.3 mmt 60.48 22.3 11.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.556 -0.715 . . . . 0.02 110.295 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.89 143.33 45.48 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.429 -1.468 . . . . 0.02 109.429 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.0 tp -78.58 -31.26 47.15 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.293 -1.373 . . . . 0.98 107.293 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -157.75 -172.07 3.8 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 106.097 -1.816 . . . . 0.02 106.097 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -98.16 28.26 4.13 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.701 -1.249 . . . . 0.02 110.692 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -96.76 121.87 39.09 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.736 -1.227 . . . . 3.2 111.039 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.4 mt -142.96 122.02 12.87 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 107.422 -1.325 . . . . 2.61 107.422 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.84 -17.61 9.55 Favored Glycine 0 N--CA 1.504 3.222 0 O-C-N 121.231 -0.918 . . . . 0.02 112.859 -177.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 p -156.37 156.48 33.96 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.04 -1.859 . . . . 0.02 110.61 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 44.2 t -144.34 146.85 32.8 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.38 -0.825 . . . . 0.02 110.476 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 -138.33 143.48 39.93 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.408 -0.807 . . . . 0.01 109.486 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.42 132.25 36.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.946 . . . . 0.43 109.825 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.3 t -91.56 125.63 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.878 -0.786 . . . . 1.25 108.878 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -94.26 131.85 39.44 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.783 -1.198 . . . . 1.77 109.234 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.3 mt -96.79 140.34 31.5 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.307 -0.871 . . . . 1.63 108.681 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.5 p -111.93 127.63 55.91 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.411 -0.806 . . . . 1.08 109.339 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.7 t -103.94 -154.66 0.51 Allowed 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 106.551 -1.648 . . . . 1.26 106.551 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.01 -52.45 0.75 Allowed Glycine 0 N--CA 1.5 2.944 0 O-C-N 120.512 -1.368 . . . . 0.01 112.807 177.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.26 -101.19 0.15 Allowed Glycine 0 N--CA 1.491 2.306 0 C-N-CA 118.457 -1.83 . . . . 0.01 112.161 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -121.94 119.8 32.57 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.033 -1.275 . . . . 4.43 110.791 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.4 129.73 34.74 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.833 -0.747 . . . . 2.99 109.362 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -130.1 142.23 50.62 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.347 -0.846 . . . . 6.36 109.073 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.0 tt -129.19 146.13 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 121.302 -0.874 . . . . 1.09 110.373 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -121.54 133.25 55.02 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.432 -1.321 . . . . 2.05 107.432 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.8 m -123.58 145.35 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 120.693 -1.255 . . . . 1.1 109.772 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -119.75 141.46 49.42 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 122.064 0.935 . . . . 0.73 111.012 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -67.24 -30.5 70.43 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.922 -0.581 . . . . 0.02 112.126 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -116.27 167.33 11.11 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 120.998 -1.064 . . . . 3.18 110.413 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.64 163.85 43.02 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 111.039 -0.825 . . . . 0.01 111.039 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.2 t70 56.82 38.75 29.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.921 -0.753 . . . . 0.01 110.896 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.437 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 21.2 m-85 52.26 55.95 8.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.656 -0.652 . . . . 0.01 111.103 178.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -128.8 165.39 21.05 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.256 -1.016 . . . . 3.15 108.256 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.22 -163.79 27.99 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.324 -1.511 . . . . 0.01 109.324 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 48.3 tp60 -75.03 143.48 43.5 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.998 -1.295 . . . . 0.01 108.551 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.45 ' SD ' ' C ' ' A' ' 107' ' ' MET . 12.3 tmm? -115.99 142.45 46.77 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.52 0.676 . . . . 0.01 109.746 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -131.83 136.5 47.53 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.249 -1.019 . . . . 2.48 108.249 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -118.76 134.14 55.35 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.576 -0.703 . . . . 0.01 109.948 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.62 ' HG1' ' H ' ' A' ' 112' ' ' GLU . 4.0 t -148.86 149.99 32.23 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.24 1.019 . . . . 1.69 110.946 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 32.2 p -109.94 10.38 24.32 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 115.485 -0.78 . . . . 0.01 110.106 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.62 ' H ' ' HG1' ' A' ' 110' ' ' THR . 28.1 mm-40 -121.29 163.16 19.04 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.264 -0.898 . . . . 3.21 111.715 -178.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -67.48 156.61 36.22 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.253 -1.017 . . . . 0.01 108.253 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 37.5 t -125.4 111.95 25.9 Favored Pre-proline 0 N--CA 1.503 2.177 0 O-C-N 121.368 -0.832 . . . . 0.01 109.035 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.438 ' O ' ' OG ' ' A' ' 171' ' ' SER . 19.1 Cg_endo -76.37 -32.62 3.8 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 CA-C-N 119.997 1.034 . . . . 0.01 111.635 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.504 ' HG ' ' H ' ' A' ' 119' ' ' GLU . 7.8 t -140.6 106.54 5.17 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.223 -0.923 . . . . 0.02 108.592 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 68.0 mt -65.03 -38.82 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.717 -0.615 . . . . 1.83 111.183 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.2 ttt -66.92 -38.07 85.51 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 118.946 -1.102 . . . . 1.34 109.929 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.504 ' H ' ' HG ' ' A' ' 116' ' ' SER . 62.6 mt-10 -69.15 -38.28 78.7 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.489 -1.382 . . . . 2.11 109.546 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -79.77 -47.25 15.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.322 -0.861 . . . . 2.08 112.269 -177.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -111.77 -0.53 15.91 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.378 -0.826 . . . . 0.02 112.824 -176.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.8 m80 61.71 34.67 17.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.752 -1.218 . . . . 0.02 109.837 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 40.9 mt -114.47 136.12 53.36 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.454 -0.779 . . . . 0.02 109.426 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -90.62 -22.04 21.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.3 -0.875 . . . . 5.32 110.864 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -148.05 163.92 35.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.99 -1.069 . . . . 0.02 109.97 -178.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.9 mm -129.28 125.28 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 107.857 -1.164 . . . . 2.17 107.857 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -109.74 -13.61 14.46 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.233 -0.917 . . . . 0.02 112.833 -177.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.437 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 2.3 t -158.87 149.63 20.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.797 -1.189 . . . . 0.01 108.987 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.581 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 30.0 p -170.14 148.81 3.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 1.22 108.865 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -120.88 113.03 19.54 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 122.453 1.12 . . . . 1.41 110.062 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.0 t -112.19 128.72 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.561 -1.274 . . . . 0.01 107.561 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 47.5 t -128.73 93.11 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 107.071 -1.455 . . . . 1.98 107.071 177.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -147.71 -75.99 0.18 Allowed 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 105.831 -1.914 . . . . 0.01 105.831 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 156.55 -54.53 0.4 Allowed Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.184 -1.567 . . . . 0.01 109.184 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 54.7 p -119.77 97.8 5.8 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.551 -0.97 . . . . 2.3 111.012 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -128.16 145.53 50.99 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 107.108 -1.442 . . . . 0.01 107.108 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 61.4 mt -122.02 138.89 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 120.883 -1.136 . . . . 1.69 110.714 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -113.71 144.11 43.5 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 106.873 -1.529 . . . . 2.49 106.873 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.513 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 15.7 m-85 -123.17 144.36 49.4 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.311 -0.868 . . . . 0.02 109.658 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -76.54 -28.97 56.52 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.624 -0.673 . . . . 0.02 111.999 -176.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mt -116.04 154.93 48.52 Favored Pre-proline 0 N--CA 1.506 2.331 0 O-C-N 120.544 -1.348 . . . . 1.48 108.915 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.95 165.94 2.4 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.235 1.29 . . . . 0.02 113.071 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.559 ' N ' ' ND2' ' A' ' 143' ' ' ASN . 1.2 m120 59.68 31.48 20.9 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 115.071 -0.968 . . . . 0.75 111.471 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 57.39 51.09 10.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.45 -0.781 . . . . 0.02 111.186 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -126.26 164.91 19.96 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.426 -0.796 . . . . 0.02 109.944 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.463 ' O ' ' NE2' ' A' ' 148' ' ' GLN . . . 89.01 -165.98 33.42 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.255 -1.138 . . . . 0.02 110.255 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -69.39 142.66 53.88 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.724 -0.868 . . . . 0.02 109.061 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.47 ' N ' ' CD ' ' A' ' 148' ' ' GLN . 7.2 mp0 -115.63 149.54 38.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.803 -0.56 . . . . 0.02 109.728 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -123.53 134.76 53.82 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.616 -0.678 . . . . 0.01 109.219 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.3 tp -95.24 121.15 36.59 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.632 -1.292 . . . . 0.01 108.956 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.47 ' CD1' ' CZ ' ' A' ' 156' ' ' TYR . 0.2 OUTLIER -94.63 160.24 14.72 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.325 -0.859 . . . . 0.01 109.045 -179.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.413 ' OD2' ' OH ' ' A' ' 156' ' ' TYR . 1.4 p-10 -109.34 -111.65 0.32 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.445 -0.784 . . . . 2.27 109.335 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.525 ' N ' ' OH ' ' A' ' 156' ' ' TYR . 49.7 pttt -168.81 45.55 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.114 -0.991 . . . . 1.84 109.923 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -113.59 -153.77 0.53 Allowed 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.503 -0.748 . . . . 2.28 109.122 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -106.39 106.37 16.85 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.417 -0.802 . . . . 0.01 109.075 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.623 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 2.9 m-85 -99.34 112.4 24.58 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.267 -0.895 . . . . 0.01 109.667 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -94.56 -22.67 18.05 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.129 -0.982 . . . . 0.01 111.411 -178.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -128.19 154.44 78.79 Favored Pre-proline 0 N--CA 1.502 2.146 0 O-C-N 120.84 -1.163 . . . . 2.54 108.822 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -60.12 -37.21 85.46 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 CA-C-N 119.268 0.774 . . . . 0.7 110.631 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 6.0 t -61.11 -19.88 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.756 -1.215 . . . . 0.86 109.048 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -65.15 -15.28 62.25 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.94 -1.1 . . . . 0.02 109.921 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.623 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 12.9 m0 -97.93 11.29 37.94 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.14 -0.975 . . . . 0.02 109.025 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.4 11.0 84.7 Favored Glycine 0 N--CA 1.491 2.329 0 O-C-N 120.793 -1.192 . . . . 0.02 111.177 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.34 140.88 32.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.066 -1.255 . . . . 0.02 110.066 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.68 -8.76 58.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.598 -0.689 . . . . 0.59 110.045 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 8.1 p -142.47 151.31 57.39 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 120.981 -1.075 . . . . 0.87 109.318 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -76.21 16.67 0.82 Allowed 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 120.837 1.024 . . . . 0.38 112.263 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.41 122.17 27.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.872 -1.142 . . . . 0.18 111.366 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 3.1 mt -149.12 123.51 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 105.873 -1.899 . . . . 3.99 105.873 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -112.21 -15.9 13.11 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.227 -0.92 . . . . 5.17 113.286 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 115' ' ' PRO . 20.9 m -156.6 160.42 39.4 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 119.245 -2.159 . . . . 0.02 110.041 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.419 ' CD1' ' C ' ' A' ' 172' ' ' PHE . 21.4 p90 -152.67 153.0 32.41 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.147 -0.971 . . . . 2.02 110.633 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 29.6 mtp180 -145.58 149.65 34.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.36 -0.837 . . . . 0.01 109.679 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -88.4 142.44 27.72 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.507 -0.746 . . . . 0.01 109.455 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.7 mt -93.59 129.93 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.257 -0.902 . . . . 3.04 109.126 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.5 p -137.53 148.7 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.239 -0.913 . . . . 1.89 109.902 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 . . . . . 0 N--CA 1.494 1.764 0 O-C-N 121.514 -0.741 . . . . 4.89 109.656 179.827 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 99.3 p . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.401 -0.592 . . . . 5.28 109.401 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.43 ' O ' ' OG1' ' A' ' 3' ' ' THR . 53.1 mttp -49.85 146.34 4.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 5.96 109.68 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 2' ' ' LYS . 47.4 m -168.42 167.19 12.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.034 -1.041 . . . . 2.22 108.748 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -118.0 117.07 3.63 Favored Glycine 0 N--CA 1.499 2.872 0 N-CA-C 106.94 -2.464 . . . . 0.81 106.94 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.9 144.76 32.83 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.768 -1.333 . . . . 0.01 109.768 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -149.92 136.45 19.12 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.481 -1.011 . . . . 0.02 109.882 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.418 HG22 HD12 ' A' ' 7' ' ' ILE . 6.3 tt -128.87 139.24 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.157 -1.053 . . . . 0.02 108.157 178.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.1 t -121.7 130.18 53.26 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.328 -0.858 . . . . 0.39 110.033 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.545 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.8 m-85 -110.25 140.65 44.18 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.871 -0.788 . . . . 0.02 108.871 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.528 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 6.0 m-85 -122.37 138.79 54.41 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.214 -0.929 . . . . 0.02 109.612 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.425 ' OE2' ' NH2' ' A' ' 18' ' ' ARG . 87.7 mt-10 -68.03 -27.74 66.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.025 -1.047 . . . . 0.03 111.663 -178.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -114.53 169.86 8.74 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.812 -1.18 . . . . 0.03 110.379 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -75.67 158.92 31.72 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.611 0.719 . . . . 0.03 109.974 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 66.09 32.99 7.86 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.949 0.88 . . . . 0.74 110.97 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 55.23 41.57 31.27 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.31 0.576 . . . . 0.02 111.392 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 -112.94 166.23 11.59 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.327 -0.99 . . . . 0.02 108.327 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.68 -168.06 35.73 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 119.857 -1.163 . . . . 0.03 110.75 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.425 ' NH2' ' OE2' ' A' ' 11' ' ' GLU . 23.4 ttp180 -68.83 143.37 54.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.476 -1.014 . . . . 2.76 109.135 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -120.87 148.98 43.3 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.506 -0.746 . . . . 1.89 110.189 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -132.79 127.76 35.3 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.327 -0.99 . . . . 0.02 108.327 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -112.2 136.67 51.33 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.403 -0.811 . . . . 1.12 109.789 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.4 t -131.17 139.06 49.69 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.663 -0.648 . . . . 0.02 109.602 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -116.46 11.85 15.01 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.677 -0.639 . . . . 0.2 109.655 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.435 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 7.0 p -158.63 174.6 14.81 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.358 -0.978 . . . . 1.23 108.358 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -60.45 144.66 50.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.642 -1.286 . . . . 0.02 109.858 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 44.2 t -131.97 117.76 18.86 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.691 -0.855 . . . . 0.02 108.691 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.49 -25.37 50.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.18 -0.95 . . . . 0.24 110.894 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -154.2 102.96 2.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.97 -1.082 . . . . 1.14 109.218 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -102.41 9.43 39.72 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 122.127 0.965 . . . . 6.37 109.673 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -59.55 -25.17 64.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.523 -0.736 . . . . 3.11 111.362 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.3 t -76.15 -17.55 59.51 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.505 -1.372 . . . . 0.88 110.596 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -104.08 -21.86 13.52 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.358 -0.839 . . . . 0.02 109.486 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.4 tp -150.43 129.25 12.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.194 -0.941 . . . . 3.32 109.005 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.0 p -85.26 -10.22 56.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.81 -0.556 . . . . 0.02 111.131 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -171.1 162.38 7.06 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.009 -1.108 . . . . 0.02 108.009 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.8 p -144.08 115.33 7.97 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.703 -1.248 . . . . 0.02 108.766 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -108.26 1.75 22.22 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 120.86 -1.15 . . . . 0.03 110.969 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.8 t -154.95 154.3 32.38 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.636 -1.246 . . . . 0.02 107.636 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 61.3 mt -145.14 146.84 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.038 -1.039 . . . . 0.02 110.044 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -123.33 124.0 41.97 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.86 -1.163 . . . . 0.02 107.86 177.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.0 t -106.64 115.09 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 106.867 -1.531 . . . . 0.02 106.867 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -83.69 -33.75 25.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.655 -0.653 . . . . 3.81 110.754 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.76 152.09 21.83 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 118.92 -1.609 . . . . 0.02 110.881 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.76 173.21 49.6 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.727 -1.225 . . . . 0.01 110.617 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.2 m -119.62 135.4 54.82 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 107.861 -1.163 . . . . 1.48 107.861 177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.449 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 33.7 m95 -126.6 155.57 42.29 Favored 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 122.576 1.179 . . . . 0.02 112.188 -176.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.68 134.16 52.29 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 105.666 -1.976 . . . . 0.24 105.666 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.3 m -119.4 143.72 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.542 -0.724 . . . . 0.65 109.054 178.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -120.9 146.28 46.78 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 122.226 1.012 . . . . 0.02 109.963 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -66.42 -34.59 78.29 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.756 -0.656 . . . . 0.02 111.183 -177.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -125.38 157.95 65.94 Favored Pre-proline 0 N--CA 1.502 2.139 0 O-C-N 121.162 -0.961 . . . . 0.02 109.465 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -53.89 167.17 1.17 Allowed 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 121.672 1.581 . . . . 0.02 113.082 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.2 t30 63.79 36.53 10.42 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.04 -0.982 . . . . 0.02 111.119 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 45.93 51.68 10.49 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.596 0.712 . . . . 3.39 110.663 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.4 m -126.63 164.03 22.14 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.121 0.486 . . . . 2.33 109.924 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.86 -161.74 32.2 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.881 -1.288 . . . . 0.02 109.881 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -65.66 139.51 58.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.109 -1.23 . . . . 0.02 110.017 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 17.2 ptm -117.94 137.07 53.08 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.761 -0.587 . . . . 5.01 109.53 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -133.75 136.31 44.5 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.487 -0.758 . . . . 0.02 109.847 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.449 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 1.8 mp -95.39 131.64 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.522 -0.918 . . . . 1.72 108.522 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.7 mt -120.05 111.06 35.79 Favored Pre-proline 0 N--CA 1.502 2.146 0 O-C-N 121.504 -0.748 . . . . 0.02 110.682 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -77.13 168.73 22.73 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 CA-C-N 119.846 0.981 . . . . 1.47 109.981 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -52.67 141.49 20.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.831 -1.168 . . . . 4.25 110.184 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.04 -176.68 31.84 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.579 -1.296 . . . . 0.02 110.666 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -119.65 130.98 55.34 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.467 -1.019 . . . . 0.96 109.58 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.41 ' CD1' ' N ' ' A' ' 66' ' ' TYR . 31.3 m-85 -120.41 96.53 49.05 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 107.889 -1.152 . . . . 0.02 107.889 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.4 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.8 Cg_endo -67.24 -5.03 12.82 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 120.746 0.964 . . . . 0.02 114.0 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 32.6 mt-10 -157.66 156.07 31.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.592 -1.317 . . . . 2.02 108.373 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -61.55 -38.17 86.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.408 -0.807 . . . . 0.02 112.324 -177.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -61.01 -22.08 64.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.023 -1.048 . . . . 0.02 109.961 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.9 tpm_? -67.0 -19.04 65.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.508 -0.745 . . . . 3.42 110.03 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.454 ' C ' ' SD ' ' A' ' 73' ' ' MET . 2.2 p90 -110.42 16.3 21.68 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.336 -0.852 . . . . 0.02 109.091 178.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.454 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 3.0 mpp? 63.34 25.03 14.48 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.482 0.658 . . . . 0.02 110.768 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.51 145.17 47.41 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.838 -1.305 . . . . 0.02 109.838 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.6 tp -80.77 -31.2 35.89 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.663 -1.236 . . . . 0.98 107.663 177.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -157.56 -171.84 3.73 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 106.482 -1.673 . . . . 0.02 106.482 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -98.99 28.27 4.49 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.707 -1.245 . . . . 0.02 110.835 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.582 ' CG ' HH11 ' A' ' 78' ' ' ARG . 3.3 mtt-85 -96.2 122.66 39.29 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.859 -1.151 . . . . 3.2 110.872 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.0 mt -144.13 122.49 12.34 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.73 -1.211 . . . . 2.61 107.73 178.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.44 -16.45 10.23 Favored Glycine 0 N--CA 1.504 3.216 0 O-C-N 121.102 -0.998 . . . . 0.02 112.94 -177.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 73.3 p -156.79 156.53 33.43 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.177 -1.778 . . . . 0.02 110.339 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 53.2 t -143.97 147.2 33.6 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.539 -0.725 . . . . 0.02 110.191 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.1 mtp180 -137.8 142.83 40.84 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.335 -0.853 . . . . 0.01 109.456 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.87 132.03 36.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.92 . . . . 0.43 109.7 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.9 t -90.67 124.7 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.618 -0.882 . . . . 1.25 108.618 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -93.14 132.32 37.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.847 -1.158 . . . . 1.77 108.928 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.2 mt -97.37 139.77 32.82 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.669 -0.863 . . . . 1.63 108.669 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.3 m -110.74 124.87 52.81 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.46 -0.941 . . . . 1.08 108.46 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.8 t -115.85 130.39 56.82 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.651 -1.281 . . . . 1.26 107.608 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -154.13 -51.93 0.01 OUTLIER Glycine 0 N--CA 1.505 3.295 0 C-N-CA 117.951 -2.071 . . . . 0.01 113.24 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.11 -106.17 0.19 Allowed Glycine 0 N--CA 1.489 2.176 0 O-C-N 120.162 -1.787 . . . . 0.01 111.198 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -119.8 117.55 28.49 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.0 -1.294 . . . . 4.43 110.212 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.77 130.28 36.53 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.066 -0.654 . . . . 2.99 109.395 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.415 ' NZ ' ' CB ' ' A' ' 94' ' ' LYS . 7.3 ttpm? -131.72 141.27 49.5 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.492 -0.755 . . . . 6.36 109.409 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.0 tt -127.65 146.99 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.418 0 CA-C-O 121.809 0.814 . . . . 1.09 110.292 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -122.79 131.63 53.86 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.904 -1.147 . . . . 2.05 107.904 177.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.7 m -125.35 147.65 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 O-C-N 120.95 -1.094 . . . . 1.1 109.947 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.563 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 80.5 m-85 -119.19 141.67 48.66 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-O 121.948 0.88 . . . . 0.73 111.139 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -67.74 -31.17 70.91 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 116.104 -0.498 . . . . 0.02 111.322 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.436 ' O ' ' OG ' ' A' ' 128' ' ' SER . 45.6 mttp -116.31 170.15 8.76 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.089 -1.007 . . . . 3.18 110.04 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.56 169.72 43.97 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 111.174 -0.77 . . . . 0.01 111.174 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.6 t70 52.68 39.32 28.22 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.654 0.74 . . . . 0.01 111.611 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 52.42 48.72 22.01 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.601 -0.687 . . . . 0.01 110.975 178.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -123.09 164.93 17.68 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.379 -0.971 . . . . 3.15 108.379 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.64 -163.54 28.56 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.427 -1.469 . . . . 0.01 109.427 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -76.93 144.05 39.11 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.049 -1.265 . . . . 0.01 109.121 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.563 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 28.1 ttp -116.19 142.32 46.97 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.487 0.66 . . . . 0.01 109.824 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -131.75 136.26 47.44 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.413 -0.958 . . . . 2.48 108.413 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -121.55 135.21 55.03 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.53 -0.731 . . . . 0.01 109.9 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.0 t -148.57 151.94 35.93 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.97 -1.081 . . . . 1.69 110.799 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.4 p -111.54 8.68 21.09 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 116.028 -0.533 . . . . 0.01 110.618 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -120.63 162.96 18.76 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.162 -0.961 . . . . 3.21 111.311 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -67.6 156.52 36.59 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.397 -0.964 . . . . 0.01 108.397 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.492 ' SG ' ' OE1' ' A' ' 120' ' ' GLN . 42.8 t -125.57 114.36 25.19 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 108.928 -0.767 . . . . 0.01 108.928 178.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.446 ' O ' ' OG ' ' A' ' 171' ' ' SER . 20.6 Cg_endo -77.05 -31.92 3.49 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 CA-C-N 120.156 1.091 . . . . 0.01 111.122 178.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 41.1 t -141.74 107.56 5.13 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.556 -0.905 . . . . 0.02 108.556 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.419 HG22 HD12 ' A' ' 117' ' ' ILE . 64.7 mt -65.3 -38.69 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.656 -0.653 . . . . 1.83 110.951 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 118' ' ' MET . 1.1 tmt? -66.69 -38.37 86.63 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.942 -1.103 . . . . 1.34 109.758 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -68.56 -38.27 80.62 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.463 -1.398 . . . . 2.11 109.63 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.492 ' OE1' ' SG ' ' A' ' 114' ' ' CYS . 54.5 tt0 -80.11 -46.73 15.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.245 -0.91 . . . . 2.08 112.314 -177.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -112.27 -0.86 15.33 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.28 -0.887 . . . . 0.02 112.852 -176.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.7 m80 61.61 34.91 17.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.666 -1.272 . . . . 0.02 109.871 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.0 mt -114.01 135.63 53.8 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.521 -0.737 . . . . 0.02 109.229 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -90.9 -22.1 21.07 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.277 -0.889 . . . . 5.32 110.965 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -148.03 164.0 35.15 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.993 -1.067 . . . . 0.02 110.022 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.0 mm -128.69 124.77 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 107.555 -1.276 . . . . 2.17 107.555 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -109.43 -14.69 14.38 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.165 -0.959 . . . . 0.02 112.982 -176.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 10.0 p -161.14 153.21 19.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.563 -1.336 . . . . 0.01 109.467 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.428 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 27.9 p -167.79 149.43 5.47 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.796 -1.187 . . . . 1.22 107.796 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -112.83 103.59 11.59 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.104 -0.997 . . . . 1.41 108.924 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.8 t -111.22 125.92 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 115.766 -0.652 . . . . 0.01 109.569 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.2 t -122.92 86.42 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.77 -1.937 . . . . 1.98 105.77 175.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.438 ' O ' ' O ' ' A' ' 152' ' ' ASP . 3.3 tp10 -161.36 -158.17 0.55 Allowed 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 106.786 -1.561 . . . . 0.01 106.786 178.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -157.65 -3.7 0.08 OUTLIER Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.113 -1.995 . . . . 0.01 108.113 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.6 p -115.06 45.04 1.69 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 122.0 -0.706 . . . . 2.3 109.66 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -125.97 136.17 52.68 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.293 -0.879 . . . . 0.01 108.927 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 12.4 mt -123.71 141.28 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.693 -0.63 . . . . 1.69 109.383 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -114.3 144.82 42.63 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.059 -1.46 . . . . 2.49 107.059 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 19.9 m-85 -123.23 144.44 49.38 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.493 -0.754 . . . . 0.02 109.674 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.44 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 78.1 tt0 -75.58 -29.31 59.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.634 -0.667 . . . . 0.02 111.781 -176.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mt -115.05 154.94 47.15 Favored Pre-proline 0 N--CA 1.505 2.309 0 O-C-N 120.654 -1.279 . . . . 1.48 109.128 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -55.91 165.55 3.7 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.159 1.239 . . . . 0.02 112.809 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.485 ' OD1' ' N ' ' A' ' 143' ' ' ASN . 1.0 OUTLIER 60.71 32.46 20.25 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.198 -0.91 . . . . 0.75 111.451 178.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.417 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.9 m-85 57.43 51.72 9.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.563 -0.711 . . . . 0.02 110.96 177.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -127.13 165.11 20.18 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.492 -0.755 . . . . 0.02 110.325 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.59 -166.29 32.88 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.553 -1.019 . . . . 0.02 110.553 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -70.31 144.44 51.71 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.672 -0.899 . . . . 0.02 109.116 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -113.51 148.96 35.05 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.808 -0.558 . . . . 0.02 110.218 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -125.91 134.0 51.7 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.629 -0.669 . . . . 0.01 109.584 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.6 tt -103.91 123.56 47.37 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.073 -1.017 . . . . 0.01 109.776 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 8.8 mp -96.6 152.3 18.78 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.971 -1.081 . . . . 0.01 108.374 178.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.438 ' O ' ' O ' ' A' ' 133' ' ' GLU . 74.9 m-20 -111.32 -126.18 0.28 Allowed 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.309 -0.869 . . . . 2.27 110.492 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -129.25 42.03 3.37 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.399 -0.813 . . . . 1.84 109.7 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.411 ' H ' ' HH ' ' A' ' 156' ' ' TYR . 63.0 mttm -113.01 -174.39 2.44 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.403 -0.81 . . . . 2.28 109.141 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -105.11 111.87 24.8 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.667 -0.864 . . . . 0.01 108.667 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.624 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 20.2 m-85 -97.94 110.53 23.09 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.289 -0.882 . . . . 0.01 109.859 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -95.1 -22.19 18.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.143 -0.973 . . . . 0.01 111.128 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -127.55 155.15 77.35 Favored Pre-proline 0 N--CA 1.501 2.122 0 O-C-N 121.034 -1.042 . . . . 2.54 108.521 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -60.19 -36.74 87.32 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 120.449 0.766 . . . . 0.7 110.264 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -61.26 -20.16 21.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.936 -1.102 . . . . 0.86 109.255 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -66.11 -16.04 63.61 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.92 -1.113 . . . . 0.02 110.188 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.624 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 10.4 m0 -97.42 11.16 37.67 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.086 -1.009 . . . . 0.02 108.712 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.65 11.04 85.16 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.805 -1.188 . . . . 0.02 110.774 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.36 141.29 33.41 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.176 -1.191 . . . . 0.02 110.1 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.16 -8.58 58.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.567 -0.708 . . . . 0.59 110.302 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 9.7 p -143.96 151.02 51.52 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 120.769 -1.207 . . . . 0.87 109.21 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.81 18.42 0.62 Allowed 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 120.931 1.087 . . . . 0.38 112.318 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.8 121.84 26.94 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 122.427 1.108 . . . . 0.18 111.346 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.415 HD12 HG23 ' A' ' 169' ' ' ILE . 3.1 mt -150.05 123.7 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 105.831 -1.915 . . . . 3.99 105.831 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.528 ' N ' ' OE1' ' A' ' 170' ' ' GLN . 9.7 mp0 -113.5 -13.26 12.82 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.108 -0.995 . . . . 5.17 113.109 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 115' ' ' PRO . 26.7 m -157.05 160.63 39.13 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 119.255 -2.153 . . . . 0.02 110.185 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -152.59 151.92 31.22 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.163 -0.96 . . . . 2.02 110.301 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.417 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 27.0 mtp180 -145.16 152.41 39.98 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.3 -0.875 . . . . 0.01 110.252 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -89.5 143.42 26.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.695 -0.628 . . . . 0.01 109.588 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 9.1 mt -95.64 130.32 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 108.482 -0.933 . . . . 3.04 108.482 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.22 147.12 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.121 -0.987 . . . . 1.89 109.825 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.365 -0.834 . . . . 4.89 109.525 -179.927 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.5 ' C ' ' H ' ' A' ' 3' ' ' THR . 34.9 t . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.461 -0.57 . . . . 5.28 109.461 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.442 ' C ' ' HG1' ' A' ' 3' ' ' THR . 8.7 mtmp? -76.4 23.45 0.15 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.221 -0.924 . . . . 5.96 109.376 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.5 ' H ' ' C ' ' A' ' 1' ' ' SER . 43.0 m -169.09 168.44 10.01 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.574 -0.898 . . . . 2.22 108.574 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -118.61 116.87 3.51 Favored Glycine 0 N--CA 1.502 3.038 0 N-CA-C 107.042 -2.423 . . . . 0.81 107.042 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.1 145.68 33.82 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.557 -1.417 . . . . 0.01 109.557 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -152.71 137.84 17.36 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.334 -1.098 . . . . 0.02 109.66 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.8 tt -129.69 141.02 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.96 -0.756 . . . . 0.02 108.96 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.528 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.3 t -121.47 130.26 53.46 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.577 -0.702 . . . . 0.39 109.699 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 8.4 m-85 -109.76 139.97 44.21 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 109.123 -0.695 . . . . 0.02 109.123 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.528 ' CZ ' ' OG ' ' A' ' 8' ' ' SER . 6.3 m-85 -122.4 138.35 54.56 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.152 -0.967 . . . . 0.02 109.487 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -68.69 -27.75 66.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.219 -0.926 . . . . 0.03 111.424 -178.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.1 m-20 -114.75 170.49 8.28 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.937 -1.102 . . . . 0.03 110.384 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.487 ' CZ ' ' OE2' ' A' ' 68' ' ' GLU . 7.6 mtp180 -75.18 160.84 29.94 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.59 0.709 . . . . 0.03 110.122 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.596 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 2.0 m-80 62.87 35.13 13.77 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.792 0.806 . . . . 0.74 110.661 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.596 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 21.0 p90 49.58 42.21 22.65 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.451 -0.795 . . . . 0.02 111.057 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -109.03 165.95 11.2 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.851 -1.166 . . . . 0.02 107.851 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.82 -167.64 35.08 Favored Glycine 0 N--CA 1.495 2.628 0 O-C-N 120.687 -1.258 . . . . 0.03 110.794 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -69.07 144.08 54.06 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.426 -1.044 . . . . 2.76 109.285 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.478 ' NE ' ' OG ' ' A' ' 8' ' ' SER . 56.0 ttt180 -120.29 148.28 43.91 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.577 0.703 . . . . 1.89 109.996 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -132.38 127.42 35.4 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.169 -1.049 . . . . 0.02 108.169 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -112.28 136.85 51.21 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.37 -0.831 . . . . 1.12 109.89 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.4 t -131.17 138.99 49.69 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.582 -0.698 . . . . 0.02 109.681 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.498 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 33.3 t70 -117.09 10.67 13.98 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.648 -0.658 . . . . 0.2 109.7 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 48.9 m -158.35 174.21 15.49 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.377 -0.972 . . . . 1.23 108.377 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -61.12 144.66 53.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.66 -1.275 . . . . 0.02 110.163 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.3 t -131.92 117.69 18.79 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.56 -0.904 . . . . 0.02 108.56 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.54 -26.09 45.65 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.091 -1.005 . . . . 0.24 110.996 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 28.3 p-10 -153.47 101.39 2.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.971 -1.08 . . . . 1.14 108.968 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -104.69 9.73 35.0 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 122.108 0.956 . . . . 6.37 109.96 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -58.75 -24.79 62.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.541 -0.724 . . . . 3.11 111.035 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.0 t -74.1 -16.78 61.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.806 -1.184 . . . . 0.88 110.192 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.51 ' CD1' ' N ' ' A' ' 32' ' ' TYR . 18.1 m-85 -103.88 -22.03 13.56 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.349 -0.844 . . . . 0.02 109.388 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.2 tp -149.8 128.11 12.13 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.247 -0.908 . . . . 3.32 108.98 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.5 m -85.2 -9.85 57.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.698 -0.626 . . . . 0.02 110.828 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -170.55 163.05 8.28 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.619 -1.252 . . . . 0.02 107.619 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 t -142.04 114.98 8.68 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.723 -1.236 . . . . 0.02 108.772 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.55 ' N ' HD21 ' A' ' 37' ' ' ASN . 1.1 m-80 -108.86 -1.82 18.89 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.807 -1.183 . . . . 0.03 111.422 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 t -153.42 154.04 33.68 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.188 -1.041 . . . . 0.02 108.188 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.3 mt -145.85 145.86 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 120.955 -1.091 . . . . 0.02 110.802 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -124.03 124.84 43.42 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.495 -1.298 . . . . 0.02 107.495 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.7 t -104.91 114.18 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 107.144 -1.428 . . . . 0.02 107.144 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -84.56 -34.49 23.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.471 -0.768 . . . . 3.81 110.098 -178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.45 150.26 18.73 Favored Glycine 0 N--CA 1.489 2.212 0 C-N-CA 118.552 -1.785 . . . . 0.02 110.845 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.69 171.99 48.67 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.168 -1.173 . . . . 0.01 110.168 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.9 m -119.5 134.9 55.01 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.763 -1.199 . . . . 1.48 107.763 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.455 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 33.6 m95 -126.69 155.81 42.07 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 122.655 1.217 . . . . 0.02 112.448 -176.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.21 134.0 52.31 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 105.571 -2.011 . . . . 0.24 105.571 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.3 m -118.6 143.21 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.624 -0.673 . . . . 0.65 109.387 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -120.89 145.61 47.47 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 122.318 1.056 . . . . 0.02 110.06 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -66.22 -34.5 78.17 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.607 -0.724 . . . . 0.02 111.125 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 40.5 mtm180 -124.95 157.78 65.38 Favored Pre-proline 0 N--CA 1.503 2.215 0 O-C-N 121.035 -1.041 . . . . 0.02 109.546 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.58 167.09 1.03 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.773 1.649 . . . . 0.02 112.99 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 63.53 36.74 10.93 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.126 -0.943 . . . . 0.02 111.156 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 45.05 51.7 8.73 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.678 0.751 . . . . 3.39 110.574 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 94.8 p -125.86 163.53 22.73 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.27 0.557 . . . . 2.33 109.779 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.94 -161.5 31.92 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.686 -1.366 . . . . 0.02 109.686 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -67.01 139.94 57.69 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.992 -1.299 . . . . 0.02 110.281 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 15.4 ptm -118.69 138.16 52.82 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.578 -0.701 . . . . 5.01 109.962 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.421 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 58.8 m-85 -134.01 137.41 44.73 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.48 -0.762 . . . . 0.02 109.938 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.461 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 1.8 mp -96.03 131.81 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.597 -0.89 . . . . 1.72 108.597 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.5 mt -120.86 112.32 33.71 Favored Pre-proline 0 N--CA 1.504 2.231 0 O-C-N 121.329 -0.857 . . . . 0.02 110.886 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -77.64 169.95 20.01 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 CA-C-N 119.901 1.0 . . . . 1.47 110.061 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -53.46 140.56 27.59 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.917 -1.115 . . . . 4.25 110.449 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.07 -177.92 32.04 Favored Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.463 -1.351 . . . . 0.02 110.709 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -118.98 130.65 55.8 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.586 -0.949 . . . . 0.96 109.528 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -119.87 96.26 49.42 Favored Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 107.912 -1.144 . . . . 0.02 107.912 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -71.83 -6.18 18.59 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 120.891 1.061 . . . . 0.02 113.909 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.527 ' OE1' ' CE1' ' A' ' 69' ' ' TYR . 1.0 OUTLIER -154.57 152.53 30.15 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.755 -1.202 . . . . 2.02 107.755 179.384 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.527 ' CE1' ' OE1' ' A' ' 68' ' ' GLU . 9.3 p90 -60.24 -37.6 80.88 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.52 -0.737 . . . . 0.02 111.522 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -59.64 -24.3 63.75 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.77 -1.206 . . . . 0.02 109.491 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -71.74 -21.43 61.75 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.699 0.762 . . . . 3.42 109.064 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.548 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 2.2 t90 -108.22 6.77 26.99 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.482 -1.303 . . . . 0.02 107.482 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 13.3 mmt 61.01 22.37 12.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.646 -0.659 . . . . 0.02 110.832 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.83 145.78 47.71 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.293 -1.523 . . . . 0.02 109.293 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.446 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 7.6 mp -80.29 -31.14 38.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.225 -1.162 . . . . 0.98 108.336 178.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.515 ' ND2' ' CZ ' ' A' ' 78' ' ' ARG . 66.8 t30 -157.6 -171.86 3.73 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.635 -1.617 . . . . 0.02 106.635 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -98.62 28.53 4.17 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.723 -1.235 . . . . 0.02 110.613 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.574 ' CG ' HH11 ' A' ' 78' ' ' ARG . 3.3 mtt-85 -97.47 122.51 40.61 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.082 -1.011 . . . . 3.2 110.849 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.9 mt -143.65 121.89 12.26 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.684 -1.228 . . . . 2.61 107.684 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.83 -17.53 9.62 Favored Glycine 0 N--CA 1.504 3.184 0 O-C-N 121.078 -1.014 . . . . 0.02 112.981 -177.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.1 p -156.82 156.12 32.68 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.082 -1.834 . . . . 0.02 110.365 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 33.7 m -144.68 147.9 33.58 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.522 -0.736 . . . . 0.02 110.221 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 24.6 mtm180 -138.24 142.95 39.92 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.255 -0.903 . . . . 0.01 109.42 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.95 131.55 36.39 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.107 -0.995 . . . . 0.43 109.85 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.5 t -90.8 124.9 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.809 -0.811 . . . . 1.25 108.809 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -93.79 131.77 38.84 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.81 -1.181 . . . . 1.77 109.339 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.5 mt -96.38 140.19 31.41 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.408 -0.96 . . . . 1.63 108.408 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.2 m -111.73 127.17 55.7 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.374 -0.829 . . . . 1.08 109.313 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.3 m -103.56 -154.89 0.51 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 106.425 -1.694 . . . . 1.26 106.425 176.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.53 -52.36 0.74 Allowed Glycine 0 N--CA 1.5 2.942 0 O-C-N 120.404 -1.435 . . . . 0.01 112.772 177.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.44 -101.52 0.15 Allowed Glycine 0 N--CA 1.489 2.193 0 C-N-CA 118.533 -1.794 . . . . 0.01 111.942 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -121.0 119.41 32.45 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.09 -1.241 . . . . 4.43 110.549 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.08 129.48 35.26 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.808 -0.757 . . . . 2.99 109.355 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -129.9 140.55 50.94 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.559 -0.713 . . . . 6.36 109.172 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.8 tt -129.6 146.42 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 O-C-N 121.36 -0.837 . . . . 1.09 110.157 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -122.2 133.86 54.72 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 107.558 -1.275 . . . . 2.05 107.558 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.4 m -123.73 145.73 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 120.729 -1.232 . . . . 1.1 109.829 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.587 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 39.6 m-85 -119.88 141.62 49.41 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-O 122.02 0.915 . . . . 0.73 111.158 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -67.37 -31.04 71.0 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 116.025 -0.534 . . . . 0.02 111.776 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -115.9 167.44 10.95 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.912 -1.118 . . . . 3.18 110.46 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.512 ' CA ' ' HD1' ' A' ' 127' ' ' HIS . . . -66.96 164.12 43.87 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 111.005 -0.838 . . . . 0.01 111.005 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.0 t70 56.75 39.11 29.83 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.656 0.741 . . . . 0.01 110.927 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 52.1 55.74 8.77 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.577 -0.702 . . . . 0.01 111.085 177.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -129.24 165.7 20.86 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 108.304 -0.999 . . . . 3.15 108.304 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.36 -163.42 27.59 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.31 -1.516 . . . . 0.01 109.31 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.523 ' OE1' ' CE2' ' A' ' 108' ' ' TYR . 10.4 tm0? -75.94 143.62 41.51 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.946 -1.326 . . . . 0.01 108.459 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.587 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 33.2 ttp -116.33 142.36 46.95 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.492 0.663 . . . . 0.01 109.774 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.523 ' CE2' ' OE1' ' A' ' 106' ' ' GLN . 49.3 m-85 -131.39 136.54 48.11 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.197 -1.038 . . . . 2.48 108.197 178.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -117.73 133.59 55.78 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.558 -0.714 . . . . 0.01 109.959 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.1 t -148.47 149.24 31.32 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.352 1.072 . . . . 1.69 111.223 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.42 ' OG1' ' OE2' ' A' ' 112' ' ' GLU . 1.1 p -110.05 10.17 24.12 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.38 -0.827 . . . . 0.01 110.122 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 42.0 mp0 -121.42 163.36 18.86 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.253 -0.904 . . . . 3.21 111.694 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.54 156.46 36.67 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.153 -1.054 . . . . 0.01 108.153 178.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.566 ' SG ' ' NE2' ' A' ' 120' ' ' GLN . 48.2 t -124.84 112.36 27.12 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 121.429 -0.795 . . . . 0.01 109.077 178.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -76.52 -33.17 3.32 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 CA-C-N 120.073 1.062 . . . . 0.01 111.515 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.7 m -140.73 107.12 5.27 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.22 -0.925 . . . . 0.02 108.585 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 76.0 mt -64.92 -38.82 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.854 -0.529 . . . . 1.83 111.037 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 34.2 ttp -66.95 -38.47 86.18 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 118.902 -1.119 . . . . 1.34 109.95 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.85 -38.16 79.59 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.381 -1.45 . . . . 2.11 109.723 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.566 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 7.7 tt0 -79.68 -47.35 15.5 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.358 -0.839 . . . . 2.08 112.322 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -112.37 -0.67 15.3 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.39 -0.819 . . . . 0.02 112.832 -176.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 61.71 34.74 17.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.743 -1.223 . . . . 0.02 109.846 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 43.6 mt -114.09 136.15 53.24 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.453 -0.78 . . . . 0.02 109.442 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -90.59 -22.12 21.4 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.142 -0.974 . . . . 5.32 110.768 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -147.99 164.26 34.34 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.015 -1.053 . . . . 0.02 109.948 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.1 mm -129.2 125.94 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 107.784 -1.191 . . . . 2.17 107.784 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.512 ' HD1' ' CA ' ' A' ' 101' ' ' GLY . 22.0 t-80 -108.74 -13.97 14.69 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.175 -0.953 . . . . 0.02 112.599 -177.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.6 m -160.07 151.35 19.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.754 -1.216 . . . . 0.01 109.072 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.564 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 19.6 p -167.5 146.11 4.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.316 -0.865 . . . . 1.22 109.057 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.3 111.02 14.05 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-O 122.151 0.977 . . . . 1.41 110.27 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.6 p -112.84 137.71 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.03 -1.1 . . . . 0.01 108.03 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.8 t -128.32 93.65 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 106.768 -1.567 . . . . 1.98 106.768 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 134' ' ' GLY . 10.4 tm-20 -146.55 -77.69 0.18 Allowed 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 105.827 -1.916 . . . . 0.01 105.827 177.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.512 ' N ' ' OE1' ' A' ' 133' ' ' GLU . . . -177.63 -80.39 0.06 OUTLIER Glycine 0 N--CA 1.485 1.916 0 N-CA-C 108.263 -1.935 . . . . 0.01 108.263 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.1 t -120.72 127.3 51.89 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.559 -0.965 . . . . 2.3 110.161 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -127.3 152.24 47.7 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 106.907 -1.516 . . . . 0.01 106.907 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.5 mt -121.0 136.99 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 120.427 -1.421 . . . . 1.69 110.088 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -113.62 143.95 43.72 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.34 -1.355 . . . . 2.49 107.34 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 26.3 m-85 -122.42 144.71 48.87 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.292 -0.88 . . . . 0.02 109.297 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.436 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 78.0 tt0 -76.46 -29.0 56.76 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.501 -0.749 . . . . 0.02 111.705 -176.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.0 mt -115.95 154.67 48.37 Favored Pre-proline 0 N--CA 1.505 2.282 0 O-C-N 120.751 -1.218 . . . . 1.48 108.806 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -55.69 167.37 2.19 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 121.213 1.275 . . . . 0.02 112.794 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 59.47 31.14 20.83 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.147 -0.933 . . . . 0.75 111.408 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 57.28 51.25 10.33 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.534 -0.729 . . . . 0.02 110.993 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -126.1 164.62 20.5 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.545 -0.722 . . . . 0.02 109.938 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.18 -165.84 33.12 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.283 -1.127 . . . . 0.02 110.283 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.413 ' HG3' HH11 ' A' ' 147' ' ' ARG . 23.5 ttm-85 -69.34 142.6 53.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.51 -0.994 . . . . 0.02 109.067 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.464 ' N ' ' CD ' ' A' ' 148' ' ' GLN . 7.9 mp0 -114.8 148.52 38.32 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.343 0.592 . . . . 0.02 110.184 -178.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -124.78 135.61 53.11 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 109.048 -0.723 . . . . 0.01 109.048 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.7 tt -99.45 120.28 39.35 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.889 -1.132 . . . . 0.01 108.846 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.0 tp -101.85 154.06 19.27 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.256 -0.903 . . . . 0.01 109.066 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -104.71 -121.18 0.21 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.233 -0.917 . . . . 2.27 109.432 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.7 pttm -155.56 51.6 0.57 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.043 -1.036 . . . . 1.84 109.608 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -112.48 -152.99 0.51 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.496 -0.753 . . . . 2.28 109.068 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -106.39 100.21 9.75 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.385 -0.822 . . . . 0.01 109.045 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.655 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 6.7 m-85 -98.33 112.03 24.17 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.269 -0.894 . . . . 0.01 109.464 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -94.45 -22.52 18.22 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.242 -0.911 . . . . 0.01 111.448 -178.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -129.14 154.1 80.45 Favored Pre-proline 0 N--CA 1.502 2.167 0 O-C-N 120.758 -1.214 . . . . 2.54 108.808 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -59.46 -36.19 94.17 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 120.507 0.805 . . . . 0.7 110.795 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 60.5 t -61.02 -20.2 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.758 -1.214 . . . . 0.86 108.909 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -65.21 -15.31 62.32 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.882 -1.136 . . . . 0.02 109.691 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.655 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 11.5 m0 -98.06 11.06 38.88 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.254 -0.904 . . . . 0.02 109.067 178.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.81 11.45 83.9 Favored Glycine 0 N--CA 1.491 2.336 0 O-C-N 120.829 -1.169 . . . . 0.02 111.213 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.03 140.6 34.03 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.056 -1.261 . . . . 0.02 110.076 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -86.02 -8.77 57.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.566 -0.709 . . . . 0.59 110.322 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 9.7 p -141.41 150.97 59.74 Favored Pre-proline 0 N--CA 1.5 2.051 0 O-C-N 121.019 -1.05 . . . . 0.87 109.712 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -75.88 14.62 1.02 Allowed 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 120.908 1.072 . . . . 0.38 112.142 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.72 122.07 27.19 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.361 1.077 . . . . 0.18 111.212 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 3.8 mt -148.97 122.98 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 105.89 -1.892 . . . . 3.99 105.89 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.53 ' N ' ' OE1' ' A' ' 170' ' ' GLN . 13.9 mp0 -112.95 -15.69 12.82 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.115 -0.99 . . . . 5.17 113.07 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 12.8 t -156.31 159.57 38.95 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 119.328 -2.107 . . . . 0.02 109.941 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -153.08 154.12 34.21 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.039 -1.038 . . . . 2.02 110.689 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -145.24 149.93 35.78 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.776 0.798 . . . . 0.01 110.12 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -88.11 143.29 27.15 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.132 -0.692 . . . . 0.01 109.132 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.7 mt -94.48 129.71 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.266 -0.896 . . . . 3.04 109.024 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.3 m -136.29 147.04 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.158 -0.964 . . . . 1.89 109.526 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.533 ' CD ' ' H ' ' A' ' 177' ' ' GLU . 1.4 pm0 . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.89 . . . . 4.89 109.725 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 3' ' ' THR . 95.0 p . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.466 -0.568 . . . . 5.28 109.466 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.9 mttt 52.44 -87.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 5.96 109.625 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.517 ' N ' ' O ' ' A' ' 1' ' ' SER . 1.5 t -171.9 170.03 5.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.798 -1.189 . . . . 2.22 109.303 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -118.63 117.74 3.79 Favored Glycine 0 N--CA 1.501 2.987 0 N-CA-C 106.815 -2.514 . . . . 0.81 106.815 177.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.73 144.51 32.71 Favored Glycine 0 N--CA 1.492 2.402 0 O-C-N 121.089 -1.242 . . . . 0.01 110.037 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.5 tttm -149.19 135.82 19.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.473 -1.016 . . . . 0.02 109.753 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.428 HG22 HD12 ' A' ' 7' ' ' ILE . 7.7 tt -128.24 138.34 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 108.054 -1.091 . . . . 0.02 108.054 178.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 m -121.5 129.99 53.28 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.325 -0.86 . . . . 0.39 110.169 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 4.4 m-85 -110.58 141.18 44.12 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.967 -0.753 . . . . 0.02 108.967 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.546 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.7 m-85 -122.35 138.43 54.52 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.223 -0.923 . . . . 0.02 109.53 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -67.91 -27.78 66.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.99 -1.069 . . . . 0.03 111.409 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 2.4 m-20 -114.62 170.24 8.47 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.844 -1.16 . . . . 0.03 110.22 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -75.85 162.1 28.43 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.794 0.807 . . . . 0.03 110.241 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.402 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 21.2 t-20 62.76 33.09 15.68 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.106 0.955 . . . . 0.74 110.836 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 55.22 39.81 31.48 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.841 -0.618 . . . . 0.02 110.973 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -110.11 165.65 11.57 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.18 -1.044 . . . . 0.02 108.18 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.82 -168.07 35.49 Favored Glycine 0 N--CA 1.497 2.708 0 C-N-CA 119.827 -1.178 . . . . 0.03 110.748 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -69.45 143.87 53.45 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.483 -1.01 . . . . 2.76 109.239 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -120.67 148.95 43.25 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.584 0.707 . . . . 1.89 110.214 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -132.09 127.56 36.31 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.189 -1.041 . . . . 0.02 108.189 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.52 136.71 51.72 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.434 -0.791 . . . . 1.12 109.888 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 13.3 t -131.26 139.22 49.6 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.665 -0.647 . . . . 0.02 109.557 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.497 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 2.5 m-20 -116.83 11.13 14.38 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.71 -0.619 . . . . 0.2 109.694 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 47.5 m -158.23 174.76 14.68 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.263 -1.014 . . . . 1.23 108.263 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 3.5 m-20 -60.57 144.32 51.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.644 -1.285 . . . . 0.02 109.899 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 41.9 t -132.01 117.82 18.9 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.577 -0.897 . . . . 0.02 108.577 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.87 -25.26 48.48 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.168 -0.958 . . . . 0.24 110.922 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -154.31 102.87 2.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.931 -1.106 . . . . 1.14 109.274 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.433 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 43.6 p90 -102.06 9.95 39.93 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 122.019 0.914 . . . . 6.37 109.788 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.3 mtm180 -59.43 -25.46 64.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.475 -0.765 . . . . 3.11 111.505 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.9 p -76.05 -17.68 59.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.58 -1.325 . . . . 0.88 110.769 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -104.07 -22.17 13.48 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.335 -0.853 . . . . 0.02 109.589 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.4 tp -150.4 129.44 12.63 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.278 -0.889 . . . . 3.32 108.967 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.7 p -85.24 -9.92 57.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.8 -0.563 . . . . 0.02 111.129 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -171.46 162.78 6.71 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.77 -1.206 . . . . 0.02 108.015 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.493 ' C ' HD21 ' A' ' 37' ' ' ASN . 5.1 p -143.55 115.23 8.16 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.827 -1.17 . . . . 0.02 108.66 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.493 HD21 ' C ' ' A' ' 36' ' ' CYS . 2.0 m120 -107.54 2.08 23.83 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 120.756 -1.215 . . . . 0.03 110.881 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.531 ' HG ' ' N ' ' A' ' 39' ' ' ILE . 4.1 t -155.54 154.84 32.37 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.821 -1.177 . . . . 0.02 107.821 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.531 ' N ' ' HG ' ' A' ' 38' ' ' SER . 10.4 mt -146.29 146.58 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.951 -1.093 . . . . 0.02 110.654 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -123.68 124.82 43.6 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.159 -1.052 . . . . 0.02 108.159 177.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.5 t -106.6 115.19 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 106.803 -1.554 . . . . 0.02 106.803 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -83.98 -33.85 24.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.636 -0.665 . . . . 3.81 110.759 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.79 152.38 22.26 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 118.821 -1.656 . . . . 0.02 110.807 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.26 173.21 49.53 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.62 -1.276 . . . . 0.01 110.474 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.2 m -119.68 135.4 54.84 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.983 -1.118 . . . . 1.48 107.983 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.458 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 32.9 m95 -126.35 155.26 42.33 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-O 122.573 1.178 . . . . 0.02 112.263 -176.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.5 134.16 52.22 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 105.509 -2.034 . . . . 0.24 105.509 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.2 m -118.96 143.3 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.154 -0.684 . . . . 0.65 109.154 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.565 ' CE2' ' SD ' ' A' ' 58' ' ' MET . 28.1 m-85 -121.41 146.32 47.01 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 122.386 1.089 . . . . 0.02 110.046 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -66.2 -35.1 79.57 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.509 -0.769 . . . . 0.02 111.228 -177.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -125.36 157.67 66.89 Favored Pre-proline 0 N--CA 1.503 2.182 0 O-C-N 121.051 -1.03 . . . . 0.02 109.498 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -53.63 167.3 1.0 Allowed 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.704 1.602 . . . . 0.02 112.958 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 63.68 36.53 10.72 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 114.999 -1.0 . . . . 0.02 111.182 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 45.15 51.54 9.01 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.631 0.729 . . . . 3.39 110.612 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.0 t -126.29 163.78 22.46 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 121.201 0.524 . . . . 2.33 109.804 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.61 -161.57 32.4 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.738 -1.345 . . . . 0.02 109.738 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.98 140.34 57.72 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.054 -1.263 . . . . 0.02 110.346 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.565 ' SD ' ' CE2' ' A' ' 49' ' ' TYR . 49.2 ttp -118.84 138.17 52.91 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.691 -0.631 . . . . 5.01 109.827 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.47 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 56.1 m-85 -133.66 137.06 45.15 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.492 -0.755 . . . . 0.02 109.695 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.8 mm -94.74 131.09 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.912 -0.773 . . . . 1.72 108.912 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.561 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -119.21 110.56 37.67 Favored Pre-proline 0 N--CA 1.505 2.277 0 O-C-N 121.461 -0.775 . . . . 0.02 110.73 -178.316 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -77.63 168.32 22.74 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 CA-C-N 119.791 0.961 . . . . 1.47 110.068 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -53.16 141.74 22.4 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.757 -1.214 . . . . 4.25 110.35 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.27 -177.96 31.37 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.584 -1.293 . . . . 0.02 110.844 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -119.65 131.8 55.54 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.393 -1.063 . . . . 0.96 109.692 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.561 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 69.9 m-85 -122.04 96.07 46.96 Favored Pre-proline 0 N--CA 1.494 1.755 0 N-CA-C 108.015 -1.105 . . . . 0.02 108.015 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.28 -4.38 10.43 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 120.811 1.007 . . . . 0.02 113.729 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -157.61 155.44 30.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.603 -1.311 . . . . 2.02 108.229 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -60.46 -39.17 86.59 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.535 -0.728 . . . . 0.02 112.17 -177.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -60.34 -23.82 64.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.132 -0.98 . . . . 0.02 110.373 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -69.37 -18.45 63.78 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.764 0.793 . . . . 3.42 108.982 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.553 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.4 t90 -108.38 11.06 27.35 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.584 -1.265 . . . . 0.02 107.584 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.6 mmt 60.74 22.09 12.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.585 -0.697 . . . . 0.02 110.553 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.68 143.7 44.6 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.319 -1.512 . . . . 0.02 109.319 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.3 tp -78.79 -31.51 46.04 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.452 -1.314 . . . . 0.98 107.452 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -157.87 -172.47 3.94 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 106.262 -1.755 . . . . 0.02 106.262 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -98.44 28.39 4.18 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.659 -1.276 . . . . 0.02 110.627 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.421 ' HG3' HH11 ' A' ' 78' ' ' ARG . 20.9 ttm-85 -97.23 122.05 39.81 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.725 -1.234 . . . . 3.2 110.905 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.433 ' O ' ' CZ ' ' A' ' 29' ' ' PHE . 35.1 mt -144.14 122.8 12.55 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.566 -1.272 . . . . 2.61 107.566 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.17 -16.9 10.62 Favored Glycine 0 N--CA 1.504 3.189 0 O-C-N 121.024 -1.048 . . . . 0.02 112.814 -177.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 73.3 p -156.8 156.34 33.08 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.22 -1.753 . . . . 0.02 110.299 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 28.4 p -143.84 147.29 33.87 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.481 -0.762 . . . . 0.02 110.038 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.5 mtm180 -138.25 143.15 39.96 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.469 -0.769 . . . . 0.01 109.644 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.26 132.54 36.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.43 109.829 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.6 t -91.29 125.16 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.863 -0.791 . . . . 1.25 108.863 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -94.1 131.79 39.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.831 -1.168 . . . . 1.77 109.298 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.9 mt -96.38 140.15 31.45 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.312 -0.867 . . . . 1.63 108.855 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.1 t -111.57 127.1 55.62 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.449 -0.782 . . . . 1.08 109.092 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.5 p -103.56 -154.94 0.51 Allowed 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 106.485 -1.672 . . . . 1.26 106.485 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.96 -53.14 0.73 Allowed Glycine 0 N--CA 1.5 2.9 0 O-C-N 120.366 -1.459 . . . . 0.01 112.684 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -179.53 -101.72 0.15 Allowed Glycine 0 N--CA 1.489 2.221 0 C-N-CA 118.605 -1.76 . . . . 0.01 112.029 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -121.19 119.45 32.37 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.098 -1.236 . . . . 4.43 110.72 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.87 130.59 35.82 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.822 -0.751 . . . . 2.99 109.294 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -131.03 141.81 50.25 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.483 -0.761 . . . . 6.36 108.964 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.8 tt -129.28 146.66 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.366 -0.834 . . . . 1.09 110.038 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -122.01 133.68 54.81 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.766 -1.198 . . . . 2.05 107.766 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.2 m -123.42 145.56 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 120.788 -1.195 . . . . 1.1 109.736 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.594 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 32.2 m-85 -118.7 141.19 48.84 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 122.016 0.913 . . . . 0.73 110.716 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -66.2 -30.21 70.63 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.995 -0.548 . . . . 0.02 111.295 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -116.54 170.16 8.78 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.099 -1.001 . . . . 3.18 110.412 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.02 170.37 44.26 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.742 -0.943 . . . . 0.01 110.742 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 52.91 38.94 28.25 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.527 0.68 . . . . 0.01 111.587 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.424 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 24.7 m-85 51.8 49.17 21.35 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.525 -0.734 . . . . 0.01 111.059 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -123.62 165.59 16.94 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.322 -0.992 . . . . 3.15 108.322 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.72 -163.79 27.36 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.519 -1.432 . . . . 0.01 109.519 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.4 tp60 -76.75 144.56 39.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.028 -1.277 . . . . 0.01 108.497 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.594 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 12.6 ttt -116.01 141.53 48.0 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.658 0.742 . . . . 0.01 109.801 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -131.0 136.42 48.5 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.069 -1.086 . . . . 2.48 108.069 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -118.89 133.7 55.66 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.52 -0.738 . . . . 0.01 110.117 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 t -148.17 149.41 31.92 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 122.318 1.056 . . . . 1.69 110.962 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.0 p -111.33 9.95 21.59 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 115.501 -0.772 . . . . 0.01 110.336 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.468 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 23.6 mp0 -121.11 163.12 18.89 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.214 -0.929 . . . . 3.21 111.491 -178.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.74 156.61 37.98 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.471 -0.937 . . . . 0.01 108.471 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 19.6 t -127.15 113.67 21.67 Favored Pre-proline 0 N--CA 1.501 2.088 0 N-CA-C 108.749 -0.834 . . . . 0.01 108.749 178.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -74.52 -29.17 9.41 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 CA-C-N 120.446 1.195 . . . . 0.01 111.034 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 7.8 p -142.34 109.12 5.41 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.444 -0.785 . . . . 0.02 109.074 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.411 HG21 HD11 ' A' ' 117' ' ' ILE . 97.6 mt -63.81 -38.74 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.884 -0.51 . . . . 1.83 110.653 -178.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 118' ' ' MET . 12.4 tmm? -68.52 -37.74 80.27 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.255 -0.978 . . . . 1.34 110.208 -178.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -69.53 -38.27 77.46 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.48 -1.388 . . . . 2.11 109.958 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -79.78 -47.21 15.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.238 -0.914 . . . . 2.08 112.381 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -111.39 0.41 16.59 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.299 -0.875 . . . . 0.02 112.647 -176.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 59.98 33.48 21.42 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.749 -1.219 . . . . 0.02 109.529 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.3 mt -112.09 135.54 52.62 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.718 -0.845 . . . . 0.02 108.718 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -91.61 -22.9 20.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.17 -0.956 . . . . 5.32 110.24 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -149.48 164.28 35.46 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.159 -0.963 . . . . 0.02 109.88 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 35.0 mt -131.89 129.0 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 107.654 -1.239 . . . . 2.17 107.654 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 61.2 m80 -108.09 -11.95 15.2 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.364 -0.835 . . . . 0.02 112.314 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.424 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 2.7 t -159.01 151.14 21.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.915 -1.115 . . . . 0.01 108.871 178.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 5.7 t -168.43 144.05 3.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 1.22 108.873 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.7 tttm -125.57 109.33 12.53 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 122.509 1.147 . . . . 1.41 109.963 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.5 p -111.32 135.86 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.184 -1.413 . . . . 0.01 107.184 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 72.1 t -126.68 93.31 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 106.788 -1.56 . . . . 1.98 106.788 177.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -147.13 -75.3 0.19 Allowed 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 105.781 -1.933 . . . . 0.01 105.781 177.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 152.82 -53.79 0.46 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.567 -1.413 . . . . 0.01 109.567 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.4 p -120.16 99.79 6.81 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.494 -1.004 . . . . 2.3 111.348 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -128.64 145.37 51.17 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 107.572 -1.27 . . . . 0.01 107.572 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.448 HG23 HD12 ' A' ' 137' ' ' ILE . 56.8 mt -121.01 137.93 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 120.662 -1.274 . . . . 1.69 110.37 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -114.92 144.72 43.11 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 106.935 -1.506 . . . . 2.49 106.935 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 10.3 m-85 -124.2 144.32 50.0 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.411 -0.806 . . . . 0.02 109.857 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.42 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 38.7 tt0 -74.13 -29.08 61.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.687 -0.633 . . . . 0.02 111.874 -176.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.5 mt -115.74 154.56 48.08 Favored Pre-proline 0 N--CA 1.504 2.241 0 O-C-N 120.735 -1.228 . . . . 1.48 108.997 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -55.81 167.38 2.28 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.113 1.209 . . . . 0.02 112.726 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.1 m120 59.64 31.15 20.73 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.215 -0.902 . . . . 0.75 111.391 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 57.91 51.51 8.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.46 -0.775 . . . . 0.02 111.171 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -126.92 164.86 20.52 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.454 -0.779 . . . . 0.02 110.1 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.46 -165.95 32.82 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 110.414 -1.074 . . . . 0.02 110.414 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -69.37 142.73 53.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.554 -0.968 . . . . 0.02 108.883 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -114.69 148.94 37.54 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.339 0.59 . . . . 0.02 110.123 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.437 ' CD1' ' N ' ' A' ' 149' ' ' TYR . 13.0 m-85 -124.84 135.03 52.55 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 109.169 -0.678 . . . . 0.01 109.169 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.1 tt -100.36 122.42 43.1 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.907 -1.121 . . . . 0.01 109.021 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.1 mp -97.19 164.25 12.57 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.072 -1.018 . . . . 0.01 108.656 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -108.2 -101.71 0.37 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.462 -0.773 . . . . 2.27 109.527 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -172.99 43.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 1.84 109.617 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -112.41 -156.55 0.59 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.524 -0.735 . . . . 2.28 109.343 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -106.86 108.23 19.64 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.445 -0.785 . . . . 0.01 109.196 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.612 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 37.1 m-85 -98.92 113.58 25.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.343 -0.848 . . . . 0.01 109.532 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -94.62 -22.72 17.99 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.149 -0.97 . . . . 0.01 111.596 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -127.49 154.94 77.45 Favored Pre-proline 0 N--CA 1.503 2.187 0 O-C-N 120.916 -1.115 . . . . 2.54 108.775 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -60.7 -37.97 75.0 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 CA-C-N 119.317 0.792 . . . . 0.7 110.543 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 95.7 t -61.04 -19.92 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.842 -1.161 . . . . 0.86 109.259 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -65.26 -15.34 62.39 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.901 -1.125 . . . . 0.02 110.023 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.612 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 8.8 m0 -97.65 11.68 36.22 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.096 -1.003 . . . . 0.02 109.152 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.52 10.72 84.94 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.827 -1.178 . . . . 0.02 111.127 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.39 140.61 33.32 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.081 -1.246 . . . . 0.02 110.008 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.18 -8.92 58.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.708 -0.62 . . . . 0.59 110.025 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 4.6 m -143.26 150.03 50.51 Favored Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.033 -1.042 . . . . 0.87 109.013 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.5 17.68 0.64 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 120.583 0.855 . . . . 0.38 112.102 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.31 123.25 28.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.851 -1.155 . . . . 0.18 111.524 -177.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.5 mt -150.04 126.32 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 106.714 -1.588 . . . . 3.99 106.714 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' A' ' 170' ' ' GLN . 10.8 mp0 -112.3 -16.83 12.88 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.082 -1.011 . . . . 5.17 113.059 -177.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.7 p -157.33 160.77 38.85 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 119.162 -2.211 . . . . 0.02 110.242 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.414 ' CD1' ' C ' ' A' ' 172' ' ' PHE . 21.1 p90 -152.4 152.65 32.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.074 -1.016 . . . . 2.02 110.521 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -144.85 149.84 36.08 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.467 -0.77 . . . . 0.01 109.698 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -87.17 140.87 29.11 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.246 -0.65 . . . . 0.01 109.246 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 31.4 mt -92.47 129.44 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.14 -0.975 . . . . 3.04 108.839 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.9 m -136.76 148.04 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.244 -0.91 . . . . 1.89 109.793 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 4.89 109.529 179.925 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.428 ' H1 ' ' H ' ' A' ' 2' ' ' LYS . 92.2 p . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.452 -0.573 . . . . 5.28 109.452 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.428 ' H ' ' H1 ' ' A' ' 1' ' ' SER . 46.3 mtmt -67.03 -1.71 4.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.224 -0.922 . . . . 5.96 109.538 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.445 ' HG1' ' H ' ' A' ' 4' ' ' GLY . 4.3 t -90.01 -140.05 0.14 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.272 -1.381 . . . . 2.22 107.272 177.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.445 ' H ' ' HG1' ' A' ' 3' ' ' THR . . . 174.03 -176.23 46.49 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 117.302 -2.38 . . . . 0.81 112.679 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -80.32 160.38 43.96 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.603 -1.399 . . . . 0.01 109.603 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.519 ' NZ ' ' CB ' ' A' ' 6' ' ' LYS . 5.5 ttpm? -146.41 135.68 22.79 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.263 -1.139 . . . . 0.02 110.43 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.402 HG21 HD11 ' A' ' 7' ' ' ILE . 6.7 tt -129.77 139.85 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.256 -1.016 . . . . 0.02 108.256 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 m -120.7 129.48 53.68 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.337 -0.852 . . . . 0.39 110.065 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -109.8 139.46 44.83 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.846 -0.798 . . . . 0.02 108.846 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.551 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.6 m-85 -122.07 138.44 54.44 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.258 -0.901 . . . . 0.02 109.731 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -69.29 -27.5 65.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.03 111.575 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -114.36 169.5 8.99 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.894 -1.129 . . . . 0.03 110.242 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -75.44 158.56 32.48 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.663 0.744 . . . . 0.03 110.105 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.417 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 4.5 t-20 66.13 33.48 7.43 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.954 0.883 . . . . 0.74 111.16 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.417 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 1.0 OUTLIER 55.42 41.63 30.82 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 116.053 -0.521 . . . . 0.02 111.161 177.901 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -113.46 166.15 11.78 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.374 -0.973 . . . . 0.02 108.374 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.9 -167.29 36.33 Favored Glycine 0 N--CA 1.494 2.539 0 C-N-CA 119.927 -1.13 . . . . 0.03 110.765 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -69.06 142.0 54.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.524 -0.986 . . . . 2.76 109.302 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -120.48 149.09 42.94 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.625 0.726 . . . . 1.89 110.144 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -132.73 127.55 34.96 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.325 -0.991 . . . . 0.02 108.325 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 23.0 p-10 -112.57 136.85 51.62 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.412 -0.805 . . . . 1.12 109.733 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 13.2 t -131.07 138.83 49.75 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.678 -0.639 . . . . 0.02 109.626 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.494 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 2.6 p30 -116.41 11.06 14.83 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.529 -0.732 . . . . 0.2 109.817 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 43.1 m -158.38 174.66 14.79 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.318 -0.993 . . . . 1.23 108.318 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -60.8 144.16 53.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.714 -1.242 . . . . 0.02 109.916 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.5 p -131.57 117.16 18.36 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.594 -0.891 . . . . 0.02 108.594 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.03 -25.43 47.86 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.107 -0.996 . . . . 0.24 110.799 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -154.33 101.17 2.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.977 -1.077 . . . . 1.14 108.948 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -105.33 9.42 33.85 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.103 0.954 . . . . 6.37 109.788 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -58.52 -23.93 59.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.492 -0.755 . . . . 3.11 110.865 -178.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 53.6 p -74.58 -16.28 60.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.739 -1.226 . . . . 0.88 110.328 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -104.63 -22.14 13.29 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.462 -0.774 . . . . 0.02 109.63 -179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.7 tp -150.56 129.22 12.31 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.15 -0.969 . . . . 3.32 109.287 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.0 p -86.83 -10.41 53.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.657 -0.652 . . . . 0.02 111.69 -178.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.51 HH21 ' ND2' ' A' ' 37' ' ' ASN . 42.7 ttt180 -170.36 161.34 8.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.811 -1.181 . . . . 0.02 107.963 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.1 m -141.96 115.27 8.9 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.702 -1.249 . . . . 0.02 109.642 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.523 ' ND2' ' OD2' ' A' ' 77' ' ' ASP . 0.8 OUTLIER -107.88 0.14 21.87 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.837 -1.165 . . . . 0.03 110.801 -178.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 66' ' ' TYR . 37.1 t -156.31 154.58 30.86 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.039 -1.097 . . . . 0.02 108.039 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.4 mt -146.42 147.31 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.132 -0.98 . . . . 0.02 110.477 -178.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.506 ' NE ' ' HH ' ' A' ' 10' ' ' TYR . 25.3 ttm180 -123.53 124.4 42.76 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.189 -1.041 . . . . 0.02 108.189 177.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.8 t -106.54 115.04 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 106.921 -1.511 . . . . 0.02 106.921 177.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -83.76 -33.64 24.98 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.939 -0.705 . . . . 3.81 110.643 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.7 152.11 21.89 Favored Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.009 -1.567 . . . . 0.02 110.831 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.57 172.98 49.4 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.517 -1.325 . . . . 0.01 110.522 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.5 m -119.7 135.28 54.89 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 108.019 -1.104 . . . . 1.48 108.019 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.42 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 36.1 m95 -126.94 155.58 42.86 Favored 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 122.486 1.136 . . . . 0.02 112.112 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.39 134.05 52.31 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 105.573 -2.01 . . . . 0.24 105.573 176.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.3 m -118.6 143.59 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.584 -0.697 . . . . 0.65 109.226 178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -121.46 145.93 47.42 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 122.427 1.108 . . . . 0.02 110.335 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -66.35 -33.93 76.82 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.678 -0.692 . . . . 0.02 111.198 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.8 mtp180 -125.41 157.85 66.4 Favored Pre-proline 0 N--CA 1.502 2.16 0 O-C-N 121.046 -1.034 . . . . 0.02 109.515 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -53.74 166.97 1.15 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.742 1.628 . . . . 0.02 113.0 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 64.03 36.53 9.84 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.214 -0.903 . . . . 0.02 111.175 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 45.31 51.88 9.13 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.638 0.732 . . . . 3.39 110.593 178.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.3 p -126.51 163.84 22.5 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.167 0.508 . . . . 2.33 109.87 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.37 -162.12 31.81 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.766 -1.334 . . . . 0.02 109.766 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.414 ' H ' ' CD2' ' A' ' 57' ' ' HIS . 20.9 m-70 -65.52 138.27 57.96 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.035 -1.274 . . . . 0.02 110.066 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 20.6 ptm -118.12 137.21 53.1 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.326 0.584 . . . . 5.01 109.583 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.531 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 86.9 m-85 -133.98 138.67 45.58 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.419 -0.801 . . . . 0.02 109.752 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.1 mm -95.54 131.37 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 109.089 -0.708 . . . . 1.72 109.089 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.4 mt -120.89 111.91 33.94 Favored Pre-proline 0 N--CA 1.506 2.328 0 O-C-N 121.361 -0.837 . . . . 0.02 110.962 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -77.52 169.77 20.45 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 CA-C-N 119.876 0.991 . . . . 1.47 109.871 177.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -52.9 141.19 22.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.794 -1.192 . . . . 4.25 110.211 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.42 -177.83 32.38 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.52 -1.324 . . . . 0.02 110.781 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -120.67 131.93 54.83 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.374 -1.074 . . . . 0.96 109.832 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.411 ' O ' ' OG ' ' A' ' 38' ' ' SER . 94.7 m-85 -121.68 96.41 47.35 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 108.068 -1.086 . . . . 0.02 108.068 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.37 -3.8 10.67 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 120.796 0.997 . . . . 0.02 113.702 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -157.58 155.69 30.6 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.621 -1.3 . . . . 2.02 108.36 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -60.43 -39.29 86.93 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.54 -0.725 . . . . 0.02 112.013 -177.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -60.17 -23.37 63.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.968 -1.083 . . . . 0.02 110.279 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -70.61 -18.72 62.88 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.897 0.856 . . . . 3.42 109.044 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.546 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 1.3 t90 -107.8 10.29 28.75 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.409 -1.33 . . . . 0.02 107.409 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 13.5 mmt 60.46 22.26 11.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.627 -0.671 . . . . 0.02 110.294 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.76 144.39 46.28 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.398 -1.481 . . . . 0.02 109.398 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.9 mt -78.86 -30.44 45.12 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.626 -1.25 . . . . 0.98 107.626 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -157.11 -171.61 3.7 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 106.427 -1.694 . . . . 0.02 106.427 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.523 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 92.4 m-20 -98.82 28.37 4.35 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.733 -1.229 . . . . 0.02 110.42 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -96.91 122.62 40.09 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.005 -1.059 . . . . 3.2 110.936 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.7 mt -143.56 120.96 11.65 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.585 -1.265 . . . . 2.61 107.585 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.35 -17.3 10.11 Favored Glycine 0 N--CA 1.506 3.302 0 O-C-N 121.065 -1.022 . . . . 0.02 112.928 -177.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.2 t -156.99 156.46 33.0 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.159 -1.789 . . . . 0.02 110.331 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 38.6 m -145.42 148.19 33.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.453 -0.779 . . . . 0.02 110.086 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -138.14 143.12 40.17 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.308 -0.87 . . . . 0.01 109.413 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.37 132.36 36.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -0.952 . . . . 0.43 109.68 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.4 t -91.59 125.28 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.938 -0.764 . . . . 1.25 108.938 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 26.3 m-70 -95.57 129.99 42.57 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.707 -1.246 . . . . 1.77 109.274 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.6 mt -94.47 141.27 28.79 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.159 -0.963 . . . . 1.63 108.688 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.5 m -111.21 128.14 55.82 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.386 -0.821 . . . . 1.08 109.237 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.0 p -104.54 -153.96 0.49 Allowed 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 106.63 -1.618 . . . . 1.26 106.63 177.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.64 -52.76 0.74 Allowed Glycine 0 N--CA 1.501 3.024 0 O-C-N 120.414 -1.428 . . . . 0.01 112.807 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.35 -101.95 0.16 Allowed Glycine 0 N--CA 1.49 2.237 0 C-N-CA 118.533 -1.794 . . . . 0.01 112.108 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -121.53 119.13 31.08 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.144 -1.209 . . . . 4.43 110.788 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.05 130.39 35.47 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.92 -0.712 . . . . 2.99 109.267 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.473 ' NZ ' ' CB ' ' A' ' 94' ' ' LYS . 2.8 ttmp? -129.79 141.57 50.83 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.423 -0.798 . . . . 6.36 109.149 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.8 tt -128.14 145.64 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 121.356 -0.84 . . . . 1.09 110.465 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.541 ' OE1' ' N ' ' A' ' 96' ' ' GLN . 0.5 OUTLIER -122.32 132.29 54.33 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.382 -1.34 . . . . 2.05 107.382 177.203 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.5 m -124.51 146.47 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 O-C-N 120.601 -1.312 . . . . 1.1 109.746 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.577 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 71.3 m-85 -119.58 141.01 49.65 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 122.045 0.926 . . . . 0.73 111.161 -178.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -66.12 -30.37 70.85 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 116.004 -0.544 . . . . 0.02 111.365 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -117.0 170.57 8.53 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.13 -0.981 . . . . 3.18 110.473 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.66 169.29 45.05 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.805 -0.918 . . . . 0.01 110.805 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 23.9 t70 53.23 38.83 28.6 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.576 0.703 . . . . 0.01 111.55 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.464 ' H ' ' HG ' ' A' ' 128' ' ' SER . 20.1 m-85 52.14 48.8 21.95 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.503 -0.748 . . . . 0.01 110.846 178.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -123.28 165.55 16.77 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.215 -1.032 . . . . 3.15 108.215 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.43 -164.29 28.03 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.302 -1.519 . . . . 0.01 109.302 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.459 ' NE2' ' HH ' ' A' ' 108' ' ' TYR . 55.1 tt0 -76.84 144.57 38.97 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.053 -1.263 . . . . 0.01 108.675 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.577 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 30.3 ttp -116.74 142.57 46.74 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.638 0.732 . . . . 0.01 109.984 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.459 ' HH ' ' NE2' ' A' ' 106' ' ' GLN . 68.0 m-85 -131.27 136.49 48.23 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.184 -1.043 . . . . 2.48 108.184 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -118.56 133.92 55.49 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.466 -0.771 . . . . 0.01 109.817 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.459 ' HG1' ' N ' ' A' ' 111' ' ' THR . 4.5 t -148.15 149.86 32.77 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.128 0.966 . . . . 1.69 110.965 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.459 ' N ' ' HG1' ' A' ' 110' ' ' THR . 1.2 p -110.44 9.97 23.31 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 115.614 -0.721 . . . . 0.01 110.168 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -121.53 163.1 19.4 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.214 -0.929 . . . . 3.21 111.901 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 9.8 p30 -68.15 157.28 35.69 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.233 -1.025 . . . . 0.01 108.233 178.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.574 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 86.2 m -125.77 112.8 24.87 Favored Pre-proline 0 N--CA 1.501 2.104 0 O-C-N 121.503 -0.748 . . . . 0.01 109.172 178.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.446 ' O ' ' OG ' ' A' ' 171' ' ' SER . 19.1 Cg_endo -75.62 -30.93 5.84 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 CA-C-N 120.095 1.07 . . . . 0.01 111.042 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.4 m -141.96 106.55 4.85 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.493 -0.928 . . . . 0.02 108.493 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 95.0 mt -65.12 -38.1 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.745 -0.597 . . . . 1.83 111.203 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.1 ttt -67.75 -37.16 81.76 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.013 -1.075 . . . . 1.34 109.815 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -69.75 -38.34 76.77 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.493 -1.379 . . . . 2.11 109.721 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.529 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 7.7 tt0 -80.19 -47.24 14.99 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.404 -0.81 . . . . 2.08 112.345 -177.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -110.95 -0.4 16.76 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.386 -0.821 . . . . 0.02 112.67 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.9 m170 59.86 33.44 21.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.818 -1.176 . . . . 0.02 109.58 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 11.7 mt -112.42 135.53 53.01 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 108.791 -0.818 . . . . 0.02 108.791 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -92.06 -23.09 19.6 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.256 -0.902 . . . . 5.32 110.565 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -149.14 163.81 36.52 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.142 -0.973 . . . . 0.02 109.911 -178.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.408 HD11 HG21 ' A' ' 126' ' ' ILE . 43.2 mt -132.57 129.39 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 107.811 -1.181 . . . . 2.17 107.811 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.5 m80 -108.96 -12.07 14.91 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.364 -0.835 . . . . 0.02 112.466 -177.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.464 ' HG ' ' H ' ' A' ' 103' ' ' PHE . 3.2 t -159.26 151.21 20.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.736 -1.228 . . . . 0.01 109.239 178.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 28.4 p -166.5 149.61 7.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.971 -1.08 . . . . 1.22 109.295 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.434 ' O ' ' OE1' ' A' ' 96' ' ' GLN . 3.7 tmtp? -119.69 108.99 15.12 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 122.298 1.047 . . . . 1.41 109.422 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.4 t -114.71 127.84 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 107.673 -1.232 . . . . 0.01 107.673 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.2 t -130.67 94.88 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 107.378 -1.341 . . . . 1.98 107.378 177.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.606 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 22.5 tt0 -146.39 -74.61 0.21 Allowed 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 106.128 -1.804 . . . . 0.01 106.128 177.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 167.91 -65.69 0.19 Allowed Glycine 0 N--CA 1.484 1.841 0 N-CA-C 108.697 -1.761 . . . . 0.01 108.697 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.7 p -122.87 115.15 21.48 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.52 -0.988 . . . . 2.3 110.508 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.606 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 8.3 m95 -126.57 148.18 49.78 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 107.338 -1.356 . . . . 0.01 107.338 178.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.2 mt -120.4 134.67 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 120.392 -1.443 . . . . 1.69 110.343 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -114.71 143.93 44.26 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.366 -1.346 . . . . 2.49 107.366 178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.541 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 8.4 m-85 -123.65 144.78 49.41 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.373 -0.829 . . . . 0.02 109.741 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -77.36 -28.17 52.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.569 -0.707 . . . . 0.02 112.046 -176.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 47.7 mt -114.86 151.92 45.93 Favored Pre-proline 0 N--CA 1.504 2.235 0 O-C-N 120.683 -1.26 . . . . 1.48 109.143 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -52.93 166.12 1.01 Allowed 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 120.737 0.958 . . . . 0.02 112.72 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 59.25 31.19 21.0 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.111 -0.949 . . . . 0.75 111.432 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 57.24 51.47 10.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.562 -0.711 . . . . 0.02 111.298 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 51.0 mtp180 -125.96 164.46 20.77 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.499 -0.751 . . . . 0.02 109.935 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.37 -165.31 32.5 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.312 -1.115 . . . . 0.02 110.312 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -69.48 142.99 53.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.617 -0.931 . . . . 0.02 109.109 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -115.11 149.01 38.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.801 -0.562 . . . . 0.02 109.77 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -124.97 135.68 53.03 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.653 -0.654 . . . . 0.01 109.284 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.9 tp -97.07 120.61 37.74 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.648 -1.282 . . . . 0.01 109.368 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.4 tp -100.38 150.18 22.88 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.291 -0.881 . . . . 0.01 109.013 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -104.17 -108.72 0.27 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.673 -0.642 . . . . 2.27 109.374 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -167.59 54.68 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.967 -1.083 . . . . 1.84 109.839 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -113.76 -167.51 1.22 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.523 -0.736 . . . . 2.28 109.268 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -106.14 105.45 15.49 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.879 -0.785 . . . . 0.01 108.879 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -99.41 115.83 30.17 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.354 -0.841 . . . . 0.01 110.018 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -92.33 -25.26 18.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.993 -1.067 . . . . 0.01 110.873 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -127.5 153.73 77.42 Favored Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 108.14 -1.059 . . . . 2.54 108.14 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -58.78 -40.47 72.29 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 CA-C-N 119.502 0.858 . . . . 0.7 110.462 178.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 5.6 t -63.09 -22.96 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.716 -1.24 . . . . 0.86 109.821 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -66.37 -16.35 64.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.556 -1.34 . . . . 0.02 110.076 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.539 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 18.9 t90 -100.31 10.68 40.87 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.424 -0.797 . . . . 0.02 109.03 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.42 8.52 87.49 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 120.208 -0.996 . . . . 0.02 111.902 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -98.51 141.3 31.54 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.056 -1.261 . . . . 0.02 110.154 -178.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -88.66 -13.08 40.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.63 -0.669 . . . . 0.59 110.701 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 60.6 p -147.31 150.23 37.12 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 120.717 -1.239 . . . . 0.87 108.988 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -78.6 20.25 0.79 Allowed 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 120.816 1.011 . . . . 0.38 113.085 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.17 123.86 29.95 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.446 -1.409 . . . . 0.18 111.78 -177.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 11.7 mm -151.5 127.63 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 107.03 -1.47 . . . . 3.99 107.03 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -112.07 -16.6 13.02 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 121.078 -1.014 . . . . 5.17 113.719 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 115' ' ' PRO . 67.2 m -156.92 160.44 39.1 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 119.124 -2.235 . . . . 0.02 110.288 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.574 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 9.8 p90 -152.74 153.28 32.9 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.131 -0.981 . . . . 2.02 111.004 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -145.12 149.57 35.26 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.469 -0.769 . . . . 0.01 110.112 -179.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -88.52 144.1 26.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.603 -0.685 . . . . 0.01 109.416 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 8.2 mt -95.74 129.44 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.212 -0.93 . . . . 3.04 109.218 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.8 m -136.37 146.97 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.189 -0.944 . . . . 1.89 109.589 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.337 -0.852 . . . . 4.89 109.485 -179.854 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 84.5 p . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.46 -0.57 . . . . 5.28 109.46 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -153.62 117.24 4.68 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.226 -0.921 . . . . 5.96 109.355 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 72.8 p -90.32 -139.51 0.15 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.399 -1.334 . . . . 2.22 107.399 177.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.61 -176.66 46.88 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 117.45 -2.309 . . . . 0.81 112.728 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -80.13 160.36 44.29 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.705 -1.358 . . . . 0.01 109.705 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -145.33 134.66 23.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.248 -1.148 . . . . 0.02 110.522 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.412 HG23 HD11 ' A' ' 7' ' ' ILE . 6.8 tt -129.55 139.71 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.097 -1.075 . . . . 0.02 108.097 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.529 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.7 t -121.99 130.19 53.1 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.336 -0.853 . . . . 0.39 110.174 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.9 m-85 -110.61 140.37 45.01 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.919 -0.771 . . . . 0.02 108.919 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.577 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 1.9 m-85 -122.2 138.99 54.28 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.28 -0.888 . . . . 0.02 109.758 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -69.34 -27.79 65.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.075 -1.016 . . . . 0.03 111.673 -178.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -114.0 169.16 9.21 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.956 -1.09 . . . . 0.03 110.117 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -75.5 158.28 32.8 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.731 0.777 . . . . 0.03 110.087 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.408 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 2.0 m-20 66.72 33.36 6.34 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.948 0.88 . . . . 0.74 111.225 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.408 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 1.3 m-85 55.64 42.23 29.69 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.28 0.562 . . . . 0.02 111.555 177.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -113.79 165.6 12.4 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.216 -1.031 . . . . 0.02 108.216 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.46 -167.38 35.44 Favored Glycine 0 N--CA 1.494 2.504 0 C-N-CA 119.769 -1.205 . . . . 0.03 111.023 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -68.62 141.75 55.32 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.473 -1.016 . . . . 2.76 109.468 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.524 ' NE ' ' OG ' ' A' ' 8' ' ' SER . 54.4 ttt180 -121.09 149.16 43.16 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.609 -0.682 . . . . 1.89 109.935 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -134.99 130.03 35.11 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 108.729 -0.841 . . . . 0.02 108.729 178.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 3.3 m-20 -110.64 136.08 50.28 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.471 -0.768 . . . . 1.12 109.105 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.6 t -129.08 138.17 51.69 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.714 -0.616 . . . . 0.02 109.491 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -117.76 12.31 13.87 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.626 -0.671 . . . . 0.2 110.282 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 44.4 t -159.45 174.29 14.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.949 -1.094 . . . . 1.23 108.777 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.466 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 3.3 p-10 -61.91 145.36 53.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.685 -1.26 . . . . 0.02 110.142 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.0 t -132.6 117.09 17.49 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.78 -0.822 . . . . 0.02 108.78 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.55 -23.31 50.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.308 -0.87 . . . . 0.24 111.173 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -155.3 101.41 2.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.197 -0.939 . . . . 1.14 108.779 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.489 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 21.2 p90 -108.02 9.65 28.44 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 122.059 0.933 . . . . 6.37 110.504 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -59.58 -22.77 62.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.359 -0.838 . . . . 3.11 110.663 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.0 m -74.71 -15.73 60.77 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.672 -1.267 . . . . 0.88 109.968 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -103.77 -21.32 13.7 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.587 -0.696 . . . . 0.02 109.396 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.1 mt -149.8 129.64 13.33 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.915 0.864 . . . . 3.32 109.519 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.4 p -85.86 -10.11 55.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.819 -0.551 . . . . 0.02 110.23 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -171.77 161.81 6.04 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.098 -1.075 . . . . 0.02 108.098 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 77.4 m -143.24 116.44 8.96 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.902 -1.124 . . . . 0.02 108.861 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.523 ' ND2' ' OD2' ' A' ' 77' ' ' ASP . 4.0 m120 -108.43 0.58 21.13 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 120.901 -1.125 . . . . 0.03 111.429 -178.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.9 p -156.41 154.43 30.47 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.964 -1.124 . . . . 0.02 107.964 178.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.2 mt -146.81 147.77 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.188 -0.945 . . . . 0.02 110.357 -178.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -124.65 125.77 44.65 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.987 -1.116 . . . . 0.02 107.987 177.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.3 t -106.75 115.46 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 107.0 -1.481 . . . . 0.02 107.0 177.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -83.46 -33.95 25.51 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.652 -0.655 . . . . 3.81 110.486 -178.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.94 152.21 21.97 Favored Glycine 0 N--CA 1.488 2.126 0 C-N-CA 118.917 -1.611 . . . . 0.02 110.834 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.67 173.08 49.5 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.505 -1.331 . . . . 0.01 110.374 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.5 m -119.22 134.9 54.95 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 107.844 -1.169 . . . . 1.48 107.844 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.407 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 38.1 m95 -127.54 155.52 43.65 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 122.499 1.142 . . . . 0.02 111.991 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.98 134.19 51.97 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 105.676 -1.972 . . . . 0.24 105.676 176.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.4 m -117.76 143.06 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.629 -0.67 . . . . 0.65 109.213 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -120.97 145.32 47.86 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 122.23 1.015 . . . . 0.02 110.064 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -66.32 -32.78 74.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.756 -0.59 . . . . 0.02 111.326 -177.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -125.12 157.61 66.51 Favored Pre-proline 0 N--CA 1.502 2.146 0 O-C-N 121.114 -0.991 . . . . 0.02 109.503 -178.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -53.12 167.1 0.79 Allowed 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 121.739 1.626 . . . . 0.02 112.915 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 63.34 36.57 11.53 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.407 -0.815 . . . . 0.02 110.99 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.476 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 2.3 m-85 44.92 51.6 8.55 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.535 0.683 . . . . 3.39 110.565 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.0 p -125.97 163.68 22.47 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.207 0.527 . . . . 2.33 110.016 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.56 -162.1 31.54 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.794 -1.323 . . . . 0.02 109.794 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.599 ' HD1' ' H ' ' A' ' 57' ' ' HIS . 4.1 m80 -64.15 138.04 58.25 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.957 -1.319 . . . . 0.02 109.938 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 17.2 ptm -118.59 136.9 53.61 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.317 0.58 . . . . 5.01 109.643 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.542 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 84.5 m-85 -134.3 139.39 45.66 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 121.62 0.724 . . . . 0.02 109.702 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.5 mm -94.94 131.32 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.768 -0.827 . . . . 1.72 108.768 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.526 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.17 110.51 36.12 Favored Pre-proline 0 N--CA 1.505 2.282 0 O-C-N 121.386 -0.821 . . . . 0.02 110.693 -178.29 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -77.24 168.86 22.37 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 CA-C-N 119.958 1.021 . . . . 1.47 109.997 177.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -53.33 141.16 24.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.626 -1.296 . . . . 4.25 110.415 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.57 -177.71 32.57 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.558 -1.306 . . . . 0.02 110.571 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -120.04 131.14 55.01 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.537 -0.978 . . . . 0.96 109.656 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.526 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 48.7 m-85 -123.11 94.37 47.18 Favored Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 108.371 -0.974 . . . . 0.02 108.371 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -65.95 -3.04 7.61 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.027 1.152 . . . . 0.02 114.11 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -157.53 155.83 30.95 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.55 -1.343 . . . . 2.02 108.589 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -60.78 -39.41 88.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.484 -0.76 . . . . 0.02 112.21 -177.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -59.86 -23.63 63.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.969 -1.082 . . . . 0.02 110.324 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -70.72 -18.36 62.8 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.833 0.825 . . . . 3.42 108.858 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.544 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.1 t90 -108.07 10.42 28.16 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.29 -1.374 . . . . 0.02 107.29 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.445 ' N ' ' SD ' ' A' ' 73' ' ' MET . 2.6 mpt? 59.82 23.63 12.6 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.495 0.664 . . . . 0.02 110.535 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.54 144.89 45.55 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.377 -1.489 . . . . 0.02 109.377 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.3 tp -79.92 -31.05 40.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.119 -1.224 . . . . 0.98 107.701 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -157.47 -172.06 3.83 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 106.312 -1.736 . . . . 0.02 106.312 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.523 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 54.0 m-20 -97.9 27.52 4.44 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.705 -1.247 . . . . 0.02 110.674 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -95.98 121.62 37.92 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.879 -1.138 . . . . 3.2 110.561 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.489 ' O ' ' CZ ' ' A' ' 29' ' ' PHE . 27.5 mt -144.47 121.17 11.18 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 107.735 -1.209 . . . . 2.61 107.735 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -111.99 -15.97 9.53 Favored Glycine 0 N--CA 1.507 3.402 0 O-C-N 121.152 -0.968 . . . . 0.02 113.087 -177.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.496 ' HG ' ' N ' ' A' ' 82' ' ' CYS . 37.3 t -156.42 156.68 34.24 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 119.862 1.831 . . . . 0.02 110.921 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.496 ' N ' ' HG ' ' A' ' 81' ' ' SER . 20.0 p -145.92 148.29 32.65 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.635 -0.666 . . . . 0.02 110.108 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -137.81 142.91 40.81 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.386 -0.821 . . . . 0.01 109.396 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.85 131.99 36.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.43 109.767 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 t -91.11 125.47 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.843 -0.799 . . . . 1.25 108.843 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -93.13 132.32 37.37 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.764 -1.21 . . . . 1.77 108.826 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mt -98.56 140.33 32.95 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.3 -0.875 . . . . 1.63 108.928 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 60.7 p -111.41 124.8 52.99 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.533 -0.914 . . . . 1.08 108.533 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.4 m -116.35 133.0 56.51 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.697 -1.252 . . . . 1.26 107.924 177.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.11 -49.26 0.01 OUTLIER Glycine 0 N--CA 1.505 3.277 0 C-N-CA 117.707 -2.187 . . . . 0.01 113.724 -177.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -167.57 -105.76 0.19 Allowed Glycine 0 N--CA 1.49 2.25 0 CA-C-N 119.962 1.881 . . . . 0.01 111.213 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -120.11 117.89 29.14 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.97 -1.312 . . . . 4.43 110.306 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.38 129.92 35.53 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.684 -0.806 . . . . 2.99 109.392 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -131.03 140.79 50.14 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.545 -0.722 . . . . 6.36 109.178 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.9 tt -129.31 146.07 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.322 -0.861 . . . . 1.09 110.211 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -121.24 133.7 55.16 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.559 -1.274 . . . . 2.05 107.559 177.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.2 m -124.34 145.98 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 120.965 -1.084 . . . . 1.1 109.783 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -119.13 141.61 48.65 Favored 'General case' 0 N--CA 1.503 2.205 0 CA-C-O 122.124 0.964 . . . . 0.73 111.092 -178.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -66.63 -30.31 70.55 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 115.87 -0.605 . . . . 0.02 111.908 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -116.53 167.65 10.87 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.004 -1.06 . . . . 3.18 110.494 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.71 163.9 43.21 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 111.01 -0.836 . . . . 0.01 111.01 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 102' ' ' ASP . 2.3 m-20 57.09 38.73 29.28 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.808 0.813 . . . . 0.01 110.823 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.407 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 15.2 m-85 52.3 55.75 8.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.571 -0.705 . . . . 0.01 111.045 178.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -128.06 165.81 19.62 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 108.425 -0.954 . . . . 3.15 108.425 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.4 -163.95 27.86 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.235 -1.546 . . . . 0.01 109.235 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -75.31 144.64 42.32 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.993 -1.298 . . . . 0.01 108.527 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.45 ' SD ' ' C ' ' A' ' 107' ' ' MET . 10.8 tmm? -116.59 142.33 47.03 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.569 0.7 . . . . 0.01 109.865 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -131.97 136.3 47.21 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.259 -1.015 . . . . 2.48 108.259 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.519 ' OE2' ' N ' ' A' ' 110' ' ' THR . 1.9 tm-20 -118.94 134.88 54.89 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.575 -0.703 . . . . 0.01 109.931 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.519 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 3.0 t -148.55 150.71 33.83 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 122.27 1.033 . . . . 1.69 111.166 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 65.8 p -112.0 9.3 20.42 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 115.581 -0.736 . . . . 0.01 110.41 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -121.06 162.93 19.16 Favored 'General case' 0 N--CA 1.508 2.452 0 O-C-N 121.201 -0.937 . . . . 3.21 111.762 -178.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -67.97 156.62 36.89 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.266 -1.013 . . . . 0.01 108.266 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 30.6 t -127.12 114.84 21.79 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.556 -0.715 . . . . 0.01 109.196 178.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -75.08 -28.9 8.65 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 CA-C-N 120.396 1.177 . . . . 0.01 111.0 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 56.0 m -142.88 109.07 5.25 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.389 -0.819 . . . . 0.02 109.224 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 117' ' ' ILE . 97.3 mt -63.17 -38.77 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.832 -0.542 . . . . 1.83 110.627 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.5 ttp -68.89 -37.23 78.88 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.164 -1.014 . . . . 1.34 110.259 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -69.53 -38.8 77.66 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 120.352 -1.468 . . . . 2.11 110.058 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -79.99 -46.47 16.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.392 -0.817 . . . . 2.08 112.227 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -110.62 0.14 17.44 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.364 -0.835 . . . . 0.02 112.573 -176.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 59.63 33.22 21.92 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.644 -1.285 . . . . 0.02 109.404 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.0 mt -112.52 135.57 53.08 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 108.716 -0.846 . . . . 0.02 108.716 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -91.39 -22.53 20.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.155 -0.966 . . . . 5.32 110.361 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -149.64 164.02 36.32 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.136 -0.978 . . . . 0.02 109.833 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.6 mt -131.83 128.61 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 107.557 -1.275 . . . . 2.17 107.557 178.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.513 ' ND1' ' N ' ' A' ' 127' ' ' HIS . 1.8 m80 -107.93 -12.44 15.17 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.496 -0.753 . . . . 0.02 112.293 -177.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.407 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 7.0 t -159.92 152.12 20.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.015 -1.053 . . . . 0.01 109.05 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 6.3 p -169.98 145.17 2.86 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.183 -0.948 . . . . 1.22 109.016 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.6 tttp -125.74 111.58 15.08 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 122.452 1.12 . . . . 1.41 110.172 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.2 p -111.86 136.5 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.282 -1.377 . . . . 0.01 107.282 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 44.5 t -128.32 93.53 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 N-CA-C 106.865 -1.532 . . . . 1.98 106.865 177.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -146.33 -81.26 0.15 Allowed 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 105.911 -1.885 . . . . 0.01 105.911 178.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -178.91 -79.13 0.06 OUTLIER Glycine 0 N--CA 1.486 1.985 0 N-CA-C 108.488 -1.845 . . . . 0.01 108.488 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.4 t -119.08 122.13 41.41 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.454 -1.027 . . . . 2.3 110.068 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -125.75 150.74 47.49 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 106.847 -1.538 . . . . 0.01 106.847 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 82.6 mt -121.17 136.78 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 120.467 -1.396 . . . . 1.69 110.166 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -115.59 144.88 43.25 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.625 -1.25 . . . . 2.49 107.625 178.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.517 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 12.1 m-85 -123.4 144.09 49.71 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.436 -0.79 . . . . 0.02 109.666 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -74.74 -29.4 61.14 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.478 -0.764 . . . . 0.02 111.771 -176.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.5 mt -115.64 154.65 47.94 Favored Pre-proline 0 N--CA 1.505 2.29 0 O-C-N 120.706 -1.246 . . . . 1.48 108.939 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -55.64 167.31 2.18 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.131 1.221 . . . . 0.02 112.609 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.404 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 14.4 t-20 59.7 30.94 20.54 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.009 -0.996 . . . . 0.75 111.284 178.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 58.02 51.64 8.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.425 -0.797 . . . . 0.02 111.208 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -127.04 164.89 20.54 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.541 -0.725 . . . . 0.02 110.187 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.98 -165.81 33.36 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.385 -1.086 . . . . 0.02 110.385 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -69.1 142.5 54.44 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.558 -0.966 . . . . 0.02 109.027 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -113.99 148.52 36.79 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.554 0.692 . . . . 0.02 110.257 -177.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -125.09 134.34 52.53 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.01 -0.737 . . . . 0.01 109.01 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.9 tt -99.25 121.9 41.69 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.92 -1.113 . . . . 0.01 109.221 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.6 tt -98.35 140.98 31.82 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.587 -0.894 . . . . 0.01 108.587 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -103.39 -108.32 0.26 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.313 -0.867 . . . . 2.27 109.967 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 14.2 ttpp -153.27 52.47 0.73 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.939 -1.1 . . . . 1.84 109.611 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.413 ' CG ' ' H ' ' A' ' 155' ' ' GLU . 71.0 tttt -115.25 175.58 5.45 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.374 -0.829 . . . . 2.28 109.087 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.413 ' H ' ' CG ' ' A' ' 154' ' ' LYS . 78.8 mt-10 -102.94 111.72 24.18 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.237 -0.914 . . . . 0.01 108.644 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.51 ' N ' ' CD1' ' A' ' 156' ' ' TYR . 16.1 m-85 -99.76 115.6 29.9 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.373 -0.829 . . . . 0.01 110.506 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -92.82 -24.91 18.35 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.927 -1.108 . . . . 0.01 110.633 -178.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -127.82 154.04 78.05 Favored Pre-proline 0 N--CA 1.499 2.018 0 N-CA-C 108.139 -1.06 . . . . 2.54 108.139 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -58.86 -40.31 73.28 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 CA-C-N 119.416 0.827 . . . . 0.7 110.518 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 51.1 t -62.14 -23.02 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.887 -1.133 . . . . 0.86 109.594 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -66.54 -16.22 63.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.588 -1.32 . . . . 0.02 109.824 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.572 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 12.5 t90 -99.66 9.53 42.96 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.648 -0.871 . . . . 0.02 108.648 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 78.57 8.4 87.66 Favored Glycine 0 N--CA 1.492 2.373 0 O-C-N 120.904 -1.122 . . . . 0.02 111.512 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -98.23 141.61 30.93 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.231 -1.158 . . . . 0.02 109.973 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -87.27 -12.35 46.9 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.796 -0.565 . . . . 0.59 110.439 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.9 m -147.22 149.99 36.66 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 120.713 -1.242 . . . . 0.87 108.758 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -78.17 22.46 0.62 Allowed 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 120.807 1.005 . . . . 0.38 112.98 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.433 ' O ' ' CD1' ' A' ' 169' ' ' ILE . . . -83.6 123.18 29.52 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.618 -1.301 . . . . 0.18 111.812 -177.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.433 ' CD1' ' O ' ' A' ' 168' ' ' ALA . 5.4 mm -147.75 128.9 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 106.975 -1.491 . . . . 3.99 106.975 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -112.64 -17.83 12.51 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 120.95 -1.094 . . . . 5.17 113.497 -177.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.406 ' HG ' ' N ' ' A' ' 172' ' ' PHE . 20.1 t -157.36 160.52 38.55 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 119.108 -2.245 . . . . 0.02 110.265 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.441 ' CD1' ' C ' ' A' ' 172' ' ' PHE . 16.0 p90 -151.8 152.83 33.17 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.075 -1.015 . . . . 2.02 110.937 179.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -145.31 149.78 35.45 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.832 0.825 . . . . 0.01 110.119 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -88.77 145.5 25.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.732 -0.605 . . . . 0.01 109.403 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.1 mt -95.29 128.79 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.316 -0.865 . . . . 3.04 109.169 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 20.1 t -136.09 145.84 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.114 -0.991 . . . . 1.89 109.47 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.273 -0.892 . . . . 4.89 109.376 -179.978 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.463 -0.569 . . . . 5.28 109.463 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -66.0 116.41 7.09 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.301 -0.875 . . . . 5.96 109.449 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.496 ' HG1' ' N ' ' A' ' 4' ' ' GLY . 30.5 p -89.57 -139.89 0.14 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.303 -1.369 . . . . 2.22 107.303 177.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.496 ' N ' ' HG1' ' A' ' 3' ' ' THR . . . 174.2 -176.78 46.59 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 117.41 -2.328 . . . . 0.81 112.679 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -80.04 160.11 44.2 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.555 -1.418 . . . . 0.01 109.555 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -145.55 135.4 23.54 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.233 -1.157 . . . . 0.02 110.436 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.417 HG21 HD13 ' A' ' 7' ' ' ILE . 6.6 tt -129.67 139.04 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.204 -1.036 . . . . 0.02 108.204 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.9 m -121.28 129.81 53.33 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.348 -0.845 . . . . 0.39 110.141 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 8.0 m-85 -110.06 140.29 44.27 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.672 -0.862 . . . . 0.02 108.672 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.556 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.3 m-85 -122.04 138.6 54.38 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.202 -0.936 . . . . 0.02 109.538 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -69.02 -27.6 65.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.012 -1.055 . . . . 0.03 111.44 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -114.29 169.26 9.17 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.787 -1.196 . . . . 0.03 110.161 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -75.68 158.84 31.81 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.736 0.779 . . . . 0.03 110.207 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.7 t30 65.9 33.49 7.89 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.992 0.901 . . . . 0.74 111.21 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 55.33 41.87 30.78 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.195 0.522 . . . . 0.02 111.341 178.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -113.6 166.08 11.88 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.232 -1.025 . . . . 0.02 108.232 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.73 -167.34 36.67 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.773 -1.203 . . . . 0.03 110.783 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -69.06 141.6 54.74 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.613 -0.934 . . . . 2.76 109.407 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -120.57 149.28 42.7 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.575 -0.703 . . . . 1.89 110.165 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -132.69 127.67 35.3 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.271 -1.011 . . . . 0.02 108.271 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -112.85 137.3 51.4 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.479 -0.763 . . . . 1.12 109.765 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 10.6 t -131.29 139.04 49.52 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.628 -0.67 . . . . 0.02 109.642 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.489 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 19.0 t70 -116.61 10.92 14.56 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.593 -0.692 . . . . 0.2 109.925 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 40.4 m -158.24 174.34 15.31 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.245 -1.02 . . . . 1.23 108.245 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 11.9 p-10 -60.66 144.31 52.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.541 -1.349 . . . . 0.02 109.848 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.1 t -131.83 117.61 18.77 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.559 -0.904 . . . . 0.02 108.559 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.94 -25.06 48.05 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.239 -0.913 . . . . 0.24 110.841 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -155.08 101.72 2.27 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.061 -1.024 . . . . 1.14 109.021 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.401 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 24.0 p90 -105.25 9.56 33.96 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 122.157 0.98 . . . . 6.37 109.84 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -58.5 -23.75 58.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.448 -0.782 . . . . 3.11 110.873 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.8 m -74.55 -16.77 60.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.641 -1.287 . . . . 0.88 110.174 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -104.12 -21.98 13.49 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.499 -0.751 . . . . 0.02 109.6 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.8 tp -150.58 129.15 12.24 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.11 -0.994 . . . . 3.32 109.157 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.7 m -85.38 -9.94 56.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.831 -0.543 . . . . 0.02 111.06 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -171.45 162.9 6.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.847 -1.158 . . . . 0.02 107.931 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.4 p -143.21 115.16 8.28 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.789 -1.194 . . . . 0.02 108.905 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -107.21 1.94 24.37 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.759 -1.213 . . . . 0.03 110.875 -178.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.6 t -156.23 154.37 30.63 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.749 -1.204 . . . . 0.02 107.749 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.8 mt -146.66 147.61 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 120.959 -1.088 . . . . 0.02 110.362 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -124.58 125.06 43.55 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.083 -1.08 . . . . 0.02 108.083 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.8 t -106.87 115.12 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 107.147 -1.427 . . . . 0.02 107.147 177.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -83.52 -33.9 25.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.528 -0.732 . . . . 3.81 110.906 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.15 152.35 22.11 Favored Glycine 0 N--CA 1.487 2.037 0 C-N-CA 118.919 -1.61 . . . . 0.02 110.937 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.45 173.13 49.5 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.577 -1.297 . . . . 0.01 110.418 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.5 m -119.23 134.97 54.91 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.827 -1.175 . . . . 1.48 107.827 178.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.425 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 35.0 m95 -126.8 155.22 43.21 Favored 'General case' 0 N--CA 1.504 2.234 0 CA-C-O 122.506 1.146 . . . . 0.02 112.08 -176.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.52 133.89 52.56 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 105.724 -1.954 . . . . 0.24 105.724 176.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.8 m -118.09 142.92 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 109.009 -0.737 . . . . 0.65 109.009 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -121.39 146.28 47.04 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 122.325 1.06 . . . . 0.02 110.155 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.497 ' OE2' ' ND2' ' A' ' 76' ' ' ASN . 7.6 tp10 -66.31 -35.08 79.46 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.548 -0.751 . . . . 0.02 111.185 -177.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 -125.44 157.77 66.78 Favored Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 121.126 -0.983 . . . . 0.02 109.529 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -53.61 167.17 1.03 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.761 1.641 . . . . 0.02 112.992 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 53' ' ' ASN . 1.1 t30 63.57 36.52 10.99 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.027 -0.988 . . . . 0.02 111.191 178.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 45.28 51.82 9.12 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.621 0.724 . . . . 3.39 110.572 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 88.2 p -126.1 163.61 22.72 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 121.223 0.535 . . . . 2.33 109.755 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.88 -161.92 32.32 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.708 -1.357 . . . . 0.02 109.708 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -66.7 139.23 57.83 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.015 -1.285 . . . . 0.02 110.281 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 14.3 ptm -118.64 137.98 52.91 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.598 -0.689 . . . . 5.01 109.758 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.442 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 59.4 m-85 -133.25 137.84 46.23 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.506 -0.746 . . . . 0.02 109.836 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.7 mm -94.98 131.12 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.846 -0.798 . . . . 1.72 108.846 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.56 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.19 110.94 35.67 Favored Pre-proline 0 N--CA 1.505 2.297 0 O-C-N 121.452 -0.78 . . . . 0.02 110.748 -178.233 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -77.74 168.37 22.5 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 CA-C-N 119.958 1.021 . . . . 1.47 110.115 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.89 141.28 28.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.822 -1.174 . . . . 4.25 110.489 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.26 -177.81 32.26 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 119.535 -1.316 . . . . 0.02 110.567 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -119.41 131.13 55.6 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.527 -0.984 . . . . 0.96 109.766 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.56 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 70.6 m-85 -122.05 96.26 46.79 Favored Pre-proline 0 N--CA 1.494 1.737 0 N-CA-C 108.162 -1.051 . . . . 0.02 108.162 178.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.401 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.6 Cg_endo -67.41 -3.77 10.66 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 120.77 0.98 . . . . 0.02 113.734 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.401 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 34.2 mt-10 -157.55 155.19 29.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.592 -1.317 . . . . 2.02 108.132 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -60.48 -38.92 85.8 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.622 -0.674 . . . . 0.02 112.11 -177.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -60.49 -23.83 64.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.042 -1.036 . . . . 0.02 110.366 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -69.46 -18.95 63.76 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.427 -0.796 . . . . 3.42 108.992 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.553 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 1.1 t90 -108.3 11.09 27.49 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.403 -1.332 . . . . 0.02 107.403 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.5 mtt 60.88 22.21 12.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.47 -0.769 . . . . 0.02 110.215 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.11 145.11 46.6 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.169 -1.572 . . . . 0.02 109.169 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.62 -31.03 41.6 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.66 -1.237 . . . . 0.98 107.66 178.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.657 ' N ' HD21 ' A' ' 76' ' ' ASN . 0.0 OUTLIER -157.16 -171.45 3.63 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 106.525 -1.657 . . . . 0.02 106.525 178.453 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -98.86 28.6 4.23 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.85 -1.156 . . . . 0.02 110.425 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -98.47 123.37 42.57 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.152 -0.967 . . . . 3.2 111.183 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.401 ' O ' ' CZ ' ' A' ' 29' ' ' PHE . 36.1 mt -145.03 122.33 11.57 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.518 -1.29 . . . . 2.61 107.518 177.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.99 -16.44 11.43 Favored Glycine 0 N--CA 1.504 3.173 0 O-C-N 121.132 -0.98 . . . . 0.02 112.695 -177.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.6 t -156.96 155.97 32.22 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.242 -1.74 . . . . 0.02 110.304 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.5 p -145.28 147.85 32.81 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.503 -0.748 . . . . 0.02 110.332 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.0 mtm180 -137.7 143.0 41.05 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.278 -0.889 . . . . 0.01 109.36 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.52 132.16 36.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.127 -0.983 . . . . 0.43 109.76 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.4 t -91.06 125.03 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.782 -0.821 . . . . 1.25 108.782 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -94.6 131.18 40.63 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.82 -1.175 . . . . 1.77 109.16 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -94.87 139.62 31.06 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.196 -0.94 . . . . 1.63 108.508 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.7 t -110.66 127.87 55.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.388 -0.82 . . . . 1.08 109.108 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 95.5 p -104.52 -154.32 0.5 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 106.547 -1.649 . . . . 1.26 106.547 177.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.55 -53.1 0.74 Allowed Glycine 0 N--CA 1.5 2.9 0 O-C-N 120.553 -1.342 . . . . 0.01 112.762 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.46 -101.5 0.15 Allowed Glycine 0 N--CA 1.489 2.168 0 C-N-CA 118.603 -1.76 . . . . 0.01 111.978 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -122.39 119.56 31.4 Favored 'General case' 0 N--CA 1.506 2.343 0 CA-C-N 118.666 1.233 . . . . 4.43 110.757 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.36 130.82 35.8 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.762 -0.775 . . . . 2.99 109.483 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -129.62 141.85 50.86 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.377 -0.827 . . . . 6.36 109.229 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.9 tt -128.3 144.73 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 O-C-N 121.35 -0.844 . . . . 1.09 110.123 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -122.5 133.39 54.59 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.501 -1.296 . . . . 2.05 107.501 177.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.9 m -124.56 146.36 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 O-C-N 120.628 -1.295 . . . . 1.1 109.884 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -120.04 141.85 49.38 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 122.013 0.911 . . . . 0.73 111.129 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -67.28 -30.82 70.8 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 116.03 -0.532 . . . . 0.02 111.908 -178.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -115.98 167.47 10.93 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.938 -1.101 . . . . 3.18 110.384 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.15 164.26 44.28 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.974 -0.851 . . . . 0.01 110.974 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 57.08 38.77 29.33 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.701 0.762 . . . . 0.01 110.935 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 52.44 55.97 8.36 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.467 -0.77 . . . . 0.01 110.991 178.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -129.14 165.77 20.63 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.238 -1.023 . . . . 3.15 108.238 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.57 -163.73 27.52 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.244 -1.542 . . . . 0.01 109.244 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -75.7 144.41 41.57 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.05 -1.265 . . . . 0.01 108.543 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.452 ' SD ' ' C ' ' A' ' 107' ' ' MET . 12.8 tmm? -116.56 142.33 47.02 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.623 0.725 . . . . 0.01 109.831 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -131.88 135.7 46.86 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.255 -1.017 . . . . 2.48 108.255 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.519 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.1 tm-20 -118.55 134.11 55.34 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.584 -0.698 . . . . 0.01 110.033 -178.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.574 ' HG1' ' H ' ' A' ' 112' ' ' GLU . 6.0 t -148.17 150.74 34.34 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.278 1.037 . . . . 1.69 111.072 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 72.9 p -110.85 9.68 22.47 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 115.498 -0.774 . . . . 0.01 110.227 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.574 ' H ' ' HG1' ' A' ' 110' ' ' THR . 58.5 mt-10 -120.86 162.74 19.31 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.234 -0.916 . . . . 3.21 111.563 -178.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -68.59 157.54 35.87 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.392 -0.966 . . . . 0.01 108.392 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 19.2 t -127.36 113.43 21.32 Favored Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 121.491 -0.756 . . . . 0.01 109.072 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -75.25 -28.09 9.06 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 CA-C-N 120.315 1.148 . . . . 0.01 111.02 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.8 t -142.38 109.08 5.38 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.363 -0.836 . . . . 0.02 109.088 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.405 HG23 HD13 ' A' ' 117' ' ' ILE . 98.0 mt -63.63 -39.31 84.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.824 -0.547 . . . . 1.83 110.76 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 15.3 ttt -68.85 -38.16 79.6 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.246 -0.982 . . . . 1.34 110.372 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -69.26 -38.48 78.43 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.528 -1.358 . . . . 2.11 109.872 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -79.98 -47.02 15.62 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.219 -0.925 . . . . 2.08 112.331 -177.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.448 ' C ' ' HD1' ' A' ' 122' ' ' HIS . 54.3 m-85 -110.94 0.23 17.01 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.251 -0.905 . . . . 0.02 112.653 -176.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.448 ' HD1' ' C ' ' A' ' 121' ' ' PHE . 5.3 m80 60.14 33.34 21.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.753 -1.217 . . . . 0.02 109.407 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.9 mt -112.46 135.36 53.25 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 108.791 -0.818 . . . . 0.02 108.791 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -91.47 -22.82 20.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.233 -0.917 . . . . 5.32 110.174 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -149.29 164.1 35.8 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.216 -0.928 . . . . 0.02 109.899 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 31.9 mt -131.78 128.7 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 N-CA-C 107.854 -1.165 . . . . 2.17 107.854 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -108.5 -12.88 14.94 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.286 -0.884 . . . . 0.02 112.256 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.5 m -159.4 150.75 20.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.992 -1.067 . . . . 0.01 108.937 178.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.46 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 24.9 p -168.95 147.63 3.98 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.356 -0.84 . . . . 1.22 108.782 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -121.3 111.39 17.29 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 122.542 1.163 . . . . 1.41 109.845 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.47 129.78 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.472 -1.307 . . . . 0.01 107.472 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.7 t -129.52 93.57 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 107.328 -1.36 . . . . 1.98 107.328 177.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.451 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 11.0 tm-20 -147.41 -75.55 0.19 Allowed 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 105.914 -1.884 . . . . 0.01 105.914 177.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.438 ' N ' ' OE1' ' A' ' 133' ' ' GLU . . . 171.06 -71.81 0.11 Allowed Glycine 0 N--CA 1.483 1.813 0 N-CA-C 108.601 -1.8 . . . . 0.01 108.601 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 16.5 p -119.56 115.82 24.79 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.604 -0.939 . . . . 2.3 110.24 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.451 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 6.4 m95 -126.33 149.71 49.0 Favored 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 106.677 -1.601 . . . . 0.01 106.677 178.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 81.3 mt -122.51 137.72 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 120.377 -1.452 . . . . 1.69 110.586 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -114.48 143.95 44.12 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.221 -1.4 . . . . 2.49 107.221 178.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.516 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 10.6 m-85 -123.18 143.87 49.73 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.241 -0.912 . . . . 0.02 109.521 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -74.32 -29.99 61.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.715 -0.616 . . . . 0.02 111.754 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.5 mt -116.76 153.97 49.33 Favored Pre-proline 0 N--CA 1.504 2.261 0 O-C-N 120.877 -1.14 . . . . 1.48 108.856 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.46 169.49 0.74 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.281 1.32 . . . . 0.02 113.122 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.414 HD21 ' NH2' ' A' ' 145' ' ' ARG . 53.4 m-20 57.61 32.31 21.66 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.046 -0.979 . . . . 0.75 111.511 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 55.83 48.36 18.31 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.551 -0.718 . . . . 0.02 110.908 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.414 ' NH2' HD21 ' A' ' 143' ' ' ASN . 82.9 mtm180 -122.6 163.92 19.14 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.505 -0.747 . . . . 0.02 109.914 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.23 -165.85 33.06 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.361 -1.096 . . . . 0.02 110.361 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.477 ' CZ ' ' OH ' ' A' ' 149' ' ' TYR . 17.9 ttp180 -69.26 142.71 54.08 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.523 -0.987 . . . . 0.02 109.244 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -114.62 148.36 38.23 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.368 0.604 . . . . 0.02 110.261 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.477 ' OH ' ' CZ ' ' A' ' 147' ' ' ARG . 67.4 m-85 -125.07 135.19 52.48 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.871 -0.788 . . . . 0.01 108.871 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.4 tt -99.73 122.18 42.34 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.919 -1.113 . . . . 0.01 109.12 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.9 tp -96.75 146.45 24.87 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.101 -1.0 . . . . 0.01 108.736 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -104.31 -130.65 0.27 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.422 -0.799 . . . . 2.27 110.215 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -133.78 52.0 2.1 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.398 -0.814 . . . . 1.84 109.654 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -116.24 -169.52 1.63 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.463 -0.773 . . . . 2.28 109.473 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -105.49 108.39 19.88 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.335 -0.987 . . . . 0.01 108.335 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.605 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 6.0 m-85 -99.42 111.78 24.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.343 -0.848 . . . . 0.01 110.522 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -96.34 -22.03 17.44 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.294 -0.879 . . . . 0.01 111.412 -178.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -127.4 154.36 77.26 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 121.018 -1.051 . . . . 2.54 108.845 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -59.52 -38.76 80.92 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 CA-C-N 119.261 0.772 . . . . 0.7 110.538 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 41.0 t -60.71 -20.18 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.901 -1.124 . . . . 0.86 109.014 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -65.46 -15.67 62.87 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.91 -1.119 . . . . 0.02 110.022 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.605 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 10.0 m0 -98.11 10.96 39.22 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.148 -0.97 . . . . 0.02 108.842 178.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.42 11.39 84.24 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.839 -1.172 . . . . 0.02 111.079 178.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.23 140.63 34.19 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.137 -1.213 . . . . 0.02 110.191 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.18 -8.54 58.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.608 -0.682 . . . . 0.59 110.271 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.8 t -143.42 150.38 51.19 Favored Pre-proline 0 N--CA 1.5 2.048 0 O-C-N 120.905 -1.122 . . . . 0.87 109.345 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -75.79 17.72 0.67 Allowed 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 120.771 0.98 . . . . 0.38 112.122 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.431 ' O ' ' CD1' ' A' ' 169' ' ' ILE . . . -82.84 122.89 28.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.883 -1.136 . . . . 0.18 111.258 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.431 ' CD1' ' O ' ' A' ' 168' ' ' ALA . 4.6 mm -147.27 128.14 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 106.725 -1.583 . . . . 3.99 106.725 178.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -111.22 -18.37 12.98 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.111 -0.993 . . . . 5.17 113.115 -177.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 4.8 p -157.91 161.58 38.24 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 119.319 -2.113 . . . . 0.02 110.309 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' A' ' 172' ' ' PHE . 17.5 p90 -150.73 152.07 33.34 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.142 -0.974 . . . . 2.02 110.02 178.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -144.9 149.23 34.93 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.701 0.762 . . . . 0.01 109.758 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 18.4 ttm180 -87.9 144.06 26.78 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.67 -0.644 . . . . 0.01 109.503 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.0 mt -94.27 128.84 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.249 -0.907 . . . . 3.04 109.045 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 25.6 m -136.34 146.79 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.061 -1.024 . . . . 1.89 109.586 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.337 -0.852 . . . . 4.89 109.438 -179.94 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.357 0.599 . . . . 5.28 109.549 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt -71.34 -130.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.141 -0.974 . . . . 5.96 109.292 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 44.8 p -90.26 -141.76 0.16 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 107.466 -1.309 . . . . 2.22 107.466 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.88 -175.28 45.9 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 117.49 -2.29 . . . . 0.81 112.67 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.79 160.67 45.25 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.444 -1.462 . . . . 0.01 109.444 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -148.17 136.63 21.46 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.004 -1.292 . . . . 0.02 110.344 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.6 tt -130.73 140.86 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.906 -0.775 . . . . 0.02 108.906 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 m -121.42 130.4 53.56 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.499 -0.75 . . . . 0.39 109.934 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.6 m-85 -109.92 138.88 45.67 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.496 -0.752 . . . . 0.02 109.224 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.534 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.5 m-85 -122.32 139.14 54.16 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.317 -0.865 . . . . 0.02 109.805 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -69.5 -28.3 65.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.139 -0.976 . . . . 0.03 111.868 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -114.17 168.87 9.45 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.85 -1.156 . . . . 0.03 110.18 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -74.94 158.52 33.17 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.683 0.754 . . . . 0.03 109.938 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 66.52 33.52 6.63 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.953 0.882 . . . . 0.74 111.217 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 55.56 42.51 29.58 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.241 0.543 . . . . 0.02 111.32 177.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -113.56 165.88 12.07 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.357 -0.979 . . . . 0.02 108.357 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.63 -167.5 35.26 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.825 -1.179 . . . . 0.03 110.974 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -68.74 142.1 55.07 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.506 -0.997 . . . . 2.76 109.314 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -121.59 149.9 42.47 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.551 -0.718 . . . . 1.89 110.302 -178.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -134.72 129.28 34.47 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.662 -0.866 . . . . 0.02 108.662 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 15.9 p-10 -110.59 136.49 49.63 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.525 -0.734 . . . . 1.12 109.156 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 14.2 t -129.33 137.88 51.25 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.483 0.659 . . . . 0.02 109.44 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -116.96 12.02 14.51 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.597 -0.689 . . . . 0.2 109.753 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.444 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 42.3 t -159.44 174.24 15.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.052 -1.03 . . . . 1.23 108.559 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.419 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.4 p30 -61.03 144.16 53.95 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.715 -1.241 . . . . 0.02 110.006 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.8 t -131.85 116.96 17.89 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.576 -0.898 . . . . 0.02 108.576 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.53 -24.76 45.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.181 -0.95 . . . . 0.24 111.31 -178.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -153.85 101.97 2.48 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.955 -1.09 . . . . 1.14 109.113 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -104.5 9.31 35.55 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 122.148 0.975 . . . . 6.37 109.839 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -58.99 -25.31 63.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.466 -0.771 . . . . 3.11 111.17 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.0 p -74.28 -15.98 60.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.74 -1.225 . . . . 0.88 110.139 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -103.59 -21.81 13.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.46 -0.775 . . . . 0.02 109.741 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.5 mt -149.01 128.7 13.24 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.817 0.818 . . . . 3.32 109.443 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 76.7 p -84.74 -9.71 57.94 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.322 0.582 . . . . 0.02 109.626 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -171.51 162.09 6.45 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.835 -1.172 . . . . 0.02 107.835 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.0 p -142.21 115.1 8.68 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.952 -1.093 . . . . 0.02 108.462 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.429 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 50.8 t-20 -106.92 -0.59 23.07 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 120.811 -1.181 . . . . 0.03 111.649 -177.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 t -153.48 154.37 34.23 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.884 -1.154 . . . . 0.02 107.884 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.5 mt -146.47 145.93 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.864 -1.147 . . . . 0.02 110.726 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -124.97 125.73 44.36 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.044 -1.095 . . . . 0.02 108.044 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.0 t -104.93 113.71 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 106.727 -1.583 . . . . 0.02 106.727 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -84.92 -34.51 22.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.414 -0.804 . . . . 3.81 110.266 -178.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.32 150.43 19.16 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 118.541 -1.79 . . . . 0.02 110.879 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.75 172.0 48.7 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.102 -1.199 . . . . 0.01 110.102 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.6 m -119.43 134.72 55.08 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.844 -1.169 . . . . 1.48 107.844 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.453 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 32.8 m95 -127.2 154.95 44.18 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 122.567 1.175 . . . . 0.02 112.339 -176.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.91 134.62 51.33 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 105.267 -2.123 . . . . 0.24 105.267 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.2 m -116.5 141.42 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.589 -0.695 . . . . 0.65 109.251 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -120.72 143.56 48.7 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 122.04 0.924 . . . . 0.02 109.655 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -65.51 -34.55 78.52 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.472 -0.786 . . . . 0.02 111.595 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -125.52 157.84 66.72 Favored Pre-proline 0 N--CA 1.504 2.229 0 O-C-N 120.985 -1.072 . . . . 0.02 109.45 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -53.71 167.54 0.98 Allowed 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.711 1.607 . . . . 0.02 112.992 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 63.22 36.59 11.82 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 115.191 -0.913 . . . . 0.02 111.136 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 45.03 51.92 8.58 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.671 0.748 . . . . 3.39 110.674 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.9 t -125.94 163.66 22.5 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.183 0.516 . . . . 2.33 109.811 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.99 -162.08 32.3 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.744 -1.342 . . . . 0.02 109.744 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -66.06 138.58 57.87 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.079 -1.248 . . . . 0.02 110.204 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 23.4 ptm -118.87 137.12 53.66 Favored 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.326 0.584 . . . . 5.01 109.666 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -134.04 139.33 45.93 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.484 -0.76 . . . . 0.02 109.735 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.3 mm -95.35 131.04 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 109.048 -0.723 . . . . 1.72 109.048 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.537 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -119.56 111.3 36.4 Favored Pre-proline 0 N--CA 1.506 2.329 0 O-C-N 121.417 -0.802 . . . . 0.02 110.732 -178.259 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -78.28 168.98 20.87 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 CA-C-N 119.859 0.985 . . . . 1.47 110.258 177.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -54.19 141.0 30.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.812 -1.18 . . . . 4.25 110.593 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.31 -177.67 32.38 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.548 -1.311 . . . . 0.02 110.604 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -119.95 131.67 55.27 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.534 -0.98 . . . . 0.96 109.618 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.537 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 67.9 m-85 -120.4 95.86 49.04 Favored Pre-proline 0 N--CA 1.493 1.715 0 N-CA-C 108.144 -1.058 . . . . 0.02 108.144 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -68.29 -5.75 15.73 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 120.77 0.98 . . . . 0.02 113.394 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -156.74 154.08 29.43 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.653 -1.279 . . . . 2.02 107.705 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -60.04 -37.92 81.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.627 -0.671 . . . . 0.02 112.157 -177.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -59.8 -23.35 63.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.066 -1.021 . . . . 0.02 110.442 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -70.54 -19.21 62.91 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.822 0.82 . . . . 3.42 109.053 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.543 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.8 t90 -108.01 9.84 28.41 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.672 -1.233 . . . . 0.02 107.672 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.2 mtt 61.14 22.57 12.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.588 -0.695 . . . . 0.02 110.622 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.67 143.89 46.4 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.526 -1.43 . . . . 0.02 109.526 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.2 mt -79.2 -30.86 43.55 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.525 -1.287 . . . . 0.98 107.525 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.612 ' ND2' ' H ' ' A' ' 77' ' ' ASP . 18.0 t30 -157.33 -171.71 3.71 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 106.206 -1.775 . . . . 0.02 106.206 178.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.612 ' H ' ' ND2' ' A' ' 76' ' ' ASN . 72.0 m-20 -98.71 28.62 4.15 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.65 -1.281 . . . . 0.02 110.633 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.4 ttp180 -96.66 122.08 39.2 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.827 -1.171 . . . . 3.2 111.107 -178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.2 mt -142.91 121.83 12.76 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.473 -1.306 . . . . 2.61 107.473 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.6 -17.21 9.37 Favored Glycine 0 N--CA 1.502 3.082 0 O-C-N 121.15 -0.969 . . . . 0.02 112.894 -177.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.0 t -156.36 156.13 33.37 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.019 -1.871 . . . . 0.02 110.761 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.2 p -145.24 147.33 32.28 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.395 -0.816 . . . . 0.02 110.609 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 33.9 mtp180 -137.74 143.19 41.06 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.568 -0.707 . . . . 0.01 109.208 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.36 132.48 36.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.43 109.724 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.2 t -91.64 125.35 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.056 -0.72 . . . . 1.25 109.056 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -93.51 131.78 38.42 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.752 -1.217 . . . . 1.77 108.835 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.4 mt -98.15 141.62 30.84 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.369 -0.832 . . . . 1.63 109.147 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.1 m -111.78 124.86 53.24 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.547 -0.909 . . . . 1.08 108.547 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.4 t -116.57 134.02 55.33 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.686 -1.259 . . . . 1.26 108.173 177.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.66 -48.13 0.01 OUTLIER Glycine 0 N--CA 1.505 3.245 0 C-N-CA 117.677 -2.201 . . . . 0.01 114.077 -177.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -168.0 -105.45 0.18 Allowed Glycine 0 N--CA 1.491 2.364 0 CA-C-N 120.336 2.068 . . . . 0.01 111.29 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -120.01 117.98 29.46 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.998 -1.295 . . . . 4.43 110.391 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.56 129.93 35.37 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.74 -0.784 . . . . 2.99 109.291 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -129.22 140.84 51.32 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.46 -0.775 . . . . 6.36 109.158 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.9 tt -128.49 144.55 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.35 0 O-C-N 121.306 -0.871 . . . . 1.09 110.215 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -122.81 133.59 54.44 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.562 -1.273 . . . . 2.05 107.562 177.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.0 m -124.53 146.15 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 120.679 -1.263 . . . . 1.1 109.788 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.581 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 77.5 m-85 -118.67 141.56 48.49 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-O 121.99 0.9 . . . . 0.73 111.11 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -67.73 -30.9 70.5 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 116.012 -0.54 . . . . 0.02 111.829 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -116.54 167.43 11.07 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.023 -1.048 . . . . 3.18 110.413 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.403 ' CA ' ' ND1' ' A' ' 127' ' ' HIS . . . -66.68 164.07 42.89 Favored Glycine 0 N--CA 1.493 2.447 0 CA-C-O 121.989 0.771 . . . . 0.01 111.309 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.0 t70 56.45 39.13 30.11 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.647 0.737 . . . . 0.01 110.965 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 52.24 55.14 9.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.69 -0.631 . . . . 0.01 110.985 177.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -129.09 165.19 21.72 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.047 -1.094 . . . . 3.15 108.047 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.53 -163.93 27.7 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.27 -1.532 . . . . 0.01 109.27 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.519 ' NE2' ' HH ' ' A' ' 108' ' ' TYR . 9.2 tt0 -75.96 144.11 41.17 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.928 -1.336 . . . . 0.01 108.782 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.581 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 25.3 ttp -116.52 142.36 46.98 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.473 0.654 . . . . 0.01 109.928 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.519 ' HH ' ' NE2' ' A' ' 106' ' ' GLN . 60.9 m-85 -131.12 136.34 48.28 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.231 -1.026 . . . . 2.48 108.231 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -117.74 134.15 55.2 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.666 -0.646 . . . . 0.01 110.127 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.5 t -148.98 149.11 30.62 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.025 -1.047 . . . . 1.69 111.087 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 37.4 p -111.04 9.64 22.09 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 115.505 -0.77 . . . . 0.01 110.349 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -120.82 163.12 18.65 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 121.234 -0.916 . . . . 3.21 111.56 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.69 156.92 35.78 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.318 -0.993 . . . . 0.01 108.318 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 20.6 t -127.55 113.8 21.03 Favored Pre-proline 0 N--CA 1.498 1.973 0 N-CA-C 108.846 -0.798 . . . . 0.01 108.846 178.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -75.01 -27.7 9.78 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 CA-C-N 120.389 1.175 . . . . 0.01 110.911 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.2 t -143.05 109.01 5.18 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.336 -0.853 . . . . 0.02 109.137 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.41 HG21 HD12 ' A' ' 117' ' ' ILE . 87.1 mt -63.45 -39.24 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.892 -0.505 . . . . 1.83 110.547 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 118' ' ' MET . 0.7 OUTLIER -68.73 -37.27 79.32 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.277 -0.969 . . . . 1.34 110.365 -178.308 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -69.8 -38.66 76.72 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.4 -1.437 . . . . 2.11 109.974 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -79.71 -46.54 16.89 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.291 -0.881 . . . . 2.08 112.264 -177.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -111.05 0.49 16.95 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.312 -0.867 . . . . 0.02 112.674 -176.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 59.95 33.53 21.48 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.737 -1.227 . . . . 0.02 109.442 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.2 mt -112.62 135.38 53.41 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 108.713 -0.847 . . . . 0.02 108.713 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -91.25 -22.86 20.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.144 -0.972 . . . . 5.32 110.246 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -149.62 164.33 35.46 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.241 -0.912 . . . . 0.02 109.791 -178.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.7 mt -131.74 128.64 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 107.65 -1.241 . . . . 2.17 107.65 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 127' ' ' HIS . 51.4 t-80 -107.97 -12.85 15.08 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.421 -0.799 . . . . 0.02 112.107 -177.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.4 m -159.15 150.62 20.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.004 -1.06 . . . . 0.01 109.018 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 6.0 p -169.39 148.45 3.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.39 -0.818 . . . . 1.22 109.045 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -122.96 113.4 19.03 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 122.396 1.093 . . . . 1.41 110.102 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 t -112.09 129.86 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 107.351 -1.352 . . . . 0.01 107.351 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 96.3 t -129.61 93.9 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 107.392 -1.336 . . . . 1.98 107.392 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.462 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 3.5 tm-20 -146.97 -78.48 0.17 Allowed 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 105.87 -1.9 . . . . 0.01 105.87 177.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 173.24 -69.49 0.1 Allowed Glycine 0 N--CA 1.484 1.882 0 N-CA-C 108.77 -1.732 . . . . 0.01 108.77 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.9 p -120.51 114.04 21.19 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.587 -0.949 . . . . 2.3 110.387 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.462 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 6.5 m95 -124.94 148.8 48.18 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 107.303 -1.369 . . . . 0.01 107.303 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.8 mt -121.58 136.46 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 120.452 -1.405 . . . . 1.69 110.184 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -115.32 144.35 43.89 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.69 -1.226 . . . . 2.49 107.69 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 8.9 m-85 -123.45 144.04 49.77 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.324 -0.86 . . . . 0.02 109.648 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -75.9 -28.95 58.28 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.698 -0.626 . . . . 0.02 111.881 -176.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 47.3 mt -114.64 151.37 45.25 Favored Pre-proline 0 N--CA 1.504 2.267 0 O-C-N 120.712 -1.242 . . . . 1.48 109.014 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -53.6 167.36 0.97 Allowed 'Trans proline' 0 N--CA 1.49 1.275 0 CA-C-O 122.555 0.981 . . . . 0.02 112.543 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.6 m120 59.51 30.45 20.11 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 115.023 -0.99 . . . . 0.75 111.268 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.428 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.7 m-85 57.8 51.3 9.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.429 -0.794 . . . . 0.02 111.236 177.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -126.24 164.25 21.39 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.498 -0.751 . . . . 0.02 109.993 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.23 -165.25 32.64 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.352 -1.099 . . . . 0.02 110.352 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.573 ' CZ ' ' HH ' ' A' ' 149' ' ' TYR . 16.6 ttp180 -69.19 142.29 54.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.685 -0.891 . . . . 0.02 109.122 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -114.58 148.42 38.06 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.343 0.592 . . . . 0.02 110.134 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.573 ' HH ' ' CZ ' ' A' ' 147' ' ' ARG . 80.9 m-85 -124.07 134.3 53.43 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 109.019 -0.734 . . . . 0.01 109.019 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.1 tt -98.51 121.55 40.59 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.852 -1.155 . . . . 0.01 108.86 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 42.5 tp -97.3 142.45 29.17 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.212 -0.93 . . . . 0.01 108.67 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -107.13 -113.3 0.28 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.612 -0.68 . . . . 2.27 109.662 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -149.04 57.28 1.02 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.129 -0.982 . . . . 1.84 109.212 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -118.11 -179.31 3.73 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.386 -0.821 . . . . 2.28 109.091 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -106.49 107.41 18.4 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.63 -0.878 . . . . 0.01 108.63 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 156' ' ' TYR . 30.9 m-85 -98.78 113.44 25.55 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.29 -0.881 . . . . 0.01 110.328 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -93.51 -24.66 17.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.0 -1.062 . . . . 0.01 110.445 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -129.08 154.51 80.45 Favored Pre-proline 0 N--CA 1.498 1.974 0 N-CA-C 107.969 -1.123 . . . . 2.54 107.969 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -58.09 -38.62 90.87 Favored 'Trans proline' 0 N--CA 1.489 1.214 0 CA-C-N 119.467 0.845 . . . . 0.7 110.245 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.2 t -63.77 -24.71 36.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.825 -1.172 . . . . 0.86 109.586 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.06 -18.14 65.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.592 -1.317 . . . . 0.02 109.938 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.569 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 12.4 t90 -100.18 9.03 43.4 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.789 -1.189 . . . . 0.02 107.789 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.09 10.12 86.43 Favored Glycine 0 N--CA 1.485 1.96 0 C-N-CA 120.229 -0.986 . . . . 0.02 111.244 178.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.63 140.98 33.03 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.073 -1.251 . . . . 0.02 110.207 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -87.23 -11.85 48.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.627 -0.671 . . . . 0.59 110.733 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 43.5 m -147.83 149.85 34.44 Favored Pre-proline 0 N--CA 1.499 1.994 0 O-C-N 120.547 -1.345 . . . . 0.87 108.895 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -78.1 22.86 0.6 Allowed 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 120.879 1.052 . . . . 0.38 112.872 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.43 ' O ' ' CD1' ' A' ' 169' ' ' ILE . . . -83.61 124.32 30.68 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.708 -1.245 . . . . 0.18 111.784 -177.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.43 ' CD1' ' O ' ' A' ' 168' ' ' ALA . 4.8 mm -147.83 129.52 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 106.908 -1.516 . . . . 3.99 106.908 178.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -112.58 -18.38 12.4 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 120.998 -1.064 . . . . 5.17 113.475 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.4 p -157.21 161.0 39.26 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 119.36 -2.088 . . . . 0.02 110.117 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.418 ' CD1' ' C ' ' A' ' 172' ' ' PHE . 19.8 p90 -152.27 152.4 32.12 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.051 -1.03 . . . . 2.02 110.809 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.428 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 26.0 mtp180 -144.49 149.92 36.75 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.38 -0.825 . . . . 0.01 110.155 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 60.4 mtm180 -87.76 144.1 26.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.535 -0.728 . . . . 0.01 109.363 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.2 mt -94.82 128.57 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.282 -0.886 . . . . 3.04 109.149 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.1 t -136.44 146.68 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.254 -0.903 . . . . 1.89 109.65 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 4.89 109.476 179.935 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.452 ' O ' ' O ' ' A' ' 2' ' ' LYS . 90.6 p . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.442 -0.577 . . . . 5.28 109.442 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.523 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 3.1 mptp? 55.04 113.32 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.613 -0.68 . . . . 5.96 109.718 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.5 p -89.02 -139.37 0.13 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.19 -1.411 . . . . 2.22 107.19 177.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.29 -175.81 46.06 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 117.406 -2.331 . . . . 0.81 112.634 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.8 160.24 44.8 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.287 -1.525 . . . . 0.01 109.287 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -148.55 136.94 21.25 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.124 -1.221 . . . . 0.02 110.376 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.41 HD13 HG23 ' A' ' 7' ' ' ILE . 7.3 tt -130.66 140.55 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 109.073 -0.714 . . . . 0.02 109.073 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.1 m -121.78 130.82 53.69 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.4 -0.812 . . . . 0.39 109.979 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.4 m-85 -110.6 140.54 44.82 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.624 -0.673 . . . . 0.02 109.38 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.516 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 5.1 m-85 -122.8 139.17 54.29 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.223 -0.923 . . . . 0.02 109.646 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -69.75 -27.77 65.21 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.167 -0.958 . . . . 0.03 112.097 -178.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 2.9 m-20 -114.24 169.44 9.03 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.887 -1.133 . . . . 0.03 110.225 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -75.04 157.81 34.22 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.69 0.757 . . . . 0.03 109.982 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.2 t30 66.54 33.47 6.63 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.918 0.866 . . . . 0.74 111.158 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 55.58 41.91 30.15 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.249 0.547 . . . . 0.02 111.413 177.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -112.86 165.75 12.02 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.244 -1.021 . . . . 0.02 108.244 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.48 -167.84 34.29 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.85 -1.167 . . . . 0.03 110.677 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.564 HH11 ' CG ' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -70.11 144.02 52.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.419 -1.047 . . . . 2.76 108.999 179.453 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -120.2 148.63 43.43 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.559 -0.713 . . . . 1.89 110.219 -178.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -131.99 127.31 35.99 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.221 -1.029 . . . . 0.02 108.221 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.46 136.9 51.4 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.42 -0.8 . . . . 1.12 109.779 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 13.2 t -130.94 138.73 49.88 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.446 0.641 . . . . 0.02 109.654 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.3 p30 -116.77 11.23 14.48 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.631 -0.668 . . . . 0.2 109.77 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.458 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 28.2 p -158.74 174.91 14.3 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.348 -0.982 . . . . 1.23 108.348 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -60.94 143.88 54.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.665 -1.272 . . . . 0.02 109.832 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 43.5 t -131.28 117.48 19.02 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.51 -0.922 . . . . 0.02 108.51 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.437 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -78.07 -25.08 47.52 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.045 -1.035 . . . . 0.24 110.989 -178.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -155.1 102.38 2.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.025 -1.047 . . . . 1.14 109.256 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -102.65 10.08 38.89 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 122.017 0.913 . . . . 6.37 109.753 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -59.68 -25.41 64.73 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.532 -0.73 . . . . 3.11 111.582 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.2 m -76.24 -17.15 59.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.522 -1.361 . . . . 0.88 110.609 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -104.06 -21.91 13.52 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.387 -0.82 . . . . 0.02 109.457 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.5 tp -149.92 128.56 12.36 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.328 -0.858 . . . . 3.32 109.159 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.7 p -85.71 -10.96 54.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.642 -0.661 . . . . 0.02 111.069 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -171.72 162.3 6.23 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.927 -1.138 . . . . 0.02 107.927 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.2 p -141.48 113.95 8.24 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.987 -1.07 . . . . 0.02 108.452 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.17 0.17 27.1 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.767 -1.208 . . . . 0.03 110.964 -178.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 m -154.44 155.65 35.34 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.669 -1.234 . . . . 0.02 107.669 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.5 mt -146.24 145.51 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.795 -1.19 . . . . 0.02 110.928 -178.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -124.09 124.84 43.4 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.874 -1.158 . . . . 0.02 107.874 177.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.6 t -105.16 114.03 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 106.745 -1.576 . . . . 0.02 106.745 177.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -84.7 -34.74 22.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.559 -0.713 . . . . 3.81 110.101 -178.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.01 150.54 19.55 Favored Glycine 0 N--CA 1.488 2.128 0 C-N-CA 118.514 -1.803 . . . . 0.02 110.722 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.19 172.15 48.84 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 120.027 -1.082 . . . . 0.01 110.563 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.9 m -119.42 135.03 54.93 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 107.711 -1.218 . . . . 1.48 107.711 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.448 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 32.7 m95 -127.49 155.0 44.44 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 122.584 1.183 . . . . 0.02 112.462 -176.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.99 134.51 51.54 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 105.545 -2.02 . . . . 0.24 105.545 176.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.7 m -119.03 143.63 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.585 -0.697 . . . . 0.65 109.158 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -120.84 146.05 46.96 Favored 'General case' 0 N--CA 1.503 2.204 0 CA-C-O 122.143 0.973 . . . . 0.02 109.949 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -67.35 -34.59 77.62 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.839 -0.619 . . . . 0.02 111.392 -177.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -125.17 157.91 65.51 Favored Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 121.047 -1.033 . . . . 0.02 109.379 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -53.84 166.4 1.45 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 121.63 1.553 . . . . 0.02 113.242 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 63.9 36.66 10.05 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.218 -0.901 . . . . 0.02 111.116 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 45.36 51.68 9.35 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.667 0.746 . . . . 3.39 110.633 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.7 m -126.11 163.64 22.66 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.13 0.491 . . . . 2.33 109.714 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.8 -161.82 32.35 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.803 -1.319 . . . . 0.02 109.803 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -66.16 140.1 58.18 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.081 -1.247 . . . . 0.02 110.314 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.452 ' SD ' ' C ' ' A' ' 58' ' ' MET . 10.4 tmm? -119.37 136.81 54.1 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.76 -0.588 . . . . 5.01 109.639 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.418 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 97.9 m-85 -133.98 138.35 45.37 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.393 -0.817 . . . . 0.02 109.935 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.3 mm -96.23 132.17 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 109.205 -0.665 . . . . 1.72 109.205 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.1 mt -120.35 111.6 34.96 Favored Pre-proline 0 N--CA 1.505 2.288 0 O-C-N 121.413 -0.804 . . . . 0.02 110.897 -178.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -77.72 169.72 20.32 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 CA-C-N 119.79 0.961 . . . . 1.47 110.042 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -53.14 140.89 24.57 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.745 -1.222 . . . . 4.25 110.458 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.96 -178.05 31.88 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.505 -1.331 . . . . 0.02 110.746 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -120.47 131.76 54.9 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.454 -1.027 . . . . 0.96 109.822 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -121.11 94.98 48.91 Favored Pre-proline 0 N--CA 1.494 1.725 0 N-CA-C 108.094 -1.076 . . . . 0.02 108.094 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.402 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 3.4 Cg_exo -66.11 -4.65 10.71 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 120.829 1.019 . . . . 0.02 113.641 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 77.7 mt-10 -157.64 155.27 29.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.818 -1.176 . . . . 2.02 108.306 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -61.21 -38.53 86.92 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.371 -0.831 . . . . 0.02 112.08 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -59.95 -23.44 63.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.971 -1.081 . . . . 0.02 110.191 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -70.55 -19.38 62.89 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.706 0.765 . . . . 3.42 109.09 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.542 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 1.6 t90 -108.37 9.08 27.82 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.627 -1.249 . . . . 0.02 107.627 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 10.3 mtt 60.94 22.22 12.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.649 -0.657 . . . . 0.02 110.53 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.65 143.44 44.76 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.494 -1.443 . . . . 0.02 109.494 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 26.8 tp -78.96 -31.64 45.1 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.387 -1.338 . . . . 0.98 107.387 177.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -157.87 -172.31 3.88 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 106.191 -1.781 . . . . 0.02 106.191 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -98.67 28.46 4.24 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.591 -1.318 . . . . 0.02 110.805 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 -96.94 122.05 39.49 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.779 -1.201 . . . . 3.2 110.997 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.9 mt -144.03 122.19 12.2 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 107.627 -1.249 . . . . 2.61 107.627 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.55 -16.41 11.0 Favored Glycine 0 N--CA 1.504 3.211 0 O-C-N 121.279 -0.888 . . . . 0.02 112.741 -177.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 23.5 m -156.69 156.32 33.23 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.245 -1.738 . . . . 0.02 110.445 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 25.1 t -144.03 146.89 33.17 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.574 -0.704 . . . . 0.02 110.027 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -138.47 143.6 39.69 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.174 -0.954 . . . . 0.01 109.691 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.86 132.78 36.18 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.282 -0.886 . . . . 0.43 110.001 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.6 t -92.18 126.14 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 109.363 -0.606 . . . . 1.25 109.363 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -94.48 130.92 40.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.741 -1.224 . . . . 1.77 109.379 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.7 mt -97.7 142.69 29.18 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.384 -0.823 . . . . 1.63 109.07 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 51.7 p -113.33 126.41 55.35 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.331 -0.855 . . . . 1.08 109.422 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 90' ' ' GLY . 54.5 m -108.15 9.33 28.24 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 106.766 -1.568 . . . . 1.26 106.766 176.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 89' ' ' SER . . . -26.35 -49.83 0.05 OUTLIER Glycine 0 N--CA 1.495 2.583 0 CA-C-N 115.54 -0.755 . . . . 0.01 112.528 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.76 -105.89 0.19 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 118.724 -1.703 . . . . 0.01 111.737 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.428 ' NE2' ' C ' ' A' ' 92' ' ' GLN . 0.8 OUTLIER -122.07 120.47 34.4 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.125 -1.221 . . . . 4.43 110.434 -178.317 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.48 129.28 34.41 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.893 -0.723 . . . . 2.99 109.637 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -130.57 143.02 50.48 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 108.605 -0.887 . . . . 6.36 108.605 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.405 ' C ' ' NE2' ' A' ' 96' ' ' GLN . 4.7 tt -129.35 145.22 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 121.151 -0.968 . . . . 1.09 110.708 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.629 ' NE2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -122.93 133.26 54.4 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 107.599 -1.26 . . . . 2.05 107.599 177.296 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.5 m -124.26 146.2 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 O-C-N 120.658 -1.276 . . . . 1.1 109.826 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.584 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 71.7 m-85 -118.83 141.09 48.96 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.939 0.876 . . . . 0.73 110.862 -178.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -66.09 -30.13 70.59 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 116.09 -0.504 . . . . 0.02 111.572 -178.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -117.3 170.88 8.35 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.024 -1.047 . . . . 3.18 110.247 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.41 169.88 43.21 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.862 -0.895 . . . . 0.01 110.862 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 52.92 38.95 28.3 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.501 0.667 . . . . 0.01 111.663 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 52.25 48.93 21.64 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.495 -0.753 . . . . 0.01 111.022 178.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -123.42 165.95 16.19 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.311 -0.996 . . . . 3.15 108.311 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.02 -164.36 28.58 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.538 -1.425 . . . . 0.01 109.538 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -76.38 144.97 39.73 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.942 -1.328 . . . . 0.01 108.569 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.584 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 28.3 ttp -117.09 142.65 46.72 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.637 0.732 . . . . 0.01 110.028 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -131.15 137.07 48.85 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.067 -1.086 . . . . 2.48 108.067 178.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -118.3 133.76 55.61 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.611 -0.681 . . . . 0.01 110.153 -178.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.2 t -148.6 148.61 30.33 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.284 1.04 . . . . 1.69 111.061 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 31.2 p -111.38 9.7 21.51 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 115.435 -0.802 . . . . 0.01 110.26 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -121.2 163.01 19.17 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.204 -0.935 . . . . 3.21 111.479 -178.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.05 156.27 37.75 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.645 -0.872 . . . . 0.01 108.645 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.489 ' SG ' ' OE1' ' A' ' 120' ' ' GLN . 23.9 t -127.7 114.15 20.82 Favored Pre-proline 0 N--CA 1.5 2.032 0 N-CA-C 108.795 -0.817 . . . . 0.01 108.795 178.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -74.59 -29.0 9.45 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 CA-C-N 120.364 1.166 . . . . 0.01 111.07 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 65.3 m -142.58 108.94 5.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.41 -0.806 . . . . 0.02 108.954 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 92.1 mt -63.54 -38.64 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.936 -0.477 . . . . 1.83 110.674 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 118' ' ' MET . 12.2 tmm? -68.32 -37.23 80.35 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.31 -0.956 . . . . 1.34 110.048 -178.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -69.54 -38.54 77.52 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.578 -1.326 . . . . 2.11 110.074 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.489 ' OE1' ' SG ' ' A' ' 114' ' ' CYS . 50.5 tt0 -79.82 -46.84 16.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.279 -0.888 . . . . 2.08 112.333 -177.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.452 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 32.5 m-85 -111.0 0.01 16.83 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.379 -0.826 . . . . 0.02 112.712 -176.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 59.93 33.44 21.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.774 -1.204 . . . . 0.02 109.433 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 11.0 mt -112.52 135.81 52.78 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 108.77 -0.826 . . . . 0.02 108.77 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -91.8 -22.68 20.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.198 -0.939 . . . . 5.32 110.361 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -149.64 164.08 36.15 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.169 -0.957 . . . . 0.02 109.981 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.411 HD12 HG21 ' A' ' 126' ' ' ILE . 42.2 mt -132.1 128.92 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 107.751 -1.203 . . . . 2.17 107.751 178.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -108.54 -11.91 15.06 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.343 -0.848 . . . . 0.02 112.278 -177.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.4 m -159.1 151.73 21.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.948 -1.095 . . . . 0.01 108.765 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 8.2 t -165.38 149.01 8.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.107 -0.996 . . . . 1.22 109.157 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.415 ' O ' ' OE1' ' A' ' 96' ' ' GLN . 7.2 ttpt -119.49 108.24 14.28 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 122.339 1.066 . . . . 1.41 109.28 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.2 t -113.52 127.15 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.555 -1.276 . . . . 0.01 107.555 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.9 t -131.42 94.18 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 107.632 -1.247 . . . . 1.98 107.632 177.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.599 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 26.7 tt0 -147.46 -77.2 0.17 Allowed 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 105.772 -1.936 . . . . 0.01 105.772 177.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 170.64 -63.59 0.17 Allowed Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.737 -1.745 . . . . 0.01 108.737 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.8 p -123.33 113.2 18.54 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.497 -1.002 . . . . 2.3 110.846 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.599 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 9.8 m95 -126.07 147.15 49.65 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 107.335 -1.358 . . . . 0.01 107.335 178.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.5 mt -121.86 136.2 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 O-C-N 120.568 -1.332 . . . . 1.69 110.248 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -116.17 145.28 43.21 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.339 -1.356 . . . . 2.49 107.339 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.5 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 15.2 m-85 -123.21 143.75 49.83 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.311 -0.868 . . . . 0.02 109.722 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -74.59 -29.31 61.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.523 -0.735 . . . . 0.02 111.74 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.4 mt -115.78 154.9 48.16 Favored Pre-proline 0 N--CA 1.503 2.212 0 O-C-N 120.697 -1.252 . . . . 1.48 109.054 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -56.06 166.9 2.75 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 121.123 1.215 . . . . 0.02 112.802 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.2 m120 59.79 31.24 20.69 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.043 -0.98 . . . . 0.75 111.437 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 57.68 51.62 9.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.513 -0.742 . . . . 0.02 111.141 177.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 41.2 mtm180 -127.1 164.91 20.55 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.531 -0.73 . . . . 0.02 110.241 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.74 -165.67 33.64 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.538 -1.025 . . . . 0.02 110.538 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -69.25 142.33 54.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.539 -0.977 . . . . 0.02 108.98 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -113.64 148.33 36.47 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.834 -0.541 . . . . 0.02 110.344 -178.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -124.23 133.56 53.49 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 108.853 -0.795 . . . . 0.01 108.853 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.2 tt -100.22 122.47 43.08 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.06 -1.025 . . . . 0.01 109.231 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.6 mp -98.12 147.03 24.98 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.235 -1.024 . . . . 0.01 108.235 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -105.06 -121.08 0.22 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.627 -0.671 . . . . 2.27 110.009 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -139.28 53.32 1.73 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.229 -0.919 . . . . 1.84 109.401 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -116.38 -172.35 2.17 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.406 -0.809 . . . . 2.28 109.195 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -105.55 109.51 21.51 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.39 -0.967 . . . . 0.01 108.39 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.606 ' CG ' ' NE1' ' A' ' 162' ' ' TRP . 35.9 m-85 -98.58 111.36 23.75 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.239 -0.913 . . . . 0.01 110.575 -178.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -95.65 -22.22 17.71 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.21 -0.931 . . . . 0.01 111.298 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 39.6 mttp -127.51 154.59 77.49 Favored Pre-proline 0 N--CA 1.502 2.153 0 O-C-N 121.142 -0.974 . . . . 2.54 108.656 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -59.59 -39.05 78.27 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 120.423 0.748 . . . . 0.7 110.596 178.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.99 -20.08 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.895 -1.128 . . . . 0.86 109.079 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -65.33 -15.48 62.59 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.946 -1.096 . . . . 0.02 110.134 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.606 ' NE1' ' CG ' ' A' ' 156' ' ' TYR . 9.6 m0 -97.55 11.85 35.47 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.245 -0.909 . . . . 0.02 108.94 178.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.14 10.07 85.92 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.767 -1.206 . . . . 0.02 111.089 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.03 141.08 32.23 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.193 -1.181 . . . . 0.02 110.073 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.12 -8.95 58.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.654 -0.654 . . . . 0.59 109.797 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.3 p -143.59 150.74 51.88 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 121.044 -1.035 . . . . 0.87 108.924 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -76.04 18.74 0.63 Allowed 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 120.704 0.936 . . . . 0.38 112.3 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.43 ' O ' ' CD1' ' A' ' 169' ' ' ILE . . . -83.07 122.24 28.09 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.824 -1.173 . . . . 0.18 111.321 -178.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.43 ' CD1' ' O ' ' A' ' 168' ' ' ALA . 4.1 mm -146.54 126.82 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 106.521 -1.659 . . . . 3.99 106.521 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -112.16 -18.09 12.65 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.955 -1.091 . . . . 5.17 113.405 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.6 p -157.49 160.67 38.49 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 119.196 -2.19 . . . . 0.02 110.179 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 172' ' ' PHE . 21.0 p90 -151.45 152.26 32.78 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.069 -1.019 . . . . 2.02 110.481 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -145.26 150.67 37.09 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.857 0.837 . . . . 0.01 110.393 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -89.11 145.24 25.58 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.138 -0.69 . . . . 0.01 109.138 178.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.1 mt -95.85 129.81 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.399 -0.813 . . . . 3.04 108.89 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 25.4 m -137.76 147.63 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.088 -1.007 . . . . 1.89 109.912 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.371 -0.831 . . . . 4.89 109.366 179.479 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 81.7 p . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.471 -0.566 . . . . 5.28 109.471 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -154.19 116.57 4.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.203 -0.936 . . . . 5.96 109.226 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.415 ' OG1' ' N ' ' A' ' 4' ' ' GLY . 3.4 t -89.44 -139.72 0.13 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.282 -1.377 . . . . 2.22 107.282 177.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.415 ' N ' ' OG1' ' A' ' 3' ' ' THR . . . 175.14 -177.14 47.21 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 117.472 -2.299 . . . . 0.81 112.765 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.88 159.61 44.0 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.706 -1.357 . . . . 0.01 109.706 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -144.13 133.57 23.32 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.226 -1.161 . . . . 0.02 110.538 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.418 HG23 HD11 ' A' ' 7' ' ' ILE . 7.4 tt -129.45 139.41 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.11 -1.07 . . . . 0.02 108.11 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.1 m -120.99 129.14 53.29 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.291 -0.88 . . . . 0.39 110.103 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 9.1 m-85 -109.8 140.19 44.01 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.641 -0.874 . . . . 0.02 108.641 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.554 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.8 m-85 -121.9 138.09 54.53 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.334 -0.854 . . . . 0.02 109.446 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -68.69 -27.14 65.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -0.943 . . . . 0.03 111.389 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.0 OUTLIER -114.56 170.12 8.55 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.992 -1.068 . . . . 0.03 109.958 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -75.98 161.87 28.56 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.633 0.73 . . . . 0.03 110.4 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 62.9 33.02 15.39 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.025 0.917 . . . . 0.74 110.916 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 55.46 40.32 31.25 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.858 -0.61 . . . . 0.02 111.05 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -110.62 165.22 11.99 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.188 -1.041 . . . . 0.02 108.188 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.25 -167.91 34.67 Favored Glycine 0 N--CA 1.497 2.708 0 O-C-N 120.907 -1.12 . . . . 0.03 110.911 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.42 ' HG3' HH11 ' A' ' 18' ' ' ARG . 13.4 ttm-85 -69.95 143.46 52.65 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.471 -1.017 . . . . 2.76 109.316 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.1 ttp180 -122.03 149.98 42.74 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.38 -0.825 . . . . 1.89 110.431 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.49 ' CZ ' ' CG ' ' A' ' 32' ' ' TYR . 9.4 t80 -135.14 131.35 36.73 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.811 -0.811 . . . . 0.02 108.811 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -111.7 137.08 50.08 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.458 -0.776 . . . . 1.12 109.463 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 40.2 t -129.35 138.75 51.73 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 121.41 0.624 . . . . 0.02 109.629 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -117.7 11.9 13.8 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.545 -0.722 . . . . 0.2 110.245 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.483 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 42.5 t -159.17 174.24 15.15 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.916 -1.115 . . . . 1.23 108.757 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.473 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 17.6 p30 -61.74 145.14 53.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.613 -1.304 . . . . 0.02 110.219 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.423 ' CB ' ' CZ ' ' A' ' 29' ' ' PHE . 0.6 OUTLIER -134.35 119.12 18.25 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.543 -0.91 . . . . 0.02 108.543 178.59 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.62 -19.73 57.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.557 -0.715 . . . . 0.24 111.672 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -154.28 108.72 3.03 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.923 -1.111 . . . . 1.14 111.005 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.423 ' CZ ' ' CB ' ' A' ' 26' ' ' CYS . 22.2 m-85 -96.01 5.88 50.16 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.283 -0.886 . . . . 6.37 109.283 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -60.63 -30.7 70.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.282 -0.886 . . . . 3.11 112.246 -176.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.5 m -78.72 -19.07 53.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.271 -1.518 . . . . 0.88 111.55 -178.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.49 ' CG ' ' CZ ' ' A' ' 20' ' ' TYR . 65.2 m-85 -107.06 -21.83 12.86 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.266 -0.896 . . . . 0.02 110.819 -178.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.415 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 6.1 tp -149.16 127.63 12.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.895 -1.128 . . . . 3.32 109.793 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.9 m -86.56 -11.77 50.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.53 -0.731 . . . . 0.02 111.127 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.415 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 4.8 ptp180 -171.68 161.95 6.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.933 -1.105 . . . . 0.02 108.24 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -142.65 115.75 8.87 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.909 -1.119 . . . . 0.02 108.887 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -109.49 0.32 19.2 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.85 -1.156 . . . . 0.03 111.458 -178.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.3 m -156.8 153.81 28.9 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.385 -0.969 . . . . 0.02 108.385 178.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.0 mt -146.2 147.16 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-O 122.325 1.06 . . . . 0.02 111.176 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -122.59 123.66 41.71 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.738 -1.208 . . . . 0.02 107.738 176.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.3 t -106.8 115.2 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 106.902 -1.518 . . . . 0.02 106.902 177.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -83.31 -33.85 25.85 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 120.068 -0.653 . . . . 3.81 111.024 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.97 152.36 22.19 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 118.878 -1.63 . . . . 0.02 110.854 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.602 ' H ' ' NE2' ' A' ' 63' ' ' GLN . . . 83.59 173.24 49.59 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.66 -1.257 . . . . 0.01 110.418 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 65.6 m -119.6 135.16 54.92 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.033 -1.099 . . . . 1.48 108.033 178.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -127.31 155.98 42.68 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 122.639 1.209 . . . . 0.02 112.172 -176.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.422 ' O ' ' SG ' ' A' ' 82' ' ' CYS . . . -109.51 134.57 51.73 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 105.527 -2.027 . . . . 0.24 105.527 176.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.6 m -116.31 142.01 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.549 -0.719 . . . . 0.65 109.306 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -120.53 143.32 48.64 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 122.056 0.931 . . . . 0.02 109.508 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.504 ' OE1' ' CE1' ' A' ' 57' ' ' HIS . 36.9 tt0 -65.67 -33.37 75.73 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.671 -0.695 . . . . 0.02 111.712 -177.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 35.8 mtm180 -124.85 157.8 65.0 Favored Pre-proline 0 N--CA 1.503 2.194 0 O-C-N 120.991 -1.068 . . . . 0.02 109.368 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -53.31 167.36 0.83 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.753 1.635 . . . . 0.02 112.634 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 63.02 36.2 12.58 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 115.254 -0.885 . . . . 0.02 111.273 178.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.509 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 5.5 m-85 45.28 51.11 9.53 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.707 0.765 . . . . 3.39 110.706 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.8 m -125.54 163.57 22.41 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 121.2 0.524 . . . . 2.33 109.802 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.44 -161.67 31.39 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.844 -1.302 . . . . 0.02 109.844 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.504 ' CE1' ' OE1' ' A' ' 50' ' ' GLU . 10.1 m80 -65.13 137.84 57.9 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.11 -1.229 . . . . 0.02 110.219 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.496 ' SD ' ' O ' ' A' ' 58' ' ' MET . 2.8 ppp? -118.68 137.49 53.28 Favored 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 121.357 0.599 . . . . 5.01 109.553 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.437 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 81.6 m-85 -135.44 140.48 44.92 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.503 -0.748 . . . . 0.02 109.61 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.9 mm -95.19 131.05 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.607 -0.683 . . . . 1.72 109.164 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.531 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 1.0 OUTLIER -121.09 111.39 33.95 Favored Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 121.284 -0.885 . . . . 0.02 110.743 -178.284 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -77.27 169.02 22.07 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 CA-C-N 119.898 0.999 . . . . 1.47 110.371 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.602 ' NE2' ' H ' ' A' ' 44' ' ' GLY . 71.0 mt-30 -53.39 141.73 23.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.96 -1.087 . . . . 4.25 110.369 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.81 -177.7 31.96 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.523 -1.322 . . . . 0.02 110.755 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -120.21 131.56 55.02 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.464 -1.021 . . . . 0.96 109.661 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.531 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 59.5 m-85 -122.41 97.62 44.75 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 108.022 -1.103 . . . . 0.02 108.022 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.404 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 3.4 Cg_endo -68.77 -3.26 10.94 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 120.745 0.963 . . . . 0.02 113.898 -178.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 79.2 mt-10 -157.64 155.2 29.65 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.433 -1.417 . . . . 2.02 108.281 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -60.69 -39.1 87.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.63 -0.669 . . . . 0.02 112.108 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -60.28 -23.47 64.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.058 -1.026 . . . . 0.02 110.32 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -69.82 -18.75 63.47 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.88 -0.785 . . . . 3.42 108.88 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.56 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.7 t90 -107.95 10.95 28.29 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.464 -1.31 . . . . 0.02 107.464 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.3 mtt 61.21 22.49 12.82 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.476 0.655 . . . . 0.02 110.409 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.72 144.29 48.07 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.574 -1.41 . . . . 0.02 109.574 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.3 mp -79.78 -29.95 40.52 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.708 -1.219 . . . . 0.98 107.708 177.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -156.83 -171.17 3.56 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 106.342 -1.725 . . . . 0.02 106.342 178.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 23.0 p-10 -98.91 28.72 4.18 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.697 -1.252 . . . . 0.02 110.526 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -96.49 122.33 39.27 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.796 -1.19 . . . . 3.2 111.057 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.1 mt -141.92 119.83 11.97 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.609 -1.256 . . . . 2.61 107.609 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.51 -18.54 8.47 Favored Glycine 0 N--CA 1.499 2.853 0 O-C-N 121.245 -0.909 . . . . 0.02 112.809 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.509 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 12.6 t -156.0 156.48 34.54 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-N 120.324 2.062 . . . . 0.02 111.13 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 47' ' ' ALA . 11.9 t -146.45 148.78 32.61 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.342 -0.849 . . . . 0.02 110.723 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.425 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 52.1 mtp180 -138.16 143.13 40.13 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.509 -0.745 . . . . 0.01 109.345 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.19 132.46 36.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.102 -0.998 . . . . 0.43 109.938 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.9 t -91.12 125.01 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.571 -0.706 . . . . 1.25 109.139 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -93.97 131.89 38.97 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.877 -1.139 . . . . 1.77 109.079 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 mt -96.66 139.45 32.71 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.54 -0.911 . . . . 1.63 108.54 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.1 p -111.8 127.88 55.94 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.362 -0.836 . . . . 1.08 109.312 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.7 m -104.39 -153.97 0.49 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 106.492 -1.669 . . . . 1.26 106.492 176.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.33 -53.15 0.72 Allowed Glycine 0 N--CA 1.5 2.928 0 O-C-N 120.386 -1.446 . . . . 0.01 112.818 177.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.16 -101.65 0.16 Allowed Glycine 0 N--CA 1.491 2.337 0 C-N-CA 118.476 -1.821 . . . . 0.01 111.844 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -121.25 118.91 30.77 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.043 -1.269 . . . . 4.43 110.569 -178.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.0 129.62 34.65 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.79 -0.764 . . . . 2.99 109.349 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.449 ' NZ ' ' CB ' ' A' ' 94' ' ' LYS . 6.8 ttpm? -129.15 141.95 51.02 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.334 -0.854 . . . . 6.36 109.09 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.3 tt -128.64 144.92 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 O-C-N 121.352 -0.842 . . . . 1.09 110.237 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -122.67 134.02 54.49 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.911 -1.144 . . . . 2.05 107.911 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.1 m -123.78 145.05 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 120.823 -1.173 . . . . 1.1 110.051 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.572 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 47.5 m-85 -119.92 142.16 48.97 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-O 121.996 0.903 . . . . 0.73 111.098 -178.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -67.53 -31.84 72.21 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 116.06 -0.518 . . . . 0.02 111.745 -178.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -115.62 167.44 10.9 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 120.811 -1.181 . . . . 3.18 110.593 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.15 163.69 45.01 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.833 -0.907 . . . . 0.01 110.833 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 57.6 38.93 27.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.913 -0.757 . . . . 0.01 110.99 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 52.57 55.92 8.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.696 -0.627 . . . . 0.01 111.184 178.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -128.45 165.87 19.84 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.266 -1.013 . . . . 3.15 108.266 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.17 -163.39 27.81 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.234 -1.547 . . . . 0.01 109.234 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 38.4 tp60 -76.29 144.5 40.23 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.965 -1.315 . . . . 0.01 108.656 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.572 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 29.5 ttp -116.68 141.8 47.73 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.638 0.733 . . . . 0.01 109.812 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -131.57 136.3 47.7 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.328 -0.99 . . . . 2.48 108.328 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.521 ' OE2' ' N ' ' A' ' 110' ' ' THR . 1.9 tm-20 -118.12 133.9 55.49 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.559 -0.713 . . . . 0.01 109.997 -178.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.521 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 6.2 t -148.09 148.89 31.14 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.106 -0.996 . . . . 1.69 110.969 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 33.3 p -110.78 10.17 22.61 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 115.551 -0.75 . . . . 0.01 110.365 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -120.92 163.16 18.65 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.28 -0.888 . . . . 3.21 111.571 -178.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.06 156.67 36.9 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.255 -1.017 . . . . 0.01 108.255 178.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 19.8 t -125.92 112.53 24.53 Favored Pre-proline 0 N--CA 1.502 2.138 0 O-C-N 121.456 -0.778 . . . . 0.01 108.944 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -75.41 -31.63 5.56 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 120.133 1.083 . . . . 0.01 111.102 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 16.5 m -141.05 107.95 5.41 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.287 -0.883 . . . . 0.02 108.798 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.9 mt -63.36 -39.19 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.949 -0.469 . . . . 1.83 110.74 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 118' ' ' MET . 1.7 tmt? -67.81 -37.18 81.64 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.416 -0.914 . . . . 1.34 110.46 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -71.09 -39.26 72.23 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 120.464 -1.397 . . . . 2.11 110.243 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -79.56 -46.7 16.83 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.239 -0.913 . . . . 2.08 112.358 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -109.67 -0.11 18.74 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.34 -0.85 . . . . 0.02 112.531 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 58.85 32.03 21.84 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.687 -1.258 . . . . 0.02 108.865 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.7 mt -111.47 135.3 52.22 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.656 -0.868 . . . . 0.02 108.656 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -92.09 -23.4 19.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.158 -0.964 . . . . 5.32 110.031 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -149.76 163.41 38.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.231 -0.918 . . . . 0.02 109.839 -178.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 45.6 mt -133.31 130.32 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 107.493 -1.299 . . . . 2.17 107.493 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -107.83 -11.76 15.32 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.301 -0.875 . . . . 0.02 112.787 -177.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.9 m -158.98 152.7 23.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.734 -1.229 . . . . 0.01 108.82 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 9.2 t -167.65 147.67 5.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.121 -0.987 . . . . 1.22 109.123 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.442 ' NZ ' ' OE2' ' A' ' 155' ' ' GLU . 4.8 tptm -121.0 111.09 17.04 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 122.346 1.069 . . . . 1.41 109.717 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.2 t -112.23 128.7 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.603 -1.258 . . . . 0.01 107.603 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.2 t -129.81 94.02 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 106.922 -1.51 . . . . 1.98 106.922 177.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -146.84 -78.57 0.17 Allowed 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 105.824 -1.917 . . . . 0.01 105.824 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 178.51 -75.14 0.07 OUTLIER Glycine 0 N--CA 1.485 1.951 0 N-CA-C 108.144 -1.982 . . . . 0.01 108.144 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.22 120.55 35.51 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.654 -0.909 . . . . 2.3 110.12 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -126.42 151.0 48.29 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 106.77 -1.567 . . . . 0.01 106.77 179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 59.1 mt -121.41 135.13 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 120.552 -1.343 . . . . 1.69 110.495 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -111.03 142.73 42.79 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 106.269 -1.752 . . . . 2.49 106.269 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -122.76 143.49 49.79 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.014 -1.054 . . . . 0.02 109.763 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -74.66 -29.66 61.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.409 -0.807 . . . . 0.02 111.869 -176.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.4 mt -116.1 155.04 48.55 Favored Pre-proline 0 N--CA 1.506 2.372 0 O-C-N 120.793 -1.192 . . . . 1.48 108.983 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -55.92 167.36 2.37 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.116 1.211 . . . . 0.02 112.843 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.448 ' N ' ' ND2' ' A' ' 143' ' ' ASN . 2.2 m120 59.31 30.44 20.16 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.035 -0.984 . . . . 0.75 111.211 178.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 58.06 51.43 8.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.484 -0.76 . . . . 0.02 111.055 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -125.97 164.88 19.84 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.546 -0.721 . . . . 0.02 109.863 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.432 ' O ' ' OE1' ' A' ' 148' ' ' GLN . . . 88.79 -166.06 33.84 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.093 -1.203 . . . . 0.02 110.093 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -69.25 142.62 54.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.55 -0.971 . . . . 0.02 108.97 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.474 ' N ' ' CD ' ' A' ' 148' ' ' GLN . 0.1 OUTLIER -114.58 148.38 38.12 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.315 0.579 . . . . 0.02 110.155 -178.155 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 149' ' ' TYR . 13.1 m-85 -124.48 135.32 53.12 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.66 -0.867 . . . . 0.01 108.66 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.5 tt -98.33 122.44 41.5 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.872 -1.143 . . . . 0.01 109.253 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.406 ' CD1' ' N ' ' A' ' 151' ' ' LEU . 10.3 mp -96.43 146.86 24.4 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.294 -0.879 . . . . 0.01 109.043 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -104.68 -124.71 0.22 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.348 -0.845 . . . . 2.27 109.418 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -146.49 47.7 1.19 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.177 -0.952 . . . . 1.84 109.514 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -112.73 -161.26 0.75 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.543 -0.723 . . . . 2.28 109.168 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.442 ' OE2' ' NZ ' ' A' ' 130' ' ' LYS . 4.1 mm-40 -107.02 104.72 14.45 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.579 -0.701 . . . . 0.01 109.154 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.609 ' CD2' ' CD1' ' A' ' 162' ' ' TRP . 55.3 m-85 -98.15 111.27 23.66 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.249 -0.907 . . . . 0.01 109.448 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -94.39 -22.51 18.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.042 -1.036 . . . . 0.01 111.268 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -127.59 154.42 77.62 Favored Pre-proline 0 N--CA 1.503 2.177 0 O-C-N 120.977 -1.077 . . . . 2.54 108.548 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -59.71 -36.83 90.67 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 CA-C-N 119.148 0.731 . . . . 0.7 110.265 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 92.0 t -61.68 -19.78 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.975 -1.078 . . . . 0.86 109.094 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -65.57 -15.78 63.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.963 -1.086 . . . . 0.02 110.267 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.609 ' CD1' ' CD2' ' A' ' 156' ' ' TYR . 6.1 m0 -98.6 11.75 37.44 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.175 -0.953 . . . . 0.02 108.986 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.67 10.37 85.27 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 119.861 -1.161 . . . . 0.02 111.207 178.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.63 141.09 32.88 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.179 -1.189 . . . . 0.02 110.072 -178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.27 -9.32 57.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.627 -0.671 . . . . 0.59 110.062 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 39.8 m -143.94 150.09 48.31 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 120.921 -1.112 . . . . 0.87 109.098 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -76.41 18.43 0.69 Allowed 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 120.876 1.05 . . . . 0.38 112.512 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.75 123.45 28.77 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.794 -1.192 . . . . 0.18 111.698 -177.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 29.2 mm -148.52 127.96 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 106.77 -1.567 . . . . 3.99 106.77 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -112.31 -15.93 13.06 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.137 -0.977 . . . . 5.17 112.525 -178.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.419 ' HG ' ' N ' ' A' ' 172' ' ' PHE . 22.9 t -157.89 160.67 37.9 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 119.459 -2.026 . . . . 0.02 109.858 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 172' ' ' PHE . 18.0 p90 -151.12 152.93 34.08 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.18 -0.95 . . . . 2.02 110.113 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -145.0 150.26 36.59 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.192 -0.942 . . . . 0.01 110.408 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -88.81 144.8 25.99 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.925 -0.768 . . . . 0.01 108.925 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.9 mt -96.22 130.13 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.354 -0.841 . . . . 3.04 109.398 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 24.7 t -136.13 146.77 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.315 -0.866 . . . . 1.89 109.671 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.181 -0.949 . . . . 4.89 109.454 179.953 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.6 p . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.296 0.57 . . . . 5.28 109.494 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.9 mmtm -71.58 65.53 0.47 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 5.96 109.256 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.8 t -81.16 142.57 33.12 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.352 -0.981 . . . . 2.22 108.352 178.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.82 179.02 48.49 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 118.271 -1.919 . . . . 0.81 112.042 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.04 156.84 42.47 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.521 -1.432 . . . . 0.01 109.521 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.53 ' HZ1' HH21 ' A' ' 40' ' ' ARG . 26.0 ttpp -145.95 135.55 23.22 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.296 -1.12 . . . . 0.02 110.373 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.4 tt -129.63 139.1 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.02 -1.104 . . . . 0.02 108.02 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 m -120.61 129.25 53.66 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.35 -0.844 . . . . 0.39 110.316 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.437 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.9 m-85 -110.76 140.78 44.86 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.852 -0.795 . . . . 0.02 108.852 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.557 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.9 m-85 -122.57 138.61 54.52 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.294 -0.879 . . . . 0.02 109.425 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -68.91 -27.21 65.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.121 -0.987 . . . . 0.03 111.597 -178.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.3 m-20 -114.43 169.85 8.74 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.944 -1.098 . . . . 0.03 109.995 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -75.02 161.91 29.04 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.617 0.722 . . . . 0.03 110.262 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.592 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 11.4 t-20 62.45 35.11 14.97 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.892 0.853 . . . . 0.74 110.634 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.592 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.7 p90 49.27 43.16 22.8 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.478 -0.783 . . . . 0.02 110.94 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -109.62 165.91 11.31 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.676 -1.231 . . . . 0.02 107.676 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.7 -167.71 35.35 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 119.707 -1.235 . . . . 0.03 110.752 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.567 HH11 ' CG ' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -69.62 143.28 53.3 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.408 -1.054 . . . . 2.76 109.059 179.368 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -122.59 150.7 42.27 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.499 -0.75 . . . . 1.89 110.244 -178.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.472 ' CE1' ' CE1' ' A' ' 29' ' ' PHE . 34.4 t80 -136.34 133.11 36.48 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.689 -0.632 . . . . 0.02 109.678 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 20.6 p-10 -110.74 136.63 49.52 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.389 -0.819 . . . . 1.12 109.309 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 42.2 t -128.73 138.65 52.24 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.631 -0.668 . . . . 0.02 109.422 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.434 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 0.9 OUTLIER -118.93 11.4 12.53 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.477 -0.765 . . . . 0.2 110.877 -179.406 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.491 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 8.0 p -159.31 173.84 15.68 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.644 -1.285 . . . . 1.23 109.305 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 22.8 p30 -62.13 145.22 53.97 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.684 -1.26 . . . . 0.02 110.361 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.553 ' CB ' ' CE2' ' A' ' 29' ' ' PHE . 51.2 t -134.49 118.44 17.34 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.529 -0.732 . . . . 0.02 109.046 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.81 -20.67 56.12 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.494 -0.754 . . . . 0.24 111.515 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -155.45 104.78 2.41 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.851 -1.155 . . . . 1.14 109.417 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.553 ' CE2' ' CB ' ' A' ' 26' ' ' CYS . 0.4 OUTLIER -101.82 9.03 41.11 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.321 -0.862 . . . . 6.37 109.934 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -60.32 -27.18 67.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.391 -0.818 . . . . 3.11 111.83 -177.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.3 t -77.89 -18.07 56.58 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.477 -1.389 . . . . 0.88 111.391 -178.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.551 ' CD1' ' N ' ' A' ' 32' ' ' TYR . 8.3 m-85 -106.64 -21.08 13.16 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.306 -0.871 . . . . 0.02 110.561 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.9 tp -148.66 127.16 12.35 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.95 -1.094 . . . . 3.32 109.472 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.3 t -87.53 -12.55 45.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.629 -0.669 . . . . 0.02 111.388 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -172.5 161.95 5.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.743 -1.223 . . . . 0.02 108.47 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.3 p -143.45 115.74 8.49 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.069 -1.02 . . . . 0.02 108.877 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.469 ' N ' HD21 ' A' ' 37' ' ' ASN . 1.5 m-80 -107.8 -0.41 21.65 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.812 -1.18 . . . . 0.03 111.007 -178.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.3 m -155.08 153.58 31.11 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.829 -1.175 . . . . 0.02 107.829 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.7 mt -146.83 147.14 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 122.205 1.002 . . . . 0.02 110.778 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.53 HH21 ' HZ1' ' A' ' 6' ' ' LYS . 35.3 ttp180 -124.03 124.73 43.19 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.181 -1.044 . . . . 0.02 108.181 177.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.8 t -106.68 115.27 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 106.876 -1.527 . . . . 0.02 106.876 177.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -83.88 -33.81 24.72 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.565 -0.709 . . . . 3.81 110.952 -177.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.13 152.64 22.57 Favored Glycine 0 N--CA 1.49 2.272 0 C-N-CA 118.811 -1.661 . . . . 0.02 110.877 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.45 172.98 49.39 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.688 -1.244 . . . . 0.01 110.468 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.1 m -119.85 134.94 55.07 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 107.97 -1.122 . . . . 1.48 107.97 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.42 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 35.3 m95 -127.46 156.11 42.63 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 122.595 1.188 . . . . 0.02 112.212 -176.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.83 134.39 52.1 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 105.613 -1.995 . . . . 0.24 105.613 176.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.7 m -117.09 142.6 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.53 -0.731 . . . . 0.65 109.14 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -120.68 143.57 48.65 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 122.093 0.949 . . . . 0.02 109.66 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -65.05 -33.7 76.67 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.584 -0.735 . . . . 0.02 111.534 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -125.3 157.95 65.73 Favored Pre-proline 0 N--CA 1.503 2.21 0 O-C-N 121.029 -1.044 . . . . 0.02 109.425 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -53.49 167.36 0.92 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.688 1.592 . . . . 0.02 112.916 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.532 ' N ' ' ND2' ' A' ' 53' ' ' ASN . 0.9 OUTLIER 63.36 36.31 11.66 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.232 -0.895 . . . . 0.02 111.134 178.19 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.414 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 4.9 m-85 44.92 51.65 8.51 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.614 0.721 . . . . 3.39 110.77 178.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.9 t -125.8 163.6 22.53 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.186 0.517 . . . . 2.33 109.846 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.33 -161.86 31.67 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.892 -1.283 . . . . 0.02 109.892 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 -65.54 139.03 58.43 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.038 -1.272 . . . . 0.02 110.245 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.495 ' SD ' ' O ' ' A' ' 58' ' ' MET . 2.6 ppp? -118.88 137.03 53.72 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.662 -0.649 . . . . 5.01 109.802 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.4 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 90.8 m-85 -134.06 138.86 45.59 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.497 -0.752 . . . . 0.02 109.693 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.7 mm -95.76 131.17 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.123 -0.695 . . . . 1.72 109.123 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.3 mt -120.77 111.78 34.2 Favored Pre-proline 0 N--CA 1.506 2.335 0 O-C-N 121.41 -0.806 . . . . 0.02 110.929 -178.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -77.53 169.25 21.33 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 CA-C-N 119.868 0.989 . . . . 1.47 110.126 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -53.29 141.26 24.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.878 -1.139 . . . . 4.25 110.368 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.23 -177.94 32.16 Favored Glycine 0 N--CA 1.496 2.667 0 C-N-CA 119.54 -1.314 . . . . 0.02 110.825 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -120.25 131.7 55.04 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.433 -1.039 . . . . 0.96 109.746 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -121.08 95.82 48.65 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 108.041 -1.096 . . . . 0.02 108.041 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -65.98 -4.7 10.62 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 120.761 0.974 . . . . 0.02 113.618 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -157.58 155.2 29.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.655 -1.278 . . . . 2.02 108.15 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -60.25 -38.6 83.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.576 -0.702 . . . . 0.02 112.029 -177.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -60.07 -23.42 63.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.142 -0.974 . . . . 0.02 110.293 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -70.79 -18.76 62.74 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.831 0.824 . . . . 3.42 109.063 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.54 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 1.6 t90 -107.9 9.8 28.65 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.424 -1.324 . . . . 0.02 107.424 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.8 mtt 60.83 22.08 12.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.601 -0.687 . . . . 0.02 110.419 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.89 143.83 46.8 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.336 -1.506 . . . . 0.02 109.336 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.427 HD11 ' H ' ' A' ' 76' ' ' ASN . 0.2 OUTLIER -78.71 -28.88 45.14 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.609 -1.256 . . . . 0.98 107.609 177.783 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.427 ' H ' HD11 ' A' ' 75' ' ' LEU . 65.6 m-80 -158.75 -171.69 3.52 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 106.286 -1.746 . . . . 0.02 106.286 178.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -98.53 29.01 3.85 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.642 -1.286 . . . . 0.02 110.472 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -97.86 122.77 41.37 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.974 -1.079 . . . . 3.2 111.43 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.3 mt -142.28 119.53 11.5 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 107.232 -1.396 . . . . 2.61 107.232 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.69 -18.6 9.94 Favored Glycine 0 N--CA 1.497 2.736 0 O-C-N 121.207 -0.933 . . . . 0.02 112.27 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.5 p -155.83 156.36 34.59 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 119.612 1.706 . . . . 0.02 110.839 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 20.5 p -146.14 148.47 32.62 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.453 -0.779 . . . . 0.02 110.529 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.414 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 50.5 mtp180 -138.55 143.12 39.3 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.473 -0.767 . . . . 0.01 109.327 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.28 132.16 36.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.128 -0.982 . . . . 0.43 109.829 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.4 t -90.76 125.23 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.529 -0.732 . . . . 1.25 109.117 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -93.87 132.18 38.54 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.701 -1.249 . . . . 1.77 109.26 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.1 mt -97.31 139.96 32.49 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.805 -0.813 . . . . 1.63 108.805 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.9 t -112.52 127.83 56.17 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.377 -0.827 . . . . 1.08 109.465 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 77.8 p -104.26 -154.43 0.5 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 106.602 -1.629 . . . . 1.26 106.602 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 139.25 -52.53 0.72 Allowed Glycine 0 N--CA 1.501 3.003 0 O-C-N 120.356 -1.465 . . . . 0.01 113.111 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.8 -101.66 0.16 Allowed Glycine 0 N--CA 1.49 2.281 0 C-N-CA 118.413 -1.851 . . . . 0.01 112.095 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -121.35 119.17 31.37 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.133 -1.216 . . . . 4.43 110.676 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.15 129.56 34.59 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.745 -0.782 . . . . 2.99 109.403 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -129.76 143.09 50.64 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.383 -0.823 . . . . 6.36 108.917 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.2 tt -128.84 145.0 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 O-C-N 121.292 -0.88 . . . . 1.09 110.437 -178.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -122.25 134.08 54.69 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.58 -1.266 . . . . 2.05 107.58 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.6 m -124.61 145.71 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 O-C-N 120.772 -1.205 . . . . 1.1 109.914 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.587 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 64.4 m-85 -119.35 141.62 48.87 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 121.971 0.891 . . . . 0.73 110.91 -178.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -67.23 -30.73 70.73 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 116.066 -0.515 . . . . 0.02 111.904 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.434 ' O ' ' OG ' ' A' ' 128' ' ' SER . 48.0 mttm -116.35 167.46 11.01 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.97 -1.082 . . . . 3.18 110.492 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.52 164.02 42.37 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.899 -0.88 . . . . 0.01 110.899 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 56.77 38.85 29.77 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.628 0.727 . . . . 0.01 110.932 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 52.29 55.91 8.47 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.58 -0.7 . . . . 0.01 111.11 178.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -129.18 165.68 20.84 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.319 -0.993 . . . . 3.15 108.319 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.23 -163.87 28.02 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.242 -1.543 . . . . 0.01 109.242 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -75.6 144.34 41.84 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.034 -1.274 . . . . 0.01 108.664 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.587 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 27.0 ttp -116.99 142.16 47.31 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.47 0.653 . . . . 0.01 109.859 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -131.72 136.61 47.76 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.127 -1.064 . . . . 2.48 108.127 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -117.96 134.3 55.09 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.495 -0.753 . . . . 0.01 110.08 -178.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.5 t -148.45 149.42 31.67 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 122.276 1.036 . . . . 1.69 111.119 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.5 p -110.51 10.25 23.16 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 115.45 -0.795 . . . . 0.01 110.304 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -121.36 163.45 18.65 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.155 -0.966 . . . . 3.21 111.826 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.5 156.64 36.17 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.142 -1.059 . . . . 0.01 108.142 178.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 21.9 t -126.51 113.17 23.04 Favored Pre-proline 0 N--CA 1.501 2.115 0 O-C-N 121.401 -0.812 . . . . 0.01 108.843 178.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -76.27 -31.21 4.82 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 CA-C-N 120.086 1.066 . . . . 0.01 111.516 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.6 m -141.42 108.05 5.35 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.264 -0.898 . . . . 0.02 109.006 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.88 -38.83 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.861 -0.524 . . . . 1.83 110.876 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.1 ttt -68.16 -36.76 80.15 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.234 -0.986 . . . . 1.34 110.384 -178.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -71.15 -39.08 72.14 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.421 -1.424 . . . . 2.11 110.18 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -79.48 -47.41 15.67 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.236 -0.915 . . . . 2.08 112.448 -176.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -110.25 0.85 18.28 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.405 -0.809 . . . . 0.02 112.517 -176.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.565 ' ND1' ' N ' ' A' ' 122' ' ' HIS . 1.2 m-70 59.11 32.36 22.07 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.815 -1.178 . . . . 0.02 109.269 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.3 mt -112.29 135.9 52.39 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 108.433 -0.951 . . . . 0.02 108.433 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -91.44 -22.73 20.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 5.32 110.108 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -149.82 163.95 36.65 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.222 -0.924 . . . . 0.02 110.204 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 44.8 mt -132.21 129.34 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 107.434 -1.321 . . . . 2.17 107.434 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -106.95 -12.08 15.54 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.318 -0.864 . . . . 0.02 112.457 -177.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 12.5 p -159.54 153.05 22.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.855 -1.153 . . . . 0.01 108.835 178.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 7.2 t -168.51 147.36 4.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.303 -0.873 . . . . 1.22 108.751 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.516 ' NZ ' ' OE1' ' A' ' 155' ' ' GLU . 26.1 tttp -121.1 111.64 17.7 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 122.422 1.106 . . . . 1.41 109.561 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.3 t -112.52 129.06 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 107.352 -1.351 . . . . 0.01 107.352 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.2 t -129.48 92.93 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 107.267 -1.383 . . . . 1.98 107.267 177.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.476 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 4.1 tm-20 -147.85 -74.58 0.19 Allowed 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 105.683 -1.969 . . . . 0.01 105.683 177.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 157.55 -55.03 0.38 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.45 -1.46 . . . . 0.01 109.45 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 41.8 p -119.75 101.52 7.95 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.542 -0.975 . . . . 2.3 111.446 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.476 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 11.4 m95 -129.51 144.54 51.3 Favored 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 107.516 -1.29 . . . . 0.01 107.516 178.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.426 HG22 HD11 ' A' ' 137' ' ' ILE . 97.6 mt -124.25 140.87 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 120.874 -1.141 . . . . 1.69 110.486 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -114.17 143.97 43.95 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.153 -1.425 . . . . 2.49 107.153 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 11.8 m-85 -122.93 144.88 48.94 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.146 -0.971 . . . . 0.02 109.531 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -74.64 -29.53 61.3 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.532 -0.73 . . . . 0.02 111.97 -176.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.4 mt -115.82 154.79 48.2 Favored Pre-proline 0 N--CA 1.505 2.299 0 O-C-N 120.783 -1.198 . . . . 1.48 109.166 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -55.37 167.38 1.94 Allowed 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.219 1.279 . . . . 0.02 112.674 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 59.6 31.23 20.81 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.193 -0.912 . . . . 0.75 111.283 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 57.55 51.08 10.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.451 -0.781 . . . . 0.02 111.136 177.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -126.54 165.07 19.82 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.52 -0.737 . . . . 0.02 110.153 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.41 -166.21 33.06 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.285 -1.126 . . . . 0.02 110.285 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -68.68 142.59 55.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.606 -0.937 . . . . 0.02 108.898 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -114.53 148.95 37.19 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.336 0.588 . . . . 0.02 109.932 -178.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -124.48 134.65 52.98 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.824 -0.806 . . . . 0.01 108.824 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.1 tt -98.23 121.32 40.02 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.737 -1.227 . . . . 0.01 108.728 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 59.6 tp -95.47 155.28 16.81 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.247 -0.908 . . . . 0.01 109.171 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -105.46 -117.88 0.23 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.295 -0.878 . . . . 2.27 109.374 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -156.97 44.6 0.38 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.049 -1.032 . . . . 1.84 109.671 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -112.35 -156.06 0.58 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.459 -0.776 . . . . 2.28 109.289 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.516 ' OE1' ' NZ ' ' A' ' 130' ' ' LYS . 77.9 mm-40 -106.94 106.24 16.67 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.442 -0.786 . . . . 0.01 109.141 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.612 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 5.2 m-85 -98.97 111.51 23.89 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.341 -0.849 . . . . 0.01 109.531 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -94.7 -22.29 18.22 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.184 -0.947 . . . . 0.01 111.566 -177.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -128.15 154.16 78.69 Favored Pre-proline 0 N--CA 1.503 2.176 0 O-C-N 120.875 -1.141 . . . . 2.54 108.708 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -59.4 -37.19 91.46 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 CA-C-N 119.286 0.781 . . . . 0.7 110.64 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 85.3 t -61.25 -19.76 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.795 -1.191 . . . . 0.86 109.146 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -65.32 -15.32 62.41 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.952 -1.093 . . . . 0.02 109.996 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.612 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 8.5 m0 -98.13 11.71 36.83 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.19 -0.944 . . . . 0.02 109.102 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 81.11 10.46 84.85 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.934 -1.127 . . . . 0.02 111.341 178.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.09 140.64 32.94 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.031 -1.276 . . . . 0.02 110.206 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.73 -9.54 56.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.608 -0.683 . . . . 0.59 109.978 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.1 m -142.02 150.49 56.2 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.181 -0.949 . . . . 0.87 109.134 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -76.61 16.53 0.9 Allowed 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 120.741 0.96 . . . . 0.38 112.47 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.65 122.72 27.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.649 -1.282 . . . . 0.18 111.198 -177.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 15.2 mm -151.81 126.39 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 106.595 -1.631 . . . . 3.99 106.595 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 64.1 mm-40 -113.57 -12.9 12.82 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.081 -1.012 . . . . 5.17 113.634 -177.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.0 p -157.6 162.05 38.71 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 119.083 -2.261 . . . . 0.02 110.235 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.426 ' CD1' ' C ' ' A' ' 172' ' ' PHE . 16.9 p90 -151.97 151.98 31.89 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.132 -0.98 . . . . 2.02 110.633 179.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -145.0 149.66 35.53 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.304 -0.872 . . . . 0.01 109.991 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -88.52 144.29 26.43 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.512 -0.742 . . . . 0.01 109.439 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.4 mt -93.67 129.55 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.233 -0.917 . . . . 3.04 109.092 178.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 14.5 t -137.1 147.4 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.248 -0.907 . . . . 1.89 109.676 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.35 -0.844 . . . . 4.89 109.39 179.815 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.606 ' HG ' ' H ' ' A' ' 2' ' ' LYS . 9.4 t . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.313 0.578 . . . . 5.28 109.479 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.606 ' H ' ' HG ' ' A' ' 1' ' ' SER . 90.9 mttt -151.53 64.93 0.87 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.219 -0.926 . . . . 5.96 109.36 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.6 t -80.89 142.82 33.21 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.39 -0.967 . . . . 2.22 108.39 178.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.23 179.33 48.17 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 118.289 -1.91 . . . . 0.81 112.043 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.92 157.11 43.03 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.416 -1.474 . . . . 0.01 109.416 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -146.18 135.18 22.58 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.363 -1.081 . . . . 0.02 110.603 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 7' ' ' ILE . 6.3 tt -129.44 139.6 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.108 -1.071 . . . . 0.02 108.108 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 m -120.45 129.55 53.93 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.326 -0.859 . . . . 0.39 110.208 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 6.2 m-85 -110.34 139.89 45.08 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 109.026 -0.731 . . . . 0.02 109.026 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.561 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.2 m-85 -121.28 137.99 54.44 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.135 -0.978 . . . . 0.02 109.299 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -69.71 -27.59 65.11 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.096 -1.003 . . . . 0.03 111.531 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -113.68 169.54 8.91 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.932 -1.105 . . . . 0.03 110.067 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -75.37 157.41 34.28 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.66 0.743 . . . . 0.03 110.401 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.546 ' N ' ' ND2' ' A' ' 14' ' ' ASN . 0.6 OUTLIER 66.31 33.95 6.77 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.768 0.794 . . . . 0.74 111.297 178.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 55.41 41.23 31.24 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.247 0.546 . . . . 0.02 111.335 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -113.13 165.61 12.22 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.152 -1.055 . . . . 0.02 108.152 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.09 -167.01 35.72 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.758 -1.211 . . . . 0.03 110.757 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.557 HH11 ' CG ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -68.59 141.57 55.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.502 -0.999 . . . . 2.76 109.275 179.553 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -121.96 150.1 42.52 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.629 -0.67 . . . . 1.89 109.842 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -137.96 133.95 34.33 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.559 -0.713 . . . . 0.02 109.677 178.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -109.26 135.77 49.8 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.327 -0.858 . . . . 1.12 108.886 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.536 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 5.6 t -127.16 137.98 53.06 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.55 -0.719 . . . . 0.02 109.125 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.5 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 4.1 p30 -118.62 11.72 12.91 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.644 -0.66 . . . . 0.2 110.611 -179.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 25.5 m -158.88 174.26 15.26 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.664 -1.272 . . . . 1.23 108.948 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 2.3 m-20 -62.2 145.98 52.04 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.756 -1.215 . . . . 0.02 110.418 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.536 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 18.0 m -134.04 117.05 16.22 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.779 -0.822 . . . . 0.02 108.779 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.12 -20.48 52.07 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.369 -0.832 . . . . 0.24 111.911 -177.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -151.16 106.14 3.3 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.57 -1.331 . . . . 1.14 109.547 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.61 5.04 43.8 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.436 -0.79 . . . . 6.37 110.276 -178.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -61.22 -28.36 69.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 3.11 112.204 -177.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.5 t -79.12 -18.7 52.74 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.262 -1.523 . . . . 0.88 111.779 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -105.75 -21.82 13.09 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.138 -0.976 . . . . 0.02 110.682 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 50.9 mt -148.88 128.31 13.05 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.032 -1.043 . . . . 3.32 109.109 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.2 t -86.1 -11.11 53.58 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.676 -0.64 . . . . 0.02 110.385 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -172.84 162.26 4.78 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.147 -1.056 . . . . 0.02 108.147 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 24.9 m -144.03 116.32 8.5 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.064 -1.022 . . . . 0.02 108.632 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.421 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 17.9 t-20 -108.84 0.46 20.32 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 120.822 -1.174 . . . . 0.03 111.673 -177.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.2 t -155.87 153.51 29.83 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.048 -1.093 . . . . 0.02 108.048 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.7 mt -146.9 147.37 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.069 -1.019 . . . . 0.02 110.871 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -123.65 124.56 43.03 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.154 -1.054 . . . . 0.02 108.154 177.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.7 t -106.32 115.0 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 106.917 -1.512 . . . . 0.02 106.917 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -83.32 -33.8 25.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.448 -0.782 . . . . 3.81 110.728 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.48 152.09 21.93 Favored Glycine 0 N--CA 1.488 2.11 0 C-N-CA 118.883 -1.627 . . . . 0.02 110.82 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.04 173.18 49.62 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.655 -1.259 . . . . 0.01 110.708 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.2 m -119.32 134.88 54.98 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.011 -1.107 . . . . 1.48 108.011 177.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -126.75 155.51 42.64 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 122.587 1.185 . . . . 0.02 112.214 -176.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.39 134.02 52.35 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 105.631 -1.989 . . . . 0.24 105.631 176.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.3 m -118.86 143.76 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.561 -0.712 . . . . 0.65 109.083 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -120.99 145.72 47.45 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 122.222 1.01 . . . . 0.02 110.079 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -65.92 -33.8 76.66 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.805 -0.634 . . . . 0.02 111.052 -177.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -125.17 157.7 66.3 Favored Pre-proline 0 N--CA 1.503 2.21 0 O-C-N 121.092 -1.005 . . . . 0.02 109.416 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.47 166.95 1.01 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.714 1.61 . . . . 0.02 113.119 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.519 ' N ' ' ND2' ' A' ' 53' ' ' ASN . 1.0 OUTLIER 63.73 36.4 10.66 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.198 -0.91 . . . . 0.02 111.123 178.219 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 45.19 51.71 9.01 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.576 0.703 . . . . 3.39 110.804 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.4 t -126.03 163.44 23.05 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.137 0.494 . . . . 2.33 109.857 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.18 -161.62 31.69 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.761 -1.335 . . . . 0.02 109.761 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -64.88 138.97 58.7 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.102 -1.234 . . . . 0.02 110.029 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 14.6 ptm -119.06 137.18 53.73 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.674 -0.641 . . . . 5.01 109.524 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.551 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 89.8 m-85 -134.03 138.46 45.38 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.422 -0.798 . . . . 0.02 109.836 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.1 mm -95.24 131.45 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.058 -0.719 . . . . 1.72 109.058 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.2 mt -121.0 111.45 34.06 Favored Pre-proline 0 N--CA 1.504 2.244 0 O-C-N 121.411 -0.806 . . . . 0.02 110.812 -178.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -77.11 169.55 21.3 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 CA-C-N 119.867 0.988 . . . . 1.47 109.853 177.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -52.6 141.31 20.91 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.766 -1.208 . . . . 4.25 110.338 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.38 -177.76 32.39 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.621 -1.276 . . . . 0.02 110.692 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -120.48 131.83 54.92 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.432 -1.04 . . . . 0.96 109.774 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -121.49 98.68 46.02 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 108.15 -1.056 . . . . 0.02 108.15 179.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -70.39 -3.66 12.88 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 120.861 1.041 . . . . 0.02 113.813 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -157.55 154.46 28.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.824 -1.172 . . . . 2.02 108.141 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -60.46 -38.85 85.5 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.557 -0.715 . . . . 0.02 111.929 -177.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -59.79 -23.71 63.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.916 -1.115 . . . . 0.02 110.272 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -70.68 -18.68 62.83 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.924 0.869 . . . . 3.42 108.763 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.551 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.2 t90 -107.96 9.93 28.5 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.496 -1.298 . . . . 0.02 107.496 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 8.5 mtt 61.29 22.63 12.97 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.494 0.664 . . . . 0.02 110.503 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.52 144.41 45.81 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.762 -1.335 . . . . 0.02 109.762 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.63 -31.54 41.61 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.34 -1.356 . . . . 0.98 107.34 177.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.581 ' ND2' ' H ' ' A' ' 77' ' ' ASP . 15.4 t30 -157.02 -171.43 3.64 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 106.317 -1.734 . . . . 0.02 106.317 178.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.581 ' H ' ' ND2' ' A' ' 76' ' ' ASN . 10.6 p30 -98.49 28.52 4.12 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.55 -1.344 . . . . 0.02 110.757 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -97.07 122.51 40.15 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.863 -1.148 . . . . 3.2 110.974 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 75.0 mt -141.92 119.13 11.41 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.611 -1.255 . . . . 2.61 107.611 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.73 -18.04 9.86 Favored Glycine 0 N--CA 1.499 2.875 0 O-C-N 121.211 -0.931 . . . . 0.02 112.524 -177.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.4 p -156.18 155.67 32.87 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 119.967 -1.902 . . . . 0.02 110.464 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 24.8 p -145.32 147.92 32.86 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.698 -0.626 . . . . 0.02 110.0 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 33.5 mtp180 -137.47 142.74 41.54 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.412 -0.805 . . . . 0.01 109.397 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.73 132.99 36.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 0.43 109.862 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.6 t -91.97 124.86 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 109.027 -0.731 . . . . 1.25 109.027 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -94.36 132.1 39.33 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.706 -1.246 . . . . 1.77 109.238 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -96.33 139.77 31.98 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.672 -0.862 . . . . 1.63 108.672 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.424 ' O ' ' OE2' ' A' ' 133' ' ' GLU . 87.8 p -111.47 128.02 55.87 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.345 -0.847 . . . . 1.08 109.26 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.8 m -104.47 -154.18 0.5 Allowed 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 106.63 -1.618 . . . . 1.26 106.63 177.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.75 -52.7 0.74 Allowed Glycine 0 N--CA 1.5 2.965 0 O-C-N 120.399 -1.438 . . . . 0.01 112.737 177.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.17 -101.65 0.16 Allowed Glycine 0 N--CA 1.491 2.335 0 C-N-CA 118.467 -1.825 . . . . 0.01 111.953 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -121.61 118.86 30.25 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.122 -1.222 . . . . 4.43 110.635 -178.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.5 129.85 34.85 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.836 -0.746 . . . . 2.99 109.488 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -129.82 142.41 50.68 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.436 -0.79 . . . . 6.36 109.058 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.435 ' O ' ' OE2' ' A' ' 109' ' ' GLU . 4.3 tt -128.81 144.56 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.344 -0.848 . . . . 1.09 110.181 -179.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -121.52 134.16 55.04 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.541 -1.281 . . . . 2.05 107.541 177.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.5 m -124.03 145.51 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 O-C-N 120.728 -1.232 . . . . 1.1 109.903 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -119.05 141.4 48.76 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.983 0.896 . . . . 0.73 110.851 -178.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -67.09 -30.64 70.73 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 116.065 -0.516 . . . . 0.02 111.812 -178.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -116.46 168.1 10.46 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.945 -1.097 . . . . 3.18 110.473 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.2 163.92 44.86 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 111.044 -0.822 . . . . 0.01 111.044 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.5 t0 56.91 39.33 29.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.878 -0.778 . . . . 0.01 111.059 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 51.71 56.47 7.81 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.617 -0.677 . . . . 0.01 111.007 178.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -129.7 165.98 20.75 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.023 -1.103 . . . . 3.15 108.023 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.24 -164.41 28.34 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.13 -1.588 . . . . 0.01 109.13 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -75.7 144.61 41.47 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.981 -1.305 . . . . 0.01 108.573 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.452 ' SD ' ' C ' ' A' ' 107' ' ' MET . 12.5 tmm? -116.25 142.21 47.14 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.634 0.73 . . . . 0.01 109.897 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.501 ' CD1' ' N ' ' A' ' 108' ' ' TYR . 8.0 m-85 -131.15 136.48 48.37 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.337 -0.986 . . . . 2.48 108.337 178.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.435 ' OE2' ' O ' ' A' ' 95' ' ' ILE . 5.2 tp10 -115.72 133.47 56.0 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.687 -0.633 . . . . 0.01 109.968 -178.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.9 t -148.47 147.95 29.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.021 -1.049 . . . . 1.69 111.183 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.421 ' OG1' ' OE2' ' A' ' 112' ' ' GLU . 21.1 p -111.67 9.72 21.0 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 115.451 -0.795 . . . . 0.01 110.24 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 26.5 mp0 -121.39 163.5 18.6 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 121.238 -0.914 . . . . 3.21 111.72 -178.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -68.1 156.81 36.65 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.323 -0.991 . . . . 0.01 108.323 178.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.483 ' SG ' ' OE1' ' A' ' 120' ' ' GLN . 33.7 t -125.57 113.98 25.23 Favored Pre-proline 0 N--CA 1.502 2.142 0 O-C-N 121.531 -0.731 . . . . 0.01 109.23 178.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -75.27 -30.89 6.34 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 CA-C-N 120.245 1.123 . . . . 0.01 111.035 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.4 p -142.45 108.44 5.19 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.804 0.811 . . . . 0.02 109.0 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 73.1 mt -63.21 -38.35 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.839 -0.538 . . . . 1.83 110.742 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 20.4 ttt -68.14 -36.53 79.83 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.121 -1.032 . . . . 1.34 110.227 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -70.53 -38.75 74.27 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.514 -1.367 . . . . 2.11 110.001 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.483 ' OE1' ' SG ' ' A' ' 114' ' ' CYS . 52.0 tt0 -79.61 -47.47 15.4 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.317 -0.865 . . . . 2.08 112.471 -177.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -110.42 0.46 17.87 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.362 -0.837 . . . . 0.02 112.698 -176.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 59.28 32.99 22.37 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.761 -1.212 . . . . 0.02 109.067 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 mt -112.09 135.26 52.98 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 108.487 -0.931 . . . . 0.02 108.487 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -91.23 -22.28 20.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 5.32 110.031 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -149.79 163.89 36.77 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.36 -0.838 . . . . 0.02 110.0 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.418 HG22 HD11 ' A' ' 126' ' ' ILE . 55.4 mt -131.33 128.47 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 107.474 -1.306 . . . . 2.17 107.474 178.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -107.85 -12.16 15.24 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.412 -0.805 . . . . 0.02 112.36 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.3 m -159.16 152.17 22.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.887 -1.133 . . . . 0.01 108.99 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 10.9 t -168.86 146.87 3.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 1.22 108.795 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.3 tttp -120.6 112.45 18.93 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 122.422 1.106 . . . . 1.41 109.515 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.3 t -113.46 129.52 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 107.821 -1.177 . . . . 0.01 107.821 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.9 t -129.72 92.97 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 106.936 -1.505 . . . . 1.98 106.936 177.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.541 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 9.4 tm-20 -147.16 -74.84 0.2 Allowed 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 105.829 -1.915 . . . . 0.01 105.829 177.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.422 ' N ' ' OE1' ' A' ' 133' ' ' GLU . . . 169.68 -69.64 0.15 Allowed Glycine 0 N--CA 1.482 1.723 0 N-CA-C 108.656 -1.777 . . . . 0.01 108.656 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.9 p -121.17 118.48 29.76 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.631 -0.923 . . . . 2.3 110.569 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.541 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 8.4 m95 -128.1 148.55 50.58 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 107.063 -1.458 . . . . 0.01 107.063 178.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 89.9 mt -123.27 138.07 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 120.373 -1.454 . . . . 1.69 110.491 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -114.96 144.11 44.09 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 107.553 -1.277 . . . . 2.49 107.553 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.507 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 12.1 m-85 -123.02 143.94 49.6 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.235 -0.916 . . . . 0.02 109.592 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -75.06 -28.79 60.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.389 -0.82 . . . . 0.02 112.028 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 55.0 mt -115.28 151.82 46.23 Favored Pre-proline 0 N--CA 1.504 2.264 0 O-C-N 120.563 -1.335 . . . . 1.48 109.027 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -54.06 167.66 1.11 Allowed 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 120.906 1.071 . . . . 0.02 112.54 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 4.5 m120 59.12 30.18 19.9 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 115.164 -0.925 . . . . 0.75 111.19 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 57.94 51.39 9.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.4 -0.813 . . . . 0.02 111.469 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -125.84 164.13 21.39 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.398 -0.814 . . . . 0.02 109.951 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.38 -165.18 32.41 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.31 -1.116 . . . . 0.02 110.31 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -69.06 142.09 54.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.604 -0.939 . . . . 0.02 109.126 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -115.24 149.07 38.34 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.832 -0.543 . . . . 0.02 109.918 -178.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.534 ' CE1' ' O ' ' A' ' 162' ' ' TRP . 42.6 t80 -124.94 135.82 53.18 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 109.15 -0.685 . . . . 0.01 109.15 179.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.5 tt -98.45 120.88 39.63 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.941 -1.1 . . . . 0.01 108.808 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.4 tt -98.51 149.74 22.41 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.139 -0.976 . . . . 0.01 108.857 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.462 ' CG ' ' H ' ' A' ' 153' ' ' LYS . 2.1 p-10 -104.93 -98.47 0.32 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.424 -0.798 . . . . 2.27 110.007 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.462 ' H ' ' CG ' ' A' ' 152' ' ' ASP . 47.1 pttt -167.36 49.09 0.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.077 -1.014 . . . . 1.84 109.515 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.607 ' CG ' ' H ' ' A' ' 155' ' ' GLU . 38.5 tttm -113.34 -175.58 2.7 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.984 -0.747 . . . . 2.28 108.984 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.607 ' H ' ' CG ' ' A' ' 154' ' ' LYS . 84.6 mt-10 -100.25 109.5 21.72 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.197 -0.939 . . . . 0.01 108.693 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.628 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 30.2 m-85 -98.33 113.87 25.99 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.427 -0.795 . . . . 0.01 110.079 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -94.8 -22.48 18.03 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.23 -0.919 . . . . 0.01 111.614 -178.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -127.7 154.79 77.87 Favored Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 120.771 -1.206 . . . . 2.54 109.148 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -60.78 -38.94 66.9 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 120.489 0.793 . . . . 0.7 110.443 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 96.8 t -60.94 -20.11 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.867 -1.146 . . . . 0.86 108.821 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 161' ' ' ASP . 43.2 t0 -65.68 -15.39 62.74 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.976 -1.078 . . . . 0.02 109.785 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.628 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 22.8 m0 -95.79 10.74 36.01 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.497 -0.927 . . . . 0.02 108.497 178.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 78.56 9.87 86.67 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.603 -1.284 . . . . 0.02 110.621 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.38 142.04 31.38 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.361 -1.082 . . . . 0.02 110.078 -178.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.59 -8.72 58.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.655 -0.653 . . . . 0.59 109.629 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 21.6 p -144.81 150.32 46.03 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 120.894 -1.129 . . . . 0.87 108.534 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -75.94 21.26 0.51 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 120.718 0.945 . . . . 0.38 112.518 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.38 123.05 28.75 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.786 -1.197 . . . . 0.18 111.566 -177.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 4.1 mt -149.78 127.6 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 107.041 -1.466 . . . . 3.99 107.041 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -113.67 -15.15 12.53 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 113.684 0.994 . . . . 5.17 113.684 -177.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 8.2 t -157.63 160.96 38.6 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 119.132 -2.23 . . . . 0.02 110.445 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 172' ' ' PHE . 16.4 p90 -151.66 152.73 33.21 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.085 -1.01 . . . . 2.02 110.499 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 43.4 mtp180 -144.76 149.93 36.36 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.882 0.849 . . . . 0.01 110.189 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -88.08 144.32 26.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.59 -0.694 . . . . 0.01 109.154 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.6 mt -94.32 128.86 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.274 -0.891 . . . . 3.04 109.128 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.8 p -136.2 146.24 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.124 -0.985 . . . . 1.89 109.499 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 N--CA 1.488 1.448 0 O-C-N 121.151 -0.968 . . . . 4.89 109.465 -179.978 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.9 m . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.473 -0.565 . . . . 5.28 109.473 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -71.76 64.94 0.49 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.215 -0.928 . . . . 5.96 109.387 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 44.6 p -81.11 143.35 32.48 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.391 -0.966 . . . . 2.22 108.391 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.58 179.73 47.89 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 118.322 -1.894 . . . . 0.81 112.026 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.92 157.63 43.63 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.412 -1.475 . . . . 0.01 109.412 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -145.9 134.74 22.44 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.312 -1.111 . . . . 0.02 110.531 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.404 HG22 HD11 ' A' ' 7' ' ' ILE . 7.1 tt -129.46 139.57 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.053 -1.092 . . . . 0.02 108.053 178.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.527 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.0 OUTLIER -121.89 130.54 53.44 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.437 -0.789 . . . . 0.39 110.119 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.1 m-85 -110.18 139.98 44.77 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 109.114 -0.699 . . . . 0.02 109.114 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.527 ' CZ ' ' OG ' ' A' ' 8' ' ' SER . 4.8 m-85 -121.9 138.47 54.39 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.302 -0.874 . . . . 0.02 109.325 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -69.32 -27.32 65.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.16 -0.962 . . . . 0.03 111.508 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 2.1 m-20 -114.11 169.4 9.04 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.921 -1.112 . . . . 0.03 110.217 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -75.96 158.71 31.66 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.612 0.72 . . . . 0.03 110.258 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.9 t30 66.06 33.25 7.72 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 122.018 0.913 . . . . 0.74 111.123 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 55.68 42.29 29.52 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 116.007 -0.542 . . . . 0.02 111.471 177.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -113.81 166.18 11.82 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.395 -0.965 . . . . 0.02 108.395 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.87 -167.61 34.97 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 119.923 -1.132 . . . . 0.03 110.75 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.573 HH11 ' CG ' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -69.42 143.0 53.74 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.48 -1.012 . . . . 2.76 109.091 179.445 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.466 ' HE ' ' CB ' ' A' ' 8' ' ' SER . 52.5 ttt180 -121.58 148.94 43.86 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.582 -0.699 . . . . 1.89 110.105 -178.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.603 ' CZ ' ' CG ' ' A' ' 32' ' ' TYR . 7.2 t80 -135.1 130.75 36.0 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.781 -0.822 . . . . 0.02 108.781 178.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 18.7 p-10 -111.94 137.78 49.46 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.468 -0.77 . . . . 1.12 109.411 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 45.9 t -130.38 139.81 50.62 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.596 -0.69 . . . . 0.02 109.6 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.5 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 10.8 p30 -117.78 11.93 13.73 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.723 -0.611 . . . . 0.2 110.225 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 34.6 m -158.63 174.77 14.54 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.887 -1.133 . . . . 1.23 108.644 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -61.96 145.17 53.76 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.694 -1.254 . . . . 0.02 110.033 -179.731 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.435 ' CB ' ' CZ ' ' A' ' 29' ' ' PHE . 0.8 OUTLIER -133.68 119.08 18.9 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 108.725 -0.842 . . . . 0.02 108.725 178.449 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.44 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -77.11 -19.39 57.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.24 111.745 -177.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -154.13 107.94 2.97 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.559 -1.338 . . . . 1.14 110.862 -178.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.435 ' CZ ' ' CB ' ' A' ' 26' ' ' CYS . 17.1 m-85 -96.53 5.72 50.2 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.206 -0.934 . . . . 6.37 109.303 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -60.25 -30.67 69.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.364 -0.835 . . . . 3.11 112.206 -176.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.6 m -78.82 -18.96 53.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.308 -1.495 . . . . 0.88 111.29 -178.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.603 ' CG ' ' CZ ' ' A' ' 20' ' ' TYR . 56.6 m-85 -106.68 -22.17 12.82 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.345 -0.847 . . . . 0.02 110.905 -178.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.442 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 5.1 tp -149.24 127.2 11.9 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.83 -1.169 . . . . 3.32 109.609 -178.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.0 t -86.21 -11.31 52.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.64 -0.662 . . . . 0.02 110.95 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.442 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 13.2 ptm180 -172.96 162.69 4.72 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.914 -1.117 . . . . 0.02 108.404 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.0 t -142.23 115.02 8.63 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.968 -1.083 . . . . 0.02 108.663 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 16.1 t-20 -107.5 -0.71 21.98 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.864 -1.147 . . . . 0.03 110.866 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.5 t -156.08 152.67 28.29 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.902 -1.147 . . . . 0.02 107.902 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 87.6 mt -145.67 148.12 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 CA-C-O 122.435 1.112 . . . . 0.02 110.313 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -123.86 124.08 41.86 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.82 -1.178 . . . . 0.02 107.82 176.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.7 t -106.47 115.25 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 106.859 -1.534 . . . . 0.02 106.859 177.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -83.49 -33.74 25.51 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.021 -0.672 . . . . 3.81 110.738 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.48 152.17 22.05 Favored Glycine 0 N--CA 1.489 2.175 0 C-N-CA 118.922 -1.608 . . . . 0.02 110.891 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.97 173.22 49.63 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.709 -1.234 . . . . 0.01 110.632 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.6 m -120.15 135.76 54.85 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.099 -1.075 . . . . 1.48 108.099 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.417 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 37.8 m95 -128.01 155.74 43.82 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 122.7 1.238 . . . . 0.02 112.17 -176.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.75 134.5 51.38 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 105.57 -2.011 . . . . 0.24 105.57 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.4 m -119.92 144.76 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.579 -0.701 . . . . 0.65 109.3 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -121.45 145.7 47.66 Favored 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 122.313 1.054 . . . . 0.02 110.263 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -66.87 -34.09 77.03 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.836 -0.62 . . . . 0.02 111.496 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -124.93 157.97 64.64 Favored Pre-proline 0 N--CA 1.503 2.185 0 O-C-N 121.028 -1.045 . . . . 0.02 109.36 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.35 165.31 1.55 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.716 1.611 . . . . 0.02 113.176 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 63.84 36.95 10.02 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.159 -0.928 . . . . 0.02 111.055 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 45.08 51.84 8.71 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.686 0.755 . . . . 3.39 110.78 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.5 t -125.92 163.61 22.59 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 121.145 0.498 . . . . 2.33 109.811 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.83 -161.46 32.04 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.797 -1.321 . . . . 0.02 109.797 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.564 ' HD1' ' H ' ' A' ' 57' ' ' HIS . 4.7 m80 -64.63 139.77 58.8 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.075 -1.25 . . . . 0.02 110.289 -179.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.497 ' SD ' ' O ' ' A' ' 58' ' ' MET . 2.9 ppp? -119.97 136.95 54.34 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.648 -0.657 . . . . 5.01 109.594 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.546 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 88.2 m-85 -134.81 138.85 44.62 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.353 -0.842 . . . . 0.02 109.948 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.417 HG21 HD11 ' A' ' 60' ' ' ILE . 20.5 mm -95.25 131.36 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.034 -0.728 . . . . 1.72 109.034 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.4 mt -120.26 111.06 35.47 Favored Pre-proline 0 N--CA 1.506 2.361 0 O-C-N 121.371 -0.831 . . . . 0.02 110.763 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -77.32 169.42 21.3 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 CA-C-N 119.836 0.977 . . . . 1.47 109.769 177.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -52.59 140.94 21.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.821 -1.174 . . . . 4.25 110.307 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.75 -177.52 32.82 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.454 -1.355 . . . . 0.02 110.597 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -120.48 131.75 54.88 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.535 -0.98 . . . . 0.96 109.692 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -121.54 99.13 45.51 Favored Pre-proline 0 N--CA 1.495 1.783 0 N-CA-C 107.882 -1.155 . . . . 0.02 107.882 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -70.86 -3.71 13.29 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 120.628 0.885 . . . . 0.02 113.642 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -157.6 154.9 29.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.71 -1.243 . . . . 2.02 108.029 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -60.2 -39.0 85.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.474 -0.767 . . . . 0.02 111.881 -177.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -59.79 -24.0 63.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.094 -1.004 . . . . 0.02 110.386 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -70.59 -18.83 62.89 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.901 0.858 . . . . 3.42 108.802 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.546 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.4 t90 -107.92 9.9 28.6 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.477 -1.305 . . . . 0.02 107.477 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.5 mtp 61.27 22.47 12.82 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.495 0.664 . . . . 0.02 110.536 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.53 144.08 46.06 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.492 -1.443 . . . . 0.02 109.492 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.7 tp -79.05 -30.92 44.33 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.552 -1.277 . . . . 0.98 107.552 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -157.05 -171.39 3.62 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 106.241 -1.763 . . . . 0.02 106.241 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -98.22 28.33 4.12 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.647 -1.283 . . . . 0.02 110.609 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.7 mtm180 -96.84 122.15 39.49 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.95 -1.094 . . . . 3.2 110.985 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.5 mt -142.82 120.5 11.84 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.672 -1.232 . . . . 2.61 107.672 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.68 -18.32 9.07 Favored Glycine 0 N--CA 1.502 3.05 0 O-C-N 121.215 -0.928 . . . . 0.02 112.871 -177.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 12.6 m -156.96 157.71 35.27 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 119.956 1.878 . . . . 0.02 110.864 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 27.0 m -146.49 149.84 34.42 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.627 -0.671 . . . . 0.02 109.943 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -138.51 143.17 39.42 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.395 -0.815 . . . . 0.01 109.183 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.3 132.18 36.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -0.94 . . . . 0.43 109.725 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.8 t -90.61 124.83 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.726 -0.842 . . . . 1.25 108.726 178.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -93.35 132.17 37.83 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.797 -1.189 . . . . 1.77 109.017 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mt -96.8 139.29 33.07 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.453 -0.943 . . . . 1.63 108.453 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.5 p -111.35 127.5 55.67 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.355 -0.84 . . . . 1.08 109.17 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 51.8 p -104.12 -154.53 0.51 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 106.448 -1.686 . . . . 1.26 106.448 177.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.39 -51.63 0.78 Allowed Glycine 0 N--CA 1.502 3.05 0 O-C-N 120.558 -1.339 . . . . 0.01 112.636 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.26 -100.92 0.15 Allowed Glycine 0 N--CA 1.489 2.193 0 C-N-CA 118.464 -1.827 . . . . 0.01 111.932 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -121.4 118.79 30.31 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.034 -1.274 . . . . 4.43 110.543 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.41 131.08 36.79 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.819 -0.753 . . . . 2.99 109.399 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -129.81 140.56 51.0 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.472 -0.767 . . . . 6.36 109.203 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 tt -127.4 144.12 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.407 -0.808 . . . . 1.09 109.864 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -122.29 133.05 54.69 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.692 -1.225 . . . . 2.05 107.692 176.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.8 m -123.67 145.86 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 O-C-N 120.662 -1.274 . . . . 1.1 109.682 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -119.13 141.31 48.92 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 121.97 0.891 . . . . 0.73 110.843 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -67.03 -30.41 70.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.888 -0.507 . . . . 0.02 111.775 -178.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.445 ' HZ2' ' CA ' ' A' ' 105' ' ' GLY . 42.5 mttp -116.12 167.39 11.03 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.046 -1.033 . . . . 3.18 110.533 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.06 164.43 43.79 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.981 -0.848 . . . . 0.01 110.981 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.423 ' O ' ' ND2' ' A' ' 104' ' ' ASN . 3.0 m-20 56.95 38.8 29.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.909 -0.759 . . . . 0.01 110.884 179.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 52.14 56.02 8.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.637 -0.665 . . . . 0.01 111.047 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.423 ' ND2' ' O ' ' A' ' 102' ' ' ASP . 24.5 m-80 -129.19 165.81 20.6 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 108.208 -1.034 . . . . 3.15 108.208 178.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.445 ' CA ' ' HZ2' ' A' ' 100' ' ' LYS . . . 92.99 -163.92 27.11 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.247 -1.541 . . . . 0.01 109.247 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.619 ' NE2' ' CE2' ' A' ' 108' ' ' TYR . 0.6 OUTLIER -76.0 144.39 40.94 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.043 -1.269 . . . . 0.01 108.348 179.116 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.526 ' N ' ' NE2' ' A' ' 106' ' ' GLN . 12.8 tmm? -116.57 141.81 47.7 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.635 0.731 . . . . 0.01 109.959 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.619 ' CE2' ' NE2' ' A' ' 106' ' ' GLN . 39.4 m-85 -131.2 136.45 48.27 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.176 -1.046 . . . . 2.48 108.176 178.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.522 ' OE2' ' N ' ' A' ' 110' ' ' THR . 1.9 tm-20 -119.47 134.73 55.08 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.544 -0.723 . . . . 0.01 109.961 -178.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.522 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 7.8 t -148.69 151.81 35.58 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 122.233 1.016 . . . . 1.69 111.065 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.483 ' N ' ' HG1' ' A' ' 110' ' ' THR . 21.7 p -111.83 9.49 20.72 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.645 -0.707 . . . . 0.01 110.377 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -121.43 163.27 19.02 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.122 -0.986 . . . . 3.21 111.719 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -68.12 157.09 36.08 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.344 -0.984 . . . . 0.01 108.344 178.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 20.7 t -126.59 114.15 22.87 Favored Pre-proline 0 N--CA 1.504 2.231 0 O-C-N 121.48 -0.763 . . . . 0.01 109.088 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.427 ' O ' ' OG ' ' A' ' 171' ' ' SER . 19.4 Cg_endo -75.12 -29.42 8.06 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 CA-C-N 120.319 1.15 . . . . 0.01 111.213 178.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 69.4 m -142.61 109.1 5.33 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.485 -0.759 . . . . 0.02 109.055 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.404 HG23 HD13 ' A' ' 117' ' ' ILE . 97.4 mt -63.9 -38.96 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.801 -0.562 . . . . 1.83 110.667 -178.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 41.9 ttp -68.58 -37.29 79.73 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.272 -0.971 . . . . 1.34 110.247 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -69.93 -38.64 76.26 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.502 -1.374 . . . . 2.11 110.026 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -79.93 -46.89 15.93 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.289 -0.882 . . . . 2.08 112.379 -176.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -110.67 -0.01 17.32 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.434 -0.792 . . . . 0.02 112.657 -176.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.1 m80 59.69 33.13 21.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.73 -1.231 . . . . 0.02 109.489 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.5 mt -112.78 135.94 52.95 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 108.728 -0.841 . . . . 0.02 108.728 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -91.6 -22.71 20.16 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.266 -0.896 . . . . 5.32 110.415 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -149.59 164.33 35.43 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.089 -1.007 . . . . 0.02 109.867 -178.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.428 ' C ' ' HD1' ' A' ' 127' ' ' HIS . 37.3 mt -131.92 128.86 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 107.642 -1.244 . . . . 2.17 107.642 178.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.431 ' N ' ' HD1' ' A' ' 127' ' ' HIS . 1.3 m80 -108.76 -12.3 14.94 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.342 -0.849 . . . . 0.02 112.462 -177.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.5 t -159.03 151.75 21.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.736 -1.228 . . . . 0.01 109.019 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 7.6 t -168.74 147.25 4.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 1.22 109.114 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -121.9 111.48 17.14 Favored 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 122.415 1.103 . . . . 1.41 109.711 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.1 t -113.33 130.7 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.678 -1.23 . . . . 0.01 107.678 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 44.1 t -129.89 93.37 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 107.176 -1.416 . . . . 1.98 107.176 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.465 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 26.0 tt0 -147.02 -75.21 0.2 Allowed 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 105.799 -1.926 . . . . 0.01 105.799 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 177.44 -78.19 0.07 OUTLIER Glycine 0 N--CA 1.483 1.791 0 N-CA-C 108.104 -1.998 . . . . 0.01 108.104 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.2 t -121.82 125.3 46.17 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.649 -0.912 . . . . 2.3 110.183 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.465 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 7.5 m95 -126.47 151.98 47.04 Favored 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 107.07 -1.456 . . . . 0.01 107.07 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 48.2 mt -120.61 135.37 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 120.329 -1.482 . . . . 1.69 110.297 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -114.73 144.56 43.27 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 107.465 -1.309 . . . . 2.49 107.465 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.503 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 15.2 m-85 -123.25 143.68 49.89 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.33 -0.856 . . . . 0.02 109.631 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -76.15 -29.23 57.7 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.54 -0.725 . . . . 0.02 112.389 -176.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.4 mt -115.43 154.78 47.67 Favored Pre-proline 0 N--CA 1.507 2.408 0 O-C-N 120.654 -1.279 . . . . 1.48 109.081 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.34 164.71 2.66 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 121.191 1.261 . . . . 0.02 112.79 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 51.9 t30 59.94 32.0 20.95 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.077 -0.965 . . . . 0.75 111.59 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 57.24 51.48 10.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.482 -0.762 . . . . 0.02 111.315 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -126.05 164.86 19.93 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.487 -0.758 . . . . 0.02 109.864 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.19 -165.92 33.15 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.346 -1.102 . . . . 0.02 110.346 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -69.57 143.31 53.38 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.563 -0.963 . . . . 0.02 109.207 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -115.16 149.67 37.28 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.206 0.526 . . . . 0.02 109.788 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -124.38 135.11 53.06 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 109.17 -0.678 . . . . 0.01 109.17 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.7 tp -96.7 119.93 36.09 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.608 -1.308 . . . . 0.01 109.264 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 59.1 tp -98.92 153.44 18.82 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.347 -0.846 . . . . 0.01 109.159 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.415 ' CG ' ' H ' ' A' ' 153' ' ' LYS . 21.2 t70 -104.41 -113.3 0.24 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.496 -0.752 . . . . 2.27 109.336 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.415 ' H ' ' CG ' ' A' ' 152' ' ' ASP . 17.6 pttm -163.04 50.59 0.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.081 -1.012 . . . . 1.84 109.855 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -113.01 -155.71 0.57 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.466 -0.771 . . . . 2.28 109.225 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -106.28 103.86 13.42 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.807 -0.812 . . . . 0.01 108.807 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.609 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 17.4 m-85 -98.36 112.31 24.36 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.263 -0.898 . . . . 0.01 109.739 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 22.5 mtm180 -95.27 -22.87 17.51 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.232 -0.918 . . . . 0.01 111.685 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -127.3 154.41 77.06 Favored Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 120.878 -1.139 . . . . 2.54 108.764 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -59.52 -37.92 86.03 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 CA-C-N 119.235 0.763 . . . . 0.7 110.637 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.9 t -60.99 -20.05 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.869 -1.145 . . . . 0.86 109.2 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -65.43 -15.59 62.77 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.983 -1.073 . . . . 0.02 109.98 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.609 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 9.5 m0 -97.8 11.43 37.27 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.124 -0.985 . . . . 0.02 108.997 178.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.59 10.6 85.04 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.89 -1.148 . . . . 0.02 111.04 178.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.38 140.84 32.97 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.111 -1.229 . . . . 0.02 110.126 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.32 -9.09 58.08 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.59 -0.694 . . . . 0.59 109.989 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.8 m -143.6 150.83 52.15 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.039 -1.038 . . . . 0.87 109.032 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -75.98 17.95 0.68 Allowed 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 120.721 0.947 . . . . 0.38 112.405 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.04 123.59 29.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.916 -1.115 . . . . 0.18 111.56 -177.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.0 mt -149.46 126.92 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.071 -1.455 . . . . 3.99 107.071 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 24.1 mm100 -111.38 -18.26 12.93 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.165 -0.959 . . . . 5.17 113.248 -177.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 115' ' ' PRO . 3.8 m -156.73 160.22 39.08 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 119.216 -2.177 . . . . 0.02 110.4 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.433 ' CD1' ' C ' ' A' ' 172' ' ' PHE . 18.3 p90 -151.72 153.05 33.59 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.101 -0.999 . . . . 2.02 110.321 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.3 mtm180 -145.79 150.53 36.37 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.358 -0.839 . . . . 0.01 110.145 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -87.83 144.04 26.81 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.233 -0.655 . . . . 0.01 109.233 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.4 mt -94.79 129.25 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.308 -0.87 . . . . 3.04 108.967 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.49 146.71 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.153 -0.967 . . . . 1.89 109.649 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.33 -0.856 . . . . 4.89 109.466 179.954 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.333 0.587 . . . . 5.28 109.489 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -75.86 65.65 1.99 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.211 -0.93 . . . . 5.96 109.429 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 30.5 p -81.14 142.69 33.01 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.426 -0.953 . . . . 2.22 108.426 178.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.04 -179.79 47.79 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 118.343 -1.884 . . . . 0.81 112.071 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.71 157.65 44.06 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.273 -1.531 . . . . 0.01 109.273 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -147.45 136.28 22.07 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.099 -1.236 . . . . 0.02 110.52 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.4 tt -130.12 138.91 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.698 -0.853 . . . . 0.02 108.698 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 m -120.91 130.24 53.81 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.559 -0.713 . . . . 0.39 110.014 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.9 m-85 -110.4 139.68 45.37 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.581 -0.699 . . . . 0.02 109.247 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.525 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 6.6 m-85 -121.31 138.32 54.3 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.427 -0.796 . . . . 0.02 109.32 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.523 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 83.3 mt-10 -69.38 -27.43 65.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.041 -1.037 . . . . 0.03 111.475 -178.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 2.3 m-20 -114.05 169.35 9.08 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.888 -1.133 . . . . 0.03 110.097 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -76.03 158.66 31.63 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.567 0.699 . . . . 0.03 110.229 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 66.53 33.17 6.82 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 122.012 0.911 . . . . 0.74 111.185 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 55.32 41.72 30.93 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.374 0.607 . . . . 0.02 111.373 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -113.64 165.81 12.15 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.25 -1.019 . . . . 0.02 108.25 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.44 -167.46 35.56 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.765 -1.207 . . . . 0.03 110.766 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.564 HH11 ' CG ' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -68.84 141.69 55.04 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.535 -0.979 . . . . 2.76 109.37 179.383 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -122.77 150.19 43.12 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.6 0.714 . . . . 1.89 110.124 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -135.87 131.74 35.68 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 109.113 -0.699 . . . . 0.02 109.113 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -109.53 136.47 48.87 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.83 -0.804 . . . . 1.12 108.83 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 49.6 t -128.63 138.15 52.04 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.617 -0.677 . . . . 0.02 109.619 -179.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -118.14 12.17 13.48 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.673 -0.642 . . . . 0.2 110.144 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.495 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 14.6 t -159.46 174.2 15.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.822 -1.174 . . . . 1.23 108.918 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -61.55 144.35 54.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.849 -1.157 . . . . 0.02 110.376 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.6 m -134.16 117.92 17.08 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.733 -0.839 . . . . 0.02 108.733 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.38 -19.81 52.57 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.524 -0.735 . . . . 0.24 112.55 -177.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 19.2 p30 -152.95 108.75 3.31 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.703 -1.248 . . . . 1.14 110.831 -178.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -97.68 5.29 49.52 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.428 -0.795 . . . . 6.37 109.771 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.2 mtm180 -60.33 -30.35 69.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.481 -0.762 . . . . 3.11 112.307 -176.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.435 ' OG ' ' CE2' ' A' ' 32' ' ' TYR . 30.3 p -79.35 -18.77 51.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.258 -1.526 . . . . 0.88 111.631 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.435 ' CE2' ' OG ' ' A' ' 31' ' ' SER . 51.1 m-85 -106.57 -22.04 12.88 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.291 -0.881 . . . . 0.02 110.98 -178.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.0 mt -148.89 128.15 12.92 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.948 -1.095 . . . . 3.32 109.216 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.9 t -86.76 -11.13 51.94 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.766 -0.584 . . . . 0.02 110.439 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.0 ttp180 -171.5 160.92 6.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.016 -1.053 . . . . 0.02 108.187 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 82.0 m -144.19 116.49 8.5 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.907 -1.121 . . . . 0.02 109.011 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 11' ' ' GLU . 1.3 m-80 -109.93 0.87 18.78 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 120.836 -1.165 . . . . 0.03 111.857 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.2 m -156.01 153.22 29.16 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.11 -1.07 . . . . 0.02 108.11 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.5 mt -146.9 148.04 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 CA-C-O 122.207 1.004 . . . . 0.02 110.753 -178.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -123.59 124.85 43.72 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.136 -1.061 . . . . 0.02 108.136 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.2 t -106.69 113.92 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 106.805 -1.554 . . . . 0.02 106.805 177.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -84.16 -34.07 24.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.691 -0.631 . . . . 3.81 110.475 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.82 150.25 19.0 Favored Glycine 0 N--CA 1.486 2.004 0 C-N-CA 118.885 -1.626 . . . . 0.02 110.601 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.0 172.44 49.19 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.758 -1.211 . . . . 0.01 110.235 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.9 m -120.04 135.75 54.82 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.098 -1.075 . . . . 1.48 108.098 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.422 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 36.9 m95 -128.35 156.2 43.48 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 122.698 1.237 . . . . 0.02 112.468 -176.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.96 135.02 50.83 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 105.412 -2.07 . . . . 0.24 105.412 176.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.6 m -116.21 141.81 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.597 -0.689 . . . . 0.65 109.286 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -120.72 143.01 48.99 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.987 0.899 . . . . 0.02 109.643 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.46 -33.69 76.52 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.627 -0.715 . . . . 0.02 111.832 -177.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -124.71 157.82 64.5 Favored Pre-proline 0 N--CA 1.504 2.227 0 O-C-N 120.991 -1.068 . . . . 0.02 109.357 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.21 166.7 0.96 Allowed 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 121.724 1.616 . . . . 0.02 112.827 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.5 m120 63.42 36.74 11.2 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.262 -0.881 . . . . 0.02 111.163 178.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.449 ' CD1' ' CD ' ' A' ' 83' ' ' ARG . 3.8 m-85 45.09 51.39 8.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.584 -0.698 . . . . 3.39 110.767 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.7 t -125.65 163.49 22.67 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.241 0.543 . . . . 2.33 109.883 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.53 -161.72 31.31 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.779 -1.328 . . . . 0.02 109.779 -179.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 12.4 m80 -64.61 138.13 58.22 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.983 -1.304 . . . . 0.02 110.209 -178.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 16.0 ptm -118.79 136.7 53.85 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.721 -0.612 . . . . 5.01 109.672 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.486 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 86.6 m-85 -134.33 139.59 45.77 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.483 -0.761 . . . . 0.02 109.647 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.9 mm -95.0 131.03 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.983 -0.747 . . . . 1.72 108.983 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.551 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -120.59 111.32 34.79 Favored Pre-proline 0 N--CA 1.505 2.28 0 O-C-N 121.319 -0.863 . . . . 0.02 110.767 -178.347 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -77.55 169.02 21.72 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 CA-C-N 119.958 1.021 . . . . 1.47 110.135 177.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -53.04 141.43 22.57 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.831 -1.168 . . . . 4.25 110.417 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.78 -177.2 32.2 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 119.403 -1.379 . . . . 0.02 110.743 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -120.72 131.79 54.72 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.334 -1.098 . . . . 0.96 109.8 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.551 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 63.2 m-85 -122.52 95.77 46.46 Favored Pre-proline 0 N--CA 1.496 1.846 0 N-CA-C 107.903 -1.147 . . . . 0.02 107.903 179.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.401 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.9 Cg_endo -66.91 -3.5 9.66 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 120.787 0.992 . . . . 0.02 113.865 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.401 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 79.1 mt-10 -157.47 155.17 29.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.617 -1.302 . . . . 2.02 108.142 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -60.47 -39.26 86.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.623 -0.673 . . . . 0.02 111.974 -177.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -60.02 -23.91 64.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.031 -1.043 . . . . 0.02 110.395 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -69.73 -18.67 63.54 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.809 0.814 . . . . 3.42 108.907 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.547 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.1 t90 -107.84 11.06 28.45 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.515 -1.291 . . . . 0.02 107.515 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 17.9 mtt 61.09 22.49 12.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.446 -0.784 . . . . 0.02 110.439 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.98 144.03 46.86 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.391 -1.484 . . . . 0.02 109.391 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.4 mt -78.87 -30.49 45.09 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.684 -1.228 . . . . 0.98 107.684 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.645 ' N ' HD21 ' A' ' 76' ' ' ASN . 0.0 OUTLIER -157.0 -171.31 3.6 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 106.386 -1.709 . . . . 0.02 106.386 178.299 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.409 ' OD2' ' OD1' ' A' ' 37' ' ' ASN . 63.6 m-20 -98.2 28.21 4.18 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.722 -1.236 . . . . 0.02 110.698 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -96.55 122.33 39.35 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.856 -1.153 . . . . 3.2 110.898 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 68.4 mt -142.17 119.56 11.59 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 107.636 -1.246 . . . . 2.61 107.636 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.86 -17.92 9.29 Favored Glycine 0 N--CA 1.5 2.907 0 O-C-N 121.293 -0.879 . . . . 0.02 112.738 -177.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.446 ' HG ' ' N ' ' A' ' 82' ' ' CYS . 26.4 t -156.16 156.59 34.48 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 120.239 2.02 . . . . 0.02 111.033 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.446 ' N ' ' HG ' ' A' ' 81' ' ' SER . 18.7 m -145.89 148.07 32.45 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.621 -0.674 . . . . 0.02 110.395 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.449 ' CD ' ' CD1' ' A' ' 54' ' ' PHE . 19.4 mtp180 -138.21 143.22 40.07 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.559 -0.713 . . . . 0.01 109.186 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.22 131.69 36.27 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.192 -0.942 . . . . 0.43 109.635 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.5 t -91.2 125.07 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.906 -0.775 . . . . 1.25 108.906 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -93.91 131.21 39.56 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.808 -1.182 . . . . 1.77 108.974 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 mt -96.05 140.01 31.4 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.389 -0.967 . . . . 1.63 108.389 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.2 m -111.83 127.52 55.84 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.347 -0.846 . . . . 1.08 109.318 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.3 m -104.09 -154.04 0.49 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 106.62 -1.622 . . . . 1.26 106.62 177.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.95 -52.6 0.74 Allowed Glycine 0 N--CA 1.501 2.981 0 O-C-N 120.396 -1.44 . . . . 0.01 112.82 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.92 -101.28 0.15 Allowed Glycine 0 N--CA 1.49 2.253 0 C-N-CA 118.491 -1.814 . . . . 0.01 112.042 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 38.8 tp60 -121.48 118.99 30.73 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.172 -1.193 . . . . 4.43 110.683 -178.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.59 130.54 35.47 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.769 -0.772 . . . . 2.99 109.424 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -129.53 142.01 50.86 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.353 -0.842 . . . . 6.36 109.062 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.0 tt -128.28 144.77 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 O-C-N 121.322 -0.862 . . . . 1.09 110.245 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -123.15 133.83 54.23 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.838 -1.171 . . . . 2.05 107.838 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.2 m -124.24 146.25 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 O-C-N 120.625 -1.297 . . . . 1.1 109.882 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -119.31 141.32 49.09 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.844 0.831 . . . . 0.73 110.848 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -66.99 -30.26 70.33 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 116.126 -0.488 . . . . 0.02 111.581 -178.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -116.31 169.69 9.11 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.138 -0.976 . . . . 3.18 110.44 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.4 165.25 52.01 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.827 -0.909 . . . . 0.01 110.827 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.435 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 0.9 OUTLIER 57.27 38.23 28.55 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.925 -0.75 . . . . 0.01 111.57 178.659 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 51.97 54.68 10.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.467 -0.771 . . . . 0.01 111.228 177.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' A' ' 105' ' ' GLY . 19.6 t-20 -129.71 166.01 20.69 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.92 -1.141 . . . . 3.15 107.92 178.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.512 ' N ' ' OD1' ' A' ' 104' ' ' ASN . . . 91.1 -163.37 29.14 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.19 -1.564 . . . . 0.01 109.19 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.7 tp60 -76.68 143.65 39.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.968 -1.313 . . . . 0.01 108.974 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.447 ' SD ' ' C ' ' A' ' 107' ' ' MET . 12.6 tmm? -116.47 142.23 47.13 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.553 0.692 . . . . 0.01 109.985 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -131.46 136.8 48.25 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.326 -0.99 . . . . 2.48 108.326 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -118.83 134.47 55.13 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.495 -0.753 . . . . 0.01 110.007 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.4 t -148.89 149.57 31.48 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.255 1.026 . . . . 1.69 110.951 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 20.2 p -110.97 9.76 22.21 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 115.53 -0.759 . . . . 0.01 110.314 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -120.9 163.24 18.52 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.203 -0.936 . . . . 3.21 111.514 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -68.08 156.57 37.15 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.212 -1.033 . . . . 0.01 108.212 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 19.8 t -126.72 114.04 22.58 Favored Pre-proline 0 N--CA 1.5 2.053 0 O-C-N 121.484 -0.76 . . . . 0.01 109.029 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -75.1 -29.43 8.07 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 CA-C-N 120.376 1.17 . . . . 0.01 111.116 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 69.6 m -142.12 109.37 5.57 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.383 -0.823 . . . . 0.02 109.324 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.58 -39.38 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.777 -0.577 . . . . 1.83 110.567 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 22.6 ttt -68.82 -37.57 79.29 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.398 -0.921 . . . . 1.34 110.358 -178.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -69.58 -38.67 77.47 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.434 -1.416 . . . . 2.11 109.986 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -79.94 -46.93 15.83 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.291 -0.881 . . . . 2.08 112.297 -177.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -111.34 0.06 16.53 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.391 -0.818 . . . . 0.02 112.663 -176.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.3 m80 60.27 33.48 20.92 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.789 -1.194 . . . . 0.02 109.618 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.1 mt -112.51 135.02 53.72 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 108.743 -0.836 . . . . 0.02 108.743 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -91.59 -22.79 20.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 5.32 110.27 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -149.05 163.79 36.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.198 -0.939 . . . . 0.02 109.702 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.0 mt -131.63 129.06 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 107.831 -1.174 . . . . 2.17 107.831 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -108.84 -12.54 14.89 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.368 -0.832 . . . . 0.02 112.231 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.0 t -158.86 150.56 20.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.851 -1.156 . . . . 0.01 109.196 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 6.2 t -167.75 147.04 4.88 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.696 -0.853 . . . . 1.22 108.696 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -122.06 111.64 17.27 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 122.348 1.071 . . . . 1.41 109.79 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 t -112.56 130.32 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 107.532 -1.284 . . . . 0.01 107.532 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 48.6 t -129.57 93.6 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 N-CA-C 107.204 -1.406 . . . . 1.98 107.204 177.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.485 ' OE1' ' N ' ' A' ' 134' ' ' GLY . 11.7 tm-20 -147.19 -76.54 0.18 Allowed 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 105.869 -1.9 . . . . 0.01 105.869 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.485 ' N ' ' OE1' ' A' ' 133' ' ' GLU . . . 176.31 -75.63 0.08 OUTLIER Glycine 0 N--CA 1.485 1.905 0 N-CA-C 108.308 -1.917 . . . . 0.01 108.308 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.29 121.04 37.78 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.686 -0.891 . . . . 2.3 110.235 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.451 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 6.8 m95 -126.99 151.17 48.92 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 106.87 -1.53 . . . . 0.01 106.87 179.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 81.1 mt -122.55 137.43 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 120.321 -1.487 . . . . 1.69 110.669 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -114.77 144.39 43.57 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 107.268 -1.382 . . . . 2.49 107.268 178.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.501 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 14.6 m-85 -122.75 143.76 49.61 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.217 -0.927 . . . . 0.02 109.559 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -74.66 -29.08 61.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.524 -0.735 . . . . 0.02 111.864 -176.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mt -116.18 154.89 48.69 Favored Pre-proline 0 N--CA 1.506 2.346 0 O-C-N 120.757 -1.215 . . . . 1.48 108.92 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -55.69 167.23 2.25 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.19 1.26 . . . . 0.02 112.817 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 59.67 30.67 20.29 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.125 -0.943 . . . . 0.75 111.286 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 57.82 51.44 9.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.59 -0.694 . . . . 0.02 111.152 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -126.21 164.89 19.98 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.457 -0.777 . . . . 0.02 110.106 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.07 -165.82 33.24 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.387 -1.085 . . . . 0.02 110.387 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -69.0 142.45 54.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.544 -0.974 . . . . 0.02 108.903 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -114.2 148.47 37.26 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.414 0.626 . . . . 0.02 110.129 -178.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -125.13 134.75 52.32 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.073 -0.714 . . . . 0.01 109.073 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.6 tt -99.27 121.67 41.39 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.907 -1.121 . . . . 0.01 109.004 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.484 ' CD1' ' CD1' ' A' ' 162' ' ' TRP . 21.3 tp -97.27 144.64 26.86 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.245 -0.909 . . . . 0.01 109.247 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -106.42 -162.07 0.83 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.494 -0.753 . . . . 2.27 109.852 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -99.78 51.31 0.92 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.337 -0.852 . . . . 1.84 109.867 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -115.06 -174.93 2.58 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.361 -0.837 . . . . 2.28 109.578 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -105.01 110.28 22.62 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.497 -0.927 . . . . 0.01 108.497 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.626 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 4.5 m-85 -100.72 113.46 26.36 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.385 -0.822 . . . . 0.01 110.523 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -96.48 -22.23 17.24 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.31 -0.869 . . . . 0.01 111.586 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -127.23 153.67 76.9 Favored Pre-proline 0 N--CA 1.505 2.294 0 O-C-N 120.892 -1.13 . . . . 2.54 109.173 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -59.76 -40.38 64.53 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 120.466 0.777 . . . . 0.7 110.574 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 41.7 t -61.03 -19.83 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.751 -1.218 . . . . 0.86 108.675 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 161' ' ' ASP . 41.4 t0 -65.54 -15.37 62.63 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.019 -1.05 . . . . 0.02 109.851 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.626 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 11.1 m0 -97.68 11.01 38.5 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.219 -0.926 . . . . 0.02 108.887 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.67 11.09 85.09 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.817 -1.182 . . . . 0.02 110.939 178.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.1 141.26 33.17 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.188 -1.184 . . . . 0.02 110.15 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.94 -8.64 58.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.592 -0.692 . . . . 0.59 110.219 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.1 t -143.62 150.32 50.26 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 120.931 -1.105 . . . . 0.87 109.195 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -75.91 18.52 0.63 Allowed 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 120.708 0.939 . . . . 0.38 112.161 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.62 124.19 29.94 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.952 -1.093 . . . . 0.18 111.42 -178.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.9 mt -149.48 126.88 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.052 -1.462 . . . . 3.99 107.052 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -112.11 -17.25 12.87 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.05 -1.031 . . . . 5.17 113.096 -177.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 17.0 t -157.04 160.13 38.65 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 119.14 -2.225 . . . . 0.02 110.374 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.428 ' CD1' ' C ' ' A' ' 172' ' ' PHE . 18.7 p90 -151.17 152.7 33.7 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.037 -1.039 . . . . 2.02 110.37 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -144.96 149.45 35.21 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.807 0.813 . . . . 0.01 110.225 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -88.62 145.15 25.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.613 -0.679 . . . . 0.01 109.293 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.2 mt -95.3 129.18 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.319 -0.863 . . . . 3.04 109.359 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.9 p -135.77 146.12 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.222 -0.924 . . . . 1.89 109.605 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.311 -0.868 . . . . 4.89 109.413 179.965 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.312 -1.515 . . . . 0.01 109.312 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -148.51 136.5 20.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.976 -1.308 . . . . 0.02 110.374 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.7 tt -130.62 140.68 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.724 -0.843 . . . . 0.02 108.724 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 t -120.83 130.42 53.95 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.573 -0.704 . . . . 0.39000000000000001 109.952 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.6 m-85 -110.33 139.94 45.01 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 109.217 -0.66 . . . . 0.02 109.217 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.564 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.7 m-85 -121.41 137.87 54.52 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.232 -0.917 . . . . 0.02 109.572 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -69.72 -27.43 64.97 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.995 -1.066 . . . . 0.029999999999999999 111.36 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 3.1 m-20 -114.23 169.68 8.85 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.927 -1.108 . . . . 0.029999999999999999 110.203 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 71.2 mtm180 -75.5 157.79 33.48 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.707 0.765 . . . . 0.029999999999999999 110.41 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 m120 66.16 33.84 7.13 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.884 0.85 . . . . 0.73999999999999999 111.192 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 55.54 41.25 30.93 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.301 0.572 . . . . 0.02 111.241 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -113.11 165.51 12.31 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.273 -1.01 . . . . 0.02 108.273 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.3 -166.97 35.32 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.767 -1.206 . . . . 0.029999999999999999 110.651 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.431 ' HG3' HH11 ' A' ' 18' ' ' ARG . 25.8 ttm-85 -68.77 141.68 55.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.494 -1.004 . . . . 2.7599999999999998 109.247 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -122.66 150.13 43.1 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.547 -0.721 . . . . 1.8899999999999999 109.88 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -138.11 134.02 34.14 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.706 -0.621 . . . . 0.02 109.659 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -109.08 136.17 49.03 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.393 -0.817 . . . . 1.1200000000000001 108.83 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.6 t -127.17 138.15 53.08 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.575 -0.703 . . . . 0.02 109.406 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.501 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 2.0 m-20 -118.93 11.75 12.63 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.494 -0.754 . . . . 0.20000000000000001 110.633 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 22.0 m -159.4 174.11 15.22 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.818 -1.176 . . . . 1.23 109.058 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -62.57 145.84 53.38 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.824 -1.173 . . . . 0.02 110.453 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 7.5 m -133.74 117.47 16.97 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 108.777 -0.823 . . . . 0.02 108.777 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.14 -21.92 49.59 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.167 -0.958 . . . . 0.23999999999999999 111.731 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -150.22 105.68 3.38 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.799 -1.188 . . . . 1.1399999999999999 109.526 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.8 5.32 45.54 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.54 0.686 . . . . 6.3700000000000001 110.067 -178.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -61.53 -28.3 69.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.404 -0.81 . . . . 3.1099999999999999 112.311 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.1 m -78.69 -18.85 53.72 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.248 -1.533 . . . . 0.88 111.741 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -105.74 -21.5 13.16 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.175 -0.953 . . . . 0.02 110.472 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 33' ' ' LEU . 47.6 mt -148.55 127.81 12.96 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.098 -1.001 . . . . 3.3199999999999998 109.125 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.5 p -86.18 -11.3 52.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.791 -0.568 . . . . 0.02 110.414 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -172.44 161.83 5.2 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.133 -1.062 . . . . 0.02 108.133 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 80.4 m -143.68 116.25 8.64 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.1 -1.0 . . . . 0.02 108.454 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.611 ' ND2' ' CD1' ' A' ' 69' ' ' TYR . 1.8 t-20 -110.23 0.94 18.36 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 120.862 -1.149 . . . . 0.029999999999999999 111.519 -177.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.6 t -155.71 152.8 29.01 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.647 -1.242 . . . . 0.02 107.647 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.7 mt -146.94 148.7 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.104 -0.998 . . . . 0.02 110.63 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -124.52 125.35 44.06 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.614 -1.254 . . . . 0.02 107.614 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.5 t -105.24 113.99 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 107.018 -1.475 . . . . 0.02 107.018 177.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -84.71 -34.67 22.88 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.411 -0.805 . . . . 3.8100000000000001 110.135 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.83 150.02 18.52 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 118.519 -1.8 . . . . 0.02 110.802 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.15 172.13 48.84 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.269 -1.132 . . . . 0.01 110.269 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.4 m -119.62 135.17 54.92 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 107.934 -1.135 . . . . 1.48 107.934 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.436 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 35.6 m95 -127.94 155.55 44.05 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 122.625 1.202 . . . . 0.02 112.518 -176.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.65 134.26 51.63 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 105.283 -2.117 . . . . 0.23999999999999999 105.283 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.414 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.8 m -118.36 143.82 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 109.172 -0.677 . . . . 0.65000000000000002 109.172 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -120.93 145.19 47.96 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 122.172 0.987 . . . . 0.02 109.977 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -66.07 -33.52 75.99 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.917 -0.583 . . . . 0.02 111.385 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -124.97 158.15 64.09 Favored Pre-proline 0 N--CA 1.503 2.222 0 O-C-N 121.127 -0.983 . . . . 0.02 109.43 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.62 166.92 1.1 Allowed 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.753 1.635 . . . . 0.02 112.905 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' ' 53' ' ' ASN . 1.5 t30 63.38 36.31 11.61 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 115.279 -0.873 . . . . 0.02 111.048 178.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.43 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 7.2 m-85 45.47 51.49 9.7 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.611 0.72 . . . . 3.3900000000000001 110.904 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 t -126.08 163.46 23.02 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.182 0.515 . . . . 2.3300000000000001 109.88 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.61 -161.69 31.18 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.878 -1.289 . . . . 0.02 109.878 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 15.0 m80 -64.54 138.94 58.68 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.001 -1.293 . . . . 0.02 110.077 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.44 ' C ' ' SD ' ' A' ' 58' ' ' MET . 10.9 tmm? -119.09 137.16 53.76 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 121.301 0.572 . . . . 5.0099999999999998 109.72 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.572 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 86.1 m-85 -135.33 138.96 43.92 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.477 -0.764 . . . . 0.02 109.854 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.5 mm -95.51 131.52 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 109.192 -0.67 . . . . 1.72 109.192 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.497 HD22 ' CE1' ' A' ' 66' ' ' TYR . 11.2 mt -121.04 111.98 33.65 Favored Pre-proline 0 N--CA 1.506 2.333 0 O-C-N 121.368 -0.832 . . . . 0.02 110.984 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -77.85 169.61 20.36 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 CA-C-N 119.886 0.995 . . . . 1.47 110.092 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -53.06 140.74 24.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.768 -1.207 . . . . 4.25 110.439 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.64 -177.48 32.75 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.548 -1.311 . . . . 0.02 110.533 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -119.3 130.6 55.48 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.267 -1.137 . . . . 0.95999999999999996 109.759 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.497 ' CE1' HD22 ' A' ' 61' ' ' LEU . 96.8 m-85 -120.97 94.59 48.99 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 108.113 -1.069 . . . . 0.02 108.113 178.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.404 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 2.5 Cg_endo -66.8 -3.49 9.5 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 120.874 1.049 . . . . 0.02 113.908 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 35.0 mt-10 -157.95 154.97 28.65 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.687 -1.258 . . . . 2.02 108.238 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.611 ' CD1' ' ND2' ' A' ' 37' ' ' ASN . 24.2 p90 -60.25 -39.17 85.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.57 -0.706 . . . . 0.02 112.019 -177.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -59.88 -23.83 63.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.946 -1.096 . . . . 0.02 110.189 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -69.99 -18.93 63.35 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.947 0.879 . . . . 3.4199999999999999 108.895 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.572 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.5 t90 -107.7 9.85 29.07 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.402 -1.333 . . . . 0.02 107.402 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 33.2 mtm 60.46 23.03 12.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.589 -0.695 . . . . 0.02 110.266 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.46 144.11 45.91 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.598 -1.401 . . . . 0.02 109.598 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.0 tp -79.37 -31.17 42.84 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.5 -1.296 . . . . 0.97999999999999998 107.5 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -157.16 -171.76 3.75 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.342 -1.725 . . . . 0.02 106.342 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -98.43 28.54 4.09 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.618 -1.302 . . . . 0.02 110.703 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -97.0 122.61 40.18 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.83 -1.169 . . . . 3.2000000000000002 111.014 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.51 HD21 ' CH2' ' A' ' 72' ' ' TRP . 75.5 mt -141.92 119.21 11.48 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.541 -1.281 . . . . 2.6099999999999999 107.541 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.21 -18.33 9.91 Favored Glycine 0 N--CA 1.498 2.809 0 O-C-N 121.157 -0.964 . . . . 0.02 112.344 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 91.3 p -156.38 155.86 32.88 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.256 -1.732 . . . . 0.02 110.491 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 49.1 t -145.35 148.23 33.15 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.493 -0.754 . . . . 0.02 109.912 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.43 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 41.8 mtm180 -138.3 142.98 39.78 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.253 -0.904 . . . . 0.01 109.429 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.21 132.04 36.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.23 -0.919 . . . . 0.42999999999999999 109.691 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.9 t -91.14 125.21 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.796 -0.816 . . . . 1.25 108.796 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -93.31 131.97 37.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.762 -1.211 . . . . 1.77 108.995 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mt -97.01 139.3 33.22 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.249 -1.019 . . . . 1.6299999999999999 108.249 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.6 m -111.49 127.39 55.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.291 -0.881 . . . . 1.0800000000000001 109.192 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.9 m -103.88 -154.18 0.5 Allowed 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 106.387 -1.709 . . . . 1.26 106.387 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.46 -51.58 0.79 Allowed Glycine 0 N--CA 1.501 2.985 0 O-C-N 120.408 -1.433 . . . . 0.01 112.656 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.68 -100.86 0.15 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 118.493 -1.813 . . . . 0.01 111.977 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -121.43 118.7 30.05 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.085 -1.244 . . . . 4.4299999999999997 110.668 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.99 130.06 36.05 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.881 -0.728 . . . . 2.9900000000000002 109.374 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -130.2 140.48 50.73 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.459 -0.776 . . . . 6.3600000000000003 109.139 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.411 HG22 ' O ' ' A' ' 110' ' ' THR . 4.5 tt -128.33 145.54 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 121.425 -0.797 . . . . 1.0900000000000001 110.215 -179.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -122.18 133.2 54.73 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 107.607 -1.257 . . . . 2.0499999999999998 107.607 177.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.8 m -124.57 146.1 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 O-C-N 120.657 -1.277 . . . . 1.1000000000000001 109.805 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.581 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 62.3 m-85 -119.49 141.47 49.15 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 122.036 0.922 . . . . 0.72999999999999998 111.134 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -67.07 -30.31 70.33 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 115.963 -0.562 . . . . 0.02 111.511 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -116.05 169.28 9.38 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.13 -0.981 . . . . 3.1800000000000002 110.264 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.46 165.12 52.25 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.982 -0.847 . . . . 0.01 110.982 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 57.07 38.34 29.12 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.785 -0.833 . . . . 0.01 111.418 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 52.16 54.46 10.74 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.459 -0.776 . . . . 0.01 111.271 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -129.48 165.87 20.77 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.994 -1.113 . . . . 3.1499999999999999 107.994 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.08 -163.65 29.32 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.259 -1.537 . . . . 0.01 109.259 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -76.1 143.55 41.21 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.948 -1.325 . . . . 0.01 108.918 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.581 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 38.1 ttp -116.44 142.52 46.76 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.575 0.702 . . . . 0.01 109.803 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -131.64 136.55 47.82 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.234 -1.024 . . . . 2.48 108.234 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -118.45 134.1 55.34 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.541 -0.725 . . . . 0.01 110.193 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.411 ' O ' HG22 ' A' ' 95' ' ' ILE . 4.9 t -148.4 150.04 32.81 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 122.191 0.996 . . . . 1.6899999999999999 110.973 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.7 p -110.31 10.23 23.56 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 115.555 -0.748 . . . . 0.01 110.214 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -120.96 163.53 18.11 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.234 -0.916 . . . . 3.21 111.597 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -66.89 156.71 35.03 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.951 -1.129 . . . . 0.01 107.951 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.608 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 22.0 p -122.83 115.16 29.48 Favored Pre-proline 0 N--CA 1.5 2.069 0 O-C-N 121.459 -0.776 . . . . 0.01 109.153 178.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -78.15 -34.72 1.53 Allowed 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 119.993 1.033 . . . . 0.01 110.906 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.6 m -141.07 107.91 5.39 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.687 -0.856 . . . . 0.02 108.687 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.86 -38.93 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.988 -0.445 . . . . 1.8300000000000001 110.897 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 19.6 ttt -67.59 -38.11 83.54 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.155 -1.018 . . . . 1.3400000000000001 110.034 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -68.85 -38.09 79.54 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.407 -1.433 . . . . 2.1099999999999999 109.599 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -79.72 -46.92 16.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.324 -0.86 . . . . 2.0800000000000001 112.267 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -112.07 -0.51 15.63 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.398 -0.814 . . . . 0.02 112.841 -176.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.417 ' ND1' ' N ' ' A' ' 122' ' ' HIS . 2.2 m-70 61.61 34.66 17.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.852 -1.155 . . . . 0.02 109.811 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.1 mt -114.13 135.99 53.43 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.446 -0.784 . . . . 0.02 109.299 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -90.87 -22.09 21.1 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.239 -0.913 . . . . 5.3200000000000003 110.868 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -147.59 163.71 35.75 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.992 -1.067 . . . . 0.02 109.863 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.1 mm -129.49 125.68 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 107.853 -1.166 . . . . 2.1699999999999999 107.853 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -110.9 -13.4 14.13 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.204 -0.935 . . . . 0.02 112.821 -177.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.2 t -159.45 150.96 20.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.673 -1.267 . . . . 0.01 109.312 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.509 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 7.9 p -166.29 148.5 6.86 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.092 -1.005 . . . . 1.22 108.992 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.03 109.26 15.72 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 122.395 1.093 . . . . 1.4099999999999999 109.095 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.1 t -113.27 128.41 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 107.648 -1.241 . . . . 0.01 107.648 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.4 t -129.55 93.23 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 107.391 -1.336 . . . . 1.98 107.391 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.52 ' OE1' ' NE1' ' A' ' 136' ' ' TRP . 31.5 tt0 -147.08 -75.34 0.19 Allowed 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 105.882 -1.895 . . . . 0.01 105.882 177.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 177.26 -77.01 0.07 OUTLIER Glycine 0 N--CA 1.483 1.821 0 N-CA-C 108.403 -1.879 . . . . 0.01 108.403 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.512 ' OG1' HD12 ' A' ' 175' ' ' ILE . 2.7 t -120.23 125.5 48.29 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.541 -0.976 . . . . 2.2999999999999998 110.226 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.52 ' NE1' ' OE1' ' A' ' 133' ' ' GLU . 8.2 m95 -128.97 151.57 49.54 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 107.066 -1.457 . . . . 0.01 107.066 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 41.0 mt -119.53 134.84 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 120.383 -1.448 . . . . 1.6899999999999999 109.987 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -114.36 143.91 44.14 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.262 -1.384 . . . . 2.4900000000000002 107.262 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.511 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 11.5 m-85 -123.02 144.67 49.12 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.244 -0.91 . . . . 0.02 109.346 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -76.3 -28.89 57.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.687 -0.633 . . . . 0.02 111.732 -176.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.1 mt -116.32 155.03 48.87 Favored Pre-proline 0 N--CA 1.504 2.248 0 O-C-N 120.698 -1.251 . . . . 1.48 108.896 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -56.17 167.2 2.65 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.186 1.257 . . . . 0.02 113.072 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 59.49 31.3 20.93 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 114.995 -1.002 . . . . 0.75 111.363 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 57.63 51.22 9.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.536 -0.727 . . . . 0.02 111.092 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -127.02 165.19 19.92 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.583 -0.698 . . . . 0.02 110.157 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.89 -166.03 33.66 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.395 -1.082 . . . . 0.02 110.395 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -69.38 142.54 53.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.551 -0.97 . . . . 0.02 109.162 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -115.13 149.76 37.08 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.729 -0.607 . . . . 0.02 110.028 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -123.68 134.27 53.76 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 109.004 -0.739 . . . . 0.01 109.004 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.6 tp -97.07 121.11 38.6 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.797 -1.189 . . . . 0.01 109.4 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.479 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 12.9 tp -98.5 146.52 25.69 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.234 -0.916 . . . . 0.01 108.787 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -104.68 -124.77 0.22 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.465 -0.772 . . . . 2.27 110.251 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -138.63 50.45 1.86 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.218 -0.926 . . . . 1.8400000000000001 109.657 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -115.37 -167.2 1.21 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.344 -0.848 . . . . 2.2799999999999998 109.517 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -105.6 109.97 22.13 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.565 -0.902 . . . . 0.01 108.565 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.655 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 4.1 m-85 -99.97 111.53 23.83 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.382 -0.823 . . . . 0.01 110.301 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -96.14 -22.1 17.51 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.147 -0.97 . . . . 0.01 111.32 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -127.42 154.11 77.29 Favored Pre-proline 0 N--CA 1.505 2.275 0 O-C-N 121.04 -1.037 . . . . 2.54 108.957 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -59.62 -38.4 82.07 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 120.442 0.761 . . . . 0.69999999999999996 110.533 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 65.5 t -61.07 -19.68 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.948 -1.095 . . . . 0.85999999999999999 109.047 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -65.24 -15.18 62.2 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.973 -1.079 . . . . 0.02 109.856 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.655 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 9.8 m0 -97.65 11.04 38.39 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.173 -0.954 . . . . 0.02 108.985 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.31 11.13 84.61 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.899 -1.144 . . . . 0.02 110.988 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.71 140.88 33.27 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.042 -1.269 . . . . 0.02 110.155 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.39 -8.53 58.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.64 -0.662 . . . . 0.58999999999999997 110.178 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.7 p -142.29 150.95 56.94 Favored Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 120.93 -1.106 . . . . 0.87 109.237 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -75.69 16.8 0.73 Allowed 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 120.81 1.007 . . . . 0.38 112.241 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.14 121.78 27.03 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.359 1.076 . . . . 0.17999999999999999 111.27 -178.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.1 mt -149.33 124.21 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 106.096 -1.816 . . . . 3.9900000000000002 106.096 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -112.32 -15.46 13.15 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.217 -0.927 . . . . 5.1699999999999999 113.271 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 5.4 p -157.34 160.77 38.84 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 119.285 -2.135 . . . . 0.02 110.204 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.608 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 7.1 p90 -152.25 154.07 35.02 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.007 -1.058 . . . . 2.02 110.737 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.4 mtm180 -145.61 150.41 36.31 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.272 -0.892 . . . . 0.01 110.293 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -88.31 143.55 26.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.554 -0.716 . . . . 0.01 109.199 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.512 HD12 ' OG1' ' A' ' 135' ' ' THR . 3.1 mt -94.58 129.77 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.242 -0.912 . . . . 3.04 109.034 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.47 146.84 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.203 -0.936 . . . . 1.8899999999999999 109.639 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.365 -0.834 . . . . 4.8899999999999997 109.462 -179.922 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 107.86 -2.096 . . . . 0.01 107.86 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -148.51 134.66 19.29 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.96 -1.318 . . . . 0.02 110.983 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.9 tt -128.56 138.95 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 107.703 -1.221 . . . . 0.02 107.703 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.4 t -122.33 130.21 52.91 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.225 -0.922 . . . . 0.39000000000000001 110.339 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 5.2 m-85 -110.36 140.45 44.54 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.82 -0.807 . . . . 0.02 108.82 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.555 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.7 m-85 -122.39 138.69 54.45 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.219 -0.926 . . . . 0.02 109.512 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.486 ' HG3' HD11 ' A' ' 33' ' ' LEU . 88.0 mt-10 -68.62 -27.46 66.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.083 -1.011 . . . . 0.029999999999999999 111.438 -178.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -114.77 170.17 8.53 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.822 -1.174 . . . . 0.029999999999999999 110.161 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -75.4 161.68 29.03 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.932 0.872 . . . . 0.029999999999999999 110.39 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.4 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 1.7 m-20 63.22 32.9 14.67 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.048 0.928 . . . . 0.73999999999999999 110.853 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.4 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 1.3 m-85 55.03 40.02 31.83 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.94 -0.573 . . . . 0.02 110.874 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -110.08 166.07 11.24 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.134 -1.061 . . . . 0.02 108.134 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.14 -167.59 36.21 Favored Glycine 0 N--CA 1.496 2.638 0 C-N-CA 119.765 -1.207 . . . . 0.029999999999999999 111.037 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -69.01 143.03 54.46 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.49 -1.006 . . . . 2.7599999999999998 109.171 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -120.76 149.02 43.18 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.5 0.667 . . . . 1.8899999999999999 110.197 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -132.7 127.56 35.04 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.323 -0.991 . . . . 0.02 108.323 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 7.8 p30 -112.6 136.76 51.77 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.429 -0.794 . . . . 1.1200000000000001 109.934 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.9 t -131.5 138.79 49.11 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.631 -0.668 . . . . 0.02 109.547 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -116.63 11.07 14.59 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.671 -0.643 . . . . 0.20000000000000001 109.912 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 9.8 p -158.63 174.86 14.42 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.408 -0.96 . . . . 1.23 108.408 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -60.75 143.66 53.96 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.669 -1.269 . . . . 0.02 109.912 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.3 t -131.51 117.44 18.79 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.487 -0.931 . . . . 0.02 108.487 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.81 -25.04 48.61 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.156 -0.965 . . . . 0.23999999999999999 110.83 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -155.15 101.38 2.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.031 -1.043 . . . . 1.1399999999999999 108.968 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.402 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 24.1 p90 -104.92 9.83 34.5 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 122.111 0.958 . . . . 6.3700000000000001 109.622 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 45.4 mtp180 -58.65 -24.0 60.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.509 -0.744 . . . . 3.1099999999999999 110.847 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.5 t -74.46 -16.49 60.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.796 -1.19 . . . . 0.88 110.071 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -104.53 -22.17 13.32 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.536 -0.728 . . . . 0.02 109.588 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.486 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.9 tp -150.38 128.89 12.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.194 -0.941 . . . . 3.3199999999999998 109.085 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.2 t -85.44 -9.86 56.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.786 -0.571 . . . . 0.02 111.11 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -171.36 162.75 6.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.859 -1.15 . . . . 0.02 107.954 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.2 p -143.25 115.42 8.4 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.806 -1.184 . . . . 0.02 108.717 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.407 HD22 ' HB3' ' A' ' 77' ' ' ASP . 5.2 t-20 -108.0 2.36 23.16 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 120.877 -1.14 . . . . 0.029999999999999999 110.889 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.0 p -156.94 154.63 30.01 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.553 -1.277 . . . . 0.02 107.553 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.3 mt -147.02 148.37 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.039 -1.038 . . . . 0.02 110.376 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -124.59 125.79 44.73 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.982 -1.118 . . . . 0.02 107.982 177.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.1 t -107.16 115.31 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 107.105 -1.443 . . . . 0.02 107.105 177.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -83.88 -34.14 24.64 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.585 -0.697 . . . . 3.8100000000000001 110.824 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.95 152.3 22.1 Favored Glycine 0 N--CA 1.486 2.016 0 C-N-CA 118.935 -1.602 . . . . 0.02 110.816 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.31 172.78 49.12 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.517 -1.325 . . . . 0.01 110.398 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 47.1 m -119.82 134.89 55.08 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.053 -1.091 . . . . 1.48 108.053 178.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.598 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 3.3 m95 -125.99 154.53 42.77 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 122.522 1.153 . . . . 0.02 112.178 -176.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.98 133.56 52.81 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 105.369 -2.085 . . . . 0.23999999999999999 105.369 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.531 ' HB ' HD22 ' A' ' 79' ' ' LEU . 33.0 m -118.46 143.17 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 109.005 -0.739 . . . . 0.65000000000000002 109.005 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -121.03 146.76 46.37 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 122.192 0.996 . . . . 0.02 110.041 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.25 -34.6 78.74 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.831 -0.622 . . . . 0.02 111.517 -177.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.55 163.02 45.41 Favored Pre-proline 0 N--CA 1.509 2.489 0 O-C-N 120.92 -1.113 . . . . 0.02 109.135 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -55.94 168.07 2.01 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.294 1.33 . . . . 0.02 113.208 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 63.79 36.41 10.52 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.103 -0.953 . . . . 0.02 111.863 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 45.57 52.24 9.38 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.669 0.747 . . . . 3.3900000000000001 111.188 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.1 m -127.2 164.22 22.15 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.261 0.553 . . . . 2.3300000000000001 109.912 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.32 -161.58 32.79 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.918 -1.273 . . . . 0.02 109.918 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -65.85 137.94 57.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.101 -1.234 . . . . 0.02 109.99 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 14.8 ptm -118.66 136.68 53.78 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.82 -0.55 . . . . 5.0099999999999998 109.556 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.477 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 96.5 m-85 -133.04 138.88 46.92 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-O 121.639 0.733 . . . . 0.02 109.756 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.9 mm -95.17 131.16 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.934 -0.765 . . . . 1.72 108.934 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.517 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 1.1 mt -120.02 110.73 36.16 Favored Pre-proline 0 N--CA 1.504 2.246 0 O-C-N 121.477 -0.764 . . . . 0.02 110.711 -178.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -77.65 168.59 22.28 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 CA-C-N 119.979 1.028 . . . . 1.47 110.139 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -54.18 141.15 30.19 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.836 -1.165 . . . . 4.25 110.395 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.43 -177.27 32.69 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 119.684 -1.246 . . . . 0.02 110.52 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -119.21 130.53 55.53 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.433 -1.039 . . . . 0.95999999999999996 109.662 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.517 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 51.1 m-85 -120.87 97.97 47.97 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 107.762 -1.199 . . . . 0.02 107.762 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -70.23 -3.91 13.27 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 120.681 0.921 . . . . 0.02 113.674 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -157.33 154.79 29.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.651 -1.281 . . . . 2.02 108.048 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -60.14 -39.23 85.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.542 -0.724 . . . . 0.02 111.871 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -59.89 -23.99 63.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.003 -1.061 . . . . 0.02 110.329 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -70.19 -18.79 63.2 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.955 0.883 . . . . 3.4199999999999999 108.898 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.544 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.4 t90 -108.27 10.39 27.75 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.396 -1.335 . . . . 0.02 107.396 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 7.5 mmt 60.6 22.52 12.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.533 -0.729 . . . . 0.02 110.51 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.66 145.17 47.72 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.535 -1.426 . . . . 0.02 109.535 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.8 mt -79.62 -30.85 41.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.062 -1.258 . . . . 0.97999999999999998 108.09 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -157.67 -171.48 3.58 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.541 -1.652 . . . . 0.02 106.541 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.407 ' HB3' HD22 ' A' ' 37' ' ' ASN . 2.4 p-10 -98.57 28.56 4.13 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.628 -1.295 . . . . 0.02 110.518 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.592 HH11 ' CG ' ' A' ' 78' ' ' ARG . 3.1 mtt-85 -97.87 122.74 41.34 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.163 -0.96 . . . . 3.2000000000000002 111.361 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.531 HD22 ' HB ' ' A' ' 48' ' ' VAL . 34.7 mt -144.78 122.24 11.68 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 107.6 -1.259 . . . . 2.6099999999999999 107.6 177.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.09 -16.06 11.88 Favored Glycine 0 N--CA 1.503 3.112 0 O-C-N 121.184 -0.948 . . . . 0.02 112.696 -177.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.8 t -156.55 155.91 32.73 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.171 -1.782 . . . . 0.02 110.363 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.1 p -145.39 148.03 32.91 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.532 -0.73 . . . . 0.02 110.303 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -138.44 143.61 39.75 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.311 -0.868 . . . . 0.01 109.386 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.95 133.13 36.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.42999999999999999 109.813 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.5 t -92.23 125.58 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.968 -0.753 . . . . 1.25 108.968 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -93.31 132.63 37.34 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.833 -1.167 . . . . 1.77 109.173 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.5 mt -98.95 141.27 31.92 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.499 -0.75 . . . . 1.6299999999999999 109.029 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.0 t -111.6 125.11 53.58 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.693 -0.855 . . . . 1.0800000000000001 108.693 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 90.2 p -116.7 133.29 56.19 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.717 -1.239 . . . . 1.26 108.039 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.02 -48.99 0.01 OUTLIER Glycine 0 N--CA 1.505 3.284 0 C-N-CA 117.723 -2.179 . . . . 0.01 113.839 -177.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -167.26 -105.47 0.18 Allowed Glycine 0 N--CA 1.491 2.358 0 CA-C-N 120.045 1.923 . . . . 0.01 111.098 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -118.95 117.23 28.27 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.061 -1.258 . . . . 4.4299999999999997 109.998 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.04 130.58 36.62 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.834 -0.747 . . . . 2.9900000000000002 109.132 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.462 ' HZ3' ' HB2' ' A' ' 94' ' ' LYS . 10.3 ttmm -130.16 139.95 50.82 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.51 -0.744 . . . . 6.3600000000000003 109.258 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.5 tt -129.28 145.8 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 O-C-N 121.39 -0.819 . . . . 1.0900000000000001 110.159 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -122.52 134.03 54.56 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 107.761 -1.2 . . . . 2.0499999999999998 107.761 177.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.491 HG12 ' SG ' ' A' ' 129' ' ' CYS . 29.6 m -123.18 146.06 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 120.868 -1.145 . . . . 1.1000000000000001 109.612 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.584 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 67.2 m-85 -118.51 140.56 49.69 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 122.104 0.954 . . . . 0.72999999999999998 110.845 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.43 ' OE2' ' O ' ' A' ' 99' ' ' GLU . 4.3 tm-20 -66.35 -30.18 70.53 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.957 -0.565 . . . . 0.02 111.357 -178.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.434 ' O ' ' OG ' ' A' ' 128' ' ' SER . 79.1 mttt -117.04 170.56 8.55 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.078 -1.014 . . . . 3.1800000000000002 110.327 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.48 170.86 41.65 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 111.003 -0.839 . . . . 0.01 111.003 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 51.86 38.76 24.26 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.55 0.691 . . . . 0.01 111.629 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 51.94 48.24 23.16 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.569 -0.707 . . . . 0.01 111.174 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.508 ' OD1' ' N ' ' A' ' 105' ' ' GLY . 21.2 t-20 -122.52 166.26 15.08 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.331 -0.988 . . . . 3.1499999999999999 108.331 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.508 ' N ' ' OD1' ' A' ' 104' ' ' ASN . . . 91.95 -164.45 28.72 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.507 -1.437 . . . . 0.01 109.507 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 64.0 tp60 -76.36 144.22 40.24 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.988 -1.301 . . . . 0.01 108.559 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.584 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 31.8 ttp -116.44 142.61 46.63 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.684 0.754 . . . . 0.01 109.907 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -131.15 137.4 49.0 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.225 -1.028 . . . . 2.48 108.225 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -118.16 133.82 55.56 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.549 -0.719 . . . . 0.01 110.044 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.3 t -148.67 149.45 31.5 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 122.287 1.041 . . . . 1.6899999999999999 110.984 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 p -111.03 9.65 22.1 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 115.452 -0.794 . . . . 0.01 110.025 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -121.17 163.28 18.71 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.202 -0.936 . . . . 3.21 111.719 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -67.42 156.64 36.06 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.326 -0.99 . . . . 0.01 108.326 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.59 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 92.2 m -124.7 111.14 27.67 Favored Pre-proline 0 N--CA 1.502 2.165 0 O-C-N 121.43 -0.794 . . . . 0.01 109.098 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -76.53 -32.83 3.5 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 CA-C-N 120.099 1.071 . . . . 0.01 111.492 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.9 t -140.41 106.33 5.18 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.331 -0.989 . . . . 0.02 108.331 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 73.8 mt -65.2 -38.84 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.81 -0.556 . . . . 1.8300000000000001 111.044 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.437 ' SD ' ' C ' ' A' ' 123' ' ' LEU . 8.9 tpt -66.52 -38.24 86.78 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.046 -1.062 . . . . 1.3400000000000001 110.022 -178.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -69.6 -38.53 77.32 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.455 -1.403 . . . . 2.1099999999999999 109.77 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -80.55 -47.12 14.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.34 -0.85 . . . . 2.0800000000000001 112.453 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -111.7 -1.3 15.72 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.433 -0.792 . . . . 0.02 112.556 -176.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 61.42 34.08 18.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.837 -1.164 . . . . 0.02 109.655 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.437 ' C ' ' SD ' ' A' ' 118' ' ' MET . 38.7 mt -114.21 136.13 53.29 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.48 -0.763 . . . . 0.02 109.269 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -90.63 -21.9 21.46 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.212 -0.93 . . . . 5.3200000000000003 110.918 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -148.18 164.02 35.21 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.853 -1.155 . . . . 0.02 110.009 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.4 mm -129.8 126.02 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 107.554 -1.276 . . . . 2.1699999999999999 107.554 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -109.84 -13.4 14.46 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.156 -0.965 . . . . 0.02 112.966 -177.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 16.6 p -161.2 153.07 19.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.59 -1.319 . . . . 0.01 109.295 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.491 ' SG ' HG12 ' A' ' 97' ' ' VAL . 6.6 t -169.34 145.47 3.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.385 -0.822 . . . . 1.22 108.832 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -124.98 107.83 11.24 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 122.311 1.053 . . . . 1.4099999999999999 109.685 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.595 HG21 ' CD1' ' A' ' 136' ' ' TRP . 11.9 p -110.91 138.26 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.46 -1.311 . . . . 0.01 107.46 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.5 t -127.78 94.46 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 107.186 -1.412 . . . . 1.98 107.186 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.518 ' OE1' ' NE1' ' A' ' 136' ' ' TRP . 52.2 tt0 -146.19 -75.31 0.21 Allowed 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 105.987 -1.857 . . . . 0.01 105.987 177.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 176.57 -77.39 0.07 OUTLIER Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.648 -1.781 . . . . 0.01 108.648 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.56 ' OG1' HD12 ' A' ' 175' ' ' ILE . 1.6 t -119.49 126.13 50.55 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.623 -0.928 . . . . 2.2999999999999998 110.318 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.595 ' CD1' HG21 ' A' ' 131' ' ' VAL . 43.8 m95 -128.72 150.01 50.45 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 107.166 -1.42 . . . . 0.01 107.166 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 56.2 mt -120.87 136.5 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 120.441 -1.412 . . . . 1.6899999999999999 109.973 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -114.75 144.38 43.57 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.604 -1.258 . . . . 2.4900000000000002 107.604 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.444 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 24.0 m-85 -122.8 144.13 49.38 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.372 -0.83 . . . . 0.02 109.53 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -75.62 -29.18 59.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.448 -0.782 . . . . 0.02 111.671 -176.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.3 mt -116.39 154.78 48.97 Favored Pre-proline 0 N--CA 1.505 2.302 0 O-C-N 120.759 -1.213 . . . . 1.48 109.029 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -55.62 167.2 2.22 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.19 1.26 . . . . 0.02 113.022 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 11.3 m120 59.62 30.74 20.38 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.105 -0.952 . . . . 0.75 111.318 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 57.47 51.24 10.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.426 -0.796 . . . . 0.02 110.921 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -126.17 164.52 20.77 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.55 -0.719 . . . . 0.02 109.911 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.95 -165.61 33.26 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.17 -1.172 . . . . 0.02 110.17 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -69.42 142.07 53.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.551 -0.97 . . . . 0.02 109.142 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.47 ' CD ' ' N ' ' A' ' 148' ' ' GLN . 7.1 mp0 -114.79 149.39 37.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.831 -0.543 . . . . 0.02 110.047 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 149' ' ' TYR . 20.2 m-85 -124.51 134.4 53.02 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.18 -0.674 . . . . 0.01 109.18 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.6 tt -98.93 121.39 40.82 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.865 -1.147 . . . . 0.01 108.972 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.417 HD21 ' CE1' ' A' ' 156' ' ' TYR . 4.4 tp -100.2 151.12 21.81 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.253 -0.904 . . . . 0.01 108.89 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.4 ' CG ' ' H ' ' A' ' 153' ' ' LYS . 62.8 t0 -104.23 -124.4 0.21 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.369 -0.832 . . . . 2.27 109.883 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.4 ' H ' ' CG ' ' A' ' 152' ' ' ASP . 29.0 ttmt -136.46 49.55 2.08 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.352 -0.843 . . . . 1.8400000000000001 109.586 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -113.55 -172.36 2.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.546 -0.721 . . . . 2.2799999999999998 109.252 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -105.61 113.32 26.82 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.752 -0.833 . . . . 0.01 108.752 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.417 ' CE1' HD21 ' A' ' 151' ' ' LEU . 60.6 m-85 -98.58 112.68 24.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.328 -0.857 . . . . 0.01 110.133 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -94.81 -24.5 17.03 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.195 -0.941 . . . . 0.01 110.91 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -125.43 154.99 72.44 Favored Pre-proline 0 N--CA 1.498 1.972 0 N-CA-C 108.383 -0.969 . . . . 2.54 108.383 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.553 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 8.4 Cg_endo -60.48 -39.19 67.92 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 CA-C-N 119.197 0.749 . . . . 0.69999999999999996 110.844 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 68.0 t -61.45 -18.8 19.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 O-C-N 120.742 -1.224 . . . . 0.85999999999999999 109.282 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -65.44 -17.84 64.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.915 -1.116 . . . . 0.02 111.852 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.553 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.6 OUTLIER -101.74 16.39 25.99 Favored 'General case' 0 N--CA 1.513 2.702 0 O-C-N 120.886 -1.134 . . . . 0.02 110.19 178.476 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.03 9.74 79.91 Favored Glycine 0 N--CA 1.499 2.844 0 O-C-N 121.136 -0.978 . . . . 0.02 113.091 176.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.509 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.02 141.6 32.62 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.799 -1.412 . . . . 0.02 110.193 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.78 -8.25 58.89 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.374 -0.602 . . . . 0.58999999999999997 109.374 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.3 t -142.96 150.55 53.41 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.078 -1.014 . . . . 0.87 108.887 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -75.63 18.47 0.6 Allowed 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 120.746 0.964 . . . . 0.38 112.33 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.57 121.99 27.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.899 -1.126 . . . . 0.17999999999999999 111.282 -178.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.8 mt -149.12 123.62 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 105.986 -1.857 . . . . 3.9900000000000002 105.986 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -112.17 -15.92 13.12 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.103 -0.998 . . . . 5.1699999999999999 113.301 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 26.0 t -156.71 159.71 38.63 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 119.231 -2.168 . . . . 0.02 109.993 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.59 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 12.7 p90 -152.69 153.89 34.17 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.969 -1.082 . . . . 2.02 110.53 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 48.5 mtp180 -144.83 150.62 37.44 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.907 0.861 . . . . 0.01 110.439 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -88.5 143.77 26.76 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.424 -0.584 . . . . 0.01 109.424 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.56 HD12 ' OG1' ' A' ' 135' ' ' THR . 6.2 mt -95.17 128.82 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.158 -0.964 . . . . 3.04 109.039 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 75.0 t -136.3 146.56 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.136 -0.977 . . . . 1.8899999999999999 109.543 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.335 -0.853 . . . . 4.8899999999999997 109.586 -179.928 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.349 -1.5 . . . . 0.01 109.349 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -147.12 136.13 22.35 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.098 -1.237 . . . . 0.02 110.77 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.0 tt -130.73 140.13 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 108.927 -0.768 . . . . 0.02 108.927 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.0 t -122.12 130.51 53.31 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.428 -0.795 . . . . 0.39000000000000001 110.009 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 8.7 m-85 -110.93 140.96 44.99 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 109.092 -0.707 . . . . 0.02 109.092 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.526 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 7.5 m-85 -122.97 139.21 54.31 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.222 -0.924 . . . . 0.02 109.76 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.469 ' HG3' HD11 ' A' ' 33' ' ' LEU . 82.5 mt-10 -68.97 -27.75 66.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.033 -1.042 . . . . 0.029999999999999999 111.599 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -114.54 169.56 8.96 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.876 -1.14 . . . . 0.029999999999999999 110.306 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -75.21 158.24 33.27 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.651 0.739 . . . . 0.029999999999999999 110.211 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 66.26 33.37 7.25 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.906 0.86 . . . . 0.73999999999999999 111.131 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 55.26 41.82 30.98 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.185 0.517 . . . . 0.02 111.177 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -113.15 165.99 11.86 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.208 -1.034 . . . . 0.02 108.208 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.89 -167.26 36.31 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.834 -1.174 . . . . 0.029999999999999999 110.683 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -69.44 142.05 53.92 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.44 -1.036 . . . . 2.7599999999999998 109.135 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -120.89 149.41 42.65 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.586 0.708 . . . . 1.8899999999999999 110.204 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -132.54 127.5 35.24 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.358 -0.978 . . . . 0.02 108.358 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -112.48 137.12 51.14 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.566 -0.709 . . . . 1.1200000000000001 109.806 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 14.9 t -131.67 139.1 48.98 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.514 0.673 . . . . 0.02 109.761 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -116.91 11.22 14.33 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.578 -0.701 . . . . 0.20000000000000001 109.674 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.535 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 50.4 t -158.19 174.4 15.25 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.362 -0.977 . . . . 1.23 108.362 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.535 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 3.2 p30 -60.97 144.08 53.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.646 -1.284 . . . . 0.02 109.867 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.1 p -131.76 117.42 18.57 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.494 -0.928 . . . . 0.02 108.494 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.16 -25.62 47.36 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.052 -1.03 . . . . 0.23999999999999999 110.889 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 28' ' ' ASP . 8.4 p30 -154.14 101.31 2.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.966 -1.084 . . . . 1.1399999999999999 109.022 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -104.71 9.46 35.06 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 122.219 1.009 . . . . 6.3700000000000001 109.897 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -58.52 -24.13 59.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.411 -0.805 . . . . 3.1099999999999999 111.012 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.7 p -74.47 -16.69 60.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.656 -1.278 . . . . 0.88 110.105 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -103.97 -22.1 13.52 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.458 -0.776 . . . . 0.02 109.628 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.469 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.8 tp -150.43 128.98 12.23 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.131 -0.981 . . . . 3.3199999999999998 109.223 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.8 p -85.86 -10.19 55.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.791 -0.568 . . . . 0.02 111.124 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -171.23 162.68 6.98 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.908 -1.145 . . . . 0.02 107.908 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.1 p -144.11 116.36 8.47 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.826 -1.171 . . . . 0.02 109.056 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.497 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 1.0 OUTLIER -108.28 1.63 22.1 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.745 -1.222 . . . . 0.029999999999999999 110.924 -178.601 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 56.1 m -155.86 154.24 30.98 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.786 -1.19 . . . . 0.02 107.786 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.8 mt -146.02 146.8 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.118 -0.989 . . . . 0.02 110.616 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -123.46 124.63 43.32 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.112 -1.07 . . . . 0.02 108.112 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.0 t -106.15 114.47 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 106.849 -1.537 . . . . 0.02 106.849 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -84.67 -34.32 23.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.476 -0.765 . . . . 3.8100000000000001 110.452 -178.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.82 149.89 18.25 Favored Glycine 0 N--CA 1.486 1.991 0 C-N-CA 119.071 -1.538 . . . . 0.02 110.507 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.29 172.48 49.09 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.915 -1.136 . . . . 0.01 110.448 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.5 m -119.13 135.12 54.82 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.045 -1.094 . . . . 1.48 108.045 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 36.2 m95 -126.86 154.24 44.64 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 122.563 1.173 . . . . 0.02 112.316 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.75 134.41 51.51 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 105.448 -2.056 . . . . 0.23999999999999999 105.448 176.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.509 ' HB ' HD22 ' A' ' 79' ' ' LEU . 27.4 m -118.44 143.31 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.622 -0.674 . . . . 0.65000000000000002 109.257 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.538 ' CE2' ' SD ' ' A' ' 58' ' ' MET . 33.0 m-85 -120.95 145.53 47.62 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 122.256 1.027 . . . . 0.02 109.975 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -66.5 -34.18 77.35 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.798 -0.637 . . . . 0.02 111.42 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -125.61 157.92 66.68 Favored Pre-proline 0 N--CA 1.502 2.158 0 O-C-N 121.194 -0.941 . . . . 0.02 109.511 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -53.68 167.1 1.08 Allowed 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.707 1.604 . . . . 0.02 113.169 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.414 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.5 m-20 63.9 36.2 10.4 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.079 -0.964 . . . . 0.02 111.092 178.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 45.39 51.92 9.27 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.692 0.758 . . . . 3.3900000000000001 110.673 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.8 m -126.52 163.89 22.39 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.235 0.54 . . . . 2.3300000000000001 109.871 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.11 -161.8 31.92 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.958 -1.257 . . . . 0.02 109.958 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -65.22 138.88 58.52 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.093 -1.239 . . . . 0.02 110.176 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.538 ' SD ' ' CE2' ' A' ' 49' ' ' TYR . 48.6 ttp -118.52 136.97 53.53 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.798 -0.564 . . . . 5.0099999999999998 109.507 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.482 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 90.1 m-85 -134.5 138.42 44.68 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 121.763 0.792 . . . . 0.02 109.807 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.8 mm -96.06 131.64 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.082 -0.711 . . . . 1.72 109.082 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.459 HD22 ' CE1' ' A' ' 66' ' ' TYR . 12.2 mt -121.5 112.18 32.8 Favored Pre-proline 0 N--CA 1.506 2.326 0 O-C-N 121.365 -0.835 . . . . 0.02 110.853 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -77.7 169.98 19.91 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 CA-C-N 119.822 0.972 . . . . 1.47 109.981 177.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -52.64 140.98 21.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.833 -1.167 . . . . 4.25 110.263 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.44 -178.25 32.17 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.507 -1.33 . . . . 0.02 110.845 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -120.37 131.85 55.01 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.492 -1.005 . . . . 0.95999999999999996 109.804 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.459 ' CE1' HD22 ' A' ' 61' ' ' LEU . 94.1 m-85 -121.91 96.1 47.15 Favored Pre-proline 0 N--CA 1.495 1.822 0 N-CA-C 107.958 -1.127 . . . . 0.02 107.958 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.4 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.3 Cg_endo -67.21 -3.84 10.59 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 120.712 0.941 . . . . 0.02 113.868 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 35.0 mt-10 -157.52 155.44 30.28 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.64 -1.288 . . . . 2.02 108.239 179.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -60.42 -39.22 86.64 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.6 -0.687 . . . . 0.02 112.048 -177.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -59.88 -23.77 63.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.091 -1.006 . . . . 0.02 110.202 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -70.36 -19.2 63.06 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.87 0.843 . . . . 3.4199999999999999 108.948 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.544 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 1.6 t90 -107.68 9.9 29.1 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.483 -1.303 . . . . 0.02 107.483 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.7 mtt 60.52 22.5 12.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.605 -0.684 . . . . 0.02 110.335 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.35 144.6 47.3 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.435 -1.466 . . . . 0.02 109.435 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.0 mt -79.13 -30.42 43.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.101 -1.235 . . . . 0.97999999999999998 107.779 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -157.68 -171.26 3.49 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 106.393 -1.706 . . . . 0.02 106.393 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -98.61 29.04 3.87 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.7 -1.25 . . . . 0.02 110.484 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.582 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -98.58 123.08 42.54 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.178 -0.951 . . . . 3.2000000000000002 111.383 -178.771 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.509 HD22 ' HB ' ' A' ' 48' ' ' VAL . 35.4 mt -144.93 122.73 11.91 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 107.39 -1.337 . . . . 2.6099999999999999 107.39 177.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.96 -16.57 11.27 Favored Glycine 0 N--CA 1.502 3.096 0 O-C-N 121.158 -0.964 . . . . 0.02 112.686 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 90.2 p -156.68 156.42 33.4 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.154 -1.792 . . . . 0.02 110.351 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 12.7 m -145.0 147.81 33.05 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.545 -0.722 . . . . 0.02 110.012 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -138.04 142.99 40.32 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.317 -0.864 . . . . 0.01 109.593 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.56 132.99 36.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.31 -0.869 . . . . 0.42999999999999999 109.804 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.9 t -91.57 125.07 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.994 -0.743 . . . . 1.25 108.994 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -93.61 132.06 38.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.735 -1.228 . . . . 1.77 109.044 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -97.37 139.79 32.79 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.579 -0.897 . . . . 1.6299999999999999 108.579 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.5 t -111.8 127.72 55.89 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.351 -0.843 . . . . 1.0800000000000001 109.281 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.6 p -104.32 -154.33 0.5 Allowed 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 106.506 -1.664 . . . . 1.26 106.506 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.82 -51.37 0.78 Allowed Glycine 0 N--CA 1.5 2.95 0 O-C-N 120.39 -1.444 . . . . 0.01 112.771 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.43 -101.14 0.15 Allowed Glycine 0 N--CA 1.489 2.203 0 C-N-CA 118.515 -1.803 . . . . 0.01 111.877 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -121.4 119.1 31.13 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.194 -1.18 . . . . 4.4299999999999997 110.556 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.62 128.8 33.99 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.66 -0.816 . . . . 2.9900000000000002 109.359 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -130.62 141.75 50.44 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.458 -0.776 . . . . 6.3600000000000003 109.064 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.6 tt -129.69 146.76 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 O-C-N 121.281 -0.887 . . . . 1.0900000000000001 110.307 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -121.55 133.56 55.02 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 107.437 -1.319 . . . . 2.0499999999999998 107.437 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.5 m -124.04 146.09 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 120.768 -1.207 . . . . 1.1000000000000001 109.902 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.581 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 61.4 m-85 -118.74 141.27 48.77 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 122.007 0.908 . . . . 0.72999999999999998 110.879 -178.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -66.58 -30.55 70.88 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 116.007 -0.542 . . . . 0.02 111.351 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -116.82 170.28 8.73 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.124 -0.985 . . . . 3.1800000000000002 110.298 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.54 170.09 43.24 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.874 -0.89 . . . . 0.01 110.874 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 2.5 m-20 52.74 38.61 26.84 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.562 0.696 . . . . 0.01 111.704 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 52.42 48.71 22.02 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.65 -0.656 . . . . 0.01 110.944 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -123.08 165.36 16.95 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.252 -1.018 . . . . 3.1499999999999999 108.252 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.9 -163.93 28.48 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.476 -1.45 . . . . 0.01 109.476 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.2 tp60 -76.73 144.05 39.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.936 -1.332 . . . . 0.01 108.899 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.581 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 30.5 ttp -116.4 142.32 47.01 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.65 0.738 . . . . 0.01 109.93 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -131.66 137.16 48.22 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.51 -0.922 . . . . 2.48 108.51 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -117.9 133.9 55.47 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.425 -0.797 . . . . 0.01 110.141 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.1 t -148.18 148.49 30.61 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 122.262 1.029 . . . . 1.6899999999999999 110.967 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 63.4 p -110.87 10.35 22.41 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 115.579 -0.737 . . . . 0.01 110.331 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -121.16 163.16 18.88 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.152 -0.967 . . . . 3.21 111.566 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -67.03 156.46 35.99 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.107 -1.072 . . . . 0.01 108.107 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.474 ' HG ' ' HZ ' ' A' ' 172' ' ' PHE . 19.9 m -125.37 113.75 25.7 Favored Pre-proline 0 N--CA 1.501 2.115 0 O-C-N 121.485 -0.759 . . . . 0.01 109.37 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -76.91 -31.6 3.81 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 CA-C-N 119.916 1.006 . . . . 0.01 111.562 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.0 t -142.49 108.12 5.1 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.238 -0.913 . . . . 0.02 109.068 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.67 -38.82 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.885 -0.509 . . . . 1.8300000000000001 110.949 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.8 ttt -68.33 -37.2 80.3 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.222 -0.991 . . . . 1.3400000000000001 110.263 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -70.36 -38.95 74.88 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.532 -1.355 . . . . 2.1099999999999999 110.302 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -79.01 -47.39 16.33 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.307 -0.871 . . . . 2.0800000000000001 112.483 -176.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -110.64 1.18 17.84 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.348 -0.845 . . . . 0.02 112.53 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.2 m170 59.31 32.77 22.16 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.724 -1.235 . . . . 0.02 109.236 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.7 mt -112.29 135.69 52.66 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 108.631 -0.877 . . . . 0.02 108.631 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -90.69 -22.39 21.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.842 . . . . 5.3200000000000003 110.109 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -150.47 164.47 35.85 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.24 -0.913 . . . . 0.02 110.16 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.9 mt -132.25 129.64 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 107.38 -1.341 . . . . 2.1699999999999999 107.38 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -107.91 -11.64 15.31 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.321 -0.862 . . . . 0.02 112.571 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.0 t -159.21 152.26 22.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.816 -1.177 . . . . 0.01 109.101 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 6.5 p -169.44 144.71 3.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.187 -0.945 . . . . 1.22 109.168 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -126.18 111.75 14.99 Favored 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 122.445 1.117 . . . . 1.4099999999999999 110.161 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.4 p -113.89 137.44 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 107.361 -1.348 . . . . 0.01 107.361 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 23.4 t -127.74 94.43 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 106.854 -1.536 . . . . 1.98 106.854 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.501 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 10.4 tm-20 -145.07 -77.78 0.2 Allowed 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 105.929 -1.878 . . . . 0.01 105.929 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.461 ' N ' ' OE1' ' A' ' 133' ' ' GLU . . . 175.58 -73.76 0.08 OUTLIER Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.934 -1.666 . . . . 0.01 108.934 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.406 ' OG1' HD12 ' A' ' 175' ' ' ILE . 29.8 p -119.18 120.14 36.19 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.565 -0.962 . . . . 2.2999999999999998 110.262 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.501 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 8.1 m95 -127.45 149.53 50.06 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 107.227 -1.398 . . . . 0.01 107.227 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 83.6 mt -123.31 138.88 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 120.504 -1.373 . . . . 1.6899999999999999 110.491 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -115.29 144.73 43.3 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 107.158 -1.423 . . . . 2.4900000000000002 107.158 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.496 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 14.0 m-85 -123.06 145.23 48.72 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.15 -0.969 . . . . 0.02 109.617 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -75.77 -30.21 59.05 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.5 -0.75 . . . . 0.02 112.237 -176.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.5 mt -115.07 155.07 47.09 Favored Pre-proline 0 N--CA 1.506 2.366 0 O-C-N 120.595 -1.316 . . . . 1.48 109.225 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.91 165.54 2.61 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.183 1.255 . . . . 0.02 112.547 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 60.08 31.38 20.57 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.131 -0.94 . . . . 0.75 111.484 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 57.55 51.77 9.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.367 -0.833 . . . . 0.02 111.183 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -126.15 164.52 20.75 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.547 -0.721 . . . . 0.02 109.859 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.27 -165.69 32.89 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.419 -1.073 . . . . 0.02 110.419 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -68.89 142.79 54.68 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.612 -0.934 . . . . 0.02 109.053 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -115.18 148.91 38.47 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.386 0.612 . . . . 0.02 109.869 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -124.38 134.4 53.14 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.532 -0.73 . . . . 0.01 109.069 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.513 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.8 tt -98.85 120.22 38.93 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.941 -1.099 . . . . 0.01 108.651 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.513 ' N ' HD23 ' A' ' 150' ' ' LEU . 6.6 tp -103.07 150.89 23.15 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.27 -0.894 . . . . 0.01 109.12 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -104.56 -110.26 0.26 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.431 -0.793 . . . . 2.27 109.54 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -156.5 51.68 0.52 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.118 -0.989 . . . . 1.8400000000000001 109.638 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -112.71 -163.08 0.83 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.584 -0.697 . . . . 2.2799999999999998 109.264 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -106.39 104.41 14.1 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.452 -0.78 . . . . 0.01 109.073 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.653 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 6.5 m-85 -98.7 112.36 24.45 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.244 -0.91 . . . . 0.01 109.51 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -95.09 -22.15 18.08 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.188 -0.945 . . . . 0.01 111.775 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -127.73 154.24 77.9 Favored Pre-proline 0 N--CA 1.502 2.171 0 O-C-N 120.715 -1.241 . . . . 2.54 109.036 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -60.53 -38.68 71.36 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 120.483 0.789 . . . . 0.69999999999999996 110.517 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.93 -20.08 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.819 -1.176 . . . . 0.85999999999999999 108.93 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 13.7 t0 -65.18 -15.4 62.4 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.955 -1.091 . . . . 0.02 109.925 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.653 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 9.9 m0 -97.89 11.34 37.69 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.111 -0.993 . . . . 0.02 109.099 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.83 10.21 85.93 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.789 -1.196 . . . . 0.02 110.968 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.49 141.47 32.23 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.313 -1.11 . . . . 0.02 110.061 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.57 -8.97 57.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.663 -0.648 . . . . 0.58999999999999997 109.948 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.1 p -143.2 150.35 51.86 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 120.919 -1.113 . . . . 0.87 108.869 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -76.6 18.81 0.68 Allowed 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 120.825 1.016 . . . . 0.38 112.371 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.14 123.08 28.66 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.855 -1.153 . . . . 0.17999999999999999 111.496 -177.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 169' ' ' ILE . 16.1 mm -151.75 127.04 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 106.815 -1.55 . . . . 3.9900000000000002 106.815 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -113.92 -12.91 12.6 Favored 'General case' 0 N--CA 1.508 2.429 0 O-C-N 121.065 -1.022 . . . . 5.1699999999999999 113.725 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 22.7 m -157.53 161.77 38.81 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 119.12 -2.237 . . . . 0.02 110.439 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.474 ' HZ ' ' HG ' ' A' ' 114' ' ' CYS . 21.3 p90 -152.74 153.77 33.87 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.044 -1.035 . . . . 2.02 110.662 178.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 48.8 mtp180 -145.44 150.38 36.4 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.775 0.798 . . . . 0.01 110.23 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -87.9 143.99 26.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.483 -0.761 . . . . 0.01 109.183 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.406 HD12 ' OG1' ' A' ' 135' ' ' THR . 5.1 mt -94.38 129.26 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.184 -0.948 . . . . 3.04 109.045 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.4 t -136.17 146.6 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.174 -0.953 . . . . 1.8899999999999999 109.675 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 4.8899999999999997 109.51 179.962 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 107.85 -2.1 . . . . 0.01 107.85 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -149.67 136.11 19.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.916 -1.344 . . . . 0.02 110.755 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.7 tt -128.62 139.25 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 107.822 -1.177 . . . . 0.02 107.822 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 t -121.11 129.63 53.38 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.321 -0.862 . . . . 0.39000000000000001 110.337 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 11.5 m-85 -109.67 139.69 44.41 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.803 -0.814 . . . . 0.02 108.803 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.528 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 6.3 m-85 -122.15 138.33 54.51 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.139 -0.975 . . . . 0.02 109.664 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.521 ' OE2' ' N ' ' A' ' 35' ' ' ARG . 6.1 mm-40 -67.83 -28.63 67.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.934 . . . . 0.029999999999999999 111.093 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.5 m-20 -114.77 170.06 8.61 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.882 -1.136 . . . . 0.029999999999999999 110.163 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -75.56 162.35 28.37 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.729 0.776 . . . . 0.029999999999999999 110.295 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 3.0 t30 62.8 33.33 15.4 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.002 0.906 . . . . 0.73999999999999999 110.806 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 55.0 40.36 32.0 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.975 -0.557 . . . . 0.02 110.843 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -110.67 165.96 11.4 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.14 -1.059 . . . . 0.02 108.14 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.02 -167.73 36.56 Favored Glycine 0 N--CA 1.495 2.62 0 C-N-CA 119.719 -1.229 . . . . 0.029999999999999999 110.918 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -68.73 142.66 54.92 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.63 -0.923 . . . . 2.7599999999999998 109.354 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 -120.6 148.83 43.37 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.658 0.742 . . . . 1.8899999999999999 110.195 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -132.81 127.57 34.84 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.436 -0.95 . . . . 0.02 108.436 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 21.4 p-10 -112.79 137.28 51.35 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.499 -0.75 . . . . 1.1200000000000001 109.857 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 15.3 t -131.48 139.08 49.25 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.742 -0.599 . . . . 0.02 109.515 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.0 p30 -117.04 11.4 14.25 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.528 -0.733 . . . . 0.20000000000000001 109.939 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.405 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 34.7 t -158.31 174.46 15.11 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.389 -0.967 . . . . 1.23 108.389 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -61.17 144.25 54.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.597 -1.315 . . . . 0.02 109.869 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.5 t -131.75 117.32 18.44 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.54 -0.911 . . . . 0.02 108.54 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.66 -25.02 49.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.122 -0.986 . . . . 0.23999999999999999 110.778 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.47 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 20.8 p-10 -154.8 101.26 2.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.09 -1.006 . . . . 1.1399999999999999 108.882 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -105.85 9.58 32.79 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-O 122.004 0.907 . . . . 6.3700000000000001 109.835 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -58.63 -24.24 60.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.674 -0.641 . . . . 3.1099999999999999 110.861 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.5 m -74.05 -16.59 61.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.716 -1.24 . . . . 0.88 109.836 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -105.72 -21.99 13.06 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.616 -0.677 . . . . 0.02 109.561 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.453 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 3.0 tp -148.83 126.36 11.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.023 -1.048 . . . . 3.3199999999999998 109.686 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.7 m -86.83 -11.0 52.16 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.488 -0.757 . . . . 0.02 111.446 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.521 ' N ' ' OE2' ' A' ' 11' ' ' GLU . 17.8 ttp180 -170.98 161.17 6.84 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.682 -1.229 . . . . 0.02 107.682 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.5 t -141.65 115.41 9.12 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.8 -1.187 . . . . 0.02 109.213 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.416 ' ND2' ' OD2' ' A' ' 77' ' ' ASP . 3.5 m120 -107.57 -0.19 22.2 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.914 -1.116 . . . . 0.029999999999999999 110.858 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.1 t -156.18 153.38 29.13 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.851 -1.166 . . . . 0.02 107.851 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.5 mt -145.43 147.57 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.11 -0.994 . . . . 0.02 110.313 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -123.22 124.13 42.32 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.753 -1.203 . . . . 0.02 107.753 176.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.3 t -106.56 114.88 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 107.058 -1.46 . . . . 0.02 107.058 177.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.434 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 30.3 tt0 -83.61 -34.07 25.19 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 120.099 -0.64 . . . . 3.8100000000000001 110.912 -178.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.96 152.21 21.95 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 118.896 -1.621 . . . . 0.02 111.03 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.43 172.86 49.24 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.627 -1.273 . . . . 0.01 110.514 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.4 m -119.51 135.06 54.94 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.978 -1.119 . . . . 1.48 107.978 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.458 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 32.5 m95 -127.14 155.77 42.83 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 122.56 1.172 . . . . 0.02 112.151 -176.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.59 134.3 52.1 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 105.697 -1.964 . . . . 0.23999999999999999 105.697 176.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.521 ' HB ' HD22 ' A' ' 79' ' ' LEU . 34.6 m -116.65 141.73 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.556 -0.715 . . . . 0.65000000000000002 109.222 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -120.61 143.32 48.72 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 122.098 0.951 . . . . 0.02 109.793 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -65.69 -34.24 77.75 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.661 -0.7 . . . . 0.02 111.646 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -125.15 157.6 66.62 Favored Pre-proline 0 N--CA 1.502 2.173 0 O-C-N 121.033 -1.042 . . . . 0.02 109.359 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.56 167.2 1.0 Allowed 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.718 1.612 . . . . 0.02 113.015 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.3 m120 63.76 36.09 10.81 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.154 -0.93 . . . . 0.02 111.16 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.407 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 4.2 m-85 45.38 51.56 9.46 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.722 0.772 . . . . 3.3900000000000001 110.503 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 90.3 p -126.13 163.83 22.26 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.318 0.58 . . . . 2.3300000000000001 109.847 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.88 -161.76 32.19 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.816 -1.314 . . . . 0.02 109.816 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.514 ' N ' ' ND1' ' A' ' 57' ' ' HIS . 1.9 m80 -65.27 138.72 58.39 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.065 -1.256 . . . . 0.02 110.337 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.497 ' O ' ' SD ' ' A' ' 58' ' ' MET . 2.6 ppp? -119.11 137.13 53.79 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.492 0.663 . . . . 5.0099999999999998 109.517 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.446 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 96.8 m-85 -134.28 138.81 45.28 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.395 -0.816 . . . . 0.02 109.648 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.4 mm -95.32 131.09 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 109.057 -0.719 . . . . 1.72 109.057 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.561 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -119.6 110.83 36.73 Favored Pre-proline 0 N--CA 1.503 2.184 0 O-C-N 121.299 -0.876 . . . . 0.02 110.769 -178.266 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -77.54 168.49 22.59 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 CA-C-N 119.934 1.012 . . . . 1.47 110.221 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.434 ' NE2' ' O ' ' A' ' 42' ' ' GLU . 63.1 tt0 -53.58 141.19 26.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.824 -1.173 . . . . 4.25 110.43 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.79 -177.76 31.9 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.529 -1.32 . . . . 0.02 110.712 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -120.5 131.69 54.84 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.558 -0.966 . . . . 0.95999999999999996 109.732 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.561 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 63.8 m-85 -122.3 94.19 48.04 Favored Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 108.023 -1.103 . . . . 0.02 108.023 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.402 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 5.3 Cg_exo -64.44 -4.24 7.8 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 120.928 1.085 . . . . 0.02 113.799 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 34.8 mt-10 -157.58 155.3 29.95 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.555 -1.34 . . . . 2.02 108.287 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -60.63 -39.0 86.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.481 -0.762 . . . . 0.02 112.199 -176.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -59.93 -23.72 63.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.093 -1.004 . . . . 0.02 110.329 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -70.62 -18.57 62.87 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.782 0.801 . . . . 3.4199999999999999 109.021 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.547 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.6 t90 -107.98 10.14 28.42 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.415 -1.328 . . . . 0.02 107.415 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.4 mmt 60.77 22.49 12.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.66 -0.65 . . . . 0.02 110.545 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.78 144.33 46.35 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.401 -1.48 . . . . 0.02 109.401 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.8 tp -79.29 -31.03 43.23 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.617 -1.253 . . . . 0.97999999999999998 107.617 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -157.02 -171.74 3.76 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 106.342 -1.725 . . . . 0.02 106.342 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.416 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 52.1 m-20 -98.71 27.54 4.82 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.616 -1.303 . . . . 0.02 110.708 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -95.97 122.56 38.92 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.939 -1.101 . . . . 3.2000000000000002 110.865 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.521 HD22 ' HB ' ' A' ' 48' ' ' VAL . 31.2 mt -142.9 121.35 12.4 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.558 -1.275 . . . . 2.6099999999999999 107.558 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.2 -17.85 9.15 Favored Glycine 0 N--CA 1.501 2.977 0 O-C-N 121.257 -0.902 . . . . 0.02 112.878 -177.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.407 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 11.1 t -156.03 155.78 33.28 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-N 120.004 1.902 . . . . 0.02 111.023 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 13.5 p -145.34 147.43 32.29 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.321 -0.862 . . . . 0.02 110.624 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -138.23 143.63 40.22 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.529 -0.732 . . . . 0.01 109.292 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.66 132.11 36.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -0.915 . . . . 0.42999999999999999 109.759 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.8 t -91.28 125.2 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.961 -0.755 . . . . 1.25 108.961 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -94.36 131.13 40.33 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.884 -1.135 . . . . 1.77 109.029 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 mt -95.76 140.3 30.74 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.621 -0.881 . . . . 1.6299999999999999 108.621 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t -111.64 127.87 55.89 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.37 -0.831 . . . . 1.0800000000000001 109.33 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 71.5 p -104.41 -154.58 0.51 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 106.631 -1.618 . . . . 1.26 106.631 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.32 -52.65 0.73 Allowed Glycine 0 N--CA 1.5 2.956 0 O-C-N 120.498 -1.376 . . . . 0.01 112.895 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.18 -101.44 0.15 Allowed Glycine 0 N--CA 1.49 2.256 0 C-N-CA 118.456 -1.83 . . . . 0.01 112.022 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -121.88 119.53 31.84 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.056 -1.261 . . . . 4.4299999999999997 110.695 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.42 129.22 34.26 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.682 -0.807 . . . . 2.9900000000000002 109.303 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -130.54 142.1 50.47 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.866 -0.79 . . . . 6.3600000000000003 108.866 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.7 tt -129.97 146.05 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 O-C-N 121.255 -0.903 . . . . 1.0900000000000001 110.451 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -121.26 133.61 55.15 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.354 -1.35 . . . . 2.0499999999999998 107.354 177.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.4 m -123.93 146.41 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 120.895 -1.128 . . . . 1.1000000000000001 109.709 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.576 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 72.0 m-85 -119.32 141.61 48.86 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.978 0.894 . . . . 0.72999999999999998 111.059 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -66.96 -30.28 70.36 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 116.066 -0.515 . . . . 0.02 111.734 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 43.8 mttp -116.37 167.22 11.22 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.965 -1.084 . . . . 3.1800000000000002 110.425 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.05 164.05 44.24 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.958 -0.857 . . . . 0.01 110.958 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 57.23 38.87 28.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.932 -0.746 . . . . 0.01 110.913 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 52.29 55.72 8.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.723 -0.611 . . . . 0.01 111.079 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -128.97 165.66 20.68 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.29 -1.004 . . . . 3.1499999999999999 108.29 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.66 -164.0 27.57 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.279 -1.528 . . . . 0.01 109.279 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -75.69 144.29 41.67 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.968 -1.313 . . . . 0.01 108.438 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.576 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 27.6 ttp -116.41 142.19 47.18 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.543 0.687 . . . . 0.01 109.889 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -131.58 136.54 47.88 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.176 -1.046 . . . . 2.48 108.176 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -119.19 134.48 55.18 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.57 -0.706 . . . . 0.01 109.923 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 t -148.67 150.52 33.35 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 122.278 1.037 . . . . 1.6899999999999999 111.145 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 48.2 p -110.89 9.62 22.38 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 115.572 -0.74 . . . . 0.01 110.336 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -121.15 163.22 18.78 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.15 -0.969 . . . . 3.21 111.721 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -68.2 157.18 36.0 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.268 -1.012 . . . . 0.01 108.268 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 19.1 t -126.88 114.16 22.21 Favored Pre-proline 0 N--CA 1.501 2.075 0 O-C-N 121.457 -0.777 . . . . 0.01 109.101 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -75.05 -29.72 7.85 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 CA-C-N 120.247 1.124 . . . . 0.01 111.035 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.5 m -142.3 109.19 5.45 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.309 -0.869 . . . . 0.02 109.121 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.41 HD12 ' O ' ' A' ' 169' ' ' ILE . 97.7 mt -63.58 -38.99 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.866 -0.521 . . . . 1.8300000000000001 110.59 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 19.0 ttt -68.82 -37.74 79.4 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.349 -0.94 . . . . 1.3400000000000001 110.399 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -69.46 -38.57 77.8 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.417 -1.427 . . . . 2.1099999999999999 109.995 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -80.11 -47.14 15.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.331 -0.856 . . . . 2.0800000000000001 112.339 -177.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -111.18 0.0 16.66 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.363 -0.836 . . . . 0.02 112.637 -176.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.7 m80 60.01 33.64 21.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.768 -1.208 . . . . 0.02 109.516 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.0 mt -112.65 135.51 53.29 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 108.83 -0.804 . . . . 0.02 108.83 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -91.69 -22.96 19.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.254 -0.904 . . . . 5.3200000000000003 110.393 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -149.45 164.34 35.27 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.187 -0.945 . . . . 0.02 109.813 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.5 mt -132.15 128.89 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 107.804 -1.184 . . . . 2.1699999999999999 107.804 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.39 -11.98 15.1 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.365 -0.834 . . . . 0.02 112.25 -178.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.2 p -160.31 151.06 18.72 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.917 -1.114 . . . . 0.01 109.273 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 27.1 p -168.25 145.01 3.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.362 -0.836 . . . . 1.22 109.133 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 40.5 tttm -126.31 111.67 14.8 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 122.42 1.105 . . . . 1.4099999999999999 110.417 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.2 p -114.38 138.44 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 107.408 -1.33 . . . . 0.01 107.408 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.5 t -126.8 94.03 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 106.732 -1.581 . . . . 1.98 106.732 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.422 ' CD ' ' N ' ' A' ' 134' ' ' GLY . 6.1 tm-20 -145.65 -80.65 0.16 Allowed 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 106.218 -1.771 . . . . 0.01 106.218 177.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.422 ' N ' ' CD ' ' A' ' 133' ' ' GLU . . . 176.45 -76.2 0.07 OUTLIER Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.987 -1.645 . . . . 0.01 108.987 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 30.9 p -118.0 118.14 31.13 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.593 -0.945 . . . . 2.2999999999999998 110.192 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -124.88 150.4 46.52 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 107.244 -1.391 . . . . 0.01 107.244 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 12.4 mt -121.79 136.88 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 120.484 -1.385 . . . . 1.6899999999999999 110.15 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -114.55 144.29 43.6 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.364 -1.347 . . . . 2.4900000000000002 107.364 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.463 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 24.5 m-85 -123.29 143.56 49.99 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.271 -0.893 . . . . 0.02 109.575 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.461 ' O ' ' NE2' ' A' ' 170' ' ' GLN . 81.8 tt0 -73.96 -29.24 61.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.506 -0.746 . . . . 0.02 111.911 -176.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.1 mt -116.09 154.9 48.58 Favored Pre-proline 0 N--CA 1.505 2.291 0 O-C-N 120.725 -1.234 . . . . 1.48 108.964 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -55.66 167.36 2.17 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.151 1.234 . . . . 0.02 112.757 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.429 ' OD1' ' N ' ' A' ' 143' ' ' ASN . 2.3 m-20 59.37 31.11 20.87 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.174 -0.921 . . . . 0.75 111.233 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 57.41 50.62 11.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.45 -0.781 . . . . 0.02 111.064 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -125.13 164.36 20.42 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.554 -0.716 . . . . 0.02 109.898 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.558 ' O ' ' NE2' ' A' ' 148' ' ' GLN . . . 89.16 -165.72 33.06 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.184 -1.167 . . . . 0.02 110.184 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -69.08 142.55 54.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.54 -0.977 . . . . 0.02 109.034 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.558 ' NE2' ' O ' ' A' ' 146' ' ' GLY . 5.6 mp0 -114.53 148.54 37.78 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.44 0.638 . . . . 0.02 110.011 -178.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -124.92 134.98 52.45 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 109.083 -0.71 . . . . 0.01 109.083 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.5 HD23 ' N ' ' A' ' 151' ' ' LEU . 4.1 tt -100.09 121.25 41.11 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.872 -1.142 . . . . 0.01 108.92 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.5 ' N ' HD23 ' A' ' 150' ' ' LEU . 4.9 tp -99.32 145.34 27.43 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.198 -0.939 . . . . 0.01 108.96 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -106.73 -166.41 1.17 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.647 -0.658 . . . . 2.27 109.882 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -90.68 52.85 2.28 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.405 -0.809 . . . . 1.8400000000000001 109.833 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -115.35 -178.88 3.48 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.473 -0.767 . . . . 2.2799999999999998 109.448 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -105.47 111.48 24.21 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.476 -0.935 . . . . 0.01 108.476 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -99.65 112.7 24.9 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.387 -0.82 . . . . 0.01 110.493 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -94.54 -24.06 17.41 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.165 -0.959 . . . . 0.01 110.855 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -126.04 153.59 73.96 Favored Pre-proline 0 N--CA 1.501 2.078 0 N-CA-C 108.451 -0.944 . . . . 2.54 108.451 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -59.85 -39.73 69.49 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 CA-C-N 119.285 0.78 . . . . 0.69999999999999996 110.609 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 6.7 t -61.84 -19.57 21.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.755 -1.216 . . . . 0.85999999999999999 108.863 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 10.6 t0 -65.96 -18.06 65.09 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.954 -1.091 . . . . 0.02 111.059 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.621 ' HE1' ' CB ' ' A' ' 164' ' ' ALA . 1.8 p90 -103.0 14.16 32.6 Favored 'General case' 0 N--CA 1.508 2.467 0 O-C-N 121.077 -1.014 . . . . 0.02 109.811 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 87.42 10.37 70.89 Favored Glycine 0 N--CA 1.497 2.728 0 O-C-N 121.462 -0.774 . . . . 0.02 113.854 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.621 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . . . -100.93 141.32 33.98 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 120.472 -1.604 . . . . 0.02 110.757 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.61 -7.66 59.17 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.673 -0.642 . . . . 0.58999999999999997 109.484 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 39.0 m -143.54 150.67 51.82 Favored Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 120.961 -1.087 . . . . 0.87 109.154 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -76.75 18.45 0.72 Allowed 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.0 1.134 . . . . 0.38 112.474 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.87 125.47 31.38 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 122.373 1.082 . . . . 0.17999999999999999 111.698 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.508 HD11 ' CZ2' ' A' ' 162' ' ' TRP . 1.6 mt -149.94 127.01 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.344 -1.354 . . . . 3.9900000000000002 107.344 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.461 ' NE2' ' O ' ' A' ' 140' ' ' GLU . 2.9 mp0 -111.95 -18.06 12.74 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.075 -1.016 . . . . 5.1699999999999999 112.816 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 20.5 t -157.06 159.93 38.42 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 119.141 -2.224 . . . . 0.02 110.315 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.431 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 19.0 p90 -151.67 153.38 34.29 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.971 -1.081 . . . . 2.02 110.538 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 -144.97 149.98 36.14 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.882 0.849 . . . . 0.01 110.433 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -87.17 143.14 27.43 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.874 -0.788 . . . . 0.01 108.874 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.1 mt -94.76 129.13 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.28 -0.887 . . . . 3.04 109.108 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 11.7 p -136.38 146.99 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.194 -0.942 . . . . 1.8899999999999999 109.686 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 4.8899999999999997 109.411 -179.991 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 110.45 -1.06 . . . . 0.01 110.45 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -152.85 138.34 17.68 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.52 -0.988 . . . . 0.02 109.666 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.8 tt -130.85 140.87 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 109.222 -0.659 . . . . 0.02 109.222 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.8 m -121.95 130.89 53.7 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.444 -0.785 . . . . 0.39000000000000001 109.996 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.487 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 5.4 m-85 -111.11 140.74 45.41 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.561 -0.712 . . . . 0.02 109.332 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.575 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.1 m-85 -122.68 138.6 54.56 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.266 -0.896 . . . . 0.02 109.756 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -69.29 -27.29 65.27 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.925 -1.11 . . . . 0.029999999999999999 111.736 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 3.3 m-20 -113.87 169.4 9.03 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.804 -1.185 . . . . 0.029999999999999999 110.172 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -75.33 158.31 32.99 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.662 0.744 . . . . 0.029999999999999999 110.034 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.413 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 7.1 t-20 65.96 33.44 7.8 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.913 0.863 . . . . 0.73999999999999999 111.173 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.413 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 0.8 OUTLIER 55.42 41.8 30.65 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.296 0.57 . . . . 0.02 111.214 177.836 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -112.8 165.6 12.15 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.236 -1.024 . . . . 0.02 108.236 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.17 -167.59 34.49 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.801 -1.19 . . . . 0.029999999999999999 110.6 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -70.19 143.88 52.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.425 -1.044 . . . . 2.7599999999999998 108.957 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -120.41 149.13 42.85 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.65 0.738 . . . . 1.8899999999999999 110.296 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -132.76 127.7 35.23 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.399 -0.963 . . . . 0.02 108.399 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 18.9 p30 -112.22 136.85 51.13 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.441 -0.787 . . . . 1.1200000000000001 109.709 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.0 t -130.65 138.6 50.15 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.515 0.674 . . . . 0.02 109.679 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.498 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 33.9 t70 -117.07 11.14 14.13 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.567 -0.708 . . . . 0.20000000000000001 109.852 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 42.3 m -158.55 174.57 14.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.118 -0.988 . . . . 1.23 108.505 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -61.27 144.04 54.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.71 -1.244 . . . . 0.02 110.09 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.5 t -131.67 117.46 18.69 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.654 -0.869 . . . . 0.02 108.654 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.12 -25.77 47.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.974 -1.079 . . . . 0.23999999999999999 110.988 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -153.4 101.6 2.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.979 -1.075 . . . . 1.1399999999999999 108.977 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -104.0 9.28 36.62 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 122.109 0.956 . . . . 6.3700000000000001 109.806 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.4 mtm180 -59.3 -24.69 63.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.525 -0.734 . . . . 3.1099999999999999 111.221 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.3 t -75.39 -16.93 60.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.629 -1.295 . . . . 0.88 110.315 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -105.14 -21.69 13.22 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.366 -0.833 . . . . 0.02 109.503 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.4 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 4.5 tp -148.7 126.81 12.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.223 -0.923 . . . . 3.3199999999999998 109.447 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.5 t -86.51 -11.88 50.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.634 -0.666 . . . . 0.02 111.206 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.4 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 24.4 ttp180 -171.47 161.58 6.36 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.84 -1.162 . . . . 0.02 108.154 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.405 ' SG ' HD12 ' A' ' 79' ' ' LEU . 1.5 p -142.55 114.98 8.46 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.881 -1.137 . . . . 0.02 108.761 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -106.63 1.15 24.95 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 120.777 -1.202 . . . . 0.029999999999999999 110.379 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.8 t -155.94 154.51 31.28 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.5 -1.296 . . . . 0.02 107.5 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.8 mt -146.63 147.68 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.029 -1.045 . . . . 0.02 110.401 -178.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.579 HH11 ' CG ' ' A' ' 40' ' ' ARG . 0.2 OUTLIER -124.39 125.02 43.61 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.997 -1.112 . . . . 0.02 107.997 177.651 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.1 t -105.1 113.65 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 106.644 -1.613 . . . . 0.02 106.644 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -84.18 -34.76 23.91 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.467 -0.77 . . . . 3.8100000000000001 110.033 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.41 150.93 20.21 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 118.618 -1.753 . . . . 0.02 110.722 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.43 171.99 48.58 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.357 -1.097 . . . . 0.01 110.357 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.8 m -119.6 134.9 55.03 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 107.805 -1.183 . . . . 1.48 107.805 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.467 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 31.2 m95 -127.36 154.94 44.36 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 122.583 1.182 . . . . 0.02 112.329 -176.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.29 134.06 51.64 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 105.282 -2.118 . . . . 0.23999999999999999 105.282 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.51 ' HB ' HD22 ' A' ' 79' ' ' LEU . 23.7 m -119.12 143.7 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 109.066 -0.716 . . . . 0.65000000000000002 109.066 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -120.96 145.92 47.21 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 122.276 1.036 . . . . 0.02 110.041 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -66.09 -34.05 77.18 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 115.816 -0.629 . . . . 0.02 111.009 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -125.46 157.54 67.63 Favored Pre-proline 0 N--CA 1.502 2.162 0 O-C-N 121.051 -1.03 . . . . 0.02 109.487 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.45 167.26 0.93 Allowed 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.692 1.594 . . . . 0.02 113.074 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.8 m120 63.77 36.36 10.59 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.253 -0.885 . . . . 0.02 111.113 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 45.09 51.58 8.88 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.66 0.743 . . . . 3.3900000000000001 110.67 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.7 m -126.36 163.82 22.43 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.168 0.509 . . . . 2.3300000000000001 109.814 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.78 -161.65 32.24 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.815 -1.314 . . . . 0.02 109.815 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -65.3 139.15 58.57 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.124 -1.221 . . . . 0.02 110.146 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.497 ' O ' ' SD ' ' A' ' 58' ' ' MET . 2.8 ppp? -118.84 137.28 53.53 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.714 -0.616 . . . . 5.0099999999999998 109.593 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.469 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 96.2 m-85 -134.85 138.63 44.36 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.494 -0.754 . . . . 0.02 109.78 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.4 mm -95.2 131.61 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.857 -0.794 . . . . 1.72 108.857 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.561 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -120.08 110.64 36.15 Favored Pre-proline 0 N--CA 1.505 2.278 0 O-C-N 121.289 -0.882 . . . . 0.02 110.858 -178.346 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -77.86 168.99 21.38 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 CA-C-N 119.916 1.006 . . . . 1.47 110.296 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -53.9 140.62 30.15 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.861 -1.15 . . . . 4.25 110.522 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.93 -177.79 32.82 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.451 -1.356 . . . . 0.02 110.618 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -119.93 131.16 55.12 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.362 -1.081 . . . . 0.95999999999999996 109.646 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.561 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 75.9 m-85 -121.8 96.27 47.21 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 108.128 -1.064 . . . . 0.02 108.128 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.404 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.6 Cg_endo -67.07 -3.75 10.29 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 120.778 0.986 . . . . 0.02 113.756 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 35.1 mt-10 -157.81 155.21 29.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.685 -1.259 . . . . 2.02 108.288 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -60.56 -39.37 87.72 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.572 -0.705 . . . . 0.02 112.042 -177.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -59.96 -23.68 63.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.083 -1.011 . . . . 0.02 110.276 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -69.97 -18.92 63.37 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.778 0.799 . . . . 3.4199999999999999 109.021 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.547 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.1 t90 -108.04 10.6 28.19 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.432 -1.321 . . . . 0.02 107.432 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.5 mtt 61.08 22.27 12.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.537 -0.727 . . . . 0.02 110.463 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.76 143.65 44.88 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.49 -1.444 . . . . 0.02 109.49 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.4 tp -79.57 -31.93 41.98 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.558 -1.275 . . . . 0.97999999999999998 107.558 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -157.63 -172.65 4.04 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 106.312 -1.736 . . . . 0.02 106.312 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -98.49 28.06 4.4 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.821 -1.174 . . . . 0.02 110.823 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 -96.83 121.89 39.19 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.828 -1.17 . . . . 3.2000000000000002 110.887 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.51 HD22 ' HB ' ' A' ' 48' ' ' VAL . 31.0 mt -144.0 121.39 11.65 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 107.574 -1.269 . . . . 2.6099999999999999 107.574 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.34 -16.19 11.48 Favored Glycine 0 N--CA 1.505 3.243 0 O-C-N 121.192 -0.943 . . . . 0.02 112.804 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.6 p -157.09 156.37 32.66 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.107 -1.819 . . . . 0.02 110.344 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 23.4 m -144.89 147.93 33.33 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.584 -0.698 . . . . 0.02 110.047 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 39.1 mtp180 -137.84 143.19 40.84 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.368 -0.832 . . . . 0.01 109.585 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.57 132.21 36.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.201 -0.937 . . . . 0.42999999999999999 109.669 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.3 t -91.0 125.03 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.873 -0.788 . . . . 1.25 108.873 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -92.56 132.53 36.77 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.877 -1.139 . . . . 1.77 108.865 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mt -98.42 140.57 32.48 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.865 -0.791 . . . . 1.6299999999999999 108.865 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 52.9 p -112.08 124.68 52.95 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.474 -0.936 . . . . 1.0800000000000001 108.474 178.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.4 m -115.76 132.81 56.53 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 107.754 -1.202 . . . . 1.26 107.754 177.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -156.78 -49.58 0.01 OUTLIER Glycine 0 N--CA 1.505 3.279 0 C-N-CA 117.709 -2.186 . . . . 0.01 113.636 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.71 -105.73 0.19 Allowed Glycine 0 N--CA 1.489 2.203 0 CA-C-N 120.192 1.996 . . . . 0.01 111.352 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -120.81 118.59 30.39 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.125 -1.221 . . . . 4.4299999999999997 110.401 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.14 129.14 34.81 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.806 -0.758 . . . . 2.9900000000000002 109.369 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -131.23 141.19 49.98 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.497 -0.752 . . . . 6.3600000000000003 109.241 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.0 tt -129.8 146.91 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 O-C-N 121.247 -0.908 . . . . 1.0900000000000001 110.344 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.523 ' NE2' ' O ' ' A' ' 130' ' ' LYS . 2.4 pm0 -122.1 134.31 54.76 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 107.561 -1.274 . . . . 2.0499999999999998 107.561 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.8 m -124.37 146.25 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 O-C-N 120.721 -1.237 . . . . 1.1000000000000001 110.158 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.584 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 79.5 m-85 -119.4 141.2 49.29 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.973 0.892 . . . . 0.72999999999999998 111.081 -178.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -67.18 -30.22 70.12 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 115.921 -0.581 . . . . 0.02 111.819 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -116.18 168.99 9.62 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.028 -1.045 . . . . 3.1800000000000002 110.441 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.27 164.94 50.0 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.796 -0.921 . . . . 0.01 110.796 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 56.46 38.45 29.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.719 -0.871 . . . . 0.01 111.432 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 51.94 55.08 9.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.559 -0.713 . . . . 0.01 111.256 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -129.06 165.01 22.02 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.018 -1.105 . . . . 3.1499999999999999 108.018 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.18 -163.64 27.95 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.255 -1.538 . . . . 0.01 109.255 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -76.19 144.19 40.64 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.005 -1.291 . . . . 0.01 108.834 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.584 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 32.7 ttp -116.66 142.55 46.75 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.524 0.678 . . . . 0.01 109.821 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -131.48 136.86 48.26 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.265 -1.013 . . . . 2.48 108.265 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -118.15 134.16 55.25 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.551 -0.718 . . . . 0.01 110.248 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.9 t -149.01 148.33 29.61 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.276 1.036 . . . . 1.6899999999999999 111.197 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 30.1 p -111.16 9.7 21.88 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 115.547 -0.751 . . . . 0.01 110.496 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -120.85 163.16 18.61 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.235 -0.916 . . . . 3.21 111.438 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -67.46 156.8 35.72 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.217 -1.031 . . . . 0.01 108.217 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.609 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 26.4 p -123.86 116.47 27.6 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.515 -0.741 . . . . 0.01 109.414 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -76.7 -31.93 3.86 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 CA-C-N 120.181 1.1 . . . . 0.01 110.445 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.4 p -143.84 108.91 4.98 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.733 0.778 . . . . 0.02 109.016 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.9 mt -64.16 -39.27 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.771 -0.581 . . . . 1.8300000000000001 110.822 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 118' ' ' MET . 1.8 tmt? -67.95 -37.24 81.34 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.175 -1.01 . . . . 1.3400000000000001 110.034 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -69.47 -38.02 77.55 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.543 -1.348 . . . . 2.1099999999999999 109.87 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -80.25 -46.72 15.75 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.274 -0.891 . . . . 2.0800000000000001 112.373 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -110.87 0.13 17.07 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.395 -0.815 . . . . 0.02 112.58 -176.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.519 ' O ' ' NH1' ' A' ' 124' ' ' ARG . 8.7 m80 60.01 33.47 21.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.768 -1.207 . . . . 0.02 109.639 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.6 mt -112.63 135.8 52.94 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 108.754 -0.832 . . . . 0.02 108.754 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 122' ' ' HIS . 0.1 OUTLIER -92.27 -22.79 19.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.242 -0.911 . . . . 5.3200000000000003 110.208 -179.486 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -149.33 163.61 37.21 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.189 -0.945 . . . . 0.02 109.883 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.1 mt -131.91 128.81 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 107.899 -1.148 . . . . 2.1699999999999999 107.899 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -107.61 -12.54 15.24 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.27 -0.893 . . . . 0.02 112.084 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.5 m -158.44 150.7 21.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.848 -1.158 . . . . 0.01 108.511 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.572 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 0.5 OUTLIER -169.62 144.67 2.97 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.425 -0.954 . . . . 1.22 108.425 -179.526 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.523 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 32.1 tttp -125.93 110.6 13.82 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 122.497 1.142 . . . . 1.4099999999999999 110.61 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 131' ' ' VAL . 10.1 p -109.09 134.5 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 106.948 -1.501 . . . . 0.01 106.948 178.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 50.7 t -128.58 94.77 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 N-CA-C 107.148 -1.427 . . . . 1.98 107.148 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -146.66 -76.58 0.19 Allowed 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 105.816 -1.92 . . . . 0.01 105.816 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 156.27 -54.14 0.41 Allowed Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.982 -1.647 . . . . 0.01 108.982 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 76.3 p -119.21 98.32 6.1 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.643 -0.916 . . . . 2.2999999999999998 111.021 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -129.25 145.38 51.35 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 107.265 -1.383 . . . . 0.01 107.265 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 96.4 mt -123.74 139.47 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 120.957 -1.089 . . . . 1.6899999999999999 110.071 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -114.26 144.06 43.84 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 106.99 -1.485 . . . . 2.4900000000000002 106.99 177.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.497 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 14.3 m-85 -123.19 144.19 49.53 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.348 -0.845 . . . . 0.02 109.465 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -74.1 -29.45 61.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.595 -0.69 . . . . 0.02 111.838 -176.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.3 mt -115.94 154.76 48.36 Favored Pre-proline 0 N--CA 1.505 2.283 0 O-C-N 120.693 -1.254 . . . . 1.48 108.985 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -56.15 167.22 2.62 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.123 1.215 . . . . 0.02 112.889 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 59.58 31.15 20.76 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.149 -0.932 . . . . 0.75 111.487 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 144' ' ' TYR . 0.7 OUTLIER 58.05 50.98 9.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.447 -0.783 . . . . 0.02 111.152 177.869 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -125.99 164.57 20.54 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.494 -0.754 . . . . 0.02 109.973 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.06 -165.6 33.11 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.323 -1.111 . . . . 0.02 110.323 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -69.4 142.22 53.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.596 -0.943 . . . . 0.02 109.055 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.467 ' CD ' ' N ' ' A' ' 148' ' ' GLN . 5.3 mp0 -115.34 149.55 37.71 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.851 -0.531 . . . . 0.02 109.75 -178.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -124.72 134.61 52.78 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.618 -0.676 . . . . 0.01 109.189 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.493 HD23 ' N ' ' A' ' 151' ' ' LEU . 2.8 tt -99.91 121.46 41.37 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.072 -1.017 . . . . 0.01 108.743 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.493 ' N ' HD23 ' A' ' 150' ' ' LEU . 3.8 mm? -99.98 165.33 11.59 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.022 -1.049 . . . . 0.01 109.506 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -109.91 -96.96 0.4 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.59 -0.694 . . . . 2.27 109.215 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -176.37 51.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.198 -0.939 . . . . 1.8400000000000001 109.626 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -113.82 -159.77 0.7 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.547 -0.721 . . . . 2.2799999999999998 109.512 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.518 ' OE2' ' NZ ' ' A' ' 130' ' ' LYS . 66.3 mm-40 -106.37 107.05 17.87 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.494 -0.753 . . . . 0.01 109.064 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.705 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 29.7 m-85 -99.96 114.3 27.47 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.301 -0.874 . . . . 0.01 109.993 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -96.09 -22.34 17.39 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.227 -0.921 . . . . 0.01 111.928 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -127.84 155.34 77.61 Favored Pre-proline 0 N--CA 1.504 2.26 0 O-C-N 120.803 -1.185 . . . . 2.54 109.023 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -60.79 -39.64 60.94 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 120.497 0.798 . . . . 0.69999999999999996 110.614 178.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.0 t -60.72 -20.76 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.763 -1.211 . . . . 0.85999999999999999 109.011 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -65.09 -14.93 61.72 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.815 -1.178 . . . . 0.02 109.732 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.705 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 21.8 m0 -96.2 10.71 36.91 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.329 -0.857 . . . . 0.02 108.712 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.03 9.47 87.07 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.727 -1.225 . . . . 0.02 110.716 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -98.63 141.86 30.93 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.296 -1.12 . . . . 0.02 110.065 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.19 -9.09 58.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.574 -0.703 . . . . 0.58999999999999997 109.661 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.1 t -144.61 150.09 45.96 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.079 -1.013 . . . . 0.87 108.728 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -75.9 19.96 0.56 Allowed 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 120.663 0.908 . . . . 0.38 112.259 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.26 123.57 29.72 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.88 -1.138 . . . . 0.17999999999999999 111.584 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.8 mt -149.49 128.15 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 107.041 -1.466 . . . . 3.9900000000000002 107.041 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -112.15 -17.39 12.82 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.055 -1.028 . . . . 5.1699999999999999 113.356 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.6 p -158.11 160.98 37.9 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 119.122 -2.236 . . . . 0.02 110.148 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.609 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 3.8 p90 -151.51 153.66 35.03 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.056 -1.028 . . . . 2.02 110.925 178.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -145.38 149.64 35.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.297 -0.877 . . . . 0.01 110.215 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -88.36 144.03 26.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.527 -0.733 . . . . 0.01 109.51 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.5 mt -93.59 129.59 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.155 -0.965 . . . . 3.04 109.159 178.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 10.2 p -136.09 146.56 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.254 -0.904 . . . . 1.8899999999999999 109.473 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.291 -0.881 . . . . 4.8899999999999997 109.404 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.194 -1.562 . . . . 0.01 109.194 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -147.87 136.89 22.09 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.059 -1.259 . . . . 0.02 110.641 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.8 tt -130.72 139.62 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.731 -0.841 . . . . 0.02 108.731 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 m -120.89 130.14 53.78 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.489 -0.757 . . . . 0.39000000000000001 109.866 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -109.94 139.57 44.88 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.077 -0.712 . . . . 0.02 109.077 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.534 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 5.3 m-85 -122.14 138.41 54.47 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.146 -0.971 . . . . 0.02 109.531 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.491 ' HG3' HD11 ' A' ' 33' ' ' LEU . 92.0 mt-10 -69.39 -27.67 65.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.193 -0.942 . . . . 0.029999999999999999 111.539 -178.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -114.05 169.16 9.22 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.849 -1.157 . . . . 0.029999999999999999 110.14 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -75.39 158.32 32.9 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.598 0.713 . . . . 0.029999999999999999 110.218 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 66.42 33.3 6.98 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.948 0.88 . . . . 0.73999999999999999 111.117 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 55.48 41.94 30.36 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 116.056 -0.52 . . . . 0.02 111.324 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -113.66 165.68 12.28 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.193 -1.04 . . . . 0.02 108.193 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.39 -167.46 35.66 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.826 -1.178 . . . . 0.029999999999999999 110.793 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -69.22 142.27 54.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.398 -1.06 . . . . 2.7599999999999998 109.315 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -120.76 149.09 43.08 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.618 0.723 . . . . 1.8899999999999999 110.167 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -132.43 127.16 34.76 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.255 -1.017 . . . . 0.02 108.255 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -112.48 137.41 50.72 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.57 -0.706 . . . . 1.1200000000000001 109.827 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.9 t -131.67 139.21 49.01 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 121.523 0.678 . . . . 0.02 109.777 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -116.98 11.26 14.26 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.583 -0.698 . . . . 0.20000000000000001 109.671 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.409 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 29.5 p -158.29 174.3 15.37 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.275 -1.009 . . . . 1.23 108.275 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 2.3 p30 -60.93 143.84 54.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.647 -1.283 . . . . 0.02 109.855 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 26' ' ' CYS . 27.4 p -131.19 117.14 18.62 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.52 -0.918 . . . . 0.02 108.52 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.17 -24.83 47.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.143 -0.973 . . . . 0.23999999999999999 110.965 -178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -154.8 101.65 2.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.834 -1.166 . . . . 1.1399999999999999 108.985 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -105.21 9.53 34.03 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 122.197 0.998 . . . . 6.3700000000000001 109.903 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -58.86 -24.55 62.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.388 -0.82 . . . . 3.1099999999999999 110.934 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.5 m -74.16 -16.55 60.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.755 -1.216 . . . . 0.88 110.124 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -103.97 -21.97 13.54 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.482 -0.761 . . . . 0.02 109.488 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.491 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.6 tp -150.04 128.86 12.48 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.196 -0.94 . . . . 3.3199999999999998 109.207 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.7 t -85.54 -10.1 56.44 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.768 -0.583 . . . . 0.02 111.191 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -170.55 162.28 8.02 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.696 -1.224 . . . . 0.02 107.696 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.6 t -143.05 115.57 8.58 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.73 -1.231 . . . . 0.02 109.136 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.573 ' ND2' ' OD2' ' A' ' 77' ' ' ASP . 2.6 m120 -109.8 1.95 19.66 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 120.839 -1.163 . . . . 0.029999999999999999 111.532 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.2 t -156.67 154.47 30.14 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.098 -1.075 . . . . 0.02 108.098 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.1 mt -145.94 146.61 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-O 122.402 1.096 . . . . 0.02 111.209 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -123.07 124.22 42.62 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.672 -1.233 . . . . 0.02 107.672 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.3 t -106.47 113.92 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 106.91 -1.515 . . . . 0.02 106.91 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -84.07 -34.42 24.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.746 -0.596 . . . . 3.8100000000000001 110.5 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.84 149.93 18.32 Favored Glycine 0 N--CA 1.486 2.026 0 C-N-CA 119.064 -1.541 . . . . 0.02 110.589 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.96 172.08 48.84 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.845 -1.169 . . . . 0.01 110.432 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.7 m -119.99 135.69 54.82 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.171 -1.048 . . . . 1.48 108.171 178.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.421 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 35.8 m95 -127.41 155.48 43.58 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 122.62 1.2 . . . . 0.02 112.526 -176.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.41 134.69 51.53 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 105.586 -2.005 . . . . 0.23999999999999999 105.586 176.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.416 ' HB ' HD22 ' A' ' 79' ' ' LEU . 11.5 m -120.12 144.51 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.629 -0.669 . . . . 0.65000000000000002 109.408 179.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -121.15 146.04 47.18 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 122.291 1.043 . . . . 0.02 110.22 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -67.5 -34.55 77.37 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.801 -0.636 . . . . 0.02 111.496 -177.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 24.4 mtm180 -124.72 158.22 63.11 Favored Pre-proline 0 N--CA 1.504 2.249 0 O-C-N 120.983 -1.073 . . . . 0.02 109.576 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -54.04 165.32 2.08 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.619 1.546 . . . . 0.02 113.253 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 64.37 37.02 8.65 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.111 -0.949 . . . . 0.02 111.268 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 45.22 51.68 9.06 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.662 0.744 . . . . 3.3900000000000001 110.603 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.9 p -126.2 163.47 23.1 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.58 -0.526 . . . . 2.3300000000000001 109.58 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.92 -161.76 32.14 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.811 -1.316 . . . . 0.02 109.811 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -65.27 138.91 58.51 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.085 -1.244 . . . . 0.02 110.388 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' A' ' 58' ' ' MET . 11.6 tmm? -120.1 137.18 54.29 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 109.376 -0.601 . . . . 5.0099999999999998 109.376 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.469 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 86.7 m-85 -134.67 139.68 45.44 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.799 0.809 . . . . 0.02 109.949 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.7 mm -94.77 131.26 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.762 -0.829 . . . . 1.72 108.762 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.556 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -120.45 111.95 34.58 Favored Pre-proline 0 N--CA 1.505 2.311 0 O-C-N 121.397 -0.814 . . . . 0.02 110.946 -178.165 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -78.31 169.16 20.55 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 CA-C-N 119.842 0.979 . . . . 1.47 110.338 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -53.72 141.52 26.22 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.88 -1.137 . . . . 4.25 110.514 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.85 -177.46 32.12 Favored Glycine 0 N--CA 1.496 2.636 0 C-N-CA 119.515 -1.326 . . . . 0.02 110.824 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -119.99 131.39 55.14 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.46 -1.023 . . . . 0.95999999999999996 109.803 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.556 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 75.1 m-85 -121.73 97.83 46.12 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 107.795 -1.187 . . . . 0.02 107.795 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.402 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 5.8 Cg_endo -69.6 -3.34 11.71 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 120.704 0.936 . . . . 0.02 113.671 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 33.4 mt-10 -157.77 155.11 29.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.723 -1.235 . . . . 2.02 108.137 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -60.4 -39.5 87.59 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.666 -0.646 . . . . 0.02 112.018 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -60.06 -24.02 64.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.058 -1.026 . . . . 0.02 110.411 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -69.74 -18.5 63.52 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.903 0.859 . . . . 3.4199999999999999 108.87 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.558 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.3 t90 -108.21 10.59 27.84 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.458 -1.312 . . . . 0.02 107.458 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.7 mtt 61.5 22.55 12.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.53 -0.731 . . . . 0.02 110.536 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.53 145.46 47.24 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.579 -1.409 . . . . 0.02 109.579 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.3 mt -80.48 -31.04 37.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -1.158 . . . . 0.97999999999999998 108.039 177.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -157.02 -171.55 3.69 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 106.513 -1.662 . . . . 0.02 106.513 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.573 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 66.0 m-20 -98.63 28.31 4.31 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.595 -1.316 . . . . 0.02 110.774 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.4 mtp180 -97.19 122.89 40.71 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.059 -1.026 . . . . 3.2000000000000002 110.99 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 79' ' ' LEU . 42.8 mt -143.47 121.59 12.17 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 107.632 -1.247 . . . . 2.6099999999999999 107.632 178.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.07 -17.27 9.67 Favored Glycine 0 N--CA 1.506 3.327 0 O-C-N 121.098 -1.001 . . . . 0.02 113.026 -177.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.9 m -156.74 156.86 34.05 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.085 -1.832 . . . . 0.02 110.483 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 44.9 t -144.79 147.26 32.69 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.529 -0.732 . . . . 0.02 110.242 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 38.1 mtm180 -138.52 143.17 39.4 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.33 -0.856 . . . . 0.01 109.392 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.81 132.46 36.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.251 -0.906 . . . . 0.42999999999999999 109.816 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.6 t -91.25 125.44 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.851 -0.796 . . . . 1.25 108.851 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -94.1 131.34 39.73 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.773 -1.204 . . . . 1.77 109.085 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mt -96.37 140.18 31.41 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.439 -0.949 . . . . 1.6299999999999999 108.439 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.2 t -111.89 127.86 55.97 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.285 -0.884 . . . . 1.0800000000000001 109.406 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.6 p -104.34 -154.17 0.5 Allowed 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 106.573 -1.64 . . . . 1.26 106.573 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.93 -52.97 0.73 Allowed Glycine 0 N--CA 1.502 3.044 0 O-C-N 120.392 -1.443 . . . . 0.01 112.895 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.81 -101.42 0.15 Allowed Glycine 0 N--CA 1.491 2.312 0 C-N-CA 118.467 -1.825 . . . . 0.01 111.966 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -121.64 118.89 30.31 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.057 -1.261 . . . . 4.4299999999999997 110.648 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.3 129.1 34.13 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.702 -0.799 . . . . 2.9900000000000002 109.555 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -131.1 142.23 50.24 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 109.039 -0.726 . . . . 6.3600000000000003 109.039 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.2 tt -129.68 147.36 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 O-C-N 121.24 -0.912 . . . . 1.0900000000000001 110.362 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -121.64 134.13 54.98 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.615 -1.254 . . . . 2.0499999999999998 107.615 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.7 m -124.36 145.88 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 120.69 -1.256 . . . . 1.1000000000000001 110.002 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.592 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 96.4 m-85 -119.13 141.44 48.81 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.995 0.902 . . . . 0.72999999999999998 110.935 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -67.02 -30.93 71.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.881 -0.512 . . . . 0.02 111.852 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -116.36 167.63 10.86 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.949 -1.094 . . . . 3.1800000000000002 110.561 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.18 164.17 44.49 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 111.057 -0.817 . . . . 0.01 111.057 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 57.1 38.56 29.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.884 -0.774 . . . . 0.01 110.963 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 52.4 55.32 9.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.582 -0.699 . . . . 0.01 111.058 178.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -129.08 165.85 20.42 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.216 -1.031 . . . . 3.1499999999999999 108.216 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.41 -163.8 27.76 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.231 -1.548 . . . . 0.01 109.231 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -76.0 144.24 41.02 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.025 -1.279 . . . . 0.01 108.711 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.592 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 52.2 ttp -116.29 141.84 47.63 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.608 0.718 . . . . 0.01 109.882 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -131.57 136.63 47.97 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.237 -1.023 . . . . 2.48 108.237 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -118.1 133.69 55.67 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.502 -0.749 . . . . 0.01 110.012 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.1 t -147.84 148.76 31.23 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 122.195 0.998 . . . . 1.6899999999999999 110.941 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 60.3 p -111.17 10.06 21.87 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 115.619 -0.718 . . . . 0.01 110.293 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -121.67 163.09 19.58 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.257 -0.902 . . . . 3.21 111.677 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.17 157.48 36.82 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.278 -1.008 . . . . 0.01 108.278 178.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.58 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 0.8 OUTLIER -128.46 119.51 20.54 Favored Pre-proline 0 N--CA 1.504 2.26 0 O-C-N 121.476 -0.765 . . . . 0.01 108.989 177.695 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -76.47 -28.76 6.57 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 CA-C-N 120.24 1.121 . . . . 0.01 110.85 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 64.1 m -144.04 109.75 5.25 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.718 0.771 . . . . 0.02 109.25 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.72 -38.28 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.819 -0.551 . . . . 1.8300000000000001 110.514 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 20.5 ttt -68.49 -36.39 78.87 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.399 -0.92 . . . . 1.3400000000000001 110.359 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -70.91 -39.06 72.96 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.5 -1.375 . . . . 2.1099999999999999 110.167 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -79.66 -47.54 15.22 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.307 -0.871 . . . . 2.0800000000000001 112.535 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -110.27 0.51 18.12 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.358 -0.839 . . . . 0.02 112.476 -176.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.6 m80 59.49 32.64 21.84 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.757 -1.214 . . . . 0.02 109.32 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.1 mt -112.2 135.46 52.84 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 108.477 -0.934 . . . . 0.02 108.477 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -91.24 -22.66 20.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.289 -0.882 . . . . 5.3200000000000003 110.158 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -149.84 164.04 36.42 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.296 -0.878 . . . . 0.02 110.024 -178.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 48.6 mt -131.42 128.49 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 107.558 -1.275 . . . . 2.1699999999999999 107.558 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -107.81 -12.25 15.24 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.313 -0.867 . . . . 0.02 112.376 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.4 t -158.74 151.39 21.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.837 -1.164 . . . . 0.01 108.911 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.504 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 2.8 p -170.41 145.25 2.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.092 -1.005 . . . . 1.22 109.178 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -124.67 110.18 14.07 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 122.361 1.077 . . . . 1.4099999999999999 109.894 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 131' ' ' VAL . 8.6 p -111.21 135.34 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.365 -1.346 . . . . 0.01 107.365 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.9 t -128.95 94.69 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 107.05 -1.463 . . . . 1.98 107.05 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.413 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 4.5 tm-20 -146.03 -74.73 0.22 Allowed 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 105.869 -1.9 . . . . 0.01 105.869 177.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 167.36 -69.74 0.18 Allowed Glycine 0 N--CA 1.485 1.902 0 N-CA-C 108.7 -1.76 . . . . 0.01 108.7 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.783 ' OG1' HD12 ' A' ' 175' ' ' ILE . 0.1 OUTLIER -120.18 115.4 23.57 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.556 -0.967 . . . . 2.2999999999999998 110.456 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.413 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 5.8 m95 -127.05 149.37 49.94 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 106.809 -1.552 . . . . 0.01 106.809 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 97.7 mt -122.98 138.37 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 120.42 -1.425 . . . . 1.6899999999999999 110.647 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -113.72 143.64 44.28 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.265 -1.383 . . . . 2.4900000000000002 107.265 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.501 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 10.5 m-85 -122.45 144.68 48.9 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.178 -0.951 . . . . 0.02 109.307 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -75.72 -29.34 58.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.608 -0.682 . . . . 0.02 111.566 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mt -116.41 154.21 48.91 Favored Pre-proline 0 N--CA 1.504 2.234 0 O-C-N 120.69 -1.256 . . . . 1.48 108.899 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -55.16 170.02 0.83 Allowed 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.225 1.283 . . . . 0.02 112.962 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 58.25 31.62 21.04 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 114.937 -1.029 . . . . 0.75 111.274 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 56.21 48.01 18.21 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.532 -0.73 . . . . 0.02 110.424 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -123.03 164.4 18.65 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.585 -0.697 . . . . 0.02 109.97 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.86 -166.03 32.35 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.375 -1.09 . . . . 0.02 110.375 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -69.04 142.85 54.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.581 -0.952 . . . . 0.02 109.133 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -114.49 147.99 38.54 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.393 0.616 . . . . 0.02 110.242 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -125.22 135.71 52.84 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.919 -0.771 . . . . 0.01 108.919 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.7 tt -97.9 121.64 40.05 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.839 -1.163 . . . . 0.01 109.495 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.686 HD21 ' CD1' ' A' ' 162' ' ' TRP . 0.1 OUTLIER -96.04 145.5 25.4 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.309 -0.869 . . . . 0.01 108.752 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.671 ' H ' HD13 ' A' ' 151' ' ' LEU . 29.3 t0 -103.06 -116.15 0.21 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.339 -0.851 . . . . 2.27 109.412 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -157.78 49.69 0.42 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.053 -1.029 . . . . 1.8400000000000001 109.712 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -113.64 -162.97 0.83 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.495 -0.753 . . . . 2.2799999999999998 109.315 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -105.93 103.52 13.03 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.43 -0.794 . . . . 0.01 108.94 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.616 ' CG ' ' NE1' ' A' ' 162' ' ' TRP . 66.8 m-85 -98.7 113.24 25.24 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.365 -0.835 . . . . 0.01 109.722 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -95.11 -22.33 17.95 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.297 -0.877 . . . . 0.01 111.61 -177.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -127.39 154.52 77.24 Favored Pre-proline 0 N--CA 1.504 2.25 0 O-C-N 120.767 -1.208 . . . . 2.54 108.855 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -60.5 -38.97 69.58 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 120.58 0.854 . . . . 0.69999999999999996 110.512 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 84.6 t -61.51 -20.02 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.958 -1.089 . . . . 0.85999999999999999 108.931 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -65.41 -15.6 62.77 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.934 -1.104 . . . . 0.02 110.074 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.686 ' CD1' HD21 ' A' ' 151' ' ' LEU . 9.7 m0 -98.22 11.4 37.98 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.144 -0.973 . . . . 0.02 108.925 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.06 10.34 85.65 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.842 -1.171 . . . . 0.02 111.087 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.57 141.25 32.6 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.181 -1.188 . . . . 0.02 110.023 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.08 -9.46 57.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.671 -0.643 . . . . 0.58999999999999997 110.217 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.0 m -143.49 149.78 48.75 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 120.891 -1.131 . . . . 0.87 109.057 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -76.64 19.1 0.66 Allowed 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 120.822 1.015 . . . . 0.38 112.294 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.7 124.7 29.82 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.812 -1.18 . . . . 0.17999999999999999 111.493 -177.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -150.21 126.6 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 107.075 -1.454 . . . . 3.9900000000000002 107.075 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -115.11 -15.07 11.74 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.051 -1.031 . . . . 5.1699999999999999 113.582 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 6.2 t -156.77 160.16 38.99 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 119.189 -2.194 . . . . 0.02 110.294 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.58 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 13.9 p90 -151.84 153.29 33.93 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.919 -1.113 . . . . 2.02 110.718 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -144.78 149.42 35.46 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.364 -0.835 . . . . 0.01 110.293 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.415 ' HG2' ' H ' ' A' ' 174' ' ' ARG . 12.5 ptm180 -89.26 145.46 25.37 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.27 -0.641 . . . . 0.01 109.27 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.783 HD12 ' OG1' ' A' ' 135' ' ' THR . 4.7 mt -96.76 129.93 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.308 -0.87 . . . . 3.04 109.324 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.14 146.31 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.227 -0.92 . . . . 1.8899999999999999 109.484 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 4.8899999999999997 109.404 179.931 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.421 -1.471 . . . . 0.01 109.421 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.519 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 2.8 ttmp? -145.99 135.27 22.9 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.174 -1.192 . . . . 0.02 110.517 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.5 tt -129.54 139.15 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.062 -1.088 . . . . 0.02 108.062 178.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.49 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.4 t -122.41 130.86 53.53 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.348 -0.845 . . . . 0.39000000000000001 110.119 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.0 m-85 -111.18 141.54 44.57 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 109.067 -0.716 . . . . 0.02 109.067 178.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.548 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.9 m-85 -122.08 138.58 54.39 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.181 -0.949 . . . . 0.02 109.61 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.486 ' HG3' HD11 ' A' ' 33' ' ' LEU . 96.1 mt-10 -68.33 -27.91 66.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.878 -1.139 . . . . 0.029999999999999999 111.39 -178.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.1 m-20 -114.65 169.88 8.73 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.873 -1.142 . . . . 0.029999999999999999 110.163 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -75.5 161.91 28.78 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.793 0.806 . . . . 0.029999999999999999 110.411 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.3 m120 63.12 33.13 14.75 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.054 0.931 . . . . 0.73999999999999999 110.894 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 54.92 40.07 31.83 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.865 -0.607 . . . . 0.02 110.978 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -110.29 165.75 11.52 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.215 -1.031 . . . . 0.02 108.215 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.46 -167.57 35.63 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.889 -1.148 . . . . 0.029999999999999999 110.889 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -69.65 143.28 53.26 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.477 -1.014 . . . . 2.7599999999999998 109.261 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -120.47 149.23 42.72 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.505 0.669 . . . . 1.8899999999999999 110.171 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -132.34 127.59 35.85 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.25 -1.018 . . . . 0.02 108.25 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -112.78 136.75 52.04 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.422 -0.799 . . . . 1.1200000000000001 109.751 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.427 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 15.9 t -131.22 139.14 49.64 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.765 -0.585 . . . . 0.02 109.515 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -116.58 11.69 14.83 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.624 -0.672 . . . . 0.20000000000000001 109.836 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.513 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 52.9 t -158.37 174.69 14.75 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.248 -1.019 . . . . 1.23 108.248 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.513 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.1 m-20 -60.53 144.19 52.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.756 -1.215 . . . . 0.02 109.721 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 22.2 t -131.75 117.41 18.56 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.654 -0.869 . . . . 0.02 108.654 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.89 -24.42 48.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.143 -0.973 . . . . 0.23999999999999999 110.919 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -155.18 102.36 2.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.927 -1.108 . . . . 1.1399999999999999 109.234 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -102.57 9.9 39.13 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 122.024 0.916 . . . . 6.3700000000000001 109.734 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -59.45 -25.22 64.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.589 -0.694 . . . . 3.1099999999999999 111.416 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.9 m -76.23 -17.3 59.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.508 -1.37 . . . . 0.88 110.687 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -103.88 -22.06 13.56 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.361 -0.837 . . . . 0.02 109.411 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.486 HD11 ' HG3' ' A' ' 11' ' ' GLU . 6.1 tp -150.25 129.1 12.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.317 -0.865 . . . . 3.3199999999999998 109.0 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.5 m -85.03 -9.81 57.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.743 -0.598 . . . . 0.02 110.944 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -171.15 162.36 6.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.954 -1.091 . . . . 0.02 108.066 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.9 p -144.03 115.09 7.88 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.747 -1.221 . . . . 0.02 108.53 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.42 HD22 ' HB3' ' A' ' 77' ' ' ASP . 5.8 t-20 -108.65 3.29 22.66 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.787 -1.195 . . . . 0.029999999999999999 110.862 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.3 m -155.48 154.28 31.58 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.651 -1.241 . . . . 0.02 107.651 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.404 HD13 HG21 ' A' ' 39' ' ' ILE . 10.5 mt -146.36 147.1 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.977 -1.077 . . . . 0.02 110.574 -178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -124.6 125.07 43.55 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 107.814 -1.18 . . . . 0.02 107.814 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.7 t -106.38 115.21 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 106.972 -1.492 . . . . 0.02 106.972 177.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.519 ' OE1' ' NZ ' ' A' ' 6' ' ' LYS . 30.5 tt0 -83.38 -34.0 25.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.37 -0.831 . . . . 3.8100000000000001 110.93 -178.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.04 152.58 22.5 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 118.893 -1.622 . . . . 0.02 110.799 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.53 172.97 49.39 Favored Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.698 -1.239 . . . . 0.01 110.423 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 86.6 m -119.81 135.16 54.97 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 107.982 -1.118 . . . . 1.48 107.982 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.442 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 32.0 m95 -126.53 154.99 43.07 Favored 'General case' 0 N--CA 1.502 2.173 0 CA-C-O 122.581 1.181 . . . . 0.02 112.301 -176.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.14 134.28 51.92 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 105.225 -2.139 . . . . 0.23999999999999999 105.225 176.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.437 ' HB ' HD22 ' A' ' 79' ' ' LEU . 35.5 m -116.99 141.93 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.532 -0.73 . . . . 0.65000000000000002 109.235 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -121.18 143.89 48.88 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 122.061 0.934 . . . . 0.02 109.753 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -65.01 -34.82 79.36 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.448 -0.796 . . . . 0.02 111.655 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.9 mtm180 -125.37 157.74 66.67 Favored Pre-proline 0 N--CA 1.503 2.2 0 O-C-N 121.004 -1.06 . . . . 0.02 109.332 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.48 167.73 0.84 Allowed 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.657 1.572 . . . . 0.02 113.022 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 63.13 36.39 12.19 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.212 -0.903 . . . . 0.02 111.207 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' A' ' 54' ' ' PHE . 0.6 OUTLIER 45.5 51.62 9.67 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.591 0.71 . . . . 3.3900000000000001 110.717 178.472 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.8 m -126.02 163.85 22.13 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.187 0.517 . . . . 2.3300000000000001 109.846 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.85 -161.54 32.06 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.869 -1.292 . . . . 0.02 109.869 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.407 ' CD2' ' N ' ' A' ' 57' ' ' HIS . 15.8 m170 -65.22 138.62 58.36 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.035 -1.274 . . . . 0.02 110.068 -178.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.447 ' C ' ' SD ' ' A' ' 58' ' ' MET . 11.2 tmm? -118.97 136.39 54.11 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.362 0.601 . . . . 5.0099999999999998 109.693 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.455 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 93.8 m-85 -134.31 138.76 45.2 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 121.714 0.768 . . . . 0.02 109.828 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.419 HD11 ' SD ' ' A' ' 58' ' ' MET . 15.9 mm -95.38 131.11 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 109.031 -0.729 . . . . 1.72 109.031 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.565 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -119.66 110.62 36.85 Favored Pre-proline 0 N--CA 1.504 2.247 0 O-C-N 121.449 -0.782 . . . . 0.02 110.67 -178.3 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -77.26 167.86 24.01 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 CA-C-N 119.966 1.024 . . . . 1.47 110.167 177.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.614 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -53.36 141.61 23.88 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.834 -1.166 . . . . 4.25 110.445 -179.621 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.13 -177.81 32.15 Favored Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.549 -1.31 . . . . 0.02 110.671 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -119.78 131.64 55.39 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.382 -1.07 . . . . 0.95999999999999996 109.823 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.565 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 75.6 m-85 -121.46 97.81 46.78 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 108.047 -1.094 . . . . 0.02 108.047 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -69.42 -3.88 12.68 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 120.743 0.962 . . . . 0.02 113.48 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -157.65 154.76 28.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.781 -1.199 . . . . 2.02 108.041 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -60.36 -38.8 84.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.58 -0.7 . . . . 0.02 112.154 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -60.52 -24.15 65.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.176 -0.953 . . . . 0.02 110.494 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -68.74 -18.03 64.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.327 -0.858 . . . . 3.4199999999999999 109.076 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.562 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.3 t90 -108.09 11.74 27.39 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.673 -1.232 . . . . 0.02 107.673 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.3 mmt 60.48 22.3 11.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.556 -0.715 . . . . 0.02 110.295 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.89 143.33 45.48 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.429 -1.468 . . . . 0.02 109.429 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.0 tp -78.58 -31.26 47.15 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.293 -1.373 . . . . 0.97999999999999998 107.293 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -157.75 -172.07 3.8 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 106.097 -1.816 . . . . 0.02 106.097 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.42 ' HB3' HD22 ' A' ' 37' ' ' ASN . 1.4 p30 -98.16 28.26 4.13 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.701 -1.249 . . . . 0.02 110.692 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -96.76 121.87 39.09 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.736 -1.227 . . . . 3.2000000000000002 111.039 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.437 HD22 ' HB ' ' A' ' 48' ' ' VAL . 59.4 mt -142.96 122.02 12.87 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 107.422 -1.325 . . . . 2.6099999999999999 107.422 178.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.84 -17.61 9.55 Favored Glycine 0 N--CA 1.504 3.222 0 O-C-N 121.231 -0.918 . . . . 0.02 112.859 -177.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 p -156.37 156.48 33.96 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.04 -1.859 . . . . 0.02 110.61 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 44.2 t -144.34 146.85 32.8 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.38 -0.825 . . . . 0.02 110.476 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 -138.33 143.48 39.93 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.408 -0.807 . . . . 0.01 109.486 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.42 132.25 36.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.946 . . . . 0.42999999999999999 109.825 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.3 t -91.56 125.63 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.878 -0.786 . . . . 1.25 108.878 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -94.26 131.85 39.44 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.783 -1.198 . . . . 1.77 109.234 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.3 mt -96.79 140.34 31.5 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.307 -0.871 . . . . 1.6299999999999999 108.681 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.5 p -111.93 127.63 55.91 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.411 -0.806 . . . . 1.0800000000000001 109.339 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.7 t -103.94 -154.66 0.51 Allowed 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 106.551 -1.648 . . . . 1.26 106.551 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.01 -52.45 0.75 Allowed Glycine 0 N--CA 1.5 2.944 0 O-C-N 120.512 -1.368 . . . . 0.01 112.807 177.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.26 -101.19 0.15 Allowed Glycine 0 N--CA 1.491 2.306 0 C-N-CA 118.457 -1.83 . . . . 0.01 112.161 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -121.94 119.8 32.57 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.033 -1.275 . . . . 4.4299999999999997 110.791 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.4 129.73 34.74 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.833 -0.747 . . . . 2.9900000000000002 109.362 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -130.1 142.23 50.62 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.347 -0.846 . . . . 6.3600000000000003 109.073 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.0 tt -129.19 146.13 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 121.302 -0.874 . . . . 1.0900000000000001 110.373 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -121.54 133.25 55.02 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.432 -1.321 . . . . 2.0499999999999998 107.432 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.8 m -123.58 145.35 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 120.693 -1.255 . . . . 1.1000000000000001 109.772 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -119.75 141.46 49.42 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 122.064 0.935 . . . . 0.72999999999999998 111.012 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -67.24 -30.5 70.43 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.922 -0.581 . . . . 0.02 112.126 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -116.27 167.33 11.11 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 120.998 -1.064 . . . . 3.1800000000000002 110.413 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.64 163.85 43.02 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 111.039 -0.825 . . . . 0.01 111.039 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.2 t70 56.82 38.75 29.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.921 -0.753 . . . . 0.01 110.896 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.437 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 21.2 m-85 52.26 55.95 8.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.656 -0.652 . . . . 0.01 111.103 178.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -128.8 165.39 21.05 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.256 -1.016 . . . . 3.1499999999999999 108.256 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.22 -163.79 27.99 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.324 -1.511 . . . . 0.01 109.324 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 48.3 tp60 -75.03 143.48 43.5 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.998 -1.295 . . . . 0.01 108.551 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.45 ' C ' ' SD ' ' A' ' 107' ' ' MET . 12.3 tmm? -115.99 142.45 46.77 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.52 0.676 . . . . 0.01 109.746 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -131.83 136.5 47.53 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.249 -1.019 . . . . 2.48 108.249 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -118.76 134.14 55.35 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.576 -0.703 . . . . 0.01 109.948 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.0 t -148.86 149.99 32.23 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.24 1.019 . . . . 1.6899999999999999 110.946 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 32.2 p -109.94 10.38 24.32 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 115.485 -0.78 . . . . 0.01 110.106 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -121.29 163.16 19.04 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.264 -0.898 . . . . 3.21 111.715 -178.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -67.48 156.61 36.22 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.253 -1.017 . . . . 0.01 108.253 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 37.5 t -125.4 111.95 25.9 Favored Pre-proline 0 N--CA 1.503 2.177 0 O-C-N 121.368 -0.832 . . . . 0.01 109.035 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -76.37 -32.62 3.8 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 CA-C-N 119.997 1.034 . . . . 0.01 111.635 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 7.8 t -140.6 106.54 5.17 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.223 -0.923 . . . . 0.02 108.592 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 68.0 mt -65.03 -38.82 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.717 -0.615 . . . . 1.8300000000000001 111.183 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.2 ttt -66.92 -38.07 85.51 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 118.946 -1.102 . . . . 1.3400000000000001 109.929 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -69.15 -38.28 78.7 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.489 -1.382 . . . . 2.1099999999999999 109.546 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -79.77 -47.25 15.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.322 -0.861 . . . . 2.0800000000000001 112.269 -177.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -111.77 -0.53 15.91 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.378 -0.826 . . . . 0.02 112.824 -176.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.8 m80 61.71 34.67 17.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.752 -1.218 . . . . 0.02 109.837 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 40.9 mt -114.47 136.12 53.36 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.454 -0.779 . . . . 0.02 109.426 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -90.62 -22.04 21.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.3 -0.875 . . . . 5.3200000000000003 110.864 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -148.05 163.92 35.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.99 -1.069 . . . . 0.02 109.97 -178.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.9 mm -129.28 125.28 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 107.857 -1.164 . . . . 2.1699999999999999 107.857 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -109.74 -13.61 14.46 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.233 -0.917 . . . . 0.02 112.833 -177.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.437 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 2.3 t -158.87 149.63 20.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.797 -1.189 . . . . 0.01 108.987 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.486 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 30.0 p -170.14 148.81 3.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 1.22 108.865 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -120.88 113.03 19.54 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 122.453 1.12 . . . . 1.4099999999999999 110.062 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.0 t -112.19 128.72 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.561 -1.274 . . . . 0.01 107.561 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 47.5 t -128.73 93.11 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 107.071 -1.455 . . . . 1.98 107.071 177.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -147.71 -75.99 0.18 Allowed 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 105.831 -1.914 . . . . 0.01 105.831 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 156.55 -54.53 0.4 Allowed Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.184 -1.567 . . . . 0.01 109.184 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 54.7 p -119.77 97.8 5.8 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.551 -0.97 . . . . 2.2999999999999998 111.012 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -128.16 145.53 50.99 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 107.108 -1.442 . . . . 0.01 107.108 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.402 ' CG1' HD11 ' A' ' 175' ' ' ILE . 61.4 mt -122.02 138.89 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 120.883 -1.136 . . . . 1.6899999999999999 110.714 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -113.71 144.11 43.5 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 106.873 -1.529 . . . . 2.4900000000000002 106.873 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.513 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 15.7 m-85 -123.17 144.36 49.4 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.311 -0.868 . . . . 0.02 109.658 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -76.54 -28.97 56.52 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.624 -0.673 . . . . 0.02 111.999 -176.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mt -116.04 154.93 48.52 Favored Pre-proline 0 N--CA 1.506 2.331 0 O-C-N 120.544 -1.348 . . . . 1.48 108.915 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.95 165.94 2.4 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.235 1.29 . . . . 0.02 113.071 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.409 ' N ' ' OD1' ' A' ' 143' ' ' ASN . 3.6 m-20 59.68 31.48 20.9 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 115.071 -0.968 . . . . 0.75 111.471 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 57.39 51.09 10.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.45 -0.781 . . . . 0.02 111.186 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -126.26 164.91 19.96 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.426 -0.796 . . . . 0.02 109.944 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.463 ' O ' ' NE2' ' A' ' 148' ' ' GLN . . . 89.01 -165.98 33.42 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.255 -1.138 . . . . 0.02 110.255 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -69.39 142.66 53.88 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.724 -0.868 . . . . 0.02 109.061 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.47 ' CD ' ' N ' ' A' ' 148' ' ' GLN . 7.2 mp0 -115.63 149.54 38.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.803 -0.56 . . . . 0.02 109.728 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -123.53 134.76 53.82 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.616 -0.678 . . . . 0.01 109.219 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.3 tp -95.24 121.15 36.59 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.632 -1.292 . . . . 0.01 108.956 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.564 HD21 ' CG ' ' A' ' 162' ' ' TRP . 0.2 OUTLIER -94.63 160.24 14.72 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.325 -0.859 . . . . 0.01 109.045 -179.852 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.48 ' H ' HD13 ' A' ' 151' ' ' LEU . 1.4 p-10 -109.34 -111.65 0.32 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.445 -0.784 . . . . 2.27 109.335 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.525 ' N ' ' OH ' ' A' ' 156' ' ' TYR . 49.7 pttt -168.81 45.55 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.114 -0.991 . . . . 1.8400000000000001 109.923 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -113.59 -153.77 0.53 Allowed 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.503 -0.748 . . . . 2.2799999999999998 109.122 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -106.39 106.37 16.85 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.417 -0.802 . . . . 0.01 109.075 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.644 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 2.9 m-85 -99.34 112.4 24.58 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.267 -0.895 . . . . 0.01 109.667 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -94.56 -22.67 18.05 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.129 -0.982 . . . . 0.01 111.411 -178.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -128.19 154.44 78.79 Favored Pre-proline 0 N--CA 1.502 2.146 0 O-C-N 120.84 -1.163 . . . . 2.54 108.822 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -60.12 -37.21 85.46 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 CA-C-N 119.268 0.774 . . . . 0.69999999999999996 110.631 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 6.0 t -61.11 -19.88 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.756 -1.215 . . . . 0.85999999999999999 109.048 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -65.15 -15.28 62.25 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.94 -1.1 . . . . 0.02 109.921 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.644 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 12.9 m0 -97.93 11.29 37.94 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.14 -0.975 . . . . 0.02 109.025 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.4 11.0 84.7 Favored Glycine 0 N--CA 1.491 2.329 0 O-C-N 120.793 -1.192 . . . . 0.02 111.177 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.34 140.88 32.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.066 -1.255 . . . . 0.02 110.066 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.68 -8.76 58.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.598 -0.689 . . . . 0.58999999999999997 110.045 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 8.1 p -142.47 151.31 57.39 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 120.981 -1.075 . . . . 0.87 109.318 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -76.21 16.67 0.82 Allowed 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 120.837 1.024 . . . . 0.38 112.263 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.41 122.17 27.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.872 -1.142 . . . . 0.17999999999999999 111.366 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 3.1 mt -149.12 123.51 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 105.873 -1.899 . . . . 3.9900000000000002 105.873 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -112.21 -15.9 13.11 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.227 -0.92 . . . . 5.1699999999999999 113.286 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 20.9 m -156.6 160.42 39.4 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 119.245 -2.159 . . . . 0.02 110.041 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.419 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 21.4 p90 -152.67 153.0 32.41 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.147 -0.971 . . . . 2.02 110.633 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 29.6 mtp180 -145.58 149.65 34.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.36 -0.837 . . . . 0.01 109.679 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -88.4 142.44 27.72 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.507 -0.746 . . . . 0.01 109.455 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.402 HD11 ' CG1' ' A' ' 137' ' ' ILE . 3.7 mt -93.59 129.93 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.257 -0.902 . . . . 3.04 109.126 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.5 p -137.53 148.7 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.239 -0.913 . . . . 1.8899999999999999 109.902 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 . . . . . 0 N--CA 1.494 1.764 0 O-C-N 121.514 -0.741 . . . . 4.8899999999999997 109.656 179.827 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.768 -1.333 . . . . 0.01 109.768 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -149.92 136.45 19.12 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.481 -1.011 . . . . 0.02 109.882 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.3 tt -128.87 139.24 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.157 -1.053 . . . . 0.02 108.157 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.1 t -121.7 130.18 53.26 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.328 -0.858 . . . . 0.39000000000000001 110.033 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.545 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.8 m-85 -110.25 140.65 44.18 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.871 -0.788 . . . . 0.02 108.871 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.528 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 6.0 m-85 -122.37 138.79 54.41 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.214 -0.929 . . . . 0.02 109.612 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.47 ' HG3' HD11 ' A' ' 33' ' ' LEU . 87.7 mt-10 -68.03 -27.74 66.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.025 -1.047 . . . . 0.029999999999999999 111.663 -178.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -114.53 169.86 8.74 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.812 -1.18 . . . . 0.029999999999999999 110.379 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -75.67 158.92 31.72 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.611 0.719 . . . . 0.029999999999999999 109.974 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 66.09 32.99 7.86 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.949 0.88 . . . . 0.73999999999999999 110.97 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 55.23 41.57 31.27 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.31 0.576 . . . . 0.02 111.392 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 -112.94 166.23 11.59 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.327 -0.99 . . . . 0.02 108.327 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.68 -168.06 35.73 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 119.857 -1.163 . . . . 0.029999999999999999 110.75 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.425 ' NH2' ' OE2' ' A' ' 11' ' ' GLU . 23.4 ttp180 -68.83 143.37 54.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.476 -1.014 . . . . 2.7599999999999998 109.135 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -120.87 148.98 43.3 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.506 -0.746 . . . . 1.8899999999999999 110.189 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -132.79 127.76 35.3 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.327 -0.99 . . . . 0.02 108.327 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -112.2 136.67 51.33 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.403 -0.811 . . . . 1.1200000000000001 109.789 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.4 t -131.17 139.06 49.69 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.663 -0.648 . . . . 0.02 109.602 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -116.46 11.85 15.01 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.677 -0.639 . . . . 0.20000000000000001 109.655 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.0 p -158.63 174.6 14.81 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.358 -0.978 . . . . 1.23 108.358 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -60.45 144.66 50.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.642 -1.286 . . . . 0.02 109.858 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 44.2 t -131.97 117.76 18.86 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.691 -0.855 . . . . 0.02 108.691 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.49 -25.37 50.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.18 -0.95 . . . . 0.23999999999999999 110.894 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -154.2 102.96 2.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.97 -1.082 . . . . 1.1399999999999999 109.218 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -102.41 9.43 39.72 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 122.127 0.965 . . . . 6.3700000000000001 109.673 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -59.55 -25.17 64.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.523 -0.736 . . . . 3.1099999999999999 111.362 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.3 t -76.15 -17.55 59.51 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.505 -1.372 . . . . 0.88 110.596 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -104.08 -21.86 13.52 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.358 -0.839 . . . . 0.02 109.486 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.47 HD11 ' HG3' ' A' ' 11' ' ' GLU . 6.4 tp -150.43 129.25 12.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.194 -0.941 . . . . 3.3199999999999998 109.005 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.0 p -85.26 -10.22 56.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.81 -0.556 . . . . 0.02 111.131 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -171.1 162.38 7.06 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.009 -1.108 . . . . 0.02 108.009 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.8 p -144.08 115.33 7.97 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.703 -1.248 . . . . 0.02 108.766 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 -108.26 1.75 22.22 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 120.86 -1.15 . . . . 0.029999999999999999 110.969 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.8 t -154.95 154.3 32.38 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.636 -1.246 . . . . 0.02 107.636 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 61.3 mt -145.14 146.84 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.038 -1.039 . . . . 0.02 110.044 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -123.33 124.0 41.97 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.86 -1.163 . . . . 0.02 107.86 177.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.0 t -106.64 115.09 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 106.867 -1.531 . . . . 0.02 106.867 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -83.69 -33.75 25.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.655 -0.653 . . . . 3.8100000000000001 110.754 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.76 152.09 21.83 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 118.92 -1.609 . . . . 0.02 110.881 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.76 173.21 49.6 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.727 -1.225 . . . . 0.01 110.617 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.2 m -119.62 135.4 54.82 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 107.861 -1.163 . . . . 1.48 107.861 177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.449 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 33.7 m95 -126.6 155.57 42.29 Favored 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 122.576 1.179 . . . . 0.02 112.188 -176.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.68 134.16 52.29 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 105.666 -1.976 . . . . 0.23999999999999999 105.666 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.504 ' HB ' HD22 ' A' ' 79' ' ' LEU . 33.3 m -119.4 143.72 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.542 -0.724 . . . . 0.65000000000000002 109.054 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -120.9 146.28 46.78 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 122.226 1.012 . . . . 0.02 109.963 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -66.42 -34.59 78.29 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.756 -0.656 . . . . 0.02 111.183 -177.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -125.38 157.95 65.94 Favored Pre-proline 0 N--CA 1.502 2.139 0 O-C-N 121.162 -0.961 . . . . 0.02 109.465 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -53.89 167.17 1.17 Allowed 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 121.672 1.581 . . . . 0.02 113.082 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.2 t30 63.79 36.53 10.42 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.04 -0.982 . . . . 0.02 111.119 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 45.93 51.68 10.49 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.596 0.712 . . . . 3.3900000000000001 110.663 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.4 m -126.63 164.03 22.14 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.121 0.486 . . . . 2.3300000000000001 109.924 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.86 -161.74 32.2 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.881 -1.288 . . . . 0.02 109.881 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -65.66 139.51 58.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.109 -1.23 . . . . 0.02 110.017 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 17.2 ptm -117.94 137.07 53.08 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.761 -0.587 . . . . 5.0099999999999998 109.53 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -133.75 136.31 44.5 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.487 -0.758 . . . . 0.02 109.847 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.628 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.8 mp -95.39 131.64 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.522 -0.918 . . . . 1.72 108.522 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.7 mt -120.05 111.06 35.79 Favored Pre-proline 0 N--CA 1.502 2.146 0 O-C-N 121.504 -0.748 . . . . 0.02 110.682 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -77.13 168.73 22.73 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 CA-C-N 119.846 0.981 . . . . 1.47 109.981 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -52.67 141.49 20.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.831 -1.168 . . . . 4.25 110.184 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.04 -176.68 31.84 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.579 -1.296 . . . . 0.02 110.666 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -119.65 130.98 55.34 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.467 -1.019 . . . . 0.95999999999999996 109.58 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.41 ' N ' ' CD1' ' A' ' 66' ' ' TYR . 31.3 m-85 -120.41 96.53 49.05 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 107.889 -1.152 . . . . 0.02 107.889 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.4 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.8 Cg_endo -67.24 -5.03 12.82 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 120.746 0.964 . . . . 0.02 114.0 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 32.6 mt-10 -157.66 156.07 31.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.592 -1.317 . . . . 2.02 108.373 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -61.55 -38.17 86.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.408 -0.807 . . . . 0.02 112.324 -177.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -61.01 -22.08 64.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.023 -1.048 . . . . 0.02 109.961 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.9 tpm_? -67.0 -19.04 65.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.508 -0.745 . . . . 3.4199999999999999 110.03 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.454 ' C ' ' SD ' ' A' ' 73' ' ' MET . 2.2 p90 -110.42 16.3 21.68 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.336 -0.852 . . . . 0.02 109.091 178.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.454 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 3.0 mpp? 63.34 25.03 14.48 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.482 0.658 . . . . 0.02 110.768 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.412 ' HA3' ' HE1' ' A' ' 72' ' ' TRP . . . -60.51 145.17 47.41 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.838 -1.305 . . . . 0.02 109.838 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.6 tp -80.77 -31.2 35.89 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.663 -1.236 . . . . 0.97999999999999998 107.663 177.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -157.56 -171.84 3.73 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 106.482 -1.673 . . . . 0.02 106.482 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -98.99 28.27 4.49 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.707 -1.245 . . . . 0.02 110.835 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.595 HH11 ' CG ' ' A' ' 78' ' ' ARG . 3.3 mtt-85 -96.2 122.66 39.29 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.859 -1.151 . . . . 3.2000000000000002 110.872 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.504 HD22 ' HB ' ' A' ' 48' ' ' VAL . 33.0 mt -144.13 122.49 12.34 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.73 -1.211 . . . . 2.6099999999999999 107.73 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.44 -16.45 10.23 Favored Glycine 0 N--CA 1.504 3.216 0 O-C-N 121.102 -0.998 . . . . 0.02 112.94 -177.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 73.3 p -156.79 156.53 33.43 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.177 -1.778 . . . . 0.02 110.339 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 53.2 t -143.97 147.2 33.6 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.539 -0.725 . . . . 0.02 110.191 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.1 mtp180 -137.8 142.83 40.84 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.335 -0.853 . . . . 0.01 109.456 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.87 132.03 36.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.92 . . . . 0.42999999999999999 109.7 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.9 t -90.67 124.7 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.618 -0.882 . . . . 1.25 108.618 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -93.14 132.32 37.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.847 -1.158 . . . . 1.77 108.928 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.2 mt -97.37 139.77 32.82 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.669 -0.863 . . . . 1.6299999999999999 108.669 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.3 m -110.74 124.87 52.81 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.46 -0.941 . . . . 1.0800000000000001 108.46 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.8 t -115.85 130.39 56.82 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.651 -1.281 . . . . 1.26 107.608 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -154.13 -51.93 0.01 OUTLIER Glycine 0 N--CA 1.505 3.295 0 C-N-CA 117.951 -2.071 . . . . 0.01 113.24 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.11 -106.17 0.19 Allowed Glycine 0 N--CA 1.489 2.176 0 O-C-N 120.162 -1.787 . . . . 0.01 111.198 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -119.8 117.55 28.49 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.0 -1.294 . . . . 4.4299999999999997 110.212 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.77 130.28 36.53 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.066 -0.654 . . . . 2.9900000000000002 109.395 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.415 ' CB ' ' NZ ' ' A' ' 94' ' ' LYS . 7.3 ttpm? -131.72 141.27 49.5 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.492 -0.755 . . . . 6.3600000000000003 109.409 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.0 tt -127.65 146.99 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.418 0 CA-C-O 121.809 0.814 . . . . 1.0900000000000001 110.292 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -122.79 131.63 53.86 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.904 -1.147 . . . . 2.0499999999999998 107.904 177.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.7 m -125.35 147.65 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 O-C-N 120.95 -1.094 . . . . 1.1000000000000001 109.947 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.563 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 80.5 m-85 -119.19 141.67 48.66 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-O 121.948 0.88 . . . . 0.72999999999999998 111.139 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -67.74 -31.17 70.91 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 116.104 -0.498 . . . . 0.02 111.322 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.436 ' O ' ' OG ' ' A' ' 128' ' ' SER . 45.6 mttp -116.31 170.15 8.76 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.089 -1.007 . . . . 3.1800000000000002 110.04 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.56 169.72 43.97 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 111.174 -0.77 . . . . 0.01 111.174 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.6 t70 52.68 39.32 28.22 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.654 0.74 . . . . 0.01 111.611 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 52.42 48.72 22.01 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.601 -0.687 . . . . 0.01 110.975 178.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -123.09 164.93 17.68 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.379 -0.971 . . . . 3.1499999999999999 108.379 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.64 -163.54 28.56 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.427 -1.469 . . . . 0.01 109.427 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -76.93 144.05 39.11 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.049 -1.265 . . . . 0.01 109.121 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.563 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 28.1 ttp -116.19 142.32 46.97 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.487 0.66 . . . . 0.01 109.824 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -131.75 136.26 47.44 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.413 -0.958 . . . . 2.48 108.413 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -121.55 135.21 55.03 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.53 -0.731 . . . . 0.01 109.9 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.0 t -148.57 151.94 35.93 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.97 -1.081 . . . . 1.6899999999999999 110.799 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.4 p -111.54 8.68 21.09 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 116.028 -0.533 . . . . 0.01 110.618 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -120.63 162.96 18.76 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.162 -0.961 . . . . 3.21 111.311 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -67.6 156.52 36.59 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.397 -0.964 . . . . 0.01 108.397 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.434 ' SG ' ' OE1' ' A' ' 120' ' ' GLN . 42.8 t -125.57 114.36 25.19 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 108.928 -0.767 . . . . 0.01 108.928 178.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.415 ' O ' ' OG ' ' A' ' 171' ' ' SER . 20.6 Cg_endo -77.05 -31.92 3.49 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 CA-C-N 120.156 1.091 . . . . 0.01 111.122 178.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 41.1 t -141.74 107.56 5.13 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.556 -0.905 . . . . 0.02 108.556 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 64.7 mt -65.3 -38.69 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.656 -0.653 . . . . 1.8300000000000001 110.951 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 118' ' ' MET . 1.1 tmt? -66.69 -38.37 86.63 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.942 -1.103 . . . . 1.3400000000000001 109.758 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -68.56 -38.27 80.62 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.463 -1.398 . . . . 2.1099999999999999 109.63 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.434 ' OE1' ' SG ' ' A' ' 114' ' ' CYS . 54.5 tt0 -80.11 -46.73 15.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.245 -0.91 . . . . 2.0800000000000001 112.314 -177.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -112.27 -0.86 15.33 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.28 -0.887 . . . . 0.02 112.852 -176.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.7 m80 61.61 34.91 17.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.666 -1.272 . . . . 0.02 109.871 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.0 mt -114.01 135.63 53.8 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.521 -0.737 . . . . 0.02 109.229 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -90.9 -22.1 21.07 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.277 -0.889 . . . . 5.3200000000000003 110.965 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -148.03 164.0 35.15 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.993 -1.067 . . . . 0.02 110.022 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.0 mm -128.69 124.77 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 107.555 -1.276 . . . . 2.1699999999999999 107.555 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -109.43 -14.69 14.38 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.165 -0.959 . . . . 0.02 112.982 -176.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 10.0 p -161.14 153.21 19.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.563 -1.336 . . . . 0.01 109.467 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.409 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 27.9 p -167.79 149.43 5.47 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.796 -1.187 . . . . 1.22 107.796 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -112.83 103.59 11.59 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.104 -0.997 . . . . 1.4099999999999999 108.924 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.8 t -111.22 125.92 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 115.766 -0.652 . . . . 0.01 109.569 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.2 t -122.92 86.42 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.77 -1.937 . . . . 1.98 105.77 175.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.438 ' O ' ' O ' ' A' ' 152' ' ' ASP . 3.3 tp10 -161.36 -158.17 0.55 Allowed 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 106.786 -1.561 . . . . 0.01 106.786 178.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -157.65 -3.7 0.08 OUTLIER Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.113 -1.995 . . . . 0.01 108.113 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.6 p -115.06 45.04 1.69 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 122.0 -0.706 . . . . 2.2999999999999998 109.66 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -125.97 136.17 52.68 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.293 -0.879 . . . . 0.01 108.927 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 12.4 mt -123.71 141.28 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.693 -0.63 . . . . 1.6899999999999999 109.383 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -114.3 144.82 42.63 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.059 -1.46 . . . . 2.4900000000000002 107.059 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.464 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 19.9 m-85 -123.23 144.44 49.38 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.493 -0.754 . . . . 0.02 109.674 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.44 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 78.1 tt0 -75.58 -29.31 59.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.634 -0.667 . . . . 0.02 111.781 -176.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mt -115.05 154.94 47.15 Favored Pre-proline 0 N--CA 1.505 2.309 0 O-C-N 120.654 -1.279 . . . . 1.48 109.128 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -55.91 165.55 3.7 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.159 1.239 . . . . 0.02 112.809 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.485 ' N ' ' OD1' ' A' ' 143' ' ' ASN . 1.0 OUTLIER 60.71 32.46 20.25 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.198 -0.91 . . . . 0.75 111.451 178.632 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.417 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.9 m-85 57.43 51.72 9.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.563 -0.711 . . . . 0.02 110.96 177.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -127.13 165.11 20.18 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.492 -0.755 . . . . 0.02 110.325 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.59 -166.29 32.88 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.553 -1.019 . . . . 0.02 110.553 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -70.31 144.44 51.71 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.672 -0.899 . . . . 0.02 109.116 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -113.51 148.96 35.05 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.808 -0.558 . . . . 0.02 110.218 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -125.91 134.0 51.7 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.629 -0.669 . . . . 0.01 109.584 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.482 HD23 ' N ' ' A' ' 151' ' ' LEU . 2.6 tt -103.91 123.56 47.37 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.073 -1.017 . . . . 0.01 109.776 -179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.482 ' N ' HD23 ' A' ' 150' ' ' LEU . 8.8 mp -96.6 152.3 18.78 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.971 -1.081 . . . . 0.01 108.374 178.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.438 ' O ' ' O ' ' A' ' 133' ' ' GLU . 74.9 m-20 -111.32 -126.18 0.28 Allowed 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.309 -0.869 . . . . 2.27 110.492 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -129.25 42.03 3.37 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.399 -0.813 . . . . 1.8400000000000001 109.7 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -113.01 -174.39 2.44 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.403 -0.81 . . . . 2.2799999999999998 109.141 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -105.11 111.87 24.8 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.667 -0.864 . . . . 0.01 108.667 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.65 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 20.2 m-85 -97.94 110.53 23.09 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.289 -0.882 . . . . 0.01 109.859 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -95.1 -22.19 18.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.143 -0.973 . . . . 0.01 111.128 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -127.55 155.15 77.35 Favored Pre-proline 0 N--CA 1.501 2.122 0 O-C-N 121.034 -1.042 . . . . 2.54 108.521 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -60.19 -36.74 87.32 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 120.449 0.766 . . . . 0.69999999999999996 110.264 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -61.26 -20.16 21.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.936 -1.102 . . . . 0.85999999999999999 109.255 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -66.11 -16.04 63.61 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.92 -1.113 . . . . 0.02 110.188 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.65 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 10.4 m0 -97.42 11.16 37.67 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.086 -1.009 . . . . 0.02 108.712 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.65 11.04 85.16 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.805 -1.188 . . . . 0.02 110.774 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.36 141.29 33.41 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.176 -1.191 . . . . 0.02 110.1 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.16 -8.58 58.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.567 -0.708 . . . . 0.58999999999999997 110.302 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 9.7 p -143.96 151.02 51.52 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 120.769 -1.207 . . . . 0.87 109.21 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.81 18.42 0.62 Allowed 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 120.931 1.087 . . . . 0.38 112.318 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.8 121.84 26.94 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 122.427 1.108 . . . . 0.17999999999999999 111.346 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 3.1 mt -150.05 123.7 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 105.831 -1.915 . . . . 3.9900000000000002 105.831 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.528 ' OE1' ' N ' ' A' ' 170' ' ' GLN . 9.7 mp0 -113.5 -13.26 12.82 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.108 -0.995 . . . . 5.1699999999999999 113.109 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 115' ' ' PRO . 26.7 m -157.05 160.63 39.13 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 119.255 -2.153 . . . . 0.02 110.185 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -152.59 151.92 31.22 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.163 -0.96 . . . . 2.02 110.301 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.417 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 27.0 mtp180 -145.16 152.41 39.98 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.3 -0.875 . . . . 0.01 110.252 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -89.5 143.42 26.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.695 -0.628 . . . . 0.01 109.588 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 9.1 mt -95.64 130.32 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 108.482 -0.933 . . . . 3.04 108.482 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.22 147.12 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.121 -0.987 . . . . 1.8899999999999999 109.825 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.365 -0.834 . . . . 4.8899999999999997 109.525 -179.927 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 109.557 -1.417 . . . . 0.01 109.557 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -152.71 137.84 17.36 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.334 -1.098 . . . . 0.02 109.66 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.8 tt -129.69 141.02 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.96 -0.756 . . . . 0.02 108.96 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.503 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.3 t -121.47 130.26 53.46 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.577 -0.702 . . . . 0.39000000000000001 109.699 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 8.4 m-85 -109.76 139.97 44.21 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 109.123 -0.695 . . . . 0.02 109.123 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.514 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 6.3 m-85 -122.4 138.35 54.56 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.152 -0.967 . . . . 0.02 109.487 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.466 ' HG3' HD11 ' A' ' 33' ' ' LEU . 93.4 mt-10 -68.69 -27.75 66.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.219 -0.926 . . . . 0.029999999999999999 111.424 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.1 m-20 -114.75 170.49 8.28 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.937 -1.102 . . . . 0.029999999999999999 110.384 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.487 ' CZ ' ' OE2' ' A' ' 68' ' ' GLU . 7.6 mtp180 -75.18 160.84 29.94 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.59 0.709 . . . . 0.029999999999999999 110.122 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.596 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 2.6 m120 62.87 35.13 13.77 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.792 0.806 . . . . 0.73999999999999999 110.661 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.596 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 21.0 p90 49.58 42.21 22.65 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.451 -0.795 . . . . 0.02 111.057 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -109.03 165.95 11.2 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.851 -1.166 . . . . 0.02 107.851 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.82 -167.64 35.08 Favored Glycine 0 N--CA 1.495 2.628 0 O-C-N 120.687 -1.258 . . . . 0.029999999999999999 110.794 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -69.07 144.08 54.06 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.426 -1.044 . . . . 2.7599999999999998 109.285 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.486 ' HE ' ' CB ' ' A' ' 8' ' ' SER . 56.0 ttt180 -120.29 148.28 43.91 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.577 0.703 . . . . 1.8899999999999999 109.996 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -132.38 127.42 35.4 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.169 -1.049 . . . . 0.02 108.169 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -112.28 136.85 51.21 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.37 -0.831 . . . . 1.1200000000000001 109.89 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.427 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.4 t -131.17 138.99 49.69 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.582 -0.698 . . . . 0.02 109.681 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.498 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 33.3 t70 -117.09 10.67 13.98 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.648 -0.658 . . . . 0.20000000000000001 109.7 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 48.9 m -158.35 174.21 15.49 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.377 -0.972 . . . . 1.23 108.377 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -61.12 144.66 53.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.66 -1.275 . . . . 0.02 110.163 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.3 t -131.92 117.69 18.79 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.56 -0.904 . . . . 0.02 108.56 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.54 -26.09 45.65 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.091 -1.005 . . . . 0.23999999999999999 110.996 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 28.3 p-10 -153.47 101.39 2.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.971 -1.08 . . . . 1.1399999999999999 108.968 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -104.69 9.73 35.0 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 122.108 0.956 . . . . 6.3700000000000001 109.96 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -58.75 -24.79 62.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.541 -0.724 . . . . 3.1099999999999999 111.035 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.0 t -74.1 -16.78 61.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.806 -1.184 . . . . 0.88 110.192 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.51 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 18.1 m-85 -103.88 -22.03 13.56 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.349 -0.844 . . . . 0.02 109.388 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.466 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.2 tp -149.8 128.11 12.13 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.247 -0.908 . . . . 3.3199999999999998 108.98 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.5 m -85.2 -9.85 57.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.698 -0.626 . . . . 0.02 110.828 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -170.55 163.05 8.28 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.619 -1.252 . . . . 0.02 107.619 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 t -142.04 114.98 8.68 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.723 -1.236 . . . . 0.02 108.772 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -108.86 -1.82 18.89 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.807 -1.183 . . . . 0.029999999999999999 111.422 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 t -153.42 154.04 33.68 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.188 -1.041 . . . . 0.02 108.188 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.41 HG21 HD13 ' A' ' 39' ' ' ILE . 19.3 mt -145.85 145.86 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 120.955 -1.091 . . . . 0.02 110.802 -178.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -124.03 124.84 43.42 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.495 -1.298 . . . . 0.02 107.495 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.7 t -104.91 114.18 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 107.144 -1.428 . . . . 0.02 107.144 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.452 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 31.3 tt0 -84.56 -34.49 23.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.471 -0.768 . . . . 3.8100000000000001 110.098 -178.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.45 150.26 18.73 Favored Glycine 0 N--CA 1.489 2.212 0 C-N-CA 118.552 -1.785 . . . . 0.02 110.845 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.69 171.99 48.67 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.168 -1.173 . . . . 0.01 110.168 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.9 m -119.5 134.9 55.01 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.763 -1.199 . . . . 1.48 107.763 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.455 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 33.6 m95 -126.69 155.81 42.07 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 122.655 1.217 . . . . 0.02 112.448 -176.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.21 134.0 52.31 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 105.571 -2.011 . . . . 0.23999999999999999 105.571 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.514 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.3 m -118.6 143.21 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.624 -0.673 . . . . 0.65000000000000002 109.387 178.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -120.89 145.61 47.47 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 122.318 1.056 . . . . 0.02 110.06 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -66.22 -34.5 78.17 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.607 -0.724 . . . . 0.02 111.125 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 40.5 mtm180 -124.95 157.78 65.38 Favored Pre-proline 0 N--CA 1.503 2.215 0 O-C-N 121.035 -1.041 . . . . 0.02 109.546 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.58 167.09 1.03 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.773 1.649 . . . . 0.02 112.99 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.452 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.5 OUTLIER 63.53 36.74 10.93 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.126 -0.943 . . . . 0.02 111.156 178.19 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 45.05 51.7 8.73 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.678 0.751 . . . . 3.3900000000000001 110.574 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 94.8 p -125.86 163.53 22.73 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.27 0.557 . . . . 2.3300000000000001 109.779 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.94 -161.5 31.92 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.686 -1.366 . . . . 0.02 109.686 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -67.01 139.94 57.69 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.992 -1.299 . . . . 0.02 110.281 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 15.4 ptm -118.69 138.16 52.82 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.578 -0.701 . . . . 5.0099999999999998 109.962 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.455 ' OH ' HD13 ' A' ' 75' ' ' LEU . 58.8 m-85 -134.01 137.41 44.73 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.48 -0.762 . . . . 0.02 109.938 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.648 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.8 mp -96.03 131.81 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.597 -0.89 . . . . 1.72 108.597 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.416 HD21 ' CD1' ' A' ' 72' ' ' TRP . 11.5 mt -120.86 112.32 33.71 Favored Pre-proline 0 N--CA 1.504 2.231 0 O-C-N 121.329 -0.857 . . . . 0.02 110.886 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -77.64 169.95 20.01 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 CA-C-N 119.901 1.0 . . . . 1.47 110.061 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.452 ' NE2' ' O ' ' A' ' 42' ' ' GLU . 62.8 tt0 -53.46 140.56 27.59 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.917 -1.115 . . . . 4.25 110.449 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.07 -177.92 32.04 Favored Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.463 -1.351 . . . . 0.02 110.709 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -118.98 130.65 55.8 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.586 -0.949 . . . . 0.95999999999999996 109.528 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -119.87 96.26 49.42 Favored Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 107.912 -1.144 . . . . 0.02 107.912 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -71.83 -6.18 18.59 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 120.891 1.061 . . . . 0.02 113.909 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.527 ' OE1' ' CE1' ' A' ' 69' ' ' TYR . 1.0 OUTLIER -154.57 152.53 30.15 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.755 -1.202 . . . . 2.02 107.755 179.384 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.527 ' CE1' ' OE1' ' A' ' 68' ' ' GLU . 9.3 p90 -60.24 -37.6 80.88 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.52 -0.737 . . . . 0.02 111.522 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -59.64 -24.3 63.75 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.77 -1.206 . . . . 0.02 109.491 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -71.74 -21.43 61.75 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.699 0.762 . . . . 3.4199999999999999 109.064 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.548 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 2.2 t90 -108.22 6.77 26.99 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.482 -1.303 . . . . 0.02 107.482 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 13.3 mmt 61.01 22.37 12.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.646 -0.659 . . . . 0.02 110.832 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.83 145.78 47.71 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.293 -1.523 . . . . 0.02 109.293 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.455 HD13 ' OH ' ' A' ' 59' ' ' TYR . 7.6 mp -80.29 -31.14 38.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.225 -1.162 . . . . 0.97999999999999998 108.336 178.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -157.6 -171.86 3.73 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.635 -1.617 . . . . 0.02 106.635 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -98.62 28.53 4.17 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.723 -1.235 . . . . 0.02 110.613 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.587 HH11 ' CG ' ' A' ' 78' ' ' ARG . 3.3 mtt-85 -97.47 122.51 40.61 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.082 -1.011 . . . . 3.2000000000000002 110.849 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.514 HD22 ' HB ' ' A' ' 48' ' ' VAL . 34.9 mt -143.65 121.89 12.26 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.684 -1.228 . . . . 2.6099999999999999 107.684 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.83 -17.53 9.62 Favored Glycine 0 N--CA 1.504 3.184 0 O-C-N 121.078 -1.014 . . . . 0.02 112.981 -177.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.1 p -156.82 156.12 32.68 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.082 -1.834 . . . . 0.02 110.365 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 33.7 m -144.68 147.9 33.58 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.522 -0.736 . . . . 0.02 110.221 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 24.6 mtm180 -138.24 142.95 39.92 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.255 -0.903 . . . . 0.01 109.42 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.95 131.55 36.39 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.107 -0.995 . . . . 0.42999999999999999 109.85 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.5 t -90.8 124.9 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.809 -0.811 . . . . 1.25 108.809 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -93.79 131.77 38.84 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.81 -1.181 . . . . 1.77 109.339 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.5 mt -96.38 140.19 31.41 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.408 -0.96 . . . . 1.6299999999999999 108.408 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.2 m -111.73 127.17 55.7 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.374 -0.829 . . . . 1.0800000000000001 109.313 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.3 m -103.56 -154.89 0.51 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 106.425 -1.694 . . . . 1.26 106.425 176.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.53 -52.36 0.74 Allowed Glycine 0 N--CA 1.5 2.942 0 O-C-N 120.404 -1.435 . . . . 0.01 112.772 177.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.44 -101.52 0.15 Allowed Glycine 0 N--CA 1.489 2.193 0 C-N-CA 118.533 -1.794 . . . . 0.01 111.942 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -121.0 119.41 32.45 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.09 -1.241 . . . . 4.4299999999999997 110.549 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.08 129.48 35.26 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.808 -0.757 . . . . 2.9900000000000002 109.355 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -129.9 140.55 50.94 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.559 -0.713 . . . . 6.3600000000000003 109.172 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.8 tt -129.6 146.42 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 O-C-N 121.36 -0.837 . . . . 1.0900000000000001 110.157 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -122.2 133.86 54.72 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 107.558 -1.275 . . . . 2.0499999999999998 107.558 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.4 m -123.73 145.73 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 120.729 -1.232 . . . . 1.1000000000000001 109.829 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.587 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 39.6 m-85 -119.88 141.62 49.41 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-O 122.02 0.915 . . . . 0.72999999999999998 111.158 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -67.37 -31.04 71.0 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 116.025 -0.534 . . . . 0.02 111.776 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -115.9 167.44 10.95 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.912 -1.118 . . . . 3.1800000000000002 110.46 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.96 164.12 43.87 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 111.005 -0.838 . . . . 0.01 111.005 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.0 t70 56.75 39.11 29.83 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.656 0.741 . . . . 0.01 110.927 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 52.1 55.74 8.77 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.577 -0.702 . . . . 0.01 111.085 177.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -129.24 165.7 20.86 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 108.304 -0.999 . . . . 3.1499999999999999 108.304 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.36 -163.42 27.59 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.31 -1.516 . . . . 0.01 109.31 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.523 ' OE1' ' CE2' ' A' ' 108' ' ' TYR . 10.4 tm0? -75.94 143.62 41.51 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.946 -1.326 . . . . 0.01 108.459 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.587 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 33.2 ttp -116.33 142.36 46.95 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.492 0.663 . . . . 0.01 109.774 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.523 ' CE2' ' OE1' ' A' ' 106' ' ' GLN . 49.3 m-85 -131.39 136.54 48.11 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.197 -1.038 . . . . 2.48 108.197 178.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -117.73 133.59 55.78 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.558 -0.714 . . . . 0.01 109.959 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.1 t -148.47 149.24 31.32 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.352 1.072 . . . . 1.6899999999999999 111.223 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.1 p -110.05 10.17 24.12 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.38 -0.827 . . . . 0.01 110.122 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 42.0 mp0 -121.42 163.36 18.86 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.253 -0.904 . . . . 3.21 111.694 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.54 156.46 36.67 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.153 -1.054 . . . . 0.01 108.153 178.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 48.2 t -124.84 112.36 27.12 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 121.429 -0.795 . . . . 0.01 109.077 178.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -76.52 -33.17 3.32 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 CA-C-N 120.073 1.062 . . . . 0.01 111.515 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.7 m -140.73 107.12 5.27 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.22 -0.925 . . . . 0.02 108.585 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 76.0 mt -64.92 -38.82 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.854 -0.529 . . . . 1.8300000000000001 111.037 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 34.2 ttp -66.95 -38.47 86.18 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 118.902 -1.119 . . . . 1.3400000000000001 109.95 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.85 -38.16 79.59 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.381 -1.45 . . . . 2.1099999999999999 109.723 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -79.68 -47.35 15.5 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.358 -0.839 . . . . 2.0800000000000001 112.322 -177.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -112.37 -0.67 15.3 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.39 -0.819 . . . . 0.02 112.832 -176.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 61.71 34.74 17.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.743 -1.223 . . . . 0.02 109.846 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 43.6 mt -114.09 136.15 53.24 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.453 -0.78 . . . . 0.02 109.442 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -90.59 -22.12 21.4 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.142 -0.974 . . . . 5.3200000000000003 110.768 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -147.99 164.26 34.34 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.015 -1.053 . . . . 0.02 109.948 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.1 mm -129.2 125.94 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 107.784 -1.191 . . . . 2.1699999999999999 107.784 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 -108.74 -13.97 14.69 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.175 -0.953 . . . . 0.02 112.599 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.6 m -160.07 151.35 19.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.754 -1.216 . . . . 0.01 109.072 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.538 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 19.6 p -167.5 146.11 4.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.316 -0.865 . . . . 1.22 109.057 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.3 111.02 14.05 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-O 122.151 0.977 . . . . 1.4099999999999999 110.27 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.6 p -112.84 137.71 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.03 -1.1 . . . . 0.01 108.03 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.8 t -128.32 93.65 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 106.768 -1.567 . . . . 1.98 106.768 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 134' ' ' GLY . 10.4 tm-20 -146.55 -77.69 0.18 Allowed 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 105.827 -1.916 . . . . 0.01 105.827 177.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.512 ' N ' ' OE1' ' A' ' 133' ' ' GLU . . . -177.63 -80.39 0.06 OUTLIER Glycine 0 N--CA 1.485 1.916 0 N-CA-C 108.263 -1.935 . . . . 0.01 108.263 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.496 ' OG1' HD12 ' A' ' 175' ' ' ILE . 1.1 t -120.72 127.3 51.89 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.559 -0.965 . . . . 2.2999999999999998 110.161 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -127.3 152.24 47.7 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 106.907 -1.516 . . . . 0.01 106.907 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.5 mt -121.0 136.99 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 120.427 -1.421 . . . . 1.6899999999999999 110.088 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -113.62 143.95 43.72 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.34 -1.355 . . . . 2.4900000000000002 107.34 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.436 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 26.3 m-85 -122.42 144.71 48.87 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.292 -0.88 . . . . 0.02 109.297 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.436 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 78.0 tt0 -76.46 -29.0 56.76 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.501 -0.749 . . . . 0.02 111.705 -176.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.0 mt -115.95 154.67 48.37 Favored Pre-proline 0 N--CA 1.505 2.282 0 O-C-N 120.751 -1.218 . . . . 1.48 108.806 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -55.69 167.37 2.19 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 121.213 1.275 . . . . 0.02 112.794 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 59.47 31.14 20.83 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.147 -0.933 . . . . 0.75 111.408 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 57.28 51.25 10.33 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.534 -0.729 . . . . 0.02 110.993 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -126.1 164.62 20.5 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.545 -0.722 . . . . 0.02 109.938 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.18 -165.84 33.12 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.283 -1.127 . . . . 0.02 110.283 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.429 HH11 ' HG3' ' A' ' 147' ' ' ARG . 23.5 ttm-85 -69.34 142.6 53.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.51 -0.994 . . . . 0.02 109.067 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.464 ' CD ' ' N ' ' A' ' 148' ' ' GLN . 7.9 mp0 -114.8 148.52 38.32 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.343 0.592 . . . . 0.02 110.184 -178.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -124.78 135.61 53.11 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 109.048 -0.723 . . . . 0.01 109.048 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.502 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.7 tt -99.45 120.28 39.35 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.889 -1.132 . . . . 0.01 108.846 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.618 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 54.0 tp -101.85 154.06 19.27 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.256 -0.903 . . . . 0.01 109.066 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -104.71 -121.18 0.21 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.233 -0.917 . . . . 2.27 109.432 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.7 pttm -155.56 51.6 0.57 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.043 -1.036 . . . . 1.8400000000000001 109.608 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -112.48 -152.99 0.51 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.496 -0.753 . . . . 2.2799999999999998 109.068 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -106.39 100.21 9.75 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.385 -0.822 . . . . 0.01 109.045 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.68 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 6.7 m-85 -98.33 112.03 24.17 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.269 -0.894 . . . . 0.01 109.464 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -94.45 -22.52 18.22 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.242 -0.911 . . . . 0.01 111.448 -178.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -129.14 154.1 80.45 Favored Pre-proline 0 N--CA 1.502 2.167 0 O-C-N 120.758 -1.214 . . . . 2.54 108.808 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -59.46 -36.19 94.17 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 120.507 0.805 . . . . 0.69999999999999996 110.795 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 60.5 t -61.02 -20.2 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.758 -1.214 . . . . 0.85999999999999999 108.909 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -65.21 -15.31 62.32 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.882 -1.136 . . . . 0.02 109.691 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.68 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 11.5 m0 -98.06 11.06 38.88 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.254 -0.904 . . . . 0.02 109.067 178.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.81 11.45 83.9 Favored Glycine 0 N--CA 1.491 2.336 0 O-C-N 120.829 -1.169 . . . . 0.02 111.213 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.03 140.6 34.03 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.056 -1.261 . . . . 0.02 110.076 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -86.02 -8.77 57.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.566 -0.709 . . . . 0.58999999999999997 110.322 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 9.7 p -141.41 150.97 59.74 Favored Pre-proline 0 N--CA 1.5 2.051 0 O-C-N 121.019 -1.05 . . . . 0.87 109.712 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -75.88 14.62 1.02 Allowed 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 120.908 1.072 . . . . 0.38 112.142 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.72 122.07 27.19 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.361 1.077 . . . . 0.17999999999999999 111.212 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 3.8 mt -148.97 122.98 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 105.89 -1.892 . . . . 3.9900000000000002 105.89 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.53 ' OE1' ' N ' ' A' ' 170' ' ' GLN . 13.9 mp0 -112.95 -15.69 12.82 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.115 -0.99 . . . . 5.1699999999999999 113.07 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 12.8 t -156.31 159.57 38.95 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 119.328 -2.107 . . . . 0.02 109.941 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -153.08 154.12 34.21 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.039 -1.038 . . . . 2.02 110.689 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -145.24 149.93 35.78 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.776 0.798 . . . . 0.01 110.12 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -88.11 143.29 27.15 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.132 -0.692 . . . . 0.01 109.132 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.496 HD12 ' OG1' ' A' ' 135' ' ' THR . 6.7 mt -94.48 129.71 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.266 -0.896 . . . . 3.04 109.024 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.3 m -136.29 147.04 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.158 -0.964 . . . . 1.8899999999999999 109.526 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.61 ' H ' ' CD ' ' A' ' 177' ' ' GLU . 1.4 pm0 . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.89 . . . . 4.8899999999999997 109.725 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.402 0 N-CA-C 110.037 -1.225 . . . . 0.01 110.037 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.5 tttm -149.19 135.82 19.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.473 -1.016 . . . . 0.02 109.753 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.7 tt -128.24 138.34 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 108.054 -1.091 . . . . 0.02 108.054 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 m -121.5 129.99 53.28 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.325 -0.86 . . . . 0.39000000000000001 110.169 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 4.4 m-85 -110.58 141.18 44.12 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.967 -0.753 . . . . 0.02 108.967 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.546 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.7 m-85 -122.35 138.43 54.52 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.223 -0.923 . . . . 0.02 109.53 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.484 ' HG3' HD11 ' A' ' 33' ' ' LEU . 90.4 mt-10 -67.91 -27.78 66.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.99 -1.069 . . . . 0.029999999999999999 111.409 -178.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 2.4 m-20 -114.62 170.24 8.47 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.844 -1.16 . . . . 0.029999999999999999 110.22 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -75.85 162.1 28.43 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.794 0.807 . . . . 0.029999999999999999 110.241 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.432 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 0.1 OUTLIER 62.76 33.09 15.68 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.106 0.955 . . . . 0.73999999999999999 110.836 179.394 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 55.22 39.81 31.48 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.841 -0.618 . . . . 0.02 110.973 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -110.11 165.65 11.57 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.18 -1.044 . . . . 0.02 108.18 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.82 -168.07 35.49 Favored Glycine 0 N--CA 1.497 2.708 0 C-N-CA 119.827 -1.178 . . . . 0.029999999999999999 110.748 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -69.45 143.87 53.45 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.483 -1.01 . . . . 2.7599999999999998 109.239 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -120.67 148.95 43.25 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.584 0.707 . . . . 1.8899999999999999 110.214 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -132.09 127.56 36.31 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.189 -1.041 . . . . 0.02 108.189 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.52 136.71 51.72 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.434 -0.791 . . . . 1.1200000000000001 109.888 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 13.3 t -131.26 139.22 49.6 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.665 -0.647 . . . . 0.02 109.557 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.497 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 2.5 m-20 -116.83 11.13 14.38 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.71 -0.619 . . . . 0.20000000000000001 109.694 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 47.5 m -158.23 174.76 14.68 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.263 -1.014 . . . . 1.23 108.263 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 3.5 m-20 -60.57 144.32 51.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.644 -1.285 . . . . 0.02 109.899 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 41.9 t -132.01 117.82 18.9 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.577 -0.897 . . . . 0.02 108.577 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.87 -25.26 48.48 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.168 -0.958 . . . . 0.23999999999999999 110.922 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -154.31 102.87 2.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.931 -1.106 . . . . 1.1399999999999999 109.274 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.433 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 43.6 p90 -102.06 9.95 39.93 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 122.019 0.914 . . . . 6.3700000000000001 109.788 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.3 mtm180 -59.43 -25.46 64.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.475 -0.765 . . . . 3.1099999999999999 111.505 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.9 p -76.05 -17.68 59.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.58 -1.325 . . . . 0.88 110.769 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -104.07 -22.17 13.48 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.335 -0.853 . . . . 0.02 109.589 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.484 HD11 ' HG3' ' A' ' 11' ' ' GLU . 6.4 tp -150.4 129.44 12.63 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.278 -0.889 . . . . 3.3199999999999998 108.967 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.7 p -85.24 -9.92 57.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.8 -0.563 . . . . 0.02 111.129 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -171.46 162.78 6.71 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.77 -1.206 . . . . 0.02 108.015 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.1 p -143.55 115.23 8.16 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.827 -1.17 . . . . 0.02 108.66 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -107.54 2.08 23.83 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 120.756 -1.215 . . . . 0.029999999999999999 110.881 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.1 t -155.54 154.84 32.37 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.821 -1.177 . . . . 0.02 107.821 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 39' ' ' ILE . 10.4 mt -146.29 146.58 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.951 -1.093 . . . . 0.02 110.654 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -123.68 124.82 43.6 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.159 -1.052 . . . . 0.02 108.159 177.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.5 t -106.6 115.19 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 106.803 -1.554 . . . . 0.02 106.803 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -83.98 -33.85 24.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.636 -0.665 . . . . 3.8100000000000001 110.759 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.79 152.38 22.26 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 118.821 -1.656 . . . . 0.02 110.807 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.26 173.21 49.53 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.62 -1.276 . . . . 0.01 110.474 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.2 m -119.68 135.4 54.84 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.983 -1.118 . . . . 1.48 107.983 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.458 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 32.9 m95 -126.35 155.26 42.33 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-O 122.573 1.178 . . . . 0.02 112.263 -176.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.5 134.16 52.22 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 105.509 -2.034 . . . . 0.23999999999999999 105.509 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.5 ' HB ' HD22 ' A' ' 79' ' ' LEU . 27.2 m -118.96 143.3 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.154 -0.684 . . . . 0.65000000000000002 109.154 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.565 ' CE2' ' SD ' ' A' ' 58' ' ' MET . 28.1 m-85 -121.41 146.32 47.01 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 122.386 1.089 . . . . 0.02 110.046 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -66.2 -35.1 79.57 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.509 -0.769 . . . . 0.02 111.228 -177.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -125.36 157.67 66.89 Favored Pre-proline 0 N--CA 1.503 2.182 0 O-C-N 121.051 -1.03 . . . . 0.02 109.498 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -53.63 167.3 1.0 Allowed 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.704 1.602 . . . . 0.02 112.958 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 63.68 36.53 10.72 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 114.999 -1.0 . . . . 0.02 111.182 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 45.15 51.54 9.01 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.631 0.729 . . . . 3.3900000000000001 110.612 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.0 t -126.29 163.78 22.46 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 121.201 0.524 . . . . 2.3300000000000001 109.804 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.61 -161.57 32.4 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.738 -1.345 . . . . 0.02 109.738 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.98 140.34 57.72 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.054 -1.263 . . . . 0.02 110.346 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.565 ' SD ' ' CE2' ' A' ' 49' ' ' TYR . 49.2 ttp -118.84 138.17 52.91 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.691 -0.631 . . . . 5.0099999999999998 109.827 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.49 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 56.1 m-85 -133.66 137.06 45.15 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.492 -0.755 . . . . 0.02 109.695 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.8 mm -94.74 131.09 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.912 -0.773 . . . . 1.72 108.912 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.561 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -119.21 110.56 37.67 Favored Pre-proline 0 N--CA 1.505 2.277 0 O-C-N 121.461 -0.775 . . . . 0.02 110.73 -178.316 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -77.63 168.32 22.74 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 CA-C-N 119.791 0.961 . . . . 1.47 110.068 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -53.16 141.74 22.4 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.757 -1.214 . . . . 4.25 110.35 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.27 -177.96 31.37 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.584 -1.293 . . . . 0.02 110.844 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -119.65 131.8 55.54 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.393 -1.063 . . . . 0.95999999999999996 109.692 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.561 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 69.9 m-85 -122.04 96.07 46.96 Favored Pre-proline 0 N--CA 1.494 1.755 0 N-CA-C 108.015 -1.105 . . . . 0.02 108.015 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.28 -4.38 10.43 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 120.811 1.007 . . . . 0.02 113.729 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -157.61 155.44 30.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.603 -1.311 . . . . 2.02 108.229 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -60.46 -39.17 86.59 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.535 -0.728 . . . . 0.02 112.17 -177.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -60.34 -23.82 64.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.132 -0.98 . . . . 0.02 110.373 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -69.37 -18.45 63.78 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.764 0.793 . . . . 3.4199999999999999 108.982 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.553 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.4 t90 -108.38 11.06 27.35 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.584 -1.265 . . . . 0.02 107.584 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.6 mmt 60.74 22.09 12.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.585 -0.697 . . . . 0.02 110.553 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.68 143.7 44.6 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.319 -1.512 . . . . 0.02 109.319 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.3 tp -78.79 -31.51 46.04 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.452 -1.314 . . . . 0.97999999999999998 107.452 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -157.87 -172.47 3.94 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 106.262 -1.755 . . . . 0.02 106.262 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -98.44 28.39 4.18 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.659 -1.276 . . . . 0.02 110.627 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.434 HH11 ' HG3' ' A' ' 78' ' ' ARG . 20.9 ttm-85 -97.23 122.05 39.81 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.725 -1.234 . . . . 3.2000000000000002 110.905 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.5 HD22 ' HB ' ' A' ' 48' ' ' VAL . 35.1 mt -144.14 122.8 12.55 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.566 -1.272 . . . . 2.6099999999999999 107.566 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.17 -16.9 10.62 Favored Glycine 0 N--CA 1.504 3.189 0 O-C-N 121.024 -1.048 . . . . 0.02 112.814 -177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 73.3 p -156.8 156.34 33.08 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.22 -1.753 . . . . 0.02 110.299 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 28.4 p -143.84 147.29 33.87 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.481 -0.762 . . . . 0.02 110.038 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.5 mtm180 -138.25 143.15 39.96 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.469 -0.769 . . . . 0.01 109.644 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.26 132.54 36.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.42999999999999999 109.829 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.6 t -91.29 125.16 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.863 -0.791 . . . . 1.25 108.863 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -94.1 131.79 39.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.831 -1.168 . . . . 1.77 109.298 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.9 mt -96.38 140.15 31.45 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.312 -0.867 . . . . 1.6299999999999999 108.855 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.1 t -111.57 127.1 55.62 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.449 -0.782 . . . . 1.0800000000000001 109.092 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.5 p -103.56 -154.94 0.51 Allowed 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 106.485 -1.672 . . . . 1.26 106.485 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.96 -53.14 0.73 Allowed Glycine 0 N--CA 1.5 2.9 0 O-C-N 120.366 -1.459 . . . . 0.01 112.684 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -179.53 -101.72 0.15 Allowed Glycine 0 N--CA 1.489 2.221 0 C-N-CA 118.605 -1.76 . . . . 0.01 112.029 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -121.19 119.45 32.37 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.098 -1.236 . . . . 4.4299999999999997 110.72 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.87 130.59 35.82 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.822 -0.751 . . . . 2.9900000000000002 109.294 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -131.03 141.81 50.25 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.483 -0.761 . . . . 6.3600000000000003 108.964 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.8 tt -129.28 146.66 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.366 -0.834 . . . . 1.0900000000000001 110.038 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -122.01 133.68 54.81 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.766 -1.198 . . . . 2.0499999999999998 107.766 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.46 HG12 ' SG ' ' A' ' 129' ' ' CYS . 25.2 m -123.42 145.56 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 120.788 -1.195 . . . . 1.1000000000000001 109.736 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.594 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 32.2 m-85 -118.7 141.19 48.84 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 122.016 0.913 . . . . 0.72999999999999998 110.716 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -66.2 -30.21 70.63 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.995 -0.548 . . . . 0.02 111.295 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -116.54 170.16 8.78 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.099 -1.001 . . . . 3.1800000000000002 110.412 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.02 170.37 44.26 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.742 -0.943 . . . . 0.01 110.742 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 52.91 38.94 28.25 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.527 0.68 . . . . 0.01 111.587 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.424 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 24.7 m-85 51.8 49.17 21.35 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.525 -0.734 . . . . 0.01 111.059 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -123.62 165.59 16.94 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.322 -0.992 . . . . 3.1499999999999999 108.322 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.72 -163.79 27.36 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.519 -1.432 . . . . 0.01 109.519 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.4 tp60 -76.75 144.56 39.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.028 -1.277 . . . . 0.01 108.497 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.594 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 12.6 ttt -116.01 141.53 48.0 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.658 0.742 . . . . 0.01 109.801 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -131.0 136.42 48.5 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.069 -1.086 . . . . 2.48 108.069 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -118.89 133.7 55.66 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.52 -0.738 . . . . 0.01 110.117 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 t -148.17 149.41 31.92 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 122.318 1.056 . . . . 1.6899999999999999 110.962 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.0 p -111.33 9.95 21.59 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 115.501 -0.772 . . . . 0.01 110.336 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.468 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 23.6 mp0 -121.11 163.12 18.89 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.214 -0.929 . . . . 3.21 111.491 -178.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.74 156.61 37.98 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.471 -0.937 . . . . 0.01 108.471 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 19.6 t -127.15 113.67 21.67 Favored Pre-proline 0 N--CA 1.501 2.088 0 N-CA-C 108.749 -0.834 . . . . 0.01 108.749 178.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -74.52 -29.17 9.41 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 CA-C-N 120.446 1.195 . . . . 0.01 111.034 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 7.8 p -142.34 109.12 5.41 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.444 -0.785 . . . . 0.02 109.074 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.429 HD12 ' O ' ' A' ' 169' ' ' ILE . 97.6 mt -63.81 -38.74 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.884 -0.51 . . . . 1.8300000000000001 110.653 -178.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 118' ' ' MET . 12.4 tmm? -68.52 -37.74 80.27 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.255 -0.978 . . . . 1.3400000000000001 110.208 -178.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -69.53 -38.27 77.46 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.48 -1.388 . . . . 2.1099999999999999 109.958 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -79.78 -47.21 15.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.238 -0.914 . . . . 2.0800000000000001 112.381 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -111.39 0.41 16.59 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.299 -0.875 . . . . 0.02 112.647 -176.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 59.98 33.48 21.42 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.749 -1.219 . . . . 0.02 109.529 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.3 mt -112.09 135.54 52.62 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.718 -0.845 . . . . 0.02 108.718 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -91.61 -22.9 20.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.17 -0.956 . . . . 5.3200000000000003 110.24 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -149.48 164.28 35.46 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.159 -0.963 . . . . 0.02 109.88 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 35.0 mt -131.89 129.0 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 107.654 -1.239 . . . . 2.1699999999999999 107.654 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 61.2 m80 -108.09 -11.95 15.2 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.364 -0.835 . . . . 0.02 112.314 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.424 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 2.7 t -159.01 151.14 21.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.915 -1.115 . . . . 0.01 108.871 178.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.46 ' SG ' HG12 ' A' ' 97' ' ' VAL . 5.7 t -168.43 144.05 3.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 1.22 108.873 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.7 tttm -125.57 109.33 12.53 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 122.509 1.147 . . . . 1.4099999999999999 109.963 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 131' ' ' VAL . 7.5 p -111.32 135.86 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.184 -1.413 . . . . 0.01 107.184 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 72.1 t -126.68 93.31 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 106.788 -1.56 . . . . 1.98 106.788 177.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.428 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 54.2 tp10 -147.13 -75.3 0.19 Allowed 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 105.781 -1.933 . . . . 0.01 105.781 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 152.82 -53.79 0.46 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.567 -1.413 . . . . 0.01 109.567 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.67 ' HB ' HD12 ' A' ' 175' ' ' ILE . 72.4 p -120.16 99.79 6.81 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.494 -1.004 . . . . 2.2999999999999998 111.348 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.428 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 8.4 m95 -128.64 145.37 51.17 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 107.572 -1.27 . . . . 0.01 107.572 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.416 ' CG1' HD11 ' A' ' 175' ' ' ILE . 56.8 mt -121.01 137.93 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 120.662 -1.274 . . . . 1.6899999999999999 110.37 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.4 ' CE1' HD22 ' A' ' 151' ' ' LEU . 49.7 m-85 -114.92 144.72 43.11 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 106.935 -1.506 . . . . 2.4900000000000002 106.935 177.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.531 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 10.3 m-85 -124.2 144.32 50.0 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.411 -0.806 . . . . 0.02 109.857 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.42 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 38.7 tt0 -74.13 -29.08 61.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.687 -0.633 . . . . 0.02 111.874 -176.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.5 mt -115.74 154.56 48.08 Favored Pre-proline 0 N--CA 1.504 2.241 0 O-C-N 120.735 -1.228 . . . . 1.48 108.997 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -55.81 167.38 2.28 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.113 1.209 . . . . 0.02 112.726 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.1 m120 59.64 31.15 20.73 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.215 -0.902 . . . . 0.75 111.391 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 57.91 51.51 8.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.46 -0.775 . . . . 0.02 111.171 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -126.92 164.86 20.52 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.454 -0.779 . . . . 0.02 110.1 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.46 -165.95 32.82 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 110.414 -1.074 . . . . 0.02 110.414 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -69.37 142.73 53.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.554 -0.968 . . . . 0.02 108.883 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -114.69 148.94 37.54 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.339 0.59 . . . . 0.02 110.123 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.437 ' CD1' ' N ' ' A' ' 149' ' ' TYR . 13.0 m-85 -124.84 135.03 52.55 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 109.169 -0.678 . . . . 0.01 109.169 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.1 tt -100.36 122.42 43.1 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.907 -1.121 . . . . 0.01 109.021 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.4 HD22 ' CE1' ' A' ' 138' ' ' PHE . 6.1 mp -97.19 164.25 12.57 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.072 -1.018 . . . . 0.01 108.656 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -108.2 -101.71 0.37 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.462 -0.773 . . . . 2.27 109.527 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -172.99 43.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 1.8400000000000001 109.617 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -112.41 -156.55 0.59 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.524 -0.735 . . . . 2.2799999999999998 109.343 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -106.86 108.23 19.64 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.445 -0.785 . . . . 0.01 109.196 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.632 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 37.1 m-85 -98.92 113.58 25.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.343 -0.848 . . . . 0.01 109.532 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -94.62 -22.72 17.99 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.149 -0.97 . . . . 0.01 111.596 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -127.49 154.94 77.45 Favored Pre-proline 0 N--CA 1.503 2.187 0 O-C-N 120.916 -1.115 . . . . 2.54 108.775 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -60.7 -37.97 75.0 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 CA-C-N 119.317 0.792 . . . . 0.69999999999999996 110.543 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 95.7 t -61.04 -19.92 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.842 -1.161 . . . . 0.85999999999999999 109.259 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -65.26 -15.34 62.39 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.901 -1.125 . . . . 0.02 110.023 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.632 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 8.8 m0 -97.65 11.68 36.22 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.096 -1.003 . . . . 0.02 109.152 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.52 10.72 84.94 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.827 -1.178 . . . . 0.02 111.127 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.39 140.61 33.32 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.081 -1.246 . . . . 0.02 110.008 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.18 -8.92 58.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.708 -0.62 . . . . 0.58999999999999997 110.025 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 4.6 m -143.26 150.03 50.51 Favored Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.033 -1.042 . . . . 0.87 109.013 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.5 17.68 0.64 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 120.583 0.855 . . . . 0.38 112.102 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.31 123.25 28.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.851 -1.155 . . . . 0.17999999999999999 111.524 -177.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.429 ' O ' HD12 ' A' ' 117' ' ' ILE . 1.5 mt -150.04 126.32 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 106.714 -1.588 . . . . 3.9900000000000002 106.714 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 170' ' ' GLN . 10.8 mp0 -112.3 -16.83 12.88 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.082 -1.011 . . . . 5.1699999999999999 113.059 -177.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.7 p -157.33 160.77 38.85 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 119.162 -2.211 . . . . 0.02 110.242 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.414 ' CD1' ' C ' ' A' ' 172' ' ' PHE . 21.1 p90 -152.4 152.65 32.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.074 -1.016 . . . . 2.02 110.521 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -144.85 149.84 36.08 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.467 -0.77 . . . . 0.01 109.698 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.408 HH21 HG11 ' A' ' 176' ' ' VAL . 41.2 ttp180 -87.17 140.87 29.11 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.246 -0.65 . . . . 0.01 109.246 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.67 HD12 ' HB ' ' A' ' 135' ' ' THR . 31.4 mt -92.47 129.44 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.14 -0.975 . . . . 3.04 108.839 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.408 HG11 HH21 ' A' ' 174' ' ' ARG . 12.9 m -136.76 148.04 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.244 -0.91 . . . . 1.8899999999999999 109.793 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 4.8899999999999997 109.529 179.925 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.603 -1.399 . . . . 0.01 109.603 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.519 ' CB ' ' NZ ' ' A' ' 6' ' ' LYS . 5.5 ttpm? -146.41 135.68 22.79 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.263 -1.139 . . . . 0.02 110.43 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.7 tt -129.77 139.85 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.256 -1.016 . . . . 0.02 108.256 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 m -120.7 129.48 53.68 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.337 -0.852 . . . . 0.39000000000000001 110.065 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -109.8 139.46 44.83 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.846 -0.798 . . . . 0.02 108.846 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.551 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.6 m-85 -122.07 138.44 54.44 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.258 -0.901 . . . . 0.02 109.731 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.449 ' HG3' HD11 ' A' ' 33' ' ' LEU . 94.6 mt-10 -69.29 -27.5 65.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.029999999999999999 111.575 -178.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -114.36 169.5 8.99 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.894 -1.129 . . . . 0.029999999999999999 110.242 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -75.44 158.56 32.48 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.663 0.744 . . . . 0.029999999999999999 110.105 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.417 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 46.4 t30 66.13 33.48 7.43 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.954 0.883 . . . . 0.73999999999999999 111.16 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.417 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 1.0 OUTLIER 55.42 41.63 30.82 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 116.053 -0.521 . . . . 0.02 111.161 177.901 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -113.46 166.15 11.78 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.374 -0.973 . . . . 0.02 108.374 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.9 -167.29 36.33 Favored Glycine 0 N--CA 1.494 2.539 0 C-N-CA 119.927 -1.13 . . . . 0.029999999999999999 110.765 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -69.06 142.0 54.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.524 -0.986 . . . . 2.7599999999999998 109.302 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -120.48 149.09 42.94 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.625 0.726 . . . . 1.8899999999999999 110.144 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -132.73 127.55 34.96 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.325 -0.991 . . . . 0.02 108.325 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 23.0 p-10 -112.57 136.85 51.62 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.412 -0.805 . . . . 1.1200000000000001 109.733 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.2 t -131.07 138.83 49.75 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.678 -0.639 . . . . 0.02 109.626 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.494 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 2.6 p30 -116.41 11.06 14.83 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.529 -0.732 . . . . 0.20000000000000001 109.817 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 43.1 m -158.38 174.66 14.79 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.318 -0.993 . . . . 1.23 108.318 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -60.8 144.16 53.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.714 -1.242 . . . . 0.02 109.916 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.5 p -131.57 117.16 18.36 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.594 -0.891 . . . . 0.02 108.594 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.03 -25.43 47.86 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.107 -0.996 . . . . 0.23999999999999999 110.799 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -154.33 101.17 2.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.977 -1.077 . . . . 1.1399999999999999 108.948 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -105.33 9.42 33.85 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.103 0.954 . . . . 6.3700000000000001 109.788 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -58.52 -23.93 59.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.492 -0.755 . . . . 3.1099999999999999 110.865 -178.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 53.6 p -74.58 -16.28 60.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.739 -1.226 . . . . 0.88 110.328 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -104.63 -22.14 13.29 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.462 -0.774 . . . . 0.02 109.63 -179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.449 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.7 tp -150.56 129.22 12.31 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.15 -0.969 . . . . 3.3199999999999998 109.287 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.0 p -86.83 -10.41 53.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.657 -0.652 . . . . 0.02 111.69 -178.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.522 HH21 ' ND2' ' A' ' 37' ' ' ASN . 42.7 ttt180 -170.36 161.34 8.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.811 -1.181 . . . . 0.02 107.963 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.412 ' SG ' HD23 ' A' ' 33' ' ' LEU . 4.1 m -141.96 115.27 8.9 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.702 -1.249 . . . . 0.02 109.642 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.523 ' ND2' ' OD2' ' A' ' 77' ' ' ASP . 0.8 OUTLIER -107.88 0.14 21.87 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.837 -1.165 . . . . 0.029999999999999999 110.801 -178.893 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.1 t -156.31 154.58 30.86 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.039 -1.097 . . . . 0.02 108.039 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.4 mt -146.42 147.31 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.132 -0.98 . . . . 0.02 110.477 -178.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -123.53 124.4 42.76 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.189 -1.041 . . . . 0.02 108.189 177.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.8 t -106.54 115.04 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 106.921 -1.511 . . . . 0.02 106.921 177.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -83.76 -33.64 24.98 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.939 -0.705 . . . . 3.8100000000000001 110.643 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.7 152.11 21.89 Favored Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.009 -1.567 . . . . 0.02 110.831 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.57 172.98 49.4 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.517 -1.325 . . . . 0.01 110.522 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.5 m -119.7 135.28 54.89 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 108.019 -1.104 . . . . 1.48 108.019 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.42 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 36.1 m95 -126.94 155.58 42.86 Favored 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 122.486 1.136 . . . . 0.02 112.112 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.39 134.05 52.31 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 105.573 -2.01 . . . . 0.23999999999999999 105.573 176.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.513 ' HB ' HD22 ' A' ' 79' ' ' LEU . 29.3 m -118.6 143.59 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.584 -0.697 . . . . 0.65000000000000002 109.226 178.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -121.46 145.93 47.42 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 122.427 1.108 . . . . 0.02 110.335 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -66.35 -33.93 76.82 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.678 -0.692 . . . . 0.02 111.198 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.8 mtp180 -125.41 157.85 66.4 Favored Pre-proline 0 N--CA 1.502 2.16 0 O-C-N 121.046 -1.034 . . . . 0.02 109.515 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -53.74 166.97 1.15 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.742 1.628 . . . . 0.02 113.0 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 64.03 36.53 9.84 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.214 -0.903 . . . . 0.02 111.175 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 45.31 51.88 9.13 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.638 0.732 . . . . 3.3900000000000001 110.593 178.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.3 p -126.51 163.84 22.5 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.167 0.508 . . . . 2.3300000000000001 109.87 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.37 -162.12 31.81 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.766 -1.334 . . . . 0.02 109.766 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 21.8 m80 -65.52 138.27 57.96 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.035 -1.274 . . . . 0.02 110.066 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 20.6 ptm -118.12 137.21 53.1 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.326 0.584 . . . . 5.0099999999999998 109.583 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.562 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 86.9 m-85 -133.98 138.67 45.58 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.419 -0.801 . . . . 0.02 109.752 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.1 mm -95.54 131.37 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 109.089 -0.708 . . . . 1.72 109.089 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.478 HD22 ' CE1' ' A' ' 66' ' ' TYR . 12.4 mt -120.89 111.91 33.94 Favored Pre-proline 0 N--CA 1.506 2.328 0 O-C-N 121.361 -0.837 . . . . 0.02 110.962 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -77.52 169.77 20.45 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 CA-C-N 119.876 0.991 . . . . 1.47 109.871 177.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -52.9 141.19 22.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.794 -1.192 . . . . 4.25 110.211 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.42 -177.83 32.38 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.52 -1.324 . . . . 0.02 110.781 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -120.67 131.93 54.83 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.374 -1.074 . . . . 0.95999999999999996 109.832 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.478 ' CE1' HD22 ' A' ' 61' ' ' LEU . 94.7 m-85 -121.68 96.41 47.35 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 108.068 -1.086 . . . . 0.02 108.068 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.37 -3.8 10.67 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 120.796 0.997 . . . . 0.02 113.702 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -157.58 155.69 30.6 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.621 -1.3 . . . . 2.02 108.36 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -60.43 -39.29 86.93 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.54 -0.725 . . . . 0.02 112.013 -177.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -60.17 -23.37 63.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.968 -1.083 . . . . 0.02 110.279 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -70.61 -18.72 62.88 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.897 0.856 . . . . 3.4199999999999999 109.044 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.562 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.3 t90 -107.8 10.29 28.75 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.409 -1.33 . . . . 0.02 107.409 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 13.5 mmt 60.46 22.26 11.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.627 -0.671 . . . . 0.02 110.294 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.76 144.39 46.28 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.398 -1.481 . . . . 0.02 109.398 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.9 mt -78.86 -30.44 45.12 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.626 -1.25 . . . . 0.97999999999999998 107.626 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -157.11 -171.61 3.7 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 106.427 -1.694 . . . . 0.02 106.427 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.523 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 92.4 m-20 -98.82 28.37 4.35 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.733 -1.229 . . . . 0.02 110.42 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -96.91 122.62 40.09 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.005 -1.059 . . . . 3.2000000000000002 110.936 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.513 HD22 ' HB ' ' A' ' 48' ' ' VAL . 39.7 mt -143.56 120.96 11.65 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.585 -1.265 . . . . 2.6099999999999999 107.585 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.35 -17.3 10.11 Favored Glycine 0 N--CA 1.506 3.302 0 O-C-N 121.065 -1.022 . . . . 0.02 112.928 -177.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.2 t -156.99 156.46 33.0 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.159 -1.789 . . . . 0.02 110.331 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 38.6 m -145.42 148.19 33.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.453 -0.779 . . . . 0.02 110.086 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -138.14 143.12 40.17 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.308 -0.87 . . . . 0.01 109.413 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.37 132.36 36.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -0.952 . . . . 0.42999999999999999 109.68 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.4 t -91.59 125.28 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.938 -0.764 . . . . 1.25 108.938 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -95.57 129.99 42.57 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.707 -1.246 . . . . 1.77 109.274 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.6 mt -94.47 141.27 28.79 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.159 -0.963 . . . . 1.6299999999999999 108.688 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.5 m -111.21 128.14 55.82 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.386 -0.821 . . . . 1.0800000000000001 109.237 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.0 p -104.54 -153.96 0.49 Allowed 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 106.63 -1.618 . . . . 1.26 106.63 177.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.64 -52.76 0.74 Allowed Glycine 0 N--CA 1.501 3.024 0 O-C-N 120.414 -1.428 . . . . 0.01 112.807 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.35 -101.95 0.16 Allowed Glycine 0 N--CA 1.49 2.237 0 C-N-CA 118.533 -1.794 . . . . 0.01 112.108 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -121.53 119.13 31.08 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.144 -1.209 . . . . 4.4299999999999997 110.788 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.05 130.39 35.47 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.92 -0.712 . . . . 2.9900000000000002 109.267 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.473 ' CB ' ' NZ ' ' A' ' 94' ' ' LYS . 2.8 ttmp? -129.79 141.57 50.83 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.423 -0.798 . . . . 6.3600000000000003 109.149 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 110' ' ' THR . 3.8 tt -128.14 145.64 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 121.356 -0.84 . . . . 1.0900000000000001 110.465 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.541 ' OE1' ' N ' ' A' ' 96' ' ' GLN . 0.5 OUTLIER -122.32 132.29 54.33 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.382 -1.34 . . . . 2.0499999999999998 107.382 177.203 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.5 m -124.51 146.47 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 O-C-N 120.601 -1.312 . . . . 1.1000000000000001 109.746 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.577 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 71.3 m-85 -119.58 141.01 49.65 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 122.045 0.926 . . . . 0.72999999999999998 111.161 -178.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -66.12 -30.37 70.85 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 116.004 -0.544 . . . . 0.02 111.365 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -117.0 170.57 8.53 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.13 -0.981 . . . . 3.1800000000000002 110.473 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.66 169.29 45.05 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.805 -0.918 . . . . 0.01 110.805 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 23.9 t70 53.23 38.83 28.6 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.576 0.703 . . . . 0.01 111.55 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 52.14 48.8 21.95 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.503 -0.748 . . . . 0.01 110.846 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -123.28 165.55 16.77 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.215 -1.032 . . . . 3.1499999999999999 108.215 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.43 -164.29 28.03 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.302 -1.519 . . . . 0.01 109.302 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -76.84 144.57 38.97 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.053 -1.263 . . . . 0.01 108.675 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.577 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 30.3 ttp -116.74 142.57 46.74 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.638 0.732 . . . . 0.01 109.984 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -131.27 136.49 48.23 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.184 -1.043 . . . . 2.48 108.184 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -118.56 133.92 55.49 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.466 -0.771 . . . . 0.01 109.817 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.415 ' O ' HG22 ' A' ' 95' ' ' ILE . 4.5 t -148.15 149.86 32.77 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.128 0.966 . . . . 1.6899999999999999 110.965 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 p -110.44 9.97 23.31 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 115.614 -0.721 . . . . 0.01 110.168 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -121.53 163.1 19.4 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.214 -0.929 . . . . 3.21 111.901 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 9.8 p30 -68.15 157.28 35.69 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.233 -1.025 . . . . 0.01 108.233 178.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.574 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 86.2 m -125.77 112.8 24.87 Favored Pre-proline 0 N--CA 1.501 2.104 0 O-C-N 121.503 -0.748 . . . . 0.01 109.172 178.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -75.62 -30.93 5.84 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 CA-C-N 120.095 1.07 . . . . 0.01 111.042 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.4 m -141.96 106.55 4.85 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.493 -0.928 . . . . 0.02 108.493 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 95.0 mt -65.12 -38.1 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.745 -0.597 . . . . 1.8300000000000001 111.203 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.1 ttt -67.75 -37.16 81.76 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.013 -1.075 . . . . 1.3400000000000001 109.815 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -69.75 -38.34 76.77 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.493 -1.379 . . . . 2.1099999999999999 109.721 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -80.19 -47.24 14.99 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.404 -0.81 . . . . 2.0800000000000001 112.345 -177.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -110.95 -0.4 16.76 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.386 -0.821 . . . . 0.02 112.67 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.9 m170 59.86 33.44 21.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.818 -1.176 . . . . 0.02 109.58 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 11.7 mt -112.42 135.53 53.01 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 108.791 -0.818 . . . . 0.02 108.791 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -92.06 -23.09 19.6 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.256 -0.902 . . . . 5.3200000000000003 110.565 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -149.14 163.81 36.52 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.142 -0.973 . . . . 0.02 109.911 -178.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 43.2 mt -132.57 129.39 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 107.811 -1.181 . . . . 2.1699999999999999 107.811 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.5 m80 -108.96 -12.07 14.91 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.364 -0.835 . . . . 0.02 112.466 -177.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.2 t -159.26 151.21 20.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.736 -1.228 . . . . 0.01 109.239 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 28.4 p -166.5 149.61 7.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.971 -1.08 . . . . 1.22 109.295 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.434 ' O ' ' OE1' ' A' ' 96' ' ' GLN . 3.7 tmtp? -119.69 108.99 15.12 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 122.298 1.047 . . . . 1.4099999999999999 109.422 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.4 t -114.71 127.84 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 107.673 -1.232 . . . . 0.01 107.673 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.2 t -130.67 94.88 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 107.378 -1.341 . . . . 1.98 107.378 177.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.644 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 22.5 tt0 -146.39 -74.61 0.21 Allowed 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 106.128 -1.804 . . . . 0.01 106.128 177.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 167.91 -65.69 0.19 Allowed Glycine 0 N--CA 1.484 1.841 0 N-CA-C 108.697 -1.761 . . . . 0.01 108.697 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.7 p -122.87 115.15 21.48 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.52 -0.988 . . . . 2.2999999999999998 110.508 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.644 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 8.3 m95 -126.57 148.18 49.78 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 107.338 -1.356 . . . . 0.01 107.338 178.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.437 HG21 HD13 ' A' ' 137' ' ' ILE . 14.2 mt -120.4 134.67 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 120.392 -1.443 . . . . 1.6899999999999999 110.343 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.401 ' HB3' HD12 ' A' ' 169' ' ' ILE . 66.0 m-85 -114.71 143.93 44.26 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.366 -1.346 . . . . 2.4900000000000002 107.366 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.541 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 8.4 m-85 -123.65 144.78 49.41 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.373 -0.829 . . . . 0.02 109.741 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -77.36 -28.17 52.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.569 -0.707 . . . . 0.02 112.046 -176.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 47.7 mt -114.86 151.92 45.93 Favored Pre-proline 0 N--CA 1.504 2.235 0 O-C-N 120.683 -1.26 . . . . 1.48 109.143 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -52.93 166.12 1.01 Allowed 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 120.737 0.958 . . . . 0.02 112.72 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 59.25 31.19 21.0 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.111 -0.949 . . . . 0.75 111.432 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 57.24 51.47 10.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.562 -0.711 . . . . 0.02 111.298 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 51.0 mtp180 -125.96 164.46 20.77 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.499 -0.751 . . . . 0.02 109.935 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.37 -165.31 32.5 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.312 -1.115 . . . . 0.02 110.312 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -69.48 142.99 53.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.617 -0.931 . . . . 0.02 109.109 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -115.11 149.01 38.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.801 -0.562 . . . . 0.02 109.77 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -124.97 135.68 53.03 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.653 -0.654 . . . . 0.01 109.284 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.9 tp -97.07 120.61 37.74 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.648 -1.282 . . . . 0.01 109.368 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.4 tp -100.38 150.18 22.88 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.291 -0.881 . . . . 0.01 109.013 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -104.17 -108.72 0.27 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.673 -0.642 . . . . 2.27 109.374 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -167.59 54.68 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.967 -1.083 . . . . 1.8400000000000001 109.839 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -113.76 -167.51 1.22 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.523 -0.736 . . . . 2.2799999999999998 109.268 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -106.14 105.45 15.49 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.879 -0.785 . . . . 0.01 108.879 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -99.41 115.83 30.17 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.354 -0.841 . . . . 0.01 110.018 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -92.33 -25.26 18.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.993 -1.067 . . . . 0.01 110.873 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -127.5 153.73 77.42 Favored Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 108.14 -1.059 . . . . 2.54 108.14 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -58.78 -40.47 72.29 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 CA-C-N 119.502 0.858 . . . . 0.69999999999999996 110.462 178.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 5.6 t -63.09 -22.96 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.716 -1.24 . . . . 0.85999999999999999 109.821 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -66.37 -16.35 64.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.556 -1.34 . . . . 0.02 110.076 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.539 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 18.9 t90 -100.31 10.68 40.87 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.424 -0.797 . . . . 0.02 109.03 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.42 8.52 87.49 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 120.208 -0.996 . . . . 0.02 111.902 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -98.51 141.3 31.54 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.056 -1.261 . . . . 0.02 110.154 -178.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -88.66 -13.08 40.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.63 -0.669 . . . . 0.58999999999999997 110.701 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 60.6 p -147.31 150.23 37.12 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 120.717 -1.239 . . . . 0.87 108.988 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -78.6 20.25 0.79 Allowed 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 120.816 1.011 . . . . 0.38 113.085 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.17 123.86 29.95 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.446 -1.409 . . . . 0.17999999999999999 111.78 -177.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.447 HD13 ' HA ' ' A' ' 169' ' ' ILE . 11.7 mm -151.5 127.63 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 107.03 -1.47 . . . . 3.9900000000000002 107.03 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -112.07 -16.6 13.02 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 121.078 -1.014 . . . . 5.1699999999999999 113.719 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 67.2 m -156.92 160.44 39.1 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 119.124 -2.235 . . . . 0.02 110.288 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.574 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 9.8 p90 -152.74 153.28 32.9 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.131 -0.981 . . . . 2.02 111.004 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -145.12 149.57 35.26 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.469 -0.769 . . . . 0.01 110.112 -179.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -88.52 144.1 26.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.603 -0.685 . . . . 0.01 109.416 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 8.2 mt -95.74 129.44 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.212 -0.93 . . . . 3.04 109.218 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.8 m -136.37 146.97 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.189 -0.944 . . . . 1.8899999999999999 109.589 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.337 -0.852 . . . . 4.8899999999999997 109.485 -179.854 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.705 -1.358 . . . . 0.01 109.705 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -145.33 134.66 23.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.248 -1.148 . . . . 0.02 110.522 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.8 tt -129.55 139.71 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.097 -1.075 . . . . 0.02 108.097 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.524 ' OG ' ' NE ' ' A' ' 19' ' ' ARG . 1.7 t -121.99 130.19 53.1 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.336 -0.853 . . . . 0.39000000000000001 110.174 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.9 m-85 -110.61 140.37 45.01 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.919 -0.771 . . . . 0.02 108.919 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.577 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 1.9 m-85 -122.2 138.99 54.28 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.28 -0.888 . . . . 0.02 109.758 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -69.34 -27.79 65.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.075 -1.016 . . . . 0.029999999999999999 111.673 -178.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -114.0 169.16 9.21 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.956 -1.09 . . . . 0.029999999999999999 110.117 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -75.5 158.28 32.8 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.731 0.777 . . . . 0.029999999999999999 110.087 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.408 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 2.0 m-20 66.72 33.36 6.34 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.948 0.88 . . . . 0.73999999999999999 111.225 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.408 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 1.3 m-85 55.64 42.23 29.69 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.28 0.562 . . . . 0.02 111.555 177.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -113.79 165.6 12.4 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.216 -1.031 . . . . 0.02 108.216 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.46 -167.38 35.44 Favored Glycine 0 N--CA 1.494 2.504 0 C-N-CA 119.769 -1.205 . . . . 0.029999999999999999 111.023 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -68.62 141.75 55.32 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.473 -1.016 . . . . 2.7599999999999998 109.468 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.524 ' NE ' ' OG ' ' A' ' 8' ' ' SER . 54.4 ttt180 -121.09 149.16 43.16 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.609 -0.682 . . . . 1.8899999999999999 109.935 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -134.99 130.03 35.11 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 108.729 -0.841 . . . . 0.02 108.729 178.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 3.3 m-20 -110.64 136.08 50.28 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.471 -0.768 . . . . 1.1200000000000001 109.105 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.6 t -129.08 138.17 51.69 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.714 -0.616 . . . . 0.02 109.491 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -117.76 12.31 13.87 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.626 -0.671 . . . . 0.20000000000000001 110.282 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 44.4 t -159.45 174.29 14.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.949 -1.094 . . . . 1.23 108.777 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.466 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 3.3 p-10 -61.91 145.36 53.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.685 -1.26 . . . . 0.02 110.142 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.0 t -132.6 117.09 17.49 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.78 -0.822 . . . . 0.02 108.78 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.55 -23.31 50.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.308 -0.87 . . . . 0.23999999999999999 111.173 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -155.3 101.41 2.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.197 -0.939 . . . . 1.1399999999999999 108.779 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.489 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 21.2 p90 -108.02 9.65 28.44 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 122.059 0.933 . . . . 6.3700000000000001 110.504 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -59.58 -22.77 62.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.359 -0.838 . . . . 3.1099999999999999 110.663 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.0 m -74.71 -15.73 60.77 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.672 -1.267 . . . . 0.88 109.968 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -103.77 -21.32 13.7 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.587 -0.696 . . . . 0.02 109.396 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 33' ' ' LEU . 48.1 mt -149.8 129.64 13.33 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.915 0.864 . . . . 3.3199999999999998 109.519 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.4 p -85.86 -10.11 55.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.819 -0.551 . . . . 0.02 110.23 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -171.77 161.81 6.04 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.098 -1.075 . . . . 0.02 108.098 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 77.4 m -143.24 116.44 8.96 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.902 -1.124 . . . . 0.02 108.861 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.523 ' ND2' ' OD2' ' A' ' 77' ' ' ASP . 4.0 m120 -108.43 0.58 21.13 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 120.901 -1.125 . . . . 0.029999999999999999 111.429 -178.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.9 p -156.41 154.43 30.47 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.964 -1.124 . . . . 0.02 107.964 178.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.2 mt -146.81 147.77 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.188 -0.945 . . . . 0.02 110.357 -178.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -124.65 125.77 44.65 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.987 -1.116 . . . . 0.02 107.987 177.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.3 t -106.75 115.46 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 107.0 -1.481 . . . . 0.02 107.0 177.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -83.46 -33.95 25.51 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.652 -0.655 . . . . 3.8100000000000001 110.486 -178.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.94 152.21 21.97 Favored Glycine 0 N--CA 1.488 2.126 0 C-N-CA 118.917 -1.611 . . . . 0.02 110.834 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.67 173.08 49.5 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.505 -1.331 . . . . 0.01 110.374 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.5 m -119.22 134.9 54.95 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 107.844 -1.169 . . . . 1.48 107.844 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.407 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 38.1 m95 -127.54 155.52 43.65 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 122.499 1.142 . . . . 0.02 111.991 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.98 134.19 51.97 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 105.676 -1.972 . . . . 0.23999999999999999 105.676 176.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.48 ' HB ' HD22 ' A' ' 79' ' ' LEU . 27.4 m -117.76 143.06 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.629 -0.67 . . . . 0.65000000000000002 109.213 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -120.97 145.32 47.86 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 122.23 1.015 . . . . 0.02 110.064 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -66.32 -32.78 74.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.756 -0.59 . . . . 0.02 111.326 -177.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -125.12 157.61 66.51 Favored Pre-proline 0 N--CA 1.502 2.146 0 O-C-N 121.114 -0.991 . . . . 0.02 109.503 -178.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -53.12 167.1 0.79 Allowed 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 121.739 1.626 . . . . 0.02 112.915 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 63.34 36.57 11.53 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.407 -0.815 . . . . 0.02 110.99 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.476 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 2.3 m-85 44.92 51.6 8.55 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.535 0.683 . . . . 3.3900000000000001 110.565 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.0 p -125.97 163.68 22.47 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.207 0.527 . . . . 2.3300000000000001 110.016 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.56 -162.1 31.54 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.794 -1.323 . . . . 0.02 109.794 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.443 ' ND1' ' N ' ' A' ' 57' ' ' HIS . 4.1 m80 -64.15 138.04 58.25 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.957 -1.319 . . . . 0.02 109.938 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 17.2 ptm -118.59 136.9 53.61 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.317 0.58 . . . . 5.0099999999999998 109.643 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.576 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 84.5 m-85 -134.3 139.39 45.66 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 121.62 0.724 . . . . 0.02 109.702 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.5 mm -94.94 131.32 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.768 -0.827 . . . . 1.72 108.768 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.526 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.17 110.51 36.12 Favored Pre-proline 0 N--CA 1.505 2.282 0 O-C-N 121.386 -0.821 . . . . 0.02 110.693 -178.29 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -77.24 168.86 22.37 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 CA-C-N 119.958 1.021 . . . . 1.47 109.997 177.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -53.33 141.16 24.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.626 -1.296 . . . . 4.25 110.415 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.57 -177.71 32.57 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.558 -1.306 . . . . 0.02 110.571 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -120.04 131.14 55.01 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.537 -0.978 . . . . 0.95999999999999996 109.656 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.526 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 48.7 m-85 -123.11 94.37 47.18 Favored Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 108.371 -0.974 . . . . 0.02 108.371 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -65.95 -3.04 7.61 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.027 1.152 . . . . 0.02 114.11 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -157.53 155.83 30.95 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.55 -1.343 . . . . 2.02 108.589 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -60.78 -39.41 88.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.484 -0.76 . . . . 0.02 112.21 -177.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -59.86 -23.63 63.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.969 -1.082 . . . . 0.02 110.324 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -70.72 -18.36 62.8 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.833 0.825 . . . . 3.4199999999999999 108.858 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.576 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.1 t90 -108.07 10.42 28.16 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.29 -1.374 . . . . 0.02 107.29 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.445 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 2.6 mpt? 59.82 23.63 12.6 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.495 0.664 . . . . 0.02 110.535 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.54 144.89 45.55 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.377 -1.489 . . . . 0.02 109.377 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.3 tp -79.92 -31.05 40.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.119 -1.224 . . . . 0.97999999999999998 107.701 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -157.47 -172.06 3.83 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 106.312 -1.736 . . . . 0.02 106.312 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.523 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 54.0 m-20 -97.9 27.52 4.44 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.705 -1.247 . . . . 0.02 110.674 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -95.98 121.62 37.92 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.879 -1.138 . . . . 3.2000000000000002 110.561 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.489 ' O ' ' CZ ' ' A' ' 29' ' ' PHE . 27.5 mt -144.47 121.17 11.18 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 107.735 -1.209 . . . . 2.6099999999999999 107.735 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -111.99 -15.97 9.53 Favored Glycine 0 N--CA 1.507 3.402 0 O-C-N 121.152 -0.968 . . . . 0.02 113.087 -177.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.476 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 37.3 t -156.42 156.68 34.24 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 119.862 1.831 . . . . 0.02 110.921 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 20.0 p -145.92 148.29 32.65 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.635 -0.666 . . . . 0.02 110.108 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -137.81 142.91 40.81 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.386 -0.821 . . . . 0.01 109.396 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.85 131.99 36.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.42999999999999999 109.767 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 t -91.11 125.47 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.843 -0.799 . . . . 1.25 108.843 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -93.13 132.32 37.37 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.764 -1.21 . . . . 1.77 108.826 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mt -98.56 140.33 32.95 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.3 -0.875 . . . . 1.6299999999999999 108.928 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 60.7 p -111.41 124.8 52.99 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.533 -0.914 . . . . 1.0800000000000001 108.533 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.4 m -116.35 133.0 56.51 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.697 -1.252 . . . . 1.26 107.924 177.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.11 -49.26 0.01 OUTLIER Glycine 0 N--CA 1.505 3.277 0 C-N-CA 117.707 -2.187 . . . . 0.01 113.724 -177.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -167.57 -105.76 0.19 Allowed Glycine 0 N--CA 1.49 2.25 0 CA-C-N 119.962 1.881 . . . . 0.01 111.213 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -120.11 117.89 29.14 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.97 -1.312 . . . . 4.4299999999999997 110.306 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.38 129.92 35.53 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.684 -0.806 . . . . 2.9900000000000002 109.392 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -131.03 140.79 50.14 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.545 -0.722 . . . . 6.3600000000000003 109.178 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.9 tt -129.31 146.07 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.322 -0.861 . . . . 1.0900000000000001 110.211 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -121.24 133.7 55.16 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.559 -1.274 . . . . 2.0499999999999998 107.559 177.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.2 m -124.34 145.98 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 120.965 -1.084 . . . . 1.1000000000000001 109.783 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -119.13 141.61 48.65 Favored 'General case' 0 N--CA 1.503 2.205 0 CA-C-O 122.124 0.964 . . . . 0.72999999999999998 111.092 -178.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -66.63 -30.31 70.55 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 115.87 -0.605 . . . . 0.02 111.908 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -116.53 167.65 10.87 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.004 -1.06 . . . . 3.1800000000000002 110.494 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.71 163.9 43.21 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 111.01 -0.836 . . . . 0.01 111.01 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 102' ' ' ASP . 2.3 m-20 57.09 38.73 29.28 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.808 0.813 . . . . 0.01 110.823 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.407 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 15.2 m-85 52.3 55.75 8.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.571 -0.705 . . . . 0.01 111.045 178.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -128.06 165.81 19.62 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 108.425 -0.954 . . . . 3.1499999999999999 108.425 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.4 -163.95 27.86 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.235 -1.546 . . . . 0.01 109.235 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -75.31 144.64 42.32 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.993 -1.298 . . . . 0.01 108.527 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.45 ' C ' ' SD ' ' A' ' 107' ' ' MET . 10.8 tmm? -116.59 142.33 47.03 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.569 0.7 . . . . 0.01 109.865 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -131.97 136.3 47.21 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.259 -1.015 . . . . 2.48 108.259 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.519 ' OE2' ' N ' ' A' ' 110' ' ' THR . 1.9 tm-20 -118.94 134.88 54.89 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.575 -0.703 . . . . 0.01 109.931 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.519 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 3.0 t -148.55 150.71 33.83 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 122.27 1.033 . . . . 1.6899999999999999 111.166 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 65.8 p -112.0 9.3 20.42 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 115.581 -0.736 . . . . 0.01 110.41 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -121.06 162.93 19.16 Favored 'General case' 0 N--CA 1.508 2.452 0 O-C-N 121.201 -0.937 . . . . 3.21 111.762 -178.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -67.97 156.62 36.89 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.266 -1.013 . . . . 0.01 108.266 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 30.6 t -127.12 114.84 21.79 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.556 -0.715 . . . . 0.01 109.196 178.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -75.08 -28.9 8.65 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 CA-C-N 120.396 1.177 . . . . 0.01 111.0 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 56.0 m -142.88 109.07 5.25 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.389 -0.819 . . . . 0.02 109.224 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.17 -38.77 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.832 -0.542 . . . . 1.8300000000000001 110.627 -178.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.5 ttp -68.89 -37.23 78.88 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.164 -1.014 . . . . 1.3400000000000001 110.259 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -69.53 -38.8 77.66 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 120.352 -1.468 . . . . 2.1099999999999999 110.058 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.541 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 41.2 tt0 -79.99 -46.47 16.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.392 -0.817 . . . . 2.0800000000000001 112.227 -177.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.541 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 33.8 m-85 -110.62 0.14 17.44 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.364 -0.835 . . . . 0.02 112.573 -176.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 59.63 33.22 21.92 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.644 -1.285 . . . . 0.02 109.404 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.0 mt -112.52 135.57 53.08 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 108.716 -0.846 . . . . 0.02 108.716 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -91.39 -22.53 20.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.155 -0.966 . . . . 5.3200000000000003 110.361 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -149.64 164.02 36.32 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.136 -0.978 . . . . 0.02 109.833 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.6 mt -131.83 128.61 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 107.557 -1.275 . . . . 2.1699999999999999 107.557 178.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.513 ' N ' ' ND1' ' A' ' 127' ' ' HIS . 1.8 m80 -107.93 -12.44 15.17 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.496 -0.753 . . . . 0.02 112.293 -177.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.407 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 7.0 t -159.92 152.12 20.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.015 -1.053 . . . . 0.01 109.05 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 6.3 p -169.98 145.17 2.86 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.183 -0.948 . . . . 1.22 109.016 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.6 tttp -125.74 111.58 15.08 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 122.452 1.12 . . . . 1.4099999999999999 110.172 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 131' ' ' VAL . 11.2 p -111.86 136.5 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.282 -1.377 . . . . 0.01 107.282 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 44.5 t -128.32 93.53 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 N-CA-C 106.865 -1.532 . . . . 1.98 106.865 177.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -146.33 -81.26 0.15 Allowed 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 105.911 -1.885 . . . . 0.01 105.911 178.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -178.91 -79.13 0.06 OUTLIER Glycine 0 N--CA 1.486 1.985 0 N-CA-C 108.488 -1.845 . . . . 0.01 108.488 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.585 ' OG1' HD12 ' A' ' 175' ' ' ILE . 1.4 t -119.08 122.13 41.41 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.454 -1.027 . . . . 2.2999999999999998 110.068 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -125.75 150.74 47.49 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 106.847 -1.538 . . . . 0.01 106.847 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 82.6 mt -121.17 136.78 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 120.467 -1.396 . . . . 1.6899999999999999 110.166 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -115.59 144.88 43.25 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.625 -1.25 . . . . 2.4900000000000002 107.625 178.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.517 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 12.1 m-85 -123.4 144.09 49.71 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.436 -0.79 . . . . 0.02 109.666 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -74.74 -29.4 61.14 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.478 -0.764 . . . . 0.02 111.771 -176.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.5 mt -115.64 154.65 47.94 Favored Pre-proline 0 N--CA 1.505 2.29 0 O-C-N 120.706 -1.246 . . . . 1.48 108.939 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -55.64 167.31 2.18 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.131 1.221 . . . . 0.02 112.609 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.554 ' ND2' ' O ' ' A' ' 143' ' ' ASN . 1.7 t30 59.7 30.94 20.54 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.009 -0.996 . . . . 0.75 111.284 178.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 58.02 51.64 8.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.425 -0.797 . . . . 0.02 111.208 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -127.04 164.89 20.54 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.541 -0.725 . . . . 0.02 110.187 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.98 -165.81 33.36 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.385 -1.086 . . . . 0.02 110.385 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -69.1 142.5 54.44 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.558 -0.966 . . . . 0.02 109.027 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -113.99 148.52 36.79 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.554 0.692 . . . . 0.02 110.257 -177.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -125.09 134.34 52.53 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.01 -0.737 . . . . 0.01 109.01 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.496 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.9 tt -99.25 121.9 41.69 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.92 -1.113 . . . . 0.01 109.221 -179.044 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.642 HD23 ' N ' ' A' ' 152' ' ' ASP . 1.6 tt -98.35 140.98 31.82 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.587 -0.894 . . . . 0.01 108.587 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.642 ' N ' HD23 ' A' ' 151' ' ' LEU . 1.3 m-20 -103.39 -108.32 0.26 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.313 -0.867 . . . . 2.27 109.967 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.417 ' HZ2' ' HB3' ' A' ' 153' ' ' LYS . 14.2 ttpp -153.27 52.47 0.73 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.939 -1.1 . . . . 1.8400000000000001 109.611 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -115.25 175.58 5.45 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.374 -0.829 . . . . 2.2799999999999998 109.087 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -102.94 111.72 24.18 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.237 -0.914 . . . . 0.01 108.644 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.51 ' N ' ' CD1' ' A' ' 156' ' ' TYR . 16.1 m-85 -99.76 115.6 29.9 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.373 -0.829 . . . . 0.01 110.506 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -92.82 -24.91 18.35 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.927 -1.108 . . . . 0.01 110.633 -178.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -127.82 154.04 78.05 Favored Pre-proline 0 N--CA 1.499 2.018 0 N-CA-C 108.139 -1.06 . . . . 2.54 108.139 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -58.86 -40.31 73.28 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 CA-C-N 119.416 0.827 . . . . 0.69999999999999996 110.518 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 51.1 t -62.14 -23.02 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.887 -1.133 . . . . 0.85999999999999999 109.594 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -66.54 -16.22 63.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.588 -1.32 . . . . 0.02 109.824 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.572 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 12.5 t90 -99.66 9.53 42.96 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.648 -0.871 . . . . 0.02 108.648 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 78.57 8.4 87.66 Favored Glycine 0 N--CA 1.492 2.373 0 O-C-N 120.904 -1.122 . . . . 0.02 111.512 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -98.23 141.61 30.93 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.231 -1.158 . . . . 0.02 109.973 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -87.27 -12.35 46.9 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.796 -0.565 . . . . 0.58999999999999997 110.439 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.9 m -147.22 149.99 36.66 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 120.713 -1.242 . . . . 0.87 108.758 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -78.17 22.46 0.62 Allowed 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 120.807 1.005 . . . . 0.38 112.98 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.841 ' O ' HD13 ' A' ' 169' ' ' ILE . . . -83.6 123.18 29.52 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.618 -1.301 . . . . 0.17999999999999999 111.812 -177.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.841 HD13 ' O ' ' A' ' 168' ' ' ALA . 5.4 mm -147.75 128.9 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 106.975 -1.491 . . . . 3.9900000000000002 106.975 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -112.64 -17.83 12.51 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 120.95 -1.094 . . . . 5.1699999999999999 113.497 -177.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 20.1 t -157.36 160.52 38.55 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 119.108 -2.245 . . . . 0.02 110.265 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.441 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 16.0 p90 -151.8 152.83 33.17 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.075 -1.015 . . . . 2.02 110.937 179.168 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -145.31 149.78 35.45 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.832 0.825 . . . . 0.01 110.119 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -88.77 145.5 25.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.732 -0.605 . . . . 0.01 109.403 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.585 HD12 ' OG1' ' A' ' 135' ' ' THR . 6.1 mt -95.29 128.79 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.316 -0.865 . . . . 3.04 109.169 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 20.1 t -136.09 145.84 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.114 -0.991 . . . . 1.8899999999999999 109.47 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.273 -0.892 . . . . 4.8899999999999997 109.376 -179.978 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.555 -1.418 . . . . 0.01 109.555 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -145.55 135.4 23.54 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.233 -1.157 . . . . 0.02 110.436 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.6 tt -129.67 139.04 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.204 -1.036 . . . . 0.02 108.204 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.9 m -121.28 129.81 53.33 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.348 -0.845 . . . . 0.39000000000000001 110.141 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 8.0 m-85 -110.06 140.29 44.27 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.672 -0.862 . . . . 0.02 108.672 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.556 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.3 m-85 -122.04 138.6 54.38 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.202 -0.936 . . . . 0.02 109.538 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.489 ' HG3' HD11 ' A' ' 33' ' ' LEU . 87.5 mt-10 -69.02 -27.6 65.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.012 -1.055 . . . . 0.029999999999999999 111.44 -178.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -114.29 169.26 9.17 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.787 -1.196 . . . . 0.029999999999999999 110.161 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -75.68 158.84 31.81 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.736 0.779 . . . . 0.029999999999999999 110.207 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.7 t30 65.9 33.49 7.89 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.992 0.901 . . . . 0.73999999999999999 111.21 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 55.33 41.87 30.78 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.195 0.522 . . . . 0.02 111.341 178.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -113.6 166.08 11.88 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.232 -1.025 . . . . 0.02 108.232 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.73 -167.34 36.67 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.773 -1.203 . . . . 0.029999999999999999 110.783 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -69.06 141.6 54.74 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.613 -0.934 . . . . 2.7599999999999998 109.407 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -120.57 149.28 42.7 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.575 -0.703 . . . . 1.8899999999999999 110.165 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -132.69 127.67 35.3 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.271 -1.011 . . . . 0.02 108.271 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -112.85 137.3 51.4 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.479 -0.763 . . . . 1.1200000000000001 109.765 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.6 t -131.29 139.04 49.52 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.628 -0.67 . . . . 0.02 109.642 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.489 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 19.0 t70 -116.61 10.92 14.56 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.593 -0.692 . . . . 0.20000000000000001 109.925 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 40.4 m -158.24 174.34 15.31 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.245 -1.02 . . . . 1.23 108.245 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 11.9 p-10 -60.66 144.31 52.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.541 -1.349 . . . . 0.02 109.848 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.1 t -131.83 117.61 18.77 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.559 -0.904 . . . . 0.02 108.559 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.94 -25.06 48.05 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.239 -0.913 . . . . 0.23999999999999999 110.841 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -155.08 101.72 2.27 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.061 -1.024 . . . . 1.1399999999999999 109.021 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.401 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 24.0 p90 -105.25 9.56 33.96 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 122.157 0.98 . . . . 6.3700000000000001 109.84 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -58.5 -23.75 58.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.448 -0.782 . . . . 3.1099999999999999 110.873 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.8 m -74.55 -16.77 60.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.641 -1.287 . . . . 0.88 110.174 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -104.12 -21.98 13.49 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.499 -0.751 . . . . 0.02 109.6 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.489 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.8 tp -150.58 129.15 12.24 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.11 -0.994 . . . . 3.3199999999999998 109.157 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.7 m -85.38 -9.94 56.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.831 -0.543 . . . . 0.02 111.06 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -171.45 162.9 6.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.847 -1.158 . . . . 0.02 107.931 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.4 p -143.21 115.16 8.28 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.789 -1.194 . . . . 0.02 108.905 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -107.21 1.94 24.37 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.759 -1.213 . . . . 0.029999999999999999 110.875 -178.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.6 t -156.23 154.37 30.63 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.749 -1.204 . . . . 0.02 107.749 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.8 mt -146.66 147.61 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 120.959 -1.088 . . . . 0.02 110.362 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -124.58 125.06 43.55 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.083 -1.08 . . . . 0.02 108.083 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.8 t -106.87 115.12 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 107.147 -1.427 . . . . 0.02 107.147 177.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -83.52 -33.9 25.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.528 -0.732 . . . . 3.8100000000000001 110.906 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.15 152.35 22.11 Favored Glycine 0 N--CA 1.487 2.037 0 C-N-CA 118.919 -1.61 . . . . 0.02 110.937 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.45 173.13 49.5 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.577 -1.297 . . . . 0.01 110.418 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.5 m -119.23 134.97 54.91 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.827 -1.175 . . . . 1.48 107.827 178.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.425 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 35.0 m95 -126.8 155.22 43.21 Favored 'General case' 0 N--CA 1.504 2.234 0 CA-C-O 122.506 1.146 . . . . 0.02 112.08 -176.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.52 133.89 52.56 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 105.724 -1.954 . . . . 0.23999999999999999 105.724 176.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.521 ' HB ' HD22 ' A' ' 79' ' ' LEU . 26.8 m -118.09 142.92 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 109.009 -0.737 . . . . 0.65000000000000002 109.009 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -121.39 146.28 47.04 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 122.325 1.06 . . . . 0.02 110.155 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.575 ' OE2' ' ND2' ' A' ' 76' ' ' ASN . 7.6 tp10 -66.31 -35.08 79.46 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.548 -0.751 . . . . 0.02 111.185 -177.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 -125.44 157.77 66.78 Favored Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 121.126 -0.983 . . . . 0.02 109.529 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -53.61 167.17 1.03 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.761 1.641 . . . . 0.02 112.992 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 53' ' ' ASN . 1.1 t30 63.57 36.52 10.99 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.027 -0.988 . . . . 0.02 111.191 178.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 45.28 51.82 9.12 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.621 0.724 . . . . 3.3900000000000001 110.572 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 88.2 p -126.1 163.61 22.72 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 121.223 0.535 . . . . 2.3300000000000001 109.755 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.88 -161.92 32.32 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.708 -1.357 . . . . 0.02 109.708 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -66.7 139.23 57.83 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.015 -1.285 . . . . 0.02 110.281 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 14.3 ptm -118.64 137.98 52.91 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.598 -0.689 . . . . 5.0099999999999998 109.758 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.462 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 59.4 m-85 -133.25 137.84 46.23 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.506 -0.746 . . . . 0.02 109.836 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.7 mm -94.98 131.12 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.846 -0.798 . . . . 1.72 108.846 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.56 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.19 110.94 35.67 Favored Pre-proline 0 N--CA 1.505 2.297 0 O-C-N 121.452 -0.78 . . . . 0.02 110.748 -178.233 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -77.74 168.37 22.5 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 CA-C-N 119.958 1.021 . . . . 1.47 110.115 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.89 141.28 28.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.822 -1.174 . . . . 4.25 110.489 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.26 -177.81 32.26 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 119.535 -1.316 . . . . 0.02 110.567 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -119.41 131.13 55.6 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.527 -0.984 . . . . 0.95999999999999996 109.766 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.56 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 70.6 m-85 -122.05 96.26 46.79 Favored Pre-proline 0 N--CA 1.494 1.737 0 N-CA-C 108.162 -1.051 . . . . 0.02 108.162 178.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.401 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.6 Cg_endo -67.41 -3.77 10.66 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 120.77 0.98 . . . . 0.02 113.734 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.401 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 34.2 mt-10 -157.55 155.19 29.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.592 -1.317 . . . . 2.02 108.132 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -60.48 -38.92 85.8 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.622 -0.674 . . . . 0.02 112.11 -177.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -60.49 -23.83 64.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.042 -1.036 . . . . 0.02 110.366 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -69.46 -18.95 63.76 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.427 -0.796 . . . . 3.4199999999999999 108.992 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.553 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 1.1 t90 -108.3 11.09 27.49 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.403 -1.332 . . . . 0.02 107.403 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.5 mtt 60.88 22.21 12.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.47 -0.769 . . . . 0.02 110.215 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.11 145.11 46.6 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.169 -1.572 . . . . 0.02 109.169 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.551 HD23 ' O ' ' A' ' 75' ' ' LEU . 1.0 OUTLIER -79.62 -31.03 41.6 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.66 -1.237 . . . . 0.97999999999999998 107.66 178.114 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.575 ' ND2' ' OE2' ' A' ' 50' ' ' GLU . 13.2 p30 -157.16 -171.45 3.63 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 106.525 -1.657 . . . . 0.02 106.525 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -98.86 28.6 4.23 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.85 -1.156 . . . . 0.02 110.425 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -98.47 123.37 42.57 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.152 -0.967 . . . . 3.2000000000000002 111.183 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.521 HD22 ' HB ' ' A' ' 48' ' ' VAL . 36.1 mt -145.03 122.33 11.57 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.518 -1.29 . . . . 2.6099999999999999 107.518 177.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.99 -16.44 11.43 Favored Glycine 0 N--CA 1.504 3.173 0 O-C-N 121.132 -0.98 . . . . 0.02 112.695 -177.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.6 t -156.96 155.97 32.22 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.242 -1.74 . . . . 0.02 110.304 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.5 p -145.28 147.85 32.81 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.503 -0.748 . . . . 0.02 110.332 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.0 mtm180 -137.7 143.0 41.05 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.278 -0.889 . . . . 0.01 109.36 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.52 132.16 36.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.127 -0.983 . . . . 0.42999999999999999 109.76 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.4 t -91.06 125.03 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.782 -0.821 . . . . 1.25 108.782 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -94.6 131.18 40.63 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.82 -1.175 . . . . 1.77 109.16 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -94.87 139.62 31.06 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.196 -0.94 . . . . 1.6299999999999999 108.508 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.7 t -110.66 127.87 55.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.388 -0.82 . . . . 1.0800000000000001 109.108 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 95.5 p -104.52 -154.32 0.5 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 106.547 -1.649 . . . . 1.26 106.547 177.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.55 -53.1 0.74 Allowed Glycine 0 N--CA 1.5 2.9 0 O-C-N 120.553 -1.342 . . . . 0.01 112.762 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.46 -101.5 0.15 Allowed Glycine 0 N--CA 1.489 2.168 0 C-N-CA 118.603 -1.76 . . . . 0.01 111.978 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -122.39 119.56 31.4 Favored 'General case' 0 N--CA 1.506 2.343 0 CA-C-N 118.666 1.233 . . . . 4.4299999999999997 110.757 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.36 130.82 35.8 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.762 -0.775 . . . . 2.9900000000000002 109.483 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -129.62 141.85 50.86 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.377 -0.827 . . . . 6.3600000000000003 109.229 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.9 tt -128.3 144.73 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 O-C-N 121.35 -0.844 . . . . 1.0900000000000001 110.123 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -122.5 133.39 54.59 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.501 -1.296 . . . . 2.0499999999999998 107.501 177.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.9 m -124.56 146.36 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 O-C-N 120.628 -1.295 . . . . 1.1000000000000001 109.884 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -120.04 141.85 49.38 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 122.013 0.911 . . . . 0.72999999999999998 111.129 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -67.28 -30.82 70.8 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 116.03 -0.532 . . . . 0.02 111.908 -178.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -115.98 167.47 10.93 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.938 -1.101 . . . . 3.1800000000000002 110.384 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.15 164.26 44.28 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.974 -0.851 . . . . 0.01 110.974 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 57.08 38.77 29.33 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.701 0.762 . . . . 0.01 110.935 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 52.44 55.97 8.36 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.467 -0.77 . . . . 0.01 110.991 178.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -129.14 165.77 20.63 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.238 -1.023 . . . . 3.1499999999999999 108.238 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.57 -163.73 27.52 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.244 -1.542 . . . . 0.01 109.244 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -75.7 144.41 41.57 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.05 -1.265 . . . . 0.01 108.543 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.452 ' C ' ' SD ' ' A' ' 107' ' ' MET . 12.8 tmm? -116.56 142.33 47.02 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.623 0.725 . . . . 0.01 109.831 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -131.88 135.7 46.86 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.255 -1.017 . . . . 2.48 108.255 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.519 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.1 tm-20 -118.55 134.11 55.34 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.584 -0.698 . . . . 0.01 110.033 -178.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.519 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 6.0 t -148.17 150.74 34.34 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.278 1.037 . . . . 1.6899999999999999 111.072 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 72.9 p -110.85 9.68 22.47 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 115.498 -0.774 . . . . 0.01 110.227 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -120.86 162.74 19.31 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.234 -0.916 . . . . 3.21 111.563 -178.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -68.59 157.54 35.87 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.392 -0.966 . . . . 0.01 108.392 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 19.2 t -127.36 113.43 21.32 Favored Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 121.491 -0.756 . . . . 0.01 109.072 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -75.25 -28.09 9.06 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 CA-C-N 120.315 1.148 . . . . 0.01 111.02 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.8 t -142.38 109.08 5.38 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.363 -0.836 . . . . 0.02 109.088 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 98.0 mt -63.63 -39.31 84.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.824 -0.547 . . . . 1.8300000000000001 110.76 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 15.3 ttt -68.85 -38.16 79.6 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.246 -0.982 . . . . 1.3400000000000001 110.372 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -69.26 -38.48 78.43 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.528 -1.358 . . . . 2.1099999999999999 109.872 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -79.98 -47.02 15.62 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.219 -0.925 . . . . 2.0800000000000001 112.331 -177.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.443 ' C ' ' ND1' ' A' ' 122' ' ' HIS . 54.3 m-85 -110.94 0.23 17.01 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.251 -0.905 . . . . 0.02 112.653 -176.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.443 ' ND1' ' C ' ' A' ' 121' ' ' PHE . 5.3 m80 60.14 33.34 21.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.753 -1.217 . . . . 0.02 109.407 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.9 mt -112.46 135.36 53.25 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 108.791 -0.818 . . . . 0.02 108.791 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -91.47 -22.82 20.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.233 -0.917 . . . . 5.3200000000000003 110.174 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -149.29 164.1 35.8 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.216 -0.928 . . . . 0.02 109.899 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 31.9 mt -131.78 128.7 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 N-CA-C 107.854 -1.165 . . . . 2.1699999999999999 107.854 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -108.5 -12.88 14.94 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.286 -0.884 . . . . 0.02 112.256 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.5 m -159.4 150.75 20.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.992 -1.067 . . . . 0.01 108.937 178.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 24.9 p -168.95 147.63 3.98 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.356 -0.84 . . . . 1.22 108.782 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -121.3 111.39 17.29 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 122.542 1.163 . . . . 1.4099999999999999 109.845 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.47 129.78 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.472 -1.307 . . . . 0.01 107.472 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.7 t -129.52 93.57 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 107.328 -1.36 . . . . 1.98 107.328 177.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.488 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 11.0 tm-20 -147.41 -75.55 0.19 Allowed 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 105.914 -1.884 . . . . 0.01 105.914 177.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.438 ' N ' ' OE1' ' A' ' 133' ' ' GLU . . . 171.06 -71.81 0.11 Allowed Glycine 0 N--CA 1.483 1.813 0 N-CA-C 108.601 -1.8 . . . . 0.01 108.601 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.418 ' OG1' HD12 ' A' ' 175' ' ' ILE . 16.5 p -119.56 115.82 24.79 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.604 -0.939 . . . . 2.2999999999999998 110.24 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.488 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 6.4 m95 -126.33 149.71 49.0 Favored 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 106.677 -1.601 . . . . 0.01 106.677 178.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 81.3 mt -122.51 137.72 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 120.377 -1.452 . . . . 1.6899999999999999 110.586 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -114.48 143.95 44.12 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.221 -1.4 . . . . 2.4900000000000002 107.221 178.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.516 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 10.6 m-85 -123.18 143.87 49.73 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.241 -0.912 . . . . 0.02 109.521 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -74.32 -29.99 61.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.715 -0.616 . . . . 0.02 111.754 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.5 mt -116.76 153.97 49.33 Favored Pre-proline 0 N--CA 1.504 2.261 0 O-C-N 120.877 -1.14 . . . . 1.48 108.856 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.46 169.49 0.74 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.281 1.32 . . . . 0.02 113.122 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 21.8 m120 57.61 32.31 21.66 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.046 -0.979 . . . . 0.75 111.511 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 55.83 48.36 18.31 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.551 -0.718 . . . . 0.02 110.908 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -122.6 163.92 19.14 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.505 -0.747 . . . . 0.02 109.914 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.23 -165.85 33.06 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.361 -1.096 . . . . 0.02 110.361 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.477 ' CZ ' ' OH ' ' A' ' 149' ' ' TYR . 17.9 ttp180 -69.26 142.71 54.08 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.523 -0.987 . . . . 0.02 109.244 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -114.62 148.36 38.23 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.368 0.604 . . . . 0.02 110.261 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.477 ' OH ' ' CZ ' ' A' ' 147' ' ' ARG . 67.4 m-85 -125.07 135.19 52.48 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.871 -0.788 . . . . 0.01 108.871 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.516 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.4 tt -99.73 122.18 42.34 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.919 -1.113 . . . . 0.01 109.12 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.642 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 32.9 tp -96.75 146.45 24.87 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.101 -1.0 . . . . 0.01 108.736 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -104.31 -130.65 0.27 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.422 -0.799 . . . . 2.27 110.215 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -133.78 52.0 2.1 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.398 -0.814 . . . . 1.8400000000000001 109.654 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -116.24 -169.52 1.63 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.463 -0.773 . . . . 2.2799999999999998 109.473 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -105.49 108.39 19.88 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.335 -0.987 . . . . 0.01 108.335 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.642 ' CZ ' HD11 ' A' ' 151' ' ' LEU . 6.0 m-85 -99.42 111.78 24.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.343 -0.848 . . . . 0.01 110.522 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -96.34 -22.03 17.44 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.294 -0.879 . . . . 0.01 111.412 -178.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -127.4 154.36 77.26 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 121.018 -1.051 . . . . 2.54 108.845 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -59.52 -38.76 80.92 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 CA-C-N 119.261 0.772 . . . . 0.69999999999999996 110.538 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 41.0 t -60.71 -20.18 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.901 -1.124 . . . . 0.85999999999999999 109.014 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -65.46 -15.67 62.87 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.91 -1.119 . . . . 0.02 110.022 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.628 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 10.0 m0 -98.11 10.96 39.22 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.148 -0.97 . . . . 0.02 108.842 178.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.42 11.39 84.24 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.839 -1.172 . . . . 0.02 111.079 178.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.23 140.63 34.19 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.137 -1.213 . . . . 0.02 110.191 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.18 -8.54 58.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.608 -0.682 . . . . 0.58999999999999997 110.271 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.8 t -143.42 150.38 51.19 Favored Pre-proline 0 N--CA 1.5 2.048 0 O-C-N 120.905 -1.122 . . . . 0.87 109.345 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -75.79 17.72 0.67 Allowed 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 120.771 0.98 . . . . 0.38 112.122 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.863 ' O ' HD13 ' A' ' 169' ' ' ILE . . . -82.84 122.89 28.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.883 -1.136 . . . . 0.17999999999999999 111.258 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.863 HD13 ' O ' ' A' ' 168' ' ' ALA . 4.6 mm -147.27 128.14 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 106.725 -1.583 . . . . 3.9900000000000002 106.725 178.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -111.22 -18.37 12.98 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.111 -0.993 . . . . 5.1699999999999999 113.115 -177.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 4.8 p -157.91 161.58 38.24 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 119.319 -2.113 . . . . 0.02 110.309 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.425 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 17.5 p90 -150.73 152.07 33.34 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.142 -0.974 . . . . 2.02 110.02 178.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -144.9 149.23 34.93 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.701 0.762 . . . . 0.01 109.758 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 18.4 ttm180 -87.9 144.06 26.78 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.67 -0.644 . . . . 0.01 109.503 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.418 HD12 ' OG1' ' A' ' 135' ' ' THR . 4.0 mt -94.27 128.84 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.249 -0.907 . . . . 3.04 109.045 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 25.6 m -136.34 146.79 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.061 -1.024 . . . . 1.8899999999999999 109.586 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.337 -0.852 . . . . 4.8899999999999997 109.438 -179.94 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.444 -1.462 . . . . 0.01 109.444 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -148.17 136.63 21.46 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.004 -1.292 . . . . 0.02 110.344 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.6 tt -130.73 140.86 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.906 -0.775 . . . . 0.02 108.906 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 m -121.42 130.4 53.56 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.499 -0.75 . . . . 0.39000000000000001 109.934 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.6 m-85 -109.92 138.88 45.67 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.496 -0.752 . . . . 0.02 109.224 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.534 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.5 m-85 -122.32 139.14 54.16 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.317 -0.865 . . . . 0.02 109.805 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -69.5 -28.3 65.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.139 -0.976 . . . . 0.029999999999999999 111.868 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -114.17 168.87 9.45 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.85 -1.156 . . . . 0.029999999999999999 110.18 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -74.94 158.52 33.17 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.683 0.754 . . . . 0.029999999999999999 109.938 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 66.52 33.52 6.63 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.953 0.882 . . . . 0.73999999999999999 111.217 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 55.56 42.51 29.58 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.241 0.543 . . . . 0.02 111.32 177.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -113.56 165.88 12.07 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.357 -0.979 . . . . 0.02 108.357 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.63 -167.5 35.26 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.825 -1.179 . . . . 0.029999999999999999 110.974 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -68.74 142.1 55.07 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.506 -0.997 . . . . 2.7599999999999998 109.314 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -121.59 149.9 42.47 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.551 -0.718 . . . . 1.8899999999999999 110.302 -178.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -134.72 129.28 34.47 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.662 -0.866 . . . . 0.02 108.662 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 15.9 p-10 -110.59 136.49 49.63 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.525 -0.734 . . . . 1.1200000000000001 109.156 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 14.2 t -129.33 137.88 51.25 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.483 0.659 . . . . 0.02 109.44 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -116.96 12.02 14.51 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.597 -0.689 . . . . 0.20000000000000001 109.753 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.444 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 42.3 t -159.44 174.24 15.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.052 -1.03 . . . . 1.23 108.559 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.419 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.4 p30 -61.03 144.16 53.95 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.715 -1.241 . . . . 0.02 110.006 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.8 t -131.85 116.96 17.89 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.576 -0.898 . . . . 0.02 108.576 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.53 -24.76 45.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.181 -0.95 . . . . 0.23999999999999999 111.31 -178.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -153.85 101.97 2.48 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.955 -1.09 . . . . 1.1399999999999999 109.113 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -104.5 9.31 35.55 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 122.148 0.975 . . . . 6.3700000000000001 109.839 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -58.99 -25.31 63.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.466 -0.771 . . . . 3.1099999999999999 111.17 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.0 p -74.28 -15.98 60.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.74 -1.225 . . . . 0.88 110.139 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -103.59 -21.81 13.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.46 -0.775 . . . . 0.02 109.741 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.5 mt -149.01 128.7 13.24 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.817 0.818 . . . . 3.3199999999999998 109.443 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 76.7 p -84.74 -9.71 57.94 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.322 0.582 . . . . 0.02 109.626 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -171.51 162.09 6.45 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.835 -1.172 . . . . 0.02 107.835 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.0 p -142.21 115.1 8.68 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.952 -1.093 . . . . 0.02 108.462 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.429 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 50.8 t-20 -106.92 -0.59 23.07 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 120.811 -1.181 . . . . 0.029999999999999999 111.649 -177.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 t -153.48 154.37 34.23 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.884 -1.154 . . . . 0.02 107.884 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 39' ' ' ILE . 10.5 mt -146.47 145.93 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.864 -1.147 . . . . 0.02 110.726 -178.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -124.97 125.73 44.36 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.044 -1.095 . . . . 0.02 108.044 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.0 t -104.93 113.71 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 106.727 -1.583 . . . . 0.02 106.727 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -84.92 -34.51 22.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.414 -0.804 . . . . 3.8100000000000001 110.266 -178.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.32 150.43 19.16 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 118.541 -1.79 . . . . 0.02 110.879 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.75 172.0 48.7 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.102 -1.199 . . . . 0.01 110.102 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.6 m -119.43 134.72 55.08 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.844 -1.169 . . . . 1.48 107.844 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.453 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 32.8 m95 -127.2 154.95 44.18 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 122.567 1.175 . . . . 0.02 112.339 -176.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.91 134.62 51.33 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 105.267 -2.123 . . . . 0.23999999999999999 105.267 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.436 ' HB ' HD22 ' A' ' 79' ' ' LEU . 35.2 m -116.5 141.42 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.589 -0.695 . . . . 0.65000000000000002 109.251 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -120.72 143.56 48.7 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 122.04 0.924 . . . . 0.02 109.655 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -65.51 -34.55 78.52 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.472 -0.786 . . . . 0.02 111.595 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -125.52 157.84 66.72 Favored Pre-proline 0 N--CA 1.504 2.229 0 O-C-N 120.985 -1.072 . . . . 0.02 109.45 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -53.71 167.54 0.98 Allowed 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.711 1.607 . . . . 0.02 112.992 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 63.22 36.59 11.82 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 115.191 -0.913 . . . . 0.02 111.136 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 45.03 51.92 8.58 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.671 0.748 . . . . 3.3900000000000001 110.674 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.9 t -125.94 163.66 22.5 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.183 0.516 . . . . 2.3300000000000001 109.811 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.99 -162.08 32.3 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.744 -1.342 . . . . 0.02 109.744 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -66.06 138.58 57.87 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.079 -1.248 . . . . 0.02 110.204 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 23.4 ptm -118.87 137.12 53.66 Favored 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.326 0.584 . . . . 5.0099999999999998 109.666 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.459 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 96.5 m-85 -134.04 139.33 45.93 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.484 -0.76 . . . . 0.02 109.735 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.3 mm -95.35 131.04 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 109.048 -0.723 . . . . 1.72 109.048 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.537 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -119.56 111.3 36.4 Favored Pre-proline 0 N--CA 1.506 2.329 0 O-C-N 121.417 -0.802 . . . . 0.02 110.732 -178.259 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -78.28 168.98 20.87 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 CA-C-N 119.859 0.985 . . . . 1.47 110.258 177.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -54.19 141.0 30.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.812 -1.18 . . . . 4.25 110.593 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.31 -177.67 32.38 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.548 -1.311 . . . . 0.02 110.604 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -119.95 131.67 55.27 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.534 -0.98 . . . . 0.95999999999999996 109.618 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.537 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 67.9 m-85 -120.4 95.86 49.04 Favored Pre-proline 0 N--CA 1.493 1.715 0 N-CA-C 108.144 -1.058 . . . . 0.02 108.144 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -68.29 -5.75 15.73 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 120.77 0.98 . . . . 0.02 113.394 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -156.74 154.08 29.43 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.653 -1.279 . . . . 2.02 107.705 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -60.04 -37.92 81.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.627 -0.671 . . . . 0.02 112.157 -177.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -59.8 -23.35 63.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.066 -1.021 . . . . 0.02 110.442 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -70.54 -19.21 62.91 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.822 0.82 . . . . 3.4199999999999999 109.053 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.543 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.8 t90 -108.01 9.84 28.41 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.672 -1.233 . . . . 0.02 107.672 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.2 mtt 61.14 22.57 12.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.588 -0.695 . . . . 0.02 110.622 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.67 143.89 46.4 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.526 -1.43 . . . . 0.02 109.526 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.2 mt -79.2 -30.86 43.55 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.525 -1.287 . . . . 0.97999999999999998 107.525 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.486 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 25.3 t-20 -157.33 -171.71 3.71 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 106.206 -1.775 . . . . 0.02 106.206 178.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.486 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 72.0 m-20 -98.71 28.62 4.15 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.65 -1.281 . . . . 0.02 110.633 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.4 ttp180 -96.66 122.08 39.2 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.827 -1.171 . . . . 3.2000000000000002 111.107 -178.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.436 HD22 ' HB ' ' A' ' 48' ' ' VAL . 66.2 mt -142.91 121.83 12.76 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.473 -1.306 . . . . 2.6099999999999999 107.473 178.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.6 -17.21 9.37 Favored Glycine 0 N--CA 1.502 3.082 0 O-C-N 121.15 -0.969 . . . . 0.02 112.894 -177.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.0 t -156.36 156.13 33.37 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.019 -1.871 . . . . 0.02 110.761 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.2 p -145.24 147.33 32.28 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.395 -0.816 . . . . 0.02 110.609 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 33.9 mtp180 -137.74 143.19 41.06 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.568 -0.707 . . . . 0.01 109.208 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.36 132.48 36.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.42999999999999999 109.724 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.2 t -91.64 125.35 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.056 -0.72 . . . . 1.25 109.056 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -93.51 131.78 38.42 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.752 -1.217 . . . . 1.77 108.835 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.4 mt -98.15 141.62 30.84 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.369 -0.832 . . . . 1.6299999999999999 109.147 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.1 m -111.78 124.86 53.24 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.547 -0.909 . . . . 1.0800000000000001 108.547 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.4 t -116.57 134.02 55.33 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.686 -1.259 . . . . 1.26 108.173 177.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.66 -48.13 0.01 OUTLIER Glycine 0 N--CA 1.505 3.245 0 C-N-CA 117.677 -2.201 . . . . 0.01 114.077 -177.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -168.0 -105.45 0.18 Allowed Glycine 0 N--CA 1.491 2.364 0 CA-C-N 120.336 2.068 . . . . 0.01 111.29 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -120.01 117.98 29.46 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.998 -1.295 . . . . 4.4299999999999997 110.391 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.56 129.93 35.37 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.74 -0.784 . . . . 2.9900000000000002 109.291 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -129.22 140.84 51.32 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.46 -0.775 . . . . 6.3600000000000003 109.158 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.409 HG22 ' O ' ' A' ' 110' ' ' THR . 3.9 tt -128.49 144.55 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.35 0 O-C-N 121.306 -0.871 . . . . 1.0900000000000001 110.215 -179.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -122.81 133.59 54.44 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.562 -1.273 . . . . 2.0499999999999998 107.562 177.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.0 m -124.53 146.15 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 120.679 -1.263 . . . . 1.1000000000000001 109.788 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.581 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 77.5 m-85 -118.67 141.56 48.49 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-O 121.99 0.9 . . . . 0.72999999999999998 111.11 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -67.73 -30.9 70.5 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 116.012 -0.54 . . . . 0.02 111.829 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -116.54 167.43 11.07 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.023 -1.048 . . . . 3.1800000000000002 110.413 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.403 ' CA ' ' ND1' ' A' ' 127' ' ' HIS . . . -66.68 164.07 42.89 Favored Glycine 0 N--CA 1.493 2.447 0 CA-C-O 121.989 0.771 . . . . 0.01 111.309 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.0 t70 56.45 39.13 30.11 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.647 0.737 . . . . 0.01 110.965 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 52.24 55.14 9.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.69 -0.631 . . . . 0.01 110.985 177.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -129.09 165.19 21.72 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.047 -1.094 . . . . 3.1499999999999999 108.047 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.53 -163.93 27.7 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.27 -1.532 . . . . 0.01 109.27 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -75.96 144.11 41.17 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.928 -1.336 . . . . 0.01 108.782 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.581 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 25.3 ttp -116.52 142.36 46.98 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.473 0.654 . . . . 0.01 109.928 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -131.12 136.34 48.28 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.231 -1.026 . . . . 2.48 108.231 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -117.74 134.15 55.2 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.666 -0.646 . . . . 0.01 110.127 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.409 ' O ' HG22 ' A' ' 95' ' ' ILE . 6.5 t -148.98 149.11 30.62 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.025 -1.047 . . . . 1.6899999999999999 111.087 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 37.4 p -111.04 9.64 22.09 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 115.505 -0.77 . . . . 0.01 110.349 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -120.82 163.12 18.65 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 121.234 -0.916 . . . . 3.21 111.56 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.69 156.92 35.78 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.318 -0.993 . . . . 0.01 108.318 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 20.6 t -127.55 113.8 21.03 Favored Pre-proline 0 N--CA 1.498 1.973 0 N-CA-C 108.846 -0.798 . . . . 0.01 108.846 178.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -75.01 -27.7 9.78 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 CA-C-N 120.389 1.175 . . . . 0.01 110.911 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.2 t -143.05 109.01 5.18 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.336 -0.853 . . . . 0.02 109.137 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.424 HD12 ' O ' ' A' ' 169' ' ' ILE . 87.1 mt -63.45 -39.24 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.892 -0.505 . . . . 1.8300000000000001 110.547 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 118' ' ' MET . 0.7 OUTLIER -68.73 -37.27 79.32 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.277 -0.969 . . . . 1.3400000000000001 110.365 -178.308 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -69.8 -38.66 76.72 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.4 -1.437 . . . . 2.1099999999999999 109.974 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -79.71 -46.54 16.89 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.291 -0.881 . . . . 2.0800000000000001 112.264 -177.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -111.05 0.49 16.95 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.312 -0.867 . . . . 0.02 112.674 -176.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 59.95 33.53 21.48 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.737 -1.227 . . . . 0.02 109.442 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.2 mt -112.62 135.38 53.41 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 108.713 -0.847 . . . . 0.02 108.713 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -91.25 -22.86 20.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.144 -0.972 . . . . 5.3200000000000003 110.246 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -149.62 164.33 35.46 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.241 -0.912 . . . . 0.02 109.791 -178.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.7 mt -131.74 128.64 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 107.65 -1.241 . . . . 2.1699999999999999 107.65 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.524 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 51.4 t-80 -107.97 -12.85 15.08 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.421 -0.799 . . . . 0.02 112.107 -177.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.4 m -159.15 150.62 20.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.004 -1.06 . . . . 0.01 109.018 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 6.0 p -169.39 148.45 3.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.39 -0.818 . . . . 1.22 109.045 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -122.96 113.4 19.03 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 122.396 1.093 . . . . 1.4099999999999999 110.102 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 t -112.09 129.86 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 107.351 -1.352 . . . . 0.01 107.351 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 96.3 t -129.61 93.9 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 107.392 -1.336 . . . . 1.98 107.392 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.504 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 3.5 tm-20 -146.97 -78.48 0.17 Allowed 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 105.87 -1.9 . . . . 0.01 105.87 177.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 173.24 -69.49 0.1 Allowed Glycine 0 N--CA 1.484 1.882 0 N-CA-C 108.77 -1.732 . . . . 0.01 108.77 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.9 p -120.51 114.04 21.19 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.587 -0.949 . . . . 2.2999999999999998 110.387 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.504 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 6.5 m95 -124.94 148.8 48.18 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 107.303 -1.369 . . . . 0.01 107.303 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.8 mt -121.58 136.46 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 120.452 -1.405 . . . . 1.6899999999999999 110.184 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -115.32 144.35 43.89 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.69 -1.226 . . . . 2.4900000000000002 107.69 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 8.9 m-85 -123.45 144.04 49.77 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.324 -0.86 . . . . 0.02 109.648 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -75.9 -28.95 58.28 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.698 -0.626 . . . . 0.02 111.881 -176.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 47.3 mt -114.64 151.37 45.25 Favored Pre-proline 0 N--CA 1.504 2.267 0 O-C-N 120.712 -1.242 . . . . 1.48 109.014 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -53.6 167.36 0.97 Allowed 'Trans proline' 0 N--CA 1.49 1.275 0 CA-C-O 122.555 0.981 . . . . 0.02 112.543 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 59.51 30.45 20.11 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 115.023 -0.99 . . . . 0.75 111.268 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.428 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.7 m-85 57.8 51.3 9.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.429 -0.794 . . . . 0.02 111.236 177.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -126.24 164.25 21.39 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.498 -0.751 . . . . 0.02 109.993 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.23 -165.25 32.64 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.352 -1.099 . . . . 0.02 110.352 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.465 ' CZ ' ' OH ' ' A' ' 149' ' ' TYR . 16.6 ttp180 -69.19 142.29 54.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.685 -0.891 . . . . 0.02 109.122 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -114.58 148.42 38.06 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.343 0.592 . . . . 0.02 110.134 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.465 ' OH ' ' CZ ' ' A' ' 147' ' ' ARG . 80.9 m-85 -124.07 134.3 53.43 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 109.019 -0.734 . . . . 0.01 109.019 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 151' ' ' LEU . 4.1 tt -98.51 121.55 40.59 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.852 -1.155 . . . . 0.01 108.86 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.596 HD11 ' CE1' ' A' ' 156' ' ' TYR . 42.5 tp -97.3 142.45 29.17 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.212 -0.93 . . . . 0.01 108.67 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -107.13 -113.3 0.28 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.612 -0.68 . . . . 2.27 109.662 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -149.04 57.28 1.02 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.129 -0.982 . . . . 1.8400000000000001 109.212 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -118.11 -179.31 3.73 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.386 -0.821 . . . . 2.2799999999999998 109.091 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -106.49 107.41 18.4 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.63 -0.878 . . . . 0.01 108.63 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.596 ' CE1' HD11 ' A' ' 151' ' ' LEU . 30.9 m-85 -98.78 113.44 25.55 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.29 -0.881 . . . . 0.01 110.328 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -93.51 -24.66 17.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.0 -1.062 . . . . 0.01 110.445 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -129.08 154.51 80.45 Favored Pre-proline 0 N--CA 1.498 1.974 0 N-CA-C 107.969 -1.123 . . . . 2.54 107.969 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -58.09 -38.62 90.87 Favored 'Trans proline' 0 N--CA 1.489 1.214 0 CA-C-N 119.467 0.845 . . . . 0.69999999999999996 110.245 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.2 t -63.77 -24.71 36.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.825 -1.172 . . . . 0.85999999999999999 109.586 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.06 -18.14 65.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.592 -1.317 . . . . 0.02 109.938 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.569 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 12.4 t90 -100.18 9.03 43.4 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.789 -1.189 . . . . 0.02 107.789 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.09 10.12 86.43 Favored Glycine 0 N--CA 1.485 1.96 0 C-N-CA 120.229 -0.986 . . . . 0.02 111.244 178.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.63 140.98 33.03 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.073 -1.251 . . . . 0.02 110.207 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -87.23 -11.85 48.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.627 -0.671 . . . . 0.58999999999999997 110.733 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 43.5 m -147.83 149.85 34.44 Favored Pre-proline 0 N--CA 1.499 1.994 0 O-C-N 120.547 -1.345 . . . . 0.87 108.895 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -78.1 22.86 0.6 Allowed 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 120.879 1.052 . . . . 0.38 112.872 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.854 ' O ' HD13 ' A' ' 169' ' ' ILE . . . -83.61 124.32 30.68 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.708 -1.245 . . . . 0.17999999999999999 111.784 -177.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.854 HD13 ' O ' ' A' ' 168' ' ' ALA . 4.8 mm -147.83 129.52 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 106.908 -1.516 . . . . 3.9900000000000002 106.908 178.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -112.58 -18.38 12.4 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 120.998 -1.064 . . . . 5.1699999999999999 113.475 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.4 p -157.21 161.0 39.26 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 119.36 -2.088 . . . . 0.02 110.117 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.418 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 19.8 p90 -152.27 152.4 32.12 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.051 -1.03 . . . . 2.02 110.809 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.428 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 26.0 mtp180 -144.49 149.92 36.75 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.38 -0.825 . . . . 0.01 110.155 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 60.4 mtm180 -87.76 144.1 26.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.535 -0.728 . . . . 0.01 109.363 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.2 mt -94.82 128.57 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.282 -0.886 . . . . 3.04 109.149 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.1 t -136.44 146.68 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.254 -0.903 . . . . 1.8899999999999999 109.65 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 4.8899999999999997 109.476 179.935 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.287 -1.525 . . . . 0.01 109.287 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -148.55 136.94 21.25 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.124 -1.221 . . . . 0.02 110.376 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 tt -130.66 140.55 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 109.073 -0.714 . . . . 0.02 109.073 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.1 m -121.78 130.82 53.69 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.4 -0.812 . . . . 0.39000000000000001 109.979 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.4 m-85 -110.6 140.54 44.82 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.624 -0.673 . . . . 0.02 109.38 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.516 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 5.1 m-85 -122.8 139.17 54.29 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.223 -0.923 . . . . 0.02 109.646 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.474 ' CG ' HD11 ' A' ' 33' ' ' LEU . 38.5 mt-10 -69.75 -27.77 65.21 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.167 -0.958 . . . . 0.029999999999999999 112.097 -178.128 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 2.9 m-20 -114.24 169.44 9.03 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.887 -1.133 . . . . 0.029999999999999999 110.225 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -75.04 157.81 34.22 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.69 0.757 . . . . 0.029999999999999999 109.982 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.2 t30 66.54 33.47 6.63 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.918 0.866 . . . . 0.73999999999999999 111.158 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 55.58 41.91 30.15 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.249 0.547 . . . . 0.02 111.413 177.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -112.86 165.75 12.02 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.244 -1.021 . . . . 0.02 108.244 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.48 -167.84 34.29 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.85 -1.167 . . . . 0.029999999999999999 110.677 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.579 ' CG ' HH11 ' A' ' 18' ' ' ARG . 0.3 OUTLIER -70.11 144.02 52.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.419 -1.047 . . . . 2.7599999999999998 108.999 179.453 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -120.2 148.63 43.43 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.559 -0.713 . . . . 1.8899999999999999 110.219 -178.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -131.99 127.31 35.99 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.221 -1.029 . . . . 0.02 108.221 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.46 136.9 51.4 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.42 -0.8 . . . . 1.1200000000000001 109.779 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.408 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 13.2 t -130.94 138.73 49.88 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.446 0.641 . . . . 0.02 109.654 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.3 p30 -116.77 11.23 14.48 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.631 -0.668 . . . . 0.20000000000000001 109.77 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.408 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 28.2 p -158.74 174.91 14.3 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.348 -0.982 . . . . 1.23 108.348 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -60.94 143.88 54.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.665 -1.272 . . . . 0.02 109.832 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 43.5 t -131.28 117.48 19.02 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.51 -0.922 . . . . 0.02 108.51 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.437 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -78.07 -25.08 47.52 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.045 -1.035 . . . . 0.23999999999999999 110.989 -178.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -155.1 102.38 2.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.025 -1.047 . . . . 1.1399999999999999 109.256 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -102.65 10.08 38.89 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 122.017 0.913 . . . . 6.3700000000000001 109.753 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -59.68 -25.41 64.73 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.532 -0.73 . . . . 3.1099999999999999 111.582 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.2 m -76.24 -17.15 59.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.522 -1.361 . . . . 0.88 110.609 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -104.06 -21.91 13.52 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.387 -0.82 . . . . 0.02 109.457 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.474 HD11 ' CG ' ' A' ' 11' ' ' GLU . 10.5 tp -149.92 128.56 12.36 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.328 -0.858 . . . . 3.3199999999999998 109.159 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.7 p -85.71 -10.96 54.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.642 -0.661 . . . . 0.02 111.069 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -171.72 162.3 6.23 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.927 -1.138 . . . . 0.02 107.927 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.2 p -141.48 113.95 8.24 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.987 -1.07 . . . . 0.02 108.452 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -105.17 0.17 27.1 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.767 -1.208 . . . . 0.029999999999999999 110.964 -178.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 m -154.44 155.65 35.34 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.669 -1.234 . . . . 0.02 107.669 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.5 mt -146.24 145.51 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.795 -1.19 . . . . 0.02 110.928 -178.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -124.09 124.84 43.4 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.874 -1.158 . . . . 0.02 107.874 177.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.6 t -105.16 114.03 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 106.745 -1.576 . . . . 0.02 106.745 177.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -84.7 -34.74 22.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.559 -0.713 . . . . 3.8100000000000001 110.101 -178.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.01 150.54 19.55 Favored Glycine 0 N--CA 1.488 2.128 0 C-N-CA 118.514 -1.803 . . . . 0.02 110.722 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.19 172.15 48.84 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 120.027 -1.082 . . . . 0.01 110.563 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.9 m -119.42 135.03 54.93 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 107.711 -1.218 . . . . 1.48 107.711 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.448 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 32.7 m95 -127.49 155.0 44.44 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 122.584 1.183 . . . . 0.02 112.462 -176.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.99 134.51 51.54 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 105.545 -2.02 . . . . 0.23999999999999999 105.545 176.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.475 ' HB ' HD22 ' A' ' 79' ' ' LEU . 28.7 m -119.03 143.63 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.585 -0.697 . . . . 0.65000000000000002 109.158 178.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -120.84 146.05 46.96 Favored 'General case' 0 N--CA 1.503 2.204 0 CA-C-O 122.143 0.973 . . . . 0.02 109.949 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -67.35 -34.59 77.62 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.839 -0.619 . . . . 0.02 111.392 -177.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -125.17 157.91 65.51 Favored Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 121.047 -1.033 . . . . 0.02 109.379 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -53.84 166.4 1.45 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 121.63 1.553 . . . . 0.02 113.242 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 63.9 36.66 10.05 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.218 -0.901 . . . . 0.02 111.116 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 45.36 51.68 9.35 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.667 0.746 . . . . 3.3900000000000001 110.633 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.7 m -126.11 163.64 22.66 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.13 0.491 . . . . 2.3300000000000001 109.714 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.8 -161.82 32.35 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.803 -1.319 . . . . 0.02 109.803 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -66.16 140.1 58.18 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.081 -1.247 . . . . 0.02 110.314 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.452 ' C ' ' SD ' ' A' ' 58' ' ' MET . 10.4 tmm? -119.37 136.81 54.1 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.76 -0.588 . . . . 5.0099999999999998 109.639 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.447 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 97.9 m-85 -133.98 138.35 45.37 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.393 -0.817 . . . . 0.02 109.935 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.3 mm -96.23 132.17 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 109.205 -0.665 . . . . 1.72 109.205 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.448 HD22 ' CE1' ' A' ' 66' ' ' TYR . 10.1 mt -120.35 111.6 34.96 Favored Pre-proline 0 N--CA 1.505 2.288 0 O-C-N 121.413 -0.804 . . . . 0.02 110.897 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -77.72 169.72 20.32 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 CA-C-N 119.79 0.961 . . . . 1.47 110.042 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -53.14 140.89 24.57 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.745 -1.222 . . . . 4.25 110.458 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.96 -178.05 31.88 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.505 -1.331 . . . . 0.02 110.746 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -120.47 131.76 54.9 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.454 -1.027 . . . . 0.95999999999999996 109.822 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.448 ' CE1' HD22 ' A' ' 61' ' ' LEU . 81.9 m-85 -121.11 94.98 48.91 Favored Pre-proline 0 N--CA 1.494 1.725 0 N-CA-C 108.094 -1.076 . . . . 0.02 108.094 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.402 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 3.4 Cg_exo -66.11 -4.65 10.71 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 120.829 1.019 . . . . 0.02 113.641 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 77.7 mt-10 -157.64 155.27 29.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.818 -1.176 . . . . 2.02 108.306 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -61.21 -38.53 86.92 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.371 -0.831 . . . . 0.02 112.08 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -59.95 -23.44 63.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.971 -1.081 . . . . 0.02 110.191 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -70.55 -19.38 62.89 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.706 0.765 . . . . 3.4199999999999999 109.09 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.542 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 1.6 t90 -108.37 9.08 27.82 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.627 -1.249 . . . . 0.02 107.627 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 10.3 mtt 60.94 22.22 12.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.649 -0.657 . . . . 0.02 110.53 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.65 143.44 44.76 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.494 -1.443 . . . . 0.02 109.494 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 26.8 tp -78.96 -31.64 45.1 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.387 -1.338 . . . . 0.97999999999999998 107.387 177.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -157.87 -172.31 3.88 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 106.191 -1.781 . . . . 0.02 106.191 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -98.67 28.46 4.24 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.591 -1.318 . . . . 0.02 110.805 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 -96.94 122.05 39.49 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.779 -1.201 . . . . 3.2000000000000002 110.997 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.475 HD22 ' HB ' ' A' ' 48' ' ' VAL . 63.9 mt -144.03 122.19 12.2 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 107.627 -1.249 . . . . 2.6099999999999999 107.627 178.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.55 -16.41 11.0 Favored Glycine 0 N--CA 1.504 3.211 0 O-C-N 121.279 -0.888 . . . . 0.02 112.741 -177.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 23.5 m -156.69 156.32 33.23 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.245 -1.738 . . . . 0.02 110.445 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 25.1 t -144.03 146.89 33.17 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.574 -0.704 . . . . 0.02 110.027 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -138.47 143.6 39.69 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.174 -0.954 . . . . 0.01 109.691 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.86 132.78 36.18 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.282 -0.886 . . . . 0.42999999999999999 110.001 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.6 t -92.18 126.14 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 109.363 -0.606 . . . . 1.25 109.363 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -94.48 130.92 40.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.741 -1.224 . . . . 1.77 109.379 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.7 mt -97.7 142.69 29.18 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.384 -0.823 . . . . 1.6299999999999999 109.07 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 51.7 p -113.33 126.41 55.35 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.331 -0.855 . . . . 1.0800000000000001 109.422 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 90' ' ' GLY . 54.5 m -108.15 9.33 28.24 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 106.766 -1.568 . . . . 1.26 106.766 176.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 89' ' ' SER . . . -26.35 -49.83 0.05 OUTLIER Glycine 0 N--CA 1.495 2.583 0 CA-C-N 115.54 -0.755 . . . . 0.01 112.528 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.76 -105.89 0.19 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 118.724 -1.703 . . . . 0.01 111.737 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' A' ' 93' ' ' ALA . 11.5 tm0? -122.07 120.47 34.4 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.125 -1.221 . . . . 4.4299999999999997 110.434 -178.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.537 ' O ' ' NE2' ' A' ' 92' ' ' GLN . . . -80.48 129.28 34.41 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.893 -0.723 . . . . 2.9900000000000002 109.637 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -130.57 143.02 50.48 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 108.605 -0.887 . . . . 6.3600000000000003 108.605 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.405 ' C ' ' NE2' ' A' ' 96' ' ' GLN . 4.7 tt -129.35 145.22 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 121.151 -0.968 . . . . 1.0900000000000001 110.708 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.629 ' N ' ' NE2' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -122.93 133.26 54.4 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 107.599 -1.26 . . . . 2.0499999999999998 107.599 177.296 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.48 HG12 ' SG ' ' A' ' 129' ' ' CYS . 17.5 m -124.26 146.2 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 O-C-N 120.658 -1.276 . . . . 1.1000000000000001 109.826 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.584 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 71.7 m-85 -118.83 141.09 48.96 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.939 0.876 . . . . 0.72999999999999998 110.862 -178.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -66.09 -30.13 70.59 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 116.09 -0.504 . . . . 0.02 111.572 -178.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -117.3 170.88 8.35 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.024 -1.047 . . . . 3.1800000000000002 110.247 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.41 169.88 43.21 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.862 -0.895 . . . . 0.01 110.862 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 52.92 38.95 28.3 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.501 0.667 . . . . 0.01 111.663 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 52.25 48.93 21.64 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.495 -0.753 . . . . 0.01 111.022 178.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -123.42 165.95 16.19 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.311 -0.996 . . . . 3.1499999999999999 108.311 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.02 -164.36 28.58 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.538 -1.425 . . . . 0.01 109.538 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -76.38 144.97 39.73 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.942 -1.328 . . . . 0.01 108.569 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.584 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 28.3 ttp -117.09 142.65 46.72 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.637 0.732 . . . . 0.01 110.028 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -131.15 137.07 48.85 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.067 -1.086 . . . . 2.48 108.067 178.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -118.3 133.76 55.61 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.611 -0.681 . . . . 0.01 110.153 -178.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.4 ' O ' HG22 ' A' ' 95' ' ' ILE . 5.2 t -148.6 148.61 30.33 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.284 1.04 . . . . 1.6899999999999999 111.061 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 31.2 p -111.38 9.7 21.51 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 115.435 -0.802 . . . . 0.01 110.26 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -121.2 163.01 19.17 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.204 -0.935 . . . . 3.21 111.479 -178.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.05 156.27 37.75 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.645 -0.872 . . . . 0.01 108.645 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 23.9 t -127.7 114.15 20.82 Favored Pre-proline 0 N--CA 1.5 2.032 0 N-CA-C 108.795 -0.817 . . . . 0.01 108.795 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -74.59 -29.0 9.45 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 CA-C-N 120.364 1.166 . . . . 0.01 111.07 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 65.3 m -142.58 108.94 5.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.41 -0.806 . . . . 0.02 108.954 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.41 HD12 ' O ' ' A' ' 169' ' ' ILE . 92.1 mt -63.54 -38.64 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.936 -0.477 . . . . 1.8300000000000001 110.674 -178.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 118' ' ' MET . 12.2 tmm? -68.32 -37.23 80.35 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.31 -0.956 . . . . 1.3400000000000001 110.048 -178.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -69.54 -38.54 77.52 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.578 -1.326 . . . . 2.1099999999999999 110.074 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.452 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 50.5 tt0 -79.82 -46.84 16.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.279 -0.888 . . . . 2.0800000000000001 112.333 -177.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.452 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 32.5 m-85 -111.0 0.01 16.83 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.379 -0.826 . . . . 0.02 112.712 -176.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 59.93 33.44 21.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.774 -1.204 . . . . 0.02 109.433 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 11.0 mt -112.52 135.81 52.78 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 108.77 -0.826 . . . . 0.02 108.77 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -91.8 -22.68 20.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.198 -0.939 . . . . 5.3200000000000003 110.361 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -149.64 164.08 36.15 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.169 -0.957 . . . . 0.02 109.981 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.2 mt -132.1 128.92 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 107.751 -1.203 . . . . 2.1699999999999999 107.751 178.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -108.54 -11.91 15.06 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.343 -0.848 . . . . 0.02 112.278 -177.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.4 m -159.1 151.73 21.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.948 -1.095 . . . . 0.01 108.765 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.48 ' SG ' HG12 ' A' ' 97' ' ' VAL . 8.2 t -165.38 149.01 8.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.107 -0.996 . . . . 1.22 109.157 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.415 ' O ' ' OE1' ' A' ' 96' ' ' GLN . 7.2 ttpt -119.49 108.24 14.28 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 122.339 1.066 . . . . 1.4099999999999999 109.28 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.2 t -113.52 127.15 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.555 -1.276 . . . . 0.01 107.555 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.9 t -131.42 94.18 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 107.632 -1.247 . . . . 1.98 107.632 177.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.642 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 26.7 tt0 -147.46 -77.2 0.17 Allowed 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 105.772 -1.936 . . . . 0.01 105.772 177.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 170.64 -63.59 0.17 Allowed Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.737 -1.745 . . . . 0.01 108.737 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.8 p -123.33 113.2 18.54 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.497 -1.002 . . . . 2.2999999999999998 110.846 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.642 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 9.8 m95 -126.07 147.15 49.65 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 107.335 -1.358 . . . . 0.01 107.335 178.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.5 mt -121.86 136.2 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 O-C-N 120.568 -1.332 . . . . 1.6899999999999999 110.248 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -116.17 145.28 43.21 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.339 -1.356 . . . . 2.4900000000000002 107.339 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.5 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 15.2 m-85 -123.21 143.75 49.83 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.311 -0.868 . . . . 0.02 109.722 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -74.59 -29.31 61.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.523 -0.735 . . . . 0.02 111.74 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.4 mt -115.78 154.9 48.16 Favored Pre-proline 0 N--CA 1.503 2.212 0 O-C-N 120.697 -1.252 . . . . 1.48 109.054 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -56.06 166.9 2.75 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 121.123 1.215 . . . . 0.02 112.802 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.2 m120 59.79 31.24 20.69 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.043 -0.98 . . . . 0.75 111.437 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.446 ' HD1' ' HG ' ' A' ' 171' ' ' SER . 1.9 m-85 57.68 51.62 9.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.513 -0.742 . . . . 0.02 111.141 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 41.2 mtm180 -127.1 164.91 20.55 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.531 -0.73 . . . . 0.02 110.241 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.74 -165.67 33.64 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.538 -1.025 . . . . 0.02 110.538 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -69.25 142.33 54.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.539 -0.977 . . . . 0.02 108.98 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -113.64 148.33 36.47 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.834 -0.541 . . . . 0.02 110.344 -178.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -124.23 133.56 53.49 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 108.853 -0.795 . . . . 0.01 108.853 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.477 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.2 tt -100.22 122.47 43.08 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.06 -1.025 . . . . 0.01 109.231 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.477 ' N ' HD23 ' A' ' 150' ' ' LEU . 2.6 mp -98.12 147.03 24.98 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.235 -1.024 . . . . 0.01 108.235 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -105.06 -121.08 0.22 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.627 -0.671 . . . . 2.27 110.009 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -139.28 53.32 1.73 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.229 -0.919 . . . . 1.8400000000000001 109.401 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -116.38 -172.35 2.17 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.406 -0.809 . . . . 2.2799999999999998 109.195 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -105.55 109.51 21.51 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.39 -0.967 . . . . 0.01 108.39 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.606 ' CG ' ' NE1' ' A' ' 162' ' ' TRP . 35.9 m-85 -98.58 111.36 23.75 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.239 -0.913 . . . . 0.01 110.575 -178.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -95.65 -22.22 17.71 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.21 -0.931 . . . . 0.01 111.298 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 39.6 mttp -127.51 154.59 77.49 Favored Pre-proline 0 N--CA 1.502 2.153 0 O-C-N 121.142 -0.974 . . . . 2.54 108.656 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -59.59 -39.05 78.27 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 120.423 0.748 . . . . 0.69999999999999996 110.596 178.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.99 -20.08 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.895 -1.128 . . . . 0.85999999999999999 109.079 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -65.33 -15.48 62.59 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.946 -1.096 . . . . 0.02 110.134 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.606 ' NE1' ' CG ' ' A' ' 156' ' ' TYR . 9.6 m0 -97.55 11.85 35.47 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.245 -0.909 . . . . 0.02 108.94 178.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.14 10.07 85.92 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.767 -1.206 . . . . 0.02 111.089 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.03 141.08 32.23 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.193 -1.181 . . . . 0.02 110.073 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.12 -8.95 58.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.654 -0.654 . . . . 0.58999999999999997 109.797 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.3 p -143.59 150.74 51.88 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 121.044 -1.035 . . . . 0.87 108.924 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -76.04 18.74 0.63 Allowed 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 120.704 0.936 . . . . 0.38 112.3 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.859 ' O ' HD13 ' A' ' 169' ' ' ILE . . . -83.07 122.24 28.09 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.824 -1.173 . . . . 0.17999999999999999 111.321 -178.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.859 HD13 ' O ' ' A' ' 168' ' ' ALA . 4.1 mm -146.54 126.82 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 106.521 -1.659 . . . . 3.9900000000000002 106.521 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -112.16 -18.09 12.65 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.955 -1.091 . . . . 5.1699999999999999 113.405 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' SER . . . . . 0.446 ' HG ' ' HD1' ' A' ' 144' ' ' TYR . 1.6 p -157.49 160.67 38.49 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 119.196 -2.19 . . . . 0.02 110.179 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.411 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 21.0 p90 -151.45 152.26 32.78 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.069 -1.019 . . . . 2.02 110.481 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -145.26 150.67 37.09 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.857 0.837 . . . . 0.01 110.393 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -89.11 145.24 25.58 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.138 -0.69 . . . . 0.01 109.138 178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 175' ' ' ILE . 5.1 mt -95.85 129.81 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.399 -0.813 . . . . 3.04 108.89 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 25.4 m -137.76 147.63 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.088 -1.007 . . . . 1.8899999999999999 109.912 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.371 -0.831 . . . . 4.8899999999999997 109.366 179.479 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.706 -1.357 . . . . 0.01 109.706 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -144.13 133.57 23.32 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.226 -1.161 . . . . 0.02 110.538 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.4 tt -129.45 139.41 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.11 -1.07 . . . . 0.02 108.11 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.1 m -120.99 129.14 53.29 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.291 -0.88 . . . . 0.39000000000000001 110.103 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 9.1 m-85 -109.8 140.19 44.01 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.641 -0.874 . . . . 0.02 108.641 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.554 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.8 m-85 -121.9 138.09 54.53 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.334 -0.854 . . . . 0.02 109.446 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -68.69 -27.14 65.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -0.943 . . . . 0.029999999999999999 111.389 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.0 OUTLIER -114.56 170.12 8.55 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.992 -1.068 . . . . 0.029999999999999999 109.958 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -75.98 161.87 28.56 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.633 0.73 . . . . 0.029999999999999999 110.4 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.455 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 0.2 OUTLIER 62.9 33.02 15.39 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.025 0.917 . . . . 0.73999999999999999 110.916 179.342 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 55.46 40.32 31.25 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.858 -0.61 . . . . 0.02 111.05 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -110.62 165.22 11.99 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.188 -1.041 . . . . 0.02 108.188 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.25 -167.91 34.67 Favored Glycine 0 N--CA 1.497 2.708 0 O-C-N 120.907 -1.12 . . . . 0.029999999999999999 110.911 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.433 ' HG3' HH11 ' A' ' 18' ' ' ARG . 13.4 ttm-85 -69.95 143.46 52.65 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.471 -1.017 . . . . 2.7599999999999998 109.316 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.1 ttp180 -122.03 149.98 42.74 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.38 -0.825 . . . . 1.8899999999999999 110.431 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.49 ' CZ ' ' CG ' ' A' ' 32' ' ' TYR . 9.4 t80 -135.14 131.35 36.73 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.811 -0.811 . . . . 0.02 108.811 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -111.7 137.08 50.08 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.458 -0.776 . . . . 1.1200000000000001 109.463 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 40.2 t -129.35 138.75 51.73 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 121.41 0.624 . . . . 0.02 109.629 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -117.7 11.9 13.8 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.545 -0.722 . . . . 0.20000000000000001 110.245 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.483 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 42.5 t -159.17 174.24 15.15 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.916 -1.115 . . . . 1.23 108.757 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.473 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 17.6 p30 -61.74 145.14 53.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.613 -1.304 . . . . 0.02 110.219 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.423 ' CB ' ' CZ ' ' A' ' 29' ' ' PHE . 0.6 OUTLIER -134.35 119.12 18.25 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.543 -0.91 . . . . 0.02 108.543 178.59 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.62 -19.73 57.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.557 -0.715 . . . . 0.23999999999999999 111.672 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -154.28 108.72 3.03 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.923 -1.111 . . . . 1.1399999999999999 111.005 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.423 ' CZ ' ' CB ' ' A' ' 26' ' ' CYS . 22.2 m-85 -96.01 5.88 50.16 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.283 -0.886 . . . . 6.3700000000000001 109.283 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -60.63 -30.7 70.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.282 -0.886 . . . . 3.1099999999999999 112.246 -176.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.5 m -78.72 -19.07 53.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.271 -1.518 . . . . 0.88 111.55 -178.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.49 ' CG ' ' CZ ' ' A' ' 20' ' ' TYR . 65.2 m-85 -107.06 -21.83 12.86 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.266 -0.896 . . . . 0.02 110.819 -178.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.415 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 6.1 tp -149.16 127.63 12.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.895 -1.128 . . . . 3.3199999999999998 109.793 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.9 m -86.56 -11.77 50.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.53 -0.731 . . . . 0.02 111.127 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.415 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 4.8 ptp180 -171.68 161.95 6.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.933 -1.105 . . . . 0.02 108.24 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -142.65 115.75 8.87 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.909 -1.119 . . . . 0.02 108.887 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -109.49 0.32 19.2 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.85 -1.156 . . . . 0.029999999999999999 111.458 -178.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.3 m -156.8 153.81 28.9 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.385 -0.969 . . . . 0.02 108.385 178.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.0 mt -146.2 147.16 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-O 122.325 1.06 . . . . 0.02 111.176 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -122.59 123.66 41.71 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.738 -1.208 . . . . 0.02 107.738 176.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.3 t -106.8 115.2 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 106.902 -1.518 . . . . 0.02 106.902 177.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -83.31 -33.85 25.85 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 120.068 -0.653 . . . . 3.8100000000000001 111.024 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.97 152.36 22.19 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 118.878 -1.63 . . . . 0.02 110.854 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.59 173.24 49.59 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.66 -1.257 . . . . 0.01 110.418 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 65.6 m -119.6 135.16 54.92 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.033 -1.099 . . . . 1.48 108.033 178.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -127.31 155.98 42.68 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 122.639 1.209 . . . . 0.02 112.172 -176.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.51 134.57 51.73 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 105.527 -2.027 . . . . 0.23999999999999999 105.527 176.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.6 m -116.31 142.01 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.549 -0.719 . . . . 0.65000000000000002 109.306 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -120.53 143.32 48.64 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 122.056 0.931 . . . . 0.02 109.508 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.504 ' OE1' ' CE1' ' A' ' 57' ' ' HIS . 36.9 tt0 -65.67 -33.37 75.73 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.671 -0.695 . . . . 0.02 111.712 -177.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 35.8 mtm180 -124.85 157.8 65.0 Favored Pre-proline 0 N--CA 1.503 2.194 0 O-C-N 120.991 -1.068 . . . . 0.02 109.368 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -53.31 167.36 0.83 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.753 1.635 . . . . 0.02 112.634 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.5 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.4 OUTLIER 63.02 36.2 12.58 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 115.254 -0.885 . . . . 0.02 111.273 178.138 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.509 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 5.5 m-85 45.28 51.11 9.53 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.707 0.765 . . . . 3.3900000000000001 110.706 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.8 m -125.54 163.57 22.41 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 121.2 0.524 . . . . 2.3300000000000001 109.802 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.44 -161.67 31.39 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.844 -1.302 . . . . 0.02 109.844 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.504 ' CE1' ' OE1' ' A' ' 50' ' ' GLU . 10.1 m80 -65.13 137.84 57.9 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.11 -1.229 . . . . 0.02 110.219 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.496 ' O ' ' SD ' ' A' ' 58' ' ' MET . 2.8 ppp? -118.68 137.49 53.28 Favored 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 121.357 0.599 . . . . 5.0099999999999998 109.553 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.473 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 81.6 m-85 -135.44 140.48 44.92 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.503 -0.748 . . . . 0.02 109.61 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.9 mm -95.19 131.05 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.607 -0.683 . . . . 1.72 109.164 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.531 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 1.0 OUTLIER -121.09 111.39 33.95 Favored Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 121.284 -0.885 . . . . 0.02 110.743 -178.284 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -77.27 169.02 22.07 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 CA-C-N 119.898 0.999 . . . . 1.47 110.371 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -53.39 141.73 23.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.96 -1.087 . . . . 4.25 110.369 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.81 -177.7 31.96 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.523 -1.322 . . . . 0.02 110.755 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -120.21 131.56 55.02 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.464 -1.021 . . . . 0.95999999999999996 109.661 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.531 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 59.5 m-85 -122.41 97.62 44.75 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 108.022 -1.103 . . . . 0.02 108.022 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.404 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 3.4 Cg_endo -68.77 -3.26 10.94 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 120.745 0.963 . . . . 0.02 113.898 -178.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 79.2 mt-10 -157.64 155.2 29.65 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.433 -1.417 . . . . 2.02 108.281 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -60.69 -39.1 87.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.63 -0.669 . . . . 0.02 112.108 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -60.28 -23.47 64.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.058 -1.026 . . . . 0.02 110.32 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -69.82 -18.75 63.47 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.88 -0.785 . . . . 3.4199999999999999 108.88 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.589 ' CH2' HD21 ' A' ' 79' ' ' LEU . 1.7 t90 -107.95 10.95 28.29 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.464 -1.31 . . . . 0.02 107.464 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.3 mtt 61.21 22.49 12.82 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.476 0.655 . . . . 0.02 110.409 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.72 144.29 48.07 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.574 -1.41 . . . . 0.02 109.574 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.429 ' N ' HD12 ' A' ' 75' ' ' LEU . 9.3 mp -79.78 -29.95 40.52 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.708 -1.219 . . . . 0.97999999999999998 107.708 177.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -156.83 -171.17 3.56 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 106.342 -1.725 . . . . 0.02 106.342 178.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 23.0 p-10 -98.91 28.72 4.18 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.697 -1.252 . . . . 0.02 110.526 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -96.49 122.33 39.27 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.796 -1.19 . . . . 3.2000000000000002 111.057 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.589 HD21 ' CH2' ' A' ' 72' ' ' TRP . 78.1 mt -141.92 119.83 11.97 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.609 -1.256 . . . . 2.6099999999999999 107.609 178.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.51 -18.54 8.47 Favored Glycine 0 N--CA 1.499 2.853 0 O-C-N 121.245 -0.909 . . . . 0.02 112.809 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.509 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 12.6 t -156.0 156.48 34.54 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-N 120.324 2.062 . . . . 0.02 111.13 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 11.9 t -146.45 148.78 32.61 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.342 -0.849 . . . . 0.02 110.723 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.425 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 52.1 mtp180 -138.16 143.13 40.13 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.509 -0.745 . . . . 0.01 109.345 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.19 132.46 36.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.102 -0.998 . . . . 0.42999999999999999 109.938 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.9 t -91.12 125.01 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.571 -0.706 . . . . 1.25 109.139 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -93.97 131.89 38.97 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.877 -1.139 . . . . 1.77 109.079 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 mt -96.66 139.45 32.71 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.54 -0.911 . . . . 1.6299999999999999 108.54 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.1 p -111.8 127.88 55.94 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.362 -0.836 . . . . 1.0800000000000001 109.312 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.7 m -104.39 -153.97 0.49 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 106.492 -1.669 . . . . 1.26 106.492 176.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.33 -53.15 0.72 Allowed Glycine 0 N--CA 1.5 2.928 0 O-C-N 120.386 -1.446 . . . . 0.01 112.818 177.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.16 -101.65 0.16 Allowed Glycine 0 N--CA 1.491 2.337 0 C-N-CA 118.476 -1.821 . . . . 0.01 111.844 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -121.25 118.91 30.77 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.043 -1.269 . . . . 4.4299999999999997 110.569 -178.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.0 129.62 34.65 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.79 -0.764 . . . . 2.9900000000000002 109.349 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.449 ' CB ' ' NZ ' ' A' ' 94' ' ' LYS . 6.8 ttpm? -129.15 141.95 51.02 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.334 -0.854 . . . . 6.3600000000000003 109.09 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.3 tt -128.64 144.92 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 O-C-N 121.352 -0.842 . . . . 1.0900000000000001 110.237 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -122.67 134.02 54.49 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.911 -1.144 . . . . 2.0499999999999998 107.911 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.469 HG12 ' SG ' ' A' ' 129' ' ' CYS . 29.1 m -123.78 145.05 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 120.823 -1.173 . . . . 1.1000000000000001 110.051 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.572 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 47.5 m-85 -119.92 142.16 48.97 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-O 121.996 0.903 . . . . 0.72999999999999998 111.098 -178.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -67.53 -31.84 72.21 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 116.06 -0.518 . . . . 0.02 111.745 -178.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -115.62 167.44 10.9 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 120.811 -1.181 . . . . 3.1800000000000002 110.593 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.15 163.69 45.01 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.833 -0.907 . . . . 0.01 110.833 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 57.6 38.93 27.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.913 -0.757 . . . . 0.01 110.99 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 52.57 55.92 8.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.696 -0.627 . . . . 0.01 111.184 178.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -128.45 165.87 19.84 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.266 -1.013 . . . . 3.1499999999999999 108.266 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.17 -163.39 27.81 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.234 -1.547 . . . . 0.01 109.234 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 38.4 tp60 -76.29 144.5 40.23 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.965 -1.315 . . . . 0.01 108.656 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.572 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 29.5 ttp -116.68 141.8 47.73 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.638 0.733 . . . . 0.01 109.812 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -131.57 136.3 47.7 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.328 -0.99 . . . . 2.48 108.328 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.521 ' OE2' ' N ' ' A' ' 110' ' ' THR . 1.9 tm-20 -118.12 133.9 55.49 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.559 -0.713 . . . . 0.01 109.997 -178.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.521 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 6.2 t -148.09 148.89 31.14 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.106 -0.996 . . . . 1.6899999999999999 110.969 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 33.3 p -110.78 10.17 22.61 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 115.551 -0.75 . . . . 0.01 110.365 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -120.92 163.16 18.65 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.28 -0.888 . . . . 3.21 111.571 -178.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.06 156.67 36.9 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.255 -1.017 . . . . 0.01 108.255 178.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 19.8 t -125.92 112.53 24.53 Favored Pre-proline 0 N--CA 1.502 2.138 0 O-C-N 121.456 -0.778 . . . . 0.01 108.944 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -75.41 -31.63 5.56 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 120.133 1.083 . . . . 0.01 111.102 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 16.5 m -141.05 107.95 5.41 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.287 -0.883 . . . . 0.02 108.798 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.9 mt -63.36 -39.19 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.949 -0.469 . . . . 1.8300000000000001 110.74 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 118' ' ' MET . 1.7 tmt? -67.81 -37.18 81.64 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.416 -0.914 . . . . 1.3400000000000001 110.46 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -71.09 -39.26 72.23 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 120.464 -1.397 . . . . 2.1099999999999999 110.243 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -79.56 -46.7 16.83 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.239 -0.913 . . . . 2.0800000000000001 112.358 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -109.67 -0.11 18.74 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.34 -0.85 . . . . 0.02 112.531 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 10.3 m80 58.85 32.03 21.84 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.687 -1.258 . . . . 0.02 108.865 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.7 mt -111.47 135.3 52.22 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.656 -0.868 . . . . 0.02 108.656 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -92.09 -23.4 19.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.158 -0.964 . . . . 5.3200000000000003 110.031 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -149.76 163.41 38.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.231 -0.918 . . . . 0.02 109.839 -178.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 45.6 mt -133.31 130.32 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 107.493 -1.299 . . . . 2.1699999999999999 107.493 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -107.83 -11.76 15.32 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.301 -0.875 . . . . 0.02 112.787 -177.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.9 m -158.98 152.7 23.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.734 -1.229 . . . . 0.01 108.82 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.469 ' SG ' HG12 ' A' ' 97' ' ' VAL . 9.2 t -167.65 147.67 5.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.121 -0.987 . . . . 1.22 109.123 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.442 ' NZ ' ' OE2' ' A' ' 155' ' ' GLU . 4.8 tptm -121.0 111.09 17.04 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 122.346 1.069 . . . . 1.4099999999999999 109.717 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.2 t -112.23 128.7 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.603 -1.258 . . . . 0.01 107.603 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.2 t -129.81 94.02 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 106.922 -1.51 . . . . 1.98 106.922 177.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -146.84 -78.57 0.17 Allowed 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 105.824 -1.917 . . . . 0.01 105.824 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 178.51 -75.14 0.07 OUTLIER Glycine 0 N--CA 1.485 1.951 0 N-CA-C 108.144 -1.982 . . . . 0.01 108.144 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.712 ' OG1' HD12 ' A' ' 175' ' ' ILE . 0.1 OUTLIER -121.22 120.55 35.51 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.654 -0.909 . . . . 2.2999999999999998 110.12 179.371 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -126.42 151.0 48.29 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 106.77 -1.567 . . . . 0.01 106.77 179.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 59.1 mt -121.41 135.13 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 120.552 -1.343 . . . . 1.6899999999999999 110.495 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.46 ' HB3' HD12 ' A' ' 169' ' ' ILE . 3.8 m-30 -111.03 142.73 42.79 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 106.269 -1.752 . . . . 2.4900000000000002 106.269 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -122.76 143.49 49.79 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.014 -1.054 . . . . 0.02 109.763 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -74.66 -29.66 61.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.409 -0.807 . . . . 0.02 111.869 -176.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.4 mt -116.1 155.04 48.55 Favored Pre-proline 0 N--CA 1.506 2.372 0 O-C-N 120.793 -1.192 . . . . 1.48 108.983 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -55.92 167.36 2.37 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.116 1.211 . . . . 0.02 112.843 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 59.31 30.44 20.16 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.035 -0.984 . . . . 0.75 111.211 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 58.06 51.43 8.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.484 -0.76 . . . . 0.02 111.055 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -125.97 164.88 19.84 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.546 -0.721 . . . . 0.02 109.863 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.56 ' O ' ' NE2' ' A' ' 148' ' ' GLN . . . 88.79 -166.06 33.84 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.093 -1.203 . . . . 0.02 110.093 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -69.25 142.62 54.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.55 -0.971 . . . . 0.02 108.97 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.56 ' NE2' ' O ' ' A' ' 146' ' ' GLY . 5.6 mp0 -114.58 148.38 38.12 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.315 0.579 . . . . 0.02 110.155 -178.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 149' ' ' TYR . 13.1 m-85 -124.48 135.32 53.12 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.66 -0.867 . . . . 0.01 108.66 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.458 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.5 tt -98.33 122.44 41.5 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.872 -1.143 . . . . 0.01 109.253 -178.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.3 mp -96.43 146.86 24.4 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.294 -0.879 . . . . 0.01 109.043 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -104.68 -124.71 0.22 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.348 -0.845 . . . . 2.27 109.418 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -146.49 47.7 1.19 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.177 -0.952 . . . . 1.8400000000000001 109.514 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -112.73 -161.26 0.75 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.543 -0.723 . . . . 2.2799999999999998 109.168 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.442 ' OE2' ' NZ ' ' A' ' 130' ' ' LYS . 4.1 mm-40 -107.02 104.72 14.45 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.579 -0.701 . . . . 0.01 109.154 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.609 ' CD2' ' CD1' ' A' ' 162' ' ' TRP . 55.3 m-85 -98.15 111.27 23.66 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.249 -0.907 . . . . 0.01 109.448 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -94.39 -22.51 18.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.042 -1.036 . . . . 0.01 111.268 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -127.59 154.42 77.62 Favored Pre-proline 0 N--CA 1.503 2.177 0 O-C-N 120.977 -1.077 . . . . 2.54 108.548 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -59.71 -36.83 90.67 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 CA-C-N 119.148 0.731 . . . . 0.69999999999999996 110.265 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 92.0 t -61.68 -19.78 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.975 -1.078 . . . . 0.85999999999999999 109.094 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -65.57 -15.78 63.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.963 -1.086 . . . . 0.02 110.267 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.609 ' CD1' ' CD2' ' A' ' 156' ' ' TYR . 6.1 m0 -98.6 11.75 37.44 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.175 -0.953 . . . . 0.02 108.986 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.67 10.37 85.27 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 119.861 -1.161 . . . . 0.02 111.207 178.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.63 141.09 32.88 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.179 -1.189 . . . . 0.02 110.072 -178.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.27 -9.32 57.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.627 -0.671 . . . . 0.58999999999999997 110.062 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 39.8 m -143.94 150.09 48.31 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 120.921 -1.112 . . . . 0.87 109.098 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -76.41 18.43 0.69 Allowed 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 120.876 1.05 . . . . 0.38 112.512 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.75 123.45 28.77 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.794 -1.192 . . . . 0.17999999999999999 111.698 -177.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.46 HD12 ' HB3' ' A' ' 138' ' ' PHE . 29.2 mm -148.52 127.96 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 106.77 -1.567 . . . . 3.9900000000000002 106.77 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -112.31 -15.93 13.06 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.137 -0.977 . . . . 5.1699999999999999 112.525 -178.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 22.9 t -157.89 160.67 37.9 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 119.459 -2.026 . . . . 0.02 109.858 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.422 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 18.0 p90 -151.12 152.93 34.08 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.18 -0.95 . . . . 2.02 110.113 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -145.0 150.26 36.59 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.192 -0.942 . . . . 0.01 110.408 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -88.81 144.8 25.99 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.925 -0.768 . . . . 0.01 108.925 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.712 HD12 ' OG1' ' A' ' 135' ' ' THR . 4.9 mt -96.22 130.13 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.354 -0.841 . . . . 3.04 109.398 178.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 24.7 t -136.13 146.77 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.315 -0.866 . . . . 1.8899999999999999 109.671 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.181 -0.949 . . . . 4.8899999999999997 109.454 179.953 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.521 -1.432 . . . . 0.01 109.521 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.497 ' HZ1' HH21 ' A' ' 40' ' ' ARG . 26.0 ttpp -145.95 135.55 23.22 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.296 -1.12 . . . . 0.02 110.373 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.4 tt -129.63 139.1 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.02 -1.104 . . . . 0.02 108.02 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 m -120.61 129.25 53.66 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.35 -0.844 . . . . 0.39000000000000001 110.316 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.437 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.9 m-85 -110.76 140.78 44.86 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.852 -0.795 . . . . 0.02 108.852 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.557 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.9 m-85 -122.57 138.61 54.52 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.294 -0.879 . . . . 0.02 109.425 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -68.91 -27.21 65.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.121 -0.987 . . . . 0.029999999999999999 111.597 -178.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.3 m-20 -114.43 169.85 8.74 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.944 -1.098 . . . . 0.029999999999999999 109.995 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -75.02 161.91 29.04 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.617 0.722 . . . . 0.029999999999999999 110.262 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.592 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 11.4 t-20 62.45 35.11 14.97 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.892 0.853 . . . . 0.73999999999999999 110.634 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.592 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.7 p90 49.27 43.16 22.8 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.478 -0.783 . . . . 0.02 110.94 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -109.62 165.91 11.31 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.676 -1.231 . . . . 0.02 107.676 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.7 -167.71 35.35 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 119.707 -1.235 . . . . 0.029999999999999999 110.752 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.583 ' CG ' HH11 ' A' ' 18' ' ' ARG . 0.2 OUTLIER -69.62 143.28 53.3 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.408 -1.054 . . . . 2.7599999999999998 109.059 179.368 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -122.59 150.7 42.27 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.499 -0.75 . . . . 1.8899999999999999 110.244 -178.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.472 ' CE1' ' CE1' ' A' ' 29' ' ' PHE . 34.4 t80 -136.34 133.11 36.48 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.689 -0.632 . . . . 0.02 109.678 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 20.6 p-10 -110.74 136.63 49.52 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.389 -0.819 . . . . 1.1200000000000001 109.309 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 42.2 t -128.73 138.65 52.24 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.631 -0.668 . . . . 0.02 109.422 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.434 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 0.9 OUTLIER -118.93 11.4 12.53 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.477 -0.765 . . . . 0.20000000000000001 110.877 -179.406 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.491 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 8.0 p -159.31 173.84 15.68 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.644 -1.285 . . . . 1.23 109.305 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 22.8 p30 -62.13 145.22 53.97 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.684 -1.26 . . . . 0.02 110.361 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.553 ' CB ' ' CE2' ' A' ' 29' ' ' PHE . 51.2 t -134.49 118.44 17.34 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.529 -0.732 . . . . 0.02 109.046 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.81 -20.67 56.12 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.494 -0.754 . . . . 0.23999999999999999 111.515 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -155.45 104.78 2.41 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.851 -1.155 . . . . 1.1399999999999999 109.417 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.553 ' CE2' ' CB ' ' A' ' 26' ' ' CYS . 0.4 OUTLIER -101.82 9.03 41.11 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.321 -0.862 . . . . 6.3700000000000001 109.934 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -60.32 -27.18 67.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.391 -0.818 . . . . 3.1099999999999999 111.83 -177.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.3 t -77.89 -18.07 56.58 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.477 -1.389 . . . . 0.88 111.391 -178.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.551 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 8.3 m-85 -106.64 -21.08 13.16 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.306 -0.871 . . . . 0.02 110.561 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.9 tp -148.66 127.16 12.35 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.95 -1.094 . . . . 3.3199999999999998 109.472 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.3 t -87.53 -12.55 45.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.629 -0.669 . . . . 0.02 111.388 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -172.5 161.95 5.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.743 -1.223 . . . . 0.02 108.47 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.458 ' SG ' HD12 ' A' ' 79' ' ' LEU . 2.3 p -143.45 115.74 8.49 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.069 -1.02 . . . . 0.02 108.877 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -107.8 -0.41 21.65 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.812 -1.18 . . . . 0.029999999999999999 111.007 -178.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.3 m -155.08 153.58 31.11 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.829 -1.175 . . . . 0.02 107.829 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.7 mt -146.83 147.14 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 122.205 1.002 . . . . 0.02 110.778 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.497 HH21 ' HZ1' ' A' ' 6' ' ' LYS . 35.3 ttp180 -124.03 124.73 43.19 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.181 -1.044 . . . . 0.02 108.181 177.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.8 t -106.68 115.27 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 106.876 -1.527 . . . . 0.02 106.876 177.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.4 ' HG3' ' HZ2' ' A' ' 6' ' ' LYS . 18.2 mm-40 -83.88 -33.81 24.72 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.565 -0.709 . . . . 3.8100000000000001 110.952 -177.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.13 152.64 22.57 Favored Glycine 0 N--CA 1.49 2.272 0 C-N-CA 118.811 -1.661 . . . . 0.02 110.877 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.45 172.98 49.39 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.688 -1.244 . . . . 0.01 110.468 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.1 m -119.85 134.94 55.07 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 107.97 -1.122 . . . . 1.48 107.97 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.42 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 35.3 m95 -127.46 156.11 42.63 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 122.595 1.188 . . . . 0.02 112.212 -176.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.83 134.39 52.1 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 105.613 -1.995 . . . . 0.23999999999999999 105.613 176.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.462 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.7 m -117.09 142.6 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.53 -0.731 . . . . 0.65000000000000002 109.14 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -120.68 143.57 48.65 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 122.093 0.949 . . . . 0.02 109.66 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -65.05 -33.7 76.67 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.584 -0.735 . . . . 0.02 111.534 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -125.3 157.95 65.73 Favored Pre-proline 0 N--CA 1.503 2.21 0 O-C-N 121.029 -1.044 . . . . 0.02 109.425 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -53.49 167.36 0.92 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.688 1.592 . . . . 0.02 112.916 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 63.36 36.31 11.66 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.232 -0.895 . . . . 0.02 111.134 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.414 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 4.9 m-85 44.92 51.65 8.51 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.614 0.721 . . . . 3.3900000000000001 110.77 178.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.9 t -125.8 163.6 22.53 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.186 0.517 . . . . 2.3300000000000001 109.846 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.33 -161.86 31.67 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.892 -1.283 . . . . 0.02 109.892 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -65.54 139.03 58.43 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.038 -1.272 . . . . 0.02 110.245 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.495 ' O ' ' SD ' ' A' ' 58' ' ' MET . 2.6 ppp? -118.88 137.03 53.72 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.662 -0.649 . . . . 5.0099999999999998 109.802 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.452 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 90.8 m-85 -134.06 138.86 45.59 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.497 -0.752 . . . . 0.02 109.693 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.7 mm -95.76 131.17 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.123 -0.695 . . . . 1.72 109.123 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.489 HD22 ' CE1' ' A' ' 66' ' ' TYR . 9.3 mt -120.77 111.78 34.2 Favored Pre-proline 0 N--CA 1.506 2.335 0 O-C-N 121.41 -0.806 . . . . 0.02 110.929 -178.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -77.53 169.25 21.33 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 CA-C-N 119.868 0.989 . . . . 1.47 110.126 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -53.29 141.26 24.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.878 -1.139 . . . . 4.25 110.368 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.23 -177.94 32.16 Favored Glycine 0 N--CA 1.496 2.667 0 C-N-CA 119.54 -1.314 . . . . 0.02 110.825 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -120.25 131.7 55.04 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.433 -1.039 . . . . 0.95999999999999996 109.746 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.489 ' CE1' HD22 ' A' ' 61' ' ' LEU . 88.4 m-85 -121.08 95.82 48.65 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 108.041 -1.096 . . . . 0.02 108.041 178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -65.98 -4.7 10.62 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 120.761 0.974 . . . . 0.02 113.618 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -157.58 155.2 29.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.655 -1.278 . . . . 2.02 108.15 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -60.25 -38.6 83.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.576 -0.702 . . . . 0.02 112.029 -177.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -60.07 -23.42 63.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.142 -0.974 . . . . 0.02 110.293 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -70.79 -18.76 62.74 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.831 0.824 . . . . 3.4199999999999999 109.063 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.54 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 1.6 t90 -107.9 9.8 28.65 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.424 -1.324 . . . . 0.02 107.424 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.8 mtt 60.83 22.08 12.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.601 -0.687 . . . . 0.02 110.419 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.89 143.83 46.8 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.336 -1.506 . . . . 0.02 109.336 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.816 HD12 ' H ' ' A' ' 76' ' ' ASN . 0.2 OUTLIER -78.71 -28.88 45.14 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.609 -1.256 . . . . 0.97999999999999998 107.609 177.783 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.816 ' H ' HD12 ' A' ' 75' ' ' LEU . 65.6 m-80 -158.75 -171.69 3.52 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 106.286 -1.746 . . . . 0.02 106.286 178.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -98.53 29.01 3.85 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.642 -1.286 . . . . 0.02 110.472 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -97.86 122.77 41.37 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.974 -1.079 . . . . 3.2000000000000002 111.43 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.462 HD22 ' HB ' ' A' ' 48' ' ' VAL . 49.3 mt -142.28 119.53 11.5 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 107.232 -1.396 . . . . 2.6099999999999999 107.232 177.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.69 -18.6 9.94 Favored Glycine 0 N--CA 1.497 2.736 0 O-C-N 121.207 -0.933 . . . . 0.02 112.27 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.5 p -155.83 156.36 34.59 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 119.612 1.706 . . . . 0.02 110.839 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 20.5 p -146.14 148.47 32.62 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.453 -0.779 . . . . 0.02 110.529 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.414 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 50.5 mtp180 -138.55 143.12 39.3 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.473 -0.767 . . . . 0.01 109.327 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.28 132.16 36.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.128 -0.982 . . . . 0.42999999999999999 109.829 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.4 t -90.76 125.23 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.529 -0.732 . . . . 1.25 109.117 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -93.87 132.18 38.54 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.701 -1.249 . . . . 1.77 109.26 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.1 mt -97.31 139.96 32.49 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.805 -0.813 . . . . 1.6299999999999999 108.805 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.9 t -112.52 127.83 56.17 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.377 -0.827 . . . . 1.0800000000000001 109.465 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 77.8 p -104.26 -154.43 0.5 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 106.602 -1.629 . . . . 1.26 106.602 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 139.25 -52.53 0.72 Allowed Glycine 0 N--CA 1.501 3.003 0 O-C-N 120.356 -1.465 . . . . 0.01 113.111 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.8 -101.66 0.16 Allowed Glycine 0 N--CA 1.49 2.281 0 C-N-CA 118.413 -1.851 . . . . 0.01 112.095 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -121.35 119.17 31.37 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.133 -1.216 . . . . 4.4299999999999997 110.676 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.15 129.56 34.59 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.745 -0.782 . . . . 2.9900000000000002 109.403 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -129.76 143.09 50.64 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.383 -0.823 . . . . 6.3600000000000003 108.917 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.401 HG22 ' O ' ' A' ' 110' ' ' THR . 4.2 tt -128.84 145.0 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 O-C-N 121.292 -0.88 . . . . 1.0900000000000001 110.437 -178.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -122.25 134.08 54.69 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.58 -1.266 . . . . 2.0499999999999998 107.58 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.527 HG12 ' SG ' ' A' ' 129' ' ' CYS . 15.6 m -124.61 145.71 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 O-C-N 120.772 -1.205 . . . . 1.1000000000000001 109.914 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.587 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 64.4 m-85 -119.35 141.62 48.87 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 121.971 0.891 . . . . 0.72999999999999998 110.91 -178.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -67.23 -30.73 70.73 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 116.066 -0.515 . . . . 0.02 111.904 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.416 ' O ' ' OG ' ' A' ' 128' ' ' SER . 48.0 mttm -116.35 167.46 11.01 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.97 -1.082 . . . . 3.1800000000000002 110.492 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.52 164.02 42.37 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.899 -0.88 . . . . 0.01 110.899 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 56.77 38.85 29.77 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.628 0.727 . . . . 0.01 110.932 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 52.29 55.91 8.47 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.58 -0.7 . . . . 0.01 111.11 178.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -129.18 165.68 20.84 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.319 -0.993 . . . . 3.1499999999999999 108.319 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.23 -163.87 28.02 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.242 -1.543 . . . . 0.01 109.242 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -75.6 144.34 41.84 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.034 -1.274 . . . . 0.01 108.664 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.587 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 27.0 ttp -116.99 142.16 47.31 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.47 0.653 . . . . 0.01 109.859 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -131.72 136.61 47.76 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.127 -1.064 . . . . 2.48 108.127 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -117.96 134.3 55.09 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.495 -0.753 . . . . 0.01 110.08 -178.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.401 ' O ' HG22 ' A' ' 95' ' ' ILE . 7.5 t -148.45 149.42 31.67 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 122.276 1.036 . . . . 1.6899999999999999 111.119 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.5 p -110.51 10.25 23.16 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 115.45 -0.795 . . . . 0.01 110.304 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -121.36 163.45 18.65 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.155 -0.966 . . . . 3.21 111.826 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.5 156.64 36.17 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.142 -1.059 . . . . 0.01 108.142 178.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 21.9 t -126.51 113.17 23.04 Favored Pre-proline 0 N--CA 1.501 2.115 0 O-C-N 121.401 -0.812 . . . . 0.01 108.843 178.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -76.27 -31.21 4.82 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 CA-C-N 120.086 1.066 . . . . 0.01 111.516 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.6 m -141.42 108.05 5.35 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.264 -0.898 . . . . 0.02 109.006 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.88 -38.83 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.861 -0.524 . . . . 1.8300000000000001 110.876 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.1 ttt -68.16 -36.76 80.15 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.234 -0.986 . . . . 1.3400000000000001 110.384 -178.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -71.15 -39.08 72.14 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.421 -1.424 . . . . 2.1099999999999999 110.18 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -79.48 -47.41 15.67 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.236 -0.915 . . . . 2.0800000000000001 112.448 -176.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -110.25 0.85 18.28 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.405 -0.809 . . . . 0.02 112.517 -176.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.565 ' N ' ' ND1' ' A' ' 122' ' ' HIS . 1.2 m-70 59.11 32.36 22.07 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.815 -1.178 . . . . 0.02 109.269 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.3 mt -112.29 135.9 52.39 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 108.433 -0.951 . . . . 0.02 108.433 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -91.44 -22.73 20.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 5.3200000000000003 110.108 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -149.82 163.95 36.65 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.222 -0.924 . . . . 0.02 110.204 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 44.8 mt -132.21 129.34 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 107.434 -1.321 . . . . 2.1699999999999999 107.434 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -106.95 -12.08 15.54 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.318 -0.864 . . . . 0.02 112.457 -177.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 12.5 p -159.54 153.05 22.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.855 -1.153 . . . . 0.01 108.835 178.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.527 ' SG ' HG12 ' A' ' 97' ' ' VAL . 7.2 t -168.51 147.36 4.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.303 -0.873 . . . . 1.22 108.751 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.516 ' NZ ' ' OE1' ' A' ' 155' ' ' GLU . 26.1 tttp -121.1 111.64 17.7 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 122.422 1.106 . . . . 1.4099999999999999 109.561 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.3 t -112.52 129.06 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 107.352 -1.351 . . . . 0.01 107.352 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.2 t -129.48 92.93 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 107.267 -1.383 . . . . 1.98 107.267 177.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.514 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 4.1 tm-20 -147.85 -74.58 0.19 Allowed 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 105.683 -1.969 . . . . 0.01 105.683 177.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 157.55 -55.03 0.38 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.45 -1.46 . . . . 0.01 109.45 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 41.8 p -119.75 101.52 7.95 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.542 -0.975 . . . . 2.2999999999999998 111.446 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.514 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 11.4 m95 -129.51 144.54 51.3 Favored 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 107.516 -1.29 . . . . 0.01 107.516 178.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 97.6 mt -124.25 140.87 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 120.874 -1.141 . . . . 1.6899999999999999 110.486 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.409 ' HB3' HD12 ' A' ' 169' ' ' ILE . 72.5 m-85 -114.17 143.97 43.95 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.153 -1.425 . . . . 2.4900000000000002 107.153 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.498 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 11.8 m-85 -122.93 144.88 48.94 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.146 -0.971 . . . . 0.02 109.531 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -74.64 -29.53 61.3 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.532 -0.73 . . . . 0.02 111.97 -176.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.4 mt -115.82 154.79 48.2 Favored Pre-proline 0 N--CA 1.505 2.299 0 O-C-N 120.783 -1.198 . . . . 1.48 109.166 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -55.37 167.38 1.94 Allowed 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.219 1.279 . . . . 0.02 112.674 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 59.6 31.23 20.81 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.193 -0.912 . . . . 0.75 111.283 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 57.55 51.08 10.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.451 -0.781 . . . . 0.02 111.136 177.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -126.54 165.07 19.82 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.52 -0.737 . . . . 0.02 110.153 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.41 -166.21 33.06 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.285 -1.126 . . . . 0.02 110.285 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -68.68 142.59 55.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.606 -0.937 . . . . 0.02 108.898 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -114.53 148.95 37.19 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.336 0.588 . . . . 0.02 109.932 -178.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -124.48 134.65 52.98 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.824 -0.806 . . . . 0.01 108.824 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.1 tt -98.23 121.32 40.02 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.737 -1.227 . . . . 0.01 108.728 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.716 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 59.6 tp -95.47 155.28 16.81 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.247 -0.908 . . . . 0.01 109.171 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -105.46 -117.88 0.23 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.295 -0.878 . . . . 2.27 109.374 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -156.97 44.6 0.38 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.049 -1.032 . . . . 1.8400000000000001 109.671 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -112.35 -156.06 0.58 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.459 -0.776 . . . . 2.2799999999999998 109.289 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.516 ' OE1' ' NZ ' ' A' ' 130' ' ' LYS . 77.9 mm-40 -106.94 106.24 16.67 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.442 -0.786 . . . . 0.01 109.141 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.716 ' CZ ' HD11 ' A' ' 151' ' ' LEU . 5.2 m-85 -98.97 111.51 23.89 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.341 -0.849 . . . . 0.01 109.531 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -94.7 -22.29 18.22 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.184 -0.947 . . . . 0.01 111.566 -177.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -128.15 154.16 78.69 Favored Pre-proline 0 N--CA 1.503 2.176 0 O-C-N 120.875 -1.141 . . . . 2.54 108.708 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -59.4 -37.19 91.46 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 CA-C-N 119.286 0.781 . . . . 0.69999999999999996 110.64 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 85.3 t -61.25 -19.76 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.795 -1.191 . . . . 0.85999999999999999 109.146 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -65.32 -15.32 62.41 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.952 -1.093 . . . . 0.02 109.996 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.638 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 8.5 m0 -98.13 11.71 36.83 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.19 -0.944 . . . . 0.02 109.102 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 81.11 10.46 84.85 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.934 -1.127 . . . . 0.02 111.341 178.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.09 140.64 32.94 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.031 -1.276 . . . . 0.02 110.206 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.73 -9.54 56.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.608 -0.683 . . . . 0.58999999999999997 109.978 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.1 m -142.02 150.49 56.2 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.181 -0.949 . . . . 0.87 109.134 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -76.61 16.53 0.9 Allowed 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 120.741 0.96 . . . . 0.38 112.47 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.65 122.72 27.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.649 -1.282 . . . . 0.17999999999999999 111.198 -177.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.409 HD12 ' HB3' ' A' ' 138' ' ' PHE . 15.2 mm -151.81 126.39 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 106.595 -1.631 . . . . 3.9900000000000002 106.595 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 64.1 mm-40 -113.57 -12.9 12.82 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.081 -1.012 . . . . 5.1699999999999999 113.634 -177.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.0 p -157.6 162.05 38.71 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 119.083 -2.261 . . . . 0.02 110.235 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.426 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 16.9 p90 -151.97 151.98 31.89 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.132 -0.98 . . . . 2.02 110.633 179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -145.0 149.66 35.53 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.304 -0.872 . . . . 0.01 109.991 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -88.52 144.29 26.43 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.512 -0.742 . . . . 0.01 109.439 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.4 mt -93.67 129.55 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.233 -0.917 . . . . 3.04 109.092 178.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 14.5 t -137.1 147.4 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.248 -0.907 . . . . 1.8899999999999999 109.676 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.35 -0.844 . . . . 4.8899999999999997 109.39 179.815 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 109.416 -1.474 . . . . 0.01 109.416 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -146.18 135.18 22.58 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.363 -1.081 . . . . 0.02 110.603 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.3 tt -129.44 139.6 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.108 -1.071 . . . . 0.02 108.108 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 m -120.45 129.55 53.93 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.326 -0.859 . . . . 0.39000000000000001 110.208 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 6.2 m-85 -110.34 139.89 45.08 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 109.026 -0.731 . . . . 0.02 109.026 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.561 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.2 m-85 -121.28 137.99 54.44 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.135 -0.978 . . . . 0.02 109.299 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -69.71 -27.59 65.11 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.096 -1.003 . . . . 0.029999999999999999 111.531 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -113.68 169.54 8.91 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.932 -1.105 . . . . 0.029999999999999999 110.067 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -75.37 157.41 34.28 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.66 0.743 . . . . 0.029999999999999999 110.401 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 1.1 m-20 66.31 33.95 6.77 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.768 0.794 . . . . 0.73999999999999999 111.297 178.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 55.41 41.23 31.24 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.247 0.546 . . . . 0.02 111.335 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -113.13 165.61 12.22 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.152 -1.055 . . . . 0.02 108.152 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.09 -167.01 35.72 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.758 -1.211 . . . . 0.029999999999999999 110.757 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.569 ' CG ' HH11 ' A' ' 18' ' ' ARG . 0.0 OUTLIER -68.59 141.57 55.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.502 -0.999 . . . . 2.7599999999999998 109.275 179.553 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -121.96 150.1 42.52 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.629 -0.67 . . . . 1.8899999999999999 109.842 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -137.96 133.95 34.33 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.559 -0.713 . . . . 0.02 109.677 178.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -109.26 135.77 49.8 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.327 -0.858 . . . . 1.1200000000000001 108.886 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.6 t -127.16 137.98 53.06 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.55 -0.719 . . . . 0.02 109.125 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.5 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 4.1 p30 -118.62 11.72 12.91 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.644 -0.66 . . . . 0.20000000000000001 110.611 -179.389 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 25.5 m -158.88 174.26 15.26 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.664 -1.272 . . . . 1.23 108.948 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.454 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 2.3 m-20 -62.2 145.98 52.04 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.756 -1.215 . . . . 0.02 110.418 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 18.0 m -134.04 117.05 16.22 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.779 -0.822 . . . . 0.02 108.779 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.12 -20.48 52.07 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.369 -0.832 . . . . 0.23999999999999999 111.911 -177.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -151.16 106.14 3.3 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.57 -1.331 . . . . 1.1399999999999999 109.547 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.61 5.04 43.8 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.436 -0.79 . . . . 6.3700000000000001 110.276 -178.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -61.22 -28.36 69.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 3.1099999999999999 112.204 -177.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.5 t -79.12 -18.7 52.74 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.262 -1.523 . . . . 0.88 111.779 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -105.75 -21.82 13.09 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.138 -0.976 . . . . 0.02 110.682 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 33' ' ' LEU . 50.9 mt -148.88 128.31 13.05 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.032 -1.043 . . . . 3.3199999999999998 109.109 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.2 t -86.1 -11.11 53.58 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.676 -0.64 . . . . 0.02 110.385 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -172.84 162.26 4.78 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.147 -1.056 . . . . 0.02 108.147 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 24.9 m -144.03 116.32 8.5 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.064 -1.022 . . . . 0.02 108.632 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.421 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 17.9 t-20 -108.84 0.46 20.32 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 120.822 -1.174 . . . . 0.029999999999999999 111.673 -177.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.2 t -155.87 153.51 29.83 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.048 -1.093 . . . . 0.02 108.048 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.7 mt -146.9 147.37 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.069 -1.019 . . . . 0.02 110.871 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -123.65 124.56 43.03 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.154 -1.054 . . . . 0.02 108.154 177.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.7 t -106.32 115.0 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 106.917 -1.512 . . . . 0.02 106.917 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -83.32 -33.8 25.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.448 -0.782 . . . . 3.8100000000000001 110.728 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.48 152.09 21.93 Favored Glycine 0 N--CA 1.488 2.11 0 C-N-CA 118.883 -1.627 . . . . 0.02 110.82 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.04 173.18 49.62 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.655 -1.259 . . . . 0.01 110.708 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.2 m -119.32 134.88 54.98 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.011 -1.107 . . . . 1.48 108.011 177.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -126.75 155.51 42.64 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 122.587 1.185 . . . . 0.02 112.214 -176.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.39 134.02 52.35 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 105.631 -1.989 . . . . 0.23999999999999999 105.631 176.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.416 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.3 m -118.86 143.76 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.561 -0.712 . . . . 0.65000000000000002 109.083 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -120.99 145.72 47.45 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 122.222 1.01 . . . . 0.02 110.079 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -65.92 -33.8 76.66 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.805 -0.634 . . . . 0.02 111.052 -177.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -125.17 157.7 66.3 Favored Pre-proline 0 N--CA 1.503 2.21 0 O-C-N 121.092 -1.005 . . . . 0.02 109.416 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.47 166.95 1.01 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.714 1.61 . . . . 0.02 113.119 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 63.73 36.4 10.66 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.198 -0.91 . . . . 0.02 111.123 178.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 45.19 51.71 9.01 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.576 0.703 . . . . 3.3900000000000001 110.804 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.4 t -126.03 163.44 23.05 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.137 0.494 . . . . 2.3300000000000001 109.857 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.18 -161.62 31.69 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.761 -1.335 . . . . 0.02 109.761 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -64.88 138.97 58.7 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.102 -1.234 . . . . 0.02 110.029 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 14.6 ptm -119.06 137.18 53.73 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.674 -0.641 . . . . 5.0099999999999998 109.524 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.581 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 89.8 m-85 -134.03 138.46 45.38 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.422 -0.798 . . . . 0.02 109.836 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.1 mm -95.24 131.45 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.058 -0.719 . . . . 1.72 109.058 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.467 HD22 ' CE1' ' A' ' 66' ' ' TYR . 12.2 mt -121.0 111.45 34.06 Favored Pre-proline 0 N--CA 1.504 2.244 0 O-C-N 121.411 -0.806 . . . . 0.02 110.812 -178.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -77.11 169.55 21.3 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 CA-C-N 119.867 0.988 . . . . 1.47 109.853 177.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -52.6 141.31 20.91 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.766 -1.208 . . . . 4.25 110.338 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.38 -177.76 32.39 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.621 -1.276 . . . . 0.02 110.692 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -120.48 131.83 54.92 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.432 -1.04 . . . . 0.95999999999999996 109.774 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.467 ' CE1' HD22 ' A' ' 61' ' ' LEU . 92.6 m-85 -121.49 98.68 46.02 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 108.15 -1.056 . . . . 0.02 108.15 179.104 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -70.39 -3.66 12.88 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 120.861 1.041 . . . . 0.02 113.813 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -157.55 154.46 28.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.824 -1.172 . . . . 2.02 108.141 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -60.46 -38.85 85.5 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.557 -0.715 . . . . 0.02 111.929 -177.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -59.79 -23.71 63.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.916 -1.115 . . . . 0.02 110.272 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -70.68 -18.68 62.83 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.924 0.869 . . . . 3.4199999999999999 108.763 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.581 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.2 t90 -107.96 9.93 28.5 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.496 -1.298 . . . . 0.02 107.496 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 8.5 mtt 61.29 22.63 12.97 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.494 0.664 . . . . 0.02 110.503 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.52 144.41 45.81 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.762 -1.335 . . . . 0.02 109.762 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.545 HD23 ' O ' ' A' ' 75' ' ' LEU . 1.0 OUTLIER -79.63 -31.54 41.61 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.34 -1.356 . . . . 0.97999999999999998 107.34 177.826 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -157.02 -171.43 3.64 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 106.317 -1.734 . . . . 0.02 106.317 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -98.49 28.52 4.12 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.55 -1.344 . . . . 0.02 110.757 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -97.07 122.51 40.15 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.863 -1.148 . . . . 3.2000000000000002 110.974 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.503 HD21 ' CH2' ' A' ' 72' ' ' TRP . 75.0 mt -141.92 119.13 11.41 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.611 -1.255 . . . . 2.6099999999999999 107.611 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.73 -18.04 9.86 Favored Glycine 0 N--CA 1.499 2.875 0 O-C-N 121.211 -0.931 . . . . 0.02 112.524 -177.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.4 p -156.18 155.67 32.87 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 119.967 -1.902 . . . . 0.02 110.464 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 24.8 p -145.32 147.92 32.86 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.698 -0.626 . . . . 0.02 110.0 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 33.5 mtp180 -137.47 142.74 41.54 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.412 -0.805 . . . . 0.01 109.397 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.73 132.99 36.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 0.42999999999999999 109.862 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.6 t -91.97 124.86 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 109.027 -0.731 . . . . 1.25 109.027 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -94.36 132.1 39.33 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.706 -1.246 . . . . 1.77 109.238 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -96.33 139.77 31.98 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.672 -0.862 . . . . 1.6299999999999999 108.672 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.424 ' O ' ' OE2' ' A' ' 133' ' ' GLU . 87.8 p -111.47 128.02 55.87 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.345 -0.847 . . . . 1.0800000000000001 109.26 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.8 m -104.47 -154.18 0.5 Allowed 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 106.63 -1.618 . . . . 1.26 106.63 177.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.75 -52.7 0.74 Allowed Glycine 0 N--CA 1.5 2.965 0 O-C-N 120.399 -1.438 . . . . 0.01 112.737 177.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.17 -101.65 0.16 Allowed Glycine 0 N--CA 1.491 2.335 0 C-N-CA 118.467 -1.825 . . . . 0.01 111.953 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -121.61 118.86 30.25 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.122 -1.222 . . . . 4.4299999999999997 110.635 -178.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.5 129.85 34.85 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.836 -0.746 . . . . 2.9900000000000002 109.488 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -129.82 142.41 50.68 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.436 -0.79 . . . . 6.3600000000000003 109.058 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.435 ' O ' ' OE2' ' A' ' 109' ' ' GLU . 4.3 tt -128.81 144.56 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.344 -0.848 . . . . 1.0900000000000001 110.181 -179.109 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -121.52 134.16 55.04 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.541 -1.281 . . . . 2.0499999999999998 107.541 177.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.492 HG12 ' SG ' ' A' ' 129' ' ' CYS . 14.5 m -124.03 145.51 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 O-C-N 120.728 -1.232 . . . . 1.1000000000000001 109.903 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -119.05 141.4 48.76 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.983 0.896 . . . . 0.72999999999999998 110.851 -178.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -67.09 -30.64 70.73 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 116.065 -0.516 . . . . 0.02 111.812 -178.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -116.46 168.1 10.46 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.945 -1.097 . . . . 3.1800000000000002 110.473 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.2 163.92 44.86 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 111.044 -0.822 . . . . 0.01 111.044 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.5 t0 56.91 39.33 29.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.878 -0.778 . . . . 0.01 111.059 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 51.71 56.47 7.81 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.617 -0.677 . . . . 0.01 111.007 178.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -129.7 165.98 20.75 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.023 -1.103 . . . . 3.1499999999999999 108.023 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.24 -164.41 28.34 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.13 -1.588 . . . . 0.01 109.13 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -75.7 144.61 41.47 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.981 -1.305 . . . . 0.01 108.573 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.452 ' C ' ' SD ' ' A' ' 107' ' ' MET . 12.5 tmm? -116.25 142.21 47.14 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.634 0.73 . . . . 0.01 109.897 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.501 ' CD1' ' N ' ' A' ' 108' ' ' TYR . 8.0 m-85 -131.15 136.48 48.37 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.337 -0.986 . . . . 2.48 108.337 178.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.435 ' OE2' ' O ' ' A' ' 95' ' ' ILE . 5.2 tp10 -115.72 133.47 56.0 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.687 -0.633 . . . . 0.01 109.968 -178.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.9 t -148.47 147.95 29.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.021 -1.049 . . . . 1.6899999999999999 111.183 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.1 p -111.67 9.72 21.0 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 115.451 -0.795 . . . . 0.01 110.24 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 26.5 mp0 -121.39 163.5 18.6 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 121.238 -0.914 . . . . 3.21 111.72 -178.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -68.1 156.81 36.65 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.323 -0.991 . . . . 0.01 108.323 178.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.437 ' SG ' ' OE1' ' A' ' 120' ' ' GLN . 33.7 t -125.57 113.98 25.23 Favored Pre-proline 0 N--CA 1.502 2.142 0 O-C-N 121.531 -0.731 . . . . 0.01 109.23 178.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -75.27 -30.89 6.34 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 CA-C-N 120.245 1.123 . . . . 0.01 111.035 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.4 p -142.45 108.44 5.19 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.804 0.811 . . . . 0.02 109.0 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 73.1 mt -63.21 -38.35 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.839 -0.538 . . . . 1.8300000000000001 110.742 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 20.4 ttt -68.14 -36.53 79.83 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.121 -1.032 . . . . 1.3400000000000001 110.227 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -70.53 -38.75 74.27 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.514 -1.367 . . . . 2.1099999999999999 110.001 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.437 ' OE1' ' SG ' ' A' ' 114' ' ' CYS . 52.0 tt0 -79.61 -47.47 15.4 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.317 -0.865 . . . . 2.0800000000000001 112.471 -177.003 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -110.42 0.46 17.87 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.362 -0.837 . . . . 0.02 112.698 -176.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 59.28 32.99 22.37 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.761 -1.212 . . . . 0.02 109.067 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 mt -112.09 135.26 52.98 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 108.487 -0.931 . . . . 0.02 108.487 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -91.23 -22.28 20.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 5.3200000000000003 110.031 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -149.79 163.89 36.77 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.36 -0.838 . . . . 0.02 110.0 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 55.4 mt -131.33 128.47 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 107.474 -1.306 . . . . 2.1699999999999999 107.474 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -107.85 -12.16 15.24 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.412 -0.805 . . . . 0.02 112.36 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.3 m -159.16 152.17 22.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.887 -1.133 . . . . 0.01 108.99 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.492 ' SG ' HG12 ' A' ' 97' ' ' VAL . 10.9 t -168.86 146.87 3.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 1.22 108.795 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.3 tttp -120.6 112.45 18.93 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 122.422 1.106 . . . . 1.4099999999999999 109.515 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.3 t -113.46 129.52 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 107.821 -1.177 . . . . 0.01 107.821 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.9 t -129.72 92.97 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 106.936 -1.505 . . . . 1.98 106.936 177.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.584 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 9.4 tm-20 -147.16 -74.84 0.2 Allowed 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 105.829 -1.915 . . . . 0.01 105.829 177.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.422 ' N ' ' OE1' ' A' ' 133' ' ' GLU . . . 169.68 -69.64 0.15 Allowed Glycine 0 N--CA 1.482 1.723 0 N-CA-C 108.656 -1.777 . . . . 0.01 108.656 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.436 ' CB ' HD12 ' A' ' 175' ' ' ILE . 17.9 p -121.17 118.48 29.76 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.631 -0.923 . . . . 2.2999999999999998 110.569 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.584 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 8.4 m95 -128.1 148.55 50.58 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 107.063 -1.458 . . . . 0.01 107.063 178.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 89.9 mt -123.27 138.07 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 120.373 -1.454 . . . . 1.6899999999999999 110.491 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -114.96 144.11 44.09 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 107.553 -1.277 . . . . 2.4900000000000002 107.553 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.507 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 12.1 m-85 -123.02 143.94 49.6 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.235 -0.916 . . . . 0.02 109.592 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -75.06 -28.79 60.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.389 -0.82 . . . . 0.02 112.028 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 55.0 mt -115.28 151.82 46.23 Favored Pre-proline 0 N--CA 1.504 2.264 0 O-C-N 120.563 -1.335 . . . . 1.48 109.027 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -54.06 167.66 1.11 Allowed 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 120.906 1.071 . . . . 0.02 112.54 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 59.12 30.18 19.9 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 115.164 -0.925 . . . . 0.75 111.19 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 57.94 51.39 9.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.4 -0.813 . . . . 0.02 111.469 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -125.84 164.13 21.39 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.398 -0.814 . . . . 0.02 109.951 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.38 -165.18 32.41 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.31 -1.116 . . . . 0.02 110.31 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -69.06 142.09 54.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.604 -0.939 . . . . 0.02 109.126 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -115.24 149.07 38.34 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.832 -0.543 . . . . 0.02 109.918 -178.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.534 ' CE1' ' O ' ' A' ' 162' ' ' TRP . 42.6 t80 -124.94 135.82 53.18 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 109.15 -0.685 . . . . 0.01 109.15 179.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.5 tt -98.45 120.88 39.63 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.941 -1.1 . . . . 0.01 108.808 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.507 ' N ' HD23 ' A' ' 150' ' ' LEU . 7.4 tt -98.51 149.74 22.41 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.139 -0.976 . . . . 0.01 108.857 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -104.93 -98.47 0.32 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.424 -0.798 . . . . 2.27 110.007 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 47.1 pttt -167.36 49.09 0.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.077 -1.014 . . . . 1.8400000000000001 109.515 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.575 ' CG ' ' H ' ' A' ' 155' ' ' GLU . 38.5 tttm -113.34 -175.58 2.7 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.984 -0.747 . . . . 2.2799999999999998 108.984 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.575 ' H ' ' CG ' ' A' ' 154' ' ' LYS . 84.6 mt-10 -100.25 109.5 21.72 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.197 -0.939 . . . . 0.01 108.693 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.675 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 30.2 m-85 -98.33 113.87 25.99 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.427 -0.795 . . . . 0.01 110.079 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -94.8 -22.48 18.03 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.23 -0.919 . . . . 0.01 111.614 -178.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -127.7 154.79 77.87 Favored Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 120.771 -1.206 . . . . 2.54 109.148 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -60.78 -38.94 66.9 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 120.489 0.793 . . . . 0.69999999999999996 110.443 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 96.8 t -60.94 -20.11 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.867 -1.146 . . . . 0.85999999999999999 108.821 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 43.2 t0 -65.68 -15.39 62.74 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.976 -1.078 . . . . 0.02 109.785 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.675 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 22.8 m0 -95.79 10.74 36.01 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.497 -0.927 . . . . 0.02 108.497 178.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 78.56 9.87 86.67 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.603 -1.284 . . . . 0.02 110.621 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.38 142.04 31.38 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.361 -1.082 . . . . 0.02 110.078 -178.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.59 -8.72 58.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.655 -0.653 . . . . 0.58999999999999997 109.629 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 21.6 p -144.81 150.32 46.03 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 120.894 -1.129 . . . . 0.87 108.534 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -75.94 21.26 0.51 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 120.718 0.945 . . . . 0.38 112.518 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.38 123.05 28.75 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.786 -1.197 . . . . 0.17999999999999999 111.566 -177.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 4.1 mt -149.78 127.6 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 107.041 -1.466 . . . . 3.9900000000000002 107.041 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -113.67 -15.15 12.53 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 113.684 0.994 . . . . 5.1699999999999999 113.684 -177.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 8.2 t -157.63 160.96 38.6 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 119.132 -2.23 . . . . 0.02 110.445 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.439 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 16.4 p90 -151.66 152.73 33.21 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.085 -1.01 . . . . 2.02 110.499 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 43.4 mtp180 -144.76 149.93 36.36 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.882 0.849 . . . . 0.01 110.189 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -88.08 144.32 26.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.59 -0.694 . . . . 0.01 109.154 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.436 HD12 ' CB ' ' A' ' 135' ' ' THR . 4.6 mt -94.32 128.86 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.274 -0.891 . . . . 3.04 109.128 178.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.8 p -136.2 146.24 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.124 -0.985 . . . . 1.8899999999999999 109.499 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 N--CA 1.488 1.448 0 O-C-N 121.151 -0.968 . . . . 4.8899999999999997 109.465 -179.978 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.412 -1.475 . . . . 0.01 109.412 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -145.9 134.74 22.44 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.312 -1.111 . . . . 0.02 110.531 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.1 tt -129.46 139.57 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.053 -1.092 . . . . 0.02 108.053 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.507 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.0 OUTLIER -121.89 130.54 53.44 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.437 -0.789 . . . . 0.39000000000000001 110.119 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.1 m-85 -110.18 139.98 44.77 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 109.114 -0.699 . . . . 0.02 109.114 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.525 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.8 m-85 -121.9 138.47 54.39 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.302 -0.874 . . . . 0.02 109.325 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -69.32 -27.32 65.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.16 -0.962 . . . . 0.029999999999999999 111.508 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 2.1 m-20 -114.11 169.4 9.04 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.921 -1.112 . . . . 0.029999999999999999 110.217 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -75.96 158.71 31.66 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.612 0.72 . . . . 0.029999999999999999 110.258 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.9 t30 66.06 33.25 7.72 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 122.018 0.913 . . . . 0.73999999999999999 111.123 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 55.68 42.29 29.52 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 116.007 -0.542 . . . . 0.02 111.471 177.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -113.81 166.18 11.82 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.395 -0.965 . . . . 0.02 108.395 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.87 -167.61 34.97 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 119.923 -1.132 . . . . 0.029999999999999999 110.75 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.587 ' CG ' HH11 ' A' ' 18' ' ' ARG . 0.4 OUTLIER -69.42 143.0 53.74 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.48 -1.012 . . . . 2.7599999999999998 109.091 179.445 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.504 ' HE ' ' CB ' ' A' ' 8' ' ' SER . 52.5 ttt180 -121.58 148.94 43.86 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.582 -0.699 . . . . 1.8899999999999999 110.105 -178.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.603 ' CZ ' ' CG ' ' A' ' 32' ' ' TYR . 7.2 t80 -135.1 130.75 36.0 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.781 -0.822 . . . . 0.02 108.781 178.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 18.7 p-10 -111.94 137.78 49.46 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.468 -0.77 . . . . 1.1200000000000001 109.411 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 45.9 t -130.38 139.81 50.62 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.596 -0.69 . . . . 0.02 109.6 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.5 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 10.8 p30 -117.78 11.93 13.73 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.723 -0.611 . . . . 0.20000000000000001 110.225 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 34.6 m -158.63 174.77 14.54 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.887 -1.133 . . . . 1.23 108.644 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -61.96 145.17 53.76 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.694 -1.254 . . . . 0.02 110.033 -179.731 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.435 ' CB ' ' CZ ' ' A' ' 29' ' ' PHE . 0.8 OUTLIER -133.68 119.08 18.9 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 108.725 -0.842 . . . . 0.02 108.725 178.449 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.44 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -77.11 -19.39 57.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.23999999999999999 111.745 -177.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -154.13 107.94 2.97 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.559 -1.338 . . . . 1.1399999999999999 110.862 -178.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.435 ' CZ ' ' CB ' ' A' ' 26' ' ' CYS . 17.1 m-85 -96.53 5.72 50.2 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.206 -0.934 . . . . 6.3700000000000001 109.303 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -60.25 -30.67 69.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.364 -0.835 . . . . 3.1099999999999999 112.206 -176.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.6 m -78.82 -18.96 53.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.308 -1.495 . . . . 0.88 111.29 -178.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.603 ' CG ' ' CZ ' ' A' ' 20' ' ' TYR . 56.6 m-85 -106.68 -22.17 12.82 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.345 -0.847 . . . . 0.02 110.905 -178.165 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.442 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 5.1 tp -149.24 127.2 11.9 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.83 -1.169 . . . . 3.3199999999999998 109.609 -178.05 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.0 t -86.21 -11.31 52.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.64 -0.662 . . . . 0.02 110.95 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.442 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 13.2 ptm180 -172.96 162.69 4.72 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.914 -1.117 . . . . 0.02 108.404 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.0 t -142.23 115.02 8.63 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.968 -1.083 . . . . 0.02 108.663 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 16.1 t-20 -107.5 -0.71 21.98 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.864 -1.147 . . . . 0.029999999999999999 110.866 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.5 t -156.08 152.67 28.29 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.902 -1.147 . . . . 0.02 107.902 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 87.6 mt -145.67 148.12 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 CA-C-O 122.435 1.112 . . . . 0.02 110.313 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -123.86 124.08 41.86 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.82 -1.178 . . . . 0.02 107.82 176.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.7 t -106.47 115.25 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 106.859 -1.534 . . . . 0.02 106.859 177.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -83.49 -33.74 25.51 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.021 -0.672 . . . . 3.8100000000000001 110.738 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.48 152.17 22.05 Favored Glycine 0 N--CA 1.489 2.175 0 C-N-CA 118.922 -1.608 . . . . 0.02 110.891 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.97 173.22 49.63 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.709 -1.234 . . . . 0.01 110.632 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.6 m -120.15 135.76 54.85 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.099 -1.075 . . . . 1.48 108.099 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.417 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 37.8 m95 -128.01 155.74 43.82 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 122.7 1.238 . . . . 0.02 112.17 -176.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.75 134.5 51.38 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 105.57 -2.011 . . . . 0.23999999999999999 105.57 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.441 ' HB ' HD22 ' A' ' 79' ' ' LEU . 31.4 m -119.92 144.76 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.579 -0.701 . . . . 0.65000000000000002 109.3 179.076 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -121.45 145.7 47.66 Favored 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 122.313 1.054 . . . . 0.02 110.263 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -66.87 -34.09 77.03 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.836 -0.62 . . . . 0.02 111.496 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -124.93 157.97 64.64 Favored Pre-proline 0 N--CA 1.503 2.185 0 O-C-N 121.028 -1.045 . . . . 0.02 109.36 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.35 165.31 1.55 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.716 1.611 . . . . 0.02 113.176 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 63.84 36.95 10.02 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.159 -0.928 . . . . 0.02 111.055 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 45.08 51.84 8.71 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.686 0.755 . . . . 3.3900000000000001 110.78 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.5 t -125.92 163.61 22.59 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 121.145 0.498 . . . . 2.3300000000000001 109.811 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.83 -161.46 32.04 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.797 -1.321 . . . . 0.02 109.797 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.425 ' ND1' ' N ' ' A' ' 57' ' ' HIS . 4.7 m80 -64.63 139.77 58.8 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.075 -1.25 . . . . 0.02 110.289 -179.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.497 ' O ' ' SD ' ' A' ' 58' ' ' MET . 2.9 ppp? -119.97 136.95 54.34 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.648 -0.657 . . . . 5.0099999999999998 109.594 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.567 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 88.2 m-85 -134.81 138.85 44.62 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.353 -0.842 . . . . 0.02 109.948 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.5 mm -95.25 131.36 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.034 -0.728 . . . . 1.72 109.034 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.48 HD22 ' CE1' ' A' ' 66' ' ' TYR . 11.4 mt -120.26 111.06 35.47 Favored Pre-proline 0 N--CA 1.506 2.361 0 O-C-N 121.371 -0.831 . . . . 0.02 110.763 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -77.32 169.42 21.3 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 CA-C-N 119.836 0.977 . . . . 1.47 109.769 177.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -52.59 140.94 21.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.821 -1.174 . . . . 4.25 110.307 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.75 -177.52 32.82 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.454 -1.355 . . . . 0.02 110.597 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -120.48 131.75 54.88 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.535 -0.98 . . . . 0.95999999999999996 109.692 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.48 ' CE1' HD22 ' A' ' 61' ' ' LEU . 91.0 m-85 -121.54 99.13 45.51 Favored Pre-proline 0 N--CA 1.495 1.783 0 N-CA-C 107.882 -1.155 . . . . 0.02 107.882 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -70.86 -3.71 13.29 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 120.628 0.885 . . . . 0.02 113.642 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -157.6 154.9 29.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.71 -1.243 . . . . 2.02 108.029 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -60.2 -39.0 85.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.474 -0.767 . . . . 0.02 111.881 -177.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -59.79 -24.0 63.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.094 -1.004 . . . . 0.02 110.386 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -70.59 -18.83 62.89 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.901 0.858 . . . . 3.4199999999999999 108.802 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.567 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.4 t90 -107.92 9.9 28.6 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.477 -1.305 . . . . 0.02 107.477 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.5 mtp 61.27 22.47 12.82 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.495 0.664 . . . . 0.02 110.536 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.53 144.08 46.06 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.492 -1.443 . . . . 0.02 109.492 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.7 tp -79.05 -30.92 44.33 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.552 -1.277 . . . . 0.97999999999999998 107.552 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -157.05 -171.39 3.62 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 106.241 -1.763 . . . . 0.02 106.241 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -98.22 28.33 4.12 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.647 -1.283 . . . . 0.02 110.609 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.7 mtm180 -96.84 122.15 39.49 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.95 -1.094 . . . . 3.2000000000000002 110.985 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.513 HD21 ' CH2' ' A' ' 72' ' ' TRP . 63.5 mt -142.82 120.5 11.84 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.672 -1.232 . . . . 2.6099999999999999 107.672 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.68 -18.32 9.07 Favored Glycine 0 N--CA 1.502 3.05 0 O-C-N 121.215 -0.928 . . . . 0.02 112.871 -177.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 12.6 m -156.96 157.71 35.27 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 119.956 1.878 . . . . 0.02 110.864 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 27.0 m -146.49 149.84 34.42 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.627 -0.671 . . . . 0.02 109.943 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -138.51 143.17 39.42 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.395 -0.815 . . . . 0.01 109.183 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.3 132.18 36.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -0.94 . . . . 0.42999999999999999 109.725 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.8 t -90.61 124.83 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.726 -0.842 . . . . 1.25 108.726 178.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -93.35 132.17 37.83 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.797 -1.189 . . . . 1.77 109.017 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mt -96.8 139.29 33.07 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.453 -0.943 . . . . 1.6299999999999999 108.453 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.5 p -111.35 127.5 55.67 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.355 -0.84 . . . . 1.0800000000000001 109.17 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 51.8 p -104.12 -154.53 0.51 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 106.448 -1.686 . . . . 1.26 106.448 177.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.39 -51.63 0.78 Allowed Glycine 0 N--CA 1.502 3.05 0 O-C-N 120.558 -1.339 . . . . 0.01 112.636 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.26 -100.92 0.15 Allowed Glycine 0 N--CA 1.489 2.193 0 C-N-CA 118.464 -1.827 . . . . 0.01 111.932 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -121.4 118.79 30.31 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.034 -1.274 . . . . 4.4299999999999997 110.543 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.41 131.08 36.79 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.819 -0.753 . . . . 2.9900000000000002 109.399 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -129.81 140.56 51.0 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.472 -0.767 . . . . 6.3600000000000003 109.203 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 tt -127.4 144.12 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.407 -0.808 . . . . 1.0900000000000001 109.864 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -122.29 133.05 54.69 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.692 -1.225 . . . . 2.0499999999999998 107.692 176.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.502 HG12 ' SG ' ' A' ' 129' ' ' CYS . 15.8 m -123.67 145.86 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 O-C-N 120.662 -1.274 . . . . 1.1000000000000001 109.682 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -119.13 141.31 48.92 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 121.97 0.891 . . . . 0.72999999999999998 110.843 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -67.03 -30.41 70.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.888 -0.507 . . . . 0.02 111.775 -178.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -116.12 167.39 11.03 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.046 -1.033 . . . . 3.1800000000000002 110.533 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.06 164.43 43.79 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.981 -0.848 . . . . 0.01 110.981 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 56.95 38.8 29.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.909 -0.759 . . . . 0.01 110.884 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 52.14 56.02 8.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.637 -0.665 . . . . 0.01 111.047 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -129.19 165.81 20.6 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 108.208 -1.034 . . . . 3.1499999999999999 108.208 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.99 -163.92 27.11 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.247 -1.541 . . . . 0.01 109.247 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.559 ' NE2' ' O ' ' A' ' 107' ' ' MET . 11.1 tm0? -76.0 144.39 40.94 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.043 -1.269 . . . . 0.01 108.348 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.559 ' O ' ' NE2' ' A' ' 106' ' ' GLN . 12.8 tmm? -116.57 141.81 47.7 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.635 0.731 . . . . 0.01 109.959 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.472 ' CE2' ' OE1' ' A' ' 106' ' ' GLN . 39.4 m-85 -131.2 136.45 48.27 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.176 -1.046 . . . . 2.48 108.176 178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.522 ' OE2' ' N ' ' A' ' 110' ' ' THR . 1.9 tm-20 -119.47 134.73 55.08 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.544 -0.723 . . . . 0.01 109.961 -178.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.522 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 7.8 t -148.69 151.81 35.58 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 122.233 1.016 . . . . 1.6899999999999999 111.065 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.7 p -111.83 9.49 20.72 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.645 -0.707 . . . . 0.01 110.377 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -121.43 163.27 19.02 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.122 -0.986 . . . . 3.21 111.719 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -68.12 157.09 36.08 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.344 -0.984 . . . . 0.01 108.344 178.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 20.7 t -126.59 114.15 22.87 Favored Pre-proline 0 N--CA 1.504 2.231 0 O-C-N 121.48 -0.763 . . . . 0.01 109.088 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -75.12 -29.42 8.06 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 CA-C-N 120.319 1.15 . . . . 0.01 111.213 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 69.4 m -142.61 109.1 5.33 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.485 -0.759 . . . . 0.02 109.055 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.408 HD12 ' O ' ' A' ' 169' ' ' ILE . 97.4 mt -63.9 -38.96 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.801 -0.562 . . . . 1.8300000000000001 110.667 -178.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 41.9 ttp -68.58 -37.29 79.73 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.272 -0.971 . . . . 1.3400000000000001 110.247 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -69.93 -38.64 76.26 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.502 -1.374 . . . . 2.1099999999999999 110.026 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.534 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 42.7 tt0 -79.93 -46.89 15.93 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.289 -0.882 . . . . 2.0800000000000001 112.379 -176.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.534 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 44.3 m-85 -110.67 -0.01 17.32 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.434 -0.792 . . . . 0.02 112.657 -176.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.1 m80 59.69 33.13 21.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.73 -1.231 . . . . 0.02 109.489 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.5 mt -112.78 135.94 52.95 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 108.728 -0.841 . . . . 0.02 108.728 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -91.6 -22.71 20.16 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.266 -0.896 . . . . 5.3200000000000003 110.415 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -149.59 164.33 35.43 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.089 -1.007 . . . . 0.02 109.867 -178.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 37.3 mt -131.92 128.86 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 107.642 -1.244 . . . . 2.1699999999999999 107.642 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -108.76 -12.3 14.94 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.342 -0.849 . . . . 0.02 112.462 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.5 t -159.03 151.75 21.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.736 -1.228 . . . . 0.01 109.019 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.502 ' SG ' HG12 ' A' ' 97' ' ' VAL . 7.6 t -168.74 147.25 4.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 1.22 109.114 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -121.9 111.48 17.14 Favored 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 122.415 1.103 . . . . 1.4099999999999999 109.711 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.1 t -113.33 130.7 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.678 -1.23 . . . . 0.01 107.678 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 44.1 t -129.89 93.37 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 107.176 -1.416 . . . . 1.98 107.176 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.507 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 26.0 tt0 -147.02 -75.21 0.2 Allowed 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 105.799 -1.926 . . . . 0.01 105.799 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 177.44 -78.19 0.07 OUTLIER Glycine 0 N--CA 1.483 1.791 0 N-CA-C 108.104 -1.998 . . . . 0.01 108.104 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.574 ' OG1' HD12 ' A' ' 175' ' ' ILE . 1.2 t -121.82 125.3 46.17 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.649 -0.912 . . . . 2.2999999999999998 110.183 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.507 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 7.5 m95 -126.47 151.98 47.04 Favored 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 107.07 -1.456 . . . . 0.01 107.07 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 48.2 mt -120.61 135.37 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 120.329 -1.482 . . . . 1.6899999999999999 110.297 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -114.73 144.56 43.27 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 107.465 -1.309 . . . . 2.4900000000000002 107.465 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.503 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 15.2 m-85 -123.25 143.68 49.89 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.33 -0.856 . . . . 0.02 109.631 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -76.15 -29.23 57.7 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.54 -0.725 . . . . 0.02 112.389 -176.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.4 mt -115.43 154.78 47.67 Favored Pre-proline 0 N--CA 1.507 2.408 0 O-C-N 120.654 -1.279 . . . . 1.48 109.081 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.34 164.71 2.66 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 121.191 1.261 . . . . 0.02 112.79 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 51.9 t30 59.94 32.0 20.95 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.077 -0.965 . . . . 0.75 111.59 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 57.24 51.48 10.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.482 -0.762 . . . . 0.02 111.315 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -126.05 164.86 19.93 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.487 -0.758 . . . . 0.02 109.864 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.19 -165.92 33.15 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.346 -1.102 . . . . 0.02 110.346 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -69.57 143.31 53.38 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.563 -0.963 . . . . 0.02 109.207 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -115.16 149.67 37.28 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.206 0.526 . . . . 0.02 109.788 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -124.38 135.11 53.06 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 109.17 -0.678 . . . . 0.01 109.17 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.7 tp -96.7 119.93 36.09 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.608 -1.308 . . . . 0.01 109.264 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.694 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 59.1 tp -98.92 153.44 18.82 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.347 -0.846 . . . . 0.01 109.159 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.411 ' CG ' ' N ' ' A' ' 153' ' ' LYS . 21.2 t70 -104.41 -113.3 0.24 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.496 -0.752 . . . . 2.27 109.336 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.411 ' N ' ' CG ' ' A' ' 152' ' ' ASP . 17.6 pttm -163.04 50.59 0.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.081 -1.012 . . . . 1.8400000000000001 109.855 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -113.01 -155.71 0.57 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.466 -0.771 . . . . 2.2799999999999998 109.225 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -106.28 103.86 13.42 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.807 -0.812 . . . . 0.01 108.807 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.694 ' CZ ' HD11 ' A' ' 151' ' ' LEU . 17.4 m-85 -98.36 112.31 24.36 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.263 -0.898 . . . . 0.01 109.739 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 22.5 mtm180 -95.27 -22.87 17.51 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.232 -0.918 . . . . 0.01 111.685 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -127.3 154.41 77.06 Favored Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 120.878 -1.139 . . . . 2.54 108.764 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -59.52 -37.92 86.03 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 CA-C-N 119.235 0.763 . . . . 0.69999999999999996 110.637 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.9 t -60.99 -20.05 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.869 -1.145 . . . . 0.85999999999999999 109.2 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -65.43 -15.59 62.77 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.983 -1.073 . . . . 0.02 109.98 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.635 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 9.5 m0 -97.8 11.43 37.27 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.124 -0.985 . . . . 0.02 108.997 178.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.59 10.6 85.04 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.89 -1.148 . . . . 0.02 111.04 178.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.38 140.84 32.97 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.111 -1.229 . . . . 0.02 110.126 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.32 -9.09 58.08 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.59 -0.694 . . . . 0.58999999999999997 109.989 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.8 m -143.6 150.83 52.15 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.039 -1.038 . . . . 0.87 109.032 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -75.98 17.95 0.68 Allowed 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 120.721 0.947 . . . . 0.38 112.405 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.04 123.59 29.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.916 -1.115 . . . . 0.17999999999999999 111.56 -177.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.408 ' O ' HD12 ' A' ' 117' ' ' ILE . 2.0 mt -149.46 126.92 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.071 -1.455 . . . . 3.9900000000000002 107.071 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 24.1 mm100 -111.38 -18.26 12.93 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.165 -0.959 . . . . 5.1699999999999999 113.248 -177.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.8 m -156.73 160.22 39.08 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 119.216 -2.177 . . . . 0.02 110.4 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.433 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 18.3 p90 -151.72 153.05 33.59 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.101 -0.999 . . . . 2.02 110.321 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.3 mtm180 -145.79 150.53 36.37 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.358 -0.839 . . . . 0.01 110.145 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -87.83 144.04 26.81 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.233 -0.655 . . . . 0.01 109.233 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.574 HD12 ' OG1' ' A' ' 135' ' ' THR . 4.4 mt -94.79 129.25 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.308 -0.87 . . . . 3.04 108.967 179.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.49 146.71 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.153 -0.967 . . . . 1.8899999999999999 109.649 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.33 -0.856 . . . . 4.8899999999999997 109.466 179.954 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.273 -1.531 . . . . 0.01 109.273 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -147.45 136.28 22.07 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.099 -1.236 . . . . 0.02 110.52 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.4 tt -130.12 138.91 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.698 -0.853 . . . . 0.02 108.698 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 m -120.91 130.24 53.81 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.559 -0.713 . . . . 0.39000000000000001 110.014 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.9 m-85 -110.4 139.68 45.37 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.581 -0.699 . . . . 0.02 109.247 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.525 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 6.6 m-85 -121.31 138.32 54.3 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.427 -0.796 . . . . 0.02 109.32 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.523 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 83.3 mt-10 -69.38 -27.43 65.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.041 -1.037 . . . . 0.029999999999999999 111.475 -178.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 2.3 m-20 -114.05 169.35 9.08 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.888 -1.133 . . . . 0.029999999999999999 110.097 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -76.03 158.66 31.63 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.567 0.699 . . . . 0.029999999999999999 110.229 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 66.53 33.17 6.82 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 122.012 0.911 . . . . 0.73999999999999999 111.185 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 55.32 41.72 30.93 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.374 0.607 . . . . 0.02 111.373 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -113.64 165.81 12.15 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.25 -1.019 . . . . 0.02 108.25 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.44 -167.46 35.56 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.765 -1.207 . . . . 0.029999999999999999 110.766 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.574 ' CG ' HH11 ' A' ' 18' ' ' ARG . 0.3 OUTLIER -68.84 141.69 55.04 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.535 -0.979 . . . . 2.7599999999999998 109.37 179.383 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -122.77 150.19 43.12 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.6 0.714 . . . . 1.8899999999999999 110.124 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.412 ' CB ' HD11 ' A' ' 33' ' ' LEU . 32.0 t80 -135.87 131.74 35.68 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 109.113 -0.699 . . . . 0.02 109.113 178.081 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -109.53 136.47 48.87 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.83 -0.804 . . . . 1.1200000000000001 108.83 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 49.6 t -128.63 138.15 52.04 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.617 -0.677 . . . . 0.02 109.619 -179.027 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -118.14 12.17 13.48 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.673 -0.642 . . . . 0.20000000000000001 110.144 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.495 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 14.6 t -159.46 174.2 15.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.822 -1.174 . . . . 1.23 108.918 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -61.55 144.35 54.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.849 -1.157 . . . . 0.02 110.376 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.6 m -134.16 117.92 17.08 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.733 -0.839 . . . . 0.02 108.733 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.38 -19.81 52.57 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.524 -0.735 . . . . 0.23999999999999999 112.55 -177.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 19.2 p30 -152.95 108.75 3.31 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.703 -1.248 . . . . 1.1399999999999999 110.831 -178.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -97.68 5.29 49.52 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.428 -0.795 . . . . 6.3700000000000001 109.771 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.2 mtm180 -60.33 -30.35 69.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.481 -0.762 . . . . 3.1099999999999999 112.307 -176.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.435 ' OG ' ' CE2' ' A' ' 32' ' ' TYR . 30.3 p -79.35 -18.77 51.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.258 -1.526 . . . . 0.88 111.631 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.435 ' CE2' ' OG ' ' A' ' 31' ' ' SER . 51.1 m-85 -106.57 -22.04 12.88 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.291 -0.881 . . . . 0.02 110.98 -178.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.412 HD11 ' CB ' ' A' ' 20' ' ' TYR . 58.0 mt -148.89 128.15 12.92 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.948 -1.095 . . . . 3.3199999999999998 109.216 -178.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.9 t -86.76 -11.13 51.94 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.766 -0.584 . . . . 0.02 110.439 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.0 ttp180 -171.5 160.92 6.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.016 -1.053 . . . . 0.02 108.187 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 82.0 m -144.19 116.49 8.5 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.907 -1.121 . . . . 0.02 109.011 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 11' ' ' GLU . 1.3 m-80 -109.93 0.87 18.78 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 120.836 -1.165 . . . . 0.029999999999999999 111.857 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.2 m -156.01 153.22 29.16 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.11 -1.07 . . . . 0.02 108.11 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.5 mt -146.9 148.04 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 CA-C-O 122.207 1.004 . . . . 0.02 110.753 -178.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -123.59 124.85 43.72 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.136 -1.061 . . . . 0.02 108.136 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.2 t -106.69 113.92 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 106.805 -1.554 . . . . 0.02 106.805 177.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -84.16 -34.07 24.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.691 -0.631 . . . . 3.8100000000000001 110.475 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.82 150.25 19.0 Favored Glycine 0 N--CA 1.486 2.004 0 C-N-CA 118.885 -1.626 . . . . 0.02 110.601 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.0 172.44 49.19 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.758 -1.211 . . . . 0.01 110.235 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.9 m -120.04 135.75 54.82 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.098 -1.075 . . . . 1.48 108.098 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.422 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 36.9 m95 -128.35 156.2 43.48 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 122.698 1.237 . . . . 0.02 112.468 -176.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.96 135.02 50.83 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 105.412 -2.07 . . . . 0.23999999999999999 105.412 176.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.409 ' HB ' HD22 ' A' ' 79' ' ' LEU . 34.6 m -116.21 141.81 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.597 -0.689 . . . . 0.65000000000000002 109.286 179.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -120.72 143.01 48.99 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.987 0.899 . . . . 0.02 109.643 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.46 -33.69 76.52 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.627 -0.715 . . . . 0.02 111.832 -177.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -124.71 157.82 64.5 Favored Pre-proline 0 N--CA 1.504 2.227 0 O-C-N 120.991 -1.068 . . . . 0.02 109.357 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.21 166.7 0.96 Allowed 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 121.724 1.616 . . . . 0.02 112.827 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.5 m120 63.42 36.74 11.2 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.262 -0.881 . . . . 0.02 111.163 178.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.449 ' CD1' ' CD ' ' A' ' 83' ' ' ARG . 3.8 m-85 45.09 51.39 8.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.584 -0.698 . . . . 3.3900000000000001 110.767 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.7 t -125.65 163.49 22.67 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.241 0.543 . . . . 2.3300000000000001 109.883 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.53 -161.72 31.31 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.779 -1.328 . . . . 0.02 109.779 -179.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 12.4 m80 -64.61 138.13 58.22 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.983 -1.304 . . . . 0.02 110.209 -178.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 16.0 ptm -118.79 136.7 53.85 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.721 -0.612 . . . . 5.0099999999999998 109.672 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.515 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 86.6 m-85 -134.33 139.59 45.77 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.483 -0.761 . . . . 0.02 109.647 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.9 mm -95.0 131.03 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.983 -0.747 . . . . 1.72 108.983 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.551 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -120.59 111.32 34.79 Favored Pre-proline 0 N--CA 1.505 2.28 0 O-C-N 121.319 -0.863 . . . . 0.02 110.767 -178.347 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -77.55 169.02 21.72 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 CA-C-N 119.958 1.021 . . . . 1.47 110.135 177.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -53.04 141.43 22.57 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.831 -1.168 . . . . 4.25 110.417 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.78 -177.2 32.2 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 119.403 -1.379 . . . . 0.02 110.743 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -120.72 131.79 54.72 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.334 -1.098 . . . . 0.95999999999999996 109.8 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.551 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 63.2 m-85 -122.52 95.77 46.46 Favored Pre-proline 0 N--CA 1.496 1.846 0 N-CA-C 107.903 -1.147 . . . . 0.02 107.903 179.099 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.401 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.9 Cg_endo -66.91 -3.5 9.66 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 120.787 0.992 . . . . 0.02 113.865 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.401 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 79.1 mt-10 -157.47 155.17 29.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.617 -1.302 . . . . 2.02 108.142 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -60.47 -39.26 86.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.623 -0.673 . . . . 0.02 111.974 -177.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -60.02 -23.91 64.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.031 -1.043 . . . . 0.02 110.395 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -69.73 -18.67 63.54 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.809 0.814 . . . . 3.4199999999999999 108.907 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.57 ' CH2' HD21 ' A' ' 79' ' ' LEU . 1.1 t90 -107.84 11.06 28.45 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.515 -1.291 . . . . 0.02 107.515 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 17.9 mtt 61.09 22.49 12.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.446 -0.784 . . . . 0.02 110.439 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.98 144.03 46.86 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.391 -1.484 . . . . 0.02 109.391 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.4 mt -78.87 -30.49 45.09 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.684 -1.228 . . . . 0.97999999999999998 107.684 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.672 ' N ' HD22 ' A' ' 76' ' ' ASN . 0.0 OUTLIER -157.0 -171.31 3.6 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 106.386 -1.709 . . . . 0.02 106.386 178.299 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.409 ' OD2' ' OD1' ' A' ' 37' ' ' ASN . 63.6 m-20 -98.2 28.21 4.18 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.722 -1.236 . . . . 0.02 110.698 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -96.55 122.33 39.35 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.856 -1.153 . . . . 3.2000000000000002 110.898 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.57 HD21 ' CH2' ' A' ' 72' ' ' TRP . 68.4 mt -142.17 119.56 11.59 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 107.636 -1.246 . . . . 2.6099999999999999 107.636 178.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.86 -17.92 9.29 Favored Glycine 0 N--CA 1.5 2.907 0 O-C-N 121.293 -0.879 . . . . 0.02 112.738 -177.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.44 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 26.4 t -156.16 156.59 34.48 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 120.239 2.02 . . . . 0.02 111.033 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.7 m -145.89 148.07 32.45 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.621 -0.674 . . . . 0.02 110.395 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.449 ' CD ' ' CD1' ' A' ' 54' ' ' PHE . 19.4 mtp180 -138.21 143.22 40.07 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.559 -0.713 . . . . 0.01 109.186 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.22 131.69 36.27 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.192 -0.942 . . . . 0.42999999999999999 109.635 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.5 t -91.2 125.07 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.906 -0.775 . . . . 1.25 108.906 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -93.91 131.21 39.56 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.808 -1.182 . . . . 1.77 108.974 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 mt -96.05 140.01 31.4 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.389 -0.967 . . . . 1.6299999999999999 108.389 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.2 m -111.83 127.52 55.84 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.347 -0.846 . . . . 1.0800000000000001 109.318 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.3 m -104.09 -154.04 0.49 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 106.62 -1.622 . . . . 1.26 106.62 177.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.95 -52.6 0.74 Allowed Glycine 0 N--CA 1.501 2.981 0 O-C-N 120.396 -1.44 . . . . 0.01 112.82 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.92 -101.28 0.15 Allowed Glycine 0 N--CA 1.49 2.253 0 C-N-CA 118.491 -1.814 . . . . 0.01 112.042 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 38.8 tp60 -121.48 118.99 30.73 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.172 -1.193 . . . . 4.4299999999999997 110.683 -178.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.59 130.54 35.47 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.769 -0.772 . . . . 2.9900000000000002 109.424 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -129.53 142.01 50.86 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.353 -0.842 . . . . 6.3600000000000003 109.062 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.0 tt -128.28 144.77 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 O-C-N 121.322 -0.862 . . . . 1.0900000000000001 110.245 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -123.15 133.83 54.23 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.838 -1.171 . . . . 2.0499999999999998 107.838 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.485 HG12 ' SG ' ' A' ' 129' ' ' CYS . 27.2 m -124.24 146.25 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 O-C-N 120.625 -1.297 . . . . 1.1000000000000001 109.882 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -119.31 141.32 49.09 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.844 0.831 . . . . 0.72999999999999998 110.848 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -66.99 -30.26 70.33 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 116.126 -0.488 . . . . 0.02 111.581 -178.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -116.31 169.69 9.11 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.138 -0.976 . . . . 3.1800000000000002 110.44 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.4 165.25 52.01 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.827 -0.909 . . . . 0.01 110.827 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.435 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 0.9 OUTLIER 57.27 38.23 28.55 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.925 -0.75 . . . . 0.01 111.57 178.659 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 51.97 54.68 10.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.467 -0.771 . . . . 0.01 111.228 177.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' A' ' 105' ' ' GLY . 19.6 t-20 -129.71 166.01 20.69 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.92 -1.141 . . . . 3.1499999999999999 107.92 178.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.512 ' N ' ' OD1' ' A' ' 104' ' ' ASN . . . 91.1 -163.37 29.14 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.19 -1.564 . . . . 0.01 109.19 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.7 tp60 -76.68 143.65 39.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.968 -1.313 . . . . 0.01 108.974 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.447 ' C ' ' SD ' ' A' ' 107' ' ' MET . 12.6 tmm? -116.47 142.23 47.13 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.553 0.692 . . . . 0.01 109.985 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -131.46 136.8 48.25 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.326 -0.99 . . . . 2.48 108.326 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -118.83 134.47 55.13 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.495 -0.753 . . . . 0.01 110.007 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.4 t -148.89 149.57 31.48 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.255 1.026 . . . . 1.6899999999999999 110.951 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 20.2 p -110.97 9.76 22.21 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 115.53 -0.759 . . . . 0.01 110.314 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -120.9 163.24 18.52 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.203 -0.936 . . . . 3.21 111.514 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -68.08 156.57 37.15 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.212 -1.033 . . . . 0.01 108.212 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 19.8 t -126.72 114.04 22.58 Favored Pre-proline 0 N--CA 1.5 2.053 0 O-C-N 121.484 -0.76 . . . . 0.01 109.029 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -75.1 -29.43 8.07 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 CA-C-N 120.376 1.17 . . . . 0.01 111.116 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 69.6 m -142.12 109.37 5.57 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.383 -0.823 . . . . 0.02 109.324 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.58 -39.38 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.777 -0.577 . . . . 1.8300000000000001 110.567 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 22.6 ttt -68.82 -37.57 79.29 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.398 -0.921 . . . . 1.3400000000000001 110.358 -178.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -69.58 -38.67 77.47 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.434 -1.416 . . . . 2.1099999999999999 109.986 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -79.94 -46.93 15.83 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.291 -0.881 . . . . 2.0800000000000001 112.297 -177.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -111.34 0.06 16.53 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.391 -0.818 . . . . 0.02 112.663 -176.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.3 m80 60.27 33.48 20.92 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.789 -1.194 . . . . 0.02 109.618 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.1 mt -112.51 135.02 53.72 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 108.743 -0.836 . . . . 0.02 108.743 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -91.59 -22.79 20.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 5.3200000000000003 110.27 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -149.05 163.79 36.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.198 -0.939 . . . . 0.02 109.702 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.0 mt -131.63 129.06 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 107.831 -1.174 . . . . 2.1699999999999999 107.831 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -108.84 -12.54 14.89 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.368 -0.832 . . . . 0.02 112.231 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.0 t -158.86 150.56 20.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.851 -1.156 . . . . 0.01 109.196 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.485 ' SG ' HG12 ' A' ' 97' ' ' VAL . 6.2 t -167.75 147.04 4.88 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.696 -0.853 . . . . 1.22 108.696 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -122.06 111.64 17.27 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 122.348 1.071 . . . . 1.4099999999999999 109.79 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 t -112.56 130.32 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 107.532 -1.284 . . . . 0.01 107.532 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 48.6 t -129.57 93.6 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 N-CA-C 107.204 -1.406 . . . . 1.98 107.204 177.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.487 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 11.7 tm-20 -147.19 -76.54 0.18 Allowed 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 105.869 -1.9 . . . . 0.01 105.869 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.485 ' N ' ' OE1' ' A' ' 133' ' ' GLU . . . 176.31 -75.63 0.08 OUTLIER Glycine 0 N--CA 1.485 1.905 0 N-CA-C 108.308 -1.917 . . . . 0.01 108.308 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.679 ' OG1' HD12 ' A' ' 175' ' ' ILE . 0.5 OUTLIER -120.29 121.04 37.78 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.686 -0.891 . . . . 2.2999999999999998 110.235 179.469 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.487 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 6.8 m95 -126.99 151.17 48.92 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 106.87 -1.53 . . . . 0.01 106.87 179.006 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 81.1 mt -122.55 137.43 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 120.321 -1.487 . . . . 1.6899999999999999 110.669 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -114.77 144.39 43.57 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 107.268 -1.382 . . . . 2.4900000000000002 107.268 178.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.501 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 14.6 m-85 -122.75 143.76 49.61 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.217 -0.927 . . . . 0.02 109.559 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -74.66 -29.08 61.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.524 -0.735 . . . . 0.02 111.864 -176.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mt -116.18 154.89 48.69 Favored Pre-proline 0 N--CA 1.506 2.346 0 O-C-N 120.757 -1.215 . . . . 1.48 108.92 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -55.69 167.23 2.25 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.19 1.26 . . . . 0.02 112.817 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 59.67 30.67 20.29 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.125 -0.943 . . . . 0.75 111.286 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 57.82 51.44 9.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.59 -0.694 . . . . 0.02 111.152 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -126.21 164.89 19.98 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.457 -0.777 . . . . 0.02 110.106 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.07 -165.82 33.24 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.387 -1.085 . . . . 0.02 110.387 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -69.0 142.45 54.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.544 -0.974 . . . . 0.02 108.903 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -114.2 148.47 37.26 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.414 0.626 . . . . 0.02 110.129 -178.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -125.13 134.75 52.32 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.073 -0.714 . . . . 0.01 109.073 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.52 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.6 tt -99.27 121.67 41.39 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.907 -1.121 . . . . 0.01 109.004 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.574 HD11 ' CE1' ' A' ' 156' ' ' TYR . 21.3 tp -97.27 144.64 26.86 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.245 -0.909 . . . . 0.01 109.247 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.514 ' C ' ' HH ' ' A' ' 156' ' ' TYR . 3.3 m-20 -106.42 -162.07 0.83 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.494 -0.753 . . . . 2.27 109.852 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -99.78 51.31 0.92 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.337 -0.852 . . . . 1.8400000000000001 109.867 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -115.06 -174.93 2.58 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.361 -0.837 . . . . 2.2799999999999998 109.578 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -105.01 110.28 22.62 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.497 -0.927 . . . . 0.01 108.497 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.642 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 4.5 m-85 -100.72 113.46 26.36 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.385 -0.822 . . . . 0.01 110.523 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -96.48 -22.23 17.24 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.31 -0.869 . . . . 0.01 111.586 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -127.23 153.67 76.9 Favored Pre-proline 0 N--CA 1.505 2.294 0 O-C-N 120.892 -1.13 . . . . 2.54 109.173 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -59.76 -40.38 64.53 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 120.466 0.777 . . . . 0.69999999999999996 110.574 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 41.7 t -61.03 -19.83 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.751 -1.218 . . . . 0.85999999999999999 108.675 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 41.4 t0 -65.54 -15.37 62.63 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.019 -1.05 . . . . 0.02 109.851 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.642 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 11.1 m0 -97.68 11.01 38.5 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.219 -0.926 . . . . 0.02 108.887 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.67 11.09 85.09 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.817 -1.182 . . . . 0.02 110.939 178.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.1 141.26 33.17 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.188 -1.184 . . . . 0.02 110.15 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.94 -8.64 58.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.592 -0.692 . . . . 0.58999999999999997 110.219 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.1 t -143.62 150.32 50.26 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 120.931 -1.105 . . . . 0.87 109.195 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -75.91 18.52 0.63 Allowed 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 120.708 0.939 . . . . 0.38 112.161 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.62 124.19 29.94 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.952 -1.093 . . . . 0.17999999999999999 111.42 -178.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.9 mt -149.48 126.88 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.052 -1.462 . . . . 3.9900000000000002 107.052 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -112.11 -17.25 12.87 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.05 -1.031 . . . . 5.1699999999999999 113.096 -177.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 17.0 t -157.04 160.13 38.65 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 119.14 -2.225 . . . . 0.02 110.374 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.428 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 18.7 p90 -151.17 152.7 33.7 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.037 -1.039 . . . . 2.02 110.37 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -144.96 149.45 35.21 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.807 0.813 . . . . 0.01 110.225 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -88.62 145.15 25.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.613 -0.679 . . . . 0.01 109.293 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.679 HD12 ' OG1' ' A' ' 135' ' ' THR . 6.2 mt -95.3 129.18 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.319 -0.863 . . . . 3.04 109.359 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.9 p -135.77 146.12 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.222 -0.924 . . . . 1.8899999999999999 109.605 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.311 -0.868 . . . . 4.8899999999999997 109.413 179.965 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 41.0 m . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.483 -0.562 . . . . 5.2800000000000002 109.483 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -74.92 65.48 1.42 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.933 . . . . 5.96 109.385 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.1 m -81.0 142.93 32.92 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.411 -0.959 . . . . 2.2200000000000002 108.411 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.98 -179.84 47.73 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 118.31 -1.9 . . . . 0.81000000000000005 112.147 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.58 157.64 44.27 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.312 -1.515 . . . . 0.01 109.312 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -148.51 136.5 20.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.976 -1.308 . . . . 0.02 110.374 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.7 tt -130.62 140.68 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.724 -0.843 . . . . 0.02 108.724 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 t -120.83 130.42 53.95 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.573 -0.704 . . . . 0.39000000000000001 109.952 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.6 m-85 -110.33 139.94 45.01 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 109.217 -0.66 . . . . 0.02 109.217 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.564 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.7 m-85 -121.41 137.87 54.52 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.232 -0.917 . . . . 0.02 109.572 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -69.72 -27.43 64.97 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.995 -1.066 . . . . 0.029999999999999999 111.36 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 3.1 m-20 -114.23 169.68 8.85 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.927 -1.108 . . . . 0.029999999999999999 110.203 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 71.2 mtm180 -75.5 157.79 33.48 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.707 0.765 . . . . 0.029999999999999999 110.41 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 m120 66.16 33.84 7.13 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.884 0.85 . . . . 0.73999999999999999 111.192 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 55.54 41.25 30.93 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.301 0.572 . . . . 0.02 111.241 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -113.11 165.51 12.31 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.273 -1.01 . . . . 0.02 108.273 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.3 -166.97 35.32 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.767 -1.206 . . . . 0.029999999999999999 110.651 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.431 ' HG3' HH11 ' A' ' 18' ' ' ARG . 25.8 ttm-85 -68.77 141.68 55.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.494 -1.004 . . . . 2.7599999999999998 109.247 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -122.66 150.13 43.1 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.547 -0.721 . . . . 1.8899999999999999 109.88 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -138.11 134.02 34.14 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.706 -0.621 . . . . 0.02 109.659 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -109.08 136.17 49.03 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.393 -0.817 . . . . 1.1200000000000001 108.83 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.6 t -127.17 138.15 53.08 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.575 -0.703 . . . . 0.02 109.406 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.501 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 2.0 m-20 -118.93 11.75 12.63 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.494 -0.754 . . . . 0.20000000000000001 110.633 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 22.0 m -159.4 174.11 15.22 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.818 -1.176 . . . . 1.23 109.058 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -62.57 145.84 53.38 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.824 -1.173 . . . . 0.02 110.453 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 7.5 m -133.74 117.47 16.97 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 108.777 -0.823 . . . . 0.02 108.777 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.14 -21.92 49.59 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.167 -0.958 . . . . 0.23999999999999999 111.731 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -150.22 105.68 3.38 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.799 -1.188 . . . . 1.1399999999999999 109.526 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.8 5.32 45.54 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.54 0.686 . . . . 6.3700000000000001 110.067 -178.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -61.53 -28.3 69.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.404 -0.81 . . . . 3.1099999999999999 112.311 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.1 m -78.69 -18.85 53.72 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.248 -1.533 . . . . 0.88 111.741 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -105.74 -21.5 13.16 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.175 -0.953 . . . . 0.02 110.472 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 33' ' ' LEU . 47.6 mt -148.55 127.81 12.96 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.098 -1.001 . . . . 3.3199999999999998 109.125 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.5 p -86.18 -11.3 52.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.791 -0.568 . . . . 0.02 110.414 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -172.44 161.83 5.2 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.133 -1.062 . . . . 0.02 108.133 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 80.4 m -143.68 116.25 8.64 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.1 -1.0 . . . . 0.02 108.454 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.611 ' ND2' ' CD1' ' A' ' 69' ' ' TYR . 1.8 t-20 -110.23 0.94 18.36 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 120.862 -1.149 . . . . 0.029999999999999999 111.519 -177.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.6 t -155.71 152.8 29.01 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.647 -1.242 . . . . 0.02 107.647 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.7 mt -146.94 148.7 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.104 -0.998 . . . . 0.02 110.63 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -124.52 125.35 44.06 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.614 -1.254 . . . . 0.02 107.614 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.5 t -105.24 113.99 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 107.018 -1.475 . . . . 0.02 107.018 177.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -84.71 -34.67 22.88 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.411 -0.805 . . . . 3.8100000000000001 110.135 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.83 150.02 18.52 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 118.519 -1.8 . . . . 0.02 110.802 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.15 172.13 48.84 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.269 -1.132 . . . . 0.01 110.269 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.4 m -119.62 135.17 54.92 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 107.934 -1.135 . . . . 1.48 107.934 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.436 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 35.6 m95 -127.94 155.55 44.05 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 122.625 1.202 . . . . 0.02 112.518 -176.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.65 134.26 51.63 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 105.283 -2.117 . . . . 0.23999999999999999 105.283 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.414 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.8 m -118.36 143.82 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 109.172 -0.677 . . . . 0.65000000000000002 109.172 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -120.93 145.19 47.96 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 122.172 0.987 . . . . 0.02 109.977 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -66.07 -33.52 75.99 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.917 -0.583 . . . . 0.02 111.385 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -124.97 158.15 64.09 Favored Pre-proline 0 N--CA 1.503 2.222 0 O-C-N 121.127 -0.983 . . . . 0.02 109.43 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.62 166.92 1.1 Allowed 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.753 1.635 . . . . 0.02 112.905 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' ' 53' ' ' ASN . 1.5 t30 63.38 36.31 11.61 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 115.279 -0.873 . . . . 0.02 111.048 178.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.43 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 7.2 m-85 45.47 51.49 9.7 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.611 0.72 . . . . 3.3900000000000001 110.904 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 t -126.08 163.46 23.02 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.182 0.515 . . . . 2.3300000000000001 109.88 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.61 -161.69 31.18 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.878 -1.289 . . . . 0.02 109.878 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 15.0 m80 -64.54 138.94 58.68 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.001 -1.293 . . . . 0.02 110.077 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.44 ' C ' ' SD ' ' A' ' 58' ' ' MET . 10.9 tmm? -119.09 137.16 53.76 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 121.301 0.572 . . . . 5.0099999999999998 109.72 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.572 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 86.1 m-85 -135.33 138.96 43.92 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.477 -0.764 . . . . 0.02 109.854 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.5 mm -95.51 131.52 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 109.192 -0.67 . . . . 1.72 109.192 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.497 HD22 ' CE1' ' A' ' 66' ' ' TYR . 11.2 mt -121.04 111.98 33.65 Favored Pre-proline 0 N--CA 1.506 2.333 0 O-C-N 121.368 -0.832 . . . . 0.02 110.984 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -77.85 169.61 20.36 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 CA-C-N 119.886 0.995 . . . . 1.47 110.092 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -53.06 140.74 24.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.768 -1.207 . . . . 4.25 110.439 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.64 -177.48 32.75 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.548 -1.311 . . . . 0.02 110.533 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -119.3 130.6 55.48 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.267 -1.137 . . . . 0.95999999999999996 109.759 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.497 ' CE1' HD22 ' A' ' 61' ' ' LEU . 96.8 m-85 -120.97 94.59 48.99 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 108.113 -1.069 . . . . 0.02 108.113 178.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.404 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 2.5 Cg_endo -66.8 -3.49 9.5 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 120.874 1.049 . . . . 0.02 113.908 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 35.0 mt-10 -157.95 154.97 28.65 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.687 -1.258 . . . . 2.02 108.238 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.611 ' CD1' ' ND2' ' A' ' 37' ' ' ASN . 24.2 p90 -60.25 -39.17 85.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.57 -0.706 . . . . 0.02 112.019 -177.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -59.88 -23.83 63.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.946 -1.096 . . . . 0.02 110.189 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -69.99 -18.93 63.35 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.947 0.879 . . . . 3.4199999999999999 108.895 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.572 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.5 t90 -107.7 9.85 29.07 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.402 -1.333 . . . . 0.02 107.402 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 33.2 mtm 60.46 23.03 12.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.589 -0.695 . . . . 0.02 110.266 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.46 144.11 45.91 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.598 -1.401 . . . . 0.02 109.598 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.0 tp -79.37 -31.17 42.84 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.5 -1.296 . . . . 0.97999999999999998 107.5 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -157.16 -171.76 3.75 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.342 -1.725 . . . . 0.02 106.342 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -98.43 28.54 4.09 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.618 -1.302 . . . . 0.02 110.703 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -97.0 122.61 40.18 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.83 -1.169 . . . . 3.2000000000000002 111.014 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.51 HD21 ' CH2' ' A' ' 72' ' ' TRP . 75.5 mt -141.92 119.21 11.48 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.541 -1.281 . . . . 2.6099999999999999 107.541 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.21 -18.33 9.91 Favored Glycine 0 N--CA 1.498 2.809 0 O-C-N 121.157 -0.964 . . . . 0.02 112.344 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 91.3 p -156.38 155.86 32.88 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.256 -1.732 . . . . 0.02 110.491 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 49.1 t -145.35 148.23 33.15 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.493 -0.754 . . . . 0.02 109.912 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.43 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 41.8 mtm180 -138.3 142.98 39.78 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.253 -0.904 . . . . 0.01 109.429 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.21 132.04 36.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.23 -0.919 . . . . 0.42999999999999999 109.691 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.9 t -91.14 125.21 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.796 -0.816 . . . . 1.25 108.796 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -93.31 131.97 37.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.762 -1.211 . . . . 1.77 108.995 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mt -97.01 139.3 33.22 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.249 -1.019 . . . . 1.6299999999999999 108.249 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.6 m -111.49 127.39 55.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.291 -0.881 . . . . 1.0800000000000001 109.192 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.9 m -103.88 -154.18 0.5 Allowed 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 106.387 -1.709 . . . . 1.26 106.387 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.46 -51.58 0.79 Allowed Glycine 0 N--CA 1.501 2.985 0 O-C-N 120.408 -1.433 . . . . 0.01 112.656 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.68 -100.86 0.15 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 118.493 -1.813 . . . . 0.01 111.977 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -121.43 118.7 30.05 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.085 -1.244 . . . . 4.4299999999999997 110.668 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.99 130.06 36.05 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.881 -0.728 . . . . 2.9900000000000002 109.374 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -130.2 140.48 50.73 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.459 -0.776 . . . . 6.3600000000000003 109.139 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.411 HG22 ' O ' ' A' ' 110' ' ' THR . 4.5 tt -128.33 145.54 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 121.425 -0.797 . . . . 1.0900000000000001 110.215 -179.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -122.18 133.2 54.73 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 107.607 -1.257 . . . . 2.0499999999999998 107.607 177.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.8 m -124.57 146.1 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 O-C-N 120.657 -1.277 . . . . 1.1000000000000001 109.805 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.581 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 62.3 m-85 -119.49 141.47 49.15 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 122.036 0.922 . . . . 0.72999999999999998 111.134 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -67.07 -30.31 70.33 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 115.963 -0.562 . . . . 0.02 111.511 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -116.05 169.28 9.38 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.13 -0.981 . . . . 3.1800000000000002 110.264 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.46 165.12 52.25 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.982 -0.847 . . . . 0.01 110.982 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 57.07 38.34 29.12 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.785 -0.833 . . . . 0.01 111.418 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 52.16 54.46 10.74 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.459 -0.776 . . . . 0.01 111.271 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -129.48 165.87 20.77 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.994 -1.113 . . . . 3.1499999999999999 107.994 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.08 -163.65 29.32 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.259 -1.537 . . . . 0.01 109.259 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -76.1 143.55 41.21 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.948 -1.325 . . . . 0.01 108.918 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.581 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 38.1 ttp -116.44 142.52 46.76 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.575 0.702 . . . . 0.01 109.803 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -131.64 136.55 47.82 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.234 -1.024 . . . . 2.48 108.234 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -118.45 134.1 55.34 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.541 -0.725 . . . . 0.01 110.193 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.411 ' O ' HG22 ' A' ' 95' ' ' ILE . 4.9 t -148.4 150.04 32.81 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 122.191 0.996 . . . . 1.6899999999999999 110.973 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.7 p -110.31 10.23 23.56 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 115.555 -0.748 . . . . 0.01 110.214 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -120.96 163.53 18.11 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.234 -0.916 . . . . 3.21 111.597 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -66.89 156.71 35.03 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.951 -1.129 . . . . 0.01 107.951 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.608 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 22.0 p -122.83 115.16 29.48 Favored Pre-proline 0 N--CA 1.5 2.069 0 O-C-N 121.459 -0.776 . . . . 0.01 109.153 178.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -78.15 -34.72 1.53 Allowed 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 119.993 1.033 . . . . 0.01 110.906 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.6 m -141.07 107.91 5.39 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.687 -0.856 . . . . 0.02 108.687 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.86 -38.93 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.988 -0.445 . . . . 1.8300000000000001 110.897 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 19.6 ttt -67.59 -38.11 83.54 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.155 -1.018 . . . . 1.3400000000000001 110.034 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -68.85 -38.09 79.54 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.407 -1.433 . . . . 2.1099999999999999 109.599 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -79.72 -46.92 16.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.324 -0.86 . . . . 2.0800000000000001 112.267 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -112.07 -0.51 15.63 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.398 -0.814 . . . . 0.02 112.841 -176.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.417 ' ND1' ' N ' ' A' ' 122' ' ' HIS . 2.2 m-70 61.61 34.66 17.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.852 -1.155 . . . . 0.02 109.811 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.1 mt -114.13 135.99 53.43 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.446 -0.784 . . . . 0.02 109.299 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -90.87 -22.09 21.1 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.239 -0.913 . . . . 5.3200000000000003 110.868 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -147.59 163.71 35.75 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.992 -1.067 . . . . 0.02 109.863 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.1 mm -129.49 125.68 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 107.853 -1.166 . . . . 2.1699999999999999 107.853 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -110.9 -13.4 14.13 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.204 -0.935 . . . . 0.02 112.821 -177.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.2 t -159.45 150.96 20.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.673 -1.267 . . . . 0.01 109.312 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.509 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 7.9 p -166.29 148.5 6.86 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.092 -1.005 . . . . 1.22 108.992 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.03 109.26 15.72 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 122.395 1.093 . . . . 1.4099999999999999 109.095 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.1 t -113.27 128.41 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 107.648 -1.241 . . . . 0.01 107.648 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.4 t -129.55 93.23 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 107.391 -1.336 . . . . 1.98 107.391 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.52 ' OE1' ' NE1' ' A' ' 136' ' ' TRP . 31.5 tt0 -147.08 -75.34 0.19 Allowed 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 105.882 -1.895 . . . . 0.01 105.882 177.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 177.26 -77.01 0.07 OUTLIER Glycine 0 N--CA 1.483 1.821 0 N-CA-C 108.403 -1.879 . . . . 0.01 108.403 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.512 ' OG1' HD12 ' A' ' 175' ' ' ILE . 2.7 t -120.23 125.5 48.29 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.541 -0.976 . . . . 2.2999999999999998 110.226 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.52 ' NE1' ' OE1' ' A' ' 133' ' ' GLU . 8.2 m95 -128.97 151.57 49.54 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 107.066 -1.457 . . . . 0.01 107.066 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 41.0 mt -119.53 134.84 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 120.383 -1.448 . . . . 1.6899999999999999 109.987 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -114.36 143.91 44.14 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.262 -1.384 . . . . 2.4900000000000002 107.262 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.511 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 11.5 m-85 -123.02 144.67 49.12 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.244 -0.91 . . . . 0.02 109.346 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -76.3 -28.89 57.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.687 -0.633 . . . . 0.02 111.732 -176.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.1 mt -116.32 155.03 48.87 Favored Pre-proline 0 N--CA 1.504 2.248 0 O-C-N 120.698 -1.251 . . . . 1.48 108.896 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -56.17 167.2 2.65 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.186 1.257 . . . . 0.02 113.072 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 59.49 31.3 20.93 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 114.995 -1.002 . . . . 0.75 111.363 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 57.63 51.22 9.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.536 -0.727 . . . . 0.02 111.092 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -127.02 165.19 19.92 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.583 -0.698 . . . . 0.02 110.157 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.89 -166.03 33.66 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.395 -1.082 . . . . 0.02 110.395 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -69.38 142.54 53.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.551 -0.97 . . . . 0.02 109.162 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -115.13 149.76 37.08 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.729 -0.607 . . . . 0.02 110.028 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -123.68 134.27 53.76 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 109.004 -0.739 . . . . 0.01 109.004 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.6 tp -97.07 121.11 38.6 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.797 -1.189 . . . . 0.01 109.4 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.479 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 12.9 tp -98.5 146.52 25.69 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.234 -0.916 . . . . 0.01 108.787 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -104.68 -124.77 0.22 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.465 -0.772 . . . . 2.27 110.251 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -138.63 50.45 1.86 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.218 -0.926 . . . . 1.8400000000000001 109.657 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -115.37 -167.2 1.21 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.344 -0.848 . . . . 2.2799999999999998 109.517 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -105.6 109.97 22.13 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.565 -0.902 . . . . 0.01 108.565 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.655 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 4.1 m-85 -99.97 111.53 23.83 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.382 -0.823 . . . . 0.01 110.301 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -96.14 -22.1 17.51 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.147 -0.97 . . . . 0.01 111.32 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -127.42 154.11 77.29 Favored Pre-proline 0 N--CA 1.505 2.275 0 O-C-N 121.04 -1.037 . . . . 2.54 108.957 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -59.62 -38.4 82.07 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 120.442 0.761 . . . . 0.69999999999999996 110.533 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 65.5 t -61.07 -19.68 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.948 -1.095 . . . . 0.85999999999999999 109.047 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -65.24 -15.18 62.2 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.973 -1.079 . . . . 0.02 109.856 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.655 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 9.8 m0 -97.65 11.04 38.39 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.173 -0.954 . . . . 0.02 108.985 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.31 11.13 84.61 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.899 -1.144 . . . . 0.02 110.988 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.71 140.88 33.27 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.042 -1.269 . . . . 0.02 110.155 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.39 -8.53 58.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.64 -0.662 . . . . 0.58999999999999997 110.178 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.7 p -142.29 150.95 56.94 Favored Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 120.93 -1.106 . . . . 0.87 109.237 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -75.69 16.8 0.73 Allowed 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 120.81 1.007 . . . . 0.38 112.241 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.14 121.78 27.03 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.359 1.076 . . . . 0.17999999999999999 111.27 -178.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.1 mt -149.33 124.21 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 106.096 -1.816 . . . . 3.9900000000000002 106.096 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -112.32 -15.46 13.15 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.217 -0.927 . . . . 5.1699999999999999 113.271 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 5.4 p -157.34 160.77 38.84 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 119.285 -2.135 . . . . 0.02 110.204 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.608 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 7.1 p90 -152.25 154.07 35.02 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.007 -1.058 . . . . 2.02 110.737 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.4 mtm180 -145.61 150.41 36.31 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.272 -0.892 . . . . 0.01 110.293 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -88.31 143.55 26.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.554 -0.716 . . . . 0.01 109.199 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.512 HD12 ' OG1' ' A' ' 135' ' ' THR . 3.1 mt -94.58 129.77 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.242 -0.912 . . . . 3.04 109.034 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.47 146.84 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.203 -0.936 . . . . 1.8899999999999999 109.639 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.365 -0.834 . . . . 4.8899999999999997 109.462 -179.922 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.4 t . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.316 0.579 . . . . 5.2800000000000002 109.495 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -61.55 156.56 19.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.955 . . . . 5.96 109.458 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 73.7 p -65.4 141.13 58.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.187 -1.57 . . . . 2.2200000000000002 111.166 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.89 36.87 4.09 Favored Glycine 0 N--CA 1.502 3.071 0 O-C-N 120.997 -1.064 . . . . 0.81000000000000005 113.444 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.81 143.25 34.77 Favored Glycine 0 N--CA 1.491 2.328 0 CA-C-N 120.927 2.364 . . . . 0.01 107.86 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -148.51 134.66 19.29 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.96 -1.318 . . . . 0.02 110.983 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.9 tt -128.56 138.95 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 107.703 -1.221 . . . . 0.02 107.703 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.4 t -122.33 130.21 52.91 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.225 -0.922 . . . . 0.39000000000000001 110.339 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 5.2 m-85 -110.36 140.45 44.54 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.82 -0.807 . . . . 0.02 108.82 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.555 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.7 m-85 -122.39 138.69 54.45 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.219 -0.926 . . . . 0.02 109.512 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.486 ' HG3' HD11 ' A' ' 33' ' ' LEU . 88.0 mt-10 -68.62 -27.46 66.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.083 -1.011 . . . . 0.029999999999999999 111.438 -178.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -114.77 170.17 8.53 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.822 -1.174 . . . . 0.029999999999999999 110.161 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -75.4 161.68 29.03 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.932 0.872 . . . . 0.029999999999999999 110.39 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.4 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 1.7 m-20 63.22 32.9 14.67 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.048 0.928 . . . . 0.73999999999999999 110.853 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.4 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 1.3 m-85 55.03 40.02 31.83 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.94 -0.573 . . . . 0.02 110.874 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -110.08 166.07 11.24 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.134 -1.061 . . . . 0.02 108.134 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.14 -167.59 36.21 Favored Glycine 0 N--CA 1.496 2.638 0 C-N-CA 119.765 -1.207 . . . . 0.029999999999999999 111.037 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -69.01 143.03 54.46 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.49 -1.006 . . . . 2.7599999999999998 109.171 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -120.76 149.02 43.18 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.5 0.667 . . . . 1.8899999999999999 110.197 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -132.7 127.56 35.04 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.323 -0.991 . . . . 0.02 108.323 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 7.8 p30 -112.6 136.76 51.77 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.429 -0.794 . . . . 1.1200000000000001 109.934 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.9 t -131.5 138.79 49.11 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.631 -0.668 . . . . 0.02 109.547 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -116.63 11.07 14.59 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.671 -0.643 . . . . 0.20000000000000001 109.912 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 9.8 p -158.63 174.86 14.42 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.408 -0.96 . . . . 1.23 108.408 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -60.75 143.66 53.96 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.669 -1.269 . . . . 0.02 109.912 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.3 t -131.51 117.44 18.79 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.487 -0.931 . . . . 0.02 108.487 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.81 -25.04 48.61 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.156 -0.965 . . . . 0.23999999999999999 110.83 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -155.15 101.38 2.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.031 -1.043 . . . . 1.1399999999999999 108.968 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.402 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 24.1 p90 -104.92 9.83 34.5 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 122.111 0.958 . . . . 6.3700000000000001 109.622 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 45.4 mtp180 -58.65 -24.0 60.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.509 -0.744 . . . . 3.1099999999999999 110.847 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.5 t -74.46 -16.49 60.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.796 -1.19 . . . . 0.88 110.071 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -104.53 -22.17 13.32 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.536 -0.728 . . . . 0.02 109.588 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.486 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.9 tp -150.38 128.89 12.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.194 -0.941 . . . . 3.3199999999999998 109.085 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.2 t -85.44 -9.86 56.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.786 -0.571 . . . . 0.02 111.11 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -171.36 162.75 6.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.859 -1.15 . . . . 0.02 107.954 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.2 p -143.25 115.42 8.4 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.806 -1.184 . . . . 0.02 108.717 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.407 HD22 ' HB3' ' A' ' 77' ' ' ASP . 5.2 t-20 -108.0 2.36 23.16 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 120.877 -1.14 . . . . 0.029999999999999999 110.889 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.0 p -156.94 154.63 30.01 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.553 -1.277 . . . . 0.02 107.553 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.3 mt -147.02 148.37 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.039 -1.038 . . . . 0.02 110.376 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -124.59 125.79 44.73 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.982 -1.118 . . . . 0.02 107.982 177.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.1 t -107.16 115.31 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 107.105 -1.443 . . . . 0.02 107.105 177.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -83.88 -34.14 24.64 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.585 -0.697 . . . . 3.8100000000000001 110.824 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.95 152.3 22.1 Favored Glycine 0 N--CA 1.486 2.016 0 C-N-CA 118.935 -1.602 . . . . 0.02 110.816 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.31 172.78 49.12 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.517 -1.325 . . . . 0.01 110.398 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 47.1 m -119.82 134.89 55.08 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.053 -1.091 . . . . 1.48 108.053 178.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.598 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 3.3 m95 -125.99 154.53 42.77 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 122.522 1.153 . . . . 0.02 112.178 -176.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.98 133.56 52.81 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 105.369 -2.085 . . . . 0.23999999999999999 105.369 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.531 ' HB ' HD22 ' A' ' 79' ' ' LEU . 33.0 m -118.46 143.17 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 109.005 -0.739 . . . . 0.65000000000000002 109.005 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -121.03 146.76 46.37 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 122.192 0.996 . . . . 0.02 110.041 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.25 -34.6 78.74 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.831 -0.622 . . . . 0.02 111.517 -177.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.55 163.02 45.41 Favored Pre-proline 0 N--CA 1.509 2.489 0 O-C-N 120.92 -1.113 . . . . 0.02 109.135 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -55.94 168.07 2.01 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.294 1.33 . . . . 0.02 113.208 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 63.79 36.41 10.52 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.103 -0.953 . . . . 0.02 111.863 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 45.57 52.24 9.38 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.669 0.747 . . . . 3.3900000000000001 111.188 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.1 m -127.2 164.22 22.15 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.261 0.553 . . . . 2.3300000000000001 109.912 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.32 -161.58 32.79 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.918 -1.273 . . . . 0.02 109.918 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -65.85 137.94 57.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.101 -1.234 . . . . 0.02 109.99 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 14.8 ptm -118.66 136.68 53.78 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.82 -0.55 . . . . 5.0099999999999998 109.556 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.477 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 96.5 m-85 -133.04 138.88 46.92 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-O 121.639 0.733 . . . . 0.02 109.756 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.9 mm -95.17 131.16 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.934 -0.765 . . . . 1.72 108.934 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.517 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 1.1 mt -120.02 110.73 36.16 Favored Pre-proline 0 N--CA 1.504 2.246 0 O-C-N 121.477 -0.764 . . . . 0.02 110.711 -178.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -77.65 168.59 22.28 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 CA-C-N 119.979 1.028 . . . . 1.47 110.139 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -54.18 141.15 30.19 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.836 -1.165 . . . . 4.25 110.395 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.43 -177.27 32.69 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 119.684 -1.246 . . . . 0.02 110.52 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -119.21 130.53 55.53 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.433 -1.039 . . . . 0.95999999999999996 109.662 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.517 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 51.1 m-85 -120.87 97.97 47.97 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 107.762 -1.199 . . . . 0.02 107.762 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -70.23 -3.91 13.27 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 120.681 0.921 . . . . 0.02 113.674 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -157.33 154.79 29.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.651 -1.281 . . . . 2.02 108.048 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -60.14 -39.23 85.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.542 -0.724 . . . . 0.02 111.871 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -59.89 -23.99 63.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.003 -1.061 . . . . 0.02 110.329 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -70.19 -18.79 63.2 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.955 0.883 . . . . 3.4199999999999999 108.898 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.544 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.4 t90 -108.27 10.39 27.75 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.396 -1.335 . . . . 0.02 107.396 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 7.5 mmt 60.6 22.52 12.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.533 -0.729 . . . . 0.02 110.51 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.66 145.17 47.72 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.535 -1.426 . . . . 0.02 109.535 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.8 mt -79.62 -30.85 41.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.062 -1.258 . . . . 0.97999999999999998 108.09 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -157.67 -171.48 3.58 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.541 -1.652 . . . . 0.02 106.541 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.407 ' HB3' HD22 ' A' ' 37' ' ' ASN . 2.4 p-10 -98.57 28.56 4.13 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.628 -1.295 . . . . 0.02 110.518 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.592 HH11 ' CG ' ' A' ' 78' ' ' ARG . 3.1 mtt-85 -97.87 122.74 41.34 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.163 -0.96 . . . . 3.2000000000000002 111.361 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.531 HD22 ' HB ' ' A' ' 48' ' ' VAL . 34.7 mt -144.78 122.24 11.68 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 107.6 -1.259 . . . . 2.6099999999999999 107.6 177.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.09 -16.06 11.88 Favored Glycine 0 N--CA 1.503 3.112 0 O-C-N 121.184 -0.948 . . . . 0.02 112.696 -177.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.8 t -156.55 155.91 32.73 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.171 -1.782 . . . . 0.02 110.363 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.1 p -145.39 148.03 32.91 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.532 -0.73 . . . . 0.02 110.303 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -138.44 143.61 39.75 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.311 -0.868 . . . . 0.01 109.386 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.95 133.13 36.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.42999999999999999 109.813 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.5 t -92.23 125.58 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.968 -0.753 . . . . 1.25 108.968 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -93.31 132.63 37.34 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.833 -1.167 . . . . 1.77 109.173 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.5 mt -98.95 141.27 31.92 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.499 -0.75 . . . . 1.6299999999999999 109.029 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.0 t -111.6 125.11 53.58 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.693 -0.855 . . . . 1.0800000000000001 108.693 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 90.2 p -116.7 133.29 56.19 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.717 -1.239 . . . . 1.26 108.039 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.02 -48.99 0.01 OUTLIER Glycine 0 N--CA 1.505 3.284 0 C-N-CA 117.723 -2.179 . . . . 0.01 113.839 -177.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -167.26 -105.47 0.18 Allowed Glycine 0 N--CA 1.491 2.358 0 CA-C-N 120.045 1.923 . . . . 0.01 111.098 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -118.95 117.23 28.27 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.061 -1.258 . . . . 4.4299999999999997 109.998 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.04 130.58 36.62 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.834 -0.747 . . . . 2.9900000000000002 109.132 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.462 ' HZ3' ' HB2' ' A' ' 94' ' ' LYS . 10.3 ttmm -130.16 139.95 50.82 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.51 -0.744 . . . . 6.3600000000000003 109.258 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.5 tt -129.28 145.8 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 O-C-N 121.39 -0.819 . . . . 1.0900000000000001 110.159 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -122.52 134.03 54.56 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 107.761 -1.2 . . . . 2.0499999999999998 107.761 177.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.491 HG12 ' SG ' ' A' ' 129' ' ' CYS . 29.6 m -123.18 146.06 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 120.868 -1.145 . . . . 1.1000000000000001 109.612 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.584 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 67.2 m-85 -118.51 140.56 49.69 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 122.104 0.954 . . . . 0.72999999999999998 110.845 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.43 ' OE2' ' O ' ' A' ' 99' ' ' GLU . 4.3 tm-20 -66.35 -30.18 70.53 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.957 -0.565 . . . . 0.02 111.357 -178.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.434 ' O ' ' OG ' ' A' ' 128' ' ' SER . 79.1 mttt -117.04 170.56 8.55 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.078 -1.014 . . . . 3.1800000000000002 110.327 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.48 170.86 41.65 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 111.003 -0.839 . . . . 0.01 111.003 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 51.86 38.76 24.26 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.55 0.691 . . . . 0.01 111.629 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 51.94 48.24 23.16 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.569 -0.707 . . . . 0.01 111.174 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.508 ' OD1' ' N ' ' A' ' 105' ' ' GLY . 21.2 t-20 -122.52 166.26 15.08 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.331 -0.988 . . . . 3.1499999999999999 108.331 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.508 ' N ' ' OD1' ' A' ' 104' ' ' ASN . . . 91.95 -164.45 28.72 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.507 -1.437 . . . . 0.01 109.507 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 64.0 tp60 -76.36 144.22 40.24 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.988 -1.301 . . . . 0.01 108.559 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.584 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 31.8 ttp -116.44 142.61 46.63 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.684 0.754 . . . . 0.01 109.907 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -131.15 137.4 49.0 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.225 -1.028 . . . . 2.48 108.225 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -118.16 133.82 55.56 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.549 -0.719 . . . . 0.01 110.044 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.3 t -148.67 149.45 31.5 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 122.287 1.041 . . . . 1.6899999999999999 110.984 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 p -111.03 9.65 22.1 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 115.452 -0.794 . . . . 0.01 110.025 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -121.17 163.28 18.71 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.202 -0.936 . . . . 3.21 111.719 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -67.42 156.64 36.06 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.326 -0.99 . . . . 0.01 108.326 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.59 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 92.2 m -124.7 111.14 27.67 Favored Pre-proline 0 N--CA 1.502 2.165 0 O-C-N 121.43 -0.794 . . . . 0.01 109.098 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -76.53 -32.83 3.5 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 CA-C-N 120.099 1.071 . . . . 0.01 111.492 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.9 t -140.41 106.33 5.18 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.331 -0.989 . . . . 0.02 108.331 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 73.8 mt -65.2 -38.84 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.81 -0.556 . . . . 1.8300000000000001 111.044 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.437 ' SD ' ' C ' ' A' ' 123' ' ' LEU . 8.9 tpt -66.52 -38.24 86.78 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.046 -1.062 . . . . 1.3400000000000001 110.022 -178.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -69.6 -38.53 77.32 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.455 -1.403 . . . . 2.1099999999999999 109.77 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -80.55 -47.12 14.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.34 -0.85 . . . . 2.0800000000000001 112.453 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -111.7 -1.3 15.72 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.433 -0.792 . . . . 0.02 112.556 -176.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 61.42 34.08 18.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.837 -1.164 . . . . 0.02 109.655 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.437 ' C ' ' SD ' ' A' ' 118' ' ' MET . 38.7 mt -114.21 136.13 53.29 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.48 -0.763 . . . . 0.02 109.269 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -90.63 -21.9 21.46 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.212 -0.93 . . . . 5.3200000000000003 110.918 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -148.18 164.02 35.21 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.853 -1.155 . . . . 0.02 110.009 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.4 mm -129.8 126.02 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 107.554 -1.276 . . . . 2.1699999999999999 107.554 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -109.84 -13.4 14.46 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.156 -0.965 . . . . 0.02 112.966 -177.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 16.6 p -161.2 153.07 19.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.59 -1.319 . . . . 0.01 109.295 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.491 ' SG ' HG12 ' A' ' 97' ' ' VAL . 6.6 t -169.34 145.47 3.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.385 -0.822 . . . . 1.22 108.832 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -124.98 107.83 11.24 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 122.311 1.053 . . . . 1.4099999999999999 109.685 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.595 HG21 ' CD1' ' A' ' 136' ' ' TRP . 11.9 p -110.91 138.26 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.46 -1.311 . . . . 0.01 107.46 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.5 t -127.78 94.46 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 107.186 -1.412 . . . . 1.98 107.186 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.518 ' OE1' ' NE1' ' A' ' 136' ' ' TRP . 52.2 tt0 -146.19 -75.31 0.21 Allowed 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 105.987 -1.857 . . . . 0.01 105.987 177.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 176.57 -77.39 0.07 OUTLIER Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.648 -1.781 . . . . 0.01 108.648 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.56 ' OG1' HD12 ' A' ' 175' ' ' ILE . 1.6 t -119.49 126.13 50.55 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.623 -0.928 . . . . 2.2999999999999998 110.318 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.595 ' CD1' HG21 ' A' ' 131' ' ' VAL . 43.8 m95 -128.72 150.01 50.45 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 107.166 -1.42 . . . . 0.01 107.166 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 56.2 mt -120.87 136.5 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 120.441 -1.412 . . . . 1.6899999999999999 109.973 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -114.75 144.38 43.57 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.604 -1.258 . . . . 2.4900000000000002 107.604 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.444 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 24.0 m-85 -122.8 144.13 49.38 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.372 -0.83 . . . . 0.02 109.53 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -75.62 -29.18 59.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.448 -0.782 . . . . 0.02 111.671 -176.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.3 mt -116.39 154.78 48.97 Favored Pre-proline 0 N--CA 1.505 2.302 0 O-C-N 120.759 -1.213 . . . . 1.48 109.029 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -55.62 167.2 2.22 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.19 1.26 . . . . 0.02 113.022 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 11.3 m120 59.62 30.74 20.38 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.105 -0.952 . . . . 0.75 111.318 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 57.47 51.24 10.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.426 -0.796 . . . . 0.02 110.921 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -126.17 164.52 20.77 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.55 -0.719 . . . . 0.02 109.911 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.95 -165.61 33.26 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.17 -1.172 . . . . 0.02 110.17 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -69.42 142.07 53.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.551 -0.97 . . . . 0.02 109.142 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.47 ' CD ' ' N ' ' A' ' 148' ' ' GLN . 7.1 mp0 -114.79 149.39 37.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.831 -0.543 . . . . 0.02 110.047 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 149' ' ' TYR . 20.2 m-85 -124.51 134.4 53.02 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.18 -0.674 . . . . 0.01 109.18 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.6 tt -98.93 121.39 40.82 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.865 -1.147 . . . . 0.01 108.972 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.417 HD21 ' CE1' ' A' ' 156' ' ' TYR . 4.4 tp -100.2 151.12 21.81 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.253 -0.904 . . . . 0.01 108.89 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.4 ' CG ' ' H ' ' A' ' 153' ' ' LYS . 62.8 t0 -104.23 -124.4 0.21 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.369 -0.832 . . . . 2.27 109.883 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.4 ' H ' ' CG ' ' A' ' 152' ' ' ASP . 29.0 ttmt -136.46 49.55 2.08 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.352 -0.843 . . . . 1.8400000000000001 109.586 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -113.55 -172.36 2.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.546 -0.721 . . . . 2.2799999999999998 109.252 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -105.61 113.32 26.82 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.752 -0.833 . . . . 0.01 108.752 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.417 ' CE1' HD21 ' A' ' 151' ' ' LEU . 60.6 m-85 -98.58 112.68 24.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.328 -0.857 . . . . 0.01 110.133 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -94.81 -24.5 17.03 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.195 -0.941 . . . . 0.01 110.91 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -125.43 154.99 72.44 Favored Pre-proline 0 N--CA 1.498 1.972 0 N-CA-C 108.383 -0.969 . . . . 2.54 108.383 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.553 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 8.4 Cg_endo -60.48 -39.19 67.92 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 CA-C-N 119.197 0.749 . . . . 0.69999999999999996 110.844 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 68.0 t -61.45 -18.8 19.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 O-C-N 120.742 -1.224 . . . . 0.85999999999999999 109.282 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -65.44 -17.84 64.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.915 -1.116 . . . . 0.02 111.852 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.553 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.6 OUTLIER -101.74 16.39 25.99 Favored 'General case' 0 N--CA 1.513 2.702 0 O-C-N 120.886 -1.134 . . . . 0.02 110.19 178.476 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.03 9.74 79.91 Favored Glycine 0 N--CA 1.499 2.844 0 O-C-N 121.136 -0.978 . . . . 0.02 113.091 176.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.509 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.02 141.6 32.62 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.799 -1.412 . . . . 0.02 110.193 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.78 -8.25 58.89 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.374 -0.602 . . . . 0.58999999999999997 109.374 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.3 t -142.96 150.55 53.41 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.078 -1.014 . . . . 0.87 108.887 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -75.63 18.47 0.6 Allowed 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 120.746 0.964 . . . . 0.38 112.33 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.57 121.99 27.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.899 -1.126 . . . . 0.17999999999999999 111.282 -178.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.8 mt -149.12 123.62 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 105.986 -1.857 . . . . 3.9900000000000002 105.986 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -112.17 -15.92 13.12 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.103 -0.998 . . . . 5.1699999999999999 113.301 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 26.0 t -156.71 159.71 38.63 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 119.231 -2.168 . . . . 0.02 109.993 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.59 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 12.7 p90 -152.69 153.89 34.17 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.969 -1.082 . . . . 2.02 110.53 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 48.5 mtp180 -144.83 150.62 37.44 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.907 0.861 . . . . 0.01 110.439 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -88.5 143.77 26.76 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.424 -0.584 . . . . 0.01 109.424 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.56 HD12 ' OG1' ' A' ' 135' ' ' THR . 6.2 mt -95.17 128.82 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.158 -0.964 . . . . 3.04 109.039 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 75.0 t -136.3 146.56 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.136 -0.977 . . . . 1.8899999999999999 109.543 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.335 -0.853 . . . . 4.8899999999999997 109.586 -179.928 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.446 -0.576 . . . . 5.2800000000000002 109.446 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 50.8 mttp -79.26 166.87 21.69 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.171 -0.956 . . . . 5.96 109.457 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.428 ' H ' HG22 ' A' ' 3' ' ' THR . 0.0 OUTLIER -80.77 141.7 34.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.135 -0.978 . . . . 2.2200000000000002 108.413 178.438 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.26 -179.83 47.89 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 118.27 -1.919 . . . . 0.81000000000000005 111.935 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.98 157.87 43.8 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.349 -1.5 . . . . 0.01 109.349 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -147.12 136.13 22.35 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.098 -1.237 . . . . 0.02 110.77 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.0 tt -130.73 140.13 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 108.927 -0.768 . . . . 0.02 108.927 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.0 t -122.12 130.51 53.31 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.428 -0.795 . . . . 0.39000000000000001 110.009 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 8.7 m-85 -110.93 140.96 44.99 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 109.092 -0.707 . . . . 0.02 109.092 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.526 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 7.5 m-85 -122.97 139.21 54.31 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.222 -0.924 . . . . 0.02 109.76 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.469 ' HG3' HD11 ' A' ' 33' ' ' LEU . 82.5 mt-10 -68.97 -27.75 66.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.033 -1.042 . . . . 0.029999999999999999 111.599 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -114.54 169.56 8.96 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.876 -1.14 . . . . 0.029999999999999999 110.306 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -75.21 158.24 33.27 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.651 0.739 . . . . 0.029999999999999999 110.211 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 66.26 33.37 7.25 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.906 0.86 . . . . 0.73999999999999999 111.131 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 55.26 41.82 30.98 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.185 0.517 . . . . 0.02 111.177 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -113.15 165.99 11.86 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.208 -1.034 . . . . 0.02 108.208 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.89 -167.26 36.31 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.834 -1.174 . . . . 0.029999999999999999 110.683 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -69.44 142.05 53.92 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.44 -1.036 . . . . 2.7599999999999998 109.135 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -120.89 149.41 42.65 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.586 0.708 . . . . 1.8899999999999999 110.204 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -132.54 127.5 35.24 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.358 -0.978 . . . . 0.02 108.358 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -112.48 137.12 51.14 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.566 -0.709 . . . . 1.1200000000000001 109.806 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 14.9 t -131.67 139.1 48.98 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.514 0.673 . . . . 0.02 109.761 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -116.91 11.22 14.33 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.578 -0.701 . . . . 0.20000000000000001 109.674 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.535 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 50.4 t -158.19 174.4 15.25 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.362 -0.977 . . . . 1.23 108.362 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.535 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 3.2 p30 -60.97 144.08 53.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.646 -1.284 . . . . 0.02 109.867 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.1 p -131.76 117.42 18.57 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.494 -0.928 . . . . 0.02 108.494 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.16 -25.62 47.36 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.052 -1.03 . . . . 0.23999999999999999 110.889 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 28' ' ' ASP . 8.4 p30 -154.14 101.31 2.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.966 -1.084 . . . . 1.1399999999999999 109.022 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -104.71 9.46 35.06 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 122.219 1.009 . . . . 6.3700000000000001 109.897 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -58.52 -24.13 59.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.411 -0.805 . . . . 3.1099999999999999 111.012 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.7 p -74.47 -16.69 60.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.656 -1.278 . . . . 0.88 110.105 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -103.97 -22.1 13.52 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.458 -0.776 . . . . 0.02 109.628 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.469 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.8 tp -150.43 128.98 12.23 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.131 -0.981 . . . . 3.3199999999999998 109.223 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.8 p -85.86 -10.19 55.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.791 -0.568 . . . . 0.02 111.124 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -171.23 162.68 6.98 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.908 -1.145 . . . . 0.02 107.908 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.1 p -144.11 116.36 8.47 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.826 -1.171 . . . . 0.02 109.056 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.497 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 1.0 OUTLIER -108.28 1.63 22.1 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.745 -1.222 . . . . 0.029999999999999999 110.924 -178.601 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 56.1 m -155.86 154.24 30.98 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.786 -1.19 . . . . 0.02 107.786 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.8 mt -146.02 146.8 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.118 -0.989 . . . . 0.02 110.616 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -123.46 124.63 43.32 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.112 -1.07 . . . . 0.02 108.112 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.0 t -106.15 114.47 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 106.849 -1.537 . . . . 0.02 106.849 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -84.67 -34.32 23.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.476 -0.765 . . . . 3.8100000000000001 110.452 -178.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.82 149.89 18.25 Favored Glycine 0 N--CA 1.486 1.991 0 C-N-CA 119.071 -1.538 . . . . 0.02 110.507 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.29 172.48 49.09 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.915 -1.136 . . . . 0.01 110.448 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.5 m -119.13 135.12 54.82 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.045 -1.094 . . . . 1.48 108.045 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 36.2 m95 -126.86 154.24 44.64 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 122.563 1.173 . . . . 0.02 112.316 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.75 134.41 51.51 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 105.448 -2.056 . . . . 0.23999999999999999 105.448 176.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.509 ' HB ' HD22 ' A' ' 79' ' ' LEU . 27.4 m -118.44 143.31 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.622 -0.674 . . . . 0.65000000000000002 109.257 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.538 ' CE2' ' SD ' ' A' ' 58' ' ' MET . 33.0 m-85 -120.95 145.53 47.62 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 122.256 1.027 . . . . 0.02 109.975 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -66.5 -34.18 77.35 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.798 -0.637 . . . . 0.02 111.42 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -125.61 157.92 66.68 Favored Pre-proline 0 N--CA 1.502 2.158 0 O-C-N 121.194 -0.941 . . . . 0.02 109.511 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -53.68 167.1 1.08 Allowed 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.707 1.604 . . . . 0.02 113.169 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.414 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.5 m-20 63.9 36.2 10.4 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.079 -0.964 . . . . 0.02 111.092 178.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 45.39 51.92 9.27 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.692 0.758 . . . . 3.3900000000000001 110.673 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.8 m -126.52 163.89 22.39 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.235 0.54 . . . . 2.3300000000000001 109.871 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.11 -161.8 31.92 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.958 -1.257 . . . . 0.02 109.958 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -65.22 138.88 58.52 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.093 -1.239 . . . . 0.02 110.176 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.538 ' SD ' ' CE2' ' A' ' 49' ' ' TYR . 48.6 ttp -118.52 136.97 53.53 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.798 -0.564 . . . . 5.0099999999999998 109.507 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.482 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 90.1 m-85 -134.5 138.42 44.68 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 121.763 0.792 . . . . 0.02 109.807 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.8 mm -96.06 131.64 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.082 -0.711 . . . . 1.72 109.082 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.459 HD22 ' CE1' ' A' ' 66' ' ' TYR . 12.2 mt -121.5 112.18 32.8 Favored Pre-proline 0 N--CA 1.506 2.326 0 O-C-N 121.365 -0.835 . . . . 0.02 110.853 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -77.7 169.98 19.91 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 CA-C-N 119.822 0.972 . . . . 1.47 109.981 177.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -52.64 140.98 21.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.833 -1.167 . . . . 4.25 110.263 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.44 -178.25 32.17 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.507 -1.33 . . . . 0.02 110.845 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -120.37 131.85 55.01 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.492 -1.005 . . . . 0.95999999999999996 109.804 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.459 ' CE1' HD22 ' A' ' 61' ' ' LEU . 94.1 m-85 -121.91 96.1 47.15 Favored Pre-proline 0 N--CA 1.495 1.822 0 N-CA-C 107.958 -1.127 . . . . 0.02 107.958 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.4 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.3 Cg_endo -67.21 -3.84 10.59 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 120.712 0.941 . . . . 0.02 113.868 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 35.0 mt-10 -157.52 155.44 30.28 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.64 -1.288 . . . . 2.02 108.239 179.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -60.42 -39.22 86.64 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.6 -0.687 . . . . 0.02 112.048 -177.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -59.88 -23.77 63.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.091 -1.006 . . . . 0.02 110.202 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -70.36 -19.2 63.06 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.87 0.843 . . . . 3.4199999999999999 108.948 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.544 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 1.6 t90 -107.68 9.9 29.1 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.483 -1.303 . . . . 0.02 107.483 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.7 mtt 60.52 22.5 12.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.605 -0.684 . . . . 0.02 110.335 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.35 144.6 47.3 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.435 -1.466 . . . . 0.02 109.435 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.0 mt -79.13 -30.42 43.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.101 -1.235 . . . . 0.97999999999999998 107.779 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -157.68 -171.26 3.49 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 106.393 -1.706 . . . . 0.02 106.393 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -98.61 29.04 3.87 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.7 -1.25 . . . . 0.02 110.484 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.582 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -98.58 123.08 42.54 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.178 -0.951 . . . . 3.2000000000000002 111.383 -178.771 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.509 HD22 ' HB ' ' A' ' 48' ' ' VAL . 35.4 mt -144.93 122.73 11.91 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 107.39 -1.337 . . . . 2.6099999999999999 107.39 177.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.96 -16.57 11.27 Favored Glycine 0 N--CA 1.502 3.096 0 O-C-N 121.158 -0.964 . . . . 0.02 112.686 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 90.2 p -156.68 156.42 33.4 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.154 -1.792 . . . . 0.02 110.351 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 12.7 m -145.0 147.81 33.05 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.545 -0.722 . . . . 0.02 110.012 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -138.04 142.99 40.32 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.317 -0.864 . . . . 0.01 109.593 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.56 132.99 36.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.31 -0.869 . . . . 0.42999999999999999 109.804 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.9 t -91.57 125.07 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.994 -0.743 . . . . 1.25 108.994 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -93.61 132.06 38.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.735 -1.228 . . . . 1.77 109.044 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -97.37 139.79 32.79 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.579 -0.897 . . . . 1.6299999999999999 108.579 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.5 t -111.8 127.72 55.89 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.351 -0.843 . . . . 1.0800000000000001 109.281 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.6 p -104.32 -154.33 0.5 Allowed 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 106.506 -1.664 . . . . 1.26 106.506 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.82 -51.37 0.78 Allowed Glycine 0 N--CA 1.5 2.95 0 O-C-N 120.39 -1.444 . . . . 0.01 112.771 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.43 -101.14 0.15 Allowed Glycine 0 N--CA 1.489 2.203 0 C-N-CA 118.515 -1.803 . . . . 0.01 111.877 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -121.4 119.1 31.13 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.194 -1.18 . . . . 4.4299999999999997 110.556 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.62 128.8 33.99 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.66 -0.816 . . . . 2.9900000000000002 109.359 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -130.62 141.75 50.44 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.458 -0.776 . . . . 6.3600000000000003 109.064 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.6 tt -129.69 146.76 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 O-C-N 121.281 -0.887 . . . . 1.0900000000000001 110.307 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -121.55 133.56 55.02 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 107.437 -1.319 . . . . 2.0499999999999998 107.437 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.5 m -124.04 146.09 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 120.768 -1.207 . . . . 1.1000000000000001 109.902 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.581 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 61.4 m-85 -118.74 141.27 48.77 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 122.007 0.908 . . . . 0.72999999999999998 110.879 -178.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -66.58 -30.55 70.88 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 116.007 -0.542 . . . . 0.02 111.351 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -116.82 170.28 8.73 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.124 -0.985 . . . . 3.1800000000000002 110.298 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.54 170.09 43.24 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.874 -0.89 . . . . 0.01 110.874 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 2.5 m-20 52.74 38.61 26.84 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.562 0.696 . . . . 0.01 111.704 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 52.42 48.71 22.02 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.65 -0.656 . . . . 0.01 110.944 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -123.08 165.36 16.95 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.252 -1.018 . . . . 3.1499999999999999 108.252 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.9 -163.93 28.48 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.476 -1.45 . . . . 0.01 109.476 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.2 tp60 -76.73 144.05 39.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.936 -1.332 . . . . 0.01 108.899 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.581 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 30.5 ttp -116.4 142.32 47.01 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.65 0.738 . . . . 0.01 109.93 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -131.66 137.16 48.22 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.51 -0.922 . . . . 2.48 108.51 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -117.9 133.9 55.47 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.425 -0.797 . . . . 0.01 110.141 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.1 t -148.18 148.49 30.61 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 122.262 1.029 . . . . 1.6899999999999999 110.967 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 63.4 p -110.87 10.35 22.41 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 115.579 -0.737 . . . . 0.01 110.331 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -121.16 163.16 18.88 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.152 -0.967 . . . . 3.21 111.566 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -67.03 156.46 35.99 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.107 -1.072 . . . . 0.01 108.107 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.474 ' HG ' ' HZ ' ' A' ' 172' ' ' PHE . 19.9 m -125.37 113.75 25.7 Favored Pre-proline 0 N--CA 1.501 2.115 0 O-C-N 121.485 -0.759 . . . . 0.01 109.37 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -76.91 -31.6 3.81 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 CA-C-N 119.916 1.006 . . . . 0.01 111.562 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.0 t -142.49 108.12 5.1 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.238 -0.913 . . . . 0.02 109.068 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.67 -38.82 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.885 -0.509 . . . . 1.8300000000000001 110.949 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.8 ttt -68.33 -37.2 80.3 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.222 -0.991 . . . . 1.3400000000000001 110.263 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -70.36 -38.95 74.88 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.532 -1.355 . . . . 2.1099999999999999 110.302 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -79.01 -47.39 16.33 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.307 -0.871 . . . . 2.0800000000000001 112.483 -176.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -110.64 1.18 17.84 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.348 -0.845 . . . . 0.02 112.53 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.2 m170 59.31 32.77 22.16 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.724 -1.235 . . . . 0.02 109.236 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.7 mt -112.29 135.69 52.66 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 108.631 -0.877 . . . . 0.02 108.631 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -90.69 -22.39 21.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.842 . . . . 5.3200000000000003 110.109 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -150.47 164.47 35.85 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.24 -0.913 . . . . 0.02 110.16 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.9 mt -132.25 129.64 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 107.38 -1.341 . . . . 2.1699999999999999 107.38 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -107.91 -11.64 15.31 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.321 -0.862 . . . . 0.02 112.571 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.0 t -159.21 152.26 22.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.816 -1.177 . . . . 0.01 109.101 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 6.5 p -169.44 144.71 3.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.187 -0.945 . . . . 1.22 109.168 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -126.18 111.75 14.99 Favored 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 122.445 1.117 . . . . 1.4099999999999999 110.161 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.4 p -113.89 137.44 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 107.361 -1.348 . . . . 0.01 107.361 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 23.4 t -127.74 94.43 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 106.854 -1.536 . . . . 1.98 106.854 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.501 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 10.4 tm-20 -145.07 -77.78 0.2 Allowed 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 105.929 -1.878 . . . . 0.01 105.929 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.461 ' N ' ' OE1' ' A' ' 133' ' ' GLU . . . 175.58 -73.76 0.08 OUTLIER Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.934 -1.666 . . . . 0.01 108.934 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.406 ' OG1' HD12 ' A' ' 175' ' ' ILE . 29.8 p -119.18 120.14 36.19 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.565 -0.962 . . . . 2.2999999999999998 110.262 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.501 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 8.1 m95 -127.45 149.53 50.06 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 107.227 -1.398 . . . . 0.01 107.227 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 83.6 mt -123.31 138.88 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 120.504 -1.373 . . . . 1.6899999999999999 110.491 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -115.29 144.73 43.3 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 107.158 -1.423 . . . . 2.4900000000000002 107.158 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.496 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 14.0 m-85 -123.06 145.23 48.72 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.15 -0.969 . . . . 0.02 109.617 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -75.77 -30.21 59.05 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.5 -0.75 . . . . 0.02 112.237 -176.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.5 mt -115.07 155.07 47.09 Favored Pre-proline 0 N--CA 1.506 2.366 0 O-C-N 120.595 -1.316 . . . . 1.48 109.225 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.91 165.54 2.61 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.183 1.255 . . . . 0.02 112.547 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 60.08 31.38 20.57 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.131 -0.94 . . . . 0.75 111.484 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 57.55 51.77 9.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.367 -0.833 . . . . 0.02 111.183 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -126.15 164.52 20.75 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.547 -0.721 . . . . 0.02 109.859 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.27 -165.69 32.89 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.419 -1.073 . . . . 0.02 110.419 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -68.89 142.79 54.68 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.612 -0.934 . . . . 0.02 109.053 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -115.18 148.91 38.47 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.386 0.612 . . . . 0.02 109.869 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -124.38 134.4 53.14 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.532 -0.73 . . . . 0.01 109.069 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.513 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.8 tt -98.85 120.22 38.93 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.941 -1.099 . . . . 0.01 108.651 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.513 ' N ' HD23 ' A' ' 150' ' ' LEU . 6.6 tp -103.07 150.89 23.15 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.27 -0.894 . . . . 0.01 109.12 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -104.56 -110.26 0.26 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.431 -0.793 . . . . 2.27 109.54 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -156.5 51.68 0.52 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.118 -0.989 . . . . 1.8400000000000001 109.638 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -112.71 -163.08 0.83 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.584 -0.697 . . . . 2.2799999999999998 109.264 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -106.39 104.41 14.1 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.452 -0.78 . . . . 0.01 109.073 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.653 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 6.5 m-85 -98.7 112.36 24.45 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.244 -0.91 . . . . 0.01 109.51 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -95.09 -22.15 18.08 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.188 -0.945 . . . . 0.01 111.775 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -127.73 154.24 77.9 Favored Pre-proline 0 N--CA 1.502 2.171 0 O-C-N 120.715 -1.241 . . . . 2.54 109.036 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -60.53 -38.68 71.36 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 120.483 0.789 . . . . 0.69999999999999996 110.517 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.93 -20.08 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.819 -1.176 . . . . 0.85999999999999999 108.93 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 13.7 t0 -65.18 -15.4 62.4 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.955 -1.091 . . . . 0.02 109.925 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.653 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 9.9 m0 -97.89 11.34 37.69 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.111 -0.993 . . . . 0.02 109.099 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.83 10.21 85.93 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.789 -1.196 . . . . 0.02 110.968 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.49 141.47 32.23 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.313 -1.11 . . . . 0.02 110.061 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.57 -8.97 57.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.663 -0.648 . . . . 0.58999999999999997 109.948 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.1 p -143.2 150.35 51.86 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 120.919 -1.113 . . . . 0.87 108.869 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -76.6 18.81 0.68 Allowed 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 120.825 1.016 . . . . 0.38 112.371 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.14 123.08 28.66 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.855 -1.153 . . . . 0.17999999999999999 111.496 -177.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 169' ' ' ILE . 16.1 mm -151.75 127.04 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 106.815 -1.55 . . . . 3.9900000000000002 106.815 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -113.92 -12.91 12.6 Favored 'General case' 0 N--CA 1.508 2.429 0 O-C-N 121.065 -1.022 . . . . 5.1699999999999999 113.725 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 22.7 m -157.53 161.77 38.81 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 119.12 -2.237 . . . . 0.02 110.439 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.474 ' HZ ' ' HG ' ' A' ' 114' ' ' CYS . 21.3 p90 -152.74 153.77 33.87 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.044 -1.035 . . . . 2.02 110.662 178.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 48.8 mtp180 -145.44 150.38 36.4 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.775 0.798 . . . . 0.01 110.23 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -87.9 143.99 26.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.483 -0.761 . . . . 0.01 109.183 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.406 HD12 ' OG1' ' A' ' 135' ' ' THR . 5.1 mt -94.38 129.26 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.184 -0.948 . . . . 3.04 109.045 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.4 t -136.17 146.6 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.174 -0.953 . . . . 1.8899999999999999 109.675 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 4.8899999999999997 109.51 179.962 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 65.1 m . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.433 -0.58 . . . . 5.2800000000000002 109.433 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -65.47 136.55 56.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 5.96 109.53 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 39.1 m -144.13 145.47 32.14 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.01 -1.056 . . . . 2.2200000000000002 109.158 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.37 31.79 8.25 Favored Glycine 0 N--CA 1.504 3.194 0 O-C-N 120.493 -1.38 . . . . 0.81000000000000005 113.798 -176.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.14 142.52 33.13 Favored Glycine 0 N--CA 1.491 2.307 0 CA-C-N 121.174 2.487 . . . . 0.01 107.85 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -149.67 136.11 19.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.916 -1.344 . . . . 0.02 110.755 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.7 tt -128.62 139.25 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 107.822 -1.177 . . . . 0.02 107.822 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 t -121.11 129.63 53.38 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.321 -0.862 . . . . 0.39000000000000001 110.337 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 11.5 m-85 -109.67 139.69 44.41 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.803 -0.814 . . . . 0.02 108.803 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.528 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 6.3 m-85 -122.15 138.33 54.51 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.139 -0.975 . . . . 0.02 109.664 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.521 ' OE2' ' N ' ' A' ' 35' ' ' ARG . 6.1 mm-40 -67.83 -28.63 67.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.934 . . . . 0.029999999999999999 111.093 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.5 m-20 -114.77 170.06 8.61 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.882 -1.136 . . . . 0.029999999999999999 110.163 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -75.56 162.35 28.37 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.729 0.776 . . . . 0.029999999999999999 110.295 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 3.0 t30 62.8 33.33 15.4 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.002 0.906 . . . . 0.73999999999999999 110.806 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 55.0 40.36 32.0 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.975 -0.557 . . . . 0.02 110.843 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -110.67 165.96 11.4 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.14 -1.059 . . . . 0.02 108.14 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.02 -167.73 36.56 Favored Glycine 0 N--CA 1.495 2.62 0 C-N-CA 119.719 -1.229 . . . . 0.029999999999999999 110.918 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -68.73 142.66 54.92 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.63 -0.923 . . . . 2.7599999999999998 109.354 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 -120.6 148.83 43.37 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.658 0.742 . . . . 1.8899999999999999 110.195 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -132.81 127.57 34.84 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.436 -0.95 . . . . 0.02 108.436 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 21.4 p-10 -112.79 137.28 51.35 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.499 -0.75 . . . . 1.1200000000000001 109.857 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 15.3 t -131.48 139.08 49.25 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.742 -0.599 . . . . 0.02 109.515 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.0 p30 -117.04 11.4 14.25 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.528 -0.733 . . . . 0.20000000000000001 109.939 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.405 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 34.7 t -158.31 174.46 15.11 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.389 -0.967 . . . . 1.23 108.389 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -61.17 144.25 54.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.597 -1.315 . . . . 0.02 109.869 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.5 t -131.75 117.32 18.44 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.54 -0.911 . . . . 0.02 108.54 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.66 -25.02 49.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.122 -0.986 . . . . 0.23999999999999999 110.778 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.47 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 20.8 p-10 -154.8 101.26 2.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.09 -1.006 . . . . 1.1399999999999999 108.882 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -105.85 9.58 32.79 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-O 122.004 0.907 . . . . 6.3700000000000001 109.835 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -58.63 -24.24 60.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.674 -0.641 . . . . 3.1099999999999999 110.861 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.5 m -74.05 -16.59 61.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.716 -1.24 . . . . 0.88 109.836 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -105.72 -21.99 13.06 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.616 -0.677 . . . . 0.02 109.561 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.453 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 3.0 tp -148.83 126.36 11.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.023 -1.048 . . . . 3.3199999999999998 109.686 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.7 m -86.83 -11.0 52.16 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.488 -0.757 . . . . 0.02 111.446 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.521 ' N ' ' OE2' ' A' ' 11' ' ' GLU . 17.8 ttp180 -170.98 161.17 6.84 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.682 -1.229 . . . . 0.02 107.682 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.5 t -141.65 115.41 9.12 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.8 -1.187 . . . . 0.02 109.213 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.416 ' ND2' ' OD2' ' A' ' 77' ' ' ASP . 3.5 m120 -107.57 -0.19 22.2 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.914 -1.116 . . . . 0.029999999999999999 110.858 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.1 t -156.18 153.38 29.13 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.851 -1.166 . . . . 0.02 107.851 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.5 mt -145.43 147.57 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.11 -0.994 . . . . 0.02 110.313 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -123.22 124.13 42.32 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.753 -1.203 . . . . 0.02 107.753 176.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.3 t -106.56 114.88 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 107.058 -1.46 . . . . 0.02 107.058 177.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.434 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 30.3 tt0 -83.61 -34.07 25.19 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 120.099 -0.64 . . . . 3.8100000000000001 110.912 -178.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.96 152.21 21.95 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 118.896 -1.621 . . . . 0.02 111.03 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.43 172.86 49.24 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.627 -1.273 . . . . 0.01 110.514 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.4 m -119.51 135.06 54.94 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.978 -1.119 . . . . 1.48 107.978 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.458 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 32.5 m95 -127.14 155.77 42.83 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 122.56 1.172 . . . . 0.02 112.151 -176.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.59 134.3 52.1 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 105.697 -1.964 . . . . 0.23999999999999999 105.697 176.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.521 ' HB ' HD22 ' A' ' 79' ' ' LEU . 34.6 m -116.65 141.73 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.556 -0.715 . . . . 0.65000000000000002 109.222 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -120.61 143.32 48.72 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 122.098 0.951 . . . . 0.02 109.793 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -65.69 -34.24 77.75 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.661 -0.7 . . . . 0.02 111.646 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -125.15 157.6 66.62 Favored Pre-proline 0 N--CA 1.502 2.173 0 O-C-N 121.033 -1.042 . . . . 0.02 109.359 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.56 167.2 1.0 Allowed 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.718 1.612 . . . . 0.02 113.015 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.3 m120 63.76 36.09 10.81 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.154 -0.93 . . . . 0.02 111.16 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.407 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 4.2 m-85 45.38 51.56 9.46 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.722 0.772 . . . . 3.3900000000000001 110.503 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 90.3 p -126.13 163.83 22.26 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.318 0.58 . . . . 2.3300000000000001 109.847 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.88 -161.76 32.19 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.816 -1.314 . . . . 0.02 109.816 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.514 ' N ' ' ND1' ' A' ' 57' ' ' HIS . 1.9 m80 -65.27 138.72 58.39 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.065 -1.256 . . . . 0.02 110.337 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.497 ' O ' ' SD ' ' A' ' 58' ' ' MET . 2.6 ppp? -119.11 137.13 53.79 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.492 0.663 . . . . 5.0099999999999998 109.517 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.446 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 96.8 m-85 -134.28 138.81 45.28 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.395 -0.816 . . . . 0.02 109.648 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.4 mm -95.32 131.09 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 109.057 -0.719 . . . . 1.72 109.057 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.561 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -119.6 110.83 36.73 Favored Pre-proline 0 N--CA 1.503 2.184 0 O-C-N 121.299 -0.876 . . . . 0.02 110.769 -178.266 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -77.54 168.49 22.59 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 CA-C-N 119.934 1.012 . . . . 1.47 110.221 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.434 ' NE2' ' O ' ' A' ' 42' ' ' GLU . 63.1 tt0 -53.58 141.19 26.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.824 -1.173 . . . . 4.25 110.43 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.79 -177.76 31.9 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.529 -1.32 . . . . 0.02 110.712 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -120.5 131.69 54.84 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.558 -0.966 . . . . 0.95999999999999996 109.732 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.561 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 63.8 m-85 -122.3 94.19 48.04 Favored Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 108.023 -1.103 . . . . 0.02 108.023 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.402 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 5.3 Cg_exo -64.44 -4.24 7.8 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 120.928 1.085 . . . . 0.02 113.799 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 34.8 mt-10 -157.58 155.3 29.95 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.555 -1.34 . . . . 2.02 108.287 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -60.63 -39.0 86.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.481 -0.762 . . . . 0.02 112.199 -176.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -59.93 -23.72 63.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.093 -1.004 . . . . 0.02 110.329 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -70.62 -18.57 62.87 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.782 0.801 . . . . 3.4199999999999999 109.021 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.547 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.6 t90 -107.98 10.14 28.42 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.415 -1.328 . . . . 0.02 107.415 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.4 mmt 60.77 22.49 12.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.66 -0.65 . . . . 0.02 110.545 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.78 144.33 46.35 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.401 -1.48 . . . . 0.02 109.401 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.8 tp -79.29 -31.03 43.23 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.617 -1.253 . . . . 0.97999999999999998 107.617 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -157.02 -171.74 3.76 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 106.342 -1.725 . . . . 0.02 106.342 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.416 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 52.1 m-20 -98.71 27.54 4.82 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.616 -1.303 . . . . 0.02 110.708 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -95.97 122.56 38.92 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.939 -1.101 . . . . 3.2000000000000002 110.865 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.521 HD22 ' HB ' ' A' ' 48' ' ' VAL . 31.2 mt -142.9 121.35 12.4 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.558 -1.275 . . . . 2.6099999999999999 107.558 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.2 -17.85 9.15 Favored Glycine 0 N--CA 1.501 2.977 0 O-C-N 121.257 -0.902 . . . . 0.02 112.878 -177.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.407 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 11.1 t -156.03 155.78 33.28 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-N 120.004 1.902 . . . . 0.02 111.023 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 13.5 p -145.34 147.43 32.29 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.321 -0.862 . . . . 0.02 110.624 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -138.23 143.63 40.22 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.529 -0.732 . . . . 0.01 109.292 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.66 132.11 36.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -0.915 . . . . 0.42999999999999999 109.759 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.8 t -91.28 125.2 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.961 -0.755 . . . . 1.25 108.961 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -94.36 131.13 40.33 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.884 -1.135 . . . . 1.77 109.029 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 mt -95.76 140.3 30.74 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.621 -0.881 . . . . 1.6299999999999999 108.621 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t -111.64 127.87 55.89 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.37 -0.831 . . . . 1.0800000000000001 109.33 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 71.5 p -104.41 -154.58 0.51 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 106.631 -1.618 . . . . 1.26 106.631 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.32 -52.65 0.73 Allowed Glycine 0 N--CA 1.5 2.956 0 O-C-N 120.498 -1.376 . . . . 0.01 112.895 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.18 -101.44 0.15 Allowed Glycine 0 N--CA 1.49 2.256 0 C-N-CA 118.456 -1.83 . . . . 0.01 112.022 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -121.88 119.53 31.84 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.056 -1.261 . . . . 4.4299999999999997 110.695 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.42 129.22 34.26 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.682 -0.807 . . . . 2.9900000000000002 109.303 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -130.54 142.1 50.47 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.866 -0.79 . . . . 6.3600000000000003 108.866 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.7 tt -129.97 146.05 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 O-C-N 121.255 -0.903 . . . . 1.0900000000000001 110.451 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -121.26 133.61 55.15 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.354 -1.35 . . . . 2.0499999999999998 107.354 177.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.4 m -123.93 146.41 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 120.895 -1.128 . . . . 1.1000000000000001 109.709 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.576 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 72.0 m-85 -119.32 141.61 48.86 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.978 0.894 . . . . 0.72999999999999998 111.059 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -66.96 -30.28 70.36 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 116.066 -0.515 . . . . 0.02 111.734 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 43.8 mttp -116.37 167.22 11.22 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.965 -1.084 . . . . 3.1800000000000002 110.425 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.05 164.05 44.24 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.958 -0.857 . . . . 0.01 110.958 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 57.23 38.87 28.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.932 -0.746 . . . . 0.01 110.913 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 52.29 55.72 8.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.723 -0.611 . . . . 0.01 111.079 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -128.97 165.66 20.68 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.29 -1.004 . . . . 3.1499999999999999 108.29 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.66 -164.0 27.57 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.279 -1.528 . . . . 0.01 109.279 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -75.69 144.29 41.67 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.968 -1.313 . . . . 0.01 108.438 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.576 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 27.6 ttp -116.41 142.19 47.18 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.543 0.687 . . . . 0.01 109.889 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -131.58 136.54 47.88 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.176 -1.046 . . . . 2.48 108.176 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -119.19 134.48 55.18 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.57 -0.706 . . . . 0.01 109.923 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 t -148.67 150.52 33.35 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 122.278 1.037 . . . . 1.6899999999999999 111.145 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 48.2 p -110.89 9.62 22.38 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 115.572 -0.74 . . . . 0.01 110.336 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -121.15 163.22 18.78 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.15 -0.969 . . . . 3.21 111.721 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -68.2 157.18 36.0 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.268 -1.012 . . . . 0.01 108.268 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 19.1 t -126.88 114.16 22.21 Favored Pre-proline 0 N--CA 1.501 2.075 0 O-C-N 121.457 -0.777 . . . . 0.01 109.101 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -75.05 -29.72 7.85 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 CA-C-N 120.247 1.124 . . . . 0.01 111.035 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.5 m -142.3 109.19 5.45 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.309 -0.869 . . . . 0.02 109.121 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.41 HD12 ' O ' ' A' ' 169' ' ' ILE . 97.7 mt -63.58 -38.99 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.866 -0.521 . . . . 1.8300000000000001 110.59 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 19.0 ttt -68.82 -37.74 79.4 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.349 -0.94 . . . . 1.3400000000000001 110.399 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -69.46 -38.57 77.8 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.417 -1.427 . . . . 2.1099999999999999 109.995 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -80.11 -47.14 15.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.331 -0.856 . . . . 2.0800000000000001 112.339 -177.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -111.18 0.0 16.66 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.363 -0.836 . . . . 0.02 112.637 -176.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.7 m80 60.01 33.64 21.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.768 -1.208 . . . . 0.02 109.516 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.0 mt -112.65 135.51 53.29 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 108.83 -0.804 . . . . 0.02 108.83 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -91.69 -22.96 19.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.254 -0.904 . . . . 5.3200000000000003 110.393 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -149.45 164.34 35.27 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.187 -0.945 . . . . 0.02 109.813 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.5 mt -132.15 128.89 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 107.804 -1.184 . . . . 2.1699999999999999 107.804 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.39 -11.98 15.1 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.365 -0.834 . . . . 0.02 112.25 -178.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.2 p -160.31 151.06 18.72 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.917 -1.114 . . . . 0.01 109.273 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 27.1 p -168.25 145.01 3.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.362 -0.836 . . . . 1.22 109.133 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 40.5 tttm -126.31 111.67 14.8 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 122.42 1.105 . . . . 1.4099999999999999 110.417 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.2 p -114.38 138.44 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 107.408 -1.33 . . . . 0.01 107.408 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.5 t -126.8 94.03 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 106.732 -1.581 . . . . 1.98 106.732 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.422 ' CD ' ' N ' ' A' ' 134' ' ' GLY . 6.1 tm-20 -145.65 -80.65 0.16 Allowed 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 106.218 -1.771 . . . . 0.01 106.218 177.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.422 ' N ' ' CD ' ' A' ' 133' ' ' GLU . . . 176.45 -76.2 0.07 OUTLIER Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.987 -1.645 . . . . 0.01 108.987 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 30.9 p -118.0 118.14 31.13 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.593 -0.945 . . . . 2.2999999999999998 110.192 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -124.88 150.4 46.52 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 107.244 -1.391 . . . . 0.01 107.244 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 12.4 mt -121.79 136.88 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 120.484 -1.385 . . . . 1.6899999999999999 110.15 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -114.55 144.29 43.6 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.364 -1.347 . . . . 2.4900000000000002 107.364 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.463 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 24.5 m-85 -123.29 143.56 49.99 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.271 -0.893 . . . . 0.02 109.575 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.461 ' O ' ' NE2' ' A' ' 170' ' ' GLN . 81.8 tt0 -73.96 -29.24 61.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.506 -0.746 . . . . 0.02 111.911 -176.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.1 mt -116.09 154.9 48.58 Favored Pre-proline 0 N--CA 1.505 2.291 0 O-C-N 120.725 -1.234 . . . . 1.48 108.964 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -55.66 167.36 2.17 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.151 1.234 . . . . 0.02 112.757 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.429 ' OD1' ' N ' ' A' ' 143' ' ' ASN . 2.3 m-20 59.37 31.11 20.87 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.174 -0.921 . . . . 0.75 111.233 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 57.41 50.62 11.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.45 -0.781 . . . . 0.02 111.064 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -125.13 164.36 20.42 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.554 -0.716 . . . . 0.02 109.898 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.558 ' O ' ' NE2' ' A' ' 148' ' ' GLN . . . 89.16 -165.72 33.06 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.184 -1.167 . . . . 0.02 110.184 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -69.08 142.55 54.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.54 -0.977 . . . . 0.02 109.034 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.558 ' NE2' ' O ' ' A' ' 146' ' ' GLY . 5.6 mp0 -114.53 148.54 37.78 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.44 0.638 . . . . 0.02 110.011 -178.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -124.92 134.98 52.45 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 109.083 -0.71 . . . . 0.01 109.083 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.5 HD23 ' N ' ' A' ' 151' ' ' LEU . 4.1 tt -100.09 121.25 41.11 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.872 -1.142 . . . . 0.01 108.92 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.5 ' N ' HD23 ' A' ' 150' ' ' LEU . 4.9 tp -99.32 145.34 27.43 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.198 -0.939 . . . . 0.01 108.96 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -106.73 -166.41 1.17 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.647 -0.658 . . . . 2.27 109.882 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -90.68 52.85 2.28 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.405 -0.809 . . . . 1.8400000000000001 109.833 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -115.35 -178.88 3.48 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.473 -0.767 . . . . 2.2799999999999998 109.448 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -105.47 111.48 24.21 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.476 -0.935 . . . . 0.01 108.476 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -99.65 112.7 24.9 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.387 -0.82 . . . . 0.01 110.493 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -94.54 -24.06 17.41 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.165 -0.959 . . . . 0.01 110.855 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -126.04 153.59 73.96 Favored Pre-proline 0 N--CA 1.501 2.078 0 N-CA-C 108.451 -0.944 . . . . 2.54 108.451 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -59.85 -39.73 69.49 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 CA-C-N 119.285 0.78 . . . . 0.69999999999999996 110.609 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 6.7 t -61.84 -19.57 21.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.755 -1.216 . . . . 0.85999999999999999 108.863 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 10.6 t0 -65.96 -18.06 65.09 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.954 -1.091 . . . . 0.02 111.059 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.621 ' HE1' ' CB ' ' A' ' 164' ' ' ALA . 1.8 p90 -103.0 14.16 32.6 Favored 'General case' 0 N--CA 1.508 2.467 0 O-C-N 121.077 -1.014 . . . . 0.02 109.811 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 87.42 10.37 70.89 Favored Glycine 0 N--CA 1.497 2.728 0 O-C-N 121.462 -0.774 . . . . 0.02 113.854 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.621 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . . . -100.93 141.32 33.98 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 120.472 -1.604 . . . . 0.02 110.757 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.61 -7.66 59.17 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.673 -0.642 . . . . 0.58999999999999997 109.484 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 39.0 m -143.54 150.67 51.82 Favored Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 120.961 -1.087 . . . . 0.87 109.154 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -76.75 18.45 0.72 Allowed 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.0 1.134 . . . . 0.38 112.474 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.87 125.47 31.38 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 122.373 1.082 . . . . 0.17999999999999999 111.698 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.508 HD11 ' CZ2' ' A' ' 162' ' ' TRP . 1.6 mt -149.94 127.01 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.344 -1.354 . . . . 3.9900000000000002 107.344 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.461 ' NE2' ' O ' ' A' ' 140' ' ' GLU . 2.9 mp0 -111.95 -18.06 12.74 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.075 -1.016 . . . . 5.1699999999999999 112.816 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 20.5 t -157.06 159.93 38.42 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 119.141 -2.224 . . . . 0.02 110.315 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.431 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 19.0 p90 -151.67 153.38 34.29 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.971 -1.081 . . . . 2.02 110.538 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 -144.97 149.98 36.14 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.882 0.849 . . . . 0.01 110.433 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -87.17 143.14 27.43 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.874 -0.788 . . . . 0.01 108.874 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.1 mt -94.76 129.13 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.28 -0.887 . . . . 3.04 109.108 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 11.7 p -136.38 146.99 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.194 -0.942 . . . . 1.8899999999999999 109.686 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 4.8899999999999997 109.411 -179.991 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.346 -0.613 . . . . 5.2800000000000002 109.346 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -82.25 -12.79 57.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.907 . . . . 5.96 109.707 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 26.9 p -99.87 110.88 23.23 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 106.862 -1.533 . . . . 2.2200000000000002 106.862 177.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.71 94.05 0.09 OUTLIER Glycine 0 N--CA 1.492 2.379 0 N-CA-C 106.619 -2.592 . . . . 0.81000000000000005 106.619 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.69 146.94 33.21 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.45 -1.06 . . . . 0.01 110.45 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -152.85 138.34 17.68 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.52 -0.988 . . . . 0.02 109.666 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.8 tt -130.85 140.87 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 109.222 -0.659 . . . . 0.02 109.222 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.8 m -121.95 130.89 53.7 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.444 -0.785 . . . . 0.39000000000000001 109.996 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.487 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 5.4 m-85 -111.11 140.74 45.41 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.561 -0.712 . . . . 0.02 109.332 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.575 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.1 m-85 -122.68 138.6 54.56 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.266 -0.896 . . . . 0.02 109.756 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -69.29 -27.29 65.27 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.925 -1.11 . . . . 0.029999999999999999 111.736 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 3.3 m-20 -113.87 169.4 9.03 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.804 -1.185 . . . . 0.029999999999999999 110.172 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -75.33 158.31 32.99 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.662 0.744 . . . . 0.029999999999999999 110.034 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.413 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 7.1 t-20 65.96 33.44 7.8 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.913 0.863 . . . . 0.73999999999999999 111.173 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.413 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 0.8 OUTLIER 55.42 41.8 30.65 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.296 0.57 . . . . 0.02 111.214 177.836 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -112.8 165.6 12.15 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.236 -1.024 . . . . 0.02 108.236 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.17 -167.59 34.49 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.801 -1.19 . . . . 0.029999999999999999 110.6 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -70.19 143.88 52.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.425 -1.044 . . . . 2.7599999999999998 108.957 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -120.41 149.13 42.85 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.65 0.738 . . . . 1.8899999999999999 110.296 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -132.76 127.7 35.23 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.399 -0.963 . . . . 0.02 108.399 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 18.9 p30 -112.22 136.85 51.13 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.441 -0.787 . . . . 1.1200000000000001 109.709 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.0 t -130.65 138.6 50.15 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.515 0.674 . . . . 0.02 109.679 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.498 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 33.9 t70 -117.07 11.14 14.13 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.567 -0.708 . . . . 0.20000000000000001 109.852 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 42.3 m -158.55 174.57 14.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.118 -0.988 . . . . 1.23 108.505 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -61.27 144.04 54.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.71 -1.244 . . . . 0.02 110.09 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.5 t -131.67 117.46 18.69 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.654 -0.869 . . . . 0.02 108.654 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.12 -25.77 47.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.974 -1.079 . . . . 0.23999999999999999 110.988 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -153.4 101.6 2.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.979 -1.075 . . . . 1.1399999999999999 108.977 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -104.0 9.28 36.62 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 122.109 0.956 . . . . 6.3700000000000001 109.806 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.4 mtm180 -59.3 -24.69 63.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.525 -0.734 . . . . 3.1099999999999999 111.221 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.3 t -75.39 -16.93 60.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.629 -1.295 . . . . 0.88 110.315 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -105.14 -21.69 13.22 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.366 -0.833 . . . . 0.02 109.503 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.4 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 4.5 tp -148.7 126.81 12.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.223 -0.923 . . . . 3.3199999999999998 109.447 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.5 t -86.51 -11.88 50.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.634 -0.666 . . . . 0.02 111.206 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.4 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 24.4 ttp180 -171.47 161.58 6.36 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.84 -1.162 . . . . 0.02 108.154 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.405 ' SG ' HD12 ' A' ' 79' ' ' LEU . 1.5 p -142.55 114.98 8.46 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.881 -1.137 . . . . 0.02 108.761 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -106.63 1.15 24.95 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 120.777 -1.202 . . . . 0.029999999999999999 110.379 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.8 t -155.94 154.51 31.28 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.5 -1.296 . . . . 0.02 107.5 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.8 mt -146.63 147.68 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.029 -1.045 . . . . 0.02 110.401 -178.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.579 HH11 ' CG ' ' A' ' 40' ' ' ARG . 0.2 OUTLIER -124.39 125.02 43.61 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.997 -1.112 . . . . 0.02 107.997 177.651 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.1 t -105.1 113.65 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 106.644 -1.613 . . . . 0.02 106.644 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -84.18 -34.76 23.91 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.467 -0.77 . . . . 3.8100000000000001 110.033 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.41 150.93 20.21 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 118.618 -1.753 . . . . 0.02 110.722 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.43 171.99 48.58 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.357 -1.097 . . . . 0.01 110.357 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.8 m -119.6 134.9 55.03 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 107.805 -1.183 . . . . 1.48 107.805 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.467 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 31.2 m95 -127.36 154.94 44.36 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 122.583 1.182 . . . . 0.02 112.329 -176.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.29 134.06 51.64 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 105.282 -2.118 . . . . 0.23999999999999999 105.282 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.51 ' HB ' HD22 ' A' ' 79' ' ' LEU . 23.7 m -119.12 143.7 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 109.066 -0.716 . . . . 0.65000000000000002 109.066 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -120.96 145.92 47.21 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 122.276 1.036 . . . . 0.02 110.041 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -66.09 -34.05 77.18 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 115.816 -0.629 . . . . 0.02 111.009 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -125.46 157.54 67.63 Favored Pre-proline 0 N--CA 1.502 2.162 0 O-C-N 121.051 -1.03 . . . . 0.02 109.487 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.45 167.26 0.93 Allowed 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.692 1.594 . . . . 0.02 113.074 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.8 m120 63.77 36.36 10.59 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.253 -0.885 . . . . 0.02 111.113 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 45.09 51.58 8.88 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.66 0.743 . . . . 3.3900000000000001 110.67 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.7 m -126.36 163.82 22.43 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.168 0.509 . . . . 2.3300000000000001 109.814 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.78 -161.65 32.24 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.815 -1.314 . . . . 0.02 109.815 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -65.3 139.15 58.57 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.124 -1.221 . . . . 0.02 110.146 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.497 ' O ' ' SD ' ' A' ' 58' ' ' MET . 2.8 ppp? -118.84 137.28 53.53 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.714 -0.616 . . . . 5.0099999999999998 109.593 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.469 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 96.2 m-85 -134.85 138.63 44.36 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.494 -0.754 . . . . 0.02 109.78 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.4 mm -95.2 131.61 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.857 -0.794 . . . . 1.72 108.857 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.561 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -120.08 110.64 36.15 Favored Pre-proline 0 N--CA 1.505 2.278 0 O-C-N 121.289 -0.882 . . . . 0.02 110.858 -178.346 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -77.86 168.99 21.38 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 CA-C-N 119.916 1.006 . . . . 1.47 110.296 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -53.9 140.62 30.15 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.861 -1.15 . . . . 4.25 110.522 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.93 -177.79 32.82 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.451 -1.356 . . . . 0.02 110.618 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -119.93 131.16 55.12 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.362 -1.081 . . . . 0.95999999999999996 109.646 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.561 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 75.9 m-85 -121.8 96.27 47.21 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 108.128 -1.064 . . . . 0.02 108.128 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.404 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.6 Cg_endo -67.07 -3.75 10.29 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 120.778 0.986 . . . . 0.02 113.756 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 35.1 mt-10 -157.81 155.21 29.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.685 -1.259 . . . . 2.02 108.288 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -60.56 -39.37 87.72 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.572 -0.705 . . . . 0.02 112.042 -177.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -59.96 -23.68 63.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.083 -1.011 . . . . 0.02 110.276 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -69.97 -18.92 63.37 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.778 0.799 . . . . 3.4199999999999999 109.021 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.547 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.1 t90 -108.04 10.6 28.19 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.432 -1.321 . . . . 0.02 107.432 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.5 mtt 61.08 22.27 12.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.537 -0.727 . . . . 0.02 110.463 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.76 143.65 44.88 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.49 -1.444 . . . . 0.02 109.49 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.4 tp -79.57 -31.93 41.98 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.558 -1.275 . . . . 0.97999999999999998 107.558 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -157.63 -172.65 4.04 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 106.312 -1.736 . . . . 0.02 106.312 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -98.49 28.06 4.4 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.821 -1.174 . . . . 0.02 110.823 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 -96.83 121.89 39.19 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.828 -1.17 . . . . 3.2000000000000002 110.887 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.51 HD22 ' HB ' ' A' ' 48' ' ' VAL . 31.0 mt -144.0 121.39 11.65 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 107.574 -1.269 . . . . 2.6099999999999999 107.574 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.34 -16.19 11.48 Favored Glycine 0 N--CA 1.505 3.243 0 O-C-N 121.192 -0.943 . . . . 0.02 112.804 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.6 p -157.09 156.37 32.66 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.107 -1.819 . . . . 0.02 110.344 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 23.4 m -144.89 147.93 33.33 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.584 -0.698 . . . . 0.02 110.047 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 39.1 mtp180 -137.84 143.19 40.84 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.368 -0.832 . . . . 0.01 109.585 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.57 132.21 36.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.201 -0.937 . . . . 0.42999999999999999 109.669 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.3 t -91.0 125.03 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.873 -0.788 . . . . 1.25 108.873 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -92.56 132.53 36.77 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.877 -1.139 . . . . 1.77 108.865 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mt -98.42 140.57 32.48 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.865 -0.791 . . . . 1.6299999999999999 108.865 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 52.9 p -112.08 124.68 52.95 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.474 -0.936 . . . . 1.0800000000000001 108.474 178.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.4 m -115.76 132.81 56.53 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 107.754 -1.202 . . . . 1.26 107.754 177.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -156.78 -49.58 0.01 OUTLIER Glycine 0 N--CA 1.505 3.279 0 C-N-CA 117.709 -2.186 . . . . 0.01 113.636 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.71 -105.73 0.19 Allowed Glycine 0 N--CA 1.489 2.203 0 CA-C-N 120.192 1.996 . . . . 0.01 111.352 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -120.81 118.59 30.39 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.125 -1.221 . . . . 4.4299999999999997 110.401 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.14 129.14 34.81 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.806 -0.758 . . . . 2.9900000000000002 109.369 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -131.23 141.19 49.98 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.497 -0.752 . . . . 6.3600000000000003 109.241 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.0 tt -129.8 146.91 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 O-C-N 121.247 -0.908 . . . . 1.0900000000000001 110.344 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.523 ' NE2' ' O ' ' A' ' 130' ' ' LYS . 2.4 pm0 -122.1 134.31 54.76 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 107.561 -1.274 . . . . 2.0499999999999998 107.561 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.8 m -124.37 146.25 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 O-C-N 120.721 -1.237 . . . . 1.1000000000000001 110.158 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.584 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 79.5 m-85 -119.4 141.2 49.29 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.973 0.892 . . . . 0.72999999999999998 111.081 -178.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -67.18 -30.22 70.12 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 115.921 -0.581 . . . . 0.02 111.819 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -116.18 168.99 9.62 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.028 -1.045 . . . . 3.1800000000000002 110.441 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.27 164.94 50.0 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.796 -0.921 . . . . 0.01 110.796 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 56.46 38.45 29.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.719 -0.871 . . . . 0.01 111.432 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 51.94 55.08 9.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.559 -0.713 . . . . 0.01 111.256 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -129.06 165.01 22.02 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.018 -1.105 . . . . 3.1499999999999999 108.018 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.18 -163.64 27.95 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.255 -1.538 . . . . 0.01 109.255 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -76.19 144.19 40.64 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.005 -1.291 . . . . 0.01 108.834 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.584 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 32.7 ttp -116.66 142.55 46.75 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.524 0.678 . . . . 0.01 109.821 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -131.48 136.86 48.26 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.265 -1.013 . . . . 2.48 108.265 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -118.15 134.16 55.25 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.551 -0.718 . . . . 0.01 110.248 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.9 t -149.01 148.33 29.61 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.276 1.036 . . . . 1.6899999999999999 111.197 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 30.1 p -111.16 9.7 21.88 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 115.547 -0.751 . . . . 0.01 110.496 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -120.85 163.16 18.61 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.235 -0.916 . . . . 3.21 111.438 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -67.46 156.8 35.72 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.217 -1.031 . . . . 0.01 108.217 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.609 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 26.4 p -123.86 116.47 27.6 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.515 -0.741 . . . . 0.01 109.414 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -76.7 -31.93 3.86 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 CA-C-N 120.181 1.1 . . . . 0.01 110.445 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.4 p -143.84 108.91 4.98 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.733 0.778 . . . . 0.02 109.016 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.9 mt -64.16 -39.27 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.771 -0.581 . . . . 1.8300000000000001 110.822 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 118' ' ' MET . 1.8 tmt? -67.95 -37.24 81.34 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.175 -1.01 . . . . 1.3400000000000001 110.034 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -69.47 -38.02 77.55 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.543 -1.348 . . . . 2.1099999999999999 109.87 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -80.25 -46.72 15.75 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.274 -0.891 . . . . 2.0800000000000001 112.373 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -110.87 0.13 17.07 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.395 -0.815 . . . . 0.02 112.58 -176.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.519 ' O ' ' NH1' ' A' ' 124' ' ' ARG . 8.7 m80 60.01 33.47 21.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.768 -1.207 . . . . 0.02 109.639 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.6 mt -112.63 135.8 52.94 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 108.754 -0.832 . . . . 0.02 108.754 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 122' ' ' HIS . 0.1 OUTLIER -92.27 -22.79 19.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.242 -0.911 . . . . 5.3200000000000003 110.208 -179.486 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -149.33 163.61 37.21 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.189 -0.945 . . . . 0.02 109.883 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.1 mt -131.91 128.81 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 107.899 -1.148 . . . . 2.1699999999999999 107.899 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -107.61 -12.54 15.24 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.27 -0.893 . . . . 0.02 112.084 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.5 m -158.44 150.7 21.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.848 -1.158 . . . . 0.01 108.511 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.572 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 0.5 OUTLIER -169.62 144.67 2.97 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.425 -0.954 . . . . 1.22 108.425 -179.526 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.523 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 32.1 tttp -125.93 110.6 13.82 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 122.497 1.142 . . . . 1.4099999999999999 110.61 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 131' ' ' VAL . 10.1 p -109.09 134.5 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 106.948 -1.501 . . . . 0.01 106.948 178.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 50.7 t -128.58 94.77 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 N-CA-C 107.148 -1.427 . . . . 1.98 107.148 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -146.66 -76.58 0.19 Allowed 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 105.816 -1.92 . . . . 0.01 105.816 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 156.27 -54.14 0.41 Allowed Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.982 -1.647 . . . . 0.01 108.982 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 76.3 p -119.21 98.32 6.1 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.643 -0.916 . . . . 2.2999999999999998 111.021 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -129.25 145.38 51.35 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 107.265 -1.383 . . . . 0.01 107.265 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 96.4 mt -123.74 139.47 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 120.957 -1.089 . . . . 1.6899999999999999 110.071 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -114.26 144.06 43.84 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 106.99 -1.485 . . . . 2.4900000000000002 106.99 177.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.497 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 14.3 m-85 -123.19 144.19 49.53 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.348 -0.845 . . . . 0.02 109.465 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -74.1 -29.45 61.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.595 -0.69 . . . . 0.02 111.838 -176.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.3 mt -115.94 154.76 48.36 Favored Pre-proline 0 N--CA 1.505 2.283 0 O-C-N 120.693 -1.254 . . . . 1.48 108.985 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -56.15 167.22 2.62 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.123 1.215 . . . . 0.02 112.889 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 59.58 31.15 20.76 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.149 -0.932 . . . . 0.75 111.487 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 144' ' ' TYR . 0.7 OUTLIER 58.05 50.98 9.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.447 -0.783 . . . . 0.02 111.152 177.869 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -125.99 164.57 20.54 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.494 -0.754 . . . . 0.02 109.973 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.06 -165.6 33.11 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.323 -1.111 . . . . 0.02 110.323 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -69.4 142.22 53.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.596 -0.943 . . . . 0.02 109.055 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.467 ' CD ' ' N ' ' A' ' 148' ' ' GLN . 5.3 mp0 -115.34 149.55 37.71 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.851 -0.531 . . . . 0.02 109.75 -178.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -124.72 134.61 52.78 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.618 -0.676 . . . . 0.01 109.189 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.493 HD23 ' N ' ' A' ' 151' ' ' LEU . 2.8 tt -99.91 121.46 41.37 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.072 -1.017 . . . . 0.01 108.743 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.493 ' N ' HD23 ' A' ' 150' ' ' LEU . 3.8 mm? -99.98 165.33 11.59 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.022 -1.049 . . . . 0.01 109.506 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -109.91 -96.96 0.4 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.59 -0.694 . . . . 2.27 109.215 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -176.37 51.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.198 -0.939 . . . . 1.8400000000000001 109.626 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -113.82 -159.77 0.7 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.547 -0.721 . . . . 2.2799999999999998 109.512 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.518 ' OE2' ' NZ ' ' A' ' 130' ' ' LYS . 66.3 mm-40 -106.37 107.05 17.87 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.494 -0.753 . . . . 0.01 109.064 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.705 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 29.7 m-85 -99.96 114.3 27.47 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.301 -0.874 . . . . 0.01 109.993 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -96.09 -22.34 17.39 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.227 -0.921 . . . . 0.01 111.928 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -127.84 155.34 77.61 Favored Pre-proline 0 N--CA 1.504 2.26 0 O-C-N 120.803 -1.185 . . . . 2.54 109.023 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -60.79 -39.64 60.94 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 120.497 0.798 . . . . 0.69999999999999996 110.614 178.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.0 t -60.72 -20.76 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.763 -1.211 . . . . 0.85999999999999999 109.011 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -65.09 -14.93 61.72 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.815 -1.178 . . . . 0.02 109.732 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.705 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 21.8 m0 -96.2 10.71 36.91 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.329 -0.857 . . . . 0.02 108.712 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.03 9.47 87.07 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.727 -1.225 . . . . 0.02 110.716 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -98.63 141.86 30.93 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.296 -1.12 . . . . 0.02 110.065 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.19 -9.09 58.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.574 -0.703 . . . . 0.58999999999999997 109.661 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.1 t -144.61 150.09 45.96 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.079 -1.013 . . . . 0.87 108.728 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -75.9 19.96 0.56 Allowed 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 120.663 0.908 . . . . 0.38 112.259 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.26 123.57 29.72 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.88 -1.138 . . . . 0.17999999999999999 111.584 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.8 mt -149.49 128.15 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 107.041 -1.466 . . . . 3.9900000000000002 107.041 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -112.15 -17.39 12.82 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.055 -1.028 . . . . 5.1699999999999999 113.356 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.6 p -158.11 160.98 37.9 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 119.122 -2.236 . . . . 0.02 110.148 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.609 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 3.8 p90 -151.51 153.66 35.03 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.056 -1.028 . . . . 2.02 110.925 178.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -145.38 149.64 35.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.297 -0.877 . . . . 0.01 110.215 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -88.36 144.03 26.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.527 -0.733 . . . . 0.01 109.51 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.5 mt -93.59 129.59 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.155 -0.965 . . . . 3.04 109.159 178.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 10.2 p -136.09 146.56 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.254 -0.904 . . . . 1.8899999999999999 109.473 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.291 -0.881 . . . . 4.8899999999999997 109.404 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 82.3 p . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.417 -0.586 . . . . 5.2800000000000002 109.417 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -56.4 166.62 0.83 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 5.96 109.501 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 53.7 m -80.92 141.92 34.06 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.325 -0.991 . . . . 2.2200000000000002 108.325 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.12 179.91 47.69 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 118.326 -1.892 . . . . 0.81000000000000005 112.13 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.86 158.06 44.25 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.194 -1.562 . . . . 0.01 109.194 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -147.87 136.89 22.09 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.059 -1.259 . . . . 0.02 110.641 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.8 tt -130.72 139.62 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.731 -0.841 . . . . 0.02 108.731 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 m -120.89 130.14 53.78 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.489 -0.757 . . . . 0.39000000000000001 109.866 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -109.94 139.57 44.88 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.077 -0.712 . . . . 0.02 109.077 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.534 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 5.3 m-85 -122.14 138.41 54.47 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.146 -0.971 . . . . 0.02 109.531 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.491 ' HG3' HD11 ' A' ' 33' ' ' LEU . 92.0 mt-10 -69.39 -27.67 65.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.193 -0.942 . . . . 0.029999999999999999 111.539 -178.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -114.05 169.16 9.22 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.849 -1.157 . . . . 0.029999999999999999 110.14 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -75.39 158.32 32.9 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.598 0.713 . . . . 0.029999999999999999 110.218 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 66.42 33.3 6.98 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.948 0.88 . . . . 0.73999999999999999 111.117 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 55.48 41.94 30.36 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 116.056 -0.52 . . . . 0.02 111.324 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -113.66 165.68 12.28 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.193 -1.04 . . . . 0.02 108.193 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.39 -167.46 35.66 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.826 -1.178 . . . . 0.029999999999999999 110.793 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -69.22 142.27 54.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.398 -1.06 . . . . 2.7599999999999998 109.315 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -120.76 149.09 43.08 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.618 0.723 . . . . 1.8899999999999999 110.167 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -132.43 127.16 34.76 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.255 -1.017 . . . . 0.02 108.255 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -112.48 137.41 50.72 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.57 -0.706 . . . . 1.1200000000000001 109.827 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.9 t -131.67 139.21 49.01 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 121.523 0.678 . . . . 0.02 109.777 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -116.98 11.26 14.26 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.583 -0.698 . . . . 0.20000000000000001 109.671 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.409 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 29.5 p -158.29 174.3 15.37 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.275 -1.009 . . . . 1.23 108.275 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 2.3 p30 -60.93 143.84 54.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.647 -1.283 . . . . 0.02 109.855 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 26' ' ' CYS . 27.4 p -131.19 117.14 18.62 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.52 -0.918 . . . . 0.02 108.52 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.17 -24.83 47.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.143 -0.973 . . . . 0.23999999999999999 110.965 -178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -154.8 101.65 2.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.834 -1.166 . . . . 1.1399999999999999 108.985 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -105.21 9.53 34.03 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 122.197 0.998 . . . . 6.3700000000000001 109.903 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -58.86 -24.55 62.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.388 -0.82 . . . . 3.1099999999999999 110.934 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.5 m -74.16 -16.55 60.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.755 -1.216 . . . . 0.88 110.124 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -103.97 -21.97 13.54 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.482 -0.761 . . . . 0.02 109.488 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.491 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.6 tp -150.04 128.86 12.48 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.196 -0.94 . . . . 3.3199999999999998 109.207 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.7 t -85.54 -10.1 56.44 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.768 -0.583 . . . . 0.02 111.191 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -170.55 162.28 8.02 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.696 -1.224 . . . . 0.02 107.696 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.6 t -143.05 115.57 8.58 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.73 -1.231 . . . . 0.02 109.136 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.573 ' ND2' ' OD2' ' A' ' 77' ' ' ASP . 2.6 m120 -109.8 1.95 19.66 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 120.839 -1.163 . . . . 0.029999999999999999 111.532 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.2 t -156.67 154.47 30.14 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.098 -1.075 . . . . 0.02 108.098 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.1 mt -145.94 146.61 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-O 122.402 1.096 . . . . 0.02 111.209 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -123.07 124.22 42.62 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.672 -1.233 . . . . 0.02 107.672 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.3 t -106.47 113.92 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 106.91 -1.515 . . . . 0.02 106.91 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -84.07 -34.42 24.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.746 -0.596 . . . . 3.8100000000000001 110.5 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.84 149.93 18.32 Favored Glycine 0 N--CA 1.486 2.026 0 C-N-CA 119.064 -1.541 . . . . 0.02 110.589 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.96 172.08 48.84 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.845 -1.169 . . . . 0.01 110.432 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.7 m -119.99 135.69 54.82 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.171 -1.048 . . . . 1.48 108.171 178.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.421 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 35.8 m95 -127.41 155.48 43.58 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 122.62 1.2 . . . . 0.02 112.526 -176.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.41 134.69 51.53 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 105.586 -2.005 . . . . 0.23999999999999999 105.586 176.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.416 ' HB ' HD22 ' A' ' 79' ' ' LEU . 11.5 m -120.12 144.51 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.629 -0.669 . . . . 0.65000000000000002 109.408 179.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -121.15 146.04 47.18 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 122.291 1.043 . . . . 0.02 110.22 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -67.5 -34.55 77.37 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.801 -0.636 . . . . 0.02 111.496 -177.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 24.4 mtm180 -124.72 158.22 63.11 Favored Pre-proline 0 N--CA 1.504 2.249 0 O-C-N 120.983 -1.073 . . . . 0.02 109.576 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -54.04 165.32 2.08 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.619 1.546 . . . . 0.02 113.253 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 64.37 37.02 8.65 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.111 -0.949 . . . . 0.02 111.268 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 45.22 51.68 9.06 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.662 0.744 . . . . 3.3900000000000001 110.603 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.9 p -126.2 163.47 23.1 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.58 -0.526 . . . . 2.3300000000000001 109.58 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.92 -161.76 32.14 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.811 -1.316 . . . . 0.02 109.811 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -65.27 138.91 58.51 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.085 -1.244 . . . . 0.02 110.388 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' A' ' 58' ' ' MET . 11.6 tmm? -120.1 137.18 54.29 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 109.376 -0.601 . . . . 5.0099999999999998 109.376 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.469 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 86.7 m-85 -134.67 139.68 45.44 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.799 0.809 . . . . 0.02 109.949 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.7 mm -94.77 131.26 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.762 -0.829 . . . . 1.72 108.762 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.556 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -120.45 111.95 34.58 Favored Pre-proline 0 N--CA 1.505 2.311 0 O-C-N 121.397 -0.814 . . . . 0.02 110.946 -178.165 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -78.31 169.16 20.55 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 CA-C-N 119.842 0.979 . . . . 1.47 110.338 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -53.72 141.52 26.22 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.88 -1.137 . . . . 4.25 110.514 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.85 -177.46 32.12 Favored Glycine 0 N--CA 1.496 2.636 0 C-N-CA 119.515 -1.326 . . . . 0.02 110.824 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -119.99 131.39 55.14 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.46 -1.023 . . . . 0.95999999999999996 109.803 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.556 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 75.1 m-85 -121.73 97.83 46.12 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 107.795 -1.187 . . . . 0.02 107.795 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.402 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 5.8 Cg_endo -69.6 -3.34 11.71 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 120.704 0.936 . . . . 0.02 113.671 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 33.4 mt-10 -157.77 155.11 29.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.723 -1.235 . . . . 2.02 108.137 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -60.4 -39.5 87.59 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.666 -0.646 . . . . 0.02 112.018 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -60.06 -24.02 64.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.058 -1.026 . . . . 0.02 110.411 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -69.74 -18.5 63.52 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.903 0.859 . . . . 3.4199999999999999 108.87 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.558 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.3 t90 -108.21 10.59 27.84 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.458 -1.312 . . . . 0.02 107.458 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.7 mtt 61.5 22.55 12.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.53 -0.731 . . . . 0.02 110.536 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.53 145.46 47.24 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.579 -1.409 . . . . 0.02 109.579 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.3 mt -80.48 -31.04 37.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -1.158 . . . . 0.97999999999999998 108.039 177.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -157.02 -171.55 3.69 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 106.513 -1.662 . . . . 0.02 106.513 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.573 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 66.0 m-20 -98.63 28.31 4.31 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.595 -1.316 . . . . 0.02 110.774 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.4 mtp180 -97.19 122.89 40.71 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.059 -1.026 . . . . 3.2000000000000002 110.99 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 79' ' ' LEU . 42.8 mt -143.47 121.59 12.17 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 107.632 -1.247 . . . . 2.6099999999999999 107.632 178.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.07 -17.27 9.67 Favored Glycine 0 N--CA 1.506 3.327 0 O-C-N 121.098 -1.001 . . . . 0.02 113.026 -177.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.9 m -156.74 156.86 34.05 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.085 -1.832 . . . . 0.02 110.483 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 44.9 t -144.79 147.26 32.69 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.529 -0.732 . . . . 0.02 110.242 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 38.1 mtm180 -138.52 143.17 39.4 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.33 -0.856 . . . . 0.01 109.392 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.81 132.46 36.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.251 -0.906 . . . . 0.42999999999999999 109.816 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.6 t -91.25 125.44 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.851 -0.796 . . . . 1.25 108.851 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -94.1 131.34 39.73 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.773 -1.204 . . . . 1.77 109.085 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mt -96.37 140.18 31.41 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.439 -0.949 . . . . 1.6299999999999999 108.439 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.2 t -111.89 127.86 55.97 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.285 -0.884 . . . . 1.0800000000000001 109.406 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.6 p -104.34 -154.17 0.5 Allowed 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 106.573 -1.64 . . . . 1.26 106.573 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.93 -52.97 0.73 Allowed Glycine 0 N--CA 1.502 3.044 0 O-C-N 120.392 -1.443 . . . . 0.01 112.895 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.81 -101.42 0.15 Allowed Glycine 0 N--CA 1.491 2.312 0 C-N-CA 118.467 -1.825 . . . . 0.01 111.966 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -121.64 118.89 30.31 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.057 -1.261 . . . . 4.4299999999999997 110.648 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.3 129.1 34.13 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.702 -0.799 . . . . 2.9900000000000002 109.555 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -131.1 142.23 50.24 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 109.039 -0.726 . . . . 6.3600000000000003 109.039 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.2 tt -129.68 147.36 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 O-C-N 121.24 -0.912 . . . . 1.0900000000000001 110.362 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -121.64 134.13 54.98 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.615 -1.254 . . . . 2.0499999999999998 107.615 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.7 m -124.36 145.88 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 120.69 -1.256 . . . . 1.1000000000000001 110.002 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.592 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 96.4 m-85 -119.13 141.44 48.81 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.995 0.902 . . . . 0.72999999999999998 110.935 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -67.02 -30.93 71.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.881 -0.512 . . . . 0.02 111.852 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -116.36 167.63 10.86 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.949 -1.094 . . . . 3.1800000000000002 110.561 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.18 164.17 44.49 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 111.057 -0.817 . . . . 0.01 111.057 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 57.1 38.56 29.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.884 -0.774 . . . . 0.01 110.963 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 52.4 55.32 9.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.582 -0.699 . . . . 0.01 111.058 178.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -129.08 165.85 20.42 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.216 -1.031 . . . . 3.1499999999999999 108.216 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.41 -163.8 27.76 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.231 -1.548 . . . . 0.01 109.231 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -76.0 144.24 41.02 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.025 -1.279 . . . . 0.01 108.711 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.592 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 52.2 ttp -116.29 141.84 47.63 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.608 0.718 . . . . 0.01 109.882 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -131.57 136.63 47.97 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.237 -1.023 . . . . 2.48 108.237 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -118.1 133.69 55.67 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.502 -0.749 . . . . 0.01 110.012 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.1 t -147.84 148.76 31.23 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 122.195 0.998 . . . . 1.6899999999999999 110.941 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 60.3 p -111.17 10.06 21.87 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 115.619 -0.718 . . . . 0.01 110.293 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -121.67 163.09 19.58 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.257 -0.902 . . . . 3.21 111.677 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.17 157.48 36.82 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.278 -1.008 . . . . 0.01 108.278 178.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.58 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 0.8 OUTLIER -128.46 119.51 20.54 Favored Pre-proline 0 N--CA 1.504 2.26 0 O-C-N 121.476 -0.765 . . . . 0.01 108.989 177.695 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -76.47 -28.76 6.57 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 CA-C-N 120.24 1.121 . . . . 0.01 110.85 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 64.1 m -144.04 109.75 5.25 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.718 0.771 . . . . 0.02 109.25 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.72 -38.28 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.819 -0.551 . . . . 1.8300000000000001 110.514 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 20.5 ttt -68.49 -36.39 78.87 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.399 -0.92 . . . . 1.3400000000000001 110.359 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -70.91 -39.06 72.96 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.5 -1.375 . . . . 2.1099999999999999 110.167 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -79.66 -47.54 15.22 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.307 -0.871 . . . . 2.0800000000000001 112.535 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -110.27 0.51 18.12 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.358 -0.839 . . . . 0.02 112.476 -176.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.6 m80 59.49 32.64 21.84 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.757 -1.214 . . . . 0.02 109.32 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.1 mt -112.2 135.46 52.84 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 108.477 -0.934 . . . . 0.02 108.477 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -91.24 -22.66 20.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.289 -0.882 . . . . 5.3200000000000003 110.158 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -149.84 164.04 36.42 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.296 -0.878 . . . . 0.02 110.024 -178.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 48.6 mt -131.42 128.49 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 107.558 -1.275 . . . . 2.1699999999999999 107.558 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -107.81 -12.25 15.24 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.313 -0.867 . . . . 0.02 112.376 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.4 t -158.74 151.39 21.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.837 -1.164 . . . . 0.01 108.911 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.504 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 2.8 p -170.41 145.25 2.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.092 -1.005 . . . . 1.22 109.178 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -124.67 110.18 14.07 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 122.361 1.077 . . . . 1.4099999999999999 109.894 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 131' ' ' VAL . 8.6 p -111.21 135.34 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.365 -1.346 . . . . 0.01 107.365 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.9 t -128.95 94.69 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 107.05 -1.463 . . . . 1.98 107.05 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.413 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 4.5 tm-20 -146.03 -74.73 0.22 Allowed 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 105.869 -1.9 . . . . 0.01 105.869 177.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 167.36 -69.74 0.18 Allowed Glycine 0 N--CA 1.485 1.902 0 N-CA-C 108.7 -1.76 . . . . 0.01 108.7 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.783 ' OG1' HD12 ' A' ' 175' ' ' ILE . 0.1 OUTLIER -120.18 115.4 23.57 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.556 -0.967 . . . . 2.2999999999999998 110.456 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.413 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 5.8 m95 -127.05 149.37 49.94 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 106.809 -1.552 . . . . 0.01 106.809 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 97.7 mt -122.98 138.37 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 120.42 -1.425 . . . . 1.6899999999999999 110.647 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -113.72 143.64 44.28 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.265 -1.383 . . . . 2.4900000000000002 107.265 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.501 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 10.5 m-85 -122.45 144.68 48.9 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.178 -0.951 . . . . 0.02 109.307 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -75.72 -29.34 58.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.608 -0.682 . . . . 0.02 111.566 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mt -116.41 154.21 48.91 Favored Pre-proline 0 N--CA 1.504 2.234 0 O-C-N 120.69 -1.256 . . . . 1.48 108.899 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -55.16 170.02 0.83 Allowed 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.225 1.283 . . . . 0.02 112.962 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 58.25 31.62 21.04 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 114.937 -1.029 . . . . 0.75 111.274 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 56.21 48.01 18.21 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.532 -0.73 . . . . 0.02 110.424 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -123.03 164.4 18.65 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.585 -0.697 . . . . 0.02 109.97 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.86 -166.03 32.35 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.375 -1.09 . . . . 0.02 110.375 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -69.04 142.85 54.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.581 -0.952 . . . . 0.02 109.133 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -114.49 147.99 38.54 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.393 0.616 . . . . 0.02 110.242 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -125.22 135.71 52.84 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.919 -0.771 . . . . 0.01 108.919 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.7 tt -97.9 121.64 40.05 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.839 -1.163 . . . . 0.01 109.495 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.686 HD21 ' CD1' ' A' ' 162' ' ' TRP . 0.1 OUTLIER -96.04 145.5 25.4 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.309 -0.869 . . . . 0.01 108.752 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.671 ' H ' HD13 ' A' ' 151' ' ' LEU . 29.3 t0 -103.06 -116.15 0.21 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.339 -0.851 . . . . 2.27 109.412 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -157.78 49.69 0.42 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.053 -1.029 . . . . 1.8400000000000001 109.712 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -113.64 -162.97 0.83 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.495 -0.753 . . . . 2.2799999999999998 109.315 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -105.93 103.52 13.03 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.43 -0.794 . . . . 0.01 108.94 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.616 ' CG ' ' NE1' ' A' ' 162' ' ' TRP . 66.8 m-85 -98.7 113.24 25.24 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.365 -0.835 . . . . 0.01 109.722 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -95.11 -22.33 17.95 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.297 -0.877 . . . . 0.01 111.61 -177.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -127.39 154.52 77.24 Favored Pre-proline 0 N--CA 1.504 2.25 0 O-C-N 120.767 -1.208 . . . . 2.54 108.855 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -60.5 -38.97 69.58 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 120.58 0.854 . . . . 0.69999999999999996 110.512 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 84.6 t -61.51 -20.02 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.958 -1.089 . . . . 0.85999999999999999 108.931 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -65.41 -15.6 62.77 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.934 -1.104 . . . . 0.02 110.074 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.686 ' CD1' HD21 ' A' ' 151' ' ' LEU . 9.7 m0 -98.22 11.4 37.98 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.144 -0.973 . . . . 0.02 108.925 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.06 10.34 85.65 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.842 -1.171 . . . . 0.02 111.087 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.57 141.25 32.6 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.181 -1.188 . . . . 0.02 110.023 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.08 -9.46 57.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.671 -0.643 . . . . 0.58999999999999997 110.217 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.0 m -143.49 149.78 48.75 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 120.891 -1.131 . . . . 0.87 109.057 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -76.64 19.1 0.66 Allowed 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 120.822 1.015 . . . . 0.38 112.294 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.7 124.7 29.82 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.812 -1.18 . . . . 0.17999999999999999 111.493 -177.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -150.21 126.6 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 107.075 -1.454 . . . . 3.9900000000000002 107.075 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -115.11 -15.07 11.74 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.051 -1.031 . . . . 5.1699999999999999 113.582 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 6.2 t -156.77 160.16 38.99 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 119.189 -2.194 . . . . 0.02 110.294 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.58 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 13.9 p90 -151.84 153.29 33.93 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.919 -1.113 . . . . 2.02 110.718 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -144.78 149.42 35.46 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.364 -0.835 . . . . 0.01 110.293 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.415 ' HG2' ' H ' ' A' ' 174' ' ' ARG . 12.5 ptm180 -89.26 145.46 25.37 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.27 -0.641 . . . . 0.01 109.27 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.783 HD12 ' OG1' ' A' ' 135' ' ' THR . 4.7 mt -96.76 129.93 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.308 -0.87 . . . . 3.04 109.324 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.14 146.31 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.227 -0.92 . . . . 1.8899999999999999 109.484 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 4.8899999999999997 109.404 179.931 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 89.5 p . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.223 0.535 . . . . 5.2800000000000002 109.59 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -56.1 -31.21 63.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.309 -0.869 . . . . 5.96 109.503 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 55.8 p -80.48 141.82 34.84 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.194 -1.039 . . . . 2.2200000000000002 108.194 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.92 179.57 48.04 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 118.223 -1.941 . . . . 0.81000000000000005 112.117 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.12 157.76 43.4 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.421 -1.471 . . . . 0.01 109.421 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.519 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 2.8 ttmp? -145.99 135.27 22.9 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.174 -1.192 . . . . 0.02 110.517 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.5 tt -129.54 139.15 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.062 -1.088 . . . . 0.02 108.062 178.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.49 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.4 t -122.41 130.86 53.53 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.348 -0.845 . . . . 0.39000000000000001 110.119 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.0 m-85 -111.18 141.54 44.57 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 109.067 -0.716 . . . . 0.02 109.067 178.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.548 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.9 m-85 -122.08 138.58 54.39 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.181 -0.949 . . . . 0.02 109.61 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.486 ' HG3' HD11 ' A' ' 33' ' ' LEU . 96.1 mt-10 -68.33 -27.91 66.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.878 -1.139 . . . . 0.029999999999999999 111.39 -178.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.1 m-20 -114.65 169.88 8.73 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.873 -1.142 . . . . 0.029999999999999999 110.163 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -75.5 161.91 28.78 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.793 0.806 . . . . 0.029999999999999999 110.411 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.3 m120 63.12 33.13 14.75 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.054 0.931 . . . . 0.73999999999999999 110.894 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 54.92 40.07 31.83 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.865 -0.607 . . . . 0.02 110.978 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -110.29 165.75 11.52 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.215 -1.031 . . . . 0.02 108.215 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.46 -167.57 35.63 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.889 -1.148 . . . . 0.029999999999999999 110.889 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -69.65 143.28 53.26 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.477 -1.014 . . . . 2.7599999999999998 109.261 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -120.47 149.23 42.72 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.505 0.669 . . . . 1.8899999999999999 110.171 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -132.34 127.59 35.85 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.25 -1.018 . . . . 0.02 108.25 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -112.78 136.75 52.04 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.422 -0.799 . . . . 1.1200000000000001 109.751 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.427 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 15.9 t -131.22 139.14 49.64 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.765 -0.585 . . . . 0.02 109.515 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -116.58 11.69 14.83 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.624 -0.672 . . . . 0.20000000000000001 109.836 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.513 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 52.9 t -158.37 174.69 14.75 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.248 -1.019 . . . . 1.23 108.248 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.513 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.1 m-20 -60.53 144.19 52.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.756 -1.215 . . . . 0.02 109.721 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 22.2 t -131.75 117.41 18.56 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.654 -0.869 . . . . 0.02 108.654 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.89 -24.42 48.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.143 -0.973 . . . . 0.23999999999999999 110.919 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -155.18 102.36 2.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.927 -1.108 . . . . 1.1399999999999999 109.234 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -102.57 9.9 39.13 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 122.024 0.916 . . . . 6.3700000000000001 109.734 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -59.45 -25.22 64.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.589 -0.694 . . . . 3.1099999999999999 111.416 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.9 m -76.23 -17.3 59.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.508 -1.37 . . . . 0.88 110.687 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -103.88 -22.06 13.56 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.361 -0.837 . . . . 0.02 109.411 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.486 HD11 ' HG3' ' A' ' 11' ' ' GLU . 6.1 tp -150.25 129.1 12.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.317 -0.865 . . . . 3.3199999999999998 109.0 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.5 m -85.03 -9.81 57.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.743 -0.598 . . . . 0.02 110.944 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -171.15 162.36 6.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.954 -1.091 . . . . 0.02 108.066 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.9 p -144.03 115.09 7.88 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.747 -1.221 . . . . 0.02 108.53 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.42 HD22 ' HB3' ' A' ' 77' ' ' ASP . 5.8 t-20 -108.65 3.29 22.66 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.787 -1.195 . . . . 0.029999999999999999 110.862 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.3 m -155.48 154.28 31.58 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.651 -1.241 . . . . 0.02 107.651 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.404 HD13 HG21 ' A' ' 39' ' ' ILE . 10.5 mt -146.36 147.1 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.977 -1.077 . . . . 0.02 110.574 -178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -124.6 125.07 43.55 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 107.814 -1.18 . . . . 0.02 107.814 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.7 t -106.38 115.21 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 106.972 -1.492 . . . . 0.02 106.972 177.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.519 ' OE1' ' NZ ' ' A' ' 6' ' ' LYS . 30.5 tt0 -83.38 -34.0 25.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.37 -0.831 . . . . 3.8100000000000001 110.93 -178.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.04 152.58 22.5 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 118.893 -1.622 . . . . 0.02 110.799 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.53 172.97 49.39 Favored Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.698 -1.239 . . . . 0.01 110.423 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 86.6 m -119.81 135.16 54.97 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 107.982 -1.118 . . . . 1.48 107.982 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.442 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 32.0 m95 -126.53 154.99 43.07 Favored 'General case' 0 N--CA 1.502 2.173 0 CA-C-O 122.581 1.181 . . . . 0.02 112.301 -176.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.14 134.28 51.92 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 105.225 -2.139 . . . . 0.23999999999999999 105.225 176.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.437 ' HB ' HD22 ' A' ' 79' ' ' LEU . 35.5 m -116.99 141.93 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.532 -0.73 . . . . 0.65000000000000002 109.235 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -121.18 143.89 48.88 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 122.061 0.934 . . . . 0.02 109.753 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -65.01 -34.82 79.36 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.448 -0.796 . . . . 0.02 111.655 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.9 mtm180 -125.37 157.74 66.67 Favored Pre-proline 0 N--CA 1.503 2.2 0 O-C-N 121.004 -1.06 . . . . 0.02 109.332 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.48 167.73 0.84 Allowed 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.657 1.572 . . . . 0.02 113.022 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 63.13 36.39 12.19 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.212 -0.903 . . . . 0.02 111.207 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' A' ' 54' ' ' PHE . 0.6 OUTLIER 45.5 51.62 9.67 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.591 0.71 . . . . 3.3900000000000001 110.717 178.472 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.8 m -126.02 163.85 22.13 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.187 0.517 . . . . 2.3300000000000001 109.846 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.85 -161.54 32.06 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.869 -1.292 . . . . 0.02 109.869 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.407 ' CD2' ' N ' ' A' ' 57' ' ' HIS . 15.8 m170 -65.22 138.62 58.36 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.035 -1.274 . . . . 0.02 110.068 -178.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.447 ' C ' ' SD ' ' A' ' 58' ' ' MET . 11.2 tmm? -118.97 136.39 54.11 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.362 0.601 . . . . 5.0099999999999998 109.693 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.455 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 93.8 m-85 -134.31 138.76 45.2 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 121.714 0.768 . . . . 0.02 109.828 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.419 HD11 ' SD ' ' A' ' 58' ' ' MET . 15.9 mm -95.38 131.11 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 109.031 -0.729 . . . . 1.72 109.031 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.565 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -119.66 110.62 36.85 Favored Pre-proline 0 N--CA 1.504 2.247 0 O-C-N 121.449 -0.782 . . . . 0.02 110.67 -178.3 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -77.26 167.86 24.01 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 CA-C-N 119.966 1.024 . . . . 1.47 110.167 177.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.614 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -53.36 141.61 23.88 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.834 -1.166 . . . . 4.25 110.445 -179.621 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.13 -177.81 32.15 Favored Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.549 -1.31 . . . . 0.02 110.671 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -119.78 131.64 55.39 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.382 -1.07 . . . . 0.95999999999999996 109.823 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.565 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 75.6 m-85 -121.46 97.81 46.78 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 108.047 -1.094 . . . . 0.02 108.047 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -69.42 -3.88 12.68 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 120.743 0.962 . . . . 0.02 113.48 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -157.65 154.76 28.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.781 -1.199 . . . . 2.02 108.041 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -60.36 -38.8 84.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.58 -0.7 . . . . 0.02 112.154 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -60.52 -24.15 65.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.176 -0.953 . . . . 0.02 110.494 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -68.74 -18.03 64.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.327 -0.858 . . . . 3.4199999999999999 109.076 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.562 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.3 t90 -108.09 11.74 27.39 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.673 -1.232 . . . . 0.02 107.673 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.3 mmt 60.48 22.3 11.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.556 -0.715 . . . . 0.02 110.295 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.89 143.33 45.48 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.429 -1.468 . . . . 0.02 109.429 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.0 tp -78.58 -31.26 47.15 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.293 -1.373 . . . . 0.97999999999999998 107.293 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -157.75 -172.07 3.8 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 106.097 -1.816 . . . . 0.02 106.097 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.42 ' HB3' HD22 ' A' ' 37' ' ' ASN . 1.4 p30 -98.16 28.26 4.13 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.701 -1.249 . . . . 0.02 110.692 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -96.76 121.87 39.09 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.736 -1.227 . . . . 3.2000000000000002 111.039 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.437 HD22 ' HB ' ' A' ' 48' ' ' VAL . 59.4 mt -142.96 122.02 12.87 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 107.422 -1.325 . . . . 2.6099999999999999 107.422 178.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.84 -17.61 9.55 Favored Glycine 0 N--CA 1.504 3.222 0 O-C-N 121.231 -0.918 . . . . 0.02 112.859 -177.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 p -156.37 156.48 33.96 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.04 -1.859 . . . . 0.02 110.61 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 44.2 t -144.34 146.85 32.8 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.38 -0.825 . . . . 0.02 110.476 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 -138.33 143.48 39.93 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.408 -0.807 . . . . 0.01 109.486 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.42 132.25 36.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.946 . . . . 0.42999999999999999 109.825 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.3 t -91.56 125.63 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.878 -0.786 . . . . 1.25 108.878 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -94.26 131.85 39.44 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.783 -1.198 . . . . 1.77 109.234 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.3 mt -96.79 140.34 31.5 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.307 -0.871 . . . . 1.6299999999999999 108.681 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.5 p -111.93 127.63 55.91 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.411 -0.806 . . . . 1.0800000000000001 109.339 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.7 t -103.94 -154.66 0.51 Allowed 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 106.551 -1.648 . . . . 1.26 106.551 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.01 -52.45 0.75 Allowed Glycine 0 N--CA 1.5 2.944 0 O-C-N 120.512 -1.368 . . . . 0.01 112.807 177.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.26 -101.19 0.15 Allowed Glycine 0 N--CA 1.491 2.306 0 C-N-CA 118.457 -1.83 . . . . 0.01 112.161 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -121.94 119.8 32.57 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.033 -1.275 . . . . 4.4299999999999997 110.791 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.4 129.73 34.74 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.833 -0.747 . . . . 2.9900000000000002 109.362 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -130.1 142.23 50.62 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.347 -0.846 . . . . 6.3600000000000003 109.073 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.0 tt -129.19 146.13 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 121.302 -0.874 . . . . 1.0900000000000001 110.373 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -121.54 133.25 55.02 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.432 -1.321 . . . . 2.0499999999999998 107.432 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.8 m -123.58 145.35 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 120.693 -1.255 . . . . 1.1000000000000001 109.772 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -119.75 141.46 49.42 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 122.064 0.935 . . . . 0.72999999999999998 111.012 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -67.24 -30.5 70.43 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.922 -0.581 . . . . 0.02 112.126 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -116.27 167.33 11.11 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 120.998 -1.064 . . . . 3.1800000000000002 110.413 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.64 163.85 43.02 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 111.039 -0.825 . . . . 0.01 111.039 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.2 t70 56.82 38.75 29.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.921 -0.753 . . . . 0.01 110.896 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.437 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 21.2 m-85 52.26 55.95 8.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.656 -0.652 . . . . 0.01 111.103 178.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -128.8 165.39 21.05 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.256 -1.016 . . . . 3.1499999999999999 108.256 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.22 -163.79 27.99 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.324 -1.511 . . . . 0.01 109.324 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 48.3 tp60 -75.03 143.48 43.5 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.998 -1.295 . . . . 0.01 108.551 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.45 ' C ' ' SD ' ' A' ' 107' ' ' MET . 12.3 tmm? -115.99 142.45 46.77 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.52 0.676 . . . . 0.01 109.746 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -131.83 136.5 47.53 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.249 -1.019 . . . . 2.48 108.249 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -118.76 134.14 55.35 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.576 -0.703 . . . . 0.01 109.948 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.0 t -148.86 149.99 32.23 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.24 1.019 . . . . 1.6899999999999999 110.946 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 32.2 p -109.94 10.38 24.32 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 115.485 -0.78 . . . . 0.01 110.106 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -121.29 163.16 19.04 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.264 -0.898 . . . . 3.21 111.715 -178.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -67.48 156.61 36.22 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.253 -1.017 . . . . 0.01 108.253 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 37.5 t -125.4 111.95 25.9 Favored Pre-proline 0 N--CA 1.503 2.177 0 O-C-N 121.368 -0.832 . . . . 0.01 109.035 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -76.37 -32.62 3.8 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 CA-C-N 119.997 1.034 . . . . 0.01 111.635 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 7.8 t -140.6 106.54 5.17 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.223 -0.923 . . . . 0.02 108.592 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 68.0 mt -65.03 -38.82 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.717 -0.615 . . . . 1.8300000000000001 111.183 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.2 ttt -66.92 -38.07 85.51 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 118.946 -1.102 . . . . 1.3400000000000001 109.929 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -69.15 -38.28 78.7 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.489 -1.382 . . . . 2.1099999999999999 109.546 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -79.77 -47.25 15.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.322 -0.861 . . . . 2.0800000000000001 112.269 -177.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -111.77 -0.53 15.91 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.378 -0.826 . . . . 0.02 112.824 -176.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.8 m80 61.71 34.67 17.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.752 -1.218 . . . . 0.02 109.837 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 40.9 mt -114.47 136.12 53.36 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.454 -0.779 . . . . 0.02 109.426 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -90.62 -22.04 21.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.3 -0.875 . . . . 5.3200000000000003 110.864 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -148.05 163.92 35.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.99 -1.069 . . . . 0.02 109.97 -178.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.9 mm -129.28 125.28 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 107.857 -1.164 . . . . 2.1699999999999999 107.857 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -109.74 -13.61 14.46 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.233 -0.917 . . . . 0.02 112.833 -177.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.437 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 2.3 t -158.87 149.63 20.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.797 -1.189 . . . . 0.01 108.987 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.486 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 30.0 p -170.14 148.81 3.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 1.22 108.865 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -120.88 113.03 19.54 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 122.453 1.12 . . . . 1.4099999999999999 110.062 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.0 t -112.19 128.72 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.561 -1.274 . . . . 0.01 107.561 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 47.5 t -128.73 93.11 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 107.071 -1.455 . . . . 1.98 107.071 177.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -147.71 -75.99 0.18 Allowed 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 105.831 -1.914 . . . . 0.01 105.831 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 156.55 -54.53 0.4 Allowed Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.184 -1.567 . . . . 0.01 109.184 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 54.7 p -119.77 97.8 5.8 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.551 -0.97 . . . . 2.2999999999999998 111.012 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -128.16 145.53 50.99 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 107.108 -1.442 . . . . 0.01 107.108 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.402 ' CG1' HD11 ' A' ' 175' ' ' ILE . 61.4 mt -122.02 138.89 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 120.883 -1.136 . . . . 1.6899999999999999 110.714 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -113.71 144.11 43.5 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 106.873 -1.529 . . . . 2.4900000000000002 106.873 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.513 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 15.7 m-85 -123.17 144.36 49.4 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.311 -0.868 . . . . 0.02 109.658 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -76.54 -28.97 56.52 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.624 -0.673 . . . . 0.02 111.999 -176.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mt -116.04 154.93 48.52 Favored Pre-proline 0 N--CA 1.506 2.331 0 O-C-N 120.544 -1.348 . . . . 1.48 108.915 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.95 165.94 2.4 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.235 1.29 . . . . 0.02 113.071 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.409 ' N ' ' OD1' ' A' ' 143' ' ' ASN . 3.6 m-20 59.68 31.48 20.9 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 115.071 -0.968 . . . . 0.75 111.471 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 57.39 51.09 10.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.45 -0.781 . . . . 0.02 111.186 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -126.26 164.91 19.96 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.426 -0.796 . . . . 0.02 109.944 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.463 ' O ' ' NE2' ' A' ' 148' ' ' GLN . . . 89.01 -165.98 33.42 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.255 -1.138 . . . . 0.02 110.255 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -69.39 142.66 53.88 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.724 -0.868 . . . . 0.02 109.061 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.47 ' CD ' ' N ' ' A' ' 148' ' ' GLN . 7.2 mp0 -115.63 149.54 38.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.803 -0.56 . . . . 0.02 109.728 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -123.53 134.76 53.82 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.616 -0.678 . . . . 0.01 109.219 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.3 tp -95.24 121.15 36.59 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.632 -1.292 . . . . 0.01 108.956 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.564 HD21 ' CG ' ' A' ' 162' ' ' TRP . 0.2 OUTLIER -94.63 160.24 14.72 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.325 -0.859 . . . . 0.01 109.045 -179.852 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.48 ' H ' HD13 ' A' ' 151' ' ' LEU . 1.4 p-10 -109.34 -111.65 0.32 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.445 -0.784 . . . . 2.27 109.335 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.525 ' N ' ' OH ' ' A' ' 156' ' ' TYR . 49.7 pttt -168.81 45.55 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.114 -0.991 . . . . 1.8400000000000001 109.923 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -113.59 -153.77 0.53 Allowed 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.503 -0.748 . . . . 2.2799999999999998 109.122 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -106.39 106.37 16.85 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.417 -0.802 . . . . 0.01 109.075 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.644 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 2.9 m-85 -99.34 112.4 24.58 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.267 -0.895 . . . . 0.01 109.667 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -94.56 -22.67 18.05 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.129 -0.982 . . . . 0.01 111.411 -178.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -128.19 154.44 78.79 Favored Pre-proline 0 N--CA 1.502 2.146 0 O-C-N 120.84 -1.163 . . . . 2.54 108.822 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -60.12 -37.21 85.46 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 CA-C-N 119.268 0.774 . . . . 0.69999999999999996 110.631 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 6.0 t -61.11 -19.88 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.756 -1.215 . . . . 0.85999999999999999 109.048 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -65.15 -15.28 62.25 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.94 -1.1 . . . . 0.02 109.921 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.644 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 12.9 m0 -97.93 11.29 37.94 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.14 -0.975 . . . . 0.02 109.025 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.4 11.0 84.7 Favored Glycine 0 N--CA 1.491 2.329 0 O-C-N 120.793 -1.192 . . . . 0.02 111.177 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.34 140.88 32.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.066 -1.255 . . . . 0.02 110.066 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.68 -8.76 58.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.598 -0.689 . . . . 0.58999999999999997 110.045 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 8.1 p -142.47 151.31 57.39 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 120.981 -1.075 . . . . 0.87 109.318 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -76.21 16.67 0.82 Allowed 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 120.837 1.024 . . . . 0.38 112.263 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.41 122.17 27.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.872 -1.142 . . . . 0.17999999999999999 111.366 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 3.1 mt -149.12 123.51 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 105.873 -1.899 . . . . 3.9900000000000002 105.873 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -112.21 -15.9 13.11 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.227 -0.92 . . . . 5.1699999999999999 113.286 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 20.9 m -156.6 160.42 39.4 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 119.245 -2.159 . . . . 0.02 110.041 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.419 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 21.4 p90 -152.67 153.0 32.41 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.147 -0.971 . . . . 2.02 110.633 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 29.6 mtp180 -145.58 149.65 34.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.36 -0.837 . . . . 0.01 109.679 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -88.4 142.44 27.72 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.507 -0.746 . . . . 0.01 109.455 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.402 HD11 ' CG1' ' A' ' 137' ' ' ILE . 3.7 mt -93.59 129.93 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.257 -0.902 . . . . 3.04 109.126 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.5 p -137.53 148.7 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.239 -0.913 . . . . 1.8899999999999999 109.902 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 . . . . . 0 N--CA 1.494 1.764 0 O-C-N 121.514 -0.741 . . . . 4.8899999999999997 109.656 179.827 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 99.3 p . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.401 -0.592 . . . . 5.2800000000000002 109.401 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -49.85 146.34 4.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 5.96 109.68 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.53 HG22 ' N ' ' A' ' 4' ' ' GLY . 47.4 m -168.42 167.19 12.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.034 -1.041 . . . . 2.2200000000000002 108.748 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.53 ' N ' HG22 ' A' ' 3' ' ' THR . . . -118.0 117.07 3.63 Favored Glycine 0 N--CA 1.499 2.872 0 N-CA-C 106.94 -2.464 . . . . 0.81000000000000005 106.94 177.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.9 144.76 32.83 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.768 -1.333 . . . . 0.01 109.768 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -149.92 136.45 19.12 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.481 -1.011 . . . . 0.02 109.882 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.3 tt -128.87 139.24 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.157 -1.053 . . . . 0.02 108.157 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.1 t -121.7 130.18 53.26 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.328 -0.858 . . . . 0.39000000000000001 110.033 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.545 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.8 m-85 -110.25 140.65 44.18 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.871 -0.788 . . . . 0.02 108.871 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.528 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 6.0 m-85 -122.37 138.79 54.41 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.214 -0.929 . . . . 0.02 109.612 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.47 ' HG3' HD11 ' A' ' 33' ' ' LEU . 87.7 mt-10 -68.03 -27.74 66.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.025 -1.047 . . . . 0.029999999999999999 111.663 -178.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -114.53 169.86 8.74 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.812 -1.18 . . . . 0.029999999999999999 110.379 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -75.67 158.92 31.72 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.611 0.719 . . . . 0.029999999999999999 109.974 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 66.09 32.99 7.86 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.949 0.88 . . . . 0.73999999999999999 110.97 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 55.23 41.57 31.27 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.31 0.576 . . . . 0.02 111.392 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 -112.94 166.23 11.59 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.327 -0.99 . . . . 0.02 108.327 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.68 -168.06 35.73 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 119.857 -1.163 . . . . 0.029999999999999999 110.75 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.425 ' NH2' ' OE2' ' A' ' 11' ' ' GLU . 23.4 ttp180 -68.83 143.37 54.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.476 -1.014 . . . . 2.7599999999999998 109.135 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -120.87 148.98 43.3 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.506 -0.746 . . . . 1.8899999999999999 110.189 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -132.79 127.76 35.3 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.327 -0.99 . . . . 0.02 108.327 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -112.2 136.67 51.33 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.403 -0.811 . . . . 1.1200000000000001 109.789 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.4 t -131.17 139.06 49.69 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.663 -0.648 . . . . 0.02 109.602 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -116.46 11.85 15.01 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.677 -0.639 . . . . 0.20000000000000001 109.655 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.0 p -158.63 174.6 14.81 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.358 -0.978 . . . . 1.23 108.358 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -60.45 144.66 50.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.642 -1.286 . . . . 0.02 109.858 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 44.2 t -131.97 117.76 18.86 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.691 -0.855 . . . . 0.02 108.691 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.49 -25.37 50.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.18 -0.95 . . . . 0.23999999999999999 110.894 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -154.2 102.96 2.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.97 -1.082 . . . . 1.1399999999999999 109.218 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -102.41 9.43 39.72 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 122.127 0.965 . . . . 6.3700000000000001 109.673 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -59.55 -25.17 64.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.523 -0.736 . . . . 3.1099999999999999 111.362 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.3 t -76.15 -17.55 59.51 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.505 -1.372 . . . . 0.88 110.596 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -104.08 -21.86 13.52 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.358 -0.839 . . . . 0.02 109.486 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.47 HD11 ' HG3' ' A' ' 11' ' ' GLU . 6.4 tp -150.43 129.25 12.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.194 -0.941 . . . . 3.3199999999999998 109.005 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.0 p -85.26 -10.22 56.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.81 -0.556 . . . . 0.02 111.131 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -171.1 162.38 7.06 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.009 -1.108 . . . . 0.02 108.009 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.8 p -144.08 115.33 7.97 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.703 -1.248 . . . . 0.02 108.766 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 -108.26 1.75 22.22 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 120.86 -1.15 . . . . 0.029999999999999999 110.969 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.8 t -154.95 154.3 32.38 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.636 -1.246 . . . . 0.02 107.636 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 61.3 mt -145.14 146.84 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.038 -1.039 . . . . 0.02 110.044 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -123.33 124.0 41.97 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.86 -1.163 . . . . 0.02 107.86 177.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.0 t -106.64 115.09 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 106.867 -1.531 . . . . 0.02 106.867 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -83.69 -33.75 25.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.655 -0.653 . . . . 3.8100000000000001 110.754 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.76 152.09 21.83 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 118.92 -1.609 . . . . 0.02 110.881 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.76 173.21 49.6 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.727 -1.225 . . . . 0.01 110.617 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.2 m -119.62 135.4 54.82 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 107.861 -1.163 . . . . 1.48 107.861 177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.449 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 33.7 m95 -126.6 155.57 42.29 Favored 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 122.576 1.179 . . . . 0.02 112.188 -176.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.68 134.16 52.29 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 105.666 -1.976 . . . . 0.23999999999999999 105.666 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.504 ' HB ' HD22 ' A' ' 79' ' ' LEU . 33.3 m -119.4 143.72 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.542 -0.724 . . . . 0.65000000000000002 109.054 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -120.9 146.28 46.78 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 122.226 1.012 . . . . 0.02 109.963 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -66.42 -34.59 78.29 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.756 -0.656 . . . . 0.02 111.183 -177.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -125.38 157.95 65.94 Favored Pre-proline 0 N--CA 1.502 2.139 0 O-C-N 121.162 -0.961 . . . . 0.02 109.465 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -53.89 167.17 1.17 Allowed 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 121.672 1.581 . . . . 0.02 113.082 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.2 t30 63.79 36.53 10.42 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.04 -0.982 . . . . 0.02 111.119 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 45.93 51.68 10.49 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.596 0.712 . . . . 3.3900000000000001 110.663 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.4 m -126.63 164.03 22.14 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.121 0.486 . . . . 2.3300000000000001 109.924 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.86 -161.74 32.2 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.881 -1.288 . . . . 0.02 109.881 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -65.66 139.51 58.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.109 -1.23 . . . . 0.02 110.017 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 17.2 ptm -117.94 137.07 53.08 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.761 -0.587 . . . . 5.0099999999999998 109.53 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -133.75 136.31 44.5 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.487 -0.758 . . . . 0.02 109.847 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.628 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.8 mp -95.39 131.64 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.522 -0.918 . . . . 1.72 108.522 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.7 mt -120.05 111.06 35.79 Favored Pre-proline 0 N--CA 1.502 2.146 0 O-C-N 121.504 -0.748 . . . . 0.02 110.682 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -77.13 168.73 22.73 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 CA-C-N 119.846 0.981 . . . . 1.47 109.981 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -52.67 141.49 20.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.831 -1.168 . . . . 4.25 110.184 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.04 -176.68 31.84 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.579 -1.296 . . . . 0.02 110.666 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -119.65 130.98 55.34 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.467 -1.019 . . . . 0.95999999999999996 109.58 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.41 ' N ' ' CD1' ' A' ' 66' ' ' TYR . 31.3 m-85 -120.41 96.53 49.05 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 107.889 -1.152 . . . . 0.02 107.889 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.4 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.8 Cg_endo -67.24 -5.03 12.82 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 120.746 0.964 . . . . 0.02 114.0 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 32.6 mt-10 -157.66 156.07 31.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.592 -1.317 . . . . 2.02 108.373 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -61.55 -38.17 86.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.408 -0.807 . . . . 0.02 112.324 -177.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -61.01 -22.08 64.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.023 -1.048 . . . . 0.02 109.961 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.9 tpm_? -67.0 -19.04 65.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.508 -0.745 . . . . 3.4199999999999999 110.03 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.454 ' C ' ' SD ' ' A' ' 73' ' ' MET . 2.2 p90 -110.42 16.3 21.68 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.336 -0.852 . . . . 0.02 109.091 178.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.454 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 3.0 mpp? 63.34 25.03 14.48 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.482 0.658 . . . . 0.02 110.768 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.412 ' HA3' ' HE1' ' A' ' 72' ' ' TRP . . . -60.51 145.17 47.41 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.838 -1.305 . . . . 0.02 109.838 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.6 tp -80.77 -31.2 35.89 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.663 -1.236 . . . . 0.97999999999999998 107.663 177.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -157.56 -171.84 3.73 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 106.482 -1.673 . . . . 0.02 106.482 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -98.99 28.27 4.49 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.707 -1.245 . . . . 0.02 110.835 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.595 HH11 ' CG ' ' A' ' 78' ' ' ARG . 3.3 mtt-85 -96.2 122.66 39.29 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.859 -1.151 . . . . 3.2000000000000002 110.872 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.504 HD22 ' HB ' ' A' ' 48' ' ' VAL . 33.0 mt -144.13 122.49 12.34 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.73 -1.211 . . . . 2.6099999999999999 107.73 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.44 -16.45 10.23 Favored Glycine 0 N--CA 1.504 3.216 0 O-C-N 121.102 -0.998 . . . . 0.02 112.94 -177.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 73.3 p -156.79 156.53 33.43 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.177 -1.778 . . . . 0.02 110.339 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 53.2 t -143.97 147.2 33.6 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.539 -0.725 . . . . 0.02 110.191 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.1 mtp180 -137.8 142.83 40.84 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.335 -0.853 . . . . 0.01 109.456 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.87 132.03 36.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.92 . . . . 0.42999999999999999 109.7 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.9 t -90.67 124.7 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.618 -0.882 . . . . 1.25 108.618 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -93.14 132.32 37.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.847 -1.158 . . . . 1.77 108.928 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.2 mt -97.37 139.77 32.82 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.669 -0.863 . . . . 1.6299999999999999 108.669 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.3 m -110.74 124.87 52.81 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.46 -0.941 . . . . 1.0800000000000001 108.46 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.8 t -115.85 130.39 56.82 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.651 -1.281 . . . . 1.26 107.608 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -154.13 -51.93 0.01 OUTLIER Glycine 0 N--CA 1.505 3.295 0 C-N-CA 117.951 -2.071 . . . . 0.01 113.24 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.11 -106.17 0.19 Allowed Glycine 0 N--CA 1.489 2.176 0 O-C-N 120.162 -1.787 . . . . 0.01 111.198 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -119.8 117.55 28.49 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.0 -1.294 . . . . 4.4299999999999997 110.212 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.77 130.28 36.53 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.066 -0.654 . . . . 2.9900000000000002 109.395 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.415 ' CB ' ' NZ ' ' A' ' 94' ' ' LYS . 7.3 ttpm? -131.72 141.27 49.5 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.492 -0.755 . . . . 6.3600000000000003 109.409 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.0 tt -127.65 146.99 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.418 0 CA-C-O 121.809 0.814 . . . . 1.0900000000000001 110.292 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -122.79 131.63 53.86 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.904 -1.147 . . . . 2.0499999999999998 107.904 177.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.7 m -125.35 147.65 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 O-C-N 120.95 -1.094 . . . . 1.1000000000000001 109.947 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.563 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 80.5 m-85 -119.19 141.67 48.66 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-O 121.948 0.88 . . . . 0.72999999999999998 111.139 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -67.74 -31.17 70.91 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 116.104 -0.498 . . . . 0.02 111.322 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.436 ' O ' ' OG ' ' A' ' 128' ' ' SER . 45.6 mttp -116.31 170.15 8.76 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.089 -1.007 . . . . 3.1800000000000002 110.04 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.56 169.72 43.97 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 111.174 -0.77 . . . . 0.01 111.174 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.6 t70 52.68 39.32 28.22 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.654 0.74 . . . . 0.01 111.611 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 52.42 48.72 22.01 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.601 -0.687 . . . . 0.01 110.975 178.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -123.09 164.93 17.68 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.379 -0.971 . . . . 3.1499999999999999 108.379 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.64 -163.54 28.56 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.427 -1.469 . . . . 0.01 109.427 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -76.93 144.05 39.11 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.049 -1.265 . . . . 0.01 109.121 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.563 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 28.1 ttp -116.19 142.32 46.97 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.487 0.66 . . . . 0.01 109.824 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -131.75 136.26 47.44 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.413 -0.958 . . . . 2.48 108.413 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -121.55 135.21 55.03 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.53 -0.731 . . . . 0.01 109.9 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.0 t -148.57 151.94 35.93 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.97 -1.081 . . . . 1.6899999999999999 110.799 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.4 p -111.54 8.68 21.09 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 116.028 -0.533 . . . . 0.01 110.618 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -120.63 162.96 18.76 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.162 -0.961 . . . . 3.21 111.311 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -67.6 156.52 36.59 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.397 -0.964 . . . . 0.01 108.397 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.434 ' SG ' ' OE1' ' A' ' 120' ' ' GLN . 42.8 t -125.57 114.36 25.19 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 108.928 -0.767 . . . . 0.01 108.928 178.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.415 ' O ' ' OG ' ' A' ' 171' ' ' SER . 20.6 Cg_endo -77.05 -31.92 3.49 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 CA-C-N 120.156 1.091 . . . . 0.01 111.122 178.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 41.1 t -141.74 107.56 5.13 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.556 -0.905 . . . . 0.02 108.556 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 64.7 mt -65.3 -38.69 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.656 -0.653 . . . . 1.8300000000000001 110.951 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 118' ' ' MET . 1.1 tmt? -66.69 -38.37 86.63 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.942 -1.103 . . . . 1.3400000000000001 109.758 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -68.56 -38.27 80.62 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.463 -1.398 . . . . 2.1099999999999999 109.63 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.434 ' OE1' ' SG ' ' A' ' 114' ' ' CYS . 54.5 tt0 -80.11 -46.73 15.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.245 -0.91 . . . . 2.0800000000000001 112.314 -177.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -112.27 -0.86 15.33 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.28 -0.887 . . . . 0.02 112.852 -176.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.7 m80 61.61 34.91 17.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.666 -1.272 . . . . 0.02 109.871 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.0 mt -114.01 135.63 53.8 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.521 -0.737 . . . . 0.02 109.229 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -90.9 -22.1 21.07 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.277 -0.889 . . . . 5.3200000000000003 110.965 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -148.03 164.0 35.15 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.993 -1.067 . . . . 0.02 110.022 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.0 mm -128.69 124.77 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 107.555 -1.276 . . . . 2.1699999999999999 107.555 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -109.43 -14.69 14.38 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.165 -0.959 . . . . 0.02 112.982 -176.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 10.0 p -161.14 153.21 19.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.563 -1.336 . . . . 0.01 109.467 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.409 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 27.9 p -167.79 149.43 5.47 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.796 -1.187 . . . . 1.22 107.796 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -112.83 103.59 11.59 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.104 -0.997 . . . . 1.4099999999999999 108.924 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.8 t -111.22 125.92 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 115.766 -0.652 . . . . 0.01 109.569 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.2 t -122.92 86.42 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.77 -1.937 . . . . 1.98 105.77 175.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.438 ' O ' ' O ' ' A' ' 152' ' ' ASP . 3.3 tp10 -161.36 -158.17 0.55 Allowed 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 106.786 -1.561 . . . . 0.01 106.786 178.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -157.65 -3.7 0.08 OUTLIER Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.113 -1.995 . . . . 0.01 108.113 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.6 p -115.06 45.04 1.69 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 122.0 -0.706 . . . . 2.2999999999999998 109.66 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -125.97 136.17 52.68 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.293 -0.879 . . . . 0.01 108.927 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 12.4 mt -123.71 141.28 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.693 -0.63 . . . . 1.6899999999999999 109.383 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -114.3 144.82 42.63 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.059 -1.46 . . . . 2.4900000000000002 107.059 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.464 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 19.9 m-85 -123.23 144.44 49.38 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.493 -0.754 . . . . 0.02 109.674 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.44 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 78.1 tt0 -75.58 -29.31 59.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.634 -0.667 . . . . 0.02 111.781 -176.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mt -115.05 154.94 47.15 Favored Pre-proline 0 N--CA 1.505 2.309 0 O-C-N 120.654 -1.279 . . . . 1.48 109.128 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -55.91 165.55 3.7 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.159 1.239 . . . . 0.02 112.809 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.485 ' N ' ' OD1' ' A' ' 143' ' ' ASN . 1.0 OUTLIER 60.71 32.46 20.25 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.198 -0.91 . . . . 0.75 111.451 178.632 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.417 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.9 m-85 57.43 51.72 9.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.563 -0.711 . . . . 0.02 110.96 177.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -127.13 165.11 20.18 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.492 -0.755 . . . . 0.02 110.325 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.59 -166.29 32.88 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.553 -1.019 . . . . 0.02 110.553 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -70.31 144.44 51.71 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.672 -0.899 . . . . 0.02 109.116 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -113.51 148.96 35.05 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.808 -0.558 . . . . 0.02 110.218 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -125.91 134.0 51.7 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.629 -0.669 . . . . 0.01 109.584 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.482 HD23 ' N ' ' A' ' 151' ' ' LEU . 2.6 tt -103.91 123.56 47.37 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.073 -1.017 . . . . 0.01 109.776 -179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.482 ' N ' HD23 ' A' ' 150' ' ' LEU . 8.8 mp -96.6 152.3 18.78 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.971 -1.081 . . . . 0.01 108.374 178.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.438 ' O ' ' O ' ' A' ' 133' ' ' GLU . 74.9 m-20 -111.32 -126.18 0.28 Allowed 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.309 -0.869 . . . . 2.27 110.492 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -129.25 42.03 3.37 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.399 -0.813 . . . . 1.8400000000000001 109.7 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -113.01 -174.39 2.44 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.403 -0.81 . . . . 2.2799999999999998 109.141 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -105.11 111.87 24.8 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.667 -0.864 . . . . 0.01 108.667 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.65 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 20.2 m-85 -97.94 110.53 23.09 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.289 -0.882 . . . . 0.01 109.859 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -95.1 -22.19 18.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.143 -0.973 . . . . 0.01 111.128 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -127.55 155.15 77.35 Favored Pre-proline 0 N--CA 1.501 2.122 0 O-C-N 121.034 -1.042 . . . . 2.54 108.521 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -60.19 -36.74 87.32 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 120.449 0.766 . . . . 0.69999999999999996 110.264 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -61.26 -20.16 21.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.936 -1.102 . . . . 0.85999999999999999 109.255 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -66.11 -16.04 63.61 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.92 -1.113 . . . . 0.02 110.188 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.65 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 10.4 m0 -97.42 11.16 37.67 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.086 -1.009 . . . . 0.02 108.712 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.65 11.04 85.16 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.805 -1.188 . . . . 0.02 110.774 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.36 141.29 33.41 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.176 -1.191 . . . . 0.02 110.1 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.16 -8.58 58.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.567 -0.708 . . . . 0.58999999999999997 110.302 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 9.7 p -143.96 151.02 51.52 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 120.769 -1.207 . . . . 0.87 109.21 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.81 18.42 0.62 Allowed 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 120.931 1.087 . . . . 0.38 112.318 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.8 121.84 26.94 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 122.427 1.108 . . . . 0.17999999999999999 111.346 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 3.1 mt -150.05 123.7 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 105.831 -1.915 . . . . 3.9900000000000002 105.831 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.528 ' OE1' ' N ' ' A' ' 170' ' ' GLN . 9.7 mp0 -113.5 -13.26 12.82 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.108 -0.995 . . . . 5.1699999999999999 113.109 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 115' ' ' PRO . 26.7 m -157.05 160.63 39.13 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 119.255 -2.153 . . . . 0.02 110.185 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -152.59 151.92 31.22 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.163 -0.96 . . . . 2.02 110.301 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.417 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 27.0 mtp180 -145.16 152.41 39.98 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.3 -0.875 . . . . 0.01 110.252 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -89.5 143.42 26.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.695 -0.628 . . . . 0.01 109.588 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 9.1 mt -95.64 130.32 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 108.482 -0.933 . . . . 3.04 108.482 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.22 147.12 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.121 -0.987 . . . . 1.8899999999999999 109.825 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.365 -0.834 . . . . 4.8899999999999997 109.525 -179.927 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.46 ' C ' ' H ' ' A' ' 3' ' ' THR . 34.9 t . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.461 -0.57 . . . . 5.2800000000000002 109.461 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.429 ' O ' ' OG1' ' A' ' 3' ' ' THR . 8.7 mtmp? -76.4 23.45 0.15 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.221 -0.924 . . . . 5.96 109.376 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.536 HG22 ' N ' ' A' ' 4' ' ' GLY . 43.0 m -169.09 168.44 10.01 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.574 -0.898 . . . . 2.2200000000000002 108.574 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.536 ' N ' HG22 ' A' ' 3' ' ' THR . . . -118.61 116.87 3.51 Favored Glycine 0 N--CA 1.502 3.038 0 N-CA-C 107.042 -2.423 . . . . 0.81000000000000005 107.042 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.1 145.68 33.82 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.557 -1.417 . . . . 0.01 109.557 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -152.71 137.84 17.36 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.334 -1.098 . . . . 0.02 109.66 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.8 tt -129.69 141.02 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.96 -0.756 . . . . 0.02 108.96 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.503 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.3 t -121.47 130.26 53.46 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.577 -0.702 . . . . 0.39000000000000001 109.699 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 8.4 m-85 -109.76 139.97 44.21 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 109.123 -0.695 . . . . 0.02 109.123 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.514 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 6.3 m-85 -122.4 138.35 54.56 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.152 -0.967 . . . . 0.02 109.487 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.466 ' HG3' HD11 ' A' ' 33' ' ' LEU . 93.4 mt-10 -68.69 -27.75 66.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.219 -0.926 . . . . 0.029999999999999999 111.424 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.1 m-20 -114.75 170.49 8.28 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.937 -1.102 . . . . 0.029999999999999999 110.384 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.487 ' CZ ' ' OE2' ' A' ' 68' ' ' GLU . 7.6 mtp180 -75.18 160.84 29.94 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.59 0.709 . . . . 0.029999999999999999 110.122 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.596 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 2.6 m120 62.87 35.13 13.77 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.792 0.806 . . . . 0.73999999999999999 110.661 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.596 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 21.0 p90 49.58 42.21 22.65 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.451 -0.795 . . . . 0.02 111.057 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -109.03 165.95 11.2 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.851 -1.166 . . . . 0.02 107.851 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.82 -167.64 35.08 Favored Glycine 0 N--CA 1.495 2.628 0 O-C-N 120.687 -1.258 . . . . 0.029999999999999999 110.794 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -69.07 144.08 54.06 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.426 -1.044 . . . . 2.7599999999999998 109.285 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.486 ' HE ' ' CB ' ' A' ' 8' ' ' SER . 56.0 ttt180 -120.29 148.28 43.91 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.577 0.703 . . . . 1.8899999999999999 109.996 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -132.38 127.42 35.4 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.169 -1.049 . . . . 0.02 108.169 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -112.28 136.85 51.21 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.37 -0.831 . . . . 1.1200000000000001 109.89 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.427 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.4 t -131.17 138.99 49.69 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.582 -0.698 . . . . 0.02 109.681 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.498 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 33.3 t70 -117.09 10.67 13.98 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.648 -0.658 . . . . 0.20000000000000001 109.7 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 48.9 m -158.35 174.21 15.49 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.377 -0.972 . . . . 1.23 108.377 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -61.12 144.66 53.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.66 -1.275 . . . . 0.02 110.163 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.3 t -131.92 117.69 18.79 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.56 -0.904 . . . . 0.02 108.56 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.54 -26.09 45.65 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.091 -1.005 . . . . 0.23999999999999999 110.996 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 28.3 p-10 -153.47 101.39 2.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.971 -1.08 . . . . 1.1399999999999999 108.968 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -104.69 9.73 35.0 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 122.108 0.956 . . . . 6.3700000000000001 109.96 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -58.75 -24.79 62.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.541 -0.724 . . . . 3.1099999999999999 111.035 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.0 t -74.1 -16.78 61.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.806 -1.184 . . . . 0.88 110.192 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.51 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 18.1 m-85 -103.88 -22.03 13.56 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.349 -0.844 . . . . 0.02 109.388 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.466 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.2 tp -149.8 128.11 12.13 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.247 -0.908 . . . . 3.3199999999999998 108.98 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.5 m -85.2 -9.85 57.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.698 -0.626 . . . . 0.02 110.828 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -170.55 163.05 8.28 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.619 -1.252 . . . . 0.02 107.619 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 t -142.04 114.98 8.68 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.723 -1.236 . . . . 0.02 108.772 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -108.86 -1.82 18.89 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.807 -1.183 . . . . 0.029999999999999999 111.422 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 t -153.42 154.04 33.68 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.188 -1.041 . . . . 0.02 108.188 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.41 HG21 HD13 ' A' ' 39' ' ' ILE . 19.3 mt -145.85 145.86 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 120.955 -1.091 . . . . 0.02 110.802 -178.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -124.03 124.84 43.42 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.495 -1.298 . . . . 0.02 107.495 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.7 t -104.91 114.18 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 107.144 -1.428 . . . . 0.02 107.144 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.452 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 31.3 tt0 -84.56 -34.49 23.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.471 -0.768 . . . . 3.8100000000000001 110.098 -178.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.45 150.26 18.73 Favored Glycine 0 N--CA 1.489 2.212 0 C-N-CA 118.552 -1.785 . . . . 0.02 110.845 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.69 171.99 48.67 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.168 -1.173 . . . . 0.01 110.168 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.9 m -119.5 134.9 55.01 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.763 -1.199 . . . . 1.48 107.763 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.455 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 33.6 m95 -126.69 155.81 42.07 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 122.655 1.217 . . . . 0.02 112.448 -176.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.21 134.0 52.31 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 105.571 -2.011 . . . . 0.23999999999999999 105.571 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.514 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.3 m -118.6 143.21 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.624 -0.673 . . . . 0.65000000000000002 109.387 178.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -120.89 145.61 47.47 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 122.318 1.056 . . . . 0.02 110.06 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -66.22 -34.5 78.17 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.607 -0.724 . . . . 0.02 111.125 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 40.5 mtm180 -124.95 157.78 65.38 Favored Pre-proline 0 N--CA 1.503 2.215 0 O-C-N 121.035 -1.041 . . . . 0.02 109.546 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.58 167.09 1.03 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.773 1.649 . . . . 0.02 112.99 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.452 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.5 OUTLIER 63.53 36.74 10.93 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.126 -0.943 . . . . 0.02 111.156 178.19 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 45.05 51.7 8.73 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.678 0.751 . . . . 3.3900000000000001 110.574 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 94.8 p -125.86 163.53 22.73 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.27 0.557 . . . . 2.3300000000000001 109.779 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.94 -161.5 31.92 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.686 -1.366 . . . . 0.02 109.686 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -67.01 139.94 57.69 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.992 -1.299 . . . . 0.02 110.281 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 15.4 ptm -118.69 138.16 52.82 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.578 -0.701 . . . . 5.0099999999999998 109.962 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.455 ' OH ' HD13 ' A' ' 75' ' ' LEU . 58.8 m-85 -134.01 137.41 44.73 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.48 -0.762 . . . . 0.02 109.938 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.648 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.8 mp -96.03 131.81 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.597 -0.89 . . . . 1.72 108.597 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.416 HD21 ' CD1' ' A' ' 72' ' ' TRP . 11.5 mt -120.86 112.32 33.71 Favored Pre-proline 0 N--CA 1.504 2.231 0 O-C-N 121.329 -0.857 . . . . 0.02 110.886 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -77.64 169.95 20.01 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 CA-C-N 119.901 1.0 . . . . 1.47 110.061 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.452 ' NE2' ' O ' ' A' ' 42' ' ' GLU . 62.8 tt0 -53.46 140.56 27.59 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.917 -1.115 . . . . 4.25 110.449 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.07 -177.92 32.04 Favored Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.463 -1.351 . . . . 0.02 110.709 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -118.98 130.65 55.8 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.586 -0.949 . . . . 0.95999999999999996 109.528 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -119.87 96.26 49.42 Favored Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 107.912 -1.144 . . . . 0.02 107.912 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -71.83 -6.18 18.59 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 120.891 1.061 . . . . 0.02 113.909 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.527 ' OE1' ' CE1' ' A' ' 69' ' ' TYR . 1.0 OUTLIER -154.57 152.53 30.15 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.755 -1.202 . . . . 2.02 107.755 179.384 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.527 ' CE1' ' OE1' ' A' ' 68' ' ' GLU . 9.3 p90 -60.24 -37.6 80.88 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.52 -0.737 . . . . 0.02 111.522 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -59.64 -24.3 63.75 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.77 -1.206 . . . . 0.02 109.491 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -71.74 -21.43 61.75 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.699 0.762 . . . . 3.4199999999999999 109.064 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.548 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 2.2 t90 -108.22 6.77 26.99 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.482 -1.303 . . . . 0.02 107.482 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 13.3 mmt 61.01 22.37 12.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.646 -0.659 . . . . 0.02 110.832 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.83 145.78 47.71 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.293 -1.523 . . . . 0.02 109.293 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.455 HD13 ' OH ' ' A' ' 59' ' ' TYR . 7.6 mp -80.29 -31.14 38.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.225 -1.162 . . . . 0.97999999999999998 108.336 178.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -157.6 -171.86 3.73 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.635 -1.617 . . . . 0.02 106.635 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -98.62 28.53 4.17 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.723 -1.235 . . . . 0.02 110.613 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.587 HH11 ' CG ' ' A' ' 78' ' ' ARG . 3.3 mtt-85 -97.47 122.51 40.61 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.082 -1.011 . . . . 3.2000000000000002 110.849 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.514 HD22 ' HB ' ' A' ' 48' ' ' VAL . 34.9 mt -143.65 121.89 12.26 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.684 -1.228 . . . . 2.6099999999999999 107.684 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.83 -17.53 9.62 Favored Glycine 0 N--CA 1.504 3.184 0 O-C-N 121.078 -1.014 . . . . 0.02 112.981 -177.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.1 p -156.82 156.12 32.68 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.082 -1.834 . . . . 0.02 110.365 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 33.7 m -144.68 147.9 33.58 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.522 -0.736 . . . . 0.02 110.221 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 24.6 mtm180 -138.24 142.95 39.92 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.255 -0.903 . . . . 0.01 109.42 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.95 131.55 36.39 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.107 -0.995 . . . . 0.42999999999999999 109.85 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.5 t -90.8 124.9 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.809 -0.811 . . . . 1.25 108.809 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -93.79 131.77 38.84 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.81 -1.181 . . . . 1.77 109.339 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.5 mt -96.38 140.19 31.41 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.408 -0.96 . . . . 1.6299999999999999 108.408 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.2 m -111.73 127.17 55.7 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.374 -0.829 . . . . 1.0800000000000001 109.313 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.3 m -103.56 -154.89 0.51 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 106.425 -1.694 . . . . 1.26 106.425 176.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.53 -52.36 0.74 Allowed Glycine 0 N--CA 1.5 2.942 0 O-C-N 120.404 -1.435 . . . . 0.01 112.772 177.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.44 -101.52 0.15 Allowed Glycine 0 N--CA 1.489 2.193 0 C-N-CA 118.533 -1.794 . . . . 0.01 111.942 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -121.0 119.41 32.45 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.09 -1.241 . . . . 4.4299999999999997 110.549 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.08 129.48 35.26 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.808 -0.757 . . . . 2.9900000000000002 109.355 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -129.9 140.55 50.94 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.559 -0.713 . . . . 6.3600000000000003 109.172 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.8 tt -129.6 146.42 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 O-C-N 121.36 -0.837 . . . . 1.0900000000000001 110.157 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -122.2 133.86 54.72 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 107.558 -1.275 . . . . 2.0499999999999998 107.558 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.4 m -123.73 145.73 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 120.729 -1.232 . . . . 1.1000000000000001 109.829 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.587 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 39.6 m-85 -119.88 141.62 49.41 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-O 122.02 0.915 . . . . 0.72999999999999998 111.158 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -67.37 -31.04 71.0 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 116.025 -0.534 . . . . 0.02 111.776 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -115.9 167.44 10.95 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.912 -1.118 . . . . 3.1800000000000002 110.46 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.96 164.12 43.87 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 111.005 -0.838 . . . . 0.01 111.005 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.0 t70 56.75 39.11 29.83 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.656 0.741 . . . . 0.01 110.927 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 52.1 55.74 8.77 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.577 -0.702 . . . . 0.01 111.085 177.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -129.24 165.7 20.86 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 108.304 -0.999 . . . . 3.1499999999999999 108.304 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.36 -163.42 27.59 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.31 -1.516 . . . . 0.01 109.31 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.523 ' OE1' ' CE2' ' A' ' 108' ' ' TYR . 10.4 tm0? -75.94 143.62 41.51 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.946 -1.326 . . . . 0.01 108.459 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.587 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 33.2 ttp -116.33 142.36 46.95 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.492 0.663 . . . . 0.01 109.774 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.523 ' CE2' ' OE1' ' A' ' 106' ' ' GLN . 49.3 m-85 -131.39 136.54 48.11 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.197 -1.038 . . . . 2.48 108.197 178.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -117.73 133.59 55.78 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.558 -0.714 . . . . 0.01 109.959 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.1 t -148.47 149.24 31.32 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.352 1.072 . . . . 1.6899999999999999 111.223 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.1 p -110.05 10.17 24.12 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.38 -0.827 . . . . 0.01 110.122 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 42.0 mp0 -121.42 163.36 18.86 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.253 -0.904 . . . . 3.21 111.694 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.54 156.46 36.67 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.153 -1.054 . . . . 0.01 108.153 178.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 48.2 t -124.84 112.36 27.12 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 121.429 -0.795 . . . . 0.01 109.077 178.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -76.52 -33.17 3.32 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 CA-C-N 120.073 1.062 . . . . 0.01 111.515 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.7 m -140.73 107.12 5.27 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.22 -0.925 . . . . 0.02 108.585 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 76.0 mt -64.92 -38.82 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.854 -0.529 . . . . 1.8300000000000001 111.037 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 34.2 ttp -66.95 -38.47 86.18 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 118.902 -1.119 . . . . 1.3400000000000001 109.95 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.85 -38.16 79.59 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.381 -1.45 . . . . 2.1099999999999999 109.723 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -79.68 -47.35 15.5 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.358 -0.839 . . . . 2.0800000000000001 112.322 -177.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -112.37 -0.67 15.3 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.39 -0.819 . . . . 0.02 112.832 -176.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 61.71 34.74 17.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.743 -1.223 . . . . 0.02 109.846 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 43.6 mt -114.09 136.15 53.24 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.453 -0.78 . . . . 0.02 109.442 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -90.59 -22.12 21.4 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.142 -0.974 . . . . 5.3200000000000003 110.768 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -147.99 164.26 34.34 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.015 -1.053 . . . . 0.02 109.948 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.1 mm -129.2 125.94 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 107.784 -1.191 . . . . 2.1699999999999999 107.784 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 -108.74 -13.97 14.69 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.175 -0.953 . . . . 0.02 112.599 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.6 m -160.07 151.35 19.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.754 -1.216 . . . . 0.01 109.072 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.538 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 19.6 p -167.5 146.11 4.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.316 -0.865 . . . . 1.22 109.057 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.3 111.02 14.05 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-O 122.151 0.977 . . . . 1.4099999999999999 110.27 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.6 p -112.84 137.71 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.03 -1.1 . . . . 0.01 108.03 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.8 t -128.32 93.65 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 106.768 -1.567 . . . . 1.98 106.768 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 134' ' ' GLY . 10.4 tm-20 -146.55 -77.69 0.18 Allowed 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 105.827 -1.916 . . . . 0.01 105.827 177.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.512 ' N ' ' OE1' ' A' ' 133' ' ' GLU . . . -177.63 -80.39 0.06 OUTLIER Glycine 0 N--CA 1.485 1.916 0 N-CA-C 108.263 -1.935 . . . . 0.01 108.263 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.496 ' OG1' HD12 ' A' ' 175' ' ' ILE . 1.1 t -120.72 127.3 51.89 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.559 -0.965 . . . . 2.2999999999999998 110.161 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -127.3 152.24 47.7 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 106.907 -1.516 . . . . 0.01 106.907 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.5 mt -121.0 136.99 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 120.427 -1.421 . . . . 1.6899999999999999 110.088 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -113.62 143.95 43.72 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.34 -1.355 . . . . 2.4900000000000002 107.34 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.436 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 26.3 m-85 -122.42 144.71 48.87 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.292 -0.88 . . . . 0.02 109.297 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.436 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 78.0 tt0 -76.46 -29.0 56.76 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.501 -0.749 . . . . 0.02 111.705 -176.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.0 mt -115.95 154.67 48.37 Favored Pre-proline 0 N--CA 1.505 2.282 0 O-C-N 120.751 -1.218 . . . . 1.48 108.806 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -55.69 167.37 2.19 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 121.213 1.275 . . . . 0.02 112.794 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 59.47 31.14 20.83 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.147 -0.933 . . . . 0.75 111.408 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 57.28 51.25 10.33 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.534 -0.729 . . . . 0.02 110.993 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -126.1 164.62 20.5 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.545 -0.722 . . . . 0.02 109.938 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.18 -165.84 33.12 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.283 -1.127 . . . . 0.02 110.283 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.429 HH11 ' HG3' ' A' ' 147' ' ' ARG . 23.5 ttm-85 -69.34 142.6 53.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.51 -0.994 . . . . 0.02 109.067 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.464 ' CD ' ' N ' ' A' ' 148' ' ' GLN . 7.9 mp0 -114.8 148.52 38.32 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.343 0.592 . . . . 0.02 110.184 -178.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -124.78 135.61 53.11 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 109.048 -0.723 . . . . 0.01 109.048 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.502 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.7 tt -99.45 120.28 39.35 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.889 -1.132 . . . . 0.01 108.846 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.618 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 54.0 tp -101.85 154.06 19.27 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.256 -0.903 . . . . 0.01 109.066 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -104.71 -121.18 0.21 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.233 -0.917 . . . . 2.27 109.432 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.7 pttm -155.56 51.6 0.57 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.043 -1.036 . . . . 1.8400000000000001 109.608 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -112.48 -152.99 0.51 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.496 -0.753 . . . . 2.2799999999999998 109.068 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -106.39 100.21 9.75 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.385 -0.822 . . . . 0.01 109.045 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.68 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 6.7 m-85 -98.33 112.03 24.17 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.269 -0.894 . . . . 0.01 109.464 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -94.45 -22.52 18.22 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.242 -0.911 . . . . 0.01 111.448 -178.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -129.14 154.1 80.45 Favored Pre-proline 0 N--CA 1.502 2.167 0 O-C-N 120.758 -1.214 . . . . 2.54 108.808 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -59.46 -36.19 94.17 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 120.507 0.805 . . . . 0.69999999999999996 110.795 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 60.5 t -61.02 -20.2 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.758 -1.214 . . . . 0.85999999999999999 108.909 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -65.21 -15.31 62.32 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.882 -1.136 . . . . 0.02 109.691 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.68 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 11.5 m0 -98.06 11.06 38.88 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.254 -0.904 . . . . 0.02 109.067 178.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.81 11.45 83.9 Favored Glycine 0 N--CA 1.491 2.336 0 O-C-N 120.829 -1.169 . . . . 0.02 111.213 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.03 140.6 34.03 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.056 -1.261 . . . . 0.02 110.076 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -86.02 -8.77 57.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.566 -0.709 . . . . 0.58999999999999997 110.322 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 9.7 p -141.41 150.97 59.74 Favored Pre-proline 0 N--CA 1.5 2.051 0 O-C-N 121.019 -1.05 . . . . 0.87 109.712 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -75.88 14.62 1.02 Allowed 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 120.908 1.072 . . . . 0.38 112.142 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.72 122.07 27.19 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.361 1.077 . . . . 0.17999999999999999 111.212 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 3.8 mt -148.97 122.98 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 105.89 -1.892 . . . . 3.9900000000000002 105.89 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.53 ' OE1' ' N ' ' A' ' 170' ' ' GLN . 13.9 mp0 -112.95 -15.69 12.82 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.115 -0.99 . . . . 5.1699999999999999 113.07 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 12.8 t -156.31 159.57 38.95 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 119.328 -2.107 . . . . 0.02 109.941 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -153.08 154.12 34.21 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.039 -1.038 . . . . 2.02 110.689 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -145.24 149.93 35.78 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.776 0.798 . . . . 0.01 110.12 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -88.11 143.29 27.15 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.132 -0.692 . . . . 0.01 109.132 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.496 HD12 ' OG1' ' A' ' 135' ' ' THR . 6.7 mt -94.48 129.71 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.266 -0.896 . . . . 3.04 109.024 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.3 m -136.29 147.04 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.158 -0.964 . . . . 1.8899999999999999 109.526 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.61 ' H ' ' CD ' ' A' ' 177' ' ' GLU . 1.4 pm0 . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.89 . . . . 4.8899999999999997 109.725 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 3' ' ' THR . 95.0 p . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.466 -0.568 . . . . 5.2800000000000002 109.466 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.9 mttt 52.44 -87.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 5.96 109.625 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.517 ' N ' ' O ' ' A' ' 1' ' ' SER . 1.5 t -171.9 170.03 5.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.798 -1.189 . . . . 2.2200000000000002 109.303 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -118.63 117.74 3.79 Favored Glycine 0 N--CA 1.501 2.987 0 N-CA-C 106.815 -2.514 . . . . 0.81000000000000005 106.815 177.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.73 144.51 32.71 Favored Glycine 0 N--CA 1.492 2.402 0 O-C-N 121.089 -1.242 . . . . 0.01 110.037 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.5 tttm -149.19 135.82 19.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.473 -1.016 . . . . 0.02 109.753 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.7 tt -128.24 138.34 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 108.054 -1.091 . . . . 0.02 108.054 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 m -121.5 129.99 53.28 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.325 -0.86 . . . . 0.39000000000000001 110.169 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 4.4 m-85 -110.58 141.18 44.12 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.967 -0.753 . . . . 0.02 108.967 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.546 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.7 m-85 -122.35 138.43 54.52 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.223 -0.923 . . . . 0.02 109.53 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.484 ' HG3' HD11 ' A' ' 33' ' ' LEU . 90.4 mt-10 -67.91 -27.78 66.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.99 -1.069 . . . . 0.029999999999999999 111.409 -178.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 2.4 m-20 -114.62 170.24 8.47 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.844 -1.16 . . . . 0.029999999999999999 110.22 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -75.85 162.1 28.43 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.794 0.807 . . . . 0.029999999999999999 110.241 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.432 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 0.1 OUTLIER 62.76 33.09 15.68 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.106 0.955 . . . . 0.73999999999999999 110.836 179.394 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 55.22 39.81 31.48 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.841 -0.618 . . . . 0.02 110.973 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -110.11 165.65 11.57 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.18 -1.044 . . . . 0.02 108.18 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.82 -168.07 35.49 Favored Glycine 0 N--CA 1.497 2.708 0 C-N-CA 119.827 -1.178 . . . . 0.029999999999999999 110.748 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -69.45 143.87 53.45 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.483 -1.01 . . . . 2.7599999999999998 109.239 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -120.67 148.95 43.25 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.584 0.707 . . . . 1.8899999999999999 110.214 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -132.09 127.56 36.31 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.189 -1.041 . . . . 0.02 108.189 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.52 136.71 51.72 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.434 -0.791 . . . . 1.1200000000000001 109.888 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 13.3 t -131.26 139.22 49.6 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.665 -0.647 . . . . 0.02 109.557 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.497 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 2.5 m-20 -116.83 11.13 14.38 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.71 -0.619 . . . . 0.20000000000000001 109.694 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 47.5 m -158.23 174.76 14.68 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.263 -1.014 . . . . 1.23 108.263 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 3.5 m-20 -60.57 144.32 51.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.644 -1.285 . . . . 0.02 109.899 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 41.9 t -132.01 117.82 18.9 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.577 -0.897 . . . . 0.02 108.577 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.87 -25.26 48.48 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.168 -0.958 . . . . 0.23999999999999999 110.922 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -154.31 102.87 2.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.931 -1.106 . . . . 1.1399999999999999 109.274 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.433 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 43.6 p90 -102.06 9.95 39.93 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 122.019 0.914 . . . . 6.3700000000000001 109.788 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.3 mtm180 -59.43 -25.46 64.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.475 -0.765 . . . . 3.1099999999999999 111.505 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.9 p -76.05 -17.68 59.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.58 -1.325 . . . . 0.88 110.769 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -104.07 -22.17 13.48 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.335 -0.853 . . . . 0.02 109.589 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.484 HD11 ' HG3' ' A' ' 11' ' ' GLU . 6.4 tp -150.4 129.44 12.63 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.278 -0.889 . . . . 3.3199999999999998 108.967 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.7 p -85.24 -9.92 57.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.8 -0.563 . . . . 0.02 111.129 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -171.46 162.78 6.71 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.77 -1.206 . . . . 0.02 108.015 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.1 p -143.55 115.23 8.16 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.827 -1.17 . . . . 0.02 108.66 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -107.54 2.08 23.83 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 120.756 -1.215 . . . . 0.029999999999999999 110.881 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.1 t -155.54 154.84 32.37 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.821 -1.177 . . . . 0.02 107.821 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 39' ' ' ILE . 10.4 mt -146.29 146.58 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.951 -1.093 . . . . 0.02 110.654 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -123.68 124.82 43.6 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.159 -1.052 . . . . 0.02 108.159 177.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.5 t -106.6 115.19 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 106.803 -1.554 . . . . 0.02 106.803 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -83.98 -33.85 24.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.636 -0.665 . . . . 3.8100000000000001 110.759 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.79 152.38 22.26 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 118.821 -1.656 . . . . 0.02 110.807 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.26 173.21 49.53 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.62 -1.276 . . . . 0.01 110.474 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.2 m -119.68 135.4 54.84 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.983 -1.118 . . . . 1.48 107.983 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.458 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 32.9 m95 -126.35 155.26 42.33 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-O 122.573 1.178 . . . . 0.02 112.263 -176.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.5 134.16 52.22 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 105.509 -2.034 . . . . 0.23999999999999999 105.509 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.5 ' HB ' HD22 ' A' ' 79' ' ' LEU . 27.2 m -118.96 143.3 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.154 -0.684 . . . . 0.65000000000000002 109.154 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.565 ' CE2' ' SD ' ' A' ' 58' ' ' MET . 28.1 m-85 -121.41 146.32 47.01 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 122.386 1.089 . . . . 0.02 110.046 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -66.2 -35.1 79.57 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.509 -0.769 . . . . 0.02 111.228 -177.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -125.36 157.67 66.89 Favored Pre-proline 0 N--CA 1.503 2.182 0 O-C-N 121.051 -1.03 . . . . 0.02 109.498 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -53.63 167.3 1.0 Allowed 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.704 1.602 . . . . 0.02 112.958 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 63.68 36.53 10.72 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 114.999 -1.0 . . . . 0.02 111.182 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 45.15 51.54 9.01 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.631 0.729 . . . . 3.3900000000000001 110.612 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.0 t -126.29 163.78 22.46 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 121.201 0.524 . . . . 2.3300000000000001 109.804 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.61 -161.57 32.4 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.738 -1.345 . . . . 0.02 109.738 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.98 140.34 57.72 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.054 -1.263 . . . . 0.02 110.346 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.565 ' SD ' ' CE2' ' A' ' 49' ' ' TYR . 49.2 ttp -118.84 138.17 52.91 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.691 -0.631 . . . . 5.0099999999999998 109.827 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.49 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 56.1 m-85 -133.66 137.06 45.15 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.492 -0.755 . . . . 0.02 109.695 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.8 mm -94.74 131.09 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.912 -0.773 . . . . 1.72 108.912 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.561 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -119.21 110.56 37.67 Favored Pre-proline 0 N--CA 1.505 2.277 0 O-C-N 121.461 -0.775 . . . . 0.02 110.73 -178.316 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -77.63 168.32 22.74 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 CA-C-N 119.791 0.961 . . . . 1.47 110.068 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -53.16 141.74 22.4 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.757 -1.214 . . . . 4.25 110.35 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.27 -177.96 31.37 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.584 -1.293 . . . . 0.02 110.844 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -119.65 131.8 55.54 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.393 -1.063 . . . . 0.95999999999999996 109.692 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.561 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 69.9 m-85 -122.04 96.07 46.96 Favored Pre-proline 0 N--CA 1.494 1.755 0 N-CA-C 108.015 -1.105 . . . . 0.02 108.015 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.28 -4.38 10.43 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 120.811 1.007 . . . . 0.02 113.729 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -157.61 155.44 30.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.603 -1.311 . . . . 2.02 108.229 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -60.46 -39.17 86.59 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.535 -0.728 . . . . 0.02 112.17 -177.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -60.34 -23.82 64.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.132 -0.98 . . . . 0.02 110.373 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -69.37 -18.45 63.78 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.764 0.793 . . . . 3.4199999999999999 108.982 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.553 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.4 t90 -108.38 11.06 27.35 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.584 -1.265 . . . . 0.02 107.584 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.6 mmt 60.74 22.09 12.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.585 -0.697 . . . . 0.02 110.553 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.68 143.7 44.6 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.319 -1.512 . . . . 0.02 109.319 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.3 tp -78.79 -31.51 46.04 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.452 -1.314 . . . . 0.97999999999999998 107.452 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -157.87 -172.47 3.94 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 106.262 -1.755 . . . . 0.02 106.262 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -98.44 28.39 4.18 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.659 -1.276 . . . . 0.02 110.627 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.434 HH11 ' HG3' ' A' ' 78' ' ' ARG . 20.9 ttm-85 -97.23 122.05 39.81 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.725 -1.234 . . . . 3.2000000000000002 110.905 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.5 HD22 ' HB ' ' A' ' 48' ' ' VAL . 35.1 mt -144.14 122.8 12.55 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.566 -1.272 . . . . 2.6099999999999999 107.566 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.17 -16.9 10.62 Favored Glycine 0 N--CA 1.504 3.189 0 O-C-N 121.024 -1.048 . . . . 0.02 112.814 -177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 73.3 p -156.8 156.34 33.08 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.22 -1.753 . . . . 0.02 110.299 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 28.4 p -143.84 147.29 33.87 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.481 -0.762 . . . . 0.02 110.038 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.5 mtm180 -138.25 143.15 39.96 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.469 -0.769 . . . . 0.01 109.644 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.26 132.54 36.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.42999999999999999 109.829 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.6 t -91.29 125.16 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.863 -0.791 . . . . 1.25 108.863 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -94.1 131.79 39.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.831 -1.168 . . . . 1.77 109.298 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.9 mt -96.38 140.15 31.45 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.312 -0.867 . . . . 1.6299999999999999 108.855 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.1 t -111.57 127.1 55.62 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.449 -0.782 . . . . 1.0800000000000001 109.092 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.5 p -103.56 -154.94 0.51 Allowed 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 106.485 -1.672 . . . . 1.26 106.485 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.96 -53.14 0.73 Allowed Glycine 0 N--CA 1.5 2.9 0 O-C-N 120.366 -1.459 . . . . 0.01 112.684 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -179.53 -101.72 0.15 Allowed Glycine 0 N--CA 1.489 2.221 0 C-N-CA 118.605 -1.76 . . . . 0.01 112.029 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -121.19 119.45 32.37 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.098 -1.236 . . . . 4.4299999999999997 110.72 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.87 130.59 35.82 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.822 -0.751 . . . . 2.9900000000000002 109.294 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -131.03 141.81 50.25 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.483 -0.761 . . . . 6.3600000000000003 108.964 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.8 tt -129.28 146.66 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.366 -0.834 . . . . 1.0900000000000001 110.038 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -122.01 133.68 54.81 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.766 -1.198 . . . . 2.0499999999999998 107.766 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.46 HG12 ' SG ' ' A' ' 129' ' ' CYS . 25.2 m -123.42 145.56 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 120.788 -1.195 . . . . 1.1000000000000001 109.736 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.594 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 32.2 m-85 -118.7 141.19 48.84 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 122.016 0.913 . . . . 0.72999999999999998 110.716 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -66.2 -30.21 70.63 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.995 -0.548 . . . . 0.02 111.295 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -116.54 170.16 8.78 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.099 -1.001 . . . . 3.1800000000000002 110.412 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.02 170.37 44.26 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.742 -0.943 . . . . 0.01 110.742 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 52.91 38.94 28.25 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.527 0.68 . . . . 0.01 111.587 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.424 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 24.7 m-85 51.8 49.17 21.35 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.525 -0.734 . . . . 0.01 111.059 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -123.62 165.59 16.94 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.322 -0.992 . . . . 3.1499999999999999 108.322 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.72 -163.79 27.36 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.519 -1.432 . . . . 0.01 109.519 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.4 tp60 -76.75 144.56 39.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.028 -1.277 . . . . 0.01 108.497 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.594 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 12.6 ttt -116.01 141.53 48.0 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.658 0.742 . . . . 0.01 109.801 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -131.0 136.42 48.5 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.069 -1.086 . . . . 2.48 108.069 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -118.89 133.7 55.66 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.52 -0.738 . . . . 0.01 110.117 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 t -148.17 149.41 31.92 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 122.318 1.056 . . . . 1.6899999999999999 110.962 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.0 p -111.33 9.95 21.59 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 115.501 -0.772 . . . . 0.01 110.336 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.468 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 23.6 mp0 -121.11 163.12 18.89 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.214 -0.929 . . . . 3.21 111.491 -178.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.74 156.61 37.98 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.471 -0.937 . . . . 0.01 108.471 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 19.6 t -127.15 113.67 21.67 Favored Pre-proline 0 N--CA 1.501 2.088 0 N-CA-C 108.749 -0.834 . . . . 0.01 108.749 178.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -74.52 -29.17 9.41 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 CA-C-N 120.446 1.195 . . . . 0.01 111.034 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 7.8 p -142.34 109.12 5.41 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.444 -0.785 . . . . 0.02 109.074 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.429 HD12 ' O ' ' A' ' 169' ' ' ILE . 97.6 mt -63.81 -38.74 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.884 -0.51 . . . . 1.8300000000000001 110.653 -178.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 118' ' ' MET . 12.4 tmm? -68.52 -37.74 80.27 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.255 -0.978 . . . . 1.3400000000000001 110.208 -178.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -69.53 -38.27 77.46 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.48 -1.388 . . . . 2.1099999999999999 109.958 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -79.78 -47.21 15.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.238 -0.914 . . . . 2.0800000000000001 112.381 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -111.39 0.41 16.59 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.299 -0.875 . . . . 0.02 112.647 -176.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 59.98 33.48 21.42 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.749 -1.219 . . . . 0.02 109.529 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.3 mt -112.09 135.54 52.62 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.718 -0.845 . . . . 0.02 108.718 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -91.61 -22.9 20.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.17 -0.956 . . . . 5.3200000000000003 110.24 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -149.48 164.28 35.46 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.159 -0.963 . . . . 0.02 109.88 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 35.0 mt -131.89 129.0 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 107.654 -1.239 . . . . 2.1699999999999999 107.654 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 61.2 m80 -108.09 -11.95 15.2 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.364 -0.835 . . . . 0.02 112.314 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.424 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 2.7 t -159.01 151.14 21.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.915 -1.115 . . . . 0.01 108.871 178.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.46 ' SG ' HG12 ' A' ' 97' ' ' VAL . 5.7 t -168.43 144.05 3.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 1.22 108.873 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.7 tttm -125.57 109.33 12.53 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 122.509 1.147 . . . . 1.4099999999999999 109.963 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 131' ' ' VAL . 7.5 p -111.32 135.86 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.184 -1.413 . . . . 0.01 107.184 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 72.1 t -126.68 93.31 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 106.788 -1.56 . . . . 1.98 106.788 177.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.428 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 54.2 tp10 -147.13 -75.3 0.19 Allowed 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 105.781 -1.933 . . . . 0.01 105.781 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 152.82 -53.79 0.46 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.567 -1.413 . . . . 0.01 109.567 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.67 ' HB ' HD12 ' A' ' 175' ' ' ILE . 72.4 p -120.16 99.79 6.81 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.494 -1.004 . . . . 2.2999999999999998 111.348 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.428 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 8.4 m95 -128.64 145.37 51.17 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 107.572 -1.27 . . . . 0.01 107.572 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.416 ' CG1' HD11 ' A' ' 175' ' ' ILE . 56.8 mt -121.01 137.93 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 120.662 -1.274 . . . . 1.6899999999999999 110.37 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.4 ' CE1' HD22 ' A' ' 151' ' ' LEU . 49.7 m-85 -114.92 144.72 43.11 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 106.935 -1.506 . . . . 2.4900000000000002 106.935 177.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.531 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 10.3 m-85 -124.2 144.32 50.0 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.411 -0.806 . . . . 0.02 109.857 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.42 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 38.7 tt0 -74.13 -29.08 61.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.687 -0.633 . . . . 0.02 111.874 -176.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.5 mt -115.74 154.56 48.08 Favored Pre-proline 0 N--CA 1.504 2.241 0 O-C-N 120.735 -1.228 . . . . 1.48 108.997 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -55.81 167.38 2.28 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.113 1.209 . . . . 0.02 112.726 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.1 m120 59.64 31.15 20.73 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.215 -0.902 . . . . 0.75 111.391 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 57.91 51.51 8.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.46 -0.775 . . . . 0.02 111.171 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -126.92 164.86 20.52 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.454 -0.779 . . . . 0.02 110.1 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.46 -165.95 32.82 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 110.414 -1.074 . . . . 0.02 110.414 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -69.37 142.73 53.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.554 -0.968 . . . . 0.02 108.883 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -114.69 148.94 37.54 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.339 0.59 . . . . 0.02 110.123 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.437 ' CD1' ' N ' ' A' ' 149' ' ' TYR . 13.0 m-85 -124.84 135.03 52.55 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 109.169 -0.678 . . . . 0.01 109.169 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.1 tt -100.36 122.42 43.1 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.907 -1.121 . . . . 0.01 109.021 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.4 HD22 ' CE1' ' A' ' 138' ' ' PHE . 6.1 mp -97.19 164.25 12.57 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.072 -1.018 . . . . 0.01 108.656 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -108.2 -101.71 0.37 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.462 -0.773 . . . . 2.27 109.527 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -172.99 43.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 1.8400000000000001 109.617 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -112.41 -156.55 0.59 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.524 -0.735 . . . . 2.2799999999999998 109.343 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -106.86 108.23 19.64 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.445 -0.785 . . . . 0.01 109.196 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.632 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 37.1 m-85 -98.92 113.58 25.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.343 -0.848 . . . . 0.01 109.532 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -94.62 -22.72 17.99 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.149 -0.97 . . . . 0.01 111.596 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -127.49 154.94 77.45 Favored Pre-proline 0 N--CA 1.503 2.187 0 O-C-N 120.916 -1.115 . . . . 2.54 108.775 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -60.7 -37.97 75.0 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 CA-C-N 119.317 0.792 . . . . 0.69999999999999996 110.543 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 95.7 t -61.04 -19.92 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.842 -1.161 . . . . 0.85999999999999999 109.259 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -65.26 -15.34 62.39 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.901 -1.125 . . . . 0.02 110.023 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.632 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 8.8 m0 -97.65 11.68 36.22 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.096 -1.003 . . . . 0.02 109.152 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.52 10.72 84.94 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.827 -1.178 . . . . 0.02 111.127 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.39 140.61 33.32 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.081 -1.246 . . . . 0.02 110.008 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.18 -8.92 58.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.708 -0.62 . . . . 0.58999999999999997 110.025 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 4.6 m -143.26 150.03 50.51 Favored Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.033 -1.042 . . . . 0.87 109.013 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.5 17.68 0.64 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 120.583 0.855 . . . . 0.38 112.102 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.31 123.25 28.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.851 -1.155 . . . . 0.17999999999999999 111.524 -177.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.429 ' O ' HD12 ' A' ' 117' ' ' ILE . 1.5 mt -150.04 126.32 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 106.714 -1.588 . . . . 3.9900000000000002 106.714 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 170' ' ' GLN . 10.8 mp0 -112.3 -16.83 12.88 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.082 -1.011 . . . . 5.1699999999999999 113.059 -177.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.7 p -157.33 160.77 38.85 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 119.162 -2.211 . . . . 0.02 110.242 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.414 ' CD1' ' C ' ' A' ' 172' ' ' PHE . 21.1 p90 -152.4 152.65 32.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.074 -1.016 . . . . 2.02 110.521 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -144.85 149.84 36.08 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.467 -0.77 . . . . 0.01 109.698 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.408 HH21 HG11 ' A' ' 176' ' ' VAL . 41.2 ttp180 -87.17 140.87 29.11 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.246 -0.65 . . . . 0.01 109.246 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.67 HD12 ' HB ' ' A' ' 135' ' ' THR . 31.4 mt -92.47 129.44 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.14 -0.975 . . . . 3.04 108.839 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.408 HG11 HH21 ' A' ' 174' ' ' ARG . 12.9 m -136.76 148.04 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.244 -0.91 . . . . 1.8899999999999999 109.793 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 4.8899999999999997 109.529 179.925 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 92.2 p . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.452 -0.573 . . . . 5.2800000000000002 109.452 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -67.03 -1.71 4.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.224 -0.922 . . . . 5.96 109.538 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.3 t -90.01 -140.05 0.14 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.272 -1.381 . . . . 2.2200000000000002 107.272 177.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.03 -176.23 46.49 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 117.302 -2.38 . . . . 0.81000000000000005 112.679 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -80.32 160.38 43.96 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.603 -1.399 . . . . 0.01 109.603 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.519 ' CB ' ' NZ ' ' A' ' 6' ' ' LYS . 5.5 ttpm? -146.41 135.68 22.79 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.263 -1.139 . . . . 0.02 110.43 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.7 tt -129.77 139.85 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.256 -1.016 . . . . 0.02 108.256 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 m -120.7 129.48 53.68 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.337 -0.852 . . . . 0.39000000000000001 110.065 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -109.8 139.46 44.83 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.846 -0.798 . . . . 0.02 108.846 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.551 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.6 m-85 -122.07 138.44 54.44 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.258 -0.901 . . . . 0.02 109.731 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.449 ' HG3' HD11 ' A' ' 33' ' ' LEU . 94.6 mt-10 -69.29 -27.5 65.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.029999999999999999 111.575 -178.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -114.36 169.5 8.99 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.894 -1.129 . . . . 0.029999999999999999 110.242 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -75.44 158.56 32.48 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.663 0.744 . . . . 0.029999999999999999 110.105 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.417 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 46.4 t30 66.13 33.48 7.43 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.954 0.883 . . . . 0.73999999999999999 111.16 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.417 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 1.0 OUTLIER 55.42 41.63 30.82 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 116.053 -0.521 . . . . 0.02 111.161 177.901 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -113.46 166.15 11.78 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.374 -0.973 . . . . 0.02 108.374 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.9 -167.29 36.33 Favored Glycine 0 N--CA 1.494 2.539 0 C-N-CA 119.927 -1.13 . . . . 0.029999999999999999 110.765 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -69.06 142.0 54.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.524 -0.986 . . . . 2.7599999999999998 109.302 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -120.48 149.09 42.94 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.625 0.726 . . . . 1.8899999999999999 110.144 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -132.73 127.55 34.96 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.325 -0.991 . . . . 0.02 108.325 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 23.0 p-10 -112.57 136.85 51.62 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.412 -0.805 . . . . 1.1200000000000001 109.733 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.2 t -131.07 138.83 49.75 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.678 -0.639 . . . . 0.02 109.626 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.494 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 2.6 p30 -116.41 11.06 14.83 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.529 -0.732 . . . . 0.20000000000000001 109.817 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 43.1 m -158.38 174.66 14.79 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.318 -0.993 . . . . 1.23 108.318 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -60.8 144.16 53.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.714 -1.242 . . . . 0.02 109.916 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.5 p -131.57 117.16 18.36 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.594 -0.891 . . . . 0.02 108.594 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.03 -25.43 47.86 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.107 -0.996 . . . . 0.23999999999999999 110.799 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -154.33 101.17 2.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.977 -1.077 . . . . 1.1399999999999999 108.948 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -105.33 9.42 33.85 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.103 0.954 . . . . 6.3700000000000001 109.788 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -58.52 -23.93 59.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.492 -0.755 . . . . 3.1099999999999999 110.865 -178.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 53.6 p -74.58 -16.28 60.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.739 -1.226 . . . . 0.88 110.328 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -104.63 -22.14 13.29 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.462 -0.774 . . . . 0.02 109.63 -179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.449 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.7 tp -150.56 129.22 12.31 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.15 -0.969 . . . . 3.3199999999999998 109.287 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.0 p -86.83 -10.41 53.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.657 -0.652 . . . . 0.02 111.69 -178.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.522 HH21 ' ND2' ' A' ' 37' ' ' ASN . 42.7 ttt180 -170.36 161.34 8.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.811 -1.181 . . . . 0.02 107.963 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.412 ' SG ' HD23 ' A' ' 33' ' ' LEU . 4.1 m -141.96 115.27 8.9 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.702 -1.249 . . . . 0.02 109.642 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.523 ' ND2' ' OD2' ' A' ' 77' ' ' ASP . 0.8 OUTLIER -107.88 0.14 21.87 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.837 -1.165 . . . . 0.029999999999999999 110.801 -178.893 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.1 t -156.31 154.58 30.86 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.039 -1.097 . . . . 0.02 108.039 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.4 mt -146.42 147.31 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.132 -0.98 . . . . 0.02 110.477 -178.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -123.53 124.4 42.76 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.189 -1.041 . . . . 0.02 108.189 177.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.8 t -106.54 115.04 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 106.921 -1.511 . . . . 0.02 106.921 177.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -83.76 -33.64 24.98 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.939 -0.705 . . . . 3.8100000000000001 110.643 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.7 152.11 21.89 Favored Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.009 -1.567 . . . . 0.02 110.831 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.57 172.98 49.4 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.517 -1.325 . . . . 0.01 110.522 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.5 m -119.7 135.28 54.89 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 108.019 -1.104 . . . . 1.48 108.019 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.42 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 36.1 m95 -126.94 155.58 42.86 Favored 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 122.486 1.136 . . . . 0.02 112.112 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.39 134.05 52.31 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 105.573 -2.01 . . . . 0.23999999999999999 105.573 176.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.513 ' HB ' HD22 ' A' ' 79' ' ' LEU . 29.3 m -118.6 143.59 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.584 -0.697 . . . . 0.65000000000000002 109.226 178.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -121.46 145.93 47.42 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 122.427 1.108 . . . . 0.02 110.335 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -66.35 -33.93 76.82 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.678 -0.692 . . . . 0.02 111.198 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.8 mtp180 -125.41 157.85 66.4 Favored Pre-proline 0 N--CA 1.502 2.16 0 O-C-N 121.046 -1.034 . . . . 0.02 109.515 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -53.74 166.97 1.15 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.742 1.628 . . . . 0.02 113.0 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 64.03 36.53 9.84 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.214 -0.903 . . . . 0.02 111.175 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 45.31 51.88 9.13 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.638 0.732 . . . . 3.3900000000000001 110.593 178.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.3 p -126.51 163.84 22.5 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.167 0.508 . . . . 2.3300000000000001 109.87 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.37 -162.12 31.81 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.766 -1.334 . . . . 0.02 109.766 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 21.8 m80 -65.52 138.27 57.96 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.035 -1.274 . . . . 0.02 110.066 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 20.6 ptm -118.12 137.21 53.1 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.326 0.584 . . . . 5.0099999999999998 109.583 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.562 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 86.9 m-85 -133.98 138.67 45.58 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.419 -0.801 . . . . 0.02 109.752 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.1 mm -95.54 131.37 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 109.089 -0.708 . . . . 1.72 109.089 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.478 HD22 ' CE1' ' A' ' 66' ' ' TYR . 12.4 mt -120.89 111.91 33.94 Favored Pre-proline 0 N--CA 1.506 2.328 0 O-C-N 121.361 -0.837 . . . . 0.02 110.962 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -77.52 169.77 20.45 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 CA-C-N 119.876 0.991 . . . . 1.47 109.871 177.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -52.9 141.19 22.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.794 -1.192 . . . . 4.25 110.211 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.42 -177.83 32.38 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.52 -1.324 . . . . 0.02 110.781 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -120.67 131.93 54.83 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.374 -1.074 . . . . 0.95999999999999996 109.832 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.478 ' CE1' HD22 ' A' ' 61' ' ' LEU . 94.7 m-85 -121.68 96.41 47.35 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 108.068 -1.086 . . . . 0.02 108.068 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.37 -3.8 10.67 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 120.796 0.997 . . . . 0.02 113.702 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -157.58 155.69 30.6 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.621 -1.3 . . . . 2.02 108.36 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -60.43 -39.29 86.93 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.54 -0.725 . . . . 0.02 112.013 -177.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -60.17 -23.37 63.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.968 -1.083 . . . . 0.02 110.279 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -70.61 -18.72 62.88 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.897 0.856 . . . . 3.4199999999999999 109.044 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.562 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.3 t90 -107.8 10.29 28.75 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.409 -1.33 . . . . 0.02 107.409 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 13.5 mmt 60.46 22.26 11.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.627 -0.671 . . . . 0.02 110.294 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.76 144.39 46.28 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.398 -1.481 . . . . 0.02 109.398 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.9 mt -78.86 -30.44 45.12 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.626 -1.25 . . . . 0.97999999999999998 107.626 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -157.11 -171.61 3.7 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 106.427 -1.694 . . . . 0.02 106.427 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.523 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 92.4 m-20 -98.82 28.37 4.35 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.733 -1.229 . . . . 0.02 110.42 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -96.91 122.62 40.09 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.005 -1.059 . . . . 3.2000000000000002 110.936 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.513 HD22 ' HB ' ' A' ' 48' ' ' VAL . 39.7 mt -143.56 120.96 11.65 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.585 -1.265 . . . . 2.6099999999999999 107.585 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.35 -17.3 10.11 Favored Glycine 0 N--CA 1.506 3.302 0 O-C-N 121.065 -1.022 . . . . 0.02 112.928 -177.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.2 t -156.99 156.46 33.0 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.159 -1.789 . . . . 0.02 110.331 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 38.6 m -145.42 148.19 33.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.453 -0.779 . . . . 0.02 110.086 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -138.14 143.12 40.17 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.308 -0.87 . . . . 0.01 109.413 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.37 132.36 36.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -0.952 . . . . 0.42999999999999999 109.68 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.4 t -91.59 125.28 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.938 -0.764 . . . . 1.25 108.938 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -95.57 129.99 42.57 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.707 -1.246 . . . . 1.77 109.274 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.6 mt -94.47 141.27 28.79 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.159 -0.963 . . . . 1.6299999999999999 108.688 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.5 m -111.21 128.14 55.82 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.386 -0.821 . . . . 1.0800000000000001 109.237 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.0 p -104.54 -153.96 0.49 Allowed 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 106.63 -1.618 . . . . 1.26 106.63 177.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.64 -52.76 0.74 Allowed Glycine 0 N--CA 1.501 3.024 0 O-C-N 120.414 -1.428 . . . . 0.01 112.807 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.35 -101.95 0.16 Allowed Glycine 0 N--CA 1.49 2.237 0 C-N-CA 118.533 -1.794 . . . . 0.01 112.108 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -121.53 119.13 31.08 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.144 -1.209 . . . . 4.4299999999999997 110.788 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.05 130.39 35.47 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.92 -0.712 . . . . 2.9900000000000002 109.267 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.473 ' CB ' ' NZ ' ' A' ' 94' ' ' LYS . 2.8 ttmp? -129.79 141.57 50.83 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.423 -0.798 . . . . 6.3600000000000003 109.149 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 110' ' ' THR . 3.8 tt -128.14 145.64 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 121.356 -0.84 . . . . 1.0900000000000001 110.465 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.541 ' OE1' ' N ' ' A' ' 96' ' ' GLN . 0.5 OUTLIER -122.32 132.29 54.33 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.382 -1.34 . . . . 2.0499999999999998 107.382 177.203 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.5 m -124.51 146.47 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 O-C-N 120.601 -1.312 . . . . 1.1000000000000001 109.746 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.577 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 71.3 m-85 -119.58 141.01 49.65 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 122.045 0.926 . . . . 0.72999999999999998 111.161 -178.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -66.12 -30.37 70.85 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 116.004 -0.544 . . . . 0.02 111.365 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -117.0 170.57 8.53 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.13 -0.981 . . . . 3.1800000000000002 110.473 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.66 169.29 45.05 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.805 -0.918 . . . . 0.01 110.805 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 23.9 t70 53.23 38.83 28.6 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.576 0.703 . . . . 0.01 111.55 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 52.14 48.8 21.95 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.503 -0.748 . . . . 0.01 110.846 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -123.28 165.55 16.77 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.215 -1.032 . . . . 3.1499999999999999 108.215 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.43 -164.29 28.03 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.302 -1.519 . . . . 0.01 109.302 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -76.84 144.57 38.97 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.053 -1.263 . . . . 0.01 108.675 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.577 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 30.3 ttp -116.74 142.57 46.74 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.638 0.732 . . . . 0.01 109.984 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -131.27 136.49 48.23 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.184 -1.043 . . . . 2.48 108.184 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -118.56 133.92 55.49 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.466 -0.771 . . . . 0.01 109.817 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.415 ' O ' HG22 ' A' ' 95' ' ' ILE . 4.5 t -148.15 149.86 32.77 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.128 0.966 . . . . 1.6899999999999999 110.965 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 p -110.44 9.97 23.31 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 115.614 -0.721 . . . . 0.01 110.168 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -121.53 163.1 19.4 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.214 -0.929 . . . . 3.21 111.901 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 9.8 p30 -68.15 157.28 35.69 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.233 -1.025 . . . . 0.01 108.233 178.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.574 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 86.2 m -125.77 112.8 24.87 Favored Pre-proline 0 N--CA 1.501 2.104 0 O-C-N 121.503 -0.748 . . . . 0.01 109.172 178.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -75.62 -30.93 5.84 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 CA-C-N 120.095 1.07 . . . . 0.01 111.042 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.4 m -141.96 106.55 4.85 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.493 -0.928 . . . . 0.02 108.493 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 95.0 mt -65.12 -38.1 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.745 -0.597 . . . . 1.8300000000000001 111.203 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.1 ttt -67.75 -37.16 81.76 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.013 -1.075 . . . . 1.3400000000000001 109.815 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -69.75 -38.34 76.77 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.493 -1.379 . . . . 2.1099999999999999 109.721 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -80.19 -47.24 14.99 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.404 -0.81 . . . . 2.0800000000000001 112.345 -177.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -110.95 -0.4 16.76 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.386 -0.821 . . . . 0.02 112.67 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.9 m170 59.86 33.44 21.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.818 -1.176 . . . . 0.02 109.58 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 11.7 mt -112.42 135.53 53.01 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 108.791 -0.818 . . . . 0.02 108.791 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -92.06 -23.09 19.6 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.256 -0.902 . . . . 5.3200000000000003 110.565 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -149.14 163.81 36.52 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.142 -0.973 . . . . 0.02 109.911 -178.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 43.2 mt -132.57 129.39 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 107.811 -1.181 . . . . 2.1699999999999999 107.811 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.5 m80 -108.96 -12.07 14.91 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.364 -0.835 . . . . 0.02 112.466 -177.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.2 t -159.26 151.21 20.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.736 -1.228 . . . . 0.01 109.239 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 28.4 p -166.5 149.61 7.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.971 -1.08 . . . . 1.22 109.295 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.434 ' O ' ' OE1' ' A' ' 96' ' ' GLN . 3.7 tmtp? -119.69 108.99 15.12 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 122.298 1.047 . . . . 1.4099999999999999 109.422 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.4 t -114.71 127.84 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 107.673 -1.232 . . . . 0.01 107.673 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.2 t -130.67 94.88 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 107.378 -1.341 . . . . 1.98 107.378 177.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.644 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 22.5 tt0 -146.39 -74.61 0.21 Allowed 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 106.128 -1.804 . . . . 0.01 106.128 177.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 167.91 -65.69 0.19 Allowed Glycine 0 N--CA 1.484 1.841 0 N-CA-C 108.697 -1.761 . . . . 0.01 108.697 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.7 p -122.87 115.15 21.48 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.52 -0.988 . . . . 2.2999999999999998 110.508 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.644 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 8.3 m95 -126.57 148.18 49.78 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 107.338 -1.356 . . . . 0.01 107.338 178.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.437 HG21 HD13 ' A' ' 137' ' ' ILE . 14.2 mt -120.4 134.67 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 120.392 -1.443 . . . . 1.6899999999999999 110.343 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.401 ' HB3' HD12 ' A' ' 169' ' ' ILE . 66.0 m-85 -114.71 143.93 44.26 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.366 -1.346 . . . . 2.4900000000000002 107.366 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.541 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 8.4 m-85 -123.65 144.78 49.41 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.373 -0.829 . . . . 0.02 109.741 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -77.36 -28.17 52.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.569 -0.707 . . . . 0.02 112.046 -176.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 47.7 mt -114.86 151.92 45.93 Favored Pre-proline 0 N--CA 1.504 2.235 0 O-C-N 120.683 -1.26 . . . . 1.48 109.143 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -52.93 166.12 1.01 Allowed 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 120.737 0.958 . . . . 0.02 112.72 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 59.25 31.19 21.0 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.111 -0.949 . . . . 0.75 111.432 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 57.24 51.47 10.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.562 -0.711 . . . . 0.02 111.298 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 51.0 mtp180 -125.96 164.46 20.77 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.499 -0.751 . . . . 0.02 109.935 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.37 -165.31 32.5 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.312 -1.115 . . . . 0.02 110.312 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -69.48 142.99 53.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.617 -0.931 . . . . 0.02 109.109 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -115.11 149.01 38.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.801 -0.562 . . . . 0.02 109.77 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -124.97 135.68 53.03 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.653 -0.654 . . . . 0.01 109.284 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.9 tp -97.07 120.61 37.74 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.648 -1.282 . . . . 0.01 109.368 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.4 tp -100.38 150.18 22.88 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.291 -0.881 . . . . 0.01 109.013 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -104.17 -108.72 0.27 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.673 -0.642 . . . . 2.27 109.374 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -167.59 54.68 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.967 -1.083 . . . . 1.8400000000000001 109.839 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -113.76 -167.51 1.22 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.523 -0.736 . . . . 2.2799999999999998 109.268 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -106.14 105.45 15.49 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.879 -0.785 . . . . 0.01 108.879 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -99.41 115.83 30.17 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.354 -0.841 . . . . 0.01 110.018 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -92.33 -25.26 18.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.993 -1.067 . . . . 0.01 110.873 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -127.5 153.73 77.42 Favored Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 108.14 -1.059 . . . . 2.54 108.14 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -58.78 -40.47 72.29 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 CA-C-N 119.502 0.858 . . . . 0.69999999999999996 110.462 178.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 5.6 t -63.09 -22.96 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.716 -1.24 . . . . 0.85999999999999999 109.821 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -66.37 -16.35 64.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.556 -1.34 . . . . 0.02 110.076 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.539 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 18.9 t90 -100.31 10.68 40.87 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.424 -0.797 . . . . 0.02 109.03 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.42 8.52 87.49 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 120.208 -0.996 . . . . 0.02 111.902 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -98.51 141.3 31.54 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.056 -1.261 . . . . 0.02 110.154 -178.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -88.66 -13.08 40.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.63 -0.669 . . . . 0.58999999999999997 110.701 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 60.6 p -147.31 150.23 37.12 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 120.717 -1.239 . . . . 0.87 108.988 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -78.6 20.25 0.79 Allowed 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 120.816 1.011 . . . . 0.38 113.085 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.17 123.86 29.95 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.446 -1.409 . . . . 0.17999999999999999 111.78 -177.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.447 HD13 ' HA ' ' A' ' 169' ' ' ILE . 11.7 mm -151.5 127.63 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 107.03 -1.47 . . . . 3.9900000000000002 107.03 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -112.07 -16.6 13.02 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 121.078 -1.014 . . . . 5.1699999999999999 113.719 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 67.2 m -156.92 160.44 39.1 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 119.124 -2.235 . . . . 0.02 110.288 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.574 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 9.8 p90 -152.74 153.28 32.9 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.131 -0.981 . . . . 2.02 111.004 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -145.12 149.57 35.26 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.469 -0.769 . . . . 0.01 110.112 -179.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -88.52 144.1 26.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.603 -0.685 . . . . 0.01 109.416 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 8.2 mt -95.74 129.44 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.212 -0.93 . . . . 3.04 109.218 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.8 m -136.37 146.97 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.189 -0.944 . . . . 1.8899999999999999 109.589 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.337 -0.852 . . . . 4.8899999999999997 109.485 -179.854 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 84.5 p . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.46 -0.57 . . . . 5.2800000000000002 109.46 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -153.62 117.24 4.68 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.226 -0.921 . . . . 5.96 109.355 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 72.8 p -90.32 -139.51 0.15 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.399 -1.334 . . . . 2.2200000000000002 107.399 177.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.61 -176.66 46.88 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 117.45 -2.309 . . . . 0.81000000000000005 112.728 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -80.13 160.36 44.29 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.705 -1.358 . . . . 0.01 109.705 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -145.33 134.66 23.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.248 -1.148 . . . . 0.02 110.522 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.8 tt -129.55 139.71 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.097 -1.075 . . . . 0.02 108.097 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.524 ' OG ' ' NE ' ' A' ' 19' ' ' ARG . 1.7 t -121.99 130.19 53.1 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.336 -0.853 . . . . 0.39000000000000001 110.174 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.9 m-85 -110.61 140.37 45.01 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.919 -0.771 . . . . 0.02 108.919 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.577 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 1.9 m-85 -122.2 138.99 54.28 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.28 -0.888 . . . . 0.02 109.758 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -69.34 -27.79 65.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.075 -1.016 . . . . 0.029999999999999999 111.673 -178.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -114.0 169.16 9.21 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.956 -1.09 . . . . 0.029999999999999999 110.117 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -75.5 158.28 32.8 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.731 0.777 . . . . 0.029999999999999999 110.087 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.408 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 2.0 m-20 66.72 33.36 6.34 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.948 0.88 . . . . 0.73999999999999999 111.225 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.408 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 1.3 m-85 55.64 42.23 29.69 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.28 0.562 . . . . 0.02 111.555 177.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -113.79 165.6 12.4 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.216 -1.031 . . . . 0.02 108.216 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.46 -167.38 35.44 Favored Glycine 0 N--CA 1.494 2.504 0 C-N-CA 119.769 -1.205 . . . . 0.029999999999999999 111.023 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -68.62 141.75 55.32 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.473 -1.016 . . . . 2.7599999999999998 109.468 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.524 ' NE ' ' OG ' ' A' ' 8' ' ' SER . 54.4 ttt180 -121.09 149.16 43.16 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.609 -0.682 . . . . 1.8899999999999999 109.935 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -134.99 130.03 35.11 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 108.729 -0.841 . . . . 0.02 108.729 178.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 3.3 m-20 -110.64 136.08 50.28 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.471 -0.768 . . . . 1.1200000000000001 109.105 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.6 t -129.08 138.17 51.69 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.714 -0.616 . . . . 0.02 109.491 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -117.76 12.31 13.87 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.626 -0.671 . . . . 0.20000000000000001 110.282 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 44.4 t -159.45 174.29 14.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.949 -1.094 . . . . 1.23 108.777 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.466 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 3.3 p-10 -61.91 145.36 53.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.685 -1.26 . . . . 0.02 110.142 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.0 t -132.6 117.09 17.49 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.78 -0.822 . . . . 0.02 108.78 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.55 -23.31 50.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.308 -0.87 . . . . 0.23999999999999999 111.173 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -155.3 101.41 2.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.197 -0.939 . . . . 1.1399999999999999 108.779 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.489 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 21.2 p90 -108.02 9.65 28.44 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 122.059 0.933 . . . . 6.3700000000000001 110.504 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -59.58 -22.77 62.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.359 -0.838 . . . . 3.1099999999999999 110.663 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.0 m -74.71 -15.73 60.77 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.672 -1.267 . . . . 0.88 109.968 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -103.77 -21.32 13.7 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.587 -0.696 . . . . 0.02 109.396 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 33' ' ' LEU . 48.1 mt -149.8 129.64 13.33 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.915 0.864 . . . . 3.3199999999999998 109.519 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.4 p -85.86 -10.11 55.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.819 -0.551 . . . . 0.02 110.23 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -171.77 161.81 6.04 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.098 -1.075 . . . . 0.02 108.098 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 77.4 m -143.24 116.44 8.96 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.902 -1.124 . . . . 0.02 108.861 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.523 ' ND2' ' OD2' ' A' ' 77' ' ' ASP . 4.0 m120 -108.43 0.58 21.13 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 120.901 -1.125 . . . . 0.029999999999999999 111.429 -178.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.9 p -156.41 154.43 30.47 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.964 -1.124 . . . . 0.02 107.964 178.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.2 mt -146.81 147.77 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.188 -0.945 . . . . 0.02 110.357 -178.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -124.65 125.77 44.65 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.987 -1.116 . . . . 0.02 107.987 177.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.3 t -106.75 115.46 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 107.0 -1.481 . . . . 0.02 107.0 177.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -83.46 -33.95 25.51 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.652 -0.655 . . . . 3.8100000000000001 110.486 -178.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.94 152.21 21.97 Favored Glycine 0 N--CA 1.488 2.126 0 C-N-CA 118.917 -1.611 . . . . 0.02 110.834 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.67 173.08 49.5 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.505 -1.331 . . . . 0.01 110.374 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.5 m -119.22 134.9 54.95 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 107.844 -1.169 . . . . 1.48 107.844 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.407 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 38.1 m95 -127.54 155.52 43.65 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 122.499 1.142 . . . . 0.02 111.991 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.98 134.19 51.97 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 105.676 -1.972 . . . . 0.23999999999999999 105.676 176.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.48 ' HB ' HD22 ' A' ' 79' ' ' LEU . 27.4 m -117.76 143.06 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.629 -0.67 . . . . 0.65000000000000002 109.213 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -120.97 145.32 47.86 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 122.23 1.015 . . . . 0.02 110.064 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -66.32 -32.78 74.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.756 -0.59 . . . . 0.02 111.326 -177.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -125.12 157.61 66.51 Favored Pre-proline 0 N--CA 1.502 2.146 0 O-C-N 121.114 -0.991 . . . . 0.02 109.503 -178.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -53.12 167.1 0.79 Allowed 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 121.739 1.626 . . . . 0.02 112.915 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 63.34 36.57 11.53 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.407 -0.815 . . . . 0.02 110.99 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.476 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 2.3 m-85 44.92 51.6 8.55 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.535 0.683 . . . . 3.3900000000000001 110.565 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.0 p -125.97 163.68 22.47 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.207 0.527 . . . . 2.3300000000000001 110.016 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.56 -162.1 31.54 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.794 -1.323 . . . . 0.02 109.794 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.443 ' ND1' ' N ' ' A' ' 57' ' ' HIS . 4.1 m80 -64.15 138.04 58.25 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.957 -1.319 . . . . 0.02 109.938 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 17.2 ptm -118.59 136.9 53.61 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.317 0.58 . . . . 5.0099999999999998 109.643 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.576 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 84.5 m-85 -134.3 139.39 45.66 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 121.62 0.724 . . . . 0.02 109.702 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.5 mm -94.94 131.32 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.768 -0.827 . . . . 1.72 108.768 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.526 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.17 110.51 36.12 Favored Pre-proline 0 N--CA 1.505 2.282 0 O-C-N 121.386 -0.821 . . . . 0.02 110.693 -178.29 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -77.24 168.86 22.37 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 CA-C-N 119.958 1.021 . . . . 1.47 109.997 177.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -53.33 141.16 24.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.626 -1.296 . . . . 4.25 110.415 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.57 -177.71 32.57 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.558 -1.306 . . . . 0.02 110.571 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -120.04 131.14 55.01 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.537 -0.978 . . . . 0.95999999999999996 109.656 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.526 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 48.7 m-85 -123.11 94.37 47.18 Favored Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 108.371 -0.974 . . . . 0.02 108.371 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -65.95 -3.04 7.61 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.027 1.152 . . . . 0.02 114.11 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -157.53 155.83 30.95 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.55 -1.343 . . . . 2.02 108.589 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -60.78 -39.41 88.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.484 -0.76 . . . . 0.02 112.21 -177.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -59.86 -23.63 63.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.969 -1.082 . . . . 0.02 110.324 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -70.72 -18.36 62.8 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.833 0.825 . . . . 3.4199999999999999 108.858 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.576 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.1 t90 -108.07 10.42 28.16 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.29 -1.374 . . . . 0.02 107.29 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.445 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 2.6 mpt? 59.82 23.63 12.6 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.495 0.664 . . . . 0.02 110.535 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.54 144.89 45.55 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.377 -1.489 . . . . 0.02 109.377 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.3 tp -79.92 -31.05 40.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.119 -1.224 . . . . 0.97999999999999998 107.701 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -157.47 -172.06 3.83 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 106.312 -1.736 . . . . 0.02 106.312 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.523 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 54.0 m-20 -97.9 27.52 4.44 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.705 -1.247 . . . . 0.02 110.674 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -95.98 121.62 37.92 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.879 -1.138 . . . . 3.2000000000000002 110.561 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.489 ' O ' ' CZ ' ' A' ' 29' ' ' PHE . 27.5 mt -144.47 121.17 11.18 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 107.735 -1.209 . . . . 2.6099999999999999 107.735 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -111.99 -15.97 9.53 Favored Glycine 0 N--CA 1.507 3.402 0 O-C-N 121.152 -0.968 . . . . 0.02 113.087 -177.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.476 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 37.3 t -156.42 156.68 34.24 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 119.862 1.831 . . . . 0.02 110.921 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 20.0 p -145.92 148.29 32.65 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.635 -0.666 . . . . 0.02 110.108 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -137.81 142.91 40.81 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.386 -0.821 . . . . 0.01 109.396 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.85 131.99 36.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.42999999999999999 109.767 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 t -91.11 125.47 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.843 -0.799 . . . . 1.25 108.843 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -93.13 132.32 37.37 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.764 -1.21 . . . . 1.77 108.826 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mt -98.56 140.33 32.95 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.3 -0.875 . . . . 1.6299999999999999 108.928 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 60.7 p -111.41 124.8 52.99 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.533 -0.914 . . . . 1.0800000000000001 108.533 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.4 m -116.35 133.0 56.51 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.697 -1.252 . . . . 1.26 107.924 177.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.11 -49.26 0.01 OUTLIER Glycine 0 N--CA 1.505 3.277 0 C-N-CA 117.707 -2.187 . . . . 0.01 113.724 -177.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -167.57 -105.76 0.19 Allowed Glycine 0 N--CA 1.49 2.25 0 CA-C-N 119.962 1.881 . . . . 0.01 111.213 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -120.11 117.89 29.14 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.97 -1.312 . . . . 4.4299999999999997 110.306 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.38 129.92 35.53 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.684 -0.806 . . . . 2.9900000000000002 109.392 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -131.03 140.79 50.14 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.545 -0.722 . . . . 6.3600000000000003 109.178 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.9 tt -129.31 146.07 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.322 -0.861 . . . . 1.0900000000000001 110.211 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -121.24 133.7 55.16 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.559 -1.274 . . . . 2.0499999999999998 107.559 177.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.2 m -124.34 145.98 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 120.965 -1.084 . . . . 1.1000000000000001 109.783 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -119.13 141.61 48.65 Favored 'General case' 0 N--CA 1.503 2.205 0 CA-C-O 122.124 0.964 . . . . 0.72999999999999998 111.092 -178.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -66.63 -30.31 70.55 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 115.87 -0.605 . . . . 0.02 111.908 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -116.53 167.65 10.87 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.004 -1.06 . . . . 3.1800000000000002 110.494 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.71 163.9 43.21 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 111.01 -0.836 . . . . 0.01 111.01 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 102' ' ' ASP . 2.3 m-20 57.09 38.73 29.28 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.808 0.813 . . . . 0.01 110.823 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.407 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 15.2 m-85 52.3 55.75 8.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.571 -0.705 . . . . 0.01 111.045 178.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -128.06 165.81 19.62 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 108.425 -0.954 . . . . 3.1499999999999999 108.425 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.4 -163.95 27.86 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.235 -1.546 . . . . 0.01 109.235 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -75.31 144.64 42.32 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.993 -1.298 . . . . 0.01 108.527 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.45 ' C ' ' SD ' ' A' ' 107' ' ' MET . 10.8 tmm? -116.59 142.33 47.03 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.569 0.7 . . . . 0.01 109.865 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -131.97 136.3 47.21 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.259 -1.015 . . . . 2.48 108.259 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.519 ' OE2' ' N ' ' A' ' 110' ' ' THR . 1.9 tm-20 -118.94 134.88 54.89 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.575 -0.703 . . . . 0.01 109.931 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.519 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 3.0 t -148.55 150.71 33.83 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 122.27 1.033 . . . . 1.6899999999999999 111.166 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 65.8 p -112.0 9.3 20.42 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 115.581 -0.736 . . . . 0.01 110.41 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -121.06 162.93 19.16 Favored 'General case' 0 N--CA 1.508 2.452 0 O-C-N 121.201 -0.937 . . . . 3.21 111.762 -178.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -67.97 156.62 36.89 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.266 -1.013 . . . . 0.01 108.266 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 30.6 t -127.12 114.84 21.79 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.556 -0.715 . . . . 0.01 109.196 178.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -75.08 -28.9 8.65 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 CA-C-N 120.396 1.177 . . . . 0.01 111.0 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 56.0 m -142.88 109.07 5.25 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.389 -0.819 . . . . 0.02 109.224 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.17 -38.77 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.832 -0.542 . . . . 1.8300000000000001 110.627 -178.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.5 ttp -68.89 -37.23 78.88 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.164 -1.014 . . . . 1.3400000000000001 110.259 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -69.53 -38.8 77.66 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 120.352 -1.468 . . . . 2.1099999999999999 110.058 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.541 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 41.2 tt0 -79.99 -46.47 16.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.392 -0.817 . . . . 2.0800000000000001 112.227 -177.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.541 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 33.8 m-85 -110.62 0.14 17.44 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.364 -0.835 . . . . 0.02 112.573 -176.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 59.63 33.22 21.92 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.644 -1.285 . . . . 0.02 109.404 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.0 mt -112.52 135.57 53.08 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 108.716 -0.846 . . . . 0.02 108.716 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -91.39 -22.53 20.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.155 -0.966 . . . . 5.3200000000000003 110.361 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -149.64 164.02 36.32 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.136 -0.978 . . . . 0.02 109.833 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.6 mt -131.83 128.61 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 107.557 -1.275 . . . . 2.1699999999999999 107.557 178.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.513 ' N ' ' ND1' ' A' ' 127' ' ' HIS . 1.8 m80 -107.93 -12.44 15.17 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.496 -0.753 . . . . 0.02 112.293 -177.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.407 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 7.0 t -159.92 152.12 20.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.015 -1.053 . . . . 0.01 109.05 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 6.3 p -169.98 145.17 2.86 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.183 -0.948 . . . . 1.22 109.016 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.6 tttp -125.74 111.58 15.08 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 122.452 1.12 . . . . 1.4099999999999999 110.172 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 131' ' ' VAL . 11.2 p -111.86 136.5 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.282 -1.377 . . . . 0.01 107.282 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 44.5 t -128.32 93.53 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 N-CA-C 106.865 -1.532 . . . . 1.98 106.865 177.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -146.33 -81.26 0.15 Allowed 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 105.911 -1.885 . . . . 0.01 105.911 178.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -178.91 -79.13 0.06 OUTLIER Glycine 0 N--CA 1.486 1.985 0 N-CA-C 108.488 -1.845 . . . . 0.01 108.488 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.585 ' OG1' HD12 ' A' ' 175' ' ' ILE . 1.4 t -119.08 122.13 41.41 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.454 -1.027 . . . . 2.2999999999999998 110.068 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -125.75 150.74 47.49 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 106.847 -1.538 . . . . 0.01 106.847 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 82.6 mt -121.17 136.78 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 120.467 -1.396 . . . . 1.6899999999999999 110.166 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -115.59 144.88 43.25 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.625 -1.25 . . . . 2.4900000000000002 107.625 178.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.517 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 12.1 m-85 -123.4 144.09 49.71 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.436 -0.79 . . . . 0.02 109.666 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -74.74 -29.4 61.14 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.478 -0.764 . . . . 0.02 111.771 -176.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.5 mt -115.64 154.65 47.94 Favored Pre-proline 0 N--CA 1.505 2.29 0 O-C-N 120.706 -1.246 . . . . 1.48 108.939 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -55.64 167.31 2.18 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.131 1.221 . . . . 0.02 112.609 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.554 ' ND2' ' O ' ' A' ' 143' ' ' ASN . 1.7 t30 59.7 30.94 20.54 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.009 -0.996 . . . . 0.75 111.284 178.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 58.02 51.64 8.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.425 -0.797 . . . . 0.02 111.208 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -127.04 164.89 20.54 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.541 -0.725 . . . . 0.02 110.187 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.98 -165.81 33.36 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.385 -1.086 . . . . 0.02 110.385 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -69.1 142.5 54.44 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.558 -0.966 . . . . 0.02 109.027 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -113.99 148.52 36.79 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.554 0.692 . . . . 0.02 110.257 -177.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -125.09 134.34 52.53 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.01 -0.737 . . . . 0.01 109.01 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.496 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.9 tt -99.25 121.9 41.69 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.92 -1.113 . . . . 0.01 109.221 -179.044 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.642 HD23 ' N ' ' A' ' 152' ' ' ASP . 1.6 tt -98.35 140.98 31.82 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.587 -0.894 . . . . 0.01 108.587 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.642 ' N ' HD23 ' A' ' 151' ' ' LEU . 1.3 m-20 -103.39 -108.32 0.26 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.313 -0.867 . . . . 2.27 109.967 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.417 ' HZ2' ' HB3' ' A' ' 153' ' ' LYS . 14.2 ttpp -153.27 52.47 0.73 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.939 -1.1 . . . . 1.8400000000000001 109.611 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -115.25 175.58 5.45 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.374 -0.829 . . . . 2.2799999999999998 109.087 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -102.94 111.72 24.18 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.237 -0.914 . . . . 0.01 108.644 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.51 ' N ' ' CD1' ' A' ' 156' ' ' TYR . 16.1 m-85 -99.76 115.6 29.9 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.373 -0.829 . . . . 0.01 110.506 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -92.82 -24.91 18.35 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.927 -1.108 . . . . 0.01 110.633 -178.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -127.82 154.04 78.05 Favored Pre-proline 0 N--CA 1.499 2.018 0 N-CA-C 108.139 -1.06 . . . . 2.54 108.139 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -58.86 -40.31 73.28 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 CA-C-N 119.416 0.827 . . . . 0.69999999999999996 110.518 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 51.1 t -62.14 -23.02 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.887 -1.133 . . . . 0.85999999999999999 109.594 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -66.54 -16.22 63.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.588 -1.32 . . . . 0.02 109.824 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.572 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 12.5 t90 -99.66 9.53 42.96 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.648 -0.871 . . . . 0.02 108.648 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 78.57 8.4 87.66 Favored Glycine 0 N--CA 1.492 2.373 0 O-C-N 120.904 -1.122 . . . . 0.02 111.512 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -98.23 141.61 30.93 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.231 -1.158 . . . . 0.02 109.973 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -87.27 -12.35 46.9 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.796 -0.565 . . . . 0.58999999999999997 110.439 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.9 m -147.22 149.99 36.66 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 120.713 -1.242 . . . . 0.87 108.758 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -78.17 22.46 0.62 Allowed 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 120.807 1.005 . . . . 0.38 112.98 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.841 ' O ' HD13 ' A' ' 169' ' ' ILE . . . -83.6 123.18 29.52 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.618 -1.301 . . . . 0.17999999999999999 111.812 -177.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.841 HD13 ' O ' ' A' ' 168' ' ' ALA . 5.4 mm -147.75 128.9 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 106.975 -1.491 . . . . 3.9900000000000002 106.975 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -112.64 -17.83 12.51 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 120.95 -1.094 . . . . 5.1699999999999999 113.497 -177.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 20.1 t -157.36 160.52 38.55 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 119.108 -2.245 . . . . 0.02 110.265 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.441 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 16.0 p90 -151.8 152.83 33.17 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.075 -1.015 . . . . 2.02 110.937 179.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -145.31 149.78 35.45 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.832 0.825 . . . . 0.01 110.119 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -88.77 145.5 25.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.732 -0.605 . . . . 0.01 109.403 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.585 HD12 ' OG1' ' A' ' 135' ' ' THR . 6.1 mt -95.29 128.79 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.316 -0.865 . . . . 3.04 109.169 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 20.1 t -136.09 145.84 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.114 -0.991 . . . . 1.8899999999999999 109.47 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.273 -0.892 . . . . 4.8899999999999997 109.376 -179.978 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.463 -0.569 . . . . 5.2800000000000002 109.463 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -66.0 116.41 7.09 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.301 -0.875 . . . . 5.96 109.449 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 30.5 p -89.57 -139.89 0.14 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.303 -1.369 . . . . 2.2200000000000002 107.303 177.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.2 -176.78 46.59 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 117.41 -2.328 . . . . 0.81000000000000005 112.679 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -80.04 160.11 44.2 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.555 -1.418 . . . . 0.01 109.555 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -145.55 135.4 23.54 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.233 -1.157 . . . . 0.02 110.436 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.6 tt -129.67 139.04 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.204 -1.036 . . . . 0.02 108.204 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.9 m -121.28 129.81 53.33 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.348 -0.845 . . . . 0.39000000000000001 110.141 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 8.0 m-85 -110.06 140.29 44.27 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.672 -0.862 . . . . 0.02 108.672 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.556 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.3 m-85 -122.04 138.6 54.38 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.202 -0.936 . . . . 0.02 109.538 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.489 ' HG3' HD11 ' A' ' 33' ' ' LEU . 87.5 mt-10 -69.02 -27.6 65.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.012 -1.055 . . . . 0.029999999999999999 111.44 -178.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -114.29 169.26 9.17 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.787 -1.196 . . . . 0.029999999999999999 110.161 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -75.68 158.84 31.81 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.736 0.779 . . . . 0.029999999999999999 110.207 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.7 t30 65.9 33.49 7.89 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.992 0.901 . . . . 0.73999999999999999 111.21 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 55.33 41.87 30.78 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.195 0.522 . . . . 0.02 111.341 178.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -113.6 166.08 11.88 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.232 -1.025 . . . . 0.02 108.232 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.73 -167.34 36.67 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.773 -1.203 . . . . 0.029999999999999999 110.783 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -69.06 141.6 54.74 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.613 -0.934 . . . . 2.7599999999999998 109.407 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -120.57 149.28 42.7 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.575 -0.703 . . . . 1.8899999999999999 110.165 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -132.69 127.67 35.3 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.271 -1.011 . . . . 0.02 108.271 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -112.85 137.3 51.4 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.479 -0.763 . . . . 1.1200000000000001 109.765 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.6 t -131.29 139.04 49.52 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.628 -0.67 . . . . 0.02 109.642 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.489 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 19.0 t70 -116.61 10.92 14.56 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.593 -0.692 . . . . 0.20000000000000001 109.925 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 40.4 m -158.24 174.34 15.31 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.245 -1.02 . . . . 1.23 108.245 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 11.9 p-10 -60.66 144.31 52.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.541 -1.349 . . . . 0.02 109.848 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.1 t -131.83 117.61 18.77 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.559 -0.904 . . . . 0.02 108.559 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.94 -25.06 48.05 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.239 -0.913 . . . . 0.23999999999999999 110.841 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -155.08 101.72 2.27 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.061 -1.024 . . . . 1.1399999999999999 109.021 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.401 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 24.0 p90 -105.25 9.56 33.96 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 122.157 0.98 . . . . 6.3700000000000001 109.84 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -58.5 -23.75 58.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.448 -0.782 . . . . 3.1099999999999999 110.873 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.8 m -74.55 -16.77 60.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.641 -1.287 . . . . 0.88 110.174 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -104.12 -21.98 13.49 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.499 -0.751 . . . . 0.02 109.6 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.489 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.8 tp -150.58 129.15 12.24 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.11 -0.994 . . . . 3.3199999999999998 109.157 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.7 m -85.38 -9.94 56.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.831 -0.543 . . . . 0.02 111.06 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -171.45 162.9 6.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.847 -1.158 . . . . 0.02 107.931 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.4 p -143.21 115.16 8.28 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.789 -1.194 . . . . 0.02 108.905 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -107.21 1.94 24.37 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.759 -1.213 . . . . 0.029999999999999999 110.875 -178.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.6 t -156.23 154.37 30.63 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.749 -1.204 . . . . 0.02 107.749 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.8 mt -146.66 147.61 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 120.959 -1.088 . . . . 0.02 110.362 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -124.58 125.06 43.55 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.083 -1.08 . . . . 0.02 108.083 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.8 t -106.87 115.12 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 107.147 -1.427 . . . . 0.02 107.147 177.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -83.52 -33.9 25.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.528 -0.732 . . . . 3.8100000000000001 110.906 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.15 152.35 22.11 Favored Glycine 0 N--CA 1.487 2.037 0 C-N-CA 118.919 -1.61 . . . . 0.02 110.937 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.45 173.13 49.5 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.577 -1.297 . . . . 0.01 110.418 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.5 m -119.23 134.97 54.91 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.827 -1.175 . . . . 1.48 107.827 178.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.425 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 35.0 m95 -126.8 155.22 43.21 Favored 'General case' 0 N--CA 1.504 2.234 0 CA-C-O 122.506 1.146 . . . . 0.02 112.08 -176.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.52 133.89 52.56 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 105.724 -1.954 . . . . 0.23999999999999999 105.724 176.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.521 ' HB ' HD22 ' A' ' 79' ' ' LEU . 26.8 m -118.09 142.92 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 109.009 -0.737 . . . . 0.65000000000000002 109.009 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -121.39 146.28 47.04 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 122.325 1.06 . . . . 0.02 110.155 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.575 ' OE2' ' ND2' ' A' ' 76' ' ' ASN . 7.6 tp10 -66.31 -35.08 79.46 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.548 -0.751 . . . . 0.02 111.185 -177.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 -125.44 157.77 66.78 Favored Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 121.126 -0.983 . . . . 0.02 109.529 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -53.61 167.17 1.03 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.761 1.641 . . . . 0.02 112.992 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 53' ' ' ASN . 1.1 t30 63.57 36.52 10.99 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.027 -0.988 . . . . 0.02 111.191 178.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 45.28 51.82 9.12 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.621 0.724 . . . . 3.3900000000000001 110.572 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 88.2 p -126.1 163.61 22.72 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 121.223 0.535 . . . . 2.3300000000000001 109.755 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.88 -161.92 32.32 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.708 -1.357 . . . . 0.02 109.708 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -66.7 139.23 57.83 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.015 -1.285 . . . . 0.02 110.281 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 14.3 ptm -118.64 137.98 52.91 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.598 -0.689 . . . . 5.0099999999999998 109.758 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.462 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 59.4 m-85 -133.25 137.84 46.23 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.506 -0.746 . . . . 0.02 109.836 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.7 mm -94.98 131.12 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.846 -0.798 . . . . 1.72 108.846 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.56 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.19 110.94 35.67 Favored Pre-proline 0 N--CA 1.505 2.297 0 O-C-N 121.452 -0.78 . . . . 0.02 110.748 -178.233 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -77.74 168.37 22.5 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 CA-C-N 119.958 1.021 . . . . 1.47 110.115 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.89 141.28 28.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.822 -1.174 . . . . 4.25 110.489 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.26 -177.81 32.26 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 119.535 -1.316 . . . . 0.02 110.567 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -119.41 131.13 55.6 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.527 -0.984 . . . . 0.95999999999999996 109.766 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.56 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 70.6 m-85 -122.05 96.26 46.79 Favored Pre-proline 0 N--CA 1.494 1.737 0 N-CA-C 108.162 -1.051 . . . . 0.02 108.162 178.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.401 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.6 Cg_endo -67.41 -3.77 10.66 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 120.77 0.98 . . . . 0.02 113.734 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.401 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 34.2 mt-10 -157.55 155.19 29.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.592 -1.317 . . . . 2.02 108.132 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -60.48 -38.92 85.8 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.622 -0.674 . . . . 0.02 112.11 -177.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -60.49 -23.83 64.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.042 -1.036 . . . . 0.02 110.366 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -69.46 -18.95 63.76 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.427 -0.796 . . . . 3.4199999999999999 108.992 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.553 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 1.1 t90 -108.3 11.09 27.49 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.403 -1.332 . . . . 0.02 107.403 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.5 mtt 60.88 22.21 12.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.47 -0.769 . . . . 0.02 110.215 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.11 145.11 46.6 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.169 -1.572 . . . . 0.02 109.169 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.551 HD23 ' O ' ' A' ' 75' ' ' LEU . 1.0 OUTLIER -79.62 -31.03 41.6 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.66 -1.237 . . . . 0.97999999999999998 107.66 178.114 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.575 ' ND2' ' OE2' ' A' ' 50' ' ' GLU . 13.2 p30 -157.16 -171.45 3.63 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 106.525 -1.657 . . . . 0.02 106.525 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -98.86 28.6 4.23 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.85 -1.156 . . . . 0.02 110.425 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -98.47 123.37 42.57 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.152 -0.967 . . . . 3.2000000000000002 111.183 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.521 HD22 ' HB ' ' A' ' 48' ' ' VAL . 36.1 mt -145.03 122.33 11.57 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.518 -1.29 . . . . 2.6099999999999999 107.518 177.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.99 -16.44 11.43 Favored Glycine 0 N--CA 1.504 3.173 0 O-C-N 121.132 -0.98 . . . . 0.02 112.695 -177.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.6 t -156.96 155.97 32.22 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.242 -1.74 . . . . 0.02 110.304 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.5 p -145.28 147.85 32.81 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.503 -0.748 . . . . 0.02 110.332 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.0 mtm180 -137.7 143.0 41.05 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.278 -0.889 . . . . 0.01 109.36 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.52 132.16 36.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.127 -0.983 . . . . 0.42999999999999999 109.76 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.4 t -91.06 125.03 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.782 -0.821 . . . . 1.25 108.782 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -94.6 131.18 40.63 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.82 -1.175 . . . . 1.77 109.16 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -94.87 139.62 31.06 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.196 -0.94 . . . . 1.6299999999999999 108.508 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.7 t -110.66 127.87 55.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.388 -0.82 . . . . 1.0800000000000001 109.108 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 95.5 p -104.52 -154.32 0.5 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 106.547 -1.649 . . . . 1.26 106.547 177.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.55 -53.1 0.74 Allowed Glycine 0 N--CA 1.5 2.9 0 O-C-N 120.553 -1.342 . . . . 0.01 112.762 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.46 -101.5 0.15 Allowed Glycine 0 N--CA 1.489 2.168 0 C-N-CA 118.603 -1.76 . . . . 0.01 111.978 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -122.39 119.56 31.4 Favored 'General case' 0 N--CA 1.506 2.343 0 CA-C-N 118.666 1.233 . . . . 4.4299999999999997 110.757 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.36 130.82 35.8 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.762 -0.775 . . . . 2.9900000000000002 109.483 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -129.62 141.85 50.86 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.377 -0.827 . . . . 6.3600000000000003 109.229 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.9 tt -128.3 144.73 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 O-C-N 121.35 -0.844 . . . . 1.0900000000000001 110.123 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -122.5 133.39 54.59 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.501 -1.296 . . . . 2.0499999999999998 107.501 177.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.9 m -124.56 146.36 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 O-C-N 120.628 -1.295 . . . . 1.1000000000000001 109.884 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -120.04 141.85 49.38 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 122.013 0.911 . . . . 0.72999999999999998 111.129 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -67.28 -30.82 70.8 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 116.03 -0.532 . . . . 0.02 111.908 -178.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -115.98 167.47 10.93 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.938 -1.101 . . . . 3.1800000000000002 110.384 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.15 164.26 44.28 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.974 -0.851 . . . . 0.01 110.974 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 57.08 38.77 29.33 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.701 0.762 . . . . 0.01 110.935 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 52.44 55.97 8.36 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.467 -0.77 . . . . 0.01 110.991 178.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -129.14 165.77 20.63 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.238 -1.023 . . . . 3.1499999999999999 108.238 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.57 -163.73 27.52 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.244 -1.542 . . . . 0.01 109.244 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -75.7 144.41 41.57 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.05 -1.265 . . . . 0.01 108.543 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.452 ' C ' ' SD ' ' A' ' 107' ' ' MET . 12.8 tmm? -116.56 142.33 47.02 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.623 0.725 . . . . 0.01 109.831 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -131.88 135.7 46.86 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.255 -1.017 . . . . 2.48 108.255 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.519 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.1 tm-20 -118.55 134.11 55.34 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.584 -0.698 . . . . 0.01 110.033 -178.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.519 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 6.0 t -148.17 150.74 34.34 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.278 1.037 . . . . 1.6899999999999999 111.072 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 72.9 p -110.85 9.68 22.47 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 115.498 -0.774 . . . . 0.01 110.227 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -120.86 162.74 19.31 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.234 -0.916 . . . . 3.21 111.563 -178.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -68.59 157.54 35.87 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.392 -0.966 . . . . 0.01 108.392 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 19.2 t -127.36 113.43 21.32 Favored Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 121.491 -0.756 . . . . 0.01 109.072 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -75.25 -28.09 9.06 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 CA-C-N 120.315 1.148 . . . . 0.01 111.02 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.8 t -142.38 109.08 5.38 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.363 -0.836 . . . . 0.02 109.088 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 98.0 mt -63.63 -39.31 84.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.824 -0.547 . . . . 1.8300000000000001 110.76 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 15.3 ttt -68.85 -38.16 79.6 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.246 -0.982 . . . . 1.3400000000000001 110.372 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -69.26 -38.48 78.43 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.528 -1.358 . . . . 2.1099999999999999 109.872 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -79.98 -47.02 15.62 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.219 -0.925 . . . . 2.0800000000000001 112.331 -177.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.443 ' C ' ' ND1' ' A' ' 122' ' ' HIS . 54.3 m-85 -110.94 0.23 17.01 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.251 -0.905 . . . . 0.02 112.653 -176.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.443 ' ND1' ' C ' ' A' ' 121' ' ' PHE . 5.3 m80 60.14 33.34 21.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.753 -1.217 . . . . 0.02 109.407 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.9 mt -112.46 135.36 53.25 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 108.791 -0.818 . . . . 0.02 108.791 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -91.47 -22.82 20.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.233 -0.917 . . . . 5.3200000000000003 110.174 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -149.29 164.1 35.8 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.216 -0.928 . . . . 0.02 109.899 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 31.9 mt -131.78 128.7 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 N-CA-C 107.854 -1.165 . . . . 2.1699999999999999 107.854 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -108.5 -12.88 14.94 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.286 -0.884 . . . . 0.02 112.256 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.5 m -159.4 150.75 20.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.992 -1.067 . . . . 0.01 108.937 178.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 24.9 p -168.95 147.63 3.98 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.356 -0.84 . . . . 1.22 108.782 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -121.3 111.39 17.29 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 122.542 1.163 . . . . 1.4099999999999999 109.845 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.47 129.78 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.472 -1.307 . . . . 0.01 107.472 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.7 t -129.52 93.57 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 107.328 -1.36 . . . . 1.98 107.328 177.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.488 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 11.0 tm-20 -147.41 -75.55 0.19 Allowed 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 105.914 -1.884 . . . . 0.01 105.914 177.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.438 ' N ' ' OE1' ' A' ' 133' ' ' GLU . . . 171.06 -71.81 0.11 Allowed Glycine 0 N--CA 1.483 1.813 0 N-CA-C 108.601 -1.8 . . . . 0.01 108.601 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.418 ' OG1' HD12 ' A' ' 175' ' ' ILE . 16.5 p -119.56 115.82 24.79 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.604 -0.939 . . . . 2.2999999999999998 110.24 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.488 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 6.4 m95 -126.33 149.71 49.0 Favored 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 106.677 -1.601 . . . . 0.01 106.677 178.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 81.3 mt -122.51 137.72 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 120.377 -1.452 . . . . 1.6899999999999999 110.586 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -114.48 143.95 44.12 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.221 -1.4 . . . . 2.4900000000000002 107.221 178.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.516 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 10.6 m-85 -123.18 143.87 49.73 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.241 -0.912 . . . . 0.02 109.521 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -74.32 -29.99 61.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.715 -0.616 . . . . 0.02 111.754 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.5 mt -116.76 153.97 49.33 Favored Pre-proline 0 N--CA 1.504 2.261 0 O-C-N 120.877 -1.14 . . . . 1.48 108.856 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.46 169.49 0.74 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.281 1.32 . . . . 0.02 113.122 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 21.8 m120 57.61 32.31 21.66 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.046 -0.979 . . . . 0.75 111.511 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 55.83 48.36 18.31 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.551 -0.718 . . . . 0.02 110.908 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -122.6 163.92 19.14 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.505 -0.747 . . . . 0.02 109.914 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.23 -165.85 33.06 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.361 -1.096 . . . . 0.02 110.361 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.477 ' CZ ' ' OH ' ' A' ' 149' ' ' TYR . 17.9 ttp180 -69.26 142.71 54.08 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.523 -0.987 . . . . 0.02 109.244 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -114.62 148.36 38.23 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.368 0.604 . . . . 0.02 110.261 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.477 ' OH ' ' CZ ' ' A' ' 147' ' ' ARG . 67.4 m-85 -125.07 135.19 52.48 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.871 -0.788 . . . . 0.01 108.871 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.516 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.4 tt -99.73 122.18 42.34 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.919 -1.113 . . . . 0.01 109.12 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.642 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 32.9 tp -96.75 146.45 24.87 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.101 -1.0 . . . . 0.01 108.736 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -104.31 -130.65 0.27 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.422 -0.799 . . . . 2.27 110.215 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -133.78 52.0 2.1 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.398 -0.814 . . . . 1.8400000000000001 109.654 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -116.24 -169.52 1.63 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.463 -0.773 . . . . 2.2799999999999998 109.473 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -105.49 108.39 19.88 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.335 -0.987 . . . . 0.01 108.335 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.642 ' CZ ' HD11 ' A' ' 151' ' ' LEU . 6.0 m-85 -99.42 111.78 24.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.343 -0.848 . . . . 0.01 110.522 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -96.34 -22.03 17.44 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.294 -0.879 . . . . 0.01 111.412 -178.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -127.4 154.36 77.26 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 121.018 -1.051 . . . . 2.54 108.845 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -59.52 -38.76 80.92 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 CA-C-N 119.261 0.772 . . . . 0.69999999999999996 110.538 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 41.0 t -60.71 -20.18 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.901 -1.124 . . . . 0.85999999999999999 109.014 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -65.46 -15.67 62.87 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.91 -1.119 . . . . 0.02 110.022 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.628 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 10.0 m0 -98.11 10.96 39.22 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.148 -0.97 . . . . 0.02 108.842 178.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.42 11.39 84.24 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.839 -1.172 . . . . 0.02 111.079 178.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.23 140.63 34.19 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.137 -1.213 . . . . 0.02 110.191 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.18 -8.54 58.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.608 -0.682 . . . . 0.58999999999999997 110.271 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.8 t -143.42 150.38 51.19 Favored Pre-proline 0 N--CA 1.5 2.048 0 O-C-N 120.905 -1.122 . . . . 0.87 109.345 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -75.79 17.72 0.67 Allowed 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 120.771 0.98 . . . . 0.38 112.122 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.863 ' O ' HD13 ' A' ' 169' ' ' ILE . . . -82.84 122.89 28.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.883 -1.136 . . . . 0.17999999999999999 111.258 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.863 HD13 ' O ' ' A' ' 168' ' ' ALA . 4.6 mm -147.27 128.14 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 106.725 -1.583 . . . . 3.9900000000000002 106.725 178.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -111.22 -18.37 12.98 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.111 -0.993 . . . . 5.1699999999999999 113.115 -177.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 4.8 p -157.91 161.58 38.24 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 119.319 -2.113 . . . . 0.02 110.309 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.425 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 17.5 p90 -150.73 152.07 33.34 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.142 -0.974 . . . . 2.02 110.02 178.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -144.9 149.23 34.93 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.701 0.762 . . . . 0.01 109.758 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 18.4 ttm180 -87.9 144.06 26.78 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.67 -0.644 . . . . 0.01 109.503 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.418 HD12 ' OG1' ' A' ' 135' ' ' THR . 4.0 mt -94.27 128.84 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.249 -0.907 . . . . 3.04 109.045 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 25.6 m -136.34 146.79 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.061 -1.024 . . . . 1.8899999999999999 109.586 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.337 -0.852 . . . . 4.8899999999999997 109.438 -179.94 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.357 0.599 . . . . 5.2800000000000002 109.549 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt -71.34 -130.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.141 -0.974 . . . . 5.96 109.292 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 44.8 p -90.26 -141.76 0.16 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 107.466 -1.309 . . . . 2.2200000000000002 107.466 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.88 -175.28 45.9 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 117.49 -2.29 . . . . 0.81000000000000005 112.67 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.79 160.67 45.25 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.444 -1.462 . . . . 0.01 109.444 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -148.17 136.63 21.46 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.004 -1.292 . . . . 0.02 110.344 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.6 tt -130.73 140.86 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.906 -0.775 . . . . 0.02 108.906 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 m -121.42 130.4 53.56 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.499 -0.75 . . . . 0.39000000000000001 109.934 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.6 m-85 -109.92 138.88 45.67 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.496 -0.752 . . . . 0.02 109.224 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.534 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.5 m-85 -122.32 139.14 54.16 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.317 -0.865 . . . . 0.02 109.805 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -69.5 -28.3 65.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.139 -0.976 . . . . 0.029999999999999999 111.868 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -114.17 168.87 9.45 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.85 -1.156 . . . . 0.029999999999999999 110.18 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -74.94 158.52 33.17 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.683 0.754 . . . . 0.029999999999999999 109.938 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 66.52 33.52 6.63 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.953 0.882 . . . . 0.73999999999999999 111.217 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 55.56 42.51 29.58 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.241 0.543 . . . . 0.02 111.32 177.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -113.56 165.88 12.07 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.357 -0.979 . . . . 0.02 108.357 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.63 -167.5 35.26 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.825 -1.179 . . . . 0.029999999999999999 110.974 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -68.74 142.1 55.07 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.506 -0.997 . . . . 2.7599999999999998 109.314 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -121.59 149.9 42.47 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.551 -0.718 . . . . 1.8899999999999999 110.302 -178.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -134.72 129.28 34.47 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.662 -0.866 . . . . 0.02 108.662 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 15.9 p-10 -110.59 136.49 49.63 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.525 -0.734 . . . . 1.1200000000000001 109.156 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 14.2 t -129.33 137.88 51.25 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.483 0.659 . . . . 0.02 109.44 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -116.96 12.02 14.51 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.597 -0.689 . . . . 0.20000000000000001 109.753 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.444 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 42.3 t -159.44 174.24 15.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.052 -1.03 . . . . 1.23 108.559 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.419 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.4 p30 -61.03 144.16 53.95 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.715 -1.241 . . . . 0.02 110.006 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.8 t -131.85 116.96 17.89 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.576 -0.898 . . . . 0.02 108.576 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.53 -24.76 45.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.181 -0.95 . . . . 0.23999999999999999 111.31 -178.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -153.85 101.97 2.48 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.955 -1.09 . . . . 1.1399999999999999 109.113 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -104.5 9.31 35.55 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 122.148 0.975 . . . . 6.3700000000000001 109.839 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -58.99 -25.31 63.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.466 -0.771 . . . . 3.1099999999999999 111.17 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.0 p -74.28 -15.98 60.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.74 -1.225 . . . . 0.88 110.139 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -103.59 -21.81 13.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.46 -0.775 . . . . 0.02 109.741 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.5 mt -149.01 128.7 13.24 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.817 0.818 . . . . 3.3199999999999998 109.443 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 76.7 p -84.74 -9.71 57.94 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.322 0.582 . . . . 0.02 109.626 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -171.51 162.09 6.45 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.835 -1.172 . . . . 0.02 107.835 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.0 p -142.21 115.1 8.68 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.952 -1.093 . . . . 0.02 108.462 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.429 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 50.8 t-20 -106.92 -0.59 23.07 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 120.811 -1.181 . . . . 0.029999999999999999 111.649 -177.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 t -153.48 154.37 34.23 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.884 -1.154 . . . . 0.02 107.884 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 39' ' ' ILE . 10.5 mt -146.47 145.93 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.864 -1.147 . . . . 0.02 110.726 -178.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -124.97 125.73 44.36 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.044 -1.095 . . . . 0.02 108.044 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.0 t -104.93 113.71 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 106.727 -1.583 . . . . 0.02 106.727 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -84.92 -34.51 22.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.414 -0.804 . . . . 3.8100000000000001 110.266 -178.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.32 150.43 19.16 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 118.541 -1.79 . . . . 0.02 110.879 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.75 172.0 48.7 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.102 -1.199 . . . . 0.01 110.102 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.6 m -119.43 134.72 55.08 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.844 -1.169 . . . . 1.48 107.844 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.453 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 32.8 m95 -127.2 154.95 44.18 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 122.567 1.175 . . . . 0.02 112.339 -176.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.91 134.62 51.33 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 105.267 -2.123 . . . . 0.23999999999999999 105.267 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.436 ' HB ' HD22 ' A' ' 79' ' ' LEU . 35.2 m -116.5 141.42 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.589 -0.695 . . . . 0.65000000000000002 109.251 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -120.72 143.56 48.7 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 122.04 0.924 . . . . 0.02 109.655 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -65.51 -34.55 78.52 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.472 -0.786 . . . . 0.02 111.595 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -125.52 157.84 66.72 Favored Pre-proline 0 N--CA 1.504 2.229 0 O-C-N 120.985 -1.072 . . . . 0.02 109.45 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -53.71 167.54 0.98 Allowed 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.711 1.607 . . . . 0.02 112.992 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 63.22 36.59 11.82 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 115.191 -0.913 . . . . 0.02 111.136 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 45.03 51.92 8.58 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.671 0.748 . . . . 3.3900000000000001 110.674 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.9 t -125.94 163.66 22.5 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.183 0.516 . . . . 2.3300000000000001 109.811 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.99 -162.08 32.3 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.744 -1.342 . . . . 0.02 109.744 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -66.06 138.58 57.87 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.079 -1.248 . . . . 0.02 110.204 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 23.4 ptm -118.87 137.12 53.66 Favored 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.326 0.584 . . . . 5.0099999999999998 109.666 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.459 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 96.5 m-85 -134.04 139.33 45.93 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.484 -0.76 . . . . 0.02 109.735 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.3 mm -95.35 131.04 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 109.048 -0.723 . . . . 1.72 109.048 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.537 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -119.56 111.3 36.4 Favored Pre-proline 0 N--CA 1.506 2.329 0 O-C-N 121.417 -0.802 . . . . 0.02 110.732 -178.259 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -78.28 168.98 20.87 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 CA-C-N 119.859 0.985 . . . . 1.47 110.258 177.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -54.19 141.0 30.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.812 -1.18 . . . . 4.25 110.593 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.31 -177.67 32.38 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.548 -1.311 . . . . 0.02 110.604 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -119.95 131.67 55.27 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.534 -0.98 . . . . 0.95999999999999996 109.618 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.537 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 67.9 m-85 -120.4 95.86 49.04 Favored Pre-proline 0 N--CA 1.493 1.715 0 N-CA-C 108.144 -1.058 . . . . 0.02 108.144 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -68.29 -5.75 15.73 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 120.77 0.98 . . . . 0.02 113.394 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -156.74 154.08 29.43 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.653 -1.279 . . . . 2.02 107.705 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -60.04 -37.92 81.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.627 -0.671 . . . . 0.02 112.157 -177.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -59.8 -23.35 63.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.066 -1.021 . . . . 0.02 110.442 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -70.54 -19.21 62.91 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.822 0.82 . . . . 3.4199999999999999 109.053 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.543 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.8 t90 -108.01 9.84 28.41 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.672 -1.233 . . . . 0.02 107.672 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.2 mtt 61.14 22.57 12.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.588 -0.695 . . . . 0.02 110.622 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.67 143.89 46.4 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.526 -1.43 . . . . 0.02 109.526 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.2 mt -79.2 -30.86 43.55 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.525 -1.287 . . . . 0.97999999999999998 107.525 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.486 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 25.3 t-20 -157.33 -171.71 3.71 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 106.206 -1.775 . . . . 0.02 106.206 178.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.486 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 72.0 m-20 -98.71 28.62 4.15 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.65 -1.281 . . . . 0.02 110.633 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.4 ttp180 -96.66 122.08 39.2 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.827 -1.171 . . . . 3.2000000000000002 111.107 -178.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.436 HD22 ' HB ' ' A' ' 48' ' ' VAL . 66.2 mt -142.91 121.83 12.76 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.473 -1.306 . . . . 2.6099999999999999 107.473 178.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.6 -17.21 9.37 Favored Glycine 0 N--CA 1.502 3.082 0 O-C-N 121.15 -0.969 . . . . 0.02 112.894 -177.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.0 t -156.36 156.13 33.37 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.019 -1.871 . . . . 0.02 110.761 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.2 p -145.24 147.33 32.28 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.395 -0.816 . . . . 0.02 110.609 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 33.9 mtp180 -137.74 143.19 41.06 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.568 -0.707 . . . . 0.01 109.208 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.36 132.48 36.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.42999999999999999 109.724 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.2 t -91.64 125.35 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.056 -0.72 . . . . 1.25 109.056 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -93.51 131.78 38.42 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.752 -1.217 . . . . 1.77 108.835 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.4 mt -98.15 141.62 30.84 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.369 -0.832 . . . . 1.6299999999999999 109.147 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.1 m -111.78 124.86 53.24 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.547 -0.909 . . . . 1.0800000000000001 108.547 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.4 t -116.57 134.02 55.33 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.686 -1.259 . . . . 1.26 108.173 177.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.66 -48.13 0.01 OUTLIER Glycine 0 N--CA 1.505 3.245 0 C-N-CA 117.677 -2.201 . . . . 0.01 114.077 -177.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -168.0 -105.45 0.18 Allowed Glycine 0 N--CA 1.491 2.364 0 CA-C-N 120.336 2.068 . . . . 0.01 111.29 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -120.01 117.98 29.46 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.998 -1.295 . . . . 4.4299999999999997 110.391 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.56 129.93 35.37 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.74 -0.784 . . . . 2.9900000000000002 109.291 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -129.22 140.84 51.32 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.46 -0.775 . . . . 6.3600000000000003 109.158 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.409 HG22 ' O ' ' A' ' 110' ' ' THR . 3.9 tt -128.49 144.55 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.35 0 O-C-N 121.306 -0.871 . . . . 1.0900000000000001 110.215 -179.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -122.81 133.59 54.44 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.562 -1.273 . . . . 2.0499999999999998 107.562 177.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.0 m -124.53 146.15 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 120.679 -1.263 . . . . 1.1000000000000001 109.788 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.581 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 77.5 m-85 -118.67 141.56 48.49 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-O 121.99 0.9 . . . . 0.72999999999999998 111.11 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -67.73 -30.9 70.5 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 116.012 -0.54 . . . . 0.02 111.829 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -116.54 167.43 11.07 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.023 -1.048 . . . . 3.1800000000000002 110.413 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.403 ' CA ' ' ND1' ' A' ' 127' ' ' HIS . . . -66.68 164.07 42.89 Favored Glycine 0 N--CA 1.493 2.447 0 CA-C-O 121.989 0.771 . . . . 0.01 111.309 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.0 t70 56.45 39.13 30.11 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.647 0.737 . . . . 0.01 110.965 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 52.24 55.14 9.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.69 -0.631 . . . . 0.01 110.985 177.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -129.09 165.19 21.72 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.047 -1.094 . . . . 3.1499999999999999 108.047 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.53 -163.93 27.7 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.27 -1.532 . . . . 0.01 109.27 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -75.96 144.11 41.17 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.928 -1.336 . . . . 0.01 108.782 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.581 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 25.3 ttp -116.52 142.36 46.98 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.473 0.654 . . . . 0.01 109.928 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -131.12 136.34 48.28 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.231 -1.026 . . . . 2.48 108.231 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -117.74 134.15 55.2 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.666 -0.646 . . . . 0.01 110.127 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.409 ' O ' HG22 ' A' ' 95' ' ' ILE . 6.5 t -148.98 149.11 30.62 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.025 -1.047 . . . . 1.6899999999999999 111.087 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 37.4 p -111.04 9.64 22.09 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 115.505 -0.77 . . . . 0.01 110.349 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -120.82 163.12 18.65 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 121.234 -0.916 . . . . 3.21 111.56 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.69 156.92 35.78 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.318 -0.993 . . . . 0.01 108.318 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 20.6 t -127.55 113.8 21.03 Favored Pre-proline 0 N--CA 1.498 1.973 0 N-CA-C 108.846 -0.798 . . . . 0.01 108.846 178.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -75.01 -27.7 9.78 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 CA-C-N 120.389 1.175 . . . . 0.01 110.911 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.2 t -143.05 109.01 5.18 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.336 -0.853 . . . . 0.02 109.137 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.424 HD12 ' O ' ' A' ' 169' ' ' ILE . 87.1 mt -63.45 -39.24 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.892 -0.505 . . . . 1.8300000000000001 110.547 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 118' ' ' MET . 0.7 OUTLIER -68.73 -37.27 79.32 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.277 -0.969 . . . . 1.3400000000000001 110.365 -178.308 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -69.8 -38.66 76.72 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.4 -1.437 . . . . 2.1099999999999999 109.974 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -79.71 -46.54 16.89 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.291 -0.881 . . . . 2.0800000000000001 112.264 -177.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -111.05 0.49 16.95 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.312 -0.867 . . . . 0.02 112.674 -176.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 59.95 33.53 21.48 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.737 -1.227 . . . . 0.02 109.442 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.2 mt -112.62 135.38 53.41 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 108.713 -0.847 . . . . 0.02 108.713 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -91.25 -22.86 20.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.144 -0.972 . . . . 5.3200000000000003 110.246 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -149.62 164.33 35.46 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.241 -0.912 . . . . 0.02 109.791 -178.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.7 mt -131.74 128.64 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 107.65 -1.241 . . . . 2.1699999999999999 107.65 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.524 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 51.4 t-80 -107.97 -12.85 15.08 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.421 -0.799 . . . . 0.02 112.107 -177.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.4 m -159.15 150.62 20.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.004 -1.06 . . . . 0.01 109.018 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 6.0 p -169.39 148.45 3.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.39 -0.818 . . . . 1.22 109.045 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -122.96 113.4 19.03 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 122.396 1.093 . . . . 1.4099999999999999 110.102 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 t -112.09 129.86 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 107.351 -1.352 . . . . 0.01 107.351 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 96.3 t -129.61 93.9 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 107.392 -1.336 . . . . 1.98 107.392 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.504 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 3.5 tm-20 -146.97 -78.48 0.17 Allowed 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 105.87 -1.9 . . . . 0.01 105.87 177.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 173.24 -69.49 0.1 Allowed Glycine 0 N--CA 1.484 1.882 0 N-CA-C 108.77 -1.732 . . . . 0.01 108.77 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.9 p -120.51 114.04 21.19 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.587 -0.949 . . . . 2.2999999999999998 110.387 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.504 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 6.5 m95 -124.94 148.8 48.18 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 107.303 -1.369 . . . . 0.01 107.303 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.8 mt -121.58 136.46 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 120.452 -1.405 . . . . 1.6899999999999999 110.184 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -115.32 144.35 43.89 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.69 -1.226 . . . . 2.4900000000000002 107.69 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 8.9 m-85 -123.45 144.04 49.77 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.324 -0.86 . . . . 0.02 109.648 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -75.9 -28.95 58.28 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.698 -0.626 . . . . 0.02 111.881 -176.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 47.3 mt -114.64 151.37 45.25 Favored Pre-proline 0 N--CA 1.504 2.267 0 O-C-N 120.712 -1.242 . . . . 1.48 109.014 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -53.6 167.36 0.97 Allowed 'Trans proline' 0 N--CA 1.49 1.275 0 CA-C-O 122.555 0.981 . . . . 0.02 112.543 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 59.51 30.45 20.11 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 115.023 -0.99 . . . . 0.75 111.268 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.428 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.7 m-85 57.8 51.3 9.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.429 -0.794 . . . . 0.02 111.236 177.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -126.24 164.25 21.39 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.498 -0.751 . . . . 0.02 109.993 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.23 -165.25 32.64 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.352 -1.099 . . . . 0.02 110.352 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.465 ' CZ ' ' OH ' ' A' ' 149' ' ' TYR . 16.6 ttp180 -69.19 142.29 54.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.685 -0.891 . . . . 0.02 109.122 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -114.58 148.42 38.06 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.343 0.592 . . . . 0.02 110.134 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.465 ' OH ' ' CZ ' ' A' ' 147' ' ' ARG . 80.9 m-85 -124.07 134.3 53.43 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 109.019 -0.734 . . . . 0.01 109.019 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 151' ' ' LEU . 4.1 tt -98.51 121.55 40.59 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.852 -1.155 . . . . 0.01 108.86 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.596 HD11 ' CE1' ' A' ' 156' ' ' TYR . 42.5 tp -97.3 142.45 29.17 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.212 -0.93 . . . . 0.01 108.67 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -107.13 -113.3 0.28 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.612 -0.68 . . . . 2.27 109.662 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -149.04 57.28 1.02 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.129 -0.982 . . . . 1.8400000000000001 109.212 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -118.11 -179.31 3.73 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.386 -0.821 . . . . 2.2799999999999998 109.091 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -106.49 107.41 18.4 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.63 -0.878 . . . . 0.01 108.63 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.596 ' CE1' HD11 ' A' ' 151' ' ' LEU . 30.9 m-85 -98.78 113.44 25.55 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.29 -0.881 . . . . 0.01 110.328 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -93.51 -24.66 17.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.0 -1.062 . . . . 0.01 110.445 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -129.08 154.51 80.45 Favored Pre-proline 0 N--CA 1.498 1.974 0 N-CA-C 107.969 -1.123 . . . . 2.54 107.969 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -58.09 -38.62 90.87 Favored 'Trans proline' 0 N--CA 1.489 1.214 0 CA-C-N 119.467 0.845 . . . . 0.69999999999999996 110.245 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.2 t -63.77 -24.71 36.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.825 -1.172 . . . . 0.85999999999999999 109.586 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.06 -18.14 65.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.592 -1.317 . . . . 0.02 109.938 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.569 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 12.4 t90 -100.18 9.03 43.4 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.789 -1.189 . . . . 0.02 107.789 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.09 10.12 86.43 Favored Glycine 0 N--CA 1.485 1.96 0 C-N-CA 120.229 -0.986 . . . . 0.02 111.244 178.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.63 140.98 33.03 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.073 -1.251 . . . . 0.02 110.207 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -87.23 -11.85 48.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.627 -0.671 . . . . 0.58999999999999997 110.733 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 43.5 m -147.83 149.85 34.44 Favored Pre-proline 0 N--CA 1.499 1.994 0 O-C-N 120.547 -1.345 . . . . 0.87 108.895 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -78.1 22.86 0.6 Allowed 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 120.879 1.052 . . . . 0.38 112.872 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.854 ' O ' HD13 ' A' ' 169' ' ' ILE . . . -83.61 124.32 30.68 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.708 -1.245 . . . . 0.17999999999999999 111.784 -177.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.854 HD13 ' O ' ' A' ' 168' ' ' ALA . 4.8 mm -147.83 129.52 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 106.908 -1.516 . . . . 3.9900000000000002 106.908 178.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -112.58 -18.38 12.4 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 120.998 -1.064 . . . . 5.1699999999999999 113.475 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.4 p -157.21 161.0 39.26 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 119.36 -2.088 . . . . 0.02 110.117 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.418 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 19.8 p90 -152.27 152.4 32.12 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.051 -1.03 . . . . 2.02 110.809 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.428 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 26.0 mtp180 -144.49 149.92 36.75 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.38 -0.825 . . . . 0.01 110.155 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 60.4 mtm180 -87.76 144.1 26.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.535 -0.728 . . . . 0.01 109.363 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.2 mt -94.82 128.57 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.282 -0.886 . . . . 3.04 109.149 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.1 t -136.44 146.68 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.254 -0.903 . . . . 1.8899999999999999 109.65 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 4.8899999999999997 109.476 179.935 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.452 ' O ' ' O ' ' A' ' 2' ' ' LYS . 90.6 p . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.442 -0.577 . . . . 5.2800000000000002 109.442 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.523 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 3.1 mptp? 55.04 113.32 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.613 -0.68 . . . . 5.96 109.718 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.5 p -89.02 -139.37 0.13 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.19 -1.411 . . . . 2.2200000000000002 107.19 177.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.29 -175.81 46.06 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 117.406 -2.331 . . . . 0.81000000000000005 112.634 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.8 160.24 44.8 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.287 -1.525 . . . . 0.01 109.287 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -148.55 136.94 21.25 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.124 -1.221 . . . . 0.02 110.376 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 tt -130.66 140.55 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 109.073 -0.714 . . . . 0.02 109.073 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.1 m -121.78 130.82 53.69 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.4 -0.812 . . . . 0.39000000000000001 109.979 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.4 m-85 -110.6 140.54 44.82 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.624 -0.673 . . . . 0.02 109.38 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.516 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 5.1 m-85 -122.8 139.17 54.29 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.223 -0.923 . . . . 0.02 109.646 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.474 ' CG ' HD11 ' A' ' 33' ' ' LEU . 38.5 mt-10 -69.75 -27.77 65.21 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.167 -0.958 . . . . 0.029999999999999999 112.097 -178.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 2.9 m-20 -114.24 169.44 9.03 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.887 -1.133 . . . . 0.029999999999999999 110.225 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -75.04 157.81 34.22 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.69 0.757 . . . . 0.029999999999999999 109.982 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.2 t30 66.54 33.47 6.63 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.918 0.866 . . . . 0.73999999999999999 111.158 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 55.58 41.91 30.15 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.249 0.547 . . . . 0.02 111.413 177.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -112.86 165.75 12.02 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.244 -1.021 . . . . 0.02 108.244 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.48 -167.84 34.29 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.85 -1.167 . . . . 0.029999999999999999 110.677 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.579 ' CG ' HH11 ' A' ' 18' ' ' ARG . 0.3 OUTLIER -70.11 144.02 52.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.419 -1.047 . . . . 2.7599999999999998 108.999 179.453 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -120.2 148.63 43.43 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.559 -0.713 . . . . 1.8899999999999999 110.219 -178.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -131.99 127.31 35.99 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.221 -1.029 . . . . 0.02 108.221 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.46 136.9 51.4 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.42 -0.8 . . . . 1.1200000000000001 109.779 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.408 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 13.2 t -130.94 138.73 49.88 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.446 0.641 . . . . 0.02 109.654 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.3 p30 -116.77 11.23 14.48 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.631 -0.668 . . . . 0.20000000000000001 109.77 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.408 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 28.2 p -158.74 174.91 14.3 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.348 -0.982 . . . . 1.23 108.348 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -60.94 143.88 54.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.665 -1.272 . . . . 0.02 109.832 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 43.5 t -131.28 117.48 19.02 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.51 -0.922 . . . . 0.02 108.51 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.437 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -78.07 -25.08 47.52 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.045 -1.035 . . . . 0.23999999999999999 110.989 -178.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -155.1 102.38 2.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.025 -1.047 . . . . 1.1399999999999999 109.256 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -102.65 10.08 38.89 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 122.017 0.913 . . . . 6.3700000000000001 109.753 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -59.68 -25.41 64.73 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.532 -0.73 . . . . 3.1099999999999999 111.582 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.2 m -76.24 -17.15 59.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.522 -1.361 . . . . 0.88 110.609 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -104.06 -21.91 13.52 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.387 -0.82 . . . . 0.02 109.457 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.474 HD11 ' CG ' ' A' ' 11' ' ' GLU . 10.5 tp -149.92 128.56 12.36 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.328 -0.858 . . . . 3.3199999999999998 109.159 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.7 p -85.71 -10.96 54.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.642 -0.661 . . . . 0.02 111.069 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -171.72 162.3 6.23 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.927 -1.138 . . . . 0.02 107.927 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.2 p -141.48 113.95 8.24 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.987 -1.07 . . . . 0.02 108.452 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -105.17 0.17 27.1 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.767 -1.208 . . . . 0.029999999999999999 110.964 -178.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 m -154.44 155.65 35.34 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.669 -1.234 . . . . 0.02 107.669 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.5 mt -146.24 145.51 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.795 -1.19 . . . . 0.02 110.928 -178.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -124.09 124.84 43.4 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.874 -1.158 . . . . 0.02 107.874 177.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.6 t -105.16 114.03 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 106.745 -1.576 . . . . 0.02 106.745 177.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -84.7 -34.74 22.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.559 -0.713 . . . . 3.8100000000000001 110.101 -178.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.01 150.54 19.55 Favored Glycine 0 N--CA 1.488 2.128 0 C-N-CA 118.514 -1.803 . . . . 0.02 110.722 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.19 172.15 48.84 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 120.027 -1.082 . . . . 0.01 110.563 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.9 m -119.42 135.03 54.93 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 107.711 -1.218 . . . . 1.48 107.711 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.448 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 32.7 m95 -127.49 155.0 44.44 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 122.584 1.183 . . . . 0.02 112.462 -176.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.99 134.51 51.54 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 105.545 -2.02 . . . . 0.23999999999999999 105.545 176.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.475 ' HB ' HD22 ' A' ' 79' ' ' LEU . 28.7 m -119.03 143.63 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.585 -0.697 . . . . 0.65000000000000002 109.158 178.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -120.84 146.05 46.96 Favored 'General case' 0 N--CA 1.503 2.204 0 CA-C-O 122.143 0.973 . . . . 0.02 109.949 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -67.35 -34.59 77.62 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.839 -0.619 . . . . 0.02 111.392 -177.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -125.17 157.91 65.51 Favored Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 121.047 -1.033 . . . . 0.02 109.379 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -53.84 166.4 1.45 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 121.63 1.553 . . . . 0.02 113.242 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 63.9 36.66 10.05 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.218 -0.901 . . . . 0.02 111.116 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 45.36 51.68 9.35 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.667 0.746 . . . . 3.3900000000000001 110.633 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.7 m -126.11 163.64 22.66 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.13 0.491 . . . . 2.3300000000000001 109.714 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.8 -161.82 32.35 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.803 -1.319 . . . . 0.02 109.803 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -66.16 140.1 58.18 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.081 -1.247 . . . . 0.02 110.314 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.452 ' C ' ' SD ' ' A' ' 58' ' ' MET . 10.4 tmm? -119.37 136.81 54.1 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.76 -0.588 . . . . 5.0099999999999998 109.639 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.447 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 97.9 m-85 -133.98 138.35 45.37 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.393 -0.817 . . . . 0.02 109.935 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.3 mm -96.23 132.17 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 109.205 -0.665 . . . . 1.72 109.205 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.448 HD22 ' CE1' ' A' ' 66' ' ' TYR . 10.1 mt -120.35 111.6 34.96 Favored Pre-proline 0 N--CA 1.505 2.288 0 O-C-N 121.413 -0.804 . . . . 0.02 110.897 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -77.72 169.72 20.32 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 CA-C-N 119.79 0.961 . . . . 1.47 110.042 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -53.14 140.89 24.57 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.745 -1.222 . . . . 4.25 110.458 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.96 -178.05 31.88 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.505 -1.331 . . . . 0.02 110.746 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -120.47 131.76 54.9 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.454 -1.027 . . . . 0.95999999999999996 109.822 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.448 ' CE1' HD22 ' A' ' 61' ' ' LEU . 81.9 m-85 -121.11 94.98 48.91 Favored Pre-proline 0 N--CA 1.494 1.725 0 N-CA-C 108.094 -1.076 . . . . 0.02 108.094 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.402 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 3.4 Cg_exo -66.11 -4.65 10.71 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 120.829 1.019 . . . . 0.02 113.641 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 77.7 mt-10 -157.64 155.27 29.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.818 -1.176 . . . . 2.02 108.306 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -61.21 -38.53 86.92 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.371 -0.831 . . . . 0.02 112.08 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -59.95 -23.44 63.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.971 -1.081 . . . . 0.02 110.191 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -70.55 -19.38 62.89 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.706 0.765 . . . . 3.4199999999999999 109.09 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.542 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 1.6 t90 -108.37 9.08 27.82 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.627 -1.249 . . . . 0.02 107.627 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 10.3 mtt 60.94 22.22 12.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.649 -0.657 . . . . 0.02 110.53 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.65 143.44 44.76 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.494 -1.443 . . . . 0.02 109.494 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 26.8 tp -78.96 -31.64 45.1 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.387 -1.338 . . . . 0.97999999999999998 107.387 177.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -157.87 -172.31 3.88 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 106.191 -1.781 . . . . 0.02 106.191 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -98.67 28.46 4.24 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.591 -1.318 . . . . 0.02 110.805 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 -96.94 122.05 39.49 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.779 -1.201 . . . . 3.2000000000000002 110.997 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.475 HD22 ' HB ' ' A' ' 48' ' ' VAL . 63.9 mt -144.03 122.19 12.2 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 107.627 -1.249 . . . . 2.6099999999999999 107.627 178.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.55 -16.41 11.0 Favored Glycine 0 N--CA 1.504 3.211 0 O-C-N 121.279 -0.888 . . . . 0.02 112.741 -177.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 23.5 m -156.69 156.32 33.23 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.245 -1.738 . . . . 0.02 110.445 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 25.1 t -144.03 146.89 33.17 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.574 -0.704 . . . . 0.02 110.027 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -138.47 143.6 39.69 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.174 -0.954 . . . . 0.01 109.691 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.86 132.78 36.18 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.282 -0.886 . . . . 0.42999999999999999 110.001 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.6 t -92.18 126.14 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 109.363 -0.606 . . . . 1.25 109.363 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -94.48 130.92 40.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.741 -1.224 . . . . 1.77 109.379 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.7 mt -97.7 142.69 29.18 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.384 -0.823 . . . . 1.6299999999999999 109.07 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 51.7 p -113.33 126.41 55.35 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.331 -0.855 . . . . 1.0800000000000001 109.422 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 90' ' ' GLY . 54.5 m -108.15 9.33 28.24 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 106.766 -1.568 . . . . 1.26 106.766 176.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 89' ' ' SER . . . -26.35 -49.83 0.05 OUTLIER Glycine 0 N--CA 1.495 2.583 0 CA-C-N 115.54 -0.755 . . . . 0.01 112.528 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.76 -105.89 0.19 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 118.724 -1.703 . . . . 0.01 111.737 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' A' ' 93' ' ' ALA . 11.5 tm0? -122.07 120.47 34.4 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.125 -1.221 . . . . 4.4299999999999997 110.434 -178.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.537 ' O ' ' NE2' ' A' ' 92' ' ' GLN . . . -80.48 129.28 34.41 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.893 -0.723 . . . . 2.9900000000000002 109.637 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -130.57 143.02 50.48 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 108.605 -0.887 . . . . 6.3600000000000003 108.605 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.405 ' C ' ' NE2' ' A' ' 96' ' ' GLN . 4.7 tt -129.35 145.22 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 121.151 -0.968 . . . . 1.0900000000000001 110.708 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.629 ' N ' ' NE2' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -122.93 133.26 54.4 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 107.599 -1.26 . . . . 2.0499999999999998 107.599 177.296 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.48 HG12 ' SG ' ' A' ' 129' ' ' CYS . 17.5 m -124.26 146.2 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 O-C-N 120.658 -1.276 . . . . 1.1000000000000001 109.826 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.584 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 71.7 m-85 -118.83 141.09 48.96 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.939 0.876 . . . . 0.72999999999999998 110.862 -178.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -66.09 -30.13 70.59 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 116.09 -0.504 . . . . 0.02 111.572 -178.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -117.3 170.88 8.35 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.024 -1.047 . . . . 3.1800000000000002 110.247 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.41 169.88 43.21 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.862 -0.895 . . . . 0.01 110.862 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 52.92 38.95 28.3 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.501 0.667 . . . . 0.01 111.663 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 52.25 48.93 21.64 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.495 -0.753 . . . . 0.01 111.022 178.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -123.42 165.95 16.19 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.311 -0.996 . . . . 3.1499999999999999 108.311 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.02 -164.36 28.58 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.538 -1.425 . . . . 0.01 109.538 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -76.38 144.97 39.73 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.942 -1.328 . . . . 0.01 108.569 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.584 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 28.3 ttp -117.09 142.65 46.72 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.637 0.732 . . . . 0.01 110.028 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -131.15 137.07 48.85 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.067 -1.086 . . . . 2.48 108.067 178.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -118.3 133.76 55.61 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.611 -0.681 . . . . 0.01 110.153 -178.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.4 ' O ' HG22 ' A' ' 95' ' ' ILE . 5.2 t -148.6 148.61 30.33 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.284 1.04 . . . . 1.6899999999999999 111.061 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 31.2 p -111.38 9.7 21.51 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 115.435 -0.802 . . . . 0.01 110.26 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -121.2 163.01 19.17 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.204 -0.935 . . . . 3.21 111.479 -178.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.05 156.27 37.75 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.645 -0.872 . . . . 0.01 108.645 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 23.9 t -127.7 114.15 20.82 Favored Pre-proline 0 N--CA 1.5 2.032 0 N-CA-C 108.795 -0.817 . . . . 0.01 108.795 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -74.59 -29.0 9.45 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 CA-C-N 120.364 1.166 . . . . 0.01 111.07 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 65.3 m -142.58 108.94 5.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.41 -0.806 . . . . 0.02 108.954 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.41 HD12 ' O ' ' A' ' 169' ' ' ILE . 92.1 mt -63.54 -38.64 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.936 -0.477 . . . . 1.8300000000000001 110.674 -178.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 118' ' ' MET . 12.2 tmm? -68.32 -37.23 80.35 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.31 -0.956 . . . . 1.3400000000000001 110.048 -178.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -69.54 -38.54 77.52 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.578 -1.326 . . . . 2.1099999999999999 110.074 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.452 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 50.5 tt0 -79.82 -46.84 16.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.279 -0.888 . . . . 2.0800000000000001 112.333 -177.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.452 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 32.5 m-85 -111.0 0.01 16.83 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.379 -0.826 . . . . 0.02 112.712 -176.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 59.93 33.44 21.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.774 -1.204 . . . . 0.02 109.433 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 11.0 mt -112.52 135.81 52.78 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 108.77 -0.826 . . . . 0.02 108.77 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -91.8 -22.68 20.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.198 -0.939 . . . . 5.3200000000000003 110.361 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -149.64 164.08 36.15 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.169 -0.957 . . . . 0.02 109.981 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.2 mt -132.1 128.92 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 107.751 -1.203 . . . . 2.1699999999999999 107.751 178.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -108.54 -11.91 15.06 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.343 -0.848 . . . . 0.02 112.278 -177.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.4 m -159.1 151.73 21.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.948 -1.095 . . . . 0.01 108.765 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.48 ' SG ' HG12 ' A' ' 97' ' ' VAL . 8.2 t -165.38 149.01 8.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.107 -0.996 . . . . 1.22 109.157 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.415 ' O ' ' OE1' ' A' ' 96' ' ' GLN . 7.2 ttpt -119.49 108.24 14.28 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 122.339 1.066 . . . . 1.4099999999999999 109.28 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.2 t -113.52 127.15 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.555 -1.276 . . . . 0.01 107.555 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.9 t -131.42 94.18 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 107.632 -1.247 . . . . 1.98 107.632 177.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.642 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 26.7 tt0 -147.46 -77.2 0.17 Allowed 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 105.772 -1.936 . . . . 0.01 105.772 177.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 170.64 -63.59 0.17 Allowed Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.737 -1.745 . . . . 0.01 108.737 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.8 p -123.33 113.2 18.54 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.497 -1.002 . . . . 2.2999999999999998 110.846 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.642 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 9.8 m95 -126.07 147.15 49.65 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 107.335 -1.358 . . . . 0.01 107.335 178.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.5 mt -121.86 136.2 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 O-C-N 120.568 -1.332 . . . . 1.6899999999999999 110.248 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -116.17 145.28 43.21 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.339 -1.356 . . . . 2.4900000000000002 107.339 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.5 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 15.2 m-85 -123.21 143.75 49.83 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.311 -0.868 . . . . 0.02 109.722 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -74.59 -29.31 61.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.523 -0.735 . . . . 0.02 111.74 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.4 mt -115.78 154.9 48.16 Favored Pre-proline 0 N--CA 1.503 2.212 0 O-C-N 120.697 -1.252 . . . . 1.48 109.054 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -56.06 166.9 2.75 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 121.123 1.215 . . . . 0.02 112.802 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.2 m120 59.79 31.24 20.69 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.043 -0.98 . . . . 0.75 111.437 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.446 ' HD1' ' HG ' ' A' ' 171' ' ' SER . 1.9 m-85 57.68 51.62 9.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.513 -0.742 . . . . 0.02 111.141 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 41.2 mtm180 -127.1 164.91 20.55 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.531 -0.73 . . . . 0.02 110.241 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.74 -165.67 33.64 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.538 -1.025 . . . . 0.02 110.538 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -69.25 142.33 54.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.539 -0.977 . . . . 0.02 108.98 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -113.64 148.33 36.47 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.834 -0.541 . . . . 0.02 110.344 -178.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -124.23 133.56 53.49 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 108.853 -0.795 . . . . 0.01 108.853 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.477 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.2 tt -100.22 122.47 43.08 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.06 -1.025 . . . . 0.01 109.231 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.477 ' N ' HD23 ' A' ' 150' ' ' LEU . 2.6 mp -98.12 147.03 24.98 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.235 -1.024 . . . . 0.01 108.235 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -105.06 -121.08 0.22 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.627 -0.671 . . . . 2.27 110.009 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -139.28 53.32 1.73 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.229 -0.919 . . . . 1.8400000000000001 109.401 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -116.38 -172.35 2.17 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.406 -0.809 . . . . 2.2799999999999998 109.195 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -105.55 109.51 21.51 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.39 -0.967 . . . . 0.01 108.39 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.606 ' CG ' ' NE1' ' A' ' 162' ' ' TRP . 35.9 m-85 -98.58 111.36 23.75 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.239 -0.913 . . . . 0.01 110.575 -178.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -95.65 -22.22 17.71 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.21 -0.931 . . . . 0.01 111.298 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 39.6 mttp -127.51 154.59 77.49 Favored Pre-proline 0 N--CA 1.502 2.153 0 O-C-N 121.142 -0.974 . . . . 2.54 108.656 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -59.59 -39.05 78.27 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 120.423 0.748 . . . . 0.69999999999999996 110.596 178.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.99 -20.08 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.895 -1.128 . . . . 0.85999999999999999 109.079 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -65.33 -15.48 62.59 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.946 -1.096 . . . . 0.02 110.134 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.606 ' NE1' ' CG ' ' A' ' 156' ' ' TYR . 9.6 m0 -97.55 11.85 35.47 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.245 -0.909 . . . . 0.02 108.94 178.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.14 10.07 85.92 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.767 -1.206 . . . . 0.02 111.089 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.03 141.08 32.23 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.193 -1.181 . . . . 0.02 110.073 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.12 -8.95 58.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.654 -0.654 . . . . 0.58999999999999997 109.797 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.3 p -143.59 150.74 51.88 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 121.044 -1.035 . . . . 0.87 108.924 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -76.04 18.74 0.63 Allowed 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 120.704 0.936 . . . . 0.38 112.3 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.859 ' O ' HD13 ' A' ' 169' ' ' ILE . . . -83.07 122.24 28.09 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.824 -1.173 . . . . 0.17999999999999999 111.321 -178.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.859 HD13 ' O ' ' A' ' 168' ' ' ALA . 4.1 mm -146.54 126.82 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 106.521 -1.659 . . . . 3.9900000000000002 106.521 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -112.16 -18.09 12.65 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.955 -1.091 . . . . 5.1699999999999999 113.405 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.446 ' HG ' ' HD1' ' A' ' 144' ' ' TYR . 1.6 p -157.49 160.67 38.49 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 119.196 -2.19 . . . . 0.02 110.179 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.411 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 21.0 p90 -151.45 152.26 32.78 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.069 -1.019 . . . . 2.02 110.481 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -145.26 150.67 37.09 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.857 0.837 . . . . 0.01 110.393 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -89.11 145.24 25.58 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.138 -0.69 . . . . 0.01 109.138 178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 175' ' ' ILE . 5.1 mt -95.85 129.81 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.399 -0.813 . . . . 3.04 108.89 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 25.4 m -137.76 147.63 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.088 -1.007 . . . . 1.8899999999999999 109.912 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.371 -0.831 . . . . 4.8899999999999997 109.366 179.479 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 81.7 p . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.471 -0.566 . . . . 5.2800000000000002 109.471 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -154.19 116.57 4.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.203 -0.936 . . . . 5.96 109.226 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.415 ' OG1' ' N ' ' A' ' 4' ' ' GLY . 3.4 t -89.44 -139.72 0.13 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.282 -1.377 . . . . 2.2200000000000002 107.282 177.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.415 ' N ' ' OG1' ' A' ' 3' ' ' THR . . . 175.14 -177.14 47.21 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 117.472 -2.299 . . . . 0.81000000000000005 112.765 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.88 159.61 44.0 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.706 -1.357 . . . . 0.01 109.706 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -144.13 133.57 23.32 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.226 -1.161 . . . . 0.02 110.538 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.4 tt -129.45 139.41 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.11 -1.07 . . . . 0.02 108.11 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.1 m -120.99 129.14 53.29 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.291 -0.88 . . . . 0.39000000000000001 110.103 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 9.1 m-85 -109.8 140.19 44.01 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.641 -0.874 . . . . 0.02 108.641 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.554 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.8 m-85 -121.9 138.09 54.53 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.334 -0.854 . . . . 0.02 109.446 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -68.69 -27.14 65.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -0.943 . . . . 0.029999999999999999 111.389 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.0 OUTLIER -114.56 170.12 8.55 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.992 -1.068 . . . . 0.029999999999999999 109.958 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -75.98 161.87 28.56 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.633 0.73 . . . . 0.029999999999999999 110.4 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.455 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 0.2 OUTLIER 62.9 33.02 15.39 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.025 0.917 . . . . 0.73999999999999999 110.916 179.342 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 55.46 40.32 31.25 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.858 -0.61 . . . . 0.02 111.05 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -110.62 165.22 11.99 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.188 -1.041 . . . . 0.02 108.188 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.25 -167.91 34.67 Favored Glycine 0 N--CA 1.497 2.708 0 O-C-N 120.907 -1.12 . . . . 0.029999999999999999 110.911 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.433 ' HG3' HH11 ' A' ' 18' ' ' ARG . 13.4 ttm-85 -69.95 143.46 52.65 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.471 -1.017 . . . . 2.7599999999999998 109.316 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.1 ttp180 -122.03 149.98 42.74 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.38 -0.825 . . . . 1.8899999999999999 110.431 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.49 ' CZ ' ' CG ' ' A' ' 32' ' ' TYR . 9.4 t80 -135.14 131.35 36.73 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.811 -0.811 . . . . 0.02 108.811 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -111.7 137.08 50.08 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.458 -0.776 . . . . 1.1200000000000001 109.463 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 40.2 t -129.35 138.75 51.73 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 121.41 0.624 . . . . 0.02 109.629 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -117.7 11.9 13.8 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.545 -0.722 . . . . 0.20000000000000001 110.245 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.483 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 42.5 t -159.17 174.24 15.15 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.916 -1.115 . . . . 1.23 108.757 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.473 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 17.6 p30 -61.74 145.14 53.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.613 -1.304 . . . . 0.02 110.219 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.423 ' CB ' ' CZ ' ' A' ' 29' ' ' PHE . 0.6 OUTLIER -134.35 119.12 18.25 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.543 -0.91 . . . . 0.02 108.543 178.59 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.62 -19.73 57.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.557 -0.715 . . . . 0.23999999999999999 111.672 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -154.28 108.72 3.03 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.923 -1.111 . . . . 1.1399999999999999 111.005 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.423 ' CZ ' ' CB ' ' A' ' 26' ' ' CYS . 22.2 m-85 -96.01 5.88 50.16 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.283 -0.886 . . . . 6.3700000000000001 109.283 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -60.63 -30.7 70.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.282 -0.886 . . . . 3.1099999999999999 112.246 -176.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.5 m -78.72 -19.07 53.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.271 -1.518 . . . . 0.88 111.55 -178.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.49 ' CG ' ' CZ ' ' A' ' 20' ' ' TYR . 65.2 m-85 -107.06 -21.83 12.86 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.266 -0.896 . . . . 0.02 110.819 -178.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.415 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 6.1 tp -149.16 127.63 12.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.895 -1.128 . . . . 3.3199999999999998 109.793 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.9 m -86.56 -11.77 50.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.53 -0.731 . . . . 0.02 111.127 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.415 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 4.8 ptp180 -171.68 161.95 6.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.933 -1.105 . . . . 0.02 108.24 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -142.65 115.75 8.87 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.909 -1.119 . . . . 0.02 108.887 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -109.49 0.32 19.2 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.85 -1.156 . . . . 0.029999999999999999 111.458 -178.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.3 m -156.8 153.81 28.9 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.385 -0.969 . . . . 0.02 108.385 178.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.0 mt -146.2 147.16 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-O 122.325 1.06 . . . . 0.02 111.176 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -122.59 123.66 41.71 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.738 -1.208 . . . . 0.02 107.738 176.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.3 t -106.8 115.2 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 106.902 -1.518 . . . . 0.02 106.902 177.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -83.31 -33.85 25.85 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 120.068 -0.653 . . . . 3.8100000000000001 111.024 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.97 152.36 22.19 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 118.878 -1.63 . . . . 0.02 110.854 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.59 173.24 49.59 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.66 -1.257 . . . . 0.01 110.418 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 65.6 m -119.6 135.16 54.92 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.033 -1.099 . . . . 1.48 108.033 178.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -127.31 155.98 42.68 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 122.639 1.209 . . . . 0.02 112.172 -176.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.51 134.57 51.73 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 105.527 -2.027 . . . . 0.23999999999999999 105.527 176.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.6 m -116.31 142.01 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.549 -0.719 . . . . 0.65000000000000002 109.306 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -120.53 143.32 48.64 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 122.056 0.931 . . . . 0.02 109.508 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.504 ' OE1' ' CE1' ' A' ' 57' ' ' HIS . 36.9 tt0 -65.67 -33.37 75.73 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.671 -0.695 . . . . 0.02 111.712 -177.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 35.8 mtm180 -124.85 157.8 65.0 Favored Pre-proline 0 N--CA 1.503 2.194 0 O-C-N 120.991 -1.068 . . . . 0.02 109.368 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -53.31 167.36 0.83 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.753 1.635 . . . . 0.02 112.634 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.5 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.4 OUTLIER 63.02 36.2 12.58 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 115.254 -0.885 . . . . 0.02 111.273 178.138 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.509 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 5.5 m-85 45.28 51.11 9.53 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.707 0.765 . . . . 3.3900000000000001 110.706 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.8 m -125.54 163.57 22.41 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 121.2 0.524 . . . . 2.3300000000000001 109.802 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.44 -161.67 31.39 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.844 -1.302 . . . . 0.02 109.844 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.504 ' CE1' ' OE1' ' A' ' 50' ' ' GLU . 10.1 m80 -65.13 137.84 57.9 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.11 -1.229 . . . . 0.02 110.219 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.496 ' O ' ' SD ' ' A' ' 58' ' ' MET . 2.8 ppp? -118.68 137.49 53.28 Favored 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 121.357 0.599 . . . . 5.0099999999999998 109.553 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.473 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 81.6 m-85 -135.44 140.48 44.92 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.503 -0.748 . . . . 0.02 109.61 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.9 mm -95.19 131.05 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.607 -0.683 . . . . 1.72 109.164 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.531 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 1.0 OUTLIER -121.09 111.39 33.95 Favored Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 121.284 -0.885 . . . . 0.02 110.743 -178.284 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -77.27 169.02 22.07 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 CA-C-N 119.898 0.999 . . . . 1.47 110.371 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -53.39 141.73 23.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.96 -1.087 . . . . 4.25 110.369 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.81 -177.7 31.96 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.523 -1.322 . . . . 0.02 110.755 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -120.21 131.56 55.02 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.464 -1.021 . . . . 0.95999999999999996 109.661 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.531 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 59.5 m-85 -122.41 97.62 44.75 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 108.022 -1.103 . . . . 0.02 108.022 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.404 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 3.4 Cg_endo -68.77 -3.26 10.94 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 120.745 0.963 . . . . 0.02 113.898 -178.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 79.2 mt-10 -157.64 155.2 29.65 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.433 -1.417 . . . . 2.02 108.281 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -60.69 -39.1 87.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.63 -0.669 . . . . 0.02 112.108 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -60.28 -23.47 64.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.058 -1.026 . . . . 0.02 110.32 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -69.82 -18.75 63.47 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.88 -0.785 . . . . 3.4199999999999999 108.88 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.589 ' CH2' HD21 ' A' ' 79' ' ' LEU . 1.7 t90 -107.95 10.95 28.29 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.464 -1.31 . . . . 0.02 107.464 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.3 mtt 61.21 22.49 12.82 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.476 0.655 . . . . 0.02 110.409 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.72 144.29 48.07 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.574 -1.41 . . . . 0.02 109.574 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.429 ' N ' HD12 ' A' ' 75' ' ' LEU . 9.3 mp -79.78 -29.95 40.52 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.708 -1.219 . . . . 0.97999999999999998 107.708 177.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -156.83 -171.17 3.56 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 106.342 -1.725 . . . . 0.02 106.342 178.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 23.0 p-10 -98.91 28.72 4.18 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.697 -1.252 . . . . 0.02 110.526 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -96.49 122.33 39.27 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.796 -1.19 . . . . 3.2000000000000002 111.057 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.589 HD21 ' CH2' ' A' ' 72' ' ' TRP . 78.1 mt -141.92 119.83 11.97 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.609 -1.256 . . . . 2.6099999999999999 107.609 178.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.51 -18.54 8.47 Favored Glycine 0 N--CA 1.499 2.853 0 O-C-N 121.245 -0.909 . . . . 0.02 112.809 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.509 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 12.6 t -156.0 156.48 34.54 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-N 120.324 2.062 . . . . 0.02 111.13 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 11.9 t -146.45 148.78 32.61 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.342 -0.849 . . . . 0.02 110.723 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.425 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 52.1 mtp180 -138.16 143.13 40.13 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.509 -0.745 . . . . 0.01 109.345 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.19 132.46 36.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.102 -0.998 . . . . 0.42999999999999999 109.938 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.9 t -91.12 125.01 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.571 -0.706 . . . . 1.25 109.139 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -93.97 131.89 38.97 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.877 -1.139 . . . . 1.77 109.079 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 mt -96.66 139.45 32.71 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.54 -0.911 . . . . 1.6299999999999999 108.54 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.1 p -111.8 127.88 55.94 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.362 -0.836 . . . . 1.0800000000000001 109.312 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.7 m -104.39 -153.97 0.49 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 106.492 -1.669 . . . . 1.26 106.492 176.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.33 -53.15 0.72 Allowed Glycine 0 N--CA 1.5 2.928 0 O-C-N 120.386 -1.446 . . . . 0.01 112.818 177.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.16 -101.65 0.16 Allowed Glycine 0 N--CA 1.491 2.337 0 C-N-CA 118.476 -1.821 . . . . 0.01 111.844 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -121.25 118.91 30.77 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.043 -1.269 . . . . 4.4299999999999997 110.569 -178.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.0 129.62 34.65 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.79 -0.764 . . . . 2.9900000000000002 109.349 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.449 ' CB ' ' NZ ' ' A' ' 94' ' ' LYS . 6.8 ttpm? -129.15 141.95 51.02 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.334 -0.854 . . . . 6.3600000000000003 109.09 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.3 tt -128.64 144.92 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 O-C-N 121.352 -0.842 . . . . 1.0900000000000001 110.237 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -122.67 134.02 54.49 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.911 -1.144 . . . . 2.0499999999999998 107.911 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.469 HG12 ' SG ' ' A' ' 129' ' ' CYS . 29.1 m -123.78 145.05 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 120.823 -1.173 . . . . 1.1000000000000001 110.051 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.572 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 47.5 m-85 -119.92 142.16 48.97 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-O 121.996 0.903 . . . . 0.72999999999999998 111.098 -178.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -67.53 -31.84 72.21 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 116.06 -0.518 . . . . 0.02 111.745 -178.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -115.62 167.44 10.9 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 120.811 -1.181 . . . . 3.1800000000000002 110.593 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.15 163.69 45.01 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.833 -0.907 . . . . 0.01 110.833 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 57.6 38.93 27.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.913 -0.757 . . . . 0.01 110.99 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 52.57 55.92 8.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.696 -0.627 . . . . 0.01 111.184 178.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -128.45 165.87 19.84 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.266 -1.013 . . . . 3.1499999999999999 108.266 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.17 -163.39 27.81 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.234 -1.547 . . . . 0.01 109.234 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 38.4 tp60 -76.29 144.5 40.23 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.965 -1.315 . . . . 0.01 108.656 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.572 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 29.5 ttp -116.68 141.8 47.73 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.638 0.733 . . . . 0.01 109.812 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -131.57 136.3 47.7 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.328 -0.99 . . . . 2.48 108.328 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.521 ' OE2' ' N ' ' A' ' 110' ' ' THR . 1.9 tm-20 -118.12 133.9 55.49 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.559 -0.713 . . . . 0.01 109.997 -178.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.521 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 6.2 t -148.09 148.89 31.14 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.106 -0.996 . . . . 1.6899999999999999 110.969 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 33.3 p -110.78 10.17 22.61 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 115.551 -0.75 . . . . 0.01 110.365 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -120.92 163.16 18.65 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.28 -0.888 . . . . 3.21 111.571 -178.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.06 156.67 36.9 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.255 -1.017 . . . . 0.01 108.255 178.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 19.8 t -125.92 112.53 24.53 Favored Pre-proline 0 N--CA 1.502 2.138 0 O-C-N 121.456 -0.778 . . . . 0.01 108.944 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -75.41 -31.63 5.56 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 120.133 1.083 . . . . 0.01 111.102 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 16.5 m -141.05 107.95 5.41 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.287 -0.883 . . . . 0.02 108.798 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.9 mt -63.36 -39.19 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.949 -0.469 . . . . 1.8300000000000001 110.74 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 118' ' ' MET . 1.7 tmt? -67.81 -37.18 81.64 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.416 -0.914 . . . . 1.3400000000000001 110.46 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -71.09 -39.26 72.23 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 120.464 -1.397 . . . . 2.1099999999999999 110.243 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -79.56 -46.7 16.83 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.239 -0.913 . . . . 2.0800000000000001 112.358 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -109.67 -0.11 18.74 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.34 -0.85 . . . . 0.02 112.531 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 10.3 m80 58.85 32.03 21.84 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.687 -1.258 . . . . 0.02 108.865 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.7 mt -111.47 135.3 52.22 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.656 -0.868 . . . . 0.02 108.656 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -92.09 -23.4 19.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.158 -0.964 . . . . 5.3200000000000003 110.031 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -149.76 163.41 38.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.231 -0.918 . . . . 0.02 109.839 -178.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 45.6 mt -133.31 130.32 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 107.493 -1.299 . . . . 2.1699999999999999 107.493 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -107.83 -11.76 15.32 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.301 -0.875 . . . . 0.02 112.787 -177.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.9 m -158.98 152.7 23.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.734 -1.229 . . . . 0.01 108.82 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.469 ' SG ' HG12 ' A' ' 97' ' ' VAL . 9.2 t -167.65 147.67 5.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.121 -0.987 . . . . 1.22 109.123 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.442 ' NZ ' ' OE2' ' A' ' 155' ' ' GLU . 4.8 tptm -121.0 111.09 17.04 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 122.346 1.069 . . . . 1.4099999999999999 109.717 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.2 t -112.23 128.7 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.603 -1.258 . . . . 0.01 107.603 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.2 t -129.81 94.02 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 106.922 -1.51 . . . . 1.98 106.922 177.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -146.84 -78.57 0.17 Allowed 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 105.824 -1.917 . . . . 0.01 105.824 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 178.51 -75.14 0.07 OUTLIER Glycine 0 N--CA 1.485 1.951 0 N-CA-C 108.144 -1.982 . . . . 0.01 108.144 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.712 ' OG1' HD12 ' A' ' 175' ' ' ILE . 0.1 OUTLIER -121.22 120.55 35.51 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.654 -0.909 . . . . 2.2999999999999998 110.12 179.371 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -126.42 151.0 48.29 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 106.77 -1.567 . . . . 0.01 106.77 179.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 59.1 mt -121.41 135.13 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 120.552 -1.343 . . . . 1.6899999999999999 110.495 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.46 ' HB3' HD12 ' A' ' 169' ' ' ILE . 3.8 m-30 -111.03 142.73 42.79 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 106.269 -1.752 . . . . 2.4900000000000002 106.269 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -122.76 143.49 49.79 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.014 -1.054 . . . . 0.02 109.763 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -74.66 -29.66 61.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.409 -0.807 . . . . 0.02 111.869 -176.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.4 mt -116.1 155.04 48.55 Favored Pre-proline 0 N--CA 1.506 2.372 0 O-C-N 120.793 -1.192 . . . . 1.48 108.983 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -55.92 167.36 2.37 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.116 1.211 . . . . 0.02 112.843 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 59.31 30.44 20.16 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.035 -0.984 . . . . 0.75 111.211 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 58.06 51.43 8.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.484 -0.76 . . . . 0.02 111.055 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -125.97 164.88 19.84 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.546 -0.721 . . . . 0.02 109.863 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.56 ' O ' ' NE2' ' A' ' 148' ' ' GLN . . . 88.79 -166.06 33.84 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.093 -1.203 . . . . 0.02 110.093 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -69.25 142.62 54.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.55 -0.971 . . . . 0.02 108.97 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.56 ' NE2' ' O ' ' A' ' 146' ' ' GLY . 5.6 mp0 -114.58 148.38 38.12 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.315 0.579 . . . . 0.02 110.155 -178.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 149' ' ' TYR . 13.1 m-85 -124.48 135.32 53.12 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.66 -0.867 . . . . 0.01 108.66 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.458 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.5 tt -98.33 122.44 41.5 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.872 -1.143 . . . . 0.01 109.253 -178.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.3 mp -96.43 146.86 24.4 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.294 -0.879 . . . . 0.01 109.043 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -104.68 -124.71 0.22 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.348 -0.845 . . . . 2.27 109.418 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -146.49 47.7 1.19 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.177 -0.952 . . . . 1.8400000000000001 109.514 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -112.73 -161.26 0.75 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.543 -0.723 . . . . 2.2799999999999998 109.168 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.442 ' OE2' ' NZ ' ' A' ' 130' ' ' LYS . 4.1 mm-40 -107.02 104.72 14.45 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.579 -0.701 . . . . 0.01 109.154 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.609 ' CD2' ' CD1' ' A' ' 162' ' ' TRP . 55.3 m-85 -98.15 111.27 23.66 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.249 -0.907 . . . . 0.01 109.448 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -94.39 -22.51 18.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.042 -1.036 . . . . 0.01 111.268 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -127.59 154.42 77.62 Favored Pre-proline 0 N--CA 1.503 2.177 0 O-C-N 120.977 -1.077 . . . . 2.54 108.548 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -59.71 -36.83 90.67 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 CA-C-N 119.148 0.731 . . . . 0.69999999999999996 110.265 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 92.0 t -61.68 -19.78 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.975 -1.078 . . . . 0.85999999999999999 109.094 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -65.57 -15.78 63.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.963 -1.086 . . . . 0.02 110.267 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.609 ' CD1' ' CD2' ' A' ' 156' ' ' TYR . 6.1 m0 -98.6 11.75 37.44 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.175 -0.953 . . . . 0.02 108.986 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.67 10.37 85.27 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 119.861 -1.161 . . . . 0.02 111.207 178.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.63 141.09 32.88 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.179 -1.189 . . . . 0.02 110.072 -178.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.27 -9.32 57.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.627 -0.671 . . . . 0.58999999999999997 110.062 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 39.8 m -143.94 150.09 48.31 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 120.921 -1.112 . . . . 0.87 109.098 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -76.41 18.43 0.69 Allowed 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 120.876 1.05 . . . . 0.38 112.512 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.75 123.45 28.77 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.794 -1.192 . . . . 0.17999999999999999 111.698 -177.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.46 HD12 ' HB3' ' A' ' 138' ' ' PHE . 29.2 mm -148.52 127.96 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 106.77 -1.567 . . . . 3.9900000000000002 106.77 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -112.31 -15.93 13.06 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.137 -0.977 . . . . 5.1699999999999999 112.525 -178.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 22.9 t -157.89 160.67 37.9 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 119.459 -2.026 . . . . 0.02 109.858 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.422 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 18.0 p90 -151.12 152.93 34.08 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.18 -0.95 . . . . 2.02 110.113 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -145.0 150.26 36.59 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.192 -0.942 . . . . 0.01 110.408 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -88.81 144.8 25.99 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.925 -0.768 . . . . 0.01 108.925 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.712 HD12 ' OG1' ' A' ' 135' ' ' THR . 4.9 mt -96.22 130.13 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.354 -0.841 . . . . 3.04 109.398 178.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 24.7 t -136.13 146.77 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.315 -0.866 . . . . 1.8899999999999999 109.671 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.181 -0.949 . . . . 4.8899999999999997 109.454 179.953 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.6 p . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.296 0.57 . . . . 5.2800000000000002 109.494 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.9 mmtm -71.58 65.53 0.47 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 5.96 109.256 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.8 t -81.16 142.57 33.12 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.352 -0.981 . . . . 2.2200000000000002 108.352 178.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.82 179.02 48.49 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 118.271 -1.919 . . . . 0.81000000000000005 112.042 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.04 156.84 42.47 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.521 -1.432 . . . . 0.01 109.521 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.497 ' HZ1' HH21 ' A' ' 40' ' ' ARG . 26.0 ttpp -145.95 135.55 23.22 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.296 -1.12 . . . . 0.02 110.373 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.4 tt -129.63 139.1 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.02 -1.104 . . . . 0.02 108.02 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 m -120.61 129.25 53.66 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.35 -0.844 . . . . 0.39000000000000001 110.316 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.437 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.9 m-85 -110.76 140.78 44.86 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.852 -0.795 . . . . 0.02 108.852 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.557 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.9 m-85 -122.57 138.61 54.52 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.294 -0.879 . . . . 0.02 109.425 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -68.91 -27.21 65.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.121 -0.987 . . . . 0.029999999999999999 111.597 -178.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.3 m-20 -114.43 169.85 8.74 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.944 -1.098 . . . . 0.029999999999999999 109.995 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -75.02 161.91 29.04 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.617 0.722 . . . . 0.029999999999999999 110.262 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.592 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 11.4 t-20 62.45 35.11 14.97 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.892 0.853 . . . . 0.73999999999999999 110.634 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.592 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.7 p90 49.27 43.16 22.8 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.478 -0.783 . . . . 0.02 110.94 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -109.62 165.91 11.31 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.676 -1.231 . . . . 0.02 107.676 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.7 -167.71 35.35 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 119.707 -1.235 . . . . 0.029999999999999999 110.752 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.583 ' CG ' HH11 ' A' ' 18' ' ' ARG . 0.2 OUTLIER -69.62 143.28 53.3 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.408 -1.054 . . . . 2.7599999999999998 109.059 179.368 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -122.59 150.7 42.27 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.499 -0.75 . . . . 1.8899999999999999 110.244 -178.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.472 ' CE1' ' CE1' ' A' ' 29' ' ' PHE . 34.4 t80 -136.34 133.11 36.48 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.689 -0.632 . . . . 0.02 109.678 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 20.6 p-10 -110.74 136.63 49.52 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.389 -0.819 . . . . 1.1200000000000001 109.309 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 42.2 t -128.73 138.65 52.24 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.631 -0.668 . . . . 0.02 109.422 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.434 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 0.9 OUTLIER -118.93 11.4 12.53 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.477 -0.765 . . . . 0.20000000000000001 110.877 -179.406 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.491 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 8.0 p -159.31 173.84 15.68 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.644 -1.285 . . . . 1.23 109.305 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 22.8 p30 -62.13 145.22 53.97 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.684 -1.26 . . . . 0.02 110.361 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.553 ' CB ' ' CE2' ' A' ' 29' ' ' PHE . 51.2 t -134.49 118.44 17.34 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.529 -0.732 . . . . 0.02 109.046 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.81 -20.67 56.12 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.494 -0.754 . . . . 0.23999999999999999 111.515 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -155.45 104.78 2.41 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.851 -1.155 . . . . 1.1399999999999999 109.417 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.553 ' CE2' ' CB ' ' A' ' 26' ' ' CYS . 0.4 OUTLIER -101.82 9.03 41.11 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.321 -0.862 . . . . 6.3700000000000001 109.934 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -60.32 -27.18 67.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.391 -0.818 . . . . 3.1099999999999999 111.83 -177.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.3 t -77.89 -18.07 56.58 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.477 -1.389 . . . . 0.88 111.391 -178.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.551 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 8.3 m-85 -106.64 -21.08 13.16 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.306 -0.871 . . . . 0.02 110.561 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.9 tp -148.66 127.16 12.35 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.95 -1.094 . . . . 3.3199999999999998 109.472 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.3 t -87.53 -12.55 45.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.629 -0.669 . . . . 0.02 111.388 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -172.5 161.95 5.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.743 -1.223 . . . . 0.02 108.47 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.458 ' SG ' HD12 ' A' ' 79' ' ' LEU . 2.3 p -143.45 115.74 8.49 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.069 -1.02 . . . . 0.02 108.877 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -107.8 -0.41 21.65 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.812 -1.18 . . . . 0.029999999999999999 111.007 -178.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.3 m -155.08 153.58 31.11 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.829 -1.175 . . . . 0.02 107.829 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.7 mt -146.83 147.14 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 122.205 1.002 . . . . 0.02 110.778 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.497 HH21 ' HZ1' ' A' ' 6' ' ' LYS . 35.3 ttp180 -124.03 124.73 43.19 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.181 -1.044 . . . . 0.02 108.181 177.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.8 t -106.68 115.27 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 106.876 -1.527 . . . . 0.02 106.876 177.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.4 ' HG3' ' HZ2' ' A' ' 6' ' ' LYS . 18.2 mm-40 -83.88 -33.81 24.72 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.565 -0.709 . . . . 3.8100000000000001 110.952 -177.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.13 152.64 22.57 Favored Glycine 0 N--CA 1.49 2.272 0 C-N-CA 118.811 -1.661 . . . . 0.02 110.877 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.45 172.98 49.39 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.688 -1.244 . . . . 0.01 110.468 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.1 m -119.85 134.94 55.07 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 107.97 -1.122 . . . . 1.48 107.97 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.42 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 35.3 m95 -127.46 156.11 42.63 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 122.595 1.188 . . . . 0.02 112.212 -176.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.83 134.39 52.1 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 105.613 -1.995 . . . . 0.23999999999999999 105.613 176.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.462 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.7 m -117.09 142.6 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.53 -0.731 . . . . 0.65000000000000002 109.14 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -120.68 143.57 48.65 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 122.093 0.949 . . . . 0.02 109.66 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -65.05 -33.7 76.67 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.584 -0.735 . . . . 0.02 111.534 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -125.3 157.95 65.73 Favored Pre-proline 0 N--CA 1.503 2.21 0 O-C-N 121.029 -1.044 . . . . 0.02 109.425 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -53.49 167.36 0.92 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.688 1.592 . . . . 0.02 112.916 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 63.36 36.31 11.66 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.232 -0.895 . . . . 0.02 111.134 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.414 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 4.9 m-85 44.92 51.65 8.51 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.614 0.721 . . . . 3.3900000000000001 110.77 178.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.9 t -125.8 163.6 22.53 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.186 0.517 . . . . 2.3300000000000001 109.846 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.33 -161.86 31.67 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.892 -1.283 . . . . 0.02 109.892 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -65.54 139.03 58.43 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.038 -1.272 . . . . 0.02 110.245 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.495 ' O ' ' SD ' ' A' ' 58' ' ' MET . 2.6 ppp? -118.88 137.03 53.72 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.662 -0.649 . . . . 5.0099999999999998 109.802 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.452 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 90.8 m-85 -134.06 138.86 45.59 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.497 -0.752 . . . . 0.02 109.693 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.7 mm -95.76 131.17 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.123 -0.695 . . . . 1.72 109.123 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.489 HD22 ' CE1' ' A' ' 66' ' ' TYR . 9.3 mt -120.77 111.78 34.2 Favored Pre-proline 0 N--CA 1.506 2.335 0 O-C-N 121.41 -0.806 . . . . 0.02 110.929 -178.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -77.53 169.25 21.33 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 CA-C-N 119.868 0.989 . . . . 1.47 110.126 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -53.29 141.26 24.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.878 -1.139 . . . . 4.25 110.368 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.23 -177.94 32.16 Favored Glycine 0 N--CA 1.496 2.667 0 C-N-CA 119.54 -1.314 . . . . 0.02 110.825 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -120.25 131.7 55.04 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.433 -1.039 . . . . 0.95999999999999996 109.746 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.489 ' CE1' HD22 ' A' ' 61' ' ' LEU . 88.4 m-85 -121.08 95.82 48.65 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 108.041 -1.096 . . . . 0.02 108.041 178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -65.98 -4.7 10.62 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 120.761 0.974 . . . . 0.02 113.618 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -157.58 155.2 29.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.655 -1.278 . . . . 2.02 108.15 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -60.25 -38.6 83.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.576 -0.702 . . . . 0.02 112.029 -177.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -60.07 -23.42 63.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.142 -0.974 . . . . 0.02 110.293 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -70.79 -18.76 62.74 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.831 0.824 . . . . 3.4199999999999999 109.063 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.54 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 1.6 t90 -107.9 9.8 28.65 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.424 -1.324 . . . . 0.02 107.424 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.8 mtt 60.83 22.08 12.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.601 -0.687 . . . . 0.02 110.419 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.89 143.83 46.8 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.336 -1.506 . . . . 0.02 109.336 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.816 HD12 ' H ' ' A' ' 76' ' ' ASN . 0.2 OUTLIER -78.71 -28.88 45.14 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.609 -1.256 . . . . 0.97999999999999998 107.609 177.783 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.816 ' H ' HD12 ' A' ' 75' ' ' LEU . 65.6 m-80 -158.75 -171.69 3.52 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 106.286 -1.746 . . . . 0.02 106.286 178.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -98.53 29.01 3.85 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.642 -1.286 . . . . 0.02 110.472 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -97.86 122.77 41.37 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.974 -1.079 . . . . 3.2000000000000002 111.43 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.462 HD22 ' HB ' ' A' ' 48' ' ' VAL . 49.3 mt -142.28 119.53 11.5 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 107.232 -1.396 . . . . 2.6099999999999999 107.232 177.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.69 -18.6 9.94 Favored Glycine 0 N--CA 1.497 2.736 0 O-C-N 121.207 -0.933 . . . . 0.02 112.27 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.5 p -155.83 156.36 34.59 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 119.612 1.706 . . . . 0.02 110.839 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 20.5 p -146.14 148.47 32.62 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.453 -0.779 . . . . 0.02 110.529 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.414 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 50.5 mtp180 -138.55 143.12 39.3 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.473 -0.767 . . . . 0.01 109.327 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.28 132.16 36.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.128 -0.982 . . . . 0.42999999999999999 109.829 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.4 t -90.76 125.23 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.529 -0.732 . . . . 1.25 109.117 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -93.87 132.18 38.54 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.701 -1.249 . . . . 1.77 109.26 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.1 mt -97.31 139.96 32.49 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.805 -0.813 . . . . 1.6299999999999999 108.805 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.9 t -112.52 127.83 56.17 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.377 -0.827 . . . . 1.0800000000000001 109.465 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 77.8 p -104.26 -154.43 0.5 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 106.602 -1.629 . . . . 1.26 106.602 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 139.25 -52.53 0.72 Allowed Glycine 0 N--CA 1.501 3.003 0 O-C-N 120.356 -1.465 . . . . 0.01 113.111 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.8 -101.66 0.16 Allowed Glycine 0 N--CA 1.49 2.281 0 C-N-CA 118.413 -1.851 . . . . 0.01 112.095 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -121.35 119.17 31.37 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.133 -1.216 . . . . 4.4299999999999997 110.676 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.15 129.56 34.59 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.745 -0.782 . . . . 2.9900000000000002 109.403 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -129.76 143.09 50.64 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.383 -0.823 . . . . 6.3600000000000003 108.917 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.401 HG22 ' O ' ' A' ' 110' ' ' THR . 4.2 tt -128.84 145.0 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 O-C-N 121.292 -0.88 . . . . 1.0900000000000001 110.437 -178.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -122.25 134.08 54.69 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.58 -1.266 . . . . 2.0499999999999998 107.58 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.527 HG12 ' SG ' ' A' ' 129' ' ' CYS . 15.6 m -124.61 145.71 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 O-C-N 120.772 -1.205 . . . . 1.1000000000000001 109.914 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.587 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 64.4 m-85 -119.35 141.62 48.87 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 121.971 0.891 . . . . 0.72999999999999998 110.91 -178.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -67.23 -30.73 70.73 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 116.066 -0.515 . . . . 0.02 111.904 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.416 ' O ' ' OG ' ' A' ' 128' ' ' SER . 48.0 mttm -116.35 167.46 11.01 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.97 -1.082 . . . . 3.1800000000000002 110.492 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.52 164.02 42.37 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.899 -0.88 . . . . 0.01 110.899 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 56.77 38.85 29.77 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.628 0.727 . . . . 0.01 110.932 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 52.29 55.91 8.47 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.58 -0.7 . . . . 0.01 111.11 178.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -129.18 165.68 20.84 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.319 -0.993 . . . . 3.1499999999999999 108.319 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.23 -163.87 28.02 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.242 -1.543 . . . . 0.01 109.242 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -75.6 144.34 41.84 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.034 -1.274 . . . . 0.01 108.664 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.587 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 27.0 ttp -116.99 142.16 47.31 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.47 0.653 . . . . 0.01 109.859 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -131.72 136.61 47.76 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.127 -1.064 . . . . 2.48 108.127 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -117.96 134.3 55.09 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.495 -0.753 . . . . 0.01 110.08 -178.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.401 ' O ' HG22 ' A' ' 95' ' ' ILE . 7.5 t -148.45 149.42 31.67 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 122.276 1.036 . . . . 1.6899999999999999 111.119 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.5 p -110.51 10.25 23.16 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 115.45 -0.795 . . . . 0.01 110.304 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -121.36 163.45 18.65 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.155 -0.966 . . . . 3.21 111.826 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.5 156.64 36.17 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.142 -1.059 . . . . 0.01 108.142 178.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 21.9 t -126.51 113.17 23.04 Favored Pre-proline 0 N--CA 1.501 2.115 0 O-C-N 121.401 -0.812 . . . . 0.01 108.843 178.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -76.27 -31.21 4.82 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 CA-C-N 120.086 1.066 . . . . 0.01 111.516 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.6 m -141.42 108.05 5.35 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.264 -0.898 . . . . 0.02 109.006 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.88 -38.83 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.861 -0.524 . . . . 1.8300000000000001 110.876 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.1 ttt -68.16 -36.76 80.15 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.234 -0.986 . . . . 1.3400000000000001 110.384 -178.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -71.15 -39.08 72.14 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.421 -1.424 . . . . 2.1099999999999999 110.18 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -79.48 -47.41 15.67 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.236 -0.915 . . . . 2.0800000000000001 112.448 -176.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -110.25 0.85 18.28 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.405 -0.809 . . . . 0.02 112.517 -176.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.565 ' N ' ' ND1' ' A' ' 122' ' ' HIS . 1.2 m-70 59.11 32.36 22.07 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.815 -1.178 . . . . 0.02 109.269 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.3 mt -112.29 135.9 52.39 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 108.433 -0.951 . . . . 0.02 108.433 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -91.44 -22.73 20.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 5.3200000000000003 110.108 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -149.82 163.95 36.65 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.222 -0.924 . . . . 0.02 110.204 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 44.8 mt -132.21 129.34 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 107.434 -1.321 . . . . 2.1699999999999999 107.434 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -106.95 -12.08 15.54 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.318 -0.864 . . . . 0.02 112.457 -177.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 12.5 p -159.54 153.05 22.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.855 -1.153 . . . . 0.01 108.835 178.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.527 ' SG ' HG12 ' A' ' 97' ' ' VAL . 7.2 t -168.51 147.36 4.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.303 -0.873 . . . . 1.22 108.751 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.516 ' NZ ' ' OE1' ' A' ' 155' ' ' GLU . 26.1 tttp -121.1 111.64 17.7 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 122.422 1.106 . . . . 1.4099999999999999 109.561 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.3 t -112.52 129.06 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 107.352 -1.351 . . . . 0.01 107.352 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.2 t -129.48 92.93 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 107.267 -1.383 . . . . 1.98 107.267 177.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.514 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 4.1 tm-20 -147.85 -74.58 0.19 Allowed 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 105.683 -1.969 . . . . 0.01 105.683 177.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 157.55 -55.03 0.38 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.45 -1.46 . . . . 0.01 109.45 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 41.8 p -119.75 101.52 7.95 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.542 -0.975 . . . . 2.2999999999999998 111.446 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.514 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 11.4 m95 -129.51 144.54 51.3 Favored 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 107.516 -1.29 . . . . 0.01 107.516 178.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 97.6 mt -124.25 140.87 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 120.874 -1.141 . . . . 1.6899999999999999 110.486 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.409 ' HB3' HD12 ' A' ' 169' ' ' ILE . 72.5 m-85 -114.17 143.97 43.95 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.153 -1.425 . . . . 2.4900000000000002 107.153 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.498 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 11.8 m-85 -122.93 144.88 48.94 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.146 -0.971 . . . . 0.02 109.531 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -74.64 -29.53 61.3 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.532 -0.73 . . . . 0.02 111.97 -176.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.4 mt -115.82 154.79 48.2 Favored Pre-proline 0 N--CA 1.505 2.299 0 O-C-N 120.783 -1.198 . . . . 1.48 109.166 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -55.37 167.38 1.94 Allowed 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.219 1.279 . . . . 0.02 112.674 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 59.6 31.23 20.81 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.193 -0.912 . . . . 0.75 111.283 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 57.55 51.08 10.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.451 -0.781 . . . . 0.02 111.136 177.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -126.54 165.07 19.82 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.52 -0.737 . . . . 0.02 110.153 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.41 -166.21 33.06 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.285 -1.126 . . . . 0.02 110.285 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -68.68 142.59 55.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.606 -0.937 . . . . 0.02 108.898 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -114.53 148.95 37.19 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.336 0.588 . . . . 0.02 109.932 -178.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -124.48 134.65 52.98 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.824 -0.806 . . . . 0.01 108.824 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.1 tt -98.23 121.32 40.02 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.737 -1.227 . . . . 0.01 108.728 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.716 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 59.6 tp -95.47 155.28 16.81 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.247 -0.908 . . . . 0.01 109.171 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -105.46 -117.88 0.23 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.295 -0.878 . . . . 2.27 109.374 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -156.97 44.6 0.38 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.049 -1.032 . . . . 1.8400000000000001 109.671 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -112.35 -156.06 0.58 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.459 -0.776 . . . . 2.2799999999999998 109.289 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.516 ' OE1' ' NZ ' ' A' ' 130' ' ' LYS . 77.9 mm-40 -106.94 106.24 16.67 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.442 -0.786 . . . . 0.01 109.141 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.716 ' CZ ' HD11 ' A' ' 151' ' ' LEU . 5.2 m-85 -98.97 111.51 23.89 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.341 -0.849 . . . . 0.01 109.531 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -94.7 -22.29 18.22 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.184 -0.947 . . . . 0.01 111.566 -177.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -128.15 154.16 78.69 Favored Pre-proline 0 N--CA 1.503 2.176 0 O-C-N 120.875 -1.141 . . . . 2.54 108.708 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -59.4 -37.19 91.46 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 CA-C-N 119.286 0.781 . . . . 0.69999999999999996 110.64 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 85.3 t -61.25 -19.76 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.795 -1.191 . . . . 0.85999999999999999 109.146 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -65.32 -15.32 62.41 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.952 -1.093 . . . . 0.02 109.996 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.638 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 8.5 m0 -98.13 11.71 36.83 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.19 -0.944 . . . . 0.02 109.102 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 81.11 10.46 84.85 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.934 -1.127 . . . . 0.02 111.341 178.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.09 140.64 32.94 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.031 -1.276 . . . . 0.02 110.206 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.73 -9.54 56.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.608 -0.683 . . . . 0.58999999999999997 109.978 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.1 m -142.02 150.49 56.2 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.181 -0.949 . . . . 0.87 109.134 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -76.61 16.53 0.9 Allowed 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 120.741 0.96 . . . . 0.38 112.47 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.65 122.72 27.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.649 -1.282 . . . . 0.17999999999999999 111.198 -177.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.409 HD12 ' HB3' ' A' ' 138' ' ' PHE . 15.2 mm -151.81 126.39 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 106.595 -1.631 . . . . 3.9900000000000002 106.595 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 64.1 mm-40 -113.57 -12.9 12.82 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.081 -1.012 . . . . 5.1699999999999999 113.634 -177.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.0 p -157.6 162.05 38.71 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 119.083 -2.261 . . . . 0.02 110.235 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.426 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 16.9 p90 -151.97 151.98 31.89 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.132 -0.98 . . . . 2.02 110.633 179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -145.0 149.66 35.53 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.304 -0.872 . . . . 0.01 109.991 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -88.52 144.29 26.43 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.512 -0.742 . . . . 0.01 109.439 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.4 mt -93.67 129.55 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.233 -0.917 . . . . 3.04 109.092 178.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 14.5 t -137.1 147.4 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.248 -0.907 . . . . 1.8899999999999999 109.676 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.35 -0.844 . . . . 4.8899999999999997 109.39 179.815 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.313 0.578 . . . . 5.2800000000000002 109.479 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -151.53 64.93 0.87 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.219 -0.926 . . . . 5.96 109.36 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.6 t -80.89 142.82 33.21 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.39 -0.967 . . . . 2.2200000000000002 108.39 178.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.23 179.33 48.17 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 118.289 -1.91 . . . . 0.81000000000000005 112.043 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.92 157.11 43.03 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.416 -1.474 . . . . 0.01 109.416 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -146.18 135.18 22.58 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.363 -1.081 . . . . 0.02 110.603 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.3 tt -129.44 139.6 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.108 -1.071 . . . . 0.02 108.108 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 m -120.45 129.55 53.93 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.326 -0.859 . . . . 0.39000000000000001 110.208 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 6.2 m-85 -110.34 139.89 45.08 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 109.026 -0.731 . . . . 0.02 109.026 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.561 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.2 m-85 -121.28 137.99 54.44 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.135 -0.978 . . . . 0.02 109.299 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -69.71 -27.59 65.11 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.096 -1.003 . . . . 0.029999999999999999 111.531 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -113.68 169.54 8.91 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.932 -1.105 . . . . 0.029999999999999999 110.067 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -75.37 157.41 34.28 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.66 0.743 . . . . 0.029999999999999999 110.401 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 1.1 m-20 66.31 33.95 6.77 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.768 0.794 . . . . 0.73999999999999999 111.297 178.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 55.41 41.23 31.24 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.247 0.546 . . . . 0.02 111.335 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -113.13 165.61 12.22 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.152 -1.055 . . . . 0.02 108.152 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.09 -167.01 35.72 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.758 -1.211 . . . . 0.029999999999999999 110.757 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.569 ' CG ' HH11 ' A' ' 18' ' ' ARG . 0.0 OUTLIER -68.59 141.57 55.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.502 -0.999 . . . . 2.7599999999999998 109.275 179.553 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -121.96 150.1 42.52 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.629 -0.67 . . . . 1.8899999999999999 109.842 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -137.96 133.95 34.33 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.559 -0.713 . . . . 0.02 109.677 178.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -109.26 135.77 49.8 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.327 -0.858 . . . . 1.1200000000000001 108.886 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.6 t -127.16 137.98 53.06 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.55 -0.719 . . . . 0.02 109.125 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.5 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 4.1 p30 -118.62 11.72 12.91 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.644 -0.66 . . . . 0.20000000000000001 110.611 -179.389 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 25.5 m -158.88 174.26 15.26 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.664 -1.272 . . . . 1.23 108.948 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.454 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 2.3 m-20 -62.2 145.98 52.04 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.756 -1.215 . . . . 0.02 110.418 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 18.0 m -134.04 117.05 16.22 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.779 -0.822 . . . . 0.02 108.779 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.12 -20.48 52.07 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.369 -0.832 . . . . 0.23999999999999999 111.911 -177.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -151.16 106.14 3.3 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.57 -1.331 . . . . 1.1399999999999999 109.547 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.61 5.04 43.8 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.436 -0.79 . . . . 6.3700000000000001 110.276 -178.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -61.22 -28.36 69.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 3.1099999999999999 112.204 -177.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.5 t -79.12 -18.7 52.74 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.262 -1.523 . . . . 0.88 111.779 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -105.75 -21.82 13.09 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.138 -0.976 . . . . 0.02 110.682 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 33' ' ' LEU . 50.9 mt -148.88 128.31 13.05 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.032 -1.043 . . . . 3.3199999999999998 109.109 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.2 t -86.1 -11.11 53.58 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.676 -0.64 . . . . 0.02 110.385 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -172.84 162.26 4.78 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.147 -1.056 . . . . 0.02 108.147 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 24.9 m -144.03 116.32 8.5 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.064 -1.022 . . . . 0.02 108.632 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.421 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 17.9 t-20 -108.84 0.46 20.32 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 120.822 -1.174 . . . . 0.029999999999999999 111.673 -177.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.2 t -155.87 153.51 29.83 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.048 -1.093 . . . . 0.02 108.048 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.7 mt -146.9 147.37 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.069 -1.019 . . . . 0.02 110.871 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -123.65 124.56 43.03 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.154 -1.054 . . . . 0.02 108.154 177.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.7 t -106.32 115.0 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 106.917 -1.512 . . . . 0.02 106.917 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -83.32 -33.8 25.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.448 -0.782 . . . . 3.8100000000000001 110.728 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.48 152.09 21.93 Favored Glycine 0 N--CA 1.488 2.11 0 C-N-CA 118.883 -1.627 . . . . 0.02 110.82 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.04 173.18 49.62 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.655 -1.259 . . . . 0.01 110.708 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.2 m -119.32 134.88 54.98 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.011 -1.107 . . . . 1.48 108.011 177.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -126.75 155.51 42.64 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 122.587 1.185 . . . . 0.02 112.214 -176.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.39 134.02 52.35 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 105.631 -1.989 . . . . 0.23999999999999999 105.631 176.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.416 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.3 m -118.86 143.76 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.561 -0.712 . . . . 0.65000000000000002 109.083 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -120.99 145.72 47.45 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 122.222 1.01 . . . . 0.02 110.079 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -65.92 -33.8 76.66 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.805 -0.634 . . . . 0.02 111.052 -177.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -125.17 157.7 66.3 Favored Pre-proline 0 N--CA 1.503 2.21 0 O-C-N 121.092 -1.005 . . . . 0.02 109.416 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.47 166.95 1.01 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.714 1.61 . . . . 0.02 113.119 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 63.73 36.4 10.66 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.198 -0.91 . . . . 0.02 111.123 178.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 45.19 51.71 9.01 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.576 0.703 . . . . 3.3900000000000001 110.804 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.4 t -126.03 163.44 23.05 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.137 0.494 . . . . 2.3300000000000001 109.857 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.18 -161.62 31.69 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.761 -1.335 . . . . 0.02 109.761 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -64.88 138.97 58.7 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.102 -1.234 . . . . 0.02 110.029 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 14.6 ptm -119.06 137.18 53.73 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.674 -0.641 . . . . 5.0099999999999998 109.524 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.581 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 89.8 m-85 -134.03 138.46 45.38 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.422 -0.798 . . . . 0.02 109.836 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.1 mm -95.24 131.45 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.058 -0.719 . . . . 1.72 109.058 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.467 HD22 ' CE1' ' A' ' 66' ' ' TYR . 12.2 mt -121.0 111.45 34.06 Favored Pre-proline 0 N--CA 1.504 2.244 0 O-C-N 121.411 -0.806 . . . . 0.02 110.812 -178.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -77.11 169.55 21.3 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 CA-C-N 119.867 0.988 . . . . 1.47 109.853 177.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -52.6 141.31 20.91 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.766 -1.208 . . . . 4.25 110.338 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.38 -177.76 32.39 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.621 -1.276 . . . . 0.02 110.692 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -120.48 131.83 54.92 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.432 -1.04 . . . . 0.95999999999999996 109.774 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.467 ' CE1' HD22 ' A' ' 61' ' ' LEU . 92.6 m-85 -121.49 98.68 46.02 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 108.15 -1.056 . . . . 0.02 108.15 179.104 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -70.39 -3.66 12.88 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 120.861 1.041 . . . . 0.02 113.813 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -157.55 154.46 28.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.824 -1.172 . . . . 2.02 108.141 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -60.46 -38.85 85.5 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.557 -0.715 . . . . 0.02 111.929 -177.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -59.79 -23.71 63.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.916 -1.115 . . . . 0.02 110.272 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -70.68 -18.68 62.83 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.924 0.869 . . . . 3.4199999999999999 108.763 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.581 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.2 t90 -107.96 9.93 28.5 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.496 -1.298 . . . . 0.02 107.496 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 8.5 mtt 61.29 22.63 12.97 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.494 0.664 . . . . 0.02 110.503 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.52 144.41 45.81 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.762 -1.335 . . . . 0.02 109.762 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.545 HD23 ' O ' ' A' ' 75' ' ' LEU . 1.0 OUTLIER -79.63 -31.54 41.61 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.34 -1.356 . . . . 0.97999999999999998 107.34 177.826 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -157.02 -171.43 3.64 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 106.317 -1.734 . . . . 0.02 106.317 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -98.49 28.52 4.12 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.55 -1.344 . . . . 0.02 110.757 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -97.07 122.51 40.15 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.863 -1.148 . . . . 3.2000000000000002 110.974 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.503 HD21 ' CH2' ' A' ' 72' ' ' TRP . 75.0 mt -141.92 119.13 11.41 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.611 -1.255 . . . . 2.6099999999999999 107.611 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.73 -18.04 9.86 Favored Glycine 0 N--CA 1.499 2.875 0 O-C-N 121.211 -0.931 . . . . 0.02 112.524 -177.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.4 p -156.18 155.67 32.87 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 119.967 -1.902 . . . . 0.02 110.464 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 24.8 p -145.32 147.92 32.86 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.698 -0.626 . . . . 0.02 110.0 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 33.5 mtp180 -137.47 142.74 41.54 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.412 -0.805 . . . . 0.01 109.397 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.73 132.99 36.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 0.42999999999999999 109.862 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.6 t -91.97 124.86 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 109.027 -0.731 . . . . 1.25 109.027 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -94.36 132.1 39.33 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.706 -1.246 . . . . 1.77 109.238 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -96.33 139.77 31.98 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.672 -0.862 . . . . 1.6299999999999999 108.672 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.424 ' O ' ' OE2' ' A' ' 133' ' ' GLU . 87.8 p -111.47 128.02 55.87 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.345 -0.847 . . . . 1.0800000000000001 109.26 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.8 m -104.47 -154.18 0.5 Allowed 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 106.63 -1.618 . . . . 1.26 106.63 177.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.75 -52.7 0.74 Allowed Glycine 0 N--CA 1.5 2.965 0 O-C-N 120.399 -1.438 . . . . 0.01 112.737 177.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.17 -101.65 0.16 Allowed Glycine 0 N--CA 1.491 2.335 0 C-N-CA 118.467 -1.825 . . . . 0.01 111.953 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -121.61 118.86 30.25 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.122 -1.222 . . . . 4.4299999999999997 110.635 -178.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.5 129.85 34.85 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.836 -0.746 . . . . 2.9900000000000002 109.488 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -129.82 142.41 50.68 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.436 -0.79 . . . . 6.3600000000000003 109.058 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.435 ' O ' ' OE2' ' A' ' 109' ' ' GLU . 4.3 tt -128.81 144.56 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.344 -0.848 . . . . 1.0900000000000001 110.181 -179.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -121.52 134.16 55.04 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.541 -1.281 . . . . 2.0499999999999998 107.541 177.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.492 HG12 ' SG ' ' A' ' 129' ' ' CYS . 14.5 m -124.03 145.51 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 O-C-N 120.728 -1.232 . . . . 1.1000000000000001 109.903 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -119.05 141.4 48.76 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.983 0.896 . . . . 0.72999999999999998 110.851 -178.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -67.09 -30.64 70.73 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 116.065 -0.516 . . . . 0.02 111.812 -178.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -116.46 168.1 10.46 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.945 -1.097 . . . . 3.1800000000000002 110.473 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.2 163.92 44.86 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 111.044 -0.822 . . . . 0.01 111.044 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.5 t0 56.91 39.33 29.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.878 -0.778 . . . . 0.01 111.059 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 51.71 56.47 7.81 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.617 -0.677 . . . . 0.01 111.007 178.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -129.7 165.98 20.75 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.023 -1.103 . . . . 3.1499999999999999 108.023 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.24 -164.41 28.34 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.13 -1.588 . . . . 0.01 109.13 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -75.7 144.61 41.47 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.981 -1.305 . . . . 0.01 108.573 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.452 ' C ' ' SD ' ' A' ' 107' ' ' MET . 12.5 tmm? -116.25 142.21 47.14 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.634 0.73 . . . . 0.01 109.897 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.501 ' CD1' ' N ' ' A' ' 108' ' ' TYR . 8.0 m-85 -131.15 136.48 48.37 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.337 -0.986 . . . . 2.48 108.337 178.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.435 ' OE2' ' O ' ' A' ' 95' ' ' ILE . 5.2 tp10 -115.72 133.47 56.0 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.687 -0.633 . . . . 0.01 109.968 -178.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.9 t -148.47 147.95 29.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.021 -1.049 . . . . 1.6899999999999999 111.183 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.1 p -111.67 9.72 21.0 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 115.451 -0.795 . . . . 0.01 110.24 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 26.5 mp0 -121.39 163.5 18.6 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 121.238 -0.914 . . . . 3.21 111.72 -178.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -68.1 156.81 36.65 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.323 -0.991 . . . . 0.01 108.323 178.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.437 ' SG ' ' OE1' ' A' ' 120' ' ' GLN . 33.7 t -125.57 113.98 25.23 Favored Pre-proline 0 N--CA 1.502 2.142 0 O-C-N 121.531 -0.731 . . . . 0.01 109.23 178.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -75.27 -30.89 6.34 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 CA-C-N 120.245 1.123 . . . . 0.01 111.035 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.4 p -142.45 108.44 5.19 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.804 0.811 . . . . 0.02 109.0 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 73.1 mt -63.21 -38.35 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.839 -0.538 . . . . 1.8300000000000001 110.742 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 20.4 ttt -68.14 -36.53 79.83 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.121 -1.032 . . . . 1.3400000000000001 110.227 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -70.53 -38.75 74.27 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.514 -1.367 . . . . 2.1099999999999999 110.001 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.437 ' OE1' ' SG ' ' A' ' 114' ' ' CYS . 52.0 tt0 -79.61 -47.47 15.4 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.317 -0.865 . . . . 2.0800000000000001 112.471 -177.003 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -110.42 0.46 17.87 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.362 -0.837 . . . . 0.02 112.698 -176.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 59.28 32.99 22.37 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.761 -1.212 . . . . 0.02 109.067 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 mt -112.09 135.26 52.98 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 108.487 -0.931 . . . . 0.02 108.487 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -91.23 -22.28 20.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 5.3200000000000003 110.031 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -149.79 163.89 36.77 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.36 -0.838 . . . . 0.02 110.0 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 55.4 mt -131.33 128.47 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 107.474 -1.306 . . . . 2.1699999999999999 107.474 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -107.85 -12.16 15.24 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.412 -0.805 . . . . 0.02 112.36 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.3 m -159.16 152.17 22.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.887 -1.133 . . . . 0.01 108.99 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.492 ' SG ' HG12 ' A' ' 97' ' ' VAL . 10.9 t -168.86 146.87 3.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 1.22 108.795 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.3 tttp -120.6 112.45 18.93 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 122.422 1.106 . . . . 1.4099999999999999 109.515 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.3 t -113.46 129.52 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 107.821 -1.177 . . . . 0.01 107.821 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.9 t -129.72 92.97 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 106.936 -1.505 . . . . 1.98 106.936 177.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.584 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 9.4 tm-20 -147.16 -74.84 0.2 Allowed 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 105.829 -1.915 . . . . 0.01 105.829 177.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.422 ' N ' ' OE1' ' A' ' 133' ' ' GLU . . . 169.68 -69.64 0.15 Allowed Glycine 0 N--CA 1.482 1.723 0 N-CA-C 108.656 -1.777 . . . . 0.01 108.656 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.436 ' CB ' HD12 ' A' ' 175' ' ' ILE . 17.9 p -121.17 118.48 29.76 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.631 -0.923 . . . . 2.2999999999999998 110.569 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.584 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 8.4 m95 -128.1 148.55 50.58 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 107.063 -1.458 . . . . 0.01 107.063 178.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 89.9 mt -123.27 138.07 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 120.373 -1.454 . . . . 1.6899999999999999 110.491 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -114.96 144.11 44.09 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 107.553 -1.277 . . . . 2.4900000000000002 107.553 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.507 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 12.1 m-85 -123.02 143.94 49.6 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.235 -0.916 . . . . 0.02 109.592 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -75.06 -28.79 60.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.389 -0.82 . . . . 0.02 112.028 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 55.0 mt -115.28 151.82 46.23 Favored Pre-proline 0 N--CA 1.504 2.264 0 O-C-N 120.563 -1.335 . . . . 1.48 109.027 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -54.06 167.66 1.11 Allowed 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 120.906 1.071 . . . . 0.02 112.54 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 59.12 30.18 19.9 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 115.164 -0.925 . . . . 0.75 111.19 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 57.94 51.39 9.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.4 -0.813 . . . . 0.02 111.469 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -125.84 164.13 21.39 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.398 -0.814 . . . . 0.02 109.951 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.38 -165.18 32.41 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.31 -1.116 . . . . 0.02 110.31 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -69.06 142.09 54.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.604 -0.939 . . . . 0.02 109.126 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -115.24 149.07 38.34 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.832 -0.543 . . . . 0.02 109.918 -178.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.534 ' CE1' ' O ' ' A' ' 162' ' ' TRP . 42.6 t80 -124.94 135.82 53.18 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 109.15 -0.685 . . . . 0.01 109.15 179.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.5 tt -98.45 120.88 39.63 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.941 -1.1 . . . . 0.01 108.808 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.507 ' N ' HD23 ' A' ' 150' ' ' LEU . 7.4 tt -98.51 149.74 22.41 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.139 -0.976 . . . . 0.01 108.857 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -104.93 -98.47 0.32 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.424 -0.798 . . . . 2.27 110.007 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 47.1 pttt -167.36 49.09 0.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.077 -1.014 . . . . 1.8400000000000001 109.515 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.575 ' CG ' ' H ' ' A' ' 155' ' ' GLU . 38.5 tttm -113.34 -175.58 2.7 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.984 -0.747 . . . . 2.2799999999999998 108.984 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.575 ' H ' ' CG ' ' A' ' 154' ' ' LYS . 84.6 mt-10 -100.25 109.5 21.72 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.197 -0.939 . . . . 0.01 108.693 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.675 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 30.2 m-85 -98.33 113.87 25.99 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.427 -0.795 . . . . 0.01 110.079 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -94.8 -22.48 18.03 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.23 -0.919 . . . . 0.01 111.614 -178.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -127.7 154.79 77.87 Favored Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 120.771 -1.206 . . . . 2.54 109.148 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -60.78 -38.94 66.9 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 120.489 0.793 . . . . 0.69999999999999996 110.443 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 96.8 t -60.94 -20.11 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.867 -1.146 . . . . 0.85999999999999999 108.821 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 43.2 t0 -65.68 -15.39 62.74 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.976 -1.078 . . . . 0.02 109.785 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.675 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 22.8 m0 -95.79 10.74 36.01 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.497 -0.927 . . . . 0.02 108.497 178.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 78.56 9.87 86.67 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.603 -1.284 . . . . 0.02 110.621 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.38 142.04 31.38 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.361 -1.082 . . . . 0.02 110.078 -178.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.59 -8.72 58.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.655 -0.653 . . . . 0.58999999999999997 109.629 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 21.6 p -144.81 150.32 46.03 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 120.894 -1.129 . . . . 0.87 108.534 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -75.94 21.26 0.51 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 120.718 0.945 . . . . 0.38 112.518 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.38 123.05 28.75 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.786 -1.197 . . . . 0.17999999999999999 111.566 -177.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 4.1 mt -149.78 127.6 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 107.041 -1.466 . . . . 3.9900000000000002 107.041 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -113.67 -15.15 12.53 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 113.684 0.994 . . . . 5.1699999999999999 113.684 -177.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 8.2 t -157.63 160.96 38.6 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 119.132 -2.23 . . . . 0.02 110.445 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.439 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 16.4 p90 -151.66 152.73 33.21 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.085 -1.01 . . . . 2.02 110.499 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 43.4 mtp180 -144.76 149.93 36.36 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.882 0.849 . . . . 0.01 110.189 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -88.08 144.32 26.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.59 -0.694 . . . . 0.01 109.154 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.436 HD12 ' CB ' ' A' ' 135' ' ' THR . 4.6 mt -94.32 128.86 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.274 -0.891 . . . . 3.04 109.128 178.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.8 p -136.2 146.24 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.124 -0.985 . . . . 1.8899999999999999 109.499 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 N--CA 1.488 1.448 0 O-C-N 121.151 -0.968 . . . . 4.8899999999999997 109.465 -179.978 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.9 m . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.473 -0.565 . . . . 5.2800000000000002 109.473 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -71.76 64.94 0.49 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.215 -0.928 . . . . 5.96 109.387 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 44.6 p -81.11 143.35 32.48 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.391 -0.966 . . . . 2.2200000000000002 108.391 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.58 179.73 47.89 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 118.322 -1.894 . . . . 0.81000000000000005 112.026 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.92 157.63 43.63 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.412 -1.475 . . . . 0.01 109.412 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -145.9 134.74 22.44 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.312 -1.111 . . . . 0.02 110.531 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.1 tt -129.46 139.57 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.053 -1.092 . . . . 0.02 108.053 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.507 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.0 OUTLIER -121.89 130.54 53.44 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.437 -0.789 . . . . 0.39000000000000001 110.119 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.1 m-85 -110.18 139.98 44.77 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 109.114 -0.699 . . . . 0.02 109.114 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.525 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.8 m-85 -121.9 138.47 54.39 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.302 -0.874 . . . . 0.02 109.325 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -69.32 -27.32 65.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.16 -0.962 . . . . 0.029999999999999999 111.508 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 2.1 m-20 -114.11 169.4 9.04 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.921 -1.112 . . . . 0.029999999999999999 110.217 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -75.96 158.71 31.66 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.612 0.72 . . . . 0.029999999999999999 110.258 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.9 t30 66.06 33.25 7.72 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 122.018 0.913 . . . . 0.73999999999999999 111.123 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 55.68 42.29 29.52 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 116.007 -0.542 . . . . 0.02 111.471 177.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -113.81 166.18 11.82 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.395 -0.965 . . . . 0.02 108.395 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.87 -167.61 34.97 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 119.923 -1.132 . . . . 0.029999999999999999 110.75 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.587 ' CG ' HH11 ' A' ' 18' ' ' ARG . 0.4 OUTLIER -69.42 143.0 53.74 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.48 -1.012 . . . . 2.7599999999999998 109.091 179.445 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.504 ' HE ' ' CB ' ' A' ' 8' ' ' SER . 52.5 ttt180 -121.58 148.94 43.86 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.582 -0.699 . . . . 1.8899999999999999 110.105 -178.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.603 ' CZ ' ' CG ' ' A' ' 32' ' ' TYR . 7.2 t80 -135.1 130.75 36.0 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.781 -0.822 . . . . 0.02 108.781 178.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 18.7 p-10 -111.94 137.78 49.46 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.468 -0.77 . . . . 1.1200000000000001 109.411 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 45.9 t -130.38 139.81 50.62 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.596 -0.69 . . . . 0.02 109.6 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.5 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 10.8 p30 -117.78 11.93 13.73 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.723 -0.611 . . . . 0.20000000000000001 110.225 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 34.6 m -158.63 174.77 14.54 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.887 -1.133 . . . . 1.23 108.644 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -61.96 145.17 53.76 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.694 -1.254 . . . . 0.02 110.033 -179.731 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.435 ' CB ' ' CZ ' ' A' ' 29' ' ' PHE . 0.8 OUTLIER -133.68 119.08 18.9 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 108.725 -0.842 . . . . 0.02 108.725 178.449 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.44 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -77.11 -19.39 57.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.23999999999999999 111.745 -177.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -154.13 107.94 2.97 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.559 -1.338 . . . . 1.1399999999999999 110.862 -178.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.435 ' CZ ' ' CB ' ' A' ' 26' ' ' CYS . 17.1 m-85 -96.53 5.72 50.2 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.206 -0.934 . . . . 6.3700000000000001 109.303 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -60.25 -30.67 69.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.364 -0.835 . . . . 3.1099999999999999 112.206 -176.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.6 m -78.82 -18.96 53.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.308 -1.495 . . . . 0.88 111.29 -178.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.603 ' CG ' ' CZ ' ' A' ' 20' ' ' TYR . 56.6 m-85 -106.68 -22.17 12.82 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.345 -0.847 . . . . 0.02 110.905 -178.165 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.442 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 5.1 tp -149.24 127.2 11.9 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.83 -1.169 . . . . 3.3199999999999998 109.609 -178.05 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.0 t -86.21 -11.31 52.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.64 -0.662 . . . . 0.02 110.95 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.442 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 13.2 ptm180 -172.96 162.69 4.72 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.914 -1.117 . . . . 0.02 108.404 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.0 t -142.23 115.02 8.63 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.968 -1.083 . . . . 0.02 108.663 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 16.1 t-20 -107.5 -0.71 21.98 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.864 -1.147 . . . . 0.029999999999999999 110.866 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.5 t -156.08 152.67 28.29 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.902 -1.147 . . . . 0.02 107.902 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 87.6 mt -145.67 148.12 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 CA-C-O 122.435 1.112 . . . . 0.02 110.313 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -123.86 124.08 41.86 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.82 -1.178 . . . . 0.02 107.82 176.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.7 t -106.47 115.25 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 106.859 -1.534 . . . . 0.02 106.859 177.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -83.49 -33.74 25.51 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.021 -0.672 . . . . 3.8100000000000001 110.738 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.48 152.17 22.05 Favored Glycine 0 N--CA 1.489 2.175 0 C-N-CA 118.922 -1.608 . . . . 0.02 110.891 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.97 173.22 49.63 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.709 -1.234 . . . . 0.01 110.632 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.6 m -120.15 135.76 54.85 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.099 -1.075 . . . . 1.48 108.099 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.417 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 37.8 m95 -128.01 155.74 43.82 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 122.7 1.238 . . . . 0.02 112.17 -176.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.75 134.5 51.38 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 105.57 -2.011 . . . . 0.23999999999999999 105.57 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.441 ' HB ' HD22 ' A' ' 79' ' ' LEU . 31.4 m -119.92 144.76 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.579 -0.701 . . . . 0.65000000000000002 109.3 179.076 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -121.45 145.7 47.66 Favored 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 122.313 1.054 . . . . 0.02 110.263 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -66.87 -34.09 77.03 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.836 -0.62 . . . . 0.02 111.496 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -124.93 157.97 64.64 Favored Pre-proline 0 N--CA 1.503 2.185 0 O-C-N 121.028 -1.045 . . . . 0.02 109.36 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.35 165.31 1.55 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.716 1.611 . . . . 0.02 113.176 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 63.84 36.95 10.02 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.159 -0.928 . . . . 0.02 111.055 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 45.08 51.84 8.71 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.686 0.755 . . . . 3.3900000000000001 110.78 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.5 t -125.92 163.61 22.59 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 121.145 0.498 . . . . 2.3300000000000001 109.811 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.83 -161.46 32.04 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.797 -1.321 . . . . 0.02 109.797 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.425 ' ND1' ' N ' ' A' ' 57' ' ' HIS . 4.7 m80 -64.63 139.77 58.8 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.075 -1.25 . . . . 0.02 110.289 -179.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.497 ' O ' ' SD ' ' A' ' 58' ' ' MET . 2.9 ppp? -119.97 136.95 54.34 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.648 -0.657 . . . . 5.0099999999999998 109.594 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.567 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 88.2 m-85 -134.81 138.85 44.62 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.353 -0.842 . . . . 0.02 109.948 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.5 mm -95.25 131.36 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.034 -0.728 . . . . 1.72 109.034 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.48 HD22 ' CE1' ' A' ' 66' ' ' TYR . 11.4 mt -120.26 111.06 35.47 Favored Pre-proline 0 N--CA 1.506 2.361 0 O-C-N 121.371 -0.831 . . . . 0.02 110.763 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -77.32 169.42 21.3 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 CA-C-N 119.836 0.977 . . . . 1.47 109.769 177.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -52.59 140.94 21.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.821 -1.174 . . . . 4.25 110.307 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.75 -177.52 32.82 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.454 -1.355 . . . . 0.02 110.597 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -120.48 131.75 54.88 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.535 -0.98 . . . . 0.95999999999999996 109.692 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.48 ' CE1' HD22 ' A' ' 61' ' ' LEU . 91.0 m-85 -121.54 99.13 45.51 Favored Pre-proline 0 N--CA 1.495 1.783 0 N-CA-C 107.882 -1.155 . . . . 0.02 107.882 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -70.86 -3.71 13.29 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 120.628 0.885 . . . . 0.02 113.642 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -157.6 154.9 29.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.71 -1.243 . . . . 2.02 108.029 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -60.2 -39.0 85.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.474 -0.767 . . . . 0.02 111.881 -177.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -59.79 -24.0 63.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.094 -1.004 . . . . 0.02 110.386 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -70.59 -18.83 62.89 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.901 0.858 . . . . 3.4199999999999999 108.802 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.567 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.4 t90 -107.92 9.9 28.6 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.477 -1.305 . . . . 0.02 107.477 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.5 mtp 61.27 22.47 12.82 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.495 0.664 . . . . 0.02 110.536 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.53 144.08 46.06 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.492 -1.443 . . . . 0.02 109.492 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.7 tp -79.05 -30.92 44.33 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.552 -1.277 . . . . 0.97999999999999998 107.552 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -157.05 -171.39 3.62 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 106.241 -1.763 . . . . 0.02 106.241 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -98.22 28.33 4.12 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.647 -1.283 . . . . 0.02 110.609 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.7 mtm180 -96.84 122.15 39.49 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.95 -1.094 . . . . 3.2000000000000002 110.985 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.513 HD21 ' CH2' ' A' ' 72' ' ' TRP . 63.5 mt -142.82 120.5 11.84 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.672 -1.232 . . . . 2.6099999999999999 107.672 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.68 -18.32 9.07 Favored Glycine 0 N--CA 1.502 3.05 0 O-C-N 121.215 -0.928 . . . . 0.02 112.871 -177.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 12.6 m -156.96 157.71 35.27 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 119.956 1.878 . . . . 0.02 110.864 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 27.0 m -146.49 149.84 34.42 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.627 -0.671 . . . . 0.02 109.943 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -138.51 143.17 39.42 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.395 -0.815 . . . . 0.01 109.183 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.3 132.18 36.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -0.94 . . . . 0.42999999999999999 109.725 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.8 t -90.61 124.83 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.726 -0.842 . . . . 1.25 108.726 178.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -93.35 132.17 37.83 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.797 -1.189 . . . . 1.77 109.017 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mt -96.8 139.29 33.07 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.453 -0.943 . . . . 1.6299999999999999 108.453 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.5 p -111.35 127.5 55.67 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.355 -0.84 . . . . 1.0800000000000001 109.17 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 51.8 p -104.12 -154.53 0.51 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 106.448 -1.686 . . . . 1.26 106.448 177.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.39 -51.63 0.78 Allowed Glycine 0 N--CA 1.502 3.05 0 O-C-N 120.558 -1.339 . . . . 0.01 112.636 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.26 -100.92 0.15 Allowed Glycine 0 N--CA 1.489 2.193 0 C-N-CA 118.464 -1.827 . . . . 0.01 111.932 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -121.4 118.79 30.31 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.034 -1.274 . . . . 4.4299999999999997 110.543 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.41 131.08 36.79 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.819 -0.753 . . . . 2.9900000000000002 109.399 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -129.81 140.56 51.0 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.472 -0.767 . . . . 6.3600000000000003 109.203 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 tt -127.4 144.12 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.407 -0.808 . . . . 1.0900000000000001 109.864 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -122.29 133.05 54.69 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.692 -1.225 . . . . 2.0499999999999998 107.692 176.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.502 HG12 ' SG ' ' A' ' 129' ' ' CYS . 15.8 m -123.67 145.86 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 O-C-N 120.662 -1.274 . . . . 1.1000000000000001 109.682 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -119.13 141.31 48.92 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 121.97 0.891 . . . . 0.72999999999999998 110.843 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -67.03 -30.41 70.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.888 -0.507 . . . . 0.02 111.775 -178.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -116.12 167.39 11.03 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.046 -1.033 . . . . 3.1800000000000002 110.533 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.06 164.43 43.79 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.981 -0.848 . . . . 0.01 110.981 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 56.95 38.8 29.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.909 -0.759 . . . . 0.01 110.884 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 52.14 56.02 8.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.637 -0.665 . . . . 0.01 111.047 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -129.19 165.81 20.6 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 108.208 -1.034 . . . . 3.1499999999999999 108.208 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.99 -163.92 27.11 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.247 -1.541 . . . . 0.01 109.247 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.559 ' NE2' ' O ' ' A' ' 107' ' ' MET . 11.1 tm0? -76.0 144.39 40.94 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.043 -1.269 . . . . 0.01 108.348 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.559 ' O ' ' NE2' ' A' ' 106' ' ' GLN . 12.8 tmm? -116.57 141.81 47.7 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.635 0.731 . . . . 0.01 109.959 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.472 ' CE2' ' OE1' ' A' ' 106' ' ' GLN . 39.4 m-85 -131.2 136.45 48.27 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.176 -1.046 . . . . 2.48 108.176 178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.522 ' OE2' ' N ' ' A' ' 110' ' ' THR . 1.9 tm-20 -119.47 134.73 55.08 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.544 -0.723 . . . . 0.01 109.961 -178.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.522 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 7.8 t -148.69 151.81 35.58 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 122.233 1.016 . . . . 1.6899999999999999 111.065 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.7 p -111.83 9.49 20.72 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.645 -0.707 . . . . 0.01 110.377 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -121.43 163.27 19.02 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.122 -0.986 . . . . 3.21 111.719 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -68.12 157.09 36.08 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.344 -0.984 . . . . 0.01 108.344 178.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 20.7 t -126.59 114.15 22.87 Favored Pre-proline 0 N--CA 1.504 2.231 0 O-C-N 121.48 -0.763 . . . . 0.01 109.088 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -75.12 -29.42 8.06 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 CA-C-N 120.319 1.15 . . . . 0.01 111.213 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 69.4 m -142.61 109.1 5.33 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.485 -0.759 . . . . 0.02 109.055 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.408 HD12 ' O ' ' A' ' 169' ' ' ILE . 97.4 mt -63.9 -38.96 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.801 -0.562 . . . . 1.8300000000000001 110.667 -178.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 41.9 ttp -68.58 -37.29 79.73 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.272 -0.971 . . . . 1.3400000000000001 110.247 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -69.93 -38.64 76.26 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.502 -1.374 . . . . 2.1099999999999999 110.026 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.534 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 42.7 tt0 -79.93 -46.89 15.93 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.289 -0.882 . . . . 2.0800000000000001 112.379 -176.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.534 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 44.3 m-85 -110.67 -0.01 17.32 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.434 -0.792 . . . . 0.02 112.657 -176.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.1 m80 59.69 33.13 21.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.73 -1.231 . . . . 0.02 109.489 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.5 mt -112.78 135.94 52.95 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 108.728 -0.841 . . . . 0.02 108.728 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -91.6 -22.71 20.16 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.266 -0.896 . . . . 5.3200000000000003 110.415 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -149.59 164.33 35.43 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.089 -1.007 . . . . 0.02 109.867 -178.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 37.3 mt -131.92 128.86 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 107.642 -1.244 . . . . 2.1699999999999999 107.642 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -108.76 -12.3 14.94 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.342 -0.849 . . . . 0.02 112.462 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.5 t -159.03 151.75 21.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.736 -1.228 . . . . 0.01 109.019 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.502 ' SG ' HG12 ' A' ' 97' ' ' VAL . 7.6 t -168.74 147.25 4.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 1.22 109.114 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -121.9 111.48 17.14 Favored 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 122.415 1.103 . . . . 1.4099999999999999 109.711 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.1 t -113.33 130.7 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.678 -1.23 . . . . 0.01 107.678 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 44.1 t -129.89 93.37 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 107.176 -1.416 . . . . 1.98 107.176 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.507 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 26.0 tt0 -147.02 -75.21 0.2 Allowed 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 105.799 -1.926 . . . . 0.01 105.799 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 177.44 -78.19 0.07 OUTLIER Glycine 0 N--CA 1.483 1.791 0 N-CA-C 108.104 -1.998 . . . . 0.01 108.104 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.574 ' OG1' HD12 ' A' ' 175' ' ' ILE . 1.2 t -121.82 125.3 46.17 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.649 -0.912 . . . . 2.2999999999999998 110.183 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.507 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 7.5 m95 -126.47 151.98 47.04 Favored 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 107.07 -1.456 . . . . 0.01 107.07 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 48.2 mt -120.61 135.37 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 120.329 -1.482 . . . . 1.6899999999999999 110.297 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -114.73 144.56 43.27 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 107.465 -1.309 . . . . 2.4900000000000002 107.465 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.503 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 15.2 m-85 -123.25 143.68 49.89 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.33 -0.856 . . . . 0.02 109.631 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -76.15 -29.23 57.7 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.54 -0.725 . . . . 0.02 112.389 -176.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.4 mt -115.43 154.78 47.67 Favored Pre-proline 0 N--CA 1.507 2.408 0 O-C-N 120.654 -1.279 . . . . 1.48 109.081 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.34 164.71 2.66 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 121.191 1.261 . . . . 0.02 112.79 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 51.9 t30 59.94 32.0 20.95 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.077 -0.965 . . . . 0.75 111.59 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 57.24 51.48 10.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.482 -0.762 . . . . 0.02 111.315 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -126.05 164.86 19.93 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.487 -0.758 . . . . 0.02 109.864 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.19 -165.92 33.15 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.346 -1.102 . . . . 0.02 110.346 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -69.57 143.31 53.38 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.563 -0.963 . . . . 0.02 109.207 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -115.16 149.67 37.28 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.206 0.526 . . . . 0.02 109.788 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -124.38 135.11 53.06 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 109.17 -0.678 . . . . 0.01 109.17 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.7 tp -96.7 119.93 36.09 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.608 -1.308 . . . . 0.01 109.264 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.694 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 59.1 tp -98.92 153.44 18.82 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.347 -0.846 . . . . 0.01 109.159 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.411 ' CG ' ' N ' ' A' ' 153' ' ' LYS . 21.2 t70 -104.41 -113.3 0.24 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.496 -0.752 . . . . 2.27 109.336 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.411 ' N ' ' CG ' ' A' ' 152' ' ' ASP . 17.6 pttm -163.04 50.59 0.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.081 -1.012 . . . . 1.8400000000000001 109.855 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -113.01 -155.71 0.57 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.466 -0.771 . . . . 2.2799999999999998 109.225 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -106.28 103.86 13.42 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.807 -0.812 . . . . 0.01 108.807 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.694 ' CZ ' HD11 ' A' ' 151' ' ' LEU . 17.4 m-85 -98.36 112.31 24.36 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.263 -0.898 . . . . 0.01 109.739 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 22.5 mtm180 -95.27 -22.87 17.51 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.232 -0.918 . . . . 0.01 111.685 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -127.3 154.41 77.06 Favored Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 120.878 -1.139 . . . . 2.54 108.764 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -59.52 -37.92 86.03 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 CA-C-N 119.235 0.763 . . . . 0.69999999999999996 110.637 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.9 t -60.99 -20.05 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.869 -1.145 . . . . 0.85999999999999999 109.2 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -65.43 -15.59 62.77 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.983 -1.073 . . . . 0.02 109.98 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.635 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 9.5 m0 -97.8 11.43 37.27 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.124 -0.985 . . . . 0.02 108.997 178.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.59 10.6 85.04 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.89 -1.148 . . . . 0.02 111.04 178.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.38 140.84 32.97 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.111 -1.229 . . . . 0.02 110.126 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.32 -9.09 58.08 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.59 -0.694 . . . . 0.58999999999999997 109.989 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.8 m -143.6 150.83 52.15 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.039 -1.038 . . . . 0.87 109.032 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -75.98 17.95 0.68 Allowed 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 120.721 0.947 . . . . 0.38 112.405 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.04 123.59 29.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.916 -1.115 . . . . 0.17999999999999999 111.56 -177.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.408 ' O ' HD12 ' A' ' 117' ' ' ILE . 2.0 mt -149.46 126.92 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.071 -1.455 . . . . 3.9900000000000002 107.071 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 24.1 mm100 -111.38 -18.26 12.93 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.165 -0.959 . . . . 5.1699999999999999 113.248 -177.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.8 m -156.73 160.22 39.08 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 119.216 -2.177 . . . . 0.02 110.4 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.433 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 18.3 p90 -151.72 153.05 33.59 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.101 -0.999 . . . . 2.02 110.321 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.3 mtm180 -145.79 150.53 36.37 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.358 -0.839 . . . . 0.01 110.145 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -87.83 144.04 26.81 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.233 -0.655 . . . . 0.01 109.233 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.574 HD12 ' OG1' ' A' ' 135' ' ' THR . 4.4 mt -94.79 129.25 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.308 -0.87 . . . . 3.04 108.967 179.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.49 146.71 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.153 -0.967 . . . . 1.8899999999999999 109.649 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.33 -0.856 . . . . 4.8899999999999997 109.466 179.954 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.333 0.587 . . . . 5.2800000000000002 109.489 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -75.86 65.65 1.99 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.211 -0.93 . . . . 5.96 109.429 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 30.5 p -81.14 142.69 33.01 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.426 -0.953 . . . . 2.2200000000000002 108.426 178.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.04 -179.79 47.79 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 118.343 -1.884 . . . . 0.81000000000000005 112.071 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.71 157.65 44.06 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.273 -1.531 . . . . 0.01 109.273 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -147.45 136.28 22.07 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.099 -1.236 . . . . 0.02 110.52 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.4 tt -130.12 138.91 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.698 -0.853 . . . . 0.02 108.698 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 m -120.91 130.24 53.81 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.559 -0.713 . . . . 0.39000000000000001 110.014 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.9 m-85 -110.4 139.68 45.37 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.581 -0.699 . . . . 0.02 109.247 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.525 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 6.6 m-85 -121.31 138.32 54.3 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.427 -0.796 . . . . 0.02 109.32 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.523 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 83.3 mt-10 -69.38 -27.43 65.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.041 -1.037 . . . . 0.029999999999999999 111.475 -178.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 2.3 m-20 -114.05 169.35 9.08 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.888 -1.133 . . . . 0.029999999999999999 110.097 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -76.03 158.66 31.63 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.567 0.699 . . . . 0.029999999999999999 110.229 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 66.53 33.17 6.82 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 122.012 0.911 . . . . 0.73999999999999999 111.185 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 55.32 41.72 30.93 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.374 0.607 . . . . 0.02 111.373 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -113.64 165.81 12.15 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.25 -1.019 . . . . 0.02 108.25 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.44 -167.46 35.56 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.765 -1.207 . . . . 0.029999999999999999 110.766 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.574 ' CG ' HH11 ' A' ' 18' ' ' ARG . 0.3 OUTLIER -68.84 141.69 55.04 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.535 -0.979 . . . . 2.7599999999999998 109.37 179.383 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -122.77 150.19 43.12 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.6 0.714 . . . . 1.8899999999999999 110.124 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.412 ' CB ' HD11 ' A' ' 33' ' ' LEU . 32.0 t80 -135.87 131.74 35.68 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 109.113 -0.699 . . . . 0.02 109.113 178.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -109.53 136.47 48.87 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.83 -0.804 . . . . 1.1200000000000001 108.83 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 49.6 t -128.63 138.15 52.04 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.617 -0.677 . . . . 0.02 109.619 -179.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -118.14 12.17 13.48 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.673 -0.642 . . . . 0.20000000000000001 110.144 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.495 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 14.6 t -159.46 174.2 15.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.822 -1.174 . . . . 1.23 108.918 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -61.55 144.35 54.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.849 -1.157 . . . . 0.02 110.376 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.6 m -134.16 117.92 17.08 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.733 -0.839 . . . . 0.02 108.733 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.38 -19.81 52.57 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.524 -0.735 . . . . 0.23999999999999999 112.55 -177.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 19.2 p30 -152.95 108.75 3.31 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.703 -1.248 . . . . 1.1399999999999999 110.831 -178.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -97.68 5.29 49.52 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.428 -0.795 . . . . 6.3700000000000001 109.771 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.2 mtm180 -60.33 -30.35 69.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.481 -0.762 . . . . 3.1099999999999999 112.307 -176.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.435 ' OG ' ' CE2' ' A' ' 32' ' ' TYR . 30.3 p -79.35 -18.77 51.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.258 -1.526 . . . . 0.88 111.631 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.435 ' CE2' ' OG ' ' A' ' 31' ' ' SER . 51.1 m-85 -106.57 -22.04 12.88 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.291 -0.881 . . . . 0.02 110.98 -178.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.412 HD11 ' CB ' ' A' ' 20' ' ' TYR . 58.0 mt -148.89 128.15 12.92 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.948 -1.095 . . . . 3.3199999999999998 109.216 -178.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.9 t -86.76 -11.13 51.94 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.766 -0.584 . . . . 0.02 110.439 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.0 ttp180 -171.5 160.92 6.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.016 -1.053 . . . . 0.02 108.187 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 82.0 m -144.19 116.49 8.5 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.907 -1.121 . . . . 0.02 109.011 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 11' ' ' GLU . 1.3 m-80 -109.93 0.87 18.78 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 120.836 -1.165 . . . . 0.029999999999999999 111.857 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.2 m -156.01 153.22 29.16 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.11 -1.07 . . . . 0.02 108.11 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.5 mt -146.9 148.04 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 CA-C-O 122.207 1.004 . . . . 0.02 110.753 -178.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -123.59 124.85 43.72 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.136 -1.061 . . . . 0.02 108.136 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.2 t -106.69 113.92 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 106.805 -1.554 . . . . 0.02 106.805 177.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -84.16 -34.07 24.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.691 -0.631 . . . . 3.8100000000000001 110.475 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.82 150.25 19.0 Favored Glycine 0 N--CA 1.486 2.004 0 C-N-CA 118.885 -1.626 . . . . 0.02 110.601 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.0 172.44 49.19 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.758 -1.211 . . . . 0.01 110.235 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.9 m -120.04 135.75 54.82 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.098 -1.075 . . . . 1.48 108.098 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.422 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 36.9 m95 -128.35 156.2 43.48 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 122.698 1.237 . . . . 0.02 112.468 -176.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.96 135.02 50.83 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 105.412 -2.07 . . . . 0.23999999999999999 105.412 176.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.409 ' HB ' HD22 ' A' ' 79' ' ' LEU . 34.6 m -116.21 141.81 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.597 -0.689 . . . . 0.65000000000000002 109.286 179.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -120.72 143.01 48.99 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.987 0.899 . . . . 0.02 109.643 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.46 -33.69 76.52 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.627 -0.715 . . . . 0.02 111.832 -177.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -124.71 157.82 64.5 Favored Pre-proline 0 N--CA 1.504 2.227 0 O-C-N 120.991 -1.068 . . . . 0.02 109.357 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.21 166.7 0.96 Allowed 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 121.724 1.616 . . . . 0.02 112.827 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.5 m120 63.42 36.74 11.2 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.262 -0.881 . . . . 0.02 111.163 178.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.449 ' CD1' ' CD ' ' A' ' 83' ' ' ARG . 3.8 m-85 45.09 51.39 8.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.584 -0.698 . . . . 3.3900000000000001 110.767 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.7 t -125.65 163.49 22.67 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.241 0.543 . . . . 2.3300000000000001 109.883 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.53 -161.72 31.31 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.779 -1.328 . . . . 0.02 109.779 -179.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 12.4 m80 -64.61 138.13 58.22 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.983 -1.304 . . . . 0.02 110.209 -178.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 16.0 ptm -118.79 136.7 53.85 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.721 -0.612 . . . . 5.0099999999999998 109.672 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.515 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 86.6 m-85 -134.33 139.59 45.77 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.483 -0.761 . . . . 0.02 109.647 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.9 mm -95.0 131.03 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.983 -0.747 . . . . 1.72 108.983 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.551 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -120.59 111.32 34.79 Favored Pre-proline 0 N--CA 1.505 2.28 0 O-C-N 121.319 -0.863 . . . . 0.02 110.767 -178.347 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -77.55 169.02 21.72 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 CA-C-N 119.958 1.021 . . . . 1.47 110.135 177.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -53.04 141.43 22.57 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.831 -1.168 . . . . 4.25 110.417 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.78 -177.2 32.2 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 119.403 -1.379 . . . . 0.02 110.743 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -120.72 131.79 54.72 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.334 -1.098 . . . . 0.95999999999999996 109.8 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.551 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 63.2 m-85 -122.52 95.77 46.46 Favored Pre-proline 0 N--CA 1.496 1.846 0 N-CA-C 107.903 -1.147 . . . . 0.02 107.903 179.099 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.401 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.9 Cg_endo -66.91 -3.5 9.66 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 120.787 0.992 . . . . 0.02 113.865 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.401 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 79.1 mt-10 -157.47 155.17 29.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.617 -1.302 . . . . 2.02 108.142 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -60.47 -39.26 86.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.623 -0.673 . . . . 0.02 111.974 -177.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -60.02 -23.91 64.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.031 -1.043 . . . . 0.02 110.395 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -69.73 -18.67 63.54 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.809 0.814 . . . . 3.4199999999999999 108.907 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.57 ' CH2' HD21 ' A' ' 79' ' ' LEU . 1.1 t90 -107.84 11.06 28.45 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.515 -1.291 . . . . 0.02 107.515 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 17.9 mtt 61.09 22.49 12.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.446 -0.784 . . . . 0.02 110.439 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.98 144.03 46.86 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.391 -1.484 . . . . 0.02 109.391 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.4 mt -78.87 -30.49 45.09 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.684 -1.228 . . . . 0.97999999999999998 107.684 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.672 ' N ' HD22 ' A' ' 76' ' ' ASN . 0.0 OUTLIER -157.0 -171.31 3.6 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 106.386 -1.709 . . . . 0.02 106.386 178.299 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.409 ' OD2' ' OD1' ' A' ' 37' ' ' ASN . 63.6 m-20 -98.2 28.21 4.18 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.722 -1.236 . . . . 0.02 110.698 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -96.55 122.33 39.35 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.856 -1.153 . . . . 3.2000000000000002 110.898 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.57 HD21 ' CH2' ' A' ' 72' ' ' TRP . 68.4 mt -142.17 119.56 11.59 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 107.636 -1.246 . . . . 2.6099999999999999 107.636 178.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.86 -17.92 9.29 Favored Glycine 0 N--CA 1.5 2.907 0 O-C-N 121.293 -0.879 . . . . 0.02 112.738 -177.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.44 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 26.4 t -156.16 156.59 34.48 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 120.239 2.02 . . . . 0.02 111.033 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.7 m -145.89 148.07 32.45 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.621 -0.674 . . . . 0.02 110.395 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.449 ' CD ' ' CD1' ' A' ' 54' ' ' PHE . 19.4 mtp180 -138.21 143.22 40.07 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.559 -0.713 . . . . 0.01 109.186 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.22 131.69 36.27 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.192 -0.942 . . . . 0.42999999999999999 109.635 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.5 t -91.2 125.07 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.906 -0.775 . . . . 1.25 108.906 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -93.91 131.21 39.56 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.808 -1.182 . . . . 1.77 108.974 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 mt -96.05 140.01 31.4 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.389 -0.967 . . . . 1.6299999999999999 108.389 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.2 m -111.83 127.52 55.84 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.347 -0.846 . . . . 1.0800000000000001 109.318 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.3 m -104.09 -154.04 0.49 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 106.62 -1.622 . . . . 1.26 106.62 177.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.95 -52.6 0.74 Allowed Glycine 0 N--CA 1.501 2.981 0 O-C-N 120.396 -1.44 . . . . 0.01 112.82 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.92 -101.28 0.15 Allowed Glycine 0 N--CA 1.49 2.253 0 C-N-CA 118.491 -1.814 . . . . 0.01 112.042 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 38.8 tp60 -121.48 118.99 30.73 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.172 -1.193 . . . . 4.4299999999999997 110.683 -178.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.59 130.54 35.47 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.769 -0.772 . . . . 2.9900000000000002 109.424 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -129.53 142.01 50.86 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.353 -0.842 . . . . 6.3600000000000003 109.062 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.0 tt -128.28 144.77 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 O-C-N 121.322 -0.862 . . . . 1.0900000000000001 110.245 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -123.15 133.83 54.23 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.838 -1.171 . . . . 2.0499999999999998 107.838 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.485 HG12 ' SG ' ' A' ' 129' ' ' CYS . 27.2 m -124.24 146.25 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 O-C-N 120.625 -1.297 . . . . 1.1000000000000001 109.882 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -119.31 141.32 49.09 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.844 0.831 . . . . 0.72999999999999998 110.848 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -66.99 -30.26 70.33 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 116.126 -0.488 . . . . 0.02 111.581 -178.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -116.31 169.69 9.11 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.138 -0.976 . . . . 3.1800000000000002 110.44 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.4 165.25 52.01 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.827 -0.909 . . . . 0.01 110.827 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.435 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 0.9 OUTLIER 57.27 38.23 28.55 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.925 -0.75 . . . . 0.01 111.57 178.659 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 51.97 54.68 10.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.467 -0.771 . . . . 0.01 111.228 177.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' A' ' 105' ' ' GLY . 19.6 t-20 -129.71 166.01 20.69 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.92 -1.141 . . . . 3.1499999999999999 107.92 178.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.512 ' N ' ' OD1' ' A' ' 104' ' ' ASN . . . 91.1 -163.37 29.14 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.19 -1.564 . . . . 0.01 109.19 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.7 tp60 -76.68 143.65 39.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.968 -1.313 . . . . 0.01 108.974 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.447 ' C ' ' SD ' ' A' ' 107' ' ' MET . 12.6 tmm? -116.47 142.23 47.13 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.553 0.692 . . . . 0.01 109.985 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -131.46 136.8 48.25 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.326 -0.99 . . . . 2.48 108.326 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -118.83 134.47 55.13 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.495 -0.753 . . . . 0.01 110.007 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.4 t -148.89 149.57 31.48 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.255 1.026 . . . . 1.6899999999999999 110.951 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 20.2 p -110.97 9.76 22.21 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 115.53 -0.759 . . . . 0.01 110.314 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -120.9 163.24 18.52 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.203 -0.936 . . . . 3.21 111.514 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -68.08 156.57 37.15 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.212 -1.033 . . . . 0.01 108.212 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 19.8 t -126.72 114.04 22.58 Favored Pre-proline 0 N--CA 1.5 2.053 0 O-C-N 121.484 -0.76 . . . . 0.01 109.029 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -75.1 -29.43 8.07 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 CA-C-N 120.376 1.17 . . . . 0.01 111.116 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 69.6 m -142.12 109.37 5.57 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.383 -0.823 . . . . 0.02 109.324 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.58 -39.38 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.777 -0.577 . . . . 1.8300000000000001 110.567 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 22.6 ttt -68.82 -37.57 79.29 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.398 -0.921 . . . . 1.3400000000000001 110.358 -178.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -69.58 -38.67 77.47 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.434 -1.416 . . . . 2.1099999999999999 109.986 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -79.94 -46.93 15.83 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.291 -0.881 . . . . 2.0800000000000001 112.297 -177.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -111.34 0.06 16.53 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.391 -0.818 . . . . 0.02 112.663 -176.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.3 m80 60.27 33.48 20.92 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.789 -1.194 . . . . 0.02 109.618 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.1 mt -112.51 135.02 53.72 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 108.743 -0.836 . . . . 0.02 108.743 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -91.59 -22.79 20.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 5.3200000000000003 110.27 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -149.05 163.79 36.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.198 -0.939 . . . . 0.02 109.702 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.0 mt -131.63 129.06 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 107.831 -1.174 . . . . 2.1699999999999999 107.831 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -108.84 -12.54 14.89 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.368 -0.832 . . . . 0.02 112.231 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.0 t -158.86 150.56 20.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.851 -1.156 . . . . 0.01 109.196 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.485 ' SG ' HG12 ' A' ' 97' ' ' VAL . 6.2 t -167.75 147.04 4.88 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.696 -0.853 . . . . 1.22 108.696 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -122.06 111.64 17.27 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 122.348 1.071 . . . . 1.4099999999999999 109.79 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 t -112.56 130.32 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 107.532 -1.284 . . . . 0.01 107.532 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 48.6 t -129.57 93.6 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 N-CA-C 107.204 -1.406 . . . . 1.98 107.204 177.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.487 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 11.7 tm-20 -147.19 -76.54 0.18 Allowed 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 105.869 -1.9 . . . . 0.01 105.869 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.485 ' N ' ' OE1' ' A' ' 133' ' ' GLU . . . 176.31 -75.63 0.08 OUTLIER Glycine 0 N--CA 1.485 1.905 0 N-CA-C 108.308 -1.917 . . . . 0.01 108.308 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.679 ' OG1' HD12 ' A' ' 175' ' ' ILE . 0.5 OUTLIER -120.29 121.04 37.78 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.686 -0.891 . . . . 2.2999999999999998 110.235 179.469 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.487 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 6.8 m95 -126.99 151.17 48.92 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 106.87 -1.53 . . . . 0.01 106.87 179.006 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 81.1 mt -122.55 137.43 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 120.321 -1.487 . . . . 1.6899999999999999 110.669 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -114.77 144.39 43.57 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 107.268 -1.382 . . . . 2.4900000000000002 107.268 178.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.501 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 14.6 m-85 -122.75 143.76 49.61 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.217 -0.927 . . . . 0.02 109.559 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -74.66 -29.08 61.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.524 -0.735 . . . . 0.02 111.864 -176.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mt -116.18 154.89 48.69 Favored Pre-proline 0 N--CA 1.506 2.346 0 O-C-N 120.757 -1.215 . . . . 1.48 108.92 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -55.69 167.23 2.25 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.19 1.26 . . . . 0.02 112.817 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 59.67 30.67 20.29 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.125 -0.943 . . . . 0.75 111.286 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 57.82 51.44 9.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.59 -0.694 . . . . 0.02 111.152 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -126.21 164.89 19.98 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.457 -0.777 . . . . 0.02 110.106 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.07 -165.82 33.24 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.387 -1.085 . . . . 0.02 110.387 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -69.0 142.45 54.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.544 -0.974 . . . . 0.02 108.903 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -114.2 148.47 37.26 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.414 0.626 . . . . 0.02 110.129 -178.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -125.13 134.75 52.32 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.073 -0.714 . . . . 0.01 109.073 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.52 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.6 tt -99.27 121.67 41.39 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.907 -1.121 . . . . 0.01 109.004 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.574 HD11 ' CE1' ' A' ' 156' ' ' TYR . 21.3 tp -97.27 144.64 26.86 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.245 -0.909 . . . . 0.01 109.247 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.514 ' C ' ' HH ' ' A' ' 156' ' ' TYR . 3.3 m-20 -106.42 -162.07 0.83 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.494 -0.753 . . . . 2.27 109.852 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -99.78 51.31 0.92 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.337 -0.852 . . . . 1.8400000000000001 109.867 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -115.06 -174.93 2.58 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.361 -0.837 . . . . 2.2799999999999998 109.578 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -105.01 110.28 22.62 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.497 -0.927 . . . . 0.01 108.497 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.642 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 4.5 m-85 -100.72 113.46 26.36 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.385 -0.822 . . . . 0.01 110.523 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -96.48 -22.23 17.24 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.31 -0.869 . . . . 0.01 111.586 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -127.23 153.67 76.9 Favored Pre-proline 0 N--CA 1.505 2.294 0 O-C-N 120.892 -1.13 . . . . 2.54 109.173 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -59.76 -40.38 64.53 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 120.466 0.777 . . . . 0.69999999999999996 110.574 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 41.7 t -61.03 -19.83 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.751 -1.218 . . . . 0.85999999999999999 108.675 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 41.4 t0 -65.54 -15.37 62.63 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.019 -1.05 . . . . 0.02 109.851 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.642 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 11.1 m0 -97.68 11.01 38.5 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.219 -0.926 . . . . 0.02 108.887 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.67 11.09 85.09 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.817 -1.182 . . . . 0.02 110.939 178.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.1 141.26 33.17 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.188 -1.184 . . . . 0.02 110.15 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.94 -8.64 58.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.592 -0.692 . . . . 0.58999999999999997 110.219 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.1 t -143.62 150.32 50.26 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 120.931 -1.105 . . . . 0.87 109.195 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -75.91 18.52 0.63 Allowed 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 120.708 0.939 . . . . 0.38 112.161 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.62 124.19 29.94 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.952 -1.093 . . . . 0.17999999999999999 111.42 -178.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.9 mt -149.48 126.88 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.052 -1.462 . . . . 3.9900000000000002 107.052 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -112.11 -17.25 12.87 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.05 -1.031 . . . . 5.1699999999999999 113.096 -177.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 17.0 t -157.04 160.13 38.65 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 119.14 -2.225 . . . . 0.02 110.374 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.428 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 18.7 p90 -151.17 152.7 33.7 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.037 -1.039 . . . . 2.02 110.37 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -144.96 149.45 35.21 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.807 0.813 . . . . 0.01 110.225 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -88.62 145.15 25.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.613 -0.679 . . . . 0.01 109.293 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.679 HD12 ' OG1' ' A' ' 135' ' ' THR . 6.2 mt -95.3 129.18 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.319 -0.863 . . . . 3.04 109.359 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.9 p -135.77 146.12 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.222 -0.924 . . . . 1.8899999999999999 109.605 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.311 -0.868 . . . . 4.8899999999999997 109.413 179.965 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.312 -1.515 . . . . 0.01 109.312 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -148.51 136.5 20.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.976 -1.308 . . . . 0.02 110.374 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.7 tt -130.62 140.68 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.724 -0.843 . . . . 0.02 108.724 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 t -120.83 130.42 53.95 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.573 -0.704 . . . . 0.39000000000000001 109.952 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.6 m-85 -110.33 139.94 45.01 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 109.217 -0.66 . . . . 0.02 109.217 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.564 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.7 m-85 -121.41 137.87 54.52 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.232 -0.917 . . . . 0.02 109.572 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -69.72 -27.43 64.97 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.995 -1.066 . . . . 0.029999999999999999 111.36 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 3.1 m-20 -114.23 169.68 8.85 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.927 -1.108 . . . . 0.029999999999999999 110.203 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.488 ' CG ' HD22 ' A' ' 37' ' ' ASN . 71.2 mtm180 -75.5 157.79 33.48 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.707 0.765 . . . . 0.029999999999999999 110.41 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 m120 66.16 33.84 7.13 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.884 0.85 . . . . 0.73999999999999999 111.192 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 55.54 41.25 30.93 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.301 0.572 . . . . 0.02 111.241 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -113.11 165.51 12.31 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.273 -1.01 . . . . 0.02 108.273 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.3 -166.97 35.32 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.767 -1.206 . . . . 0.029999999999999999 110.651 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.431 ' HG3' HH11 ' A' ' 18' ' ' ARG . 25.8 ttm-85 -68.77 141.68 55.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.494 -1.004 . . . . 2.7599999999999998 109.247 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -122.66 150.13 43.1 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.547 -0.721 . . . . 1.8899999999999999 109.88 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -138.11 134.02 34.14 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.706 -0.621 . . . . 0.02 109.659 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -109.08 136.17 49.03 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.393 -0.817 . . . . 1.1200000000000001 108.83 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.6 t -127.17 138.15 53.08 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.575 -0.703 . . . . 0.02 109.406 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.501 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 2.0 m-20 -118.93 11.75 12.63 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.494 -0.754 . . . . 0.20000000000000001 110.633 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 22.0 m -159.4 174.11 15.22 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.818 -1.176 . . . . 1.23 109.058 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -62.57 145.84 53.38 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.824 -1.173 . . . . 0.02 110.453 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 7.5 m -133.74 117.47 16.97 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 108.777 -0.823 . . . . 0.02 108.777 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.14 -21.92 49.59 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.167 -0.958 . . . . 0.23999999999999999 111.731 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -150.22 105.68 3.38 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.799 -1.188 . . . . 1.1399999999999999 109.526 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.8 5.32 45.54 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.54 0.686 . . . . 6.3700000000000001 110.067 -178.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -61.53 -28.3 69.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.404 -0.81 . . . . 3.1099999999999999 112.311 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.1 m -78.69 -18.85 53.72 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.248 -1.533 . . . . 0.88 111.741 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -105.74 -21.5 13.16 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.175 -0.953 . . . . 0.02 110.472 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 33' ' ' LEU . 47.6 mt -148.55 127.81 12.96 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.098 -1.001 . . . . 3.3199999999999998 109.125 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.5 p -86.18 -11.3 52.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.791 -0.568 . . . . 0.02 110.414 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -172.44 161.83 5.2 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.133 -1.062 . . . . 0.02 108.133 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 80.4 m -143.68 116.25 8.64 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.1 -1.0 . . . . 0.02 108.454 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.488 HD22 ' CG ' ' A' ' 13' ' ' ARG . 52.5 t30 -110.23 0.94 18.36 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 120.862 -1.149 . . . . 0.029999999999999999 111.519 -177.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.6 t -155.71 152.8 29.01 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.647 -1.242 . . . . 0.02 107.647 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.7 mt -146.94 148.7 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.104 -0.998 . . . . 0.02 110.63 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -124.52 125.35 44.06 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.614 -1.254 . . . . 0.02 107.614 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.5 t -105.24 113.99 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 107.018 -1.475 . . . . 0.02 107.018 177.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -84.71 -34.67 22.88 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.411 -0.805 . . . . 3.8100000000000001 110.135 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.83 150.02 18.52 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 118.519 -1.8 . . . . 0.02 110.802 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.15 172.13 48.84 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.269 -1.132 . . . . 0.01 110.269 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.4 m -119.62 135.17 54.92 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 107.934 -1.135 . . . . 1.48 107.934 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.436 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 35.6 m95 -127.94 155.55 44.05 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 122.625 1.202 . . . . 0.02 112.518 -176.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.65 134.26 51.63 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 105.283 -2.117 . . . . 0.23999999999999999 105.283 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.414 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.8 m -118.36 143.82 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 109.172 -0.677 . . . . 0.65000000000000002 109.172 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -120.93 145.19 47.96 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 122.172 0.987 . . . . 0.02 109.977 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -66.07 -33.52 75.99 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.917 -0.583 . . . . 0.02 111.385 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -124.97 158.15 64.09 Favored Pre-proline 0 N--CA 1.503 2.222 0 O-C-N 121.127 -0.983 . . . . 0.02 109.43 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.62 166.92 1.1 Allowed 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.753 1.635 . . . . 0.02 112.905 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' ' 53' ' ' ASN . 1.5 t30 63.38 36.31 11.61 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 115.279 -0.873 . . . . 0.02 111.048 178.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.43 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 7.2 m-85 45.47 51.49 9.7 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.611 0.72 . . . . 3.3900000000000001 110.904 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 t -126.08 163.46 23.02 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.182 0.515 . . . . 2.3300000000000001 109.88 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.61 -161.69 31.18 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.878 -1.289 . . . . 0.02 109.878 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 15.0 m80 -64.54 138.94 58.68 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.001 -1.293 . . . . 0.02 110.077 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.44 ' C ' ' SD ' ' A' ' 58' ' ' MET . 10.9 tmm? -119.09 137.16 53.76 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 121.301 0.572 . . . . 5.0099999999999998 109.72 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.572 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 86.1 m-85 -135.33 138.96 43.92 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.477 -0.764 . . . . 0.02 109.854 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.5 mm -95.51 131.52 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 109.192 -0.67 . . . . 1.72 109.192 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.497 HD22 ' CE1' ' A' ' 66' ' ' TYR . 11.2 mt -121.04 111.98 33.65 Favored Pre-proline 0 N--CA 1.506 2.333 0 O-C-N 121.368 -0.832 . . . . 0.02 110.984 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -77.85 169.61 20.36 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 CA-C-N 119.886 0.995 . . . . 1.47 110.092 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -53.06 140.74 24.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.768 -1.207 . . . . 4.25 110.439 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.64 -177.48 32.75 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.548 -1.311 . . . . 0.02 110.533 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -119.3 130.6 55.48 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.267 -1.137 . . . . 0.95999999999999996 109.759 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.497 ' CE1' HD22 ' A' ' 61' ' ' LEU . 96.8 m-85 -120.97 94.59 48.99 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 108.113 -1.069 . . . . 0.02 108.113 178.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.404 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 2.5 Cg_endo -66.8 -3.49 9.5 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 120.874 1.049 . . . . 0.02 113.908 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 35.0 mt-10 -157.95 154.97 28.65 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.687 -1.258 . . . . 2.02 108.238 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.461 ' CD1' ' OD1' ' A' ' 37' ' ' ASN . 24.2 p90 -60.25 -39.17 85.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.57 -0.706 . . . . 0.02 112.019 -177.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -59.88 -23.83 63.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.946 -1.096 . . . . 0.02 110.189 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -69.99 -18.93 63.35 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.947 0.879 . . . . 3.4199999999999999 108.895 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.572 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.5 t90 -107.7 9.85 29.07 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.402 -1.333 . . . . 0.02 107.402 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 33.2 mtm 60.46 23.03 12.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.589 -0.695 . . . . 0.02 110.266 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.46 144.11 45.91 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.598 -1.401 . . . . 0.02 109.598 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.0 tp -79.37 -31.17 42.84 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.5 -1.296 . . . . 0.97999999999999998 107.5 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -157.16 -171.76 3.75 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.342 -1.725 . . . . 0.02 106.342 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -98.43 28.54 4.09 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.618 -1.302 . . . . 0.02 110.703 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -97.0 122.61 40.18 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.83 -1.169 . . . . 3.2000000000000002 111.014 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.51 HD21 ' CH2' ' A' ' 72' ' ' TRP . 75.5 mt -141.92 119.21 11.48 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.541 -1.281 . . . . 2.6099999999999999 107.541 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.21 -18.33 9.91 Favored Glycine 0 N--CA 1.498 2.809 0 O-C-N 121.157 -0.964 . . . . 0.02 112.344 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 91.3 p -156.38 155.86 32.88 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.256 -1.732 . . . . 0.02 110.491 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 49.1 t -145.35 148.23 33.15 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.493 -0.754 . . . . 0.02 109.912 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.43 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 41.8 mtm180 -138.3 142.98 39.78 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.253 -0.904 . . . . 0.01 109.429 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.21 132.04 36.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.23 -0.919 . . . . 0.42999999999999999 109.691 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.9 t -91.14 125.21 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.796 -0.816 . . . . 1.25 108.796 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -93.31 131.97 37.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.762 -1.211 . . . . 1.77 108.995 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mt -97.01 139.3 33.22 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.249 -1.019 . . . . 1.6299999999999999 108.249 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.6 m -111.49 127.39 55.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.291 -0.881 . . . . 1.0800000000000001 109.192 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.9 m -103.88 -154.18 0.5 Allowed 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 106.387 -1.709 . . . . 1.26 106.387 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.46 -51.58 0.79 Allowed Glycine 0 N--CA 1.501 2.985 0 O-C-N 120.408 -1.433 . . . . 0.01 112.656 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.68 -100.86 0.15 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 118.493 -1.813 . . . . 0.01 111.977 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -121.43 118.7 30.05 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.085 -1.244 . . . . 4.4299999999999997 110.668 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.99 130.06 36.05 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.881 -0.728 . . . . 2.9900000000000002 109.374 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -130.2 140.48 50.73 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.459 -0.776 . . . . 6.3600000000000003 109.139 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.411 HG22 ' O ' ' A' ' 110' ' ' THR . 4.5 tt -128.33 145.54 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 121.425 -0.797 . . . . 1.0900000000000001 110.215 -179.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -122.18 133.2 54.73 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 107.607 -1.257 . . . . 2.0499999999999998 107.607 177.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.8 m -124.57 146.1 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 O-C-N 120.657 -1.277 . . . . 1.1000000000000001 109.805 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.581 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 62.3 m-85 -119.49 141.47 49.15 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 122.036 0.922 . . . . 0.72999999999999998 111.134 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -67.07 -30.31 70.33 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 115.963 -0.562 . . . . 0.02 111.511 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -116.05 169.28 9.38 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.13 -0.981 . . . . 3.1800000000000002 110.264 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.46 165.12 52.25 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.982 -0.847 . . . . 0.01 110.982 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 57.07 38.34 29.12 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.785 -0.833 . . . . 0.01 111.418 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 52.16 54.46 10.74 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.459 -0.776 . . . . 0.01 111.271 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -129.48 165.87 20.77 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.994 -1.113 . . . . 3.1499999999999999 107.994 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.08 -163.65 29.32 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.259 -1.537 . . . . 0.01 109.259 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -76.1 143.55 41.21 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.948 -1.325 . . . . 0.01 108.918 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.581 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 38.1 ttp -116.44 142.52 46.76 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.575 0.702 . . . . 0.01 109.803 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -131.64 136.55 47.82 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.234 -1.024 . . . . 2.48 108.234 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -118.45 134.1 55.34 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.541 -0.725 . . . . 0.01 110.193 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.411 ' O ' HG22 ' A' ' 95' ' ' ILE . 4.9 t -148.4 150.04 32.81 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 122.191 0.996 . . . . 1.6899999999999999 110.973 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.7 p -110.31 10.23 23.56 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 115.555 -0.748 . . . . 0.01 110.214 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -120.96 163.53 18.11 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.234 -0.916 . . . . 3.21 111.597 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -66.89 156.71 35.03 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.951 -1.129 . . . . 0.01 107.951 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.608 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 22.0 p -122.83 115.16 29.48 Favored Pre-proline 0 N--CA 1.5 2.069 0 O-C-N 121.459 -0.776 . . . . 0.01 109.153 178.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -78.15 -34.72 1.53 Allowed 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 119.993 1.033 . . . . 0.01 110.906 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.6 m -141.07 107.91 5.39 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.687 -0.856 . . . . 0.02 108.687 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.86 -38.93 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.988 -0.445 . . . . 1.8300000000000001 110.897 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 19.6 ttt -67.59 -38.11 83.54 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.155 -1.018 . . . . 1.3400000000000001 110.034 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -68.85 -38.09 79.54 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.407 -1.433 . . . . 2.1099999999999999 109.599 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -79.72 -46.92 16.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.324 -0.86 . . . . 2.0800000000000001 112.267 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -112.07 -0.51 15.63 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.398 -0.814 . . . . 0.02 112.841 -176.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.417 ' ND1' ' N ' ' A' ' 122' ' ' HIS . 2.2 m-70 61.61 34.66 17.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.852 -1.155 . . . . 0.02 109.811 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.1 mt -114.13 135.99 53.43 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.446 -0.784 . . . . 0.02 109.299 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -90.87 -22.09 21.1 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.239 -0.913 . . . . 5.3200000000000003 110.868 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -147.59 163.71 35.75 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.992 -1.067 . . . . 0.02 109.863 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.1 mm -129.49 125.68 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 107.853 -1.166 . . . . 2.1699999999999999 107.853 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -110.9 -13.4 14.13 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.204 -0.935 . . . . 0.02 112.821 -177.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.2 t -159.45 150.96 20.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.673 -1.267 . . . . 0.01 109.312 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.509 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 7.9 p -166.29 148.5 6.86 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.092 -1.005 . . . . 1.22 108.992 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.03 109.26 15.72 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 122.395 1.093 . . . . 1.4099999999999999 109.095 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.1 t -113.27 128.41 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 107.648 -1.241 . . . . 0.01 107.648 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.4 t -129.55 93.23 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 107.391 -1.336 . . . . 1.98 107.391 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.52 ' OE1' ' NE1' ' A' ' 136' ' ' TRP . 31.5 tt0 -147.08 -75.34 0.19 Allowed 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 105.882 -1.895 . . . . 0.01 105.882 177.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 177.26 -77.01 0.07 OUTLIER Glycine 0 N--CA 1.483 1.821 0 N-CA-C 108.403 -1.879 . . . . 0.01 108.403 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.512 ' OG1' HD12 ' A' ' 175' ' ' ILE . 2.7 t -120.23 125.5 48.29 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.541 -0.976 . . . . 2.2999999999999998 110.226 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.52 ' NE1' ' OE1' ' A' ' 133' ' ' GLU . 8.2 m95 -128.97 151.57 49.54 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 107.066 -1.457 . . . . 0.01 107.066 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 41.0 mt -119.53 134.84 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 120.383 -1.448 . . . . 1.6899999999999999 109.987 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -114.36 143.91 44.14 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.262 -1.384 . . . . 2.4900000000000002 107.262 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.511 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 11.5 m-85 -123.02 144.67 49.12 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.244 -0.91 . . . . 0.02 109.346 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -76.3 -28.89 57.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.687 -0.633 . . . . 0.02 111.732 -176.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.1 mt -116.32 155.03 48.87 Favored Pre-proline 0 N--CA 1.504 2.248 0 O-C-N 120.698 -1.251 . . . . 1.48 108.896 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -56.17 167.2 2.65 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.186 1.257 . . . . 0.02 113.072 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 59.49 31.3 20.93 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 114.995 -1.002 . . . . 0.75 111.363 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 57.63 51.22 9.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.536 -0.727 . . . . 0.02 111.092 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -127.02 165.19 19.92 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.583 -0.698 . . . . 0.02 110.157 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.89 -166.03 33.66 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.395 -1.082 . . . . 0.02 110.395 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -69.38 142.54 53.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.551 -0.97 . . . . 0.02 109.162 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -115.13 149.76 37.08 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.729 -0.607 . . . . 0.02 110.028 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -123.68 134.27 53.76 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 109.004 -0.739 . . . . 0.01 109.004 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.6 tp -97.07 121.11 38.6 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.797 -1.189 . . . . 0.01 109.4 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.479 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 12.9 tp -98.5 146.52 25.69 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.234 -0.916 . . . . 0.01 108.787 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -104.68 -124.77 0.22 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.465 -0.772 . . . . 2.27 110.251 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -138.63 50.45 1.86 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.218 -0.926 . . . . 1.8400000000000001 109.657 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -115.37 -167.2 1.21 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.344 -0.848 . . . . 2.2799999999999998 109.517 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -105.6 109.97 22.13 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.565 -0.902 . . . . 0.01 108.565 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.655 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 4.1 m-85 -99.97 111.53 23.83 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.382 -0.823 . . . . 0.01 110.301 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -96.14 -22.1 17.51 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.147 -0.97 . . . . 0.01 111.32 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -127.42 154.11 77.29 Favored Pre-proline 0 N--CA 1.505 2.275 0 O-C-N 121.04 -1.037 . . . . 2.54 108.957 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -59.62 -38.4 82.07 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 120.442 0.761 . . . . 0.69999999999999996 110.533 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 65.5 t -61.07 -19.68 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.948 -1.095 . . . . 0.85999999999999999 109.047 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -65.24 -15.18 62.2 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.973 -1.079 . . . . 0.02 109.856 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.655 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 9.8 m0 -97.65 11.04 38.39 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.173 -0.954 . . . . 0.02 108.985 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.31 11.13 84.61 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.899 -1.144 . . . . 0.02 110.988 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.71 140.88 33.27 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.042 -1.269 . . . . 0.02 110.155 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.39 -8.53 58.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.64 -0.662 . . . . 0.58999999999999997 110.178 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.7 p -142.29 150.95 56.94 Favored Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 120.93 -1.106 . . . . 0.87 109.237 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -75.69 16.8 0.73 Allowed 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 120.81 1.007 . . . . 0.38 112.241 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.14 121.78 27.03 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.359 1.076 . . . . 0.17999999999999999 111.27 -178.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.1 mt -149.33 124.21 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 106.096 -1.816 . . . . 3.9900000000000002 106.096 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -112.32 -15.46 13.15 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.217 -0.927 . . . . 5.1699999999999999 113.271 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 5.4 p -157.34 160.77 38.84 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 119.285 -2.135 . . . . 0.02 110.204 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.608 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 7.1 p90 -152.25 154.07 35.02 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.007 -1.058 . . . . 2.02 110.737 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.4 mtm180 -145.61 150.41 36.31 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.272 -0.892 . . . . 0.01 110.293 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -88.31 143.55 26.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.554 -0.716 . . . . 0.01 109.199 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.512 HD12 ' OG1' ' A' ' 135' ' ' THR . 3.1 mt -94.58 129.77 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.242 -0.912 . . . . 3.04 109.034 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.47 146.84 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.203 -0.936 . . . . 1.8899999999999999 109.639 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.365 -0.834 . . . . 4.8899999999999997 109.462 -179.922 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 107.86 -2.096 . . . . 0.01 107.86 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -148.51 134.66 19.29 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.96 -1.318 . . . . 0.02 110.983 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.9 tt -128.56 138.95 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 107.703 -1.221 . . . . 0.02 107.703 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.4 t -122.33 130.21 52.91 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.225 -0.922 . . . . 0.39000000000000001 110.339 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 5.2 m-85 -110.36 140.45 44.54 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.82 -0.807 . . . . 0.02 108.82 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.555 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.7 m-85 -122.39 138.69 54.45 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.219 -0.926 . . . . 0.02 109.512 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.486 ' HG3' HD11 ' A' ' 33' ' ' LEU . 88.0 mt-10 -68.62 -27.46 66.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.083 -1.011 . . . . 0.029999999999999999 111.438 -178.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -114.77 170.17 8.53 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.822 -1.174 . . . . 0.029999999999999999 110.161 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -75.4 161.68 29.03 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.932 0.872 . . . . 0.029999999999999999 110.39 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.534 ' N ' ' ND2' ' A' ' 14' ' ' ASN . 0.9 OUTLIER 63.22 32.9 14.67 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.048 0.928 . . . . 0.73999999999999999 110.853 179.196 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.4 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 1.3 m-85 55.03 40.02 31.83 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.94 -0.573 . . . . 0.02 110.874 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -110.08 166.07 11.24 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.134 -1.061 . . . . 0.02 108.134 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.14 -167.59 36.21 Favored Glycine 0 N--CA 1.496 2.638 0 C-N-CA 119.765 -1.207 . . . . 0.029999999999999999 111.037 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -69.01 143.03 54.46 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.49 -1.006 . . . . 2.7599999999999998 109.171 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -120.76 149.02 43.18 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.5 0.667 . . . . 1.8899999999999999 110.197 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -132.7 127.56 35.04 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.323 -0.991 . . . . 0.02 108.323 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 7.8 p30 -112.6 136.76 51.77 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.429 -0.794 . . . . 1.1200000000000001 109.934 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.9 t -131.5 138.79 49.11 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.631 -0.668 . . . . 0.02 109.547 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -116.63 11.07 14.59 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.671 -0.643 . . . . 0.20000000000000001 109.912 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 9.8 p -158.63 174.86 14.42 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.408 -0.96 . . . . 1.23 108.408 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -60.75 143.66 53.96 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.669 -1.269 . . . . 0.02 109.912 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.3 t -131.51 117.44 18.79 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.487 -0.931 . . . . 0.02 108.487 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.81 -25.04 48.61 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.156 -0.965 . . . . 0.23999999999999999 110.83 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -155.15 101.38 2.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.031 -1.043 . . . . 1.1399999999999999 108.968 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.402 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 24.1 p90 -104.92 9.83 34.5 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 122.111 0.958 . . . . 6.3700000000000001 109.622 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 45.4 mtp180 -58.65 -24.0 60.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.509 -0.744 . . . . 3.1099999999999999 110.847 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.5 t -74.46 -16.49 60.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.796 -1.19 . . . . 0.88 110.071 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -104.53 -22.17 13.32 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.536 -0.728 . . . . 0.02 109.588 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.486 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.9 tp -150.38 128.89 12.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.194 -0.941 . . . . 3.3199999999999998 109.085 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.2 t -85.44 -9.86 56.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.786 -0.571 . . . . 0.02 111.11 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -171.36 162.75 6.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.859 -1.15 . . . . 0.02 107.954 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.2 p -143.25 115.42 8.4 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.806 -1.184 . . . . 0.02 108.717 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.407 HD22 ' HB3' ' A' ' 77' ' ' ASP . 5.2 t-20 -108.0 2.36 23.16 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 120.877 -1.14 . . . . 0.029999999999999999 110.889 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.0 p -156.94 154.63 30.01 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.553 -1.277 . . . . 0.02 107.553 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.3 mt -147.02 148.37 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.039 -1.038 . . . . 0.02 110.376 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -124.59 125.79 44.73 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.982 -1.118 . . . . 0.02 107.982 177.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.1 t -107.16 115.31 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 107.105 -1.443 . . . . 0.02 107.105 177.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -83.88 -34.14 24.64 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.585 -0.697 . . . . 3.8100000000000001 110.824 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.95 152.3 22.1 Favored Glycine 0 N--CA 1.486 2.016 0 C-N-CA 118.935 -1.602 . . . . 0.02 110.816 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.31 172.78 49.12 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.517 -1.325 . . . . 0.01 110.398 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 47.1 m -119.82 134.89 55.08 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.053 -1.091 . . . . 1.48 108.053 178.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.598 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 3.3 m95 -125.99 154.53 42.77 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 122.522 1.153 . . . . 0.02 112.178 -176.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.98 133.56 52.81 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 105.369 -2.085 . . . . 0.23999999999999999 105.369 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.531 ' HB ' HD22 ' A' ' 79' ' ' LEU . 33.0 m -118.46 143.17 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 109.005 -0.739 . . . . 0.65000000000000002 109.005 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -121.03 146.76 46.37 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 122.192 0.996 . . . . 0.02 110.041 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.25 -34.6 78.74 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.831 -0.622 . . . . 0.02 111.517 -177.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.55 163.02 45.41 Favored Pre-proline 0 N--CA 1.509 2.489 0 O-C-N 120.92 -1.113 . . . . 0.02 109.135 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -55.94 168.07 2.01 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.294 1.33 . . . . 0.02 113.208 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 63.79 36.41 10.52 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.103 -0.953 . . . . 0.02 111.863 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 45.57 52.24 9.38 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.669 0.747 . . . . 3.3900000000000001 111.188 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.1 m -127.2 164.22 22.15 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.261 0.553 . . . . 2.3300000000000001 109.912 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.32 -161.58 32.79 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.918 -1.273 . . . . 0.02 109.918 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -65.85 137.94 57.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.101 -1.234 . . . . 0.02 109.99 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 14.8 ptm -118.66 136.68 53.78 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.82 -0.55 . . . . 5.0099999999999998 109.556 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.477 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 96.5 m-85 -133.04 138.88 46.92 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-O 121.639 0.733 . . . . 0.02 109.756 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.9 mm -95.17 131.16 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.934 -0.765 . . . . 1.72 108.934 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.517 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 1.1 mt -120.02 110.73 36.16 Favored Pre-proline 0 N--CA 1.504 2.246 0 O-C-N 121.477 -0.764 . . . . 0.02 110.711 -178.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -77.65 168.59 22.28 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 CA-C-N 119.979 1.028 . . . . 1.47 110.139 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -54.18 141.15 30.19 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.836 -1.165 . . . . 4.25 110.395 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.43 -177.27 32.69 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 119.684 -1.246 . . . . 0.02 110.52 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -119.21 130.53 55.53 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.433 -1.039 . . . . 0.95999999999999996 109.662 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.517 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 51.1 m-85 -120.87 97.97 47.97 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 107.762 -1.199 . . . . 0.02 107.762 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -70.23 -3.91 13.27 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 120.681 0.921 . . . . 0.02 113.674 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -157.33 154.79 29.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.651 -1.281 . . . . 2.02 108.048 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -60.14 -39.23 85.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.542 -0.724 . . . . 0.02 111.871 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -59.89 -23.99 63.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.003 -1.061 . . . . 0.02 110.329 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -70.19 -18.79 63.2 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.955 0.883 . . . . 3.4199999999999999 108.898 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.544 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.4 t90 -108.27 10.39 27.75 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.396 -1.335 . . . . 0.02 107.396 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 7.5 mmt 60.6 22.52 12.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.533 -0.729 . . . . 0.02 110.51 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.66 145.17 47.72 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.535 -1.426 . . . . 0.02 109.535 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.8 mt -79.62 -30.85 41.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.062 -1.258 . . . . 0.97999999999999998 108.09 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -157.67 -171.48 3.58 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.541 -1.652 . . . . 0.02 106.541 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.407 ' HB3' HD22 ' A' ' 37' ' ' ASN . 2.4 p-10 -98.57 28.56 4.13 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.628 -1.295 . . . . 0.02 110.518 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.592 HH11 ' CG ' ' A' ' 78' ' ' ARG . 3.1 mtt-85 -97.87 122.74 41.34 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.163 -0.96 . . . . 3.2000000000000002 111.361 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.531 HD22 ' HB ' ' A' ' 48' ' ' VAL . 34.7 mt -144.78 122.24 11.68 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 107.6 -1.259 . . . . 2.6099999999999999 107.6 177.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.09 -16.06 11.88 Favored Glycine 0 N--CA 1.503 3.112 0 O-C-N 121.184 -0.948 . . . . 0.02 112.696 -177.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.8 t -156.55 155.91 32.73 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.171 -1.782 . . . . 0.02 110.363 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.1 p -145.39 148.03 32.91 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.532 -0.73 . . . . 0.02 110.303 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -138.44 143.61 39.75 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.311 -0.868 . . . . 0.01 109.386 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.95 133.13 36.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.42999999999999999 109.813 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.5 t -92.23 125.58 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.968 -0.753 . . . . 1.25 108.968 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -93.31 132.63 37.34 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.833 -1.167 . . . . 1.77 109.173 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.5 mt -98.95 141.27 31.92 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.499 -0.75 . . . . 1.6299999999999999 109.029 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.0 t -111.6 125.11 53.58 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.693 -0.855 . . . . 1.0800000000000001 108.693 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 90.2 p -116.7 133.29 56.19 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.717 -1.239 . . . . 1.26 108.039 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.02 -48.99 0.01 OUTLIER Glycine 0 N--CA 1.505 3.284 0 C-N-CA 117.723 -2.179 . . . . 0.01 113.839 -177.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -167.26 -105.47 0.18 Allowed Glycine 0 N--CA 1.491 2.358 0 CA-C-N 120.045 1.923 . . . . 0.01 111.098 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -118.95 117.23 28.27 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.061 -1.258 . . . . 4.4299999999999997 109.998 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.04 130.58 36.62 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.834 -0.747 . . . . 2.9900000000000002 109.132 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.462 ' HZ3' ' HB2' ' A' ' 94' ' ' LYS . 10.3 ttmm -130.16 139.95 50.82 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.51 -0.744 . . . . 6.3600000000000003 109.258 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.5 tt -129.28 145.8 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 O-C-N 121.39 -0.819 . . . . 1.0900000000000001 110.159 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -122.52 134.03 54.56 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 107.761 -1.2 . . . . 2.0499999999999998 107.761 177.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.491 HG12 ' SG ' ' A' ' 129' ' ' CYS . 29.6 m -123.18 146.06 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 120.868 -1.145 . . . . 1.1000000000000001 109.612 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.584 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 67.2 m-85 -118.51 140.56 49.69 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 122.104 0.954 . . . . 0.72999999999999998 110.845 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.43 ' OE2' ' O ' ' A' ' 99' ' ' GLU . 4.3 tm-20 -66.35 -30.18 70.53 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.957 -0.565 . . . . 0.02 111.357 -178.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.434 ' O ' ' OG ' ' A' ' 128' ' ' SER . 79.1 mttt -117.04 170.56 8.55 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.078 -1.014 . . . . 3.1800000000000002 110.327 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.48 170.86 41.65 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 111.003 -0.839 . . . . 0.01 111.003 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 51.86 38.76 24.26 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.55 0.691 . . . . 0.01 111.629 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 51.94 48.24 23.16 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.569 -0.707 . . . . 0.01 111.174 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.508 ' OD1' ' N ' ' A' ' 105' ' ' GLY . 21.2 t-20 -122.52 166.26 15.08 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.331 -0.988 . . . . 3.1499999999999999 108.331 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.508 ' N ' ' OD1' ' A' ' 104' ' ' ASN . . . 91.95 -164.45 28.72 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.507 -1.437 . . . . 0.01 109.507 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 64.0 tp60 -76.36 144.22 40.24 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.988 -1.301 . . . . 0.01 108.559 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.584 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 31.8 ttp -116.44 142.61 46.63 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.684 0.754 . . . . 0.01 109.907 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -131.15 137.4 49.0 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.225 -1.028 . . . . 2.48 108.225 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -118.16 133.82 55.56 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.549 -0.719 . . . . 0.01 110.044 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.3 t -148.67 149.45 31.5 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 122.287 1.041 . . . . 1.6899999999999999 110.984 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 p -111.03 9.65 22.1 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 115.452 -0.794 . . . . 0.01 110.025 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -121.17 163.28 18.71 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.202 -0.936 . . . . 3.21 111.719 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -67.42 156.64 36.06 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.326 -0.99 . . . . 0.01 108.326 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.59 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 92.2 m -124.7 111.14 27.67 Favored Pre-proline 0 N--CA 1.502 2.165 0 O-C-N 121.43 -0.794 . . . . 0.01 109.098 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -76.53 -32.83 3.5 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 CA-C-N 120.099 1.071 . . . . 0.01 111.492 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.9 t -140.41 106.33 5.18 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.331 -0.989 . . . . 0.02 108.331 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 73.8 mt -65.2 -38.84 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.81 -0.556 . . . . 1.8300000000000001 111.044 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.437 ' SD ' ' C ' ' A' ' 123' ' ' LEU . 8.9 tpt -66.52 -38.24 86.78 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.046 -1.062 . . . . 1.3400000000000001 110.022 -178.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -69.6 -38.53 77.32 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.455 -1.403 . . . . 2.1099999999999999 109.77 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -80.55 -47.12 14.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.34 -0.85 . . . . 2.0800000000000001 112.453 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -111.7 -1.3 15.72 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.433 -0.792 . . . . 0.02 112.556 -176.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 61.42 34.08 18.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.837 -1.164 . . . . 0.02 109.655 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.437 ' C ' ' SD ' ' A' ' 118' ' ' MET . 38.7 mt -114.21 136.13 53.29 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.48 -0.763 . . . . 0.02 109.269 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -90.63 -21.9 21.46 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.212 -0.93 . . . . 5.3200000000000003 110.918 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -148.18 164.02 35.21 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.853 -1.155 . . . . 0.02 110.009 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.4 mm -129.8 126.02 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 107.554 -1.276 . . . . 2.1699999999999999 107.554 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -109.84 -13.4 14.46 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.156 -0.965 . . . . 0.02 112.966 -177.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 16.6 p -161.2 153.07 19.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.59 -1.319 . . . . 0.01 109.295 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.491 ' SG ' HG12 ' A' ' 97' ' ' VAL . 6.6 t -169.34 145.47 3.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.385 -0.822 . . . . 1.22 108.832 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -124.98 107.83 11.24 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 122.311 1.053 . . . . 1.4099999999999999 109.685 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.595 HG21 ' CD1' ' A' ' 136' ' ' TRP . 11.9 p -110.91 138.26 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.46 -1.311 . . . . 0.01 107.46 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.5 t -127.78 94.46 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 107.186 -1.412 . . . . 1.98 107.186 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.518 ' OE1' ' NE1' ' A' ' 136' ' ' TRP . 52.2 tt0 -146.19 -75.31 0.21 Allowed 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 105.987 -1.857 . . . . 0.01 105.987 177.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 176.57 -77.39 0.07 OUTLIER Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.648 -1.781 . . . . 0.01 108.648 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.56 ' OG1' HD12 ' A' ' 175' ' ' ILE . 1.6 t -119.49 126.13 50.55 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.623 -0.928 . . . . 2.2999999999999998 110.318 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.595 ' CD1' HG21 ' A' ' 131' ' ' VAL . 43.8 m95 -128.72 150.01 50.45 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 107.166 -1.42 . . . . 0.01 107.166 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 56.2 mt -120.87 136.5 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 120.441 -1.412 . . . . 1.6899999999999999 109.973 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -114.75 144.38 43.57 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.604 -1.258 . . . . 2.4900000000000002 107.604 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.444 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 24.0 m-85 -122.8 144.13 49.38 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.372 -0.83 . . . . 0.02 109.53 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -75.62 -29.18 59.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.448 -0.782 . . . . 0.02 111.671 -176.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.3 mt -116.39 154.78 48.97 Favored Pre-proline 0 N--CA 1.505 2.302 0 O-C-N 120.759 -1.213 . . . . 1.48 109.029 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -55.62 167.2 2.22 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.19 1.26 . . . . 0.02 113.022 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 11.3 m120 59.62 30.74 20.38 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.105 -0.952 . . . . 0.75 111.318 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 57.47 51.24 10.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.426 -0.796 . . . . 0.02 110.921 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -126.17 164.52 20.77 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.55 -0.719 . . . . 0.02 109.911 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.95 -165.61 33.26 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.17 -1.172 . . . . 0.02 110.17 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -69.42 142.07 53.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.551 -0.97 . . . . 0.02 109.142 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.47 ' CD ' ' N ' ' A' ' 148' ' ' GLN . 7.1 mp0 -114.79 149.39 37.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.831 -0.543 . . . . 0.02 110.047 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 149' ' ' TYR . 20.2 m-85 -124.51 134.4 53.02 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.18 -0.674 . . . . 0.01 109.18 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.6 tt -98.93 121.39 40.82 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.865 -1.147 . . . . 0.01 108.972 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.417 HD21 ' CE1' ' A' ' 156' ' ' TYR . 4.4 tp -100.2 151.12 21.81 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.253 -0.904 . . . . 0.01 108.89 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.4 ' CG ' ' H ' ' A' ' 153' ' ' LYS . 62.8 t0 -104.23 -124.4 0.21 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.369 -0.832 . . . . 2.27 109.883 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.4 ' H ' ' CG ' ' A' ' 152' ' ' ASP . 29.0 ttmt -136.46 49.55 2.08 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.352 -0.843 . . . . 1.8400000000000001 109.586 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -113.55 -172.36 2.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.546 -0.721 . . . . 2.2799999999999998 109.252 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -105.61 113.32 26.82 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.752 -0.833 . . . . 0.01 108.752 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.417 ' CE1' HD21 ' A' ' 151' ' ' LEU . 60.6 m-85 -98.58 112.68 24.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.328 -0.857 . . . . 0.01 110.133 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -94.81 -24.5 17.03 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.195 -0.941 . . . . 0.01 110.91 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -125.43 154.99 72.44 Favored Pre-proline 0 N--CA 1.498 1.972 0 N-CA-C 108.383 -0.969 . . . . 2.54 108.383 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.553 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 8.4 Cg_endo -60.48 -39.19 67.92 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 CA-C-N 119.197 0.749 . . . . 0.69999999999999996 110.844 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 68.0 t -61.45 -18.8 19.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 O-C-N 120.742 -1.224 . . . . 0.85999999999999999 109.282 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -65.44 -17.84 64.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.915 -1.116 . . . . 0.02 111.852 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.553 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.6 OUTLIER -101.74 16.39 25.99 Favored 'General case' 0 N--CA 1.513 2.702 0 O-C-N 120.886 -1.134 . . . . 0.02 110.19 178.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.03 9.74 79.91 Favored Glycine 0 N--CA 1.499 2.844 0 O-C-N 121.136 -0.978 . . . . 0.02 113.091 176.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.509 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.02 141.6 32.62 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.799 -1.412 . . . . 0.02 110.193 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.78 -8.25 58.89 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.374 -0.602 . . . . 0.58999999999999997 109.374 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.3 t -142.96 150.55 53.41 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.078 -1.014 . . . . 0.87 108.887 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -75.63 18.47 0.6 Allowed 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 120.746 0.964 . . . . 0.38 112.33 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.57 121.99 27.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.899 -1.126 . . . . 0.17999999999999999 111.282 -178.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.8 mt -149.12 123.62 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 105.986 -1.857 . . . . 3.9900000000000002 105.986 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -112.17 -15.92 13.12 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.103 -0.998 . . . . 5.1699999999999999 113.301 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 26.0 t -156.71 159.71 38.63 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 119.231 -2.168 . . . . 0.02 109.993 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.59 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 12.7 p90 -152.69 153.89 34.17 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.969 -1.082 . . . . 2.02 110.53 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 48.5 mtp180 -144.83 150.62 37.44 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.907 0.861 . . . . 0.01 110.439 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -88.5 143.77 26.76 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.424 -0.584 . . . . 0.01 109.424 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.56 HD12 ' OG1' ' A' ' 135' ' ' THR . 6.2 mt -95.17 128.82 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.158 -0.964 . . . . 3.04 109.039 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 75.0 t -136.3 146.56 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.136 -0.977 . . . . 1.8899999999999999 109.543 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.335 -0.853 . . . . 4.8899999999999997 109.586 -179.928 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.349 -1.5 . . . . 0.01 109.349 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -147.12 136.13 22.35 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.098 -1.237 . . . . 0.02 110.77 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.0 tt -130.73 140.13 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 108.927 -0.768 . . . . 0.02 108.927 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.0 t -122.12 130.51 53.31 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.428 -0.795 . . . . 0.39000000000000001 110.009 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 8.7 m-85 -110.93 140.96 44.99 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 109.092 -0.707 . . . . 0.02 109.092 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.526 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 7.5 m-85 -122.97 139.21 54.31 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.222 -0.924 . . . . 0.02 109.76 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.469 ' HG3' HD11 ' A' ' 33' ' ' LEU . 82.5 mt-10 -68.97 -27.75 66.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.033 -1.042 . . . . 0.029999999999999999 111.599 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -114.54 169.56 8.96 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.876 -1.14 . . . . 0.029999999999999999 110.306 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -75.21 158.24 33.27 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.651 0.739 . . . . 0.029999999999999999 110.211 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 66.26 33.37 7.25 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.906 0.86 . . . . 0.73999999999999999 111.131 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 55.26 41.82 30.98 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.185 0.517 . . . . 0.02 111.177 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -113.15 165.99 11.86 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.208 -1.034 . . . . 0.02 108.208 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.89 -167.26 36.31 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.834 -1.174 . . . . 0.029999999999999999 110.683 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -69.44 142.05 53.92 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.44 -1.036 . . . . 2.7599999999999998 109.135 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -120.89 149.41 42.65 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.586 0.708 . . . . 1.8899999999999999 110.204 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -132.54 127.5 35.24 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.358 -0.978 . . . . 0.02 108.358 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -112.48 137.12 51.14 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.566 -0.709 . . . . 1.1200000000000001 109.806 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 14.9 t -131.67 139.1 48.98 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.514 0.673 . . . . 0.02 109.761 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -116.91 11.22 14.33 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.578 -0.701 . . . . 0.20000000000000001 109.674 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.535 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 50.4 t -158.19 174.4 15.25 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.362 -0.977 . . . . 1.23 108.362 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.535 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 3.2 p30 -60.97 144.08 53.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.646 -1.284 . . . . 0.02 109.867 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.1 p -131.76 117.42 18.57 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.494 -0.928 . . . . 0.02 108.494 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.16 -25.62 47.36 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.052 -1.03 . . . . 0.23999999999999999 110.889 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 28' ' ' ASP . 8.4 p30 -154.14 101.31 2.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.966 -1.084 . . . . 1.1399999999999999 109.022 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -104.71 9.46 35.06 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 122.219 1.009 . . . . 6.3700000000000001 109.897 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -58.52 -24.13 59.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.411 -0.805 . . . . 3.1099999999999999 111.012 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.7 p -74.47 -16.69 60.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.656 -1.278 . . . . 0.88 110.105 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -103.97 -22.1 13.52 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.458 -0.776 . . . . 0.02 109.628 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.469 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.8 tp -150.43 128.98 12.23 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.131 -0.981 . . . . 3.3199999999999998 109.223 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.8 p -85.86 -10.19 55.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.791 -0.568 . . . . 0.02 111.124 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -171.23 162.68 6.98 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.908 -1.145 . . . . 0.02 107.908 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.1 p -144.11 116.36 8.47 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.826 -1.171 . . . . 0.02 109.056 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.497 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 1.0 OUTLIER -108.28 1.63 22.1 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.745 -1.222 . . . . 0.029999999999999999 110.924 -178.601 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 56.1 m -155.86 154.24 30.98 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.786 -1.19 . . . . 0.02 107.786 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.8 mt -146.02 146.8 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.118 -0.989 . . . . 0.02 110.616 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -123.46 124.63 43.32 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.112 -1.07 . . . . 0.02 108.112 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.0 t -106.15 114.47 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 106.849 -1.537 . . . . 0.02 106.849 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -84.67 -34.32 23.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.476 -0.765 . . . . 3.8100000000000001 110.452 -178.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.82 149.89 18.25 Favored Glycine 0 N--CA 1.486 1.991 0 C-N-CA 119.071 -1.538 . . . . 0.02 110.507 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.29 172.48 49.09 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.915 -1.136 . . . . 0.01 110.448 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.5 m -119.13 135.12 54.82 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.045 -1.094 . . . . 1.48 108.045 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 36.2 m95 -126.86 154.24 44.64 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 122.563 1.173 . . . . 0.02 112.316 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.75 134.41 51.51 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 105.448 -2.056 . . . . 0.23999999999999999 105.448 176.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.509 ' HB ' HD22 ' A' ' 79' ' ' LEU . 27.4 m -118.44 143.31 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.622 -0.674 . . . . 0.65000000000000002 109.257 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.538 ' CE2' ' SD ' ' A' ' 58' ' ' MET . 33.0 m-85 -120.95 145.53 47.62 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 122.256 1.027 . . . . 0.02 109.975 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -66.5 -34.18 77.35 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.798 -0.637 . . . . 0.02 111.42 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -125.61 157.92 66.68 Favored Pre-proline 0 N--CA 1.502 2.158 0 O-C-N 121.194 -0.941 . . . . 0.02 109.511 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -53.68 167.1 1.08 Allowed 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.707 1.604 . . . . 0.02 113.169 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.414 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.5 m-20 63.9 36.2 10.4 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.079 -0.964 . . . . 0.02 111.092 178.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 45.39 51.92 9.27 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.692 0.758 . . . . 3.3900000000000001 110.673 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.8 m -126.52 163.89 22.39 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.235 0.54 . . . . 2.3300000000000001 109.871 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.11 -161.8 31.92 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.958 -1.257 . . . . 0.02 109.958 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -65.22 138.88 58.52 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.093 -1.239 . . . . 0.02 110.176 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.538 ' SD ' ' CE2' ' A' ' 49' ' ' TYR . 48.6 ttp -118.52 136.97 53.53 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.798 -0.564 . . . . 5.0099999999999998 109.507 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.482 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 90.1 m-85 -134.5 138.42 44.68 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 121.763 0.792 . . . . 0.02 109.807 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.8 mm -96.06 131.64 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.082 -0.711 . . . . 1.72 109.082 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.459 HD22 ' CE1' ' A' ' 66' ' ' TYR . 12.2 mt -121.5 112.18 32.8 Favored Pre-proline 0 N--CA 1.506 2.326 0 O-C-N 121.365 -0.835 . . . . 0.02 110.853 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -77.7 169.98 19.91 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 CA-C-N 119.822 0.972 . . . . 1.47 109.981 177.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -52.64 140.98 21.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.833 -1.167 . . . . 4.25 110.263 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.44 -178.25 32.17 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.507 -1.33 . . . . 0.02 110.845 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -120.37 131.85 55.01 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.492 -1.005 . . . . 0.95999999999999996 109.804 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.459 ' CE1' HD22 ' A' ' 61' ' ' LEU . 94.1 m-85 -121.91 96.1 47.15 Favored Pre-proline 0 N--CA 1.495 1.822 0 N-CA-C 107.958 -1.127 . . . . 0.02 107.958 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.4 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.3 Cg_endo -67.21 -3.84 10.59 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 120.712 0.941 . . . . 0.02 113.868 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 35.0 mt-10 -157.52 155.44 30.28 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.64 -1.288 . . . . 2.02 108.239 179.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -60.42 -39.22 86.64 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.6 -0.687 . . . . 0.02 112.048 -177.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -59.88 -23.77 63.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.091 -1.006 . . . . 0.02 110.202 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -70.36 -19.2 63.06 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.87 0.843 . . . . 3.4199999999999999 108.948 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.544 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 1.6 t90 -107.68 9.9 29.1 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.483 -1.303 . . . . 0.02 107.483 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.7 mtt 60.52 22.5 12.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.605 -0.684 . . . . 0.02 110.335 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.35 144.6 47.3 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.435 -1.466 . . . . 0.02 109.435 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.0 mt -79.13 -30.42 43.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.101 -1.235 . . . . 0.97999999999999998 107.779 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -157.68 -171.26 3.49 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 106.393 -1.706 . . . . 0.02 106.393 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -98.61 29.04 3.87 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.7 -1.25 . . . . 0.02 110.484 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.582 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -98.58 123.08 42.54 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.178 -0.951 . . . . 3.2000000000000002 111.383 -178.771 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.509 HD22 ' HB ' ' A' ' 48' ' ' VAL . 35.4 mt -144.93 122.73 11.91 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 107.39 -1.337 . . . . 2.6099999999999999 107.39 177.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.96 -16.57 11.27 Favored Glycine 0 N--CA 1.502 3.096 0 O-C-N 121.158 -0.964 . . . . 0.02 112.686 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 90.2 p -156.68 156.42 33.4 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.154 -1.792 . . . . 0.02 110.351 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 12.7 m -145.0 147.81 33.05 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.545 -0.722 . . . . 0.02 110.012 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -138.04 142.99 40.32 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.317 -0.864 . . . . 0.01 109.593 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.56 132.99 36.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.31 -0.869 . . . . 0.42999999999999999 109.804 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.9 t -91.57 125.07 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.994 -0.743 . . . . 1.25 108.994 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -93.61 132.06 38.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.735 -1.228 . . . . 1.77 109.044 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -97.37 139.79 32.79 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.579 -0.897 . . . . 1.6299999999999999 108.579 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.5 t -111.8 127.72 55.89 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.351 -0.843 . . . . 1.0800000000000001 109.281 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.6 p -104.32 -154.33 0.5 Allowed 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 106.506 -1.664 . . . . 1.26 106.506 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.82 -51.37 0.78 Allowed Glycine 0 N--CA 1.5 2.95 0 O-C-N 120.39 -1.444 . . . . 0.01 112.771 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.43 -101.14 0.15 Allowed Glycine 0 N--CA 1.489 2.203 0 C-N-CA 118.515 -1.803 . . . . 0.01 111.877 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -121.4 119.1 31.13 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.194 -1.18 . . . . 4.4299999999999997 110.556 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.62 128.8 33.99 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.66 -0.816 . . . . 2.9900000000000002 109.359 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -130.62 141.75 50.44 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.458 -0.776 . . . . 6.3600000000000003 109.064 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.6 tt -129.69 146.76 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 O-C-N 121.281 -0.887 . . . . 1.0900000000000001 110.307 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -121.55 133.56 55.02 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 107.437 -1.319 . . . . 2.0499999999999998 107.437 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.5 m -124.04 146.09 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 120.768 -1.207 . . . . 1.1000000000000001 109.902 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.581 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 61.4 m-85 -118.74 141.27 48.77 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 122.007 0.908 . . . . 0.72999999999999998 110.879 -178.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -66.58 -30.55 70.88 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 116.007 -0.542 . . . . 0.02 111.351 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -116.82 170.28 8.73 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.124 -0.985 . . . . 3.1800000000000002 110.298 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.54 170.09 43.24 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.874 -0.89 . . . . 0.01 110.874 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 2.5 m-20 52.74 38.61 26.84 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.562 0.696 . . . . 0.01 111.704 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 52.42 48.71 22.02 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.65 -0.656 . . . . 0.01 110.944 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.504 ' ND2' ' H ' ' A' ' 105' ' ' GLY . 8.3 t-20 -123.08 165.36 16.95 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.252 -1.018 . . . . 3.1499999999999999 108.252 178.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.504 ' H ' ' ND2' ' A' ' 104' ' ' ASN . . . 91.9 -163.93 28.48 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.476 -1.45 . . . . 0.01 109.476 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.2 tp60 -76.73 144.05 39.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.936 -1.332 . . . . 0.01 108.899 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.581 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 30.5 ttp -116.4 142.32 47.01 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.65 0.738 . . . . 0.01 109.93 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -131.66 137.16 48.22 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.51 -0.922 . . . . 2.48 108.51 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -117.9 133.9 55.47 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.425 -0.797 . . . . 0.01 110.141 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.1 t -148.18 148.49 30.61 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 122.262 1.029 . . . . 1.6899999999999999 110.967 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 63.4 p -110.87 10.35 22.41 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 115.579 -0.737 . . . . 0.01 110.331 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -121.16 163.16 18.88 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.152 -0.967 . . . . 3.21 111.566 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -67.03 156.46 35.99 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.107 -1.072 . . . . 0.01 108.107 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.474 ' HG ' ' HZ ' ' A' ' 172' ' ' PHE . 19.9 m -125.37 113.75 25.7 Favored Pre-proline 0 N--CA 1.501 2.115 0 O-C-N 121.485 -0.759 . . . . 0.01 109.37 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -76.91 -31.6 3.81 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 CA-C-N 119.916 1.006 . . . . 0.01 111.562 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.0 t -142.49 108.12 5.1 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.238 -0.913 . . . . 0.02 109.068 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.67 -38.82 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.885 -0.509 . . . . 1.8300000000000001 110.949 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.8 ttt -68.33 -37.2 80.3 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.222 -0.991 . . . . 1.3400000000000001 110.263 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -70.36 -38.95 74.88 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.532 -1.355 . . . . 2.1099999999999999 110.302 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -79.01 -47.39 16.33 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.307 -0.871 . . . . 2.0800000000000001 112.483 -176.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -110.64 1.18 17.84 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.348 -0.845 . . . . 0.02 112.53 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.2 m170 59.31 32.77 22.16 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.724 -1.235 . . . . 0.02 109.236 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.7 mt -112.29 135.69 52.66 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 108.631 -0.877 . . . . 0.02 108.631 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -90.69 -22.39 21.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.842 . . . . 5.3200000000000003 110.109 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -150.47 164.47 35.85 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.24 -0.913 . . . . 0.02 110.16 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.9 mt -132.25 129.64 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 107.38 -1.341 . . . . 2.1699999999999999 107.38 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -107.91 -11.64 15.31 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.321 -0.862 . . . . 0.02 112.571 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.0 t -159.21 152.26 22.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.816 -1.177 . . . . 0.01 109.101 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 6.5 p -169.44 144.71 3.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.187 -0.945 . . . . 1.22 109.168 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -126.18 111.75 14.99 Favored 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 122.445 1.117 . . . . 1.4099999999999999 110.161 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.4 p -113.89 137.44 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 107.361 -1.348 . . . . 0.01 107.361 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 23.4 t -127.74 94.43 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 106.854 -1.536 . . . . 1.98 106.854 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.501 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 10.4 tm-20 -145.07 -77.78 0.2 Allowed 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 105.929 -1.878 . . . . 0.01 105.929 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.461 ' N ' ' OE1' ' A' ' 133' ' ' GLU . . . 175.58 -73.76 0.08 OUTLIER Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.934 -1.666 . . . . 0.01 108.934 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.406 ' OG1' HD12 ' A' ' 175' ' ' ILE . 29.8 p -119.18 120.14 36.19 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.565 -0.962 . . . . 2.2999999999999998 110.262 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.501 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 8.1 m95 -127.45 149.53 50.06 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 107.227 -1.398 . . . . 0.01 107.227 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 83.6 mt -123.31 138.88 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 120.504 -1.373 . . . . 1.6899999999999999 110.491 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -115.29 144.73 43.3 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 107.158 -1.423 . . . . 2.4900000000000002 107.158 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.496 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 14.0 m-85 -123.06 145.23 48.72 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.15 -0.969 . . . . 0.02 109.617 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -75.77 -30.21 59.05 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.5 -0.75 . . . . 0.02 112.237 -176.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.5 mt -115.07 155.07 47.09 Favored Pre-proline 0 N--CA 1.506 2.366 0 O-C-N 120.595 -1.316 . . . . 1.48 109.225 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.91 165.54 2.61 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.183 1.255 . . . . 0.02 112.547 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 60.08 31.38 20.57 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.131 -0.94 . . . . 0.75 111.484 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 57.55 51.77 9.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.367 -0.833 . . . . 0.02 111.183 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -126.15 164.52 20.75 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.547 -0.721 . . . . 0.02 109.859 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.27 -165.69 32.89 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.419 -1.073 . . . . 0.02 110.419 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -68.89 142.79 54.68 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.612 -0.934 . . . . 0.02 109.053 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -115.18 148.91 38.47 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.386 0.612 . . . . 0.02 109.869 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -124.38 134.4 53.14 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.532 -0.73 . . . . 0.01 109.069 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.513 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.8 tt -98.85 120.22 38.93 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.941 -1.099 . . . . 0.01 108.651 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.513 ' N ' HD23 ' A' ' 150' ' ' LEU . 6.6 tp -103.07 150.89 23.15 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.27 -0.894 . . . . 0.01 109.12 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -104.56 -110.26 0.26 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.431 -0.793 . . . . 2.27 109.54 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -156.5 51.68 0.52 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.118 -0.989 . . . . 1.8400000000000001 109.638 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -112.71 -163.08 0.83 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.584 -0.697 . . . . 2.2799999999999998 109.264 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -106.39 104.41 14.1 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.452 -0.78 . . . . 0.01 109.073 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.653 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 6.5 m-85 -98.7 112.36 24.45 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.244 -0.91 . . . . 0.01 109.51 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -95.09 -22.15 18.08 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.188 -0.945 . . . . 0.01 111.775 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -127.73 154.24 77.9 Favored Pre-proline 0 N--CA 1.502 2.171 0 O-C-N 120.715 -1.241 . . . . 2.54 109.036 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -60.53 -38.68 71.36 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 120.483 0.789 . . . . 0.69999999999999996 110.517 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.93 -20.08 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.819 -1.176 . . . . 0.85999999999999999 108.93 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 13.7 t0 -65.18 -15.4 62.4 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.955 -1.091 . . . . 0.02 109.925 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.653 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 9.9 m0 -97.89 11.34 37.69 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.111 -0.993 . . . . 0.02 109.099 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.83 10.21 85.93 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.789 -1.196 . . . . 0.02 110.968 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.49 141.47 32.23 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.313 -1.11 . . . . 0.02 110.061 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.57 -8.97 57.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.663 -0.648 . . . . 0.58999999999999997 109.948 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.1 p -143.2 150.35 51.86 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 120.919 -1.113 . . . . 0.87 108.869 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -76.6 18.81 0.68 Allowed 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 120.825 1.016 . . . . 0.38 112.371 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.14 123.08 28.66 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.855 -1.153 . . . . 0.17999999999999999 111.496 -177.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 169' ' ' ILE . 16.1 mm -151.75 127.04 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 106.815 -1.55 . . . . 3.9900000000000002 106.815 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -113.92 -12.91 12.6 Favored 'General case' 0 N--CA 1.508 2.429 0 O-C-N 121.065 -1.022 . . . . 5.1699999999999999 113.725 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 22.7 m -157.53 161.77 38.81 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 119.12 -2.237 . . . . 0.02 110.439 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.474 ' HZ ' ' HG ' ' A' ' 114' ' ' CYS . 21.3 p90 -152.74 153.77 33.87 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.044 -1.035 . . . . 2.02 110.662 178.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 48.8 mtp180 -145.44 150.38 36.4 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.775 0.798 . . . . 0.01 110.23 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -87.9 143.99 26.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.483 -0.761 . . . . 0.01 109.183 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.406 HD12 ' OG1' ' A' ' 135' ' ' THR . 5.1 mt -94.38 129.26 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.184 -0.948 . . . . 3.04 109.045 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.4 t -136.17 146.6 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.174 -0.953 . . . . 1.8899999999999999 109.675 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 4.8899999999999997 109.51 179.962 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 107.85 -2.1 . . . . 0.01 107.85 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -149.67 136.11 19.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.916 -1.344 . . . . 0.02 110.755 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.7 tt -128.62 139.25 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 107.822 -1.177 . . . . 0.02 107.822 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 t -121.11 129.63 53.38 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.321 -0.862 . . . . 0.39000000000000001 110.337 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 11.5 m-85 -109.67 139.69 44.41 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.803 -0.814 . . . . 0.02 108.803 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.528 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 6.3 m-85 -122.15 138.33 54.51 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.139 -0.975 . . . . 0.02 109.664 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.521 ' OE2' ' N ' ' A' ' 35' ' ' ARG . 6.1 mm-40 -67.83 -28.63 67.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.934 . . . . 0.029999999999999999 111.093 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.5 m-20 -114.77 170.06 8.61 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.882 -1.136 . . . . 0.029999999999999999 110.163 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -75.56 162.35 28.37 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.729 0.776 . . . . 0.029999999999999999 110.295 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 3.0 t30 62.8 33.33 15.4 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.002 0.906 . . . . 0.73999999999999999 110.806 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 55.0 40.36 32.0 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.975 -0.557 . . . . 0.02 110.843 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -110.67 165.96 11.4 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.14 -1.059 . . . . 0.02 108.14 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.02 -167.73 36.56 Favored Glycine 0 N--CA 1.495 2.62 0 C-N-CA 119.719 -1.229 . . . . 0.029999999999999999 110.918 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -68.73 142.66 54.92 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.63 -0.923 . . . . 2.7599999999999998 109.354 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 -120.6 148.83 43.37 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.658 0.742 . . . . 1.8899999999999999 110.195 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -132.81 127.57 34.84 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.436 -0.95 . . . . 0.02 108.436 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 21.4 p-10 -112.79 137.28 51.35 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.499 -0.75 . . . . 1.1200000000000001 109.857 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 15.3 t -131.48 139.08 49.25 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.742 -0.599 . . . . 0.02 109.515 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.0 p30 -117.04 11.4 14.25 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.528 -0.733 . . . . 0.20000000000000001 109.939 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.405 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 34.7 t -158.31 174.46 15.11 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.389 -0.967 . . . . 1.23 108.389 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -61.17 144.25 54.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.597 -1.315 . . . . 0.02 109.869 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.5 t -131.75 117.32 18.44 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.54 -0.911 . . . . 0.02 108.54 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.66 -25.02 49.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.122 -0.986 . . . . 0.23999999999999999 110.778 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.47 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 20.8 p-10 -154.8 101.26 2.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.09 -1.006 . . . . 1.1399999999999999 108.882 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -105.85 9.58 32.79 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-O 122.004 0.907 . . . . 6.3700000000000001 109.835 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -58.63 -24.24 60.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.674 -0.641 . . . . 3.1099999999999999 110.861 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.5 m -74.05 -16.59 61.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.716 -1.24 . . . . 0.88 109.836 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -105.72 -21.99 13.06 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.616 -0.677 . . . . 0.02 109.561 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.453 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 3.0 tp -148.83 126.36 11.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.023 -1.048 . . . . 3.3199999999999998 109.686 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.7 m -86.83 -11.0 52.16 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.488 -0.757 . . . . 0.02 111.446 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.521 ' N ' ' OE2' ' A' ' 11' ' ' GLU . 17.8 ttp180 -170.98 161.17 6.84 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.682 -1.229 . . . . 0.02 107.682 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.5 t -141.65 115.41 9.12 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.8 -1.187 . . . . 0.02 109.213 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.416 ' ND2' ' OD2' ' A' ' 77' ' ' ASP . 3.5 m120 -107.57 -0.19 22.2 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.914 -1.116 . . . . 0.029999999999999999 110.858 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.1 t -156.18 153.38 29.13 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.851 -1.166 . . . . 0.02 107.851 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.5 mt -145.43 147.57 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.11 -0.994 . . . . 0.02 110.313 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -123.22 124.13 42.32 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.753 -1.203 . . . . 0.02 107.753 176.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.3 t -106.56 114.88 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 107.058 -1.46 . . . . 0.02 107.058 177.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.434 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 30.3 tt0 -83.61 -34.07 25.19 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 120.099 -0.64 . . . . 3.8100000000000001 110.912 -178.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.96 152.21 21.95 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 118.896 -1.621 . . . . 0.02 111.03 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.43 172.86 49.24 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.627 -1.273 . . . . 0.01 110.514 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.4 m -119.51 135.06 54.94 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.978 -1.119 . . . . 1.48 107.978 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.458 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 32.5 m95 -127.14 155.77 42.83 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 122.56 1.172 . . . . 0.02 112.151 -176.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.59 134.3 52.1 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 105.697 -1.964 . . . . 0.23999999999999999 105.697 176.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.521 ' HB ' HD22 ' A' ' 79' ' ' LEU . 34.6 m -116.65 141.73 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.556 -0.715 . . . . 0.65000000000000002 109.222 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -120.61 143.32 48.72 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 122.098 0.951 . . . . 0.02 109.793 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -65.69 -34.24 77.75 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.661 -0.7 . . . . 0.02 111.646 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -125.15 157.6 66.62 Favored Pre-proline 0 N--CA 1.502 2.173 0 O-C-N 121.033 -1.042 . . . . 0.02 109.359 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.56 167.2 1.0 Allowed 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.718 1.612 . . . . 0.02 113.015 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.3 m120 63.76 36.09 10.81 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.154 -0.93 . . . . 0.02 111.16 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.407 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 4.2 m-85 45.38 51.56 9.46 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.722 0.772 . . . . 3.3900000000000001 110.503 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 90.3 p -126.13 163.83 22.26 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.318 0.58 . . . . 2.3300000000000001 109.847 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.88 -161.76 32.19 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.816 -1.314 . . . . 0.02 109.816 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.514 ' N ' ' ND1' ' A' ' 57' ' ' HIS . 1.9 m80 -65.27 138.72 58.39 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.065 -1.256 . . . . 0.02 110.337 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.497 ' O ' ' SD ' ' A' ' 58' ' ' MET . 2.6 ppp? -119.11 137.13 53.79 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.492 0.663 . . . . 5.0099999999999998 109.517 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.446 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 96.8 m-85 -134.28 138.81 45.28 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.395 -0.816 . . . . 0.02 109.648 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.4 mm -95.32 131.09 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 109.057 -0.719 . . . . 1.72 109.057 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.561 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -119.6 110.83 36.73 Favored Pre-proline 0 N--CA 1.503 2.184 0 O-C-N 121.299 -0.876 . . . . 0.02 110.769 -178.266 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -77.54 168.49 22.59 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 CA-C-N 119.934 1.012 . . . . 1.47 110.221 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.434 ' NE2' ' O ' ' A' ' 42' ' ' GLU . 63.1 tt0 -53.58 141.19 26.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.824 -1.173 . . . . 4.25 110.43 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.79 -177.76 31.9 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.529 -1.32 . . . . 0.02 110.712 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -120.5 131.69 54.84 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.558 -0.966 . . . . 0.95999999999999996 109.732 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.561 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 63.8 m-85 -122.3 94.19 48.04 Favored Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 108.023 -1.103 . . . . 0.02 108.023 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.402 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 5.3 Cg_exo -64.44 -4.24 7.8 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 120.928 1.085 . . . . 0.02 113.799 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 34.8 mt-10 -157.58 155.3 29.95 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.555 -1.34 . . . . 2.02 108.287 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -60.63 -39.0 86.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.481 -0.762 . . . . 0.02 112.199 -176.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -59.93 -23.72 63.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.093 -1.004 . . . . 0.02 110.329 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -70.62 -18.57 62.87 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.782 0.801 . . . . 3.4199999999999999 109.021 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.547 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.6 t90 -107.98 10.14 28.42 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.415 -1.328 . . . . 0.02 107.415 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.4 mmt 60.77 22.49 12.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.66 -0.65 . . . . 0.02 110.545 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.78 144.33 46.35 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.401 -1.48 . . . . 0.02 109.401 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.8 tp -79.29 -31.03 43.23 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.617 -1.253 . . . . 0.97999999999999998 107.617 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -157.02 -171.74 3.76 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 106.342 -1.725 . . . . 0.02 106.342 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.416 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 52.1 m-20 -98.71 27.54 4.82 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.616 -1.303 . . . . 0.02 110.708 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -95.97 122.56 38.92 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.939 -1.101 . . . . 3.2000000000000002 110.865 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.521 HD22 ' HB ' ' A' ' 48' ' ' VAL . 31.2 mt -142.9 121.35 12.4 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.558 -1.275 . . . . 2.6099999999999999 107.558 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.2 -17.85 9.15 Favored Glycine 0 N--CA 1.501 2.977 0 O-C-N 121.257 -0.902 . . . . 0.02 112.878 -177.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.407 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 11.1 t -156.03 155.78 33.28 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-N 120.004 1.902 . . . . 0.02 111.023 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 13.5 p -145.34 147.43 32.29 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.321 -0.862 . . . . 0.02 110.624 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -138.23 143.63 40.22 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.529 -0.732 . . . . 0.01 109.292 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.66 132.11 36.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -0.915 . . . . 0.42999999999999999 109.759 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.8 t -91.28 125.2 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.961 -0.755 . . . . 1.25 108.961 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -94.36 131.13 40.33 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.884 -1.135 . . . . 1.77 109.029 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 mt -95.76 140.3 30.74 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.621 -0.881 . . . . 1.6299999999999999 108.621 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t -111.64 127.87 55.89 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.37 -0.831 . . . . 1.0800000000000001 109.33 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 71.5 p -104.41 -154.58 0.51 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 106.631 -1.618 . . . . 1.26 106.631 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.32 -52.65 0.73 Allowed Glycine 0 N--CA 1.5 2.956 0 O-C-N 120.498 -1.376 . . . . 0.01 112.895 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.18 -101.44 0.15 Allowed Glycine 0 N--CA 1.49 2.256 0 C-N-CA 118.456 -1.83 . . . . 0.01 112.022 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.494 ' NE2' HG21 ' A' ' 111' ' ' THR . 30.8 tt0 -121.88 119.53 31.84 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.056 -1.261 . . . . 4.4299999999999997 110.695 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.42 129.22 34.26 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.682 -0.807 . . . . 2.9900000000000002 109.303 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -130.54 142.1 50.47 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.866 -0.79 . . . . 6.3600000000000003 108.866 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.7 tt -129.97 146.05 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 O-C-N 121.255 -0.903 . . . . 1.0900000000000001 110.451 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -121.26 133.61 55.15 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.354 -1.35 . . . . 2.0499999999999998 107.354 177.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.4 m -123.93 146.41 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 120.895 -1.128 . . . . 1.1000000000000001 109.709 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.576 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 72.0 m-85 -119.32 141.61 48.86 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.978 0.894 . . . . 0.72999999999999998 111.059 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -66.96 -30.28 70.36 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 116.066 -0.515 . . . . 0.02 111.734 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 43.8 mttp -116.37 167.22 11.22 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.965 -1.084 . . . . 3.1800000000000002 110.425 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.05 164.05 44.24 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.958 -0.857 . . . . 0.01 110.958 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 57.23 38.87 28.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.932 -0.746 . . . . 0.01 110.913 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 52.29 55.72 8.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.723 -0.611 . . . . 0.01 111.079 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -128.97 165.66 20.68 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.29 -1.004 . . . . 3.1499999999999999 108.29 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.66 -164.0 27.57 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.279 -1.528 . . . . 0.01 109.279 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -75.69 144.29 41.67 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.968 -1.313 . . . . 0.01 108.438 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.576 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 27.6 ttp -116.41 142.19 47.18 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.543 0.687 . . . . 0.01 109.889 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -131.58 136.54 47.88 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.176 -1.046 . . . . 2.48 108.176 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -119.19 134.48 55.18 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.57 -0.706 . . . . 0.01 109.923 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 t -148.67 150.52 33.35 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 122.278 1.037 . . . . 1.6899999999999999 111.145 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.494 HG21 ' NE2' ' A' ' 92' ' ' GLN . 48.2 p -110.89 9.62 22.38 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 115.572 -0.74 . . . . 0.01 110.336 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -121.15 163.22 18.78 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.15 -0.969 . . . . 3.21 111.721 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -68.2 157.18 36.0 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.268 -1.012 . . . . 0.01 108.268 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 19.1 t -126.88 114.16 22.21 Favored Pre-proline 0 N--CA 1.501 2.075 0 O-C-N 121.457 -0.777 . . . . 0.01 109.101 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -75.05 -29.72 7.85 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 CA-C-N 120.247 1.124 . . . . 0.01 111.035 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.5 m -142.3 109.19 5.45 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.309 -0.869 . . . . 0.02 109.121 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.41 HD12 ' O ' ' A' ' 169' ' ' ILE . 97.7 mt -63.58 -38.99 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.866 -0.521 . . . . 1.8300000000000001 110.59 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 19.0 ttt -68.82 -37.74 79.4 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.349 -0.94 . . . . 1.3400000000000001 110.399 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -69.46 -38.57 77.8 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.417 -1.427 . . . . 2.1099999999999999 109.995 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -80.11 -47.14 15.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.331 -0.856 . . . . 2.0800000000000001 112.339 -177.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -111.18 0.0 16.66 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.363 -0.836 . . . . 0.02 112.637 -176.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.7 m80 60.01 33.64 21.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.768 -1.208 . . . . 0.02 109.516 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.0 mt -112.65 135.51 53.29 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 108.83 -0.804 . . . . 0.02 108.83 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -91.69 -22.96 19.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.254 -0.904 . . . . 5.3200000000000003 110.393 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -149.45 164.34 35.27 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.187 -0.945 . . . . 0.02 109.813 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.5 mt -132.15 128.89 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 107.804 -1.184 . . . . 2.1699999999999999 107.804 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.39 -11.98 15.1 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.365 -0.834 . . . . 0.02 112.25 -178.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.2 p -160.31 151.06 18.72 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.917 -1.114 . . . . 0.01 109.273 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 27.1 p -168.25 145.01 3.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.362 -0.836 . . . . 1.22 109.133 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 40.5 tttm -126.31 111.67 14.8 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 122.42 1.105 . . . . 1.4099999999999999 110.417 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.2 p -114.38 138.44 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 107.408 -1.33 . . . . 0.01 107.408 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.5 t -126.8 94.03 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 106.732 -1.581 . . . . 1.98 106.732 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.422 ' CD ' ' N ' ' A' ' 134' ' ' GLY . 6.1 tm-20 -145.65 -80.65 0.16 Allowed 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 106.218 -1.771 . . . . 0.01 106.218 177.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.422 ' N ' ' CD ' ' A' ' 133' ' ' GLU . . . 176.45 -76.2 0.07 OUTLIER Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.987 -1.645 . . . . 0.01 108.987 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 30.9 p -118.0 118.14 31.13 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.593 -0.945 . . . . 2.2999999999999998 110.192 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -124.88 150.4 46.52 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 107.244 -1.391 . . . . 0.01 107.244 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 12.4 mt -121.79 136.88 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 120.484 -1.385 . . . . 1.6899999999999999 110.15 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -114.55 144.29 43.6 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.364 -1.347 . . . . 2.4900000000000002 107.364 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.463 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 24.5 m-85 -123.29 143.56 49.99 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.271 -0.893 . . . . 0.02 109.575 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.461 ' O ' ' NE2' ' A' ' 170' ' ' GLN . 81.8 tt0 -73.96 -29.24 61.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.506 -0.746 . . . . 0.02 111.911 -176.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.1 mt -116.09 154.9 48.58 Favored Pre-proline 0 N--CA 1.505 2.291 0 O-C-N 120.725 -1.234 . . . . 1.48 108.964 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -55.66 167.36 2.17 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.151 1.234 . . . . 0.02 112.757 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.633 HD22 ' N ' ' A' ' 143' ' ' ASN . 0.8 OUTLIER 59.37 31.11 20.87 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.174 -0.921 . . . . 0.75 111.233 178.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 57.41 50.62 11.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.45 -0.781 . . . . 0.02 111.064 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -125.13 164.36 20.42 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.554 -0.716 . . . . 0.02 109.898 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.427 ' O ' ' OE1' ' A' ' 148' ' ' GLN . . . 89.16 -165.72 33.06 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.184 -1.167 . . . . 0.02 110.184 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -69.08 142.55 54.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.54 -0.977 . . . . 0.02 109.034 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.472 ' CD ' ' N ' ' A' ' 148' ' ' GLN . 0.1 OUTLIER -114.53 148.54 37.78 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.44 0.638 . . . . 0.02 110.011 -178.191 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -124.92 134.98 52.45 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 109.083 -0.71 . . . . 0.01 109.083 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.5 HD23 ' N ' ' A' ' 151' ' ' LEU . 4.1 tt -100.09 121.25 41.11 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.872 -1.142 . . . . 0.01 108.92 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.5 ' N ' HD23 ' A' ' 150' ' ' LEU . 4.9 tp -99.32 145.34 27.43 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.198 -0.939 . . . . 0.01 108.96 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -106.73 -166.41 1.17 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.647 -0.658 . . . . 2.27 109.882 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -90.68 52.85 2.28 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.405 -0.809 . . . . 1.8400000000000001 109.833 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -115.35 -178.88 3.48 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.473 -0.767 . . . . 2.2799999999999998 109.448 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -105.47 111.48 24.21 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.476 -0.935 . . . . 0.01 108.476 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -99.65 112.7 24.9 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.387 -0.82 . . . . 0.01 110.493 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -94.54 -24.06 17.41 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.165 -0.959 . . . . 0.01 110.855 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -126.04 153.59 73.96 Favored Pre-proline 0 N--CA 1.501 2.078 0 N-CA-C 108.451 -0.944 . . . . 2.54 108.451 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -59.85 -39.73 69.49 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 CA-C-N 119.285 0.78 . . . . 0.69999999999999996 110.609 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 6.7 t -61.84 -19.57 21.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.755 -1.216 . . . . 0.85999999999999999 108.863 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 10.6 t0 -65.96 -18.06 65.09 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.954 -1.091 . . . . 0.02 111.059 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.621 ' HE1' ' CB ' ' A' ' 164' ' ' ALA . 1.8 p90 -103.0 14.16 32.6 Favored 'General case' 0 N--CA 1.508 2.467 0 O-C-N 121.077 -1.014 . . . . 0.02 109.811 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 87.42 10.37 70.89 Favored Glycine 0 N--CA 1.497 2.728 0 O-C-N 121.462 -0.774 . . . . 0.02 113.854 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.621 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . . . -100.93 141.32 33.98 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 120.472 -1.604 . . . . 0.02 110.757 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.61 -7.66 59.17 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.673 -0.642 . . . . 0.58999999999999997 109.484 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 39.0 m -143.54 150.67 51.82 Favored Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 120.961 -1.087 . . . . 0.87 109.154 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -76.75 18.45 0.72 Allowed 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.0 1.134 . . . . 0.38 112.474 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.87 125.47 31.38 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 122.373 1.082 . . . . 0.17999999999999999 111.698 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.508 HD11 ' CZ2' ' A' ' 162' ' ' TRP . 1.6 mt -149.94 127.01 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.344 -1.354 . . . . 3.9900000000000002 107.344 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.461 ' NE2' ' O ' ' A' ' 140' ' ' GLU . 2.9 mp0 -111.95 -18.06 12.74 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.075 -1.016 . . . . 5.1699999999999999 112.816 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 20.5 t -157.06 159.93 38.42 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 119.141 -2.224 . . . . 0.02 110.315 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.431 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 19.0 p90 -151.67 153.38 34.29 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.971 -1.081 . . . . 2.02 110.538 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 -144.97 149.98 36.14 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.882 0.849 . . . . 0.01 110.433 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -87.17 143.14 27.43 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.874 -0.788 . . . . 0.01 108.874 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.1 mt -94.76 129.13 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.28 -0.887 . . . . 3.04 109.108 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 11.7 p -136.38 146.99 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.194 -0.942 . . . . 1.8899999999999999 109.686 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 4.8899999999999997 109.411 -179.991 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 110.45 -1.06 . . . . 0.01 110.45 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -152.85 138.34 17.68 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.52 -0.988 . . . . 0.02 109.666 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.8 tt -130.85 140.87 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 109.222 -0.659 . . . . 0.02 109.222 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.8 m -121.95 130.89 53.7 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.444 -0.785 . . . . 0.39000000000000001 109.996 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.487 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 5.4 m-85 -111.11 140.74 45.41 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.561 -0.712 . . . . 0.02 109.332 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.575 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.1 m-85 -122.68 138.6 54.56 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.266 -0.896 . . . . 0.02 109.756 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -69.29 -27.29 65.27 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.925 -1.11 . . . . 0.029999999999999999 111.736 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 3.3 m-20 -113.87 169.4 9.03 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.804 -1.185 . . . . 0.029999999999999999 110.172 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -75.33 158.31 32.99 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.662 0.744 . . . . 0.029999999999999999 110.034 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.413 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 7.1 t-20 65.96 33.44 7.8 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.913 0.863 . . . . 0.73999999999999999 111.173 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.413 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 0.8 OUTLIER 55.42 41.8 30.65 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.296 0.57 . . . . 0.02 111.214 177.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -112.8 165.6 12.15 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.236 -1.024 . . . . 0.02 108.236 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.17 -167.59 34.49 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.801 -1.19 . . . . 0.029999999999999999 110.6 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -70.19 143.88 52.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.425 -1.044 . . . . 2.7599999999999998 108.957 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -120.41 149.13 42.85 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.65 0.738 . . . . 1.8899999999999999 110.296 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -132.76 127.7 35.23 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.399 -0.963 . . . . 0.02 108.399 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 18.9 p30 -112.22 136.85 51.13 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.441 -0.787 . . . . 1.1200000000000001 109.709 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.0 t -130.65 138.6 50.15 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.515 0.674 . . . . 0.02 109.679 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.498 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 33.9 t70 -117.07 11.14 14.13 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.567 -0.708 . . . . 0.20000000000000001 109.852 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 42.3 m -158.55 174.57 14.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.118 -0.988 . . . . 1.23 108.505 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -61.27 144.04 54.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.71 -1.244 . . . . 0.02 110.09 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.5 t -131.67 117.46 18.69 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.654 -0.869 . . . . 0.02 108.654 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.12 -25.77 47.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.974 -1.079 . . . . 0.23999999999999999 110.988 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -153.4 101.6 2.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.979 -1.075 . . . . 1.1399999999999999 108.977 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -104.0 9.28 36.62 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 122.109 0.956 . . . . 6.3700000000000001 109.806 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.4 mtm180 -59.3 -24.69 63.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.525 -0.734 . . . . 3.1099999999999999 111.221 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.3 t -75.39 -16.93 60.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.629 -1.295 . . . . 0.88 110.315 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -105.14 -21.69 13.22 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.366 -0.833 . . . . 0.02 109.503 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.4 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 4.5 tp -148.7 126.81 12.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.223 -0.923 . . . . 3.3199999999999998 109.447 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.5 t -86.51 -11.88 50.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.634 -0.666 . . . . 0.02 111.206 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.4 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 24.4 ttp180 -171.47 161.58 6.36 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.84 -1.162 . . . . 0.02 108.154 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.405 ' SG ' HD12 ' A' ' 79' ' ' LEU . 1.5 p -142.55 114.98 8.46 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.881 -1.137 . . . . 0.02 108.761 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -106.63 1.15 24.95 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 120.777 -1.202 . . . . 0.029999999999999999 110.379 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.8 t -155.94 154.51 31.28 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.5 -1.296 . . . . 0.02 107.5 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.8 mt -146.63 147.68 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.029 -1.045 . . . . 0.02 110.401 -178.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.579 HH11 ' CG ' ' A' ' 40' ' ' ARG . 0.2 OUTLIER -124.39 125.02 43.61 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.997 -1.112 . . . . 0.02 107.997 177.651 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.1 t -105.1 113.65 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 106.644 -1.613 . . . . 0.02 106.644 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -84.18 -34.76 23.91 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.467 -0.77 . . . . 3.8100000000000001 110.033 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.41 150.93 20.21 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 118.618 -1.753 . . . . 0.02 110.722 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.43 171.99 48.58 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.357 -1.097 . . . . 0.01 110.357 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.8 m -119.6 134.9 55.03 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 107.805 -1.183 . . . . 1.48 107.805 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.467 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 31.2 m95 -127.36 154.94 44.36 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 122.583 1.182 . . . . 0.02 112.329 -176.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.29 134.06 51.64 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 105.282 -2.118 . . . . 0.23999999999999999 105.282 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.51 ' HB ' HD22 ' A' ' 79' ' ' LEU . 23.7 m -119.12 143.7 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 109.066 -0.716 . . . . 0.65000000000000002 109.066 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -120.96 145.92 47.21 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 122.276 1.036 . . . . 0.02 110.041 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -66.09 -34.05 77.18 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 115.816 -0.629 . . . . 0.02 111.009 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -125.46 157.54 67.63 Favored Pre-proline 0 N--CA 1.502 2.162 0 O-C-N 121.051 -1.03 . . . . 0.02 109.487 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.45 167.26 0.93 Allowed 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.692 1.594 . . . . 0.02 113.074 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.8 m120 63.77 36.36 10.59 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.253 -0.885 . . . . 0.02 111.113 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 45.09 51.58 8.88 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.66 0.743 . . . . 3.3900000000000001 110.67 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.7 m -126.36 163.82 22.43 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.168 0.509 . . . . 2.3300000000000001 109.814 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.78 -161.65 32.24 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.815 -1.314 . . . . 0.02 109.815 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -65.3 139.15 58.57 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.124 -1.221 . . . . 0.02 110.146 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.497 ' O ' ' SD ' ' A' ' 58' ' ' MET . 2.8 ppp? -118.84 137.28 53.53 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.714 -0.616 . . . . 5.0099999999999998 109.593 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.469 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 96.2 m-85 -134.85 138.63 44.36 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.494 -0.754 . . . . 0.02 109.78 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.4 mm -95.2 131.61 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.857 -0.794 . . . . 1.72 108.857 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.561 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -120.08 110.64 36.15 Favored Pre-proline 0 N--CA 1.505 2.278 0 O-C-N 121.289 -0.882 . . . . 0.02 110.858 -178.346 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -77.86 168.99 21.38 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 CA-C-N 119.916 1.006 . . . . 1.47 110.296 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -53.9 140.62 30.15 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.861 -1.15 . . . . 4.25 110.522 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.93 -177.79 32.82 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.451 -1.356 . . . . 0.02 110.618 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -119.93 131.16 55.12 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.362 -1.081 . . . . 0.95999999999999996 109.646 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.561 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 75.9 m-85 -121.8 96.27 47.21 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 108.128 -1.064 . . . . 0.02 108.128 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.404 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.6 Cg_endo -67.07 -3.75 10.29 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 120.778 0.986 . . . . 0.02 113.756 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 35.1 mt-10 -157.81 155.21 29.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.685 -1.259 . . . . 2.02 108.288 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -60.56 -39.37 87.72 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.572 -0.705 . . . . 0.02 112.042 -177.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -59.96 -23.68 63.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.083 -1.011 . . . . 0.02 110.276 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -69.97 -18.92 63.37 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.778 0.799 . . . . 3.4199999999999999 109.021 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.547 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.1 t90 -108.04 10.6 28.19 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.432 -1.321 . . . . 0.02 107.432 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.5 mtt 61.08 22.27 12.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.537 -0.727 . . . . 0.02 110.463 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.76 143.65 44.88 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.49 -1.444 . . . . 0.02 109.49 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.4 tp -79.57 -31.93 41.98 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.558 -1.275 . . . . 0.97999999999999998 107.558 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -157.63 -172.65 4.04 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 106.312 -1.736 . . . . 0.02 106.312 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -98.49 28.06 4.4 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.821 -1.174 . . . . 0.02 110.823 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 -96.83 121.89 39.19 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.828 -1.17 . . . . 3.2000000000000002 110.887 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.51 HD22 ' HB ' ' A' ' 48' ' ' VAL . 31.0 mt -144.0 121.39 11.65 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 107.574 -1.269 . . . . 2.6099999999999999 107.574 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.34 -16.19 11.48 Favored Glycine 0 N--CA 1.505 3.243 0 O-C-N 121.192 -0.943 . . . . 0.02 112.804 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.6 p -157.09 156.37 32.66 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.107 -1.819 . . . . 0.02 110.344 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 23.4 m -144.89 147.93 33.33 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.584 -0.698 . . . . 0.02 110.047 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 39.1 mtp180 -137.84 143.19 40.84 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.368 -0.832 . . . . 0.01 109.585 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.57 132.21 36.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.201 -0.937 . . . . 0.42999999999999999 109.669 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.3 t -91.0 125.03 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.873 -0.788 . . . . 1.25 108.873 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -92.56 132.53 36.77 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.877 -1.139 . . . . 1.77 108.865 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mt -98.42 140.57 32.48 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.865 -0.791 . . . . 1.6299999999999999 108.865 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 52.9 p -112.08 124.68 52.95 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.474 -0.936 . . . . 1.0800000000000001 108.474 178.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.4 m -115.76 132.81 56.53 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 107.754 -1.202 . . . . 1.26 107.754 177.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -156.78 -49.58 0.01 OUTLIER Glycine 0 N--CA 1.505 3.279 0 C-N-CA 117.709 -2.186 . . . . 0.01 113.636 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.71 -105.73 0.19 Allowed Glycine 0 N--CA 1.489 2.203 0 CA-C-N 120.192 1.996 . . . . 0.01 111.352 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -120.81 118.59 30.39 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.125 -1.221 . . . . 4.4299999999999997 110.401 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.14 129.14 34.81 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.806 -0.758 . . . . 2.9900000000000002 109.369 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -131.23 141.19 49.98 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.497 -0.752 . . . . 6.3600000000000003 109.241 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.0 tt -129.8 146.91 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 O-C-N 121.247 -0.908 . . . . 1.0900000000000001 110.344 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.523 ' NE2' ' O ' ' A' ' 130' ' ' LYS . 2.4 pm0 -122.1 134.31 54.76 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 107.561 -1.274 . . . . 2.0499999999999998 107.561 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.8 m -124.37 146.25 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 O-C-N 120.721 -1.237 . . . . 1.1000000000000001 110.158 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.584 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 79.5 m-85 -119.4 141.2 49.29 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.973 0.892 . . . . 0.72999999999999998 111.081 -178.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -67.18 -30.22 70.12 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 115.921 -0.581 . . . . 0.02 111.819 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -116.18 168.99 9.62 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.028 -1.045 . . . . 3.1800000000000002 110.441 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.27 164.94 50.0 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.796 -0.921 . . . . 0.01 110.796 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 56.46 38.45 29.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.719 -0.871 . . . . 0.01 111.432 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 51.94 55.08 9.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.559 -0.713 . . . . 0.01 111.256 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -129.06 165.01 22.02 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.018 -1.105 . . . . 3.1499999999999999 108.018 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.18 -163.64 27.95 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.255 -1.538 . . . . 0.01 109.255 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.498 ' NE2' ' OH ' ' A' ' 108' ' ' TYR . 57.1 tt0 -76.19 144.19 40.64 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.005 -1.291 . . . . 0.01 108.834 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.584 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 32.7 ttp -116.66 142.55 46.75 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.524 0.678 . . . . 0.01 109.821 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.498 ' OH ' ' NE2' ' A' ' 106' ' ' GLN . 55.5 m-85 -131.48 136.86 48.26 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.265 -1.013 . . . . 2.48 108.265 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -118.15 134.16 55.25 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.551 -0.718 . . . . 0.01 110.248 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.9 t -149.01 148.33 29.61 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.276 1.036 . . . . 1.6899999999999999 111.197 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 30.1 p -111.16 9.7 21.88 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 115.547 -0.751 . . . . 0.01 110.496 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -120.85 163.16 18.61 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.235 -0.916 . . . . 3.21 111.438 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -67.46 156.8 35.72 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.217 -1.031 . . . . 0.01 108.217 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.609 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 26.4 p -123.86 116.47 27.6 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.515 -0.741 . . . . 0.01 109.414 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -76.7 -31.93 3.86 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 CA-C-N 120.181 1.1 . . . . 0.01 110.445 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.4 p -143.84 108.91 4.98 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.733 0.778 . . . . 0.02 109.016 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.9 mt -64.16 -39.27 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.771 -0.581 . . . . 1.8300000000000001 110.822 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 118' ' ' MET . 1.8 tmt? -67.95 -37.24 81.34 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.175 -1.01 . . . . 1.3400000000000001 110.034 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -69.47 -38.02 77.55 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.543 -1.348 . . . . 2.1099999999999999 109.87 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -80.25 -46.72 15.75 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.274 -0.891 . . . . 2.0800000000000001 112.373 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -110.87 0.13 17.07 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.395 -0.815 . . . . 0.02 112.58 -176.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.519 ' O ' ' NH1' ' A' ' 124' ' ' ARG . 8.7 m80 60.01 33.47 21.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.768 -1.207 . . . . 0.02 109.639 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.6 mt -112.63 135.8 52.94 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 108.754 -0.832 . . . . 0.02 108.754 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 122' ' ' HIS . 0.1 OUTLIER -92.27 -22.79 19.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.242 -0.911 . . . . 5.3200000000000003 110.208 -179.486 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -149.33 163.61 37.21 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.189 -0.945 . . . . 0.02 109.883 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.1 mt -131.91 128.81 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 107.899 -1.148 . . . . 2.1699999999999999 107.899 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -107.61 -12.54 15.24 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.27 -0.893 . . . . 0.02 112.084 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.5 m -158.44 150.7 21.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.848 -1.158 . . . . 0.01 108.511 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.572 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 0.5 OUTLIER -169.62 144.67 2.97 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.425 -0.954 . . . . 1.22 108.425 -179.526 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.523 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 32.1 tttp -125.93 110.6 13.82 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 122.497 1.142 . . . . 1.4099999999999999 110.61 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 131' ' ' VAL . 10.1 p -109.09 134.5 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 106.948 -1.501 . . . . 0.01 106.948 178.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 50.7 t -128.58 94.77 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 N-CA-C 107.148 -1.427 . . . . 1.98 107.148 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -146.66 -76.58 0.19 Allowed 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 105.816 -1.92 . . . . 0.01 105.816 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 156.27 -54.14 0.41 Allowed Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.982 -1.647 . . . . 0.01 108.982 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 76.3 p -119.21 98.32 6.1 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.643 -0.916 . . . . 2.2999999999999998 111.021 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -129.25 145.38 51.35 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 107.265 -1.383 . . . . 0.01 107.265 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 96.4 mt -123.74 139.47 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 120.957 -1.089 . . . . 1.6899999999999999 110.071 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -114.26 144.06 43.84 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 106.99 -1.485 . . . . 2.4900000000000002 106.99 177.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.497 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 14.3 m-85 -123.19 144.19 49.53 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.348 -0.845 . . . . 0.02 109.465 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -74.1 -29.45 61.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.595 -0.69 . . . . 0.02 111.838 -176.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.3 mt -115.94 154.76 48.36 Favored Pre-proline 0 N--CA 1.505 2.283 0 O-C-N 120.693 -1.254 . . . . 1.48 108.985 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -56.15 167.22 2.62 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.123 1.215 . . . . 0.02 112.889 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 143' ' ' ASN . 0.4 OUTLIER 59.58 31.15 20.76 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.149 -0.932 . . . . 0.75 111.487 178.588 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 144' ' ' TYR . 0.7 OUTLIER 58.05 50.98 9.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.447 -0.783 . . . . 0.02 111.152 177.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -125.99 164.57 20.54 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.494 -0.754 . . . . 0.02 109.973 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.06 -165.6 33.11 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.323 -1.111 . . . . 0.02 110.323 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -69.4 142.22 53.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.596 -0.943 . . . . 0.02 109.055 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.467 ' CD ' ' N ' ' A' ' 148' ' ' GLN . 5.3 mp0 -115.34 149.55 37.71 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.851 -0.531 . . . . 0.02 109.75 -178.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -124.72 134.61 52.78 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.618 -0.676 . . . . 0.01 109.189 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.493 HD23 ' N ' ' A' ' 151' ' ' LEU . 2.8 tt -99.91 121.46 41.37 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.072 -1.017 . . . . 0.01 108.743 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.493 ' N ' HD23 ' A' ' 150' ' ' LEU . 3.8 mm? -99.98 165.33 11.59 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.022 -1.049 . . . . 0.01 109.506 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -109.91 -96.96 0.4 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.59 -0.694 . . . . 2.27 109.215 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -176.37 51.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.198 -0.939 . . . . 1.8400000000000001 109.626 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -113.82 -159.77 0.7 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.547 -0.721 . . . . 2.2799999999999998 109.512 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.518 ' OE2' ' NZ ' ' A' ' 130' ' ' LYS . 66.3 mm-40 -106.37 107.05 17.87 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.494 -0.753 . . . . 0.01 109.064 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.705 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 29.7 m-85 -99.96 114.3 27.47 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.301 -0.874 . . . . 0.01 109.993 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -96.09 -22.34 17.39 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.227 -0.921 . . . . 0.01 111.928 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -127.84 155.34 77.61 Favored Pre-proline 0 N--CA 1.504 2.26 0 O-C-N 120.803 -1.185 . . . . 2.54 109.023 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -60.79 -39.64 60.94 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 120.497 0.798 . . . . 0.69999999999999996 110.614 178.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.0 t -60.72 -20.76 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.763 -1.211 . . . . 0.85999999999999999 109.011 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -65.09 -14.93 61.72 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.815 -1.178 . . . . 0.02 109.732 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.705 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 21.8 m0 -96.2 10.71 36.91 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.329 -0.857 . . . . 0.02 108.712 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.03 9.47 87.07 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.727 -1.225 . . . . 0.02 110.716 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -98.63 141.86 30.93 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.296 -1.12 . . . . 0.02 110.065 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.19 -9.09 58.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.574 -0.703 . . . . 0.58999999999999997 109.661 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.1 t -144.61 150.09 45.96 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.079 -1.013 . . . . 0.87 108.728 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -75.9 19.96 0.56 Allowed 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 120.663 0.908 . . . . 0.38 112.259 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.26 123.57 29.72 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.88 -1.138 . . . . 0.17999999999999999 111.584 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.8 mt -149.49 128.15 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 107.041 -1.466 . . . . 3.9900000000000002 107.041 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -112.15 -17.39 12.82 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.055 -1.028 . . . . 5.1699999999999999 113.356 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.6 p -158.11 160.98 37.9 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 119.122 -2.236 . . . . 0.02 110.148 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.609 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 3.8 p90 -151.51 153.66 35.03 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.056 -1.028 . . . . 2.02 110.925 178.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -145.38 149.64 35.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.297 -0.877 . . . . 0.01 110.215 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -88.36 144.03 26.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.527 -0.733 . . . . 0.01 109.51 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.5 mt -93.59 129.59 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.155 -0.965 . . . . 3.04 109.159 178.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 10.2 p -136.09 146.56 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.254 -0.904 . . . . 1.8899999999999999 109.473 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.291 -0.881 . . . . 4.8899999999999997 109.404 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.194 -1.562 . . . . 0.01 109.194 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -147.87 136.89 22.09 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.059 -1.259 . . . . 0.02 110.641 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.8 tt -130.72 139.62 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.731 -0.841 . . . . 0.02 108.731 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 m -120.89 130.14 53.78 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.489 -0.757 . . . . 0.39000000000000001 109.866 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -109.94 139.57 44.88 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.077 -0.712 . . . . 0.02 109.077 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.534 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 5.3 m-85 -122.14 138.41 54.47 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.146 -0.971 . . . . 0.02 109.531 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.491 ' HG3' HD11 ' A' ' 33' ' ' LEU . 92.0 mt-10 -69.39 -27.67 65.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.193 -0.942 . . . . 0.029999999999999999 111.539 -178.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -114.05 169.16 9.22 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.849 -1.157 . . . . 0.029999999999999999 110.14 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -75.39 158.32 32.9 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.598 0.713 . . . . 0.029999999999999999 110.218 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 66.42 33.3 6.98 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.948 0.88 . . . . 0.73999999999999999 111.117 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 55.48 41.94 30.36 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 116.056 -0.52 . . . . 0.02 111.324 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -113.66 165.68 12.28 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.193 -1.04 . . . . 0.02 108.193 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.39 -167.46 35.66 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.826 -1.178 . . . . 0.029999999999999999 110.793 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -69.22 142.27 54.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.398 -1.06 . . . . 2.7599999999999998 109.315 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -120.76 149.09 43.08 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.618 0.723 . . . . 1.8899999999999999 110.167 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -132.43 127.16 34.76 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.255 -1.017 . . . . 0.02 108.255 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -112.48 137.41 50.72 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.57 -0.706 . . . . 1.1200000000000001 109.827 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.9 t -131.67 139.21 49.01 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 121.523 0.678 . . . . 0.02 109.777 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -116.98 11.26 14.26 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.583 -0.698 . . . . 0.20000000000000001 109.671 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.409 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 29.5 p -158.29 174.3 15.37 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.275 -1.009 . . . . 1.23 108.275 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 2.3 p30 -60.93 143.84 54.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.647 -1.283 . . . . 0.02 109.855 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 26' ' ' CYS . 27.4 p -131.19 117.14 18.62 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.52 -0.918 . . . . 0.02 108.52 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.17 -24.83 47.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.143 -0.973 . . . . 0.23999999999999999 110.965 -178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -154.8 101.65 2.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.834 -1.166 . . . . 1.1399999999999999 108.985 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -105.21 9.53 34.03 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 122.197 0.998 . . . . 6.3700000000000001 109.903 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -58.86 -24.55 62.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.388 -0.82 . . . . 3.1099999999999999 110.934 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.5 m -74.16 -16.55 60.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.755 -1.216 . . . . 0.88 110.124 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -103.97 -21.97 13.54 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.482 -0.761 . . . . 0.02 109.488 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.491 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.6 tp -150.04 128.86 12.48 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.196 -0.94 . . . . 3.3199999999999998 109.207 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.7 t -85.54 -10.1 56.44 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.768 -0.583 . . . . 0.02 111.191 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.461 ' HE ' HD21 ' A' ' 37' ' ' ASN . 15.7 ptm180 -170.55 162.28 8.02 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.696 -1.224 . . . . 0.02 107.696 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.6 t -143.05 115.57 8.58 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.73 -1.231 . . . . 0.02 109.136 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.639 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.5 OUTLIER -109.8 1.95 19.66 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 120.839 -1.163 . . . . 0.029999999999999999 111.532 -178.563 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.2 t -156.67 154.47 30.14 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.098 -1.075 . . . . 0.02 108.098 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.1 mt -145.94 146.61 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-O 122.402 1.096 . . . . 0.02 111.209 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -123.07 124.22 42.62 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.672 -1.233 . . . . 0.02 107.672 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.3 t -106.47 113.92 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 106.91 -1.515 . . . . 0.02 106.91 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -84.07 -34.42 24.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.746 -0.596 . . . . 3.8100000000000001 110.5 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.84 149.93 18.32 Favored Glycine 0 N--CA 1.486 2.026 0 C-N-CA 119.064 -1.541 . . . . 0.02 110.589 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.96 172.08 48.84 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.845 -1.169 . . . . 0.01 110.432 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.7 m -119.99 135.69 54.82 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.171 -1.048 . . . . 1.48 108.171 178.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.421 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 35.8 m95 -127.41 155.48 43.58 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 122.62 1.2 . . . . 0.02 112.526 -176.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.41 134.69 51.53 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 105.586 -2.005 . . . . 0.23999999999999999 105.586 176.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.416 ' HB ' HD22 ' A' ' 79' ' ' LEU . 11.5 m -120.12 144.51 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.629 -0.669 . . . . 0.65000000000000002 109.408 179.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -121.15 146.04 47.18 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 122.291 1.043 . . . . 0.02 110.22 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -67.5 -34.55 77.37 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.801 -0.636 . . . . 0.02 111.496 -177.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 24.4 mtm180 -124.72 158.22 63.11 Favored Pre-proline 0 N--CA 1.504 2.249 0 O-C-N 120.983 -1.073 . . . . 0.02 109.576 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -54.04 165.32 2.08 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.619 1.546 . . . . 0.02 113.253 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.474 ' ND2' ' N ' ' A' ' 53' ' ' ASN . 1.2 m120 64.37 37.02 8.65 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.111 -0.949 . . . . 0.02 111.268 178.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 45.22 51.68 9.06 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.662 0.744 . . . . 3.3900000000000001 110.603 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.9 p -126.2 163.47 23.1 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.58 -0.526 . . . . 2.3300000000000001 109.58 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.92 -161.76 32.14 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.811 -1.316 . . . . 0.02 109.811 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -65.27 138.91 58.51 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.085 -1.244 . . . . 0.02 110.388 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' A' ' 58' ' ' MET . 11.6 tmm? -120.1 137.18 54.29 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 109.376 -0.601 . . . . 5.0099999999999998 109.376 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.469 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 86.7 m-85 -134.67 139.68 45.44 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.799 0.809 . . . . 0.02 109.949 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.7 mm -94.77 131.26 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.762 -0.829 . . . . 1.72 108.762 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.556 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -120.45 111.95 34.58 Favored Pre-proline 0 N--CA 1.505 2.311 0 O-C-N 121.397 -0.814 . . . . 0.02 110.946 -178.165 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -78.31 169.16 20.55 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 CA-C-N 119.842 0.979 . . . . 1.47 110.338 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -53.72 141.52 26.22 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.88 -1.137 . . . . 4.25 110.514 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.85 -177.46 32.12 Favored Glycine 0 N--CA 1.496 2.636 0 C-N-CA 119.515 -1.326 . . . . 0.02 110.824 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -119.99 131.39 55.14 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.46 -1.023 . . . . 0.95999999999999996 109.803 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.556 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 75.1 m-85 -121.73 97.83 46.12 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 107.795 -1.187 . . . . 0.02 107.795 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.402 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 5.8 Cg_endo -69.6 -3.34 11.71 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 120.704 0.936 . . . . 0.02 113.671 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 33.4 mt-10 -157.77 155.11 29.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.723 -1.235 . . . . 2.02 108.137 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -60.4 -39.5 87.59 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.666 -0.646 . . . . 0.02 112.018 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -60.06 -24.02 64.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.058 -1.026 . . . . 0.02 110.411 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -69.74 -18.5 63.52 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.903 0.859 . . . . 3.4199999999999999 108.87 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.558 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.3 t90 -108.21 10.59 27.84 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.458 -1.312 . . . . 0.02 107.458 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.7 mtt 61.5 22.55 12.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.53 -0.731 . . . . 0.02 110.536 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.53 145.46 47.24 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.579 -1.409 . . . . 0.02 109.579 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.3 mt -80.48 -31.04 37.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -1.158 . . . . 0.97999999999999998 108.039 177.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -157.02 -171.55 3.69 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 106.513 -1.662 . . . . 0.02 106.513 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.424 ' OD2' ' OD1' ' A' ' 37' ' ' ASN . 66.0 m-20 -98.63 28.31 4.31 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.595 -1.316 . . . . 0.02 110.774 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.4 mtp180 -97.19 122.89 40.71 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.059 -1.026 . . . . 3.2000000000000002 110.99 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 79' ' ' LEU . 42.8 mt -143.47 121.59 12.17 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 107.632 -1.247 . . . . 2.6099999999999999 107.632 178.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.07 -17.27 9.67 Favored Glycine 0 N--CA 1.506 3.327 0 O-C-N 121.098 -1.001 . . . . 0.02 113.026 -177.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.9 m -156.74 156.86 34.05 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.085 -1.832 . . . . 0.02 110.483 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 44.9 t -144.79 147.26 32.69 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.529 -0.732 . . . . 0.02 110.242 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 38.1 mtm180 -138.52 143.17 39.4 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.33 -0.856 . . . . 0.01 109.392 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.81 132.46 36.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.251 -0.906 . . . . 0.42999999999999999 109.816 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.6 t -91.25 125.44 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.851 -0.796 . . . . 1.25 108.851 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -94.1 131.34 39.73 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.773 -1.204 . . . . 1.77 109.085 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mt -96.37 140.18 31.41 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.439 -0.949 . . . . 1.6299999999999999 108.439 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.2 t -111.89 127.86 55.97 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.285 -0.884 . . . . 1.0800000000000001 109.406 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.6 p -104.34 -154.17 0.5 Allowed 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 106.573 -1.64 . . . . 1.26 106.573 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.93 -52.97 0.73 Allowed Glycine 0 N--CA 1.502 3.044 0 O-C-N 120.392 -1.443 . . . . 0.01 112.895 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.81 -101.42 0.15 Allowed Glycine 0 N--CA 1.491 2.312 0 C-N-CA 118.467 -1.825 . . . . 0.01 111.966 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -121.64 118.89 30.31 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.057 -1.261 . . . . 4.4299999999999997 110.648 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.3 129.1 34.13 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.702 -0.799 . . . . 2.9900000000000002 109.555 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -131.1 142.23 50.24 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 109.039 -0.726 . . . . 6.3600000000000003 109.039 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.2 tt -129.68 147.36 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 O-C-N 121.24 -0.912 . . . . 1.0900000000000001 110.362 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -121.64 134.13 54.98 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.615 -1.254 . . . . 2.0499999999999998 107.615 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.7 m -124.36 145.88 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 120.69 -1.256 . . . . 1.1000000000000001 110.002 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.592 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 96.4 m-85 -119.13 141.44 48.81 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.995 0.902 . . . . 0.72999999999999998 110.935 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -67.02 -30.93 71.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.881 -0.512 . . . . 0.02 111.852 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -116.36 167.63 10.86 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.949 -1.094 . . . . 3.1800000000000002 110.561 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.18 164.17 44.49 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 111.057 -0.817 . . . . 0.01 111.057 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 57.1 38.56 29.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.884 -0.774 . . . . 0.01 110.963 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 52.4 55.32 9.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.582 -0.699 . . . . 0.01 111.058 178.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -129.08 165.85 20.42 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.216 -1.031 . . . . 3.1499999999999999 108.216 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.41 -163.8 27.76 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.231 -1.548 . . . . 0.01 109.231 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -76.0 144.24 41.02 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.025 -1.279 . . . . 0.01 108.711 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.592 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 52.2 ttp -116.29 141.84 47.63 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.608 0.718 . . . . 0.01 109.882 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -131.57 136.63 47.97 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.237 -1.023 . . . . 2.48 108.237 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -118.1 133.69 55.67 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.502 -0.749 . . . . 0.01 110.012 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.1 t -147.84 148.76 31.23 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 122.195 0.998 . . . . 1.6899999999999999 110.941 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 60.3 p -111.17 10.06 21.87 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 115.619 -0.718 . . . . 0.01 110.293 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -121.67 163.09 19.58 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.257 -0.902 . . . . 3.21 111.677 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.17 157.48 36.82 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.278 -1.008 . . . . 0.01 108.278 178.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.58 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 0.8 OUTLIER -128.46 119.51 20.54 Favored Pre-proline 0 N--CA 1.504 2.26 0 O-C-N 121.476 -0.765 . . . . 0.01 108.989 177.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -76.47 -28.76 6.57 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 CA-C-N 120.24 1.121 . . . . 0.01 110.85 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 64.1 m -144.04 109.75 5.25 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.718 0.771 . . . . 0.02 109.25 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.72 -38.28 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.819 -0.551 . . . . 1.8300000000000001 110.514 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 20.5 ttt -68.49 -36.39 78.87 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.399 -0.92 . . . . 1.3400000000000001 110.359 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -70.91 -39.06 72.96 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.5 -1.375 . . . . 2.1099999999999999 110.167 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -79.66 -47.54 15.22 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.307 -0.871 . . . . 2.0800000000000001 112.535 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -110.27 0.51 18.12 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.358 -0.839 . . . . 0.02 112.476 -176.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.6 m80 59.49 32.64 21.84 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.757 -1.214 . . . . 0.02 109.32 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.1 mt -112.2 135.46 52.84 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 108.477 -0.934 . . . . 0.02 108.477 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -91.24 -22.66 20.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.289 -0.882 . . . . 5.3200000000000003 110.158 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -149.84 164.04 36.42 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.296 -0.878 . . . . 0.02 110.024 -178.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 48.6 mt -131.42 128.49 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 107.558 -1.275 . . . . 2.1699999999999999 107.558 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -107.81 -12.25 15.24 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.313 -0.867 . . . . 0.02 112.376 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.4 t -158.74 151.39 21.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.837 -1.164 . . . . 0.01 108.911 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.504 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 2.8 p -170.41 145.25 2.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.092 -1.005 . . . . 1.22 109.178 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -124.67 110.18 14.07 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 122.361 1.077 . . . . 1.4099999999999999 109.894 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 131' ' ' VAL . 8.6 p -111.21 135.34 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.365 -1.346 . . . . 0.01 107.365 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.9 t -128.95 94.69 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 107.05 -1.463 . . . . 1.98 107.05 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.413 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 4.5 tm-20 -146.03 -74.73 0.22 Allowed 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 105.869 -1.9 . . . . 0.01 105.869 177.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 167.36 -69.74 0.18 Allowed Glycine 0 N--CA 1.485 1.902 0 N-CA-C 108.7 -1.76 . . . . 0.01 108.7 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.783 ' OG1' HD12 ' A' ' 175' ' ' ILE . 0.1 OUTLIER -120.18 115.4 23.57 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.556 -0.967 . . . . 2.2999999999999998 110.456 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.413 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 5.8 m95 -127.05 149.37 49.94 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 106.809 -1.552 . . . . 0.01 106.809 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 97.7 mt -122.98 138.37 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 120.42 -1.425 . . . . 1.6899999999999999 110.647 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -113.72 143.64 44.28 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.265 -1.383 . . . . 2.4900000000000002 107.265 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.501 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 10.5 m-85 -122.45 144.68 48.9 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.178 -0.951 . . . . 0.02 109.307 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -75.72 -29.34 58.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.608 -0.682 . . . . 0.02 111.566 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mt -116.41 154.21 48.91 Favored Pre-proline 0 N--CA 1.504 2.234 0 O-C-N 120.69 -1.256 . . . . 1.48 108.899 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -55.16 170.02 0.83 Allowed 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.225 1.283 . . . . 0.02 112.962 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 14.2 t30 58.25 31.62 21.04 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 114.937 -1.029 . . . . 0.75 111.274 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 56.21 48.01 18.21 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.532 -0.73 . . . . 0.02 110.424 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -123.03 164.4 18.65 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.585 -0.697 . . . . 0.02 109.97 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.86 -166.03 32.35 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.375 -1.09 . . . . 0.02 110.375 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -69.04 142.85 54.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.581 -0.952 . . . . 0.02 109.133 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -114.49 147.99 38.54 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.393 0.616 . . . . 0.02 110.242 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -125.22 135.71 52.84 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.919 -0.771 . . . . 0.01 108.919 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.7 tt -97.9 121.64 40.05 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.839 -1.163 . . . . 0.01 109.495 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.686 HD21 ' CD1' ' A' ' 162' ' ' TRP . 0.1 OUTLIER -96.04 145.5 25.4 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.309 -0.869 . . . . 0.01 108.752 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.671 ' H ' HD13 ' A' ' 151' ' ' LEU . 29.3 t0 -103.06 -116.15 0.21 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.339 -0.851 . . . . 2.27 109.412 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -157.78 49.69 0.42 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.053 -1.029 . . . . 1.8400000000000001 109.712 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -113.64 -162.97 0.83 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.495 -0.753 . . . . 2.2799999999999998 109.315 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -105.93 103.52 13.03 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.43 -0.794 . . . . 0.01 108.94 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.616 ' CG ' ' NE1' ' A' ' 162' ' ' TRP . 66.8 m-85 -98.7 113.24 25.24 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.365 -0.835 . . . . 0.01 109.722 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -95.11 -22.33 17.95 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.297 -0.877 . . . . 0.01 111.61 -177.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -127.39 154.52 77.24 Favored Pre-proline 0 N--CA 1.504 2.25 0 O-C-N 120.767 -1.208 . . . . 2.54 108.855 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -60.5 -38.97 69.58 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 120.58 0.854 . . . . 0.69999999999999996 110.512 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 84.6 t -61.51 -20.02 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.958 -1.089 . . . . 0.85999999999999999 108.931 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -65.41 -15.6 62.77 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.934 -1.104 . . . . 0.02 110.074 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.686 ' CD1' HD21 ' A' ' 151' ' ' LEU . 9.7 m0 -98.22 11.4 37.98 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.144 -0.973 . . . . 0.02 108.925 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.06 10.34 85.65 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.842 -1.171 . . . . 0.02 111.087 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.57 141.25 32.6 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.181 -1.188 . . . . 0.02 110.023 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.08 -9.46 57.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.671 -0.643 . . . . 0.58999999999999997 110.217 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.0 m -143.49 149.78 48.75 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 120.891 -1.131 . . . . 0.87 109.057 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -76.64 19.1 0.66 Allowed 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 120.822 1.015 . . . . 0.38 112.294 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.7 124.7 29.82 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.812 -1.18 . . . . 0.17999999999999999 111.493 -177.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -150.21 126.6 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 107.075 -1.454 . . . . 3.9900000000000002 107.075 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -115.11 -15.07 11.74 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.051 -1.031 . . . . 5.1699999999999999 113.582 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 6.2 t -156.77 160.16 38.99 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 119.189 -2.194 . . . . 0.02 110.294 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.58 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 13.9 p90 -151.84 153.29 33.93 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.919 -1.113 . . . . 2.02 110.718 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -144.78 149.42 35.46 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.364 -0.835 . . . . 0.01 110.293 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.415 ' HG2' ' H ' ' A' ' 174' ' ' ARG . 12.5 ptm180 -89.26 145.46 25.37 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.27 -0.641 . . . . 0.01 109.27 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.783 HD12 ' OG1' ' A' ' 135' ' ' THR . 4.7 mt -96.76 129.93 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.308 -0.87 . . . . 3.04 109.324 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.14 146.31 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.227 -0.92 . . . . 1.8899999999999999 109.484 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 4.8899999999999997 109.404 179.931 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.421 -1.471 . . . . 0.01 109.421 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.519 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 2.8 ttmp? -145.99 135.27 22.9 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.174 -1.192 . . . . 0.02 110.517 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.5 tt -129.54 139.15 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.062 -1.088 . . . . 0.02 108.062 178.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.49 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.4 t -122.41 130.86 53.53 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.348 -0.845 . . . . 0.39000000000000001 110.119 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.0 m-85 -111.18 141.54 44.57 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 109.067 -0.716 . . . . 0.02 109.067 178.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.548 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.9 m-85 -122.08 138.58 54.39 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.181 -0.949 . . . . 0.02 109.61 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.486 ' HG3' HD11 ' A' ' 33' ' ' LEU . 96.1 mt-10 -68.33 -27.91 66.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.878 -1.139 . . . . 0.029999999999999999 111.39 -178.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.1 m-20 -114.65 169.88 8.73 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.873 -1.142 . . . . 0.029999999999999999 110.163 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -75.5 161.91 28.78 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.793 0.806 . . . . 0.029999999999999999 110.411 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.3 m120 63.12 33.13 14.75 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.054 0.931 . . . . 0.73999999999999999 110.894 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 54.92 40.07 31.83 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.865 -0.607 . . . . 0.02 110.978 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -110.29 165.75 11.52 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.215 -1.031 . . . . 0.02 108.215 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.46 -167.57 35.63 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.889 -1.148 . . . . 0.029999999999999999 110.889 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -69.65 143.28 53.26 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.477 -1.014 . . . . 2.7599999999999998 109.261 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -120.47 149.23 42.72 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.505 0.669 . . . . 1.8899999999999999 110.171 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -132.34 127.59 35.85 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.25 -1.018 . . . . 0.02 108.25 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -112.78 136.75 52.04 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.422 -0.799 . . . . 1.1200000000000001 109.751 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.427 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 15.9 t -131.22 139.14 49.64 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.765 -0.585 . . . . 0.02 109.515 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -116.58 11.69 14.83 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.624 -0.672 . . . . 0.20000000000000001 109.836 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.513 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 52.9 t -158.37 174.69 14.75 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.248 -1.019 . . . . 1.23 108.248 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.513 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.1 m-20 -60.53 144.19 52.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.756 -1.215 . . . . 0.02 109.721 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 22.2 t -131.75 117.41 18.56 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.654 -0.869 . . . . 0.02 108.654 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.89 -24.42 48.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.143 -0.973 . . . . 0.23999999999999999 110.919 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -155.18 102.36 2.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.927 -1.108 . . . . 1.1399999999999999 109.234 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -102.57 9.9 39.13 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 122.024 0.916 . . . . 6.3700000000000001 109.734 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -59.45 -25.22 64.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.589 -0.694 . . . . 3.1099999999999999 111.416 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.9 m -76.23 -17.3 59.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.508 -1.37 . . . . 0.88 110.687 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -103.88 -22.06 13.56 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.361 -0.837 . . . . 0.02 109.411 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.486 HD11 ' HG3' ' A' ' 11' ' ' GLU . 6.1 tp -150.25 129.1 12.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.317 -0.865 . . . . 3.3199999999999998 109.0 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.5 m -85.03 -9.81 57.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.743 -0.598 . . . . 0.02 110.944 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -171.15 162.36 6.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.954 -1.091 . . . . 0.02 108.066 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.9 p -144.03 115.09 7.88 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.747 -1.221 . . . . 0.02 108.53 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.42 HD22 ' HB3' ' A' ' 77' ' ' ASP . 5.8 t-20 -108.65 3.29 22.66 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.787 -1.195 . . . . 0.029999999999999999 110.862 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.3 m -155.48 154.28 31.58 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.651 -1.241 . . . . 0.02 107.651 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.404 HD13 HG21 ' A' ' 39' ' ' ILE . 10.5 mt -146.36 147.1 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.977 -1.077 . . . . 0.02 110.574 -178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -124.6 125.07 43.55 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 107.814 -1.18 . . . . 0.02 107.814 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.7 t -106.38 115.21 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 106.972 -1.492 . . . . 0.02 106.972 177.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.519 ' OE1' ' NZ ' ' A' ' 6' ' ' LYS . 30.5 tt0 -83.38 -34.0 25.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.37 -0.831 . . . . 3.8100000000000001 110.93 -178.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.04 152.58 22.5 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 118.893 -1.622 . . . . 0.02 110.799 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.53 172.97 49.39 Favored Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.698 -1.239 . . . . 0.01 110.423 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 86.6 m -119.81 135.16 54.97 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 107.982 -1.118 . . . . 1.48 107.982 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.442 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 32.0 m95 -126.53 154.99 43.07 Favored 'General case' 0 N--CA 1.502 2.173 0 CA-C-O 122.581 1.181 . . . . 0.02 112.301 -176.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.14 134.28 51.92 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 105.225 -2.139 . . . . 0.23999999999999999 105.225 176.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.437 ' HB ' HD22 ' A' ' 79' ' ' LEU . 35.5 m -116.99 141.93 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.532 -0.73 . . . . 0.65000000000000002 109.235 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -121.18 143.89 48.88 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 122.061 0.934 . . . . 0.02 109.753 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -65.01 -34.82 79.36 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.448 -0.796 . . . . 0.02 111.655 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.9 mtm180 -125.37 157.74 66.67 Favored Pre-proline 0 N--CA 1.503 2.2 0 O-C-N 121.004 -1.06 . . . . 0.02 109.332 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.48 167.73 0.84 Allowed 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.657 1.572 . . . . 0.02 113.022 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 63.13 36.39 12.19 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.212 -0.903 . . . . 0.02 111.207 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' A' ' 54' ' ' PHE . 0.6 OUTLIER 45.5 51.62 9.67 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.591 0.71 . . . . 3.3900000000000001 110.717 178.472 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.8 m -126.02 163.85 22.13 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.187 0.517 . . . . 2.3300000000000001 109.846 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.85 -161.54 32.06 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.869 -1.292 . . . . 0.02 109.869 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.407 ' CD2' ' N ' ' A' ' 57' ' ' HIS . 15.8 m170 -65.22 138.62 58.36 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.035 -1.274 . . . . 0.02 110.068 -178.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.447 ' C ' ' SD ' ' A' ' 58' ' ' MET . 11.2 tmm? -118.97 136.39 54.11 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.362 0.601 . . . . 5.0099999999999998 109.693 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.455 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 93.8 m-85 -134.31 138.76 45.2 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 121.714 0.768 . . . . 0.02 109.828 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.419 HD11 ' SD ' ' A' ' 58' ' ' MET . 15.9 mm -95.38 131.11 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 109.031 -0.729 . . . . 1.72 109.031 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.565 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -119.66 110.62 36.85 Favored Pre-proline 0 N--CA 1.504 2.247 0 O-C-N 121.449 -0.782 . . . . 0.02 110.67 -178.3 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -77.26 167.86 24.01 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 CA-C-N 119.966 1.024 . . . . 1.47 110.167 177.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.614 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -53.36 141.61 23.88 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.834 -1.166 . . . . 4.25 110.445 -179.621 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.13 -177.81 32.15 Favored Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.549 -1.31 . . . . 0.02 110.671 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -119.78 131.64 55.39 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.382 -1.07 . . . . 0.95999999999999996 109.823 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.565 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 75.6 m-85 -121.46 97.81 46.78 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 108.047 -1.094 . . . . 0.02 108.047 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -69.42 -3.88 12.68 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 120.743 0.962 . . . . 0.02 113.48 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -157.65 154.76 28.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.781 -1.199 . . . . 2.02 108.041 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -60.36 -38.8 84.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.58 -0.7 . . . . 0.02 112.154 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -60.52 -24.15 65.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.176 -0.953 . . . . 0.02 110.494 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -68.74 -18.03 64.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.327 -0.858 . . . . 3.4199999999999999 109.076 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.562 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.3 t90 -108.09 11.74 27.39 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.673 -1.232 . . . . 0.02 107.673 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.3 mmt 60.48 22.3 11.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.556 -0.715 . . . . 0.02 110.295 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.89 143.33 45.48 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.429 -1.468 . . . . 0.02 109.429 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.0 tp -78.58 -31.26 47.15 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.293 -1.373 . . . . 0.97999999999999998 107.293 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -157.75 -172.07 3.8 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 106.097 -1.816 . . . . 0.02 106.097 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.42 ' HB3' HD22 ' A' ' 37' ' ' ASN . 1.4 p30 -98.16 28.26 4.13 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.701 -1.249 . . . . 0.02 110.692 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -96.76 121.87 39.09 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.736 -1.227 . . . . 3.2000000000000002 111.039 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.437 HD22 ' HB ' ' A' ' 48' ' ' VAL . 59.4 mt -142.96 122.02 12.87 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 107.422 -1.325 . . . . 2.6099999999999999 107.422 178.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.84 -17.61 9.55 Favored Glycine 0 N--CA 1.504 3.222 0 O-C-N 121.231 -0.918 . . . . 0.02 112.859 -177.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 p -156.37 156.48 33.96 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.04 -1.859 . . . . 0.02 110.61 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 44.2 t -144.34 146.85 32.8 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.38 -0.825 . . . . 0.02 110.476 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 -138.33 143.48 39.93 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.408 -0.807 . . . . 0.01 109.486 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.42 132.25 36.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.946 . . . . 0.42999999999999999 109.825 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.3 t -91.56 125.63 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.878 -0.786 . . . . 1.25 108.878 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -94.26 131.85 39.44 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.783 -1.198 . . . . 1.77 109.234 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.3 mt -96.79 140.34 31.5 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.307 -0.871 . . . . 1.6299999999999999 108.681 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.5 p -111.93 127.63 55.91 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.411 -0.806 . . . . 1.0800000000000001 109.339 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.7 t -103.94 -154.66 0.51 Allowed 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 106.551 -1.648 . . . . 1.26 106.551 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.01 -52.45 0.75 Allowed Glycine 0 N--CA 1.5 2.944 0 O-C-N 120.512 -1.368 . . . . 0.01 112.807 177.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.26 -101.19 0.15 Allowed Glycine 0 N--CA 1.491 2.306 0 C-N-CA 118.457 -1.83 . . . . 0.01 112.161 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -121.94 119.8 32.57 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.033 -1.275 . . . . 4.4299999999999997 110.791 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.4 129.73 34.74 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.833 -0.747 . . . . 2.9900000000000002 109.362 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -130.1 142.23 50.62 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.347 -0.846 . . . . 6.3600000000000003 109.073 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.0 tt -129.19 146.13 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 121.302 -0.874 . . . . 1.0900000000000001 110.373 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -121.54 133.25 55.02 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.432 -1.321 . . . . 2.0499999999999998 107.432 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.8 m -123.58 145.35 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 120.693 -1.255 . . . . 1.1000000000000001 109.772 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -119.75 141.46 49.42 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 122.064 0.935 . . . . 0.72999999999999998 111.012 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -67.24 -30.5 70.43 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.922 -0.581 . . . . 0.02 112.126 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -116.27 167.33 11.11 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 120.998 -1.064 . . . . 3.1800000000000002 110.413 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.64 163.85 43.02 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 111.039 -0.825 . . . . 0.01 111.039 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.2 t70 56.82 38.75 29.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.921 -0.753 . . . . 0.01 110.896 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.437 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 21.2 m-85 52.26 55.95 8.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.656 -0.652 . . . . 0.01 111.103 178.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -128.8 165.39 21.05 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.256 -1.016 . . . . 3.1499999999999999 108.256 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.22 -163.79 27.99 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.324 -1.511 . . . . 0.01 109.324 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 48.3 tp60 -75.03 143.48 43.5 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.998 -1.295 . . . . 0.01 108.551 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.45 ' C ' ' SD ' ' A' ' 107' ' ' MET . 12.3 tmm? -115.99 142.45 46.77 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.52 0.676 . . . . 0.01 109.746 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -131.83 136.5 47.53 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.249 -1.019 . . . . 2.48 108.249 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -118.76 134.14 55.35 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.576 -0.703 . . . . 0.01 109.948 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.0 t -148.86 149.99 32.23 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.24 1.019 . . . . 1.6899999999999999 110.946 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 32.2 p -109.94 10.38 24.32 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 115.485 -0.78 . . . . 0.01 110.106 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -121.29 163.16 19.04 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.264 -0.898 . . . . 3.21 111.715 -178.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -67.48 156.61 36.22 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.253 -1.017 . . . . 0.01 108.253 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 37.5 t -125.4 111.95 25.9 Favored Pre-proline 0 N--CA 1.503 2.177 0 O-C-N 121.368 -0.832 . . . . 0.01 109.035 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -76.37 -32.62 3.8 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 CA-C-N 119.997 1.034 . . . . 0.01 111.635 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 7.8 t -140.6 106.54 5.17 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.223 -0.923 . . . . 0.02 108.592 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 68.0 mt -65.03 -38.82 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.717 -0.615 . . . . 1.8300000000000001 111.183 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.2 ttt -66.92 -38.07 85.51 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 118.946 -1.102 . . . . 1.3400000000000001 109.929 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -69.15 -38.28 78.7 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.489 -1.382 . . . . 2.1099999999999999 109.546 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -79.77 -47.25 15.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.322 -0.861 . . . . 2.0800000000000001 112.269 -177.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -111.77 -0.53 15.91 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.378 -0.826 . . . . 0.02 112.824 -176.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.8 m80 61.71 34.67 17.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.752 -1.218 . . . . 0.02 109.837 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 40.9 mt -114.47 136.12 53.36 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.454 -0.779 . . . . 0.02 109.426 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -90.62 -22.04 21.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.3 -0.875 . . . . 5.3200000000000003 110.864 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -148.05 163.92 35.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.99 -1.069 . . . . 0.02 109.97 -178.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.9 mm -129.28 125.28 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 107.857 -1.164 . . . . 2.1699999999999999 107.857 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -109.74 -13.61 14.46 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.233 -0.917 . . . . 0.02 112.833 -177.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.437 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 2.3 t -158.87 149.63 20.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.797 -1.189 . . . . 0.01 108.987 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.486 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 30.0 p -170.14 148.81 3.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 1.22 108.865 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -120.88 113.03 19.54 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 122.453 1.12 . . . . 1.4099999999999999 110.062 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.0 t -112.19 128.72 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.561 -1.274 . . . . 0.01 107.561 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 47.5 t -128.73 93.11 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 107.071 -1.455 . . . . 1.98 107.071 177.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -147.71 -75.99 0.18 Allowed 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 105.831 -1.914 . . . . 0.01 105.831 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 156.55 -54.53 0.4 Allowed Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.184 -1.567 . . . . 0.01 109.184 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 54.7 p -119.77 97.8 5.8 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.551 -0.97 . . . . 2.2999999999999998 111.012 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -128.16 145.53 50.99 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 107.108 -1.442 . . . . 0.01 107.108 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.402 ' CG1' HD11 ' A' ' 175' ' ' ILE . 61.4 mt -122.02 138.89 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 120.883 -1.136 . . . . 1.6899999999999999 110.714 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -113.71 144.11 43.5 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 106.873 -1.529 . . . . 2.4900000000000002 106.873 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.513 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 15.7 m-85 -123.17 144.36 49.4 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.311 -0.868 . . . . 0.02 109.658 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -76.54 -28.97 56.52 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.624 -0.673 . . . . 0.02 111.999 -176.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mt -116.04 154.93 48.52 Favored Pre-proline 0 N--CA 1.506 2.331 0 O-C-N 120.544 -1.348 . . . . 1.48 108.915 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.95 165.94 2.4 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.235 1.29 . . . . 0.02 113.071 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.564 HD22 ' N ' ' A' ' 143' ' ' ASN . 1.2 m120 59.68 31.48 20.9 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 115.071 -0.968 . . . . 0.75 111.471 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 57.39 51.09 10.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.45 -0.781 . . . . 0.02 111.186 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -126.26 164.91 19.96 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.426 -0.796 . . . . 0.02 109.944 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.463 ' O ' ' NE2' ' A' ' 148' ' ' GLN . . . 89.01 -165.98 33.42 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.255 -1.138 . . . . 0.02 110.255 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -69.39 142.66 53.88 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.724 -0.868 . . . . 0.02 109.061 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.47 ' CD ' ' N ' ' A' ' 148' ' ' GLN . 7.2 mp0 -115.63 149.54 38.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.803 -0.56 . . . . 0.02 109.728 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -123.53 134.76 53.82 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.616 -0.678 . . . . 0.01 109.219 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.3 tp -95.24 121.15 36.59 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.632 -1.292 . . . . 0.01 108.956 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.564 HD21 ' CG ' ' A' ' 162' ' ' TRP . 0.2 OUTLIER -94.63 160.24 14.72 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.325 -0.859 . . . . 0.01 109.045 -179.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.48 ' H ' HD13 ' A' ' 151' ' ' LEU . 1.4 p-10 -109.34 -111.65 0.32 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.445 -0.784 . . . . 2.27 109.335 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.525 ' N ' ' OH ' ' A' ' 156' ' ' TYR . 49.7 pttt -168.81 45.55 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.114 -0.991 . . . . 1.8400000000000001 109.923 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -113.59 -153.77 0.53 Allowed 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.503 -0.748 . . . . 2.2799999999999998 109.122 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -106.39 106.37 16.85 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.417 -0.802 . . . . 0.01 109.075 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.644 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 2.9 m-85 -99.34 112.4 24.58 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.267 -0.895 . . . . 0.01 109.667 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -94.56 -22.67 18.05 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.129 -0.982 . . . . 0.01 111.411 -178.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -128.19 154.44 78.79 Favored Pre-proline 0 N--CA 1.502 2.146 0 O-C-N 120.84 -1.163 . . . . 2.54 108.822 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -60.12 -37.21 85.46 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 CA-C-N 119.268 0.774 . . . . 0.69999999999999996 110.631 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 6.0 t -61.11 -19.88 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.756 -1.215 . . . . 0.85999999999999999 109.048 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -65.15 -15.28 62.25 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.94 -1.1 . . . . 0.02 109.921 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.644 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 12.9 m0 -97.93 11.29 37.94 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.14 -0.975 . . . . 0.02 109.025 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.4 11.0 84.7 Favored Glycine 0 N--CA 1.491 2.329 0 O-C-N 120.793 -1.192 . . . . 0.02 111.177 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.34 140.88 32.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.066 -1.255 . . . . 0.02 110.066 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.68 -8.76 58.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.598 -0.689 . . . . 0.58999999999999997 110.045 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 8.1 p -142.47 151.31 57.39 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 120.981 -1.075 . . . . 0.87 109.318 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -76.21 16.67 0.82 Allowed 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 120.837 1.024 . . . . 0.38 112.263 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.41 122.17 27.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.872 -1.142 . . . . 0.17999999999999999 111.366 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 3.1 mt -149.12 123.51 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 105.873 -1.899 . . . . 3.9900000000000002 105.873 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -112.21 -15.9 13.11 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.227 -0.92 . . . . 5.1699999999999999 113.286 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 20.9 m -156.6 160.42 39.4 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 119.245 -2.159 . . . . 0.02 110.041 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.419 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 21.4 p90 -152.67 153.0 32.41 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.147 -0.971 . . . . 2.02 110.633 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 29.6 mtp180 -145.58 149.65 34.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.36 -0.837 . . . . 0.01 109.679 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -88.4 142.44 27.72 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.507 -0.746 . . . . 0.01 109.455 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.402 HD11 ' CG1' ' A' ' 137' ' ' ILE . 3.7 mt -93.59 129.93 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.257 -0.902 . . . . 3.04 109.126 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.5 p -137.53 148.7 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.239 -0.913 . . . . 1.8899999999999999 109.902 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 . . . . . 0 N--CA 1.494 1.764 0 O-C-N 121.514 -0.741 . . . . 4.8899999999999997 109.656 179.827 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.768 -1.333 . . . . 0.01 109.768 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -149.92 136.45 19.12 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.481 -1.011 . . . . 0.02 109.882 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.3 tt -128.87 139.24 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.157 -1.053 . . . . 0.02 108.157 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.1 t -121.7 130.18 53.26 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.328 -0.858 . . . . 0.39000000000000001 110.033 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.545 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.8 m-85 -110.25 140.65 44.18 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.871 -0.788 . . . . 0.02 108.871 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.528 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 6.0 m-85 -122.37 138.79 54.41 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.214 -0.929 . . . . 0.02 109.612 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.47 ' HG3' HD11 ' A' ' 33' ' ' LEU . 87.7 mt-10 -68.03 -27.74 66.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.025 -1.047 . . . . 0.029999999999999999 111.663 -178.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -114.53 169.86 8.74 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.812 -1.18 . . . . 0.029999999999999999 110.379 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -75.67 158.92 31.72 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.611 0.719 . . . . 0.029999999999999999 109.974 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 66.09 32.99 7.86 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.949 0.88 . . . . 0.73999999999999999 110.97 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 55.23 41.57 31.27 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.31 0.576 . . . . 0.02 111.392 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 -112.94 166.23 11.59 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.327 -0.99 . . . . 0.02 108.327 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.68 -168.06 35.73 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 119.857 -1.163 . . . . 0.029999999999999999 110.75 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.425 ' NH2' ' OE2' ' A' ' 11' ' ' GLU . 23.4 ttp180 -68.83 143.37 54.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.476 -1.014 . . . . 2.7599999999999998 109.135 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -120.87 148.98 43.3 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.506 -0.746 . . . . 1.8899999999999999 110.189 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -132.79 127.76 35.3 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.327 -0.99 . . . . 0.02 108.327 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -112.2 136.67 51.33 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.403 -0.811 . . . . 1.1200000000000001 109.789 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.4 t -131.17 139.06 49.69 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.663 -0.648 . . . . 0.02 109.602 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -116.46 11.85 15.01 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.677 -0.639 . . . . 0.20000000000000001 109.655 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.0 p -158.63 174.6 14.81 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.358 -0.978 . . . . 1.23 108.358 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -60.45 144.66 50.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.642 -1.286 . . . . 0.02 109.858 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 44.2 t -131.97 117.76 18.86 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.691 -0.855 . . . . 0.02 108.691 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.49 -25.37 50.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.18 -0.95 . . . . 0.23999999999999999 110.894 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -154.2 102.96 2.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.97 -1.082 . . . . 1.1399999999999999 109.218 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -102.41 9.43 39.72 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 122.127 0.965 . . . . 6.3700000000000001 109.673 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -59.55 -25.17 64.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.523 -0.736 . . . . 3.1099999999999999 111.362 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.3 t -76.15 -17.55 59.51 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.505 -1.372 . . . . 0.88 110.596 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -104.08 -21.86 13.52 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.358 -0.839 . . . . 0.02 109.486 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.47 HD11 ' HG3' ' A' ' 11' ' ' GLU . 6.4 tp -150.43 129.25 12.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.194 -0.941 . . . . 3.3199999999999998 109.005 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.0 p -85.26 -10.22 56.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.81 -0.556 . . . . 0.02 111.131 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -171.1 162.38 7.06 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.009 -1.108 . . . . 0.02 108.009 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.8 p -144.08 115.33 7.97 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.703 -1.248 . . . . 0.02 108.766 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -108.26 1.75 22.22 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 120.86 -1.15 . . . . 0.029999999999999999 110.969 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.8 t -154.95 154.3 32.38 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.636 -1.246 . . . . 0.02 107.636 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 61.3 mt -145.14 146.84 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.038 -1.039 . . . . 0.02 110.044 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -123.33 124.0 41.97 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.86 -1.163 . . . . 0.02 107.86 177.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.0 t -106.64 115.09 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 106.867 -1.531 . . . . 0.02 106.867 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -83.69 -33.75 25.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.655 -0.653 . . . . 3.8100000000000001 110.754 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.76 152.09 21.83 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 118.92 -1.609 . . . . 0.02 110.881 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.76 173.21 49.6 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.727 -1.225 . . . . 0.01 110.617 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.2 m -119.62 135.4 54.82 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 107.861 -1.163 . . . . 1.48 107.861 177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.449 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 33.7 m95 -126.6 155.57 42.29 Favored 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 122.576 1.179 . . . . 0.02 112.188 -176.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.68 134.16 52.29 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 105.666 -1.976 . . . . 0.23999999999999999 105.666 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.504 ' HB ' HD22 ' A' ' 79' ' ' LEU . 33.3 m -119.4 143.72 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.542 -0.724 . . . . 0.65000000000000002 109.054 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -120.9 146.28 46.78 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 122.226 1.012 . . . . 0.02 109.963 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -66.42 -34.59 78.29 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.756 -0.656 . . . . 0.02 111.183 -177.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -125.38 157.95 65.94 Favored Pre-proline 0 N--CA 1.502 2.139 0 O-C-N 121.162 -0.961 . . . . 0.02 109.465 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -53.89 167.17 1.17 Allowed 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 121.672 1.581 . . . . 0.02 113.082 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.2 t30 63.79 36.53 10.42 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.04 -0.982 . . . . 0.02 111.119 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 45.93 51.68 10.49 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.596 0.712 . . . . 3.3900000000000001 110.663 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.4 m -126.63 164.03 22.14 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.121 0.486 . . . . 2.3300000000000001 109.924 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.86 -161.74 32.2 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.881 -1.288 . . . . 0.02 109.881 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -65.66 139.51 58.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.109 -1.23 . . . . 0.02 110.017 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 17.2 ptm -117.94 137.07 53.08 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.761 -0.587 . . . . 5.0099999999999998 109.53 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -133.75 136.31 44.5 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.487 -0.758 . . . . 0.02 109.847 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.628 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.8 mp -95.39 131.64 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.522 -0.918 . . . . 1.72 108.522 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.7 mt -120.05 111.06 35.79 Favored Pre-proline 0 N--CA 1.502 2.146 0 O-C-N 121.504 -0.748 . . . . 0.02 110.682 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -77.13 168.73 22.73 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 CA-C-N 119.846 0.981 . . . . 1.47 109.981 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -52.67 141.49 20.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.831 -1.168 . . . . 4.25 110.184 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.04 -176.68 31.84 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.579 -1.296 . . . . 0.02 110.666 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -119.65 130.98 55.34 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.467 -1.019 . . . . 0.95999999999999996 109.58 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.41 ' N ' ' CD1' ' A' ' 66' ' ' TYR . 31.3 m-85 -120.41 96.53 49.05 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 107.889 -1.152 . . . . 0.02 107.889 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.4 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.8 Cg_endo -67.24 -5.03 12.82 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 120.746 0.964 . . . . 0.02 114.0 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 32.6 mt-10 -157.66 156.07 31.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.592 -1.317 . . . . 2.02 108.373 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -61.55 -38.17 86.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.408 -0.807 . . . . 0.02 112.324 -177.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -61.01 -22.08 64.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.023 -1.048 . . . . 0.02 109.961 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.9 tpm_? -67.0 -19.04 65.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.508 -0.745 . . . . 3.4199999999999999 110.03 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.454 ' C ' ' SD ' ' A' ' 73' ' ' MET . 2.2 p90 -110.42 16.3 21.68 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.336 -0.852 . . . . 0.02 109.091 178.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.454 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 3.0 mpp? 63.34 25.03 14.48 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.482 0.658 . . . . 0.02 110.768 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.412 ' HA3' ' HE1' ' A' ' 72' ' ' TRP . . . -60.51 145.17 47.41 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.838 -1.305 . . . . 0.02 109.838 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.6 tp -80.77 -31.2 35.89 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.663 -1.236 . . . . 0.97999999999999998 107.663 177.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -157.56 -171.84 3.73 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 106.482 -1.673 . . . . 0.02 106.482 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -98.99 28.27 4.49 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.707 -1.245 . . . . 0.02 110.835 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.595 HH11 ' CG ' ' A' ' 78' ' ' ARG . 3.3 mtt-85 -96.2 122.66 39.29 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.859 -1.151 . . . . 3.2000000000000002 110.872 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.504 HD22 ' HB ' ' A' ' 48' ' ' VAL . 33.0 mt -144.13 122.49 12.34 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.73 -1.211 . . . . 2.6099999999999999 107.73 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.44 -16.45 10.23 Favored Glycine 0 N--CA 1.504 3.216 0 O-C-N 121.102 -0.998 . . . . 0.02 112.94 -177.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 73.3 p -156.79 156.53 33.43 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.177 -1.778 . . . . 0.02 110.339 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 53.2 t -143.97 147.2 33.6 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.539 -0.725 . . . . 0.02 110.191 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.1 mtp180 -137.8 142.83 40.84 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.335 -0.853 . . . . 0.01 109.456 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.87 132.03 36.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.92 . . . . 0.42999999999999999 109.7 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.9 t -90.67 124.7 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.618 -0.882 . . . . 1.25 108.618 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -93.14 132.32 37.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.847 -1.158 . . . . 1.77 108.928 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.2 mt -97.37 139.77 32.82 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.669 -0.863 . . . . 1.6299999999999999 108.669 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.3 m -110.74 124.87 52.81 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.46 -0.941 . . . . 1.0800000000000001 108.46 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.8 t -115.85 130.39 56.82 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.651 -1.281 . . . . 1.26 107.608 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -154.13 -51.93 0.01 OUTLIER Glycine 0 N--CA 1.505 3.295 0 C-N-CA 117.951 -2.071 . . . . 0.01 113.24 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.11 -106.17 0.19 Allowed Glycine 0 N--CA 1.489 2.176 0 O-C-N 120.162 -1.787 . . . . 0.01 111.198 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -119.8 117.55 28.49 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.0 -1.294 . . . . 4.4299999999999997 110.212 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.77 130.28 36.53 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.066 -0.654 . . . . 2.9900000000000002 109.395 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.415 ' CB ' ' NZ ' ' A' ' 94' ' ' LYS . 7.3 ttpm? -131.72 141.27 49.5 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.492 -0.755 . . . . 6.3600000000000003 109.409 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.0 tt -127.65 146.99 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.418 0 CA-C-O 121.809 0.814 . . . . 1.0900000000000001 110.292 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -122.79 131.63 53.86 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.904 -1.147 . . . . 2.0499999999999998 107.904 177.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.7 m -125.35 147.65 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 O-C-N 120.95 -1.094 . . . . 1.1000000000000001 109.947 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.563 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 80.5 m-85 -119.19 141.67 48.66 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-O 121.948 0.88 . . . . 0.72999999999999998 111.139 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -67.74 -31.17 70.91 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 116.104 -0.498 . . . . 0.02 111.322 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.436 ' O ' ' OG ' ' A' ' 128' ' ' SER . 45.6 mttp -116.31 170.15 8.76 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.089 -1.007 . . . . 3.1800000000000002 110.04 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.56 169.72 43.97 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 111.174 -0.77 . . . . 0.01 111.174 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.6 t70 52.68 39.32 28.22 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.654 0.74 . . . . 0.01 111.611 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 52.42 48.72 22.01 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.601 -0.687 . . . . 0.01 110.975 178.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -123.09 164.93 17.68 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.379 -0.971 . . . . 3.1499999999999999 108.379 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.64 -163.54 28.56 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.427 -1.469 . . . . 0.01 109.427 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -76.93 144.05 39.11 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.049 -1.265 . . . . 0.01 109.121 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.563 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 28.1 ttp -116.19 142.32 46.97 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.487 0.66 . . . . 0.01 109.824 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -131.75 136.26 47.44 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.413 -0.958 . . . . 2.48 108.413 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -121.55 135.21 55.03 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.53 -0.731 . . . . 0.01 109.9 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.0 t -148.57 151.94 35.93 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.97 -1.081 . . . . 1.6899999999999999 110.799 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.4 p -111.54 8.68 21.09 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 116.028 -0.533 . . . . 0.01 110.618 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -120.63 162.96 18.76 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.162 -0.961 . . . . 3.21 111.311 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -67.6 156.52 36.59 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.397 -0.964 . . . . 0.01 108.397 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.434 ' SG ' ' OE1' ' A' ' 120' ' ' GLN . 42.8 t -125.57 114.36 25.19 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 108.928 -0.767 . . . . 0.01 108.928 178.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.415 ' O ' ' OG ' ' A' ' 171' ' ' SER . 20.6 Cg_endo -77.05 -31.92 3.49 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 CA-C-N 120.156 1.091 . . . . 0.01 111.122 178.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 41.1 t -141.74 107.56 5.13 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.556 -0.905 . . . . 0.02 108.556 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 64.7 mt -65.3 -38.69 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.656 -0.653 . . . . 1.8300000000000001 110.951 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 118' ' ' MET . 1.1 tmt? -66.69 -38.37 86.63 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.942 -1.103 . . . . 1.3400000000000001 109.758 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -68.56 -38.27 80.62 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.463 -1.398 . . . . 2.1099999999999999 109.63 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.434 ' OE1' ' SG ' ' A' ' 114' ' ' CYS . 54.5 tt0 -80.11 -46.73 15.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.245 -0.91 . . . . 2.0800000000000001 112.314 -177.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -112.27 -0.86 15.33 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.28 -0.887 . . . . 0.02 112.852 -176.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.7 m80 61.61 34.91 17.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.666 -1.272 . . . . 0.02 109.871 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.0 mt -114.01 135.63 53.8 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.521 -0.737 . . . . 0.02 109.229 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -90.9 -22.1 21.07 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.277 -0.889 . . . . 5.3200000000000003 110.965 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -148.03 164.0 35.15 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.993 -1.067 . . . . 0.02 110.022 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.0 mm -128.69 124.77 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 107.555 -1.276 . . . . 2.1699999999999999 107.555 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -109.43 -14.69 14.38 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.165 -0.959 . . . . 0.02 112.982 -176.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 10.0 p -161.14 153.21 19.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.563 -1.336 . . . . 0.01 109.467 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.409 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 27.9 p -167.79 149.43 5.47 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.796 -1.187 . . . . 1.22 107.796 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -112.83 103.59 11.59 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.104 -0.997 . . . . 1.4099999999999999 108.924 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.8 t -111.22 125.92 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 115.766 -0.652 . . . . 0.01 109.569 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.2 t -122.92 86.42 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.77 -1.937 . . . . 1.98 105.77 175.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.438 ' O ' ' O ' ' A' ' 152' ' ' ASP . 3.3 tp10 -161.36 -158.17 0.55 Allowed 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 106.786 -1.561 . . . . 0.01 106.786 178.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -157.65 -3.7 0.08 OUTLIER Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.113 -1.995 . . . . 0.01 108.113 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.6 p -115.06 45.04 1.69 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 122.0 -0.706 . . . . 2.2999999999999998 109.66 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -125.97 136.17 52.68 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.293 -0.879 . . . . 0.01 108.927 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 12.4 mt -123.71 141.28 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.693 -0.63 . . . . 1.6899999999999999 109.383 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -114.3 144.82 42.63 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.059 -1.46 . . . . 2.4900000000000002 107.059 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.464 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 19.9 m-85 -123.23 144.44 49.38 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.493 -0.754 . . . . 0.02 109.674 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.44 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 78.1 tt0 -75.58 -29.31 59.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.634 -0.667 . . . . 0.02 111.781 -176.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mt -115.05 154.94 47.15 Favored Pre-proline 0 N--CA 1.505 2.309 0 O-C-N 120.654 -1.279 . . . . 1.48 109.128 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -55.91 165.55 3.7 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.159 1.239 . . . . 0.02 112.809 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.485 ' N ' ' OD1' ' A' ' 143' ' ' ASN . 1.0 OUTLIER 60.71 32.46 20.25 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.198 -0.91 . . . . 0.75 111.451 178.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.417 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.9 m-85 57.43 51.72 9.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.563 -0.711 . . . . 0.02 110.96 177.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -127.13 165.11 20.18 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.492 -0.755 . . . . 0.02 110.325 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.59 -166.29 32.88 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.553 -1.019 . . . . 0.02 110.553 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -70.31 144.44 51.71 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.672 -0.899 . . . . 0.02 109.116 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -113.51 148.96 35.05 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.808 -0.558 . . . . 0.02 110.218 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -125.91 134.0 51.7 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.629 -0.669 . . . . 0.01 109.584 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.482 HD23 ' N ' ' A' ' 151' ' ' LEU . 2.6 tt -103.91 123.56 47.37 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.073 -1.017 . . . . 0.01 109.776 -179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.482 ' N ' HD23 ' A' ' 150' ' ' LEU . 8.8 mp -96.6 152.3 18.78 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.971 -1.081 . . . . 0.01 108.374 178.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.438 ' O ' ' O ' ' A' ' 133' ' ' GLU . 74.9 m-20 -111.32 -126.18 0.28 Allowed 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.309 -0.869 . . . . 2.27 110.492 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -129.25 42.03 3.37 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.399 -0.813 . . . . 1.8400000000000001 109.7 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -113.01 -174.39 2.44 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.403 -0.81 . . . . 2.2799999999999998 109.141 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -105.11 111.87 24.8 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.667 -0.864 . . . . 0.01 108.667 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.65 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 20.2 m-85 -97.94 110.53 23.09 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.289 -0.882 . . . . 0.01 109.859 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -95.1 -22.19 18.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.143 -0.973 . . . . 0.01 111.128 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -127.55 155.15 77.35 Favored Pre-proline 0 N--CA 1.501 2.122 0 O-C-N 121.034 -1.042 . . . . 2.54 108.521 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -60.19 -36.74 87.32 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 120.449 0.766 . . . . 0.69999999999999996 110.264 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -61.26 -20.16 21.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.936 -1.102 . . . . 0.85999999999999999 109.255 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -66.11 -16.04 63.61 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.92 -1.113 . . . . 0.02 110.188 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.65 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 10.4 m0 -97.42 11.16 37.67 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.086 -1.009 . . . . 0.02 108.712 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.65 11.04 85.16 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.805 -1.188 . . . . 0.02 110.774 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.36 141.29 33.41 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.176 -1.191 . . . . 0.02 110.1 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.16 -8.58 58.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.567 -0.708 . . . . 0.58999999999999997 110.302 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 9.7 p -143.96 151.02 51.52 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 120.769 -1.207 . . . . 0.87 109.21 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.81 18.42 0.62 Allowed 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 120.931 1.087 . . . . 0.38 112.318 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.8 121.84 26.94 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 122.427 1.108 . . . . 0.17999999999999999 111.346 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 3.1 mt -150.05 123.7 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 105.831 -1.915 . . . . 3.9900000000000002 105.831 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.528 ' OE1' ' N ' ' A' ' 170' ' ' GLN . 9.7 mp0 -113.5 -13.26 12.82 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.108 -0.995 . . . . 5.1699999999999999 113.109 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 115' ' ' PRO . 26.7 m -157.05 160.63 39.13 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 119.255 -2.153 . . . . 0.02 110.185 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -152.59 151.92 31.22 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.163 -0.96 . . . . 2.02 110.301 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.417 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 27.0 mtp180 -145.16 152.41 39.98 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.3 -0.875 . . . . 0.01 110.252 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -89.5 143.42 26.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.695 -0.628 . . . . 0.01 109.588 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 9.1 mt -95.64 130.32 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 108.482 -0.933 . . . . 3.04 108.482 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.22 147.12 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.121 -0.987 . . . . 1.8899999999999999 109.825 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.365 -0.834 . . . . 4.8899999999999997 109.525 -179.927 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 109.557 -1.417 . . . . 0.01 109.557 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -152.71 137.84 17.36 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.334 -1.098 . . . . 0.02 109.66 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.8 tt -129.69 141.02 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.96 -0.756 . . . . 0.02 108.96 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.503 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.3 t -121.47 130.26 53.46 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.577 -0.702 . . . . 0.39000000000000001 109.699 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 8.4 m-85 -109.76 139.97 44.21 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 109.123 -0.695 . . . . 0.02 109.123 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.514 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 6.3 m-85 -122.4 138.35 54.56 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.152 -0.967 . . . . 0.02 109.487 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.466 ' HG3' HD11 ' A' ' 33' ' ' LEU . 93.4 mt-10 -68.69 -27.75 66.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.219 -0.926 . . . . 0.029999999999999999 111.424 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.1 m-20 -114.75 170.49 8.28 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.937 -1.102 . . . . 0.029999999999999999 110.384 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.487 ' CZ ' ' OE2' ' A' ' 68' ' ' GLU . 7.6 mtp180 -75.18 160.84 29.94 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.59 0.709 . . . . 0.029999999999999999 110.122 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.596 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 2.0 m-80 62.87 35.13 13.77 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.792 0.806 . . . . 0.73999999999999999 110.661 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.596 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 21.0 p90 49.58 42.21 22.65 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.451 -0.795 . . . . 0.02 111.057 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -109.03 165.95 11.2 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.851 -1.166 . . . . 0.02 107.851 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.82 -167.64 35.08 Favored Glycine 0 N--CA 1.495 2.628 0 O-C-N 120.687 -1.258 . . . . 0.029999999999999999 110.794 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -69.07 144.08 54.06 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.426 -1.044 . . . . 2.7599999999999998 109.285 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.486 ' HE ' ' CB ' ' A' ' 8' ' ' SER . 56.0 ttt180 -120.29 148.28 43.91 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.577 0.703 . . . . 1.8899999999999999 109.996 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -132.38 127.42 35.4 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.169 -1.049 . . . . 0.02 108.169 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -112.28 136.85 51.21 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.37 -0.831 . . . . 1.1200000000000001 109.89 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.427 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.4 t -131.17 138.99 49.69 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.582 -0.698 . . . . 0.02 109.681 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.498 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 33.3 t70 -117.09 10.67 13.98 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.648 -0.658 . . . . 0.20000000000000001 109.7 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 48.9 m -158.35 174.21 15.49 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.377 -0.972 . . . . 1.23 108.377 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -61.12 144.66 53.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.66 -1.275 . . . . 0.02 110.163 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.3 t -131.92 117.69 18.79 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.56 -0.904 . . . . 0.02 108.56 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.54 -26.09 45.65 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.091 -1.005 . . . . 0.23999999999999999 110.996 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 28.3 p-10 -153.47 101.39 2.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.971 -1.08 . . . . 1.1399999999999999 108.968 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -104.69 9.73 35.0 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 122.108 0.956 . . . . 6.3700000000000001 109.96 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -58.75 -24.79 62.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.541 -0.724 . . . . 3.1099999999999999 111.035 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.0 t -74.1 -16.78 61.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.806 -1.184 . . . . 0.88 110.192 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.51 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 18.1 m-85 -103.88 -22.03 13.56 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.349 -0.844 . . . . 0.02 109.388 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.466 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.2 tp -149.8 128.11 12.13 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.247 -0.908 . . . . 3.3199999999999998 108.98 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.5 m -85.2 -9.85 57.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.698 -0.626 . . . . 0.02 110.828 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -170.55 163.05 8.28 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.619 -1.252 . . . . 0.02 107.619 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 t -142.04 114.98 8.68 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.723 -1.236 . . . . 0.02 108.772 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.577 ' N ' HD22 ' A' ' 37' ' ' ASN . 1.1 m-80 -108.86 -1.82 18.89 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.807 -1.183 . . . . 0.029999999999999999 111.422 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 t -153.42 154.04 33.68 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.188 -1.041 . . . . 0.02 108.188 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.41 HG21 HD13 ' A' ' 39' ' ' ILE . 19.3 mt -145.85 145.86 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 120.955 -1.091 . . . . 0.02 110.802 -178.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -124.03 124.84 43.42 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.495 -1.298 . . . . 0.02 107.495 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.7 t -104.91 114.18 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 107.144 -1.428 . . . . 0.02 107.144 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -84.56 -34.49 23.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.471 -0.768 . . . . 3.8100000000000001 110.098 -178.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.45 150.26 18.73 Favored Glycine 0 N--CA 1.489 2.212 0 C-N-CA 118.552 -1.785 . . . . 0.02 110.845 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.69 171.99 48.67 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.168 -1.173 . . . . 0.01 110.168 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.9 m -119.5 134.9 55.01 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.763 -1.199 . . . . 1.48 107.763 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.455 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 33.6 m95 -126.69 155.81 42.07 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 122.655 1.217 . . . . 0.02 112.448 -176.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.21 134.0 52.31 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 105.571 -2.011 . . . . 0.23999999999999999 105.571 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.514 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.3 m -118.6 143.21 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.624 -0.673 . . . . 0.65000000000000002 109.387 178.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -120.89 145.61 47.47 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 122.318 1.056 . . . . 0.02 110.06 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -66.22 -34.5 78.17 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.607 -0.724 . . . . 0.02 111.125 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 40.5 mtm180 -124.95 157.78 65.38 Favored Pre-proline 0 N--CA 1.503 2.215 0 O-C-N 121.035 -1.041 . . . . 0.02 109.546 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.58 167.09 1.03 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.773 1.649 . . . . 0.02 112.99 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 63.53 36.74 10.93 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.126 -0.943 . . . . 0.02 111.156 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 45.05 51.7 8.73 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.678 0.751 . . . . 3.3900000000000001 110.574 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 94.8 p -125.86 163.53 22.73 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.27 0.557 . . . . 2.3300000000000001 109.779 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.94 -161.5 31.92 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.686 -1.366 . . . . 0.02 109.686 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -67.01 139.94 57.69 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.992 -1.299 . . . . 0.02 110.281 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 15.4 ptm -118.69 138.16 52.82 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.578 -0.701 . . . . 5.0099999999999998 109.962 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.455 ' OH ' HD13 ' A' ' 75' ' ' LEU . 58.8 m-85 -134.01 137.41 44.73 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.48 -0.762 . . . . 0.02 109.938 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.648 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.8 mp -96.03 131.81 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.597 -0.89 . . . . 1.72 108.597 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.416 HD21 ' CD1' ' A' ' 72' ' ' TRP . 11.5 mt -120.86 112.32 33.71 Favored Pre-proline 0 N--CA 1.504 2.231 0 O-C-N 121.329 -0.857 . . . . 0.02 110.886 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -77.64 169.95 20.01 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 CA-C-N 119.901 1.0 . . . . 1.47 110.061 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -53.46 140.56 27.59 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.917 -1.115 . . . . 4.25 110.449 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.07 -177.92 32.04 Favored Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.463 -1.351 . . . . 0.02 110.709 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -118.98 130.65 55.8 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.586 -0.949 . . . . 0.95999999999999996 109.528 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -119.87 96.26 49.42 Favored Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 107.912 -1.144 . . . . 0.02 107.912 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -71.83 -6.18 18.59 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 120.891 1.061 . . . . 0.02 113.909 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.527 ' OE1' ' CE1' ' A' ' 69' ' ' TYR . 1.0 OUTLIER -154.57 152.53 30.15 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.755 -1.202 . . . . 2.02 107.755 179.384 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.527 ' CE1' ' OE1' ' A' ' 68' ' ' GLU . 9.3 p90 -60.24 -37.6 80.88 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.52 -0.737 . . . . 0.02 111.522 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -59.64 -24.3 63.75 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.77 -1.206 . . . . 0.02 109.491 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -71.74 -21.43 61.75 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.699 0.762 . . . . 3.4199999999999999 109.064 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.548 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 2.2 t90 -108.22 6.77 26.99 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.482 -1.303 . . . . 0.02 107.482 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 13.3 mmt 61.01 22.37 12.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.646 -0.659 . . . . 0.02 110.832 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.83 145.78 47.71 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.293 -1.523 . . . . 0.02 109.293 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.455 HD13 ' OH ' ' A' ' 59' ' ' TYR . 7.6 mp -80.29 -31.14 38.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.225 -1.162 . . . . 0.97999999999999998 108.336 178.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.515 ' ND2' ' CZ ' ' A' ' 78' ' ' ARG . 66.8 t30 -157.6 -171.86 3.73 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.635 -1.617 . . . . 0.02 106.635 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -98.62 28.53 4.17 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.723 -1.235 . . . . 0.02 110.613 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.587 HH11 ' CG ' ' A' ' 78' ' ' ARG . 3.3 mtt-85 -97.47 122.51 40.61 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.082 -1.011 . . . . 3.2000000000000002 110.849 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.514 HD22 ' HB ' ' A' ' 48' ' ' VAL . 34.9 mt -143.65 121.89 12.26 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.684 -1.228 . . . . 2.6099999999999999 107.684 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.83 -17.53 9.62 Favored Glycine 0 N--CA 1.504 3.184 0 O-C-N 121.078 -1.014 . . . . 0.02 112.981 -177.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.1 p -156.82 156.12 32.68 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.082 -1.834 . . . . 0.02 110.365 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 33.7 m -144.68 147.9 33.58 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.522 -0.736 . . . . 0.02 110.221 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 24.6 mtm180 -138.24 142.95 39.92 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.255 -0.903 . . . . 0.01 109.42 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.95 131.55 36.39 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.107 -0.995 . . . . 0.42999999999999999 109.85 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.5 t -90.8 124.9 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.809 -0.811 . . . . 1.25 108.809 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -93.79 131.77 38.84 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.81 -1.181 . . . . 1.77 109.339 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.5 mt -96.38 140.19 31.41 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.408 -0.96 . . . . 1.6299999999999999 108.408 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.2 m -111.73 127.17 55.7 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.374 -0.829 . . . . 1.0800000000000001 109.313 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.3 m -103.56 -154.89 0.51 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 106.425 -1.694 . . . . 1.26 106.425 176.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.53 -52.36 0.74 Allowed Glycine 0 N--CA 1.5 2.942 0 O-C-N 120.404 -1.435 . . . . 0.01 112.772 177.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.44 -101.52 0.15 Allowed Glycine 0 N--CA 1.489 2.193 0 C-N-CA 118.533 -1.794 . . . . 0.01 111.942 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -121.0 119.41 32.45 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.09 -1.241 . . . . 4.4299999999999997 110.549 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.08 129.48 35.26 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.808 -0.757 . . . . 2.9900000000000002 109.355 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -129.9 140.55 50.94 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.559 -0.713 . . . . 6.3600000000000003 109.172 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.8 tt -129.6 146.42 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 O-C-N 121.36 -0.837 . . . . 1.0900000000000001 110.157 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -122.2 133.86 54.72 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 107.558 -1.275 . . . . 2.0499999999999998 107.558 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.4 m -123.73 145.73 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 120.729 -1.232 . . . . 1.1000000000000001 109.829 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.587 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 39.6 m-85 -119.88 141.62 49.41 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-O 122.02 0.915 . . . . 0.72999999999999998 111.158 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -67.37 -31.04 71.0 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 116.025 -0.534 . . . . 0.02 111.776 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -115.9 167.44 10.95 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.912 -1.118 . . . . 3.1800000000000002 110.46 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.96 164.12 43.87 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 111.005 -0.838 . . . . 0.01 111.005 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.0 t70 56.75 39.11 29.83 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.656 0.741 . . . . 0.01 110.927 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 52.1 55.74 8.77 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.577 -0.702 . . . . 0.01 111.085 177.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -129.24 165.7 20.86 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 108.304 -0.999 . . . . 3.1499999999999999 108.304 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.36 -163.42 27.59 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.31 -1.516 . . . . 0.01 109.31 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.523 ' OE1' ' CE2' ' A' ' 108' ' ' TYR . 10.4 tm0? -75.94 143.62 41.51 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.946 -1.326 . . . . 0.01 108.459 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.587 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 33.2 ttp -116.33 142.36 46.95 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.492 0.663 . . . . 0.01 109.774 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.523 ' CE2' ' OE1' ' A' ' 106' ' ' GLN . 49.3 m-85 -131.39 136.54 48.11 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.197 -1.038 . . . . 2.48 108.197 178.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -117.73 133.59 55.78 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.558 -0.714 . . . . 0.01 109.959 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.1 t -148.47 149.24 31.32 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.352 1.072 . . . . 1.6899999999999999 111.223 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.1 p -110.05 10.17 24.12 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.38 -0.827 . . . . 0.01 110.122 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 42.0 mp0 -121.42 163.36 18.86 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.253 -0.904 . . . . 3.21 111.694 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.54 156.46 36.67 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.153 -1.054 . . . . 0.01 108.153 178.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.566 ' SG ' ' NE2' ' A' ' 120' ' ' GLN . 48.2 t -124.84 112.36 27.12 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 121.429 -0.795 . . . . 0.01 109.077 178.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -76.52 -33.17 3.32 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 CA-C-N 120.073 1.062 . . . . 0.01 111.515 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.7 m -140.73 107.12 5.27 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.22 -0.925 . . . . 0.02 108.585 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 76.0 mt -64.92 -38.82 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.854 -0.529 . . . . 1.8300000000000001 111.037 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 34.2 ttp -66.95 -38.47 86.18 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 118.902 -1.119 . . . . 1.3400000000000001 109.95 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.85 -38.16 79.59 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.381 -1.45 . . . . 2.1099999999999999 109.723 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.566 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 7.7 tt0 -79.68 -47.35 15.5 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.358 -0.839 . . . . 2.0800000000000001 112.322 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -112.37 -0.67 15.3 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.39 -0.819 . . . . 0.02 112.832 -176.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 61.71 34.74 17.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.743 -1.223 . . . . 0.02 109.846 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 43.6 mt -114.09 136.15 53.24 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.453 -0.78 . . . . 0.02 109.442 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -90.59 -22.12 21.4 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.142 -0.974 . . . . 5.3200000000000003 110.768 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -147.99 164.26 34.34 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.015 -1.053 . . . . 0.02 109.948 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.1 mm -129.2 125.94 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 107.784 -1.191 . . . . 2.1699999999999999 107.784 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 -108.74 -13.97 14.69 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.175 -0.953 . . . . 0.02 112.599 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.6 m -160.07 151.35 19.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.754 -1.216 . . . . 0.01 109.072 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.538 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 19.6 p -167.5 146.11 4.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.316 -0.865 . . . . 1.22 109.057 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.3 111.02 14.05 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-O 122.151 0.977 . . . . 1.4099999999999999 110.27 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.6 p -112.84 137.71 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.03 -1.1 . . . . 0.01 108.03 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.8 t -128.32 93.65 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 106.768 -1.567 . . . . 1.98 106.768 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 134' ' ' GLY . 10.4 tm-20 -146.55 -77.69 0.18 Allowed 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 105.827 -1.916 . . . . 0.01 105.827 177.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.512 ' N ' ' OE1' ' A' ' 133' ' ' GLU . . . -177.63 -80.39 0.06 OUTLIER Glycine 0 N--CA 1.485 1.916 0 N-CA-C 108.263 -1.935 . . . . 0.01 108.263 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.496 ' OG1' HD12 ' A' ' 175' ' ' ILE . 1.1 t -120.72 127.3 51.89 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.559 -0.965 . . . . 2.2999999999999998 110.161 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -127.3 152.24 47.7 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 106.907 -1.516 . . . . 0.01 106.907 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.5 mt -121.0 136.99 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 120.427 -1.421 . . . . 1.6899999999999999 110.088 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -113.62 143.95 43.72 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.34 -1.355 . . . . 2.4900000000000002 107.34 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.436 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 26.3 m-85 -122.42 144.71 48.87 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.292 -0.88 . . . . 0.02 109.297 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.436 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 78.0 tt0 -76.46 -29.0 56.76 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.501 -0.749 . . . . 0.02 111.705 -176.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.0 mt -115.95 154.67 48.37 Favored Pre-proline 0 N--CA 1.505 2.282 0 O-C-N 120.751 -1.218 . . . . 1.48 108.806 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -55.69 167.37 2.19 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 121.213 1.275 . . . . 0.02 112.794 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 59.47 31.14 20.83 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.147 -0.933 . . . . 0.75 111.408 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 57.28 51.25 10.33 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.534 -0.729 . . . . 0.02 110.993 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -126.1 164.62 20.5 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.545 -0.722 . . . . 0.02 109.938 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.18 -165.84 33.12 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.283 -1.127 . . . . 0.02 110.283 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.429 HH11 ' HG3' ' A' ' 147' ' ' ARG . 23.5 ttm-85 -69.34 142.6 53.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.51 -0.994 . . . . 0.02 109.067 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.464 ' CD ' ' N ' ' A' ' 148' ' ' GLN . 7.9 mp0 -114.8 148.52 38.32 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.343 0.592 . . . . 0.02 110.184 -178.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -124.78 135.61 53.11 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 109.048 -0.723 . . . . 0.01 109.048 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.502 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.7 tt -99.45 120.28 39.35 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.889 -1.132 . . . . 0.01 108.846 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.618 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 54.0 tp -101.85 154.06 19.27 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.256 -0.903 . . . . 0.01 109.066 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -104.71 -121.18 0.21 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.233 -0.917 . . . . 2.27 109.432 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.7 pttm -155.56 51.6 0.57 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.043 -1.036 . . . . 1.8400000000000001 109.608 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -112.48 -152.99 0.51 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.496 -0.753 . . . . 2.2799999999999998 109.068 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -106.39 100.21 9.75 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.385 -0.822 . . . . 0.01 109.045 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.68 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 6.7 m-85 -98.33 112.03 24.17 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.269 -0.894 . . . . 0.01 109.464 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -94.45 -22.52 18.22 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.242 -0.911 . . . . 0.01 111.448 -178.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -129.14 154.1 80.45 Favored Pre-proline 0 N--CA 1.502 2.167 0 O-C-N 120.758 -1.214 . . . . 2.54 108.808 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -59.46 -36.19 94.17 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 120.507 0.805 . . . . 0.69999999999999996 110.795 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 60.5 t -61.02 -20.2 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.758 -1.214 . . . . 0.85999999999999999 108.909 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -65.21 -15.31 62.32 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.882 -1.136 . . . . 0.02 109.691 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.68 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 11.5 m0 -98.06 11.06 38.88 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.254 -0.904 . . . . 0.02 109.067 178.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.81 11.45 83.9 Favored Glycine 0 N--CA 1.491 2.336 0 O-C-N 120.829 -1.169 . . . . 0.02 111.213 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.03 140.6 34.03 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.056 -1.261 . . . . 0.02 110.076 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -86.02 -8.77 57.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.566 -0.709 . . . . 0.58999999999999997 110.322 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 9.7 p -141.41 150.97 59.74 Favored Pre-proline 0 N--CA 1.5 2.051 0 O-C-N 121.019 -1.05 . . . . 0.87 109.712 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -75.88 14.62 1.02 Allowed 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 120.908 1.072 . . . . 0.38 112.142 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.72 122.07 27.19 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.361 1.077 . . . . 0.17999999999999999 111.212 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 3.8 mt -148.97 122.98 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 105.89 -1.892 . . . . 3.9900000000000002 105.89 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.53 ' OE1' ' N ' ' A' ' 170' ' ' GLN . 13.9 mp0 -112.95 -15.69 12.82 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.115 -0.99 . . . . 5.1699999999999999 113.07 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 12.8 t -156.31 159.57 38.95 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 119.328 -2.107 . . . . 0.02 109.941 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -153.08 154.12 34.21 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.039 -1.038 . . . . 2.02 110.689 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -145.24 149.93 35.78 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.776 0.798 . . . . 0.01 110.12 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -88.11 143.29 27.15 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.132 -0.692 . . . . 0.01 109.132 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.496 HD12 ' OG1' ' A' ' 135' ' ' THR . 6.7 mt -94.48 129.71 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.266 -0.896 . . . . 3.04 109.024 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.3 m -136.29 147.04 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.158 -0.964 . . . . 1.8899999999999999 109.526 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.61 ' H ' ' CD ' ' A' ' 177' ' ' GLU . 1.4 pm0 . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.89 . . . . 4.8899999999999997 109.725 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.402 0 N-CA-C 110.037 -1.225 . . . . 0.01 110.037 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.5 tttm -149.19 135.82 19.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.473 -1.016 . . . . 0.02 109.753 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.7 tt -128.24 138.34 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 108.054 -1.091 . . . . 0.02 108.054 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 m -121.5 129.99 53.28 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.325 -0.86 . . . . 0.39000000000000001 110.169 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 4.4 m-85 -110.58 141.18 44.12 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.967 -0.753 . . . . 0.02 108.967 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.546 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.7 m-85 -122.35 138.43 54.52 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.223 -0.923 . . . . 0.02 109.53 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.484 ' HG3' HD11 ' A' ' 33' ' ' LEU . 90.4 mt-10 -67.91 -27.78 66.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.99 -1.069 . . . . 0.029999999999999999 111.409 -178.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 2.4 m-20 -114.62 170.24 8.47 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.844 -1.16 . . . . 0.029999999999999999 110.22 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -75.85 162.1 28.43 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.794 0.807 . . . . 0.029999999999999999 110.241 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.402 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 21.2 t-20 62.76 33.09 15.68 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.106 0.955 . . . . 0.73999999999999999 110.836 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 55.22 39.81 31.48 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.841 -0.618 . . . . 0.02 110.973 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -110.11 165.65 11.57 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.18 -1.044 . . . . 0.02 108.18 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.82 -168.07 35.49 Favored Glycine 0 N--CA 1.497 2.708 0 C-N-CA 119.827 -1.178 . . . . 0.029999999999999999 110.748 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -69.45 143.87 53.45 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.483 -1.01 . . . . 2.7599999999999998 109.239 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -120.67 148.95 43.25 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.584 0.707 . . . . 1.8899999999999999 110.214 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -132.09 127.56 36.31 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.189 -1.041 . . . . 0.02 108.189 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.52 136.71 51.72 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.434 -0.791 . . . . 1.1200000000000001 109.888 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 13.3 t -131.26 139.22 49.6 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.665 -0.647 . . . . 0.02 109.557 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.497 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 2.5 m-20 -116.83 11.13 14.38 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.71 -0.619 . . . . 0.20000000000000001 109.694 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 47.5 m -158.23 174.76 14.68 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.263 -1.014 . . . . 1.23 108.263 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 3.5 m-20 -60.57 144.32 51.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.644 -1.285 . . . . 0.02 109.899 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 41.9 t -132.01 117.82 18.9 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.577 -0.897 . . . . 0.02 108.577 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.87 -25.26 48.48 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.168 -0.958 . . . . 0.23999999999999999 110.922 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -154.31 102.87 2.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.931 -1.106 . . . . 1.1399999999999999 109.274 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.433 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 43.6 p90 -102.06 9.95 39.93 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 122.019 0.914 . . . . 6.3700000000000001 109.788 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.3 mtm180 -59.43 -25.46 64.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.475 -0.765 . . . . 3.1099999999999999 111.505 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.9 p -76.05 -17.68 59.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.58 -1.325 . . . . 0.88 110.769 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -104.07 -22.17 13.48 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.335 -0.853 . . . . 0.02 109.589 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.484 HD11 ' HG3' ' A' ' 11' ' ' GLU . 6.4 tp -150.4 129.44 12.63 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.278 -0.889 . . . . 3.3199999999999998 108.967 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.7 p -85.24 -9.92 57.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.8 -0.563 . . . . 0.02 111.129 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -171.46 162.78 6.71 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.77 -1.206 . . . . 0.02 108.015 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.518 ' C ' HD22 ' A' ' 37' ' ' ASN . 5.1 p -143.55 115.23 8.16 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.827 -1.17 . . . . 0.02 108.66 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.518 HD22 ' C ' ' A' ' 36' ' ' CYS . 2.0 m120 -107.54 2.08 23.83 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 120.756 -1.215 . . . . 0.029999999999999999 110.881 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.1 t -155.54 154.84 32.37 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.821 -1.177 . . . . 0.02 107.821 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 39' ' ' ILE . 10.4 mt -146.29 146.58 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.951 -1.093 . . . . 0.02 110.654 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -123.68 124.82 43.6 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.159 -1.052 . . . . 0.02 108.159 177.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.5 t -106.6 115.19 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 106.803 -1.554 . . . . 0.02 106.803 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -83.98 -33.85 24.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.636 -0.665 . . . . 3.8100000000000001 110.759 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.79 152.38 22.26 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 118.821 -1.656 . . . . 0.02 110.807 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.26 173.21 49.53 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.62 -1.276 . . . . 0.01 110.474 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.2 m -119.68 135.4 54.84 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.983 -1.118 . . . . 1.48 107.983 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.458 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 32.9 m95 -126.35 155.26 42.33 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-O 122.573 1.178 . . . . 0.02 112.263 -176.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.5 134.16 52.22 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 105.509 -2.034 . . . . 0.23999999999999999 105.509 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.5 ' HB ' HD22 ' A' ' 79' ' ' LEU . 27.2 m -118.96 143.3 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.154 -0.684 . . . . 0.65000000000000002 109.154 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.565 ' CE2' ' SD ' ' A' ' 58' ' ' MET . 28.1 m-85 -121.41 146.32 47.01 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 122.386 1.089 . . . . 0.02 110.046 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -66.2 -35.1 79.57 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.509 -0.769 . . . . 0.02 111.228 -177.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -125.36 157.67 66.89 Favored Pre-proline 0 N--CA 1.503 2.182 0 O-C-N 121.051 -1.03 . . . . 0.02 109.498 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -53.63 167.3 1.0 Allowed 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.704 1.602 . . . . 0.02 112.958 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 63.68 36.53 10.72 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 114.999 -1.0 . . . . 0.02 111.182 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 45.15 51.54 9.01 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.631 0.729 . . . . 3.3900000000000001 110.612 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.0 t -126.29 163.78 22.46 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 121.201 0.524 . . . . 2.3300000000000001 109.804 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.61 -161.57 32.4 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.738 -1.345 . . . . 0.02 109.738 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.98 140.34 57.72 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.054 -1.263 . . . . 0.02 110.346 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.565 ' SD ' ' CE2' ' A' ' 49' ' ' TYR . 49.2 ttp -118.84 138.17 52.91 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.691 -0.631 . . . . 5.0099999999999998 109.827 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.49 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 56.1 m-85 -133.66 137.06 45.15 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.492 -0.755 . . . . 0.02 109.695 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.8 mm -94.74 131.09 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.912 -0.773 . . . . 1.72 108.912 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.561 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -119.21 110.56 37.67 Favored Pre-proline 0 N--CA 1.505 2.277 0 O-C-N 121.461 -0.775 . . . . 0.02 110.73 -178.316 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -77.63 168.32 22.74 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 CA-C-N 119.791 0.961 . . . . 1.47 110.068 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -53.16 141.74 22.4 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.757 -1.214 . . . . 4.25 110.35 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.27 -177.96 31.37 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.584 -1.293 . . . . 0.02 110.844 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -119.65 131.8 55.54 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.393 -1.063 . . . . 0.95999999999999996 109.692 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.561 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 69.9 m-85 -122.04 96.07 46.96 Favored Pre-proline 0 N--CA 1.494 1.755 0 N-CA-C 108.015 -1.105 . . . . 0.02 108.015 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.28 -4.38 10.43 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 120.811 1.007 . . . . 0.02 113.729 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -157.61 155.44 30.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.603 -1.311 . . . . 2.02 108.229 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -60.46 -39.17 86.59 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.535 -0.728 . . . . 0.02 112.17 -177.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -60.34 -23.82 64.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.132 -0.98 . . . . 0.02 110.373 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -69.37 -18.45 63.78 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.764 0.793 . . . . 3.4199999999999999 108.982 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.553 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.4 t90 -108.38 11.06 27.35 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.584 -1.265 . . . . 0.02 107.584 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.6 mmt 60.74 22.09 12.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.585 -0.697 . . . . 0.02 110.553 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.68 143.7 44.6 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.319 -1.512 . . . . 0.02 109.319 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.3 tp -78.79 -31.51 46.04 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.452 -1.314 . . . . 0.97999999999999998 107.452 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -157.87 -172.47 3.94 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 106.262 -1.755 . . . . 0.02 106.262 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -98.44 28.39 4.18 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.659 -1.276 . . . . 0.02 110.627 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.434 HH11 ' HG3' ' A' ' 78' ' ' ARG . 20.9 ttm-85 -97.23 122.05 39.81 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.725 -1.234 . . . . 3.2000000000000002 110.905 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.5 HD22 ' HB ' ' A' ' 48' ' ' VAL . 35.1 mt -144.14 122.8 12.55 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.566 -1.272 . . . . 2.6099999999999999 107.566 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.17 -16.9 10.62 Favored Glycine 0 N--CA 1.504 3.189 0 O-C-N 121.024 -1.048 . . . . 0.02 112.814 -177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 73.3 p -156.8 156.34 33.08 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.22 -1.753 . . . . 0.02 110.299 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 28.4 p -143.84 147.29 33.87 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.481 -0.762 . . . . 0.02 110.038 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.5 mtm180 -138.25 143.15 39.96 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.469 -0.769 . . . . 0.01 109.644 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.26 132.54 36.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.42999999999999999 109.829 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.6 t -91.29 125.16 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.863 -0.791 . . . . 1.25 108.863 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -94.1 131.79 39.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.831 -1.168 . . . . 1.77 109.298 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.9 mt -96.38 140.15 31.45 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.312 -0.867 . . . . 1.6299999999999999 108.855 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.1 t -111.57 127.1 55.62 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.449 -0.782 . . . . 1.0800000000000001 109.092 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.5 p -103.56 -154.94 0.51 Allowed 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 106.485 -1.672 . . . . 1.26 106.485 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.96 -53.14 0.73 Allowed Glycine 0 N--CA 1.5 2.9 0 O-C-N 120.366 -1.459 . . . . 0.01 112.684 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -179.53 -101.72 0.15 Allowed Glycine 0 N--CA 1.489 2.221 0 C-N-CA 118.605 -1.76 . . . . 0.01 112.029 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -121.19 119.45 32.37 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.098 -1.236 . . . . 4.4299999999999997 110.72 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.87 130.59 35.82 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.822 -0.751 . . . . 2.9900000000000002 109.294 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -131.03 141.81 50.25 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.483 -0.761 . . . . 6.3600000000000003 108.964 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.8 tt -129.28 146.66 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.366 -0.834 . . . . 1.0900000000000001 110.038 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -122.01 133.68 54.81 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.766 -1.198 . . . . 2.0499999999999998 107.766 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.46 HG12 ' SG ' ' A' ' 129' ' ' CYS . 25.2 m -123.42 145.56 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 120.788 -1.195 . . . . 1.1000000000000001 109.736 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.594 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 32.2 m-85 -118.7 141.19 48.84 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 122.016 0.913 . . . . 0.72999999999999998 110.716 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -66.2 -30.21 70.63 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.995 -0.548 . . . . 0.02 111.295 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -116.54 170.16 8.78 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.099 -1.001 . . . . 3.1800000000000002 110.412 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.02 170.37 44.26 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.742 -0.943 . . . . 0.01 110.742 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 52.91 38.94 28.25 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.527 0.68 . . . . 0.01 111.587 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.424 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 24.7 m-85 51.8 49.17 21.35 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.525 -0.734 . . . . 0.01 111.059 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -123.62 165.59 16.94 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.322 -0.992 . . . . 3.1499999999999999 108.322 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.72 -163.79 27.36 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.519 -1.432 . . . . 0.01 109.519 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.4 tp60 -76.75 144.56 39.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.028 -1.277 . . . . 0.01 108.497 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.594 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 12.6 ttt -116.01 141.53 48.0 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.658 0.742 . . . . 0.01 109.801 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -131.0 136.42 48.5 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.069 -1.086 . . . . 2.48 108.069 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -118.89 133.7 55.66 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.52 -0.738 . . . . 0.01 110.117 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 t -148.17 149.41 31.92 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 122.318 1.056 . . . . 1.6899999999999999 110.962 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.0 p -111.33 9.95 21.59 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 115.501 -0.772 . . . . 0.01 110.336 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.468 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 23.6 mp0 -121.11 163.12 18.89 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.214 -0.929 . . . . 3.21 111.491 -178.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.74 156.61 37.98 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.471 -0.937 . . . . 0.01 108.471 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 19.6 t -127.15 113.67 21.67 Favored Pre-proline 0 N--CA 1.501 2.088 0 N-CA-C 108.749 -0.834 . . . . 0.01 108.749 178.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -74.52 -29.17 9.41 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 CA-C-N 120.446 1.195 . . . . 0.01 111.034 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 7.8 p -142.34 109.12 5.41 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.444 -0.785 . . . . 0.02 109.074 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.429 HD12 ' O ' ' A' ' 169' ' ' ILE . 97.6 mt -63.81 -38.74 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.884 -0.51 . . . . 1.8300000000000001 110.653 -178.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 118' ' ' MET . 12.4 tmm? -68.52 -37.74 80.27 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.255 -0.978 . . . . 1.3400000000000001 110.208 -178.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -69.53 -38.27 77.46 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.48 -1.388 . . . . 2.1099999999999999 109.958 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -79.78 -47.21 15.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.238 -0.914 . . . . 2.0800000000000001 112.381 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -111.39 0.41 16.59 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.299 -0.875 . . . . 0.02 112.647 -176.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 59.98 33.48 21.42 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.749 -1.219 . . . . 0.02 109.529 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.3 mt -112.09 135.54 52.62 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.718 -0.845 . . . . 0.02 108.718 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -91.61 -22.9 20.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.17 -0.956 . . . . 5.3200000000000003 110.24 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -149.48 164.28 35.46 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.159 -0.963 . . . . 0.02 109.88 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 35.0 mt -131.89 129.0 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 107.654 -1.239 . . . . 2.1699999999999999 107.654 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 61.2 m80 -108.09 -11.95 15.2 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.364 -0.835 . . . . 0.02 112.314 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.424 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 2.7 t -159.01 151.14 21.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.915 -1.115 . . . . 0.01 108.871 178.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.46 ' SG ' HG12 ' A' ' 97' ' ' VAL . 5.7 t -168.43 144.05 3.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 1.22 108.873 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.7 tttm -125.57 109.33 12.53 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 122.509 1.147 . . . . 1.4099999999999999 109.963 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 131' ' ' VAL . 7.5 p -111.32 135.86 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.184 -1.413 . . . . 0.01 107.184 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 72.1 t -126.68 93.31 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 106.788 -1.56 . . . . 1.98 106.788 177.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.428 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 54.2 tp10 -147.13 -75.3 0.19 Allowed 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 105.781 -1.933 . . . . 0.01 105.781 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 152.82 -53.79 0.46 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.567 -1.413 . . . . 0.01 109.567 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.67 ' HB ' HD12 ' A' ' 175' ' ' ILE . 72.4 p -120.16 99.79 6.81 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.494 -1.004 . . . . 2.2999999999999998 111.348 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.428 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 8.4 m95 -128.64 145.37 51.17 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 107.572 -1.27 . . . . 0.01 107.572 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.416 ' CG1' HD11 ' A' ' 175' ' ' ILE . 56.8 mt -121.01 137.93 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 120.662 -1.274 . . . . 1.6899999999999999 110.37 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.4 ' CE1' HD22 ' A' ' 151' ' ' LEU . 49.7 m-85 -114.92 144.72 43.11 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 106.935 -1.506 . . . . 2.4900000000000002 106.935 177.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.531 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 10.3 m-85 -124.2 144.32 50.0 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.411 -0.806 . . . . 0.02 109.857 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.42 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 38.7 tt0 -74.13 -29.08 61.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.687 -0.633 . . . . 0.02 111.874 -176.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.5 mt -115.74 154.56 48.08 Favored Pre-proline 0 N--CA 1.504 2.241 0 O-C-N 120.735 -1.228 . . . . 1.48 108.997 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -55.81 167.38 2.28 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.113 1.209 . . . . 0.02 112.726 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.1 m120 59.64 31.15 20.73 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.215 -0.902 . . . . 0.75 111.391 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 57.91 51.51 8.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.46 -0.775 . . . . 0.02 111.171 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -126.92 164.86 20.52 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.454 -0.779 . . . . 0.02 110.1 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.46 -165.95 32.82 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 110.414 -1.074 . . . . 0.02 110.414 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -69.37 142.73 53.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.554 -0.968 . . . . 0.02 108.883 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -114.69 148.94 37.54 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.339 0.59 . . . . 0.02 110.123 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.437 ' CD1' ' N ' ' A' ' 149' ' ' TYR . 13.0 m-85 -124.84 135.03 52.55 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 109.169 -0.678 . . . . 0.01 109.169 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.1 tt -100.36 122.42 43.1 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.907 -1.121 . . . . 0.01 109.021 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.4 HD22 ' CE1' ' A' ' 138' ' ' PHE . 6.1 mp -97.19 164.25 12.57 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.072 -1.018 . . . . 0.01 108.656 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -108.2 -101.71 0.37 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.462 -0.773 . . . . 2.27 109.527 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -172.99 43.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 1.8400000000000001 109.617 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -112.41 -156.55 0.59 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.524 -0.735 . . . . 2.2799999999999998 109.343 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -106.86 108.23 19.64 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.445 -0.785 . . . . 0.01 109.196 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.632 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 37.1 m-85 -98.92 113.58 25.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.343 -0.848 . . . . 0.01 109.532 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -94.62 -22.72 17.99 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.149 -0.97 . . . . 0.01 111.596 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -127.49 154.94 77.45 Favored Pre-proline 0 N--CA 1.503 2.187 0 O-C-N 120.916 -1.115 . . . . 2.54 108.775 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -60.7 -37.97 75.0 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 CA-C-N 119.317 0.792 . . . . 0.69999999999999996 110.543 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 95.7 t -61.04 -19.92 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.842 -1.161 . . . . 0.85999999999999999 109.259 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -65.26 -15.34 62.39 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.901 -1.125 . . . . 0.02 110.023 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.632 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 8.8 m0 -97.65 11.68 36.22 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.096 -1.003 . . . . 0.02 109.152 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.52 10.72 84.94 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.827 -1.178 . . . . 0.02 111.127 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.39 140.61 33.32 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.081 -1.246 . . . . 0.02 110.008 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.18 -8.92 58.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.708 -0.62 . . . . 0.58999999999999997 110.025 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 4.6 m -143.26 150.03 50.51 Favored Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.033 -1.042 . . . . 0.87 109.013 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.5 17.68 0.64 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 120.583 0.855 . . . . 0.38 112.102 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.31 123.25 28.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.851 -1.155 . . . . 0.17999999999999999 111.524 -177.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.429 ' O ' HD12 ' A' ' 117' ' ' ILE . 1.5 mt -150.04 126.32 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 106.714 -1.588 . . . . 3.9900000000000002 106.714 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 170' ' ' GLN . 10.8 mp0 -112.3 -16.83 12.88 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.082 -1.011 . . . . 5.1699999999999999 113.059 -177.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.7 p -157.33 160.77 38.85 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 119.162 -2.211 . . . . 0.02 110.242 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.414 ' CD1' ' C ' ' A' ' 172' ' ' PHE . 21.1 p90 -152.4 152.65 32.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.074 -1.016 . . . . 2.02 110.521 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -144.85 149.84 36.08 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.467 -0.77 . . . . 0.01 109.698 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.408 HH21 HG11 ' A' ' 176' ' ' VAL . 41.2 ttp180 -87.17 140.87 29.11 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.246 -0.65 . . . . 0.01 109.246 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.67 HD12 ' HB ' ' A' ' 135' ' ' THR . 31.4 mt -92.47 129.44 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.14 -0.975 . . . . 3.04 108.839 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.408 HG11 HH21 ' A' ' 174' ' ' ARG . 12.9 m -136.76 148.04 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.244 -0.91 . . . . 1.8899999999999999 109.793 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 4.8899999999999997 109.529 179.925 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.603 -1.399 . . . . 0.01 109.603 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.519 ' CB ' ' NZ ' ' A' ' 6' ' ' LYS . 5.5 ttpm? -146.41 135.68 22.79 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.263 -1.139 . . . . 0.02 110.43 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.7 tt -129.77 139.85 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.256 -1.016 . . . . 0.02 108.256 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 m -120.7 129.48 53.68 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.337 -0.852 . . . . 0.39000000000000001 110.065 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -109.8 139.46 44.83 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.846 -0.798 . . . . 0.02 108.846 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.551 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.6 m-85 -122.07 138.44 54.44 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.258 -0.901 . . . . 0.02 109.731 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.449 ' HG3' HD11 ' A' ' 33' ' ' LEU . 94.6 mt-10 -69.29 -27.5 65.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.029999999999999999 111.575 -178.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -114.36 169.5 8.99 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.894 -1.129 . . . . 0.029999999999999999 110.242 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -75.44 158.56 32.48 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.663 0.744 . . . . 0.029999999999999999 110.105 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.417 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 4.5 t-20 66.13 33.48 7.43 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.954 0.883 . . . . 0.73999999999999999 111.16 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.417 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 1.0 OUTLIER 55.42 41.63 30.82 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 116.053 -0.521 . . . . 0.02 111.161 177.901 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -113.46 166.15 11.78 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.374 -0.973 . . . . 0.02 108.374 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.9 -167.29 36.33 Favored Glycine 0 N--CA 1.494 2.539 0 C-N-CA 119.927 -1.13 . . . . 0.029999999999999999 110.765 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -69.06 142.0 54.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.524 -0.986 . . . . 2.7599999999999998 109.302 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -120.48 149.09 42.94 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.625 0.726 . . . . 1.8899999999999999 110.144 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -132.73 127.55 34.96 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.325 -0.991 . . . . 0.02 108.325 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 23.0 p-10 -112.57 136.85 51.62 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.412 -0.805 . . . . 1.1200000000000001 109.733 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.2 t -131.07 138.83 49.75 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.678 -0.639 . . . . 0.02 109.626 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.494 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 2.6 p30 -116.41 11.06 14.83 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.529 -0.732 . . . . 0.20000000000000001 109.817 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 43.1 m -158.38 174.66 14.79 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.318 -0.993 . . . . 1.23 108.318 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -60.8 144.16 53.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.714 -1.242 . . . . 0.02 109.916 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.5 p -131.57 117.16 18.36 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.594 -0.891 . . . . 0.02 108.594 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.03 -25.43 47.86 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.107 -0.996 . . . . 0.23999999999999999 110.799 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -154.33 101.17 2.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.977 -1.077 . . . . 1.1399999999999999 108.948 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -105.33 9.42 33.85 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.103 0.954 . . . . 6.3700000000000001 109.788 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -58.52 -23.93 59.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.492 -0.755 . . . . 3.1099999999999999 110.865 -178.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 53.6 p -74.58 -16.28 60.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.739 -1.226 . . . . 0.88 110.328 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -104.63 -22.14 13.29 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.462 -0.774 . . . . 0.02 109.63 -179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.449 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.7 tp -150.56 129.22 12.31 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.15 -0.969 . . . . 3.3199999999999998 109.287 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.0 p -86.83 -10.41 53.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.657 -0.652 . . . . 0.02 111.69 -178.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.522 HH21 ' ND2' ' A' ' 37' ' ' ASN . 42.7 ttt180 -170.36 161.34 8.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.811 -1.181 . . . . 0.02 107.963 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.412 ' SG ' HD23 ' A' ' 33' ' ' LEU . 4.1 m -141.96 115.27 8.9 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.702 -1.249 . . . . 0.02 109.642 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.523 ' ND2' ' OD2' ' A' ' 77' ' ' ASP . 0.8 OUTLIER -107.88 0.14 21.87 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.837 -1.165 . . . . 0.029999999999999999 110.801 -178.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.1 t -156.31 154.58 30.86 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.039 -1.097 . . . . 0.02 108.039 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.4 mt -146.42 147.31 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.132 -0.98 . . . . 0.02 110.477 -178.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -123.53 124.4 42.76 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.189 -1.041 . . . . 0.02 108.189 177.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.8 t -106.54 115.04 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 106.921 -1.511 . . . . 0.02 106.921 177.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -83.76 -33.64 24.98 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.939 -0.705 . . . . 3.8100000000000001 110.643 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.7 152.11 21.89 Favored Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.009 -1.567 . . . . 0.02 110.831 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.57 172.98 49.4 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.517 -1.325 . . . . 0.01 110.522 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.5 m -119.7 135.28 54.89 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 108.019 -1.104 . . . . 1.48 108.019 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.42 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 36.1 m95 -126.94 155.58 42.86 Favored 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 122.486 1.136 . . . . 0.02 112.112 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.39 134.05 52.31 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 105.573 -2.01 . . . . 0.23999999999999999 105.573 176.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.513 ' HB ' HD22 ' A' ' 79' ' ' LEU . 29.3 m -118.6 143.59 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.584 -0.697 . . . . 0.65000000000000002 109.226 178.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -121.46 145.93 47.42 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 122.427 1.108 . . . . 0.02 110.335 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -66.35 -33.93 76.82 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.678 -0.692 . . . . 0.02 111.198 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.8 mtp180 -125.41 157.85 66.4 Favored Pre-proline 0 N--CA 1.502 2.16 0 O-C-N 121.046 -1.034 . . . . 0.02 109.515 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -53.74 166.97 1.15 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.742 1.628 . . . . 0.02 113.0 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 64.03 36.53 9.84 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.214 -0.903 . . . . 0.02 111.175 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 45.31 51.88 9.13 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.638 0.732 . . . . 3.3900000000000001 110.593 178.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.3 p -126.51 163.84 22.5 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.167 0.508 . . . . 2.3300000000000001 109.87 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.37 -162.12 31.81 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.766 -1.334 . . . . 0.02 109.766 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.462 ' H ' ' CD2' ' A' ' 57' ' ' HIS . 20.9 m-70 -65.52 138.27 57.96 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.035 -1.274 . . . . 0.02 110.066 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 20.6 ptm -118.12 137.21 53.1 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.326 0.584 . . . . 5.0099999999999998 109.583 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.562 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 86.9 m-85 -133.98 138.67 45.58 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.419 -0.801 . . . . 0.02 109.752 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.1 mm -95.54 131.37 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 109.089 -0.708 . . . . 1.72 109.089 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.478 HD22 ' CE1' ' A' ' 66' ' ' TYR . 12.4 mt -120.89 111.91 33.94 Favored Pre-proline 0 N--CA 1.506 2.328 0 O-C-N 121.361 -0.837 . . . . 0.02 110.962 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -77.52 169.77 20.45 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 CA-C-N 119.876 0.991 . . . . 1.47 109.871 177.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -52.9 141.19 22.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.794 -1.192 . . . . 4.25 110.211 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.42 -177.83 32.38 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.52 -1.324 . . . . 0.02 110.781 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -120.67 131.93 54.83 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.374 -1.074 . . . . 0.95999999999999996 109.832 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.478 ' CE1' HD22 ' A' ' 61' ' ' LEU . 94.7 m-85 -121.68 96.41 47.35 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 108.068 -1.086 . . . . 0.02 108.068 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.37 -3.8 10.67 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 120.796 0.997 . . . . 0.02 113.702 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -157.58 155.69 30.6 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.621 -1.3 . . . . 2.02 108.36 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -60.43 -39.29 86.93 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.54 -0.725 . . . . 0.02 112.013 -177.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -60.17 -23.37 63.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.968 -1.083 . . . . 0.02 110.279 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -70.61 -18.72 62.88 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.897 0.856 . . . . 3.4199999999999999 109.044 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.562 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.3 t90 -107.8 10.29 28.75 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.409 -1.33 . . . . 0.02 107.409 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 13.5 mmt 60.46 22.26 11.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.627 -0.671 . . . . 0.02 110.294 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.76 144.39 46.28 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.398 -1.481 . . . . 0.02 109.398 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.9 mt -78.86 -30.44 45.12 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.626 -1.25 . . . . 0.97999999999999998 107.626 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -157.11 -171.61 3.7 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 106.427 -1.694 . . . . 0.02 106.427 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.523 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 92.4 m-20 -98.82 28.37 4.35 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.733 -1.229 . . . . 0.02 110.42 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -96.91 122.62 40.09 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.005 -1.059 . . . . 3.2000000000000002 110.936 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.513 HD22 ' HB ' ' A' ' 48' ' ' VAL . 39.7 mt -143.56 120.96 11.65 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.585 -1.265 . . . . 2.6099999999999999 107.585 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.35 -17.3 10.11 Favored Glycine 0 N--CA 1.506 3.302 0 O-C-N 121.065 -1.022 . . . . 0.02 112.928 -177.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.2 t -156.99 156.46 33.0 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.159 -1.789 . . . . 0.02 110.331 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 38.6 m -145.42 148.19 33.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.453 -0.779 . . . . 0.02 110.086 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -138.14 143.12 40.17 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.308 -0.87 . . . . 0.01 109.413 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.37 132.36 36.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -0.952 . . . . 0.42999999999999999 109.68 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.4 t -91.59 125.28 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.938 -0.764 . . . . 1.25 108.938 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 26.3 m-70 -95.57 129.99 42.57 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.707 -1.246 . . . . 1.77 109.274 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.6 mt -94.47 141.27 28.79 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.159 -0.963 . . . . 1.6299999999999999 108.688 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.5 m -111.21 128.14 55.82 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.386 -0.821 . . . . 1.0800000000000001 109.237 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.0 p -104.54 -153.96 0.49 Allowed 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 106.63 -1.618 . . . . 1.26 106.63 177.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.64 -52.76 0.74 Allowed Glycine 0 N--CA 1.501 3.024 0 O-C-N 120.414 -1.428 . . . . 0.01 112.807 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.35 -101.95 0.16 Allowed Glycine 0 N--CA 1.49 2.237 0 C-N-CA 118.533 -1.794 . . . . 0.01 112.108 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -121.53 119.13 31.08 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.144 -1.209 . . . . 4.4299999999999997 110.788 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.05 130.39 35.47 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.92 -0.712 . . . . 2.9900000000000002 109.267 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.473 ' CB ' ' NZ ' ' A' ' 94' ' ' LYS . 2.8 ttmp? -129.79 141.57 50.83 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.423 -0.798 . . . . 6.3600000000000003 109.149 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 110' ' ' THR . 3.8 tt -128.14 145.64 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 121.356 -0.84 . . . . 1.0900000000000001 110.465 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.541 ' OE1' ' N ' ' A' ' 96' ' ' GLN . 0.5 OUTLIER -122.32 132.29 54.33 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.382 -1.34 . . . . 2.0499999999999998 107.382 177.203 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.5 m -124.51 146.47 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 O-C-N 120.601 -1.312 . . . . 1.1000000000000001 109.746 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.577 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 71.3 m-85 -119.58 141.01 49.65 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 122.045 0.926 . . . . 0.72999999999999998 111.161 -178.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -66.12 -30.37 70.85 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 116.004 -0.544 . . . . 0.02 111.365 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -117.0 170.57 8.53 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.13 -0.981 . . . . 3.1800000000000002 110.473 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.66 169.29 45.05 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.805 -0.918 . . . . 0.01 110.805 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 23.9 t70 53.23 38.83 28.6 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.576 0.703 . . . . 0.01 111.55 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 52.14 48.8 21.95 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.503 -0.748 . . . . 0.01 110.846 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -123.28 165.55 16.77 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.215 -1.032 . . . . 3.1499999999999999 108.215 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.43 -164.29 28.03 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.302 -1.519 . . . . 0.01 109.302 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -76.84 144.57 38.97 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.053 -1.263 . . . . 0.01 108.675 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.577 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 30.3 ttp -116.74 142.57 46.74 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.638 0.732 . . . . 0.01 109.984 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -131.27 136.49 48.23 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.184 -1.043 . . . . 2.48 108.184 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -118.56 133.92 55.49 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.466 -0.771 . . . . 0.01 109.817 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.415 ' O ' HG22 ' A' ' 95' ' ' ILE . 4.5 t -148.15 149.86 32.77 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.128 0.966 . . . . 1.6899999999999999 110.965 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 p -110.44 9.97 23.31 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 115.614 -0.721 . . . . 0.01 110.168 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -121.53 163.1 19.4 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.214 -0.929 . . . . 3.21 111.901 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 9.8 p30 -68.15 157.28 35.69 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.233 -1.025 . . . . 0.01 108.233 178.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.574 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 86.2 m -125.77 112.8 24.87 Favored Pre-proline 0 N--CA 1.501 2.104 0 O-C-N 121.503 -0.748 . . . . 0.01 109.172 178.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -75.62 -30.93 5.84 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 CA-C-N 120.095 1.07 . . . . 0.01 111.042 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.4 m -141.96 106.55 4.85 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.493 -0.928 . . . . 0.02 108.493 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 95.0 mt -65.12 -38.1 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.745 -0.597 . . . . 1.8300000000000001 111.203 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.1 ttt -67.75 -37.16 81.76 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.013 -1.075 . . . . 1.3400000000000001 109.815 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -69.75 -38.34 76.77 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.493 -1.379 . . . . 2.1099999999999999 109.721 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.529 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 7.7 tt0 -80.19 -47.24 14.99 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.404 -0.81 . . . . 2.0800000000000001 112.345 -177.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -110.95 -0.4 16.76 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.386 -0.821 . . . . 0.02 112.67 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.9 m170 59.86 33.44 21.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.818 -1.176 . . . . 0.02 109.58 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 11.7 mt -112.42 135.53 53.01 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 108.791 -0.818 . . . . 0.02 108.791 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -92.06 -23.09 19.6 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.256 -0.902 . . . . 5.3200000000000003 110.565 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -149.14 163.81 36.52 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.142 -0.973 . . . . 0.02 109.911 -178.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 43.2 mt -132.57 129.39 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 107.811 -1.181 . . . . 2.1699999999999999 107.811 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.5 m80 -108.96 -12.07 14.91 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.364 -0.835 . . . . 0.02 112.466 -177.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.2 t -159.26 151.21 20.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.736 -1.228 . . . . 0.01 109.239 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 28.4 p -166.5 149.61 7.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.971 -1.08 . . . . 1.22 109.295 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.434 ' O ' ' OE1' ' A' ' 96' ' ' GLN . 3.7 tmtp? -119.69 108.99 15.12 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 122.298 1.047 . . . . 1.4099999999999999 109.422 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.4 t -114.71 127.84 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 107.673 -1.232 . . . . 0.01 107.673 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.2 t -130.67 94.88 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 107.378 -1.341 . . . . 1.98 107.378 177.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.644 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 22.5 tt0 -146.39 -74.61 0.21 Allowed 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 106.128 -1.804 . . . . 0.01 106.128 177.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 167.91 -65.69 0.19 Allowed Glycine 0 N--CA 1.484 1.841 0 N-CA-C 108.697 -1.761 . . . . 0.01 108.697 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.7 p -122.87 115.15 21.48 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.52 -0.988 . . . . 2.2999999999999998 110.508 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.644 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 8.3 m95 -126.57 148.18 49.78 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 107.338 -1.356 . . . . 0.01 107.338 178.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.437 HG21 HD13 ' A' ' 137' ' ' ILE . 14.2 mt -120.4 134.67 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 120.392 -1.443 . . . . 1.6899999999999999 110.343 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.401 ' HB3' HD12 ' A' ' 169' ' ' ILE . 66.0 m-85 -114.71 143.93 44.26 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.366 -1.346 . . . . 2.4900000000000002 107.366 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.541 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 8.4 m-85 -123.65 144.78 49.41 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.373 -0.829 . . . . 0.02 109.741 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -77.36 -28.17 52.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.569 -0.707 . . . . 0.02 112.046 -176.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 47.7 mt -114.86 151.92 45.93 Favored Pre-proline 0 N--CA 1.504 2.235 0 O-C-N 120.683 -1.26 . . . . 1.48 109.143 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -52.93 166.12 1.01 Allowed 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 120.737 0.958 . . . . 0.02 112.72 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 59.25 31.19 21.0 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.111 -0.949 . . . . 0.75 111.432 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 57.24 51.47 10.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.562 -0.711 . . . . 0.02 111.298 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 51.0 mtp180 -125.96 164.46 20.77 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.499 -0.751 . . . . 0.02 109.935 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.37 -165.31 32.5 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.312 -1.115 . . . . 0.02 110.312 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -69.48 142.99 53.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.617 -0.931 . . . . 0.02 109.109 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -115.11 149.01 38.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.801 -0.562 . . . . 0.02 109.77 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -124.97 135.68 53.03 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.653 -0.654 . . . . 0.01 109.284 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.9 tp -97.07 120.61 37.74 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.648 -1.282 . . . . 0.01 109.368 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.4 tp -100.38 150.18 22.88 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.291 -0.881 . . . . 0.01 109.013 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -104.17 -108.72 0.27 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.673 -0.642 . . . . 2.27 109.374 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -167.59 54.68 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.967 -1.083 . . . . 1.8400000000000001 109.839 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -113.76 -167.51 1.22 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.523 -0.736 . . . . 2.2799999999999998 109.268 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -106.14 105.45 15.49 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.879 -0.785 . . . . 0.01 108.879 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -99.41 115.83 30.17 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.354 -0.841 . . . . 0.01 110.018 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -92.33 -25.26 18.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.993 -1.067 . . . . 0.01 110.873 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -127.5 153.73 77.42 Favored Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 108.14 -1.059 . . . . 2.54 108.14 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -58.78 -40.47 72.29 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 CA-C-N 119.502 0.858 . . . . 0.69999999999999996 110.462 178.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 5.6 t -63.09 -22.96 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.716 -1.24 . . . . 0.85999999999999999 109.821 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -66.37 -16.35 64.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.556 -1.34 . . . . 0.02 110.076 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.539 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 18.9 t90 -100.31 10.68 40.87 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.424 -0.797 . . . . 0.02 109.03 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.42 8.52 87.49 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 120.208 -0.996 . . . . 0.02 111.902 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -98.51 141.3 31.54 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.056 -1.261 . . . . 0.02 110.154 -178.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -88.66 -13.08 40.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.63 -0.669 . . . . 0.58999999999999997 110.701 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 60.6 p -147.31 150.23 37.12 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 120.717 -1.239 . . . . 0.87 108.988 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -78.6 20.25 0.79 Allowed 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 120.816 1.011 . . . . 0.38 113.085 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.17 123.86 29.95 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.446 -1.409 . . . . 0.17999999999999999 111.78 -177.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.447 HD13 ' HA ' ' A' ' 169' ' ' ILE . 11.7 mm -151.5 127.63 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 107.03 -1.47 . . . . 3.9900000000000002 107.03 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -112.07 -16.6 13.02 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 121.078 -1.014 . . . . 5.1699999999999999 113.719 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 67.2 m -156.92 160.44 39.1 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 119.124 -2.235 . . . . 0.02 110.288 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.574 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 9.8 p90 -152.74 153.28 32.9 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.131 -0.981 . . . . 2.02 111.004 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -145.12 149.57 35.26 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.469 -0.769 . . . . 0.01 110.112 -179.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -88.52 144.1 26.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.603 -0.685 . . . . 0.01 109.416 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 8.2 mt -95.74 129.44 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.212 -0.93 . . . . 3.04 109.218 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.8 m -136.37 146.97 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.189 -0.944 . . . . 1.8899999999999999 109.589 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.337 -0.852 . . . . 4.8899999999999997 109.485 -179.854 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.705 -1.358 . . . . 0.01 109.705 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -145.33 134.66 23.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.248 -1.148 . . . . 0.02 110.522 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.8 tt -129.55 139.71 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.097 -1.075 . . . . 0.02 108.097 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.524 ' OG ' ' NE ' ' A' ' 19' ' ' ARG . 1.7 t -121.99 130.19 53.1 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.336 -0.853 . . . . 0.39000000000000001 110.174 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.9 m-85 -110.61 140.37 45.01 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.919 -0.771 . . . . 0.02 108.919 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.577 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 1.9 m-85 -122.2 138.99 54.28 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.28 -0.888 . . . . 0.02 109.758 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -69.34 -27.79 65.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.075 -1.016 . . . . 0.029999999999999999 111.673 -178.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -114.0 169.16 9.21 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.956 -1.09 . . . . 0.029999999999999999 110.117 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -75.5 158.28 32.8 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.731 0.777 . . . . 0.029999999999999999 110.087 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.408 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 2.0 m-20 66.72 33.36 6.34 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.948 0.88 . . . . 0.73999999999999999 111.225 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.408 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 1.3 m-85 55.64 42.23 29.69 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.28 0.562 . . . . 0.02 111.555 177.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -113.79 165.6 12.4 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.216 -1.031 . . . . 0.02 108.216 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.46 -167.38 35.44 Favored Glycine 0 N--CA 1.494 2.504 0 C-N-CA 119.769 -1.205 . . . . 0.029999999999999999 111.023 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -68.62 141.75 55.32 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.473 -1.016 . . . . 2.7599999999999998 109.468 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.524 ' NE ' ' OG ' ' A' ' 8' ' ' SER . 54.4 ttt180 -121.09 149.16 43.16 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.609 -0.682 . . . . 1.8899999999999999 109.935 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -134.99 130.03 35.11 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 108.729 -0.841 . . . . 0.02 108.729 178.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 3.3 m-20 -110.64 136.08 50.28 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.471 -0.768 . . . . 1.1200000000000001 109.105 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.6 t -129.08 138.17 51.69 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.714 -0.616 . . . . 0.02 109.491 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -117.76 12.31 13.87 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.626 -0.671 . . . . 0.20000000000000001 110.282 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 44.4 t -159.45 174.29 14.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.949 -1.094 . . . . 1.23 108.777 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.466 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 3.3 p-10 -61.91 145.36 53.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.685 -1.26 . . . . 0.02 110.142 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.0 t -132.6 117.09 17.49 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.78 -0.822 . . . . 0.02 108.78 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.55 -23.31 50.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.308 -0.87 . . . . 0.23999999999999999 111.173 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -155.3 101.41 2.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.197 -0.939 . . . . 1.1399999999999999 108.779 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.489 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 21.2 p90 -108.02 9.65 28.44 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 122.059 0.933 . . . . 6.3700000000000001 110.504 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -59.58 -22.77 62.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.359 -0.838 . . . . 3.1099999999999999 110.663 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.0 m -74.71 -15.73 60.77 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.672 -1.267 . . . . 0.88 109.968 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -103.77 -21.32 13.7 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.587 -0.696 . . . . 0.02 109.396 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 33' ' ' LEU . 48.1 mt -149.8 129.64 13.33 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.915 0.864 . . . . 3.3199999999999998 109.519 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.4 p -85.86 -10.11 55.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.819 -0.551 . . . . 0.02 110.23 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -171.77 161.81 6.04 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.098 -1.075 . . . . 0.02 108.098 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 77.4 m -143.24 116.44 8.96 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.902 -1.124 . . . . 0.02 108.861 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.523 ' ND2' ' OD2' ' A' ' 77' ' ' ASP . 4.0 m120 -108.43 0.58 21.13 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 120.901 -1.125 . . . . 0.029999999999999999 111.429 -178.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.9 p -156.41 154.43 30.47 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.964 -1.124 . . . . 0.02 107.964 178.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.2 mt -146.81 147.77 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.188 -0.945 . . . . 0.02 110.357 -178.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -124.65 125.77 44.65 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.987 -1.116 . . . . 0.02 107.987 177.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.3 t -106.75 115.46 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 107.0 -1.481 . . . . 0.02 107.0 177.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -83.46 -33.95 25.51 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.652 -0.655 . . . . 3.8100000000000001 110.486 -178.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.94 152.21 21.97 Favored Glycine 0 N--CA 1.488 2.126 0 C-N-CA 118.917 -1.611 . . . . 0.02 110.834 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.67 173.08 49.5 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.505 -1.331 . . . . 0.01 110.374 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.5 m -119.22 134.9 54.95 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 107.844 -1.169 . . . . 1.48 107.844 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.407 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 38.1 m95 -127.54 155.52 43.65 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 122.499 1.142 . . . . 0.02 111.991 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.98 134.19 51.97 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 105.676 -1.972 . . . . 0.23999999999999999 105.676 176.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.48 ' HB ' HD22 ' A' ' 79' ' ' LEU . 27.4 m -117.76 143.06 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.629 -0.67 . . . . 0.65000000000000002 109.213 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -120.97 145.32 47.86 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 122.23 1.015 . . . . 0.02 110.064 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -66.32 -32.78 74.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.756 -0.59 . . . . 0.02 111.326 -177.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -125.12 157.61 66.51 Favored Pre-proline 0 N--CA 1.502 2.146 0 O-C-N 121.114 -0.991 . . . . 0.02 109.503 -178.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -53.12 167.1 0.79 Allowed 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 121.739 1.626 . . . . 0.02 112.915 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 63.34 36.57 11.53 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.407 -0.815 . . . . 0.02 110.99 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.476 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 2.3 m-85 44.92 51.6 8.55 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.535 0.683 . . . . 3.3900000000000001 110.565 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.0 p -125.97 163.68 22.47 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.207 0.527 . . . . 2.3300000000000001 110.016 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.56 -162.1 31.54 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.794 -1.323 . . . . 0.02 109.794 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.443 ' ND1' ' N ' ' A' ' 57' ' ' HIS . 4.1 m80 -64.15 138.04 58.25 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.957 -1.319 . . . . 0.02 109.938 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 17.2 ptm -118.59 136.9 53.61 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.317 0.58 . . . . 5.0099999999999998 109.643 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.576 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 84.5 m-85 -134.3 139.39 45.66 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 121.62 0.724 . . . . 0.02 109.702 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.5 mm -94.94 131.32 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.768 -0.827 . . . . 1.72 108.768 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.526 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.17 110.51 36.12 Favored Pre-proline 0 N--CA 1.505 2.282 0 O-C-N 121.386 -0.821 . . . . 0.02 110.693 -178.29 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -77.24 168.86 22.37 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 CA-C-N 119.958 1.021 . . . . 1.47 109.997 177.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -53.33 141.16 24.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.626 -1.296 . . . . 4.25 110.415 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.57 -177.71 32.57 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.558 -1.306 . . . . 0.02 110.571 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -120.04 131.14 55.01 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.537 -0.978 . . . . 0.95999999999999996 109.656 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.526 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 48.7 m-85 -123.11 94.37 47.18 Favored Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 108.371 -0.974 . . . . 0.02 108.371 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -65.95 -3.04 7.61 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.027 1.152 . . . . 0.02 114.11 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -157.53 155.83 30.95 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.55 -1.343 . . . . 2.02 108.589 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -60.78 -39.41 88.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.484 -0.76 . . . . 0.02 112.21 -177.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -59.86 -23.63 63.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.969 -1.082 . . . . 0.02 110.324 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -70.72 -18.36 62.8 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.833 0.825 . . . . 3.4199999999999999 108.858 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.576 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.1 t90 -108.07 10.42 28.16 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.29 -1.374 . . . . 0.02 107.29 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.445 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 2.6 mpt? 59.82 23.63 12.6 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.495 0.664 . . . . 0.02 110.535 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.54 144.89 45.55 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.377 -1.489 . . . . 0.02 109.377 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.3 tp -79.92 -31.05 40.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.119 -1.224 . . . . 0.97999999999999998 107.701 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -157.47 -172.06 3.83 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 106.312 -1.736 . . . . 0.02 106.312 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.523 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 54.0 m-20 -97.9 27.52 4.44 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.705 -1.247 . . . . 0.02 110.674 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -95.98 121.62 37.92 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.879 -1.138 . . . . 3.2000000000000002 110.561 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.489 ' O ' ' CZ ' ' A' ' 29' ' ' PHE . 27.5 mt -144.47 121.17 11.18 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 107.735 -1.209 . . . . 2.6099999999999999 107.735 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -111.99 -15.97 9.53 Favored Glycine 0 N--CA 1.507 3.402 0 O-C-N 121.152 -0.968 . . . . 0.02 113.087 -177.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.476 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 37.3 t -156.42 156.68 34.24 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 119.862 1.831 . . . . 0.02 110.921 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 20.0 p -145.92 148.29 32.65 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.635 -0.666 . . . . 0.02 110.108 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -137.81 142.91 40.81 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.386 -0.821 . . . . 0.01 109.396 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.85 131.99 36.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.42999999999999999 109.767 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 t -91.11 125.47 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.843 -0.799 . . . . 1.25 108.843 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -93.13 132.32 37.37 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.764 -1.21 . . . . 1.77 108.826 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mt -98.56 140.33 32.95 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.3 -0.875 . . . . 1.6299999999999999 108.928 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 60.7 p -111.41 124.8 52.99 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.533 -0.914 . . . . 1.0800000000000001 108.533 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.4 m -116.35 133.0 56.51 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.697 -1.252 . . . . 1.26 107.924 177.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.11 -49.26 0.01 OUTLIER Glycine 0 N--CA 1.505 3.277 0 C-N-CA 117.707 -2.187 . . . . 0.01 113.724 -177.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -167.57 -105.76 0.19 Allowed Glycine 0 N--CA 1.49 2.25 0 CA-C-N 119.962 1.881 . . . . 0.01 111.213 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -120.11 117.89 29.14 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.97 -1.312 . . . . 4.4299999999999997 110.306 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.38 129.92 35.53 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.684 -0.806 . . . . 2.9900000000000002 109.392 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -131.03 140.79 50.14 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.545 -0.722 . . . . 6.3600000000000003 109.178 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.9 tt -129.31 146.07 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.322 -0.861 . . . . 1.0900000000000001 110.211 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -121.24 133.7 55.16 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.559 -1.274 . . . . 2.0499999999999998 107.559 177.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.2 m -124.34 145.98 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 120.965 -1.084 . . . . 1.1000000000000001 109.783 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -119.13 141.61 48.65 Favored 'General case' 0 N--CA 1.503 2.205 0 CA-C-O 122.124 0.964 . . . . 0.72999999999999998 111.092 -178.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -66.63 -30.31 70.55 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 115.87 -0.605 . . . . 0.02 111.908 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -116.53 167.65 10.87 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.004 -1.06 . . . . 3.1800000000000002 110.494 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.71 163.9 43.21 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 111.01 -0.836 . . . . 0.01 111.01 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 102' ' ' ASP . 2.3 m-20 57.09 38.73 29.28 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.808 0.813 . . . . 0.01 110.823 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.407 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 15.2 m-85 52.3 55.75 8.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.571 -0.705 . . . . 0.01 111.045 178.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -128.06 165.81 19.62 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 108.425 -0.954 . . . . 3.1499999999999999 108.425 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.4 -163.95 27.86 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.235 -1.546 . . . . 0.01 109.235 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -75.31 144.64 42.32 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.993 -1.298 . . . . 0.01 108.527 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.45 ' C ' ' SD ' ' A' ' 107' ' ' MET . 10.8 tmm? -116.59 142.33 47.03 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.569 0.7 . . . . 0.01 109.865 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -131.97 136.3 47.21 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.259 -1.015 . . . . 2.48 108.259 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.519 ' OE2' ' N ' ' A' ' 110' ' ' THR . 1.9 tm-20 -118.94 134.88 54.89 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.575 -0.703 . . . . 0.01 109.931 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.519 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 3.0 t -148.55 150.71 33.83 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 122.27 1.033 . . . . 1.6899999999999999 111.166 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 65.8 p -112.0 9.3 20.42 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 115.581 -0.736 . . . . 0.01 110.41 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -121.06 162.93 19.16 Favored 'General case' 0 N--CA 1.508 2.452 0 O-C-N 121.201 -0.937 . . . . 3.21 111.762 -178.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -67.97 156.62 36.89 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.266 -1.013 . . . . 0.01 108.266 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 30.6 t -127.12 114.84 21.79 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.556 -0.715 . . . . 0.01 109.196 178.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -75.08 -28.9 8.65 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 CA-C-N 120.396 1.177 . . . . 0.01 111.0 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 56.0 m -142.88 109.07 5.25 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.389 -0.819 . . . . 0.02 109.224 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.17 -38.77 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.832 -0.542 . . . . 1.8300000000000001 110.627 -178.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.5 ttp -68.89 -37.23 78.88 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.164 -1.014 . . . . 1.3400000000000001 110.259 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -69.53 -38.8 77.66 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 120.352 -1.468 . . . . 2.1099999999999999 110.058 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -79.99 -46.47 16.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.392 -0.817 . . . . 2.0800000000000001 112.227 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -110.62 0.14 17.44 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.364 -0.835 . . . . 0.02 112.573 -176.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 59.63 33.22 21.92 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.644 -1.285 . . . . 0.02 109.404 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.0 mt -112.52 135.57 53.08 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 108.716 -0.846 . . . . 0.02 108.716 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -91.39 -22.53 20.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.155 -0.966 . . . . 5.3200000000000003 110.361 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -149.64 164.02 36.32 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.136 -0.978 . . . . 0.02 109.833 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.6 mt -131.83 128.61 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 107.557 -1.275 . . . . 2.1699999999999999 107.557 178.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.513 ' N ' ' ND1' ' A' ' 127' ' ' HIS . 1.8 m80 -107.93 -12.44 15.17 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.496 -0.753 . . . . 0.02 112.293 -177.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.407 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 7.0 t -159.92 152.12 20.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.015 -1.053 . . . . 0.01 109.05 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 6.3 p -169.98 145.17 2.86 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.183 -0.948 . . . . 1.22 109.016 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.6 tttp -125.74 111.58 15.08 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 122.452 1.12 . . . . 1.4099999999999999 110.172 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 131' ' ' VAL . 11.2 p -111.86 136.5 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.282 -1.377 . . . . 0.01 107.282 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 44.5 t -128.32 93.53 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 N-CA-C 106.865 -1.532 . . . . 1.98 106.865 177.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -146.33 -81.26 0.15 Allowed 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 105.911 -1.885 . . . . 0.01 105.911 178.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -178.91 -79.13 0.06 OUTLIER Glycine 0 N--CA 1.486 1.985 0 N-CA-C 108.488 -1.845 . . . . 0.01 108.488 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.585 ' OG1' HD12 ' A' ' 175' ' ' ILE . 1.4 t -119.08 122.13 41.41 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.454 -1.027 . . . . 2.2999999999999998 110.068 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -125.75 150.74 47.49 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 106.847 -1.538 . . . . 0.01 106.847 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 82.6 mt -121.17 136.78 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 120.467 -1.396 . . . . 1.6899999999999999 110.166 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -115.59 144.88 43.25 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.625 -1.25 . . . . 2.4900000000000002 107.625 178.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.517 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 12.1 m-85 -123.4 144.09 49.71 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.436 -0.79 . . . . 0.02 109.666 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -74.74 -29.4 61.14 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.478 -0.764 . . . . 0.02 111.771 -176.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.5 mt -115.64 154.65 47.94 Favored Pre-proline 0 N--CA 1.505 2.29 0 O-C-N 120.706 -1.246 . . . . 1.48 108.939 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -55.64 167.31 2.18 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.131 1.221 . . . . 0.02 112.609 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.404 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 14.4 t-20 59.7 30.94 20.54 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.009 -0.996 . . . . 0.75 111.284 178.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 58.02 51.64 8.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.425 -0.797 . . . . 0.02 111.208 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -127.04 164.89 20.54 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.541 -0.725 . . . . 0.02 110.187 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.98 -165.81 33.36 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.385 -1.086 . . . . 0.02 110.385 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -69.1 142.5 54.44 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.558 -0.966 . . . . 0.02 109.027 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -113.99 148.52 36.79 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.554 0.692 . . . . 0.02 110.257 -177.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -125.09 134.34 52.53 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.01 -0.737 . . . . 0.01 109.01 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.496 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.9 tt -99.25 121.9 41.69 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.92 -1.113 . . . . 0.01 109.221 -179.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.642 HD23 ' N ' ' A' ' 152' ' ' ASP . 1.6 tt -98.35 140.98 31.82 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.587 -0.894 . . . . 0.01 108.587 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.642 ' N ' HD23 ' A' ' 151' ' ' LEU . 1.3 m-20 -103.39 -108.32 0.26 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.313 -0.867 . . . . 2.27 109.967 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.417 ' HZ2' ' HB3' ' A' ' 153' ' ' LYS . 14.2 ttpp -153.27 52.47 0.73 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.939 -1.1 . . . . 1.8400000000000001 109.611 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -115.25 175.58 5.45 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.374 -0.829 . . . . 2.2799999999999998 109.087 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -102.94 111.72 24.18 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.237 -0.914 . . . . 0.01 108.644 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.51 ' N ' ' CD1' ' A' ' 156' ' ' TYR . 16.1 m-85 -99.76 115.6 29.9 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.373 -0.829 . . . . 0.01 110.506 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -92.82 -24.91 18.35 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.927 -1.108 . . . . 0.01 110.633 -178.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -127.82 154.04 78.05 Favored Pre-proline 0 N--CA 1.499 2.018 0 N-CA-C 108.139 -1.06 . . . . 2.54 108.139 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -58.86 -40.31 73.28 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 CA-C-N 119.416 0.827 . . . . 0.69999999999999996 110.518 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 51.1 t -62.14 -23.02 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.887 -1.133 . . . . 0.85999999999999999 109.594 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -66.54 -16.22 63.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.588 -1.32 . . . . 0.02 109.824 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.572 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 12.5 t90 -99.66 9.53 42.96 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.648 -0.871 . . . . 0.02 108.648 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 78.57 8.4 87.66 Favored Glycine 0 N--CA 1.492 2.373 0 O-C-N 120.904 -1.122 . . . . 0.02 111.512 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -98.23 141.61 30.93 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.231 -1.158 . . . . 0.02 109.973 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -87.27 -12.35 46.9 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.796 -0.565 . . . . 0.58999999999999997 110.439 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.9 m -147.22 149.99 36.66 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 120.713 -1.242 . . . . 0.87 108.758 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -78.17 22.46 0.62 Allowed 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 120.807 1.005 . . . . 0.38 112.98 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.841 ' O ' HD13 ' A' ' 169' ' ' ILE . . . -83.6 123.18 29.52 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.618 -1.301 . . . . 0.17999999999999999 111.812 -177.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.841 HD13 ' O ' ' A' ' 168' ' ' ALA . 5.4 mm -147.75 128.9 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 106.975 -1.491 . . . . 3.9900000000000002 106.975 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -112.64 -17.83 12.51 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 120.95 -1.094 . . . . 5.1699999999999999 113.497 -177.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 20.1 t -157.36 160.52 38.55 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 119.108 -2.245 . . . . 0.02 110.265 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.441 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 16.0 p90 -151.8 152.83 33.17 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.075 -1.015 . . . . 2.02 110.937 179.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -145.31 149.78 35.45 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.832 0.825 . . . . 0.01 110.119 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -88.77 145.5 25.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.732 -0.605 . . . . 0.01 109.403 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.585 HD12 ' OG1' ' A' ' 135' ' ' THR . 6.1 mt -95.29 128.79 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.316 -0.865 . . . . 3.04 109.169 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 20.1 t -136.09 145.84 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.114 -0.991 . . . . 1.8899999999999999 109.47 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.273 -0.892 . . . . 4.8899999999999997 109.376 -179.978 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.555 -1.418 . . . . 0.01 109.555 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -145.55 135.4 23.54 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.233 -1.157 . . . . 0.02 110.436 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.6 tt -129.67 139.04 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.204 -1.036 . . . . 0.02 108.204 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.9 m -121.28 129.81 53.33 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.348 -0.845 . . . . 0.39000000000000001 110.141 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 8.0 m-85 -110.06 140.29 44.27 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.672 -0.862 . . . . 0.02 108.672 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.556 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.3 m-85 -122.04 138.6 54.38 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.202 -0.936 . . . . 0.02 109.538 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.489 ' HG3' HD11 ' A' ' 33' ' ' LEU . 87.5 mt-10 -69.02 -27.6 65.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.012 -1.055 . . . . 0.029999999999999999 111.44 -178.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -114.29 169.26 9.17 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.787 -1.196 . . . . 0.029999999999999999 110.161 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -75.68 158.84 31.81 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.736 0.779 . . . . 0.029999999999999999 110.207 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.7 t30 65.9 33.49 7.89 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.992 0.901 . . . . 0.73999999999999999 111.21 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 55.33 41.87 30.78 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.195 0.522 . . . . 0.02 111.341 178.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -113.6 166.08 11.88 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.232 -1.025 . . . . 0.02 108.232 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.73 -167.34 36.67 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.773 -1.203 . . . . 0.029999999999999999 110.783 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -69.06 141.6 54.74 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.613 -0.934 . . . . 2.7599999999999998 109.407 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -120.57 149.28 42.7 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.575 -0.703 . . . . 1.8899999999999999 110.165 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -132.69 127.67 35.3 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.271 -1.011 . . . . 0.02 108.271 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -112.85 137.3 51.4 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.479 -0.763 . . . . 1.1200000000000001 109.765 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.6 t -131.29 139.04 49.52 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.628 -0.67 . . . . 0.02 109.642 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.489 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 19.0 t70 -116.61 10.92 14.56 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.593 -0.692 . . . . 0.20000000000000001 109.925 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 40.4 m -158.24 174.34 15.31 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.245 -1.02 . . . . 1.23 108.245 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 11.9 p-10 -60.66 144.31 52.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.541 -1.349 . . . . 0.02 109.848 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.1 t -131.83 117.61 18.77 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.559 -0.904 . . . . 0.02 108.559 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.94 -25.06 48.05 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.239 -0.913 . . . . 0.23999999999999999 110.841 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -155.08 101.72 2.27 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.061 -1.024 . . . . 1.1399999999999999 109.021 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.401 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 24.0 p90 -105.25 9.56 33.96 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 122.157 0.98 . . . . 6.3700000000000001 109.84 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -58.5 -23.75 58.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.448 -0.782 . . . . 3.1099999999999999 110.873 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.8 m -74.55 -16.77 60.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.641 -1.287 . . . . 0.88 110.174 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -104.12 -21.98 13.49 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.499 -0.751 . . . . 0.02 109.6 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.489 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.8 tp -150.58 129.15 12.24 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.11 -0.994 . . . . 3.3199999999999998 109.157 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.7 m -85.38 -9.94 56.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.831 -0.543 . . . . 0.02 111.06 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -171.45 162.9 6.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.847 -1.158 . . . . 0.02 107.931 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.4 p -143.21 115.16 8.28 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.789 -1.194 . . . . 0.02 108.905 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -107.21 1.94 24.37 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.759 -1.213 . . . . 0.029999999999999999 110.875 -178.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.6 t -156.23 154.37 30.63 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.749 -1.204 . . . . 0.02 107.749 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.8 mt -146.66 147.61 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 120.959 -1.088 . . . . 0.02 110.362 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -124.58 125.06 43.55 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.083 -1.08 . . . . 0.02 108.083 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.8 t -106.87 115.12 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 107.147 -1.427 . . . . 0.02 107.147 177.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -83.52 -33.9 25.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.528 -0.732 . . . . 3.8100000000000001 110.906 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.15 152.35 22.11 Favored Glycine 0 N--CA 1.487 2.037 0 C-N-CA 118.919 -1.61 . . . . 0.02 110.937 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.45 173.13 49.5 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.577 -1.297 . . . . 0.01 110.418 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.5 m -119.23 134.97 54.91 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.827 -1.175 . . . . 1.48 107.827 178.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.425 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 35.0 m95 -126.8 155.22 43.21 Favored 'General case' 0 N--CA 1.504 2.234 0 CA-C-O 122.506 1.146 . . . . 0.02 112.08 -176.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.52 133.89 52.56 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 105.724 -1.954 . . . . 0.23999999999999999 105.724 176.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.521 ' HB ' HD22 ' A' ' 79' ' ' LEU . 26.8 m -118.09 142.92 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 109.009 -0.737 . . . . 0.65000000000000002 109.009 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -121.39 146.28 47.04 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 122.325 1.06 . . . . 0.02 110.155 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.497 ' OE2' ' ND2' ' A' ' 76' ' ' ASN . 7.6 tp10 -66.31 -35.08 79.46 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.548 -0.751 . . . . 0.02 111.185 -177.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 -125.44 157.77 66.78 Favored Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 121.126 -0.983 . . . . 0.02 109.529 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -53.61 167.17 1.03 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.761 1.641 . . . . 0.02 112.992 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 53' ' ' ASN . 1.1 t30 63.57 36.52 10.99 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.027 -0.988 . . . . 0.02 111.191 178.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 45.28 51.82 9.12 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.621 0.724 . . . . 3.3900000000000001 110.572 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 88.2 p -126.1 163.61 22.72 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 121.223 0.535 . . . . 2.3300000000000001 109.755 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.88 -161.92 32.32 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.708 -1.357 . . . . 0.02 109.708 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -66.7 139.23 57.83 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.015 -1.285 . . . . 0.02 110.281 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 14.3 ptm -118.64 137.98 52.91 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.598 -0.689 . . . . 5.0099999999999998 109.758 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.462 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 59.4 m-85 -133.25 137.84 46.23 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.506 -0.746 . . . . 0.02 109.836 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.7 mm -94.98 131.12 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.846 -0.798 . . . . 1.72 108.846 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.56 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.19 110.94 35.67 Favored Pre-proline 0 N--CA 1.505 2.297 0 O-C-N 121.452 -0.78 . . . . 0.02 110.748 -178.233 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -77.74 168.37 22.5 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 CA-C-N 119.958 1.021 . . . . 1.47 110.115 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.89 141.28 28.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.822 -1.174 . . . . 4.25 110.489 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.26 -177.81 32.26 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 119.535 -1.316 . . . . 0.02 110.567 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -119.41 131.13 55.6 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.527 -0.984 . . . . 0.95999999999999996 109.766 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.56 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 70.6 m-85 -122.05 96.26 46.79 Favored Pre-proline 0 N--CA 1.494 1.737 0 N-CA-C 108.162 -1.051 . . . . 0.02 108.162 178.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.401 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.6 Cg_endo -67.41 -3.77 10.66 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 120.77 0.98 . . . . 0.02 113.734 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.401 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 34.2 mt-10 -157.55 155.19 29.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.592 -1.317 . . . . 2.02 108.132 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -60.48 -38.92 85.8 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.622 -0.674 . . . . 0.02 112.11 -177.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -60.49 -23.83 64.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.042 -1.036 . . . . 0.02 110.366 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -69.46 -18.95 63.76 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.427 -0.796 . . . . 3.4199999999999999 108.992 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.553 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 1.1 t90 -108.3 11.09 27.49 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.403 -1.332 . . . . 0.02 107.403 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.5 mtt 60.88 22.21 12.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.47 -0.769 . . . . 0.02 110.215 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.11 145.11 46.6 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.169 -1.572 . . . . 0.02 109.169 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.551 HD23 ' O ' ' A' ' 75' ' ' LEU . 1.0 OUTLIER -79.62 -31.03 41.6 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.66 -1.237 . . . . 0.97999999999999998 107.66 178.114 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.702 ' H ' HD22 ' A' ' 76' ' ' ASN . 0.0 OUTLIER -157.16 -171.45 3.63 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 106.525 -1.657 . . . . 0.02 106.525 178.453 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -98.86 28.6 4.23 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.85 -1.156 . . . . 0.02 110.425 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -98.47 123.37 42.57 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.152 -0.967 . . . . 3.2000000000000002 111.183 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.521 HD22 ' HB ' ' A' ' 48' ' ' VAL . 36.1 mt -145.03 122.33 11.57 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.518 -1.29 . . . . 2.6099999999999999 107.518 177.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.99 -16.44 11.43 Favored Glycine 0 N--CA 1.504 3.173 0 O-C-N 121.132 -0.98 . . . . 0.02 112.695 -177.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.6 t -156.96 155.97 32.22 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.242 -1.74 . . . . 0.02 110.304 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.5 p -145.28 147.85 32.81 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.503 -0.748 . . . . 0.02 110.332 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.0 mtm180 -137.7 143.0 41.05 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.278 -0.889 . . . . 0.01 109.36 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.52 132.16 36.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.127 -0.983 . . . . 0.42999999999999999 109.76 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.4 t -91.06 125.03 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.782 -0.821 . . . . 1.25 108.782 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -94.6 131.18 40.63 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.82 -1.175 . . . . 1.77 109.16 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -94.87 139.62 31.06 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.196 -0.94 . . . . 1.6299999999999999 108.508 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.7 t -110.66 127.87 55.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.388 -0.82 . . . . 1.0800000000000001 109.108 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 95.5 p -104.52 -154.32 0.5 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 106.547 -1.649 . . . . 1.26 106.547 177.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.55 -53.1 0.74 Allowed Glycine 0 N--CA 1.5 2.9 0 O-C-N 120.553 -1.342 . . . . 0.01 112.762 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.46 -101.5 0.15 Allowed Glycine 0 N--CA 1.489 2.168 0 C-N-CA 118.603 -1.76 . . . . 0.01 111.978 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -122.39 119.56 31.4 Favored 'General case' 0 N--CA 1.506 2.343 0 CA-C-N 118.666 1.233 . . . . 4.4299999999999997 110.757 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.36 130.82 35.8 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.762 -0.775 . . . . 2.9900000000000002 109.483 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -129.62 141.85 50.86 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.377 -0.827 . . . . 6.3600000000000003 109.229 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.9 tt -128.3 144.73 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 O-C-N 121.35 -0.844 . . . . 1.0900000000000001 110.123 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -122.5 133.39 54.59 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.501 -1.296 . . . . 2.0499999999999998 107.501 177.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.9 m -124.56 146.36 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 O-C-N 120.628 -1.295 . . . . 1.1000000000000001 109.884 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -120.04 141.85 49.38 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 122.013 0.911 . . . . 0.72999999999999998 111.129 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -67.28 -30.82 70.8 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 116.03 -0.532 . . . . 0.02 111.908 -178.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -115.98 167.47 10.93 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.938 -1.101 . . . . 3.1800000000000002 110.384 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.15 164.26 44.28 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.974 -0.851 . . . . 0.01 110.974 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 57.08 38.77 29.33 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.701 0.762 . . . . 0.01 110.935 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 52.44 55.97 8.36 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.467 -0.77 . . . . 0.01 110.991 178.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -129.14 165.77 20.63 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.238 -1.023 . . . . 3.1499999999999999 108.238 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.57 -163.73 27.52 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.244 -1.542 . . . . 0.01 109.244 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -75.7 144.41 41.57 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.05 -1.265 . . . . 0.01 108.543 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.452 ' C ' ' SD ' ' A' ' 107' ' ' MET . 12.8 tmm? -116.56 142.33 47.02 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.623 0.725 . . . . 0.01 109.831 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -131.88 135.7 46.86 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.255 -1.017 . . . . 2.48 108.255 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.519 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.1 tm-20 -118.55 134.11 55.34 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.584 -0.698 . . . . 0.01 110.033 -178.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.519 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 6.0 t -148.17 150.74 34.34 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.278 1.037 . . . . 1.6899999999999999 111.072 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 72.9 p -110.85 9.68 22.47 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 115.498 -0.774 . . . . 0.01 110.227 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -120.86 162.74 19.31 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.234 -0.916 . . . . 3.21 111.563 -178.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -68.59 157.54 35.87 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.392 -0.966 . . . . 0.01 108.392 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 19.2 t -127.36 113.43 21.32 Favored Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 121.491 -0.756 . . . . 0.01 109.072 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -75.25 -28.09 9.06 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 CA-C-N 120.315 1.148 . . . . 0.01 111.02 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.8 t -142.38 109.08 5.38 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.363 -0.836 . . . . 0.02 109.088 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 98.0 mt -63.63 -39.31 84.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.824 -0.547 . . . . 1.8300000000000001 110.76 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 15.3 ttt -68.85 -38.16 79.6 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.246 -0.982 . . . . 1.3400000000000001 110.372 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -69.26 -38.48 78.43 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.528 -1.358 . . . . 2.1099999999999999 109.872 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -79.98 -47.02 15.62 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.219 -0.925 . . . . 2.0800000000000001 112.331 -177.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.443 ' C ' ' ND1' ' A' ' 122' ' ' HIS . 54.3 m-85 -110.94 0.23 17.01 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.251 -0.905 . . . . 0.02 112.653 -176.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.443 ' ND1' ' C ' ' A' ' 121' ' ' PHE . 5.3 m80 60.14 33.34 21.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.753 -1.217 . . . . 0.02 109.407 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.9 mt -112.46 135.36 53.25 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 108.791 -0.818 . . . . 0.02 108.791 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -91.47 -22.82 20.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.233 -0.917 . . . . 5.3200000000000003 110.174 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -149.29 164.1 35.8 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.216 -0.928 . . . . 0.02 109.899 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 31.9 mt -131.78 128.7 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 N-CA-C 107.854 -1.165 . . . . 2.1699999999999999 107.854 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -108.5 -12.88 14.94 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.286 -0.884 . . . . 0.02 112.256 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.5 m -159.4 150.75 20.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.992 -1.067 . . . . 0.01 108.937 178.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 24.9 p -168.95 147.63 3.98 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.356 -0.84 . . . . 1.22 108.782 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -121.3 111.39 17.29 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 122.542 1.163 . . . . 1.4099999999999999 109.845 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.47 129.78 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.472 -1.307 . . . . 0.01 107.472 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.7 t -129.52 93.57 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 107.328 -1.36 . . . . 1.98 107.328 177.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.488 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 11.0 tm-20 -147.41 -75.55 0.19 Allowed 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 105.914 -1.884 . . . . 0.01 105.914 177.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.438 ' N ' ' OE1' ' A' ' 133' ' ' GLU . . . 171.06 -71.81 0.11 Allowed Glycine 0 N--CA 1.483 1.813 0 N-CA-C 108.601 -1.8 . . . . 0.01 108.601 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.418 ' OG1' HD12 ' A' ' 175' ' ' ILE . 16.5 p -119.56 115.82 24.79 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.604 -0.939 . . . . 2.2999999999999998 110.24 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.488 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 6.4 m95 -126.33 149.71 49.0 Favored 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 106.677 -1.601 . . . . 0.01 106.677 178.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 81.3 mt -122.51 137.72 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 120.377 -1.452 . . . . 1.6899999999999999 110.586 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -114.48 143.95 44.12 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.221 -1.4 . . . . 2.4900000000000002 107.221 178.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.516 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 10.6 m-85 -123.18 143.87 49.73 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.241 -0.912 . . . . 0.02 109.521 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -74.32 -29.99 61.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.715 -0.616 . . . . 0.02 111.754 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.5 mt -116.76 153.97 49.33 Favored Pre-proline 0 N--CA 1.504 2.261 0 O-C-N 120.877 -1.14 . . . . 1.48 108.856 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.46 169.49 0.74 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.281 1.32 . . . . 0.02 113.122 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.448 HD22 ' NH2' ' A' ' 145' ' ' ARG . 53.4 m-20 57.61 32.31 21.66 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.046 -0.979 . . . . 0.75 111.511 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 55.83 48.36 18.31 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.551 -0.718 . . . . 0.02 110.908 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.448 ' NH2' HD22 ' A' ' 143' ' ' ASN . 82.9 mtm180 -122.6 163.92 19.14 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.505 -0.747 . . . . 0.02 109.914 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.23 -165.85 33.06 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.361 -1.096 . . . . 0.02 110.361 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.477 ' CZ ' ' OH ' ' A' ' 149' ' ' TYR . 17.9 ttp180 -69.26 142.71 54.08 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.523 -0.987 . . . . 0.02 109.244 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -114.62 148.36 38.23 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.368 0.604 . . . . 0.02 110.261 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.477 ' OH ' ' CZ ' ' A' ' 147' ' ' ARG . 67.4 m-85 -125.07 135.19 52.48 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.871 -0.788 . . . . 0.01 108.871 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.516 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.4 tt -99.73 122.18 42.34 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.919 -1.113 . . . . 0.01 109.12 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.642 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 32.9 tp -96.75 146.45 24.87 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.101 -1.0 . . . . 0.01 108.736 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -104.31 -130.65 0.27 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.422 -0.799 . . . . 2.27 110.215 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -133.78 52.0 2.1 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.398 -0.814 . . . . 1.8400000000000001 109.654 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -116.24 -169.52 1.63 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.463 -0.773 . . . . 2.2799999999999998 109.473 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -105.49 108.39 19.88 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.335 -0.987 . . . . 0.01 108.335 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.642 ' CZ ' HD11 ' A' ' 151' ' ' LEU . 6.0 m-85 -99.42 111.78 24.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.343 -0.848 . . . . 0.01 110.522 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -96.34 -22.03 17.44 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.294 -0.879 . . . . 0.01 111.412 -178.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -127.4 154.36 77.26 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 121.018 -1.051 . . . . 2.54 108.845 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -59.52 -38.76 80.92 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 CA-C-N 119.261 0.772 . . . . 0.69999999999999996 110.538 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 41.0 t -60.71 -20.18 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.901 -1.124 . . . . 0.85999999999999999 109.014 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -65.46 -15.67 62.87 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.91 -1.119 . . . . 0.02 110.022 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.628 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 10.0 m0 -98.11 10.96 39.22 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.148 -0.97 . . . . 0.02 108.842 178.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.42 11.39 84.24 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.839 -1.172 . . . . 0.02 111.079 178.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.23 140.63 34.19 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.137 -1.213 . . . . 0.02 110.191 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.18 -8.54 58.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.608 -0.682 . . . . 0.58999999999999997 110.271 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.8 t -143.42 150.38 51.19 Favored Pre-proline 0 N--CA 1.5 2.048 0 O-C-N 120.905 -1.122 . . . . 0.87 109.345 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -75.79 17.72 0.67 Allowed 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 120.771 0.98 . . . . 0.38 112.122 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.863 ' O ' HD13 ' A' ' 169' ' ' ILE . . . -82.84 122.89 28.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.883 -1.136 . . . . 0.17999999999999999 111.258 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.863 HD13 ' O ' ' A' ' 168' ' ' ALA . 4.6 mm -147.27 128.14 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 106.725 -1.583 . . . . 3.9900000000000002 106.725 178.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -111.22 -18.37 12.98 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.111 -0.993 . . . . 5.1699999999999999 113.115 -177.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 4.8 p -157.91 161.58 38.24 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 119.319 -2.113 . . . . 0.02 110.309 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.425 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 17.5 p90 -150.73 152.07 33.34 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.142 -0.974 . . . . 2.02 110.02 178.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -144.9 149.23 34.93 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.701 0.762 . . . . 0.01 109.758 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 18.4 ttm180 -87.9 144.06 26.78 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.67 -0.644 . . . . 0.01 109.503 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.418 HD12 ' OG1' ' A' ' 135' ' ' THR . 4.0 mt -94.27 128.84 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.249 -0.907 . . . . 3.04 109.045 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 25.6 m -136.34 146.79 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.061 -1.024 . . . . 1.8899999999999999 109.586 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.337 -0.852 . . . . 4.8899999999999997 109.438 -179.94 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.444 -1.462 . . . . 0.01 109.444 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -148.17 136.63 21.46 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.004 -1.292 . . . . 0.02 110.344 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.6 tt -130.73 140.86 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.906 -0.775 . . . . 0.02 108.906 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 m -121.42 130.4 53.56 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.499 -0.75 . . . . 0.39000000000000001 109.934 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.6 m-85 -109.92 138.88 45.67 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.496 -0.752 . . . . 0.02 109.224 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.534 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.5 m-85 -122.32 139.14 54.16 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.317 -0.865 . . . . 0.02 109.805 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -69.5 -28.3 65.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.139 -0.976 . . . . 0.029999999999999999 111.868 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -114.17 168.87 9.45 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.85 -1.156 . . . . 0.029999999999999999 110.18 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -74.94 158.52 33.17 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.683 0.754 . . . . 0.029999999999999999 109.938 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 66.52 33.52 6.63 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.953 0.882 . . . . 0.73999999999999999 111.217 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 55.56 42.51 29.58 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.241 0.543 . . . . 0.02 111.32 177.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -113.56 165.88 12.07 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.357 -0.979 . . . . 0.02 108.357 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.63 -167.5 35.26 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.825 -1.179 . . . . 0.029999999999999999 110.974 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -68.74 142.1 55.07 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.506 -0.997 . . . . 2.7599999999999998 109.314 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -121.59 149.9 42.47 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.551 -0.718 . . . . 1.8899999999999999 110.302 -178.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -134.72 129.28 34.47 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.662 -0.866 . . . . 0.02 108.662 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 15.9 p-10 -110.59 136.49 49.63 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.525 -0.734 . . . . 1.1200000000000001 109.156 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 14.2 t -129.33 137.88 51.25 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.483 0.659 . . . . 0.02 109.44 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -116.96 12.02 14.51 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.597 -0.689 . . . . 0.20000000000000001 109.753 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.444 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 42.3 t -159.44 174.24 15.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.052 -1.03 . . . . 1.23 108.559 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.419 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.4 p30 -61.03 144.16 53.95 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.715 -1.241 . . . . 0.02 110.006 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.8 t -131.85 116.96 17.89 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.576 -0.898 . . . . 0.02 108.576 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.53 -24.76 45.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.181 -0.95 . . . . 0.23999999999999999 111.31 -178.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -153.85 101.97 2.48 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.955 -1.09 . . . . 1.1399999999999999 109.113 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -104.5 9.31 35.55 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 122.148 0.975 . . . . 6.3700000000000001 109.839 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -58.99 -25.31 63.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.466 -0.771 . . . . 3.1099999999999999 111.17 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.0 p -74.28 -15.98 60.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.74 -1.225 . . . . 0.88 110.139 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -103.59 -21.81 13.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.46 -0.775 . . . . 0.02 109.741 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.5 mt -149.01 128.7 13.24 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.817 0.818 . . . . 3.3199999999999998 109.443 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 76.7 p -84.74 -9.71 57.94 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.322 0.582 . . . . 0.02 109.626 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -171.51 162.09 6.45 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.835 -1.172 . . . . 0.02 107.835 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.0 p -142.21 115.1 8.68 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.952 -1.093 . . . . 0.02 108.462 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.429 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 50.8 t-20 -106.92 -0.59 23.07 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 120.811 -1.181 . . . . 0.029999999999999999 111.649 -177.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 t -153.48 154.37 34.23 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.884 -1.154 . . . . 0.02 107.884 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 39' ' ' ILE . 10.5 mt -146.47 145.93 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.864 -1.147 . . . . 0.02 110.726 -178.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -124.97 125.73 44.36 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.044 -1.095 . . . . 0.02 108.044 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.0 t -104.93 113.71 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 106.727 -1.583 . . . . 0.02 106.727 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -84.92 -34.51 22.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.414 -0.804 . . . . 3.8100000000000001 110.266 -178.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.32 150.43 19.16 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 118.541 -1.79 . . . . 0.02 110.879 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.75 172.0 48.7 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.102 -1.199 . . . . 0.01 110.102 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.6 m -119.43 134.72 55.08 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.844 -1.169 . . . . 1.48 107.844 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.453 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 32.8 m95 -127.2 154.95 44.18 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 122.567 1.175 . . . . 0.02 112.339 -176.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.91 134.62 51.33 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 105.267 -2.123 . . . . 0.23999999999999999 105.267 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.436 ' HB ' HD22 ' A' ' 79' ' ' LEU . 35.2 m -116.5 141.42 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.589 -0.695 . . . . 0.65000000000000002 109.251 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -120.72 143.56 48.7 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 122.04 0.924 . . . . 0.02 109.655 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -65.51 -34.55 78.52 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.472 -0.786 . . . . 0.02 111.595 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -125.52 157.84 66.72 Favored Pre-proline 0 N--CA 1.504 2.229 0 O-C-N 120.985 -1.072 . . . . 0.02 109.45 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -53.71 167.54 0.98 Allowed 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.711 1.607 . . . . 0.02 112.992 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 63.22 36.59 11.82 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 115.191 -0.913 . . . . 0.02 111.136 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 45.03 51.92 8.58 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.671 0.748 . . . . 3.3900000000000001 110.674 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.9 t -125.94 163.66 22.5 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.183 0.516 . . . . 2.3300000000000001 109.811 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.99 -162.08 32.3 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.744 -1.342 . . . . 0.02 109.744 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -66.06 138.58 57.87 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.079 -1.248 . . . . 0.02 110.204 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 23.4 ptm -118.87 137.12 53.66 Favored 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.326 0.584 . . . . 5.0099999999999998 109.666 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.459 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 96.5 m-85 -134.04 139.33 45.93 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.484 -0.76 . . . . 0.02 109.735 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.3 mm -95.35 131.04 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 109.048 -0.723 . . . . 1.72 109.048 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.537 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -119.56 111.3 36.4 Favored Pre-proline 0 N--CA 1.506 2.329 0 O-C-N 121.417 -0.802 . . . . 0.02 110.732 -178.259 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -78.28 168.98 20.87 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 CA-C-N 119.859 0.985 . . . . 1.47 110.258 177.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -54.19 141.0 30.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.812 -1.18 . . . . 4.25 110.593 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.31 -177.67 32.38 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.548 -1.311 . . . . 0.02 110.604 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -119.95 131.67 55.27 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.534 -0.98 . . . . 0.95999999999999996 109.618 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.537 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 67.9 m-85 -120.4 95.86 49.04 Favored Pre-proline 0 N--CA 1.493 1.715 0 N-CA-C 108.144 -1.058 . . . . 0.02 108.144 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -68.29 -5.75 15.73 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 120.77 0.98 . . . . 0.02 113.394 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -156.74 154.08 29.43 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.653 -1.279 . . . . 2.02 107.705 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -60.04 -37.92 81.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.627 -0.671 . . . . 0.02 112.157 -177.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -59.8 -23.35 63.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.066 -1.021 . . . . 0.02 110.442 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -70.54 -19.21 62.91 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.822 0.82 . . . . 3.4199999999999999 109.053 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.543 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.8 t90 -108.01 9.84 28.41 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.672 -1.233 . . . . 0.02 107.672 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.2 mtt 61.14 22.57 12.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.588 -0.695 . . . . 0.02 110.622 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.67 143.89 46.4 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.526 -1.43 . . . . 0.02 109.526 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.2 mt -79.2 -30.86 43.55 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.525 -1.287 . . . . 0.97999999999999998 107.525 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.634 ' ND2' ' H ' ' A' ' 77' ' ' ASP . 18.0 t30 -157.33 -171.71 3.71 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 106.206 -1.775 . . . . 0.02 106.206 178.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.634 ' H ' ' ND2' ' A' ' 76' ' ' ASN . 72.0 m-20 -98.71 28.62 4.15 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.65 -1.281 . . . . 0.02 110.633 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.4 ttp180 -96.66 122.08 39.2 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.827 -1.171 . . . . 3.2000000000000002 111.107 -178.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.436 HD22 ' HB ' ' A' ' 48' ' ' VAL . 66.2 mt -142.91 121.83 12.76 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.473 -1.306 . . . . 2.6099999999999999 107.473 178.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.6 -17.21 9.37 Favored Glycine 0 N--CA 1.502 3.082 0 O-C-N 121.15 -0.969 . . . . 0.02 112.894 -177.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.0 t -156.36 156.13 33.37 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.019 -1.871 . . . . 0.02 110.761 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.2 p -145.24 147.33 32.28 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.395 -0.816 . . . . 0.02 110.609 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 33.9 mtp180 -137.74 143.19 41.06 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.568 -0.707 . . . . 0.01 109.208 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.36 132.48 36.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.42999999999999999 109.724 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.2 t -91.64 125.35 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.056 -0.72 . . . . 1.25 109.056 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -93.51 131.78 38.42 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.752 -1.217 . . . . 1.77 108.835 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.4 mt -98.15 141.62 30.84 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.369 -0.832 . . . . 1.6299999999999999 109.147 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.1 m -111.78 124.86 53.24 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.547 -0.909 . . . . 1.0800000000000001 108.547 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.4 t -116.57 134.02 55.33 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.686 -1.259 . . . . 1.26 108.173 177.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.66 -48.13 0.01 OUTLIER Glycine 0 N--CA 1.505 3.245 0 C-N-CA 117.677 -2.201 . . . . 0.01 114.077 -177.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -168.0 -105.45 0.18 Allowed Glycine 0 N--CA 1.491 2.364 0 CA-C-N 120.336 2.068 . . . . 0.01 111.29 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -120.01 117.98 29.46 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.998 -1.295 . . . . 4.4299999999999997 110.391 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.56 129.93 35.37 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.74 -0.784 . . . . 2.9900000000000002 109.291 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -129.22 140.84 51.32 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.46 -0.775 . . . . 6.3600000000000003 109.158 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.409 HG22 ' O ' ' A' ' 110' ' ' THR . 3.9 tt -128.49 144.55 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.35 0 O-C-N 121.306 -0.871 . . . . 1.0900000000000001 110.215 -179.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -122.81 133.59 54.44 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.562 -1.273 . . . . 2.0499999999999998 107.562 177.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.0 m -124.53 146.15 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 120.679 -1.263 . . . . 1.1000000000000001 109.788 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.581 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 77.5 m-85 -118.67 141.56 48.49 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-O 121.99 0.9 . . . . 0.72999999999999998 111.11 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -67.73 -30.9 70.5 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 116.012 -0.54 . . . . 0.02 111.829 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -116.54 167.43 11.07 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.023 -1.048 . . . . 3.1800000000000002 110.413 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.403 ' CA ' ' ND1' ' A' ' 127' ' ' HIS . . . -66.68 164.07 42.89 Favored Glycine 0 N--CA 1.493 2.447 0 CA-C-O 121.989 0.771 . . . . 0.01 111.309 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.0 t70 56.45 39.13 30.11 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.647 0.737 . . . . 0.01 110.965 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 52.24 55.14 9.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.69 -0.631 . . . . 0.01 110.985 177.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -129.09 165.19 21.72 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.047 -1.094 . . . . 3.1499999999999999 108.047 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.53 -163.93 27.7 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.27 -1.532 . . . . 0.01 109.27 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -75.96 144.11 41.17 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.928 -1.336 . . . . 0.01 108.782 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.581 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 25.3 ttp -116.52 142.36 46.98 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.473 0.654 . . . . 0.01 109.928 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -131.12 136.34 48.28 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.231 -1.026 . . . . 2.48 108.231 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -117.74 134.15 55.2 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.666 -0.646 . . . . 0.01 110.127 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.409 ' O ' HG22 ' A' ' 95' ' ' ILE . 6.5 t -148.98 149.11 30.62 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.025 -1.047 . . . . 1.6899999999999999 111.087 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 37.4 p -111.04 9.64 22.09 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 115.505 -0.77 . . . . 0.01 110.349 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -120.82 163.12 18.65 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 121.234 -0.916 . . . . 3.21 111.56 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.69 156.92 35.78 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.318 -0.993 . . . . 0.01 108.318 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 20.6 t -127.55 113.8 21.03 Favored Pre-proline 0 N--CA 1.498 1.973 0 N-CA-C 108.846 -0.798 . . . . 0.01 108.846 178.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -75.01 -27.7 9.78 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 CA-C-N 120.389 1.175 . . . . 0.01 110.911 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.2 t -143.05 109.01 5.18 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.336 -0.853 . . . . 0.02 109.137 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.424 HD12 ' O ' ' A' ' 169' ' ' ILE . 87.1 mt -63.45 -39.24 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.892 -0.505 . . . . 1.8300000000000001 110.547 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 118' ' ' MET . 0.7 OUTLIER -68.73 -37.27 79.32 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.277 -0.969 . . . . 1.3400000000000001 110.365 -178.308 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -69.8 -38.66 76.72 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.4 -1.437 . . . . 2.1099999999999999 109.974 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -79.71 -46.54 16.89 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.291 -0.881 . . . . 2.0800000000000001 112.264 -177.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -111.05 0.49 16.95 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.312 -0.867 . . . . 0.02 112.674 -176.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 59.95 33.53 21.48 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.737 -1.227 . . . . 0.02 109.442 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.2 mt -112.62 135.38 53.41 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 108.713 -0.847 . . . . 0.02 108.713 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -91.25 -22.86 20.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.144 -0.972 . . . . 5.3200000000000003 110.246 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -149.62 164.33 35.46 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.241 -0.912 . . . . 0.02 109.791 -178.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.7 mt -131.74 128.64 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 107.65 -1.241 . . . . 2.1699999999999999 107.65 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.524 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 51.4 t-80 -107.97 -12.85 15.08 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.421 -0.799 . . . . 0.02 112.107 -177.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.4 m -159.15 150.62 20.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.004 -1.06 . . . . 0.01 109.018 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 6.0 p -169.39 148.45 3.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.39 -0.818 . . . . 1.22 109.045 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -122.96 113.4 19.03 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 122.396 1.093 . . . . 1.4099999999999999 110.102 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 t -112.09 129.86 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 107.351 -1.352 . . . . 0.01 107.351 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 96.3 t -129.61 93.9 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 107.392 -1.336 . . . . 1.98 107.392 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.504 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 3.5 tm-20 -146.97 -78.48 0.17 Allowed 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 105.87 -1.9 . . . . 0.01 105.87 177.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 173.24 -69.49 0.1 Allowed Glycine 0 N--CA 1.484 1.882 0 N-CA-C 108.77 -1.732 . . . . 0.01 108.77 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.9 p -120.51 114.04 21.19 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.587 -0.949 . . . . 2.2999999999999998 110.387 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.504 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 6.5 m95 -124.94 148.8 48.18 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 107.303 -1.369 . . . . 0.01 107.303 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.8 mt -121.58 136.46 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 120.452 -1.405 . . . . 1.6899999999999999 110.184 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -115.32 144.35 43.89 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.69 -1.226 . . . . 2.4900000000000002 107.69 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 8.9 m-85 -123.45 144.04 49.77 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.324 -0.86 . . . . 0.02 109.648 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -75.9 -28.95 58.28 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.698 -0.626 . . . . 0.02 111.881 -176.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 47.3 mt -114.64 151.37 45.25 Favored Pre-proline 0 N--CA 1.504 2.267 0 O-C-N 120.712 -1.242 . . . . 1.48 109.014 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -53.6 167.36 0.97 Allowed 'Trans proline' 0 N--CA 1.49 1.275 0 CA-C-O 122.555 0.981 . . . . 0.02 112.543 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.6 m120 59.51 30.45 20.11 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 115.023 -0.99 . . . . 0.75 111.268 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.428 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.7 m-85 57.8 51.3 9.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.429 -0.794 . . . . 0.02 111.236 177.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -126.24 164.25 21.39 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.498 -0.751 . . . . 0.02 109.993 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.23 -165.25 32.64 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.352 -1.099 . . . . 0.02 110.352 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.465 ' CZ ' ' OH ' ' A' ' 149' ' ' TYR . 16.6 ttp180 -69.19 142.29 54.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.685 -0.891 . . . . 0.02 109.122 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -114.58 148.42 38.06 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.343 0.592 . . . . 0.02 110.134 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.465 ' OH ' ' CZ ' ' A' ' 147' ' ' ARG . 80.9 m-85 -124.07 134.3 53.43 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 109.019 -0.734 . . . . 0.01 109.019 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 151' ' ' LEU . 4.1 tt -98.51 121.55 40.59 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.852 -1.155 . . . . 0.01 108.86 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.596 HD11 ' CE1' ' A' ' 156' ' ' TYR . 42.5 tp -97.3 142.45 29.17 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.212 -0.93 . . . . 0.01 108.67 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -107.13 -113.3 0.28 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.612 -0.68 . . . . 2.27 109.662 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -149.04 57.28 1.02 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.129 -0.982 . . . . 1.8400000000000001 109.212 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -118.11 -179.31 3.73 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.386 -0.821 . . . . 2.2799999999999998 109.091 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -106.49 107.41 18.4 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.63 -0.878 . . . . 0.01 108.63 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.596 ' CE1' HD11 ' A' ' 151' ' ' LEU . 30.9 m-85 -98.78 113.44 25.55 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.29 -0.881 . . . . 0.01 110.328 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -93.51 -24.66 17.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.0 -1.062 . . . . 0.01 110.445 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -129.08 154.51 80.45 Favored Pre-proline 0 N--CA 1.498 1.974 0 N-CA-C 107.969 -1.123 . . . . 2.54 107.969 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -58.09 -38.62 90.87 Favored 'Trans proline' 0 N--CA 1.489 1.214 0 CA-C-N 119.467 0.845 . . . . 0.69999999999999996 110.245 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.2 t -63.77 -24.71 36.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.825 -1.172 . . . . 0.85999999999999999 109.586 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.06 -18.14 65.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.592 -1.317 . . . . 0.02 109.938 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.569 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 12.4 t90 -100.18 9.03 43.4 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.789 -1.189 . . . . 0.02 107.789 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.09 10.12 86.43 Favored Glycine 0 N--CA 1.485 1.96 0 C-N-CA 120.229 -0.986 . . . . 0.02 111.244 178.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.63 140.98 33.03 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.073 -1.251 . . . . 0.02 110.207 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -87.23 -11.85 48.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.627 -0.671 . . . . 0.58999999999999997 110.733 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 43.5 m -147.83 149.85 34.44 Favored Pre-proline 0 N--CA 1.499 1.994 0 O-C-N 120.547 -1.345 . . . . 0.87 108.895 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -78.1 22.86 0.6 Allowed 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 120.879 1.052 . . . . 0.38 112.872 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.854 ' O ' HD13 ' A' ' 169' ' ' ILE . . . -83.61 124.32 30.68 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.708 -1.245 . . . . 0.17999999999999999 111.784 -177.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.854 HD13 ' O ' ' A' ' 168' ' ' ALA . 4.8 mm -147.83 129.52 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 106.908 -1.516 . . . . 3.9900000000000002 106.908 178.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -112.58 -18.38 12.4 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 120.998 -1.064 . . . . 5.1699999999999999 113.475 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.4 p -157.21 161.0 39.26 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 119.36 -2.088 . . . . 0.02 110.117 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.418 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 19.8 p90 -152.27 152.4 32.12 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.051 -1.03 . . . . 2.02 110.809 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.428 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 26.0 mtp180 -144.49 149.92 36.75 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.38 -0.825 . . . . 0.01 110.155 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 60.4 mtm180 -87.76 144.1 26.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.535 -0.728 . . . . 0.01 109.363 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.2 mt -94.82 128.57 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.282 -0.886 . . . . 3.04 109.149 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.1 t -136.44 146.68 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.254 -0.903 . . . . 1.8899999999999999 109.65 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 4.8899999999999997 109.476 179.935 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.287 -1.525 . . . . 0.01 109.287 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -148.55 136.94 21.25 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.124 -1.221 . . . . 0.02 110.376 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 tt -130.66 140.55 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 109.073 -0.714 . . . . 0.02 109.073 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.1 m -121.78 130.82 53.69 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.4 -0.812 . . . . 0.39000000000000001 109.979 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.4 m-85 -110.6 140.54 44.82 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.624 -0.673 . . . . 0.02 109.38 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.516 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 5.1 m-85 -122.8 139.17 54.29 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.223 -0.923 . . . . 0.02 109.646 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.474 ' CG ' HD11 ' A' ' 33' ' ' LEU . 38.5 mt-10 -69.75 -27.77 65.21 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.167 -0.958 . . . . 0.029999999999999999 112.097 -178.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 2.9 m-20 -114.24 169.44 9.03 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.887 -1.133 . . . . 0.029999999999999999 110.225 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -75.04 157.81 34.22 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.69 0.757 . . . . 0.029999999999999999 109.982 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.2 t30 66.54 33.47 6.63 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.918 0.866 . . . . 0.73999999999999999 111.158 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 55.58 41.91 30.15 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.249 0.547 . . . . 0.02 111.413 177.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -112.86 165.75 12.02 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.244 -1.021 . . . . 0.02 108.244 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.48 -167.84 34.29 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.85 -1.167 . . . . 0.029999999999999999 110.677 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.579 ' CG ' HH11 ' A' ' 18' ' ' ARG . 0.3 OUTLIER -70.11 144.02 52.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.419 -1.047 . . . . 2.7599999999999998 108.999 179.453 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -120.2 148.63 43.43 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.559 -0.713 . . . . 1.8899999999999999 110.219 -178.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -131.99 127.31 35.99 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.221 -1.029 . . . . 0.02 108.221 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.46 136.9 51.4 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.42 -0.8 . . . . 1.1200000000000001 109.779 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.408 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 13.2 t -130.94 138.73 49.88 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.446 0.641 . . . . 0.02 109.654 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.3 p30 -116.77 11.23 14.48 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.631 -0.668 . . . . 0.20000000000000001 109.77 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.408 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 28.2 p -158.74 174.91 14.3 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.348 -0.982 . . . . 1.23 108.348 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -60.94 143.88 54.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.665 -1.272 . . . . 0.02 109.832 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 43.5 t -131.28 117.48 19.02 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.51 -0.922 . . . . 0.02 108.51 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.437 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -78.07 -25.08 47.52 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.045 -1.035 . . . . 0.23999999999999999 110.989 -178.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -155.1 102.38 2.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.025 -1.047 . . . . 1.1399999999999999 109.256 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -102.65 10.08 38.89 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 122.017 0.913 . . . . 6.3700000000000001 109.753 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -59.68 -25.41 64.73 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.532 -0.73 . . . . 3.1099999999999999 111.582 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.2 m -76.24 -17.15 59.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.522 -1.361 . . . . 0.88 110.609 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -104.06 -21.91 13.52 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.387 -0.82 . . . . 0.02 109.457 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.474 HD11 ' CG ' ' A' ' 11' ' ' GLU . 10.5 tp -149.92 128.56 12.36 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.328 -0.858 . . . . 3.3199999999999998 109.159 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.7 p -85.71 -10.96 54.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.642 -0.661 . . . . 0.02 111.069 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -171.72 162.3 6.23 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.927 -1.138 . . . . 0.02 107.927 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.2 p -141.48 113.95 8.24 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.987 -1.07 . . . . 0.02 108.452 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.17 0.17 27.1 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.767 -1.208 . . . . 0.029999999999999999 110.964 -178.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 m -154.44 155.65 35.34 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.669 -1.234 . . . . 0.02 107.669 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.5 mt -146.24 145.51 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.795 -1.19 . . . . 0.02 110.928 -178.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -124.09 124.84 43.4 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.874 -1.158 . . . . 0.02 107.874 177.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.6 t -105.16 114.03 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 106.745 -1.576 . . . . 0.02 106.745 177.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -84.7 -34.74 22.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.559 -0.713 . . . . 3.8100000000000001 110.101 -178.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.01 150.54 19.55 Favored Glycine 0 N--CA 1.488 2.128 0 C-N-CA 118.514 -1.803 . . . . 0.02 110.722 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.19 172.15 48.84 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 120.027 -1.082 . . . . 0.01 110.563 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.9 m -119.42 135.03 54.93 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 107.711 -1.218 . . . . 1.48 107.711 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.448 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 32.7 m95 -127.49 155.0 44.44 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 122.584 1.183 . . . . 0.02 112.462 -176.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.99 134.51 51.54 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 105.545 -2.02 . . . . 0.23999999999999999 105.545 176.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.475 ' HB ' HD22 ' A' ' 79' ' ' LEU . 28.7 m -119.03 143.63 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.585 -0.697 . . . . 0.65000000000000002 109.158 178.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -120.84 146.05 46.96 Favored 'General case' 0 N--CA 1.503 2.204 0 CA-C-O 122.143 0.973 . . . . 0.02 109.949 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -67.35 -34.59 77.62 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.839 -0.619 . . . . 0.02 111.392 -177.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -125.17 157.91 65.51 Favored Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 121.047 -1.033 . . . . 0.02 109.379 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -53.84 166.4 1.45 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 121.63 1.553 . . . . 0.02 113.242 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 63.9 36.66 10.05 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.218 -0.901 . . . . 0.02 111.116 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 45.36 51.68 9.35 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.667 0.746 . . . . 3.3900000000000001 110.633 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.7 m -126.11 163.64 22.66 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.13 0.491 . . . . 2.3300000000000001 109.714 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.8 -161.82 32.35 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.803 -1.319 . . . . 0.02 109.803 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -66.16 140.1 58.18 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.081 -1.247 . . . . 0.02 110.314 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.452 ' C ' ' SD ' ' A' ' 58' ' ' MET . 10.4 tmm? -119.37 136.81 54.1 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.76 -0.588 . . . . 5.0099999999999998 109.639 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.447 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 97.9 m-85 -133.98 138.35 45.37 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.393 -0.817 . . . . 0.02 109.935 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.3 mm -96.23 132.17 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 109.205 -0.665 . . . . 1.72 109.205 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.448 HD22 ' CE1' ' A' ' 66' ' ' TYR . 10.1 mt -120.35 111.6 34.96 Favored Pre-proline 0 N--CA 1.505 2.288 0 O-C-N 121.413 -0.804 . . . . 0.02 110.897 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -77.72 169.72 20.32 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 CA-C-N 119.79 0.961 . . . . 1.47 110.042 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -53.14 140.89 24.57 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.745 -1.222 . . . . 4.25 110.458 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.96 -178.05 31.88 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.505 -1.331 . . . . 0.02 110.746 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -120.47 131.76 54.9 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.454 -1.027 . . . . 0.95999999999999996 109.822 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.448 ' CE1' HD22 ' A' ' 61' ' ' LEU . 81.9 m-85 -121.11 94.98 48.91 Favored Pre-proline 0 N--CA 1.494 1.725 0 N-CA-C 108.094 -1.076 . . . . 0.02 108.094 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.402 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 3.4 Cg_exo -66.11 -4.65 10.71 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 120.829 1.019 . . . . 0.02 113.641 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 77.7 mt-10 -157.64 155.27 29.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.818 -1.176 . . . . 2.02 108.306 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -61.21 -38.53 86.92 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.371 -0.831 . . . . 0.02 112.08 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -59.95 -23.44 63.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.971 -1.081 . . . . 0.02 110.191 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -70.55 -19.38 62.89 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.706 0.765 . . . . 3.4199999999999999 109.09 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.542 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 1.6 t90 -108.37 9.08 27.82 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.627 -1.249 . . . . 0.02 107.627 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 10.3 mtt 60.94 22.22 12.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.649 -0.657 . . . . 0.02 110.53 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.65 143.44 44.76 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.494 -1.443 . . . . 0.02 109.494 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 26.8 tp -78.96 -31.64 45.1 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.387 -1.338 . . . . 0.97999999999999998 107.387 177.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -157.87 -172.31 3.88 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 106.191 -1.781 . . . . 0.02 106.191 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -98.67 28.46 4.24 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.591 -1.318 . . . . 0.02 110.805 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 -96.94 122.05 39.49 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.779 -1.201 . . . . 3.2000000000000002 110.997 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.475 HD22 ' HB ' ' A' ' 48' ' ' VAL . 63.9 mt -144.03 122.19 12.2 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 107.627 -1.249 . . . . 2.6099999999999999 107.627 178.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.55 -16.41 11.0 Favored Glycine 0 N--CA 1.504 3.211 0 O-C-N 121.279 -0.888 . . . . 0.02 112.741 -177.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 23.5 m -156.69 156.32 33.23 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.245 -1.738 . . . . 0.02 110.445 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 25.1 t -144.03 146.89 33.17 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.574 -0.704 . . . . 0.02 110.027 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -138.47 143.6 39.69 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.174 -0.954 . . . . 0.01 109.691 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.86 132.78 36.18 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.282 -0.886 . . . . 0.42999999999999999 110.001 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.6 t -92.18 126.14 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 109.363 -0.606 . . . . 1.25 109.363 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -94.48 130.92 40.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.741 -1.224 . . . . 1.77 109.379 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.7 mt -97.7 142.69 29.18 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.384 -0.823 . . . . 1.6299999999999999 109.07 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 51.7 p -113.33 126.41 55.35 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.331 -0.855 . . . . 1.0800000000000001 109.422 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 90' ' ' GLY . 54.5 m -108.15 9.33 28.24 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 106.766 -1.568 . . . . 1.26 106.766 176.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 89' ' ' SER . . . -26.35 -49.83 0.05 OUTLIER Glycine 0 N--CA 1.495 2.583 0 CA-C-N 115.54 -0.755 . . . . 0.01 112.528 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.76 -105.89 0.19 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 118.724 -1.703 . . . . 0.01 111.737 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.428 ' C ' ' NE2' ' A' ' 92' ' ' GLN . 0.8 OUTLIER -122.07 120.47 34.4 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.125 -1.221 . . . . 4.4299999999999997 110.434 -178.317 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.48 129.28 34.41 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.893 -0.723 . . . . 2.9900000000000002 109.637 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -130.57 143.02 50.48 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 108.605 -0.887 . . . . 6.3600000000000003 108.605 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.405 ' C ' ' NE2' ' A' ' 96' ' ' GLN . 4.7 tt -129.35 145.22 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 121.151 -0.968 . . . . 1.0900000000000001 110.708 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.629 ' N ' ' NE2' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -122.93 133.26 54.4 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 107.599 -1.26 . . . . 2.0499999999999998 107.599 177.296 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.48 HG12 ' SG ' ' A' ' 129' ' ' CYS . 17.5 m -124.26 146.2 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 O-C-N 120.658 -1.276 . . . . 1.1000000000000001 109.826 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.584 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 71.7 m-85 -118.83 141.09 48.96 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.939 0.876 . . . . 0.72999999999999998 110.862 -178.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -66.09 -30.13 70.59 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 116.09 -0.504 . . . . 0.02 111.572 -178.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -117.3 170.88 8.35 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.024 -1.047 . . . . 3.1800000000000002 110.247 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.41 169.88 43.21 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.862 -0.895 . . . . 0.01 110.862 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 52.92 38.95 28.3 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.501 0.667 . . . . 0.01 111.663 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 52.25 48.93 21.64 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.495 -0.753 . . . . 0.01 111.022 178.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -123.42 165.95 16.19 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.311 -0.996 . . . . 3.1499999999999999 108.311 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.02 -164.36 28.58 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.538 -1.425 . . . . 0.01 109.538 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -76.38 144.97 39.73 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.942 -1.328 . . . . 0.01 108.569 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.584 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 28.3 ttp -117.09 142.65 46.72 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.637 0.732 . . . . 0.01 110.028 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -131.15 137.07 48.85 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.067 -1.086 . . . . 2.48 108.067 178.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -118.3 133.76 55.61 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.611 -0.681 . . . . 0.01 110.153 -178.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.4 ' O ' HG22 ' A' ' 95' ' ' ILE . 5.2 t -148.6 148.61 30.33 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.284 1.04 . . . . 1.6899999999999999 111.061 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 31.2 p -111.38 9.7 21.51 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 115.435 -0.802 . . . . 0.01 110.26 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -121.2 163.01 19.17 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.204 -0.935 . . . . 3.21 111.479 -178.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.05 156.27 37.75 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.645 -0.872 . . . . 0.01 108.645 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 23.9 t -127.7 114.15 20.82 Favored Pre-proline 0 N--CA 1.5 2.032 0 N-CA-C 108.795 -0.817 . . . . 0.01 108.795 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -74.59 -29.0 9.45 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 CA-C-N 120.364 1.166 . . . . 0.01 111.07 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 65.3 m -142.58 108.94 5.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.41 -0.806 . . . . 0.02 108.954 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.41 HD12 ' O ' ' A' ' 169' ' ' ILE . 92.1 mt -63.54 -38.64 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.936 -0.477 . . . . 1.8300000000000001 110.674 -178.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 118' ' ' MET . 12.2 tmm? -68.32 -37.23 80.35 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.31 -0.956 . . . . 1.3400000000000001 110.048 -178.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -69.54 -38.54 77.52 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.578 -1.326 . . . . 2.1099999999999999 110.074 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.452 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 50.5 tt0 -79.82 -46.84 16.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.279 -0.888 . . . . 2.0800000000000001 112.333 -177.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.452 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 32.5 m-85 -111.0 0.01 16.83 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.379 -0.826 . . . . 0.02 112.712 -176.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 59.93 33.44 21.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.774 -1.204 . . . . 0.02 109.433 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 11.0 mt -112.52 135.81 52.78 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 108.77 -0.826 . . . . 0.02 108.77 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -91.8 -22.68 20.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.198 -0.939 . . . . 5.3200000000000003 110.361 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -149.64 164.08 36.15 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.169 -0.957 . . . . 0.02 109.981 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.2 mt -132.1 128.92 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 107.751 -1.203 . . . . 2.1699999999999999 107.751 178.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -108.54 -11.91 15.06 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.343 -0.848 . . . . 0.02 112.278 -177.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.4 m -159.1 151.73 21.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.948 -1.095 . . . . 0.01 108.765 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.48 ' SG ' HG12 ' A' ' 97' ' ' VAL . 8.2 t -165.38 149.01 8.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.107 -0.996 . . . . 1.22 109.157 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.415 ' O ' ' OE1' ' A' ' 96' ' ' GLN . 7.2 ttpt -119.49 108.24 14.28 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 122.339 1.066 . . . . 1.4099999999999999 109.28 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.2 t -113.52 127.15 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.555 -1.276 . . . . 0.01 107.555 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.9 t -131.42 94.18 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 107.632 -1.247 . . . . 1.98 107.632 177.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.642 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 26.7 tt0 -147.46 -77.2 0.17 Allowed 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 105.772 -1.936 . . . . 0.01 105.772 177.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 170.64 -63.59 0.17 Allowed Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.737 -1.745 . . . . 0.01 108.737 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.8 p -123.33 113.2 18.54 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.497 -1.002 . . . . 2.2999999999999998 110.846 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.642 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 9.8 m95 -126.07 147.15 49.65 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 107.335 -1.358 . . . . 0.01 107.335 178.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.5 mt -121.86 136.2 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 O-C-N 120.568 -1.332 . . . . 1.6899999999999999 110.248 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -116.17 145.28 43.21 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.339 -1.356 . . . . 2.4900000000000002 107.339 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.5 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 15.2 m-85 -123.21 143.75 49.83 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.311 -0.868 . . . . 0.02 109.722 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -74.59 -29.31 61.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.523 -0.735 . . . . 0.02 111.74 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.4 mt -115.78 154.9 48.16 Favored Pre-proline 0 N--CA 1.503 2.212 0 O-C-N 120.697 -1.252 . . . . 1.48 109.054 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -56.06 166.9 2.75 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 121.123 1.215 . . . . 0.02 112.802 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.2 m120 59.79 31.24 20.69 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.043 -0.98 . . . . 0.75 111.437 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.446 ' HD1' ' HG ' ' A' ' 171' ' ' SER . 1.9 m-85 57.68 51.62 9.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.513 -0.742 . . . . 0.02 111.141 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 41.2 mtm180 -127.1 164.91 20.55 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.531 -0.73 . . . . 0.02 110.241 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.74 -165.67 33.64 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.538 -1.025 . . . . 0.02 110.538 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -69.25 142.33 54.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.539 -0.977 . . . . 0.02 108.98 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -113.64 148.33 36.47 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.834 -0.541 . . . . 0.02 110.344 -178.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -124.23 133.56 53.49 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 108.853 -0.795 . . . . 0.01 108.853 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.477 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.2 tt -100.22 122.47 43.08 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.06 -1.025 . . . . 0.01 109.231 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.477 ' N ' HD23 ' A' ' 150' ' ' LEU . 2.6 mp -98.12 147.03 24.98 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.235 -1.024 . . . . 0.01 108.235 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -105.06 -121.08 0.22 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.627 -0.671 . . . . 2.27 110.009 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -139.28 53.32 1.73 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.229 -0.919 . . . . 1.8400000000000001 109.401 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -116.38 -172.35 2.17 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.406 -0.809 . . . . 2.2799999999999998 109.195 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -105.55 109.51 21.51 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.39 -0.967 . . . . 0.01 108.39 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.606 ' CG ' ' NE1' ' A' ' 162' ' ' TRP . 35.9 m-85 -98.58 111.36 23.75 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.239 -0.913 . . . . 0.01 110.575 -178.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -95.65 -22.22 17.71 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.21 -0.931 . . . . 0.01 111.298 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 39.6 mttp -127.51 154.59 77.49 Favored Pre-proline 0 N--CA 1.502 2.153 0 O-C-N 121.142 -0.974 . . . . 2.54 108.656 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -59.59 -39.05 78.27 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 120.423 0.748 . . . . 0.69999999999999996 110.596 178.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.99 -20.08 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.895 -1.128 . . . . 0.85999999999999999 109.079 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -65.33 -15.48 62.59 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.946 -1.096 . . . . 0.02 110.134 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.606 ' NE1' ' CG ' ' A' ' 156' ' ' TYR . 9.6 m0 -97.55 11.85 35.47 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.245 -0.909 . . . . 0.02 108.94 178.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.14 10.07 85.92 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.767 -1.206 . . . . 0.02 111.089 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.03 141.08 32.23 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.193 -1.181 . . . . 0.02 110.073 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.12 -8.95 58.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.654 -0.654 . . . . 0.58999999999999997 109.797 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.3 p -143.59 150.74 51.88 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 121.044 -1.035 . . . . 0.87 108.924 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -76.04 18.74 0.63 Allowed 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 120.704 0.936 . . . . 0.38 112.3 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.859 ' O ' HD13 ' A' ' 169' ' ' ILE . . . -83.07 122.24 28.09 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.824 -1.173 . . . . 0.17999999999999999 111.321 -178.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.859 HD13 ' O ' ' A' ' 168' ' ' ALA . 4.1 mm -146.54 126.82 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 106.521 -1.659 . . . . 3.9900000000000002 106.521 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -112.16 -18.09 12.65 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.955 -1.091 . . . . 5.1699999999999999 113.405 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . 0.446 ' HG ' ' HD1' ' A' ' 144' ' ' TYR . 1.6 p -157.49 160.67 38.49 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 119.196 -2.19 . . . . 0.02 110.179 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.411 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 21.0 p90 -151.45 152.26 32.78 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.069 -1.019 . . . . 2.02 110.481 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -145.26 150.67 37.09 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.857 0.837 . . . . 0.01 110.393 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -89.11 145.24 25.58 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.138 -0.69 . . . . 0.01 109.138 178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 175' ' ' ILE . 5.1 mt -95.85 129.81 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.399 -0.813 . . . . 3.04 108.89 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 25.4 m -137.76 147.63 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.088 -1.007 . . . . 1.8899999999999999 109.912 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.371 -0.831 . . . . 4.8899999999999997 109.366 179.479 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.706 -1.357 . . . . 0.01 109.706 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -144.13 133.57 23.32 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.226 -1.161 . . . . 0.02 110.538 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.4 tt -129.45 139.41 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.11 -1.07 . . . . 0.02 108.11 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.1 m -120.99 129.14 53.29 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.291 -0.88 . . . . 0.39000000000000001 110.103 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 9.1 m-85 -109.8 140.19 44.01 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.641 -0.874 . . . . 0.02 108.641 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.554 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.8 m-85 -121.9 138.09 54.53 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.334 -0.854 . . . . 0.02 109.446 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -68.69 -27.14 65.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -0.943 . . . . 0.029999999999999999 111.389 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.0 OUTLIER -114.56 170.12 8.55 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.992 -1.068 . . . . 0.029999999999999999 109.958 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -75.98 161.87 28.56 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.633 0.73 . . . . 0.029999999999999999 110.4 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 62.9 33.02 15.39 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.025 0.917 . . . . 0.73999999999999999 110.916 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 55.46 40.32 31.25 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.858 -0.61 . . . . 0.02 111.05 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -110.62 165.22 11.99 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.188 -1.041 . . . . 0.02 108.188 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.25 -167.91 34.67 Favored Glycine 0 N--CA 1.497 2.708 0 O-C-N 120.907 -1.12 . . . . 0.029999999999999999 110.911 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.433 ' HG3' HH11 ' A' ' 18' ' ' ARG . 13.4 ttm-85 -69.95 143.46 52.65 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.471 -1.017 . . . . 2.7599999999999998 109.316 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.1 ttp180 -122.03 149.98 42.74 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.38 -0.825 . . . . 1.8899999999999999 110.431 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.49 ' CZ ' ' CG ' ' A' ' 32' ' ' TYR . 9.4 t80 -135.14 131.35 36.73 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.811 -0.811 . . . . 0.02 108.811 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -111.7 137.08 50.08 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.458 -0.776 . . . . 1.1200000000000001 109.463 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 40.2 t -129.35 138.75 51.73 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 121.41 0.624 . . . . 0.02 109.629 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -117.7 11.9 13.8 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.545 -0.722 . . . . 0.20000000000000001 110.245 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.483 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 42.5 t -159.17 174.24 15.15 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.916 -1.115 . . . . 1.23 108.757 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.473 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 17.6 p30 -61.74 145.14 53.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.613 -1.304 . . . . 0.02 110.219 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.423 ' CB ' ' CZ ' ' A' ' 29' ' ' PHE . 0.6 OUTLIER -134.35 119.12 18.25 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.543 -0.91 . . . . 0.02 108.543 178.59 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.62 -19.73 57.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.557 -0.715 . . . . 0.23999999999999999 111.672 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -154.28 108.72 3.03 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.923 -1.111 . . . . 1.1399999999999999 111.005 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.423 ' CZ ' ' CB ' ' A' ' 26' ' ' CYS . 22.2 m-85 -96.01 5.88 50.16 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.283 -0.886 . . . . 6.3700000000000001 109.283 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -60.63 -30.7 70.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.282 -0.886 . . . . 3.1099999999999999 112.246 -176.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.5 m -78.72 -19.07 53.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.271 -1.518 . . . . 0.88 111.55 -178.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.49 ' CG ' ' CZ ' ' A' ' 20' ' ' TYR . 65.2 m-85 -107.06 -21.83 12.86 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.266 -0.896 . . . . 0.02 110.819 -178.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.415 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 6.1 tp -149.16 127.63 12.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.895 -1.128 . . . . 3.3199999999999998 109.793 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.9 m -86.56 -11.77 50.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.53 -0.731 . . . . 0.02 111.127 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.415 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 4.8 ptp180 -171.68 161.95 6.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.933 -1.105 . . . . 0.02 108.24 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -142.65 115.75 8.87 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.909 -1.119 . . . . 0.02 108.887 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -109.49 0.32 19.2 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.85 -1.156 . . . . 0.029999999999999999 111.458 -178.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.3 m -156.8 153.81 28.9 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.385 -0.969 . . . . 0.02 108.385 178.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.0 mt -146.2 147.16 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-O 122.325 1.06 . . . . 0.02 111.176 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -122.59 123.66 41.71 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.738 -1.208 . . . . 0.02 107.738 176.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.3 t -106.8 115.2 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 106.902 -1.518 . . . . 0.02 106.902 177.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -83.31 -33.85 25.85 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 120.068 -0.653 . . . . 3.8100000000000001 111.024 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.97 152.36 22.19 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 118.878 -1.63 . . . . 0.02 110.854 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.653 ' H ' ' NE2' ' A' ' 63' ' ' GLN . . . 83.59 173.24 49.59 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.66 -1.257 . . . . 0.01 110.418 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 65.6 m -119.6 135.16 54.92 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.033 -1.099 . . . . 1.48 108.033 178.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -127.31 155.98 42.68 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 122.639 1.209 . . . . 0.02 112.172 -176.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.51 134.57 51.73 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 105.527 -2.027 . . . . 0.23999999999999999 105.527 176.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.6 m -116.31 142.01 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.549 -0.719 . . . . 0.65000000000000002 109.306 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -120.53 143.32 48.64 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 122.056 0.931 . . . . 0.02 109.508 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.504 ' OE1' ' CE1' ' A' ' 57' ' ' HIS . 36.9 tt0 -65.67 -33.37 75.73 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.671 -0.695 . . . . 0.02 111.712 -177.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 35.8 mtm180 -124.85 157.8 65.0 Favored Pre-proline 0 N--CA 1.503 2.194 0 O-C-N 120.991 -1.068 . . . . 0.02 109.368 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -53.31 167.36 0.83 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.753 1.635 . . . . 0.02 112.634 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 63.02 36.2 12.58 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 115.254 -0.885 . . . . 0.02 111.273 178.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.509 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 5.5 m-85 45.28 51.11 9.53 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.707 0.765 . . . . 3.3900000000000001 110.706 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.8 m -125.54 163.57 22.41 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 121.2 0.524 . . . . 2.3300000000000001 109.802 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.44 -161.67 31.39 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.844 -1.302 . . . . 0.02 109.844 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.504 ' CE1' ' OE1' ' A' ' 50' ' ' GLU . 10.1 m80 -65.13 137.84 57.9 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.11 -1.229 . . . . 0.02 110.219 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.496 ' O ' ' SD ' ' A' ' 58' ' ' MET . 2.8 ppp? -118.68 137.49 53.28 Favored 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 121.357 0.599 . . . . 5.0099999999999998 109.553 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.473 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 81.6 m-85 -135.44 140.48 44.92 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.503 -0.748 . . . . 0.02 109.61 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.9 mm -95.19 131.05 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.607 -0.683 . . . . 1.72 109.164 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.531 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 1.0 OUTLIER -121.09 111.39 33.95 Favored Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 121.284 -0.885 . . . . 0.02 110.743 -178.284 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -77.27 169.02 22.07 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 CA-C-N 119.898 0.999 . . . . 1.47 110.371 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.653 ' NE2' ' H ' ' A' ' 44' ' ' GLY . 71.0 mt-30 -53.39 141.73 23.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.96 -1.087 . . . . 4.25 110.369 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.81 -177.7 31.96 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.523 -1.322 . . . . 0.02 110.755 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -120.21 131.56 55.02 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.464 -1.021 . . . . 0.95999999999999996 109.661 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.531 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 59.5 m-85 -122.41 97.62 44.75 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 108.022 -1.103 . . . . 0.02 108.022 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.404 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 3.4 Cg_endo -68.77 -3.26 10.94 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 120.745 0.963 . . . . 0.02 113.898 -178.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 79.2 mt-10 -157.64 155.2 29.65 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.433 -1.417 . . . . 2.02 108.281 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -60.69 -39.1 87.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.63 -0.669 . . . . 0.02 112.108 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -60.28 -23.47 64.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.058 -1.026 . . . . 0.02 110.32 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -69.82 -18.75 63.47 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.88 -0.785 . . . . 3.4199999999999999 108.88 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.589 ' CH2' HD21 ' A' ' 79' ' ' LEU . 1.7 t90 -107.95 10.95 28.29 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.464 -1.31 . . . . 0.02 107.464 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.3 mtt 61.21 22.49 12.82 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.476 0.655 . . . . 0.02 110.409 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.72 144.29 48.07 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.574 -1.41 . . . . 0.02 109.574 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.429 ' N ' HD12 ' A' ' 75' ' ' LEU . 9.3 mp -79.78 -29.95 40.52 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.708 -1.219 . . . . 0.97999999999999998 107.708 177.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -156.83 -171.17 3.56 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 106.342 -1.725 . . . . 0.02 106.342 178.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 23.0 p-10 -98.91 28.72 4.18 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.697 -1.252 . . . . 0.02 110.526 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -96.49 122.33 39.27 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.796 -1.19 . . . . 3.2000000000000002 111.057 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.589 HD21 ' CH2' ' A' ' 72' ' ' TRP . 78.1 mt -141.92 119.83 11.97 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.609 -1.256 . . . . 2.6099999999999999 107.609 178.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.51 -18.54 8.47 Favored Glycine 0 N--CA 1.499 2.853 0 O-C-N 121.245 -0.909 . . . . 0.02 112.809 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.509 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 12.6 t -156.0 156.48 34.54 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-N 120.324 2.062 . . . . 0.02 111.13 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 11.9 t -146.45 148.78 32.61 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.342 -0.849 . . . . 0.02 110.723 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.425 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 52.1 mtp180 -138.16 143.13 40.13 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.509 -0.745 . . . . 0.01 109.345 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.19 132.46 36.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.102 -0.998 . . . . 0.42999999999999999 109.938 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.9 t -91.12 125.01 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.571 -0.706 . . . . 1.25 109.139 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -93.97 131.89 38.97 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.877 -1.139 . . . . 1.77 109.079 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 mt -96.66 139.45 32.71 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.54 -0.911 . . . . 1.6299999999999999 108.54 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.1 p -111.8 127.88 55.94 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.362 -0.836 . . . . 1.0800000000000001 109.312 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.7 m -104.39 -153.97 0.49 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 106.492 -1.669 . . . . 1.26 106.492 176.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.33 -53.15 0.72 Allowed Glycine 0 N--CA 1.5 2.928 0 O-C-N 120.386 -1.446 . . . . 0.01 112.818 177.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.16 -101.65 0.16 Allowed Glycine 0 N--CA 1.491 2.337 0 C-N-CA 118.476 -1.821 . . . . 0.01 111.844 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -121.25 118.91 30.77 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.043 -1.269 . . . . 4.4299999999999997 110.569 -178.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.0 129.62 34.65 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.79 -0.764 . . . . 2.9900000000000002 109.349 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.449 ' CB ' ' NZ ' ' A' ' 94' ' ' LYS . 6.8 ttpm? -129.15 141.95 51.02 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.334 -0.854 . . . . 6.3600000000000003 109.09 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.3 tt -128.64 144.92 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 O-C-N 121.352 -0.842 . . . . 1.0900000000000001 110.237 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -122.67 134.02 54.49 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.911 -1.144 . . . . 2.0499999999999998 107.911 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.469 HG12 ' SG ' ' A' ' 129' ' ' CYS . 29.1 m -123.78 145.05 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 120.823 -1.173 . . . . 1.1000000000000001 110.051 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.572 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 47.5 m-85 -119.92 142.16 48.97 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-O 121.996 0.903 . . . . 0.72999999999999998 111.098 -178.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -67.53 -31.84 72.21 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 116.06 -0.518 . . . . 0.02 111.745 -178.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -115.62 167.44 10.9 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 120.811 -1.181 . . . . 3.1800000000000002 110.593 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.15 163.69 45.01 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.833 -0.907 . . . . 0.01 110.833 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 57.6 38.93 27.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.913 -0.757 . . . . 0.01 110.99 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 52.57 55.92 8.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.696 -0.627 . . . . 0.01 111.184 178.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -128.45 165.87 19.84 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.266 -1.013 . . . . 3.1499999999999999 108.266 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.17 -163.39 27.81 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.234 -1.547 . . . . 0.01 109.234 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 38.4 tp60 -76.29 144.5 40.23 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.965 -1.315 . . . . 0.01 108.656 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.572 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 29.5 ttp -116.68 141.8 47.73 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.638 0.733 . . . . 0.01 109.812 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -131.57 136.3 47.7 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.328 -0.99 . . . . 2.48 108.328 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.521 ' OE2' ' N ' ' A' ' 110' ' ' THR . 1.9 tm-20 -118.12 133.9 55.49 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.559 -0.713 . . . . 0.01 109.997 -178.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.521 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 6.2 t -148.09 148.89 31.14 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.106 -0.996 . . . . 1.6899999999999999 110.969 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 33.3 p -110.78 10.17 22.61 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 115.551 -0.75 . . . . 0.01 110.365 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -120.92 163.16 18.65 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.28 -0.888 . . . . 3.21 111.571 -178.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.06 156.67 36.9 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.255 -1.017 . . . . 0.01 108.255 178.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 19.8 t -125.92 112.53 24.53 Favored Pre-proline 0 N--CA 1.502 2.138 0 O-C-N 121.456 -0.778 . . . . 0.01 108.944 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -75.41 -31.63 5.56 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 120.133 1.083 . . . . 0.01 111.102 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 16.5 m -141.05 107.95 5.41 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.287 -0.883 . . . . 0.02 108.798 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.9 mt -63.36 -39.19 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.949 -0.469 . . . . 1.8300000000000001 110.74 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 118' ' ' MET . 1.7 tmt? -67.81 -37.18 81.64 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.416 -0.914 . . . . 1.3400000000000001 110.46 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -71.09 -39.26 72.23 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 120.464 -1.397 . . . . 2.1099999999999999 110.243 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -79.56 -46.7 16.83 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.239 -0.913 . . . . 2.0800000000000001 112.358 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -109.67 -0.11 18.74 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.34 -0.85 . . . . 0.02 112.531 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 58.85 32.03 21.84 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.687 -1.258 . . . . 0.02 108.865 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.7 mt -111.47 135.3 52.22 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.656 -0.868 . . . . 0.02 108.656 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -92.09 -23.4 19.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.158 -0.964 . . . . 5.3200000000000003 110.031 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -149.76 163.41 38.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.231 -0.918 . . . . 0.02 109.839 -178.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 45.6 mt -133.31 130.32 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 107.493 -1.299 . . . . 2.1699999999999999 107.493 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -107.83 -11.76 15.32 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.301 -0.875 . . . . 0.02 112.787 -177.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.9 m -158.98 152.7 23.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.734 -1.229 . . . . 0.01 108.82 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.469 ' SG ' HG12 ' A' ' 97' ' ' VAL . 9.2 t -167.65 147.67 5.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.121 -0.987 . . . . 1.22 109.123 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.442 ' NZ ' ' OE2' ' A' ' 155' ' ' GLU . 4.8 tptm -121.0 111.09 17.04 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 122.346 1.069 . . . . 1.4099999999999999 109.717 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.2 t -112.23 128.7 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.603 -1.258 . . . . 0.01 107.603 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.2 t -129.81 94.02 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 106.922 -1.51 . . . . 1.98 106.922 177.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -146.84 -78.57 0.17 Allowed 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 105.824 -1.917 . . . . 0.01 105.824 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 178.51 -75.14 0.07 OUTLIER Glycine 0 N--CA 1.485 1.951 0 N-CA-C 108.144 -1.982 . . . . 0.01 108.144 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.712 ' OG1' HD12 ' A' ' 175' ' ' ILE . 0.1 OUTLIER -121.22 120.55 35.51 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.654 -0.909 . . . . 2.2999999999999998 110.12 179.371 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -126.42 151.0 48.29 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 106.77 -1.567 . . . . 0.01 106.77 179.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 59.1 mt -121.41 135.13 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 120.552 -1.343 . . . . 1.6899999999999999 110.495 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.46 ' HB3' HD12 ' A' ' 169' ' ' ILE . 3.8 m-30 -111.03 142.73 42.79 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 106.269 -1.752 . . . . 2.4900000000000002 106.269 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -122.76 143.49 49.79 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.014 -1.054 . . . . 0.02 109.763 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -74.66 -29.66 61.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.409 -0.807 . . . . 0.02 111.869 -176.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.4 mt -116.1 155.04 48.55 Favored Pre-proline 0 N--CA 1.506 2.372 0 O-C-N 120.793 -1.192 . . . . 1.48 108.983 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -55.92 167.36 2.37 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.116 1.211 . . . . 0.02 112.843 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.448 ' ND2' ' N ' ' A' ' 143' ' ' ASN . 2.2 m120 59.31 30.44 20.16 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.035 -0.984 . . . . 0.75 111.211 178.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 58.06 51.43 8.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.484 -0.76 . . . . 0.02 111.055 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -125.97 164.88 19.84 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.546 -0.721 . . . . 0.02 109.863 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.432 ' O ' ' OE1' ' A' ' 148' ' ' GLN . . . 88.79 -166.06 33.84 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.093 -1.203 . . . . 0.02 110.093 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -69.25 142.62 54.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.55 -0.971 . . . . 0.02 108.97 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.474 ' CD ' ' N ' ' A' ' 148' ' ' GLN . 0.1 OUTLIER -114.58 148.38 38.12 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.315 0.579 . . . . 0.02 110.155 -178.155 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 149' ' ' TYR . 13.1 m-85 -124.48 135.32 53.12 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.66 -0.867 . . . . 0.01 108.66 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.458 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.5 tt -98.33 122.44 41.5 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.872 -1.143 . . . . 0.01 109.253 -178.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.3 mp -96.43 146.86 24.4 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.294 -0.879 . . . . 0.01 109.043 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -104.68 -124.71 0.22 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.348 -0.845 . . . . 2.27 109.418 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -146.49 47.7 1.19 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.177 -0.952 . . . . 1.8400000000000001 109.514 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -112.73 -161.26 0.75 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.543 -0.723 . . . . 2.2799999999999998 109.168 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.442 ' OE2' ' NZ ' ' A' ' 130' ' ' LYS . 4.1 mm-40 -107.02 104.72 14.45 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.579 -0.701 . . . . 0.01 109.154 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.609 ' CD2' ' CD1' ' A' ' 162' ' ' TRP . 55.3 m-85 -98.15 111.27 23.66 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.249 -0.907 . . . . 0.01 109.448 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -94.39 -22.51 18.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.042 -1.036 . . . . 0.01 111.268 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -127.59 154.42 77.62 Favored Pre-proline 0 N--CA 1.503 2.177 0 O-C-N 120.977 -1.077 . . . . 2.54 108.548 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -59.71 -36.83 90.67 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 CA-C-N 119.148 0.731 . . . . 0.69999999999999996 110.265 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 92.0 t -61.68 -19.78 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.975 -1.078 . . . . 0.85999999999999999 109.094 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -65.57 -15.78 63.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.963 -1.086 . . . . 0.02 110.267 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.609 ' CD1' ' CD2' ' A' ' 156' ' ' TYR . 6.1 m0 -98.6 11.75 37.44 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.175 -0.953 . . . . 0.02 108.986 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.67 10.37 85.27 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 119.861 -1.161 . . . . 0.02 111.207 178.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.63 141.09 32.88 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.179 -1.189 . . . . 0.02 110.072 -178.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.27 -9.32 57.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.627 -0.671 . . . . 0.58999999999999997 110.062 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 39.8 m -143.94 150.09 48.31 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 120.921 -1.112 . . . . 0.87 109.098 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -76.41 18.43 0.69 Allowed 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 120.876 1.05 . . . . 0.38 112.512 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.75 123.45 28.77 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.794 -1.192 . . . . 0.17999999999999999 111.698 -177.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.46 HD12 ' HB3' ' A' ' 138' ' ' PHE . 29.2 mm -148.52 127.96 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 106.77 -1.567 . . . . 3.9900000000000002 106.77 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -112.31 -15.93 13.06 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.137 -0.977 . . . . 5.1699999999999999 112.525 -178.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 22.9 t -157.89 160.67 37.9 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 119.459 -2.026 . . . . 0.02 109.858 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.422 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 18.0 p90 -151.12 152.93 34.08 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.18 -0.95 . . . . 2.02 110.113 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -145.0 150.26 36.59 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.192 -0.942 . . . . 0.01 110.408 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -88.81 144.8 25.99 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.925 -0.768 . . . . 0.01 108.925 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.712 HD12 ' OG1' ' A' ' 135' ' ' THR . 4.9 mt -96.22 130.13 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.354 -0.841 . . . . 3.04 109.398 178.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 24.7 t -136.13 146.77 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.315 -0.866 . . . . 1.8899999999999999 109.671 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.181 -0.949 . . . . 4.8899999999999997 109.454 179.953 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.521 -1.432 . . . . 0.01 109.521 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.497 ' HZ1' HH21 ' A' ' 40' ' ' ARG . 26.0 ttpp -145.95 135.55 23.22 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.296 -1.12 . . . . 0.02 110.373 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.4 tt -129.63 139.1 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.02 -1.104 . . . . 0.02 108.02 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 m -120.61 129.25 53.66 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.35 -0.844 . . . . 0.39000000000000001 110.316 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.437 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.9 m-85 -110.76 140.78 44.86 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.852 -0.795 . . . . 0.02 108.852 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.557 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.9 m-85 -122.57 138.61 54.52 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.294 -0.879 . . . . 0.02 109.425 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -68.91 -27.21 65.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.121 -0.987 . . . . 0.029999999999999999 111.597 -178.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.3 m-20 -114.43 169.85 8.74 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.944 -1.098 . . . . 0.029999999999999999 109.995 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -75.02 161.91 29.04 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.617 0.722 . . . . 0.029999999999999999 110.262 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.592 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 11.4 t-20 62.45 35.11 14.97 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.892 0.853 . . . . 0.73999999999999999 110.634 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.592 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.7 p90 49.27 43.16 22.8 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.478 -0.783 . . . . 0.02 110.94 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -109.62 165.91 11.31 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.676 -1.231 . . . . 0.02 107.676 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.7 -167.71 35.35 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 119.707 -1.235 . . . . 0.029999999999999999 110.752 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.583 ' CG ' HH11 ' A' ' 18' ' ' ARG . 0.2 OUTLIER -69.62 143.28 53.3 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.408 -1.054 . . . . 2.7599999999999998 109.059 179.368 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -122.59 150.7 42.27 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.499 -0.75 . . . . 1.8899999999999999 110.244 -178.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.472 ' CE1' ' CE1' ' A' ' 29' ' ' PHE . 34.4 t80 -136.34 133.11 36.48 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.689 -0.632 . . . . 0.02 109.678 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 20.6 p-10 -110.74 136.63 49.52 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.389 -0.819 . . . . 1.1200000000000001 109.309 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 42.2 t -128.73 138.65 52.24 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.631 -0.668 . . . . 0.02 109.422 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.434 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 0.9 OUTLIER -118.93 11.4 12.53 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.477 -0.765 . . . . 0.20000000000000001 110.877 -179.406 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.491 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 8.0 p -159.31 173.84 15.68 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.644 -1.285 . . . . 1.23 109.305 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 22.8 p30 -62.13 145.22 53.97 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.684 -1.26 . . . . 0.02 110.361 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.553 ' CB ' ' CE2' ' A' ' 29' ' ' PHE . 51.2 t -134.49 118.44 17.34 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.529 -0.732 . . . . 0.02 109.046 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.81 -20.67 56.12 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.494 -0.754 . . . . 0.23999999999999999 111.515 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -155.45 104.78 2.41 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.851 -1.155 . . . . 1.1399999999999999 109.417 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.553 ' CE2' ' CB ' ' A' ' 26' ' ' CYS . 0.4 OUTLIER -101.82 9.03 41.11 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.321 -0.862 . . . . 6.3700000000000001 109.934 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -60.32 -27.18 67.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.391 -0.818 . . . . 3.1099999999999999 111.83 -177.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.3 t -77.89 -18.07 56.58 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.477 -1.389 . . . . 0.88 111.391 -178.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.551 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 8.3 m-85 -106.64 -21.08 13.16 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.306 -0.871 . . . . 0.02 110.561 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.9 tp -148.66 127.16 12.35 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.95 -1.094 . . . . 3.3199999999999998 109.472 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.3 t -87.53 -12.55 45.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.629 -0.669 . . . . 0.02 111.388 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -172.5 161.95 5.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.743 -1.223 . . . . 0.02 108.47 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.458 ' SG ' HD12 ' A' ' 79' ' ' LEU . 2.3 p -143.45 115.74 8.49 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.069 -1.02 . . . . 0.02 108.877 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.492 ' N ' HD22 ' A' ' 37' ' ' ASN . 1.5 m-80 -107.8 -0.41 21.65 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.812 -1.18 . . . . 0.029999999999999999 111.007 -178.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.3 m -155.08 153.58 31.11 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.829 -1.175 . . . . 0.02 107.829 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.7 mt -146.83 147.14 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 122.205 1.002 . . . . 0.02 110.778 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.497 HH21 ' HZ1' ' A' ' 6' ' ' LYS . 35.3 ttp180 -124.03 124.73 43.19 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.181 -1.044 . . . . 0.02 108.181 177.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.8 t -106.68 115.27 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 106.876 -1.527 . . . . 0.02 106.876 177.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.4 ' HG3' ' HZ2' ' A' ' 6' ' ' LYS . 18.2 mm-40 -83.88 -33.81 24.72 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.565 -0.709 . . . . 3.8100000000000001 110.952 -177.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.13 152.64 22.57 Favored Glycine 0 N--CA 1.49 2.272 0 C-N-CA 118.811 -1.661 . . . . 0.02 110.877 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.45 172.98 49.39 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.688 -1.244 . . . . 0.01 110.468 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.1 m -119.85 134.94 55.07 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 107.97 -1.122 . . . . 1.48 107.97 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.42 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 35.3 m95 -127.46 156.11 42.63 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 122.595 1.188 . . . . 0.02 112.212 -176.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.83 134.39 52.1 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 105.613 -1.995 . . . . 0.23999999999999999 105.613 176.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.462 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.7 m -117.09 142.6 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.53 -0.731 . . . . 0.65000000000000002 109.14 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -120.68 143.57 48.65 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 122.093 0.949 . . . . 0.02 109.66 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -65.05 -33.7 76.67 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.584 -0.735 . . . . 0.02 111.534 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -125.3 157.95 65.73 Favored Pre-proline 0 N--CA 1.503 2.21 0 O-C-N 121.029 -1.044 . . . . 0.02 109.425 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -53.49 167.36 0.92 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.688 1.592 . . . . 0.02 112.916 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.532 ' ND2' ' N ' ' A' ' 53' ' ' ASN . 0.9 OUTLIER 63.36 36.31 11.66 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.232 -0.895 . . . . 0.02 111.134 178.19 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.414 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 4.9 m-85 44.92 51.65 8.51 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.614 0.721 . . . . 3.3900000000000001 110.77 178.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.9 t -125.8 163.6 22.53 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.186 0.517 . . . . 2.3300000000000001 109.846 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.33 -161.86 31.67 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.892 -1.283 . . . . 0.02 109.892 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.4 ' CD2' ' H ' ' A' ' 57' ' ' HIS . 21.9 m-70 -65.54 139.03 58.43 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.038 -1.272 . . . . 0.02 110.245 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.495 ' O ' ' SD ' ' A' ' 58' ' ' MET . 2.6 ppp? -118.88 137.03 53.72 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.662 -0.649 . . . . 5.0099999999999998 109.802 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.452 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 90.8 m-85 -134.06 138.86 45.59 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.497 -0.752 . . . . 0.02 109.693 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.7 mm -95.76 131.17 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.123 -0.695 . . . . 1.72 109.123 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.489 HD22 ' CE1' ' A' ' 66' ' ' TYR . 9.3 mt -120.77 111.78 34.2 Favored Pre-proline 0 N--CA 1.506 2.335 0 O-C-N 121.41 -0.806 . . . . 0.02 110.929 -178.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -77.53 169.25 21.33 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 CA-C-N 119.868 0.989 . . . . 1.47 110.126 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -53.29 141.26 24.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.878 -1.139 . . . . 4.25 110.368 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.23 -177.94 32.16 Favored Glycine 0 N--CA 1.496 2.667 0 C-N-CA 119.54 -1.314 . . . . 0.02 110.825 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -120.25 131.7 55.04 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.433 -1.039 . . . . 0.95999999999999996 109.746 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.489 ' CE1' HD22 ' A' ' 61' ' ' LEU . 88.4 m-85 -121.08 95.82 48.65 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 108.041 -1.096 . . . . 0.02 108.041 178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -65.98 -4.7 10.62 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 120.761 0.974 . . . . 0.02 113.618 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -157.58 155.2 29.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.655 -1.278 . . . . 2.02 108.15 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -60.25 -38.6 83.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.576 -0.702 . . . . 0.02 112.029 -177.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -60.07 -23.42 63.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.142 -0.974 . . . . 0.02 110.293 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -70.79 -18.76 62.74 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.831 0.824 . . . . 3.4199999999999999 109.063 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.54 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 1.6 t90 -107.9 9.8 28.65 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.424 -1.324 . . . . 0.02 107.424 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.8 mtt 60.83 22.08 12.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.601 -0.687 . . . . 0.02 110.419 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.89 143.83 46.8 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.336 -1.506 . . . . 0.02 109.336 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.816 HD12 ' H ' ' A' ' 76' ' ' ASN . 0.2 OUTLIER -78.71 -28.88 45.14 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.609 -1.256 . . . . 0.97999999999999998 107.609 177.783 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.816 ' H ' HD12 ' A' ' 75' ' ' LEU . 65.6 m-80 -158.75 -171.69 3.52 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 106.286 -1.746 . . . . 0.02 106.286 178.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -98.53 29.01 3.85 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.642 -1.286 . . . . 0.02 110.472 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -97.86 122.77 41.37 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.974 -1.079 . . . . 3.2000000000000002 111.43 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.462 HD22 ' HB ' ' A' ' 48' ' ' VAL . 49.3 mt -142.28 119.53 11.5 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 107.232 -1.396 . . . . 2.6099999999999999 107.232 177.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.69 -18.6 9.94 Favored Glycine 0 N--CA 1.497 2.736 0 O-C-N 121.207 -0.933 . . . . 0.02 112.27 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.5 p -155.83 156.36 34.59 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 119.612 1.706 . . . . 0.02 110.839 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 20.5 p -146.14 148.47 32.62 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.453 -0.779 . . . . 0.02 110.529 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.414 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 50.5 mtp180 -138.55 143.12 39.3 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.473 -0.767 . . . . 0.01 109.327 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.28 132.16 36.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.128 -0.982 . . . . 0.42999999999999999 109.829 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.4 t -90.76 125.23 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.529 -0.732 . . . . 1.25 109.117 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -93.87 132.18 38.54 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.701 -1.249 . . . . 1.77 109.26 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.1 mt -97.31 139.96 32.49 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.805 -0.813 . . . . 1.6299999999999999 108.805 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.9 t -112.52 127.83 56.17 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.377 -0.827 . . . . 1.0800000000000001 109.465 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 77.8 p -104.26 -154.43 0.5 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 106.602 -1.629 . . . . 1.26 106.602 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 139.25 -52.53 0.72 Allowed Glycine 0 N--CA 1.501 3.003 0 O-C-N 120.356 -1.465 . . . . 0.01 113.111 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.8 -101.66 0.16 Allowed Glycine 0 N--CA 1.49 2.281 0 C-N-CA 118.413 -1.851 . . . . 0.01 112.095 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -121.35 119.17 31.37 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.133 -1.216 . . . . 4.4299999999999997 110.676 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.15 129.56 34.59 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.745 -0.782 . . . . 2.9900000000000002 109.403 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -129.76 143.09 50.64 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.383 -0.823 . . . . 6.3600000000000003 108.917 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.401 HG22 ' O ' ' A' ' 110' ' ' THR . 4.2 tt -128.84 145.0 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 O-C-N 121.292 -0.88 . . . . 1.0900000000000001 110.437 -178.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -122.25 134.08 54.69 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.58 -1.266 . . . . 2.0499999999999998 107.58 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.527 HG12 ' SG ' ' A' ' 129' ' ' CYS . 15.6 m -124.61 145.71 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 O-C-N 120.772 -1.205 . . . . 1.1000000000000001 109.914 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.587 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 64.4 m-85 -119.35 141.62 48.87 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 121.971 0.891 . . . . 0.72999999999999998 110.91 -178.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -67.23 -30.73 70.73 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 116.066 -0.515 . . . . 0.02 111.904 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.416 ' O ' ' OG ' ' A' ' 128' ' ' SER . 48.0 mttm -116.35 167.46 11.01 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.97 -1.082 . . . . 3.1800000000000002 110.492 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.52 164.02 42.37 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.899 -0.88 . . . . 0.01 110.899 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 56.77 38.85 29.77 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.628 0.727 . . . . 0.01 110.932 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 52.29 55.91 8.47 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.58 -0.7 . . . . 0.01 111.11 178.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -129.18 165.68 20.84 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.319 -0.993 . . . . 3.1499999999999999 108.319 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.23 -163.87 28.02 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.242 -1.543 . . . . 0.01 109.242 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -75.6 144.34 41.84 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.034 -1.274 . . . . 0.01 108.664 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.587 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 27.0 ttp -116.99 142.16 47.31 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.47 0.653 . . . . 0.01 109.859 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -131.72 136.61 47.76 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.127 -1.064 . . . . 2.48 108.127 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -117.96 134.3 55.09 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.495 -0.753 . . . . 0.01 110.08 -178.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.401 ' O ' HG22 ' A' ' 95' ' ' ILE . 7.5 t -148.45 149.42 31.67 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 122.276 1.036 . . . . 1.6899999999999999 111.119 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.5 p -110.51 10.25 23.16 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 115.45 -0.795 . . . . 0.01 110.304 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -121.36 163.45 18.65 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.155 -0.966 . . . . 3.21 111.826 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.5 156.64 36.17 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.142 -1.059 . . . . 0.01 108.142 178.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 21.9 t -126.51 113.17 23.04 Favored Pre-proline 0 N--CA 1.501 2.115 0 O-C-N 121.401 -0.812 . . . . 0.01 108.843 178.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -76.27 -31.21 4.82 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 CA-C-N 120.086 1.066 . . . . 0.01 111.516 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.6 m -141.42 108.05 5.35 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.264 -0.898 . . . . 0.02 109.006 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.88 -38.83 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.861 -0.524 . . . . 1.8300000000000001 110.876 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.1 ttt -68.16 -36.76 80.15 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.234 -0.986 . . . . 1.3400000000000001 110.384 -178.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -71.15 -39.08 72.14 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.421 -1.424 . . . . 2.1099999999999999 110.18 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -79.48 -47.41 15.67 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.236 -0.915 . . . . 2.0800000000000001 112.448 -176.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -110.25 0.85 18.28 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.405 -0.809 . . . . 0.02 112.517 -176.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.565 ' N ' ' ND1' ' A' ' 122' ' ' HIS . 1.2 m-70 59.11 32.36 22.07 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.815 -1.178 . . . . 0.02 109.269 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.3 mt -112.29 135.9 52.39 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 108.433 -0.951 . . . . 0.02 108.433 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -91.44 -22.73 20.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 5.3200000000000003 110.108 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -149.82 163.95 36.65 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.222 -0.924 . . . . 0.02 110.204 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 44.8 mt -132.21 129.34 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 107.434 -1.321 . . . . 2.1699999999999999 107.434 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -106.95 -12.08 15.54 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.318 -0.864 . . . . 0.02 112.457 -177.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 12.5 p -159.54 153.05 22.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.855 -1.153 . . . . 0.01 108.835 178.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.527 ' SG ' HG12 ' A' ' 97' ' ' VAL . 7.2 t -168.51 147.36 4.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.303 -0.873 . . . . 1.22 108.751 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.516 ' NZ ' ' OE1' ' A' ' 155' ' ' GLU . 26.1 tttp -121.1 111.64 17.7 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 122.422 1.106 . . . . 1.4099999999999999 109.561 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.3 t -112.52 129.06 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 107.352 -1.351 . . . . 0.01 107.352 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.2 t -129.48 92.93 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 107.267 -1.383 . . . . 1.98 107.267 177.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.514 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 4.1 tm-20 -147.85 -74.58 0.19 Allowed 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 105.683 -1.969 . . . . 0.01 105.683 177.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 157.55 -55.03 0.38 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.45 -1.46 . . . . 0.01 109.45 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 41.8 p -119.75 101.52 7.95 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.542 -0.975 . . . . 2.2999999999999998 111.446 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.514 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 11.4 m95 -129.51 144.54 51.3 Favored 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 107.516 -1.29 . . . . 0.01 107.516 178.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 97.6 mt -124.25 140.87 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 120.874 -1.141 . . . . 1.6899999999999999 110.486 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.409 ' HB3' HD12 ' A' ' 169' ' ' ILE . 72.5 m-85 -114.17 143.97 43.95 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.153 -1.425 . . . . 2.4900000000000002 107.153 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.498 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 11.8 m-85 -122.93 144.88 48.94 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.146 -0.971 . . . . 0.02 109.531 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -74.64 -29.53 61.3 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.532 -0.73 . . . . 0.02 111.97 -176.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.4 mt -115.82 154.79 48.2 Favored Pre-proline 0 N--CA 1.505 2.299 0 O-C-N 120.783 -1.198 . . . . 1.48 109.166 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -55.37 167.38 1.94 Allowed 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.219 1.279 . . . . 0.02 112.674 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 59.6 31.23 20.81 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.193 -0.912 . . . . 0.75 111.283 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 57.55 51.08 10.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.451 -0.781 . . . . 0.02 111.136 177.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -126.54 165.07 19.82 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.52 -0.737 . . . . 0.02 110.153 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.41 -166.21 33.06 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.285 -1.126 . . . . 0.02 110.285 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -68.68 142.59 55.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.606 -0.937 . . . . 0.02 108.898 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -114.53 148.95 37.19 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.336 0.588 . . . . 0.02 109.932 -178.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -124.48 134.65 52.98 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.824 -0.806 . . . . 0.01 108.824 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.1 tt -98.23 121.32 40.02 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.737 -1.227 . . . . 0.01 108.728 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.716 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 59.6 tp -95.47 155.28 16.81 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.247 -0.908 . . . . 0.01 109.171 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -105.46 -117.88 0.23 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.295 -0.878 . . . . 2.27 109.374 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -156.97 44.6 0.38 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.049 -1.032 . . . . 1.8400000000000001 109.671 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -112.35 -156.06 0.58 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.459 -0.776 . . . . 2.2799999999999998 109.289 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.516 ' OE1' ' NZ ' ' A' ' 130' ' ' LYS . 77.9 mm-40 -106.94 106.24 16.67 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.442 -0.786 . . . . 0.01 109.141 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.716 ' CZ ' HD11 ' A' ' 151' ' ' LEU . 5.2 m-85 -98.97 111.51 23.89 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.341 -0.849 . . . . 0.01 109.531 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -94.7 -22.29 18.22 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.184 -0.947 . . . . 0.01 111.566 -177.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -128.15 154.16 78.69 Favored Pre-proline 0 N--CA 1.503 2.176 0 O-C-N 120.875 -1.141 . . . . 2.54 108.708 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -59.4 -37.19 91.46 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 CA-C-N 119.286 0.781 . . . . 0.69999999999999996 110.64 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 85.3 t -61.25 -19.76 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.795 -1.191 . . . . 0.85999999999999999 109.146 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -65.32 -15.32 62.41 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.952 -1.093 . . . . 0.02 109.996 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.638 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 8.5 m0 -98.13 11.71 36.83 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.19 -0.944 . . . . 0.02 109.102 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 81.11 10.46 84.85 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.934 -1.127 . . . . 0.02 111.341 178.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.09 140.64 32.94 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.031 -1.276 . . . . 0.02 110.206 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.73 -9.54 56.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.608 -0.683 . . . . 0.58999999999999997 109.978 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.1 m -142.02 150.49 56.2 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.181 -0.949 . . . . 0.87 109.134 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -76.61 16.53 0.9 Allowed 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 120.741 0.96 . . . . 0.38 112.47 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.65 122.72 27.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.649 -1.282 . . . . 0.17999999999999999 111.198 -177.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.409 HD12 ' HB3' ' A' ' 138' ' ' PHE . 15.2 mm -151.81 126.39 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 106.595 -1.631 . . . . 3.9900000000000002 106.595 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 64.1 mm-40 -113.57 -12.9 12.82 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.081 -1.012 . . . . 5.1699999999999999 113.634 -177.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.0 p -157.6 162.05 38.71 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 119.083 -2.261 . . . . 0.02 110.235 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.426 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 16.9 p90 -151.97 151.98 31.89 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.132 -0.98 . . . . 2.02 110.633 179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -145.0 149.66 35.53 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.304 -0.872 . . . . 0.01 109.991 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -88.52 144.29 26.43 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.512 -0.742 . . . . 0.01 109.439 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.4 mt -93.67 129.55 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.233 -0.917 . . . . 3.04 109.092 178.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 14.5 t -137.1 147.4 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.248 -0.907 . . . . 1.8899999999999999 109.676 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.35 -0.844 . . . . 4.8899999999999997 109.39 179.815 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 109.416 -1.474 . . . . 0.01 109.416 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -146.18 135.18 22.58 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.363 -1.081 . . . . 0.02 110.603 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.3 tt -129.44 139.6 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.108 -1.071 . . . . 0.02 108.108 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 m -120.45 129.55 53.93 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.326 -0.859 . . . . 0.39000000000000001 110.208 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 6.2 m-85 -110.34 139.89 45.08 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 109.026 -0.731 . . . . 0.02 109.026 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.561 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.2 m-85 -121.28 137.99 54.44 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.135 -0.978 . . . . 0.02 109.299 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -69.71 -27.59 65.11 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.096 -1.003 . . . . 0.029999999999999999 111.531 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -113.68 169.54 8.91 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.932 -1.105 . . . . 0.029999999999999999 110.067 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -75.37 157.41 34.28 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.66 0.743 . . . . 0.029999999999999999 110.401 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.546 ' N ' ' ND2' ' A' ' 14' ' ' ASN . 0.6 OUTLIER 66.31 33.95 6.77 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.768 0.794 . . . . 0.73999999999999999 111.297 178.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 55.41 41.23 31.24 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.247 0.546 . . . . 0.02 111.335 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -113.13 165.61 12.22 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.152 -1.055 . . . . 0.02 108.152 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.09 -167.01 35.72 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.758 -1.211 . . . . 0.029999999999999999 110.757 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.569 ' CG ' HH11 ' A' ' 18' ' ' ARG . 0.0 OUTLIER -68.59 141.57 55.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.502 -0.999 . . . . 2.7599999999999998 109.275 179.553 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -121.96 150.1 42.52 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.629 -0.67 . . . . 1.8899999999999999 109.842 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -137.96 133.95 34.33 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.559 -0.713 . . . . 0.02 109.677 178.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -109.26 135.77 49.8 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.327 -0.858 . . . . 1.1200000000000001 108.886 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.6 t -127.16 137.98 53.06 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.55 -0.719 . . . . 0.02 109.125 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.5 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 4.1 p30 -118.62 11.72 12.91 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.644 -0.66 . . . . 0.20000000000000001 110.611 -179.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 25.5 m -158.88 174.26 15.26 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.664 -1.272 . . . . 1.23 108.948 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.454 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 2.3 m-20 -62.2 145.98 52.04 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.756 -1.215 . . . . 0.02 110.418 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 18.0 m -134.04 117.05 16.22 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.779 -0.822 . . . . 0.02 108.779 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.12 -20.48 52.07 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.369 -0.832 . . . . 0.23999999999999999 111.911 -177.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -151.16 106.14 3.3 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.57 -1.331 . . . . 1.1399999999999999 109.547 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.61 5.04 43.8 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.436 -0.79 . . . . 6.3700000000000001 110.276 -178.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -61.22 -28.36 69.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 3.1099999999999999 112.204 -177.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.5 t -79.12 -18.7 52.74 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.262 -1.523 . . . . 0.88 111.779 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -105.75 -21.82 13.09 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.138 -0.976 . . . . 0.02 110.682 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 33' ' ' LEU . 50.9 mt -148.88 128.31 13.05 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.032 -1.043 . . . . 3.3199999999999998 109.109 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.2 t -86.1 -11.11 53.58 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.676 -0.64 . . . . 0.02 110.385 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -172.84 162.26 4.78 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.147 -1.056 . . . . 0.02 108.147 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 24.9 m -144.03 116.32 8.5 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.064 -1.022 . . . . 0.02 108.632 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.421 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 17.9 t-20 -108.84 0.46 20.32 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 120.822 -1.174 . . . . 0.029999999999999999 111.673 -177.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.2 t -155.87 153.51 29.83 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.048 -1.093 . . . . 0.02 108.048 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.7 mt -146.9 147.37 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.069 -1.019 . . . . 0.02 110.871 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -123.65 124.56 43.03 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.154 -1.054 . . . . 0.02 108.154 177.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.7 t -106.32 115.0 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 106.917 -1.512 . . . . 0.02 106.917 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -83.32 -33.8 25.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.448 -0.782 . . . . 3.8100000000000001 110.728 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.48 152.09 21.93 Favored Glycine 0 N--CA 1.488 2.11 0 C-N-CA 118.883 -1.627 . . . . 0.02 110.82 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.04 173.18 49.62 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.655 -1.259 . . . . 0.01 110.708 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.2 m -119.32 134.88 54.98 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.011 -1.107 . . . . 1.48 108.011 177.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -126.75 155.51 42.64 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 122.587 1.185 . . . . 0.02 112.214 -176.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.39 134.02 52.35 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 105.631 -1.989 . . . . 0.23999999999999999 105.631 176.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.416 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.3 m -118.86 143.76 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.561 -0.712 . . . . 0.65000000000000002 109.083 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -120.99 145.72 47.45 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 122.222 1.01 . . . . 0.02 110.079 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -65.92 -33.8 76.66 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.805 -0.634 . . . . 0.02 111.052 -177.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -125.17 157.7 66.3 Favored Pre-proline 0 N--CA 1.503 2.21 0 O-C-N 121.092 -1.005 . . . . 0.02 109.416 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.47 166.95 1.01 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.714 1.61 . . . . 0.02 113.119 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.519 ' ND2' ' N ' ' A' ' 53' ' ' ASN . 1.0 OUTLIER 63.73 36.4 10.66 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.198 -0.91 . . . . 0.02 111.123 178.219 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 45.19 51.71 9.01 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.576 0.703 . . . . 3.3900000000000001 110.804 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.4 t -126.03 163.44 23.05 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.137 0.494 . . . . 2.3300000000000001 109.857 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.18 -161.62 31.69 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.761 -1.335 . . . . 0.02 109.761 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -64.88 138.97 58.7 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.102 -1.234 . . . . 0.02 110.029 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 14.6 ptm -119.06 137.18 53.73 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.674 -0.641 . . . . 5.0099999999999998 109.524 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.581 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 89.8 m-85 -134.03 138.46 45.38 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.422 -0.798 . . . . 0.02 109.836 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.1 mm -95.24 131.45 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.058 -0.719 . . . . 1.72 109.058 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.467 HD22 ' CE1' ' A' ' 66' ' ' TYR . 12.2 mt -121.0 111.45 34.06 Favored Pre-proline 0 N--CA 1.504 2.244 0 O-C-N 121.411 -0.806 . . . . 0.02 110.812 -178.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -77.11 169.55 21.3 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 CA-C-N 119.867 0.988 . . . . 1.47 109.853 177.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -52.6 141.31 20.91 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.766 -1.208 . . . . 4.25 110.338 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.38 -177.76 32.39 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.621 -1.276 . . . . 0.02 110.692 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -120.48 131.83 54.92 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.432 -1.04 . . . . 0.95999999999999996 109.774 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.467 ' CE1' HD22 ' A' ' 61' ' ' LEU . 92.6 m-85 -121.49 98.68 46.02 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 108.15 -1.056 . . . . 0.02 108.15 179.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -70.39 -3.66 12.88 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 120.861 1.041 . . . . 0.02 113.813 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -157.55 154.46 28.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.824 -1.172 . . . . 2.02 108.141 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -60.46 -38.85 85.5 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.557 -0.715 . . . . 0.02 111.929 -177.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -59.79 -23.71 63.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.916 -1.115 . . . . 0.02 110.272 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -70.68 -18.68 62.83 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.924 0.869 . . . . 3.4199999999999999 108.763 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.581 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.2 t90 -107.96 9.93 28.5 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.496 -1.298 . . . . 0.02 107.496 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 8.5 mtt 61.29 22.63 12.97 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.494 0.664 . . . . 0.02 110.503 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.52 144.41 45.81 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.762 -1.335 . . . . 0.02 109.762 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.545 HD23 ' O ' ' A' ' 75' ' ' LEU . 1.0 OUTLIER -79.63 -31.54 41.61 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.34 -1.356 . . . . 0.97999999999999998 107.34 177.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.605 ' ND2' ' H ' ' A' ' 77' ' ' ASP . 15.4 t30 -157.02 -171.43 3.64 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 106.317 -1.734 . . . . 0.02 106.317 178.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.605 ' H ' ' ND2' ' A' ' 76' ' ' ASN . 10.6 p30 -98.49 28.52 4.12 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.55 -1.344 . . . . 0.02 110.757 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -97.07 122.51 40.15 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.863 -1.148 . . . . 3.2000000000000002 110.974 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.503 HD21 ' CH2' ' A' ' 72' ' ' TRP . 75.0 mt -141.92 119.13 11.41 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.611 -1.255 . . . . 2.6099999999999999 107.611 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.73 -18.04 9.86 Favored Glycine 0 N--CA 1.499 2.875 0 O-C-N 121.211 -0.931 . . . . 0.02 112.524 -177.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.4 p -156.18 155.67 32.87 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 119.967 -1.902 . . . . 0.02 110.464 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 24.8 p -145.32 147.92 32.86 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.698 -0.626 . . . . 0.02 110.0 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 33.5 mtp180 -137.47 142.74 41.54 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.412 -0.805 . . . . 0.01 109.397 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.73 132.99 36.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 0.42999999999999999 109.862 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.6 t -91.97 124.86 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 109.027 -0.731 . . . . 1.25 109.027 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -94.36 132.1 39.33 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.706 -1.246 . . . . 1.77 109.238 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -96.33 139.77 31.98 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.672 -0.862 . . . . 1.6299999999999999 108.672 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.424 ' O ' ' OE2' ' A' ' 133' ' ' GLU . 87.8 p -111.47 128.02 55.87 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.345 -0.847 . . . . 1.0800000000000001 109.26 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.8 m -104.47 -154.18 0.5 Allowed 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 106.63 -1.618 . . . . 1.26 106.63 177.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.75 -52.7 0.74 Allowed Glycine 0 N--CA 1.5 2.965 0 O-C-N 120.399 -1.438 . . . . 0.01 112.737 177.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.17 -101.65 0.16 Allowed Glycine 0 N--CA 1.491 2.335 0 C-N-CA 118.467 -1.825 . . . . 0.01 111.953 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -121.61 118.86 30.25 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.122 -1.222 . . . . 4.4299999999999997 110.635 -178.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.5 129.85 34.85 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.836 -0.746 . . . . 2.9900000000000002 109.488 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -129.82 142.41 50.68 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.436 -0.79 . . . . 6.3600000000000003 109.058 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.435 ' O ' ' OE2' ' A' ' 109' ' ' GLU . 4.3 tt -128.81 144.56 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.344 -0.848 . . . . 1.0900000000000001 110.181 -179.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -121.52 134.16 55.04 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.541 -1.281 . . . . 2.0499999999999998 107.541 177.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.492 HG12 ' SG ' ' A' ' 129' ' ' CYS . 14.5 m -124.03 145.51 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 O-C-N 120.728 -1.232 . . . . 1.1000000000000001 109.903 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -119.05 141.4 48.76 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.983 0.896 . . . . 0.72999999999999998 110.851 -178.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -67.09 -30.64 70.73 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 116.065 -0.516 . . . . 0.02 111.812 -178.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -116.46 168.1 10.46 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.945 -1.097 . . . . 3.1800000000000002 110.473 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.2 163.92 44.86 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 111.044 -0.822 . . . . 0.01 111.044 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.5 t0 56.91 39.33 29.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.878 -0.778 . . . . 0.01 111.059 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 51.71 56.47 7.81 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.617 -0.677 . . . . 0.01 111.007 178.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -129.7 165.98 20.75 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.023 -1.103 . . . . 3.1499999999999999 108.023 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.24 -164.41 28.34 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.13 -1.588 . . . . 0.01 109.13 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -75.7 144.61 41.47 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.981 -1.305 . . . . 0.01 108.573 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.452 ' C ' ' SD ' ' A' ' 107' ' ' MET . 12.5 tmm? -116.25 142.21 47.14 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.634 0.73 . . . . 0.01 109.897 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.501 ' CD1' ' N ' ' A' ' 108' ' ' TYR . 8.0 m-85 -131.15 136.48 48.37 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.337 -0.986 . . . . 2.48 108.337 178.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.435 ' OE2' ' O ' ' A' ' 95' ' ' ILE . 5.2 tp10 -115.72 133.47 56.0 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.687 -0.633 . . . . 0.01 109.968 -178.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.9 t -148.47 147.95 29.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.021 -1.049 . . . . 1.6899999999999999 111.183 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.1 p -111.67 9.72 21.0 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 115.451 -0.795 . . . . 0.01 110.24 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 26.5 mp0 -121.39 163.5 18.6 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 121.238 -0.914 . . . . 3.21 111.72 -178.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -68.1 156.81 36.65 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.323 -0.991 . . . . 0.01 108.323 178.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.437 ' SG ' ' OE1' ' A' ' 120' ' ' GLN . 33.7 t -125.57 113.98 25.23 Favored Pre-proline 0 N--CA 1.502 2.142 0 O-C-N 121.531 -0.731 . . . . 0.01 109.23 178.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -75.27 -30.89 6.34 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 CA-C-N 120.245 1.123 . . . . 0.01 111.035 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.4 p -142.45 108.44 5.19 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.804 0.811 . . . . 0.02 109.0 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 73.1 mt -63.21 -38.35 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.839 -0.538 . . . . 1.8300000000000001 110.742 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 20.4 ttt -68.14 -36.53 79.83 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.121 -1.032 . . . . 1.3400000000000001 110.227 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -70.53 -38.75 74.27 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.514 -1.367 . . . . 2.1099999999999999 110.001 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.437 ' OE1' ' SG ' ' A' ' 114' ' ' CYS . 52.0 tt0 -79.61 -47.47 15.4 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.317 -0.865 . . . . 2.0800000000000001 112.471 -177.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -110.42 0.46 17.87 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.362 -0.837 . . . . 0.02 112.698 -176.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 59.28 32.99 22.37 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.761 -1.212 . . . . 0.02 109.067 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 mt -112.09 135.26 52.98 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 108.487 -0.931 . . . . 0.02 108.487 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -91.23 -22.28 20.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 5.3200000000000003 110.031 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -149.79 163.89 36.77 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.36 -0.838 . . . . 0.02 110.0 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 55.4 mt -131.33 128.47 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 107.474 -1.306 . . . . 2.1699999999999999 107.474 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -107.85 -12.16 15.24 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.412 -0.805 . . . . 0.02 112.36 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.3 m -159.16 152.17 22.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.887 -1.133 . . . . 0.01 108.99 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.492 ' SG ' HG12 ' A' ' 97' ' ' VAL . 10.9 t -168.86 146.87 3.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 1.22 108.795 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.3 tttp -120.6 112.45 18.93 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 122.422 1.106 . . . . 1.4099999999999999 109.515 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.3 t -113.46 129.52 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 107.821 -1.177 . . . . 0.01 107.821 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.9 t -129.72 92.97 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 106.936 -1.505 . . . . 1.98 106.936 177.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.584 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 9.4 tm-20 -147.16 -74.84 0.2 Allowed 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 105.829 -1.915 . . . . 0.01 105.829 177.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.422 ' N ' ' OE1' ' A' ' 133' ' ' GLU . . . 169.68 -69.64 0.15 Allowed Glycine 0 N--CA 1.482 1.723 0 N-CA-C 108.656 -1.777 . . . . 0.01 108.656 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.436 ' CB ' HD12 ' A' ' 175' ' ' ILE . 17.9 p -121.17 118.48 29.76 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.631 -0.923 . . . . 2.2999999999999998 110.569 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.584 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 8.4 m95 -128.1 148.55 50.58 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 107.063 -1.458 . . . . 0.01 107.063 178.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 89.9 mt -123.27 138.07 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 120.373 -1.454 . . . . 1.6899999999999999 110.491 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -114.96 144.11 44.09 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 107.553 -1.277 . . . . 2.4900000000000002 107.553 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.507 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 12.1 m-85 -123.02 143.94 49.6 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.235 -0.916 . . . . 0.02 109.592 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -75.06 -28.79 60.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.389 -0.82 . . . . 0.02 112.028 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 55.0 mt -115.28 151.82 46.23 Favored Pre-proline 0 N--CA 1.504 2.264 0 O-C-N 120.563 -1.335 . . . . 1.48 109.027 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -54.06 167.66 1.11 Allowed 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 120.906 1.071 . . . . 0.02 112.54 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 4.5 m120 59.12 30.18 19.9 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 115.164 -0.925 . . . . 0.75 111.19 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 57.94 51.39 9.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.4 -0.813 . . . . 0.02 111.469 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -125.84 164.13 21.39 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.398 -0.814 . . . . 0.02 109.951 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.38 -165.18 32.41 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.31 -1.116 . . . . 0.02 110.31 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -69.06 142.09 54.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.604 -0.939 . . . . 0.02 109.126 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -115.24 149.07 38.34 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.832 -0.543 . . . . 0.02 109.918 -178.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.534 ' CE1' ' O ' ' A' ' 162' ' ' TRP . 42.6 t80 -124.94 135.82 53.18 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 109.15 -0.685 . . . . 0.01 109.15 179.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.5 tt -98.45 120.88 39.63 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.941 -1.1 . . . . 0.01 108.808 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.507 ' N ' HD23 ' A' ' 150' ' ' LEU . 7.4 tt -98.51 149.74 22.41 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.139 -0.976 . . . . 0.01 108.857 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -104.93 -98.47 0.32 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.424 -0.798 . . . . 2.27 110.007 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 47.1 pttt -167.36 49.09 0.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.077 -1.014 . . . . 1.8400000000000001 109.515 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.575 ' CG ' ' H ' ' A' ' 155' ' ' GLU . 38.5 tttm -113.34 -175.58 2.7 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.984 -0.747 . . . . 2.2799999999999998 108.984 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.575 ' H ' ' CG ' ' A' ' 154' ' ' LYS . 84.6 mt-10 -100.25 109.5 21.72 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.197 -0.939 . . . . 0.01 108.693 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.675 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 30.2 m-85 -98.33 113.87 25.99 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.427 -0.795 . . . . 0.01 110.079 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -94.8 -22.48 18.03 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.23 -0.919 . . . . 0.01 111.614 -178.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -127.7 154.79 77.87 Favored Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 120.771 -1.206 . . . . 2.54 109.148 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -60.78 -38.94 66.9 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 120.489 0.793 . . . . 0.69999999999999996 110.443 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 96.8 t -60.94 -20.11 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.867 -1.146 . . . . 0.85999999999999999 108.821 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 43.2 t0 -65.68 -15.39 62.74 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.976 -1.078 . . . . 0.02 109.785 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.675 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 22.8 m0 -95.79 10.74 36.01 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.497 -0.927 . . . . 0.02 108.497 178.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 78.56 9.87 86.67 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.603 -1.284 . . . . 0.02 110.621 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.38 142.04 31.38 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.361 -1.082 . . . . 0.02 110.078 -178.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.59 -8.72 58.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.655 -0.653 . . . . 0.58999999999999997 109.629 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 21.6 p -144.81 150.32 46.03 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 120.894 -1.129 . . . . 0.87 108.534 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -75.94 21.26 0.51 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 120.718 0.945 . . . . 0.38 112.518 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.38 123.05 28.75 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.786 -1.197 . . . . 0.17999999999999999 111.566 -177.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 4.1 mt -149.78 127.6 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 107.041 -1.466 . . . . 3.9900000000000002 107.041 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -113.67 -15.15 12.53 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 113.684 0.994 . . . . 5.1699999999999999 113.684 -177.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 8.2 t -157.63 160.96 38.6 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 119.132 -2.23 . . . . 0.02 110.445 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.439 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 16.4 p90 -151.66 152.73 33.21 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.085 -1.01 . . . . 2.02 110.499 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 43.4 mtp180 -144.76 149.93 36.36 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.882 0.849 . . . . 0.01 110.189 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -88.08 144.32 26.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.59 -0.694 . . . . 0.01 109.154 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.436 HD12 ' CB ' ' A' ' 135' ' ' THR . 4.6 mt -94.32 128.86 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.274 -0.891 . . . . 3.04 109.128 178.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.8 p -136.2 146.24 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.124 -0.985 . . . . 1.8899999999999999 109.499 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 N--CA 1.488 1.448 0 O-C-N 121.151 -0.968 . . . . 4.8899999999999997 109.465 -179.978 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.412 -1.475 . . . . 0.01 109.412 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -145.9 134.74 22.44 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.312 -1.111 . . . . 0.02 110.531 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.1 tt -129.46 139.57 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.053 -1.092 . . . . 0.02 108.053 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.507 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.0 OUTLIER -121.89 130.54 53.44 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.437 -0.789 . . . . 0.39000000000000001 110.119 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.1 m-85 -110.18 139.98 44.77 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 109.114 -0.699 . . . . 0.02 109.114 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.525 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.8 m-85 -121.9 138.47 54.39 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.302 -0.874 . . . . 0.02 109.325 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -69.32 -27.32 65.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.16 -0.962 . . . . 0.029999999999999999 111.508 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 2.1 m-20 -114.11 169.4 9.04 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.921 -1.112 . . . . 0.029999999999999999 110.217 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -75.96 158.71 31.66 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.612 0.72 . . . . 0.029999999999999999 110.258 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.9 t30 66.06 33.25 7.72 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 122.018 0.913 . . . . 0.73999999999999999 111.123 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 55.68 42.29 29.52 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 116.007 -0.542 . . . . 0.02 111.471 177.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -113.81 166.18 11.82 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.395 -0.965 . . . . 0.02 108.395 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.87 -167.61 34.97 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 119.923 -1.132 . . . . 0.029999999999999999 110.75 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.587 ' CG ' HH11 ' A' ' 18' ' ' ARG . 0.4 OUTLIER -69.42 143.0 53.74 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.48 -1.012 . . . . 2.7599999999999998 109.091 179.445 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.504 ' HE ' ' CB ' ' A' ' 8' ' ' SER . 52.5 ttt180 -121.58 148.94 43.86 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.582 -0.699 . . . . 1.8899999999999999 110.105 -178.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.603 ' CZ ' ' CG ' ' A' ' 32' ' ' TYR . 7.2 t80 -135.1 130.75 36.0 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.781 -0.822 . . . . 0.02 108.781 178.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 18.7 p-10 -111.94 137.78 49.46 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.468 -0.77 . . . . 1.1200000000000001 109.411 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 45.9 t -130.38 139.81 50.62 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.596 -0.69 . . . . 0.02 109.6 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.5 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 10.8 p30 -117.78 11.93 13.73 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.723 -0.611 . . . . 0.20000000000000001 110.225 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 34.6 m -158.63 174.77 14.54 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.887 -1.133 . . . . 1.23 108.644 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -61.96 145.17 53.76 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.694 -1.254 . . . . 0.02 110.033 -179.731 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.435 ' CB ' ' CZ ' ' A' ' 29' ' ' PHE . 0.8 OUTLIER -133.68 119.08 18.9 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 108.725 -0.842 . . . . 0.02 108.725 178.449 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.44 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -77.11 -19.39 57.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.23999999999999999 111.745 -177.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -154.13 107.94 2.97 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.559 -1.338 . . . . 1.1399999999999999 110.862 -178.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.435 ' CZ ' ' CB ' ' A' ' 26' ' ' CYS . 17.1 m-85 -96.53 5.72 50.2 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.206 -0.934 . . . . 6.3700000000000001 109.303 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -60.25 -30.67 69.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.364 -0.835 . . . . 3.1099999999999999 112.206 -176.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.6 m -78.82 -18.96 53.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.308 -1.495 . . . . 0.88 111.29 -178.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.603 ' CG ' ' CZ ' ' A' ' 20' ' ' TYR . 56.6 m-85 -106.68 -22.17 12.82 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.345 -0.847 . . . . 0.02 110.905 -178.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.442 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 5.1 tp -149.24 127.2 11.9 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.83 -1.169 . . . . 3.3199999999999998 109.609 -178.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.0 t -86.21 -11.31 52.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.64 -0.662 . . . . 0.02 110.95 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.442 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 13.2 ptm180 -172.96 162.69 4.72 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.914 -1.117 . . . . 0.02 108.404 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.0 t -142.23 115.02 8.63 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.968 -1.083 . . . . 0.02 108.663 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 16.1 t-20 -107.5 -0.71 21.98 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.864 -1.147 . . . . 0.029999999999999999 110.866 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.5 t -156.08 152.67 28.29 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.902 -1.147 . . . . 0.02 107.902 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 87.6 mt -145.67 148.12 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 CA-C-O 122.435 1.112 . . . . 0.02 110.313 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -123.86 124.08 41.86 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.82 -1.178 . . . . 0.02 107.82 176.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.7 t -106.47 115.25 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 106.859 -1.534 . . . . 0.02 106.859 177.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -83.49 -33.74 25.51 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.021 -0.672 . . . . 3.8100000000000001 110.738 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.48 152.17 22.05 Favored Glycine 0 N--CA 1.489 2.175 0 C-N-CA 118.922 -1.608 . . . . 0.02 110.891 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.97 173.22 49.63 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.709 -1.234 . . . . 0.01 110.632 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.6 m -120.15 135.76 54.85 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.099 -1.075 . . . . 1.48 108.099 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.417 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 37.8 m95 -128.01 155.74 43.82 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 122.7 1.238 . . . . 0.02 112.17 -176.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.75 134.5 51.38 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 105.57 -2.011 . . . . 0.23999999999999999 105.57 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.441 ' HB ' HD22 ' A' ' 79' ' ' LEU . 31.4 m -119.92 144.76 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.579 -0.701 . . . . 0.65000000000000002 109.3 179.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -121.45 145.7 47.66 Favored 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 122.313 1.054 . . . . 0.02 110.263 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -66.87 -34.09 77.03 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.836 -0.62 . . . . 0.02 111.496 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -124.93 157.97 64.64 Favored Pre-proline 0 N--CA 1.503 2.185 0 O-C-N 121.028 -1.045 . . . . 0.02 109.36 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.35 165.31 1.55 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.716 1.611 . . . . 0.02 113.176 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 63.84 36.95 10.02 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.159 -0.928 . . . . 0.02 111.055 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 45.08 51.84 8.71 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.686 0.755 . . . . 3.3900000000000001 110.78 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.5 t -125.92 163.61 22.59 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 121.145 0.498 . . . . 2.3300000000000001 109.811 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.83 -161.46 32.04 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.797 -1.321 . . . . 0.02 109.797 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.425 ' ND1' ' N ' ' A' ' 57' ' ' HIS . 4.7 m80 -64.63 139.77 58.8 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.075 -1.25 . . . . 0.02 110.289 -179.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.497 ' O ' ' SD ' ' A' ' 58' ' ' MET . 2.9 ppp? -119.97 136.95 54.34 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.648 -0.657 . . . . 5.0099999999999998 109.594 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.567 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 88.2 m-85 -134.81 138.85 44.62 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.353 -0.842 . . . . 0.02 109.948 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.5 mm -95.25 131.36 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.034 -0.728 . . . . 1.72 109.034 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.48 HD22 ' CE1' ' A' ' 66' ' ' TYR . 11.4 mt -120.26 111.06 35.47 Favored Pre-proline 0 N--CA 1.506 2.361 0 O-C-N 121.371 -0.831 . . . . 0.02 110.763 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -77.32 169.42 21.3 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 CA-C-N 119.836 0.977 . . . . 1.47 109.769 177.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -52.59 140.94 21.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.821 -1.174 . . . . 4.25 110.307 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.75 -177.52 32.82 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.454 -1.355 . . . . 0.02 110.597 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -120.48 131.75 54.88 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.535 -0.98 . . . . 0.95999999999999996 109.692 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.48 ' CE1' HD22 ' A' ' 61' ' ' LEU . 91.0 m-85 -121.54 99.13 45.51 Favored Pre-proline 0 N--CA 1.495 1.783 0 N-CA-C 107.882 -1.155 . . . . 0.02 107.882 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -70.86 -3.71 13.29 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 120.628 0.885 . . . . 0.02 113.642 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -157.6 154.9 29.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.71 -1.243 . . . . 2.02 108.029 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -60.2 -39.0 85.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.474 -0.767 . . . . 0.02 111.881 -177.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -59.79 -24.0 63.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.094 -1.004 . . . . 0.02 110.386 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -70.59 -18.83 62.89 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.901 0.858 . . . . 3.4199999999999999 108.802 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.567 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.4 t90 -107.92 9.9 28.6 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.477 -1.305 . . . . 0.02 107.477 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.5 mtp 61.27 22.47 12.82 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.495 0.664 . . . . 0.02 110.536 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.53 144.08 46.06 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.492 -1.443 . . . . 0.02 109.492 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.7 tp -79.05 -30.92 44.33 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.552 -1.277 . . . . 0.97999999999999998 107.552 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -157.05 -171.39 3.62 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 106.241 -1.763 . . . . 0.02 106.241 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -98.22 28.33 4.12 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.647 -1.283 . . . . 0.02 110.609 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.7 mtm180 -96.84 122.15 39.49 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.95 -1.094 . . . . 3.2000000000000002 110.985 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.513 HD21 ' CH2' ' A' ' 72' ' ' TRP . 63.5 mt -142.82 120.5 11.84 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.672 -1.232 . . . . 2.6099999999999999 107.672 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.68 -18.32 9.07 Favored Glycine 0 N--CA 1.502 3.05 0 O-C-N 121.215 -0.928 . . . . 0.02 112.871 -177.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 12.6 m -156.96 157.71 35.27 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 119.956 1.878 . . . . 0.02 110.864 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 27.0 m -146.49 149.84 34.42 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.627 -0.671 . . . . 0.02 109.943 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -138.51 143.17 39.42 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.395 -0.815 . . . . 0.01 109.183 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.3 132.18 36.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -0.94 . . . . 0.42999999999999999 109.725 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.8 t -90.61 124.83 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.726 -0.842 . . . . 1.25 108.726 178.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -93.35 132.17 37.83 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.797 -1.189 . . . . 1.77 109.017 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mt -96.8 139.29 33.07 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.453 -0.943 . . . . 1.6299999999999999 108.453 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.5 p -111.35 127.5 55.67 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.355 -0.84 . . . . 1.0800000000000001 109.17 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 51.8 p -104.12 -154.53 0.51 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 106.448 -1.686 . . . . 1.26 106.448 177.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.39 -51.63 0.78 Allowed Glycine 0 N--CA 1.502 3.05 0 O-C-N 120.558 -1.339 . . . . 0.01 112.636 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.26 -100.92 0.15 Allowed Glycine 0 N--CA 1.489 2.193 0 C-N-CA 118.464 -1.827 . . . . 0.01 111.932 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -121.4 118.79 30.31 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.034 -1.274 . . . . 4.4299999999999997 110.543 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.41 131.08 36.79 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.819 -0.753 . . . . 2.9900000000000002 109.399 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -129.81 140.56 51.0 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.472 -0.767 . . . . 6.3600000000000003 109.203 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 tt -127.4 144.12 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.407 -0.808 . . . . 1.0900000000000001 109.864 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -122.29 133.05 54.69 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.692 -1.225 . . . . 2.0499999999999998 107.692 176.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.502 HG12 ' SG ' ' A' ' 129' ' ' CYS . 15.8 m -123.67 145.86 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 O-C-N 120.662 -1.274 . . . . 1.1000000000000001 109.682 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -119.13 141.31 48.92 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 121.97 0.891 . . . . 0.72999999999999998 110.843 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -67.03 -30.41 70.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.888 -0.507 . . . . 0.02 111.775 -178.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -116.12 167.39 11.03 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.046 -1.033 . . . . 3.1800000000000002 110.533 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.06 164.43 43.79 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.981 -0.848 . . . . 0.01 110.981 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.423 ' O ' ' ND2' ' A' ' 104' ' ' ASN . 3.0 m-20 56.95 38.8 29.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.909 -0.759 . . . . 0.01 110.884 179.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 52.14 56.02 8.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.637 -0.665 . . . . 0.01 111.047 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.423 ' ND2' ' O ' ' A' ' 102' ' ' ASP . 24.5 m-80 -129.19 165.81 20.6 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 108.208 -1.034 . . . . 3.1499999999999999 108.208 178.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.99 -163.92 27.11 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.247 -1.541 . . . . 0.01 109.247 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.619 ' NE2' ' CE2' ' A' ' 108' ' ' TYR . 0.6 OUTLIER -76.0 144.39 40.94 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.043 -1.269 . . . . 0.01 108.348 179.116 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.545 ' C ' HE22 ' A' ' 106' ' ' GLN . 12.8 tmm? -116.57 141.81 47.7 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.635 0.731 . . . . 0.01 109.959 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.619 ' CE2' ' NE2' ' A' ' 106' ' ' GLN . 39.4 m-85 -131.2 136.45 48.27 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.176 -1.046 . . . . 2.48 108.176 178.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.522 ' OE2' ' N ' ' A' ' 110' ' ' THR . 1.9 tm-20 -119.47 134.73 55.08 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.544 -0.723 . . . . 0.01 109.961 -178.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.522 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 7.8 t -148.69 151.81 35.58 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 122.233 1.016 . . . . 1.6899999999999999 111.065 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.7 p -111.83 9.49 20.72 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.645 -0.707 . . . . 0.01 110.377 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -121.43 163.27 19.02 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.122 -0.986 . . . . 3.21 111.719 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -68.12 157.09 36.08 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.344 -0.984 . . . . 0.01 108.344 178.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 20.7 t -126.59 114.15 22.87 Favored Pre-proline 0 N--CA 1.504 2.231 0 O-C-N 121.48 -0.763 . . . . 0.01 109.088 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -75.12 -29.42 8.06 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 CA-C-N 120.319 1.15 . . . . 0.01 111.213 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 69.4 m -142.61 109.1 5.33 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.485 -0.759 . . . . 0.02 109.055 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.408 HD12 ' O ' ' A' ' 169' ' ' ILE . 97.4 mt -63.9 -38.96 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.801 -0.562 . . . . 1.8300000000000001 110.667 -178.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 41.9 ttp -68.58 -37.29 79.73 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.272 -0.971 . . . . 1.3400000000000001 110.247 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -69.93 -38.64 76.26 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.502 -1.374 . . . . 2.1099999999999999 110.026 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -79.93 -46.89 15.93 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.289 -0.882 . . . . 2.0800000000000001 112.379 -176.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -110.67 -0.01 17.32 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.434 -0.792 . . . . 0.02 112.657 -176.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.1 m80 59.69 33.13 21.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.73 -1.231 . . . . 0.02 109.489 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.5 mt -112.78 135.94 52.95 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 108.728 -0.841 . . . . 0.02 108.728 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -91.6 -22.71 20.16 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.266 -0.896 . . . . 5.3200000000000003 110.415 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -149.59 164.33 35.43 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.089 -1.007 . . . . 0.02 109.867 -178.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 37.3 mt -131.92 128.86 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 107.642 -1.244 . . . . 2.1699999999999999 107.642 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -108.76 -12.3 14.94 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.342 -0.849 . . . . 0.02 112.462 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.5 t -159.03 151.75 21.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.736 -1.228 . . . . 0.01 109.019 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.502 ' SG ' HG12 ' A' ' 97' ' ' VAL . 7.6 t -168.74 147.25 4.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 1.22 109.114 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -121.9 111.48 17.14 Favored 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 122.415 1.103 . . . . 1.4099999999999999 109.711 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.1 t -113.33 130.7 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.678 -1.23 . . . . 0.01 107.678 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 44.1 t -129.89 93.37 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 107.176 -1.416 . . . . 1.98 107.176 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.507 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 26.0 tt0 -147.02 -75.21 0.2 Allowed 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 105.799 -1.926 . . . . 0.01 105.799 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 177.44 -78.19 0.07 OUTLIER Glycine 0 N--CA 1.483 1.791 0 N-CA-C 108.104 -1.998 . . . . 0.01 108.104 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.574 ' OG1' HD12 ' A' ' 175' ' ' ILE . 1.2 t -121.82 125.3 46.17 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.649 -0.912 . . . . 2.2999999999999998 110.183 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.507 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 7.5 m95 -126.47 151.98 47.04 Favored 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 107.07 -1.456 . . . . 0.01 107.07 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 48.2 mt -120.61 135.37 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 120.329 -1.482 . . . . 1.6899999999999999 110.297 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -114.73 144.56 43.27 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 107.465 -1.309 . . . . 2.4900000000000002 107.465 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.503 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 15.2 m-85 -123.25 143.68 49.89 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.33 -0.856 . . . . 0.02 109.631 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -76.15 -29.23 57.7 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.54 -0.725 . . . . 0.02 112.389 -176.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.4 mt -115.43 154.78 47.67 Favored Pre-proline 0 N--CA 1.507 2.408 0 O-C-N 120.654 -1.279 . . . . 1.48 109.081 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.34 164.71 2.66 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 121.191 1.261 . . . . 0.02 112.79 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 51.9 t30 59.94 32.0 20.95 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.077 -0.965 . . . . 0.75 111.59 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 57.24 51.48 10.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.482 -0.762 . . . . 0.02 111.315 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -126.05 164.86 19.93 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.487 -0.758 . . . . 0.02 109.864 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.19 -165.92 33.15 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.346 -1.102 . . . . 0.02 110.346 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -69.57 143.31 53.38 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.563 -0.963 . . . . 0.02 109.207 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -115.16 149.67 37.28 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.206 0.526 . . . . 0.02 109.788 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -124.38 135.11 53.06 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 109.17 -0.678 . . . . 0.01 109.17 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.7 tp -96.7 119.93 36.09 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.608 -1.308 . . . . 0.01 109.264 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.694 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 59.1 tp -98.92 153.44 18.82 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.347 -0.846 . . . . 0.01 109.159 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.411 ' CG ' ' N ' ' A' ' 153' ' ' LYS . 21.2 t70 -104.41 -113.3 0.24 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.496 -0.752 . . . . 2.27 109.336 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.411 ' N ' ' CG ' ' A' ' 152' ' ' ASP . 17.6 pttm -163.04 50.59 0.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.081 -1.012 . . . . 1.8400000000000001 109.855 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -113.01 -155.71 0.57 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.466 -0.771 . . . . 2.2799999999999998 109.225 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -106.28 103.86 13.42 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.807 -0.812 . . . . 0.01 108.807 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.694 ' CZ ' HD11 ' A' ' 151' ' ' LEU . 17.4 m-85 -98.36 112.31 24.36 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.263 -0.898 . . . . 0.01 109.739 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 22.5 mtm180 -95.27 -22.87 17.51 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.232 -0.918 . . . . 0.01 111.685 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -127.3 154.41 77.06 Favored Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 120.878 -1.139 . . . . 2.54 108.764 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -59.52 -37.92 86.03 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 CA-C-N 119.235 0.763 . . . . 0.69999999999999996 110.637 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.9 t -60.99 -20.05 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.869 -1.145 . . . . 0.85999999999999999 109.2 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -65.43 -15.59 62.77 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.983 -1.073 . . . . 0.02 109.98 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.635 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 9.5 m0 -97.8 11.43 37.27 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.124 -0.985 . . . . 0.02 108.997 178.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.59 10.6 85.04 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.89 -1.148 . . . . 0.02 111.04 178.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.38 140.84 32.97 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.111 -1.229 . . . . 0.02 110.126 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.32 -9.09 58.08 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.59 -0.694 . . . . 0.58999999999999997 109.989 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.8 m -143.6 150.83 52.15 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.039 -1.038 . . . . 0.87 109.032 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -75.98 17.95 0.68 Allowed 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 120.721 0.947 . . . . 0.38 112.405 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.04 123.59 29.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.916 -1.115 . . . . 0.17999999999999999 111.56 -177.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.408 ' O ' HD12 ' A' ' 117' ' ' ILE . 2.0 mt -149.46 126.92 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.071 -1.455 . . . . 3.9900000000000002 107.071 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 24.1 mm100 -111.38 -18.26 12.93 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.165 -0.959 . . . . 5.1699999999999999 113.248 -177.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.8 m -156.73 160.22 39.08 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 119.216 -2.177 . . . . 0.02 110.4 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.433 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 18.3 p90 -151.72 153.05 33.59 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.101 -0.999 . . . . 2.02 110.321 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.3 mtm180 -145.79 150.53 36.37 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.358 -0.839 . . . . 0.01 110.145 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -87.83 144.04 26.81 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.233 -0.655 . . . . 0.01 109.233 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.574 HD12 ' OG1' ' A' ' 135' ' ' THR . 4.4 mt -94.79 129.25 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.308 -0.87 . . . . 3.04 108.967 179.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.49 146.71 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.153 -0.967 . . . . 1.8899999999999999 109.649 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.33 -0.856 . . . . 4.8899999999999997 109.466 179.954 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.273 -1.531 . . . . 0.01 109.273 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -147.45 136.28 22.07 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.099 -1.236 . . . . 0.02 110.52 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.4 tt -130.12 138.91 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.698 -0.853 . . . . 0.02 108.698 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 m -120.91 130.24 53.81 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.559 -0.713 . . . . 0.39000000000000001 110.014 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.9 m-85 -110.4 139.68 45.37 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.581 -0.699 . . . . 0.02 109.247 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.525 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 6.6 m-85 -121.31 138.32 54.3 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.427 -0.796 . . . . 0.02 109.32 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.523 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 83.3 mt-10 -69.38 -27.43 65.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.041 -1.037 . . . . 0.029999999999999999 111.475 -178.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 2.3 m-20 -114.05 169.35 9.08 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.888 -1.133 . . . . 0.029999999999999999 110.097 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -76.03 158.66 31.63 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.567 0.699 . . . . 0.029999999999999999 110.229 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 66.53 33.17 6.82 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 122.012 0.911 . . . . 0.73999999999999999 111.185 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 55.32 41.72 30.93 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.374 0.607 . . . . 0.02 111.373 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -113.64 165.81 12.15 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.25 -1.019 . . . . 0.02 108.25 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.44 -167.46 35.56 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.765 -1.207 . . . . 0.029999999999999999 110.766 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.574 ' CG ' HH11 ' A' ' 18' ' ' ARG . 0.3 OUTLIER -68.84 141.69 55.04 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.535 -0.979 . . . . 2.7599999999999998 109.37 179.383 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -122.77 150.19 43.12 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.6 0.714 . . . . 1.8899999999999999 110.124 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.412 ' CB ' HD11 ' A' ' 33' ' ' LEU . 32.0 t80 -135.87 131.74 35.68 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 109.113 -0.699 . . . . 0.02 109.113 178.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -109.53 136.47 48.87 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.83 -0.804 . . . . 1.1200000000000001 108.83 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 49.6 t -128.63 138.15 52.04 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.617 -0.677 . . . . 0.02 109.619 -179.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -118.14 12.17 13.48 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.673 -0.642 . . . . 0.20000000000000001 110.144 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.495 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 14.6 t -159.46 174.2 15.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.822 -1.174 . . . . 1.23 108.918 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -61.55 144.35 54.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.849 -1.157 . . . . 0.02 110.376 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.6 m -134.16 117.92 17.08 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.733 -0.839 . . . . 0.02 108.733 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.38 -19.81 52.57 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.524 -0.735 . . . . 0.23999999999999999 112.55 -177.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 19.2 p30 -152.95 108.75 3.31 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.703 -1.248 . . . . 1.1399999999999999 110.831 -178.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -97.68 5.29 49.52 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.428 -0.795 . . . . 6.3700000000000001 109.771 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.2 mtm180 -60.33 -30.35 69.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.481 -0.762 . . . . 3.1099999999999999 112.307 -176.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.435 ' OG ' ' CE2' ' A' ' 32' ' ' TYR . 30.3 p -79.35 -18.77 51.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.258 -1.526 . . . . 0.88 111.631 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.435 ' CE2' ' OG ' ' A' ' 31' ' ' SER . 51.1 m-85 -106.57 -22.04 12.88 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.291 -0.881 . . . . 0.02 110.98 -178.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.412 HD11 ' CB ' ' A' ' 20' ' ' TYR . 58.0 mt -148.89 128.15 12.92 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.948 -1.095 . . . . 3.3199999999999998 109.216 -178.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.9 t -86.76 -11.13 51.94 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.766 -0.584 . . . . 0.02 110.439 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.0 ttp180 -171.5 160.92 6.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.016 -1.053 . . . . 0.02 108.187 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 82.0 m -144.19 116.49 8.5 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.907 -1.121 . . . . 0.02 109.011 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 11' ' ' GLU . 1.3 m-80 -109.93 0.87 18.78 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 120.836 -1.165 . . . . 0.029999999999999999 111.857 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.2 m -156.01 153.22 29.16 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.11 -1.07 . . . . 0.02 108.11 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.5 mt -146.9 148.04 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 CA-C-O 122.207 1.004 . . . . 0.02 110.753 -178.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -123.59 124.85 43.72 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.136 -1.061 . . . . 0.02 108.136 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.2 t -106.69 113.92 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 106.805 -1.554 . . . . 0.02 106.805 177.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -84.16 -34.07 24.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.691 -0.631 . . . . 3.8100000000000001 110.475 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.82 150.25 19.0 Favored Glycine 0 N--CA 1.486 2.004 0 C-N-CA 118.885 -1.626 . . . . 0.02 110.601 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.0 172.44 49.19 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.758 -1.211 . . . . 0.01 110.235 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.9 m -120.04 135.75 54.82 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.098 -1.075 . . . . 1.48 108.098 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.422 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 36.9 m95 -128.35 156.2 43.48 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 122.698 1.237 . . . . 0.02 112.468 -176.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.96 135.02 50.83 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 105.412 -2.07 . . . . 0.23999999999999999 105.412 176.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.409 ' HB ' HD22 ' A' ' 79' ' ' LEU . 34.6 m -116.21 141.81 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.597 -0.689 . . . . 0.65000000000000002 109.286 179.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -120.72 143.01 48.99 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.987 0.899 . . . . 0.02 109.643 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.46 -33.69 76.52 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.627 -0.715 . . . . 0.02 111.832 -177.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -124.71 157.82 64.5 Favored Pre-proline 0 N--CA 1.504 2.227 0 O-C-N 120.991 -1.068 . . . . 0.02 109.357 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.21 166.7 0.96 Allowed 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 121.724 1.616 . . . . 0.02 112.827 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.5 m120 63.42 36.74 11.2 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.262 -0.881 . . . . 0.02 111.163 178.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.449 ' CD1' ' CD ' ' A' ' 83' ' ' ARG . 3.8 m-85 45.09 51.39 8.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.584 -0.698 . . . . 3.3900000000000001 110.767 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.7 t -125.65 163.49 22.67 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.241 0.543 . . . . 2.3300000000000001 109.883 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.53 -161.72 31.31 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.779 -1.328 . . . . 0.02 109.779 -179.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 12.4 m80 -64.61 138.13 58.22 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.983 -1.304 . . . . 0.02 110.209 -178.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 16.0 ptm -118.79 136.7 53.85 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.721 -0.612 . . . . 5.0099999999999998 109.672 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.515 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 86.6 m-85 -134.33 139.59 45.77 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.483 -0.761 . . . . 0.02 109.647 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.9 mm -95.0 131.03 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.983 -0.747 . . . . 1.72 108.983 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.551 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -120.59 111.32 34.79 Favored Pre-proline 0 N--CA 1.505 2.28 0 O-C-N 121.319 -0.863 . . . . 0.02 110.767 -178.347 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -77.55 169.02 21.72 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 CA-C-N 119.958 1.021 . . . . 1.47 110.135 177.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -53.04 141.43 22.57 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.831 -1.168 . . . . 4.25 110.417 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.78 -177.2 32.2 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 119.403 -1.379 . . . . 0.02 110.743 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -120.72 131.79 54.72 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.334 -1.098 . . . . 0.95999999999999996 109.8 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.551 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 63.2 m-85 -122.52 95.77 46.46 Favored Pre-proline 0 N--CA 1.496 1.846 0 N-CA-C 107.903 -1.147 . . . . 0.02 107.903 179.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.401 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.9 Cg_endo -66.91 -3.5 9.66 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 120.787 0.992 . . . . 0.02 113.865 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.401 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 79.1 mt-10 -157.47 155.17 29.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.617 -1.302 . . . . 2.02 108.142 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -60.47 -39.26 86.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.623 -0.673 . . . . 0.02 111.974 -177.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -60.02 -23.91 64.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.031 -1.043 . . . . 0.02 110.395 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -69.73 -18.67 63.54 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.809 0.814 . . . . 3.4199999999999999 108.907 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.57 ' CH2' HD21 ' A' ' 79' ' ' LEU . 1.1 t90 -107.84 11.06 28.45 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.515 -1.291 . . . . 0.02 107.515 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 17.9 mtt 61.09 22.49 12.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.446 -0.784 . . . . 0.02 110.439 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.98 144.03 46.86 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.391 -1.484 . . . . 0.02 109.391 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.4 mt -78.87 -30.49 45.09 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.684 -1.228 . . . . 0.97999999999999998 107.684 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.672 ' N ' HD22 ' A' ' 76' ' ' ASN . 0.0 OUTLIER -157.0 -171.31 3.6 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 106.386 -1.709 . . . . 0.02 106.386 178.299 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.409 ' OD2' ' OD1' ' A' ' 37' ' ' ASN . 63.6 m-20 -98.2 28.21 4.18 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.722 -1.236 . . . . 0.02 110.698 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -96.55 122.33 39.35 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.856 -1.153 . . . . 3.2000000000000002 110.898 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.57 HD21 ' CH2' ' A' ' 72' ' ' TRP . 68.4 mt -142.17 119.56 11.59 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 107.636 -1.246 . . . . 2.6099999999999999 107.636 178.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.86 -17.92 9.29 Favored Glycine 0 N--CA 1.5 2.907 0 O-C-N 121.293 -0.879 . . . . 0.02 112.738 -177.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.44 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 26.4 t -156.16 156.59 34.48 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 120.239 2.02 . . . . 0.02 111.033 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.7 m -145.89 148.07 32.45 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.621 -0.674 . . . . 0.02 110.395 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.449 ' CD ' ' CD1' ' A' ' 54' ' ' PHE . 19.4 mtp180 -138.21 143.22 40.07 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.559 -0.713 . . . . 0.01 109.186 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.22 131.69 36.27 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.192 -0.942 . . . . 0.42999999999999999 109.635 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.5 t -91.2 125.07 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.906 -0.775 . . . . 1.25 108.906 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -93.91 131.21 39.56 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.808 -1.182 . . . . 1.77 108.974 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 mt -96.05 140.01 31.4 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.389 -0.967 . . . . 1.6299999999999999 108.389 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.2 m -111.83 127.52 55.84 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.347 -0.846 . . . . 1.0800000000000001 109.318 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.3 m -104.09 -154.04 0.49 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 106.62 -1.622 . . . . 1.26 106.62 177.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.95 -52.6 0.74 Allowed Glycine 0 N--CA 1.501 2.981 0 O-C-N 120.396 -1.44 . . . . 0.01 112.82 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.92 -101.28 0.15 Allowed Glycine 0 N--CA 1.49 2.253 0 C-N-CA 118.491 -1.814 . . . . 0.01 112.042 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 38.8 tp60 -121.48 118.99 30.73 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.172 -1.193 . . . . 4.4299999999999997 110.683 -178.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.59 130.54 35.47 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.769 -0.772 . . . . 2.9900000000000002 109.424 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -129.53 142.01 50.86 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.353 -0.842 . . . . 6.3600000000000003 109.062 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.0 tt -128.28 144.77 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 O-C-N 121.322 -0.862 . . . . 1.0900000000000001 110.245 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -123.15 133.83 54.23 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.838 -1.171 . . . . 2.0499999999999998 107.838 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.485 HG12 ' SG ' ' A' ' 129' ' ' CYS . 27.2 m -124.24 146.25 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 O-C-N 120.625 -1.297 . . . . 1.1000000000000001 109.882 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -119.31 141.32 49.09 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.844 0.831 . . . . 0.72999999999999998 110.848 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -66.99 -30.26 70.33 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 116.126 -0.488 . . . . 0.02 111.581 -178.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -116.31 169.69 9.11 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.138 -0.976 . . . . 3.1800000000000002 110.44 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.4 165.25 52.01 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.827 -0.909 . . . . 0.01 110.827 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.435 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 0.9 OUTLIER 57.27 38.23 28.55 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.925 -0.75 . . . . 0.01 111.57 178.659 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 51.97 54.68 10.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.467 -0.771 . . . . 0.01 111.228 177.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' A' ' 105' ' ' GLY . 19.6 t-20 -129.71 166.01 20.69 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.92 -1.141 . . . . 3.1499999999999999 107.92 178.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.512 ' N ' ' OD1' ' A' ' 104' ' ' ASN . . . 91.1 -163.37 29.14 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.19 -1.564 . . . . 0.01 109.19 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.7 tp60 -76.68 143.65 39.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.968 -1.313 . . . . 0.01 108.974 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.447 ' C ' ' SD ' ' A' ' 107' ' ' MET . 12.6 tmm? -116.47 142.23 47.13 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.553 0.692 . . . . 0.01 109.985 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -131.46 136.8 48.25 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.326 -0.99 . . . . 2.48 108.326 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -118.83 134.47 55.13 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.495 -0.753 . . . . 0.01 110.007 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.4 t -148.89 149.57 31.48 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.255 1.026 . . . . 1.6899999999999999 110.951 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 20.2 p -110.97 9.76 22.21 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 115.53 -0.759 . . . . 0.01 110.314 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -120.9 163.24 18.52 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.203 -0.936 . . . . 3.21 111.514 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -68.08 156.57 37.15 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.212 -1.033 . . . . 0.01 108.212 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 19.8 t -126.72 114.04 22.58 Favored Pre-proline 0 N--CA 1.5 2.053 0 O-C-N 121.484 -0.76 . . . . 0.01 109.029 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -75.1 -29.43 8.07 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 CA-C-N 120.376 1.17 . . . . 0.01 111.116 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 69.6 m -142.12 109.37 5.57 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.383 -0.823 . . . . 0.02 109.324 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.58 -39.38 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.777 -0.577 . . . . 1.8300000000000001 110.567 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 22.6 ttt -68.82 -37.57 79.29 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.398 -0.921 . . . . 1.3400000000000001 110.358 -178.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -69.58 -38.67 77.47 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.434 -1.416 . . . . 2.1099999999999999 109.986 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -79.94 -46.93 15.83 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.291 -0.881 . . . . 2.0800000000000001 112.297 -177.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -111.34 0.06 16.53 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.391 -0.818 . . . . 0.02 112.663 -176.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.3 m80 60.27 33.48 20.92 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.789 -1.194 . . . . 0.02 109.618 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.1 mt -112.51 135.02 53.72 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 108.743 -0.836 . . . . 0.02 108.743 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -91.59 -22.79 20.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 5.3200000000000003 110.27 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -149.05 163.79 36.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.198 -0.939 . . . . 0.02 109.702 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.0 mt -131.63 129.06 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 107.831 -1.174 . . . . 2.1699999999999999 107.831 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -108.84 -12.54 14.89 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.368 -0.832 . . . . 0.02 112.231 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.0 t -158.86 150.56 20.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.851 -1.156 . . . . 0.01 109.196 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.485 ' SG ' HG12 ' A' ' 97' ' ' VAL . 6.2 t -167.75 147.04 4.88 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.696 -0.853 . . . . 1.22 108.696 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -122.06 111.64 17.27 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 122.348 1.071 . . . . 1.4099999999999999 109.79 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 t -112.56 130.32 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 107.532 -1.284 . . . . 0.01 107.532 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 48.6 t -129.57 93.6 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 N-CA-C 107.204 -1.406 . . . . 1.98 107.204 177.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.487 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 11.7 tm-20 -147.19 -76.54 0.18 Allowed 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 105.869 -1.9 . . . . 0.01 105.869 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.485 ' N ' ' OE1' ' A' ' 133' ' ' GLU . . . 176.31 -75.63 0.08 OUTLIER Glycine 0 N--CA 1.485 1.905 0 N-CA-C 108.308 -1.917 . . . . 0.01 108.308 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.679 ' OG1' HD12 ' A' ' 175' ' ' ILE . 0.5 OUTLIER -120.29 121.04 37.78 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.686 -0.891 . . . . 2.2999999999999998 110.235 179.469 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.487 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 6.8 m95 -126.99 151.17 48.92 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 106.87 -1.53 . . . . 0.01 106.87 179.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 81.1 mt -122.55 137.43 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 120.321 -1.487 . . . . 1.6899999999999999 110.669 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -114.77 144.39 43.57 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 107.268 -1.382 . . . . 2.4900000000000002 107.268 178.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.501 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 14.6 m-85 -122.75 143.76 49.61 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.217 -0.927 . . . . 0.02 109.559 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -74.66 -29.08 61.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.524 -0.735 . . . . 0.02 111.864 -176.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mt -116.18 154.89 48.69 Favored Pre-proline 0 N--CA 1.506 2.346 0 O-C-N 120.757 -1.215 . . . . 1.48 108.92 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -55.69 167.23 2.25 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.19 1.26 . . . . 0.02 112.817 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 59.67 30.67 20.29 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.125 -0.943 . . . . 0.75 111.286 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 57.82 51.44 9.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.59 -0.694 . . . . 0.02 111.152 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -126.21 164.89 19.98 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.457 -0.777 . . . . 0.02 110.106 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.07 -165.82 33.24 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.387 -1.085 . . . . 0.02 110.387 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -69.0 142.45 54.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.544 -0.974 . . . . 0.02 108.903 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -114.2 148.47 37.26 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.414 0.626 . . . . 0.02 110.129 -178.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -125.13 134.75 52.32 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.073 -0.714 . . . . 0.01 109.073 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.52 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.6 tt -99.27 121.67 41.39 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.907 -1.121 . . . . 0.01 109.004 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.574 HD11 ' CE1' ' A' ' 156' ' ' TYR . 21.3 tp -97.27 144.64 26.86 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.245 -0.909 . . . . 0.01 109.247 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.514 ' C ' ' HH ' ' A' ' 156' ' ' TYR . 3.3 m-20 -106.42 -162.07 0.83 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.494 -0.753 . . . . 2.27 109.852 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -99.78 51.31 0.92 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.337 -0.852 . . . . 1.8400000000000001 109.867 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -115.06 -174.93 2.58 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.361 -0.837 . . . . 2.2799999999999998 109.578 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -105.01 110.28 22.62 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.497 -0.927 . . . . 0.01 108.497 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.642 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 4.5 m-85 -100.72 113.46 26.36 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.385 -0.822 . . . . 0.01 110.523 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -96.48 -22.23 17.24 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.31 -0.869 . . . . 0.01 111.586 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -127.23 153.67 76.9 Favored Pre-proline 0 N--CA 1.505 2.294 0 O-C-N 120.892 -1.13 . . . . 2.54 109.173 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -59.76 -40.38 64.53 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 120.466 0.777 . . . . 0.69999999999999996 110.574 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 41.7 t -61.03 -19.83 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.751 -1.218 . . . . 0.85999999999999999 108.675 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 41.4 t0 -65.54 -15.37 62.63 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.019 -1.05 . . . . 0.02 109.851 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.642 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 11.1 m0 -97.68 11.01 38.5 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.219 -0.926 . . . . 0.02 108.887 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.67 11.09 85.09 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.817 -1.182 . . . . 0.02 110.939 178.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.1 141.26 33.17 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.188 -1.184 . . . . 0.02 110.15 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.94 -8.64 58.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.592 -0.692 . . . . 0.58999999999999997 110.219 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.1 t -143.62 150.32 50.26 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 120.931 -1.105 . . . . 0.87 109.195 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -75.91 18.52 0.63 Allowed 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 120.708 0.939 . . . . 0.38 112.161 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.62 124.19 29.94 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.952 -1.093 . . . . 0.17999999999999999 111.42 -178.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.9 mt -149.48 126.88 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.052 -1.462 . . . . 3.9900000000000002 107.052 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -112.11 -17.25 12.87 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.05 -1.031 . . . . 5.1699999999999999 113.096 -177.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 17.0 t -157.04 160.13 38.65 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 119.14 -2.225 . . . . 0.02 110.374 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.428 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 18.7 p90 -151.17 152.7 33.7 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.037 -1.039 . . . . 2.02 110.37 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -144.96 149.45 35.21 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.807 0.813 . . . . 0.01 110.225 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -88.62 145.15 25.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.613 -0.679 . . . . 0.01 109.293 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.679 HD12 ' OG1' ' A' ' 135' ' ' THR . 6.2 mt -95.3 129.18 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.319 -0.863 . . . . 3.04 109.359 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.9 p -135.77 146.12 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.222 -0.924 . . . . 1.8899999999999999 109.605 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.311 -0.868 . . . . 4.8899999999999997 109.413 179.965 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 41.0 m . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.483 -0.562 . . . . 5.2800000000000002 109.483 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -74.92 65.48 1.42 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.933 . . . . 5.96 109.385 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.1 m -81.0 142.93 32.92 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.411 -0.959 . . . . 2.2200000000000002 108.411 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.98 -179.84 47.73 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 118.31 -1.9 . . . . 0.81000000000000005 112.147 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.58 157.64 44.27 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.312 -1.515 . . . . 0.01 109.312 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -148.51 136.5 20.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.976 -1.308 . . . . 0.02 110.374 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.7 tt -130.62 140.68 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.724 -0.843 . . . . 0.02 108.724 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 t -120.83 130.42 53.95 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.573 -0.704 . . . . 0.39000000000000001 109.952 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.6 m-85 -110.33 139.94 45.01 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 109.217 -0.66 . . . . 0.02 109.217 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.564 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.7 m-85 -121.41 137.87 54.52 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.232 -0.917 . . . . 0.02 109.572 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -69.72 -27.43 64.97 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.995 -1.066 . . . . 0.029999999999999999 111.36 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 3.1 m-20 -114.23 169.68 8.85 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.927 -1.108 . . . . 0.029999999999999999 110.203 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.488 ' CG ' HD22 ' A' ' 37' ' ' ASN . 71.2 mtm180 -75.5 157.79 33.48 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.707 0.765 . . . . 0.029999999999999999 110.41 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 m120 66.16 33.84 7.13 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.884 0.85 . . . . 0.73999999999999999 111.192 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 55.54 41.25 30.93 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.301 0.572 . . . . 0.02 111.241 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -113.11 165.51 12.31 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.273 -1.01 . . . . 0.02 108.273 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.3 -166.97 35.32 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.767 -1.206 . . . . 0.029999999999999999 110.651 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.431 ' HG3' HH11 ' A' ' 18' ' ' ARG . 25.8 ttm-85 -68.77 141.68 55.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.494 -1.004 . . . . 2.7599999999999998 109.247 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -122.66 150.13 43.1 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.547 -0.721 . . . . 1.8899999999999999 109.88 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -138.11 134.02 34.14 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.706 -0.621 . . . . 0.02 109.659 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -109.08 136.17 49.03 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.393 -0.817 . . . . 1.1200000000000001 108.83 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.6 t -127.17 138.15 53.08 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.575 -0.703 . . . . 0.02 109.406 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.501 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 2.0 m-20 -118.93 11.75 12.63 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.494 -0.754 . . . . 0.20000000000000001 110.633 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 22.0 m -159.4 174.11 15.22 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.818 -1.176 . . . . 1.23 109.058 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -62.57 145.84 53.38 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.824 -1.173 . . . . 0.02 110.453 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 7.5 m -133.74 117.47 16.97 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 108.777 -0.823 . . . . 0.02 108.777 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.14 -21.92 49.59 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.167 -0.958 . . . . 0.23999999999999999 111.731 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -150.22 105.68 3.38 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.799 -1.188 . . . . 1.1399999999999999 109.526 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.8 5.32 45.54 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.54 0.686 . . . . 6.3700000000000001 110.067 -178.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -61.53 -28.3 69.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.404 -0.81 . . . . 3.1099999999999999 112.311 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.1 m -78.69 -18.85 53.72 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.248 -1.533 . . . . 0.88 111.741 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -105.74 -21.5 13.16 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.175 -0.953 . . . . 0.02 110.472 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 33' ' ' LEU . 47.6 mt -148.55 127.81 12.96 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.098 -1.001 . . . . 3.3199999999999998 109.125 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.5 p -86.18 -11.3 52.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.791 -0.568 . . . . 0.02 110.414 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -172.44 161.83 5.2 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.133 -1.062 . . . . 0.02 108.133 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 80.4 m -143.68 116.25 8.64 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.1 -1.0 . . . . 0.02 108.454 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.488 HD22 ' CG ' ' A' ' 13' ' ' ARG . 52.5 t30 -110.23 0.94 18.36 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 120.862 -1.149 . . . . 0.029999999999999999 111.519 -177.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.6 t -155.71 152.8 29.01 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.647 -1.242 . . . . 0.02 107.647 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.7 mt -146.94 148.7 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.104 -0.998 . . . . 0.02 110.63 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -124.52 125.35 44.06 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.614 -1.254 . . . . 0.02 107.614 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.5 t -105.24 113.99 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 107.018 -1.475 . . . . 0.02 107.018 177.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -84.71 -34.67 22.88 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.411 -0.805 . . . . 3.8100000000000001 110.135 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.83 150.02 18.52 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 118.519 -1.8 . . . . 0.02 110.802 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.15 172.13 48.84 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.269 -1.132 . . . . 0.01 110.269 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.4 m -119.62 135.17 54.92 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 107.934 -1.135 . . . . 1.48 107.934 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.436 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 35.6 m95 -127.94 155.55 44.05 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 122.625 1.202 . . . . 0.02 112.518 -176.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.65 134.26 51.63 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 105.283 -2.117 . . . . 0.23999999999999999 105.283 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.414 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.8 m -118.36 143.82 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 109.172 -0.677 . . . . 0.65000000000000002 109.172 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -120.93 145.19 47.96 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 122.172 0.987 . . . . 0.02 109.977 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -66.07 -33.52 75.99 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.917 -0.583 . . . . 0.02 111.385 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -124.97 158.15 64.09 Favored Pre-proline 0 N--CA 1.503 2.222 0 O-C-N 121.127 -0.983 . . . . 0.02 109.43 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.62 166.92 1.1 Allowed 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.753 1.635 . . . . 0.02 112.905 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' ' 53' ' ' ASN . 1.5 t30 63.38 36.31 11.61 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 115.279 -0.873 . . . . 0.02 111.048 178.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.43 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 7.2 m-85 45.47 51.49 9.7 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.611 0.72 . . . . 3.3900000000000001 110.904 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 t -126.08 163.46 23.02 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.182 0.515 . . . . 2.3300000000000001 109.88 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.61 -161.69 31.18 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.878 -1.289 . . . . 0.02 109.878 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 15.0 m80 -64.54 138.94 58.68 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.001 -1.293 . . . . 0.02 110.077 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.44 ' C ' ' SD ' ' A' ' 58' ' ' MET . 10.9 tmm? -119.09 137.16 53.76 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 121.301 0.572 . . . . 5.0099999999999998 109.72 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.572 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 86.1 m-85 -135.33 138.96 43.92 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.477 -0.764 . . . . 0.02 109.854 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.5 mm -95.51 131.52 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 109.192 -0.67 . . . . 1.72 109.192 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.497 HD22 ' CE1' ' A' ' 66' ' ' TYR . 11.2 mt -121.04 111.98 33.65 Favored Pre-proline 0 N--CA 1.506 2.333 0 O-C-N 121.368 -0.832 . . . . 0.02 110.984 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -77.85 169.61 20.36 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 CA-C-N 119.886 0.995 . . . . 1.47 110.092 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -53.06 140.74 24.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.768 -1.207 . . . . 4.25 110.439 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.64 -177.48 32.75 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.548 -1.311 . . . . 0.02 110.533 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -119.3 130.6 55.48 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.267 -1.137 . . . . 0.95999999999999996 109.759 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.497 ' CE1' HD22 ' A' ' 61' ' ' LEU . 96.8 m-85 -120.97 94.59 48.99 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 108.113 -1.069 . . . . 0.02 108.113 178.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.404 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 2.5 Cg_endo -66.8 -3.49 9.5 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 120.874 1.049 . . . . 0.02 113.908 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 35.0 mt-10 -157.95 154.97 28.65 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.687 -1.258 . . . . 2.02 108.238 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.461 ' CD1' ' OD1' ' A' ' 37' ' ' ASN . 24.2 p90 -60.25 -39.17 85.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.57 -0.706 . . . . 0.02 112.019 -177.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -59.88 -23.83 63.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.946 -1.096 . . . . 0.02 110.189 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -69.99 -18.93 63.35 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.947 0.879 . . . . 3.4199999999999999 108.895 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.572 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.5 t90 -107.7 9.85 29.07 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.402 -1.333 . . . . 0.02 107.402 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 33.2 mtm 60.46 23.03 12.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.589 -0.695 . . . . 0.02 110.266 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.46 144.11 45.91 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.598 -1.401 . . . . 0.02 109.598 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.0 tp -79.37 -31.17 42.84 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.5 -1.296 . . . . 0.97999999999999998 107.5 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -157.16 -171.76 3.75 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.342 -1.725 . . . . 0.02 106.342 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -98.43 28.54 4.09 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.618 -1.302 . . . . 0.02 110.703 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -97.0 122.61 40.18 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.83 -1.169 . . . . 3.2000000000000002 111.014 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.51 HD21 ' CH2' ' A' ' 72' ' ' TRP . 75.5 mt -141.92 119.21 11.48 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.541 -1.281 . . . . 2.6099999999999999 107.541 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.21 -18.33 9.91 Favored Glycine 0 N--CA 1.498 2.809 0 O-C-N 121.157 -0.964 . . . . 0.02 112.344 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 91.3 p -156.38 155.86 32.88 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.256 -1.732 . . . . 0.02 110.491 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 49.1 t -145.35 148.23 33.15 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.493 -0.754 . . . . 0.02 109.912 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.43 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 41.8 mtm180 -138.3 142.98 39.78 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.253 -0.904 . . . . 0.01 109.429 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.21 132.04 36.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.23 -0.919 . . . . 0.42999999999999999 109.691 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.9 t -91.14 125.21 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.796 -0.816 . . . . 1.25 108.796 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -93.31 131.97 37.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.762 -1.211 . . . . 1.77 108.995 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mt -97.01 139.3 33.22 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.249 -1.019 . . . . 1.6299999999999999 108.249 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.6 m -111.49 127.39 55.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.291 -0.881 . . . . 1.0800000000000001 109.192 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.9 m -103.88 -154.18 0.5 Allowed 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 106.387 -1.709 . . . . 1.26 106.387 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.46 -51.58 0.79 Allowed Glycine 0 N--CA 1.501 2.985 0 O-C-N 120.408 -1.433 . . . . 0.01 112.656 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.68 -100.86 0.15 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 118.493 -1.813 . . . . 0.01 111.977 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -121.43 118.7 30.05 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.085 -1.244 . . . . 4.4299999999999997 110.668 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.99 130.06 36.05 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.881 -0.728 . . . . 2.9900000000000002 109.374 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -130.2 140.48 50.73 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.459 -0.776 . . . . 6.3600000000000003 109.139 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.411 HG22 ' O ' ' A' ' 110' ' ' THR . 4.5 tt -128.33 145.54 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 121.425 -0.797 . . . . 1.0900000000000001 110.215 -179.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -122.18 133.2 54.73 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 107.607 -1.257 . . . . 2.0499999999999998 107.607 177.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.8 m -124.57 146.1 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 O-C-N 120.657 -1.277 . . . . 1.1000000000000001 109.805 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.581 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 62.3 m-85 -119.49 141.47 49.15 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 122.036 0.922 . . . . 0.72999999999999998 111.134 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -67.07 -30.31 70.33 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 115.963 -0.562 . . . . 0.02 111.511 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -116.05 169.28 9.38 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.13 -0.981 . . . . 3.1800000000000002 110.264 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.46 165.12 52.25 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.982 -0.847 . . . . 0.01 110.982 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 57.07 38.34 29.12 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.785 -0.833 . . . . 0.01 111.418 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 52.16 54.46 10.74 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.459 -0.776 . . . . 0.01 111.271 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -129.48 165.87 20.77 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.994 -1.113 . . . . 3.1499999999999999 107.994 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.08 -163.65 29.32 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.259 -1.537 . . . . 0.01 109.259 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -76.1 143.55 41.21 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.948 -1.325 . . . . 0.01 108.918 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.581 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 38.1 ttp -116.44 142.52 46.76 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.575 0.702 . . . . 0.01 109.803 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -131.64 136.55 47.82 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.234 -1.024 . . . . 2.48 108.234 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -118.45 134.1 55.34 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.541 -0.725 . . . . 0.01 110.193 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.411 ' O ' HG22 ' A' ' 95' ' ' ILE . 4.9 t -148.4 150.04 32.81 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 122.191 0.996 . . . . 1.6899999999999999 110.973 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.7 p -110.31 10.23 23.56 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 115.555 -0.748 . . . . 0.01 110.214 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -120.96 163.53 18.11 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.234 -0.916 . . . . 3.21 111.597 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -66.89 156.71 35.03 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.951 -1.129 . . . . 0.01 107.951 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.608 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 22.0 p -122.83 115.16 29.48 Favored Pre-proline 0 N--CA 1.5 2.069 0 O-C-N 121.459 -0.776 . . . . 0.01 109.153 178.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -78.15 -34.72 1.53 Allowed 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 119.993 1.033 . . . . 0.01 110.906 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.6 m -141.07 107.91 5.39 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.687 -0.856 . . . . 0.02 108.687 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.86 -38.93 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.988 -0.445 . . . . 1.8300000000000001 110.897 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 19.6 ttt -67.59 -38.11 83.54 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.155 -1.018 . . . . 1.3400000000000001 110.034 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -68.85 -38.09 79.54 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.407 -1.433 . . . . 2.1099999999999999 109.599 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -79.72 -46.92 16.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.324 -0.86 . . . . 2.0800000000000001 112.267 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -112.07 -0.51 15.63 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.398 -0.814 . . . . 0.02 112.841 -176.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.417 ' ND1' ' N ' ' A' ' 122' ' ' HIS . 2.2 m-70 61.61 34.66 17.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.852 -1.155 . . . . 0.02 109.811 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.1 mt -114.13 135.99 53.43 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.446 -0.784 . . . . 0.02 109.299 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -90.87 -22.09 21.1 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.239 -0.913 . . . . 5.3200000000000003 110.868 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -147.59 163.71 35.75 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.992 -1.067 . . . . 0.02 109.863 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.1 mm -129.49 125.68 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 107.853 -1.166 . . . . 2.1699999999999999 107.853 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -110.9 -13.4 14.13 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.204 -0.935 . . . . 0.02 112.821 -177.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.2 t -159.45 150.96 20.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.673 -1.267 . . . . 0.01 109.312 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.509 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 7.9 p -166.29 148.5 6.86 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.092 -1.005 . . . . 1.22 108.992 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.03 109.26 15.72 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 122.395 1.093 . . . . 1.4099999999999999 109.095 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.1 t -113.27 128.41 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 107.648 -1.241 . . . . 0.01 107.648 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.4 t -129.55 93.23 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 107.391 -1.336 . . . . 1.98 107.391 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.52 ' OE1' ' NE1' ' A' ' 136' ' ' TRP . 31.5 tt0 -147.08 -75.34 0.19 Allowed 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 105.882 -1.895 . . . . 0.01 105.882 177.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 177.26 -77.01 0.07 OUTLIER Glycine 0 N--CA 1.483 1.821 0 N-CA-C 108.403 -1.879 . . . . 0.01 108.403 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.512 ' OG1' HD12 ' A' ' 175' ' ' ILE . 2.7 t -120.23 125.5 48.29 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.541 -0.976 . . . . 2.2999999999999998 110.226 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.52 ' NE1' ' OE1' ' A' ' 133' ' ' GLU . 8.2 m95 -128.97 151.57 49.54 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 107.066 -1.457 . . . . 0.01 107.066 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 41.0 mt -119.53 134.84 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 120.383 -1.448 . . . . 1.6899999999999999 109.987 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -114.36 143.91 44.14 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.262 -1.384 . . . . 2.4900000000000002 107.262 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.511 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 11.5 m-85 -123.02 144.67 49.12 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.244 -0.91 . . . . 0.02 109.346 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -76.3 -28.89 57.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.687 -0.633 . . . . 0.02 111.732 -176.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.1 mt -116.32 155.03 48.87 Favored Pre-proline 0 N--CA 1.504 2.248 0 O-C-N 120.698 -1.251 . . . . 1.48 108.896 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -56.17 167.2 2.65 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.186 1.257 . . . . 0.02 113.072 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 59.49 31.3 20.93 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 114.995 -1.002 . . . . 0.75 111.363 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 57.63 51.22 9.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.536 -0.727 . . . . 0.02 111.092 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -127.02 165.19 19.92 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.583 -0.698 . . . . 0.02 110.157 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.89 -166.03 33.66 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.395 -1.082 . . . . 0.02 110.395 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -69.38 142.54 53.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.551 -0.97 . . . . 0.02 109.162 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -115.13 149.76 37.08 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.729 -0.607 . . . . 0.02 110.028 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -123.68 134.27 53.76 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 109.004 -0.739 . . . . 0.01 109.004 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.6 tp -97.07 121.11 38.6 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.797 -1.189 . . . . 0.01 109.4 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.479 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 12.9 tp -98.5 146.52 25.69 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.234 -0.916 . . . . 0.01 108.787 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -104.68 -124.77 0.22 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.465 -0.772 . . . . 2.27 110.251 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -138.63 50.45 1.86 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.218 -0.926 . . . . 1.8400000000000001 109.657 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -115.37 -167.2 1.21 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.344 -0.848 . . . . 2.2799999999999998 109.517 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -105.6 109.97 22.13 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.565 -0.902 . . . . 0.01 108.565 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.655 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 4.1 m-85 -99.97 111.53 23.83 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.382 -0.823 . . . . 0.01 110.301 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -96.14 -22.1 17.51 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.147 -0.97 . . . . 0.01 111.32 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -127.42 154.11 77.29 Favored Pre-proline 0 N--CA 1.505 2.275 0 O-C-N 121.04 -1.037 . . . . 2.54 108.957 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -59.62 -38.4 82.07 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 120.442 0.761 . . . . 0.69999999999999996 110.533 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 65.5 t -61.07 -19.68 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.948 -1.095 . . . . 0.85999999999999999 109.047 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -65.24 -15.18 62.2 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.973 -1.079 . . . . 0.02 109.856 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.655 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 9.8 m0 -97.65 11.04 38.39 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.173 -0.954 . . . . 0.02 108.985 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.31 11.13 84.61 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.899 -1.144 . . . . 0.02 110.988 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.71 140.88 33.27 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.042 -1.269 . . . . 0.02 110.155 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.39 -8.53 58.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.64 -0.662 . . . . 0.58999999999999997 110.178 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.7 p -142.29 150.95 56.94 Favored Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 120.93 -1.106 . . . . 0.87 109.237 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -75.69 16.8 0.73 Allowed 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 120.81 1.007 . . . . 0.38 112.241 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.14 121.78 27.03 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.359 1.076 . . . . 0.17999999999999999 111.27 -178.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.1 mt -149.33 124.21 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 106.096 -1.816 . . . . 3.9900000000000002 106.096 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -112.32 -15.46 13.15 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.217 -0.927 . . . . 5.1699999999999999 113.271 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 5.4 p -157.34 160.77 38.84 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 119.285 -2.135 . . . . 0.02 110.204 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.608 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 7.1 p90 -152.25 154.07 35.02 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.007 -1.058 . . . . 2.02 110.737 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.4 mtm180 -145.61 150.41 36.31 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.272 -0.892 . . . . 0.01 110.293 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -88.31 143.55 26.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.554 -0.716 . . . . 0.01 109.199 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.512 HD12 ' OG1' ' A' ' 135' ' ' THR . 3.1 mt -94.58 129.77 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.242 -0.912 . . . . 3.04 109.034 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.47 146.84 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.203 -0.936 . . . . 1.8899999999999999 109.639 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.365 -0.834 . . . . 4.8899999999999997 109.462 -179.922 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.4 t . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.316 0.579 . . . . 5.2800000000000002 109.495 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -61.55 156.56 19.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.955 . . . . 5.96 109.458 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 73.7 p -65.4 141.13 58.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.187 -1.57 . . . . 2.2200000000000002 111.166 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.89 36.87 4.09 Favored Glycine 0 N--CA 1.502 3.071 0 O-C-N 120.997 -1.064 . . . . 0.81000000000000005 113.444 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.81 143.25 34.77 Favored Glycine 0 N--CA 1.491 2.328 0 CA-C-N 120.927 2.364 . . . . 0.01 107.86 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -148.51 134.66 19.29 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.96 -1.318 . . . . 0.02 110.983 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.9 tt -128.56 138.95 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 107.703 -1.221 . . . . 0.02 107.703 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.4 t -122.33 130.21 52.91 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.225 -0.922 . . . . 0.39000000000000001 110.339 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 5.2 m-85 -110.36 140.45 44.54 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.82 -0.807 . . . . 0.02 108.82 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.555 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.7 m-85 -122.39 138.69 54.45 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.219 -0.926 . . . . 0.02 109.512 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.486 ' HG3' HD11 ' A' ' 33' ' ' LEU . 88.0 mt-10 -68.62 -27.46 66.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.083 -1.011 . . . . 0.029999999999999999 111.438 -178.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -114.77 170.17 8.53 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.822 -1.174 . . . . 0.029999999999999999 110.161 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -75.4 161.68 29.03 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.932 0.872 . . . . 0.029999999999999999 110.39 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.534 ' N ' ' ND2' ' A' ' 14' ' ' ASN . 0.9 OUTLIER 63.22 32.9 14.67 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.048 0.928 . . . . 0.73999999999999999 110.853 179.196 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.4 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 1.3 m-85 55.03 40.02 31.83 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.94 -0.573 . . . . 0.02 110.874 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -110.08 166.07 11.24 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.134 -1.061 . . . . 0.02 108.134 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.14 -167.59 36.21 Favored Glycine 0 N--CA 1.496 2.638 0 C-N-CA 119.765 -1.207 . . . . 0.029999999999999999 111.037 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -69.01 143.03 54.46 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.49 -1.006 . . . . 2.7599999999999998 109.171 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -120.76 149.02 43.18 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.5 0.667 . . . . 1.8899999999999999 110.197 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -132.7 127.56 35.04 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.323 -0.991 . . . . 0.02 108.323 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 7.8 p30 -112.6 136.76 51.77 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.429 -0.794 . . . . 1.1200000000000001 109.934 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.9 t -131.5 138.79 49.11 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.631 -0.668 . . . . 0.02 109.547 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -116.63 11.07 14.59 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.671 -0.643 . . . . 0.20000000000000001 109.912 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 9.8 p -158.63 174.86 14.42 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.408 -0.96 . . . . 1.23 108.408 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -60.75 143.66 53.96 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.669 -1.269 . . . . 0.02 109.912 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.3 t -131.51 117.44 18.79 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.487 -0.931 . . . . 0.02 108.487 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.81 -25.04 48.61 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.156 -0.965 . . . . 0.23999999999999999 110.83 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -155.15 101.38 2.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.031 -1.043 . . . . 1.1399999999999999 108.968 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.402 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 24.1 p90 -104.92 9.83 34.5 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 122.111 0.958 . . . . 6.3700000000000001 109.622 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 45.4 mtp180 -58.65 -24.0 60.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.509 -0.744 . . . . 3.1099999999999999 110.847 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.5 t -74.46 -16.49 60.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.796 -1.19 . . . . 0.88 110.071 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -104.53 -22.17 13.32 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.536 -0.728 . . . . 0.02 109.588 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.486 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.9 tp -150.38 128.89 12.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.194 -0.941 . . . . 3.3199999999999998 109.085 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.2 t -85.44 -9.86 56.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.786 -0.571 . . . . 0.02 111.11 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -171.36 162.75 6.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.859 -1.15 . . . . 0.02 107.954 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.2 p -143.25 115.42 8.4 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.806 -1.184 . . . . 0.02 108.717 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.407 HD22 ' HB3' ' A' ' 77' ' ' ASP . 5.2 t-20 -108.0 2.36 23.16 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 120.877 -1.14 . . . . 0.029999999999999999 110.889 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.0 p -156.94 154.63 30.01 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.553 -1.277 . . . . 0.02 107.553 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.3 mt -147.02 148.37 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.039 -1.038 . . . . 0.02 110.376 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -124.59 125.79 44.73 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.982 -1.118 . . . . 0.02 107.982 177.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.1 t -107.16 115.31 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 107.105 -1.443 . . . . 0.02 107.105 177.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -83.88 -34.14 24.64 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.585 -0.697 . . . . 3.8100000000000001 110.824 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.95 152.3 22.1 Favored Glycine 0 N--CA 1.486 2.016 0 C-N-CA 118.935 -1.602 . . . . 0.02 110.816 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.31 172.78 49.12 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.517 -1.325 . . . . 0.01 110.398 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 47.1 m -119.82 134.89 55.08 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.053 -1.091 . . . . 1.48 108.053 178.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.598 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 3.3 m95 -125.99 154.53 42.77 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 122.522 1.153 . . . . 0.02 112.178 -176.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.98 133.56 52.81 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 105.369 -2.085 . . . . 0.23999999999999999 105.369 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.531 ' HB ' HD22 ' A' ' 79' ' ' LEU . 33.0 m -118.46 143.17 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 109.005 -0.739 . . . . 0.65000000000000002 109.005 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -121.03 146.76 46.37 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 122.192 0.996 . . . . 0.02 110.041 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.25 -34.6 78.74 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.831 -0.622 . . . . 0.02 111.517 -177.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.55 163.02 45.41 Favored Pre-proline 0 N--CA 1.509 2.489 0 O-C-N 120.92 -1.113 . . . . 0.02 109.135 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -55.94 168.07 2.01 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.294 1.33 . . . . 0.02 113.208 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 63.79 36.41 10.52 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.103 -0.953 . . . . 0.02 111.863 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 45.57 52.24 9.38 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.669 0.747 . . . . 3.3900000000000001 111.188 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.1 m -127.2 164.22 22.15 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.261 0.553 . . . . 2.3300000000000001 109.912 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.32 -161.58 32.79 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.918 -1.273 . . . . 0.02 109.918 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -65.85 137.94 57.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.101 -1.234 . . . . 0.02 109.99 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 14.8 ptm -118.66 136.68 53.78 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.82 -0.55 . . . . 5.0099999999999998 109.556 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.477 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 96.5 m-85 -133.04 138.88 46.92 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-O 121.639 0.733 . . . . 0.02 109.756 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.9 mm -95.17 131.16 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.934 -0.765 . . . . 1.72 108.934 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.517 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 1.1 mt -120.02 110.73 36.16 Favored Pre-proline 0 N--CA 1.504 2.246 0 O-C-N 121.477 -0.764 . . . . 0.02 110.711 -178.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -77.65 168.59 22.28 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 CA-C-N 119.979 1.028 . . . . 1.47 110.139 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -54.18 141.15 30.19 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.836 -1.165 . . . . 4.25 110.395 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.43 -177.27 32.69 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 119.684 -1.246 . . . . 0.02 110.52 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -119.21 130.53 55.53 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.433 -1.039 . . . . 0.95999999999999996 109.662 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.517 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 51.1 m-85 -120.87 97.97 47.97 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 107.762 -1.199 . . . . 0.02 107.762 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -70.23 -3.91 13.27 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 120.681 0.921 . . . . 0.02 113.674 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -157.33 154.79 29.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.651 -1.281 . . . . 2.02 108.048 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -60.14 -39.23 85.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.542 -0.724 . . . . 0.02 111.871 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -59.89 -23.99 63.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.003 -1.061 . . . . 0.02 110.329 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -70.19 -18.79 63.2 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.955 0.883 . . . . 3.4199999999999999 108.898 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.544 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.4 t90 -108.27 10.39 27.75 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.396 -1.335 . . . . 0.02 107.396 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 7.5 mmt 60.6 22.52 12.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.533 -0.729 . . . . 0.02 110.51 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.66 145.17 47.72 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.535 -1.426 . . . . 0.02 109.535 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.8 mt -79.62 -30.85 41.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.062 -1.258 . . . . 0.97999999999999998 108.09 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -157.67 -171.48 3.58 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.541 -1.652 . . . . 0.02 106.541 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.407 ' HB3' HD22 ' A' ' 37' ' ' ASN . 2.4 p-10 -98.57 28.56 4.13 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.628 -1.295 . . . . 0.02 110.518 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.592 HH11 ' CG ' ' A' ' 78' ' ' ARG . 3.1 mtt-85 -97.87 122.74 41.34 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.163 -0.96 . . . . 3.2000000000000002 111.361 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.531 HD22 ' HB ' ' A' ' 48' ' ' VAL . 34.7 mt -144.78 122.24 11.68 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 107.6 -1.259 . . . . 2.6099999999999999 107.6 177.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.09 -16.06 11.88 Favored Glycine 0 N--CA 1.503 3.112 0 O-C-N 121.184 -0.948 . . . . 0.02 112.696 -177.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.8 t -156.55 155.91 32.73 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.171 -1.782 . . . . 0.02 110.363 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.1 p -145.39 148.03 32.91 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.532 -0.73 . . . . 0.02 110.303 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -138.44 143.61 39.75 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.311 -0.868 . . . . 0.01 109.386 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.95 133.13 36.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.42999999999999999 109.813 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.5 t -92.23 125.58 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.968 -0.753 . . . . 1.25 108.968 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -93.31 132.63 37.34 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.833 -1.167 . . . . 1.77 109.173 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.5 mt -98.95 141.27 31.92 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.499 -0.75 . . . . 1.6299999999999999 109.029 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.0 t -111.6 125.11 53.58 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.693 -0.855 . . . . 1.0800000000000001 108.693 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 90.2 p -116.7 133.29 56.19 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.717 -1.239 . . . . 1.26 108.039 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.02 -48.99 0.01 OUTLIER Glycine 0 N--CA 1.505 3.284 0 C-N-CA 117.723 -2.179 . . . . 0.01 113.839 -177.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -167.26 -105.47 0.18 Allowed Glycine 0 N--CA 1.491 2.358 0 CA-C-N 120.045 1.923 . . . . 0.01 111.098 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -118.95 117.23 28.27 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.061 -1.258 . . . . 4.4299999999999997 109.998 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.04 130.58 36.62 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.834 -0.747 . . . . 2.9900000000000002 109.132 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.462 ' HZ3' ' HB2' ' A' ' 94' ' ' LYS . 10.3 ttmm -130.16 139.95 50.82 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.51 -0.744 . . . . 6.3600000000000003 109.258 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.5 tt -129.28 145.8 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 O-C-N 121.39 -0.819 . . . . 1.0900000000000001 110.159 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -122.52 134.03 54.56 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 107.761 -1.2 . . . . 2.0499999999999998 107.761 177.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.491 HG12 ' SG ' ' A' ' 129' ' ' CYS . 29.6 m -123.18 146.06 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 120.868 -1.145 . . . . 1.1000000000000001 109.612 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.584 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 67.2 m-85 -118.51 140.56 49.69 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 122.104 0.954 . . . . 0.72999999999999998 110.845 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.43 ' OE2' ' O ' ' A' ' 99' ' ' GLU . 4.3 tm-20 -66.35 -30.18 70.53 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.957 -0.565 . . . . 0.02 111.357 -178.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.434 ' O ' ' OG ' ' A' ' 128' ' ' SER . 79.1 mttt -117.04 170.56 8.55 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.078 -1.014 . . . . 3.1800000000000002 110.327 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.48 170.86 41.65 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 111.003 -0.839 . . . . 0.01 111.003 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 51.86 38.76 24.26 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.55 0.691 . . . . 0.01 111.629 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 51.94 48.24 23.16 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.569 -0.707 . . . . 0.01 111.174 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.508 ' OD1' ' N ' ' A' ' 105' ' ' GLY . 21.2 t-20 -122.52 166.26 15.08 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.331 -0.988 . . . . 3.1499999999999999 108.331 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.508 ' N ' ' OD1' ' A' ' 104' ' ' ASN . . . 91.95 -164.45 28.72 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.507 -1.437 . . . . 0.01 109.507 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 64.0 tp60 -76.36 144.22 40.24 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.988 -1.301 . . . . 0.01 108.559 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.584 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 31.8 ttp -116.44 142.61 46.63 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.684 0.754 . . . . 0.01 109.907 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -131.15 137.4 49.0 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.225 -1.028 . . . . 2.48 108.225 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -118.16 133.82 55.56 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.549 -0.719 . . . . 0.01 110.044 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.3 t -148.67 149.45 31.5 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 122.287 1.041 . . . . 1.6899999999999999 110.984 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 p -111.03 9.65 22.1 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 115.452 -0.794 . . . . 0.01 110.025 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -121.17 163.28 18.71 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.202 -0.936 . . . . 3.21 111.719 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -67.42 156.64 36.06 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.326 -0.99 . . . . 0.01 108.326 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.59 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 92.2 m -124.7 111.14 27.67 Favored Pre-proline 0 N--CA 1.502 2.165 0 O-C-N 121.43 -0.794 . . . . 0.01 109.098 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -76.53 -32.83 3.5 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 CA-C-N 120.099 1.071 . . . . 0.01 111.492 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.9 t -140.41 106.33 5.18 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.331 -0.989 . . . . 0.02 108.331 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 73.8 mt -65.2 -38.84 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.81 -0.556 . . . . 1.8300000000000001 111.044 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.437 ' SD ' ' C ' ' A' ' 123' ' ' LEU . 8.9 tpt -66.52 -38.24 86.78 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.046 -1.062 . . . . 1.3400000000000001 110.022 -178.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -69.6 -38.53 77.32 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.455 -1.403 . . . . 2.1099999999999999 109.77 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -80.55 -47.12 14.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.34 -0.85 . . . . 2.0800000000000001 112.453 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -111.7 -1.3 15.72 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.433 -0.792 . . . . 0.02 112.556 -176.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 61.42 34.08 18.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.837 -1.164 . . . . 0.02 109.655 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.437 ' C ' ' SD ' ' A' ' 118' ' ' MET . 38.7 mt -114.21 136.13 53.29 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.48 -0.763 . . . . 0.02 109.269 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -90.63 -21.9 21.46 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.212 -0.93 . . . . 5.3200000000000003 110.918 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -148.18 164.02 35.21 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.853 -1.155 . . . . 0.02 110.009 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.4 mm -129.8 126.02 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 107.554 -1.276 . . . . 2.1699999999999999 107.554 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -109.84 -13.4 14.46 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.156 -0.965 . . . . 0.02 112.966 -177.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 16.6 p -161.2 153.07 19.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.59 -1.319 . . . . 0.01 109.295 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.491 ' SG ' HG12 ' A' ' 97' ' ' VAL . 6.6 t -169.34 145.47 3.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.385 -0.822 . . . . 1.22 108.832 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -124.98 107.83 11.24 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 122.311 1.053 . . . . 1.4099999999999999 109.685 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.595 HG21 ' CD1' ' A' ' 136' ' ' TRP . 11.9 p -110.91 138.26 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.46 -1.311 . . . . 0.01 107.46 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.5 t -127.78 94.46 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 107.186 -1.412 . . . . 1.98 107.186 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.518 ' OE1' ' NE1' ' A' ' 136' ' ' TRP . 52.2 tt0 -146.19 -75.31 0.21 Allowed 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 105.987 -1.857 . . . . 0.01 105.987 177.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 176.57 -77.39 0.07 OUTLIER Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.648 -1.781 . . . . 0.01 108.648 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.56 ' OG1' HD12 ' A' ' 175' ' ' ILE . 1.6 t -119.49 126.13 50.55 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.623 -0.928 . . . . 2.2999999999999998 110.318 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.595 ' CD1' HG21 ' A' ' 131' ' ' VAL . 43.8 m95 -128.72 150.01 50.45 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 107.166 -1.42 . . . . 0.01 107.166 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 56.2 mt -120.87 136.5 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 120.441 -1.412 . . . . 1.6899999999999999 109.973 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -114.75 144.38 43.57 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.604 -1.258 . . . . 2.4900000000000002 107.604 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.444 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 24.0 m-85 -122.8 144.13 49.38 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.372 -0.83 . . . . 0.02 109.53 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -75.62 -29.18 59.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.448 -0.782 . . . . 0.02 111.671 -176.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.3 mt -116.39 154.78 48.97 Favored Pre-proline 0 N--CA 1.505 2.302 0 O-C-N 120.759 -1.213 . . . . 1.48 109.029 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -55.62 167.2 2.22 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.19 1.26 . . . . 0.02 113.022 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 11.3 m120 59.62 30.74 20.38 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.105 -0.952 . . . . 0.75 111.318 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 57.47 51.24 10.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.426 -0.796 . . . . 0.02 110.921 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -126.17 164.52 20.77 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.55 -0.719 . . . . 0.02 109.911 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.95 -165.61 33.26 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.17 -1.172 . . . . 0.02 110.17 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -69.42 142.07 53.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.551 -0.97 . . . . 0.02 109.142 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.47 ' CD ' ' N ' ' A' ' 148' ' ' GLN . 7.1 mp0 -114.79 149.39 37.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.831 -0.543 . . . . 0.02 110.047 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 149' ' ' TYR . 20.2 m-85 -124.51 134.4 53.02 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.18 -0.674 . . . . 0.01 109.18 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.6 tt -98.93 121.39 40.82 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.865 -1.147 . . . . 0.01 108.972 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.417 HD21 ' CE1' ' A' ' 156' ' ' TYR . 4.4 tp -100.2 151.12 21.81 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.253 -0.904 . . . . 0.01 108.89 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.4 ' CG ' ' H ' ' A' ' 153' ' ' LYS . 62.8 t0 -104.23 -124.4 0.21 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.369 -0.832 . . . . 2.27 109.883 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.4 ' H ' ' CG ' ' A' ' 152' ' ' ASP . 29.0 ttmt -136.46 49.55 2.08 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.352 -0.843 . . . . 1.8400000000000001 109.586 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -113.55 -172.36 2.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.546 -0.721 . . . . 2.2799999999999998 109.252 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -105.61 113.32 26.82 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.752 -0.833 . . . . 0.01 108.752 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.417 ' CE1' HD21 ' A' ' 151' ' ' LEU . 60.6 m-85 -98.58 112.68 24.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.328 -0.857 . . . . 0.01 110.133 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -94.81 -24.5 17.03 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.195 -0.941 . . . . 0.01 110.91 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -125.43 154.99 72.44 Favored Pre-proline 0 N--CA 1.498 1.972 0 N-CA-C 108.383 -0.969 . . . . 2.54 108.383 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.553 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 8.4 Cg_endo -60.48 -39.19 67.92 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 CA-C-N 119.197 0.749 . . . . 0.69999999999999996 110.844 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 68.0 t -61.45 -18.8 19.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 O-C-N 120.742 -1.224 . . . . 0.85999999999999999 109.282 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -65.44 -17.84 64.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.915 -1.116 . . . . 0.02 111.852 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.553 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.6 OUTLIER -101.74 16.39 25.99 Favored 'General case' 0 N--CA 1.513 2.702 0 O-C-N 120.886 -1.134 . . . . 0.02 110.19 178.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.03 9.74 79.91 Favored Glycine 0 N--CA 1.499 2.844 0 O-C-N 121.136 -0.978 . . . . 0.02 113.091 176.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.509 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.02 141.6 32.62 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.799 -1.412 . . . . 0.02 110.193 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.78 -8.25 58.89 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.374 -0.602 . . . . 0.58999999999999997 109.374 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.3 t -142.96 150.55 53.41 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.078 -1.014 . . . . 0.87 108.887 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -75.63 18.47 0.6 Allowed 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 120.746 0.964 . . . . 0.38 112.33 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.57 121.99 27.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.899 -1.126 . . . . 0.17999999999999999 111.282 -178.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.8 mt -149.12 123.62 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 105.986 -1.857 . . . . 3.9900000000000002 105.986 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -112.17 -15.92 13.12 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.103 -0.998 . . . . 5.1699999999999999 113.301 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 26.0 t -156.71 159.71 38.63 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 119.231 -2.168 . . . . 0.02 109.993 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.59 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 12.7 p90 -152.69 153.89 34.17 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.969 -1.082 . . . . 2.02 110.53 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 48.5 mtp180 -144.83 150.62 37.44 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.907 0.861 . . . . 0.01 110.439 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -88.5 143.77 26.76 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.424 -0.584 . . . . 0.01 109.424 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.56 HD12 ' OG1' ' A' ' 135' ' ' THR . 6.2 mt -95.17 128.82 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.158 -0.964 . . . . 3.04 109.039 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 75.0 t -136.3 146.56 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.136 -0.977 . . . . 1.8899999999999999 109.543 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.335 -0.853 . . . . 4.8899999999999997 109.586 -179.928 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.446 -0.576 . . . . 5.2800000000000002 109.446 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 50.8 mttp -79.26 166.87 21.69 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.171 -0.956 . . . . 5.96 109.457 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.428 ' H ' HG22 ' A' ' 3' ' ' THR . 0.0 OUTLIER -80.77 141.7 34.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.135 -0.978 . . . . 2.2200000000000002 108.413 178.438 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.26 -179.83 47.89 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 118.27 -1.919 . . . . 0.81000000000000005 111.935 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.98 157.87 43.8 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.349 -1.5 . . . . 0.01 109.349 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -147.12 136.13 22.35 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.098 -1.237 . . . . 0.02 110.77 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.0 tt -130.73 140.13 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 108.927 -0.768 . . . . 0.02 108.927 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.0 t -122.12 130.51 53.31 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.428 -0.795 . . . . 0.39000000000000001 110.009 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 8.7 m-85 -110.93 140.96 44.99 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 109.092 -0.707 . . . . 0.02 109.092 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.526 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 7.5 m-85 -122.97 139.21 54.31 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.222 -0.924 . . . . 0.02 109.76 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.469 ' HG3' HD11 ' A' ' 33' ' ' LEU . 82.5 mt-10 -68.97 -27.75 66.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.033 -1.042 . . . . 0.029999999999999999 111.599 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -114.54 169.56 8.96 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.876 -1.14 . . . . 0.029999999999999999 110.306 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -75.21 158.24 33.27 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.651 0.739 . . . . 0.029999999999999999 110.211 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 66.26 33.37 7.25 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.906 0.86 . . . . 0.73999999999999999 111.131 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 55.26 41.82 30.98 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.185 0.517 . . . . 0.02 111.177 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -113.15 165.99 11.86 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.208 -1.034 . . . . 0.02 108.208 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.89 -167.26 36.31 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.834 -1.174 . . . . 0.029999999999999999 110.683 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -69.44 142.05 53.92 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.44 -1.036 . . . . 2.7599999999999998 109.135 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -120.89 149.41 42.65 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.586 0.708 . . . . 1.8899999999999999 110.204 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -132.54 127.5 35.24 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.358 -0.978 . . . . 0.02 108.358 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -112.48 137.12 51.14 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.566 -0.709 . . . . 1.1200000000000001 109.806 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 14.9 t -131.67 139.1 48.98 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.514 0.673 . . . . 0.02 109.761 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -116.91 11.22 14.33 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.578 -0.701 . . . . 0.20000000000000001 109.674 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.535 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 50.4 t -158.19 174.4 15.25 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.362 -0.977 . . . . 1.23 108.362 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.535 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 3.2 p30 -60.97 144.08 53.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.646 -1.284 . . . . 0.02 109.867 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.1 p -131.76 117.42 18.57 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.494 -0.928 . . . . 0.02 108.494 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.16 -25.62 47.36 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.052 -1.03 . . . . 0.23999999999999999 110.889 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 28' ' ' ASP . 8.4 p30 -154.14 101.31 2.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.966 -1.084 . . . . 1.1399999999999999 109.022 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -104.71 9.46 35.06 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 122.219 1.009 . . . . 6.3700000000000001 109.897 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -58.52 -24.13 59.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.411 -0.805 . . . . 3.1099999999999999 111.012 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.7 p -74.47 -16.69 60.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.656 -1.278 . . . . 0.88 110.105 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -103.97 -22.1 13.52 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.458 -0.776 . . . . 0.02 109.628 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.469 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.8 tp -150.43 128.98 12.23 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.131 -0.981 . . . . 3.3199999999999998 109.223 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.8 p -85.86 -10.19 55.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.791 -0.568 . . . . 0.02 111.124 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -171.23 162.68 6.98 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.908 -1.145 . . . . 0.02 107.908 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.1 p -144.11 116.36 8.47 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.826 -1.171 . . . . 0.02 109.056 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.497 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 1.0 OUTLIER -108.28 1.63 22.1 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.745 -1.222 . . . . 0.029999999999999999 110.924 -178.601 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 56.1 m -155.86 154.24 30.98 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.786 -1.19 . . . . 0.02 107.786 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.8 mt -146.02 146.8 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.118 -0.989 . . . . 0.02 110.616 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -123.46 124.63 43.32 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.112 -1.07 . . . . 0.02 108.112 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.0 t -106.15 114.47 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 106.849 -1.537 . . . . 0.02 106.849 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -84.67 -34.32 23.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.476 -0.765 . . . . 3.8100000000000001 110.452 -178.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.82 149.89 18.25 Favored Glycine 0 N--CA 1.486 1.991 0 C-N-CA 119.071 -1.538 . . . . 0.02 110.507 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.29 172.48 49.09 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.915 -1.136 . . . . 0.01 110.448 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.5 m -119.13 135.12 54.82 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.045 -1.094 . . . . 1.48 108.045 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 36.2 m95 -126.86 154.24 44.64 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 122.563 1.173 . . . . 0.02 112.316 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.75 134.41 51.51 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 105.448 -2.056 . . . . 0.23999999999999999 105.448 176.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.509 ' HB ' HD22 ' A' ' 79' ' ' LEU . 27.4 m -118.44 143.31 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.622 -0.674 . . . . 0.65000000000000002 109.257 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.538 ' CE2' ' SD ' ' A' ' 58' ' ' MET . 33.0 m-85 -120.95 145.53 47.62 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 122.256 1.027 . . . . 0.02 109.975 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -66.5 -34.18 77.35 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.798 -0.637 . . . . 0.02 111.42 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -125.61 157.92 66.68 Favored Pre-proline 0 N--CA 1.502 2.158 0 O-C-N 121.194 -0.941 . . . . 0.02 109.511 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -53.68 167.1 1.08 Allowed 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.707 1.604 . . . . 0.02 113.169 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.414 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.5 m-20 63.9 36.2 10.4 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.079 -0.964 . . . . 0.02 111.092 178.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 45.39 51.92 9.27 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.692 0.758 . . . . 3.3900000000000001 110.673 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.8 m -126.52 163.89 22.39 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.235 0.54 . . . . 2.3300000000000001 109.871 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.11 -161.8 31.92 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.958 -1.257 . . . . 0.02 109.958 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -65.22 138.88 58.52 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.093 -1.239 . . . . 0.02 110.176 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.538 ' SD ' ' CE2' ' A' ' 49' ' ' TYR . 48.6 ttp -118.52 136.97 53.53 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.798 -0.564 . . . . 5.0099999999999998 109.507 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.482 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 90.1 m-85 -134.5 138.42 44.68 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 121.763 0.792 . . . . 0.02 109.807 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.8 mm -96.06 131.64 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.082 -0.711 . . . . 1.72 109.082 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.459 HD22 ' CE1' ' A' ' 66' ' ' TYR . 12.2 mt -121.5 112.18 32.8 Favored Pre-proline 0 N--CA 1.506 2.326 0 O-C-N 121.365 -0.835 . . . . 0.02 110.853 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -77.7 169.98 19.91 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 CA-C-N 119.822 0.972 . . . . 1.47 109.981 177.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -52.64 140.98 21.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.833 -1.167 . . . . 4.25 110.263 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.44 -178.25 32.17 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.507 -1.33 . . . . 0.02 110.845 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -120.37 131.85 55.01 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.492 -1.005 . . . . 0.95999999999999996 109.804 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.459 ' CE1' HD22 ' A' ' 61' ' ' LEU . 94.1 m-85 -121.91 96.1 47.15 Favored Pre-proline 0 N--CA 1.495 1.822 0 N-CA-C 107.958 -1.127 . . . . 0.02 107.958 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.4 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.3 Cg_endo -67.21 -3.84 10.59 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 120.712 0.941 . . . . 0.02 113.868 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 35.0 mt-10 -157.52 155.44 30.28 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.64 -1.288 . . . . 2.02 108.239 179.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -60.42 -39.22 86.64 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.6 -0.687 . . . . 0.02 112.048 -177.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -59.88 -23.77 63.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.091 -1.006 . . . . 0.02 110.202 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -70.36 -19.2 63.06 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.87 0.843 . . . . 3.4199999999999999 108.948 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.544 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 1.6 t90 -107.68 9.9 29.1 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.483 -1.303 . . . . 0.02 107.483 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.7 mtt 60.52 22.5 12.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.605 -0.684 . . . . 0.02 110.335 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.35 144.6 47.3 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.435 -1.466 . . . . 0.02 109.435 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.0 mt -79.13 -30.42 43.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.101 -1.235 . . . . 0.97999999999999998 107.779 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -157.68 -171.26 3.49 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 106.393 -1.706 . . . . 0.02 106.393 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -98.61 29.04 3.87 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.7 -1.25 . . . . 0.02 110.484 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.582 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -98.58 123.08 42.54 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.178 -0.951 . . . . 3.2000000000000002 111.383 -178.771 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.509 HD22 ' HB ' ' A' ' 48' ' ' VAL . 35.4 mt -144.93 122.73 11.91 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 107.39 -1.337 . . . . 2.6099999999999999 107.39 177.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.96 -16.57 11.27 Favored Glycine 0 N--CA 1.502 3.096 0 O-C-N 121.158 -0.964 . . . . 0.02 112.686 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 90.2 p -156.68 156.42 33.4 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.154 -1.792 . . . . 0.02 110.351 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 12.7 m -145.0 147.81 33.05 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.545 -0.722 . . . . 0.02 110.012 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -138.04 142.99 40.32 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.317 -0.864 . . . . 0.01 109.593 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.56 132.99 36.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.31 -0.869 . . . . 0.42999999999999999 109.804 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.9 t -91.57 125.07 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.994 -0.743 . . . . 1.25 108.994 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -93.61 132.06 38.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.735 -1.228 . . . . 1.77 109.044 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -97.37 139.79 32.79 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.579 -0.897 . . . . 1.6299999999999999 108.579 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.5 t -111.8 127.72 55.89 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.351 -0.843 . . . . 1.0800000000000001 109.281 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.6 p -104.32 -154.33 0.5 Allowed 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 106.506 -1.664 . . . . 1.26 106.506 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.82 -51.37 0.78 Allowed Glycine 0 N--CA 1.5 2.95 0 O-C-N 120.39 -1.444 . . . . 0.01 112.771 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.43 -101.14 0.15 Allowed Glycine 0 N--CA 1.489 2.203 0 C-N-CA 118.515 -1.803 . . . . 0.01 111.877 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -121.4 119.1 31.13 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.194 -1.18 . . . . 4.4299999999999997 110.556 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.62 128.8 33.99 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.66 -0.816 . . . . 2.9900000000000002 109.359 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -130.62 141.75 50.44 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.458 -0.776 . . . . 6.3600000000000003 109.064 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.6 tt -129.69 146.76 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 O-C-N 121.281 -0.887 . . . . 1.0900000000000001 110.307 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -121.55 133.56 55.02 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 107.437 -1.319 . . . . 2.0499999999999998 107.437 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.5 m -124.04 146.09 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 120.768 -1.207 . . . . 1.1000000000000001 109.902 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.581 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 61.4 m-85 -118.74 141.27 48.77 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 122.007 0.908 . . . . 0.72999999999999998 110.879 -178.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -66.58 -30.55 70.88 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 116.007 -0.542 . . . . 0.02 111.351 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -116.82 170.28 8.73 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.124 -0.985 . . . . 3.1800000000000002 110.298 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.54 170.09 43.24 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.874 -0.89 . . . . 0.01 110.874 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 2.5 m-20 52.74 38.61 26.84 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.562 0.696 . . . . 0.01 111.704 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 52.42 48.71 22.02 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.65 -0.656 . . . . 0.01 110.944 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.504 ' ND2' ' H ' ' A' ' 105' ' ' GLY . 8.3 t-20 -123.08 165.36 16.95 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.252 -1.018 . . . . 3.1499999999999999 108.252 178.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.504 ' H ' ' ND2' ' A' ' 104' ' ' ASN . . . 91.9 -163.93 28.48 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.476 -1.45 . . . . 0.01 109.476 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.2 tp60 -76.73 144.05 39.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.936 -1.332 . . . . 0.01 108.899 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.581 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 30.5 ttp -116.4 142.32 47.01 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.65 0.738 . . . . 0.01 109.93 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -131.66 137.16 48.22 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.51 -0.922 . . . . 2.48 108.51 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -117.9 133.9 55.47 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.425 -0.797 . . . . 0.01 110.141 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.1 t -148.18 148.49 30.61 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 122.262 1.029 . . . . 1.6899999999999999 110.967 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 63.4 p -110.87 10.35 22.41 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 115.579 -0.737 . . . . 0.01 110.331 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -121.16 163.16 18.88 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.152 -0.967 . . . . 3.21 111.566 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -67.03 156.46 35.99 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.107 -1.072 . . . . 0.01 108.107 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.474 ' HG ' ' HZ ' ' A' ' 172' ' ' PHE . 19.9 m -125.37 113.75 25.7 Favored Pre-proline 0 N--CA 1.501 2.115 0 O-C-N 121.485 -0.759 . . . . 0.01 109.37 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -76.91 -31.6 3.81 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 CA-C-N 119.916 1.006 . . . . 0.01 111.562 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.0 t -142.49 108.12 5.1 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.238 -0.913 . . . . 0.02 109.068 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.67 -38.82 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.885 -0.509 . . . . 1.8300000000000001 110.949 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.8 ttt -68.33 -37.2 80.3 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.222 -0.991 . . . . 1.3400000000000001 110.263 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -70.36 -38.95 74.88 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.532 -1.355 . . . . 2.1099999999999999 110.302 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -79.01 -47.39 16.33 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.307 -0.871 . . . . 2.0800000000000001 112.483 -176.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -110.64 1.18 17.84 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.348 -0.845 . . . . 0.02 112.53 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.2 m170 59.31 32.77 22.16 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.724 -1.235 . . . . 0.02 109.236 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.7 mt -112.29 135.69 52.66 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 108.631 -0.877 . . . . 0.02 108.631 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -90.69 -22.39 21.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.842 . . . . 5.3200000000000003 110.109 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -150.47 164.47 35.85 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.24 -0.913 . . . . 0.02 110.16 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.9 mt -132.25 129.64 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 107.38 -1.341 . . . . 2.1699999999999999 107.38 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -107.91 -11.64 15.31 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.321 -0.862 . . . . 0.02 112.571 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.0 t -159.21 152.26 22.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.816 -1.177 . . . . 0.01 109.101 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 6.5 p -169.44 144.71 3.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.187 -0.945 . . . . 1.22 109.168 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -126.18 111.75 14.99 Favored 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 122.445 1.117 . . . . 1.4099999999999999 110.161 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.4 p -113.89 137.44 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 107.361 -1.348 . . . . 0.01 107.361 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 23.4 t -127.74 94.43 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 106.854 -1.536 . . . . 1.98 106.854 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.501 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 10.4 tm-20 -145.07 -77.78 0.2 Allowed 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 105.929 -1.878 . . . . 0.01 105.929 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.461 ' N ' ' OE1' ' A' ' 133' ' ' GLU . . . 175.58 -73.76 0.08 OUTLIER Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.934 -1.666 . . . . 0.01 108.934 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.406 ' OG1' HD12 ' A' ' 175' ' ' ILE . 29.8 p -119.18 120.14 36.19 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.565 -0.962 . . . . 2.2999999999999998 110.262 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.501 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 8.1 m95 -127.45 149.53 50.06 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 107.227 -1.398 . . . . 0.01 107.227 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 83.6 mt -123.31 138.88 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 120.504 -1.373 . . . . 1.6899999999999999 110.491 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -115.29 144.73 43.3 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 107.158 -1.423 . . . . 2.4900000000000002 107.158 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.496 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 14.0 m-85 -123.06 145.23 48.72 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.15 -0.969 . . . . 0.02 109.617 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -75.77 -30.21 59.05 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.5 -0.75 . . . . 0.02 112.237 -176.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.5 mt -115.07 155.07 47.09 Favored Pre-proline 0 N--CA 1.506 2.366 0 O-C-N 120.595 -1.316 . . . . 1.48 109.225 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.91 165.54 2.61 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.183 1.255 . . . . 0.02 112.547 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 60.08 31.38 20.57 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.131 -0.94 . . . . 0.75 111.484 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 57.55 51.77 9.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.367 -0.833 . . . . 0.02 111.183 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -126.15 164.52 20.75 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.547 -0.721 . . . . 0.02 109.859 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.27 -165.69 32.89 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.419 -1.073 . . . . 0.02 110.419 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -68.89 142.79 54.68 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.612 -0.934 . . . . 0.02 109.053 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -115.18 148.91 38.47 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.386 0.612 . . . . 0.02 109.869 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -124.38 134.4 53.14 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.532 -0.73 . . . . 0.01 109.069 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.513 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.8 tt -98.85 120.22 38.93 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.941 -1.099 . . . . 0.01 108.651 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.513 ' N ' HD23 ' A' ' 150' ' ' LEU . 6.6 tp -103.07 150.89 23.15 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.27 -0.894 . . . . 0.01 109.12 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -104.56 -110.26 0.26 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.431 -0.793 . . . . 2.27 109.54 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -156.5 51.68 0.52 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.118 -0.989 . . . . 1.8400000000000001 109.638 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -112.71 -163.08 0.83 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.584 -0.697 . . . . 2.2799999999999998 109.264 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -106.39 104.41 14.1 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.452 -0.78 . . . . 0.01 109.073 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.653 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 6.5 m-85 -98.7 112.36 24.45 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.244 -0.91 . . . . 0.01 109.51 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -95.09 -22.15 18.08 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.188 -0.945 . . . . 0.01 111.775 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -127.73 154.24 77.9 Favored Pre-proline 0 N--CA 1.502 2.171 0 O-C-N 120.715 -1.241 . . . . 2.54 109.036 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -60.53 -38.68 71.36 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 120.483 0.789 . . . . 0.69999999999999996 110.517 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.93 -20.08 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.819 -1.176 . . . . 0.85999999999999999 108.93 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 13.7 t0 -65.18 -15.4 62.4 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.955 -1.091 . . . . 0.02 109.925 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.653 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 9.9 m0 -97.89 11.34 37.69 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.111 -0.993 . . . . 0.02 109.099 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.83 10.21 85.93 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.789 -1.196 . . . . 0.02 110.968 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.49 141.47 32.23 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.313 -1.11 . . . . 0.02 110.061 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.57 -8.97 57.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.663 -0.648 . . . . 0.58999999999999997 109.948 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.1 p -143.2 150.35 51.86 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 120.919 -1.113 . . . . 0.87 108.869 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -76.6 18.81 0.68 Allowed 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 120.825 1.016 . . . . 0.38 112.371 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.14 123.08 28.66 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.855 -1.153 . . . . 0.17999999999999999 111.496 -177.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 169' ' ' ILE . 16.1 mm -151.75 127.04 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 106.815 -1.55 . . . . 3.9900000000000002 106.815 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -113.92 -12.91 12.6 Favored 'General case' 0 N--CA 1.508 2.429 0 O-C-N 121.065 -1.022 . . . . 5.1699999999999999 113.725 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 22.7 m -157.53 161.77 38.81 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 119.12 -2.237 . . . . 0.02 110.439 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.474 ' HZ ' ' HG ' ' A' ' 114' ' ' CYS . 21.3 p90 -152.74 153.77 33.87 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.044 -1.035 . . . . 2.02 110.662 178.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 48.8 mtp180 -145.44 150.38 36.4 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.775 0.798 . . . . 0.01 110.23 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -87.9 143.99 26.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.483 -0.761 . . . . 0.01 109.183 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.406 HD12 ' OG1' ' A' ' 135' ' ' THR . 5.1 mt -94.38 129.26 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.184 -0.948 . . . . 3.04 109.045 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.4 t -136.17 146.6 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.174 -0.953 . . . . 1.8899999999999999 109.675 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 4.8899999999999997 109.51 179.962 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 65.1 m . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.433 -0.58 . . . . 5.2800000000000002 109.433 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -65.47 136.55 56.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 5.96 109.53 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 39.1 m -144.13 145.47 32.14 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.01 -1.056 . . . . 2.2200000000000002 109.158 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.37 31.79 8.25 Favored Glycine 0 N--CA 1.504 3.194 0 O-C-N 120.493 -1.38 . . . . 0.81000000000000005 113.798 -176.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.14 142.52 33.13 Favored Glycine 0 N--CA 1.491 2.307 0 CA-C-N 121.174 2.487 . . . . 0.01 107.85 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -149.67 136.11 19.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.916 -1.344 . . . . 0.02 110.755 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.7 tt -128.62 139.25 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 107.822 -1.177 . . . . 0.02 107.822 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 t -121.11 129.63 53.38 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.321 -0.862 . . . . 0.39000000000000001 110.337 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 11.5 m-85 -109.67 139.69 44.41 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.803 -0.814 . . . . 0.02 108.803 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.528 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 6.3 m-85 -122.15 138.33 54.51 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.139 -0.975 . . . . 0.02 109.664 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.521 ' OE2' ' N ' ' A' ' 35' ' ' ARG . 6.1 mm-40 -67.83 -28.63 67.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.934 . . . . 0.029999999999999999 111.093 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.5 m-20 -114.77 170.06 8.61 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.882 -1.136 . . . . 0.029999999999999999 110.163 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -75.56 162.35 28.37 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.729 0.776 . . . . 0.029999999999999999 110.295 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 3.0 t30 62.8 33.33 15.4 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.002 0.906 . . . . 0.73999999999999999 110.806 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 55.0 40.36 32.0 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.975 -0.557 . . . . 0.02 110.843 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -110.67 165.96 11.4 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.14 -1.059 . . . . 0.02 108.14 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.02 -167.73 36.56 Favored Glycine 0 N--CA 1.495 2.62 0 C-N-CA 119.719 -1.229 . . . . 0.029999999999999999 110.918 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -68.73 142.66 54.92 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.63 -0.923 . . . . 2.7599999999999998 109.354 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 -120.6 148.83 43.37 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.658 0.742 . . . . 1.8899999999999999 110.195 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -132.81 127.57 34.84 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.436 -0.95 . . . . 0.02 108.436 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 21.4 p-10 -112.79 137.28 51.35 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.499 -0.75 . . . . 1.1200000000000001 109.857 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 15.3 t -131.48 139.08 49.25 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.742 -0.599 . . . . 0.02 109.515 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.0 p30 -117.04 11.4 14.25 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.528 -0.733 . . . . 0.20000000000000001 109.939 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.405 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 34.7 t -158.31 174.46 15.11 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.389 -0.967 . . . . 1.23 108.389 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -61.17 144.25 54.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.597 -1.315 . . . . 0.02 109.869 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.5 t -131.75 117.32 18.44 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.54 -0.911 . . . . 0.02 108.54 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.66 -25.02 49.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.122 -0.986 . . . . 0.23999999999999999 110.778 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.47 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 20.8 p-10 -154.8 101.26 2.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.09 -1.006 . . . . 1.1399999999999999 108.882 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -105.85 9.58 32.79 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-O 122.004 0.907 . . . . 6.3700000000000001 109.835 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -58.63 -24.24 60.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.674 -0.641 . . . . 3.1099999999999999 110.861 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.5 m -74.05 -16.59 61.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.716 -1.24 . . . . 0.88 109.836 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -105.72 -21.99 13.06 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.616 -0.677 . . . . 0.02 109.561 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.453 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 3.0 tp -148.83 126.36 11.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.023 -1.048 . . . . 3.3199999999999998 109.686 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.7 m -86.83 -11.0 52.16 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.488 -0.757 . . . . 0.02 111.446 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.521 ' N ' ' OE2' ' A' ' 11' ' ' GLU . 17.8 ttp180 -170.98 161.17 6.84 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.682 -1.229 . . . . 0.02 107.682 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.5 t -141.65 115.41 9.12 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.8 -1.187 . . . . 0.02 109.213 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.416 ' ND2' ' OD2' ' A' ' 77' ' ' ASP . 3.5 m120 -107.57 -0.19 22.2 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.914 -1.116 . . . . 0.029999999999999999 110.858 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.1 t -156.18 153.38 29.13 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.851 -1.166 . . . . 0.02 107.851 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.5 mt -145.43 147.57 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.11 -0.994 . . . . 0.02 110.313 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -123.22 124.13 42.32 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.753 -1.203 . . . . 0.02 107.753 176.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.3 t -106.56 114.88 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 107.058 -1.46 . . . . 0.02 107.058 177.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.434 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 30.3 tt0 -83.61 -34.07 25.19 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 120.099 -0.64 . . . . 3.8100000000000001 110.912 -178.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.96 152.21 21.95 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 118.896 -1.621 . . . . 0.02 111.03 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.43 172.86 49.24 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.627 -1.273 . . . . 0.01 110.514 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.4 m -119.51 135.06 54.94 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.978 -1.119 . . . . 1.48 107.978 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.458 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 32.5 m95 -127.14 155.77 42.83 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 122.56 1.172 . . . . 0.02 112.151 -176.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.59 134.3 52.1 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 105.697 -1.964 . . . . 0.23999999999999999 105.697 176.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.521 ' HB ' HD22 ' A' ' 79' ' ' LEU . 34.6 m -116.65 141.73 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.556 -0.715 . . . . 0.65000000000000002 109.222 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -120.61 143.32 48.72 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 122.098 0.951 . . . . 0.02 109.793 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -65.69 -34.24 77.75 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.661 -0.7 . . . . 0.02 111.646 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -125.15 157.6 66.62 Favored Pre-proline 0 N--CA 1.502 2.173 0 O-C-N 121.033 -1.042 . . . . 0.02 109.359 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.56 167.2 1.0 Allowed 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.718 1.612 . . . . 0.02 113.015 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.3 m120 63.76 36.09 10.81 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.154 -0.93 . . . . 0.02 111.16 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.407 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 4.2 m-85 45.38 51.56 9.46 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.722 0.772 . . . . 3.3900000000000001 110.503 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 90.3 p -126.13 163.83 22.26 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.318 0.58 . . . . 2.3300000000000001 109.847 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.88 -161.76 32.19 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.816 -1.314 . . . . 0.02 109.816 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.514 ' N ' ' ND1' ' A' ' 57' ' ' HIS . 1.9 m80 -65.27 138.72 58.39 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.065 -1.256 . . . . 0.02 110.337 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.497 ' O ' ' SD ' ' A' ' 58' ' ' MET . 2.6 ppp? -119.11 137.13 53.79 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.492 0.663 . . . . 5.0099999999999998 109.517 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.446 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 96.8 m-85 -134.28 138.81 45.28 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.395 -0.816 . . . . 0.02 109.648 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.4 mm -95.32 131.09 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 109.057 -0.719 . . . . 1.72 109.057 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.561 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -119.6 110.83 36.73 Favored Pre-proline 0 N--CA 1.503 2.184 0 O-C-N 121.299 -0.876 . . . . 0.02 110.769 -178.266 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -77.54 168.49 22.59 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 CA-C-N 119.934 1.012 . . . . 1.47 110.221 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.434 ' NE2' ' O ' ' A' ' 42' ' ' GLU . 63.1 tt0 -53.58 141.19 26.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.824 -1.173 . . . . 4.25 110.43 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.79 -177.76 31.9 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.529 -1.32 . . . . 0.02 110.712 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -120.5 131.69 54.84 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.558 -0.966 . . . . 0.95999999999999996 109.732 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.561 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 63.8 m-85 -122.3 94.19 48.04 Favored Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 108.023 -1.103 . . . . 0.02 108.023 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.402 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 5.3 Cg_exo -64.44 -4.24 7.8 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 120.928 1.085 . . . . 0.02 113.799 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 34.8 mt-10 -157.58 155.3 29.95 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.555 -1.34 . . . . 2.02 108.287 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -60.63 -39.0 86.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.481 -0.762 . . . . 0.02 112.199 -176.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -59.93 -23.72 63.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.093 -1.004 . . . . 0.02 110.329 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -70.62 -18.57 62.87 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.782 0.801 . . . . 3.4199999999999999 109.021 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.547 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.6 t90 -107.98 10.14 28.42 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.415 -1.328 . . . . 0.02 107.415 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.4 mmt 60.77 22.49 12.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.66 -0.65 . . . . 0.02 110.545 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.78 144.33 46.35 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.401 -1.48 . . . . 0.02 109.401 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.8 tp -79.29 -31.03 43.23 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.617 -1.253 . . . . 0.97999999999999998 107.617 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -157.02 -171.74 3.76 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 106.342 -1.725 . . . . 0.02 106.342 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.416 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 52.1 m-20 -98.71 27.54 4.82 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.616 -1.303 . . . . 0.02 110.708 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -95.97 122.56 38.92 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.939 -1.101 . . . . 3.2000000000000002 110.865 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.521 HD22 ' HB ' ' A' ' 48' ' ' VAL . 31.2 mt -142.9 121.35 12.4 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.558 -1.275 . . . . 2.6099999999999999 107.558 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.2 -17.85 9.15 Favored Glycine 0 N--CA 1.501 2.977 0 O-C-N 121.257 -0.902 . . . . 0.02 112.878 -177.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.407 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 11.1 t -156.03 155.78 33.28 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-N 120.004 1.902 . . . . 0.02 111.023 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 13.5 p -145.34 147.43 32.29 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.321 -0.862 . . . . 0.02 110.624 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -138.23 143.63 40.22 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.529 -0.732 . . . . 0.01 109.292 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.66 132.11 36.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -0.915 . . . . 0.42999999999999999 109.759 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.8 t -91.28 125.2 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.961 -0.755 . . . . 1.25 108.961 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -94.36 131.13 40.33 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.884 -1.135 . . . . 1.77 109.029 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 mt -95.76 140.3 30.74 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.621 -0.881 . . . . 1.6299999999999999 108.621 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t -111.64 127.87 55.89 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.37 -0.831 . . . . 1.0800000000000001 109.33 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 71.5 p -104.41 -154.58 0.51 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 106.631 -1.618 . . . . 1.26 106.631 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.32 -52.65 0.73 Allowed Glycine 0 N--CA 1.5 2.956 0 O-C-N 120.498 -1.376 . . . . 0.01 112.895 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.18 -101.44 0.15 Allowed Glycine 0 N--CA 1.49 2.256 0 C-N-CA 118.456 -1.83 . . . . 0.01 112.022 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.494 ' NE2' HG21 ' A' ' 111' ' ' THR . 30.8 tt0 -121.88 119.53 31.84 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.056 -1.261 . . . . 4.4299999999999997 110.695 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.42 129.22 34.26 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.682 -0.807 . . . . 2.9900000000000002 109.303 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -130.54 142.1 50.47 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.866 -0.79 . . . . 6.3600000000000003 108.866 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.7 tt -129.97 146.05 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 O-C-N 121.255 -0.903 . . . . 1.0900000000000001 110.451 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -121.26 133.61 55.15 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.354 -1.35 . . . . 2.0499999999999998 107.354 177.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.4 m -123.93 146.41 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 120.895 -1.128 . . . . 1.1000000000000001 109.709 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.576 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 72.0 m-85 -119.32 141.61 48.86 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.978 0.894 . . . . 0.72999999999999998 111.059 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -66.96 -30.28 70.36 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 116.066 -0.515 . . . . 0.02 111.734 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 43.8 mttp -116.37 167.22 11.22 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.965 -1.084 . . . . 3.1800000000000002 110.425 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.05 164.05 44.24 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.958 -0.857 . . . . 0.01 110.958 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 57.23 38.87 28.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.932 -0.746 . . . . 0.01 110.913 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 52.29 55.72 8.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.723 -0.611 . . . . 0.01 111.079 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -128.97 165.66 20.68 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.29 -1.004 . . . . 3.1499999999999999 108.29 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.66 -164.0 27.57 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.279 -1.528 . . . . 0.01 109.279 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -75.69 144.29 41.67 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.968 -1.313 . . . . 0.01 108.438 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.576 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 27.6 ttp -116.41 142.19 47.18 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.543 0.687 . . . . 0.01 109.889 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -131.58 136.54 47.88 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.176 -1.046 . . . . 2.48 108.176 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -119.19 134.48 55.18 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.57 -0.706 . . . . 0.01 109.923 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 t -148.67 150.52 33.35 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 122.278 1.037 . . . . 1.6899999999999999 111.145 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.494 HG21 ' NE2' ' A' ' 92' ' ' GLN . 48.2 p -110.89 9.62 22.38 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 115.572 -0.74 . . . . 0.01 110.336 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -121.15 163.22 18.78 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.15 -0.969 . . . . 3.21 111.721 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -68.2 157.18 36.0 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.268 -1.012 . . . . 0.01 108.268 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 19.1 t -126.88 114.16 22.21 Favored Pre-proline 0 N--CA 1.501 2.075 0 O-C-N 121.457 -0.777 . . . . 0.01 109.101 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -75.05 -29.72 7.85 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 CA-C-N 120.247 1.124 . . . . 0.01 111.035 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.5 m -142.3 109.19 5.45 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.309 -0.869 . . . . 0.02 109.121 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.41 HD12 ' O ' ' A' ' 169' ' ' ILE . 97.7 mt -63.58 -38.99 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.866 -0.521 . . . . 1.8300000000000001 110.59 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 19.0 ttt -68.82 -37.74 79.4 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.349 -0.94 . . . . 1.3400000000000001 110.399 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -69.46 -38.57 77.8 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.417 -1.427 . . . . 2.1099999999999999 109.995 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -80.11 -47.14 15.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.331 -0.856 . . . . 2.0800000000000001 112.339 -177.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -111.18 0.0 16.66 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.363 -0.836 . . . . 0.02 112.637 -176.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.7 m80 60.01 33.64 21.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.768 -1.208 . . . . 0.02 109.516 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.0 mt -112.65 135.51 53.29 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 108.83 -0.804 . . . . 0.02 108.83 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -91.69 -22.96 19.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.254 -0.904 . . . . 5.3200000000000003 110.393 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -149.45 164.34 35.27 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.187 -0.945 . . . . 0.02 109.813 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.5 mt -132.15 128.89 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 107.804 -1.184 . . . . 2.1699999999999999 107.804 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.39 -11.98 15.1 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.365 -0.834 . . . . 0.02 112.25 -178.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.2 p -160.31 151.06 18.72 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.917 -1.114 . . . . 0.01 109.273 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 27.1 p -168.25 145.01 3.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.362 -0.836 . . . . 1.22 109.133 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 40.5 tttm -126.31 111.67 14.8 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 122.42 1.105 . . . . 1.4099999999999999 110.417 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.2 p -114.38 138.44 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 107.408 -1.33 . . . . 0.01 107.408 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.5 t -126.8 94.03 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 106.732 -1.581 . . . . 1.98 106.732 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.422 ' CD ' ' N ' ' A' ' 134' ' ' GLY . 6.1 tm-20 -145.65 -80.65 0.16 Allowed 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 106.218 -1.771 . . . . 0.01 106.218 177.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.422 ' N ' ' CD ' ' A' ' 133' ' ' GLU . . . 176.45 -76.2 0.07 OUTLIER Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.987 -1.645 . . . . 0.01 108.987 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 30.9 p -118.0 118.14 31.13 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.593 -0.945 . . . . 2.2999999999999998 110.192 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -124.88 150.4 46.52 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 107.244 -1.391 . . . . 0.01 107.244 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 12.4 mt -121.79 136.88 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 120.484 -1.385 . . . . 1.6899999999999999 110.15 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -114.55 144.29 43.6 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.364 -1.347 . . . . 2.4900000000000002 107.364 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.463 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 24.5 m-85 -123.29 143.56 49.99 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.271 -0.893 . . . . 0.02 109.575 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.461 ' O ' ' NE2' ' A' ' 170' ' ' GLN . 81.8 tt0 -73.96 -29.24 61.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.506 -0.746 . . . . 0.02 111.911 -176.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.1 mt -116.09 154.9 48.58 Favored Pre-proline 0 N--CA 1.505 2.291 0 O-C-N 120.725 -1.234 . . . . 1.48 108.964 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -55.66 167.36 2.17 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.151 1.234 . . . . 0.02 112.757 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.633 HD22 ' N ' ' A' ' 143' ' ' ASN . 0.8 OUTLIER 59.37 31.11 20.87 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.174 -0.921 . . . . 0.75 111.233 178.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 57.41 50.62 11.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.45 -0.781 . . . . 0.02 111.064 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -125.13 164.36 20.42 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.554 -0.716 . . . . 0.02 109.898 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.427 ' O ' ' OE1' ' A' ' 148' ' ' GLN . . . 89.16 -165.72 33.06 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.184 -1.167 . . . . 0.02 110.184 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -69.08 142.55 54.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.54 -0.977 . . . . 0.02 109.034 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.472 ' CD ' ' N ' ' A' ' 148' ' ' GLN . 0.1 OUTLIER -114.53 148.54 37.78 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.44 0.638 . . . . 0.02 110.011 -178.191 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -124.92 134.98 52.45 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 109.083 -0.71 . . . . 0.01 109.083 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.5 HD23 ' N ' ' A' ' 151' ' ' LEU . 4.1 tt -100.09 121.25 41.11 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.872 -1.142 . . . . 0.01 108.92 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.5 ' N ' HD23 ' A' ' 150' ' ' LEU . 4.9 tp -99.32 145.34 27.43 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.198 -0.939 . . . . 0.01 108.96 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -106.73 -166.41 1.17 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.647 -0.658 . . . . 2.27 109.882 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -90.68 52.85 2.28 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.405 -0.809 . . . . 1.8400000000000001 109.833 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -115.35 -178.88 3.48 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.473 -0.767 . . . . 2.2799999999999998 109.448 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -105.47 111.48 24.21 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.476 -0.935 . . . . 0.01 108.476 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -99.65 112.7 24.9 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.387 -0.82 . . . . 0.01 110.493 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -94.54 -24.06 17.41 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.165 -0.959 . . . . 0.01 110.855 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -126.04 153.59 73.96 Favored Pre-proline 0 N--CA 1.501 2.078 0 N-CA-C 108.451 -0.944 . . . . 2.54 108.451 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -59.85 -39.73 69.49 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 CA-C-N 119.285 0.78 . . . . 0.69999999999999996 110.609 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 6.7 t -61.84 -19.57 21.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.755 -1.216 . . . . 0.85999999999999999 108.863 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 10.6 t0 -65.96 -18.06 65.09 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.954 -1.091 . . . . 0.02 111.059 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.621 ' HE1' ' CB ' ' A' ' 164' ' ' ALA . 1.8 p90 -103.0 14.16 32.6 Favored 'General case' 0 N--CA 1.508 2.467 0 O-C-N 121.077 -1.014 . . . . 0.02 109.811 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 87.42 10.37 70.89 Favored Glycine 0 N--CA 1.497 2.728 0 O-C-N 121.462 -0.774 . . . . 0.02 113.854 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.621 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . . . -100.93 141.32 33.98 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 120.472 -1.604 . . . . 0.02 110.757 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.61 -7.66 59.17 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.673 -0.642 . . . . 0.58999999999999997 109.484 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 39.0 m -143.54 150.67 51.82 Favored Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 120.961 -1.087 . . . . 0.87 109.154 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -76.75 18.45 0.72 Allowed 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.0 1.134 . . . . 0.38 112.474 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.87 125.47 31.38 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 122.373 1.082 . . . . 0.17999999999999999 111.698 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.508 HD11 ' CZ2' ' A' ' 162' ' ' TRP . 1.6 mt -149.94 127.01 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.344 -1.354 . . . . 3.9900000000000002 107.344 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.461 ' NE2' ' O ' ' A' ' 140' ' ' GLU . 2.9 mp0 -111.95 -18.06 12.74 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.075 -1.016 . . . . 5.1699999999999999 112.816 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 20.5 t -157.06 159.93 38.42 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 119.141 -2.224 . . . . 0.02 110.315 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.431 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 19.0 p90 -151.67 153.38 34.29 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.971 -1.081 . . . . 2.02 110.538 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 -144.97 149.98 36.14 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.882 0.849 . . . . 0.01 110.433 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -87.17 143.14 27.43 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.874 -0.788 . . . . 0.01 108.874 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.1 mt -94.76 129.13 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.28 -0.887 . . . . 3.04 109.108 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 11.7 p -136.38 146.99 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.194 -0.942 . . . . 1.8899999999999999 109.686 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 4.8899999999999997 109.411 -179.991 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.346 -0.613 . . . . 5.2800000000000002 109.346 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -82.25 -12.79 57.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.907 . . . . 5.96 109.707 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 26.9 p -99.87 110.88 23.23 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 106.862 -1.533 . . . . 2.2200000000000002 106.862 177.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.71 94.05 0.09 OUTLIER Glycine 0 N--CA 1.492 2.379 0 N-CA-C 106.619 -2.592 . . . . 0.81000000000000005 106.619 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.69 146.94 33.21 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.45 -1.06 . . . . 0.01 110.45 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -152.85 138.34 17.68 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.52 -0.988 . . . . 0.02 109.666 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.8 tt -130.85 140.87 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 109.222 -0.659 . . . . 0.02 109.222 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.8 m -121.95 130.89 53.7 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.444 -0.785 . . . . 0.39000000000000001 109.996 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.487 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 5.4 m-85 -111.11 140.74 45.41 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.561 -0.712 . . . . 0.02 109.332 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.575 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.1 m-85 -122.68 138.6 54.56 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.266 -0.896 . . . . 0.02 109.756 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -69.29 -27.29 65.27 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.925 -1.11 . . . . 0.029999999999999999 111.736 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 3.3 m-20 -113.87 169.4 9.03 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.804 -1.185 . . . . 0.029999999999999999 110.172 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -75.33 158.31 32.99 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.662 0.744 . . . . 0.029999999999999999 110.034 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.413 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 7.1 t-20 65.96 33.44 7.8 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.913 0.863 . . . . 0.73999999999999999 111.173 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.413 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 0.8 OUTLIER 55.42 41.8 30.65 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.296 0.57 . . . . 0.02 111.214 177.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -112.8 165.6 12.15 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.236 -1.024 . . . . 0.02 108.236 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.17 -167.59 34.49 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.801 -1.19 . . . . 0.029999999999999999 110.6 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -70.19 143.88 52.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.425 -1.044 . . . . 2.7599999999999998 108.957 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -120.41 149.13 42.85 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.65 0.738 . . . . 1.8899999999999999 110.296 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -132.76 127.7 35.23 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.399 -0.963 . . . . 0.02 108.399 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 18.9 p30 -112.22 136.85 51.13 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.441 -0.787 . . . . 1.1200000000000001 109.709 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.0 t -130.65 138.6 50.15 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.515 0.674 . . . . 0.02 109.679 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.498 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 33.9 t70 -117.07 11.14 14.13 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.567 -0.708 . . . . 0.20000000000000001 109.852 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 42.3 m -158.55 174.57 14.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.118 -0.988 . . . . 1.23 108.505 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -61.27 144.04 54.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.71 -1.244 . . . . 0.02 110.09 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.5 t -131.67 117.46 18.69 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.654 -0.869 . . . . 0.02 108.654 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.12 -25.77 47.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.974 -1.079 . . . . 0.23999999999999999 110.988 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -153.4 101.6 2.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.979 -1.075 . . . . 1.1399999999999999 108.977 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -104.0 9.28 36.62 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 122.109 0.956 . . . . 6.3700000000000001 109.806 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.4 mtm180 -59.3 -24.69 63.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.525 -0.734 . . . . 3.1099999999999999 111.221 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.3 t -75.39 -16.93 60.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.629 -1.295 . . . . 0.88 110.315 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -105.14 -21.69 13.22 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.366 -0.833 . . . . 0.02 109.503 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.4 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 4.5 tp -148.7 126.81 12.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.223 -0.923 . . . . 3.3199999999999998 109.447 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.5 t -86.51 -11.88 50.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.634 -0.666 . . . . 0.02 111.206 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.4 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 24.4 ttp180 -171.47 161.58 6.36 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.84 -1.162 . . . . 0.02 108.154 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.405 ' SG ' HD12 ' A' ' 79' ' ' LEU . 1.5 p -142.55 114.98 8.46 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.881 -1.137 . . . . 0.02 108.761 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -106.63 1.15 24.95 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 120.777 -1.202 . . . . 0.029999999999999999 110.379 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.8 t -155.94 154.51 31.28 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.5 -1.296 . . . . 0.02 107.5 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.8 mt -146.63 147.68 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.029 -1.045 . . . . 0.02 110.401 -178.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.579 HH11 ' CG ' ' A' ' 40' ' ' ARG . 0.2 OUTLIER -124.39 125.02 43.61 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.997 -1.112 . . . . 0.02 107.997 177.651 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.1 t -105.1 113.65 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 106.644 -1.613 . . . . 0.02 106.644 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -84.18 -34.76 23.91 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.467 -0.77 . . . . 3.8100000000000001 110.033 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.41 150.93 20.21 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 118.618 -1.753 . . . . 0.02 110.722 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.43 171.99 48.58 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.357 -1.097 . . . . 0.01 110.357 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.8 m -119.6 134.9 55.03 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 107.805 -1.183 . . . . 1.48 107.805 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.467 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 31.2 m95 -127.36 154.94 44.36 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 122.583 1.182 . . . . 0.02 112.329 -176.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.29 134.06 51.64 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 105.282 -2.118 . . . . 0.23999999999999999 105.282 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.51 ' HB ' HD22 ' A' ' 79' ' ' LEU . 23.7 m -119.12 143.7 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 109.066 -0.716 . . . . 0.65000000000000002 109.066 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -120.96 145.92 47.21 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 122.276 1.036 . . . . 0.02 110.041 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -66.09 -34.05 77.18 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 115.816 -0.629 . . . . 0.02 111.009 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -125.46 157.54 67.63 Favored Pre-proline 0 N--CA 1.502 2.162 0 O-C-N 121.051 -1.03 . . . . 0.02 109.487 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.45 167.26 0.93 Allowed 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.692 1.594 . . . . 0.02 113.074 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.8 m120 63.77 36.36 10.59 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.253 -0.885 . . . . 0.02 111.113 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 45.09 51.58 8.88 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.66 0.743 . . . . 3.3900000000000001 110.67 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.7 m -126.36 163.82 22.43 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.168 0.509 . . . . 2.3300000000000001 109.814 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.78 -161.65 32.24 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.815 -1.314 . . . . 0.02 109.815 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -65.3 139.15 58.57 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.124 -1.221 . . . . 0.02 110.146 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.497 ' O ' ' SD ' ' A' ' 58' ' ' MET . 2.8 ppp? -118.84 137.28 53.53 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.714 -0.616 . . . . 5.0099999999999998 109.593 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.469 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 96.2 m-85 -134.85 138.63 44.36 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.494 -0.754 . . . . 0.02 109.78 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.4 mm -95.2 131.61 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.857 -0.794 . . . . 1.72 108.857 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.561 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -120.08 110.64 36.15 Favored Pre-proline 0 N--CA 1.505 2.278 0 O-C-N 121.289 -0.882 . . . . 0.02 110.858 -178.346 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -77.86 168.99 21.38 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 CA-C-N 119.916 1.006 . . . . 1.47 110.296 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -53.9 140.62 30.15 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.861 -1.15 . . . . 4.25 110.522 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.93 -177.79 32.82 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.451 -1.356 . . . . 0.02 110.618 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -119.93 131.16 55.12 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.362 -1.081 . . . . 0.95999999999999996 109.646 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.561 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 75.9 m-85 -121.8 96.27 47.21 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 108.128 -1.064 . . . . 0.02 108.128 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.404 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.6 Cg_endo -67.07 -3.75 10.29 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 120.778 0.986 . . . . 0.02 113.756 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 35.1 mt-10 -157.81 155.21 29.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.685 -1.259 . . . . 2.02 108.288 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -60.56 -39.37 87.72 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.572 -0.705 . . . . 0.02 112.042 -177.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -59.96 -23.68 63.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.083 -1.011 . . . . 0.02 110.276 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -69.97 -18.92 63.37 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.778 0.799 . . . . 3.4199999999999999 109.021 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.547 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.1 t90 -108.04 10.6 28.19 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.432 -1.321 . . . . 0.02 107.432 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.5 mtt 61.08 22.27 12.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.537 -0.727 . . . . 0.02 110.463 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.76 143.65 44.88 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.49 -1.444 . . . . 0.02 109.49 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.4 tp -79.57 -31.93 41.98 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.558 -1.275 . . . . 0.97999999999999998 107.558 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -157.63 -172.65 4.04 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 106.312 -1.736 . . . . 0.02 106.312 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -98.49 28.06 4.4 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.821 -1.174 . . . . 0.02 110.823 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 -96.83 121.89 39.19 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.828 -1.17 . . . . 3.2000000000000002 110.887 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.51 HD22 ' HB ' ' A' ' 48' ' ' VAL . 31.0 mt -144.0 121.39 11.65 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 107.574 -1.269 . . . . 2.6099999999999999 107.574 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.34 -16.19 11.48 Favored Glycine 0 N--CA 1.505 3.243 0 O-C-N 121.192 -0.943 . . . . 0.02 112.804 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.6 p -157.09 156.37 32.66 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.107 -1.819 . . . . 0.02 110.344 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 23.4 m -144.89 147.93 33.33 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.584 -0.698 . . . . 0.02 110.047 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 39.1 mtp180 -137.84 143.19 40.84 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.368 -0.832 . . . . 0.01 109.585 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.57 132.21 36.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.201 -0.937 . . . . 0.42999999999999999 109.669 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.3 t -91.0 125.03 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.873 -0.788 . . . . 1.25 108.873 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -92.56 132.53 36.77 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.877 -1.139 . . . . 1.77 108.865 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mt -98.42 140.57 32.48 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.865 -0.791 . . . . 1.6299999999999999 108.865 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 52.9 p -112.08 124.68 52.95 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.474 -0.936 . . . . 1.0800000000000001 108.474 178.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.4 m -115.76 132.81 56.53 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 107.754 -1.202 . . . . 1.26 107.754 177.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -156.78 -49.58 0.01 OUTLIER Glycine 0 N--CA 1.505 3.279 0 C-N-CA 117.709 -2.186 . . . . 0.01 113.636 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.71 -105.73 0.19 Allowed Glycine 0 N--CA 1.489 2.203 0 CA-C-N 120.192 1.996 . . . . 0.01 111.352 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -120.81 118.59 30.39 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.125 -1.221 . . . . 4.4299999999999997 110.401 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.14 129.14 34.81 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.806 -0.758 . . . . 2.9900000000000002 109.369 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -131.23 141.19 49.98 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.497 -0.752 . . . . 6.3600000000000003 109.241 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.0 tt -129.8 146.91 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 O-C-N 121.247 -0.908 . . . . 1.0900000000000001 110.344 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.523 ' NE2' ' O ' ' A' ' 130' ' ' LYS . 2.4 pm0 -122.1 134.31 54.76 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 107.561 -1.274 . . . . 2.0499999999999998 107.561 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.8 m -124.37 146.25 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 O-C-N 120.721 -1.237 . . . . 1.1000000000000001 110.158 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.584 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 79.5 m-85 -119.4 141.2 49.29 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.973 0.892 . . . . 0.72999999999999998 111.081 -178.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -67.18 -30.22 70.12 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 115.921 -0.581 . . . . 0.02 111.819 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -116.18 168.99 9.62 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.028 -1.045 . . . . 3.1800000000000002 110.441 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.27 164.94 50.0 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.796 -0.921 . . . . 0.01 110.796 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 56.46 38.45 29.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.719 -0.871 . . . . 0.01 111.432 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 51.94 55.08 9.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.559 -0.713 . . . . 0.01 111.256 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -129.06 165.01 22.02 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.018 -1.105 . . . . 3.1499999999999999 108.018 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.18 -163.64 27.95 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.255 -1.538 . . . . 0.01 109.255 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.498 ' NE2' ' OH ' ' A' ' 108' ' ' TYR . 57.1 tt0 -76.19 144.19 40.64 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.005 -1.291 . . . . 0.01 108.834 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.584 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 32.7 ttp -116.66 142.55 46.75 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.524 0.678 . . . . 0.01 109.821 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.498 ' OH ' ' NE2' ' A' ' 106' ' ' GLN . 55.5 m-85 -131.48 136.86 48.26 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.265 -1.013 . . . . 2.48 108.265 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -118.15 134.16 55.25 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.551 -0.718 . . . . 0.01 110.248 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.9 t -149.01 148.33 29.61 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.276 1.036 . . . . 1.6899999999999999 111.197 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 30.1 p -111.16 9.7 21.88 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 115.547 -0.751 . . . . 0.01 110.496 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -120.85 163.16 18.61 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.235 -0.916 . . . . 3.21 111.438 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -67.46 156.8 35.72 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.217 -1.031 . . . . 0.01 108.217 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.609 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 26.4 p -123.86 116.47 27.6 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.515 -0.741 . . . . 0.01 109.414 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -76.7 -31.93 3.86 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 CA-C-N 120.181 1.1 . . . . 0.01 110.445 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.4 p -143.84 108.91 4.98 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.733 0.778 . . . . 0.02 109.016 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.9 mt -64.16 -39.27 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.771 -0.581 . . . . 1.8300000000000001 110.822 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 118' ' ' MET . 1.8 tmt? -67.95 -37.24 81.34 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.175 -1.01 . . . . 1.3400000000000001 110.034 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -69.47 -38.02 77.55 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.543 -1.348 . . . . 2.1099999999999999 109.87 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -80.25 -46.72 15.75 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.274 -0.891 . . . . 2.0800000000000001 112.373 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -110.87 0.13 17.07 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.395 -0.815 . . . . 0.02 112.58 -176.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.519 ' O ' ' NH1' ' A' ' 124' ' ' ARG . 8.7 m80 60.01 33.47 21.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.768 -1.207 . . . . 0.02 109.639 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.6 mt -112.63 135.8 52.94 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 108.754 -0.832 . . . . 0.02 108.754 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 122' ' ' HIS . 0.1 OUTLIER -92.27 -22.79 19.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.242 -0.911 . . . . 5.3200000000000003 110.208 -179.486 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -149.33 163.61 37.21 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.189 -0.945 . . . . 0.02 109.883 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.1 mt -131.91 128.81 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 107.899 -1.148 . . . . 2.1699999999999999 107.899 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -107.61 -12.54 15.24 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.27 -0.893 . . . . 0.02 112.084 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.5 m -158.44 150.7 21.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.848 -1.158 . . . . 0.01 108.511 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.572 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 0.5 OUTLIER -169.62 144.67 2.97 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.425 -0.954 . . . . 1.22 108.425 -179.526 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.523 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 32.1 tttp -125.93 110.6 13.82 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 122.497 1.142 . . . . 1.4099999999999999 110.61 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 131' ' ' VAL . 10.1 p -109.09 134.5 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 106.948 -1.501 . . . . 0.01 106.948 178.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 50.7 t -128.58 94.77 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 N-CA-C 107.148 -1.427 . . . . 1.98 107.148 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -146.66 -76.58 0.19 Allowed 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 105.816 -1.92 . . . . 0.01 105.816 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 156.27 -54.14 0.41 Allowed Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.982 -1.647 . . . . 0.01 108.982 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 76.3 p -119.21 98.32 6.1 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.643 -0.916 . . . . 2.2999999999999998 111.021 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -129.25 145.38 51.35 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 107.265 -1.383 . . . . 0.01 107.265 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 96.4 mt -123.74 139.47 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 120.957 -1.089 . . . . 1.6899999999999999 110.071 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -114.26 144.06 43.84 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 106.99 -1.485 . . . . 2.4900000000000002 106.99 177.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.497 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 14.3 m-85 -123.19 144.19 49.53 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.348 -0.845 . . . . 0.02 109.465 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -74.1 -29.45 61.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.595 -0.69 . . . . 0.02 111.838 -176.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.3 mt -115.94 154.76 48.36 Favored Pre-proline 0 N--CA 1.505 2.283 0 O-C-N 120.693 -1.254 . . . . 1.48 108.985 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -56.15 167.22 2.62 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.123 1.215 . . . . 0.02 112.889 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 143' ' ' ASN . 0.4 OUTLIER 59.58 31.15 20.76 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.149 -0.932 . . . . 0.75 111.487 178.588 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 144' ' ' TYR . 0.7 OUTLIER 58.05 50.98 9.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.447 -0.783 . . . . 0.02 111.152 177.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -125.99 164.57 20.54 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.494 -0.754 . . . . 0.02 109.973 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.06 -165.6 33.11 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.323 -1.111 . . . . 0.02 110.323 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -69.4 142.22 53.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.596 -0.943 . . . . 0.02 109.055 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.467 ' CD ' ' N ' ' A' ' 148' ' ' GLN . 5.3 mp0 -115.34 149.55 37.71 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.851 -0.531 . . . . 0.02 109.75 -178.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -124.72 134.61 52.78 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.618 -0.676 . . . . 0.01 109.189 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.493 HD23 ' N ' ' A' ' 151' ' ' LEU . 2.8 tt -99.91 121.46 41.37 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.072 -1.017 . . . . 0.01 108.743 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.493 ' N ' HD23 ' A' ' 150' ' ' LEU . 3.8 mm? -99.98 165.33 11.59 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.022 -1.049 . . . . 0.01 109.506 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -109.91 -96.96 0.4 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.59 -0.694 . . . . 2.27 109.215 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -176.37 51.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.198 -0.939 . . . . 1.8400000000000001 109.626 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -113.82 -159.77 0.7 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.547 -0.721 . . . . 2.2799999999999998 109.512 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.518 ' OE2' ' NZ ' ' A' ' 130' ' ' LYS . 66.3 mm-40 -106.37 107.05 17.87 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.494 -0.753 . . . . 0.01 109.064 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.705 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 29.7 m-85 -99.96 114.3 27.47 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.301 -0.874 . . . . 0.01 109.993 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -96.09 -22.34 17.39 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.227 -0.921 . . . . 0.01 111.928 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -127.84 155.34 77.61 Favored Pre-proline 0 N--CA 1.504 2.26 0 O-C-N 120.803 -1.185 . . . . 2.54 109.023 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -60.79 -39.64 60.94 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 120.497 0.798 . . . . 0.69999999999999996 110.614 178.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.0 t -60.72 -20.76 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.763 -1.211 . . . . 0.85999999999999999 109.011 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -65.09 -14.93 61.72 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.815 -1.178 . . . . 0.02 109.732 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.705 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 21.8 m0 -96.2 10.71 36.91 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.329 -0.857 . . . . 0.02 108.712 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.03 9.47 87.07 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.727 -1.225 . . . . 0.02 110.716 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -98.63 141.86 30.93 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.296 -1.12 . . . . 0.02 110.065 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.19 -9.09 58.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.574 -0.703 . . . . 0.58999999999999997 109.661 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.1 t -144.61 150.09 45.96 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.079 -1.013 . . . . 0.87 108.728 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -75.9 19.96 0.56 Allowed 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 120.663 0.908 . . . . 0.38 112.259 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.26 123.57 29.72 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.88 -1.138 . . . . 0.17999999999999999 111.584 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.8 mt -149.49 128.15 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 107.041 -1.466 . . . . 3.9900000000000002 107.041 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -112.15 -17.39 12.82 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.055 -1.028 . . . . 5.1699999999999999 113.356 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.6 p -158.11 160.98 37.9 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 119.122 -2.236 . . . . 0.02 110.148 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.609 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 3.8 p90 -151.51 153.66 35.03 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.056 -1.028 . . . . 2.02 110.925 178.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -145.38 149.64 35.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.297 -0.877 . . . . 0.01 110.215 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -88.36 144.03 26.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.527 -0.733 . . . . 0.01 109.51 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.5 mt -93.59 129.59 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.155 -0.965 . . . . 3.04 109.159 178.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 10.2 p -136.09 146.56 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.254 -0.904 . . . . 1.8899999999999999 109.473 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.291 -0.881 . . . . 4.8899999999999997 109.404 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 82.3 p . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.417 -0.586 . . . . 5.2800000000000002 109.417 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -56.4 166.62 0.83 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 5.96 109.501 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 53.7 m -80.92 141.92 34.06 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.325 -0.991 . . . . 2.2200000000000002 108.325 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.12 179.91 47.69 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 118.326 -1.892 . . . . 0.81000000000000005 112.13 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.86 158.06 44.25 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.194 -1.562 . . . . 0.01 109.194 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -147.87 136.89 22.09 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.059 -1.259 . . . . 0.02 110.641 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.8 tt -130.72 139.62 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.731 -0.841 . . . . 0.02 108.731 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 m -120.89 130.14 53.78 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.489 -0.757 . . . . 0.39000000000000001 109.866 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -109.94 139.57 44.88 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.077 -0.712 . . . . 0.02 109.077 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.534 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 5.3 m-85 -122.14 138.41 54.47 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.146 -0.971 . . . . 0.02 109.531 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.491 ' HG3' HD11 ' A' ' 33' ' ' LEU . 92.0 mt-10 -69.39 -27.67 65.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.193 -0.942 . . . . 0.029999999999999999 111.539 -178.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -114.05 169.16 9.22 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.849 -1.157 . . . . 0.029999999999999999 110.14 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -75.39 158.32 32.9 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.598 0.713 . . . . 0.029999999999999999 110.218 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 66.42 33.3 6.98 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.948 0.88 . . . . 0.73999999999999999 111.117 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 55.48 41.94 30.36 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 116.056 -0.52 . . . . 0.02 111.324 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -113.66 165.68 12.28 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.193 -1.04 . . . . 0.02 108.193 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.39 -167.46 35.66 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.826 -1.178 . . . . 0.029999999999999999 110.793 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -69.22 142.27 54.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.398 -1.06 . . . . 2.7599999999999998 109.315 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -120.76 149.09 43.08 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.618 0.723 . . . . 1.8899999999999999 110.167 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -132.43 127.16 34.76 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.255 -1.017 . . . . 0.02 108.255 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -112.48 137.41 50.72 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.57 -0.706 . . . . 1.1200000000000001 109.827 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.9 t -131.67 139.21 49.01 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 121.523 0.678 . . . . 0.02 109.777 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -116.98 11.26 14.26 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.583 -0.698 . . . . 0.20000000000000001 109.671 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.409 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 29.5 p -158.29 174.3 15.37 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.275 -1.009 . . . . 1.23 108.275 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 2.3 p30 -60.93 143.84 54.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.647 -1.283 . . . . 0.02 109.855 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 26' ' ' CYS . 27.4 p -131.19 117.14 18.62 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.52 -0.918 . . . . 0.02 108.52 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.17 -24.83 47.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.143 -0.973 . . . . 0.23999999999999999 110.965 -178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -154.8 101.65 2.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.834 -1.166 . . . . 1.1399999999999999 108.985 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -105.21 9.53 34.03 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 122.197 0.998 . . . . 6.3700000000000001 109.903 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -58.86 -24.55 62.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.388 -0.82 . . . . 3.1099999999999999 110.934 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.5 m -74.16 -16.55 60.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.755 -1.216 . . . . 0.88 110.124 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -103.97 -21.97 13.54 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.482 -0.761 . . . . 0.02 109.488 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.491 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.6 tp -150.04 128.86 12.48 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.196 -0.94 . . . . 3.3199999999999998 109.207 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.7 t -85.54 -10.1 56.44 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.768 -0.583 . . . . 0.02 111.191 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.461 ' HE ' HD21 ' A' ' 37' ' ' ASN . 15.7 ptm180 -170.55 162.28 8.02 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.696 -1.224 . . . . 0.02 107.696 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.6 t -143.05 115.57 8.58 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.73 -1.231 . . . . 0.02 109.136 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.639 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.5 OUTLIER -109.8 1.95 19.66 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 120.839 -1.163 . . . . 0.029999999999999999 111.532 -178.563 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.2 t -156.67 154.47 30.14 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.098 -1.075 . . . . 0.02 108.098 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.1 mt -145.94 146.61 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-O 122.402 1.096 . . . . 0.02 111.209 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -123.07 124.22 42.62 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.672 -1.233 . . . . 0.02 107.672 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.3 t -106.47 113.92 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 106.91 -1.515 . . . . 0.02 106.91 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -84.07 -34.42 24.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.746 -0.596 . . . . 3.8100000000000001 110.5 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.84 149.93 18.32 Favored Glycine 0 N--CA 1.486 2.026 0 C-N-CA 119.064 -1.541 . . . . 0.02 110.589 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.96 172.08 48.84 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.845 -1.169 . . . . 0.01 110.432 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.7 m -119.99 135.69 54.82 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.171 -1.048 . . . . 1.48 108.171 178.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.421 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 35.8 m95 -127.41 155.48 43.58 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 122.62 1.2 . . . . 0.02 112.526 -176.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.41 134.69 51.53 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 105.586 -2.005 . . . . 0.23999999999999999 105.586 176.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.416 ' HB ' HD22 ' A' ' 79' ' ' LEU . 11.5 m -120.12 144.51 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.629 -0.669 . . . . 0.65000000000000002 109.408 179.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -121.15 146.04 47.18 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 122.291 1.043 . . . . 0.02 110.22 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -67.5 -34.55 77.37 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.801 -0.636 . . . . 0.02 111.496 -177.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 24.4 mtm180 -124.72 158.22 63.11 Favored Pre-proline 0 N--CA 1.504 2.249 0 O-C-N 120.983 -1.073 . . . . 0.02 109.576 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -54.04 165.32 2.08 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.619 1.546 . . . . 0.02 113.253 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.474 ' ND2' ' N ' ' A' ' 53' ' ' ASN . 1.2 m120 64.37 37.02 8.65 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.111 -0.949 . . . . 0.02 111.268 178.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 45.22 51.68 9.06 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.662 0.744 . . . . 3.3900000000000001 110.603 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.9 p -126.2 163.47 23.1 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.58 -0.526 . . . . 2.3300000000000001 109.58 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.92 -161.76 32.14 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.811 -1.316 . . . . 0.02 109.811 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -65.27 138.91 58.51 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.085 -1.244 . . . . 0.02 110.388 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' A' ' 58' ' ' MET . 11.6 tmm? -120.1 137.18 54.29 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 109.376 -0.601 . . . . 5.0099999999999998 109.376 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.469 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 86.7 m-85 -134.67 139.68 45.44 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.799 0.809 . . . . 0.02 109.949 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.7 mm -94.77 131.26 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.762 -0.829 . . . . 1.72 108.762 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.556 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -120.45 111.95 34.58 Favored Pre-proline 0 N--CA 1.505 2.311 0 O-C-N 121.397 -0.814 . . . . 0.02 110.946 -178.165 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -78.31 169.16 20.55 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 CA-C-N 119.842 0.979 . . . . 1.47 110.338 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -53.72 141.52 26.22 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.88 -1.137 . . . . 4.25 110.514 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.85 -177.46 32.12 Favored Glycine 0 N--CA 1.496 2.636 0 C-N-CA 119.515 -1.326 . . . . 0.02 110.824 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -119.99 131.39 55.14 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.46 -1.023 . . . . 0.95999999999999996 109.803 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.556 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 75.1 m-85 -121.73 97.83 46.12 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 107.795 -1.187 . . . . 0.02 107.795 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.402 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 5.8 Cg_endo -69.6 -3.34 11.71 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 120.704 0.936 . . . . 0.02 113.671 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 33.4 mt-10 -157.77 155.11 29.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.723 -1.235 . . . . 2.02 108.137 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -60.4 -39.5 87.59 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.666 -0.646 . . . . 0.02 112.018 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -60.06 -24.02 64.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.058 -1.026 . . . . 0.02 110.411 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -69.74 -18.5 63.52 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.903 0.859 . . . . 3.4199999999999999 108.87 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.558 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.3 t90 -108.21 10.59 27.84 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.458 -1.312 . . . . 0.02 107.458 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.7 mtt 61.5 22.55 12.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.53 -0.731 . . . . 0.02 110.536 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.53 145.46 47.24 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.579 -1.409 . . . . 0.02 109.579 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.3 mt -80.48 -31.04 37.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -1.158 . . . . 0.97999999999999998 108.039 177.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -157.02 -171.55 3.69 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 106.513 -1.662 . . . . 0.02 106.513 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.424 ' OD2' ' OD1' ' A' ' 37' ' ' ASN . 66.0 m-20 -98.63 28.31 4.31 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.595 -1.316 . . . . 0.02 110.774 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.4 mtp180 -97.19 122.89 40.71 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.059 -1.026 . . . . 3.2000000000000002 110.99 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 79' ' ' LEU . 42.8 mt -143.47 121.59 12.17 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 107.632 -1.247 . . . . 2.6099999999999999 107.632 178.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.07 -17.27 9.67 Favored Glycine 0 N--CA 1.506 3.327 0 O-C-N 121.098 -1.001 . . . . 0.02 113.026 -177.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.9 m -156.74 156.86 34.05 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.085 -1.832 . . . . 0.02 110.483 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 44.9 t -144.79 147.26 32.69 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.529 -0.732 . . . . 0.02 110.242 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 38.1 mtm180 -138.52 143.17 39.4 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.33 -0.856 . . . . 0.01 109.392 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.81 132.46 36.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.251 -0.906 . . . . 0.42999999999999999 109.816 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.6 t -91.25 125.44 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.851 -0.796 . . . . 1.25 108.851 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -94.1 131.34 39.73 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.773 -1.204 . . . . 1.77 109.085 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mt -96.37 140.18 31.41 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.439 -0.949 . . . . 1.6299999999999999 108.439 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.2 t -111.89 127.86 55.97 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.285 -0.884 . . . . 1.0800000000000001 109.406 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.6 p -104.34 -154.17 0.5 Allowed 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 106.573 -1.64 . . . . 1.26 106.573 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.93 -52.97 0.73 Allowed Glycine 0 N--CA 1.502 3.044 0 O-C-N 120.392 -1.443 . . . . 0.01 112.895 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.81 -101.42 0.15 Allowed Glycine 0 N--CA 1.491 2.312 0 C-N-CA 118.467 -1.825 . . . . 0.01 111.966 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -121.64 118.89 30.31 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.057 -1.261 . . . . 4.4299999999999997 110.648 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.3 129.1 34.13 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.702 -0.799 . . . . 2.9900000000000002 109.555 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -131.1 142.23 50.24 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 109.039 -0.726 . . . . 6.3600000000000003 109.039 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.2 tt -129.68 147.36 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 O-C-N 121.24 -0.912 . . . . 1.0900000000000001 110.362 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -121.64 134.13 54.98 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.615 -1.254 . . . . 2.0499999999999998 107.615 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.7 m -124.36 145.88 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 120.69 -1.256 . . . . 1.1000000000000001 110.002 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.592 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 96.4 m-85 -119.13 141.44 48.81 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.995 0.902 . . . . 0.72999999999999998 110.935 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -67.02 -30.93 71.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.881 -0.512 . . . . 0.02 111.852 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -116.36 167.63 10.86 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.949 -1.094 . . . . 3.1800000000000002 110.561 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.18 164.17 44.49 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 111.057 -0.817 . . . . 0.01 111.057 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 57.1 38.56 29.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.884 -0.774 . . . . 0.01 110.963 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 52.4 55.32 9.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.582 -0.699 . . . . 0.01 111.058 178.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -129.08 165.85 20.42 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.216 -1.031 . . . . 3.1499999999999999 108.216 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.41 -163.8 27.76 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.231 -1.548 . . . . 0.01 109.231 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -76.0 144.24 41.02 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.025 -1.279 . . . . 0.01 108.711 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.592 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 52.2 ttp -116.29 141.84 47.63 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.608 0.718 . . . . 0.01 109.882 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -131.57 136.63 47.97 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.237 -1.023 . . . . 2.48 108.237 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -118.1 133.69 55.67 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.502 -0.749 . . . . 0.01 110.012 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.1 t -147.84 148.76 31.23 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 122.195 0.998 . . . . 1.6899999999999999 110.941 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 60.3 p -111.17 10.06 21.87 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 115.619 -0.718 . . . . 0.01 110.293 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -121.67 163.09 19.58 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.257 -0.902 . . . . 3.21 111.677 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.17 157.48 36.82 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.278 -1.008 . . . . 0.01 108.278 178.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.58 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 0.8 OUTLIER -128.46 119.51 20.54 Favored Pre-proline 0 N--CA 1.504 2.26 0 O-C-N 121.476 -0.765 . . . . 0.01 108.989 177.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -76.47 -28.76 6.57 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 CA-C-N 120.24 1.121 . . . . 0.01 110.85 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 64.1 m -144.04 109.75 5.25 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.718 0.771 . . . . 0.02 109.25 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.72 -38.28 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.819 -0.551 . . . . 1.8300000000000001 110.514 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 20.5 ttt -68.49 -36.39 78.87 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.399 -0.92 . . . . 1.3400000000000001 110.359 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -70.91 -39.06 72.96 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.5 -1.375 . . . . 2.1099999999999999 110.167 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -79.66 -47.54 15.22 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.307 -0.871 . . . . 2.0800000000000001 112.535 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -110.27 0.51 18.12 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.358 -0.839 . . . . 0.02 112.476 -176.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.6 m80 59.49 32.64 21.84 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.757 -1.214 . . . . 0.02 109.32 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.1 mt -112.2 135.46 52.84 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 108.477 -0.934 . . . . 0.02 108.477 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -91.24 -22.66 20.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.289 -0.882 . . . . 5.3200000000000003 110.158 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -149.84 164.04 36.42 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.296 -0.878 . . . . 0.02 110.024 -178.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 48.6 mt -131.42 128.49 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 107.558 -1.275 . . . . 2.1699999999999999 107.558 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -107.81 -12.25 15.24 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.313 -0.867 . . . . 0.02 112.376 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.4 t -158.74 151.39 21.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.837 -1.164 . . . . 0.01 108.911 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.504 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 2.8 p -170.41 145.25 2.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.092 -1.005 . . . . 1.22 109.178 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -124.67 110.18 14.07 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 122.361 1.077 . . . . 1.4099999999999999 109.894 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 131' ' ' VAL . 8.6 p -111.21 135.34 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.365 -1.346 . . . . 0.01 107.365 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.9 t -128.95 94.69 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 107.05 -1.463 . . . . 1.98 107.05 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.413 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 4.5 tm-20 -146.03 -74.73 0.22 Allowed 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 105.869 -1.9 . . . . 0.01 105.869 177.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 167.36 -69.74 0.18 Allowed Glycine 0 N--CA 1.485 1.902 0 N-CA-C 108.7 -1.76 . . . . 0.01 108.7 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.783 ' OG1' HD12 ' A' ' 175' ' ' ILE . 0.1 OUTLIER -120.18 115.4 23.57 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.556 -0.967 . . . . 2.2999999999999998 110.456 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.413 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 5.8 m95 -127.05 149.37 49.94 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 106.809 -1.552 . . . . 0.01 106.809 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 97.7 mt -122.98 138.37 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 120.42 -1.425 . . . . 1.6899999999999999 110.647 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -113.72 143.64 44.28 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.265 -1.383 . . . . 2.4900000000000002 107.265 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.501 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 10.5 m-85 -122.45 144.68 48.9 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.178 -0.951 . . . . 0.02 109.307 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -75.72 -29.34 58.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.608 -0.682 . . . . 0.02 111.566 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mt -116.41 154.21 48.91 Favored Pre-proline 0 N--CA 1.504 2.234 0 O-C-N 120.69 -1.256 . . . . 1.48 108.899 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -55.16 170.02 0.83 Allowed 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.225 1.283 . . . . 0.02 112.962 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 14.2 t30 58.25 31.62 21.04 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 114.937 -1.029 . . . . 0.75 111.274 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 56.21 48.01 18.21 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.532 -0.73 . . . . 0.02 110.424 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -123.03 164.4 18.65 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.585 -0.697 . . . . 0.02 109.97 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.86 -166.03 32.35 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.375 -1.09 . . . . 0.02 110.375 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -69.04 142.85 54.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.581 -0.952 . . . . 0.02 109.133 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -114.49 147.99 38.54 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.393 0.616 . . . . 0.02 110.242 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -125.22 135.71 52.84 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.919 -0.771 . . . . 0.01 108.919 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.7 tt -97.9 121.64 40.05 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.839 -1.163 . . . . 0.01 109.495 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.686 HD21 ' CD1' ' A' ' 162' ' ' TRP . 0.1 OUTLIER -96.04 145.5 25.4 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.309 -0.869 . . . . 0.01 108.752 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.671 ' H ' HD13 ' A' ' 151' ' ' LEU . 29.3 t0 -103.06 -116.15 0.21 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.339 -0.851 . . . . 2.27 109.412 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -157.78 49.69 0.42 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.053 -1.029 . . . . 1.8400000000000001 109.712 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -113.64 -162.97 0.83 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.495 -0.753 . . . . 2.2799999999999998 109.315 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -105.93 103.52 13.03 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.43 -0.794 . . . . 0.01 108.94 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.616 ' CG ' ' NE1' ' A' ' 162' ' ' TRP . 66.8 m-85 -98.7 113.24 25.24 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.365 -0.835 . . . . 0.01 109.722 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -95.11 -22.33 17.95 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.297 -0.877 . . . . 0.01 111.61 -177.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -127.39 154.52 77.24 Favored Pre-proline 0 N--CA 1.504 2.25 0 O-C-N 120.767 -1.208 . . . . 2.54 108.855 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -60.5 -38.97 69.58 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 120.58 0.854 . . . . 0.69999999999999996 110.512 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 84.6 t -61.51 -20.02 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.958 -1.089 . . . . 0.85999999999999999 108.931 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -65.41 -15.6 62.77 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.934 -1.104 . . . . 0.02 110.074 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.686 ' CD1' HD21 ' A' ' 151' ' ' LEU . 9.7 m0 -98.22 11.4 37.98 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.144 -0.973 . . . . 0.02 108.925 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.06 10.34 85.65 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.842 -1.171 . . . . 0.02 111.087 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.57 141.25 32.6 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.181 -1.188 . . . . 0.02 110.023 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.08 -9.46 57.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.671 -0.643 . . . . 0.58999999999999997 110.217 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.0 m -143.49 149.78 48.75 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 120.891 -1.131 . . . . 0.87 109.057 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -76.64 19.1 0.66 Allowed 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 120.822 1.015 . . . . 0.38 112.294 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.7 124.7 29.82 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.812 -1.18 . . . . 0.17999999999999999 111.493 -177.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -150.21 126.6 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 107.075 -1.454 . . . . 3.9900000000000002 107.075 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -115.11 -15.07 11.74 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.051 -1.031 . . . . 5.1699999999999999 113.582 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 6.2 t -156.77 160.16 38.99 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 119.189 -2.194 . . . . 0.02 110.294 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.58 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 13.9 p90 -151.84 153.29 33.93 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.919 -1.113 . . . . 2.02 110.718 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -144.78 149.42 35.46 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.364 -0.835 . . . . 0.01 110.293 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.415 ' HG2' ' H ' ' A' ' 174' ' ' ARG . 12.5 ptm180 -89.26 145.46 25.37 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.27 -0.641 . . . . 0.01 109.27 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.783 HD12 ' OG1' ' A' ' 135' ' ' THR . 4.7 mt -96.76 129.93 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.308 -0.87 . . . . 3.04 109.324 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.14 146.31 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.227 -0.92 . . . . 1.8899999999999999 109.484 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 4.8899999999999997 109.404 179.931 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 89.5 p . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.223 0.535 . . . . 5.2800000000000002 109.59 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -56.1 -31.21 63.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.309 -0.869 . . . . 5.96 109.503 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 55.8 p -80.48 141.82 34.84 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.194 -1.039 . . . . 2.2200000000000002 108.194 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.92 179.57 48.04 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 118.223 -1.941 . . . . 0.81000000000000005 112.117 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.12 157.76 43.4 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.421 -1.471 . . . . 0.01 109.421 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.519 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 2.8 ttmp? -145.99 135.27 22.9 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.174 -1.192 . . . . 0.02 110.517 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.5 tt -129.54 139.15 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.062 -1.088 . . . . 0.02 108.062 178.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.49 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.4 t -122.41 130.86 53.53 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.348 -0.845 . . . . 0.39000000000000001 110.119 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.0 m-85 -111.18 141.54 44.57 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 109.067 -0.716 . . . . 0.02 109.067 178.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.548 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.9 m-85 -122.08 138.58 54.39 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.181 -0.949 . . . . 0.02 109.61 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.486 ' HG3' HD11 ' A' ' 33' ' ' LEU . 96.1 mt-10 -68.33 -27.91 66.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.878 -1.139 . . . . 0.029999999999999999 111.39 -178.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.1 m-20 -114.65 169.88 8.73 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.873 -1.142 . . . . 0.029999999999999999 110.163 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -75.5 161.91 28.78 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.793 0.806 . . . . 0.029999999999999999 110.411 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.3 m120 63.12 33.13 14.75 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.054 0.931 . . . . 0.73999999999999999 110.894 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 54.92 40.07 31.83 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.865 -0.607 . . . . 0.02 110.978 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -110.29 165.75 11.52 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.215 -1.031 . . . . 0.02 108.215 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.46 -167.57 35.63 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.889 -1.148 . . . . 0.029999999999999999 110.889 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -69.65 143.28 53.26 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.477 -1.014 . . . . 2.7599999999999998 109.261 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -120.47 149.23 42.72 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.505 0.669 . . . . 1.8899999999999999 110.171 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -132.34 127.59 35.85 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.25 -1.018 . . . . 0.02 108.25 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -112.78 136.75 52.04 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.422 -0.799 . . . . 1.1200000000000001 109.751 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.427 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 15.9 t -131.22 139.14 49.64 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.765 -0.585 . . . . 0.02 109.515 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -116.58 11.69 14.83 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.624 -0.672 . . . . 0.20000000000000001 109.836 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.513 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 52.9 t -158.37 174.69 14.75 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.248 -1.019 . . . . 1.23 108.248 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.513 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.1 m-20 -60.53 144.19 52.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.756 -1.215 . . . . 0.02 109.721 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 22.2 t -131.75 117.41 18.56 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.654 -0.869 . . . . 0.02 108.654 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.89 -24.42 48.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.143 -0.973 . . . . 0.23999999999999999 110.919 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -155.18 102.36 2.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.927 -1.108 . . . . 1.1399999999999999 109.234 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -102.57 9.9 39.13 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 122.024 0.916 . . . . 6.3700000000000001 109.734 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -59.45 -25.22 64.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.589 -0.694 . . . . 3.1099999999999999 111.416 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.9 m -76.23 -17.3 59.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.508 -1.37 . . . . 0.88 110.687 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -103.88 -22.06 13.56 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.361 -0.837 . . . . 0.02 109.411 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.486 HD11 ' HG3' ' A' ' 11' ' ' GLU . 6.1 tp -150.25 129.1 12.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.317 -0.865 . . . . 3.3199999999999998 109.0 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.5 m -85.03 -9.81 57.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.743 -0.598 . . . . 0.02 110.944 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -171.15 162.36 6.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.954 -1.091 . . . . 0.02 108.066 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.9 p -144.03 115.09 7.88 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.747 -1.221 . . . . 0.02 108.53 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.42 HD22 ' HB3' ' A' ' 77' ' ' ASP . 5.8 t-20 -108.65 3.29 22.66 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.787 -1.195 . . . . 0.029999999999999999 110.862 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.3 m -155.48 154.28 31.58 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.651 -1.241 . . . . 0.02 107.651 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.404 HD13 HG21 ' A' ' 39' ' ' ILE . 10.5 mt -146.36 147.1 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.977 -1.077 . . . . 0.02 110.574 -178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -124.6 125.07 43.55 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 107.814 -1.18 . . . . 0.02 107.814 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.7 t -106.38 115.21 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 106.972 -1.492 . . . . 0.02 106.972 177.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.519 ' OE1' ' NZ ' ' A' ' 6' ' ' LYS . 30.5 tt0 -83.38 -34.0 25.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.37 -0.831 . . . . 3.8100000000000001 110.93 -178.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.04 152.58 22.5 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 118.893 -1.622 . . . . 0.02 110.799 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.53 172.97 49.39 Favored Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.698 -1.239 . . . . 0.01 110.423 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 86.6 m -119.81 135.16 54.97 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 107.982 -1.118 . . . . 1.48 107.982 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.442 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 32.0 m95 -126.53 154.99 43.07 Favored 'General case' 0 N--CA 1.502 2.173 0 CA-C-O 122.581 1.181 . . . . 0.02 112.301 -176.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.14 134.28 51.92 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 105.225 -2.139 . . . . 0.23999999999999999 105.225 176.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.437 ' HB ' HD22 ' A' ' 79' ' ' LEU . 35.5 m -116.99 141.93 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.532 -0.73 . . . . 0.65000000000000002 109.235 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -121.18 143.89 48.88 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 122.061 0.934 . . . . 0.02 109.753 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -65.01 -34.82 79.36 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.448 -0.796 . . . . 0.02 111.655 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.9 mtm180 -125.37 157.74 66.67 Favored Pre-proline 0 N--CA 1.503 2.2 0 O-C-N 121.004 -1.06 . . . . 0.02 109.332 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.48 167.73 0.84 Allowed 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.657 1.572 . . . . 0.02 113.022 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 63.13 36.39 12.19 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.212 -0.903 . . . . 0.02 111.207 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' A' ' 54' ' ' PHE . 0.6 OUTLIER 45.5 51.62 9.67 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.591 0.71 . . . . 3.3900000000000001 110.717 178.472 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.8 m -126.02 163.85 22.13 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.187 0.517 . . . . 2.3300000000000001 109.846 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.85 -161.54 32.06 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.869 -1.292 . . . . 0.02 109.869 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.407 ' CD2' ' N ' ' A' ' 57' ' ' HIS . 15.8 m170 -65.22 138.62 58.36 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.035 -1.274 . . . . 0.02 110.068 -178.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.447 ' C ' ' SD ' ' A' ' 58' ' ' MET . 11.2 tmm? -118.97 136.39 54.11 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.362 0.601 . . . . 5.0099999999999998 109.693 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.455 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 93.8 m-85 -134.31 138.76 45.2 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 121.714 0.768 . . . . 0.02 109.828 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.419 HD11 ' SD ' ' A' ' 58' ' ' MET . 15.9 mm -95.38 131.11 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 109.031 -0.729 . . . . 1.72 109.031 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.565 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -119.66 110.62 36.85 Favored Pre-proline 0 N--CA 1.504 2.247 0 O-C-N 121.449 -0.782 . . . . 0.02 110.67 -178.3 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -77.26 167.86 24.01 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 CA-C-N 119.966 1.024 . . . . 1.47 110.167 177.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.614 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -53.36 141.61 23.88 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.834 -1.166 . . . . 4.25 110.445 -179.621 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.13 -177.81 32.15 Favored Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.549 -1.31 . . . . 0.02 110.671 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -119.78 131.64 55.39 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.382 -1.07 . . . . 0.95999999999999996 109.823 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.565 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 75.6 m-85 -121.46 97.81 46.78 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 108.047 -1.094 . . . . 0.02 108.047 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -69.42 -3.88 12.68 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 120.743 0.962 . . . . 0.02 113.48 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -157.65 154.76 28.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.781 -1.199 . . . . 2.02 108.041 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -60.36 -38.8 84.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.58 -0.7 . . . . 0.02 112.154 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -60.52 -24.15 65.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.176 -0.953 . . . . 0.02 110.494 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -68.74 -18.03 64.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.327 -0.858 . . . . 3.4199999999999999 109.076 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.562 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.3 t90 -108.09 11.74 27.39 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.673 -1.232 . . . . 0.02 107.673 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.3 mmt 60.48 22.3 11.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.556 -0.715 . . . . 0.02 110.295 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.89 143.33 45.48 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.429 -1.468 . . . . 0.02 109.429 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.0 tp -78.58 -31.26 47.15 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.293 -1.373 . . . . 0.97999999999999998 107.293 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -157.75 -172.07 3.8 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 106.097 -1.816 . . . . 0.02 106.097 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.42 ' HB3' HD22 ' A' ' 37' ' ' ASN . 1.4 p30 -98.16 28.26 4.13 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.701 -1.249 . . . . 0.02 110.692 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -96.76 121.87 39.09 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.736 -1.227 . . . . 3.2000000000000002 111.039 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.437 HD22 ' HB ' ' A' ' 48' ' ' VAL . 59.4 mt -142.96 122.02 12.87 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 107.422 -1.325 . . . . 2.6099999999999999 107.422 178.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.84 -17.61 9.55 Favored Glycine 0 N--CA 1.504 3.222 0 O-C-N 121.231 -0.918 . . . . 0.02 112.859 -177.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 p -156.37 156.48 33.96 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.04 -1.859 . . . . 0.02 110.61 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 44.2 t -144.34 146.85 32.8 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.38 -0.825 . . . . 0.02 110.476 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 -138.33 143.48 39.93 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.408 -0.807 . . . . 0.01 109.486 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.42 132.25 36.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.946 . . . . 0.42999999999999999 109.825 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.3 t -91.56 125.63 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.878 -0.786 . . . . 1.25 108.878 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -94.26 131.85 39.44 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.783 -1.198 . . . . 1.77 109.234 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.3 mt -96.79 140.34 31.5 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.307 -0.871 . . . . 1.6299999999999999 108.681 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.5 p -111.93 127.63 55.91 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.411 -0.806 . . . . 1.0800000000000001 109.339 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.7 t -103.94 -154.66 0.51 Allowed 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 106.551 -1.648 . . . . 1.26 106.551 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.01 -52.45 0.75 Allowed Glycine 0 N--CA 1.5 2.944 0 O-C-N 120.512 -1.368 . . . . 0.01 112.807 177.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.26 -101.19 0.15 Allowed Glycine 0 N--CA 1.491 2.306 0 C-N-CA 118.457 -1.83 . . . . 0.01 112.161 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -121.94 119.8 32.57 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.033 -1.275 . . . . 4.4299999999999997 110.791 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.4 129.73 34.74 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.833 -0.747 . . . . 2.9900000000000002 109.362 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -130.1 142.23 50.62 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.347 -0.846 . . . . 6.3600000000000003 109.073 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.0 tt -129.19 146.13 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 121.302 -0.874 . . . . 1.0900000000000001 110.373 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -121.54 133.25 55.02 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.432 -1.321 . . . . 2.0499999999999998 107.432 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.8 m -123.58 145.35 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 120.693 -1.255 . . . . 1.1000000000000001 109.772 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -119.75 141.46 49.42 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 122.064 0.935 . . . . 0.72999999999999998 111.012 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -67.24 -30.5 70.43 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.922 -0.581 . . . . 0.02 112.126 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -116.27 167.33 11.11 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 120.998 -1.064 . . . . 3.1800000000000002 110.413 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.64 163.85 43.02 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 111.039 -0.825 . . . . 0.01 111.039 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.2 t70 56.82 38.75 29.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.921 -0.753 . . . . 0.01 110.896 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.437 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 21.2 m-85 52.26 55.95 8.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.656 -0.652 . . . . 0.01 111.103 178.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -128.8 165.39 21.05 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.256 -1.016 . . . . 3.1499999999999999 108.256 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.22 -163.79 27.99 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.324 -1.511 . . . . 0.01 109.324 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 48.3 tp60 -75.03 143.48 43.5 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.998 -1.295 . . . . 0.01 108.551 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.45 ' C ' ' SD ' ' A' ' 107' ' ' MET . 12.3 tmm? -115.99 142.45 46.77 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.52 0.676 . . . . 0.01 109.746 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -131.83 136.5 47.53 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.249 -1.019 . . . . 2.48 108.249 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -118.76 134.14 55.35 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.576 -0.703 . . . . 0.01 109.948 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.0 t -148.86 149.99 32.23 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.24 1.019 . . . . 1.6899999999999999 110.946 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 32.2 p -109.94 10.38 24.32 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 115.485 -0.78 . . . . 0.01 110.106 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -121.29 163.16 19.04 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.264 -0.898 . . . . 3.21 111.715 -178.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -67.48 156.61 36.22 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.253 -1.017 . . . . 0.01 108.253 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 37.5 t -125.4 111.95 25.9 Favored Pre-proline 0 N--CA 1.503 2.177 0 O-C-N 121.368 -0.832 . . . . 0.01 109.035 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -76.37 -32.62 3.8 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 CA-C-N 119.997 1.034 . . . . 0.01 111.635 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 7.8 t -140.6 106.54 5.17 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.223 -0.923 . . . . 0.02 108.592 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 68.0 mt -65.03 -38.82 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.717 -0.615 . . . . 1.8300000000000001 111.183 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.2 ttt -66.92 -38.07 85.51 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 118.946 -1.102 . . . . 1.3400000000000001 109.929 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -69.15 -38.28 78.7 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.489 -1.382 . . . . 2.1099999999999999 109.546 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -79.77 -47.25 15.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.322 -0.861 . . . . 2.0800000000000001 112.269 -177.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -111.77 -0.53 15.91 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.378 -0.826 . . . . 0.02 112.824 -176.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.8 m80 61.71 34.67 17.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.752 -1.218 . . . . 0.02 109.837 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 40.9 mt -114.47 136.12 53.36 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.454 -0.779 . . . . 0.02 109.426 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -90.62 -22.04 21.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.3 -0.875 . . . . 5.3200000000000003 110.864 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -148.05 163.92 35.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.99 -1.069 . . . . 0.02 109.97 -178.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.9 mm -129.28 125.28 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 107.857 -1.164 . . . . 2.1699999999999999 107.857 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -109.74 -13.61 14.46 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.233 -0.917 . . . . 0.02 112.833 -177.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.437 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 2.3 t -158.87 149.63 20.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.797 -1.189 . . . . 0.01 108.987 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.486 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 30.0 p -170.14 148.81 3.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 1.22 108.865 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -120.88 113.03 19.54 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 122.453 1.12 . . . . 1.4099999999999999 110.062 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.0 t -112.19 128.72 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.561 -1.274 . . . . 0.01 107.561 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 47.5 t -128.73 93.11 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 107.071 -1.455 . . . . 1.98 107.071 177.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -147.71 -75.99 0.18 Allowed 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 105.831 -1.914 . . . . 0.01 105.831 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 156.55 -54.53 0.4 Allowed Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.184 -1.567 . . . . 0.01 109.184 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 54.7 p -119.77 97.8 5.8 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.551 -0.97 . . . . 2.2999999999999998 111.012 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -128.16 145.53 50.99 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 107.108 -1.442 . . . . 0.01 107.108 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.402 ' CG1' HD11 ' A' ' 175' ' ' ILE . 61.4 mt -122.02 138.89 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 120.883 -1.136 . . . . 1.6899999999999999 110.714 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -113.71 144.11 43.5 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 106.873 -1.529 . . . . 2.4900000000000002 106.873 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.513 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 15.7 m-85 -123.17 144.36 49.4 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.311 -0.868 . . . . 0.02 109.658 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -76.54 -28.97 56.52 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.624 -0.673 . . . . 0.02 111.999 -176.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mt -116.04 154.93 48.52 Favored Pre-proline 0 N--CA 1.506 2.331 0 O-C-N 120.544 -1.348 . . . . 1.48 108.915 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.95 165.94 2.4 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.235 1.29 . . . . 0.02 113.071 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.564 HD22 ' N ' ' A' ' 143' ' ' ASN . 1.2 m120 59.68 31.48 20.9 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 115.071 -0.968 . . . . 0.75 111.471 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 57.39 51.09 10.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.45 -0.781 . . . . 0.02 111.186 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -126.26 164.91 19.96 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.426 -0.796 . . . . 0.02 109.944 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.463 ' O ' ' NE2' ' A' ' 148' ' ' GLN . . . 89.01 -165.98 33.42 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.255 -1.138 . . . . 0.02 110.255 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -69.39 142.66 53.88 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.724 -0.868 . . . . 0.02 109.061 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.47 ' CD ' ' N ' ' A' ' 148' ' ' GLN . 7.2 mp0 -115.63 149.54 38.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.803 -0.56 . . . . 0.02 109.728 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -123.53 134.76 53.82 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.616 -0.678 . . . . 0.01 109.219 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.3 tp -95.24 121.15 36.59 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.632 -1.292 . . . . 0.01 108.956 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.564 HD21 ' CG ' ' A' ' 162' ' ' TRP . 0.2 OUTLIER -94.63 160.24 14.72 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.325 -0.859 . . . . 0.01 109.045 -179.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.48 ' H ' HD13 ' A' ' 151' ' ' LEU . 1.4 p-10 -109.34 -111.65 0.32 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.445 -0.784 . . . . 2.27 109.335 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.525 ' N ' ' OH ' ' A' ' 156' ' ' TYR . 49.7 pttt -168.81 45.55 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.114 -0.991 . . . . 1.8400000000000001 109.923 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -113.59 -153.77 0.53 Allowed 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.503 -0.748 . . . . 2.2799999999999998 109.122 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -106.39 106.37 16.85 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.417 -0.802 . . . . 0.01 109.075 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.644 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 2.9 m-85 -99.34 112.4 24.58 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.267 -0.895 . . . . 0.01 109.667 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -94.56 -22.67 18.05 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.129 -0.982 . . . . 0.01 111.411 -178.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -128.19 154.44 78.79 Favored Pre-proline 0 N--CA 1.502 2.146 0 O-C-N 120.84 -1.163 . . . . 2.54 108.822 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -60.12 -37.21 85.46 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 CA-C-N 119.268 0.774 . . . . 0.69999999999999996 110.631 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 6.0 t -61.11 -19.88 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.756 -1.215 . . . . 0.85999999999999999 109.048 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -65.15 -15.28 62.25 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.94 -1.1 . . . . 0.02 109.921 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.644 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 12.9 m0 -97.93 11.29 37.94 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.14 -0.975 . . . . 0.02 109.025 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.4 11.0 84.7 Favored Glycine 0 N--CA 1.491 2.329 0 O-C-N 120.793 -1.192 . . . . 0.02 111.177 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.34 140.88 32.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.066 -1.255 . . . . 0.02 110.066 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.68 -8.76 58.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.598 -0.689 . . . . 0.58999999999999997 110.045 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 8.1 p -142.47 151.31 57.39 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 120.981 -1.075 . . . . 0.87 109.318 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -76.21 16.67 0.82 Allowed 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 120.837 1.024 . . . . 0.38 112.263 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.41 122.17 27.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.872 -1.142 . . . . 0.17999999999999999 111.366 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 3.1 mt -149.12 123.51 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 105.873 -1.899 . . . . 3.9900000000000002 105.873 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -112.21 -15.9 13.11 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.227 -0.92 . . . . 5.1699999999999999 113.286 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 20.9 m -156.6 160.42 39.4 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 119.245 -2.159 . . . . 0.02 110.041 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.419 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 21.4 p90 -152.67 153.0 32.41 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.147 -0.971 . . . . 2.02 110.633 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 29.6 mtp180 -145.58 149.65 34.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.36 -0.837 . . . . 0.01 109.679 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -88.4 142.44 27.72 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.507 -0.746 . . . . 0.01 109.455 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.402 HD11 ' CG1' ' A' ' 137' ' ' ILE . 3.7 mt -93.59 129.93 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.257 -0.902 . . . . 3.04 109.126 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.5 p -137.53 148.7 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.239 -0.913 . . . . 1.8899999999999999 109.902 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 . . . . . 0 N--CA 1.494 1.764 0 O-C-N 121.514 -0.741 . . . . 4.8899999999999997 109.656 179.827 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 99.3 p . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.401 -0.592 . . . . 5.2800000000000002 109.401 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -49.85 146.34 4.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 5.96 109.68 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.53 HG22 ' N ' ' A' ' 4' ' ' GLY . 47.4 m -168.42 167.19 12.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.034 -1.041 . . . . 2.2200000000000002 108.748 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.53 ' N ' HG22 ' A' ' 3' ' ' THR . . . -118.0 117.07 3.63 Favored Glycine 0 N--CA 1.499 2.872 0 N-CA-C 106.94 -2.464 . . . . 0.81000000000000005 106.94 177.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.9 144.76 32.83 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.768 -1.333 . . . . 0.01 109.768 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -149.92 136.45 19.12 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.481 -1.011 . . . . 0.02 109.882 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.3 tt -128.87 139.24 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.157 -1.053 . . . . 0.02 108.157 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.1 t -121.7 130.18 53.26 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.328 -0.858 . . . . 0.39000000000000001 110.033 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.545 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.8 m-85 -110.25 140.65 44.18 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.871 -0.788 . . . . 0.02 108.871 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.528 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 6.0 m-85 -122.37 138.79 54.41 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.214 -0.929 . . . . 0.02 109.612 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.47 ' HG3' HD11 ' A' ' 33' ' ' LEU . 87.7 mt-10 -68.03 -27.74 66.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.025 -1.047 . . . . 0.029999999999999999 111.663 -178.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -114.53 169.86 8.74 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.812 -1.18 . . . . 0.029999999999999999 110.379 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -75.67 158.92 31.72 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.611 0.719 . . . . 0.029999999999999999 109.974 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 66.09 32.99 7.86 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.949 0.88 . . . . 0.73999999999999999 110.97 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 55.23 41.57 31.27 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.31 0.576 . . . . 0.02 111.392 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 -112.94 166.23 11.59 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.327 -0.99 . . . . 0.02 108.327 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.68 -168.06 35.73 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 119.857 -1.163 . . . . 0.029999999999999999 110.75 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.425 ' NH2' ' OE2' ' A' ' 11' ' ' GLU . 23.4 ttp180 -68.83 143.37 54.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.476 -1.014 . . . . 2.7599999999999998 109.135 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -120.87 148.98 43.3 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.506 -0.746 . . . . 1.8899999999999999 110.189 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -132.79 127.76 35.3 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.327 -0.99 . . . . 0.02 108.327 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -112.2 136.67 51.33 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.403 -0.811 . . . . 1.1200000000000001 109.789 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.4 t -131.17 139.06 49.69 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.663 -0.648 . . . . 0.02 109.602 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -116.46 11.85 15.01 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.677 -0.639 . . . . 0.20000000000000001 109.655 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.0 p -158.63 174.6 14.81 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.358 -0.978 . . . . 1.23 108.358 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -60.45 144.66 50.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.642 -1.286 . . . . 0.02 109.858 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 44.2 t -131.97 117.76 18.86 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.691 -0.855 . . . . 0.02 108.691 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.49 -25.37 50.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.18 -0.95 . . . . 0.23999999999999999 110.894 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -154.2 102.96 2.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.97 -1.082 . . . . 1.1399999999999999 109.218 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -102.41 9.43 39.72 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 122.127 0.965 . . . . 6.3700000000000001 109.673 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -59.55 -25.17 64.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.523 -0.736 . . . . 3.1099999999999999 111.362 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.3 t -76.15 -17.55 59.51 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.505 -1.372 . . . . 0.88 110.596 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -104.08 -21.86 13.52 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.358 -0.839 . . . . 0.02 109.486 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.47 HD11 ' HG3' ' A' ' 11' ' ' GLU . 6.4 tp -150.43 129.25 12.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.194 -0.941 . . . . 3.3199999999999998 109.005 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.0 p -85.26 -10.22 56.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.81 -0.556 . . . . 0.02 111.131 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -171.1 162.38 7.06 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.009 -1.108 . . . . 0.02 108.009 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.8 p -144.08 115.33 7.97 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.703 -1.248 . . . . 0.02 108.766 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -108.26 1.75 22.22 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 120.86 -1.15 . . . . 0.029999999999999999 110.969 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.8 t -154.95 154.3 32.38 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.636 -1.246 . . . . 0.02 107.636 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 61.3 mt -145.14 146.84 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.038 -1.039 . . . . 0.02 110.044 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -123.33 124.0 41.97 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.86 -1.163 . . . . 0.02 107.86 177.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.0 t -106.64 115.09 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 106.867 -1.531 . . . . 0.02 106.867 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -83.69 -33.75 25.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.655 -0.653 . . . . 3.8100000000000001 110.754 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.76 152.09 21.83 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 118.92 -1.609 . . . . 0.02 110.881 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.76 173.21 49.6 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.727 -1.225 . . . . 0.01 110.617 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.2 m -119.62 135.4 54.82 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 107.861 -1.163 . . . . 1.48 107.861 177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.449 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 33.7 m95 -126.6 155.57 42.29 Favored 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 122.576 1.179 . . . . 0.02 112.188 -176.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.68 134.16 52.29 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 105.666 -1.976 . . . . 0.23999999999999999 105.666 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.504 ' HB ' HD22 ' A' ' 79' ' ' LEU . 33.3 m -119.4 143.72 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.542 -0.724 . . . . 0.65000000000000002 109.054 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -120.9 146.28 46.78 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 122.226 1.012 . . . . 0.02 109.963 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -66.42 -34.59 78.29 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.756 -0.656 . . . . 0.02 111.183 -177.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -125.38 157.95 65.94 Favored Pre-proline 0 N--CA 1.502 2.139 0 O-C-N 121.162 -0.961 . . . . 0.02 109.465 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -53.89 167.17 1.17 Allowed 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 121.672 1.581 . . . . 0.02 113.082 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.2 t30 63.79 36.53 10.42 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.04 -0.982 . . . . 0.02 111.119 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 45.93 51.68 10.49 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.596 0.712 . . . . 3.3900000000000001 110.663 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.4 m -126.63 164.03 22.14 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.121 0.486 . . . . 2.3300000000000001 109.924 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.86 -161.74 32.2 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.881 -1.288 . . . . 0.02 109.881 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -65.66 139.51 58.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.109 -1.23 . . . . 0.02 110.017 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 17.2 ptm -117.94 137.07 53.08 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.761 -0.587 . . . . 5.0099999999999998 109.53 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -133.75 136.31 44.5 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.487 -0.758 . . . . 0.02 109.847 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.628 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.8 mp -95.39 131.64 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.522 -0.918 . . . . 1.72 108.522 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.7 mt -120.05 111.06 35.79 Favored Pre-proline 0 N--CA 1.502 2.146 0 O-C-N 121.504 -0.748 . . . . 0.02 110.682 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -77.13 168.73 22.73 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 CA-C-N 119.846 0.981 . . . . 1.47 109.981 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -52.67 141.49 20.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.831 -1.168 . . . . 4.25 110.184 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.04 -176.68 31.84 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.579 -1.296 . . . . 0.02 110.666 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -119.65 130.98 55.34 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.467 -1.019 . . . . 0.95999999999999996 109.58 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.41 ' N ' ' CD1' ' A' ' 66' ' ' TYR . 31.3 m-85 -120.41 96.53 49.05 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 107.889 -1.152 . . . . 0.02 107.889 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.4 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.8 Cg_endo -67.24 -5.03 12.82 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 120.746 0.964 . . . . 0.02 114.0 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 32.6 mt-10 -157.66 156.07 31.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.592 -1.317 . . . . 2.02 108.373 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -61.55 -38.17 86.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.408 -0.807 . . . . 0.02 112.324 -177.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -61.01 -22.08 64.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.023 -1.048 . . . . 0.02 109.961 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.9 tpm_? -67.0 -19.04 65.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.508 -0.745 . . . . 3.4199999999999999 110.03 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.454 ' C ' ' SD ' ' A' ' 73' ' ' MET . 2.2 p90 -110.42 16.3 21.68 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.336 -0.852 . . . . 0.02 109.091 178.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.454 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 3.0 mpp? 63.34 25.03 14.48 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.482 0.658 . . . . 0.02 110.768 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.412 ' HA3' ' HE1' ' A' ' 72' ' ' TRP . . . -60.51 145.17 47.41 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.838 -1.305 . . . . 0.02 109.838 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.6 tp -80.77 -31.2 35.89 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.663 -1.236 . . . . 0.97999999999999998 107.663 177.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -157.56 -171.84 3.73 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 106.482 -1.673 . . . . 0.02 106.482 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -98.99 28.27 4.49 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.707 -1.245 . . . . 0.02 110.835 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.595 HH11 ' CG ' ' A' ' 78' ' ' ARG . 3.3 mtt-85 -96.2 122.66 39.29 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.859 -1.151 . . . . 3.2000000000000002 110.872 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.504 HD22 ' HB ' ' A' ' 48' ' ' VAL . 33.0 mt -144.13 122.49 12.34 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.73 -1.211 . . . . 2.6099999999999999 107.73 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.44 -16.45 10.23 Favored Glycine 0 N--CA 1.504 3.216 0 O-C-N 121.102 -0.998 . . . . 0.02 112.94 -177.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 73.3 p -156.79 156.53 33.43 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.177 -1.778 . . . . 0.02 110.339 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 53.2 t -143.97 147.2 33.6 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.539 -0.725 . . . . 0.02 110.191 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.1 mtp180 -137.8 142.83 40.84 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.335 -0.853 . . . . 0.01 109.456 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.87 132.03 36.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.92 . . . . 0.42999999999999999 109.7 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.9 t -90.67 124.7 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.618 -0.882 . . . . 1.25 108.618 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -93.14 132.32 37.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.847 -1.158 . . . . 1.77 108.928 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.2 mt -97.37 139.77 32.82 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.669 -0.863 . . . . 1.6299999999999999 108.669 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.3 m -110.74 124.87 52.81 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.46 -0.941 . . . . 1.0800000000000001 108.46 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.8 t -115.85 130.39 56.82 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.651 -1.281 . . . . 1.26 107.608 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -154.13 -51.93 0.01 OUTLIER Glycine 0 N--CA 1.505 3.295 0 C-N-CA 117.951 -2.071 . . . . 0.01 113.24 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.11 -106.17 0.19 Allowed Glycine 0 N--CA 1.489 2.176 0 O-C-N 120.162 -1.787 . . . . 0.01 111.198 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -119.8 117.55 28.49 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.0 -1.294 . . . . 4.4299999999999997 110.212 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.77 130.28 36.53 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.066 -0.654 . . . . 2.9900000000000002 109.395 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.415 ' CB ' ' NZ ' ' A' ' 94' ' ' LYS . 7.3 ttpm? -131.72 141.27 49.5 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.492 -0.755 . . . . 6.3600000000000003 109.409 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.0 tt -127.65 146.99 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.418 0 CA-C-O 121.809 0.814 . . . . 1.0900000000000001 110.292 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -122.79 131.63 53.86 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.904 -1.147 . . . . 2.0499999999999998 107.904 177.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.7 m -125.35 147.65 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 O-C-N 120.95 -1.094 . . . . 1.1000000000000001 109.947 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.563 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 80.5 m-85 -119.19 141.67 48.66 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-O 121.948 0.88 . . . . 0.72999999999999998 111.139 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -67.74 -31.17 70.91 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 116.104 -0.498 . . . . 0.02 111.322 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.436 ' O ' ' OG ' ' A' ' 128' ' ' SER . 45.6 mttp -116.31 170.15 8.76 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.089 -1.007 . . . . 3.1800000000000002 110.04 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.56 169.72 43.97 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 111.174 -0.77 . . . . 0.01 111.174 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.6 t70 52.68 39.32 28.22 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.654 0.74 . . . . 0.01 111.611 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 52.42 48.72 22.01 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.601 -0.687 . . . . 0.01 110.975 178.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -123.09 164.93 17.68 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.379 -0.971 . . . . 3.1499999999999999 108.379 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.64 -163.54 28.56 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.427 -1.469 . . . . 0.01 109.427 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -76.93 144.05 39.11 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.049 -1.265 . . . . 0.01 109.121 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.563 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 28.1 ttp -116.19 142.32 46.97 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.487 0.66 . . . . 0.01 109.824 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -131.75 136.26 47.44 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.413 -0.958 . . . . 2.48 108.413 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -121.55 135.21 55.03 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.53 -0.731 . . . . 0.01 109.9 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.0 t -148.57 151.94 35.93 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.97 -1.081 . . . . 1.6899999999999999 110.799 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.4 p -111.54 8.68 21.09 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 116.028 -0.533 . . . . 0.01 110.618 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -120.63 162.96 18.76 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.162 -0.961 . . . . 3.21 111.311 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -67.6 156.52 36.59 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.397 -0.964 . . . . 0.01 108.397 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.434 ' SG ' ' OE1' ' A' ' 120' ' ' GLN . 42.8 t -125.57 114.36 25.19 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 108.928 -0.767 . . . . 0.01 108.928 178.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.415 ' O ' ' OG ' ' A' ' 171' ' ' SER . 20.6 Cg_endo -77.05 -31.92 3.49 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 CA-C-N 120.156 1.091 . . . . 0.01 111.122 178.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 41.1 t -141.74 107.56 5.13 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.556 -0.905 . . . . 0.02 108.556 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 64.7 mt -65.3 -38.69 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.656 -0.653 . . . . 1.8300000000000001 110.951 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 118' ' ' MET . 1.1 tmt? -66.69 -38.37 86.63 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.942 -1.103 . . . . 1.3400000000000001 109.758 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -68.56 -38.27 80.62 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.463 -1.398 . . . . 2.1099999999999999 109.63 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.434 ' OE1' ' SG ' ' A' ' 114' ' ' CYS . 54.5 tt0 -80.11 -46.73 15.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.245 -0.91 . . . . 2.0800000000000001 112.314 -177.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -112.27 -0.86 15.33 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.28 -0.887 . . . . 0.02 112.852 -176.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.7 m80 61.61 34.91 17.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.666 -1.272 . . . . 0.02 109.871 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.0 mt -114.01 135.63 53.8 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.521 -0.737 . . . . 0.02 109.229 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -90.9 -22.1 21.07 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.277 -0.889 . . . . 5.3200000000000003 110.965 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -148.03 164.0 35.15 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.993 -1.067 . . . . 0.02 110.022 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.0 mm -128.69 124.77 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 107.555 -1.276 . . . . 2.1699999999999999 107.555 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -109.43 -14.69 14.38 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.165 -0.959 . . . . 0.02 112.982 -176.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 10.0 p -161.14 153.21 19.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.563 -1.336 . . . . 0.01 109.467 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.409 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 27.9 p -167.79 149.43 5.47 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.796 -1.187 . . . . 1.22 107.796 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -112.83 103.59 11.59 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.104 -0.997 . . . . 1.4099999999999999 108.924 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.8 t -111.22 125.92 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 115.766 -0.652 . . . . 0.01 109.569 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.2 t -122.92 86.42 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.77 -1.937 . . . . 1.98 105.77 175.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.438 ' O ' ' O ' ' A' ' 152' ' ' ASP . 3.3 tp10 -161.36 -158.17 0.55 Allowed 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 106.786 -1.561 . . . . 0.01 106.786 178.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -157.65 -3.7 0.08 OUTLIER Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.113 -1.995 . . . . 0.01 108.113 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.6 p -115.06 45.04 1.69 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 122.0 -0.706 . . . . 2.2999999999999998 109.66 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -125.97 136.17 52.68 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.293 -0.879 . . . . 0.01 108.927 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 12.4 mt -123.71 141.28 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.693 -0.63 . . . . 1.6899999999999999 109.383 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -114.3 144.82 42.63 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.059 -1.46 . . . . 2.4900000000000002 107.059 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.464 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 19.9 m-85 -123.23 144.44 49.38 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.493 -0.754 . . . . 0.02 109.674 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.44 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 78.1 tt0 -75.58 -29.31 59.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.634 -0.667 . . . . 0.02 111.781 -176.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mt -115.05 154.94 47.15 Favored Pre-proline 0 N--CA 1.505 2.309 0 O-C-N 120.654 -1.279 . . . . 1.48 109.128 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -55.91 165.55 3.7 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.159 1.239 . . . . 0.02 112.809 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.485 ' N ' ' OD1' ' A' ' 143' ' ' ASN . 1.0 OUTLIER 60.71 32.46 20.25 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.198 -0.91 . . . . 0.75 111.451 178.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.417 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.9 m-85 57.43 51.72 9.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.563 -0.711 . . . . 0.02 110.96 177.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -127.13 165.11 20.18 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.492 -0.755 . . . . 0.02 110.325 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.59 -166.29 32.88 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.553 -1.019 . . . . 0.02 110.553 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -70.31 144.44 51.71 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.672 -0.899 . . . . 0.02 109.116 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -113.51 148.96 35.05 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.808 -0.558 . . . . 0.02 110.218 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -125.91 134.0 51.7 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.629 -0.669 . . . . 0.01 109.584 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.482 HD23 ' N ' ' A' ' 151' ' ' LEU . 2.6 tt -103.91 123.56 47.37 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.073 -1.017 . . . . 0.01 109.776 -179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.482 ' N ' HD23 ' A' ' 150' ' ' LEU . 8.8 mp -96.6 152.3 18.78 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.971 -1.081 . . . . 0.01 108.374 178.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.438 ' O ' ' O ' ' A' ' 133' ' ' GLU . 74.9 m-20 -111.32 -126.18 0.28 Allowed 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.309 -0.869 . . . . 2.27 110.492 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -129.25 42.03 3.37 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.399 -0.813 . . . . 1.8400000000000001 109.7 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -113.01 -174.39 2.44 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.403 -0.81 . . . . 2.2799999999999998 109.141 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -105.11 111.87 24.8 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.667 -0.864 . . . . 0.01 108.667 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.65 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 20.2 m-85 -97.94 110.53 23.09 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.289 -0.882 . . . . 0.01 109.859 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -95.1 -22.19 18.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.143 -0.973 . . . . 0.01 111.128 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -127.55 155.15 77.35 Favored Pre-proline 0 N--CA 1.501 2.122 0 O-C-N 121.034 -1.042 . . . . 2.54 108.521 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -60.19 -36.74 87.32 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 120.449 0.766 . . . . 0.69999999999999996 110.264 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -61.26 -20.16 21.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.936 -1.102 . . . . 0.85999999999999999 109.255 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -66.11 -16.04 63.61 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.92 -1.113 . . . . 0.02 110.188 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.65 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 10.4 m0 -97.42 11.16 37.67 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.086 -1.009 . . . . 0.02 108.712 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.65 11.04 85.16 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.805 -1.188 . . . . 0.02 110.774 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.36 141.29 33.41 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.176 -1.191 . . . . 0.02 110.1 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.16 -8.58 58.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.567 -0.708 . . . . 0.58999999999999997 110.302 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 9.7 p -143.96 151.02 51.52 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 120.769 -1.207 . . . . 0.87 109.21 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.81 18.42 0.62 Allowed 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 120.931 1.087 . . . . 0.38 112.318 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.8 121.84 26.94 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 122.427 1.108 . . . . 0.17999999999999999 111.346 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 3.1 mt -150.05 123.7 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 105.831 -1.915 . . . . 3.9900000000000002 105.831 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.528 ' OE1' ' N ' ' A' ' 170' ' ' GLN . 9.7 mp0 -113.5 -13.26 12.82 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.108 -0.995 . . . . 5.1699999999999999 113.109 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 115' ' ' PRO . 26.7 m -157.05 160.63 39.13 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 119.255 -2.153 . . . . 0.02 110.185 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -152.59 151.92 31.22 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.163 -0.96 . . . . 2.02 110.301 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.417 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 27.0 mtp180 -145.16 152.41 39.98 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.3 -0.875 . . . . 0.01 110.252 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -89.5 143.42 26.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.695 -0.628 . . . . 0.01 109.588 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 9.1 mt -95.64 130.32 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 108.482 -0.933 . . . . 3.04 108.482 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.22 147.12 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.121 -0.987 . . . . 1.8899999999999999 109.825 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.365 -0.834 . . . . 4.8899999999999997 109.525 -179.927 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.46 ' C ' ' H ' ' A' ' 3' ' ' THR . 34.9 t . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.461 -0.57 . . . . 5.2800000000000002 109.461 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.429 ' O ' ' OG1' ' A' ' 3' ' ' THR . 8.7 mtmp? -76.4 23.45 0.15 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.221 -0.924 . . . . 5.96 109.376 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.536 HG22 ' N ' ' A' ' 4' ' ' GLY . 43.0 m -169.09 168.44 10.01 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.574 -0.898 . . . . 2.2200000000000002 108.574 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.536 ' N ' HG22 ' A' ' 3' ' ' THR . . . -118.61 116.87 3.51 Favored Glycine 0 N--CA 1.502 3.038 0 N-CA-C 107.042 -2.423 . . . . 0.81000000000000005 107.042 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.1 145.68 33.82 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.557 -1.417 . . . . 0.01 109.557 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -152.71 137.84 17.36 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.334 -1.098 . . . . 0.02 109.66 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.8 tt -129.69 141.02 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.96 -0.756 . . . . 0.02 108.96 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.503 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.3 t -121.47 130.26 53.46 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.577 -0.702 . . . . 0.39000000000000001 109.699 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 8.4 m-85 -109.76 139.97 44.21 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 109.123 -0.695 . . . . 0.02 109.123 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.514 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 6.3 m-85 -122.4 138.35 54.56 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.152 -0.967 . . . . 0.02 109.487 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.466 ' HG3' HD11 ' A' ' 33' ' ' LEU . 93.4 mt-10 -68.69 -27.75 66.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.219 -0.926 . . . . 0.029999999999999999 111.424 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.1 m-20 -114.75 170.49 8.28 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.937 -1.102 . . . . 0.029999999999999999 110.384 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.487 ' CZ ' ' OE2' ' A' ' 68' ' ' GLU . 7.6 mtp180 -75.18 160.84 29.94 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.59 0.709 . . . . 0.029999999999999999 110.122 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.596 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 2.0 m-80 62.87 35.13 13.77 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.792 0.806 . . . . 0.73999999999999999 110.661 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.596 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 21.0 p90 49.58 42.21 22.65 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.451 -0.795 . . . . 0.02 111.057 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -109.03 165.95 11.2 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.851 -1.166 . . . . 0.02 107.851 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.82 -167.64 35.08 Favored Glycine 0 N--CA 1.495 2.628 0 O-C-N 120.687 -1.258 . . . . 0.029999999999999999 110.794 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -69.07 144.08 54.06 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.426 -1.044 . . . . 2.7599999999999998 109.285 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.486 ' HE ' ' CB ' ' A' ' 8' ' ' SER . 56.0 ttt180 -120.29 148.28 43.91 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.577 0.703 . . . . 1.8899999999999999 109.996 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -132.38 127.42 35.4 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.169 -1.049 . . . . 0.02 108.169 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -112.28 136.85 51.21 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.37 -0.831 . . . . 1.1200000000000001 109.89 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.427 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.4 t -131.17 138.99 49.69 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.582 -0.698 . . . . 0.02 109.681 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.498 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 33.3 t70 -117.09 10.67 13.98 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.648 -0.658 . . . . 0.20000000000000001 109.7 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 48.9 m -158.35 174.21 15.49 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.377 -0.972 . . . . 1.23 108.377 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -61.12 144.66 53.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.66 -1.275 . . . . 0.02 110.163 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.3 t -131.92 117.69 18.79 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.56 -0.904 . . . . 0.02 108.56 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.54 -26.09 45.65 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.091 -1.005 . . . . 0.23999999999999999 110.996 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 28.3 p-10 -153.47 101.39 2.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.971 -1.08 . . . . 1.1399999999999999 108.968 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -104.69 9.73 35.0 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 122.108 0.956 . . . . 6.3700000000000001 109.96 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -58.75 -24.79 62.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.541 -0.724 . . . . 3.1099999999999999 111.035 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.0 t -74.1 -16.78 61.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.806 -1.184 . . . . 0.88 110.192 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.51 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 18.1 m-85 -103.88 -22.03 13.56 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.349 -0.844 . . . . 0.02 109.388 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.466 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.2 tp -149.8 128.11 12.13 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.247 -0.908 . . . . 3.3199999999999998 108.98 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.5 m -85.2 -9.85 57.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.698 -0.626 . . . . 0.02 110.828 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -170.55 163.05 8.28 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.619 -1.252 . . . . 0.02 107.619 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 t -142.04 114.98 8.68 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.723 -1.236 . . . . 0.02 108.772 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.577 ' N ' HD22 ' A' ' 37' ' ' ASN . 1.1 m-80 -108.86 -1.82 18.89 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.807 -1.183 . . . . 0.029999999999999999 111.422 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 t -153.42 154.04 33.68 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.188 -1.041 . . . . 0.02 108.188 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.41 HG21 HD13 ' A' ' 39' ' ' ILE . 19.3 mt -145.85 145.86 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 120.955 -1.091 . . . . 0.02 110.802 -178.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -124.03 124.84 43.42 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.495 -1.298 . . . . 0.02 107.495 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.7 t -104.91 114.18 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 107.144 -1.428 . . . . 0.02 107.144 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -84.56 -34.49 23.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.471 -0.768 . . . . 3.8100000000000001 110.098 -178.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.45 150.26 18.73 Favored Glycine 0 N--CA 1.489 2.212 0 C-N-CA 118.552 -1.785 . . . . 0.02 110.845 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.69 171.99 48.67 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.168 -1.173 . . . . 0.01 110.168 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.9 m -119.5 134.9 55.01 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.763 -1.199 . . . . 1.48 107.763 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.455 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 33.6 m95 -126.69 155.81 42.07 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 122.655 1.217 . . . . 0.02 112.448 -176.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.21 134.0 52.31 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 105.571 -2.011 . . . . 0.23999999999999999 105.571 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.514 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.3 m -118.6 143.21 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.624 -0.673 . . . . 0.65000000000000002 109.387 178.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -120.89 145.61 47.47 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 122.318 1.056 . . . . 0.02 110.06 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -66.22 -34.5 78.17 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.607 -0.724 . . . . 0.02 111.125 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 40.5 mtm180 -124.95 157.78 65.38 Favored Pre-proline 0 N--CA 1.503 2.215 0 O-C-N 121.035 -1.041 . . . . 0.02 109.546 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.58 167.09 1.03 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.773 1.649 . . . . 0.02 112.99 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 63.53 36.74 10.93 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.126 -0.943 . . . . 0.02 111.156 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 45.05 51.7 8.73 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.678 0.751 . . . . 3.3900000000000001 110.574 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 94.8 p -125.86 163.53 22.73 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.27 0.557 . . . . 2.3300000000000001 109.779 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.94 -161.5 31.92 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.686 -1.366 . . . . 0.02 109.686 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -67.01 139.94 57.69 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.992 -1.299 . . . . 0.02 110.281 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 15.4 ptm -118.69 138.16 52.82 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.578 -0.701 . . . . 5.0099999999999998 109.962 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.455 ' OH ' HD13 ' A' ' 75' ' ' LEU . 58.8 m-85 -134.01 137.41 44.73 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.48 -0.762 . . . . 0.02 109.938 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.648 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.8 mp -96.03 131.81 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.597 -0.89 . . . . 1.72 108.597 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.416 HD21 ' CD1' ' A' ' 72' ' ' TRP . 11.5 mt -120.86 112.32 33.71 Favored Pre-proline 0 N--CA 1.504 2.231 0 O-C-N 121.329 -0.857 . . . . 0.02 110.886 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -77.64 169.95 20.01 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 CA-C-N 119.901 1.0 . . . . 1.47 110.061 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -53.46 140.56 27.59 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.917 -1.115 . . . . 4.25 110.449 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.07 -177.92 32.04 Favored Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.463 -1.351 . . . . 0.02 110.709 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -118.98 130.65 55.8 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.586 -0.949 . . . . 0.95999999999999996 109.528 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -119.87 96.26 49.42 Favored Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 107.912 -1.144 . . . . 0.02 107.912 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -71.83 -6.18 18.59 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 120.891 1.061 . . . . 0.02 113.909 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.527 ' OE1' ' CE1' ' A' ' 69' ' ' TYR . 1.0 OUTLIER -154.57 152.53 30.15 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.755 -1.202 . . . . 2.02 107.755 179.384 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.527 ' CE1' ' OE1' ' A' ' 68' ' ' GLU . 9.3 p90 -60.24 -37.6 80.88 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.52 -0.737 . . . . 0.02 111.522 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -59.64 -24.3 63.75 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.77 -1.206 . . . . 0.02 109.491 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -71.74 -21.43 61.75 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.699 0.762 . . . . 3.4199999999999999 109.064 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.548 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 2.2 t90 -108.22 6.77 26.99 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.482 -1.303 . . . . 0.02 107.482 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 13.3 mmt 61.01 22.37 12.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.646 -0.659 . . . . 0.02 110.832 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.83 145.78 47.71 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.293 -1.523 . . . . 0.02 109.293 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.455 HD13 ' OH ' ' A' ' 59' ' ' TYR . 7.6 mp -80.29 -31.14 38.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.225 -1.162 . . . . 0.97999999999999998 108.336 178.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.515 ' ND2' ' CZ ' ' A' ' 78' ' ' ARG . 66.8 t30 -157.6 -171.86 3.73 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.635 -1.617 . . . . 0.02 106.635 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -98.62 28.53 4.17 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.723 -1.235 . . . . 0.02 110.613 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.587 HH11 ' CG ' ' A' ' 78' ' ' ARG . 3.3 mtt-85 -97.47 122.51 40.61 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.082 -1.011 . . . . 3.2000000000000002 110.849 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.514 HD22 ' HB ' ' A' ' 48' ' ' VAL . 34.9 mt -143.65 121.89 12.26 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.684 -1.228 . . . . 2.6099999999999999 107.684 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.83 -17.53 9.62 Favored Glycine 0 N--CA 1.504 3.184 0 O-C-N 121.078 -1.014 . . . . 0.02 112.981 -177.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.1 p -156.82 156.12 32.68 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.082 -1.834 . . . . 0.02 110.365 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 33.7 m -144.68 147.9 33.58 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.522 -0.736 . . . . 0.02 110.221 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 24.6 mtm180 -138.24 142.95 39.92 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.255 -0.903 . . . . 0.01 109.42 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.95 131.55 36.39 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.107 -0.995 . . . . 0.42999999999999999 109.85 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.5 t -90.8 124.9 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.809 -0.811 . . . . 1.25 108.809 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -93.79 131.77 38.84 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.81 -1.181 . . . . 1.77 109.339 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.5 mt -96.38 140.19 31.41 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.408 -0.96 . . . . 1.6299999999999999 108.408 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.2 m -111.73 127.17 55.7 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.374 -0.829 . . . . 1.0800000000000001 109.313 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.3 m -103.56 -154.89 0.51 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 106.425 -1.694 . . . . 1.26 106.425 176.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.53 -52.36 0.74 Allowed Glycine 0 N--CA 1.5 2.942 0 O-C-N 120.404 -1.435 . . . . 0.01 112.772 177.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.44 -101.52 0.15 Allowed Glycine 0 N--CA 1.489 2.193 0 C-N-CA 118.533 -1.794 . . . . 0.01 111.942 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -121.0 119.41 32.45 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.09 -1.241 . . . . 4.4299999999999997 110.549 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.08 129.48 35.26 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.808 -0.757 . . . . 2.9900000000000002 109.355 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -129.9 140.55 50.94 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.559 -0.713 . . . . 6.3600000000000003 109.172 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.8 tt -129.6 146.42 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 O-C-N 121.36 -0.837 . . . . 1.0900000000000001 110.157 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -122.2 133.86 54.72 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 107.558 -1.275 . . . . 2.0499999999999998 107.558 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.4 m -123.73 145.73 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 120.729 -1.232 . . . . 1.1000000000000001 109.829 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.587 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 39.6 m-85 -119.88 141.62 49.41 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-O 122.02 0.915 . . . . 0.72999999999999998 111.158 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -67.37 -31.04 71.0 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 116.025 -0.534 . . . . 0.02 111.776 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -115.9 167.44 10.95 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.912 -1.118 . . . . 3.1800000000000002 110.46 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.96 164.12 43.87 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 111.005 -0.838 . . . . 0.01 111.005 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.0 t70 56.75 39.11 29.83 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.656 0.741 . . . . 0.01 110.927 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 52.1 55.74 8.77 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.577 -0.702 . . . . 0.01 111.085 177.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -129.24 165.7 20.86 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 108.304 -0.999 . . . . 3.1499999999999999 108.304 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.36 -163.42 27.59 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.31 -1.516 . . . . 0.01 109.31 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.523 ' OE1' ' CE2' ' A' ' 108' ' ' TYR . 10.4 tm0? -75.94 143.62 41.51 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.946 -1.326 . . . . 0.01 108.459 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.587 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 33.2 ttp -116.33 142.36 46.95 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.492 0.663 . . . . 0.01 109.774 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.523 ' CE2' ' OE1' ' A' ' 106' ' ' GLN . 49.3 m-85 -131.39 136.54 48.11 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.197 -1.038 . . . . 2.48 108.197 178.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -117.73 133.59 55.78 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.558 -0.714 . . . . 0.01 109.959 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.1 t -148.47 149.24 31.32 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.352 1.072 . . . . 1.6899999999999999 111.223 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.1 p -110.05 10.17 24.12 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.38 -0.827 . . . . 0.01 110.122 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 42.0 mp0 -121.42 163.36 18.86 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.253 -0.904 . . . . 3.21 111.694 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.54 156.46 36.67 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.153 -1.054 . . . . 0.01 108.153 178.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.566 ' SG ' ' NE2' ' A' ' 120' ' ' GLN . 48.2 t -124.84 112.36 27.12 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 121.429 -0.795 . . . . 0.01 109.077 178.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -76.52 -33.17 3.32 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 CA-C-N 120.073 1.062 . . . . 0.01 111.515 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.7 m -140.73 107.12 5.27 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.22 -0.925 . . . . 0.02 108.585 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 76.0 mt -64.92 -38.82 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.854 -0.529 . . . . 1.8300000000000001 111.037 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 34.2 ttp -66.95 -38.47 86.18 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 118.902 -1.119 . . . . 1.3400000000000001 109.95 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.85 -38.16 79.59 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.381 -1.45 . . . . 2.1099999999999999 109.723 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.566 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 7.7 tt0 -79.68 -47.35 15.5 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.358 -0.839 . . . . 2.0800000000000001 112.322 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -112.37 -0.67 15.3 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.39 -0.819 . . . . 0.02 112.832 -176.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 61.71 34.74 17.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.743 -1.223 . . . . 0.02 109.846 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 43.6 mt -114.09 136.15 53.24 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.453 -0.78 . . . . 0.02 109.442 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -90.59 -22.12 21.4 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.142 -0.974 . . . . 5.3200000000000003 110.768 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -147.99 164.26 34.34 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.015 -1.053 . . . . 0.02 109.948 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.1 mm -129.2 125.94 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 107.784 -1.191 . . . . 2.1699999999999999 107.784 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 -108.74 -13.97 14.69 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.175 -0.953 . . . . 0.02 112.599 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.6 m -160.07 151.35 19.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.754 -1.216 . . . . 0.01 109.072 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.538 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 19.6 p -167.5 146.11 4.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.316 -0.865 . . . . 1.22 109.057 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.3 111.02 14.05 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-O 122.151 0.977 . . . . 1.4099999999999999 110.27 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.6 p -112.84 137.71 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.03 -1.1 . . . . 0.01 108.03 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.8 t -128.32 93.65 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 106.768 -1.567 . . . . 1.98 106.768 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 134' ' ' GLY . 10.4 tm-20 -146.55 -77.69 0.18 Allowed 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 105.827 -1.916 . . . . 0.01 105.827 177.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.512 ' N ' ' OE1' ' A' ' 133' ' ' GLU . . . -177.63 -80.39 0.06 OUTLIER Glycine 0 N--CA 1.485 1.916 0 N-CA-C 108.263 -1.935 . . . . 0.01 108.263 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.496 ' OG1' HD12 ' A' ' 175' ' ' ILE . 1.1 t -120.72 127.3 51.89 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.559 -0.965 . . . . 2.2999999999999998 110.161 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -127.3 152.24 47.7 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 106.907 -1.516 . . . . 0.01 106.907 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.5 mt -121.0 136.99 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 120.427 -1.421 . . . . 1.6899999999999999 110.088 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -113.62 143.95 43.72 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.34 -1.355 . . . . 2.4900000000000002 107.34 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.436 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 26.3 m-85 -122.42 144.71 48.87 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.292 -0.88 . . . . 0.02 109.297 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.436 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 78.0 tt0 -76.46 -29.0 56.76 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.501 -0.749 . . . . 0.02 111.705 -176.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.0 mt -115.95 154.67 48.37 Favored Pre-proline 0 N--CA 1.505 2.282 0 O-C-N 120.751 -1.218 . . . . 1.48 108.806 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -55.69 167.37 2.19 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 121.213 1.275 . . . . 0.02 112.794 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 59.47 31.14 20.83 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.147 -0.933 . . . . 0.75 111.408 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 57.28 51.25 10.33 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.534 -0.729 . . . . 0.02 110.993 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -126.1 164.62 20.5 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.545 -0.722 . . . . 0.02 109.938 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.18 -165.84 33.12 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.283 -1.127 . . . . 0.02 110.283 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.429 HH11 ' HG3' ' A' ' 147' ' ' ARG . 23.5 ttm-85 -69.34 142.6 53.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.51 -0.994 . . . . 0.02 109.067 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.464 ' CD ' ' N ' ' A' ' 148' ' ' GLN . 7.9 mp0 -114.8 148.52 38.32 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.343 0.592 . . . . 0.02 110.184 -178.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -124.78 135.61 53.11 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 109.048 -0.723 . . . . 0.01 109.048 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.502 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.7 tt -99.45 120.28 39.35 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.889 -1.132 . . . . 0.01 108.846 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.618 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 54.0 tp -101.85 154.06 19.27 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.256 -0.903 . . . . 0.01 109.066 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -104.71 -121.18 0.21 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.233 -0.917 . . . . 2.27 109.432 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.7 pttm -155.56 51.6 0.57 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.043 -1.036 . . . . 1.8400000000000001 109.608 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -112.48 -152.99 0.51 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.496 -0.753 . . . . 2.2799999999999998 109.068 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -106.39 100.21 9.75 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.385 -0.822 . . . . 0.01 109.045 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.68 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 6.7 m-85 -98.33 112.03 24.17 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.269 -0.894 . . . . 0.01 109.464 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -94.45 -22.52 18.22 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.242 -0.911 . . . . 0.01 111.448 -178.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -129.14 154.1 80.45 Favored Pre-proline 0 N--CA 1.502 2.167 0 O-C-N 120.758 -1.214 . . . . 2.54 108.808 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -59.46 -36.19 94.17 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 120.507 0.805 . . . . 0.69999999999999996 110.795 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 60.5 t -61.02 -20.2 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.758 -1.214 . . . . 0.85999999999999999 108.909 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -65.21 -15.31 62.32 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.882 -1.136 . . . . 0.02 109.691 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.68 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 11.5 m0 -98.06 11.06 38.88 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.254 -0.904 . . . . 0.02 109.067 178.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.81 11.45 83.9 Favored Glycine 0 N--CA 1.491 2.336 0 O-C-N 120.829 -1.169 . . . . 0.02 111.213 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.03 140.6 34.03 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.056 -1.261 . . . . 0.02 110.076 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -86.02 -8.77 57.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.566 -0.709 . . . . 0.58999999999999997 110.322 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 9.7 p -141.41 150.97 59.74 Favored Pre-proline 0 N--CA 1.5 2.051 0 O-C-N 121.019 -1.05 . . . . 0.87 109.712 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -75.88 14.62 1.02 Allowed 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 120.908 1.072 . . . . 0.38 112.142 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.72 122.07 27.19 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.361 1.077 . . . . 0.17999999999999999 111.212 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 3.8 mt -148.97 122.98 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 105.89 -1.892 . . . . 3.9900000000000002 105.89 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.53 ' OE1' ' N ' ' A' ' 170' ' ' GLN . 13.9 mp0 -112.95 -15.69 12.82 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.115 -0.99 . . . . 5.1699999999999999 113.07 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 12.8 t -156.31 159.57 38.95 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 119.328 -2.107 . . . . 0.02 109.941 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -153.08 154.12 34.21 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.039 -1.038 . . . . 2.02 110.689 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -145.24 149.93 35.78 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.776 0.798 . . . . 0.01 110.12 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -88.11 143.29 27.15 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.132 -0.692 . . . . 0.01 109.132 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.496 HD12 ' OG1' ' A' ' 135' ' ' THR . 6.7 mt -94.48 129.71 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.266 -0.896 . . . . 3.04 109.024 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.3 m -136.29 147.04 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.158 -0.964 . . . . 1.8899999999999999 109.526 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.61 ' H ' ' CD ' ' A' ' 177' ' ' GLU . 1.4 pm0 . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.89 . . . . 4.8899999999999997 109.725 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 3' ' ' THR . 95.0 p . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.466 -0.568 . . . . 5.2800000000000002 109.466 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.9 mttt 52.44 -87.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 5.96 109.625 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.517 ' N ' ' O ' ' A' ' 1' ' ' SER . 1.5 t -171.9 170.03 5.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.798 -1.189 . . . . 2.2200000000000002 109.303 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -118.63 117.74 3.79 Favored Glycine 0 N--CA 1.501 2.987 0 N-CA-C 106.815 -2.514 . . . . 0.81000000000000005 106.815 177.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.73 144.51 32.71 Favored Glycine 0 N--CA 1.492 2.402 0 O-C-N 121.089 -1.242 . . . . 0.01 110.037 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.5 tttm -149.19 135.82 19.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.473 -1.016 . . . . 0.02 109.753 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.7 tt -128.24 138.34 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 108.054 -1.091 . . . . 0.02 108.054 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 m -121.5 129.99 53.28 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.325 -0.86 . . . . 0.39000000000000001 110.169 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 4.4 m-85 -110.58 141.18 44.12 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.967 -0.753 . . . . 0.02 108.967 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.546 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.7 m-85 -122.35 138.43 54.52 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.223 -0.923 . . . . 0.02 109.53 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.484 ' HG3' HD11 ' A' ' 33' ' ' LEU . 90.4 mt-10 -67.91 -27.78 66.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.99 -1.069 . . . . 0.029999999999999999 111.409 -178.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 2.4 m-20 -114.62 170.24 8.47 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.844 -1.16 . . . . 0.029999999999999999 110.22 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -75.85 162.1 28.43 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.794 0.807 . . . . 0.029999999999999999 110.241 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.402 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 21.2 t-20 62.76 33.09 15.68 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.106 0.955 . . . . 0.73999999999999999 110.836 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 55.22 39.81 31.48 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.841 -0.618 . . . . 0.02 110.973 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -110.11 165.65 11.57 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.18 -1.044 . . . . 0.02 108.18 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.82 -168.07 35.49 Favored Glycine 0 N--CA 1.497 2.708 0 C-N-CA 119.827 -1.178 . . . . 0.029999999999999999 110.748 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -69.45 143.87 53.45 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.483 -1.01 . . . . 2.7599999999999998 109.239 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -120.67 148.95 43.25 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.584 0.707 . . . . 1.8899999999999999 110.214 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -132.09 127.56 36.31 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.189 -1.041 . . . . 0.02 108.189 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.52 136.71 51.72 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.434 -0.791 . . . . 1.1200000000000001 109.888 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 13.3 t -131.26 139.22 49.6 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.665 -0.647 . . . . 0.02 109.557 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.497 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 2.5 m-20 -116.83 11.13 14.38 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.71 -0.619 . . . . 0.20000000000000001 109.694 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 47.5 m -158.23 174.76 14.68 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.263 -1.014 . . . . 1.23 108.263 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 3.5 m-20 -60.57 144.32 51.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.644 -1.285 . . . . 0.02 109.899 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 41.9 t -132.01 117.82 18.9 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.577 -0.897 . . . . 0.02 108.577 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.87 -25.26 48.48 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.168 -0.958 . . . . 0.23999999999999999 110.922 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -154.31 102.87 2.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.931 -1.106 . . . . 1.1399999999999999 109.274 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.433 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 43.6 p90 -102.06 9.95 39.93 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 122.019 0.914 . . . . 6.3700000000000001 109.788 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.3 mtm180 -59.43 -25.46 64.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.475 -0.765 . . . . 3.1099999999999999 111.505 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.9 p -76.05 -17.68 59.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.58 -1.325 . . . . 0.88 110.769 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -104.07 -22.17 13.48 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.335 -0.853 . . . . 0.02 109.589 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.484 HD11 ' HG3' ' A' ' 11' ' ' GLU . 6.4 tp -150.4 129.44 12.63 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.278 -0.889 . . . . 3.3199999999999998 108.967 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.7 p -85.24 -9.92 57.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.8 -0.563 . . . . 0.02 111.129 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -171.46 162.78 6.71 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.77 -1.206 . . . . 0.02 108.015 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.518 ' C ' HD22 ' A' ' 37' ' ' ASN . 5.1 p -143.55 115.23 8.16 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.827 -1.17 . . . . 0.02 108.66 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.518 HD22 ' C ' ' A' ' 36' ' ' CYS . 2.0 m120 -107.54 2.08 23.83 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 120.756 -1.215 . . . . 0.029999999999999999 110.881 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.1 t -155.54 154.84 32.37 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.821 -1.177 . . . . 0.02 107.821 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 39' ' ' ILE . 10.4 mt -146.29 146.58 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.951 -1.093 . . . . 0.02 110.654 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -123.68 124.82 43.6 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.159 -1.052 . . . . 0.02 108.159 177.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.5 t -106.6 115.19 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 106.803 -1.554 . . . . 0.02 106.803 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -83.98 -33.85 24.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.636 -0.665 . . . . 3.8100000000000001 110.759 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.79 152.38 22.26 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 118.821 -1.656 . . . . 0.02 110.807 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.26 173.21 49.53 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.62 -1.276 . . . . 0.01 110.474 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.2 m -119.68 135.4 54.84 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.983 -1.118 . . . . 1.48 107.983 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.458 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 32.9 m95 -126.35 155.26 42.33 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-O 122.573 1.178 . . . . 0.02 112.263 -176.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.5 134.16 52.22 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 105.509 -2.034 . . . . 0.23999999999999999 105.509 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.5 ' HB ' HD22 ' A' ' 79' ' ' LEU . 27.2 m -118.96 143.3 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.154 -0.684 . . . . 0.65000000000000002 109.154 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.565 ' CE2' ' SD ' ' A' ' 58' ' ' MET . 28.1 m-85 -121.41 146.32 47.01 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 122.386 1.089 . . . . 0.02 110.046 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -66.2 -35.1 79.57 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.509 -0.769 . . . . 0.02 111.228 -177.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -125.36 157.67 66.89 Favored Pre-proline 0 N--CA 1.503 2.182 0 O-C-N 121.051 -1.03 . . . . 0.02 109.498 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -53.63 167.3 1.0 Allowed 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.704 1.602 . . . . 0.02 112.958 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 63.68 36.53 10.72 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 114.999 -1.0 . . . . 0.02 111.182 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 45.15 51.54 9.01 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.631 0.729 . . . . 3.3900000000000001 110.612 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.0 t -126.29 163.78 22.46 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 121.201 0.524 . . . . 2.3300000000000001 109.804 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.61 -161.57 32.4 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.738 -1.345 . . . . 0.02 109.738 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.98 140.34 57.72 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.054 -1.263 . . . . 0.02 110.346 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.565 ' SD ' ' CE2' ' A' ' 49' ' ' TYR . 49.2 ttp -118.84 138.17 52.91 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.691 -0.631 . . . . 5.0099999999999998 109.827 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.49 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 56.1 m-85 -133.66 137.06 45.15 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.492 -0.755 . . . . 0.02 109.695 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.8 mm -94.74 131.09 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.912 -0.773 . . . . 1.72 108.912 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.561 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -119.21 110.56 37.67 Favored Pre-proline 0 N--CA 1.505 2.277 0 O-C-N 121.461 -0.775 . . . . 0.02 110.73 -178.316 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -77.63 168.32 22.74 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 CA-C-N 119.791 0.961 . . . . 1.47 110.068 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -53.16 141.74 22.4 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.757 -1.214 . . . . 4.25 110.35 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.27 -177.96 31.37 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.584 -1.293 . . . . 0.02 110.844 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -119.65 131.8 55.54 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.393 -1.063 . . . . 0.95999999999999996 109.692 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.561 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 69.9 m-85 -122.04 96.07 46.96 Favored Pre-proline 0 N--CA 1.494 1.755 0 N-CA-C 108.015 -1.105 . . . . 0.02 108.015 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.28 -4.38 10.43 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 120.811 1.007 . . . . 0.02 113.729 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -157.61 155.44 30.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.603 -1.311 . . . . 2.02 108.229 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -60.46 -39.17 86.59 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.535 -0.728 . . . . 0.02 112.17 -177.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -60.34 -23.82 64.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.132 -0.98 . . . . 0.02 110.373 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -69.37 -18.45 63.78 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.764 0.793 . . . . 3.4199999999999999 108.982 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.553 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.4 t90 -108.38 11.06 27.35 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.584 -1.265 . . . . 0.02 107.584 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.6 mmt 60.74 22.09 12.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.585 -0.697 . . . . 0.02 110.553 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.68 143.7 44.6 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.319 -1.512 . . . . 0.02 109.319 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.3 tp -78.79 -31.51 46.04 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.452 -1.314 . . . . 0.97999999999999998 107.452 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -157.87 -172.47 3.94 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 106.262 -1.755 . . . . 0.02 106.262 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -98.44 28.39 4.18 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.659 -1.276 . . . . 0.02 110.627 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.434 HH11 ' HG3' ' A' ' 78' ' ' ARG . 20.9 ttm-85 -97.23 122.05 39.81 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.725 -1.234 . . . . 3.2000000000000002 110.905 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.5 HD22 ' HB ' ' A' ' 48' ' ' VAL . 35.1 mt -144.14 122.8 12.55 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.566 -1.272 . . . . 2.6099999999999999 107.566 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.17 -16.9 10.62 Favored Glycine 0 N--CA 1.504 3.189 0 O-C-N 121.024 -1.048 . . . . 0.02 112.814 -177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 73.3 p -156.8 156.34 33.08 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.22 -1.753 . . . . 0.02 110.299 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 28.4 p -143.84 147.29 33.87 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.481 -0.762 . . . . 0.02 110.038 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.5 mtm180 -138.25 143.15 39.96 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.469 -0.769 . . . . 0.01 109.644 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.26 132.54 36.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.42999999999999999 109.829 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.6 t -91.29 125.16 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.863 -0.791 . . . . 1.25 108.863 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -94.1 131.79 39.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.831 -1.168 . . . . 1.77 109.298 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.9 mt -96.38 140.15 31.45 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.312 -0.867 . . . . 1.6299999999999999 108.855 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.1 t -111.57 127.1 55.62 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.449 -0.782 . . . . 1.0800000000000001 109.092 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.5 p -103.56 -154.94 0.51 Allowed 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 106.485 -1.672 . . . . 1.26 106.485 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.96 -53.14 0.73 Allowed Glycine 0 N--CA 1.5 2.9 0 O-C-N 120.366 -1.459 . . . . 0.01 112.684 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -179.53 -101.72 0.15 Allowed Glycine 0 N--CA 1.489 2.221 0 C-N-CA 118.605 -1.76 . . . . 0.01 112.029 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -121.19 119.45 32.37 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.098 -1.236 . . . . 4.4299999999999997 110.72 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.87 130.59 35.82 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.822 -0.751 . . . . 2.9900000000000002 109.294 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -131.03 141.81 50.25 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.483 -0.761 . . . . 6.3600000000000003 108.964 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.8 tt -129.28 146.66 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.366 -0.834 . . . . 1.0900000000000001 110.038 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -122.01 133.68 54.81 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.766 -1.198 . . . . 2.0499999999999998 107.766 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.46 HG12 ' SG ' ' A' ' 129' ' ' CYS . 25.2 m -123.42 145.56 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 120.788 -1.195 . . . . 1.1000000000000001 109.736 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.594 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 32.2 m-85 -118.7 141.19 48.84 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 122.016 0.913 . . . . 0.72999999999999998 110.716 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -66.2 -30.21 70.63 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.995 -0.548 . . . . 0.02 111.295 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -116.54 170.16 8.78 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.099 -1.001 . . . . 3.1800000000000002 110.412 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.02 170.37 44.26 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.742 -0.943 . . . . 0.01 110.742 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 52.91 38.94 28.25 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.527 0.68 . . . . 0.01 111.587 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.424 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 24.7 m-85 51.8 49.17 21.35 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.525 -0.734 . . . . 0.01 111.059 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -123.62 165.59 16.94 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.322 -0.992 . . . . 3.1499999999999999 108.322 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.72 -163.79 27.36 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.519 -1.432 . . . . 0.01 109.519 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.4 tp60 -76.75 144.56 39.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.028 -1.277 . . . . 0.01 108.497 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.594 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 12.6 ttt -116.01 141.53 48.0 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.658 0.742 . . . . 0.01 109.801 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -131.0 136.42 48.5 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.069 -1.086 . . . . 2.48 108.069 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -118.89 133.7 55.66 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.52 -0.738 . . . . 0.01 110.117 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 t -148.17 149.41 31.92 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 122.318 1.056 . . . . 1.6899999999999999 110.962 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.0 p -111.33 9.95 21.59 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 115.501 -0.772 . . . . 0.01 110.336 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.468 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 23.6 mp0 -121.11 163.12 18.89 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.214 -0.929 . . . . 3.21 111.491 -178.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.74 156.61 37.98 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.471 -0.937 . . . . 0.01 108.471 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 19.6 t -127.15 113.67 21.67 Favored Pre-proline 0 N--CA 1.501 2.088 0 N-CA-C 108.749 -0.834 . . . . 0.01 108.749 178.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -74.52 -29.17 9.41 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 CA-C-N 120.446 1.195 . . . . 0.01 111.034 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 7.8 p -142.34 109.12 5.41 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.444 -0.785 . . . . 0.02 109.074 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.429 HD12 ' O ' ' A' ' 169' ' ' ILE . 97.6 mt -63.81 -38.74 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.884 -0.51 . . . . 1.8300000000000001 110.653 -178.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 118' ' ' MET . 12.4 tmm? -68.52 -37.74 80.27 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.255 -0.978 . . . . 1.3400000000000001 110.208 -178.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -69.53 -38.27 77.46 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.48 -1.388 . . . . 2.1099999999999999 109.958 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -79.78 -47.21 15.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.238 -0.914 . . . . 2.0800000000000001 112.381 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -111.39 0.41 16.59 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.299 -0.875 . . . . 0.02 112.647 -176.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 59.98 33.48 21.42 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.749 -1.219 . . . . 0.02 109.529 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.3 mt -112.09 135.54 52.62 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.718 -0.845 . . . . 0.02 108.718 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -91.61 -22.9 20.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.17 -0.956 . . . . 5.3200000000000003 110.24 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -149.48 164.28 35.46 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.159 -0.963 . . . . 0.02 109.88 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 35.0 mt -131.89 129.0 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 107.654 -1.239 . . . . 2.1699999999999999 107.654 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 61.2 m80 -108.09 -11.95 15.2 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.364 -0.835 . . . . 0.02 112.314 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.424 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 2.7 t -159.01 151.14 21.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.915 -1.115 . . . . 0.01 108.871 178.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.46 ' SG ' HG12 ' A' ' 97' ' ' VAL . 5.7 t -168.43 144.05 3.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 1.22 108.873 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.7 tttm -125.57 109.33 12.53 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 122.509 1.147 . . . . 1.4099999999999999 109.963 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 131' ' ' VAL . 7.5 p -111.32 135.86 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.184 -1.413 . . . . 0.01 107.184 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 72.1 t -126.68 93.31 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 106.788 -1.56 . . . . 1.98 106.788 177.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.428 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 54.2 tp10 -147.13 -75.3 0.19 Allowed 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 105.781 -1.933 . . . . 0.01 105.781 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 152.82 -53.79 0.46 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.567 -1.413 . . . . 0.01 109.567 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.67 ' HB ' HD12 ' A' ' 175' ' ' ILE . 72.4 p -120.16 99.79 6.81 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.494 -1.004 . . . . 2.2999999999999998 111.348 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.428 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 8.4 m95 -128.64 145.37 51.17 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 107.572 -1.27 . . . . 0.01 107.572 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.416 ' CG1' HD11 ' A' ' 175' ' ' ILE . 56.8 mt -121.01 137.93 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 120.662 -1.274 . . . . 1.6899999999999999 110.37 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.4 ' CE1' HD22 ' A' ' 151' ' ' LEU . 49.7 m-85 -114.92 144.72 43.11 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 106.935 -1.506 . . . . 2.4900000000000002 106.935 177.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.531 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 10.3 m-85 -124.2 144.32 50.0 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.411 -0.806 . . . . 0.02 109.857 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.42 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 38.7 tt0 -74.13 -29.08 61.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.687 -0.633 . . . . 0.02 111.874 -176.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.5 mt -115.74 154.56 48.08 Favored Pre-proline 0 N--CA 1.504 2.241 0 O-C-N 120.735 -1.228 . . . . 1.48 108.997 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -55.81 167.38 2.28 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.113 1.209 . . . . 0.02 112.726 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.1 m120 59.64 31.15 20.73 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.215 -0.902 . . . . 0.75 111.391 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 57.91 51.51 8.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.46 -0.775 . . . . 0.02 111.171 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -126.92 164.86 20.52 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.454 -0.779 . . . . 0.02 110.1 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.46 -165.95 32.82 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 110.414 -1.074 . . . . 0.02 110.414 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -69.37 142.73 53.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.554 -0.968 . . . . 0.02 108.883 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -114.69 148.94 37.54 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.339 0.59 . . . . 0.02 110.123 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.437 ' CD1' ' N ' ' A' ' 149' ' ' TYR . 13.0 m-85 -124.84 135.03 52.55 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 109.169 -0.678 . . . . 0.01 109.169 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.1 tt -100.36 122.42 43.1 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.907 -1.121 . . . . 0.01 109.021 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.4 HD22 ' CE1' ' A' ' 138' ' ' PHE . 6.1 mp -97.19 164.25 12.57 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.072 -1.018 . . . . 0.01 108.656 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -108.2 -101.71 0.37 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.462 -0.773 . . . . 2.27 109.527 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -172.99 43.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 1.8400000000000001 109.617 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -112.41 -156.55 0.59 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.524 -0.735 . . . . 2.2799999999999998 109.343 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -106.86 108.23 19.64 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.445 -0.785 . . . . 0.01 109.196 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.632 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 37.1 m-85 -98.92 113.58 25.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.343 -0.848 . . . . 0.01 109.532 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -94.62 -22.72 17.99 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.149 -0.97 . . . . 0.01 111.596 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -127.49 154.94 77.45 Favored Pre-proline 0 N--CA 1.503 2.187 0 O-C-N 120.916 -1.115 . . . . 2.54 108.775 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -60.7 -37.97 75.0 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 CA-C-N 119.317 0.792 . . . . 0.69999999999999996 110.543 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 95.7 t -61.04 -19.92 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.842 -1.161 . . . . 0.85999999999999999 109.259 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -65.26 -15.34 62.39 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.901 -1.125 . . . . 0.02 110.023 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.632 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 8.8 m0 -97.65 11.68 36.22 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.096 -1.003 . . . . 0.02 109.152 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.52 10.72 84.94 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.827 -1.178 . . . . 0.02 111.127 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.39 140.61 33.32 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.081 -1.246 . . . . 0.02 110.008 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.18 -8.92 58.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.708 -0.62 . . . . 0.58999999999999997 110.025 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 4.6 m -143.26 150.03 50.51 Favored Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.033 -1.042 . . . . 0.87 109.013 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.5 17.68 0.64 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 120.583 0.855 . . . . 0.38 112.102 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.31 123.25 28.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.851 -1.155 . . . . 0.17999999999999999 111.524 -177.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.429 ' O ' HD12 ' A' ' 117' ' ' ILE . 1.5 mt -150.04 126.32 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 106.714 -1.588 . . . . 3.9900000000000002 106.714 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 170' ' ' GLN . 10.8 mp0 -112.3 -16.83 12.88 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.082 -1.011 . . . . 5.1699999999999999 113.059 -177.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.7 p -157.33 160.77 38.85 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 119.162 -2.211 . . . . 0.02 110.242 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.414 ' CD1' ' C ' ' A' ' 172' ' ' PHE . 21.1 p90 -152.4 152.65 32.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.074 -1.016 . . . . 2.02 110.521 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -144.85 149.84 36.08 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.467 -0.77 . . . . 0.01 109.698 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.408 HH21 HG11 ' A' ' 176' ' ' VAL . 41.2 ttp180 -87.17 140.87 29.11 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.246 -0.65 . . . . 0.01 109.246 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.67 HD12 ' HB ' ' A' ' 135' ' ' THR . 31.4 mt -92.47 129.44 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.14 -0.975 . . . . 3.04 108.839 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.408 HG11 HH21 ' A' ' 174' ' ' ARG . 12.9 m -136.76 148.04 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.244 -0.91 . . . . 1.8899999999999999 109.793 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 4.8899999999999997 109.529 179.925 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 92.2 p . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.452 -0.573 . . . . 5.2800000000000002 109.452 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -67.03 -1.71 4.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.224 -0.922 . . . . 5.96 109.538 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.3 t -90.01 -140.05 0.14 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.272 -1.381 . . . . 2.2200000000000002 107.272 177.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.03 -176.23 46.49 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 117.302 -2.38 . . . . 0.81000000000000005 112.679 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -80.32 160.38 43.96 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.603 -1.399 . . . . 0.01 109.603 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.519 ' CB ' ' NZ ' ' A' ' 6' ' ' LYS . 5.5 ttpm? -146.41 135.68 22.79 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.263 -1.139 . . . . 0.02 110.43 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.7 tt -129.77 139.85 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.256 -1.016 . . . . 0.02 108.256 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 m -120.7 129.48 53.68 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.337 -0.852 . . . . 0.39000000000000001 110.065 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -109.8 139.46 44.83 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.846 -0.798 . . . . 0.02 108.846 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.551 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.6 m-85 -122.07 138.44 54.44 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.258 -0.901 . . . . 0.02 109.731 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.449 ' HG3' HD11 ' A' ' 33' ' ' LEU . 94.6 mt-10 -69.29 -27.5 65.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.029999999999999999 111.575 -178.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -114.36 169.5 8.99 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.894 -1.129 . . . . 0.029999999999999999 110.242 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -75.44 158.56 32.48 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.663 0.744 . . . . 0.029999999999999999 110.105 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.417 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 4.5 t-20 66.13 33.48 7.43 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.954 0.883 . . . . 0.73999999999999999 111.16 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.417 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 1.0 OUTLIER 55.42 41.63 30.82 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 116.053 -0.521 . . . . 0.02 111.161 177.901 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -113.46 166.15 11.78 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.374 -0.973 . . . . 0.02 108.374 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.9 -167.29 36.33 Favored Glycine 0 N--CA 1.494 2.539 0 C-N-CA 119.927 -1.13 . . . . 0.029999999999999999 110.765 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -69.06 142.0 54.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.524 -0.986 . . . . 2.7599999999999998 109.302 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -120.48 149.09 42.94 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.625 0.726 . . . . 1.8899999999999999 110.144 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -132.73 127.55 34.96 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.325 -0.991 . . . . 0.02 108.325 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 23.0 p-10 -112.57 136.85 51.62 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.412 -0.805 . . . . 1.1200000000000001 109.733 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.2 t -131.07 138.83 49.75 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.678 -0.639 . . . . 0.02 109.626 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.494 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 2.6 p30 -116.41 11.06 14.83 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.529 -0.732 . . . . 0.20000000000000001 109.817 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 43.1 m -158.38 174.66 14.79 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.318 -0.993 . . . . 1.23 108.318 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -60.8 144.16 53.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.714 -1.242 . . . . 0.02 109.916 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.5 p -131.57 117.16 18.36 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.594 -0.891 . . . . 0.02 108.594 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.03 -25.43 47.86 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.107 -0.996 . . . . 0.23999999999999999 110.799 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -154.33 101.17 2.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.977 -1.077 . . . . 1.1399999999999999 108.948 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -105.33 9.42 33.85 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.103 0.954 . . . . 6.3700000000000001 109.788 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -58.52 -23.93 59.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.492 -0.755 . . . . 3.1099999999999999 110.865 -178.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 53.6 p -74.58 -16.28 60.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.739 -1.226 . . . . 0.88 110.328 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -104.63 -22.14 13.29 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.462 -0.774 . . . . 0.02 109.63 -179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.449 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.7 tp -150.56 129.22 12.31 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.15 -0.969 . . . . 3.3199999999999998 109.287 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.0 p -86.83 -10.41 53.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.657 -0.652 . . . . 0.02 111.69 -178.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.522 HH21 ' ND2' ' A' ' 37' ' ' ASN . 42.7 ttt180 -170.36 161.34 8.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.811 -1.181 . . . . 0.02 107.963 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.412 ' SG ' HD23 ' A' ' 33' ' ' LEU . 4.1 m -141.96 115.27 8.9 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.702 -1.249 . . . . 0.02 109.642 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.523 ' ND2' ' OD2' ' A' ' 77' ' ' ASP . 0.8 OUTLIER -107.88 0.14 21.87 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.837 -1.165 . . . . 0.029999999999999999 110.801 -178.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.1 t -156.31 154.58 30.86 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.039 -1.097 . . . . 0.02 108.039 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.4 mt -146.42 147.31 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.132 -0.98 . . . . 0.02 110.477 -178.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -123.53 124.4 42.76 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.189 -1.041 . . . . 0.02 108.189 177.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.8 t -106.54 115.04 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 106.921 -1.511 . . . . 0.02 106.921 177.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -83.76 -33.64 24.98 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.939 -0.705 . . . . 3.8100000000000001 110.643 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.7 152.11 21.89 Favored Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.009 -1.567 . . . . 0.02 110.831 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.57 172.98 49.4 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.517 -1.325 . . . . 0.01 110.522 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.5 m -119.7 135.28 54.89 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 108.019 -1.104 . . . . 1.48 108.019 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.42 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 36.1 m95 -126.94 155.58 42.86 Favored 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 122.486 1.136 . . . . 0.02 112.112 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.39 134.05 52.31 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 105.573 -2.01 . . . . 0.23999999999999999 105.573 176.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.513 ' HB ' HD22 ' A' ' 79' ' ' LEU . 29.3 m -118.6 143.59 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.584 -0.697 . . . . 0.65000000000000002 109.226 178.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -121.46 145.93 47.42 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 122.427 1.108 . . . . 0.02 110.335 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -66.35 -33.93 76.82 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.678 -0.692 . . . . 0.02 111.198 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.8 mtp180 -125.41 157.85 66.4 Favored Pre-proline 0 N--CA 1.502 2.16 0 O-C-N 121.046 -1.034 . . . . 0.02 109.515 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -53.74 166.97 1.15 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.742 1.628 . . . . 0.02 113.0 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 64.03 36.53 9.84 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.214 -0.903 . . . . 0.02 111.175 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 45.31 51.88 9.13 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.638 0.732 . . . . 3.3900000000000001 110.593 178.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.3 p -126.51 163.84 22.5 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.167 0.508 . . . . 2.3300000000000001 109.87 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.37 -162.12 31.81 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.766 -1.334 . . . . 0.02 109.766 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.462 ' H ' ' CD2' ' A' ' 57' ' ' HIS . 20.9 m-70 -65.52 138.27 57.96 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.035 -1.274 . . . . 0.02 110.066 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 20.6 ptm -118.12 137.21 53.1 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.326 0.584 . . . . 5.0099999999999998 109.583 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.562 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 86.9 m-85 -133.98 138.67 45.58 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.419 -0.801 . . . . 0.02 109.752 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.1 mm -95.54 131.37 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 109.089 -0.708 . . . . 1.72 109.089 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.478 HD22 ' CE1' ' A' ' 66' ' ' TYR . 12.4 mt -120.89 111.91 33.94 Favored Pre-proline 0 N--CA 1.506 2.328 0 O-C-N 121.361 -0.837 . . . . 0.02 110.962 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -77.52 169.77 20.45 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 CA-C-N 119.876 0.991 . . . . 1.47 109.871 177.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -52.9 141.19 22.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.794 -1.192 . . . . 4.25 110.211 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.42 -177.83 32.38 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.52 -1.324 . . . . 0.02 110.781 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -120.67 131.93 54.83 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.374 -1.074 . . . . 0.95999999999999996 109.832 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.478 ' CE1' HD22 ' A' ' 61' ' ' LEU . 94.7 m-85 -121.68 96.41 47.35 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 108.068 -1.086 . . . . 0.02 108.068 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.37 -3.8 10.67 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 120.796 0.997 . . . . 0.02 113.702 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -157.58 155.69 30.6 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.621 -1.3 . . . . 2.02 108.36 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -60.43 -39.29 86.93 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.54 -0.725 . . . . 0.02 112.013 -177.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -60.17 -23.37 63.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.968 -1.083 . . . . 0.02 110.279 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -70.61 -18.72 62.88 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.897 0.856 . . . . 3.4199999999999999 109.044 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.562 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.3 t90 -107.8 10.29 28.75 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.409 -1.33 . . . . 0.02 107.409 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 13.5 mmt 60.46 22.26 11.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.627 -0.671 . . . . 0.02 110.294 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.76 144.39 46.28 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.398 -1.481 . . . . 0.02 109.398 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.9 mt -78.86 -30.44 45.12 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.626 -1.25 . . . . 0.97999999999999998 107.626 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -157.11 -171.61 3.7 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 106.427 -1.694 . . . . 0.02 106.427 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.523 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 92.4 m-20 -98.82 28.37 4.35 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.733 -1.229 . . . . 0.02 110.42 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -96.91 122.62 40.09 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.005 -1.059 . . . . 3.2000000000000002 110.936 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.513 HD22 ' HB ' ' A' ' 48' ' ' VAL . 39.7 mt -143.56 120.96 11.65 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.585 -1.265 . . . . 2.6099999999999999 107.585 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.35 -17.3 10.11 Favored Glycine 0 N--CA 1.506 3.302 0 O-C-N 121.065 -1.022 . . . . 0.02 112.928 -177.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.2 t -156.99 156.46 33.0 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.159 -1.789 . . . . 0.02 110.331 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 38.6 m -145.42 148.19 33.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.453 -0.779 . . . . 0.02 110.086 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -138.14 143.12 40.17 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.308 -0.87 . . . . 0.01 109.413 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.37 132.36 36.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -0.952 . . . . 0.42999999999999999 109.68 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.4 t -91.59 125.28 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.938 -0.764 . . . . 1.25 108.938 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 26.3 m-70 -95.57 129.99 42.57 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.707 -1.246 . . . . 1.77 109.274 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.6 mt -94.47 141.27 28.79 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.159 -0.963 . . . . 1.6299999999999999 108.688 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.5 m -111.21 128.14 55.82 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.386 -0.821 . . . . 1.0800000000000001 109.237 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.0 p -104.54 -153.96 0.49 Allowed 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 106.63 -1.618 . . . . 1.26 106.63 177.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.64 -52.76 0.74 Allowed Glycine 0 N--CA 1.501 3.024 0 O-C-N 120.414 -1.428 . . . . 0.01 112.807 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.35 -101.95 0.16 Allowed Glycine 0 N--CA 1.49 2.237 0 C-N-CA 118.533 -1.794 . . . . 0.01 112.108 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -121.53 119.13 31.08 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.144 -1.209 . . . . 4.4299999999999997 110.788 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.05 130.39 35.47 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.92 -0.712 . . . . 2.9900000000000002 109.267 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.473 ' CB ' ' NZ ' ' A' ' 94' ' ' LYS . 2.8 ttmp? -129.79 141.57 50.83 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.423 -0.798 . . . . 6.3600000000000003 109.149 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 110' ' ' THR . 3.8 tt -128.14 145.64 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 121.356 -0.84 . . . . 1.0900000000000001 110.465 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.541 ' OE1' ' N ' ' A' ' 96' ' ' GLN . 0.5 OUTLIER -122.32 132.29 54.33 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.382 -1.34 . . . . 2.0499999999999998 107.382 177.203 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.5 m -124.51 146.47 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 O-C-N 120.601 -1.312 . . . . 1.1000000000000001 109.746 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.577 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 71.3 m-85 -119.58 141.01 49.65 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 122.045 0.926 . . . . 0.72999999999999998 111.161 -178.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -66.12 -30.37 70.85 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 116.004 -0.544 . . . . 0.02 111.365 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -117.0 170.57 8.53 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.13 -0.981 . . . . 3.1800000000000002 110.473 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.66 169.29 45.05 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.805 -0.918 . . . . 0.01 110.805 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 23.9 t70 53.23 38.83 28.6 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.576 0.703 . . . . 0.01 111.55 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 52.14 48.8 21.95 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.503 -0.748 . . . . 0.01 110.846 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -123.28 165.55 16.77 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.215 -1.032 . . . . 3.1499999999999999 108.215 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.43 -164.29 28.03 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.302 -1.519 . . . . 0.01 109.302 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -76.84 144.57 38.97 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.053 -1.263 . . . . 0.01 108.675 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.577 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 30.3 ttp -116.74 142.57 46.74 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.638 0.732 . . . . 0.01 109.984 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -131.27 136.49 48.23 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.184 -1.043 . . . . 2.48 108.184 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -118.56 133.92 55.49 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.466 -0.771 . . . . 0.01 109.817 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.415 ' O ' HG22 ' A' ' 95' ' ' ILE . 4.5 t -148.15 149.86 32.77 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.128 0.966 . . . . 1.6899999999999999 110.965 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 p -110.44 9.97 23.31 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 115.614 -0.721 . . . . 0.01 110.168 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -121.53 163.1 19.4 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.214 -0.929 . . . . 3.21 111.901 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 9.8 p30 -68.15 157.28 35.69 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.233 -1.025 . . . . 0.01 108.233 178.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.574 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 86.2 m -125.77 112.8 24.87 Favored Pre-proline 0 N--CA 1.501 2.104 0 O-C-N 121.503 -0.748 . . . . 0.01 109.172 178.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -75.62 -30.93 5.84 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 CA-C-N 120.095 1.07 . . . . 0.01 111.042 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.4 m -141.96 106.55 4.85 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.493 -0.928 . . . . 0.02 108.493 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 95.0 mt -65.12 -38.1 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.745 -0.597 . . . . 1.8300000000000001 111.203 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.1 ttt -67.75 -37.16 81.76 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.013 -1.075 . . . . 1.3400000000000001 109.815 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -69.75 -38.34 76.77 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.493 -1.379 . . . . 2.1099999999999999 109.721 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.529 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 7.7 tt0 -80.19 -47.24 14.99 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.404 -0.81 . . . . 2.0800000000000001 112.345 -177.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -110.95 -0.4 16.76 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.386 -0.821 . . . . 0.02 112.67 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.9 m170 59.86 33.44 21.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.818 -1.176 . . . . 0.02 109.58 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 11.7 mt -112.42 135.53 53.01 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 108.791 -0.818 . . . . 0.02 108.791 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -92.06 -23.09 19.6 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.256 -0.902 . . . . 5.3200000000000003 110.565 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -149.14 163.81 36.52 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.142 -0.973 . . . . 0.02 109.911 -178.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 43.2 mt -132.57 129.39 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 107.811 -1.181 . . . . 2.1699999999999999 107.811 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.5 m80 -108.96 -12.07 14.91 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.364 -0.835 . . . . 0.02 112.466 -177.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.2 t -159.26 151.21 20.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.736 -1.228 . . . . 0.01 109.239 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 28.4 p -166.5 149.61 7.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.971 -1.08 . . . . 1.22 109.295 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.434 ' O ' ' OE1' ' A' ' 96' ' ' GLN . 3.7 tmtp? -119.69 108.99 15.12 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 122.298 1.047 . . . . 1.4099999999999999 109.422 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.4 t -114.71 127.84 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 107.673 -1.232 . . . . 0.01 107.673 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.2 t -130.67 94.88 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 107.378 -1.341 . . . . 1.98 107.378 177.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.644 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 22.5 tt0 -146.39 -74.61 0.21 Allowed 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 106.128 -1.804 . . . . 0.01 106.128 177.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 167.91 -65.69 0.19 Allowed Glycine 0 N--CA 1.484 1.841 0 N-CA-C 108.697 -1.761 . . . . 0.01 108.697 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.7 p -122.87 115.15 21.48 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.52 -0.988 . . . . 2.2999999999999998 110.508 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.644 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 8.3 m95 -126.57 148.18 49.78 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 107.338 -1.356 . . . . 0.01 107.338 178.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.437 HG21 HD13 ' A' ' 137' ' ' ILE . 14.2 mt -120.4 134.67 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 120.392 -1.443 . . . . 1.6899999999999999 110.343 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.401 ' HB3' HD12 ' A' ' 169' ' ' ILE . 66.0 m-85 -114.71 143.93 44.26 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.366 -1.346 . . . . 2.4900000000000002 107.366 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.541 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 8.4 m-85 -123.65 144.78 49.41 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.373 -0.829 . . . . 0.02 109.741 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -77.36 -28.17 52.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.569 -0.707 . . . . 0.02 112.046 -176.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 47.7 mt -114.86 151.92 45.93 Favored Pre-proline 0 N--CA 1.504 2.235 0 O-C-N 120.683 -1.26 . . . . 1.48 109.143 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -52.93 166.12 1.01 Allowed 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 120.737 0.958 . . . . 0.02 112.72 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 59.25 31.19 21.0 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.111 -0.949 . . . . 0.75 111.432 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 57.24 51.47 10.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.562 -0.711 . . . . 0.02 111.298 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 51.0 mtp180 -125.96 164.46 20.77 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.499 -0.751 . . . . 0.02 109.935 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.37 -165.31 32.5 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.312 -1.115 . . . . 0.02 110.312 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -69.48 142.99 53.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.617 -0.931 . . . . 0.02 109.109 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -115.11 149.01 38.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.801 -0.562 . . . . 0.02 109.77 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -124.97 135.68 53.03 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.653 -0.654 . . . . 0.01 109.284 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.9 tp -97.07 120.61 37.74 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.648 -1.282 . . . . 0.01 109.368 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.4 tp -100.38 150.18 22.88 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.291 -0.881 . . . . 0.01 109.013 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -104.17 -108.72 0.27 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.673 -0.642 . . . . 2.27 109.374 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -167.59 54.68 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.967 -1.083 . . . . 1.8400000000000001 109.839 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -113.76 -167.51 1.22 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.523 -0.736 . . . . 2.2799999999999998 109.268 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -106.14 105.45 15.49 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.879 -0.785 . . . . 0.01 108.879 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -99.41 115.83 30.17 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.354 -0.841 . . . . 0.01 110.018 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -92.33 -25.26 18.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.993 -1.067 . . . . 0.01 110.873 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -127.5 153.73 77.42 Favored Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 108.14 -1.059 . . . . 2.54 108.14 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -58.78 -40.47 72.29 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 CA-C-N 119.502 0.858 . . . . 0.69999999999999996 110.462 178.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 5.6 t -63.09 -22.96 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.716 -1.24 . . . . 0.85999999999999999 109.821 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -66.37 -16.35 64.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.556 -1.34 . . . . 0.02 110.076 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.539 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 18.9 t90 -100.31 10.68 40.87 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.424 -0.797 . . . . 0.02 109.03 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.42 8.52 87.49 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 120.208 -0.996 . . . . 0.02 111.902 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -98.51 141.3 31.54 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.056 -1.261 . . . . 0.02 110.154 -178.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -88.66 -13.08 40.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.63 -0.669 . . . . 0.58999999999999997 110.701 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 60.6 p -147.31 150.23 37.12 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 120.717 -1.239 . . . . 0.87 108.988 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -78.6 20.25 0.79 Allowed 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 120.816 1.011 . . . . 0.38 113.085 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.17 123.86 29.95 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.446 -1.409 . . . . 0.17999999999999999 111.78 -177.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.447 HD13 ' HA ' ' A' ' 169' ' ' ILE . 11.7 mm -151.5 127.63 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 107.03 -1.47 . . . . 3.9900000000000002 107.03 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -112.07 -16.6 13.02 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 121.078 -1.014 . . . . 5.1699999999999999 113.719 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 67.2 m -156.92 160.44 39.1 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 119.124 -2.235 . . . . 0.02 110.288 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.574 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 9.8 p90 -152.74 153.28 32.9 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.131 -0.981 . . . . 2.02 111.004 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -145.12 149.57 35.26 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.469 -0.769 . . . . 0.01 110.112 -179.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -88.52 144.1 26.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.603 -0.685 . . . . 0.01 109.416 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 8.2 mt -95.74 129.44 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.212 -0.93 . . . . 3.04 109.218 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.8 m -136.37 146.97 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.189 -0.944 . . . . 1.8899999999999999 109.589 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.337 -0.852 . . . . 4.8899999999999997 109.485 -179.854 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 84.5 p . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.46 -0.57 . . . . 5.2800000000000002 109.46 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -153.62 117.24 4.68 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.226 -0.921 . . . . 5.96 109.355 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 72.8 p -90.32 -139.51 0.15 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.399 -1.334 . . . . 2.2200000000000002 107.399 177.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.61 -176.66 46.88 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 117.45 -2.309 . . . . 0.81000000000000005 112.728 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -80.13 160.36 44.29 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.705 -1.358 . . . . 0.01 109.705 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -145.33 134.66 23.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.248 -1.148 . . . . 0.02 110.522 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.8 tt -129.55 139.71 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.097 -1.075 . . . . 0.02 108.097 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.524 ' OG ' ' NE ' ' A' ' 19' ' ' ARG . 1.7 t -121.99 130.19 53.1 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.336 -0.853 . . . . 0.39000000000000001 110.174 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.9 m-85 -110.61 140.37 45.01 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.919 -0.771 . . . . 0.02 108.919 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.577 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 1.9 m-85 -122.2 138.99 54.28 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.28 -0.888 . . . . 0.02 109.758 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -69.34 -27.79 65.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.075 -1.016 . . . . 0.029999999999999999 111.673 -178.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -114.0 169.16 9.21 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.956 -1.09 . . . . 0.029999999999999999 110.117 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -75.5 158.28 32.8 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.731 0.777 . . . . 0.029999999999999999 110.087 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.408 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 2.0 m-20 66.72 33.36 6.34 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.948 0.88 . . . . 0.73999999999999999 111.225 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.408 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 1.3 m-85 55.64 42.23 29.69 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.28 0.562 . . . . 0.02 111.555 177.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -113.79 165.6 12.4 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.216 -1.031 . . . . 0.02 108.216 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.46 -167.38 35.44 Favored Glycine 0 N--CA 1.494 2.504 0 C-N-CA 119.769 -1.205 . . . . 0.029999999999999999 111.023 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -68.62 141.75 55.32 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.473 -1.016 . . . . 2.7599999999999998 109.468 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.524 ' NE ' ' OG ' ' A' ' 8' ' ' SER . 54.4 ttt180 -121.09 149.16 43.16 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.609 -0.682 . . . . 1.8899999999999999 109.935 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -134.99 130.03 35.11 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 108.729 -0.841 . . . . 0.02 108.729 178.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 3.3 m-20 -110.64 136.08 50.28 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.471 -0.768 . . . . 1.1200000000000001 109.105 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.6 t -129.08 138.17 51.69 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.714 -0.616 . . . . 0.02 109.491 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -117.76 12.31 13.87 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.626 -0.671 . . . . 0.20000000000000001 110.282 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 44.4 t -159.45 174.29 14.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.949 -1.094 . . . . 1.23 108.777 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.466 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 3.3 p-10 -61.91 145.36 53.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.685 -1.26 . . . . 0.02 110.142 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.0 t -132.6 117.09 17.49 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.78 -0.822 . . . . 0.02 108.78 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.55 -23.31 50.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.308 -0.87 . . . . 0.23999999999999999 111.173 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -155.3 101.41 2.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.197 -0.939 . . . . 1.1399999999999999 108.779 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.489 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 21.2 p90 -108.02 9.65 28.44 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 122.059 0.933 . . . . 6.3700000000000001 110.504 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -59.58 -22.77 62.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.359 -0.838 . . . . 3.1099999999999999 110.663 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.0 m -74.71 -15.73 60.77 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.672 -1.267 . . . . 0.88 109.968 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -103.77 -21.32 13.7 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.587 -0.696 . . . . 0.02 109.396 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 33' ' ' LEU . 48.1 mt -149.8 129.64 13.33 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.915 0.864 . . . . 3.3199999999999998 109.519 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.4 p -85.86 -10.11 55.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.819 -0.551 . . . . 0.02 110.23 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -171.77 161.81 6.04 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.098 -1.075 . . . . 0.02 108.098 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 77.4 m -143.24 116.44 8.96 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.902 -1.124 . . . . 0.02 108.861 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.523 ' ND2' ' OD2' ' A' ' 77' ' ' ASP . 4.0 m120 -108.43 0.58 21.13 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 120.901 -1.125 . . . . 0.029999999999999999 111.429 -178.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.9 p -156.41 154.43 30.47 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.964 -1.124 . . . . 0.02 107.964 178.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.2 mt -146.81 147.77 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.188 -0.945 . . . . 0.02 110.357 -178.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -124.65 125.77 44.65 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.987 -1.116 . . . . 0.02 107.987 177.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.3 t -106.75 115.46 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 107.0 -1.481 . . . . 0.02 107.0 177.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -83.46 -33.95 25.51 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.652 -0.655 . . . . 3.8100000000000001 110.486 -178.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.94 152.21 21.97 Favored Glycine 0 N--CA 1.488 2.126 0 C-N-CA 118.917 -1.611 . . . . 0.02 110.834 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.67 173.08 49.5 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.505 -1.331 . . . . 0.01 110.374 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.5 m -119.22 134.9 54.95 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 107.844 -1.169 . . . . 1.48 107.844 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.407 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 38.1 m95 -127.54 155.52 43.65 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 122.499 1.142 . . . . 0.02 111.991 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.98 134.19 51.97 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 105.676 -1.972 . . . . 0.23999999999999999 105.676 176.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.48 ' HB ' HD22 ' A' ' 79' ' ' LEU . 27.4 m -117.76 143.06 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.629 -0.67 . . . . 0.65000000000000002 109.213 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -120.97 145.32 47.86 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 122.23 1.015 . . . . 0.02 110.064 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -66.32 -32.78 74.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.756 -0.59 . . . . 0.02 111.326 -177.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -125.12 157.61 66.51 Favored Pre-proline 0 N--CA 1.502 2.146 0 O-C-N 121.114 -0.991 . . . . 0.02 109.503 -178.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -53.12 167.1 0.79 Allowed 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 121.739 1.626 . . . . 0.02 112.915 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 63.34 36.57 11.53 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.407 -0.815 . . . . 0.02 110.99 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.476 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 2.3 m-85 44.92 51.6 8.55 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.535 0.683 . . . . 3.3900000000000001 110.565 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.0 p -125.97 163.68 22.47 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.207 0.527 . . . . 2.3300000000000001 110.016 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.56 -162.1 31.54 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.794 -1.323 . . . . 0.02 109.794 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.443 ' ND1' ' N ' ' A' ' 57' ' ' HIS . 4.1 m80 -64.15 138.04 58.25 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.957 -1.319 . . . . 0.02 109.938 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 17.2 ptm -118.59 136.9 53.61 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.317 0.58 . . . . 5.0099999999999998 109.643 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.576 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 84.5 m-85 -134.3 139.39 45.66 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 121.62 0.724 . . . . 0.02 109.702 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.5 mm -94.94 131.32 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.768 -0.827 . . . . 1.72 108.768 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.526 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.17 110.51 36.12 Favored Pre-proline 0 N--CA 1.505 2.282 0 O-C-N 121.386 -0.821 . . . . 0.02 110.693 -178.29 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -77.24 168.86 22.37 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 CA-C-N 119.958 1.021 . . . . 1.47 109.997 177.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -53.33 141.16 24.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.626 -1.296 . . . . 4.25 110.415 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.57 -177.71 32.57 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.558 -1.306 . . . . 0.02 110.571 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -120.04 131.14 55.01 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.537 -0.978 . . . . 0.95999999999999996 109.656 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.526 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 48.7 m-85 -123.11 94.37 47.18 Favored Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 108.371 -0.974 . . . . 0.02 108.371 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -65.95 -3.04 7.61 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.027 1.152 . . . . 0.02 114.11 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -157.53 155.83 30.95 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.55 -1.343 . . . . 2.02 108.589 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -60.78 -39.41 88.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.484 -0.76 . . . . 0.02 112.21 -177.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -59.86 -23.63 63.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.969 -1.082 . . . . 0.02 110.324 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -70.72 -18.36 62.8 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.833 0.825 . . . . 3.4199999999999999 108.858 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.576 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.1 t90 -108.07 10.42 28.16 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.29 -1.374 . . . . 0.02 107.29 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.445 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 2.6 mpt? 59.82 23.63 12.6 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.495 0.664 . . . . 0.02 110.535 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.54 144.89 45.55 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.377 -1.489 . . . . 0.02 109.377 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.3 tp -79.92 -31.05 40.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.119 -1.224 . . . . 0.97999999999999998 107.701 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -157.47 -172.06 3.83 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 106.312 -1.736 . . . . 0.02 106.312 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.523 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 54.0 m-20 -97.9 27.52 4.44 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.705 -1.247 . . . . 0.02 110.674 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -95.98 121.62 37.92 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.879 -1.138 . . . . 3.2000000000000002 110.561 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.489 ' O ' ' CZ ' ' A' ' 29' ' ' PHE . 27.5 mt -144.47 121.17 11.18 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 107.735 -1.209 . . . . 2.6099999999999999 107.735 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -111.99 -15.97 9.53 Favored Glycine 0 N--CA 1.507 3.402 0 O-C-N 121.152 -0.968 . . . . 0.02 113.087 -177.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.476 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 37.3 t -156.42 156.68 34.24 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 119.862 1.831 . . . . 0.02 110.921 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 20.0 p -145.92 148.29 32.65 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.635 -0.666 . . . . 0.02 110.108 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -137.81 142.91 40.81 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.386 -0.821 . . . . 0.01 109.396 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.85 131.99 36.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.42999999999999999 109.767 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 t -91.11 125.47 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.843 -0.799 . . . . 1.25 108.843 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -93.13 132.32 37.37 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.764 -1.21 . . . . 1.77 108.826 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mt -98.56 140.33 32.95 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.3 -0.875 . . . . 1.6299999999999999 108.928 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 60.7 p -111.41 124.8 52.99 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.533 -0.914 . . . . 1.0800000000000001 108.533 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.4 m -116.35 133.0 56.51 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.697 -1.252 . . . . 1.26 107.924 177.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.11 -49.26 0.01 OUTLIER Glycine 0 N--CA 1.505 3.277 0 C-N-CA 117.707 -2.187 . . . . 0.01 113.724 -177.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -167.57 -105.76 0.19 Allowed Glycine 0 N--CA 1.49 2.25 0 CA-C-N 119.962 1.881 . . . . 0.01 111.213 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -120.11 117.89 29.14 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.97 -1.312 . . . . 4.4299999999999997 110.306 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.38 129.92 35.53 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.684 -0.806 . . . . 2.9900000000000002 109.392 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -131.03 140.79 50.14 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.545 -0.722 . . . . 6.3600000000000003 109.178 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.9 tt -129.31 146.07 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.322 -0.861 . . . . 1.0900000000000001 110.211 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -121.24 133.7 55.16 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.559 -1.274 . . . . 2.0499999999999998 107.559 177.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.2 m -124.34 145.98 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 120.965 -1.084 . . . . 1.1000000000000001 109.783 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -119.13 141.61 48.65 Favored 'General case' 0 N--CA 1.503 2.205 0 CA-C-O 122.124 0.964 . . . . 0.72999999999999998 111.092 -178.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -66.63 -30.31 70.55 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 115.87 -0.605 . . . . 0.02 111.908 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -116.53 167.65 10.87 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.004 -1.06 . . . . 3.1800000000000002 110.494 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.71 163.9 43.21 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 111.01 -0.836 . . . . 0.01 111.01 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 102' ' ' ASP . 2.3 m-20 57.09 38.73 29.28 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.808 0.813 . . . . 0.01 110.823 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.407 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 15.2 m-85 52.3 55.75 8.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.571 -0.705 . . . . 0.01 111.045 178.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -128.06 165.81 19.62 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 108.425 -0.954 . . . . 3.1499999999999999 108.425 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.4 -163.95 27.86 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.235 -1.546 . . . . 0.01 109.235 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -75.31 144.64 42.32 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.993 -1.298 . . . . 0.01 108.527 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.45 ' C ' ' SD ' ' A' ' 107' ' ' MET . 10.8 tmm? -116.59 142.33 47.03 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.569 0.7 . . . . 0.01 109.865 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -131.97 136.3 47.21 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.259 -1.015 . . . . 2.48 108.259 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.519 ' OE2' ' N ' ' A' ' 110' ' ' THR . 1.9 tm-20 -118.94 134.88 54.89 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.575 -0.703 . . . . 0.01 109.931 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.519 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 3.0 t -148.55 150.71 33.83 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 122.27 1.033 . . . . 1.6899999999999999 111.166 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 65.8 p -112.0 9.3 20.42 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 115.581 -0.736 . . . . 0.01 110.41 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -121.06 162.93 19.16 Favored 'General case' 0 N--CA 1.508 2.452 0 O-C-N 121.201 -0.937 . . . . 3.21 111.762 -178.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -67.97 156.62 36.89 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.266 -1.013 . . . . 0.01 108.266 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 30.6 t -127.12 114.84 21.79 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.556 -0.715 . . . . 0.01 109.196 178.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -75.08 -28.9 8.65 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 CA-C-N 120.396 1.177 . . . . 0.01 111.0 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 56.0 m -142.88 109.07 5.25 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.389 -0.819 . . . . 0.02 109.224 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.17 -38.77 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.832 -0.542 . . . . 1.8300000000000001 110.627 -178.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.5 ttp -68.89 -37.23 78.88 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.164 -1.014 . . . . 1.3400000000000001 110.259 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -69.53 -38.8 77.66 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 120.352 -1.468 . . . . 2.1099999999999999 110.058 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -79.99 -46.47 16.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.392 -0.817 . . . . 2.0800000000000001 112.227 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -110.62 0.14 17.44 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.364 -0.835 . . . . 0.02 112.573 -176.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 59.63 33.22 21.92 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.644 -1.285 . . . . 0.02 109.404 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.0 mt -112.52 135.57 53.08 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 108.716 -0.846 . . . . 0.02 108.716 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -91.39 -22.53 20.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.155 -0.966 . . . . 5.3200000000000003 110.361 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -149.64 164.02 36.32 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.136 -0.978 . . . . 0.02 109.833 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.6 mt -131.83 128.61 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 107.557 -1.275 . . . . 2.1699999999999999 107.557 178.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.513 ' N ' ' ND1' ' A' ' 127' ' ' HIS . 1.8 m80 -107.93 -12.44 15.17 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.496 -0.753 . . . . 0.02 112.293 -177.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.407 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 7.0 t -159.92 152.12 20.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.015 -1.053 . . . . 0.01 109.05 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 6.3 p -169.98 145.17 2.86 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.183 -0.948 . . . . 1.22 109.016 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.6 tttp -125.74 111.58 15.08 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 122.452 1.12 . . . . 1.4099999999999999 110.172 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 131' ' ' VAL . 11.2 p -111.86 136.5 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.282 -1.377 . . . . 0.01 107.282 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 44.5 t -128.32 93.53 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 N-CA-C 106.865 -1.532 . . . . 1.98 106.865 177.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -146.33 -81.26 0.15 Allowed 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 105.911 -1.885 . . . . 0.01 105.911 178.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -178.91 -79.13 0.06 OUTLIER Glycine 0 N--CA 1.486 1.985 0 N-CA-C 108.488 -1.845 . . . . 0.01 108.488 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.585 ' OG1' HD12 ' A' ' 175' ' ' ILE . 1.4 t -119.08 122.13 41.41 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.454 -1.027 . . . . 2.2999999999999998 110.068 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -125.75 150.74 47.49 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 106.847 -1.538 . . . . 0.01 106.847 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 82.6 mt -121.17 136.78 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 120.467 -1.396 . . . . 1.6899999999999999 110.166 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -115.59 144.88 43.25 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.625 -1.25 . . . . 2.4900000000000002 107.625 178.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.517 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 12.1 m-85 -123.4 144.09 49.71 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.436 -0.79 . . . . 0.02 109.666 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -74.74 -29.4 61.14 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.478 -0.764 . . . . 0.02 111.771 -176.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.5 mt -115.64 154.65 47.94 Favored Pre-proline 0 N--CA 1.505 2.29 0 O-C-N 120.706 -1.246 . . . . 1.48 108.939 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -55.64 167.31 2.18 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.131 1.221 . . . . 0.02 112.609 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.404 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 14.4 t-20 59.7 30.94 20.54 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.009 -0.996 . . . . 0.75 111.284 178.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 58.02 51.64 8.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.425 -0.797 . . . . 0.02 111.208 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -127.04 164.89 20.54 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.541 -0.725 . . . . 0.02 110.187 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.98 -165.81 33.36 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.385 -1.086 . . . . 0.02 110.385 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -69.1 142.5 54.44 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.558 -0.966 . . . . 0.02 109.027 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -113.99 148.52 36.79 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.554 0.692 . . . . 0.02 110.257 -177.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -125.09 134.34 52.53 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.01 -0.737 . . . . 0.01 109.01 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.496 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.9 tt -99.25 121.9 41.69 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.92 -1.113 . . . . 0.01 109.221 -179.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.642 HD23 ' N ' ' A' ' 152' ' ' ASP . 1.6 tt -98.35 140.98 31.82 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.587 -0.894 . . . . 0.01 108.587 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.642 ' N ' HD23 ' A' ' 151' ' ' LEU . 1.3 m-20 -103.39 -108.32 0.26 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.313 -0.867 . . . . 2.27 109.967 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.417 ' HZ2' ' HB3' ' A' ' 153' ' ' LYS . 14.2 ttpp -153.27 52.47 0.73 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.939 -1.1 . . . . 1.8400000000000001 109.611 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -115.25 175.58 5.45 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.374 -0.829 . . . . 2.2799999999999998 109.087 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -102.94 111.72 24.18 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.237 -0.914 . . . . 0.01 108.644 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.51 ' N ' ' CD1' ' A' ' 156' ' ' TYR . 16.1 m-85 -99.76 115.6 29.9 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.373 -0.829 . . . . 0.01 110.506 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -92.82 -24.91 18.35 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.927 -1.108 . . . . 0.01 110.633 -178.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -127.82 154.04 78.05 Favored Pre-proline 0 N--CA 1.499 2.018 0 N-CA-C 108.139 -1.06 . . . . 2.54 108.139 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -58.86 -40.31 73.28 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 CA-C-N 119.416 0.827 . . . . 0.69999999999999996 110.518 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 51.1 t -62.14 -23.02 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.887 -1.133 . . . . 0.85999999999999999 109.594 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -66.54 -16.22 63.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.588 -1.32 . . . . 0.02 109.824 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.572 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 12.5 t90 -99.66 9.53 42.96 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.648 -0.871 . . . . 0.02 108.648 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 78.57 8.4 87.66 Favored Glycine 0 N--CA 1.492 2.373 0 O-C-N 120.904 -1.122 . . . . 0.02 111.512 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -98.23 141.61 30.93 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.231 -1.158 . . . . 0.02 109.973 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -87.27 -12.35 46.9 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.796 -0.565 . . . . 0.58999999999999997 110.439 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.9 m -147.22 149.99 36.66 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 120.713 -1.242 . . . . 0.87 108.758 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -78.17 22.46 0.62 Allowed 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 120.807 1.005 . . . . 0.38 112.98 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.841 ' O ' HD13 ' A' ' 169' ' ' ILE . . . -83.6 123.18 29.52 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.618 -1.301 . . . . 0.17999999999999999 111.812 -177.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.841 HD13 ' O ' ' A' ' 168' ' ' ALA . 5.4 mm -147.75 128.9 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 106.975 -1.491 . . . . 3.9900000000000002 106.975 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -112.64 -17.83 12.51 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 120.95 -1.094 . . . . 5.1699999999999999 113.497 -177.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 20.1 t -157.36 160.52 38.55 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 119.108 -2.245 . . . . 0.02 110.265 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.441 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 16.0 p90 -151.8 152.83 33.17 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.075 -1.015 . . . . 2.02 110.937 179.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -145.31 149.78 35.45 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.832 0.825 . . . . 0.01 110.119 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -88.77 145.5 25.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.732 -0.605 . . . . 0.01 109.403 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.585 HD12 ' OG1' ' A' ' 135' ' ' THR . 6.1 mt -95.29 128.79 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.316 -0.865 . . . . 3.04 109.169 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 20.1 t -136.09 145.84 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.114 -0.991 . . . . 1.8899999999999999 109.47 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.273 -0.892 . . . . 4.8899999999999997 109.376 -179.978 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.463 -0.569 . . . . 5.2800000000000002 109.463 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -66.0 116.41 7.09 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.301 -0.875 . . . . 5.96 109.449 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 30.5 p -89.57 -139.89 0.14 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.303 -1.369 . . . . 2.2200000000000002 107.303 177.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.2 -176.78 46.59 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 117.41 -2.328 . . . . 0.81000000000000005 112.679 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -80.04 160.11 44.2 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.555 -1.418 . . . . 0.01 109.555 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -145.55 135.4 23.54 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.233 -1.157 . . . . 0.02 110.436 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.6 tt -129.67 139.04 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.204 -1.036 . . . . 0.02 108.204 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.9 m -121.28 129.81 53.33 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.348 -0.845 . . . . 0.39000000000000001 110.141 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 8.0 m-85 -110.06 140.29 44.27 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.672 -0.862 . . . . 0.02 108.672 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.556 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.3 m-85 -122.04 138.6 54.38 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.202 -0.936 . . . . 0.02 109.538 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.489 ' HG3' HD11 ' A' ' 33' ' ' LEU . 87.5 mt-10 -69.02 -27.6 65.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.012 -1.055 . . . . 0.029999999999999999 111.44 -178.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -114.29 169.26 9.17 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.787 -1.196 . . . . 0.029999999999999999 110.161 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -75.68 158.84 31.81 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.736 0.779 . . . . 0.029999999999999999 110.207 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.7 t30 65.9 33.49 7.89 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.992 0.901 . . . . 0.73999999999999999 111.21 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 55.33 41.87 30.78 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.195 0.522 . . . . 0.02 111.341 178.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -113.6 166.08 11.88 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.232 -1.025 . . . . 0.02 108.232 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.73 -167.34 36.67 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.773 -1.203 . . . . 0.029999999999999999 110.783 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -69.06 141.6 54.74 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.613 -0.934 . . . . 2.7599999999999998 109.407 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -120.57 149.28 42.7 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.575 -0.703 . . . . 1.8899999999999999 110.165 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -132.69 127.67 35.3 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.271 -1.011 . . . . 0.02 108.271 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -112.85 137.3 51.4 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.479 -0.763 . . . . 1.1200000000000001 109.765 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.6 t -131.29 139.04 49.52 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.628 -0.67 . . . . 0.02 109.642 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.489 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 19.0 t70 -116.61 10.92 14.56 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.593 -0.692 . . . . 0.20000000000000001 109.925 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 40.4 m -158.24 174.34 15.31 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.245 -1.02 . . . . 1.23 108.245 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 11.9 p-10 -60.66 144.31 52.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.541 -1.349 . . . . 0.02 109.848 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.1 t -131.83 117.61 18.77 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.559 -0.904 . . . . 0.02 108.559 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.94 -25.06 48.05 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.239 -0.913 . . . . 0.23999999999999999 110.841 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -155.08 101.72 2.27 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.061 -1.024 . . . . 1.1399999999999999 109.021 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.401 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 24.0 p90 -105.25 9.56 33.96 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 122.157 0.98 . . . . 6.3700000000000001 109.84 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -58.5 -23.75 58.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.448 -0.782 . . . . 3.1099999999999999 110.873 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.8 m -74.55 -16.77 60.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.641 -1.287 . . . . 0.88 110.174 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -104.12 -21.98 13.49 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.499 -0.751 . . . . 0.02 109.6 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.489 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.8 tp -150.58 129.15 12.24 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.11 -0.994 . . . . 3.3199999999999998 109.157 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.7 m -85.38 -9.94 56.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.831 -0.543 . . . . 0.02 111.06 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -171.45 162.9 6.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.847 -1.158 . . . . 0.02 107.931 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.4 p -143.21 115.16 8.28 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.789 -1.194 . . . . 0.02 108.905 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -107.21 1.94 24.37 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.759 -1.213 . . . . 0.029999999999999999 110.875 -178.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.6 t -156.23 154.37 30.63 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.749 -1.204 . . . . 0.02 107.749 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.8 mt -146.66 147.61 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 120.959 -1.088 . . . . 0.02 110.362 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -124.58 125.06 43.55 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.083 -1.08 . . . . 0.02 108.083 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.8 t -106.87 115.12 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 107.147 -1.427 . . . . 0.02 107.147 177.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -83.52 -33.9 25.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.528 -0.732 . . . . 3.8100000000000001 110.906 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.15 152.35 22.11 Favored Glycine 0 N--CA 1.487 2.037 0 C-N-CA 118.919 -1.61 . . . . 0.02 110.937 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.45 173.13 49.5 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.577 -1.297 . . . . 0.01 110.418 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.5 m -119.23 134.97 54.91 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.827 -1.175 . . . . 1.48 107.827 178.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.425 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 35.0 m95 -126.8 155.22 43.21 Favored 'General case' 0 N--CA 1.504 2.234 0 CA-C-O 122.506 1.146 . . . . 0.02 112.08 -176.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.52 133.89 52.56 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 105.724 -1.954 . . . . 0.23999999999999999 105.724 176.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.521 ' HB ' HD22 ' A' ' 79' ' ' LEU . 26.8 m -118.09 142.92 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 109.009 -0.737 . . . . 0.65000000000000002 109.009 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -121.39 146.28 47.04 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 122.325 1.06 . . . . 0.02 110.155 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.497 ' OE2' ' ND2' ' A' ' 76' ' ' ASN . 7.6 tp10 -66.31 -35.08 79.46 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.548 -0.751 . . . . 0.02 111.185 -177.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 -125.44 157.77 66.78 Favored Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 121.126 -0.983 . . . . 0.02 109.529 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -53.61 167.17 1.03 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.761 1.641 . . . . 0.02 112.992 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 53' ' ' ASN . 1.1 t30 63.57 36.52 10.99 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.027 -0.988 . . . . 0.02 111.191 178.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 45.28 51.82 9.12 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.621 0.724 . . . . 3.3900000000000001 110.572 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 88.2 p -126.1 163.61 22.72 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 121.223 0.535 . . . . 2.3300000000000001 109.755 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.88 -161.92 32.32 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.708 -1.357 . . . . 0.02 109.708 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -66.7 139.23 57.83 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.015 -1.285 . . . . 0.02 110.281 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 14.3 ptm -118.64 137.98 52.91 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.598 -0.689 . . . . 5.0099999999999998 109.758 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.462 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 59.4 m-85 -133.25 137.84 46.23 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.506 -0.746 . . . . 0.02 109.836 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.7 mm -94.98 131.12 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.846 -0.798 . . . . 1.72 108.846 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.56 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.19 110.94 35.67 Favored Pre-proline 0 N--CA 1.505 2.297 0 O-C-N 121.452 -0.78 . . . . 0.02 110.748 -178.233 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -77.74 168.37 22.5 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 CA-C-N 119.958 1.021 . . . . 1.47 110.115 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.89 141.28 28.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.822 -1.174 . . . . 4.25 110.489 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.26 -177.81 32.26 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 119.535 -1.316 . . . . 0.02 110.567 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -119.41 131.13 55.6 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.527 -0.984 . . . . 0.95999999999999996 109.766 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.56 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 70.6 m-85 -122.05 96.26 46.79 Favored Pre-proline 0 N--CA 1.494 1.737 0 N-CA-C 108.162 -1.051 . . . . 0.02 108.162 178.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.401 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.6 Cg_endo -67.41 -3.77 10.66 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 120.77 0.98 . . . . 0.02 113.734 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.401 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 34.2 mt-10 -157.55 155.19 29.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.592 -1.317 . . . . 2.02 108.132 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -60.48 -38.92 85.8 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.622 -0.674 . . . . 0.02 112.11 -177.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -60.49 -23.83 64.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.042 -1.036 . . . . 0.02 110.366 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -69.46 -18.95 63.76 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.427 -0.796 . . . . 3.4199999999999999 108.992 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.553 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 1.1 t90 -108.3 11.09 27.49 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.403 -1.332 . . . . 0.02 107.403 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.5 mtt 60.88 22.21 12.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.47 -0.769 . . . . 0.02 110.215 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.11 145.11 46.6 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.169 -1.572 . . . . 0.02 109.169 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.551 HD23 ' O ' ' A' ' 75' ' ' LEU . 1.0 OUTLIER -79.62 -31.03 41.6 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.66 -1.237 . . . . 0.97999999999999998 107.66 178.114 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.702 ' H ' HD22 ' A' ' 76' ' ' ASN . 0.0 OUTLIER -157.16 -171.45 3.63 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 106.525 -1.657 . . . . 0.02 106.525 178.453 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -98.86 28.6 4.23 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.85 -1.156 . . . . 0.02 110.425 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -98.47 123.37 42.57 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.152 -0.967 . . . . 3.2000000000000002 111.183 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.521 HD22 ' HB ' ' A' ' 48' ' ' VAL . 36.1 mt -145.03 122.33 11.57 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.518 -1.29 . . . . 2.6099999999999999 107.518 177.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.99 -16.44 11.43 Favored Glycine 0 N--CA 1.504 3.173 0 O-C-N 121.132 -0.98 . . . . 0.02 112.695 -177.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.6 t -156.96 155.97 32.22 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.242 -1.74 . . . . 0.02 110.304 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.5 p -145.28 147.85 32.81 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.503 -0.748 . . . . 0.02 110.332 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.0 mtm180 -137.7 143.0 41.05 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.278 -0.889 . . . . 0.01 109.36 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.52 132.16 36.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.127 -0.983 . . . . 0.42999999999999999 109.76 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.4 t -91.06 125.03 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.782 -0.821 . . . . 1.25 108.782 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -94.6 131.18 40.63 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.82 -1.175 . . . . 1.77 109.16 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -94.87 139.62 31.06 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.196 -0.94 . . . . 1.6299999999999999 108.508 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.7 t -110.66 127.87 55.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.388 -0.82 . . . . 1.0800000000000001 109.108 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 95.5 p -104.52 -154.32 0.5 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 106.547 -1.649 . . . . 1.26 106.547 177.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.55 -53.1 0.74 Allowed Glycine 0 N--CA 1.5 2.9 0 O-C-N 120.553 -1.342 . . . . 0.01 112.762 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.46 -101.5 0.15 Allowed Glycine 0 N--CA 1.489 2.168 0 C-N-CA 118.603 -1.76 . . . . 0.01 111.978 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -122.39 119.56 31.4 Favored 'General case' 0 N--CA 1.506 2.343 0 CA-C-N 118.666 1.233 . . . . 4.4299999999999997 110.757 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.36 130.82 35.8 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.762 -0.775 . . . . 2.9900000000000002 109.483 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -129.62 141.85 50.86 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.377 -0.827 . . . . 6.3600000000000003 109.229 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.9 tt -128.3 144.73 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 O-C-N 121.35 -0.844 . . . . 1.0900000000000001 110.123 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -122.5 133.39 54.59 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.501 -1.296 . . . . 2.0499999999999998 107.501 177.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.9 m -124.56 146.36 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 O-C-N 120.628 -1.295 . . . . 1.1000000000000001 109.884 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -120.04 141.85 49.38 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 122.013 0.911 . . . . 0.72999999999999998 111.129 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -67.28 -30.82 70.8 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 116.03 -0.532 . . . . 0.02 111.908 -178.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -115.98 167.47 10.93 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.938 -1.101 . . . . 3.1800000000000002 110.384 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.15 164.26 44.28 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.974 -0.851 . . . . 0.01 110.974 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 57.08 38.77 29.33 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.701 0.762 . . . . 0.01 110.935 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 52.44 55.97 8.36 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.467 -0.77 . . . . 0.01 110.991 178.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -129.14 165.77 20.63 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.238 -1.023 . . . . 3.1499999999999999 108.238 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.57 -163.73 27.52 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.244 -1.542 . . . . 0.01 109.244 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -75.7 144.41 41.57 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.05 -1.265 . . . . 0.01 108.543 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.452 ' C ' ' SD ' ' A' ' 107' ' ' MET . 12.8 tmm? -116.56 142.33 47.02 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.623 0.725 . . . . 0.01 109.831 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -131.88 135.7 46.86 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.255 -1.017 . . . . 2.48 108.255 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.519 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.1 tm-20 -118.55 134.11 55.34 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.584 -0.698 . . . . 0.01 110.033 -178.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.519 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 6.0 t -148.17 150.74 34.34 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.278 1.037 . . . . 1.6899999999999999 111.072 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 72.9 p -110.85 9.68 22.47 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 115.498 -0.774 . . . . 0.01 110.227 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -120.86 162.74 19.31 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.234 -0.916 . . . . 3.21 111.563 -178.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -68.59 157.54 35.87 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.392 -0.966 . . . . 0.01 108.392 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 19.2 t -127.36 113.43 21.32 Favored Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 121.491 -0.756 . . . . 0.01 109.072 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -75.25 -28.09 9.06 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 CA-C-N 120.315 1.148 . . . . 0.01 111.02 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.8 t -142.38 109.08 5.38 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.363 -0.836 . . . . 0.02 109.088 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 98.0 mt -63.63 -39.31 84.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.824 -0.547 . . . . 1.8300000000000001 110.76 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 15.3 ttt -68.85 -38.16 79.6 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.246 -0.982 . . . . 1.3400000000000001 110.372 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -69.26 -38.48 78.43 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.528 -1.358 . . . . 2.1099999999999999 109.872 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -79.98 -47.02 15.62 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.219 -0.925 . . . . 2.0800000000000001 112.331 -177.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.443 ' C ' ' ND1' ' A' ' 122' ' ' HIS . 54.3 m-85 -110.94 0.23 17.01 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.251 -0.905 . . . . 0.02 112.653 -176.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.443 ' ND1' ' C ' ' A' ' 121' ' ' PHE . 5.3 m80 60.14 33.34 21.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.753 -1.217 . . . . 0.02 109.407 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.9 mt -112.46 135.36 53.25 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 108.791 -0.818 . . . . 0.02 108.791 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -91.47 -22.82 20.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.233 -0.917 . . . . 5.3200000000000003 110.174 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -149.29 164.1 35.8 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.216 -0.928 . . . . 0.02 109.899 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 31.9 mt -131.78 128.7 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 N-CA-C 107.854 -1.165 . . . . 2.1699999999999999 107.854 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -108.5 -12.88 14.94 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.286 -0.884 . . . . 0.02 112.256 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.5 m -159.4 150.75 20.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.992 -1.067 . . . . 0.01 108.937 178.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 24.9 p -168.95 147.63 3.98 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.356 -0.84 . . . . 1.22 108.782 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -121.3 111.39 17.29 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 122.542 1.163 . . . . 1.4099999999999999 109.845 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.47 129.78 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.472 -1.307 . . . . 0.01 107.472 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.7 t -129.52 93.57 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 107.328 -1.36 . . . . 1.98 107.328 177.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.488 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 11.0 tm-20 -147.41 -75.55 0.19 Allowed 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 105.914 -1.884 . . . . 0.01 105.914 177.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.438 ' N ' ' OE1' ' A' ' 133' ' ' GLU . . . 171.06 -71.81 0.11 Allowed Glycine 0 N--CA 1.483 1.813 0 N-CA-C 108.601 -1.8 . . . . 0.01 108.601 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.418 ' OG1' HD12 ' A' ' 175' ' ' ILE . 16.5 p -119.56 115.82 24.79 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.604 -0.939 . . . . 2.2999999999999998 110.24 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.488 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 6.4 m95 -126.33 149.71 49.0 Favored 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 106.677 -1.601 . . . . 0.01 106.677 178.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 81.3 mt -122.51 137.72 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 120.377 -1.452 . . . . 1.6899999999999999 110.586 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -114.48 143.95 44.12 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.221 -1.4 . . . . 2.4900000000000002 107.221 178.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.516 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 10.6 m-85 -123.18 143.87 49.73 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.241 -0.912 . . . . 0.02 109.521 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -74.32 -29.99 61.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.715 -0.616 . . . . 0.02 111.754 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.5 mt -116.76 153.97 49.33 Favored Pre-proline 0 N--CA 1.504 2.261 0 O-C-N 120.877 -1.14 . . . . 1.48 108.856 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.46 169.49 0.74 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.281 1.32 . . . . 0.02 113.122 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.448 HD22 ' NH2' ' A' ' 145' ' ' ARG . 53.4 m-20 57.61 32.31 21.66 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.046 -0.979 . . . . 0.75 111.511 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 55.83 48.36 18.31 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.551 -0.718 . . . . 0.02 110.908 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.448 ' NH2' HD22 ' A' ' 143' ' ' ASN . 82.9 mtm180 -122.6 163.92 19.14 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.505 -0.747 . . . . 0.02 109.914 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.23 -165.85 33.06 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.361 -1.096 . . . . 0.02 110.361 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.477 ' CZ ' ' OH ' ' A' ' 149' ' ' TYR . 17.9 ttp180 -69.26 142.71 54.08 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.523 -0.987 . . . . 0.02 109.244 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -114.62 148.36 38.23 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.368 0.604 . . . . 0.02 110.261 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.477 ' OH ' ' CZ ' ' A' ' 147' ' ' ARG . 67.4 m-85 -125.07 135.19 52.48 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.871 -0.788 . . . . 0.01 108.871 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.516 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.4 tt -99.73 122.18 42.34 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.919 -1.113 . . . . 0.01 109.12 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.642 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 32.9 tp -96.75 146.45 24.87 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.101 -1.0 . . . . 0.01 108.736 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -104.31 -130.65 0.27 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.422 -0.799 . . . . 2.27 110.215 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -133.78 52.0 2.1 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.398 -0.814 . . . . 1.8400000000000001 109.654 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -116.24 -169.52 1.63 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.463 -0.773 . . . . 2.2799999999999998 109.473 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -105.49 108.39 19.88 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.335 -0.987 . . . . 0.01 108.335 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.642 ' CZ ' HD11 ' A' ' 151' ' ' LEU . 6.0 m-85 -99.42 111.78 24.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.343 -0.848 . . . . 0.01 110.522 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -96.34 -22.03 17.44 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.294 -0.879 . . . . 0.01 111.412 -178.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -127.4 154.36 77.26 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 121.018 -1.051 . . . . 2.54 108.845 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -59.52 -38.76 80.92 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 CA-C-N 119.261 0.772 . . . . 0.69999999999999996 110.538 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 41.0 t -60.71 -20.18 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.901 -1.124 . . . . 0.85999999999999999 109.014 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -65.46 -15.67 62.87 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.91 -1.119 . . . . 0.02 110.022 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.628 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 10.0 m0 -98.11 10.96 39.22 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.148 -0.97 . . . . 0.02 108.842 178.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.42 11.39 84.24 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.839 -1.172 . . . . 0.02 111.079 178.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.23 140.63 34.19 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.137 -1.213 . . . . 0.02 110.191 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.18 -8.54 58.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.608 -0.682 . . . . 0.58999999999999997 110.271 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.8 t -143.42 150.38 51.19 Favored Pre-proline 0 N--CA 1.5 2.048 0 O-C-N 120.905 -1.122 . . . . 0.87 109.345 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -75.79 17.72 0.67 Allowed 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 120.771 0.98 . . . . 0.38 112.122 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.863 ' O ' HD13 ' A' ' 169' ' ' ILE . . . -82.84 122.89 28.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.883 -1.136 . . . . 0.17999999999999999 111.258 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.863 HD13 ' O ' ' A' ' 168' ' ' ALA . 4.6 mm -147.27 128.14 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 106.725 -1.583 . . . . 3.9900000000000002 106.725 178.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -111.22 -18.37 12.98 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.111 -0.993 . . . . 5.1699999999999999 113.115 -177.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 4.8 p -157.91 161.58 38.24 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 119.319 -2.113 . . . . 0.02 110.309 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.425 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 17.5 p90 -150.73 152.07 33.34 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.142 -0.974 . . . . 2.02 110.02 178.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -144.9 149.23 34.93 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.701 0.762 . . . . 0.01 109.758 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 18.4 ttm180 -87.9 144.06 26.78 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.67 -0.644 . . . . 0.01 109.503 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.418 HD12 ' OG1' ' A' ' 135' ' ' THR . 4.0 mt -94.27 128.84 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.249 -0.907 . . . . 3.04 109.045 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 25.6 m -136.34 146.79 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.061 -1.024 . . . . 1.8899999999999999 109.586 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.337 -0.852 . . . . 4.8899999999999997 109.438 -179.94 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.357 0.599 . . . . 5.2800000000000002 109.549 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt -71.34 -130.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.141 -0.974 . . . . 5.96 109.292 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 44.8 p -90.26 -141.76 0.16 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 107.466 -1.309 . . . . 2.2200000000000002 107.466 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.88 -175.28 45.9 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 117.49 -2.29 . . . . 0.81000000000000005 112.67 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.79 160.67 45.25 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.444 -1.462 . . . . 0.01 109.444 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -148.17 136.63 21.46 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.004 -1.292 . . . . 0.02 110.344 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.6 tt -130.73 140.86 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.906 -0.775 . . . . 0.02 108.906 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 m -121.42 130.4 53.56 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.499 -0.75 . . . . 0.39000000000000001 109.934 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.6 m-85 -109.92 138.88 45.67 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.496 -0.752 . . . . 0.02 109.224 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.534 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.5 m-85 -122.32 139.14 54.16 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.317 -0.865 . . . . 0.02 109.805 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -69.5 -28.3 65.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.139 -0.976 . . . . 0.029999999999999999 111.868 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -114.17 168.87 9.45 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.85 -1.156 . . . . 0.029999999999999999 110.18 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -74.94 158.52 33.17 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.683 0.754 . . . . 0.029999999999999999 109.938 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 66.52 33.52 6.63 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.953 0.882 . . . . 0.73999999999999999 111.217 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 55.56 42.51 29.58 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.241 0.543 . . . . 0.02 111.32 177.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -113.56 165.88 12.07 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.357 -0.979 . . . . 0.02 108.357 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.63 -167.5 35.26 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.825 -1.179 . . . . 0.029999999999999999 110.974 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -68.74 142.1 55.07 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.506 -0.997 . . . . 2.7599999999999998 109.314 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -121.59 149.9 42.47 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.551 -0.718 . . . . 1.8899999999999999 110.302 -178.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -134.72 129.28 34.47 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.662 -0.866 . . . . 0.02 108.662 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 15.9 p-10 -110.59 136.49 49.63 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.525 -0.734 . . . . 1.1200000000000001 109.156 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 14.2 t -129.33 137.88 51.25 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.483 0.659 . . . . 0.02 109.44 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -116.96 12.02 14.51 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.597 -0.689 . . . . 0.20000000000000001 109.753 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.444 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 42.3 t -159.44 174.24 15.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.052 -1.03 . . . . 1.23 108.559 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.419 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.4 p30 -61.03 144.16 53.95 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.715 -1.241 . . . . 0.02 110.006 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.8 t -131.85 116.96 17.89 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.576 -0.898 . . . . 0.02 108.576 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.53 -24.76 45.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.181 -0.95 . . . . 0.23999999999999999 111.31 -178.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -153.85 101.97 2.48 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.955 -1.09 . . . . 1.1399999999999999 109.113 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -104.5 9.31 35.55 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 122.148 0.975 . . . . 6.3700000000000001 109.839 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -58.99 -25.31 63.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.466 -0.771 . . . . 3.1099999999999999 111.17 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.0 p -74.28 -15.98 60.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.74 -1.225 . . . . 0.88 110.139 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -103.59 -21.81 13.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.46 -0.775 . . . . 0.02 109.741 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.5 mt -149.01 128.7 13.24 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.817 0.818 . . . . 3.3199999999999998 109.443 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 76.7 p -84.74 -9.71 57.94 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.322 0.582 . . . . 0.02 109.626 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -171.51 162.09 6.45 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.835 -1.172 . . . . 0.02 107.835 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.0 p -142.21 115.1 8.68 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.952 -1.093 . . . . 0.02 108.462 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.429 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 50.8 t-20 -106.92 -0.59 23.07 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 120.811 -1.181 . . . . 0.029999999999999999 111.649 -177.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 t -153.48 154.37 34.23 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.884 -1.154 . . . . 0.02 107.884 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 39' ' ' ILE . 10.5 mt -146.47 145.93 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.864 -1.147 . . . . 0.02 110.726 -178.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -124.97 125.73 44.36 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.044 -1.095 . . . . 0.02 108.044 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.0 t -104.93 113.71 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 106.727 -1.583 . . . . 0.02 106.727 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -84.92 -34.51 22.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.414 -0.804 . . . . 3.8100000000000001 110.266 -178.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.32 150.43 19.16 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 118.541 -1.79 . . . . 0.02 110.879 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.75 172.0 48.7 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.102 -1.199 . . . . 0.01 110.102 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.6 m -119.43 134.72 55.08 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.844 -1.169 . . . . 1.48 107.844 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.453 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 32.8 m95 -127.2 154.95 44.18 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 122.567 1.175 . . . . 0.02 112.339 -176.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.91 134.62 51.33 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 105.267 -2.123 . . . . 0.23999999999999999 105.267 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.436 ' HB ' HD22 ' A' ' 79' ' ' LEU . 35.2 m -116.5 141.42 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.589 -0.695 . . . . 0.65000000000000002 109.251 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -120.72 143.56 48.7 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 122.04 0.924 . . . . 0.02 109.655 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -65.51 -34.55 78.52 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.472 -0.786 . . . . 0.02 111.595 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -125.52 157.84 66.72 Favored Pre-proline 0 N--CA 1.504 2.229 0 O-C-N 120.985 -1.072 . . . . 0.02 109.45 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -53.71 167.54 0.98 Allowed 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.711 1.607 . . . . 0.02 112.992 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 63.22 36.59 11.82 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 115.191 -0.913 . . . . 0.02 111.136 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 45.03 51.92 8.58 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.671 0.748 . . . . 3.3900000000000001 110.674 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.9 t -125.94 163.66 22.5 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.183 0.516 . . . . 2.3300000000000001 109.811 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.99 -162.08 32.3 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.744 -1.342 . . . . 0.02 109.744 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -66.06 138.58 57.87 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.079 -1.248 . . . . 0.02 110.204 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 23.4 ptm -118.87 137.12 53.66 Favored 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.326 0.584 . . . . 5.0099999999999998 109.666 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.459 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 96.5 m-85 -134.04 139.33 45.93 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.484 -0.76 . . . . 0.02 109.735 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.3 mm -95.35 131.04 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 109.048 -0.723 . . . . 1.72 109.048 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.537 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -119.56 111.3 36.4 Favored Pre-proline 0 N--CA 1.506 2.329 0 O-C-N 121.417 -0.802 . . . . 0.02 110.732 -178.259 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -78.28 168.98 20.87 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 CA-C-N 119.859 0.985 . . . . 1.47 110.258 177.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -54.19 141.0 30.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.812 -1.18 . . . . 4.25 110.593 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.31 -177.67 32.38 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.548 -1.311 . . . . 0.02 110.604 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -119.95 131.67 55.27 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.534 -0.98 . . . . 0.95999999999999996 109.618 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.537 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 67.9 m-85 -120.4 95.86 49.04 Favored Pre-proline 0 N--CA 1.493 1.715 0 N-CA-C 108.144 -1.058 . . . . 0.02 108.144 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -68.29 -5.75 15.73 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 120.77 0.98 . . . . 0.02 113.394 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -156.74 154.08 29.43 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.653 -1.279 . . . . 2.02 107.705 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -60.04 -37.92 81.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.627 -0.671 . . . . 0.02 112.157 -177.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -59.8 -23.35 63.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.066 -1.021 . . . . 0.02 110.442 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -70.54 -19.21 62.91 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.822 0.82 . . . . 3.4199999999999999 109.053 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.543 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.8 t90 -108.01 9.84 28.41 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.672 -1.233 . . . . 0.02 107.672 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.2 mtt 61.14 22.57 12.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.588 -0.695 . . . . 0.02 110.622 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.67 143.89 46.4 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.526 -1.43 . . . . 0.02 109.526 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.2 mt -79.2 -30.86 43.55 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.525 -1.287 . . . . 0.97999999999999998 107.525 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.634 ' ND2' ' H ' ' A' ' 77' ' ' ASP . 18.0 t30 -157.33 -171.71 3.71 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 106.206 -1.775 . . . . 0.02 106.206 178.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.634 ' H ' ' ND2' ' A' ' 76' ' ' ASN . 72.0 m-20 -98.71 28.62 4.15 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.65 -1.281 . . . . 0.02 110.633 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.4 ttp180 -96.66 122.08 39.2 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.827 -1.171 . . . . 3.2000000000000002 111.107 -178.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.436 HD22 ' HB ' ' A' ' 48' ' ' VAL . 66.2 mt -142.91 121.83 12.76 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.473 -1.306 . . . . 2.6099999999999999 107.473 178.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.6 -17.21 9.37 Favored Glycine 0 N--CA 1.502 3.082 0 O-C-N 121.15 -0.969 . . . . 0.02 112.894 -177.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.0 t -156.36 156.13 33.37 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.019 -1.871 . . . . 0.02 110.761 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.2 p -145.24 147.33 32.28 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.395 -0.816 . . . . 0.02 110.609 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 33.9 mtp180 -137.74 143.19 41.06 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.568 -0.707 . . . . 0.01 109.208 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.36 132.48 36.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.42999999999999999 109.724 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.2 t -91.64 125.35 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.056 -0.72 . . . . 1.25 109.056 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -93.51 131.78 38.42 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.752 -1.217 . . . . 1.77 108.835 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.4 mt -98.15 141.62 30.84 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.369 -0.832 . . . . 1.6299999999999999 109.147 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.1 m -111.78 124.86 53.24 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.547 -0.909 . . . . 1.0800000000000001 108.547 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.4 t -116.57 134.02 55.33 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.686 -1.259 . . . . 1.26 108.173 177.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.66 -48.13 0.01 OUTLIER Glycine 0 N--CA 1.505 3.245 0 C-N-CA 117.677 -2.201 . . . . 0.01 114.077 -177.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -168.0 -105.45 0.18 Allowed Glycine 0 N--CA 1.491 2.364 0 CA-C-N 120.336 2.068 . . . . 0.01 111.29 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -120.01 117.98 29.46 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.998 -1.295 . . . . 4.4299999999999997 110.391 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.56 129.93 35.37 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.74 -0.784 . . . . 2.9900000000000002 109.291 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -129.22 140.84 51.32 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.46 -0.775 . . . . 6.3600000000000003 109.158 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.409 HG22 ' O ' ' A' ' 110' ' ' THR . 3.9 tt -128.49 144.55 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.35 0 O-C-N 121.306 -0.871 . . . . 1.0900000000000001 110.215 -179.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -122.81 133.59 54.44 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.562 -1.273 . . . . 2.0499999999999998 107.562 177.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.0 m -124.53 146.15 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 120.679 -1.263 . . . . 1.1000000000000001 109.788 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.581 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 77.5 m-85 -118.67 141.56 48.49 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-O 121.99 0.9 . . . . 0.72999999999999998 111.11 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -67.73 -30.9 70.5 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 116.012 -0.54 . . . . 0.02 111.829 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -116.54 167.43 11.07 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.023 -1.048 . . . . 3.1800000000000002 110.413 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.403 ' CA ' ' ND1' ' A' ' 127' ' ' HIS . . . -66.68 164.07 42.89 Favored Glycine 0 N--CA 1.493 2.447 0 CA-C-O 121.989 0.771 . . . . 0.01 111.309 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.0 t70 56.45 39.13 30.11 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.647 0.737 . . . . 0.01 110.965 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 52.24 55.14 9.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.69 -0.631 . . . . 0.01 110.985 177.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -129.09 165.19 21.72 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.047 -1.094 . . . . 3.1499999999999999 108.047 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.53 -163.93 27.7 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.27 -1.532 . . . . 0.01 109.27 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -75.96 144.11 41.17 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.928 -1.336 . . . . 0.01 108.782 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.581 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 25.3 ttp -116.52 142.36 46.98 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.473 0.654 . . . . 0.01 109.928 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -131.12 136.34 48.28 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.231 -1.026 . . . . 2.48 108.231 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -117.74 134.15 55.2 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.666 -0.646 . . . . 0.01 110.127 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.409 ' O ' HG22 ' A' ' 95' ' ' ILE . 6.5 t -148.98 149.11 30.62 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.025 -1.047 . . . . 1.6899999999999999 111.087 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 37.4 p -111.04 9.64 22.09 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 115.505 -0.77 . . . . 0.01 110.349 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -120.82 163.12 18.65 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 121.234 -0.916 . . . . 3.21 111.56 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.69 156.92 35.78 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.318 -0.993 . . . . 0.01 108.318 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 20.6 t -127.55 113.8 21.03 Favored Pre-proline 0 N--CA 1.498 1.973 0 N-CA-C 108.846 -0.798 . . . . 0.01 108.846 178.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -75.01 -27.7 9.78 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 CA-C-N 120.389 1.175 . . . . 0.01 110.911 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.2 t -143.05 109.01 5.18 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.336 -0.853 . . . . 0.02 109.137 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.424 HD12 ' O ' ' A' ' 169' ' ' ILE . 87.1 mt -63.45 -39.24 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.892 -0.505 . . . . 1.8300000000000001 110.547 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 118' ' ' MET . 0.7 OUTLIER -68.73 -37.27 79.32 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.277 -0.969 . . . . 1.3400000000000001 110.365 -178.308 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -69.8 -38.66 76.72 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.4 -1.437 . . . . 2.1099999999999999 109.974 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -79.71 -46.54 16.89 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.291 -0.881 . . . . 2.0800000000000001 112.264 -177.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -111.05 0.49 16.95 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.312 -0.867 . . . . 0.02 112.674 -176.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 59.95 33.53 21.48 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.737 -1.227 . . . . 0.02 109.442 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.2 mt -112.62 135.38 53.41 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 108.713 -0.847 . . . . 0.02 108.713 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -91.25 -22.86 20.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.144 -0.972 . . . . 5.3200000000000003 110.246 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -149.62 164.33 35.46 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.241 -0.912 . . . . 0.02 109.791 -178.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.7 mt -131.74 128.64 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 107.65 -1.241 . . . . 2.1699999999999999 107.65 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.524 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 51.4 t-80 -107.97 -12.85 15.08 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.421 -0.799 . . . . 0.02 112.107 -177.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.4 m -159.15 150.62 20.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.004 -1.06 . . . . 0.01 109.018 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 6.0 p -169.39 148.45 3.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.39 -0.818 . . . . 1.22 109.045 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -122.96 113.4 19.03 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 122.396 1.093 . . . . 1.4099999999999999 110.102 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 t -112.09 129.86 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 107.351 -1.352 . . . . 0.01 107.351 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 96.3 t -129.61 93.9 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 107.392 -1.336 . . . . 1.98 107.392 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.504 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 3.5 tm-20 -146.97 -78.48 0.17 Allowed 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 105.87 -1.9 . . . . 0.01 105.87 177.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 173.24 -69.49 0.1 Allowed Glycine 0 N--CA 1.484 1.882 0 N-CA-C 108.77 -1.732 . . . . 0.01 108.77 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.9 p -120.51 114.04 21.19 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.587 -0.949 . . . . 2.2999999999999998 110.387 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.504 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 6.5 m95 -124.94 148.8 48.18 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 107.303 -1.369 . . . . 0.01 107.303 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.8 mt -121.58 136.46 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 120.452 -1.405 . . . . 1.6899999999999999 110.184 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -115.32 144.35 43.89 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.69 -1.226 . . . . 2.4900000000000002 107.69 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 8.9 m-85 -123.45 144.04 49.77 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.324 -0.86 . . . . 0.02 109.648 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -75.9 -28.95 58.28 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.698 -0.626 . . . . 0.02 111.881 -176.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 47.3 mt -114.64 151.37 45.25 Favored Pre-proline 0 N--CA 1.504 2.267 0 O-C-N 120.712 -1.242 . . . . 1.48 109.014 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -53.6 167.36 0.97 Allowed 'Trans proline' 0 N--CA 1.49 1.275 0 CA-C-O 122.555 0.981 . . . . 0.02 112.543 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.6 m120 59.51 30.45 20.11 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 115.023 -0.99 . . . . 0.75 111.268 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.428 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.7 m-85 57.8 51.3 9.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.429 -0.794 . . . . 0.02 111.236 177.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -126.24 164.25 21.39 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.498 -0.751 . . . . 0.02 109.993 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.23 -165.25 32.64 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.352 -1.099 . . . . 0.02 110.352 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.465 ' CZ ' ' OH ' ' A' ' 149' ' ' TYR . 16.6 ttp180 -69.19 142.29 54.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.685 -0.891 . . . . 0.02 109.122 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -114.58 148.42 38.06 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.343 0.592 . . . . 0.02 110.134 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.465 ' OH ' ' CZ ' ' A' ' 147' ' ' ARG . 80.9 m-85 -124.07 134.3 53.43 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 109.019 -0.734 . . . . 0.01 109.019 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 151' ' ' LEU . 4.1 tt -98.51 121.55 40.59 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.852 -1.155 . . . . 0.01 108.86 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.596 HD11 ' CE1' ' A' ' 156' ' ' TYR . 42.5 tp -97.3 142.45 29.17 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.212 -0.93 . . . . 0.01 108.67 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -107.13 -113.3 0.28 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.612 -0.68 . . . . 2.27 109.662 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -149.04 57.28 1.02 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.129 -0.982 . . . . 1.8400000000000001 109.212 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -118.11 -179.31 3.73 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.386 -0.821 . . . . 2.2799999999999998 109.091 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -106.49 107.41 18.4 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.63 -0.878 . . . . 0.01 108.63 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.596 ' CE1' HD11 ' A' ' 151' ' ' LEU . 30.9 m-85 -98.78 113.44 25.55 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.29 -0.881 . . . . 0.01 110.328 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -93.51 -24.66 17.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.0 -1.062 . . . . 0.01 110.445 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -129.08 154.51 80.45 Favored Pre-proline 0 N--CA 1.498 1.974 0 N-CA-C 107.969 -1.123 . . . . 2.54 107.969 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -58.09 -38.62 90.87 Favored 'Trans proline' 0 N--CA 1.489 1.214 0 CA-C-N 119.467 0.845 . . . . 0.69999999999999996 110.245 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.2 t -63.77 -24.71 36.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.825 -1.172 . . . . 0.85999999999999999 109.586 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.06 -18.14 65.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.592 -1.317 . . . . 0.02 109.938 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.569 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 12.4 t90 -100.18 9.03 43.4 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.789 -1.189 . . . . 0.02 107.789 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.09 10.12 86.43 Favored Glycine 0 N--CA 1.485 1.96 0 C-N-CA 120.229 -0.986 . . . . 0.02 111.244 178.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.63 140.98 33.03 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.073 -1.251 . . . . 0.02 110.207 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -87.23 -11.85 48.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.627 -0.671 . . . . 0.58999999999999997 110.733 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 43.5 m -147.83 149.85 34.44 Favored Pre-proline 0 N--CA 1.499 1.994 0 O-C-N 120.547 -1.345 . . . . 0.87 108.895 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -78.1 22.86 0.6 Allowed 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 120.879 1.052 . . . . 0.38 112.872 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.854 ' O ' HD13 ' A' ' 169' ' ' ILE . . . -83.61 124.32 30.68 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.708 -1.245 . . . . 0.17999999999999999 111.784 -177.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.854 HD13 ' O ' ' A' ' 168' ' ' ALA . 4.8 mm -147.83 129.52 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 106.908 -1.516 . . . . 3.9900000000000002 106.908 178.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -112.58 -18.38 12.4 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 120.998 -1.064 . . . . 5.1699999999999999 113.475 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.4 p -157.21 161.0 39.26 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 119.36 -2.088 . . . . 0.02 110.117 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.418 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 19.8 p90 -152.27 152.4 32.12 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.051 -1.03 . . . . 2.02 110.809 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.428 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 26.0 mtp180 -144.49 149.92 36.75 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.38 -0.825 . . . . 0.01 110.155 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 60.4 mtm180 -87.76 144.1 26.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.535 -0.728 . . . . 0.01 109.363 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.2 mt -94.82 128.57 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.282 -0.886 . . . . 3.04 109.149 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.1 t -136.44 146.68 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.254 -0.903 . . . . 1.8899999999999999 109.65 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 4.8899999999999997 109.476 179.935 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.452 ' O ' ' O ' ' A' ' 2' ' ' LYS . 90.6 p . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.442 -0.577 . . . . 5.2800000000000002 109.442 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.523 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 3.1 mptp? 55.04 113.32 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.613 -0.68 . . . . 5.96 109.718 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.5 p -89.02 -139.37 0.13 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.19 -1.411 . . . . 2.2200000000000002 107.19 177.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.29 -175.81 46.06 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 117.406 -2.331 . . . . 0.81000000000000005 112.634 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.8 160.24 44.8 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.287 -1.525 . . . . 0.01 109.287 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -148.55 136.94 21.25 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.124 -1.221 . . . . 0.02 110.376 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 tt -130.66 140.55 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 109.073 -0.714 . . . . 0.02 109.073 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.1 m -121.78 130.82 53.69 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.4 -0.812 . . . . 0.39000000000000001 109.979 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.4 m-85 -110.6 140.54 44.82 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.624 -0.673 . . . . 0.02 109.38 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.516 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 5.1 m-85 -122.8 139.17 54.29 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.223 -0.923 . . . . 0.02 109.646 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.474 ' CG ' HD11 ' A' ' 33' ' ' LEU . 38.5 mt-10 -69.75 -27.77 65.21 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.167 -0.958 . . . . 0.029999999999999999 112.097 -178.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 2.9 m-20 -114.24 169.44 9.03 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.887 -1.133 . . . . 0.029999999999999999 110.225 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -75.04 157.81 34.22 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.69 0.757 . . . . 0.029999999999999999 109.982 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.2 t30 66.54 33.47 6.63 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.918 0.866 . . . . 0.73999999999999999 111.158 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 55.58 41.91 30.15 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.249 0.547 . . . . 0.02 111.413 177.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -112.86 165.75 12.02 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.244 -1.021 . . . . 0.02 108.244 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.48 -167.84 34.29 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.85 -1.167 . . . . 0.029999999999999999 110.677 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.579 ' CG ' HH11 ' A' ' 18' ' ' ARG . 0.3 OUTLIER -70.11 144.02 52.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.419 -1.047 . . . . 2.7599999999999998 108.999 179.453 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -120.2 148.63 43.43 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.559 -0.713 . . . . 1.8899999999999999 110.219 -178.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -131.99 127.31 35.99 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.221 -1.029 . . . . 0.02 108.221 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.46 136.9 51.4 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.42 -0.8 . . . . 1.1200000000000001 109.779 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.408 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 13.2 t -130.94 138.73 49.88 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.446 0.641 . . . . 0.02 109.654 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.3 p30 -116.77 11.23 14.48 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.631 -0.668 . . . . 0.20000000000000001 109.77 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.408 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 28.2 p -158.74 174.91 14.3 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.348 -0.982 . . . . 1.23 108.348 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -60.94 143.88 54.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.665 -1.272 . . . . 0.02 109.832 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 43.5 t -131.28 117.48 19.02 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.51 -0.922 . . . . 0.02 108.51 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.437 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -78.07 -25.08 47.52 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.045 -1.035 . . . . 0.23999999999999999 110.989 -178.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -155.1 102.38 2.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.025 -1.047 . . . . 1.1399999999999999 109.256 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -102.65 10.08 38.89 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 122.017 0.913 . . . . 6.3700000000000001 109.753 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -59.68 -25.41 64.73 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.532 -0.73 . . . . 3.1099999999999999 111.582 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.2 m -76.24 -17.15 59.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.522 -1.361 . . . . 0.88 110.609 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -104.06 -21.91 13.52 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.387 -0.82 . . . . 0.02 109.457 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.474 HD11 ' CG ' ' A' ' 11' ' ' GLU . 10.5 tp -149.92 128.56 12.36 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.328 -0.858 . . . . 3.3199999999999998 109.159 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.7 p -85.71 -10.96 54.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.642 -0.661 . . . . 0.02 111.069 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -171.72 162.3 6.23 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.927 -1.138 . . . . 0.02 107.927 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.2 p -141.48 113.95 8.24 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.987 -1.07 . . . . 0.02 108.452 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.17 0.17 27.1 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.767 -1.208 . . . . 0.029999999999999999 110.964 -178.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 m -154.44 155.65 35.34 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.669 -1.234 . . . . 0.02 107.669 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.5 mt -146.24 145.51 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.795 -1.19 . . . . 0.02 110.928 -178.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -124.09 124.84 43.4 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.874 -1.158 . . . . 0.02 107.874 177.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.6 t -105.16 114.03 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 106.745 -1.576 . . . . 0.02 106.745 177.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -84.7 -34.74 22.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.559 -0.713 . . . . 3.8100000000000001 110.101 -178.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.01 150.54 19.55 Favored Glycine 0 N--CA 1.488 2.128 0 C-N-CA 118.514 -1.803 . . . . 0.02 110.722 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.19 172.15 48.84 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 120.027 -1.082 . . . . 0.01 110.563 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.9 m -119.42 135.03 54.93 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 107.711 -1.218 . . . . 1.48 107.711 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.448 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 32.7 m95 -127.49 155.0 44.44 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 122.584 1.183 . . . . 0.02 112.462 -176.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.99 134.51 51.54 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 105.545 -2.02 . . . . 0.23999999999999999 105.545 176.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.475 ' HB ' HD22 ' A' ' 79' ' ' LEU . 28.7 m -119.03 143.63 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.585 -0.697 . . . . 0.65000000000000002 109.158 178.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -120.84 146.05 46.96 Favored 'General case' 0 N--CA 1.503 2.204 0 CA-C-O 122.143 0.973 . . . . 0.02 109.949 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -67.35 -34.59 77.62 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.839 -0.619 . . . . 0.02 111.392 -177.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -125.17 157.91 65.51 Favored Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 121.047 -1.033 . . . . 0.02 109.379 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -53.84 166.4 1.45 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 121.63 1.553 . . . . 0.02 113.242 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 63.9 36.66 10.05 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.218 -0.901 . . . . 0.02 111.116 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 45.36 51.68 9.35 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.667 0.746 . . . . 3.3900000000000001 110.633 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.7 m -126.11 163.64 22.66 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.13 0.491 . . . . 2.3300000000000001 109.714 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.8 -161.82 32.35 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.803 -1.319 . . . . 0.02 109.803 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -66.16 140.1 58.18 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.081 -1.247 . . . . 0.02 110.314 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.452 ' C ' ' SD ' ' A' ' 58' ' ' MET . 10.4 tmm? -119.37 136.81 54.1 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.76 -0.588 . . . . 5.0099999999999998 109.639 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.447 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 97.9 m-85 -133.98 138.35 45.37 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.393 -0.817 . . . . 0.02 109.935 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.3 mm -96.23 132.17 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 109.205 -0.665 . . . . 1.72 109.205 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.448 HD22 ' CE1' ' A' ' 66' ' ' TYR . 10.1 mt -120.35 111.6 34.96 Favored Pre-proline 0 N--CA 1.505 2.288 0 O-C-N 121.413 -0.804 . . . . 0.02 110.897 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -77.72 169.72 20.32 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 CA-C-N 119.79 0.961 . . . . 1.47 110.042 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -53.14 140.89 24.57 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.745 -1.222 . . . . 4.25 110.458 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.96 -178.05 31.88 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.505 -1.331 . . . . 0.02 110.746 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -120.47 131.76 54.9 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.454 -1.027 . . . . 0.95999999999999996 109.822 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.448 ' CE1' HD22 ' A' ' 61' ' ' LEU . 81.9 m-85 -121.11 94.98 48.91 Favored Pre-proline 0 N--CA 1.494 1.725 0 N-CA-C 108.094 -1.076 . . . . 0.02 108.094 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.402 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 3.4 Cg_exo -66.11 -4.65 10.71 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 120.829 1.019 . . . . 0.02 113.641 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 77.7 mt-10 -157.64 155.27 29.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.818 -1.176 . . . . 2.02 108.306 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -61.21 -38.53 86.92 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.371 -0.831 . . . . 0.02 112.08 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -59.95 -23.44 63.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.971 -1.081 . . . . 0.02 110.191 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -70.55 -19.38 62.89 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.706 0.765 . . . . 3.4199999999999999 109.09 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.542 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 1.6 t90 -108.37 9.08 27.82 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.627 -1.249 . . . . 0.02 107.627 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 10.3 mtt 60.94 22.22 12.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.649 -0.657 . . . . 0.02 110.53 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.65 143.44 44.76 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.494 -1.443 . . . . 0.02 109.494 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 26.8 tp -78.96 -31.64 45.1 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.387 -1.338 . . . . 0.97999999999999998 107.387 177.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -157.87 -172.31 3.88 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 106.191 -1.781 . . . . 0.02 106.191 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -98.67 28.46 4.24 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.591 -1.318 . . . . 0.02 110.805 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 -96.94 122.05 39.49 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.779 -1.201 . . . . 3.2000000000000002 110.997 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.475 HD22 ' HB ' ' A' ' 48' ' ' VAL . 63.9 mt -144.03 122.19 12.2 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 107.627 -1.249 . . . . 2.6099999999999999 107.627 178.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.55 -16.41 11.0 Favored Glycine 0 N--CA 1.504 3.211 0 O-C-N 121.279 -0.888 . . . . 0.02 112.741 -177.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 23.5 m -156.69 156.32 33.23 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.245 -1.738 . . . . 0.02 110.445 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 25.1 t -144.03 146.89 33.17 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.574 -0.704 . . . . 0.02 110.027 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -138.47 143.6 39.69 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.174 -0.954 . . . . 0.01 109.691 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.86 132.78 36.18 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.282 -0.886 . . . . 0.42999999999999999 110.001 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.6 t -92.18 126.14 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 109.363 -0.606 . . . . 1.25 109.363 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -94.48 130.92 40.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.741 -1.224 . . . . 1.77 109.379 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.7 mt -97.7 142.69 29.18 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.384 -0.823 . . . . 1.6299999999999999 109.07 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 51.7 p -113.33 126.41 55.35 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.331 -0.855 . . . . 1.0800000000000001 109.422 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 90' ' ' GLY . 54.5 m -108.15 9.33 28.24 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 106.766 -1.568 . . . . 1.26 106.766 176.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 89' ' ' SER . . . -26.35 -49.83 0.05 OUTLIER Glycine 0 N--CA 1.495 2.583 0 CA-C-N 115.54 -0.755 . . . . 0.01 112.528 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.76 -105.89 0.19 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 118.724 -1.703 . . . . 0.01 111.737 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.428 ' C ' ' NE2' ' A' ' 92' ' ' GLN . 0.8 OUTLIER -122.07 120.47 34.4 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.125 -1.221 . . . . 4.4299999999999997 110.434 -178.317 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.48 129.28 34.41 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.893 -0.723 . . . . 2.9900000000000002 109.637 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -130.57 143.02 50.48 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 108.605 -0.887 . . . . 6.3600000000000003 108.605 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.405 ' C ' ' NE2' ' A' ' 96' ' ' GLN . 4.7 tt -129.35 145.22 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 121.151 -0.968 . . . . 1.0900000000000001 110.708 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.629 ' N ' ' NE2' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -122.93 133.26 54.4 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 107.599 -1.26 . . . . 2.0499999999999998 107.599 177.296 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.48 HG12 ' SG ' ' A' ' 129' ' ' CYS . 17.5 m -124.26 146.2 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 O-C-N 120.658 -1.276 . . . . 1.1000000000000001 109.826 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.584 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 71.7 m-85 -118.83 141.09 48.96 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.939 0.876 . . . . 0.72999999999999998 110.862 -178.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -66.09 -30.13 70.59 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 116.09 -0.504 . . . . 0.02 111.572 -178.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -117.3 170.88 8.35 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.024 -1.047 . . . . 3.1800000000000002 110.247 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.41 169.88 43.21 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.862 -0.895 . . . . 0.01 110.862 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 52.92 38.95 28.3 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.501 0.667 . . . . 0.01 111.663 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 52.25 48.93 21.64 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.495 -0.753 . . . . 0.01 111.022 178.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -123.42 165.95 16.19 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.311 -0.996 . . . . 3.1499999999999999 108.311 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.02 -164.36 28.58 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.538 -1.425 . . . . 0.01 109.538 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -76.38 144.97 39.73 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.942 -1.328 . . . . 0.01 108.569 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.584 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 28.3 ttp -117.09 142.65 46.72 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.637 0.732 . . . . 0.01 110.028 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -131.15 137.07 48.85 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.067 -1.086 . . . . 2.48 108.067 178.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -118.3 133.76 55.61 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.611 -0.681 . . . . 0.01 110.153 -178.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.4 ' O ' HG22 ' A' ' 95' ' ' ILE . 5.2 t -148.6 148.61 30.33 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.284 1.04 . . . . 1.6899999999999999 111.061 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 31.2 p -111.38 9.7 21.51 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 115.435 -0.802 . . . . 0.01 110.26 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -121.2 163.01 19.17 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.204 -0.935 . . . . 3.21 111.479 -178.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.05 156.27 37.75 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.645 -0.872 . . . . 0.01 108.645 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 23.9 t -127.7 114.15 20.82 Favored Pre-proline 0 N--CA 1.5 2.032 0 N-CA-C 108.795 -0.817 . . . . 0.01 108.795 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -74.59 -29.0 9.45 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 CA-C-N 120.364 1.166 . . . . 0.01 111.07 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 65.3 m -142.58 108.94 5.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.41 -0.806 . . . . 0.02 108.954 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.41 HD12 ' O ' ' A' ' 169' ' ' ILE . 92.1 mt -63.54 -38.64 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.936 -0.477 . . . . 1.8300000000000001 110.674 -178.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 118' ' ' MET . 12.2 tmm? -68.32 -37.23 80.35 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.31 -0.956 . . . . 1.3400000000000001 110.048 -178.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -69.54 -38.54 77.52 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.578 -1.326 . . . . 2.1099999999999999 110.074 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.452 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 50.5 tt0 -79.82 -46.84 16.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.279 -0.888 . . . . 2.0800000000000001 112.333 -177.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.452 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 32.5 m-85 -111.0 0.01 16.83 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.379 -0.826 . . . . 0.02 112.712 -176.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 59.93 33.44 21.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.774 -1.204 . . . . 0.02 109.433 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 11.0 mt -112.52 135.81 52.78 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 108.77 -0.826 . . . . 0.02 108.77 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -91.8 -22.68 20.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.198 -0.939 . . . . 5.3200000000000003 110.361 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -149.64 164.08 36.15 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.169 -0.957 . . . . 0.02 109.981 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.2 mt -132.1 128.92 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 107.751 -1.203 . . . . 2.1699999999999999 107.751 178.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -108.54 -11.91 15.06 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.343 -0.848 . . . . 0.02 112.278 -177.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.4 m -159.1 151.73 21.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.948 -1.095 . . . . 0.01 108.765 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.48 ' SG ' HG12 ' A' ' 97' ' ' VAL . 8.2 t -165.38 149.01 8.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.107 -0.996 . . . . 1.22 109.157 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.415 ' O ' ' OE1' ' A' ' 96' ' ' GLN . 7.2 ttpt -119.49 108.24 14.28 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 122.339 1.066 . . . . 1.4099999999999999 109.28 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.2 t -113.52 127.15 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.555 -1.276 . . . . 0.01 107.555 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.9 t -131.42 94.18 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 107.632 -1.247 . . . . 1.98 107.632 177.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.642 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 26.7 tt0 -147.46 -77.2 0.17 Allowed 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 105.772 -1.936 . . . . 0.01 105.772 177.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 170.64 -63.59 0.17 Allowed Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.737 -1.745 . . . . 0.01 108.737 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.8 p -123.33 113.2 18.54 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.497 -1.002 . . . . 2.2999999999999998 110.846 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.642 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 9.8 m95 -126.07 147.15 49.65 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 107.335 -1.358 . . . . 0.01 107.335 178.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.5 mt -121.86 136.2 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 O-C-N 120.568 -1.332 . . . . 1.6899999999999999 110.248 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -116.17 145.28 43.21 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.339 -1.356 . . . . 2.4900000000000002 107.339 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.5 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 15.2 m-85 -123.21 143.75 49.83 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.311 -0.868 . . . . 0.02 109.722 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -74.59 -29.31 61.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.523 -0.735 . . . . 0.02 111.74 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.4 mt -115.78 154.9 48.16 Favored Pre-proline 0 N--CA 1.503 2.212 0 O-C-N 120.697 -1.252 . . . . 1.48 109.054 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -56.06 166.9 2.75 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 121.123 1.215 . . . . 0.02 112.802 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.2 m120 59.79 31.24 20.69 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.043 -0.98 . . . . 0.75 111.437 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.446 ' HD1' ' HG ' ' A' ' 171' ' ' SER . 1.9 m-85 57.68 51.62 9.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.513 -0.742 . . . . 0.02 111.141 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 41.2 mtm180 -127.1 164.91 20.55 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.531 -0.73 . . . . 0.02 110.241 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.74 -165.67 33.64 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.538 -1.025 . . . . 0.02 110.538 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -69.25 142.33 54.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.539 -0.977 . . . . 0.02 108.98 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -113.64 148.33 36.47 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.834 -0.541 . . . . 0.02 110.344 -178.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -124.23 133.56 53.49 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 108.853 -0.795 . . . . 0.01 108.853 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.477 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.2 tt -100.22 122.47 43.08 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.06 -1.025 . . . . 0.01 109.231 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.477 ' N ' HD23 ' A' ' 150' ' ' LEU . 2.6 mp -98.12 147.03 24.98 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.235 -1.024 . . . . 0.01 108.235 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -105.06 -121.08 0.22 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.627 -0.671 . . . . 2.27 110.009 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -139.28 53.32 1.73 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.229 -0.919 . . . . 1.8400000000000001 109.401 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -116.38 -172.35 2.17 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.406 -0.809 . . . . 2.2799999999999998 109.195 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -105.55 109.51 21.51 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.39 -0.967 . . . . 0.01 108.39 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.606 ' CG ' ' NE1' ' A' ' 162' ' ' TRP . 35.9 m-85 -98.58 111.36 23.75 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.239 -0.913 . . . . 0.01 110.575 -178.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -95.65 -22.22 17.71 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.21 -0.931 . . . . 0.01 111.298 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 39.6 mttp -127.51 154.59 77.49 Favored Pre-proline 0 N--CA 1.502 2.153 0 O-C-N 121.142 -0.974 . . . . 2.54 108.656 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -59.59 -39.05 78.27 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 120.423 0.748 . . . . 0.69999999999999996 110.596 178.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.99 -20.08 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.895 -1.128 . . . . 0.85999999999999999 109.079 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -65.33 -15.48 62.59 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.946 -1.096 . . . . 0.02 110.134 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.606 ' NE1' ' CG ' ' A' ' 156' ' ' TYR . 9.6 m0 -97.55 11.85 35.47 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.245 -0.909 . . . . 0.02 108.94 178.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.14 10.07 85.92 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.767 -1.206 . . . . 0.02 111.089 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.03 141.08 32.23 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.193 -1.181 . . . . 0.02 110.073 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.12 -8.95 58.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.654 -0.654 . . . . 0.58999999999999997 109.797 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.3 p -143.59 150.74 51.88 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 121.044 -1.035 . . . . 0.87 108.924 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -76.04 18.74 0.63 Allowed 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 120.704 0.936 . . . . 0.38 112.3 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.859 ' O ' HD13 ' A' ' 169' ' ' ILE . . . -83.07 122.24 28.09 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.824 -1.173 . . . . 0.17999999999999999 111.321 -178.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.859 HD13 ' O ' ' A' ' 168' ' ' ALA . 4.1 mm -146.54 126.82 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 106.521 -1.659 . . . . 3.9900000000000002 106.521 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -112.16 -18.09 12.65 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.955 -1.091 . . . . 5.1699999999999999 113.405 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.446 ' HG ' ' HD1' ' A' ' 144' ' ' TYR . 1.6 p -157.49 160.67 38.49 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 119.196 -2.19 . . . . 0.02 110.179 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.411 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 21.0 p90 -151.45 152.26 32.78 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.069 -1.019 . . . . 2.02 110.481 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -145.26 150.67 37.09 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.857 0.837 . . . . 0.01 110.393 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -89.11 145.24 25.58 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.138 -0.69 . . . . 0.01 109.138 178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 175' ' ' ILE . 5.1 mt -95.85 129.81 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.399 -0.813 . . . . 3.04 108.89 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 25.4 m -137.76 147.63 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.088 -1.007 . . . . 1.8899999999999999 109.912 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.371 -0.831 . . . . 4.8899999999999997 109.366 179.479 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 81.7 p . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.471 -0.566 . . . . 5.2800000000000002 109.471 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -154.19 116.57 4.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.203 -0.936 . . . . 5.96 109.226 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.415 ' OG1' ' N ' ' A' ' 4' ' ' GLY . 3.4 t -89.44 -139.72 0.13 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.282 -1.377 . . . . 2.2200000000000002 107.282 177.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.415 ' N ' ' OG1' ' A' ' 3' ' ' THR . . . 175.14 -177.14 47.21 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 117.472 -2.299 . . . . 0.81000000000000005 112.765 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.88 159.61 44.0 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.706 -1.357 . . . . 0.01 109.706 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -144.13 133.57 23.32 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.226 -1.161 . . . . 0.02 110.538 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.4 tt -129.45 139.41 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.11 -1.07 . . . . 0.02 108.11 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.1 m -120.99 129.14 53.29 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.291 -0.88 . . . . 0.39000000000000001 110.103 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 9.1 m-85 -109.8 140.19 44.01 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.641 -0.874 . . . . 0.02 108.641 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.554 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.8 m-85 -121.9 138.09 54.53 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.334 -0.854 . . . . 0.02 109.446 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -68.69 -27.14 65.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -0.943 . . . . 0.029999999999999999 111.389 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.0 OUTLIER -114.56 170.12 8.55 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.992 -1.068 . . . . 0.029999999999999999 109.958 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -75.98 161.87 28.56 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.633 0.73 . . . . 0.029999999999999999 110.4 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 62.9 33.02 15.39 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.025 0.917 . . . . 0.73999999999999999 110.916 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 55.46 40.32 31.25 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.858 -0.61 . . . . 0.02 111.05 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -110.62 165.22 11.99 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.188 -1.041 . . . . 0.02 108.188 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.25 -167.91 34.67 Favored Glycine 0 N--CA 1.497 2.708 0 O-C-N 120.907 -1.12 . . . . 0.029999999999999999 110.911 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.433 ' HG3' HH11 ' A' ' 18' ' ' ARG . 13.4 ttm-85 -69.95 143.46 52.65 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.471 -1.017 . . . . 2.7599999999999998 109.316 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.1 ttp180 -122.03 149.98 42.74 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.38 -0.825 . . . . 1.8899999999999999 110.431 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.49 ' CZ ' ' CG ' ' A' ' 32' ' ' TYR . 9.4 t80 -135.14 131.35 36.73 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.811 -0.811 . . . . 0.02 108.811 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -111.7 137.08 50.08 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.458 -0.776 . . . . 1.1200000000000001 109.463 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 40.2 t -129.35 138.75 51.73 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 121.41 0.624 . . . . 0.02 109.629 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -117.7 11.9 13.8 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.545 -0.722 . . . . 0.20000000000000001 110.245 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.483 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 42.5 t -159.17 174.24 15.15 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.916 -1.115 . . . . 1.23 108.757 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.473 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 17.6 p30 -61.74 145.14 53.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.613 -1.304 . . . . 0.02 110.219 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.423 ' CB ' ' CZ ' ' A' ' 29' ' ' PHE . 0.6 OUTLIER -134.35 119.12 18.25 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.543 -0.91 . . . . 0.02 108.543 178.59 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.62 -19.73 57.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.557 -0.715 . . . . 0.23999999999999999 111.672 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -154.28 108.72 3.03 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.923 -1.111 . . . . 1.1399999999999999 111.005 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.423 ' CZ ' ' CB ' ' A' ' 26' ' ' CYS . 22.2 m-85 -96.01 5.88 50.16 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.283 -0.886 . . . . 6.3700000000000001 109.283 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -60.63 -30.7 70.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.282 -0.886 . . . . 3.1099999999999999 112.246 -176.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.5 m -78.72 -19.07 53.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.271 -1.518 . . . . 0.88 111.55 -178.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.49 ' CG ' ' CZ ' ' A' ' 20' ' ' TYR . 65.2 m-85 -107.06 -21.83 12.86 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.266 -0.896 . . . . 0.02 110.819 -178.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.415 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 6.1 tp -149.16 127.63 12.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.895 -1.128 . . . . 3.3199999999999998 109.793 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.9 m -86.56 -11.77 50.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.53 -0.731 . . . . 0.02 111.127 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.415 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 4.8 ptp180 -171.68 161.95 6.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.933 -1.105 . . . . 0.02 108.24 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -142.65 115.75 8.87 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.909 -1.119 . . . . 0.02 108.887 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -109.49 0.32 19.2 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.85 -1.156 . . . . 0.029999999999999999 111.458 -178.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.3 m -156.8 153.81 28.9 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.385 -0.969 . . . . 0.02 108.385 178.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.0 mt -146.2 147.16 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-O 122.325 1.06 . . . . 0.02 111.176 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -122.59 123.66 41.71 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.738 -1.208 . . . . 0.02 107.738 176.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.3 t -106.8 115.2 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 106.902 -1.518 . . . . 0.02 106.902 177.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -83.31 -33.85 25.85 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 120.068 -0.653 . . . . 3.8100000000000001 111.024 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.97 152.36 22.19 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 118.878 -1.63 . . . . 0.02 110.854 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.653 ' H ' ' NE2' ' A' ' 63' ' ' GLN . . . 83.59 173.24 49.59 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.66 -1.257 . . . . 0.01 110.418 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 65.6 m -119.6 135.16 54.92 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.033 -1.099 . . . . 1.48 108.033 178.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -127.31 155.98 42.68 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 122.639 1.209 . . . . 0.02 112.172 -176.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.51 134.57 51.73 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 105.527 -2.027 . . . . 0.23999999999999999 105.527 176.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.6 m -116.31 142.01 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.549 -0.719 . . . . 0.65000000000000002 109.306 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -120.53 143.32 48.64 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 122.056 0.931 . . . . 0.02 109.508 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.504 ' OE1' ' CE1' ' A' ' 57' ' ' HIS . 36.9 tt0 -65.67 -33.37 75.73 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.671 -0.695 . . . . 0.02 111.712 -177.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 35.8 mtm180 -124.85 157.8 65.0 Favored Pre-proline 0 N--CA 1.503 2.194 0 O-C-N 120.991 -1.068 . . . . 0.02 109.368 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -53.31 167.36 0.83 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.753 1.635 . . . . 0.02 112.634 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 63.02 36.2 12.58 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 115.254 -0.885 . . . . 0.02 111.273 178.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.509 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 5.5 m-85 45.28 51.11 9.53 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.707 0.765 . . . . 3.3900000000000001 110.706 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.8 m -125.54 163.57 22.41 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 121.2 0.524 . . . . 2.3300000000000001 109.802 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.44 -161.67 31.39 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.844 -1.302 . . . . 0.02 109.844 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.504 ' CE1' ' OE1' ' A' ' 50' ' ' GLU . 10.1 m80 -65.13 137.84 57.9 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.11 -1.229 . . . . 0.02 110.219 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.496 ' O ' ' SD ' ' A' ' 58' ' ' MET . 2.8 ppp? -118.68 137.49 53.28 Favored 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 121.357 0.599 . . . . 5.0099999999999998 109.553 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.473 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 81.6 m-85 -135.44 140.48 44.92 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.503 -0.748 . . . . 0.02 109.61 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.9 mm -95.19 131.05 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.607 -0.683 . . . . 1.72 109.164 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.531 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 1.0 OUTLIER -121.09 111.39 33.95 Favored Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 121.284 -0.885 . . . . 0.02 110.743 -178.284 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -77.27 169.02 22.07 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 CA-C-N 119.898 0.999 . . . . 1.47 110.371 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.653 ' NE2' ' H ' ' A' ' 44' ' ' GLY . 71.0 mt-30 -53.39 141.73 23.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.96 -1.087 . . . . 4.25 110.369 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.81 -177.7 31.96 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.523 -1.322 . . . . 0.02 110.755 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -120.21 131.56 55.02 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.464 -1.021 . . . . 0.95999999999999996 109.661 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.531 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 59.5 m-85 -122.41 97.62 44.75 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 108.022 -1.103 . . . . 0.02 108.022 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.404 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 3.4 Cg_endo -68.77 -3.26 10.94 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 120.745 0.963 . . . . 0.02 113.898 -178.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 79.2 mt-10 -157.64 155.2 29.65 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.433 -1.417 . . . . 2.02 108.281 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -60.69 -39.1 87.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.63 -0.669 . . . . 0.02 112.108 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -60.28 -23.47 64.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.058 -1.026 . . . . 0.02 110.32 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -69.82 -18.75 63.47 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.88 -0.785 . . . . 3.4199999999999999 108.88 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.589 ' CH2' HD21 ' A' ' 79' ' ' LEU . 1.7 t90 -107.95 10.95 28.29 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.464 -1.31 . . . . 0.02 107.464 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.3 mtt 61.21 22.49 12.82 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.476 0.655 . . . . 0.02 110.409 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.72 144.29 48.07 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.574 -1.41 . . . . 0.02 109.574 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.429 ' N ' HD12 ' A' ' 75' ' ' LEU . 9.3 mp -79.78 -29.95 40.52 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.708 -1.219 . . . . 0.97999999999999998 107.708 177.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -156.83 -171.17 3.56 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 106.342 -1.725 . . . . 0.02 106.342 178.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 23.0 p-10 -98.91 28.72 4.18 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.697 -1.252 . . . . 0.02 110.526 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -96.49 122.33 39.27 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.796 -1.19 . . . . 3.2000000000000002 111.057 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.589 HD21 ' CH2' ' A' ' 72' ' ' TRP . 78.1 mt -141.92 119.83 11.97 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.609 -1.256 . . . . 2.6099999999999999 107.609 178.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.51 -18.54 8.47 Favored Glycine 0 N--CA 1.499 2.853 0 O-C-N 121.245 -0.909 . . . . 0.02 112.809 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.509 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 12.6 t -156.0 156.48 34.54 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-N 120.324 2.062 . . . . 0.02 111.13 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 11.9 t -146.45 148.78 32.61 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.342 -0.849 . . . . 0.02 110.723 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.425 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 52.1 mtp180 -138.16 143.13 40.13 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.509 -0.745 . . . . 0.01 109.345 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.19 132.46 36.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.102 -0.998 . . . . 0.42999999999999999 109.938 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.9 t -91.12 125.01 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.571 -0.706 . . . . 1.25 109.139 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -93.97 131.89 38.97 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.877 -1.139 . . . . 1.77 109.079 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 mt -96.66 139.45 32.71 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.54 -0.911 . . . . 1.6299999999999999 108.54 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.1 p -111.8 127.88 55.94 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.362 -0.836 . . . . 1.0800000000000001 109.312 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.7 m -104.39 -153.97 0.49 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 106.492 -1.669 . . . . 1.26 106.492 176.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.33 -53.15 0.72 Allowed Glycine 0 N--CA 1.5 2.928 0 O-C-N 120.386 -1.446 . . . . 0.01 112.818 177.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.16 -101.65 0.16 Allowed Glycine 0 N--CA 1.491 2.337 0 C-N-CA 118.476 -1.821 . . . . 0.01 111.844 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -121.25 118.91 30.77 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.043 -1.269 . . . . 4.4299999999999997 110.569 -178.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.0 129.62 34.65 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.79 -0.764 . . . . 2.9900000000000002 109.349 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.449 ' CB ' ' NZ ' ' A' ' 94' ' ' LYS . 6.8 ttpm? -129.15 141.95 51.02 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.334 -0.854 . . . . 6.3600000000000003 109.09 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.3 tt -128.64 144.92 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 O-C-N 121.352 -0.842 . . . . 1.0900000000000001 110.237 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -122.67 134.02 54.49 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.911 -1.144 . . . . 2.0499999999999998 107.911 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.469 HG12 ' SG ' ' A' ' 129' ' ' CYS . 29.1 m -123.78 145.05 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 120.823 -1.173 . . . . 1.1000000000000001 110.051 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.572 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 47.5 m-85 -119.92 142.16 48.97 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-O 121.996 0.903 . . . . 0.72999999999999998 111.098 -178.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -67.53 -31.84 72.21 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 116.06 -0.518 . . . . 0.02 111.745 -178.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -115.62 167.44 10.9 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 120.811 -1.181 . . . . 3.1800000000000002 110.593 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.15 163.69 45.01 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.833 -0.907 . . . . 0.01 110.833 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 57.6 38.93 27.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.913 -0.757 . . . . 0.01 110.99 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 52.57 55.92 8.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.696 -0.627 . . . . 0.01 111.184 178.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -128.45 165.87 19.84 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.266 -1.013 . . . . 3.1499999999999999 108.266 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.17 -163.39 27.81 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.234 -1.547 . . . . 0.01 109.234 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 38.4 tp60 -76.29 144.5 40.23 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.965 -1.315 . . . . 0.01 108.656 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.572 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 29.5 ttp -116.68 141.8 47.73 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.638 0.733 . . . . 0.01 109.812 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -131.57 136.3 47.7 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.328 -0.99 . . . . 2.48 108.328 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.521 ' OE2' ' N ' ' A' ' 110' ' ' THR . 1.9 tm-20 -118.12 133.9 55.49 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.559 -0.713 . . . . 0.01 109.997 -178.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.521 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 6.2 t -148.09 148.89 31.14 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.106 -0.996 . . . . 1.6899999999999999 110.969 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 33.3 p -110.78 10.17 22.61 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 115.551 -0.75 . . . . 0.01 110.365 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -120.92 163.16 18.65 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.28 -0.888 . . . . 3.21 111.571 -178.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.06 156.67 36.9 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.255 -1.017 . . . . 0.01 108.255 178.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 19.8 t -125.92 112.53 24.53 Favored Pre-proline 0 N--CA 1.502 2.138 0 O-C-N 121.456 -0.778 . . . . 0.01 108.944 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -75.41 -31.63 5.56 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 120.133 1.083 . . . . 0.01 111.102 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 16.5 m -141.05 107.95 5.41 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.287 -0.883 . . . . 0.02 108.798 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.9 mt -63.36 -39.19 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.949 -0.469 . . . . 1.8300000000000001 110.74 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 118' ' ' MET . 1.7 tmt? -67.81 -37.18 81.64 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.416 -0.914 . . . . 1.3400000000000001 110.46 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -71.09 -39.26 72.23 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 120.464 -1.397 . . . . 2.1099999999999999 110.243 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -79.56 -46.7 16.83 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.239 -0.913 . . . . 2.0800000000000001 112.358 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -109.67 -0.11 18.74 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.34 -0.85 . . . . 0.02 112.531 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 58.85 32.03 21.84 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.687 -1.258 . . . . 0.02 108.865 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.7 mt -111.47 135.3 52.22 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.656 -0.868 . . . . 0.02 108.656 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -92.09 -23.4 19.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.158 -0.964 . . . . 5.3200000000000003 110.031 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -149.76 163.41 38.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.231 -0.918 . . . . 0.02 109.839 -178.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 45.6 mt -133.31 130.32 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 107.493 -1.299 . . . . 2.1699999999999999 107.493 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -107.83 -11.76 15.32 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.301 -0.875 . . . . 0.02 112.787 -177.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.9 m -158.98 152.7 23.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.734 -1.229 . . . . 0.01 108.82 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.469 ' SG ' HG12 ' A' ' 97' ' ' VAL . 9.2 t -167.65 147.67 5.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.121 -0.987 . . . . 1.22 109.123 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.442 ' NZ ' ' OE2' ' A' ' 155' ' ' GLU . 4.8 tptm -121.0 111.09 17.04 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 122.346 1.069 . . . . 1.4099999999999999 109.717 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.2 t -112.23 128.7 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.603 -1.258 . . . . 0.01 107.603 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.2 t -129.81 94.02 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 106.922 -1.51 . . . . 1.98 106.922 177.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -146.84 -78.57 0.17 Allowed 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 105.824 -1.917 . . . . 0.01 105.824 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 178.51 -75.14 0.07 OUTLIER Glycine 0 N--CA 1.485 1.951 0 N-CA-C 108.144 -1.982 . . . . 0.01 108.144 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.712 ' OG1' HD12 ' A' ' 175' ' ' ILE . 0.1 OUTLIER -121.22 120.55 35.51 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.654 -0.909 . . . . 2.2999999999999998 110.12 179.371 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -126.42 151.0 48.29 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 106.77 -1.567 . . . . 0.01 106.77 179.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 59.1 mt -121.41 135.13 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 120.552 -1.343 . . . . 1.6899999999999999 110.495 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.46 ' HB3' HD12 ' A' ' 169' ' ' ILE . 3.8 m-30 -111.03 142.73 42.79 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 106.269 -1.752 . . . . 2.4900000000000002 106.269 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -122.76 143.49 49.79 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.014 -1.054 . . . . 0.02 109.763 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -74.66 -29.66 61.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.409 -0.807 . . . . 0.02 111.869 -176.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.4 mt -116.1 155.04 48.55 Favored Pre-proline 0 N--CA 1.506 2.372 0 O-C-N 120.793 -1.192 . . . . 1.48 108.983 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -55.92 167.36 2.37 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.116 1.211 . . . . 0.02 112.843 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.448 ' ND2' ' N ' ' A' ' 143' ' ' ASN . 2.2 m120 59.31 30.44 20.16 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.035 -0.984 . . . . 0.75 111.211 178.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 58.06 51.43 8.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.484 -0.76 . . . . 0.02 111.055 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -125.97 164.88 19.84 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.546 -0.721 . . . . 0.02 109.863 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.432 ' O ' ' OE1' ' A' ' 148' ' ' GLN . . . 88.79 -166.06 33.84 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.093 -1.203 . . . . 0.02 110.093 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -69.25 142.62 54.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.55 -0.971 . . . . 0.02 108.97 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.474 ' CD ' ' N ' ' A' ' 148' ' ' GLN . 0.1 OUTLIER -114.58 148.38 38.12 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.315 0.579 . . . . 0.02 110.155 -178.155 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 149' ' ' TYR . 13.1 m-85 -124.48 135.32 53.12 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.66 -0.867 . . . . 0.01 108.66 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.458 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.5 tt -98.33 122.44 41.5 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.872 -1.143 . . . . 0.01 109.253 -178.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.3 mp -96.43 146.86 24.4 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.294 -0.879 . . . . 0.01 109.043 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -104.68 -124.71 0.22 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.348 -0.845 . . . . 2.27 109.418 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -146.49 47.7 1.19 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.177 -0.952 . . . . 1.8400000000000001 109.514 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -112.73 -161.26 0.75 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.543 -0.723 . . . . 2.2799999999999998 109.168 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.442 ' OE2' ' NZ ' ' A' ' 130' ' ' LYS . 4.1 mm-40 -107.02 104.72 14.45 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.579 -0.701 . . . . 0.01 109.154 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.609 ' CD2' ' CD1' ' A' ' 162' ' ' TRP . 55.3 m-85 -98.15 111.27 23.66 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.249 -0.907 . . . . 0.01 109.448 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -94.39 -22.51 18.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.042 -1.036 . . . . 0.01 111.268 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -127.59 154.42 77.62 Favored Pre-proline 0 N--CA 1.503 2.177 0 O-C-N 120.977 -1.077 . . . . 2.54 108.548 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -59.71 -36.83 90.67 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 CA-C-N 119.148 0.731 . . . . 0.69999999999999996 110.265 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 92.0 t -61.68 -19.78 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.975 -1.078 . . . . 0.85999999999999999 109.094 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -65.57 -15.78 63.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.963 -1.086 . . . . 0.02 110.267 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.609 ' CD1' ' CD2' ' A' ' 156' ' ' TYR . 6.1 m0 -98.6 11.75 37.44 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.175 -0.953 . . . . 0.02 108.986 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.67 10.37 85.27 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 119.861 -1.161 . . . . 0.02 111.207 178.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.63 141.09 32.88 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.179 -1.189 . . . . 0.02 110.072 -178.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.27 -9.32 57.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.627 -0.671 . . . . 0.58999999999999997 110.062 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 39.8 m -143.94 150.09 48.31 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 120.921 -1.112 . . . . 0.87 109.098 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -76.41 18.43 0.69 Allowed 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 120.876 1.05 . . . . 0.38 112.512 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.75 123.45 28.77 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.794 -1.192 . . . . 0.17999999999999999 111.698 -177.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.46 HD12 ' HB3' ' A' ' 138' ' ' PHE . 29.2 mm -148.52 127.96 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 106.77 -1.567 . . . . 3.9900000000000002 106.77 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -112.31 -15.93 13.06 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.137 -0.977 . . . . 5.1699999999999999 112.525 -178.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 22.9 t -157.89 160.67 37.9 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 119.459 -2.026 . . . . 0.02 109.858 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.422 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 18.0 p90 -151.12 152.93 34.08 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.18 -0.95 . . . . 2.02 110.113 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -145.0 150.26 36.59 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.192 -0.942 . . . . 0.01 110.408 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -88.81 144.8 25.99 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.925 -0.768 . . . . 0.01 108.925 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.712 HD12 ' OG1' ' A' ' 135' ' ' THR . 4.9 mt -96.22 130.13 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.354 -0.841 . . . . 3.04 109.398 178.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 24.7 t -136.13 146.77 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.315 -0.866 . . . . 1.8899999999999999 109.671 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.181 -0.949 . . . . 4.8899999999999997 109.454 179.953 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.6 p . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.296 0.57 . . . . 5.2800000000000002 109.494 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.9 mmtm -71.58 65.53 0.47 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 5.96 109.256 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.8 t -81.16 142.57 33.12 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.352 -0.981 . . . . 2.2200000000000002 108.352 178.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.82 179.02 48.49 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 118.271 -1.919 . . . . 0.81000000000000005 112.042 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.04 156.84 42.47 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.521 -1.432 . . . . 0.01 109.521 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.497 ' HZ1' HH21 ' A' ' 40' ' ' ARG . 26.0 ttpp -145.95 135.55 23.22 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.296 -1.12 . . . . 0.02 110.373 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.4 tt -129.63 139.1 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.02 -1.104 . . . . 0.02 108.02 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 m -120.61 129.25 53.66 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.35 -0.844 . . . . 0.39000000000000001 110.316 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.437 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.9 m-85 -110.76 140.78 44.86 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.852 -0.795 . . . . 0.02 108.852 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.557 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.9 m-85 -122.57 138.61 54.52 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.294 -0.879 . . . . 0.02 109.425 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -68.91 -27.21 65.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.121 -0.987 . . . . 0.029999999999999999 111.597 -178.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.3 m-20 -114.43 169.85 8.74 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.944 -1.098 . . . . 0.029999999999999999 109.995 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -75.02 161.91 29.04 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.617 0.722 . . . . 0.029999999999999999 110.262 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.592 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 11.4 t-20 62.45 35.11 14.97 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.892 0.853 . . . . 0.73999999999999999 110.634 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.592 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.7 p90 49.27 43.16 22.8 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.478 -0.783 . . . . 0.02 110.94 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -109.62 165.91 11.31 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.676 -1.231 . . . . 0.02 107.676 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.7 -167.71 35.35 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 119.707 -1.235 . . . . 0.029999999999999999 110.752 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.583 ' CG ' HH11 ' A' ' 18' ' ' ARG . 0.2 OUTLIER -69.62 143.28 53.3 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.408 -1.054 . . . . 2.7599999999999998 109.059 179.368 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -122.59 150.7 42.27 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.499 -0.75 . . . . 1.8899999999999999 110.244 -178.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.472 ' CE1' ' CE1' ' A' ' 29' ' ' PHE . 34.4 t80 -136.34 133.11 36.48 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.689 -0.632 . . . . 0.02 109.678 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 20.6 p-10 -110.74 136.63 49.52 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.389 -0.819 . . . . 1.1200000000000001 109.309 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 42.2 t -128.73 138.65 52.24 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.631 -0.668 . . . . 0.02 109.422 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.434 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 0.9 OUTLIER -118.93 11.4 12.53 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.477 -0.765 . . . . 0.20000000000000001 110.877 -179.406 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.491 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 8.0 p -159.31 173.84 15.68 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.644 -1.285 . . . . 1.23 109.305 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 22.8 p30 -62.13 145.22 53.97 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.684 -1.26 . . . . 0.02 110.361 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.553 ' CB ' ' CE2' ' A' ' 29' ' ' PHE . 51.2 t -134.49 118.44 17.34 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.529 -0.732 . . . . 0.02 109.046 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.81 -20.67 56.12 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.494 -0.754 . . . . 0.23999999999999999 111.515 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -155.45 104.78 2.41 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.851 -1.155 . . . . 1.1399999999999999 109.417 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.553 ' CE2' ' CB ' ' A' ' 26' ' ' CYS . 0.4 OUTLIER -101.82 9.03 41.11 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.321 -0.862 . . . . 6.3700000000000001 109.934 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -60.32 -27.18 67.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.391 -0.818 . . . . 3.1099999999999999 111.83 -177.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.3 t -77.89 -18.07 56.58 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.477 -1.389 . . . . 0.88 111.391 -178.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.551 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 8.3 m-85 -106.64 -21.08 13.16 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.306 -0.871 . . . . 0.02 110.561 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.9 tp -148.66 127.16 12.35 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.95 -1.094 . . . . 3.3199999999999998 109.472 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.3 t -87.53 -12.55 45.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.629 -0.669 . . . . 0.02 111.388 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -172.5 161.95 5.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.743 -1.223 . . . . 0.02 108.47 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.458 ' SG ' HD12 ' A' ' 79' ' ' LEU . 2.3 p -143.45 115.74 8.49 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.069 -1.02 . . . . 0.02 108.877 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.492 ' N ' HD22 ' A' ' 37' ' ' ASN . 1.5 m-80 -107.8 -0.41 21.65 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.812 -1.18 . . . . 0.029999999999999999 111.007 -178.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.3 m -155.08 153.58 31.11 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.829 -1.175 . . . . 0.02 107.829 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.7 mt -146.83 147.14 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 122.205 1.002 . . . . 0.02 110.778 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.497 HH21 ' HZ1' ' A' ' 6' ' ' LYS . 35.3 ttp180 -124.03 124.73 43.19 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.181 -1.044 . . . . 0.02 108.181 177.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.8 t -106.68 115.27 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 106.876 -1.527 . . . . 0.02 106.876 177.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.4 ' HG3' ' HZ2' ' A' ' 6' ' ' LYS . 18.2 mm-40 -83.88 -33.81 24.72 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.565 -0.709 . . . . 3.8100000000000001 110.952 -177.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.13 152.64 22.57 Favored Glycine 0 N--CA 1.49 2.272 0 C-N-CA 118.811 -1.661 . . . . 0.02 110.877 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.45 172.98 49.39 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.688 -1.244 . . . . 0.01 110.468 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.1 m -119.85 134.94 55.07 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 107.97 -1.122 . . . . 1.48 107.97 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.42 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 35.3 m95 -127.46 156.11 42.63 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 122.595 1.188 . . . . 0.02 112.212 -176.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.83 134.39 52.1 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 105.613 -1.995 . . . . 0.23999999999999999 105.613 176.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.462 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.7 m -117.09 142.6 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.53 -0.731 . . . . 0.65000000000000002 109.14 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -120.68 143.57 48.65 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 122.093 0.949 . . . . 0.02 109.66 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -65.05 -33.7 76.67 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.584 -0.735 . . . . 0.02 111.534 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -125.3 157.95 65.73 Favored Pre-proline 0 N--CA 1.503 2.21 0 O-C-N 121.029 -1.044 . . . . 0.02 109.425 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -53.49 167.36 0.92 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.688 1.592 . . . . 0.02 112.916 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.532 ' ND2' ' N ' ' A' ' 53' ' ' ASN . 0.9 OUTLIER 63.36 36.31 11.66 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.232 -0.895 . . . . 0.02 111.134 178.19 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.414 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 4.9 m-85 44.92 51.65 8.51 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.614 0.721 . . . . 3.3900000000000001 110.77 178.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.9 t -125.8 163.6 22.53 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.186 0.517 . . . . 2.3300000000000001 109.846 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.33 -161.86 31.67 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.892 -1.283 . . . . 0.02 109.892 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.4 ' CD2' ' H ' ' A' ' 57' ' ' HIS . 21.9 m-70 -65.54 139.03 58.43 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.038 -1.272 . . . . 0.02 110.245 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.495 ' O ' ' SD ' ' A' ' 58' ' ' MET . 2.6 ppp? -118.88 137.03 53.72 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.662 -0.649 . . . . 5.0099999999999998 109.802 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.452 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 90.8 m-85 -134.06 138.86 45.59 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.497 -0.752 . . . . 0.02 109.693 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.7 mm -95.76 131.17 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.123 -0.695 . . . . 1.72 109.123 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.489 HD22 ' CE1' ' A' ' 66' ' ' TYR . 9.3 mt -120.77 111.78 34.2 Favored Pre-proline 0 N--CA 1.506 2.335 0 O-C-N 121.41 -0.806 . . . . 0.02 110.929 -178.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -77.53 169.25 21.33 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 CA-C-N 119.868 0.989 . . . . 1.47 110.126 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -53.29 141.26 24.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.878 -1.139 . . . . 4.25 110.368 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.23 -177.94 32.16 Favored Glycine 0 N--CA 1.496 2.667 0 C-N-CA 119.54 -1.314 . . . . 0.02 110.825 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -120.25 131.7 55.04 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.433 -1.039 . . . . 0.95999999999999996 109.746 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.489 ' CE1' HD22 ' A' ' 61' ' ' LEU . 88.4 m-85 -121.08 95.82 48.65 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 108.041 -1.096 . . . . 0.02 108.041 178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -65.98 -4.7 10.62 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 120.761 0.974 . . . . 0.02 113.618 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -157.58 155.2 29.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.655 -1.278 . . . . 2.02 108.15 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -60.25 -38.6 83.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.576 -0.702 . . . . 0.02 112.029 -177.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -60.07 -23.42 63.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.142 -0.974 . . . . 0.02 110.293 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -70.79 -18.76 62.74 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.831 0.824 . . . . 3.4199999999999999 109.063 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.54 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 1.6 t90 -107.9 9.8 28.65 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.424 -1.324 . . . . 0.02 107.424 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.8 mtt 60.83 22.08 12.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.601 -0.687 . . . . 0.02 110.419 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.89 143.83 46.8 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.336 -1.506 . . . . 0.02 109.336 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.816 HD12 ' H ' ' A' ' 76' ' ' ASN . 0.2 OUTLIER -78.71 -28.88 45.14 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.609 -1.256 . . . . 0.97999999999999998 107.609 177.783 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.816 ' H ' HD12 ' A' ' 75' ' ' LEU . 65.6 m-80 -158.75 -171.69 3.52 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 106.286 -1.746 . . . . 0.02 106.286 178.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -98.53 29.01 3.85 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.642 -1.286 . . . . 0.02 110.472 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -97.86 122.77 41.37 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.974 -1.079 . . . . 3.2000000000000002 111.43 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.462 HD22 ' HB ' ' A' ' 48' ' ' VAL . 49.3 mt -142.28 119.53 11.5 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 107.232 -1.396 . . . . 2.6099999999999999 107.232 177.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.69 -18.6 9.94 Favored Glycine 0 N--CA 1.497 2.736 0 O-C-N 121.207 -0.933 . . . . 0.02 112.27 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.5 p -155.83 156.36 34.59 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 119.612 1.706 . . . . 0.02 110.839 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 20.5 p -146.14 148.47 32.62 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.453 -0.779 . . . . 0.02 110.529 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.414 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 50.5 mtp180 -138.55 143.12 39.3 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.473 -0.767 . . . . 0.01 109.327 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.28 132.16 36.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.128 -0.982 . . . . 0.42999999999999999 109.829 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.4 t -90.76 125.23 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.529 -0.732 . . . . 1.25 109.117 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -93.87 132.18 38.54 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.701 -1.249 . . . . 1.77 109.26 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.1 mt -97.31 139.96 32.49 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.805 -0.813 . . . . 1.6299999999999999 108.805 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.9 t -112.52 127.83 56.17 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.377 -0.827 . . . . 1.0800000000000001 109.465 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 77.8 p -104.26 -154.43 0.5 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 106.602 -1.629 . . . . 1.26 106.602 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 139.25 -52.53 0.72 Allowed Glycine 0 N--CA 1.501 3.003 0 O-C-N 120.356 -1.465 . . . . 0.01 113.111 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.8 -101.66 0.16 Allowed Glycine 0 N--CA 1.49 2.281 0 C-N-CA 118.413 -1.851 . . . . 0.01 112.095 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -121.35 119.17 31.37 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.133 -1.216 . . . . 4.4299999999999997 110.676 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.15 129.56 34.59 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.745 -0.782 . . . . 2.9900000000000002 109.403 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -129.76 143.09 50.64 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.383 -0.823 . . . . 6.3600000000000003 108.917 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.401 HG22 ' O ' ' A' ' 110' ' ' THR . 4.2 tt -128.84 145.0 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 O-C-N 121.292 -0.88 . . . . 1.0900000000000001 110.437 -178.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -122.25 134.08 54.69 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.58 -1.266 . . . . 2.0499999999999998 107.58 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.527 HG12 ' SG ' ' A' ' 129' ' ' CYS . 15.6 m -124.61 145.71 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 O-C-N 120.772 -1.205 . . . . 1.1000000000000001 109.914 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.587 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 64.4 m-85 -119.35 141.62 48.87 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 121.971 0.891 . . . . 0.72999999999999998 110.91 -178.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -67.23 -30.73 70.73 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 116.066 -0.515 . . . . 0.02 111.904 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.416 ' O ' ' OG ' ' A' ' 128' ' ' SER . 48.0 mttm -116.35 167.46 11.01 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.97 -1.082 . . . . 3.1800000000000002 110.492 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.52 164.02 42.37 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.899 -0.88 . . . . 0.01 110.899 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 56.77 38.85 29.77 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.628 0.727 . . . . 0.01 110.932 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 52.29 55.91 8.47 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.58 -0.7 . . . . 0.01 111.11 178.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -129.18 165.68 20.84 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.319 -0.993 . . . . 3.1499999999999999 108.319 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.23 -163.87 28.02 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.242 -1.543 . . . . 0.01 109.242 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -75.6 144.34 41.84 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.034 -1.274 . . . . 0.01 108.664 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.587 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 27.0 ttp -116.99 142.16 47.31 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.47 0.653 . . . . 0.01 109.859 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -131.72 136.61 47.76 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.127 -1.064 . . . . 2.48 108.127 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -117.96 134.3 55.09 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.495 -0.753 . . . . 0.01 110.08 -178.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.401 ' O ' HG22 ' A' ' 95' ' ' ILE . 7.5 t -148.45 149.42 31.67 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 122.276 1.036 . . . . 1.6899999999999999 111.119 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.5 p -110.51 10.25 23.16 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 115.45 -0.795 . . . . 0.01 110.304 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -121.36 163.45 18.65 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.155 -0.966 . . . . 3.21 111.826 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.5 156.64 36.17 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.142 -1.059 . . . . 0.01 108.142 178.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 21.9 t -126.51 113.17 23.04 Favored Pre-proline 0 N--CA 1.501 2.115 0 O-C-N 121.401 -0.812 . . . . 0.01 108.843 178.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -76.27 -31.21 4.82 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 CA-C-N 120.086 1.066 . . . . 0.01 111.516 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.6 m -141.42 108.05 5.35 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.264 -0.898 . . . . 0.02 109.006 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.88 -38.83 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.861 -0.524 . . . . 1.8300000000000001 110.876 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.1 ttt -68.16 -36.76 80.15 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.234 -0.986 . . . . 1.3400000000000001 110.384 -178.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -71.15 -39.08 72.14 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.421 -1.424 . . . . 2.1099999999999999 110.18 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -79.48 -47.41 15.67 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.236 -0.915 . . . . 2.0800000000000001 112.448 -176.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -110.25 0.85 18.28 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.405 -0.809 . . . . 0.02 112.517 -176.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.565 ' N ' ' ND1' ' A' ' 122' ' ' HIS . 1.2 m-70 59.11 32.36 22.07 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.815 -1.178 . . . . 0.02 109.269 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.3 mt -112.29 135.9 52.39 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 108.433 -0.951 . . . . 0.02 108.433 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -91.44 -22.73 20.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 5.3200000000000003 110.108 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -149.82 163.95 36.65 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.222 -0.924 . . . . 0.02 110.204 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 44.8 mt -132.21 129.34 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 107.434 -1.321 . . . . 2.1699999999999999 107.434 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -106.95 -12.08 15.54 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.318 -0.864 . . . . 0.02 112.457 -177.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 12.5 p -159.54 153.05 22.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.855 -1.153 . . . . 0.01 108.835 178.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.527 ' SG ' HG12 ' A' ' 97' ' ' VAL . 7.2 t -168.51 147.36 4.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.303 -0.873 . . . . 1.22 108.751 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.516 ' NZ ' ' OE1' ' A' ' 155' ' ' GLU . 26.1 tttp -121.1 111.64 17.7 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 122.422 1.106 . . . . 1.4099999999999999 109.561 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.3 t -112.52 129.06 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 107.352 -1.351 . . . . 0.01 107.352 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.2 t -129.48 92.93 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 107.267 -1.383 . . . . 1.98 107.267 177.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.514 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 4.1 tm-20 -147.85 -74.58 0.19 Allowed 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 105.683 -1.969 . . . . 0.01 105.683 177.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 157.55 -55.03 0.38 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.45 -1.46 . . . . 0.01 109.45 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 41.8 p -119.75 101.52 7.95 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.542 -0.975 . . . . 2.2999999999999998 111.446 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.514 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 11.4 m95 -129.51 144.54 51.3 Favored 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 107.516 -1.29 . . . . 0.01 107.516 178.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 97.6 mt -124.25 140.87 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 120.874 -1.141 . . . . 1.6899999999999999 110.486 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.409 ' HB3' HD12 ' A' ' 169' ' ' ILE . 72.5 m-85 -114.17 143.97 43.95 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.153 -1.425 . . . . 2.4900000000000002 107.153 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.498 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 11.8 m-85 -122.93 144.88 48.94 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.146 -0.971 . . . . 0.02 109.531 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -74.64 -29.53 61.3 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.532 -0.73 . . . . 0.02 111.97 -176.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.4 mt -115.82 154.79 48.2 Favored Pre-proline 0 N--CA 1.505 2.299 0 O-C-N 120.783 -1.198 . . . . 1.48 109.166 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -55.37 167.38 1.94 Allowed 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.219 1.279 . . . . 0.02 112.674 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 59.6 31.23 20.81 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.193 -0.912 . . . . 0.75 111.283 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 57.55 51.08 10.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.451 -0.781 . . . . 0.02 111.136 177.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -126.54 165.07 19.82 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.52 -0.737 . . . . 0.02 110.153 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.41 -166.21 33.06 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.285 -1.126 . . . . 0.02 110.285 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -68.68 142.59 55.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.606 -0.937 . . . . 0.02 108.898 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -114.53 148.95 37.19 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.336 0.588 . . . . 0.02 109.932 -178.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -124.48 134.65 52.98 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.824 -0.806 . . . . 0.01 108.824 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.1 tt -98.23 121.32 40.02 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.737 -1.227 . . . . 0.01 108.728 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.716 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 59.6 tp -95.47 155.28 16.81 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.247 -0.908 . . . . 0.01 109.171 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -105.46 -117.88 0.23 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.295 -0.878 . . . . 2.27 109.374 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -156.97 44.6 0.38 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.049 -1.032 . . . . 1.8400000000000001 109.671 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -112.35 -156.06 0.58 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.459 -0.776 . . . . 2.2799999999999998 109.289 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.516 ' OE1' ' NZ ' ' A' ' 130' ' ' LYS . 77.9 mm-40 -106.94 106.24 16.67 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.442 -0.786 . . . . 0.01 109.141 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.716 ' CZ ' HD11 ' A' ' 151' ' ' LEU . 5.2 m-85 -98.97 111.51 23.89 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.341 -0.849 . . . . 0.01 109.531 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -94.7 -22.29 18.22 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.184 -0.947 . . . . 0.01 111.566 -177.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -128.15 154.16 78.69 Favored Pre-proline 0 N--CA 1.503 2.176 0 O-C-N 120.875 -1.141 . . . . 2.54 108.708 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -59.4 -37.19 91.46 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 CA-C-N 119.286 0.781 . . . . 0.69999999999999996 110.64 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 85.3 t -61.25 -19.76 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.795 -1.191 . . . . 0.85999999999999999 109.146 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -65.32 -15.32 62.41 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.952 -1.093 . . . . 0.02 109.996 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.638 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 8.5 m0 -98.13 11.71 36.83 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.19 -0.944 . . . . 0.02 109.102 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 81.11 10.46 84.85 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.934 -1.127 . . . . 0.02 111.341 178.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.09 140.64 32.94 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.031 -1.276 . . . . 0.02 110.206 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.73 -9.54 56.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.608 -0.683 . . . . 0.58999999999999997 109.978 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.1 m -142.02 150.49 56.2 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.181 -0.949 . . . . 0.87 109.134 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -76.61 16.53 0.9 Allowed 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 120.741 0.96 . . . . 0.38 112.47 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.65 122.72 27.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.649 -1.282 . . . . 0.17999999999999999 111.198 -177.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.409 HD12 ' HB3' ' A' ' 138' ' ' PHE . 15.2 mm -151.81 126.39 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 106.595 -1.631 . . . . 3.9900000000000002 106.595 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 64.1 mm-40 -113.57 -12.9 12.82 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.081 -1.012 . . . . 5.1699999999999999 113.634 -177.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.0 p -157.6 162.05 38.71 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 119.083 -2.261 . . . . 0.02 110.235 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.426 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 16.9 p90 -151.97 151.98 31.89 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.132 -0.98 . . . . 2.02 110.633 179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -145.0 149.66 35.53 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.304 -0.872 . . . . 0.01 109.991 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -88.52 144.29 26.43 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.512 -0.742 . . . . 0.01 109.439 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.4 mt -93.67 129.55 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.233 -0.917 . . . . 3.04 109.092 178.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 14.5 t -137.1 147.4 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.248 -0.907 . . . . 1.8899999999999999 109.676 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.35 -0.844 . . . . 4.8899999999999997 109.39 179.815 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.313 0.578 . . . . 5.2800000000000002 109.479 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -151.53 64.93 0.87 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.219 -0.926 . . . . 5.96 109.36 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.6 t -80.89 142.82 33.21 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.39 -0.967 . . . . 2.2200000000000002 108.39 178.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.23 179.33 48.17 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 118.289 -1.91 . . . . 0.81000000000000005 112.043 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.92 157.11 43.03 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.416 -1.474 . . . . 0.01 109.416 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -146.18 135.18 22.58 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.363 -1.081 . . . . 0.02 110.603 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.3 tt -129.44 139.6 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.108 -1.071 . . . . 0.02 108.108 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 m -120.45 129.55 53.93 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.326 -0.859 . . . . 0.39000000000000001 110.208 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 6.2 m-85 -110.34 139.89 45.08 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 109.026 -0.731 . . . . 0.02 109.026 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.561 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.2 m-85 -121.28 137.99 54.44 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.135 -0.978 . . . . 0.02 109.299 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -69.71 -27.59 65.11 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.096 -1.003 . . . . 0.029999999999999999 111.531 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -113.68 169.54 8.91 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.932 -1.105 . . . . 0.029999999999999999 110.067 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -75.37 157.41 34.28 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.66 0.743 . . . . 0.029999999999999999 110.401 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.546 ' N ' ' ND2' ' A' ' 14' ' ' ASN . 0.6 OUTLIER 66.31 33.95 6.77 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.768 0.794 . . . . 0.73999999999999999 111.297 178.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 55.41 41.23 31.24 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.247 0.546 . . . . 0.02 111.335 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -113.13 165.61 12.22 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.152 -1.055 . . . . 0.02 108.152 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.09 -167.01 35.72 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.758 -1.211 . . . . 0.029999999999999999 110.757 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.569 ' CG ' HH11 ' A' ' 18' ' ' ARG . 0.0 OUTLIER -68.59 141.57 55.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.502 -0.999 . . . . 2.7599999999999998 109.275 179.553 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -121.96 150.1 42.52 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.629 -0.67 . . . . 1.8899999999999999 109.842 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -137.96 133.95 34.33 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.559 -0.713 . . . . 0.02 109.677 178.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -109.26 135.77 49.8 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.327 -0.858 . . . . 1.1200000000000001 108.886 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.6 t -127.16 137.98 53.06 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.55 -0.719 . . . . 0.02 109.125 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.5 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 4.1 p30 -118.62 11.72 12.91 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.644 -0.66 . . . . 0.20000000000000001 110.611 -179.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 25.5 m -158.88 174.26 15.26 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.664 -1.272 . . . . 1.23 108.948 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.454 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 2.3 m-20 -62.2 145.98 52.04 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.756 -1.215 . . . . 0.02 110.418 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 18.0 m -134.04 117.05 16.22 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.779 -0.822 . . . . 0.02 108.779 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.12 -20.48 52.07 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.369 -0.832 . . . . 0.23999999999999999 111.911 -177.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -151.16 106.14 3.3 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.57 -1.331 . . . . 1.1399999999999999 109.547 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.61 5.04 43.8 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.436 -0.79 . . . . 6.3700000000000001 110.276 -178.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -61.22 -28.36 69.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 3.1099999999999999 112.204 -177.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.5 t -79.12 -18.7 52.74 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.262 -1.523 . . . . 0.88 111.779 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -105.75 -21.82 13.09 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.138 -0.976 . . . . 0.02 110.682 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 33' ' ' LEU . 50.9 mt -148.88 128.31 13.05 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.032 -1.043 . . . . 3.3199999999999998 109.109 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.2 t -86.1 -11.11 53.58 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.676 -0.64 . . . . 0.02 110.385 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -172.84 162.26 4.78 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.147 -1.056 . . . . 0.02 108.147 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 24.9 m -144.03 116.32 8.5 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.064 -1.022 . . . . 0.02 108.632 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.421 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 17.9 t-20 -108.84 0.46 20.32 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 120.822 -1.174 . . . . 0.029999999999999999 111.673 -177.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.2 t -155.87 153.51 29.83 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.048 -1.093 . . . . 0.02 108.048 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.7 mt -146.9 147.37 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.069 -1.019 . . . . 0.02 110.871 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -123.65 124.56 43.03 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.154 -1.054 . . . . 0.02 108.154 177.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.7 t -106.32 115.0 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 106.917 -1.512 . . . . 0.02 106.917 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -83.32 -33.8 25.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.448 -0.782 . . . . 3.8100000000000001 110.728 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.48 152.09 21.93 Favored Glycine 0 N--CA 1.488 2.11 0 C-N-CA 118.883 -1.627 . . . . 0.02 110.82 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.04 173.18 49.62 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.655 -1.259 . . . . 0.01 110.708 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.2 m -119.32 134.88 54.98 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.011 -1.107 . . . . 1.48 108.011 177.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -126.75 155.51 42.64 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 122.587 1.185 . . . . 0.02 112.214 -176.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.39 134.02 52.35 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 105.631 -1.989 . . . . 0.23999999999999999 105.631 176.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.416 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.3 m -118.86 143.76 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.561 -0.712 . . . . 0.65000000000000002 109.083 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -120.99 145.72 47.45 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 122.222 1.01 . . . . 0.02 110.079 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -65.92 -33.8 76.66 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.805 -0.634 . . . . 0.02 111.052 -177.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -125.17 157.7 66.3 Favored Pre-proline 0 N--CA 1.503 2.21 0 O-C-N 121.092 -1.005 . . . . 0.02 109.416 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.47 166.95 1.01 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.714 1.61 . . . . 0.02 113.119 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.519 ' ND2' ' N ' ' A' ' 53' ' ' ASN . 1.0 OUTLIER 63.73 36.4 10.66 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.198 -0.91 . . . . 0.02 111.123 178.219 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 45.19 51.71 9.01 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.576 0.703 . . . . 3.3900000000000001 110.804 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.4 t -126.03 163.44 23.05 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.137 0.494 . . . . 2.3300000000000001 109.857 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.18 -161.62 31.69 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.761 -1.335 . . . . 0.02 109.761 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -64.88 138.97 58.7 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.102 -1.234 . . . . 0.02 110.029 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 14.6 ptm -119.06 137.18 53.73 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.674 -0.641 . . . . 5.0099999999999998 109.524 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.581 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 89.8 m-85 -134.03 138.46 45.38 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.422 -0.798 . . . . 0.02 109.836 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.1 mm -95.24 131.45 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.058 -0.719 . . . . 1.72 109.058 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.467 HD22 ' CE1' ' A' ' 66' ' ' TYR . 12.2 mt -121.0 111.45 34.06 Favored Pre-proline 0 N--CA 1.504 2.244 0 O-C-N 121.411 -0.806 . . . . 0.02 110.812 -178.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -77.11 169.55 21.3 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 CA-C-N 119.867 0.988 . . . . 1.47 109.853 177.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -52.6 141.31 20.91 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.766 -1.208 . . . . 4.25 110.338 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.38 -177.76 32.39 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.621 -1.276 . . . . 0.02 110.692 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -120.48 131.83 54.92 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.432 -1.04 . . . . 0.95999999999999996 109.774 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.467 ' CE1' HD22 ' A' ' 61' ' ' LEU . 92.6 m-85 -121.49 98.68 46.02 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 108.15 -1.056 . . . . 0.02 108.15 179.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -70.39 -3.66 12.88 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 120.861 1.041 . . . . 0.02 113.813 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -157.55 154.46 28.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.824 -1.172 . . . . 2.02 108.141 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -60.46 -38.85 85.5 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.557 -0.715 . . . . 0.02 111.929 -177.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -59.79 -23.71 63.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.916 -1.115 . . . . 0.02 110.272 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -70.68 -18.68 62.83 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.924 0.869 . . . . 3.4199999999999999 108.763 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.581 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.2 t90 -107.96 9.93 28.5 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.496 -1.298 . . . . 0.02 107.496 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 8.5 mtt 61.29 22.63 12.97 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.494 0.664 . . . . 0.02 110.503 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.52 144.41 45.81 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.762 -1.335 . . . . 0.02 109.762 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.545 HD23 ' O ' ' A' ' 75' ' ' LEU . 1.0 OUTLIER -79.63 -31.54 41.61 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.34 -1.356 . . . . 0.97999999999999998 107.34 177.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.605 ' ND2' ' H ' ' A' ' 77' ' ' ASP . 15.4 t30 -157.02 -171.43 3.64 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 106.317 -1.734 . . . . 0.02 106.317 178.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.605 ' H ' ' ND2' ' A' ' 76' ' ' ASN . 10.6 p30 -98.49 28.52 4.12 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.55 -1.344 . . . . 0.02 110.757 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -97.07 122.51 40.15 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.863 -1.148 . . . . 3.2000000000000002 110.974 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.503 HD21 ' CH2' ' A' ' 72' ' ' TRP . 75.0 mt -141.92 119.13 11.41 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.611 -1.255 . . . . 2.6099999999999999 107.611 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.73 -18.04 9.86 Favored Glycine 0 N--CA 1.499 2.875 0 O-C-N 121.211 -0.931 . . . . 0.02 112.524 -177.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.4 p -156.18 155.67 32.87 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 119.967 -1.902 . . . . 0.02 110.464 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 24.8 p -145.32 147.92 32.86 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.698 -0.626 . . . . 0.02 110.0 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 33.5 mtp180 -137.47 142.74 41.54 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.412 -0.805 . . . . 0.01 109.397 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.73 132.99 36.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 0.42999999999999999 109.862 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.6 t -91.97 124.86 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 109.027 -0.731 . . . . 1.25 109.027 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -94.36 132.1 39.33 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.706 -1.246 . . . . 1.77 109.238 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -96.33 139.77 31.98 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.672 -0.862 . . . . 1.6299999999999999 108.672 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.424 ' O ' ' OE2' ' A' ' 133' ' ' GLU . 87.8 p -111.47 128.02 55.87 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.345 -0.847 . . . . 1.0800000000000001 109.26 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.8 m -104.47 -154.18 0.5 Allowed 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 106.63 -1.618 . . . . 1.26 106.63 177.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.75 -52.7 0.74 Allowed Glycine 0 N--CA 1.5 2.965 0 O-C-N 120.399 -1.438 . . . . 0.01 112.737 177.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.17 -101.65 0.16 Allowed Glycine 0 N--CA 1.491 2.335 0 C-N-CA 118.467 -1.825 . . . . 0.01 111.953 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -121.61 118.86 30.25 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.122 -1.222 . . . . 4.4299999999999997 110.635 -178.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.5 129.85 34.85 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.836 -0.746 . . . . 2.9900000000000002 109.488 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -129.82 142.41 50.68 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.436 -0.79 . . . . 6.3600000000000003 109.058 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.435 ' O ' ' OE2' ' A' ' 109' ' ' GLU . 4.3 tt -128.81 144.56 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.344 -0.848 . . . . 1.0900000000000001 110.181 -179.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -121.52 134.16 55.04 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.541 -1.281 . . . . 2.0499999999999998 107.541 177.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.492 HG12 ' SG ' ' A' ' 129' ' ' CYS . 14.5 m -124.03 145.51 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 O-C-N 120.728 -1.232 . . . . 1.1000000000000001 109.903 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -119.05 141.4 48.76 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.983 0.896 . . . . 0.72999999999999998 110.851 -178.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -67.09 -30.64 70.73 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 116.065 -0.516 . . . . 0.02 111.812 -178.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -116.46 168.1 10.46 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.945 -1.097 . . . . 3.1800000000000002 110.473 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.2 163.92 44.86 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 111.044 -0.822 . . . . 0.01 111.044 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.5 t0 56.91 39.33 29.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.878 -0.778 . . . . 0.01 111.059 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 51.71 56.47 7.81 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.617 -0.677 . . . . 0.01 111.007 178.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -129.7 165.98 20.75 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.023 -1.103 . . . . 3.1499999999999999 108.023 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.24 -164.41 28.34 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.13 -1.588 . . . . 0.01 109.13 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -75.7 144.61 41.47 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.981 -1.305 . . . . 0.01 108.573 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.452 ' C ' ' SD ' ' A' ' 107' ' ' MET . 12.5 tmm? -116.25 142.21 47.14 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.634 0.73 . . . . 0.01 109.897 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.501 ' CD1' ' N ' ' A' ' 108' ' ' TYR . 8.0 m-85 -131.15 136.48 48.37 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.337 -0.986 . . . . 2.48 108.337 178.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.435 ' OE2' ' O ' ' A' ' 95' ' ' ILE . 5.2 tp10 -115.72 133.47 56.0 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.687 -0.633 . . . . 0.01 109.968 -178.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.9 t -148.47 147.95 29.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.021 -1.049 . . . . 1.6899999999999999 111.183 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.1 p -111.67 9.72 21.0 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 115.451 -0.795 . . . . 0.01 110.24 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 26.5 mp0 -121.39 163.5 18.6 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 121.238 -0.914 . . . . 3.21 111.72 -178.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -68.1 156.81 36.65 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.323 -0.991 . . . . 0.01 108.323 178.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.437 ' SG ' ' OE1' ' A' ' 120' ' ' GLN . 33.7 t -125.57 113.98 25.23 Favored Pre-proline 0 N--CA 1.502 2.142 0 O-C-N 121.531 -0.731 . . . . 0.01 109.23 178.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -75.27 -30.89 6.34 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 CA-C-N 120.245 1.123 . . . . 0.01 111.035 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.4 p -142.45 108.44 5.19 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.804 0.811 . . . . 0.02 109.0 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 73.1 mt -63.21 -38.35 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.839 -0.538 . . . . 1.8300000000000001 110.742 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 20.4 ttt -68.14 -36.53 79.83 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.121 -1.032 . . . . 1.3400000000000001 110.227 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -70.53 -38.75 74.27 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.514 -1.367 . . . . 2.1099999999999999 110.001 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.437 ' OE1' ' SG ' ' A' ' 114' ' ' CYS . 52.0 tt0 -79.61 -47.47 15.4 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.317 -0.865 . . . . 2.0800000000000001 112.471 -177.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -110.42 0.46 17.87 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.362 -0.837 . . . . 0.02 112.698 -176.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 59.28 32.99 22.37 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.761 -1.212 . . . . 0.02 109.067 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 mt -112.09 135.26 52.98 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 108.487 -0.931 . . . . 0.02 108.487 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -91.23 -22.28 20.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 5.3200000000000003 110.031 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -149.79 163.89 36.77 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.36 -0.838 . . . . 0.02 110.0 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 55.4 mt -131.33 128.47 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 107.474 -1.306 . . . . 2.1699999999999999 107.474 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -107.85 -12.16 15.24 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.412 -0.805 . . . . 0.02 112.36 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.3 m -159.16 152.17 22.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.887 -1.133 . . . . 0.01 108.99 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.492 ' SG ' HG12 ' A' ' 97' ' ' VAL . 10.9 t -168.86 146.87 3.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 1.22 108.795 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.3 tttp -120.6 112.45 18.93 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 122.422 1.106 . . . . 1.4099999999999999 109.515 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.3 t -113.46 129.52 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 107.821 -1.177 . . . . 0.01 107.821 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.9 t -129.72 92.97 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 106.936 -1.505 . . . . 1.98 106.936 177.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.584 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 9.4 tm-20 -147.16 -74.84 0.2 Allowed 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 105.829 -1.915 . . . . 0.01 105.829 177.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.422 ' N ' ' OE1' ' A' ' 133' ' ' GLU . . . 169.68 -69.64 0.15 Allowed Glycine 0 N--CA 1.482 1.723 0 N-CA-C 108.656 -1.777 . . . . 0.01 108.656 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.436 ' CB ' HD12 ' A' ' 175' ' ' ILE . 17.9 p -121.17 118.48 29.76 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.631 -0.923 . . . . 2.2999999999999998 110.569 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.584 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 8.4 m95 -128.1 148.55 50.58 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 107.063 -1.458 . . . . 0.01 107.063 178.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 89.9 mt -123.27 138.07 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 120.373 -1.454 . . . . 1.6899999999999999 110.491 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -114.96 144.11 44.09 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 107.553 -1.277 . . . . 2.4900000000000002 107.553 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.507 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 12.1 m-85 -123.02 143.94 49.6 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.235 -0.916 . . . . 0.02 109.592 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -75.06 -28.79 60.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.389 -0.82 . . . . 0.02 112.028 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 55.0 mt -115.28 151.82 46.23 Favored Pre-proline 0 N--CA 1.504 2.264 0 O-C-N 120.563 -1.335 . . . . 1.48 109.027 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -54.06 167.66 1.11 Allowed 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 120.906 1.071 . . . . 0.02 112.54 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 4.5 m120 59.12 30.18 19.9 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 115.164 -0.925 . . . . 0.75 111.19 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 57.94 51.39 9.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.4 -0.813 . . . . 0.02 111.469 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -125.84 164.13 21.39 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.398 -0.814 . . . . 0.02 109.951 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.38 -165.18 32.41 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.31 -1.116 . . . . 0.02 110.31 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -69.06 142.09 54.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.604 -0.939 . . . . 0.02 109.126 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -115.24 149.07 38.34 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.832 -0.543 . . . . 0.02 109.918 -178.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.534 ' CE1' ' O ' ' A' ' 162' ' ' TRP . 42.6 t80 -124.94 135.82 53.18 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 109.15 -0.685 . . . . 0.01 109.15 179.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.5 tt -98.45 120.88 39.63 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.941 -1.1 . . . . 0.01 108.808 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.507 ' N ' HD23 ' A' ' 150' ' ' LEU . 7.4 tt -98.51 149.74 22.41 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.139 -0.976 . . . . 0.01 108.857 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -104.93 -98.47 0.32 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.424 -0.798 . . . . 2.27 110.007 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 47.1 pttt -167.36 49.09 0.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.077 -1.014 . . . . 1.8400000000000001 109.515 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.575 ' CG ' ' H ' ' A' ' 155' ' ' GLU . 38.5 tttm -113.34 -175.58 2.7 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.984 -0.747 . . . . 2.2799999999999998 108.984 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.575 ' H ' ' CG ' ' A' ' 154' ' ' LYS . 84.6 mt-10 -100.25 109.5 21.72 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.197 -0.939 . . . . 0.01 108.693 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.675 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 30.2 m-85 -98.33 113.87 25.99 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.427 -0.795 . . . . 0.01 110.079 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -94.8 -22.48 18.03 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.23 -0.919 . . . . 0.01 111.614 -178.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -127.7 154.79 77.87 Favored Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 120.771 -1.206 . . . . 2.54 109.148 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -60.78 -38.94 66.9 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 120.489 0.793 . . . . 0.69999999999999996 110.443 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 96.8 t -60.94 -20.11 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.867 -1.146 . . . . 0.85999999999999999 108.821 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 43.2 t0 -65.68 -15.39 62.74 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.976 -1.078 . . . . 0.02 109.785 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.675 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 22.8 m0 -95.79 10.74 36.01 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.497 -0.927 . . . . 0.02 108.497 178.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 78.56 9.87 86.67 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.603 -1.284 . . . . 0.02 110.621 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.38 142.04 31.38 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.361 -1.082 . . . . 0.02 110.078 -178.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.59 -8.72 58.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.655 -0.653 . . . . 0.58999999999999997 109.629 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 21.6 p -144.81 150.32 46.03 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 120.894 -1.129 . . . . 0.87 108.534 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -75.94 21.26 0.51 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 120.718 0.945 . . . . 0.38 112.518 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.38 123.05 28.75 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.786 -1.197 . . . . 0.17999999999999999 111.566 -177.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 4.1 mt -149.78 127.6 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 107.041 -1.466 . . . . 3.9900000000000002 107.041 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -113.67 -15.15 12.53 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 113.684 0.994 . . . . 5.1699999999999999 113.684 -177.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 8.2 t -157.63 160.96 38.6 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 119.132 -2.23 . . . . 0.02 110.445 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.439 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 16.4 p90 -151.66 152.73 33.21 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.085 -1.01 . . . . 2.02 110.499 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 43.4 mtp180 -144.76 149.93 36.36 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.882 0.849 . . . . 0.01 110.189 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -88.08 144.32 26.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.59 -0.694 . . . . 0.01 109.154 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.436 HD12 ' CB ' ' A' ' 135' ' ' THR . 4.6 mt -94.32 128.86 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.274 -0.891 . . . . 3.04 109.128 178.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.8 p -136.2 146.24 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.124 -0.985 . . . . 1.8899999999999999 109.499 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 N--CA 1.488 1.448 0 O-C-N 121.151 -0.968 . . . . 4.8899999999999997 109.465 -179.978 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.9 m . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.473 -0.565 . . . . 5.2800000000000002 109.473 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -71.76 64.94 0.49 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.215 -0.928 . . . . 5.96 109.387 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 44.6 p -81.11 143.35 32.48 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.391 -0.966 . . . . 2.2200000000000002 108.391 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.58 179.73 47.89 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 118.322 -1.894 . . . . 0.81000000000000005 112.026 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.92 157.63 43.63 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.412 -1.475 . . . . 0.01 109.412 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -145.9 134.74 22.44 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.312 -1.111 . . . . 0.02 110.531 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.1 tt -129.46 139.57 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.053 -1.092 . . . . 0.02 108.053 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.507 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.0 OUTLIER -121.89 130.54 53.44 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.437 -0.789 . . . . 0.39000000000000001 110.119 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.1 m-85 -110.18 139.98 44.77 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 109.114 -0.699 . . . . 0.02 109.114 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.525 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.8 m-85 -121.9 138.47 54.39 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.302 -0.874 . . . . 0.02 109.325 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -69.32 -27.32 65.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.16 -0.962 . . . . 0.029999999999999999 111.508 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 2.1 m-20 -114.11 169.4 9.04 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.921 -1.112 . . . . 0.029999999999999999 110.217 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -75.96 158.71 31.66 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.612 0.72 . . . . 0.029999999999999999 110.258 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.9 t30 66.06 33.25 7.72 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 122.018 0.913 . . . . 0.73999999999999999 111.123 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 55.68 42.29 29.52 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 116.007 -0.542 . . . . 0.02 111.471 177.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -113.81 166.18 11.82 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.395 -0.965 . . . . 0.02 108.395 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.87 -167.61 34.97 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 119.923 -1.132 . . . . 0.029999999999999999 110.75 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.587 ' CG ' HH11 ' A' ' 18' ' ' ARG . 0.4 OUTLIER -69.42 143.0 53.74 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.48 -1.012 . . . . 2.7599999999999998 109.091 179.445 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.504 ' HE ' ' CB ' ' A' ' 8' ' ' SER . 52.5 ttt180 -121.58 148.94 43.86 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.582 -0.699 . . . . 1.8899999999999999 110.105 -178.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.603 ' CZ ' ' CG ' ' A' ' 32' ' ' TYR . 7.2 t80 -135.1 130.75 36.0 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.781 -0.822 . . . . 0.02 108.781 178.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 18.7 p-10 -111.94 137.78 49.46 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.468 -0.77 . . . . 1.1200000000000001 109.411 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 45.9 t -130.38 139.81 50.62 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.596 -0.69 . . . . 0.02 109.6 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.5 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 10.8 p30 -117.78 11.93 13.73 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.723 -0.611 . . . . 0.20000000000000001 110.225 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 34.6 m -158.63 174.77 14.54 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.887 -1.133 . . . . 1.23 108.644 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -61.96 145.17 53.76 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.694 -1.254 . . . . 0.02 110.033 -179.731 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.435 ' CB ' ' CZ ' ' A' ' 29' ' ' PHE . 0.8 OUTLIER -133.68 119.08 18.9 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 108.725 -0.842 . . . . 0.02 108.725 178.449 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.44 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -77.11 -19.39 57.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.23999999999999999 111.745 -177.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -154.13 107.94 2.97 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.559 -1.338 . . . . 1.1399999999999999 110.862 -178.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.435 ' CZ ' ' CB ' ' A' ' 26' ' ' CYS . 17.1 m-85 -96.53 5.72 50.2 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.206 -0.934 . . . . 6.3700000000000001 109.303 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -60.25 -30.67 69.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.364 -0.835 . . . . 3.1099999999999999 112.206 -176.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.6 m -78.82 -18.96 53.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.308 -1.495 . . . . 0.88 111.29 -178.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.603 ' CG ' ' CZ ' ' A' ' 20' ' ' TYR . 56.6 m-85 -106.68 -22.17 12.82 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.345 -0.847 . . . . 0.02 110.905 -178.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.442 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 5.1 tp -149.24 127.2 11.9 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.83 -1.169 . . . . 3.3199999999999998 109.609 -178.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.0 t -86.21 -11.31 52.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.64 -0.662 . . . . 0.02 110.95 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.442 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 13.2 ptm180 -172.96 162.69 4.72 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.914 -1.117 . . . . 0.02 108.404 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.0 t -142.23 115.02 8.63 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.968 -1.083 . . . . 0.02 108.663 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 16.1 t-20 -107.5 -0.71 21.98 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.864 -1.147 . . . . 0.029999999999999999 110.866 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.5 t -156.08 152.67 28.29 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.902 -1.147 . . . . 0.02 107.902 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 87.6 mt -145.67 148.12 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 CA-C-O 122.435 1.112 . . . . 0.02 110.313 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -123.86 124.08 41.86 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.82 -1.178 . . . . 0.02 107.82 176.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.7 t -106.47 115.25 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 106.859 -1.534 . . . . 0.02 106.859 177.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -83.49 -33.74 25.51 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.021 -0.672 . . . . 3.8100000000000001 110.738 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.48 152.17 22.05 Favored Glycine 0 N--CA 1.489 2.175 0 C-N-CA 118.922 -1.608 . . . . 0.02 110.891 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.97 173.22 49.63 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.709 -1.234 . . . . 0.01 110.632 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.6 m -120.15 135.76 54.85 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.099 -1.075 . . . . 1.48 108.099 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.417 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 37.8 m95 -128.01 155.74 43.82 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 122.7 1.238 . . . . 0.02 112.17 -176.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.75 134.5 51.38 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 105.57 -2.011 . . . . 0.23999999999999999 105.57 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.441 ' HB ' HD22 ' A' ' 79' ' ' LEU . 31.4 m -119.92 144.76 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.579 -0.701 . . . . 0.65000000000000002 109.3 179.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -121.45 145.7 47.66 Favored 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 122.313 1.054 . . . . 0.02 110.263 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -66.87 -34.09 77.03 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.836 -0.62 . . . . 0.02 111.496 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -124.93 157.97 64.64 Favored Pre-proline 0 N--CA 1.503 2.185 0 O-C-N 121.028 -1.045 . . . . 0.02 109.36 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.35 165.31 1.55 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.716 1.611 . . . . 0.02 113.176 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 63.84 36.95 10.02 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.159 -0.928 . . . . 0.02 111.055 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 45.08 51.84 8.71 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.686 0.755 . . . . 3.3900000000000001 110.78 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.5 t -125.92 163.61 22.59 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 121.145 0.498 . . . . 2.3300000000000001 109.811 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.83 -161.46 32.04 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.797 -1.321 . . . . 0.02 109.797 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.425 ' ND1' ' N ' ' A' ' 57' ' ' HIS . 4.7 m80 -64.63 139.77 58.8 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.075 -1.25 . . . . 0.02 110.289 -179.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.497 ' O ' ' SD ' ' A' ' 58' ' ' MET . 2.9 ppp? -119.97 136.95 54.34 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.648 -0.657 . . . . 5.0099999999999998 109.594 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.567 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 88.2 m-85 -134.81 138.85 44.62 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.353 -0.842 . . . . 0.02 109.948 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.5 mm -95.25 131.36 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.034 -0.728 . . . . 1.72 109.034 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.48 HD22 ' CE1' ' A' ' 66' ' ' TYR . 11.4 mt -120.26 111.06 35.47 Favored Pre-proline 0 N--CA 1.506 2.361 0 O-C-N 121.371 -0.831 . . . . 0.02 110.763 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -77.32 169.42 21.3 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 CA-C-N 119.836 0.977 . . . . 1.47 109.769 177.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -52.59 140.94 21.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.821 -1.174 . . . . 4.25 110.307 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.75 -177.52 32.82 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.454 -1.355 . . . . 0.02 110.597 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -120.48 131.75 54.88 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.535 -0.98 . . . . 0.95999999999999996 109.692 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.48 ' CE1' HD22 ' A' ' 61' ' ' LEU . 91.0 m-85 -121.54 99.13 45.51 Favored Pre-proline 0 N--CA 1.495 1.783 0 N-CA-C 107.882 -1.155 . . . . 0.02 107.882 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -70.86 -3.71 13.29 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 120.628 0.885 . . . . 0.02 113.642 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -157.6 154.9 29.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.71 -1.243 . . . . 2.02 108.029 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -60.2 -39.0 85.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.474 -0.767 . . . . 0.02 111.881 -177.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -59.79 -24.0 63.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.094 -1.004 . . . . 0.02 110.386 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -70.59 -18.83 62.89 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.901 0.858 . . . . 3.4199999999999999 108.802 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.567 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.4 t90 -107.92 9.9 28.6 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.477 -1.305 . . . . 0.02 107.477 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.5 mtp 61.27 22.47 12.82 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.495 0.664 . . . . 0.02 110.536 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.53 144.08 46.06 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.492 -1.443 . . . . 0.02 109.492 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.7 tp -79.05 -30.92 44.33 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.552 -1.277 . . . . 0.97999999999999998 107.552 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -157.05 -171.39 3.62 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 106.241 -1.763 . . . . 0.02 106.241 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -98.22 28.33 4.12 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.647 -1.283 . . . . 0.02 110.609 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.7 mtm180 -96.84 122.15 39.49 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.95 -1.094 . . . . 3.2000000000000002 110.985 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.513 HD21 ' CH2' ' A' ' 72' ' ' TRP . 63.5 mt -142.82 120.5 11.84 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.672 -1.232 . . . . 2.6099999999999999 107.672 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.68 -18.32 9.07 Favored Glycine 0 N--CA 1.502 3.05 0 O-C-N 121.215 -0.928 . . . . 0.02 112.871 -177.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 12.6 m -156.96 157.71 35.27 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 119.956 1.878 . . . . 0.02 110.864 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 27.0 m -146.49 149.84 34.42 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.627 -0.671 . . . . 0.02 109.943 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -138.51 143.17 39.42 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.395 -0.815 . . . . 0.01 109.183 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.3 132.18 36.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -0.94 . . . . 0.42999999999999999 109.725 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.8 t -90.61 124.83 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.726 -0.842 . . . . 1.25 108.726 178.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -93.35 132.17 37.83 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.797 -1.189 . . . . 1.77 109.017 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mt -96.8 139.29 33.07 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.453 -0.943 . . . . 1.6299999999999999 108.453 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.5 p -111.35 127.5 55.67 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.355 -0.84 . . . . 1.0800000000000001 109.17 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 51.8 p -104.12 -154.53 0.51 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 106.448 -1.686 . . . . 1.26 106.448 177.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.39 -51.63 0.78 Allowed Glycine 0 N--CA 1.502 3.05 0 O-C-N 120.558 -1.339 . . . . 0.01 112.636 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.26 -100.92 0.15 Allowed Glycine 0 N--CA 1.489 2.193 0 C-N-CA 118.464 -1.827 . . . . 0.01 111.932 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -121.4 118.79 30.31 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.034 -1.274 . . . . 4.4299999999999997 110.543 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.41 131.08 36.79 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.819 -0.753 . . . . 2.9900000000000002 109.399 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -129.81 140.56 51.0 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.472 -0.767 . . . . 6.3600000000000003 109.203 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 tt -127.4 144.12 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.407 -0.808 . . . . 1.0900000000000001 109.864 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -122.29 133.05 54.69 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.692 -1.225 . . . . 2.0499999999999998 107.692 176.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.502 HG12 ' SG ' ' A' ' 129' ' ' CYS . 15.8 m -123.67 145.86 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 O-C-N 120.662 -1.274 . . . . 1.1000000000000001 109.682 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -119.13 141.31 48.92 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 121.97 0.891 . . . . 0.72999999999999998 110.843 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -67.03 -30.41 70.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.888 -0.507 . . . . 0.02 111.775 -178.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -116.12 167.39 11.03 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.046 -1.033 . . . . 3.1800000000000002 110.533 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.06 164.43 43.79 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.981 -0.848 . . . . 0.01 110.981 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.423 ' O ' ' ND2' ' A' ' 104' ' ' ASN . 3.0 m-20 56.95 38.8 29.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.909 -0.759 . . . . 0.01 110.884 179.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 52.14 56.02 8.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.637 -0.665 . . . . 0.01 111.047 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.423 ' ND2' ' O ' ' A' ' 102' ' ' ASP . 24.5 m-80 -129.19 165.81 20.6 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 108.208 -1.034 . . . . 3.1499999999999999 108.208 178.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.99 -163.92 27.11 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.247 -1.541 . . . . 0.01 109.247 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.619 ' NE2' ' CE2' ' A' ' 108' ' ' TYR . 0.6 OUTLIER -76.0 144.39 40.94 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.043 -1.269 . . . . 0.01 108.348 179.116 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.545 ' C ' HE22 ' A' ' 106' ' ' GLN . 12.8 tmm? -116.57 141.81 47.7 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.635 0.731 . . . . 0.01 109.959 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.619 ' CE2' ' NE2' ' A' ' 106' ' ' GLN . 39.4 m-85 -131.2 136.45 48.27 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.176 -1.046 . . . . 2.48 108.176 178.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.522 ' OE2' ' N ' ' A' ' 110' ' ' THR . 1.9 tm-20 -119.47 134.73 55.08 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.544 -0.723 . . . . 0.01 109.961 -178.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.522 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 7.8 t -148.69 151.81 35.58 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 122.233 1.016 . . . . 1.6899999999999999 111.065 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.7 p -111.83 9.49 20.72 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.645 -0.707 . . . . 0.01 110.377 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -121.43 163.27 19.02 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.122 -0.986 . . . . 3.21 111.719 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -68.12 157.09 36.08 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.344 -0.984 . . . . 0.01 108.344 178.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 20.7 t -126.59 114.15 22.87 Favored Pre-proline 0 N--CA 1.504 2.231 0 O-C-N 121.48 -0.763 . . . . 0.01 109.088 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -75.12 -29.42 8.06 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 CA-C-N 120.319 1.15 . . . . 0.01 111.213 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 69.4 m -142.61 109.1 5.33 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.485 -0.759 . . . . 0.02 109.055 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.408 HD12 ' O ' ' A' ' 169' ' ' ILE . 97.4 mt -63.9 -38.96 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.801 -0.562 . . . . 1.8300000000000001 110.667 -178.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 41.9 ttp -68.58 -37.29 79.73 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.272 -0.971 . . . . 1.3400000000000001 110.247 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -69.93 -38.64 76.26 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.502 -1.374 . . . . 2.1099999999999999 110.026 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -79.93 -46.89 15.93 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.289 -0.882 . . . . 2.0800000000000001 112.379 -176.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -110.67 -0.01 17.32 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.434 -0.792 . . . . 0.02 112.657 -176.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.1 m80 59.69 33.13 21.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.73 -1.231 . . . . 0.02 109.489 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.5 mt -112.78 135.94 52.95 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 108.728 -0.841 . . . . 0.02 108.728 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -91.6 -22.71 20.16 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.266 -0.896 . . . . 5.3200000000000003 110.415 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -149.59 164.33 35.43 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.089 -1.007 . . . . 0.02 109.867 -178.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 37.3 mt -131.92 128.86 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 107.642 -1.244 . . . . 2.1699999999999999 107.642 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -108.76 -12.3 14.94 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.342 -0.849 . . . . 0.02 112.462 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.5 t -159.03 151.75 21.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.736 -1.228 . . . . 0.01 109.019 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.502 ' SG ' HG12 ' A' ' 97' ' ' VAL . 7.6 t -168.74 147.25 4.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 1.22 109.114 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -121.9 111.48 17.14 Favored 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 122.415 1.103 . . . . 1.4099999999999999 109.711 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.1 t -113.33 130.7 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.678 -1.23 . . . . 0.01 107.678 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 44.1 t -129.89 93.37 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 107.176 -1.416 . . . . 1.98 107.176 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.507 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 26.0 tt0 -147.02 -75.21 0.2 Allowed 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 105.799 -1.926 . . . . 0.01 105.799 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 177.44 -78.19 0.07 OUTLIER Glycine 0 N--CA 1.483 1.791 0 N-CA-C 108.104 -1.998 . . . . 0.01 108.104 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.574 ' OG1' HD12 ' A' ' 175' ' ' ILE . 1.2 t -121.82 125.3 46.17 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.649 -0.912 . . . . 2.2999999999999998 110.183 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.507 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 7.5 m95 -126.47 151.98 47.04 Favored 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 107.07 -1.456 . . . . 0.01 107.07 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 48.2 mt -120.61 135.37 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 120.329 -1.482 . . . . 1.6899999999999999 110.297 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -114.73 144.56 43.27 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 107.465 -1.309 . . . . 2.4900000000000002 107.465 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.503 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 15.2 m-85 -123.25 143.68 49.89 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.33 -0.856 . . . . 0.02 109.631 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -76.15 -29.23 57.7 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.54 -0.725 . . . . 0.02 112.389 -176.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.4 mt -115.43 154.78 47.67 Favored Pre-proline 0 N--CA 1.507 2.408 0 O-C-N 120.654 -1.279 . . . . 1.48 109.081 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.34 164.71 2.66 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 121.191 1.261 . . . . 0.02 112.79 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 51.9 t30 59.94 32.0 20.95 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.077 -0.965 . . . . 0.75 111.59 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 57.24 51.48 10.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.482 -0.762 . . . . 0.02 111.315 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -126.05 164.86 19.93 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.487 -0.758 . . . . 0.02 109.864 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.19 -165.92 33.15 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.346 -1.102 . . . . 0.02 110.346 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -69.57 143.31 53.38 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.563 -0.963 . . . . 0.02 109.207 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -115.16 149.67 37.28 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.206 0.526 . . . . 0.02 109.788 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -124.38 135.11 53.06 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 109.17 -0.678 . . . . 0.01 109.17 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.7 tp -96.7 119.93 36.09 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.608 -1.308 . . . . 0.01 109.264 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.694 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 59.1 tp -98.92 153.44 18.82 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.347 -0.846 . . . . 0.01 109.159 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.411 ' CG ' ' N ' ' A' ' 153' ' ' LYS . 21.2 t70 -104.41 -113.3 0.24 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.496 -0.752 . . . . 2.27 109.336 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.411 ' N ' ' CG ' ' A' ' 152' ' ' ASP . 17.6 pttm -163.04 50.59 0.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.081 -1.012 . . . . 1.8400000000000001 109.855 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -113.01 -155.71 0.57 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.466 -0.771 . . . . 2.2799999999999998 109.225 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -106.28 103.86 13.42 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.807 -0.812 . . . . 0.01 108.807 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.694 ' CZ ' HD11 ' A' ' 151' ' ' LEU . 17.4 m-85 -98.36 112.31 24.36 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.263 -0.898 . . . . 0.01 109.739 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 22.5 mtm180 -95.27 -22.87 17.51 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.232 -0.918 . . . . 0.01 111.685 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -127.3 154.41 77.06 Favored Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 120.878 -1.139 . . . . 2.54 108.764 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -59.52 -37.92 86.03 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 CA-C-N 119.235 0.763 . . . . 0.69999999999999996 110.637 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.9 t -60.99 -20.05 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.869 -1.145 . . . . 0.85999999999999999 109.2 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -65.43 -15.59 62.77 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.983 -1.073 . . . . 0.02 109.98 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.635 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 9.5 m0 -97.8 11.43 37.27 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.124 -0.985 . . . . 0.02 108.997 178.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.59 10.6 85.04 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.89 -1.148 . . . . 0.02 111.04 178.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.38 140.84 32.97 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.111 -1.229 . . . . 0.02 110.126 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.32 -9.09 58.08 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.59 -0.694 . . . . 0.58999999999999997 109.989 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.8 m -143.6 150.83 52.15 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.039 -1.038 . . . . 0.87 109.032 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -75.98 17.95 0.68 Allowed 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 120.721 0.947 . . . . 0.38 112.405 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.04 123.59 29.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.916 -1.115 . . . . 0.17999999999999999 111.56 -177.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.408 ' O ' HD12 ' A' ' 117' ' ' ILE . 2.0 mt -149.46 126.92 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.071 -1.455 . . . . 3.9900000000000002 107.071 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 24.1 mm100 -111.38 -18.26 12.93 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.165 -0.959 . . . . 5.1699999999999999 113.248 -177.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.8 m -156.73 160.22 39.08 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 119.216 -2.177 . . . . 0.02 110.4 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.433 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 18.3 p90 -151.72 153.05 33.59 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.101 -0.999 . . . . 2.02 110.321 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.3 mtm180 -145.79 150.53 36.37 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.358 -0.839 . . . . 0.01 110.145 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -87.83 144.04 26.81 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.233 -0.655 . . . . 0.01 109.233 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.574 HD12 ' OG1' ' A' ' 135' ' ' THR . 4.4 mt -94.79 129.25 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.308 -0.87 . . . . 3.04 108.967 179.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.49 146.71 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.153 -0.967 . . . . 1.8899999999999999 109.649 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.33 -0.856 . . . . 4.8899999999999997 109.466 179.954 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.333 0.587 . . . . 5.2800000000000002 109.489 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -75.86 65.65 1.99 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.211 -0.93 . . . . 5.96 109.429 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 30.5 p -81.14 142.69 33.01 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.426 -0.953 . . . . 2.2200000000000002 108.426 178.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.04 -179.79 47.79 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 118.343 -1.884 . . . . 0.81000000000000005 112.071 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.71 157.65 44.06 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.273 -1.531 . . . . 0.01 109.273 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -147.45 136.28 22.07 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.099 -1.236 . . . . 0.02 110.52 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.4 tt -130.12 138.91 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.698 -0.853 . . . . 0.02 108.698 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 m -120.91 130.24 53.81 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.559 -0.713 . . . . 0.39000000000000001 110.014 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.9 m-85 -110.4 139.68 45.37 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.581 -0.699 . . . . 0.02 109.247 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.525 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 6.6 m-85 -121.31 138.32 54.3 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.427 -0.796 . . . . 0.02 109.32 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.523 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 83.3 mt-10 -69.38 -27.43 65.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.041 -1.037 . . . . 0.029999999999999999 111.475 -178.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 2.3 m-20 -114.05 169.35 9.08 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.888 -1.133 . . . . 0.029999999999999999 110.097 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -76.03 158.66 31.63 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.567 0.699 . . . . 0.029999999999999999 110.229 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 66.53 33.17 6.82 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 122.012 0.911 . . . . 0.73999999999999999 111.185 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 55.32 41.72 30.93 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.374 0.607 . . . . 0.02 111.373 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -113.64 165.81 12.15 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.25 -1.019 . . . . 0.02 108.25 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.44 -167.46 35.56 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.765 -1.207 . . . . 0.029999999999999999 110.766 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.574 ' CG ' HH11 ' A' ' 18' ' ' ARG . 0.3 OUTLIER -68.84 141.69 55.04 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.535 -0.979 . . . . 2.7599999999999998 109.37 179.383 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -122.77 150.19 43.12 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.6 0.714 . . . . 1.8899999999999999 110.124 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.412 ' CB ' HD11 ' A' ' 33' ' ' LEU . 32.0 t80 -135.87 131.74 35.68 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 109.113 -0.699 . . . . 0.02 109.113 178.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -109.53 136.47 48.87 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.83 -0.804 . . . . 1.1200000000000001 108.83 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 49.6 t -128.63 138.15 52.04 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.617 -0.677 . . . . 0.02 109.619 -179.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -118.14 12.17 13.48 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.673 -0.642 . . . . 0.20000000000000001 110.144 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.495 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 14.6 t -159.46 174.2 15.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.822 -1.174 . . . . 1.23 108.918 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -61.55 144.35 54.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.849 -1.157 . . . . 0.02 110.376 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.6 m -134.16 117.92 17.08 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.733 -0.839 . . . . 0.02 108.733 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.38 -19.81 52.57 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.524 -0.735 . . . . 0.23999999999999999 112.55 -177.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 19.2 p30 -152.95 108.75 3.31 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.703 -1.248 . . . . 1.1399999999999999 110.831 -178.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -97.68 5.29 49.52 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.428 -0.795 . . . . 6.3700000000000001 109.771 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.2 mtm180 -60.33 -30.35 69.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.481 -0.762 . . . . 3.1099999999999999 112.307 -176.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.435 ' OG ' ' CE2' ' A' ' 32' ' ' TYR . 30.3 p -79.35 -18.77 51.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.258 -1.526 . . . . 0.88 111.631 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.435 ' CE2' ' OG ' ' A' ' 31' ' ' SER . 51.1 m-85 -106.57 -22.04 12.88 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.291 -0.881 . . . . 0.02 110.98 -178.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.412 HD11 ' CB ' ' A' ' 20' ' ' TYR . 58.0 mt -148.89 128.15 12.92 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.948 -1.095 . . . . 3.3199999999999998 109.216 -178.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.9 t -86.76 -11.13 51.94 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.766 -0.584 . . . . 0.02 110.439 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.0 ttp180 -171.5 160.92 6.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.016 -1.053 . . . . 0.02 108.187 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 82.0 m -144.19 116.49 8.5 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.907 -1.121 . . . . 0.02 109.011 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 11' ' ' GLU . 1.3 m-80 -109.93 0.87 18.78 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 120.836 -1.165 . . . . 0.029999999999999999 111.857 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.2 m -156.01 153.22 29.16 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.11 -1.07 . . . . 0.02 108.11 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.5 mt -146.9 148.04 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 CA-C-O 122.207 1.004 . . . . 0.02 110.753 -178.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -123.59 124.85 43.72 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.136 -1.061 . . . . 0.02 108.136 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.2 t -106.69 113.92 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 106.805 -1.554 . . . . 0.02 106.805 177.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -84.16 -34.07 24.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.691 -0.631 . . . . 3.8100000000000001 110.475 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.82 150.25 19.0 Favored Glycine 0 N--CA 1.486 2.004 0 C-N-CA 118.885 -1.626 . . . . 0.02 110.601 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.0 172.44 49.19 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.758 -1.211 . . . . 0.01 110.235 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.9 m -120.04 135.75 54.82 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.098 -1.075 . . . . 1.48 108.098 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.422 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 36.9 m95 -128.35 156.2 43.48 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 122.698 1.237 . . . . 0.02 112.468 -176.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.96 135.02 50.83 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 105.412 -2.07 . . . . 0.23999999999999999 105.412 176.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.409 ' HB ' HD22 ' A' ' 79' ' ' LEU . 34.6 m -116.21 141.81 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.597 -0.689 . . . . 0.65000000000000002 109.286 179.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -120.72 143.01 48.99 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.987 0.899 . . . . 0.02 109.643 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.46 -33.69 76.52 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.627 -0.715 . . . . 0.02 111.832 -177.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -124.71 157.82 64.5 Favored Pre-proline 0 N--CA 1.504 2.227 0 O-C-N 120.991 -1.068 . . . . 0.02 109.357 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.21 166.7 0.96 Allowed 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 121.724 1.616 . . . . 0.02 112.827 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.5 m120 63.42 36.74 11.2 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.262 -0.881 . . . . 0.02 111.163 178.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.449 ' CD1' ' CD ' ' A' ' 83' ' ' ARG . 3.8 m-85 45.09 51.39 8.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.584 -0.698 . . . . 3.3900000000000001 110.767 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.7 t -125.65 163.49 22.67 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.241 0.543 . . . . 2.3300000000000001 109.883 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.53 -161.72 31.31 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.779 -1.328 . . . . 0.02 109.779 -179.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 12.4 m80 -64.61 138.13 58.22 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.983 -1.304 . . . . 0.02 110.209 -178.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 16.0 ptm -118.79 136.7 53.85 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.721 -0.612 . . . . 5.0099999999999998 109.672 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.515 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 86.6 m-85 -134.33 139.59 45.77 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.483 -0.761 . . . . 0.02 109.647 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.9 mm -95.0 131.03 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.983 -0.747 . . . . 1.72 108.983 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.551 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -120.59 111.32 34.79 Favored Pre-proline 0 N--CA 1.505 2.28 0 O-C-N 121.319 -0.863 . . . . 0.02 110.767 -178.347 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -77.55 169.02 21.72 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 CA-C-N 119.958 1.021 . . . . 1.47 110.135 177.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -53.04 141.43 22.57 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.831 -1.168 . . . . 4.25 110.417 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.78 -177.2 32.2 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 119.403 -1.379 . . . . 0.02 110.743 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -120.72 131.79 54.72 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.334 -1.098 . . . . 0.95999999999999996 109.8 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.551 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 63.2 m-85 -122.52 95.77 46.46 Favored Pre-proline 0 N--CA 1.496 1.846 0 N-CA-C 107.903 -1.147 . . . . 0.02 107.903 179.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.401 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.9 Cg_endo -66.91 -3.5 9.66 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 120.787 0.992 . . . . 0.02 113.865 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.401 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 79.1 mt-10 -157.47 155.17 29.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.617 -1.302 . . . . 2.02 108.142 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -60.47 -39.26 86.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.623 -0.673 . . . . 0.02 111.974 -177.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -60.02 -23.91 64.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.031 -1.043 . . . . 0.02 110.395 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -69.73 -18.67 63.54 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.809 0.814 . . . . 3.4199999999999999 108.907 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.57 ' CH2' HD21 ' A' ' 79' ' ' LEU . 1.1 t90 -107.84 11.06 28.45 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.515 -1.291 . . . . 0.02 107.515 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 17.9 mtt 61.09 22.49 12.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.446 -0.784 . . . . 0.02 110.439 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.98 144.03 46.86 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.391 -1.484 . . . . 0.02 109.391 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.4 mt -78.87 -30.49 45.09 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.684 -1.228 . . . . 0.97999999999999998 107.684 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.672 ' N ' HD22 ' A' ' 76' ' ' ASN . 0.0 OUTLIER -157.0 -171.31 3.6 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 106.386 -1.709 . . . . 0.02 106.386 178.299 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.409 ' OD2' ' OD1' ' A' ' 37' ' ' ASN . 63.6 m-20 -98.2 28.21 4.18 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.722 -1.236 . . . . 0.02 110.698 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -96.55 122.33 39.35 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.856 -1.153 . . . . 3.2000000000000002 110.898 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.57 HD21 ' CH2' ' A' ' 72' ' ' TRP . 68.4 mt -142.17 119.56 11.59 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 107.636 -1.246 . . . . 2.6099999999999999 107.636 178.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.86 -17.92 9.29 Favored Glycine 0 N--CA 1.5 2.907 0 O-C-N 121.293 -0.879 . . . . 0.02 112.738 -177.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.44 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 26.4 t -156.16 156.59 34.48 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 120.239 2.02 . . . . 0.02 111.033 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.7 m -145.89 148.07 32.45 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.621 -0.674 . . . . 0.02 110.395 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.449 ' CD ' ' CD1' ' A' ' 54' ' ' PHE . 19.4 mtp180 -138.21 143.22 40.07 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.559 -0.713 . . . . 0.01 109.186 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.22 131.69 36.27 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.192 -0.942 . . . . 0.42999999999999999 109.635 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.5 t -91.2 125.07 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.906 -0.775 . . . . 1.25 108.906 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -93.91 131.21 39.56 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.808 -1.182 . . . . 1.77 108.974 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 mt -96.05 140.01 31.4 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.389 -0.967 . . . . 1.6299999999999999 108.389 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.2 m -111.83 127.52 55.84 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.347 -0.846 . . . . 1.0800000000000001 109.318 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.3 m -104.09 -154.04 0.49 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 106.62 -1.622 . . . . 1.26 106.62 177.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.95 -52.6 0.74 Allowed Glycine 0 N--CA 1.501 2.981 0 O-C-N 120.396 -1.44 . . . . 0.01 112.82 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.92 -101.28 0.15 Allowed Glycine 0 N--CA 1.49 2.253 0 C-N-CA 118.491 -1.814 . . . . 0.01 112.042 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 38.8 tp60 -121.48 118.99 30.73 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.172 -1.193 . . . . 4.4299999999999997 110.683 -178.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.59 130.54 35.47 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.769 -0.772 . . . . 2.9900000000000002 109.424 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -129.53 142.01 50.86 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.353 -0.842 . . . . 6.3600000000000003 109.062 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.0 tt -128.28 144.77 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 O-C-N 121.322 -0.862 . . . . 1.0900000000000001 110.245 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -123.15 133.83 54.23 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.838 -1.171 . . . . 2.0499999999999998 107.838 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.485 HG12 ' SG ' ' A' ' 129' ' ' CYS . 27.2 m -124.24 146.25 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 O-C-N 120.625 -1.297 . . . . 1.1000000000000001 109.882 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -119.31 141.32 49.09 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.844 0.831 . . . . 0.72999999999999998 110.848 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -66.99 -30.26 70.33 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 116.126 -0.488 . . . . 0.02 111.581 -178.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -116.31 169.69 9.11 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.138 -0.976 . . . . 3.1800000000000002 110.44 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.4 165.25 52.01 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.827 -0.909 . . . . 0.01 110.827 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.435 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 0.9 OUTLIER 57.27 38.23 28.55 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.925 -0.75 . . . . 0.01 111.57 178.659 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 51.97 54.68 10.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.467 -0.771 . . . . 0.01 111.228 177.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' A' ' 105' ' ' GLY . 19.6 t-20 -129.71 166.01 20.69 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.92 -1.141 . . . . 3.1499999999999999 107.92 178.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.512 ' N ' ' OD1' ' A' ' 104' ' ' ASN . . . 91.1 -163.37 29.14 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.19 -1.564 . . . . 0.01 109.19 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.7 tp60 -76.68 143.65 39.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.968 -1.313 . . . . 0.01 108.974 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.447 ' C ' ' SD ' ' A' ' 107' ' ' MET . 12.6 tmm? -116.47 142.23 47.13 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.553 0.692 . . . . 0.01 109.985 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -131.46 136.8 48.25 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.326 -0.99 . . . . 2.48 108.326 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -118.83 134.47 55.13 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.495 -0.753 . . . . 0.01 110.007 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.4 t -148.89 149.57 31.48 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.255 1.026 . . . . 1.6899999999999999 110.951 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 20.2 p -110.97 9.76 22.21 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 115.53 -0.759 . . . . 0.01 110.314 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -120.9 163.24 18.52 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.203 -0.936 . . . . 3.21 111.514 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -68.08 156.57 37.15 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.212 -1.033 . . . . 0.01 108.212 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 19.8 t -126.72 114.04 22.58 Favored Pre-proline 0 N--CA 1.5 2.053 0 O-C-N 121.484 -0.76 . . . . 0.01 109.029 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -75.1 -29.43 8.07 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 CA-C-N 120.376 1.17 . . . . 0.01 111.116 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 69.6 m -142.12 109.37 5.57 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.383 -0.823 . . . . 0.02 109.324 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.58 -39.38 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.777 -0.577 . . . . 1.8300000000000001 110.567 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 22.6 ttt -68.82 -37.57 79.29 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.398 -0.921 . . . . 1.3400000000000001 110.358 -178.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -69.58 -38.67 77.47 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.434 -1.416 . . . . 2.1099999999999999 109.986 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -79.94 -46.93 15.83 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.291 -0.881 . . . . 2.0800000000000001 112.297 -177.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -111.34 0.06 16.53 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.391 -0.818 . . . . 0.02 112.663 -176.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.3 m80 60.27 33.48 20.92 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.789 -1.194 . . . . 0.02 109.618 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.1 mt -112.51 135.02 53.72 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 108.743 -0.836 . . . . 0.02 108.743 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -91.59 -22.79 20.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 5.3200000000000003 110.27 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -149.05 163.79 36.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.198 -0.939 . . . . 0.02 109.702 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.0 mt -131.63 129.06 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 107.831 -1.174 . . . . 2.1699999999999999 107.831 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -108.84 -12.54 14.89 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.368 -0.832 . . . . 0.02 112.231 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.0 t -158.86 150.56 20.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.851 -1.156 . . . . 0.01 109.196 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.485 ' SG ' HG12 ' A' ' 97' ' ' VAL . 6.2 t -167.75 147.04 4.88 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.696 -0.853 . . . . 1.22 108.696 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -122.06 111.64 17.27 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 122.348 1.071 . . . . 1.4099999999999999 109.79 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 t -112.56 130.32 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 107.532 -1.284 . . . . 0.01 107.532 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 48.6 t -129.57 93.6 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 N-CA-C 107.204 -1.406 . . . . 1.98 107.204 177.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.487 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 11.7 tm-20 -147.19 -76.54 0.18 Allowed 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 105.869 -1.9 . . . . 0.01 105.869 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.485 ' N ' ' OE1' ' A' ' 133' ' ' GLU . . . 176.31 -75.63 0.08 OUTLIER Glycine 0 N--CA 1.485 1.905 0 N-CA-C 108.308 -1.917 . . . . 0.01 108.308 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.679 ' OG1' HD12 ' A' ' 175' ' ' ILE . 0.5 OUTLIER -120.29 121.04 37.78 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.686 -0.891 . . . . 2.2999999999999998 110.235 179.469 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.487 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 6.8 m95 -126.99 151.17 48.92 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 106.87 -1.53 . . . . 0.01 106.87 179.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 81.1 mt -122.55 137.43 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 120.321 -1.487 . . . . 1.6899999999999999 110.669 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -114.77 144.39 43.57 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 107.268 -1.382 . . . . 2.4900000000000002 107.268 178.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.501 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 14.6 m-85 -122.75 143.76 49.61 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.217 -0.927 . . . . 0.02 109.559 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -74.66 -29.08 61.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.524 -0.735 . . . . 0.02 111.864 -176.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mt -116.18 154.89 48.69 Favored Pre-proline 0 N--CA 1.506 2.346 0 O-C-N 120.757 -1.215 . . . . 1.48 108.92 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -55.69 167.23 2.25 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.19 1.26 . . . . 0.02 112.817 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 59.67 30.67 20.29 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.125 -0.943 . . . . 0.75 111.286 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 57.82 51.44 9.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.59 -0.694 . . . . 0.02 111.152 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -126.21 164.89 19.98 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.457 -0.777 . . . . 0.02 110.106 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.07 -165.82 33.24 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.387 -1.085 . . . . 0.02 110.387 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -69.0 142.45 54.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.544 -0.974 . . . . 0.02 108.903 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -114.2 148.47 37.26 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.414 0.626 . . . . 0.02 110.129 -178.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -125.13 134.75 52.32 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.073 -0.714 . . . . 0.01 109.073 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.52 HD23 ' N ' ' A' ' 151' ' ' LEU . 3.6 tt -99.27 121.67 41.39 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.907 -1.121 . . . . 0.01 109.004 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.574 HD11 ' CE1' ' A' ' 156' ' ' TYR . 21.3 tp -97.27 144.64 26.86 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.245 -0.909 . . . . 0.01 109.247 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.514 ' C ' ' HH ' ' A' ' 156' ' ' TYR . 3.3 m-20 -106.42 -162.07 0.83 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.494 -0.753 . . . . 2.27 109.852 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -99.78 51.31 0.92 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.337 -0.852 . . . . 1.8400000000000001 109.867 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -115.06 -174.93 2.58 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.361 -0.837 . . . . 2.2799999999999998 109.578 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -105.01 110.28 22.62 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.497 -0.927 . . . . 0.01 108.497 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.642 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . 4.5 m-85 -100.72 113.46 26.36 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.385 -0.822 . . . . 0.01 110.523 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -96.48 -22.23 17.24 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.31 -0.869 . . . . 0.01 111.586 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -127.23 153.67 76.9 Favored Pre-proline 0 N--CA 1.505 2.294 0 O-C-N 120.892 -1.13 . . . . 2.54 109.173 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -59.76 -40.38 64.53 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 120.466 0.777 . . . . 0.69999999999999996 110.574 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 41.7 t -61.03 -19.83 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.751 -1.218 . . . . 0.85999999999999999 108.675 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 41.4 t0 -65.54 -15.37 62.63 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.019 -1.05 . . . . 0.02 109.851 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.642 ' HE1' ' CB ' ' A' ' 156' ' ' TYR . 11.1 m0 -97.68 11.01 38.5 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.219 -0.926 . . . . 0.02 108.887 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.67 11.09 85.09 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.817 -1.182 . . . . 0.02 110.939 178.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.1 141.26 33.17 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.188 -1.184 . . . . 0.02 110.15 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.94 -8.64 58.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.592 -0.692 . . . . 0.58999999999999997 110.219 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.1 t -143.62 150.32 50.26 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 120.931 -1.105 . . . . 0.87 109.195 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -75.91 18.52 0.63 Allowed 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 120.708 0.939 . . . . 0.38 112.161 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.62 124.19 29.94 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.952 -1.093 . . . . 0.17999999999999999 111.42 -178.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.9 mt -149.48 126.88 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.052 -1.462 . . . . 3.9900000000000002 107.052 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -112.11 -17.25 12.87 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.05 -1.031 . . . . 5.1699999999999999 113.096 -177.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 17.0 t -157.04 160.13 38.65 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 119.14 -2.225 . . . . 0.02 110.374 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.428 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 18.7 p90 -151.17 152.7 33.7 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.037 -1.039 . . . . 2.02 110.37 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -144.96 149.45 35.21 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.807 0.813 . . . . 0.01 110.225 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -88.62 145.15 25.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.613 -0.679 . . . . 0.01 109.293 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.679 HD12 ' OG1' ' A' ' 135' ' ' THR . 6.2 mt -95.3 129.18 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.319 -0.863 . . . . 3.04 109.359 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.9 p -135.77 146.12 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.222 -0.924 . . . . 1.8899999999999999 109.605 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.311 -0.868 . . . . 4.8899999999999997 109.413 179.965 . . . . . . . . 0 0 . 1 stop_ save_